Citrus Sinensis ID: 007892
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 586 | 2.2.26 [Sep-21-2011] | |||||||
| Q9C821 | 509 | Proline-rich receptor-lik | yes | no | 0.641 | 0.738 | 0.730 | 1e-164 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.651 | 0.585 | 0.717 | 1e-162 | |
| Q9LK03 | 717 | Proline-rich receptor-lik | no | no | 0.807 | 0.659 | 0.583 | 1e-151 | |
| Q8GX23 | 670 | Proline-rich receptor-lik | no | no | 0.904 | 0.791 | 0.540 | 1e-148 | |
| Q9ZNQ8 | 633 | Proline-rich receptor-lik | no | no | 0.784 | 0.726 | 0.573 | 1e-148 | |
| Q1PEM5 | 513 | Proline-rich receptor-lik | no | no | 0.568 | 0.649 | 0.669 | 1e-137 | |
| Q9LS95 | 700 | Putative proline-rich rec | no | no | 0.610 | 0.511 | 0.680 | 1e-132 | |
| Q9XI96 | 699 | Proline-rich receptor-lik | no | no | 0.697 | 0.585 | 0.626 | 1e-132 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.846 | 0.698 | 0.483 | 1e-127 | |
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.754 | 0.613 | 0.485 | 1e-123 |
| >sp|Q9C821|PEK15_ARATH Proline-rich receptor-like protein kinase PERK15 OS=Arabidopsis thaliana GN=PERK15 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 580 bits (1495), Expect = e-164, Method: Compositional matrix adjust.
Identities = 279/382 (73%), Positives = 320/382 (83%), Gaps = 6/382 (1%)
Query: 196 KSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAE 255
++ FTYE+L AT NFS NLLGQGGFGYVH+GVL +G +VAIKQLK+GSGQGEREFQAE
Sbjct: 128 QNLFTYEDLSKATSNFSNTNLLGQGGFGYVHRGVLVDGTLVAIKQLKSGSGQGEREFQAE 187
Query: 256 IEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALG 315
I+ IS+VHHRHLVSL+GYC G+QRLLVYEFVPNKTLEFHLH K+RPVM W RMKIALG
Sbjct: 188 IQTISRVHHRHLVSLLGYCITGAQRLLVYEFVPNKTLEFHLHEKERPVMEWSKRMKIALG 247
Query: 316 SARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF 375
+A+GLAYLHEDC PK IHRD+K+ANIL+DDS+EAK+ADFGLA+ SLDTDTHVSTR+MGTF
Sbjct: 248 AAKGLAYLHEDCNPKTIHRDVKAANILIDDSYEAKLADFGLARSSLDTDTHVSTRIMGTF 307
Query: 376 GYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFA-DDSMVDWAKPFLAQGL 434
GYLAPEYASSGKLTEKSDVFS GV+LLELITG RP DK+ FA DDS+VDWAKP + Q L
Sbjct: 308 GYLAPEYASSGKLTEKSDVFSIGVVLLELITGRRPVDKSQPFADDDSIVDWAKPLMIQAL 367
Query: 435 ADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMPLDDLN 493
DGNFD LVD +LE ++D EMTRM ACAAA +RHSA+RRP+MSQIVRA EGN+ +DDL
Sbjct: 368 NDGNFDGLVDPRLENDFDINEMTRMVACAAASVRHSAKRRPKMSQIVRAFEGNISIDDLT 427
Query: 494 EGITPGHSTIYGSYGGSDYNSMQYREDMKKFRKIALESVELGSSDYSGLTSDYGQNPPSS 553
EG PG STIY G SDY+S QY+ED+KKF+K+A ES GSS+ SGLTSD GQNP S
Sbjct: 428 EGAAPGQSTIYSLDGSSDYSSTQYKEDLKKFKKMAFESKTFGSSECSGLTSDNGQNPSGS 487
Query: 554 S--TEDRQATQETEP--NEKDT 571
S TE ++ TQE EP N KDT
Sbjct: 488 SSITEGQRTTQEIEPEKNTKDT 509
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 572 bits (1475), Expect = e-162, Method: Compositional matrix adjust.
Identities = 277/386 (71%), Positives = 319/386 (82%), Gaps = 4/386 (1%)
Query: 183 FPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLK 242
P SPG+ +G KSTFTYEEL AT+ FSEANLLGQGGFGYVHKG+L +GK VA+KQLK
Sbjct: 252 LPPPSPGLVLGFSKSTFTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLK 311
Query: 243 AGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRP 302
AGSGQGEREFQAE+EIIS+VHHRHLVSL+GYC G QRLLVYEFVPN LEFHLHGK RP
Sbjct: 312 AGSGQGEREFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRP 371
Query: 303 VMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362
M W TR+KIALGSA+GL+YLHEDC PKIIHRDIK++NIL+D FEAKVADFGLAK + D
Sbjct: 372 TMEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASD 431
Query: 363 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSM 422
T+THVSTRVMGTFGYLAPEYA+SGKLTEKSDVFSFGV+LLELITG RP D + + DDS+
Sbjct: 432 TNTHVSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSL 491
Query: 423 VDWAKPFLAQGLADGNFDALVDQKL-EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481
VDWA+P L + +G+F+ L D K+ EYD EM RM ACAAAC+RHSARRRPRMSQIVR
Sbjct: 492 VDWARPLLNRASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVR 551
Query: 482 ALEGNMPLDDLNEGITPGHSTIYGSYGGS-DYNSMQYREDMKKFRKIALESVELGSS-DY 539
ALEGN+ L DLNEG+ PGHS +Y SYGGS DY++ QY +DM KFRK+AL + E G++ +Y
Sbjct: 552 ALEGNVSLSDLNEGMRPGHSNVYSSYGGSTDYDTSQYNDDMIKFRKMALGTQEYGTTGEY 611
Query: 540 SGLTSDYGQNPPSSSTEDRQATQETE 565
S TSDYG P SS+E QAT+E E
Sbjct: 612 SNPTSDYGLYPSGSSSEG-QATREME 636
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 534 bits (1375), Expect = e-151, Method: Compositional matrix adjust.
Identities = 287/492 (58%), Positives = 343/492 (69%), Gaps = 19/492 (3%)
Query: 75 GMVVGVVIGAGIVL--AAVGIFLIFYKRRKRKLAAQNLPLKSIFSNVKNDPFAGKPHHWQ 132
G +VG+ IG G VL A IF + K+R+R A P+ + P+ G+ Q
Sbjct: 226 GAMVGIAIGGGFVLLVALALIFFLCKKKRRRDNEAPPAPIDGV-------PYGGQQ---Q 275
Query: 133 QNVSAPSDYQELPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGMPV 192
QN S SD+ + P + P S + ++ S S P P + +
Sbjct: 276 QNASRRSDHVVMSVPPPKSPSSAPPRPPHFMSSGSSGDYDSNYSDQSVLPPPSPGLALGL 335
Query: 193 GNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREF 252
G ++ TF YEEL AT+ FSEANLLGQGGFGYV KG+L NGK VA+KQLK GS QGEREF
Sbjct: 336 GIYQGTFNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEVAVKQLKEGSSQGEREF 395
Query: 253 QAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKI 312
QAE+ IIS+VHHRHLV+LVGYC +QRLLVYEFVPN TLEFHLHGK RP M W +R+KI
Sbjct: 396 QAEVGIISRVHHRHLVALVGYCIADAQRLLVYEFVPNNTLEFHLHGKGRPTMEWSSRLKI 455
Query: 313 ALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM 372
A+GSA+GL+YLHE+C PKIIHRDIK++NIL+D FEAKVADFGLAK + DT+THVSTRVM
Sbjct: 456 AVGSAKGLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVM 515
Query: 373 GTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQ 432
GTFGYLAPEYASSGKLTEKSDVFSFGV+LLELITG RP D + AD+S+VDWA+P L Q
Sbjct: 516 GTFGYLAPEYASSGKLTEKSDVFSFGVVLLELITGRRPIDVNNVHADNSLVDWARPLLNQ 575
Query: 433 GLADGNFDALVDQKL-EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMPLDD 491
GNF+ +VD+KL EYD EM RM ACAAAC+R +A RRPRM Q+ R LEGN+ D
Sbjct: 576 VSELGNFEVVVDKKLNNEYDKEEMARMVACAAACVRSTAPRRPRMDQVARVLEGNISPSD 635
Query: 492 LNEGITPGHSTIYGSYGGS-DYNSMQYREDMKKFRKIALESVELGSSDYSGLTSDYGQNP 550
LN+GITPGHS +YGS GGS DY+S Q E M KFRK+ LE+ +L YS S+Y P
Sbjct: 636 LNQGITPGHSNVYGSSGGSTDYDSSQDNEGMNKFRKVGLETQDL----YSNPISEYDLYP 691
Query: 551 PSSSTEDRQATQ 562
SST D Q TQ
Sbjct: 692 SWSST-DGQTTQ 702
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GX23|PERK5_ARATH Proline-rich receptor-like protein kinase PERK5 OS=Arabidopsis thaliana GN=PERK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 526 bits (1355), Expect = e-148, Method: Compositional matrix adjust.
Identities = 309/572 (54%), Positives = 379/572 (66%), Gaps = 42/572 (7%)
Query: 11 PAPPETNSTFSPPAP-PPSVSA---------VSAPAPGNLTSPPSSGTPTSG-------- 52
PAPP+T S SP P PPS A + G+ SPPSSG TSG
Sbjct: 104 PAPPQTPSNQSPERPTPPSPGANDDRNRTNGGNNNRDGSTPSPPSSGNRTSGDGGSPSPP 163
Query: 53 --STVGTRRPSPTRNGYLPPGALAGMVVGVVIGAGIVLAAVGIFLIFYKRRKRKLAAQNL 110
+ + P A G+++GV++GAG++L I R+K+K +
Sbjct: 164 RSISPPQNSGDSDSSSGNHPQANIGLIIGVLVGAGLLLLLAVCICICCNRKKKKKS---- 219
Query: 111 PLKSIFSNVKNDPFAGKPHHWQQNVSAPSDYQELPKPSLP--PSNGPTAPLPTVPVSAFN 168
P + N+P+ G P Y+ P+ + G P PVS
Sbjct: 220 PQVNHMHYYNNNPYGGAP------SGNGGYYKGTPQDHVVNMAGQGGGNWGPQQPVSG-- 271
Query: 169 EPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKG 228
P S + +L P +G+ +STFTY+EL IAT+ F+++NLLGQGGFGYVHKG
Sbjct: 272 -PHSDASNLTGRTAIPSPQAAT-LGHNQSTFTYDELSIATEGFAQSNLLGQGGFGYVHKG 329
Query: 229 VLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVP 288
VL +GK VA+K LK GSGQGEREFQAE++IIS+VHHRHLVSLVGYC G QRLLVYEF+P
Sbjct: 330 VLPSGKEVAVKSLKLGSGQGEREFQAEVDIISRVHHRHLVSLVGYCISGGQRLLVYEFIP 389
Query: 289 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE 348
N TLEFHLHGK RPV++WPTR+KIALGSARGLAYLHEDC P+IIHRDIK+ANILLD SFE
Sbjct: 390 NNTLEFHLHGKGRPVLDWPTRVKIALGSARGLAYLHEDCHPRIIHRDIKAANILLDFSFE 449
Query: 349 AKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGF 408
KVADFGLAK S D THVSTRVMGTFGYLAPEYASSGKL++KSDVFSFGV+LLELITG
Sbjct: 450 TKVADFGLAKLSQDNYTHVSTRVMGTFGYLAPEYASSGKLSDKSDVFSFGVMLLELITGR 509
Query: 409 RPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIR 467
P D +DS+VDWA+P + DG+++ L D +LE Y EM +MA+CAAA IR
Sbjct: 510 PPLDLTGEM-EDSLVDWARPLCLKAAQDGDYNQLADPRLELNYSHQEMVQMASCAAAAIR 568
Query: 468 HSARRRPRMSQIVRALEGNMPLDDLNEGITPGHSTIYGSYG--GSDYNSMQYREDMKKFR 525
HSARRRP+MSQIVRALEG+M +DDL+EG PG ST Y S G S+Y++ Y DMKKF+
Sbjct: 569 HSARRRPKMSQIVRALEGDMSMDDLSEGTRPGQST-YLSPGSVSSEYDASSYTADMKKFK 627
Query: 526 KIALESVELGSSDYSGLTSDYGQNPPSSSTED 557
K+ALE+ E SS+Y G TS+YG NP +SS+E+
Sbjct: 628 KLALENKEYQSSEYGG-TSEYGLNPSASSSEE 658
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZNQ8|PERK4_ARATH Proline-rich receptor-like protein kinase PERK4 OS=Arabidopsis thaliana GN=PERK4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 525 bits (1353), Expect = e-148, Method: Compositional matrix adjust.
Identities = 274/478 (57%), Positives = 338/478 (70%), Gaps = 18/478 (3%)
Query: 76 MVVGVVIGAGIVLAAVGIFLIFYKRRKRKLAAQNLPLKSIFSNVKNDPFAGKPH----HW 131
++VGV++GAG+++ + I + +++KRK + P+K + +W
Sbjct: 152 IIVGVLVGAGLLMIVL-IIVCLRRKKKRKDSFYPEPMKGNQYQYYGNNNNNNASQNYPNW 210
Query: 132 QQNVSAPSDYQELPKPSLPPSNGPTAPLPTV--PVSAFNEPLSTSGSLDSDKPFPRQSPG 189
N + PS P +PT S ++ P S P SP
Sbjct: 211 HLNSQGQNQQSTGGWGGGGPSPPPPPRMPTSGEDSSMYSGP--------SRPVLPPPSPA 262
Query: 190 MPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGE 249
+ +G KSTFTY+EL AT F++ANLLGQGGFGYVHKGVL +GK VA+K LKAGSGQGE
Sbjct: 263 LALGFNKSTFTYQELAAATGGFTDANLLGQGGFGYVHKGVLPSGKEVAVKSLKAGSGQGE 322
Query: 250 REFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR 309
REFQAE++IIS+VHHR+LVSLVGYC QR+LVYEFVPNKTLE+HLHGK+ PVM + TR
Sbjct: 323 REFQAEVDIISRVHHRYLVSLVGYCIADGQRMLVYEFVPNKTLEYHLHGKNLPVMEFSTR 382
Query: 310 MKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 369
++IALG+A+GLAYLHEDC P+IIHRDIKSANILLD +F+A VADFGLAK + D +THVST
Sbjct: 383 LRIALGAAKGLAYLHEDCHPRIIHRDIKSANILLDFNFDAMVADFGLAKLTSDNNTHVST 442
Query: 370 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPF 429
RVMGTFGYLAPEYASSGKLTEKSDVFS+GV+LLELITG RP D + T DD++VDWA+P
Sbjct: 443 RVMGTFGYLAPEYASSGKLTEKSDVFSYGVMLLELITGKRPVDNSITM-DDTLVDWARPL 501
Query: 430 LAQGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMP 488
+A+ L DGNF+ L D +LE Y+ EM RM CAAA IRHS R+RP+MSQIVRALEG +
Sbjct: 502 MARALEDGNFNELADARLEGNYNPQEMARMVTCAAASIRHSGRKRPKMSQIVRALEGEVS 561
Query: 489 LDDLNEGITPGHSTIYGSYGG-SDYNSMQYREDMKKFRKIALESVELGSSDYSGLTSD 545
LD LNEG+ PGHS +YGS G SDY+ Y DMKKFR+IAL S E SD G +S+
Sbjct: 562 LDALNEGVKPGHSNVYGSLGASSDYSQTSYNADMKKFRQIALSSQEFPVSDCEGTSSN 619
|
Required during abscisic acid (ABA)-mediated activation of Ca(2+) channels. Regulates ABA signaling pathways. Modulates the expression of genes related to cell elongation and ABA signaling during root growth. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q1PEM5|PERK3_ARATH Proline-rich receptor-like protein kinase PERK3 OS=Arabidopsis thaliana GN=PERK3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 488 bits (1257), Expect = e-137, Method: Compositional matrix adjust.
Identities = 233/348 (66%), Positives = 276/348 (79%), Gaps = 15/348 (4%)
Query: 180 DKPFPRQSP-GMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAI 238
DK P +P G+ +G +STFTY EL AT+ FSEANLLG+GGFG+V+KG+L NG VA+
Sbjct: 153 DKALP--APIGLVLGIHQSTFTYGELARATNKFSEANLLGEGGFGFVYKGILNNGNEVAV 210
Query: 239 KQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHG 298
KQLK GS QGE+EFQAE+ IISQ+HHR+LVSLVGYC G+QRLLVYEFVPN TLEFHLHG
Sbjct: 211 KQLKVGSAQGEKEFQAEVNIISQIHHRNLVSLVGYCIAGAQRLLVYEFVPNNTLEFHLHG 270
Query: 299 KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 358
K RP M W R+KIA+ S++GL+YLHE+C PKIIHRDIK+ANIL+D FEAKVADFGLAK
Sbjct: 271 KGRPTMEWSLRLKIAVSSSKGLSYLHENCNPKIIHRDIKAANILIDFKFEAKVADFGLAK 330
Query: 359 HSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFA 418
+LDT+THVSTRVMGTFGYLAPEYA+SGKLTEKSDV+SFGV+LLELITG RP D + +A
Sbjct: 331 IALDTNTHVSTRVMGTFGYLAPEYAASGKLTEKSDVYSFGVVLLELITGRRPVDANNVYA 390
Query: 419 DDSMVDWAKPFLAQGLADGNFDALVDQKL-EEYDSAEMTRMAACAAACIRHSARRRPRMS 477
DDS+VDWA+P L Q L + NF+ L D KL EYD EM RM ACAAAC+R++ARRRPRM
Sbjct: 391 DDSLVDWARPLLVQALEESNFEGLADIKLNNEYDREEMARMVACAAACVRYTARRRPRMD 450
Query: 478 QIVRALEGNMPLDDLNEGITPGHSTIYGSYGGSDYNSMQYREDMKKFR 525
Q+VR LEGN+ DLN+GITPGHS N++ R D + R
Sbjct: 451 QVVRVLEGNISPSDLNQGITPGHS-----------NTVSVRLDARAVR 487
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LS95|PERK6_ARATH Putative proline-rich receptor-like protein kinase PERK6 OS=Arabidopsis thaliana GN=PERK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 473 bits (1216), Expect = e-132, Method: Compositional matrix adjust.
Identities = 245/360 (68%), Positives = 290/360 (80%), Gaps = 2/360 (0%)
Query: 192 VGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGERE 251
+G KSTFTY+EL AT FS++ LLGQGGFGYVHKG+L NGK +A+K LKAGSGQGERE
Sbjct: 318 LGFNKSTFTYDELAAATQGFSQSRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSGQGERE 377
Query: 252 FQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMK 311
FQAE++IIS+VHHR LVSLVGYC G QR+LVYEF+PN TLEFHLHGK V++WPTR+K
Sbjct: 378 FQAEVDIISRVHHRFLVSLVGYCIAGGQRMLVYEFLPNDTLEFHLHGKSGKVLDWPTRLK 437
Query: 312 IALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRV 371
IALGSA+GLAYLHEDC P+IIHRDIK++NILLD+SFEAKVADFGLAK S D THVSTR+
Sbjct: 438 IALGSAKGLAYLHEDCHPRIIHRDIKASNILLDESFEAKVADFGLAKLSQDNVTHVSTRI 497
Query: 372 MGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLA 431
MGTFGYLAPEYASSGKLT++SDVFSFGV+LLEL+TG RP D +DS+VDWA+P
Sbjct: 498 MGTFGYLAPEYASSGKLTDRSDVFSFGVMLLELVTGRRPVDLTGEM-EDSLVDWARPICL 556
Query: 432 QGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMPLD 490
DG++ LVD +LE +Y+ EM +M ACAAA +RHSARRRP+MSQIVRALEG+ LD
Sbjct: 557 NAAQDGDYSELVDPRLENQYEPHEMAQMVACAAAAVRHSARRRPKMSQIVRALEGDATLD 616
Query: 491 DLNEGITPGHSTIYGSYGGSDYNSMQYREDMKKFRKIALESVELGSSDYSGLTSDYGQNP 550
DL+EG G S+ G SDY+S Y DMKKFRK+AL+S E G+S G TS+YG +P
Sbjct: 617 DLSEGGKAGQSSFLGRGSSSDYDSSTYSADMKKFRKVALDSHEYGASSEYGNTSEYGLDP 676
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XI96|PERK7_ARATH Proline-rich receptor-like protein kinase PERK7 OS=Arabidopsis thaliana GN=PERK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 472 bits (1215), Expect = e-132, Method: Compositional matrix adjust.
Identities = 263/420 (62%), Positives = 309/420 (73%), Gaps = 11/420 (2%)
Query: 140 DYQELPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTF 199
++Q +P P P S G S F +SG P P P + +G STF
Sbjct: 272 NWQPMPSPPAPVSGGANVIQSGEMSSNF-----SSGPYAPSLPPPH--PSVALGFNNSTF 324
Query: 200 TYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEII 259
TYEEL AT FS+ LLGQGGFGYVHKG+L NGK +A+K LKAGSGQGEREFQAE+EII
Sbjct: 325 TYEELASATQGFSKDRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSGQGEREFQAEVEII 384
Query: 260 SQVHHRHLVSLVGYCT-FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR 318
S+VHHRHLVSLVGYC+ G QRLLVYEF+PN TLEFHLHGK VM+WPTR+KIALGSA+
Sbjct: 385 SRVHHRHLVSLVGYCSNAGGQRLLVYEFLPNDTLEFHLHGKSGTVMDWPTRLKIALGSAK 444
Query: 319 GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYL 378
GLAYLHEDC PKIIHRDIK++NILLD +FEAKVADFGLAK S D +THVSTRVMGTFGYL
Sbjct: 445 GLAYLHEDCHPKIIHRDIKASNILLDHNFEAKVADFGLAKLSQDNNTHVSTRVMGTFGYL 504
Query: 379 APEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGN 438
APEYASSGKLTEKSDVFSFGV+LLELITG P D + +DS+VDWA+P + DG
Sbjct: 505 APEYASSGKLTEKSDVFSFGVMLLELITGRGPVDLSGDM-EDSLVDWARPLCMRVAQDGE 563
Query: 439 FDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMPLDDLNEGIT 497
+ LVD LE +Y+ EM RM ACAAA +RHS RRRP+MSQIVR LEG+ LDDL++G+
Sbjct: 564 YGELVDPFLEHQYEPYEMARMVACAAAAVRHSGRRRPKMSQIVRTLEGDASLDDLDDGVK 623
Query: 498 PGHSTIYGSYGGSDYNSMQYREDMKKFRKIALESVELGSSDYSGLTSDYGQNPPSSSTED 557
P S+ G SDY Y +M+KFRK+ LES + G+S G TS+YG +P SSS+E+
Sbjct: 624 PKQSSSG-GEGSSDYEMGTYGAEMRKFRKVTLESRDYGASSEYGATSEYGLDPSSSSSEE 682
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 456 bits (1172), Expect = e-127, Method: Compositional matrix adjust.
Identities = 268/554 (48%), Positives = 345/554 (62%), Gaps = 58/554 (10%)
Query: 21 SPPAPPPSVSAVSAPAPGNLTSPPSSGTPTSGSTVGTRRPSPTRNGYLPPGALAGMVVGV 80
S A PP +A P LTSP S G P+SG++V P P +G G + G
Sbjct: 192 SSHALPPKSTAAGGP----LTSP-SRGVPSSGNSV----PPPANSG---GGYQGKTMAGF 239
Query: 81 VIGAGIVLAAVGIFLIFYKRRKRKLAA----QNLPLKSIFSNVKNDPFAGKPHHWQQNVS 136
I V+A + + + +++KR + A Q LP S FS +K+D F
Sbjct: 240 AIAGFAVIALMAVVFLVRRKKKRNIDAYSDSQYLP-PSNFS-IKSDGFL----------- 286
Query: 137 APSDYQELPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGMPV-GNF 195
Y + P G + + ++F G S +P V G+
Sbjct: 287 ----YGQNPTKGYSGPGGYNSQQQSNSGNSFGSQRGGGGYTRSG-----SAPDSAVMGSG 337
Query: 196 KSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAE 255
++ FTYEEL T+ FS+ N+LG+GGFG V+KG L +GK+VA+KQLK GSGQG+REF+AE
Sbjct: 338 QTHFTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKAE 397
Query: 256 IEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALG 315
+EIIS+VHHRHLVSLVGYC S+RLL+YE+VPN+TLE HLHGK RPV+ W R++IA+G
Sbjct: 398 VEIISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHGKGRPVLEWARRVRIAIG 457
Query: 316 SARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF 375
SA+GLAYLHEDC PKIIHRDIKSANILLDD FEA+VADFGLAK + T THVSTRVMGTF
Sbjct: 458 SAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQTHVSTRVMGTF 517
Query: 376 GYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLA 435
GYLAPEYA SGKLT++SDVFSFGV+LLELITG +P D+ ++S+V+WA+P L + +
Sbjct: 518 GYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARPLLHKAIE 577
Query: 436 DGNFDALVDQKLEE-YDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMPLDDLNE 494
G+F LVD++LE+ Y E+ RM AAAC+RHS +RPRM Q+VRAL+ + D++
Sbjct: 578 TGDFSELVDRRLEKHYVENEVFRMIETAAACVRHSGPKRPRMVQVVRALDSEGDMGDISN 637
Query: 495 GITPGHSTIYGSYGGSDYNSMQYREDMKKFRKIAL---ESVELG--SSDYSGLTSDYGQN 549
G G S S Y+S QY D KFRK+A +S + G S DYS S G N
Sbjct: 638 GNKVGQS--------SAYDSGQYNNDTMKFRKMAFGFDDSSDSGMYSGDYSVQDSRKGSN 689
Query: 550 PPSS-----STEDR 558
SS TE+R
Sbjct: 690 GASSEFTRNETENR 703
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 443 bits (1140), Expect = e-123, Method: Compositional matrix adjust.
Identities = 239/492 (48%), Positives = 321/492 (65%), Gaps = 50/492 (10%)
Query: 77 VVGVVIGAGIVLAAVGIFLIFYKRRKRKLAAQN----LPLKSIFSNVKNDPFAGKPHHWQ 132
+VG+ + ++A +G+ + +++KR + + N LP + +VK+D F +
Sbjct: 247 MVGMAVAGFAIMALIGVVFLVRRKKKRNIDSYNHSQYLPHPNF--SVKSDGFL-----YG 299
Query: 133 QNVSAPSDYQELPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPR-QSPGMP 191
Q+ P S+GP + + ++ G+ P + QS G P
Sbjct: 300 QD------------PGKGYSSGPNGSMYNNSQQQQSSMGNSYGTAGGGYPHHQMQSSGTP 347
Query: 192 ----VGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQ 247
+G+ ++ F+YEEL T F+ N+LG+GGFG V+KG L +GKVVA+KQLKAGSGQ
Sbjct: 348 DSAILGSGQTHFSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQ 407
Query: 248 GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWP 307
G+REF+AE+EIIS+VHHRHLVSLVGYC RLL+YE+V N+TLE HLHGK PV+ W
Sbjct: 408 GDREFKAEVEIISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHGKGLPVLEWS 467
Query: 308 TRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 367
R++IA+GSA+GLAYLHEDC PKIIHRDIKSANILLDD +EA+VADFGLA+ + T THV
Sbjct: 468 KRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLARLNDTTQTHV 527
Query: 368 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAK 427
STRVMGTFGYLAPEYASSGKLT++SDVFSFGV+LLEL+TG +P D+ ++S+V+WA+
Sbjct: 528 STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLVEWAR 587
Query: 428 PFLAQGLADGNFDALVDQKLEE-YDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486
P L + + G+ L+D +LE+ Y E+ RM AAAC+RHS +RPRM Q+VRAL+ +
Sbjct: 588 PLLLKAIETGDLSELIDTRLEKRYVEHEVFRMIETAAACVRHSGPKRPRMVQVVRALDCD 647
Query: 487 MPLDDLNEGITPGHSTIYGSYGGSDYNSMQYREDMKKFRKIAL---ESVELG-------- 535
D++ GI G ST Y+S QY ED+ KFRK+A SVE G
Sbjct: 648 GDSGDISNGIKIGQSTT--------YDSGQYNEDIMKFRKMAFGGDNSVESGLYSGNYSA 699
Query: 536 --SSDYSGLTSD 545
SSD+SG S+
Sbjct: 700 KSSSDFSGNESE 711
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 586 | ||||||
| 255549982 | 374 | ATP binding protein, putative [Ricinus c | 0.626 | 0.981 | 0.774 | 1e-173 | |
| 121308607 | 665 | PERK1-like protein kinase [Nicotiana tab | 0.834 | 0.735 | 0.612 | 1e-171 | |
| 356521887 | 570 | PREDICTED: proline-rich receptor-like pr | 0.938 | 0.964 | 0.560 | 1e-171 | |
| 359484580 | 650 | PREDICTED: proline-rich receptor-like pr | 0.836 | 0.753 | 0.626 | 1e-169 | |
| 225442587 | 551 | PREDICTED: proline-rich receptor-like pr | 0.854 | 0.909 | 0.598 | 1e-167 | |
| 147828268 | 603 | hypothetical protein VITISV_010509 [Viti | 0.854 | 0.830 | 0.598 | 1e-167 | |
| 356520519 | 671 | PREDICTED: proline-rich receptor-like pr | 0.815 | 0.712 | 0.638 | 1e-165 | |
| 297852980 | 524 | kinase family protein [Arabidopsis lyrat | 0.861 | 0.963 | 0.574 | 1e-165 | |
| 351725713 | 443 | putative receptor protein kinase PERK1 [ | 0.658 | 0.871 | 0.720 | 1e-165 | |
| 224059084 | 410 | predicted protein [Populus trichocarpa] | 0.675 | 0.965 | 0.698 | 1e-165 |
| >gi|255549982|ref|XP_002516042.1| ATP binding protein, putative [Ricinus communis] gi|223544947|gb|EEF46462.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 615 bits (1587), Expect = e-173, Method: Compositional matrix adjust.
Identities = 285/368 (77%), Positives = 328/368 (89%), Gaps = 1/368 (0%)
Query: 206 IATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHR 265
+AT+ FS+ANL+GQGGFGYVHKG+L +GKV+AIKQLKAGSGQGEREFQAEIEIIS+VHHR
Sbjct: 1 MATNGFSDANLIGQGGFGYVHKGILNDGKVIAIKQLKAGSGQGEREFQAEIEIISRVHHR 60
Query: 266 HLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHE 325
HLVSL+GYC G+QR+LVYEFVPN TLEFHLHGK RP MNW TRMKIA+GSA+GLAYLHE
Sbjct: 61 HLVSLLGYCITGAQRMLVYEFVPNDTLEFHLHGKGRPTMNWSTRMKIAVGSAKGLAYLHE 120
Query: 326 DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS 385
+CQPKIIHRDIK+ANIL+DDSFEAKVADFGLAK+SLDTDTHVSTRVMGTFGY+APEYASS
Sbjct: 121 ECQPKIIHRDIKAANILIDDSFEAKVADFGLAKYSLDTDTHVSTRVMGTFGYMAPEYASS 180
Query: 386 GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQ 445
GKLTEKSDVFSFGV+LLELITG RP D+ TF DDS+VDWA+P L Q L G +DAL D
Sbjct: 181 GKLTEKSDVFSFGVVLLELITGRRPVDRTQTF-DDSIVDWARPLLNQALESGIYDALADP 239
Query: 446 KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMPLDDLNEGITPGHSTIYG 505
KL++YDS EMTRM ACAAAC+RHSAR RPRMSQI+RALEGNM LD+L++GITPGHST+YG
Sbjct: 240 KLQDYDSTEMTRMIACAAACVRHSARLRPRMSQIIRALEGNMSLDELSDGITPGHSTVYG 299
Query: 506 SYGGSDYNSMQYREDMKKFRKIALESVELGSSDYSGLTSDYGQNPPSSSTEDRQATQETE 565
SYG DY+S QY+ED+K+FRK+ALES E SS+YSG+TS++G P SSSTE +Q TQE E
Sbjct: 300 SYGSIDYSSSQYKEDLKRFRKMALESQEHVSSEYSGVTSEFGLQPSSSSTEGQQTTQEME 359
Query: 566 PNEKDTNV 573
+K+T V
Sbjct: 360 AQKKETAV 367
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|121308607|dbj|BAF43699.1| PERK1-like protein kinase [Nicotiana tabacum] | Back alignment and taxonomy information |
|---|
Score = 608 bits (1568), Expect = e-171, Method: Compositional matrix adjust.
Identities = 316/516 (61%), Positives = 374/516 (72%), Gaps = 27/516 (5%)
Query: 71 GALAGMVVGVVIGAGIVLAAVGIFLIFYKRRKRKLA---------AQNLPLKSIFSNVKN 121
G G+VVG+ IG ++LA + + I RRK++ AQ P+ K
Sbjct: 135 GVSTGLVVGIAIGGVLILAVLSLLFICCSRRKKRRNHGPVEYYPPAQPPPM-----GYKA 189
Query: 122 DPFAGKPHHWQQNVSAPSDY---------QELPKPSLPPSNGPTAP-LPTVPVSAFNEPL 171
DP+ HHWQ N +P+D+ S PP + TA L P +
Sbjct: 190 DPYGDPVHHWQHNAPSPADHVVSIPPKPSPPPAGASRPPHSPVTASSLQPPPPPPYMSSS 249
Query: 172 STSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLT 231
S + P P SPGM +G KSTFTYEEL ATD FS ANLLGQGGFGYVH+GVL
Sbjct: 250 GASSNYSGFDPLPPPSPGMVLGFSKSTFTYEELVRATDGFSNANLLGQGGFGYVHRGVLP 309
Query: 232 NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKT 291
NGK VA+KQLKAGSGQGEREFQAE+EIIS+VHH+HLVSLVGYC GSQRLLVYEFVPN T
Sbjct: 310 NGKEVAVKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYCITGSQRLLVYEFVPNNT 369
Query: 292 LEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKV 351
LEFHLHGK RP ++WP R+KIALGSA+GLAYLHEDCQPKIIHRDIK+ANIL+D +FEAKV
Sbjct: 370 LEFHLHGKGRPPLDWPIRLKIALGSAKGLAYLHEDCQPKIIHRDIKAANILVDFNFEAKV 429
Query: 352 ADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPF 411
ADFGLAK + D +THVSTRVMGTFGYLAPEYASSGKLTEKSDVFS+G++LLELITG RP
Sbjct: 430 ADFGLAKLTSDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSYGIMLLELITGRRPV 489
Query: 412 DKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL-EEYDSAEMTRMAACAAACIRHSA 470
D + T+ DDS+VDWA+P L + L D FD+L+D +L +Y+ E+ RM ACAAAC+RHSA
Sbjct: 490 DSSQTYMDDSLVDWARPQLTRALEDEKFDSLIDPRLGNDYNHNEVARMVACAAACVRHSA 549
Query: 471 RRRPRMSQIVRALEGNMPLDDLNEGITPGHSTIYGSYGGSDYNSMQYREDMKKFRKIALE 530
RRRPRMSQ+VRALEG++ L DLNEGI PGHST+Y S+G SDY++ QY EDMKKFRK+AL
Sbjct: 550 RRRPRMSQVVRALEGDVSLSDLNEGIRPGHSTVYSSHGSSDYDASQYNEDMKKFRKMALG 609
Query: 531 SVELGSS-DYSGLTSDYGQNPPSSSTEDRQATQETE 565
S E GS+ YS TS+YG P SS+E Q T+E E
Sbjct: 610 SQEYGSTGQYSNPTSEYGLYPSGSSSEG-QPTREME 644
|
Source: Nicotiana tabacum Species: Nicotiana tabacum Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356521887|ref|XP_003529582.1| PREDICTED: proline-rich receptor-like protein kinase PERK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 608 bits (1567), Expect = e-171, Method: Compositional matrix adjust.
Identities = 322/574 (56%), Positives = 407/574 (70%), Gaps = 24/574 (4%)
Query: 10 LPAPPETNS-TFSPPA---PPPSVSAVSAPAPGNLTSPPSSGTPTSGSTVGTRRPSPTRN 65
+ AP E S T SPP+ P P+ +A+S P P + + T + P+ T N
Sbjct: 1 MSAPAEAPSFTASPPSETTPSPNSTALSPPPPSTINA-----TVSPPPPEAASPPTSTVN 55
Query: 66 GYLPPGALAGMVVGVVIGAGIVLAAVGIFLIFYKRRKRKLAAQNLPLKSIFSNVKNDPFA 125
L G ++G+V+G V+G+ +L GIF FY+ KRK P K D
Sbjct: 56 SGLSTGTVSGIVIGAVLGSVGMLIIGGIFFCFYRNWKRKKNHSQPP------QPKADIAG 109
Query: 126 GKPHHWQQNVSAPSDYQELPKPSLPP-----SNGPTAPLPTVPVSAFNEPLSTSGSLDSD 180
G +WQ +V +D + P PP +A L T+ V++ N S+S +
Sbjct: 110 GTLQNWQDSVPPTTDGKVGFSPKPPPGGLVNQQQSSAALLTLVVNSSNT--SSSLGSEKA 167
Query: 181 KPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQ 240
K + SPG + +STFTY+EL +ATD FS +NLLGQGGFGYVHKGVL NGK+VA+KQ
Sbjct: 168 KSYISPSPGTSLALSQSTFTYDELSMATDGFSRSNLLGQGGFGYVHKGVLPNGKIVAVKQ 227
Query: 241 LKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKD 300
LK+ S QGEREF AE+++IS+VHHRHLVSLVGYC SQ++LVYE+V N TLEFHLHGKD
Sbjct: 228 LKSESRQGEREFHAEVDVISRVHHRHLVSLVGYCVSDSQKMLVYEYVENDTLEFHLHGKD 287
Query: 301 RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 360
R M+W TRMKIA+GSA+GLAYLHEDC PKIIHRDIK++NILLD+SFEAKVADFGLAK S
Sbjct: 288 RLPMDWSTRMKIAIGSAKGLAYLHEDCNPKIIHRDIKASNILLDESFEAKVADFGLAKFS 347
Query: 361 LDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADD 420
DTDTHVSTRVMGTFGY+APEYA+SGKLTEKSDVFSFGV+LLELITG +P DK TF DD
Sbjct: 348 SDTDTHVSTRVMGTFGYMAPEYAASGKLTEKSDVFSFGVVLLELITGRKPVDKTQTFIDD 407
Query: 421 SMVDWAKPFLAQGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQI 479
SMV+WA+P L+Q L +GN + LVD +L+ Y+ EM RM CAA C+R+SAR RPRMSQ+
Sbjct: 408 SMVEWARPLLSQALENGNLNGLVDPRLQTNYNLDEMIRMTTCAATCVRYSARLRPRMSQV 467
Query: 480 VRALEGNMPLDDLNEGITPGHSTIYGSYGGSDYNSMQYREDMKKFRKIALESVELGSSDY 539
VRALEGN+ L+DLN+GI PGHS ++GS+ S Y+S+QYRED+K F+K+ALES E G S+Y
Sbjct: 468 VRALEGNISLEDLNDGIAPGHSRVFGSFESSSYDSVQYREDLKNFKKLALESQEQGISEY 527
Query: 540 SGLTSDYGQNPPSSSTEDRQATQETE-PNEKDTN 572
SG +S+YG++P S++ D+Q TQE E N+K +N
Sbjct: 528 SGPSSEYGRHPSVSTSSDQQNTQEMEMGNKKGSN 561
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359484580|ref|XP_002284430.2| PREDICTED: proline-rich receptor-like protein kinase PERK1-like isoform 2 [Vitis vinifera] gi|297738823|emb|CBI28068.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 602 bits (1552), Expect = e-169, Method: Compositional matrix adjust.
Identities = 316/504 (62%), Positives = 373/504 (74%), Gaps = 14/504 (2%)
Query: 75 GMVVGVVIGAGIVLAAVGIFLIFYKRRKRKLAAQNLPLKSIFSNVKNDPFAGKPHHWQQN 134
G+VVG+ IG ++L + + I K++KR+ Q+ + KNDP+ G P WQ N
Sbjct: 131 GLVVGIAIGGVVILVVLSLLFICCKKKKRRDHRQDYYVPPP-PGPKNDPYGGPPQQWQHN 189
Query: 135 VSAPSDY--QELPKPSLPPSNGPTAPLPTVPVS----------AFNEPLSTSGSLDSDKP 182
V P+D+ PKPS PP P V V + S S SD P
Sbjct: 190 VPPPADHAVTVFPKPSPPPGTASRPPHSPVQVPTPPPPPQPPFVSSSGGSGSNYSGSDNP 249
Query: 183 FPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLK 242
P SP + +G KSTFTYEEL +ATD FS ANLLGQGGFGYVH+GVL NGK VA+KQLK
Sbjct: 250 LPPPSPSIALGFSKSTFTYEELVMATDGFSNANLLGQGGFGYVHRGVLPNGKEVAVKQLK 309
Query: 243 AGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRP 302
AGSGQGEREFQAE+EIIS+VHH+HLV+L GYC GS RLLVYEFVPN TLEFHLHGK RP
Sbjct: 310 AGSGQGEREFQAEVEIISRVHHKHLVTLAGYCITGSHRLLVYEFVPNNTLEFHLHGKGRP 369
Query: 303 VMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362
M+W TR+KIALGSA+GLAYLHEDC PKIIHRDIK+ANILLD FEAKVADFGLAK S D
Sbjct: 370 TMDWSTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKFSSD 429
Query: 363 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSM 422
+THVSTRVMGTFGYLAPEYA+SGKL++KSDVFSFGV+LLEL+TG RP D TF +DS+
Sbjct: 430 ANTHVSTRVMGTFGYLAPEYAASGKLSDKSDVFSFGVMLLELLTGRRPVDANQTFMEDSL 489
Query: 423 VDWAKPFLAQGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481
VDWA+P L + L DGNFD LVD +L+ +Y+ EM RM ACAAAC+RHSARRRPRMSQIVR
Sbjct: 490 VDWARPLLTRALEDGNFDTLVDPRLQKDYNHHEMARMVACAAACVRHSARRRPRMSQIVR 549
Query: 482 ALEGNMPLDDLNEGITPGHSTIYGSYGGSDYNSMQYREDMKKFRKIALESVELGSSDYSG 541
ALEG+ L DLNEG+ PG S+IY S+G SDY++ QY EDM KFRK+AL S + GSS+YSG
Sbjct: 550 ALEGDASLSDLNEGMRPGQSSIYSSHGSSDYDTNQYNEDMIKFRKMALASRDYGSSEYSG 609
Query: 542 LTSDYGQNPPSSSTEDRQATQETE 565
TS+YG P SS+E ++ T+E E
Sbjct: 610 PTSEYGLYPSGSSSEGQRTTREME 633
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225442587|ref|XP_002279197.1| PREDICTED: proline-rich receptor-like protein kinase PERK1 [Vitis vinifera] gi|297743250|emb|CBI36117.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 593 bits (1530), Expect = e-167, Method: Compositional matrix adjust.
Identities = 308/515 (59%), Positives = 374/515 (72%), Gaps = 14/515 (2%)
Query: 68 LPPGALAGMVVGVVIGAGIVLAAVGIFLIFYKRRKRKLAAQNLPLKSIFSNVKNDPFAGK 127
L L ++VG+VIG VL VG+ +IF +++KR+ + L ++ S K+DP A
Sbjct: 47 LTTATLITLIVGIVIGGLFVLIGVGVLVIFCRQKKRR---EQYGLTNV-SGSKDDPSA-P 101
Query: 128 PHHWQQNVSAPSDYQE--LPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPR 185
HWQQN P++ + LPK + S G L V + A P+ G L ++KP
Sbjct: 102 LQHWQQNAHQPTNNTDPMLPKHAPLLSIGSKPQLSPVHIPASPPPM---GILGTEKPLAP 158
Query: 186 QSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGS 245
SPG+ +G KS FTYEEL IATD FS NLLGQGGFGYVHKGVL NG+ VAIK LKAGS
Sbjct: 159 PSPGISLGFSKSAFTYEELAIATDGFSNINLLGQGGFGYVHKGVLPNGREVAIKHLKAGS 218
Query: 246 GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMN 305
GQGEREFQAE+EIIS+VHH+HLVSLVGYCT G+QR+LVYEFVPN TL+ HLHG RP MN
Sbjct: 219 GQGEREFQAEVEIISRVHHKHLVSLVGYCTTGAQRMLVYEFVPNGTLQHHLHGTGRPTMN 278
Query: 306 WPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365
W TR+KIALGSA+GLAYLHEDC PKIIHRDIK+ANILLD +FEAKVADFGLAK + DTDT
Sbjct: 279 WATRIKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDHNFEAKVADFGLAKFASDTDT 338
Query: 366 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDW 425
HVSTRVMGTFGYLAPEYASSGKLT+KSDVFSFGV+LLELITG RP DK + ++S+VDW
Sbjct: 339 HVSTRVMGTFGYLAPEYASSGKLTDKSDVFSFGVVLLELITGRRPIDKTE---NESIVDW 395
Query: 426 AKPFLAQGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484
A+P L Q L + + ALVD L+ +Y+ EM RM ACAA C+R+ AR RPRMSQ+VRALE
Sbjct: 396 ARPLLTQALEESKYGALVDPNLQKDYNYNEMARMVACAAVCVRYLARLRPRMSQVVRALE 455
Query: 485 GNMPLDDLNEGITPGHSTIYGSYGGSDYNSMQYREDMKKFRKIALESVELGSSDYSGLTS 544
GN+PLDDLNEGI PGHS+ + YG SD +++ ED+KKFRK+ALES E GS + + S
Sbjct: 456 GNLPLDDLNEGIIPGHSSFHCRYGSSDDDTIHGSEDLKKFRKMALESHEQGSIECTVPIS 515
Query: 545 DYGQNPPSSSTEDRQATQETEPNEKDTNVINQSSS 579
+ +SS E +Q +E E + N+ N S
Sbjct: 516 ASDPHTSNSSFEGQQTCKEVEMEKHKENIQNSGES 550
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147828268|emb|CAN75405.1| hypothetical protein VITISV_010509 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 593 bits (1529), Expect = e-167, Method: Compositional matrix adjust.
Identities = 308/515 (59%), Positives = 374/515 (72%), Gaps = 14/515 (2%)
Query: 68 LPPGALAGMVVGVVIGAGIVLAAVGIFLIFYKRRKRKLAAQNLPLKSIFSNVKNDPFAGK 127
L L ++VG+VIG VL VG+ +IF +++KR+ + L ++ S K+DP A
Sbjct: 99 LTTATLITLIVGIVIGGLFVLIGVGVLVIFCRQKKRR---EQYGLTNV-SGSKDDPSA-P 153
Query: 128 PHHWQQNVSAPSDYQE--LPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPR 185
HWQQN P++ + LPK + S G L V + A P+ G L ++KP
Sbjct: 154 LQHWQQNAHQPTNNTDPMLPKHAPLLSIGSKPQLSPVHIPASPPPM---GILGTEKPLAP 210
Query: 186 QSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGS 245
SPG+ +G KS FTYEEL IATD FS NLLGQGGFGYVHKGVL NG+ VAIK LKAGS
Sbjct: 211 PSPGISLGFSKSAFTYEELAIATDGFSNINLLGQGGFGYVHKGVLPNGREVAIKHLKAGS 270
Query: 246 GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMN 305
GQGEREFQAE+EIIS+VHH+HLVSLVGYCT G+QR+LVYEFVPN TL+ HLHG RP MN
Sbjct: 271 GQGEREFQAEVEIISRVHHKHLVSLVGYCTTGAQRMLVYEFVPNGTLQHHLHGTGRPTMN 330
Query: 306 WPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365
W TR+KIALGSA+GLAYLHEDC PKIIHRDIK+ANILLD +FEAKVADFGLAK + DTDT
Sbjct: 331 WATRIKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDHNFEAKVADFGLAKFASDTDT 390
Query: 366 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDW 425
HVSTRVMGTFGYLAPEYASSGKLT+KSDVFSFGV+LLELITG RP DK + ++S+VDW
Sbjct: 391 HVSTRVMGTFGYLAPEYASSGKLTDKSDVFSFGVVLLELITGRRPIDKTE---NESIVDW 447
Query: 426 AKPFLAQGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484
A+P L Q L + +DALVD L+ +Y+ EM RM ACAA C+R+ AR RPRMSQ+VRALE
Sbjct: 448 ARPLLTQALEESKYDALVDPNLQKDYNYNEMARMVACAAVCVRYLARLRPRMSQVVRALE 507
Query: 485 GNMPLDDLNEGITPGHSTIYGSYGGSDYNSMQYREDMKKFRKIALESVELGSSDYSGLTS 544
GN+PLDDLNEGI PGHS+ + YG SD +++ ED+KKFRK+ALES E G + + S
Sbjct: 508 GNLPLDDLNEGIIPGHSSFHCRYGSSDDDTIHGSEDLKKFRKMALESHEQGRIECTVPIS 567
Query: 545 DYGQNPPSSSTEDRQATQETEPNEKDTNVINQSSS 579
+ +SS E +Q +E E + N+ N S
Sbjct: 568 ASDPHTSNSSFEGQQTCKEVEMEKHKENIQNSGES 602
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356520519|ref|XP_003528909.1| PREDICTED: proline-rich receptor-like protein kinase PERK15-like isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 588 bits (1516), Expect = e-165, Method: Compositional matrix adjust.
Identities = 311/487 (63%), Positives = 367/487 (75%), Gaps = 9/487 (1%)
Query: 88 LAAVGIFLIFYKRRKRKLAAQNLPLKSIFSNV-KNDPFAGKPHHWQQNVSAPSDY---QE 143
L + I I +++KR+ + K+D + G P WQ NV P D+
Sbjct: 171 LLVLSILCICCRKKKRRRDEEYYAPPPQPPRGPKDDAYGGPPRQWQHNVPPPQDHVVSMM 230
Query: 144 LPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPF-PRQSPGMPVGNFKSTFTYE 202
PKPS PP+ A P P F SGS S F P SPG+ +G KSTFTYE
Sbjct: 231 PPKPSPPPAPPAYAAQPPPPPPPFIISSGGSGSNYSGGEFLPPPSPGIALGFSKSTFTYE 290
Query: 203 ELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQV 262
EL ATD FS+ANLLGQGGFGYVH+G+L NGK VA+KQLKAGSGQGEREFQAE+EIIS+V
Sbjct: 291 ELARATDGFSDANLLGQGGFGYVHRGILPNGKEVAVKQLKAGSGQGEREFQAEVEIISRV 350
Query: 263 HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAY 322
HH+HLVSLVGYC GSQRLLVYEFVPN TLEFHLHG+ RP M+WPTR++IALGSA+GLAY
Sbjct: 351 HHKHLVSLVGYCITGSQRLLVYEFVPNNTLEFHLHGRGRPTMDWPTRLRIALGSAKGLAY 410
Query: 323 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEY 382
LHEDC PKIIHRDIK+ANILLD FEAKVADFGLAK S D +THVSTRVMGTFGYLAPEY
Sbjct: 411 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKFSSDVNTHVSTRVMGTFGYLAPEY 470
Query: 383 ASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 442
ASSGKLT+KSDVFS+GV+LLELITG RP DK TF +DS+VDWA+P L + L + +FD++
Sbjct: 471 ASSGKLTDKSDVFSYGVMLLELITGRRPVDKNQTFMEDSLVDWARPLLTRALEEDDFDSI 530
Query: 443 VDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMPLDDLNEGITPGHS 501
+D +L+ +YD EM RM A AAACIRHSA+RRPRMSQ+VRALEG++ L DLNEGI PGHS
Sbjct: 531 IDPRLQNDYDPNEMARMVASAAACIRHSAKRRPRMSQVVRALEGDVSLADLNEGIRPGHS 590
Query: 502 TIYGSYGGSDYNSMQYREDMKKFRKIALESVELG-SSDYSGLTSDYGQNPPSSSTE--DR 558
T+Y S+ SDY++ QY+EDMKKFRK+AL + E G SS+YS TS+YG NP SS+E R
Sbjct: 591 TMYSSHESSDYDTAQYKEDMKKFRKMALGTQEYGASSEYSAATSEYGLNPSGSSSEAQSR 650
Query: 559 QATQETE 565
Q T+E E
Sbjct: 651 QTTREME 657
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297852980|ref|XP_002894371.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297340213|gb|EFH70630.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 587 bits (1514), Expect = e-165, Method: Compositional matrix adjust.
Identities = 326/567 (57%), Positives = 387/567 (68%), Gaps = 62/567 (10%)
Query: 14 PETNSTFSPPAPPPSVSAVSAPAPGNLTSPPSSGTPTSGSTVGTRRPSPTRNGYLPPGAL 73
PE ST A P+ S S P L+ P + T G G+R AL
Sbjct: 15 PEFLSTTQNTATSPAPSQPSINGPSWLSPFPETTTNIDG---GSRNV-----------AL 60
Query: 74 AGMVVGVVIGAGIVLAAVGIFLIFYKRRKRKLAAQNLP-LKSIFSNVKNDPFAGKPHHWQ 132
G++ GVV+GA VL V IF+ FYKR++RKL + L++I
Sbjct: 61 TGLITGVVLGATFVLIGVCIFVCFYKRKQRKLKMKKKKDLEAIL---------------- 104
Query: 133 QNVSAPSDYQELPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGMPV 192
AP D K S+P F + +S +L +Q +
Sbjct: 105 ----APKDSIFFMKLSIPL--------------FFFFFIESSNNL-------QQWGSSEI 139
Query: 193 GNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREF 252
G+ + FTYE+L AT NFS NL+GQGGFGYVH+GVL +G +VAIKQLKAGSGQGEREF
Sbjct: 140 GH--NLFTYEDLSKATSNFSNTNLIGQGGFGYVHRGVLVDGTLVAIKQLKAGSGQGEREF 197
Query: 253 QAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKI 312
QAEI+ IS+VHHRHLVSL+GYC G+QRLLVYEFVPNKTLEFHLH K RPVM W RMKI
Sbjct: 198 QAEIQTISRVHHRHLVSLLGYCITGAQRLLVYEFVPNKTLEFHLHEKGRPVMEWSKRMKI 257
Query: 313 ALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM 372
ALG+A+GLAYLHEDC PK IHRD+K+ANIL+DDS+EAK+ADFGLA+ SLDTDTHVSTR+M
Sbjct: 258 ALGAAKGLAYLHEDCNPKTIHRDVKAANILIDDSYEAKLADFGLARSSLDTDTHVSTRIM 317
Query: 373 GTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFA-DDSMVDWAKPFLA 431
GTFGYLAPEYASSGKLT+KSDVFSFGV+LLELITG RP DK+ FA DDS+VDWAKP +
Sbjct: 318 GTFGYLAPEYASSGKLTDKSDVFSFGVVLLELITGRRPVDKSQPFADDDSLVDWAKPLMI 377
Query: 432 QGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMPLD 490
Q L GNFD LVD +LE ++D EMTRM ACAAA +RHSA+RRP+MSQIVRA EGN+ +D
Sbjct: 378 QVLNGGNFDGLVDPRLENDFDINEMTRMVACAAASVRHSAKRRPKMSQIVRAFEGNISID 437
Query: 491 DLNEGITPGHSTIYGSYGGSDYNSMQYREDMKKFRKIALESVELGSSDYSGLTSDYGQNP 550
DL EG PGHSTIY G SDY+S QY+ED+KKF+K+ALES GSS+ SGLTSD GQNP
Sbjct: 438 DLTEGAAPGHSTIYSLDGSSDYSSTQYKEDLKKFKKMALESQTFGSSECSGLTSDNGQNP 497
Query: 551 PSSS--TEDRQATQETEPNEKDTNVIN 575
SS TE ++ TQE EP K I+
Sbjct: 498 SVSSSITEGQRTTQEIEPEMKTNETIS 524
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351725713|ref|NP_001237102.1| putative receptor protein kinase PERK1 [Glycine max] gi|77403742|dbj|BAE46451.1| putative receptor protein kinase PERK1 [Glycine max] gi|223452349|gb|ACM89502.1| PERK1-like protein kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 587 bits (1512), Expect = e-165, Method: Compositional matrix adjust.
Identities = 281/390 (72%), Positives = 328/390 (84%), Gaps = 4/390 (1%)
Query: 187 SPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSG 246
SPG+ +G KSTFTYEEL ATD FS+ANLLGQGGFGYVH+G+L NGK VA+KQLKAGSG
Sbjct: 47 SPGISLGFSKSTFTYEELARATDGFSDANLLGQGGFGYVHRGILPNGKEVAVKQLKAGSG 106
Query: 247 QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNW 306
QGEREFQAE+EIIS+VHH+HLVSLVGYC GSQRLLVYEFVPN TLEFHLHGK RP M+W
Sbjct: 107 QGEREFQAEVEIISRVHHKHLVSLVGYCITGSQRLLVYEFVPNNTLEFHLHGKGRPTMDW 166
Query: 307 PTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 366
PTR++IALGSA+GLAYLHEDC PKIIHRDIKSANILLD FEAKVADFGLAK S D +TH
Sbjct: 167 PTRLRIALGSAKGLAYLHEDCHPKIIHRDIKSANILLDFKFEAKVADFGLAKFSSDVNTH 226
Query: 367 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWA 426
VSTRVMGTFGYLAPEYASSGKLT+KSDVFS+G++LLELITG RP DK T+ +DS+VDWA
Sbjct: 227 VSTRVMGTFGYLAPEYASSGKLTDKSDVFSYGIMLLELITGRRPVDKNQTYMEDSLVDWA 286
Query: 427 KPFLAQGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 485
+P L + L + +FD+++D +L+ +YD EM RM A AAACIRHSA+RRPRMSQ+VRALEG
Sbjct: 287 RPLLTRALEEDDFDSIIDPRLQNDYDPHEMARMVASAAACIRHSAKRRPRMSQVVRALEG 346
Query: 486 NMPLDDLNEGITPGHSTIYGSYGGSDYNSMQYREDMKKFRKIALESVELG-SSDYSGLTS 544
++ L DLNEGI PGHST+Y S+ SDY++ QY+EDMKKFRK+AL + E G SS+YS TS
Sbjct: 347 DVSLADLNEGIRPGHSTMYSSHESSDYDTAQYKEDMKKFRKMALGTQEYGASSEYSAATS 406
Query: 545 DYGQNPPSSSTE--DRQATQETEPNEKDTN 572
+YG NP SS+E RQ T+E E + N
Sbjct: 407 EYGLNPSGSSSEAQSRQTTREMEMRKMKNN 436
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224059084|ref|XP_002299708.1| predicted protein [Populus trichocarpa] gi|222846966|gb|EEE84513.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 587 bits (1512), Expect = e-165, Method: Compositional matrix adjust.
Identities = 285/408 (69%), Positives = 329/408 (80%), Gaps = 12/408 (2%)
Query: 177 LDSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVV 236
+ SDK FP +PG+ +G +STFTYEEL +ATDNFSEANLLGQGGFGYVHKG+L NG VV
Sbjct: 1 MGSDKQFPPPTPGIALGYSQSTFTYEELAMATDNFSEANLLGQGGFGYVHKGILANGTVV 60
Query: 237 AIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHL 296
AIKQLK+GSGQGEREF+AEIEIIS+VHHRHLVSL GYC G+QR+LVYEFVPN TLEFHL
Sbjct: 61 AIKQLKSGSGQGEREFRAEIEIISRVHHRHLVSLFGYCIAGAQRMLVYEFVPNYTLEFHL 120
Query: 297 HGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGL 356
H RP MNW T MKIA+G+A+GLAYLHEDCQPKIIHRDIK++NIL+D SFEAKVADFGL
Sbjct: 121 HENGRPTMNWSTTMKIAVGAAKGLAYLHEDCQPKIIHRDIKASNILIDHSFEAKVADFGL 180
Query: 357 AKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADT 416
AKHSLDT+THVSTRVMGTFGY+APEYASSGKLT KSDV+SFGV+LLELI+G RP D+ +
Sbjct: 181 AKHSLDTETHVSTRVMGTFGYMAPEYASSGKLTAKSDVYSFGVVLLELISGRRPVDRTQS 240
Query: 417 FADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRM 476
F DDS+VDWA+P L Q L DGNFDA+VD KL++YDS EM RM CAAAC+RH R RPRM
Sbjct: 241 FIDDSIVDWARPLLKQALEDGNFDAVVDPKLQDYDSNEMIRMICCAAACVRHLGRFRPRM 300
Query: 477 S-QIVRALEGNMPLDDLNEGITPGHSTIYGSYGGSDYNSMQYREDMKKFRKIALESVE-- 533
S QIVRALEGNMPL +LNEGITPG S +Y S SDY + QY ED+KKFRK+ALES E
Sbjct: 301 SQQIVRALEGNMPLGELNEGITPGPSMVYSS-ASSDYTNRQYEEDLKKFRKLALESPEHD 359
Query: 534 --------LGSSDYSGLTSDYGQNPPSSSTEDRQATQETEPNEKDTNV 573
S + + TS+ G+NP SSTE +Q E + K+ N+
Sbjct: 360 SRVNPLASTSSQECTEPTSESGRNPFRSSTEGQQTKPEMDSQRKEENI 407
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 586 | ||||||
| TAIR|locus:2091722 | 652 | PERK1 "proline-rich extensin-l | 0.786 | 0.707 | 0.619 | 1.6e-147 | |
| UNIPROTKB|Q9ARH1 | 647 | Q9ARH1 "Receptor protein kinas | 0.786 | 0.712 | 0.606 | 4.3e-143 | |
| TAIR|locus:2018209 | 509 | PERK15 "proline-rich extensin- | 0.641 | 0.738 | 0.688 | 1.2e-140 | |
| TAIR|locus:2093999 | 700 | PERK6 "proline-rich extensin-l | 0.713 | 0.597 | 0.587 | 6.9e-130 | |
| TAIR|locus:2139474 | 670 | PERK5 "proline-rich extensin-l | 0.733 | 0.641 | 0.58 | 1.5e-127 | |
| TAIR|locus:2046268 | 633 | PERK4 "proline-rich extensin-l | 0.759 | 0.703 | 0.557 | 6.3e-127 | |
| TAIR|locus:2010282 | 699 | PERK7 "proline-rich extensin-l | 0.713 | 0.597 | 0.587 | 1.2e-125 | |
| TAIR|locus:2125692 | 731 | PERK14 "proline-rich extensin- | 0.648 | 0.519 | 0.533 | 3.9e-108 | |
| TAIR|locus:2026846 | 710 | PERK13 "proline-rich extensin- | 0.732 | 0.604 | 0.512 | 9.2e-107 | |
| TAIR|locus:2159873 | 681 | PERK8 "proline-rich extensin-l | 0.677 | 0.582 | 0.490 | 1e-105 |
| TAIR|locus:2091722 PERK1 "proline-rich extensin-like receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1418 (504.2 bits), Expect = 1.6e-147, Sum P(2) = 1.6e-147
Identities = 296/478 (61%), Positives = 344/478 (71%)
Query: 99 KRRKRK--LAAQNLPLKSIFSNVKNDPFAGKPHHWQQ-NVSAPSDYQ---ELPKPSLPPS 152
KRR+R AA +P P+ G+ +WQQ N S PSD LP P PPS
Sbjct: 165 KRRRRHDDEAAYYVPPPPPSGPKAGGPYGGQQQYWQQQNASRPSDNHVVTSLPPPK-PPS 223
Query: 153 NGPTAPLPTVPVSAFNEPLSTSGSLD-SDKP-FPRQSPGMPVGNFKSTFTYEELKIATDN 210
P P P P AF +S+SG D SD P P SPG+ +G KSTFTYEEL AT+
Sbjct: 224 P-PRKPPPPPPPPAF---MSSSGGSDYSDLPVLPPPSPGLVLGFSKSTFTYEELSRATNG 279
Query: 211 FSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSL 270
FSEANLLGQGGFGYVHKG+L +GK VA+KQLKAGSGQGEREFQAE+EIIS+VHHRHLVSL
Sbjct: 280 FSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQAEVEIISRVHHRHLVSL 339
Query: 271 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 330
+GYC G QRLLVYEFVPN LEFHLHGK RP M W TR+KIALGSA+GL+YLHEDC PK
Sbjct: 340 IGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRPTMEWSTRLKIALGSAKGLSYLHEDCNPK 399
Query: 331 IIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTE 390
IIHRDIK++NIL+D FEAKVADFGLAK + DT+THVSTRVMGTFGYLAPEYA+SGKLTE
Sbjct: 400 IIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMGTFGYLAPEYAASGKLTE 459
Query: 391 KSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL-EE 449
KSDVFSFGV+LLELITG RP D + + DDS+VDWA+P L + +G+F+ L D K+ E
Sbjct: 460 KSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLNRASEEGDFEGLADSKMGNE 519
Query: 450 YDXXXXXXXXXXXXXXXXXXXXXXPRMSQIVRALEGNMPLDDLNEGITPGHSTIYGSYGG 509
YD PRMSQIVRALEGN+ L DLNEG+ PGHS +Y SYGG
Sbjct: 520 YDREEMARMVACAAACVRHSARRRPRMSQIVRALEGNVSLSDLNEGMRPGHSNVYSSYGG 579
Query: 510 S-DYNSMQYREDMKKFRKIALESVELGSS-DYSGLTSDYGQNPPSSSTEDRQATQETE 565
S DY++ QY +DM KFRK+AL + E G++ +YS TSDYG P SS+E QAT+E E
Sbjct: 580 STDYDTSQYNDDMIKFRKMALGTQEYGTTGEYSNPTSDYGLYPSGSSSEG-QATREME 636
|
|
| UNIPROTKB|Q9ARH1 Q9ARH1 "Receptor protein kinase PERK1" [Brassica napus (taxid:3708)] | Back alignment and assigned GO terms |
|---|
Score = 1381 (491.2 bits), Expect = 4.3e-143, Sum P(2) = 4.3e-143
Identities = 288/475 (60%), Positives = 337/475 (70%)
Query: 99 KRRKRKLAAQNLPLKSIFSNVKNDPFAGKPHHW-QQNVSAPSDY--QELPKPSLPPSNGP 155
KRR+ + A +P P+ G+ W QQN + PSD+ LP P PS P
Sbjct: 163 KRRRDEEDAYYVPPPPPPGPKAGGPYGGQQQQWRQQNATPPSDHVVTSLPPPPKAPSP-P 221
Query: 156 TAPLPTVPVSAFNEPLSTSGSLD-SDKP-FPRQSPGMPVGNFKSTFTYEELKIATDNFSE 213
P P P F +S+SG D SD+P P SPG+ +G KSTFTYEEL AT+ FSE
Sbjct: 222 RQP-PPPPPPPF---MSSSGGSDYSDRPVLPPPSPGLVLGFSKSTFTYEELARATNGFSE 277
Query: 214 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGY 273
ANLLGQGGFGYVHKGVL +GK VA+KQLK GSGQGEREFQAE+EIIS+VHHRHLVSLVGY
Sbjct: 278 ANLLGQGGFGYVHKGVLPSGKEVAVKQLKVGSGQGEREFQAEVEIISRVHHRHLVSLVGY 337
Query: 274 CTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIH 333
C G++RLLVYEFVPN LE HLHG+ RP M W TR+KIALGSA+GL+YLHEDC PKIIH
Sbjct: 338 CIAGAKRLLVYEFVPNNNLELHLHGEGRPTMEWSTRLKIALGSAKGLSYLHEDCNPKIIH 397
Query: 334 RDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSD 393
RDIK++NIL+D FEAKVADFGLAK + DT+THVSTRVMGTFGYLAPEYA+SGKLTEKSD
Sbjct: 398 RDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMGTFGYLAPEYAASGKLTEKSD 457
Query: 394 VFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEE-YDX 452
VFSFGV+LLELITG RP D + + DDS+VDWA+P L + G+F+ L D K+ YD
Sbjct: 458 VFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLNRASEQGDFEGLADAKMNNGYDR 517
Query: 453 XXXXXXXXXXXXXXXXXXXXXPRMSQIVRALEGNMPLDDLNEGITPGHSTIYGSYGGS-D 511
PRMSQIVRALEGN+ L DLNEG+ PG S +Y SYGGS D
Sbjct: 518 EEMARMVACAAACVRHSARRRPRMSQIVRALEGNVSLSDLNEGMRPGQSNVYSSYGGSTD 577
Query: 512 YNSMQYREDMKKFRKIALESVELGSS-DYSGLTSDYGQNPPSSSTEDRQATQETE 565
Y+S QY EDMKKFRK+AL + E ++ +YS TSDYG P SS+E Q T+E E
Sbjct: 578 YDSSQYNEDMKKFRKMALGTQEYNATGEYSNPTSDYGLYPSGSSSEG-QTTREME 631
|
|
| TAIR|locus:2018209 PERK15 "proline-rich extensin-like receptor kinase 15" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1347 (479.2 bits), Expect = 1.2e-140, Sum P(2) = 1.2e-140
Identities = 263/382 (68%), Positives = 302/382 (79%)
Query: 196 KSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAE 255
++ FTYE+L AT NFS NLLGQGGFGYVH+GVL +G +VAIKQLK+GSGQGEREFQAE
Sbjct: 128 QNLFTYEDLSKATSNFSNTNLLGQGGFGYVHRGVLVDGTLVAIKQLKSGSGQGEREFQAE 187
Query: 256 IEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALG 315
I+ IS+VHHRHLVSL+GYC G+QRLLVYEFVPNKTLEFHLH K+RPVM W RMKIALG
Sbjct: 188 IQTISRVHHRHLVSLLGYCITGAQRLLVYEFVPNKTLEFHLHEKERPVMEWSKRMKIALG 247
Query: 316 SARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF 375
+A+GLAYLHEDC PK IHRD+K+ANIL+DDS+EAK+ADFGLA+ SLDTDTHVSTR+MGTF
Sbjct: 248 AAKGLAYLHEDCNPKTIHRDVKAANILIDDSYEAKLADFGLARSSLDTDTHVSTRIMGTF 307
Query: 376 GYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADD-SMVDWAKPFLAQGL 434
GYLAPEYASSGKLTEKSDVFS GV+LLELITG RP DK+ FADD S+VDWAKP + Q L
Sbjct: 308 GYLAPEYASSGKLTEKSDVFSIGVVLLELITGRRPVDKSQPFADDDSIVDWAKPLMIQAL 367
Query: 435 ADGNFDALVDQKLE-EYDXXXXXXXXXXXXXXXXXXXXXXPRMSQIVRALEGNMPLDDLN 493
DGNFD LVD +LE ++D P+MSQIVRA EGN+ +DDL
Sbjct: 368 NDGNFDGLVDPRLENDFDINEMTRMVACAAASVRHSAKRRPKMSQIVRAFEGNISIDDLT 427
Query: 494 EGITPGHSTIYGSYGGSDYNSMQYREDMKKFRKIALESVELGSSDYSGLTSDYGQNPPSS 553
EG PG STIY G SDY+S QY+ED+KKF+K+A ES GSS+ SGLTSD GQNP S
Sbjct: 428 EGAAPGQSTIYSLDGSSDYSSTQYKEDLKKFKKMAFESKTFGSSECSGLTSDNGQNPSGS 487
Query: 554 S--TEDRQATQETEP--NEKDT 571
S TE ++ TQE EP N KDT
Sbjct: 488 SSITEGQRTTQEIEPEKNTKDT 509
|
|
| TAIR|locus:2093999 PERK6 "proline-rich extensin-like receptor kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1237 (440.5 bits), Expect = 6.9e-130, Sum P(2) = 6.9e-130
Identities = 249/424 (58%), Positives = 301/424 (70%)
Query: 139 SDYQELPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPF----PRQSPGMPVGN 194
+++ P P P S P+ P P PVS S+ S + P P P + +G
Sbjct: 261 NNWMNSPPPPPPGSWQPSPPPPPPPVSGGMNGNSSDFSSNYSGPHGPSVPPPHPSVALGF 320
Query: 195 FKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQA 254
KSTFTY+EL AT FS++ LLGQGGFGYVHKG+L NGK +A+K LKAGSGQGEREFQA
Sbjct: 321 NKSTFTYDELAAATQGFSQSRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSGQGEREFQA 380
Query: 255 EIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIAL 314
E++IIS+VHHR LVSLVGYC G QR+LVYEF+PN TLEFHLHGK V++WPTR+KIAL
Sbjct: 381 EVDIISRVHHRFLVSLVGYCIAGGQRMLVYEFLPNDTLEFHLHGKSGKVLDWPTRLKIAL 440
Query: 315 GSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 374
GSA+GLAYLHEDC P+IIHRDIK++NILLD+SFEAKVADFGLAK S D THVSTR+MGT
Sbjct: 441 GSAKGLAYLHEDCHPRIIHRDIKASNILLDESFEAKVADFGLAKLSQDNVTHVSTRIMGT 500
Query: 375 FGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGL 434
FGYLAPEYASSGKLT++SDVFSFGV+LLEL+TG RP D +DS+VDWA+P
Sbjct: 501 FGYLAPEYASSGKLTDRSDVFSFGVMLLELVTGRRPVDLTGEM-EDSLVDWARPICLNAA 559
Query: 435 ADGNFDALVDQKLE-EYDXXXXXXXXXXXXXXXXXXXXXXPRMSQIVRALEGNMPLDDLN 493
DG++ LVD +LE +Y+ P+MSQIVRALEG+ LDDL+
Sbjct: 560 QDGDYSELVDPRLENQYEPHEMAQMVACAAAAVRHSARRRPKMSQIVRALEGDATLDDLS 619
Query: 494 EGITPGHSTIYGSYGGSDYNSMQYREDMKKFRKIALESVELGSSDYSGLTSDYGQNPPSS 553
EG G S+ G SDY+S Y DMKKFRK+AL+S E G+S G TS+YG +P SS
Sbjct: 620 EGGKAGQSSFLGRGSSSDYDSSTYSADMKKFRKVALDSHEYGASSEYGNTSEYGLDPSSS 679
Query: 554 STED 557
S+E+
Sbjct: 680 SSEE 683
|
|
| TAIR|locus:2139474 PERK5 "proline-rich extensin-like receptor kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1233 (439.1 bits), Expect = 1.5e-127, Sum P(2) = 1.5e-127
Identities = 261/450 (58%), Positives = 313/450 (69%)
Query: 120 KNDPFAGKPHHWQQNV--SAPSD----YQELPKPSLPPSNGPTAPL--PTVPVSAFNEPL 171
K P H++ N APS Y+ P+ + G P PVS P
Sbjct: 217 KKSPQVNHMHYYNNNPYGGAPSGNGGYYKGTPQDHVVNMAGQGGGNWGPQQPVSG---PH 273
Query: 172 STSGSLDSDKPFPRQSP-GMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVL 230
S + +L P SP +G+ +STFTY+EL IAT+ F+++NLLGQGGFGYVHKGVL
Sbjct: 274 SDASNLTGRTAIP--SPQAATLGHNQSTFTYDELSIATEGFAQSNLLGQGGFGYVHKGVL 331
Query: 231 TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNK 290
+GK VA+K LK GSGQGEREFQAE++IIS+VHHRHLVSLVGYC G QRLLVYEF+PN
Sbjct: 332 PSGKEVAVKSLKLGSGQGEREFQAEVDIISRVHHRHLVSLVGYCISGGQRLLVYEFIPNN 391
Query: 291 TLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAK 350
TLEFHLHGK RPV++WPTR+KIALGSARGLAYLHEDC P+IIHRDIK+ANILLD SFE K
Sbjct: 392 TLEFHLHGKGRPVLDWPTRVKIALGSARGLAYLHEDCHPRIIHRDIKAANILLDFSFETK 451
Query: 351 VADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRP 410
VADFGLAK S D THVSTRVMGTFGYLAPEYASSGKL++KSDVFSFGV+LLELITG P
Sbjct: 452 VADFGLAKLSQDNYTHVSTRVMGTFGYLAPEYASSGKLSDKSDVFSFGVMLLELITGRPP 511
Query: 411 FDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLE-EYDXXXXXXXXXXXXXXXXXX 469
D +DS+VDWA+P + DG+++ L D +LE Y
Sbjct: 512 LDLTGEM-EDSLVDWARPLCLKAAQDGDYNQLADPRLELNYSHQEMVQMASCAAAAIRHS 570
Query: 470 XXXXPRMSQIVRALEGNMPLDDLNEGITPGHSTIYGSYGG--SDYNSMQYREDMKKFRKI 527
P+MSQIVRALEG+M +DDL+EG PG ST Y S G S+Y++ Y DMKKF+K+
Sbjct: 571 ARRRPKMSQIVRALEGDMSMDDLSEGTRPGQST-YLSPGSVSSEYDASSYTADMKKFKKL 629
Query: 528 ALESVELGSSDYSGLTSDYGQNPPSSSTED 557
ALE+ E SS+Y G TS+YG NP +SS+E+
Sbjct: 630 ALENKEYQSSEYGG-TSEYGLNPSASSSEE 658
|
|
| TAIR|locus:2046268 PERK4 "proline-rich extensin-like receptor kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1228 (437.3 bits), Expect = 6.3e-127, Sum P(2) = 6.3e-127
Identities = 260/466 (55%), Positives = 318/466 (68%)
Query: 99 KRRKRKLAAQNLPLKS----IFSNVKNDPFAGKPHHWQQNVSAPSDYQELPKPSLPPSNG 154
+++KRK + P+K + N N+ + +W N S Q G
Sbjct: 174 RKKKRKDSFYPEPMKGNQYQYYGNNNNNNASQNYPNWHLN----SQGQNQQSTGGWGGGG 229
Query: 155 PTAPLPT-VPVSAFNEPLSTSGSLDSDKP-FPRQSPGMPVGNFKSTFTYEELKIATDNFS 212
P+ P P +P S + + + S +P P SP + +G KSTFTY+EL AT F+
Sbjct: 230 PSPPPPPRMPTSGEDSSMYSGPS----RPVLPPPSPALALGFNKSTFTYQELAAATGGFT 285
Query: 213 EANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVG 272
+ANLLGQGGFGYVHKGVL +GK VA+K LKAGSGQGEREFQAE++IIS+VHHR+LVSLVG
Sbjct: 286 DANLLGQGGFGYVHKGVLPSGKEVAVKSLKAGSGQGEREFQAEVDIISRVHHRYLVSLVG 345
Query: 273 YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKII 332
YC QR+LVYEFVPNKTLE+HLHGK+ PVM + TR++IALG+A+GLAYLHEDC P+II
Sbjct: 346 YCIADGQRMLVYEFVPNKTLEYHLHGKNLPVMEFSTRLRIALGAAKGLAYLHEDCHPRII 405
Query: 333 HRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKS 392
HRDIKSANILLD +F+A VADFGLAK + D +THVSTRVMGTFGYLAPEYASSGKLTEKS
Sbjct: 406 HRDIKSANILLDFNFDAMVADFGLAKLTSDNNTHVSTRVMGTFGYLAPEYASSGKLTEKS 465
Query: 393 DVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLE-EYD 451
DVFS+GV+LLELITG RP D + T DD++VDWA+P +A+ L DGNF+ L D +LE Y+
Sbjct: 466 DVFSYGVMLLELITGKRPVDNSITM-DDTLVDWARPLMARALEDGNFNELADARLEGNYN 524
Query: 452 XXXXXXXXXXXXXXXXXXXXXXPRMSQIVRALEGNMPLDDLNEGITPGHSTIYGSYGGS- 510
P+MSQIVRALEG + LD LNEG+ PGHS +YGS G S
Sbjct: 525 PQEMARMVTCAAASIRHSGRKRPKMSQIVRALEGEVSLDALNEGVKPGHSNVYGSLGASS 584
Query: 511 DYNSMQYREDMKKFRKIALESVELGSSDYSGLTS----DYGQNPPS 552
DY+ Y DMKKFR+IAL S E SD G +S D G P+
Sbjct: 585 DYSQTSYNADMKKFRQIALSSQEFPVSDCEGTSSNDSRDMGTKSPT 630
|
|
| TAIR|locus:2010282 PERK7 "proline-rich extensin-like receptor kinase 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1215 (432.8 bits), Expect = 1.2e-125, Sum P(2) = 1.2e-125
Identities = 253/431 (58%), Positives = 301/431 (69%)
Query: 136 SAPSDYQELPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSD---KPF----PRQSP 188
S +++ P P PP N P P PVS + SG + S+ P+ P P
Sbjct: 256 SMGTNWVSSPPPP-PPGNWQPMPSPPAPVSGGANVIQ-SGEMSSNFSSGPYAPSLPPPHP 313
Query: 189 GMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQG 248
+ +G STFTYEEL AT FS+ LLGQGGFGYVHKG+L NGK +A+K LKAGSGQG
Sbjct: 314 SVALGFNNSTFTYEELASATQGFSKDRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSGQG 373
Query: 249 EREFQAEIEIISQVHHRHLVSLVGYCT-FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWP 307
EREFQAE+EIIS+VHHRHLVSLVGYC+ G QRLLVYEF+PN TLEFHLHGK VM+WP
Sbjct: 374 EREFQAEVEIISRVHHRHLVSLVGYCSNAGGQRLLVYEFLPNDTLEFHLHGKSGTVMDWP 433
Query: 308 TRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 367
TR+KIALGSA+GLAYLHEDC PKIIHRDIK++NILLD +FEAKVADFGLAK S D +THV
Sbjct: 434 TRLKIALGSAKGLAYLHEDCHPKIIHRDIKASNILLDHNFEAKVADFGLAKLSQDNNTHV 493
Query: 368 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAK 427
STRVMGTFGYLAPEYASSGKLTEKSDVFSFGV+LLELITG P D + +DS+VDWA+
Sbjct: 494 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRGPVDLSGDM-EDSLVDWAR 552
Query: 428 PFLAQGLADGNFDALVDQKLE-EYDXXXXXXXXXXXXXXXXXXXXXXPRMSQIVRALEGN 486
P + DG + LVD LE +Y+ P+MSQIVR LEG+
Sbjct: 553 PLCMRVAQDGEYGELVDPFLEHQYEPYEMARMVACAAAAVRHSGRRRPKMSQIVRTLEGD 612
Query: 487 MPLDDLNEGITPGHSTIYGSYGGSDYNSMQYREDMKKFRKIALESVELGSSDYSGLTSDY 546
LDDL++G+ P S+ G G SDY Y +M+KFRK+ LES + G+S G TS+Y
Sbjct: 613 ASLDDLDDGVKPKQSSS-GGEGSSDYEMGTYGAEMRKFRKVTLESRDYGASSEYGATSEY 671
Query: 547 GQNPPSSSTED 557
G +P SSS+E+
Sbjct: 672 GLDPSSSSSEE 682
|
|
| TAIR|locus:2125692 PERK14 "proline-rich extensin-like receptor kinase 14" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 998 (356.4 bits), Expect = 3.9e-108, Sum P(3) = 3.9e-108
Identities = 216/405 (53%), Positives = 271/405 (66%)
Query: 161 TVPVSAFNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQG 220
T+P + +S+ G + ++ MP G F+YEEL AT FSE NLLG+G
Sbjct: 343 TMPPPIHAKYISSGGCDTKENNSVAKNISMPSG----MFSYEELSKATGGFSEENLLGEG 398
Query: 221 GFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR 280
GFGYVHKGVL NG VA+KQLK GS QGEREFQAE++ IS+VHH+HLVSLVGYC G +R
Sbjct: 399 GFGYVHKGVLKNGTEVAVKQLKIGSYQGEREFQAEVDTISRVHHKHLVSLVGYCVNGDKR 458
Query: 281 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSAN 340
LLVYEFVP TLEFHLH V+ W R++IA+G+A+GLAYLHEDC P IIHRDIK+AN
Sbjct: 459 LLVYEFVPKDTLEFHLHENRGSVLEWEMRLRIAVGAAKGLAYLHEDCSPTIIHRDIKAAN 518
Query: 341 ILLDDSFEAKVADFGLAKHSLDTD---THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSF 397
ILLD FEAKV+DFGLAK DT+ TH+STRV+GTFGY+APEYASSGK+T+KSDV+SF
Sbjct: 519 ILLDSKFEAKVSDFGLAKFFSDTNSSFTHISTRVVGTFGYMAPEYASSGKVTDKSDVYSF 578
Query: 398 GVLLLELITGFRP--FDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEE-YDXXX 454
GV+LLELITG RP F K D+ + S+VDWA+P L + ++ +FD LVD +LE+ YD
Sbjct: 579 GVVLLELITG-RPSIFAK-DSSTNQSLVDWARPLLTKAISGESFDFLVDSRLEKNYDTTQ 636
Query: 455 XXXXXXXXXXXXXXXXXXXPRMSQIVRALEGNMPLDDLNEGITPGHSTIYGSYGGSDYNS 514
PRMSQ+VRALEG + L + E G+S Y S + +
Sbjct: 637 MANMAACAAACIRQSAWLRPRMSQVVRALEGEVALRKVEE---TGNSVTYSSSENPNDIT 693
Query: 515 MQYREDMKKFRKIALESVELGSSDYSGLTSDYGQNPPSSSTEDRQ 559
+Y + ++F + GSSD G TS+YG NP SS+E +Q
Sbjct: 694 PRYGTNKRRF--------DTGSSD--GYTSEYGVNPSQSSSEHQQ 728
|
|
| TAIR|locus:2026846 PERK13 "proline-rich extensin-like receptor kinase 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1034 (369.0 bits), Expect = 9.2e-107, Sum P(2) = 9.2e-107
Identities = 234/457 (51%), Positives = 297/457 (64%)
Query: 132 QQNVSAPSDYQELPKPSLP-PSNGPT-APLPTVPVSA---FN-EPLSTSG-SLDSDKP-- 182
++N+ A SD Q LP + S+G PT S +N + S SG S S +
Sbjct: 261 KRNIDAYSDSQYLPPSNFSIKSDGFLYGQNPTKGYSGPGGYNSQQQSNSGNSFGSQRGGG 320
Query: 183 -FPRQ--SPGMPV-GNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAI 238
+ R +P V G+ ++ FTYEEL T+ FS+ N+LG+GGFG V+KG L +GK+VA+
Sbjct: 321 GYTRSGSAPDSAVMGSGQTHFTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAV 380
Query: 239 KQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHG 298
KQLK GSGQG+REF+AE+EIIS+VHHRHLVSLVGYC S+RLL+YE+VPN+TLE HLHG
Sbjct: 381 KQLKVGSGQGDREFKAEVEIISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHG 440
Query: 299 KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 358
K RPV+ W R++IA+GSA+GLAYLHEDC PKIIHRDIKSANILLDD FEA+VADFGLAK
Sbjct: 441 KGRPVLEWARRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAK 500
Query: 359 HSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFA 418
+ T THVSTRVMGTFGYLAPEYA SGKLT++SDVFSFGV+LLELITG +P D+
Sbjct: 501 LNDSTQTHVSTRVMGTFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLG 560
Query: 419 DDSMVDWAKPFLAQGLADGNFDALVDQKLEE-YDXXXXXXXXXXXXXXXXXXXXXXPRMS 477
++S+V+WA+P L + + G+F LVD++LE+ Y PRM
Sbjct: 561 EESLVEWARPLLHKAIETGDFSELVDRRLEKHYVENEVFRMIETAAACVRHSGPKRPRMV 620
Query: 478 QIVRALEGNMPLDDLNEGITPGHSTIYGSYGGSDYNSMQYREDMKKFRKIAL---ESVEL 534
Q+VRAL+ + D++ G G S S Y+S QY D KFRK+A +S +
Sbjct: 621 QVVRALDSEGDMGDISNGNKVGQS--------SAYDSGQYNNDTMKFRKMAFGFDDSSDS 672
Query: 535 G--SSDYSGLTSDYGQNPPSSSTEDRQATQETEPNEK 569
G S DYS S G N SS R T+ N +
Sbjct: 673 GMYSGDYSVQDSRKGSNGASSEFT-RNETENRNFNNR 708
|
|
| TAIR|locus:2159873 PERK8 "proline-rich extensin-like receptor kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 979 (349.7 bits), Expect = 1.0e-105, Sum P(3) = 1.0e-105
Identities = 204/416 (49%), Positives = 269/416 (64%)
Query: 148 SLPPS--NGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELK 205
++PPS + P + S + P SD + GM V N +S F+Y+EL
Sbjct: 275 TMPPSAYSSPQGSDVVLFNSRSSAPPKMRSHSGSDYMYASSDSGM-VSNQRSWFSYDELS 333
Query: 206 IATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHR 265
T FSE NLLG+GGFG V+KGVL++G+ VA+KQLK G QGEREF+AE+EIIS+VHHR
Sbjct: 334 QVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVEIISRVHHR 393
Query: 266 HLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHE 325
HLV+LVGYC RLLVY++VPN TL +HLH RPVM W TR+++A G+ARG+AYLHE
Sbjct: 394 HLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPGRPVMTWETRVRVAAGAARGIAYLHE 453
Query: 326 DCQPKIIHRDIKSANILLDDSFEAKVADFGLAK--HSLDTDTHVSTRVMGTFGYLAPEYA 383
DC P+IIHRDIKS+NILLD+SFEA VADFGLAK LD +THVSTRVMGTFGY+APEYA
Sbjct: 454 DCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVMGTFGYMAPEYA 513
Query: 384 SSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 443
+SGKL+EK+DV+S+GV+LLELITG +P D + D+S+V+WA+P L Q + + FD LV
Sbjct: 514 TSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLLGQAIENEEFDELV 573
Query: 444 DQKL-EEYDXXXXXXXXXXXXXXXXXXXXXXPRMSQIVRALEGNMPLDDLNEGITPGHST 502
D +L + + P+MSQ+VRAL+ D+ G+ PG S
Sbjct: 574 DPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALDTLEEATDITNGMRPGQSQ 633
Query: 503 IYGSYGGSDYNSMQYREDMKKFRKIALESVELGSSDYSGLTSDYGQNPPSSSTEDR 558
++ +S Q ++ F+++A GS DYS D Q+ S + D+
Sbjct: 634 VF--------DSRQQSAQIRMFQRMAF-----GSQDYSSDFFDRSQSHSSWGSRDQ 676
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9C821 | PEK15_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7303 | 0.6416 | 0.7387 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh2_kg.1__4299__AT1G52290.1 | annotation not avaliable (524 aa) | |||||||||
(Arabidopsis lyrata) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 586 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-54 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-53 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-53 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-51 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-51 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-50 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-44 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-42 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-35 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-34 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 8e-34 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-33 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-32 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-32 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-31 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-30 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-30 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-30 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-29 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-29 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-29 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-28 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-28 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-28 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-27 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-26 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-26 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-26 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 8e-26 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-26 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-25 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-25 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 9e-25 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-24 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-24 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-24 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-24 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-24 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-24 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 9e-24 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 9e-24 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-23 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-23 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-23 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-23 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-22 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-22 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-22 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-22 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-22 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-22 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-22 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-22 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-22 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-22 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-21 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-21 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-21 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-21 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-21 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-21 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 7e-21 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 8e-21 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-20 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-20 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-20 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-20 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-20 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-20 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-20 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-20 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-20 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-19 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-19 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-19 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-19 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-19 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 7e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-19 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-18 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-18 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-18 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-18 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-18 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-18 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-18 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-18 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-17 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-17 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-17 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-17 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-17 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-17 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-17 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 7e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-17 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-17 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-16 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-16 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-16 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-16 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-16 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-16 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-16 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-16 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 8e-16 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 9e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-15 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-15 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 8e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 8e-15 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-14 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-14 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-14 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-14 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-13 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-13 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-12 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-12 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-12 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 9e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 8e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 9e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-10 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 7e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 9e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 7e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 9e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 5e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-04 | |
| PRK06975 | 656 | PRK06975, PRK06975, bifunctional uroporphyrinogen- | 9e-04 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 0.001 | |
| pfam08693 | 40 | pfam08693, SKG6, Transmembrane alpha-helix domain | 0.002 | |
| cd12087 | 38 | cd12087, TM_EGFR-like, Transmembrane domain of the | 0.002 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.002 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 0.004 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 183 bits (466), Expect = 9e-54
Identities = 80/274 (29%), Positives = 124/274 (45%), Gaps = 30/274 (10%)
Query: 217 LGQGGFGYVHKGVLTNGKV-----VAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSL 270
LG+G FG V+KG L VA+K LK + + + EF E I+ ++ H ++V L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 271 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 330
+G CT +V E++ L +L K+RP ++ + AL ARG+ YL
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLR-KNRPKLSLSDLLSFALQIARGMEYLESK---N 122
Query: 331 IIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTE 390
IHRD+ + N L+ ++ K++DFGL++ D D + ++APE GK T
Sbjct: 123 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTS 182
Query: 391 KSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEE 449
KSDV+SFGVLL E+ T G +P+ + + L +G
Sbjct: 183 KSDVWSFGVLLWEIFTLGEQPYPGMSNEE-----------VLEYLKNGYR-----LPQPP 226
Query: 450 YDSAEMTRMAACAAACIRHSARRRPRMSQIVRAL 483
E+ + C RP S++V L
Sbjct: 227 NCPPELYDLMLQ---CWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 182 bits (465), Expect = 1e-53
Identities = 80/274 (29%), Positives = 120/274 (43%), Gaps = 29/274 (10%)
Query: 217 LGQGGFGYVHKGVLTNGKV-----VAIKQLKAG-SGQGEREFQAEIEIISQVHHRHLVSL 270
LG+G FG V+KG L VA+K LK S Q EF E I+ ++ H ++V L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 271 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 330
+G CT ++V E++P L +L ++ + AL ARG+ YL
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---N 123
Query: 331 IIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTE 390
IHRD+ + N L+ ++ K++DFGL++ D D + ++APE GK T
Sbjct: 124 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTS 183
Query: 391 KSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEE 449
KSDV+SFGVLL E+ T G P+ + + L G
Sbjct: 184 KSDVWSFGVLLWEIFTLGEEPYPGMSNAE-----------VLEYLKKGYR-----LPKPP 227
Query: 450 YDSAEMTRMAACAAACIRHSARRRPRMSQIVRAL 483
E+ ++ C RP S++V L
Sbjct: 228 NCPPELYKLMLQ---CWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 180 bits (460), Expect = 2e-53
Identities = 73/192 (38%), Positives = 106/192 (55%), Gaps = 9/192 (4%)
Query: 217 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE-FQAEIEIISQVHHRHLVSLVGYC 274
LG+GGFG V+ GK VAIK +K E EIEI+ +++H ++V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 275 TFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHR 334
+ LV E+ +L+ L + ++ ++I L GL YLH + IIHR
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLHSN---GIIHR 116
Query: 335 DIKSANILLD-DSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPE-YASSGKLTEKS 392
D+K NILLD D+ + K+ADFGL+K L +D + ++GT Y+APE G +EKS
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKL-LTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175
Query: 393 DVFSFGVLLLEL 404
D++S GV+L EL
Sbjct: 176 DIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 6e-51
Identities = 71/204 (34%), Positives = 100/204 (49%), Gaps = 9/204 (4%)
Query: 215 NLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE-FQAEIEIISQVHHRHLVSLVG 272
LG+G FG V+ GK+VAIK +K + +RE EI+I+ ++ H ++V L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 273 YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKII 332
+ LV E+ L L K R ++ L YLH I+
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARFYLRQILSALEYLHSK---GIV 119
Query: 333 HRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKS 392
HRD+K NILLD+ K+ADFGLA+ LD ++T V GT Y+APE +
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQ-LDPGEKLTTFV-GTPEYMAPEVLLGKGYGKAV 177
Query: 393 DVFSFGVLLLELITGFRPFDKADT 416
D++S GV+L EL+TG PF D
Sbjct: 178 DIWSLGVILYELLTGKPPFPGDDQ 201
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 175 bits (447), Expect = 7e-51
Identities = 84/283 (29%), Positives = 131/283 (46%), Gaps = 47/283 (16%)
Query: 217 LGQGGFGYVHKGVLT-----NGKVVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSL 270
LG+G FG V+KG L VA+K LK G+ + ER EF E I+ ++ H ++V L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 271 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 330
+G CT G +V E++P L L + +++AL A+G+ YL
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKL-TLKDLLQMALQIAKGMEYLESK---N 122
Query: 331 IIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG---YLAPEYASSGK 387
+HRD+ + N L+ ++ K++DFGL++ + D + G ++APE GK
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG--GGKLPIKWMAPESLKDGK 180
Query: 388 LTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 446
T KSDV+SFGVLL E+ T G +P+ + + + + L DG +
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEQPY---------PGMSNEE--VLELLEDGY-------R 222
Query: 447 LE--EYDSAE----MTRMAACAAACIRHSARRRPRMSQIVRAL 483
L E E M + C + RP S++V L
Sbjct: 223 LPRPENCPDELYELMLQ-------CWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 1e-50
Identities = 80/292 (27%), Positives = 132/292 (45%), Gaps = 52/292 (17%)
Query: 215 NLLGQGGFGYVHKGVLTNGK----VVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVS 269
LG+G FG V+KG L VA+K LK + + ER +F E ++ ++ H ++V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 270 LVGYCTFGSQRLLVYEFVPNKTLEFHLHGK-------DRPVMNWPTRMKIALGSARGLAY 322
L+G CT LV E++ L +L ++ ++ + A+ A+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 323 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST-------RVMGTF 375
L K +HRD+ + N L+ + K++DFGL++ D D + R
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----- 172
Query: 376 GYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGL 434
++APE G T KSDV+SFGVLL E+ T G P+ +++ ++++ L
Sbjct: 173 -WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPY---PGLSNEEVLEY--------L 220
Query: 435 ADGNFDALVDQKLE--EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484
G +L EY E+ + C + RP S++V LE
Sbjct: 221 RKGY-------RLPKPEYCPDELYELMLS---CWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 1e-44
Identities = 78/201 (38%), Positives = 108/201 (53%), Gaps = 12/201 (5%)
Query: 217 LGQGGFGYVHKGV-LTNGKVVAIKQLK---AGSGQGEREFQAEIEIISQVHHRHLVSLVG 272
LG G FG V+K GK+VA+K LK S + ++ + EI I+ ++ H ++V L+
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKK-DQTARREIRILRRLSHPNIVRLID 65
Query: 273 YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKII 332
LV E+ L F + P ++ KIAL RGL YLH + II
Sbjct: 66 AFEDKDHLYLVMEYCEGGDL-FDYLSRGGP-LSEDEAKKIALQILRGLEYLHSN---GII 120
Query: 333 HRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPE-YASSGKLTEK 391
HRD+K NILLD++ K+ADFGLAK L + + ++T V GT Y+APE K
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYGPK 179
Query: 392 SDVFSFGVLLLELITGFRPFD 412
DV+S GV+L EL+TG PF
Sbjct: 180 VDVWSLGVILYELLTGKPPFS 200
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 9e-42
Identities = 65/206 (31%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 215 NLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGE--REFQAEIEIISQVHHRHLVSLV 271
LLG+G FG V+ + G+++A+K ++ E + EI I+S + H ++V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 272 GYCT--FGSQRLLVYEFVPNKTLEFHLHGKDR---PVMNWPTRMKIALGSARGLAYLHED 326
G + + E+V +L L + PV+ TR + GLAYLH +
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQIL-----EGLAYLHSN 120
Query: 327 CQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM-GTFGYLAPEYASS 385
I+HRDIK ANIL+D K+ADFG AK D +T T + GT ++APE
Sbjct: 121 ---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 386 GKLTEKSDVFSFGVLLLELITGFRPF 411
+ +D++S G ++E+ TG P+
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPPW 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 2e-35
Identities = 65/202 (32%), Positives = 102/202 (50%), Gaps = 7/202 (3%)
Query: 211 FSEANLLGQGGFGYVHKG-VLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVS 269
F +G+GGFG V+K GK VAIK +K S + + + EI+I+ + H ++V
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 270 LVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQP 329
G + +V EF +L+ L ++ + + +GL YLH +
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQT-LTESQIAYVCKELLKGLEYLHSN--- 117
Query: 330 KIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLT 389
IIHRDIK+ANILL E K+ DFGL+ +DT ++GT ++APE +
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQL--SDTKARNTMVGTPYWMAPEVINGKPYD 175
Query: 390 EKSDVFSFGVLLLELITGFRPF 411
K+D++S G+ +EL G P+
Sbjct: 176 YKADIWSLGITAIELAEGKPPY 197
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 4e-34
Identities = 70/196 (35%), Positives = 110/196 (56%), Gaps = 4/196 (2%)
Query: 211 FSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSL 270
F+ LG G FG V +G+ N VAIK LK+ +++FQ E++ + ++ H+HL+SL
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 271 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 330
C+ G ++ E + +L L + V+ + + +A A G+AYL E
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---N 124
Query: 331 IIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTE 390
IHRD+ + NIL+ + KVADFGLA+ + D ++S+ + + APE AS G +
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLAR-LIKEDVYLSSDKKIPYKWTAPEAASHGTFST 183
Query: 391 KSDVFSFGVLLLELIT 406
KSDV+SFG+LL E+ T
Sbjct: 184 KSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 8e-34
Identities = 59/210 (28%), Positives = 104/210 (49%), Gaps = 23/210 (10%)
Query: 215 NLLGQGGFGYVHKGV-LTNGKVVAIKQLK-AGSGQGEREF-QAEIEIISQVHHRHLVSLV 271
+G+G FG V+ ++GK+ +K++ + + ERE E++I+ +++H +++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 272 GYCTFGSQRLL-VYEFVPNKTLEFHLH---GKDRP-----VMNWPTRMKIALGSARGLAY 322
+L V E+ L + + +P +++W ++ L L Y
Sbjct: 66 E-SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFV--QLCLA----LKY 118
Query: 323 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEY 382
LH KI+HRDIK NI L + K+ DFG++K L + ++ V+GT YL+PE
Sbjct: 119 LHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISK-VLSSTVDLAKTVVGTPYYLSPEL 174
Query: 383 ASSGKLTEKSDVFSFGVLLLELITGFRPFD 412
+ KSD++S G +L EL T PF+
Sbjct: 175 CQNKPYNYKSDIWSLGCVLYELCTLKHPFE 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 6e-33
Identities = 68/192 (35%), Positives = 99/192 (51%), Gaps = 8/192 (4%)
Query: 217 LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF 276
LG G FG V G VA+K LK G+ E F E +I+ ++ H LV L C+
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 277 GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDI 336
+V E++ +L L + + P + +A A G+AYL IHRD+
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDL 129
Query: 337 KSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF--GYLAPEYASSGKLTEKSDV 394
+ NIL+ ++ K+ADFGLA+ L D + R F + APE A+ G+ T KSDV
Sbjct: 130 AARNILVGENLVCKIADFGLAR--LIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDV 187
Query: 395 FSFGVLLLELIT 406
+SFG+LL E++T
Sbjct: 188 WSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 1e-32
Identities = 64/190 (33%), Positives = 98/190 (51%), Gaps = 4/190 (2%)
Query: 217 LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF 276
LG G FG V +G+ N VA+K LK G+ + +F AE +I+ ++ H L+ L CT
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 277 GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDI 336
+V E + +L +L G + P + +A A G+AYL IHRD+
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDL 129
Query: 337 KSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 396
+ N+L+ ++ KVADFGLA+ + + APE A + + KSDV+S
Sbjct: 130 AARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWS 189
Query: 397 FGVLLLELIT 406
FG+LL E++T
Sbjct: 190 FGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 3e-32
Identities = 63/189 (33%), Positives = 100/189 (52%), Gaps = 9/189 (4%)
Query: 216 LLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCT 275
+G+G FG V G KV A+K LK S + F AE +++ + H +LV L+G
Sbjct: 13 TIGKGEFGDVMLGDYRGQKV-AVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 276 FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRD 335
G+ +V E++ +L +L + R V+ ++ AL G+ YL E +HRD
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRD 127
Query: 336 IKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 395
+ + N+L+ + AKV+DFGLAK + + S ++ + APE K + KSDV+
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAKEA--SQGQDSGKL--PVKWTAPEALREKKFSTKSDVW 183
Query: 396 SFGVLLLEL 404
SFG+LL E+
Sbjct: 184 SFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 1e-31
Identities = 65/209 (31%), Positives = 106/209 (50%), Gaps = 17/209 (8%)
Query: 210 NFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLK-AGSGQGE-REFQAEIEIISQVHHRH 266
N+ +L+G+G FG V+KG+ L G VAIKQ+ + + EI+++ + H +
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 267 LVSLVGYCTFGSQRLLVYEFVPNKTLE--FHLHGK--DRPVMNWPTRMKIALGSARGLAY 322
+V +G ++ E+ N +L G + V + ++ +GLAY
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQV------LQGLAY 114
Query: 323 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEY 382
LHE +IHRDIK+ANIL K+ADFG+A L+ + V+GT ++APE
Sbjct: 115 LHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATK-LNDVSKDDASVVGTPYWMAPEV 170
Query: 383 ASSGKLTEKSDVFSFGVLLLELITGFRPF 411
+ SD++S G ++EL+TG P+
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTGNPPY 199
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 67/208 (32%), Positives = 99/208 (47%), Gaps = 16/208 (7%)
Query: 215 NLLGQGGFGYVHKGVLTN-----GKVVAIKQLKA-GSGQGEREFQAEIEIISQVHHRHLV 268
LG+G FG V G+ VA+K L G Q +F+ EIEI+ + H ++V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 269 SLVGYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED 326
G C R L+ E++P+ +L +L + R +N + + +G+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQ-RHRDQINLKRLLLFSSQICKGMDYLGSQ 128
Query: 327 CQPKIIHRDIKSANILLDDSFEAKVADFGLAKH-SLDTDTHVST--RVMGTFGYLAPEYA 383
+ IHRD+ + NIL++ K++DFGLAK D D + F Y APE
Sbjct: 129 ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECL 184
Query: 384 SSGKLTEKSDVFSFGVLLLELITGFRPF 411
+ K + SDV+SFGV L EL T P
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFTYGDPS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 71/212 (33%), Positives = 99/212 (46%), Gaps = 19/212 (8%)
Query: 216 LLGQGGFGYVHKGVLTNGKVVAIKQLK---AGSGQGEREFQAEIEIISQV-HHRHLVSLV 271
LG+G FG V+ K+VA+K L + F EI+I++ + H ++V L
Sbjct: 7 KLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 272 GYCTFGSQRLLVYEFVPNKTLEFHL-HGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 330
+ LV E+V +LE L + ++ + I L YLH
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--- 121
Query: 331 IIHRDIKSANILLD-DSFEAKVADFGLAKHSLDTDTHVSTR-----VMGTFGYLAPEYAS 384
IIHRDIK NILLD D K+ DFGLAK D + S +GT GY+APE
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 385 SGKL---TEKSDVFSFGVLLLELITGFRPFDK 413
L + SD++S G+ L EL+TG PF+
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEG 213
|
Length = 384 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 72/214 (33%), Positives = 97/214 (45%), Gaps = 30/214 (14%)
Query: 217 LGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGEREFQ---AEIEIISQVHHRHLVS 269
LG+G FG V K GK+ A+K LK +E + E I+S+++H +V
Sbjct: 1 LGKGSFGKVLLVRKKD---TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 270 LVGYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMK-----IALGSARGLAY 322
L + F ++ LV E+ P L HL + R + I L L Y
Sbjct: 58 L--HYAFQTEEKLYLVLEYAPGGELFSHL--SKEGRFS-EERARFYAAEIVLA----LEY 108
Query: 323 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEY 382
LH II+RD+K NILLD K+ DFGLAK + +T GT YLAPE
Sbjct: 109 LHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEV 164
Query: 383 ASSGKLTEKSDVFSFGVLLLELITGFRPFDKADT 416
+ D +S GVLL E++TG PF D
Sbjct: 165 LLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR 198
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 67/239 (28%), Positives = 109/239 (45%), Gaps = 13/239 (5%)
Query: 217 LGQGGFGYVHKGVL-TNGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVG-Y 273
LGQG G V+K GK+ A+K++ + ++ E++ + ++V G +
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 274 CTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIH 333
G + V E++ +L L K + P IA +GL YLH IIH
Sbjct: 69 YKEGEISI-VLEYMDGGSLA-DLLKKVGKI-PEPVLAYIARQILKGLDYLHTK--RHIIH 123
Query: 334 RDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSD 393
RDIK +N+L++ E K+ADFG++K +T +T V GT Y++PE + +D
Sbjct: 124 RDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYSYAAD 182
Query: 394 VFSFGVLLLELITGFRPFDKAD--TFAD--DSMVDWAKPFLAQGLADGNFDALVDQKLE 448
++S G+ LLE G PF +F + ++ D P L F + L+
Sbjct: 183 IWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQ 241
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 2e-29
Identities = 69/203 (33%), Positives = 107/203 (52%), Gaps = 14/203 (6%)
Query: 217 LGQGGFGYVHKGV--LTNGKV--VAIKQLKAG-SGQGEREFQAEIEIISQVHHRHLVSLV 271
LG G FG V KGV + +GK VA+K LK G++EF E +++Q+ H +V L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 272 GYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKI 331
G C G +LV E P L +L K R + ++A A G+AYL
Sbjct: 63 GVCK-GEPLMLVMELAPLGPLLKYL--KKRREIPVSDLKELAHQVAMGMAYLESK---HF 116
Query: 332 IHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF--GYLAPEYASSGKLT 389
+HRD+ + N+LL + +AK++DFG+++ + G + + APE + GK +
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFS 176
Query: 390 EKSDVFSFGVLLLELIT-GFRPF 411
KSDV+S+GV L E + G +P+
Sbjct: 177 SKSDVWSYGVTLWEAFSYGAKPY 199
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 4e-29
Identities = 66/197 (33%), Positives = 104/197 (52%), Gaps = 6/197 (3%)
Query: 217 LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF 276
+G G FG V G + VAIK ++ G+ E +F E +++ ++ H LV L G CT
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 277 GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDI 336
S LV+EF+ + L +L + R + T + + L G+AYL +IHRD+
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDL 126
Query: 337 KSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 396
+ N L+ ++ KV+DFG+ + LD ST + +PE S K + KSDV+S
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWS 186
Query: 397 FGVLLLELIT-GFRPFD 412
FGVL+ E+ + G P++
Sbjct: 187 FGVLMWEVFSEGKTPYE 203
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 7e-29
Identities = 66/213 (30%), Positives = 109/213 (51%), Gaps = 23/213 (10%)
Query: 217 LGQGGFGYVHKGVLT----NGKV-VAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSL 270
LG G FG V+KGV K+ VAIK L+ + + +E E +++ V H H+V L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 271 VGYCTFGSQRLLVYEFVPNKTLEFHLHG-KDR----PVMNWPTRMKIALGSARGLAYLHE 325
+G C SQ L+ + +P L ++ KD ++NW ++ A+G++YL E
Sbjct: 75 LGIC-LSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYLEE 127
Query: 326 DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH-SLDTDTHVSTRVMGTFGYLAPEYAS 384
+++HRD+ + N+L+ K+ DFGLAK +D + + ++A E
Sbjct: 128 K---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184
Query: 385 SGKLTEKSDVFSFGVLLLELIT-GFRPFDKADT 416
T KSDV+S+GV + EL+T G +P++
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA 217
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 68/208 (32%), Positives = 110/208 (52%), Gaps = 19/208 (9%)
Query: 215 NLLGQGGFGYVHKGVLT-NGK---VVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVS 269
++G G FG V +G L GK VAIK LKAGS +R +F E I+ Q H +++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 270 LVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQP 329
L G T +++ E++ N +L+ L D + + G A G+ YL E
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKF-TVGQLVGMLRGIASGMKYLSEMN-- 126
Query: 330 KIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTR-----VMGTFGYLAPEYAS 384
+HRD+ + NIL++ + KV+DFGL++ D++ +T+ + T APE +
Sbjct: 127 -YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APEAIA 181
Query: 385 SGKLTEKSDVFSFGVLLLELIT-GFRPF 411
K T SDV+SFG+++ E+++ G RP+
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMSYGERPY 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 66/216 (30%), Positives = 107/216 (49%), Gaps = 24/216 (11%)
Query: 217 LGQGGFGYVHKGVLTNGK------VVAIKQLKAGSGQGERE-FQAEIEIISQVHHRHLVS 269
LG+G FG V G + + +VA+K LK + R+ F+ E E+++ H ++V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 270 LVGYCTFGSQRLLVYEFVPNKTLEFHL--HGKDRPVMNWP-------TR---MKIALGSA 317
G CT G ++V+E++ + L L HG D + P T ++IA+ A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 318 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH-VSTRVMGTFG 376
G+ YL +HRD+ + N L+ K+ DFG+++ TD + V M
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189
Query: 377 YLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 411
++ PE K T +SDV+SFGV+L E+ T G +P+
Sbjct: 190 WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPW 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 9e-28
Identities = 72/212 (33%), Positives = 109/212 (51%), Gaps = 19/212 (8%)
Query: 210 NFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQ--LKAGSGQGEREFQAEIEIISQVHHRH 266
+F N +G+G FG V K V + +V A+KQ L + + E E +++++ +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 267 LVSLVGYCTFGSQRLL--VYEFVPNKTLEFHLHG-KDRPVMN---WPTRMKIALGSARGL 320
++ Y +F + L V E+ N L L + RP+ W ++I LG L
Sbjct: 61 IIRY--YESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----L 114
Query: 321 AYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAP 380
A+LH KI+HRDIKS N+ LD K+ D G+AK L +T+ + ++GT YL+P
Sbjct: 115 AHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAK-LLSDNTNFANTIVGTPYYLSP 170
Query: 381 EYASSGKLTEKSDVFSFGVLLLELITGFRPFD 412
E EKSDV++ GV+L E TG PFD
Sbjct: 171 ELCEDKPYNEKSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 8e-27
Identities = 60/197 (30%), Positives = 97/197 (49%), Gaps = 6/197 (3%)
Query: 217 LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF 276
LG G FG VH G VAIK ++ G+ E +F E +++ ++ H +LV L G CT
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 277 GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDI 336
+V E++ N L +L + + + + + + YL + IHRD+
Sbjct: 71 QRPIFIVTEYMANGCLLNYLR-ERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDL 126
Query: 337 KSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 396
+ N L+ + KV+DFGLA++ LD S + PE + + KSDV+S
Sbjct: 127 AARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWS 186
Query: 397 FGVLLLELIT-GFRPFD 412
FGVL+ E+ + G P++
Sbjct: 187 FGVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 65/211 (30%), Positives = 102/211 (48%), Gaps = 14/211 (6%)
Query: 215 NLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGE--REFQAEIEIISQVHHRHLVSLV 271
N +G G FG V+ V L G+++A+K+++ + +E E++++ + H +LV
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 272 GYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKI 331
G + + E+ TLE L + + L GLAYLH I
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQL--LEGLAYLHSH---GI 120
Query: 332 IHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRV---MGTFGYLAPEYASSGKL 388
+HRDIK ANI LD + K+ DFG A + T + V GT Y+APE + GK
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180
Query: 389 TEK---SDVFSFGVLLLELITGFRPFDKADT 416
+D++S G ++LE+ TG RP+ + D
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKRPWSELDN 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 72/244 (29%), Positives = 115/244 (47%), Gaps = 36/244 (14%)
Query: 216 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGE-----REFQAEIEIISQVHHRHLVS 269
LLG G FG V++G+ L +G A+K++ ++ + EI ++S++ H ++V
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 270 LVGYCTFGSQRLLVYEFVPNKTLEFHLHGK----DRPVMNWPTRMKIALGSARGLAYLHE 325
+G + E VP +L L K PV+ TR + GL YLH+
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLA-KLLKKYGSFPEPVIRLYTRQILL-----GLEYLHD 120
Query: 326 DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEY-AS 384
+HRDIK ANIL+D + K+ADFG+AK ++ S G+ ++APE A
Sbjct: 121 R---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS--FKGSPYWMAPEVIAQ 175
Query: 385 SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFA--------------DDSMVDWAKPFL 430
G +D++S G +LE+ TG P+ + + A D + D AK F+
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFI 235
Query: 431 AQGL 434
+ L
Sbjct: 236 LKCL 239
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 68/213 (31%), Positives = 102/213 (47%), Gaps = 40/213 (18%)
Query: 216 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVG-- 272
LG+G +G V+K + G+VVAIK + +E EI I+ Q ++V G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL--QEIIKEISILKQCDSPYIVKYYGSY 67
Query: 273 -----------YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIAL---GSAR 318
YC GS ++ + NKTL T +IA + +
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIMK--ITNKTL---------------TEEEIAAILYQTLK 110
Query: 319 GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYL 378
GL YLH K IHRDIK+ NILL++ +AK+ADFG++ DT +T V+GT ++
Sbjct: 111 GLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWM 166
Query: 379 APEYASSGKLTEKSDVFSFGVLLLELITGFRPF 411
APE K+D++S G+ +E+ G P+
Sbjct: 167 APEVIQEIGYNNKADIWSLGITAIEMAEGKPPY 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 8e-26
Identities = 68/192 (35%), Positives = 99/192 (51%), Gaps = 9/192 (4%)
Query: 217 LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF 276
LG G FG V G VAIK LK GS E F AE ++ Q+ H LV L T
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE-AFLAEANLMKQLQHPRLVRLYAVVT- 71
Query: 277 GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDI 336
++ E++ N +L L + + + +A A G+A++ + IHRD+
Sbjct: 72 QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDL 128
Query: 337 KSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF--GYLAPEYASSGKLTEKSDV 394
++ANIL+ ++ K+ADFGLA+ L D + R F + APE + G T KSDV
Sbjct: 129 RAANILVSETLCCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 186
Query: 395 FSFGVLLLELIT 406
+SFG+LL E++T
Sbjct: 187 WSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 8e-26
Identities = 76/285 (26%), Positives = 130/285 (45%), Gaps = 39/285 (13%)
Query: 217 LGQGGFGYVHKGVLTN------GKVVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVS 269
LGQG FG V++G+ VAIK + + ER EF E ++ + + H+V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 270 LVGYCTFGSQRLLVYEFVPNKTLEFHLHGK-----DRPVMNWPTRMKI---ALGSARGLA 321
L+G + G L+V E + L+ +L + + P + PT K A A G+A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 322 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH-VSTRVMGTFGYLAP 380
YL K +HRD+ + N ++ + K+ DFG+ + +TD + + + ++AP
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 381 EYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLA-DGNF 439
E G T KSDV+SFGV+L E+ T A +P+ QGL+ +
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMA----------TLA-------EQPY--QGLSNEEVL 231
Query: 440 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484
++D + ++ C +++ + RP +IV +L+
Sbjct: 232 KFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 73/208 (35%), Positives = 106/208 (50%), Gaps = 11/208 (5%)
Query: 205 KIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHH 264
+I ++ LG G FG V G VA+K LK G+ E F E +I+ ++ H
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE-SFLEEAQIMKKLRH 60
Query: 265 RHLVSLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYL 323
LV L Y + + +V E++ +L L + + P + +A A G+AY+
Sbjct: 61 DKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI 118
Query: 324 HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF--GYLAPE 381
+ IHRD++SANIL+ D K+ADFGLA+ L D + R F + APE
Sbjct: 119 E---RMNYIHRDLRSANILVGDGLVCKIADFGLAR--LIEDNEYTARQGAKFPIKWTAPE 173
Query: 382 YASSGKLTEKSDVFSFGVLLLELITGFR 409
A G+ T KSDV+SFG+LL EL+T R
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 7e-25
Identities = 72/196 (36%), Positives = 104/196 (53%), Gaps = 11/196 (5%)
Query: 217 LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF 276
LGQG FG V G VAIK LK G+ E F E +++ ++ H LV L Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL--YAVV 70
Query: 277 GSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRD 335
+ + +V E++ +L L G+ + P + +A A G+AY+ + +HRD
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 127
Query: 336 IKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF--GYLAPEYASSGKLTEKSD 393
+++ANIL+ ++ KVADFGLA+ L D + R F + APE A G+ T KSD
Sbjct: 128 LRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 394 VFSFGVLLLELITGFR 409
V+SFG+LL EL T R
Sbjct: 186 VWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 9e-25
Identities = 76/302 (25%), Positives = 127/302 (42%), Gaps = 63/302 (20%)
Query: 201 YEELKIATDNFSEANLLGQGGFGYVHKGV--LTNGKVVAIKQLKAGSGQGEREFQ---AE 255
YE L+ +G+G FG V K V ++GK++ K++ G+ E+E Q +E
Sbjct: 2 YEVLET----------IGKGSFGTVRK-VRRKSDGKILVWKEIDYGN-MTEKEKQQLVSE 49
Query: 256 IEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL----EFHLHG----------KDR 301
+ I+ ++ H ++V Y R++ N+TL E+ G K+R
Sbjct: 50 VNILRELKHPNIV---RYY----DRIIDRS---NQTLYIVMEYCEGGDLAQLIQKCKKER 99
Query: 302 PVMNWPTRMKIALGSARGLAYLH--EDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 359
+ +I L H D ++HRD+K ANI LD + K+ DFGLAK
Sbjct: 100 KYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK- 158
Query: 360 SLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFAD 419
L D+ + +GT Y++PE + EKSD++S G L+ EL PF A
Sbjct: 159 ILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPF-TARNQLQ 217
Query: 420 DSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQI 479
LA + +G F + + E + + + +RP ++
Sbjct: 218 ----------LASKIKEGKFRRIPYRYSSELNEV--------IKSMLNVDPDKRPSTEEL 259
Query: 480 VR 481
++
Sbjct: 260 LQ 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 1e-24
Identities = 66/205 (32%), Positives = 105/205 (51%), Gaps = 10/205 (4%)
Query: 215 NLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGY 273
+ LG G +G V++GV VA+K LK + + E EF E ++ ++ H +LV L+G
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 70
Query: 274 CTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIH 333
CT ++ EF+ L +L +R +N + +A + + YL + IH
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIH 127
Query: 334 RDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF--GYLAPEYASSGKLTEK 391
RD+ + N L+ ++ KVADFGL++ L T + F + APE + K + K
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSR--LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 185
Query: 392 SDVFSFGVLLLELIT-GFRPFDKAD 415
SDV++FGVLL E+ T G P+ D
Sbjct: 186 SDVWAFGVLLWEIATYGMSPYPGID 210
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 68/213 (31%), Positives = 99/213 (46%), Gaps = 37/213 (17%)
Query: 211 FSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREF-QAEIEIISQVHHRHLV 268
F+ +G+G FG V+K + +VVAIK + + E E Q EI+ +SQ ++
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 269 SLVG-------------YCTFGSQR-LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIAL 314
G YC GS LL + + F L R V+
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFIL----REVL---------- 108
Query: 315 GSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 374
GL YLHE+ IHRDIK+ANILL + + K+ADFG++ T + +T V GT
Sbjct: 109 ---LGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GT 161
Query: 375 FGYLAPEYASSGKLTEKSDVFSFGVLLLELITG 407
++APE EK+D++S G+ +EL G
Sbjct: 162 PFWMAPEVIKQSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 67/203 (33%), Positives = 104/203 (51%), Gaps = 19/203 (9%)
Query: 216 LLGQGGFGYVHKGVL-----TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSL 270
LG+G FG V G+VVA+K+L+ + + R+F+ EIEI+ + H ++V
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 271 VGYCTFGSQRL---LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC 327
G C + + R LV E++P +L +L K R ++ + A +G+ YL
Sbjct: 71 KGVC-YSAGRRNLRLVMEYLPYGSLRDYLQ-KHRERLDHRKLLLYASQICKGMEYLGSK- 127
Query: 328 QPKIIHRDIKSANILLDDSFEAKVADFGLAK-HSLDTDTHVSTRVMG---TFGYLAPEYA 383
+ +HRD+ + NIL++ K+ DFGL K D + + R G F Y APE
Sbjct: 128 --RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYK-VREPGESPIFWY-APESL 183
Query: 384 SSGKLTEKSDVFSFGVLLLELIT 406
+ K + SDV+SFGV+L EL T
Sbjct: 184 TESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 68/201 (33%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 217 LGQGGFGYV--HKGVLTN---GKVVAIKQLKAGSGQGERE-FQAEIEIISQVHHRHLVSL 270
LG+G FG V + N G++VA+K LK GQ ++ EI I+ ++H ++V
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 271 VGYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 328
G C+ + L+ E+VP +L +L + +N + A G+AYLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL---PKHKLNLAQLLLFAQQICEGMAYLHSQ-- 126
Query: 329 PKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMG---TFGYLAPEYASS 385
IHRD+ + N+LLD+ K+ DFGLAK + + R G F Y A E
Sbjct: 127 -HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVECLKE 184
Query: 386 GKLTEKSDVFSFGVLLLELIT 406
K + SDV+SFGV L EL+T
Sbjct: 185 NKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 5e-24
Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 39/218 (17%)
Query: 217 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA----EIEIISQVHHRHLVSLV 271
LG+G +G V+K G++VA+K+++ E + EI ++ ++ H ++V L+
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIR--LDNEEEGIPSTALREISLLKELKHPNIVKLL 64
Query: 272 GYCTFGSQRLLVYEFVPNKTLEFHLHG---KDRPVMNWPTRMKIALGSARGLAYLHEDCQ 328
+ LV+E+ + L K ++ I RGLAY H
Sbjct: 65 DVIHTERKLYLVFEY-----CDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---S 116
Query: 329 PKIIHRDIKSANILLDDSFEAKVADFGLAK---HSLDTDTHVSTRVMGTFGYLAPE---- 381
+I+HRD+K NIL++ K+ADFGLA+ L T TH V+ T Y APE
Sbjct: 117 HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH---EVV-TLWYRAPEILLG 172
Query: 382 ---YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADT 416
Y+++ D++S G + E+ITG +P D+
Sbjct: 173 SKHYSTA------VDIWSVGCIFAEMITG-KPLFPGDS 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 8e-24
Identities = 60/196 (30%), Positives = 98/196 (50%), Gaps = 10/196 (5%)
Query: 216 LLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGERE-FQAEIEIISQVHHRHLVSLVGYC 274
+G+G FG V+KGVL VA+K ++ + F E EI+ Q H ++V L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 275 TFGSQRLLVYEFVPNKTLEFHLHGKDR--PVMNWPTRMKIALGSARGLAYLHEDCQPKII 332
+V E VP +L L K V ++++L +A G+ YL I
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKK---LLQMSLDAAAGMEYLESKN---CI 115
Query: 333 HRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT-FGYLAPEYASSGKLTEK 391
HRD+ + N L+ ++ K++DFG+++ VS + + APE + G+ T +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSE 175
Query: 392 SDVFSFGVLLLELITG 407
SDV+S+G+LL E +
Sbjct: 176 SDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 9e-24
Identities = 67/216 (31%), Positives = 105/216 (48%), Gaps = 24/216 (11%)
Query: 217 LGQGGFGYVHKGVLTN------GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSL 270
LG+G FG V N +VA+K LK S ++FQ E E+++ + H+H+V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 271 VGYCTFGSQRLLVYEFVPNKTLEFHL--HGKDRPVMN-----------WPTRMKIALGSA 317
G CT G L+V+E++ + L L HG D ++ + IA A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 318 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH-VSTRVMGTFG 376
G+ YL +HRD+ + N L+ K+ DFG+++ TD + V R M
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 377 YLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 411
++ PE K T +SD++SFGV+L E+ T G +P+
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPW 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 9e-24
Identities = 75/196 (38%), Positives = 104/196 (53%), Gaps = 11/196 (5%)
Query: 217 LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF 276
LGQG FG V G VAIK LK G+ E F E +I+ ++ H LV L Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE-AFLQEAQIMKKLRHDKLVPL--YAVV 70
Query: 277 GSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRD 335
+ + +V EF+ +L L D + P + +A A G+AY+ + IHRD
Sbjct: 71 SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRD 127
Query: 336 IKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF--GYLAPEYASSGKLTEKSD 393
+++ANIL+ D+ K+ADFGLA+ L D + R F + APE A G+ T KSD
Sbjct: 128 LRAANILVGDNLVCKIADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 394 VFSFGVLLLELITGFR 409
V+SFG+LL EL+T R
Sbjct: 186 VWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 75/219 (34%), Positives = 109/219 (49%), Gaps = 26/219 (11%)
Query: 215 NLLGQGGFGYVHKGVL--TNGKVV--AIKQLKAGSGQGERE-FQAEIEIISQVHHRHLVS 269
++G+G FG V+ G L ++G+ + A+K L + E E F E I+ H +++S
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 270 LVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR-------MKIALGSARGLAY 322
L+G C L E P L + HG R + T + L A+G+ Y
Sbjct: 61 LLGIC-------LPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEY 113
Query: 323 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD---THVSTRVMGTFGYLA 379
L K +HRD+ + N +LD+SF KVADFGLA+ D + H T ++A
Sbjct: 114 L---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA 170
Query: 380 PEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTF 417
E + K T KSDV+SFGVLL EL+T G P+ D+F
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF 209
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 2e-23
Identities = 68/204 (33%), Positives = 106/204 (51%), Gaps = 14/204 (6%)
Query: 217 LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF 276
LG G FG V G VAIK +K GS E EF E +++ ++ H LV L G CT
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 277 GSQRLLVYEFVPNKTLEFHLH-GKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRD 335
+V E++ N L +L R + +++ G+AYL + IHRD
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPS--QLLEMCKDVCEGMAYLESK---QFIHRD 125
Query: 336 IKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT---FGYLAPEYASSGKLTEKS 392
+ + N L+DD KV+DFGL+++ LD D + S+ +G+ + PE K + KS
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYVLD-DEYTSS--VGSKFPVRWSPPEVLLYSKFSSKS 182
Query: 393 DVFSFGVLLLELIT-GFRPFDKAD 415
DV++FGVL+ E+ + G P+++ +
Sbjct: 183 DVWAFGVLMWEVYSLGKMPYERFN 206
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 57/219 (26%), Positives = 99/219 (45%), Gaps = 48/219 (21%)
Query: 217 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE---FQA--EIEIISQVHHRHLVSL 270
+G+G +G V+K G++VA+K+++ + E+E A EI+++ ++ H ++V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIR---MENEKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 271 VGYCT--FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR--------GL 320
T +V+E++ + + +K + GL
Sbjct: 64 KEIVTSKGKGSIYMVFEYMDHDLTGLLDSPE----------VKFTESQIKCYMKQLLEGL 113
Query: 321 AYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH-SLDTDTHVSTRVMGTFGYLA 379
YLH I+HRDIK +NIL+++ K+ADFGLA+ + + RV+ T Y
Sbjct: 114 QYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRP 169
Query: 380 PE-------YASSGKLTEKSDVFSFGVLLLELITGFRPF 411
PE Y + D++S G +L EL G +P
Sbjct: 170 PELLLGATRY------GPEVDMWSVGCILAELFLG-KPI 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 3e-23
Identities = 70/241 (29%), Positives = 115/241 (47%), Gaps = 46/241 (19%)
Query: 203 ELKIATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLK-AGSGQGEREFQAE 255
E+ ++ F E LG+G FG V+KG LT + VAIK LK + ++EF+ E
Sbjct: 1 EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58
Query: 256 IEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR------ 309
E++S + H ++V L+G CT +++E++ + L L V N P
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFL------VRNSPHSDVGAES 112
Query: 310 --------------MKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 355
+ IA+ A G+ YL +HRD+ + N L+ + K++DFG
Sbjct: 113 GDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFG 169
Query: 356 LAKHSLDTDTHVSTRVMGT----FGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRP 410
L++ D + RV ++ PE GK T +SD++SFGV+L E+ + G +P
Sbjct: 170 LSRDIYSADYY---RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
Query: 411 F 411
+
Sbjct: 227 Y 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 7e-23
Identities = 66/220 (30%), Positives = 118/220 (53%), Gaps = 30/220 (13%)
Query: 216 LLGQGGFGYVHKGV-LTNGKVVAIKQ--LKAGSGQGERE-------FQAEIEIISQVHHR 265
L+G G FG V+ G+ ++G+++A+KQ L + S + EI ++ ++ H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 266 HLVSLVGYCTFGSQRLLVY-EFVPNKTLEFHLHG----KDRPVMNWPTRMKIALGSARGL 320
++V +G + + L ++ E+VP ++ L+ ++ V N+ ++ +GL
Sbjct: 67 NIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQI------LKGL 119
Query: 321 AYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK----HSLDTDTHVS-TRVMGTF 375
YLH IIHRDIK ANIL+D+ K++DFG++K +SL T T+ + + G+
Sbjct: 120 NYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV 176
Query: 376 GYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKAD 415
++APE T K+D++S G L++E++TG PF
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT 216
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 8e-23
Identities = 65/200 (32%), Positives = 110/200 (55%), Gaps = 16/200 (8%)
Query: 217 LGQGGFGYVHKGVLTNGKVVAIKQLKAG-SGQGEREFQAEIEIISQVHHRHLVSLVGYCT 275
+G+G FG V +G T G+ VA+K +K + Q F E +++++HH++LV L+G
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLG-VI 68
Query: 276 FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRD 335
+ +V E + L L + R +++ ++ +L A G+ YL K++HRD
Sbjct: 69 LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRD 125
Query: 336 IKSANILLDDSFEAKVADFGLAK-HSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 394
+ + NIL+ + AKV+DFGLA+ S+ D +++ + APE K + KSDV
Sbjct: 126 LAARNILVSEDGVAKVSDFGLARVGSMGVDN---SKL--PVKWTAPEALKHKKFSSKSDV 180
Query: 395 FSFGVLLLELIT-GFRPFDK 413
+S+GVLL E+ + G P+ K
Sbjct: 181 WSYGVLLWEVFSYGRAPYPK 200
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 64/203 (31%), Positives = 104/203 (51%), Gaps = 18/203 (8%)
Query: 217 LGQGGFGYVHK-GVLTNGKVVAIKQLKAGSGQGEREFQA--EIEIISQVHHRHLVSLVGY 273
+G+G G V K G+ VA+K++ +G QA EI+ + H ++V L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 274 CTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR--MKIALGSARGLAYLHEDCQPKI 331
GS +LV E++P+ L L ++RP+ + M++ L +G+AY+H + I
Sbjct: 68 FPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLL---KGVAYMHAN---GI 120
Query: 332 IHRDIKSANILLDDSFEAKVADFGLAK-HSLDTDTHVSTRVMGTFGYLAPE--YASSGKL 388
+HRD+K AN+L+ K+ADFGLA+ S + S +V T Y APE Y + K
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPELLYGAR-KY 178
Query: 389 TEKSDVFSFGVLLLELITGFRPF 411
D+++ G + EL+ G P
Sbjct: 179 DPGVDLWAVGCIFAELLNG-SPL 200
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 2e-22
Identities = 64/204 (31%), Positives = 101/204 (49%), Gaps = 8/204 (3%)
Query: 205 KIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHH 264
+I ++ LG G FG V G N VA+K LK G+ + F E ++ + H
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQH 60
Query: 265 RHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH 324
LV L T ++ E++ +L L + + P + + A G+AY+
Sbjct: 61 DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE 120
Query: 325 EDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF--GYLAPEY 382
+ IHRD+++AN+L+ +S K+ADFGLA+ + D + R F + APE
Sbjct: 121 ---RKNYIHRDLRAANVLVSESLMCKIADFGLAR--VIEDNEYTAREGAKFPIKWTAPEA 175
Query: 383 ASSGKLTEKSDVFSFGVLLLELIT 406
+ G T KSDV+SFG+LL E++T
Sbjct: 176 INFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 2e-22
Identities = 71/215 (33%), Positives = 112/215 (52%), Gaps = 12/215 (5%)
Query: 210 NFSEANLLGQGGFGYVHK-GVLTNGKVVAIKQLKAGS-GQGEREFQA-EIEIISQVHHRH 266
+F LG+G +G V+K L++ + A+K++ GS Q ERE EI I++ V+H +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 267 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRM--KIALGSARGLAYLH 324
++S G++ +V E+ P L + + + P + +I + RGL LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 325 EDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYAS 384
E KI+HRD+KSANILL + K+ D G++K + T +GT Y+APE
Sbjct: 121 EQ---KILHRDLKSANILLVANDLVKIGDLGISK--VLKKNMAKT-QIGTPHYMAPEVWK 174
Query: 385 SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFAD 419
+ KSD++S G LL E+ T PF+ A + D
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPPFE-ARSMQD 208
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 2e-22
Identities = 64/227 (28%), Positives = 108/227 (47%), Gaps = 36/227 (15%)
Query: 217 LGQGGFGYVHKGVLTNGK------VVAIKQLKAGSGQGE-REFQAEIEIISQVHHRHLVS 269
LG+G FG V K K VA+K LK + E R+ +E ++ QV+H H++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 270 LVGYCTFGSQRLLVYEFVPNKTLEFHL-----------------------HGKDRPVMNW 306
L G C+ LL+ E+ +L L + +R +
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL-TM 126
Query: 307 PTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 366
+ A +RG+ YL E K++HRD+ + N+L+ + + K++DFGL++ + D++
Sbjct: 127 GDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 367 VS-TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 411
V ++ ++A E T +SDV+SFGVLL E++T G P+
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 230
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 64/240 (26%), Positives = 98/240 (40%), Gaps = 53/240 (22%)
Query: 209 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQL---------KAGSGQGEREFQAEIEI 258
D+F ++G+G F V K AIK L K + E+E +
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKE------V 54
Query: 259 ISQV-HHRHLVSLVGYCTFGSQRLL--VYEFVPNKTLEFHLH---GKDRPVMNWPTRMKI 312
++++ H ++ L Y TF + L V E+ PN L ++ D TR
Sbjct: 55 LTRLNGHPGIIKL--YYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKC----TRFYA 108
Query: 313 A-LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRV 371
A + A L YLH IIHRD+K NILLD K+ DFG AK + S +
Sbjct: 109 AEILLA--LEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKG 163
Query: 372 M-------------------GTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFD 412
GT Y++PE + + SD+++ G ++ +++TG PF
Sbjct: 164 DATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR 223
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 97.1 bits (241), Expect = 2e-22
Identities = 66/214 (30%), Positives = 104/214 (48%), Gaps = 22/214 (10%)
Query: 217 LGQGGFGYVHKGVLTN------GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSL 270
LG+G FG V N +VA+K LK S ++F E E+++ + H H+V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 271 VGYCTFGSQRLLVYEFVPNKTLEFHL--HGKDRPVM---NWPTRMK------IALGSARG 319
G C G ++V+E++ + L L HG D +M N P + IA A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 320 LAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH-VSTRVMGTFGYL 378
+ YL +HRD+ + N L+ ++ K+ DFG+++ TD + V M ++
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 379 APEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 411
PE K T +SDV+S GV+L E+ T G +P+
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPW 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 3e-22
Identities = 68/226 (30%), Positives = 113/226 (50%), Gaps = 37/226 (16%)
Query: 215 NLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGERE---FQA--EIEIISQVHHRHLV 268
LG+G + V+K G++VAIK++K G + ++ F A EI+++ ++ H +++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 269 SLVGYCTFGSQRL--LVYEFVPNKTLEFHLHGKDRPVMNWPTRMK-IALGSARGLAYLHE 325
L+ FG + LV+EF+ LE + KD+ ++ P +K L + RGL YLH
Sbjct: 66 GLLD--VFGHKSNINLVFEFMETD-LEKVI--KDKSIVLTPADIKSYMLMTLRGLEYLHS 120
Query: 326 DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPE---- 381
+ I+HRD+K N+L+ K+ADFGLA+ + ++ +V+ T Y APE
Sbjct: 121 N---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPELLFG 176
Query: 382 ---YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD 424
Y D++S G + EL+ PF DS +D
Sbjct: 177 ARHYGVG------VDMWSVGCIFAELLLR-VPF-----LPGDSDID 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 4e-22
Identities = 66/216 (30%), Positives = 117/216 (54%), Gaps = 14/216 (6%)
Query: 205 KIATDNFSEANLLGQGGFGYVHKGVL-TNGK---VVAIKQLKAGSGQGER-EFQAEIEII 259
+I + ++ ++G G FG V +G+L G+ VAIK LK G + +R +F +E I+
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIM 60
Query: 260 SQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARG 319
Q H +++ L G T +++ E++ N L+ +L D ++ + + G A G
Sbjct: 61 GQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-VGMLRGIAAG 119
Query: 320 LAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMG---TFG 376
+ YL + +HRD+ + NIL++ + E KV+DFGL++ L+ D + G
Sbjct: 120 MKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSR-VLEDDPEGTYTTSGGKIPIR 175
Query: 377 YLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 411
+ APE + K T SDV+SFG+++ E+++ G RP+
Sbjct: 176 WTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPY 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 5e-22
Identities = 71/224 (31%), Positives = 109/224 (48%), Gaps = 20/224 (8%)
Query: 205 KIATDNFSEANLLGQGGFGYVHKGV---LTNGKV---VAIKQL-KAGSGQGEREFQAEIE 257
++ D+ + LG G FG V++G+ V VA+K L ++ S Q E +F E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 258 IISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLE-FHLHGKDRPVMNWPTRMK----I 312
I+S+ +H+++V L+G R ++ E + L+ F + RP MK
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121
Query: 313 ALGSARGLAYLHEDCQPKIIHRDIKSANILLDD---SFEAKVADFGLAKHSLDTDTH-VS 368
A A+G YL E+ IHRDI + N LL AK+ADFG+A+ +
Sbjct: 122 ARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178
Query: 369 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 411
R M ++ PE G T K+DV+SFGVLL E+ + G+ P+
Sbjct: 179 GRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY 222
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 5e-22
Identities = 64/198 (32%), Positives = 100/198 (50%), Gaps = 6/198 (3%)
Query: 217 LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF 276
LG G FG VH G VAIK + G+ E +F E +++ ++ H LV L G CT
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 277 GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDI 336
+V EF+ N L +L + + ++ + + G+ YL + IHRD+
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQR-QGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDL 126
Query: 337 KSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 396
+ N L+ + KV+DFG+ ++ LD + S+ + PE + K + KSDV+S
Sbjct: 127 AARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWS 186
Query: 397 FGVLLLELIT-GFRPFDK 413
FGVL+ E+ T G PF+K
Sbjct: 187 FGVLMWEVFTEGKMPFEK 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 7e-22
Identities = 66/199 (33%), Positives = 104/199 (52%), Gaps = 8/199 (4%)
Query: 216 LLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSLVGYC 274
LLG+G FG V KG L + VA+K K Q + +F +E I+ Q H ++V L+G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 275 TFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH-EDCQPKIIH 333
T +V E VP L K + + +K AL +A G+AYL ++C IH
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLR-KKKDELKTKQLVKFALDAAAGMAYLESKNC----IH 116
Query: 334 RDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSD 393
RD+ + N L+ ++ K++DFG+++ D S + APE + G+ + +SD
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESD 176
Query: 394 VFSFGVLLLELIT-GFRPF 411
V+S+G+LL E + G P+
Sbjct: 177 VWSYGILLWETFSLGVCPY 195
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 9e-22
Identities = 64/200 (32%), Positives = 92/200 (46%), Gaps = 11/200 (5%)
Query: 217 LGQGGFGYVHK-GVLTNGKVVAIKQL---KAGSGQGEREFQAEIEIISQVHHRHLVSLVG 272
LG+GGFG V V GK+ A K+L + +GE+ E +I+ +V R +VSL
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 273 YCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKI 331
Y L LV + L++H++ P + A GL +LH Q +I
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRI 116
Query: 332 IHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEK 391
++RD+K N+LLDD +++D GLA GT GY+APE
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPGYMAPEVLQGEVYDFS 174
Query: 392 SDVFSFGVLLLELITGFRPF 411
D F+ G L E+I G PF
Sbjct: 175 VDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 1e-21
Identities = 63/206 (30%), Positives = 91/206 (44%), Gaps = 16/206 (7%)
Query: 216 LLGQGGFGYVHKGVLTN--GKV--VAIKQLKAGSGQG-EREFQAEIEIISQVHHRHLVSL 270
LG G FG V +G + GKV VA+K LK+ +F E I+ + H +L+ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 271 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 330
G ++V E P +L L T A+ A G+ YL +
Sbjct: 62 YG-VVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKR 117
Query: 331 IIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST----RVMGTFGYLAPEYASSG 386
IHRD+ + NILL + K+ DFGL + + H +V F + APE +
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESLRTR 175
Query: 387 KLTEKSDVFSFGVLLLELIT-GFRPF 411
+ SDV+ FGV L E+ T G P+
Sbjct: 176 TFSHASDVWMFGVTLWEMFTYGEEPW 201
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 1e-21
Identities = 60/220 (27%), Positives = 112/220 (50%), Gaps = 25/220 (11%)
Query: 216 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQ----------AEIEIISQVHH 264
L+G+G +G V+ + +T G+++A+KQ++ + R +EIE + + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 265 RHLVSLVGYCTFGSQRLLVYEFVPNKTLE--FHLHGK-DRPVMNWPTRMKIALGSARGLA 321
++V +G+ T + E+VP ++ +G+ + ++ + T + GLA
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL-----EGLA 122
Query: 322 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM-GTFGYLAP 380
YLH I+HRD+K+ N+L+D K++DFG++K S D + M G+ ++AP
Sbjct: 123 YLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179
Query: 381 EYASSGK--LTEKSDVFSFGVLLLELITGFRPFDKADTFA 418
E S + K D++S G ++LE+ G RP+ + A
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 34/215 (15%)
Query: 217 LGQGGFG--YVHKGVLTNGKVVAIKQLKAGSGQGEREFQ---AEIEIISQVHHRHLVSLV 271
+ +G +G ++ K T G + AIK +K + + E +I+SQ ++V L
Sbjct: 1 ISKGAYGRVFLAKKKST-GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL- 58
Query: 272 GYCTF-GSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRM------KIALGSARGLAYL 323
Y +F G + L LV E++P L L V + + +I L L YL
Sbjct: 59 -YYSFQGKKNLYLVMEYLPGGDLASLLEN----VGSLDEDVARIYIAEIVLA----LEYL 109
Query: 324 HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL-------DTDTHVSTRVMGTFG 376
H IIHRD+K NIL+D + K+ DFGL+K L + D R++GT
Sbjct: 110 H---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPD 166
Query: 377 YLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPF 411
Y+APE ++ D +S G +L E + G PF
Sbjct: 167 YIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPF 201
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 61/214 (28%), Positives = 93/214 (43%), Gaps = 23/214 (10%)
Query: 210 NFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQL---KAGSGQGEREFQAEIEIISQV 262
+F ++G+G FG V + K+ A+K + K R E I+ ++
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKR---DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL 57
Query: 263 HHRHLVSLVGYCTF--GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIA-LGSARG 319
+H LV+L + +F LV + + L +HL + + I + A
Sbjct: 58 NHPFLVNL--WYSFQDEENMYLVVDLLLGGDLRYHL-SQKVKFSEEQVKFWICEIVLA-- 112
Query: 320 LAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLA 379
L YLH IIHRDIK NILLD+ + DF +A + DT ++ GT GY+A
Sbjct: 113 LEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATK-VTPDTLTTSTS-GTPGYMA 167
Query: 380 PEYASSGKLTEKSDVFSFGVLLLELITGFRPFDK 413
PE + D +S GV E + G RP+
Sbjct: 168 PEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRG 201
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 2e-21
Identities = 70/220 (31%), Positives = 109/220 (49%), Gaps = 29/220 (13%)
Query: 215 NLLGQGGFGYVHKGVLTN------GKV-VAIKQLKAGSGQGER-EFQAEIEIISQVHHRH 266
N LG G FG V++G T+ G + VA+K L+ G+ E+ EF E ++S +H +
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 267 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDR-----PVMNWPTRMKIALGSARGLA 321
+V L+G C + ++ E + L +L P++ + I L A+G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 322 YLHEDCQPKIIHRDIKSANILL-----DDSFEAKVADFGLAKHSLDTDTHVSTRVMGT-- 374
YL Q IHRD+ + N L+ D K+ DFGLA+ +D + R G
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY---RKEGEGL 174
Query: 375 --FGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 411
++APE GK T +SDV+SFGVL+ E++T G +P+
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY 214
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 3e-21
Identities = 66/244 (27%), Positives = 117/244 (47%), Gaps = 24/244 (9%)
Query: 217 LGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSLV 271
LG G G V H+ GK++A+K ++ + + + E++I+ + + ++V
Sbjct: 9 LGAGNSGVVSKVLHRP---TGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFY 65
Query: 272 GYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKI 331
G + E++ +L+ + + + + KIA+ +GL YLHE + KI
Sbjct: 66 GAFYNNGDISICMEYMDGGSLD-KILKEVQGRIPERILGKIAVAVLKGLTYLHE--KHKI 122
Query: 332 IHRDIKSANILLDDSFEAKVADFGLAKHSLDT--DTHVSTRVMGTFGYLAPEYASSGKLT 389
IHRD+K +NIL++ + K+ DFG++ +++ T V GT Y+APE +
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYMAPERIQGNDYS 177
Query: 390 EKSDVFSFGVLLLELITGFRPFDKADTFAD------DSMVDWAKPFLAQGLADGNFDALV 443
KSD++S G+ L+EL TG P+ + D +V+ P L G +F V
Sbjct: 178 VKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFV 237
Query: 444 DQKL 447
+ L
Sbjct: 238 NLCL 241
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 4e-21
Identities = 62/222 (27%), Positives = 111/222 (50%), Gaps = 22/222 (9%)
Query: 211 FSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQ---GEREF---QAEIEIISQVHH 264
+++ +LG+G +G V+ G+ G+++A+KQ++ + E+E+ Q E++++ + H
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 265 RHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLH---GKDRPVMNWPTRMKIALGSARGLA 321
++V +G C + + EFVP ++ L+ PV T+ + G+A
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQIL-----DGVA 116
Query: 322 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM-----GTFG 376
YLH +C ++HRDIK N++L + K+ DFG A+ H + M GT
Sbjct: 117 YLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY 173
Query: 377 YLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFA 418
++APE + KSD++S G + E+ TG P D A
Sbjct: 174 WMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA 215
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 5e-21
Identities = 62/210 (29%), Positives = 105/210 (50%), Gaps = 29/210 (13%)
Query: 209 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL 267
+++ +G G +G V+K + G++VAIK +K G Q EI ++ + H ++
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 268 VSLVG-YCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIAL---GSARGLAY 322
V+ G Y +L +V E+ +L+ P+ + ++IA + +GLAY
Sbjct: 63 VAYFGSY--LRRDKLWIVMEYCGGGSLQDIYQVTRGPL----SELQIAYVCRETLKGLAY 116
Query: 323 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA---KHSLDTDTHVSTR--VMGTFGY 377
LHE IHRDIK ANILL + + K+ADFG++ ++ + R +GT +
Sbjct: 117 LHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI------AKRKSFIGTPYW 167
Query: 378 LAPEYA---SSGKLTEKSDVFSFGVLLLEL 404
+APE A G K D+++ G+ +EL
Sbjct: 168 MAPEVAAVERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 5e-21
Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 18/208 (8%)
Query: 217 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGE-REFQAEIEIISQVHHRHLVSLVGYC 274
+G G V+ + L N + VAIK++ Q E + E++ +SQ +H ++V Y
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY--YT 66
Query: 275 TF--GSQRLLVYEFVPNKTLEFHL--HGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 330
+F G + LV ++ +L + R ++ + +GL YLH + Q
Sbjct: 67 SFVVGDELWLVMPYLSGGSL-LDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ-- 123
Query: 331 IIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRV----MGTFGYLAPEYASSG 386
IHRDIK+ NILL + K+ADFG++ SL + +V +GT ++APE
Sbjct: 124 -IHRDIKAGNILLGEDGSVKIADFGVSA-SLADGGDRTRKVRKTFVGTPCWMAPEVMEQV 181
Query: 387 K-LTEKSDVFSFGVLLLELITGFRPFDK 413
K+D++SFG+ +EL TG P+ K
Sbjct: 182 HGYDFKADIWSFGITAIELATGAAPYSK 209
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 6e-21
Identities = 64/221 (28%), Positives = 102/221 (46%), Gaps = 40/221 (18%)
Query: 216 LLGQGGFGYVHKGVL------TNGKVVAIKQLKAGSGQGE-REFQAEIEIISQV-HHRHL 267
LG+G FG V K VA+K LK + + + + +E+E++ + H+++
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 268 VSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVM-------NWPTRMKI-------- 312
++L+G CT +V E+ + L L + RP P +
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRAR-RPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 313 ALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK--HSLD-----TDT 365
A ARG+ +L K IHRD+ + N+L+ + K+ADFGLA+ H +D T+
Sbjct: 138 AYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194
Query: 366 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT 406
+ + M APE T +SDV+SFGVLL E+ T
Sbjct: 195 RLPVKWM------APEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 7e-21
Identities = 69/207 (33%), Positives = 102/207 (49%), Gaps = 9/207 (4%)
Query: 211 FSEANLLGQGGFGYVHK-GVLTNGKVVAIKQL---KAGSGQGEREFQAEIEIISQVHHRH 266
F + +LG+GGFG V V GK+ A K+L + +GE E +I+ +V+ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 267 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED 326
+VSL LV + L+FH++ + A GL LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH-- 119
Query: 327 CQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSG 386
Q +I++RD+K NILLDD +++D GLA H + T + RV GT GY+APE +
Sbjct: 120 -QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNE 176
Query: 387 KLTEKSDVFSFGVLLLELITGFRPFDK 413
+ T D ++ G LL E+I G PF +
Sbjct: 177 RYTFSPDWWALGCLLYEMIAGQSPFQQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 8e-21
Identities = 69/203 (33%), Positives = 110/203 (54%), Gaps = 20/203 (9%)
Query: 217 LGQGGFGYVH------KGVLTNGKVVAIKQLKAGSGQGE-REFQAEIEIISQVHHRHLVS 269
LG+G FG V +G T G+ VA+K LK SG + + EIEI+ ++H ++V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNT-GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 270 LVGYCT--FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC 327
G CT G+ L+ EF+P+ +L+ +L +++ +N ++K A+ +G+ YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKINLKQQLKYAVQICKGMDYLGSR- 128
Query: 328 QPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST----RVMGTFGYLAPEYA 383
+ +HRD+ + N+L++ + K+ DFGL K +++TD T F Y APE
Sbjct: 129 --QYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEYYTVKDDLDSPVFWY-APECL 184
Query: 384 SSGKLTEKSDVFSFGVLLLELIT 406
K SDV+SFGV L EL+T
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-20
Identities = 67/217 (30%), Positives = 107/217 (49%), Gaps = 25/217 (11%)
Query: 217 LGQGGFGYV-----HKGVLTNGK-VVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSL 270
LG+G FG V + T K +VA+K LK + ++FQ E E+++ + H H+V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 271 VGYCTFGSQRLLVYEFVPNKTLEFHL--HGKDRPVM--NWPTRMKIALG----------S 316
G C G ++V+E++ + L L HG D ++ P + K LG
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 317 ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH-VSTRVMGTF 375
A G+ YL +HRD+ + N L+ + K+ DFG+++ TD + V M
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 376 GYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 411
++ PE K T +SDV+SFGV+L E+ T G +P+
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 60/205 (29%), Positives = 92/205 (44%), Gaps = 7/205 (3%)
Query: 208 TDNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH 266
+ + +G+G G V+K GK VAIK+++ E EI I+ H +
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN-EILIMKDCKHPN 76
Query: 267 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED 326
+V G + +V E++ +L + MN P + +GL YLH
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVR-MNEPQIAYVCREVLQGLEYLH-- 133
Query: 327 CQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSG 386
+IHRDIKS NILL K+ADFG A L + V+GT ++APE
Sbjct: 134 -SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQ-LTKEKSKRNSVVGTPYWMAPEVIKRK 191
Query: 387 KLTEKSDVFSFGVLLLELITGFRPF 411
K D++S G++ +E+ G P+
Sbjct: 192 DYGPKVDIWSLGIMCIEMAEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 2e-20
Identities = 67/206 (32%), Positives = 101/206 (49%), Gaps = 16/206 (7%)
Query: 217 LGQGGFGYVHKGVLTNGKV---VAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSLVG 272
LG G FG V KGV K VAIK LK + + R E E EI+ Q+ + ++V ++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 273 YCTFGSQRLLVYEFVPNKTLEFHLHGKDR--PVMNWPTRMKIALGSARGLAYLHEDCQPK 330
C +LV E L L GK V N M + G+ YL
Sbjct: 63 VCE-AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQV---SMGMKYLEGK---N 115
Query: 331 IIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF--GYLAPEYASSGKL 388
+HRD+ + N+LL + AK++DFGL+K D++ R G + + APE + K
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF 175
Query: 389 TEKSDVFSFGVLLLELIT-GFRPFDK 413
+ +SDV+S+G+ + E + G +P+ K
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKPYKK 201
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 3e-20
Identities = 67/216 (31%), Positives = 114/216 (52%), Gaps = 19/216 (8%)
Query: 209 DNFSEANLLGQGGFGYVHK----GVLTNGKV--VAIKQLKAGSGQGERE-FQAEIEIISQ 261
+N S LG G FG V + G+ + V VA+K LK + ERE +E++I+S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 262 V-HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGL 320
+ +H ++V+L+G CT G L++ E+ L L K + + + A+G+
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGM 154
Query: 321 AYL-HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV---STRVMGTFG 376
A+L ++C IHRD+ + N+LL K+ DFGLA+ ++ +V + R+
Sbjct: 155 AFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL--PVK 208
Query: 377 YLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 411
++APE + T +SDV+S+G+LL E+ + G P+
Sbjct: 209 WMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPY 244
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 3e-20
Identities = 70/215 (32%), Positives = 95/215 (44%), Gaps = 29/215 (13%)
Query: 209 DNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAG----SGQGEREFQAEIEIIS 260
D+F LG G FG V HKG +GK A+K L Q E E I+
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKG---SGKYYALKILSKAKIVKLKQVEHVL-NEKRILQ 56
Query: 261 QVHHRHLVSLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRM---KIALGS 316
+ H LV+L G L LV E+VP L F K R ++ L
Sbjct: 57 SIRHPFLVNLYG-SFQDDSNLYLVMEYVPGGEL-FSHLRKSGRFPEPVARFYAAQVVLA- 113
Query: 317 ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG 376
L YLH I++RD+K N+LLD K+ DFG AK + T+ + GT
Sbjct: 114 ---LEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKR-VKGRTYT---LCGTPE 163
Query: 377 YLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPF 411
YLAPE S + D ++ G+L+ E++ G+ PF
Sbjct: 164 YLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 3e-20
Identities = 60/212 (28%), Positives = 106/212 (50%), Gaps = 11/212 (5%)
Query: 206 IATDNFSEANLLGQGGFGYVHKGVLTNGK----VVAIKQLKAGSGQGERE-FQAEIEIIS 260
I ++ + +G+G FG V++GV + + VA+K K + RE F E I+
Sbjct: 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMR 62
Query: 261 QVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGL 320
Q H H+V L+G T + +V E P L +L ++ ++ + + + + L
Sbjct: 63 QFDHPHIVKLIGVIT-ENPVWIVMELAPLGELRSYLQ-VNKYSLDLASLILYSYQLSTAL 120
Query: 321 AYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAP 380
AYL + +HRDI + N+L+ K+ DFGL+++ D + +++ ++AP
Sbjct: 121 AYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAP 177
Query: 381 EYASSGKLTEKSDVFSFGVLLLE-LITGFRPF 411
E + + T SDV+ FGV + E L+ G +PF
Sbjct: 178 ESINFRRFTSASDVWMFGVCMWEILMLGVKPF 209
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 4e-20
Identities = 65/219 (29%), Positives = 113/219 (51%), Gaps = 21/219 (9%)
Query: 205 KIATDNFSEANLLGQGGFGYVHKGVLTNGKV-------VAIKQLKAGSGQGER-EFQAEI 256
++A + + + LGQG FG V++G+ G V VAIK + + ER EF E
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGI-AKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 60
Query: 257 EIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHG-----KDRPVMNWPTRMK 311
++ + + H+V L+G + G L++ E + L+ +L ++ PV P+ K
Sbjct: 61 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKK 120
Query: 312 I---ALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH-V 367
+ A A G+AYL+ + K +HRD+ + N ++ + F K+ DFG+ + +TD +
Sbjct: 121 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 177
Query: 368 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT 406
+ + +++PE G T SDV+SFGV+L E+ T
Sbjct: 178 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 4e-20
Identities = 68/282 (24%), Positives = 130/282 (46%), Gaps = 42/282 (14%)
Query: 210 NFSEANLLGQGGFGYVHKGVL----TNGKVVAIKQ--LKAGSGQGEREFQAEIEIISQVH 263
++ +LG+G FG + L + +V K+ L S + R+ EI I+S +
Sbjct: 1 HYIPIRVLGKGAFG---EATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQ 57
Query: 264 HRHLVSLVGYCTFGSQRLLVYEFVPNKTL-EFHLHGK----DRPVMNWPTRMKIALGSAR 318
H ++++ + + L+ E+ TL + + K + ++ W + SA
Sbjct: 58 HPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW---YLFQIVSA- 113
Query: 319 GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYL 378
++Y+H+ I+HRDIK+ NI L + K+ DFG++K L ++ ++ V+GT Y+
Sbjct: 114 -VSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISK-ILGSEYSMAETVVGTPYYM 168
Query: 379 APEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGN 438
+PE K KSD+++ G +L EL+T R FD + L + GN
Sbjct: 169 SPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN-----------LVVKIVQGN 217
Query: 439 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIV 480
+ +V Y S+E+ + + ++ +RP +++
Sbjct: 218 YTPVVSV----Y-SSELISL---VHSLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 5e-20
Identities = 61/224 (27%), Positives = 109/224 (48%), Gaps = 32/224 (14%)
Query: 217 LGQGGFGYVHK----GVLTNGK--VVAIKQLKAG-SGQGEREFQAEIEIISQVHHRHLVS 269
+GQG FG V + G+L +VA+K LK S + +FQ E ++++ H ++V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 270 LVGYCTFGSQRLLVYEFV--------------------PNKTLEFHLHGKDRPVMNWPTR 309
L+G C G L++E++ + T G + ++ +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 310 MKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH-VS 368
+ IA A G+AYL E K +HRD+ + N L+ ++ K+ADFGL+++ D + S
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 369 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 411
++ PE + T +SDV+++GV+L E+ + G +P+
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPY 233
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 6e-20
Identities = 69/209 (33%), Positives = 111/209 (53%), Gaps = 20/209 (9%)
Query: 216 LLGQGGFGYVHKGVLTN-GK---VVAIKQLKAG-SGQGEREFQAEIEIISQVHHRHLVSL 270
++G G FG V +G L GK VAIK LK+G + + R+F +E I+ Q H +++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 271 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDR--PVMNWPTRMKIALGSARGLAYLHEDCQ 328
G T +++ EF+ N L+ L D V+ ++ G A G+ YL E
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYLSE--- 124
Query: 329 PKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG-----YLAPEYA 383
+HRD+ + NIL++ + KV+DFGL++ L+ DT T G + APE
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRF-LEDDTSDPTYTSSLGGKIPIRWTAPEAI 183
Query: 384 SSGKLTEKSDVFSFGVLLLELIT-GFRPF 411
+ K T SDV+S+G+++ E+++ G RP+
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMSYGERPY 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 7e-20
Identities = 73/276 (26%), Positives = 131/276 (47%), Gaps = 24/276 (8%)
Query: 213 EANLLGQGGFGYVHKG-VLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLV 271
E N++ +G G +KG + NG +K++ + +EI + ++ H ++V L+
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS----SEIADMGKLQHPNIVKLI 749
Query: 272 GYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKI 331
G C L++E++ K L L ++W R KIA+G A+ L +LH C P +
Sbjct: 750 GLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAV 804
Query: 332 IHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEK 391
+ ++ I++D E + + SL T+ + Y+APE + +TEK
Sbjct: 805 VVGNLSPEKIIIDGKDEPHL------RLSLPGLLCTDTKCFISSAYVAPETRETKDITEK 858
Query: 392 SDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYD 451
SD++ FG++L+EL+TG P D A+ S+V+WA+ +D + D +D +
Sbjct: 859 SDIYGFGLILIELLTGKSPAD-AEFGVHGSIVEWAR----YCYSDCHLDMWIDPSIRGDV 913
Query: 452 SA---EMTRMAACAAACIRHSARRRPRMSQIVRALE 484
S E+ + A C RP + +++ LE
Sbjct: 914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 2e-19
Identities = 66/202 (32%), Positives = 102/202 (50%), Gaps = 9/202 (4%)
Query: 211 FSEANLLGQGGFGYVHKGVLTNGK-VVAIKQLKAGSGQGERE-FQAEIEIISQVHHRHLV 268
F++ +G+G FG V KG+ + VVAIK + + E E Q EI ++SQ ++
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 269 SLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 328
G G++ ++ E++ + L T +K L +GL YLH +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDYLHSE-- 120
Query: 329 PKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKL 388
K IHRDIK+AN+LL + + K+ADFG+A DT +T V GT ++APE
Sbjct: 121 -KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAY 178
Query: 389 TEKSDVFSFGVLLLELITGFRP 410
K+D++S G+ +EL G P
Sbjct: 179 DSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 62/213 (29%), Positives = 96/213 (45%), Gaps = 20/213 (9%)
Query: 209 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQG-EREFQAEIEIISQVHHRH 266
+ E + LG+G G V K L G + A+K + +++ E+EI +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 267 LVSLVGYCTFGSQRLL--VYEFVPNKTLEFHLHGKDRPVMNWPTRM------KIALGSAR 318
+V G S + E+ +L+ ++ K + R+ KIA +
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLD-SIYKKVKKRGG---RIGEKVLGKIAESVLK 116
Query: 319 GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYL 378
GL+YLH KIIHRDIK +NILL + K+ DFG+ S + ++ GT Y+
Sbjct: 117 GLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGV---SGELVNSLAGTFTGTSFYM 170
Query: 379 APEYASSGKLTEKSDVFSFGVLLLELITGFRPF 411
APE + SDV+S G+ LLE+ PF
Sbjct: 171 APERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 3e-19
Identities = 63/211 (29%), Positives = 106/211 (50%), Gaps = 27/211 (12%)
Query: 216 LLGQGGFGYVHKGV-LTNGKV----VAIKQLKAGSGQGEREFQA---EIEIISQVHHRHL 267
LLG G FG VHKG+ + G VAIK ++ SG+ + FQ + + + H ++
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGR--QTFQEITDHMLAMGSLDHAYI 71
Query: 268 VSLVGYCTFGSQRLLVYEFVPNKTLEFHLH---GKDRP--VMNWPTRMKIALGSARGLAY 322
V L+G C G+ LV + P +L H+ P ++NW ++ A+G+ Y
Sbjct: 72 VRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------AKGMYY 124
Query: 323 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL-DTDTHVSTRVMGTFGYLAPE 381
L E ++HR++ + NILL ++ADFG+A D + + ++A E
Sbjct: 125 LEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181
Query: 382 YASSGKLTEKSDVFSFGVLLLELIT-GFRPF 411
G+ T +SDV+S+GV + E+++ G P+
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMSYGAEPY 212
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 4e-19
Identities = 67/207 (32%), Positives = 102/207 (49%), Gaps = 9/207 (4%)
Query: 211 FSEANLLGQGGFGYVHK-GVLTNGKVVAIKQL---KAGSGQGEREFQAEIEIISQVHHRH 266
F +LG+GGFG V V GK+ A K+L + +GE E +I+ +V+ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 267 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED 326
+VSL LV + L+FH++ P + + A GL LH +
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121
Query: 327 CQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSG 386
+I++RD+K NILLDD +++D GLA + +T + RV GT GY+APE +
Sbjct: 122 ---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVGYMAPEVVKNE 176
Query: 387 KLTEKSDVFSFGVLLLELITGFRPFDK 413
+ T D + G L+ E+I G PF +
Sbjct: 177 RYTFSPDWWGLGCLIYEMIEGKSPFRQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 4e-19
Identities = 71/291 (24%), Positives = 126/291 (43%), Gaps = 38/291 (13%)
Query: 210 NFSEANLLGQGGFGYVHKGVLTNG------KVVAIKQLKAGSGQG-EREFQAEIEIISQV 262
N E LG+G FG V +V +K L+ + + EF+ E+++ ++
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 263 HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHL---HGKDRPVMNWPT----RMKIALG 315
H+++V L+G C ++ E+ L+ L KD + P ++ +
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 316 SARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF 375
A G+ +L + +HRD+ + N L+ E KV+ L+K +++ + +
Sbjct: 126 IALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPL 182
Query: 376 GYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKP-FLAQG 433
+LAPE + KSDV+SFGVL+ E+ T G PF +D+ +++ + L
Sbjct: 183 RWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG---LSDEEVLNRLQAGKLELP 239
Query: 434 LADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484
+ +G L KL M C A + + RP S++V AL
Sbjct: 240 VPEGCPSRL--YKL----------MTRCWAV----NPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 5e-19
Identities = 61/189 (32%), Positives = 96/189 (50%), Gaps = 11/189 (5%)
Query: 217 LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF 276
+G+G FG V G G VA+K +K + + F AE +++Q+ H +LV L+G
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 277 GSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRD 335
L +V E++ +L +L + R V+ +K +L + YL + +HRD
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRD 127
Query: 336 IKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 395
+ + N+L+ + AKV+DFGL K + T V T APE K + KSDV+
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTKSDVW 183
Query: 396 SFGVLLLEL 404
SFG+LL E+
Sbjct: 184 SFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 5e-19
Identities = 73/221 (33%), Positives = 102/221 (46%), Gaps = 27/221 (12%)
Query: 217 LGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGEREFQAE------IEIISQVHHRH 266
LG+G FG V +K G++ AIK LK G E ++ E + H
Sbjct: 7 LGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 267 LVSLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHE 325
LV+L C + V E+ L H+H V + P + A GL YLHE
Sbjct: 64 LVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIH---TDVFSEPRAVFYAACVVLGLQYLHE 119
Query: 326 DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS 385
+ KI++RD+K N+LLD K+ADFGL K + ST GT +LAPE +
Sbjct: 120 N---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST-FCGTPEFLAPEVLTE 175
Query: 386 GKLTEKSDVFSFGVLLLELITGFRPF---DKADTFADDSMV 423
T D + GVL+ E++ G PF D+ + F DS+V
Sbjct: 176 TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF--DSIV 214
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 5e-19
Identities = 71/208 (34%), Positives = 103/208 (49%), Gaps = 11/208 (5%)
Query: 211 FSEANLLGQGGFGYVHK-GVLTNGKVVAIKQL---KAGSGQGEREFQAEIEIISQVHHRH 266
F +LG+GGFG V V GK+ A K+L + +GE E I+ +V+ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 267 LVSLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHE 325
+VSL Y L LV + L+FH++ P + + A GL L
Sbjct: 62 VVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120
Query: 326 DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS 385
+ +I++RD+K NILLDD +++D GLA + +T V RV GT GY+APE ++
Sbjct: 121 E---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYMAPEVINN 175
Query: 386 GKLTEKSDVFSFGVLLLELITGFRPFDK 413
K T D + G L+ E+I G PF K
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQSPFRK 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 6e-19
Identities = 70/240 (29%), Positives = 104/240 (43%), Gaps = 54/240 (22%)
Query: 204 LKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQV 262
L T F ++G+G +G V+K G++VAIK + E E + E I+ +
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDI-IEDEEEEIKEEYNILRKY 59
Query: 263 -HHRHLVSLVG-------------------YCTFGSQRLLVYEFVPNKTLEFHLHGKDRP 302
+H ++ + G C GS V + V L K +
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGS----VTDLVKG------LRKKGK- 108
Query: 303 VMNWPTRMK------IALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGL 356
R+K I + RGLAYLHE+ K+IHRDIK NILL + E K+ DFG+
Sbjct: 109 ------RLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV 159
Query: 357 AKHSLDTDTHVSTRVMGTFGYLAPEY-ASSGKLTE----KSDVFSFGVLLLELITGFRPF 411
+ LD+ +GT ++APE A + +SDV+S G+ +EL G P
Sbjct: 160 SAQ-LDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL 218
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 7e-19
Identities = 62/219 (28%), Positives = 113/219 (51%), Gaps = 29/219 (13%)
Query: 215 NLLGQGGFGYVHKGVLTNGKV---VAIKQLKAGSGQGE-REFQAEIEIISQV-HHRHLVS 269
+++G+G FG V K + + AIK++K + + + R+F E+E++ ++ HH ++++
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 270 LVGYCTFGSQRLLVYEFVPNKTL--------------EFHLHGKDRPVMNWPTRMKIALG 315
L+G C L E+ P+ L F + ++ + A
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 316 SARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF 375
ARG+ YL Q + IHRD+ + NIL+ +++ AK+ADFGL++ + +V + MG
Sbjct: 133 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVK-KTMGRL 185
Query: 376 G--YLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 411
++A E + T SDV+S+GVLL E+++ G P+
Sbjct: 186 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 224
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 8e-19
Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 216 LLGQGGFGYVHKG-VLTNGKVVAIKQLKAGSGQGE--REFQAEIEIISQVHHRHLVSLVG 272
++G+G +G V K G++VAIK+ K + + E++++ Q+ H ++V+L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 273 YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKII 332
+ LV+E+V LE L + R + +AY H II
Sbjct: 68 AFRRKGRLYLVFEYVERTLLEL-LEASPGGLPPDAVR-SYIWQLLQAIAYCH---SHNII 122
Query: 333 HRDIKSANILLDDSFEAKVADFGLAKH-----SLDTDTHVSTRVMGTFGYLAPE----YA 383
HRDIK NIL+ +S K+ DFG A+ + +V+TR Y APE
Sbjct: 123 HRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATR-----WYRAPELLVGDT 177
Query: 384 SSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD 424
+ GK DV++ G ++ EL+ G P F DS +D
Sbjct: 178 NYGK---PVDVWAIGCIMAELLDG-EPL-----FPGDSDID 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 9e-19
Identities = 63/208 (30%), Positives = 106/208 (50%), Gaps = 19/208 (9%)
Query: 210 NFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAG--SGQGEREFQA---EIEIISQVH 263
N+ LLGQG FG V+ + G+ +A+KQ+ S + ++E A EI+++ +
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 264 HRHLVSLVGYCTFGSQRLLVY-EFVPNKTLEFHL--HGKDRPVMNWPTRMKIALGSARGL 320
H +V G C + L ++ E++P +++ L +G + TR K G+
Sbjct: 63 HERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYG---ALTETVTR-KYTRQILEGV 117
Query: 321 AYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK--HSLDTDTHVSTRVMGTFGYL 378
YLH + I+HRDIK ANIL D + K+ DFG +K ++ + V GT ++
Sbjct: 118 EYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWM 174
Query: 379 APEYASSGKLTEKSDVFSFGVLLLELIT 406
+PE S K+DV+S G ++E++T
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 1e-18
Identities = 57/211 (27%), Positives = 106/211 (50%), Gaps = 11/211 (5%)
Query: 210 NFSEANLLGQGGFGYVH--KGVLTNGKVVAIKQLKA-GSGQGERE-FQAEIEIISQVHHR 265
+ + ++G+G FG VH + + K+V IKQ+ + ER Q E +++ + H
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHP 59
Query: 266 HLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHE 325
+++ ++V E+ P TL ++ + +++ T + + L ++H
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH- 118
Query: 326 DCQPKIIHRDIKSANILLDD-SFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYAS 384
I+HRD+K+ NILLD K+ DFG++K L + + T V+GT Y++PE
Sbjct: 119 --TKLILHRDLKTQNILLDKHKMVVKIGDFGISK-ILSSKSKAYT-VVGTPCYISPELCE 174
Query: 385 SGKLTEKSDVFSFGVLLLELITGFRPFDKAD 415
+KSD+++ G +L EL + R F+ A+
Sbjct: 175 GKPYNQKSDIWALGCVLYELASLKRAFEAAN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 56/194 (28%), Positives = 93/194 (47%), Gaps = 11/194 (5%)
Query: 217 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCT 275
LG G FG V+K G A K ++ S + +F EI+I+S+ H ++V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 276 FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRD 335
+ ++ ++ EF L+ + +R + P + L +LH K+IHRD
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERG-LTEPQIRYVCRQMLEALNFLHSH---KVIHRD 128
Query: 336 IKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYA-----SSGKLTE 390
+K+ NILL + K+ADFG++ + T T + GT ++APE
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKDNPYDY 187
Query: 391 KSDVFSFGVLLLEL 404
K+D++S G+ L+EL
Sbjct: 188 KADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 61/219 (27%), Positives = 103/219 (47%), Gaps = 19/219 (8%)
Query: 203 ELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQ 261
E + D E +LG+G +G V+ L+ +AIK++ + + EI + S
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 262 VHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGK------DRPVMNWPTRMKIALG 315
+ HR++V +G + + E VP +L L K + + + T+ +
Sbjct: 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL--- 118
Query: 316 SARGLAYLHEDCQPKIIHRDIKSANILLDD-SFEAKVADFGLAKHSLDTDTHVSTRVMGT 374
GL YLH++ +I+HRDIK N+L++ S K++DFG +K + T GT
Sbjct: 119 --EGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET-FTGT 172
Query: 375 FGYLAPEYASSGK--LTEKSDVFSFGVLLLELITGFRPF 411
Y+APE G +D++S G ++E+ TG PF
Sbjct: 173 LQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 71/215 (33%), Positives = 115/215 (53%), Gaps = 25/215 (11%)
Query: 216 LLGQGGFGYVHKGV-LTNGKVV----AIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVS 269
+LG G FG V+KG+ + G+ V AIK L +G + EF E I++ + H HLV
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 270 LVGYCTFGSQRLLVYEFVPNKTLEFHLH-GKD----RPVMNWPTRMKIALGSARGLAYLH 324
L+G C + +L V + +P+ L ++H KD + ++NW ++ A+G+ YL
Sbjct: 74 LLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLE 126
Query: 325 EDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF--GYLAPEY 382
E +++HRD+ + N+L+ K+ DFGLA+ L+ D G ++A E
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLAR-LLEGDEKEYNADGGKMPIKWMALEC 182
Query: 383 ASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADT 416
K T +SDV+S+GV + EL+T G +P+D T
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT 217
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 64/232 (27%), Positives = 116/232 (50%), Gaps = 28/232 (12%)
Query: 203 ELKIATDNFSEANLLGQGGFGYVHKGVL-----TNGKVVAIKQLK-AGSGQGEREFQAEI 256
EL ++ F E LG+ FG ++KG L + ++VAIK LK + Q EFQ E
Sbjct: 1 ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58
Query: 257 EIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL-EFHL--------------HGKDR 301
+++++HH ++V L+G T +++E++ L EF + G +
Sbjct: 59 SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118
Query: 302 PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 361
++ + IA+ A G+ YL +H+D+ + NIL+ + K++D GL++
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIY 175
Query: 362 DTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 411
D + V + + ++ PE GK + SD++SFGV+L E+ + G +P+
Sbjct: 176 SADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 61/217 (28%), Positives = 109/217 (50%), Gaps = 21/217 (9%)
Query: 211 FSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGE-REFQAEIEIISQVHHRHLV 268
+ L+G+G +G V++G + G+VVA+K + + + + Q E+ ++SQ+
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 269 SLVGY--CTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMN-WPTRMKIALGSAR----GLA 321
++ Y RL + +E+ G R +M P K R L
Sbjct: 63 NITKYYGSYLKGPRLWI-------IMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALK 115
Query: 322 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPE 381
Y+H+ +IHRDIK+ANIL+ ++ K+ DFG+A L+ ++ + +GT ++APE
Sbjct: 116 YIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAA-LLNQNSSKRSTFVGTPYWMAPE 171
Query: 382 YASSGKLTE-KSDVFSFGVLLLELITGFRPFDKADTF 417
+ GK + K+D++S G+ + E+ TG P+ D F
Sbjct: 172 VITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF 208
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 3e-18
Identities = 63/205 (30%), Positives = 100/205 (48%), Gaps = 9/205 (4%)
Query: 211 FSEANLLGQGGFGYVHK-GVLTNGKVVAIKQL---KAGSGQGEREFQAEIEIISQVHHRH 266
F + +LG+GGFG V V GK+ A K+L + +GE E +I+ +V+ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 267 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED 326
+V+L LV + L+FH++ P + A GL LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH-- 119
Query: 327 CQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSG 386
+ ++RD+K NILLDD +++D GLA + ++ + RV GT GY+APE ++
Sbjct: 120 -RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES-IRGRV-GTVGYMAPEVLNNQ 176
Query: 387 KLTEKSDVFSFGVLLLELITGFRPF 411
+ T D + G L+ E+I G PF
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-18
Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 29/213 (13%)
Query: 211 FSEANLLGQGGFGYVHKGVLTNGK-VVAIKQLKAGSGQGERE-FQAEIEIISQVHHRHLV 268
F++ +G+G FG V+KG+ K VVAIK + + E E Q EI ++SQ ++
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 269 SLVGYCTFGSQRLLVYEFV----------PNKTLEFHLHGKDRPVMNWPTRMKIALGSAR 318
G G++ ++ E++ P E ++ R ++ +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREIL-------------K 112
Query: 319 GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYL 378
GL YLH + + IHRDIK+AN+LL + + K+ADFG+A DT +T V GT ++
Sbjct: 113 GLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWM 168
Query: 379 APEYASSGKLTEKSDVFSFGVLLLELITGFRPF 411
APE K+D++S G+ +EL G P
Sbjct: 169 APEVIKQSAYDFKADIWSLGITAIELAKGEPPN 201
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 3e-18
Identities = 67/206 (32%), Positives = 108/206 (52%), Gaps = 16/206 (7%)
Query: 216 LLGQGGFGYVHKGVL-TNGK---VVAIKQLKAG-SGQGEREFQAEIEIISQVHHRHLVSL 270
++G G FG V G L GK VAIK LKAG + + R+F +E I+ Q H +++ L
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 271 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDR--PVMNWPTRMKIALGSARGLAYLHEDCQ 328
G T ++V E++ N +L+ L D V+ ++ G A G+ YL +
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR---GIASGMKYLSD--- 124
Query: 329 PKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG--YLAPEYASSG 386
+HRD+ + NIL++ + KV+DFGL++ D T G + APE +
Sbjct: 125 MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 184
Query: 387 KLTEKSDVFSFGVLLLELIT-GFRPF 411
K T SDV+S+G+++ E+++ G RP+
Sbjct: 185 KFTSASDVWSYGIVMWEVMSYGERPY 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 4e-18
Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 28/218 (12%)
Query: 217 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA--EIEIISQVHHRHLVSLVGY 273
+G+G +G V+K G++VAIK++K A EI+++ +++H +++ L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 274 CTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIH 333
LV+EF+ + L + + R + +GLA+ H I+H
Sbjct: 67 FRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPE-SLIKSYLYQLLQGLAFCH---SHGILH 121
Query: 334 RDIKSANILLDDSFEAKVADFGLAKHSLDTD----TH-VSTRVMGTFGYLAPE--YASSG 386
RD+K N+L++ K+ADFGLA+ S + TH V TR Y APE G
Sbjct: 122 RDLKPENLLINTEGVLKLADFGLAR-SFGSPVRPYTHYVVTR-----WYRAPELLLGDKG 175
Query: 387 KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD 424
+ D++S G + EL++ RP F S +D
Sbjct: 176 -YSTPVDIWSVGCIFAELLSR-RPL-----FPGKSEID 206
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 5e-18
Identities = 63/190 (33%), Positives = 92/190 (48%), Gaps = 5/190 (2%)
Query: 217 LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF 276
LG G FG V VA+K +K GS E F AE ++ + H LV L T
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVVT- 71
Query: 277 GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDI 336
++ EF+ +L L + P + + A G+A++ Q IHRD+
Sbjct: 72 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDL 128
Query: 337 KSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 396
++ANIL+ S K+ADFGLA+ D + + APE + G T KSDV+S
Sbjct: 129 RAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS 188
Query: 397 FGVLLLELIT 406
FG+LL+E++T
Sbjct: 189 FGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 6e-18
Identities = 61/207 (29%), Positives = 103/207 (49%), Gaps = 22/207 (10%)
Query: 217 LGQGGFGYVHKGVLT---NGKVVAIKQLKAGSGQG--EREFQAEIEIISQVHHRHLVSLV 271
LG G FG V KG+ + K VA+K LK + + E E ++ Q+ + ++V ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 272 GYCTFGSQRLLVYEFVP----NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC 327
G C +LV E NK L+ + H ++ + ++ + G+ YL E
Sbjct: 63 GICE-AESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSM------GMKYLEET- 114
Query: 328 QPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF--GYLAPEYASS 385
+HRD+ + N+LL AK++DFGL+K + + + G + + APE +
Sbjct: 115 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY 172
Query: 386 GKLTEKSDVFSFGVLLLELIT-GFRPF 411
K + KSDV+SFGVL+ E + G +P+
Sbjct: 173 YKFSSKSDVWSFGVLMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 8e-18
Identities = 59/217 (27%), Positives = 106/217 (48%), Gaps = 30/217 (13%)
Query: 217 LGQGGFGYVH----KGVLT-----------NGKVVAIKQLKAGSGQGER-EFQAEIEIIS 260
LG+G FG VH +G+ +VA+K L+A + R +F EI+I+S
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 261 QVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHL----------HGKDRPVMNWPTRM 310
++ + +++ L+G C ++ E++ N L L H + P ++ +
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 311 KIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH-VST 369
+A+ A G+ YL +HRD+ + N L+ + + K+ADFG++++ D + +
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189
Query: 370 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT 406
R + ++A E GK T SDV++FGV L E+ T
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 64/220 (29%), Positives = 110/220 (50%), Gaps = 31/220 (14%)
Query: 215 NLLGQGGFGYVHKGVLT---NGKVVAIKQLKA-GSGQGEREFQAEIEIISQV-HHRHLVS 269
+++G+G FG V + ++ AIK LK S R+F E+E++ ++ HH ++++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 270 LVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPT---------------RMKIAL 314
L+G C + E+ P L L K R + P ++ A
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLR-KSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 315 GSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 374
A G+ YL E + IHRD+ + N+L+ ++ +K+ADFGL++ + +V + MG
Sbjct: 127 DVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVK-KTMGR 179
Query: 375 FG--YLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 411
++A E + T KSDV+SFGVLL E+++ G P+
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPY 219
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 1e-17
Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 14/203 (6%)
Query: 217 LGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQA---EIEIISQVHHRHLVSLVG 272
LG+GGFG V + GK+ A K+L + + ++ E I+++VH R +VSL
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLA- 59
Query: 273 YCTFGSQR--LLVYEFVPNKTLEFHLHG--KDRPVMNWPTRMKIALGSARGLAYLHEDCQ 328
F ++ LV + L +H++ ++ P P GL +LH Q
Sbjct: 60 -YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---Q 115
Query: 329 PKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKL 388
+II+RD+K N+LLD+ +++D GLA D + + GT G++APE +
Sbjct: 116 RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQGEEY 174
Query: 389 TEKSDVFSFGVLLLELITGFRPF 411
D F+ GV L E+I PF
Sbjct: 175 DFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 65/215 (30%), Positives = 110/215 (51%), Gaps = 23/215 (10%)
Query: 211 FSEANLLGQGGFGYVHKGVLT----NGKV-VAIKQLK-AGSGQGEREFQAEIEIISQVHH 264
F + +LG G FG V+KG+ K+ VAIK+L+ A S + +E E +++ V +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 265 RHLVSLVGYCTFGSQRLLVYEFVP-NKTLEFHLHGKDR----PVMNWPTRMKIALGSARG 319
H+ L+G C S L+ + +P L++ KD ++NW ++ A+G
Sbjct: 69 PHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 121
Query: 320 LAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK-HSLDTDTHVSTRVMGTFGYL 378
+ YL E +++HRD+ + N+L+ K+ DFGLAK D + + ++
Sbjct: 122 MNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178
Query: 379 APEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFD 412
A E T +SDV+S+GV + EL+T G +P+D
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 66/207 (31%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 216 LLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGEREF---QAEIEIISQV-HHRHLVSL 270
+LG+G FG V L ++ A+K LK + + E +++ H L L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 271 VGYCTFGSQ-RL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 328
+ F ++ RL V E+V L FH+ R + P A GL +LHE
Sbjct: 62 --HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGR--FDEPRARFYAAEIVLGLQFLHER-- 115
Query: 329 PKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKL 388
II+RD+K N+LLD K+ADFG+ K + ST GT Y+APE S
Sbjct: 116 -GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST-FCGTPDYIAPEILSYQPY 173
Query: 389 TEKSDVFSFGVLLLELITGFRPFDKAD 415
D ++ GVLL E++ G PF+ D
Sbjct: 174 GPAVDWWALGVLLYEMLAGQSPFEGDD 200
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 64/221 (28%), Positives = 104/221 (47%), Gaps = 46/221 (20%)
Query: 210 NFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA-------EIEIISQ 261
F + N +G+G +G V++ T+G++VA+K+++ + E EI ++
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRM-----DNERDGIPISSLREITLLLN 62
Query: 262 VHHRHLVSL----VGYCTFGSQRL----LVYEFVPNKTLEFHLHGKDRPVMNWPT----- 308
+ H ++V L VG + L LV E+ + N PT
Sbjct: 63 LRHPNIVELKEVVVG------KHLDSIFLVMEYCE--------QDLASLLDNMPTPFSES 108
Query: 309 RMK-IALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 367
++K + L RGL YLHE+ IIHRD+K +N+LL D K+ADFGLA+ +
Sbjct: 109 QVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM 165
Query: 368 STRVMGTFGYLAPEYA-SSGKLTEKSDVFSFGVLLLELITG 407
+ +V+ T Y APE T D+++ G +L EL+
Sbjct: 166 TPKVV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 3e-17
Identities = 62/219 (28%), Positives = 115/219 (52%), Gaps = 29/219 (13%)
Query: 215 NLLGQGGFGYVHKGVLTNGKV---VAIKQLKAGSGQGE-REFQAEIEIISQV-HHRHLVS 269
+++G+G FG V K + + AIK++K + + + R+F E+E++ ++ HH ++++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 270 LVGYCTFGSQRLLVYEFVP----------NKTLE----FHLHGKDRPVMNWPTRMKIALG 315
L+G C L E+ P ++ LE F + ++ + A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 316 SARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF 375
ARG+ YL + + IHRD+ + NIL+ +++ AK+ADFGL++ + +V + MG
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVK-KTMGRL 173
Query: 376 G--YLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 411
++A E + T SDV+S+GVLL E+++ G P+
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 212
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 4e-17
Identities = 69/219 (31%), Positives = 102/219 (46%), Gaps = 28/219 (12%)
Query: 216 LLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGEREFQA--EIEIISQVHHRHLVS 269
L+G+G +G V HK G++VAIK+ + A EI ++ Q+ H +LV+
Sbjct: 8 LVGEGSYGMVMKCKHK---ETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVN 64
Query: 270 LVGYCTFGSQRLLVYEFVPNKTL---EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED 326
L+ + LV+EFV + L E + +G D + K RG+ + H
Sbjct: 65 LIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVR-----KYLFQILRGIEFCHSH 119
Query: 327 CQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEY-ASS 385
IIHRDIK NIL+ S K+ DFG A+ +L V T + T Y APE
Sbjct: 120 ---NIIHRDIKPENILVSQSGVVKLCDFGFAR-TLAAPGEVYTDYVATRWYRAPELLVGD 175
Query: 386 GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD 424
K D+++ G L+ E++TG P F DS +D
Sbjct: 176 TKYGRAVDIWAVGCLVTEMLTG-EPL-----FPGDSDID 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 4e-17
Identities = 61/238 (25%), Positives = 96/238 (40%), Gaps = 78/238 (32%)
Query: 215 NLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA---------EIEIISQVHH 264
+G G +G V V G+ VAIK++ F EI+++ + H
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKI-------SNVFDDLIDAKRILREIKLLRHLRH 58
Query: 265 RHLVSLVGYCTFGSQRLLVYEFVPNKTLEFH------------LHGKDRPVMNWPTRMKI 312
+++ L L + P +F+ LH V+ +
Sbjct: 59 ENIIGL----------LDI--LRPPSPEDFNDVYIVTELMETDLH----KVI----KSPQ 98
Query: 313 ALGSA----------RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362
L RGL YLH +IHRD+K +NIL++ + + K+ DFGLA+ +D
Sbjct: 99 PLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLAR-GVD 154
Query: 363 TDT--------HVSTRVMGTFGYLAPE-YASSGKLTEKSDVFSFGVLLLELITGFRPF 411
D +V TR Y APE SS + T+ D++S G + EL+T +P
Sbjct: 155 PDEDEKGFLTEYVVTRW-----YRAPELLLSSSRYTKAIDIWSVGCIFAELLTR-KPL 206
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 65/242 (26%), Positives = 113/242 (46%), Gaps = 45/242 (18%)
Query: 199 FTYEELKIATDNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGE-REFQAEI 256
FT E+LK + +G+G FG V+K + G ++A+K++++ + E + ++
Sbjct: 1 FTAEDLK-------DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDL 53
Query: 257 EIISQVHHRHLVSLVGY--CTFGSQRLLV------------YEFVPNKTLEFHLHGKDRP 302
+++ + +V + F + Y++V + K
Sbjct: 54 DVV--MRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYV-------YEVLKSV- 103
Query: 303 VMNWPTRM--KIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 360
P + KIA+ + + L YL E+ KIIHRD+K +NILLD + K+ DFG++
Sbjct: 104 ---IPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQL 158
Query: 361 LDTDTHVSTRVMGTFGYLAPE-YASSG--KLTEKSDVFSFGVLLLELITGFRPFDKADTF 417
+ D+ TR G Y+APE S +SDV+S G+ L E+ TG P+ K ++
Sbjct: 159 V--DSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV 216
Query: 418 AD 419
D
Sbjct: 217 FD 218
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 4e-17
Identities = 71/230 (30%), Positives = 111/230 (48%), Gaps = 32/230 (13%)
Query: 202 EELKIATDNFSEANLLGQGGFGYVHK------GVLTNGKVVAIKQLKAGSGQGEREFQAE 255
E+L+ +D LG G G V K G + KVV I + Q RE Q
Sbjct: 5 EDLETISD-------LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQ-- 55
Query: 256 IEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRM--KIA 313
I+ + ++VS G + + EF+ +L+ ++ K P+ P + KIA
Sbjct: 56 --IMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLD-RIYKKGGPI---PVEILGKIA 109
Query: 314 LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT--DTHVSTRV 371
+ GL YL+ +I+HRDIK +NIL++ + K+ DFG++ +++ DT V
Sbjct: 110 VAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV---- 163
Query: 372 MGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDS 421
GT Y++PE GK T KSDV+S G+ ++EL G PF ++ D
Sbjct: 164 -GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ 212
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 5e-17
Identities = 59/199 (29%), Positives = 98/199 (49%), Gaps = 21/199 (10%)
Query: 217 LGQGGFGYVHK------GVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSL 270
LG G FG V+K G L KV+ K S + ++ EIEI++ +H ++V L
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETK-----SEEELEDYMVEIEILATCNHPYIVKL 74
Query: 271 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 330
+G + + ++ EF P ++ + DR + P I L YLH K
Sbjct: 75 LGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTE-PQIQVICRQMLEALQYLH---SMK 130
Query: 331 IIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTE 390
IIHRD+K+ N+LL + K+ADFG++ ++ T +GT ++APE + +
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-LQRRDSFIGTPYWMAPEVVMCETMKD 189
Query: 391 -----KSDVFSFGVLLLEL 404
K+D++S G+ L+E+
Sbjct: 190 TPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 6e-17
Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 25/221 (11%)
Query: 211 FSEANLLGQGGFGYVHKGVL-----TNGKVVAIKQLKA-GSGQGE-REFQAEIEIISQVH 263
+LG+G FG V +G L + KV A+K +K E EF +E +
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKV-AVKTMKLDIHTYSEIEEFLSEAACMKDFD 59
Query: 264 HRHLVSLVGYCTFGSQR------LLVYEFVPNKTLE---FHLHGKDRPVMNWPTRM--KI 312
H +++ L+G C S +++ F+ + L + P P + K
Sbjct: 60 HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPE-KLPLQTLLKF 118
Query: 313 ALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM 372
+ A G+ YL IHRD+ + N +L + VADFGL+K D + R+
Sbjct: 119 MVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA 175
Query: 373 GT-FGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 411
++A E + T KSDV++FGV + E+ T G P+
Sbjct: 176 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 6e-17
Identities = 72/301 (23%), Positives = 132/301 (43%), Gaps = 49/301 (16%)
Query: 204 LKIATDNFSEANLLGQGGFGYVHKGVLTNGKV-----VAIKQLKAGSGQGERE-FQAEIE 257
+ I+ D + ++LL +G FG + G+L + K V +K +K + + + E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 258 IISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNK-TLEFHLH-GKDRPVMNW---PTRMKI 312
++ + H++++ ++ C + V N L+ L + N T+ +
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120
Query: 313 ALGS--ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTR 370
+ A G++YLH + +IH+DI + N ++D+ + K+ D L++ D H
Sbjct: 121 HMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHC--- 174
Query: 371 VMGT-----FGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVD 424
+G ++A E + + + SDV+SFGVLL EL+T G P+ + D F
Sbjct: 175 -LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE------ 227
Query: 425 WAKPFLAQGLADGNFDALVDQKLEEYDSA--EMTRMAACAAACIRHSARRRPRMSQIVRA 482
+A L DG +L + + E+ + AC C RP SQ+V+
Sbjct: 228 -----MAAYLKDG-------YRLAQPINCPDELFAVMAC---CWALDPEERPSFSQLVQC 272
Query: 483 L 483
L
Sbjct: 273 L 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 7e-17
Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 19/206 (9%)
Query: 217 LGQGGFGYVHKGV---LTNGKV---VAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVS 269
LGQG FG V++G + G+ VA+K + + ER EF E ++ H+V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 270 LVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR--------MKIALGSARGLA 321
L+G + G L+V E + + L+ +L N P R +++A A G+A
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 322 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH-VSTRVMGTFGYLAP 380
YL+ K +HRD+ + N ++ F K+ DFG+ + +TD + + + ++AP
Sbjct: 134 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 381 EYASSGKLTEKSDVFSFGVLLLELIT 406
E G T SD++SFGV+L E+ +
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 7e-17
Identities = 59/215 (27%), Positives = 106/215 (49%), Gaps = 18/215 (8%)
Query: 210 NFSEANLLGQGGFG--YVHKGVLTNGKVVAIKQLK---AGSGQGEREFQA---EIEIISQ 261
+ + LG G F Y + V T G ++A+KQ+ S + E +A EI ++++
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKT-GTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMAR 59
Query: 262 VHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLA 321
++H H++ ++G S L E++ ++ L K + RGL+
Sbjct: 60 LNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLS-KYGAFKEAVI-INYTEQLLRGLS 117
Query: 322 YLHEDCQPKIIHRDIKSANILLDDSFE-AKVADFGLAKHSLDTDT---HVSTRVMGTFGY 377
YLHE+ +IIHRD+K AN+L+D + + ++ADFG A T +++GT +
Sbjct: 118 YLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAF 174
Query: 378 LAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFD 412
+APE + DV+S G +++E+ T P++
Sbjct: 175 MAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWN 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 7e-17
Identities = 69/207 (33%), Positives = 96/207 (46%), Gaps = 15/207 (7%)
Query: 216 LLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQ---AEIEIISQV-HHRHLVSL 270
+LG+G FG V L + AIK LK + + + E ++S H L L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 271 VGYCTFGSQRLL--VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 328
YCTF ++ L V E++ L FH+ + + P A GL +LH
Sbjct: 62 --YCTFQTKENLFFVMEYLNGGDLMFHIQSCHK--FDLPRATFYAAEIICGLQFLHSK-- 115
Query: 329 PKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKL 388
I++RD+K NILLD K+ADFG+ K ++ D T GT Y+APE K
Sbjct: 116 -GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-FCGTPDYIAPEILLGQKY 173
Query: 389 TEKSDVFSFGVLLLELITGFRPFDKAD 415
D +SFGVLL E++ G PF D
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQSPFHGHD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 8e-17
Identities = 66/202 (32%), Positives = 101/202 (50%), Gaps = 9/202 (4%)
Query: 211 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGERE-FQAEIEIISQVHHRHLV 268
F++ +G+G FG V KG+ KVVAIK + + E E Q EI ++SQ ++
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 269 SLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 328
G ++ ++ E++ + L T ++ L +GL YLH +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDYLHSE-- 120
Query: 329 PKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKL 388
K IHRDIK+AN+LL + E K+ADFG+A DT +T V GT ++APE
Sbjct: 121 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAY 178
Query: 389 TEKSDVFSFGVLLLELITGFRP 410
K+D++S G+ +EL G P
Sbjct: 179 DSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 8e-17
Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 42/217 (19%)
Query: 218 GQGGFGYVHKGVLTN---GKVVAIKQLKAGSGQGEREFQA---EIEIISQVHHRHLVSLV 271
G+G +G V+K N GK AIK+ K Q Q+ EI ++ ++ H ++VSLV
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68
Query: 272 GYC-TFGSQRL-LVYEFVPNKTLE---FHLHGKDRPVMNWPTRMKIALGSA-----RGLA 321
+ + L++++ + + FH K + P M + S G+
Sbjct: 69 EVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSI---PPSM---VKSLLWQILNGVH 122
Query: 322 YLHEDCQPKIIHRDIKSANILL----DDSFEAKVADFGLA-------KHSLDTDTHVSTR 370
YLH + ++HRD+K ANIL+ + K+ D GLA K D D
Sbjct: 123 YLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD-----P 174
Query: 371 VMGTFGYLAPEYASSGK-LTEKSDVFSFGVLLLELIT 406
V+ T Y APE + T+ D+++ G + EL+T
Sbjct: 175 VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 67/245 (27%), Positives = 114/245 (46%), Gaps = 38/245 (15%)
Query: 210 NFSEANLLGQGGFGYVH------------KGVLTNGKV-----VAIKQLKAGSGQGER-E 251
NF E LG+G FG VH K N VA+K L+ + R +
Sbjct: 8 NFVE--KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARED 65
Query: 252 FQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVP----NKTLEFHLHGKDRPVMNWP 307
F E++I+S++ ++ L+G CT ++ E++ N+ L+ H+ N
Sbjct: 66 FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125
Query: 308 -----TRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362
T + +A A G+ YL +HRD+ + N L+ ++ K+ADFG++++
Sbjct: 126 SLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182
Query: 363 TDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFR--PFDKADTFAD 419
+D + V R ++A E GK T KSDV++FGV L E++T R P++ D
Sbjct: 183 SDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT---D 239
Query: 420 DSMVD 424
+++
Sbjct: 240 QQVIE 244
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 69/262 (26%), Positives = 101/262 (38%), Gaps = 64/262 (24%)
Query: 209 DNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAG----SGQGEREFQAEIEIIS 260
D+F ++G+G FG V K G+V A+K L+ Q +AE +I++
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDK---DTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILA 56
Query: 261 QVHHRHLVSLVGYCTFGSQRLL--VYEFVPNKTLEFHLHGKDRPVMNWPTR-----MKIA 313
+V L Y +F + L V E++P L L KD R + +A
Sbjct: 57 DADSPWIVKL--YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEET-ARFYIAELVLA 113
Query: 314 LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK--------------- 358
L S L + IHRDIK NIL+D K+ADFGL K
Sbjct: 114 LDSVHKLGF---------IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDS 164
Query: 359 -------------HSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELI 405
+ +GT Y+APE + D +S GV+L E++
Sbjct: 165 HNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224
Query: 406 TGFRPFDKADTFADDSMVDWAK 427
GF PF ++D + K
Sbjct: 225 YGFPPF-----YSDTLQETYNK 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 73/220 (33%), Positives = 112/220 (50%), Gaps = 31/220 (14%)
Query: 216 LLGQGGFG---YVHKGVLTN-GKVVAIKQLKAGSGQGEREFQAEIE--IISQVHHRHLVS 269
+LGQG FG V K + G++ A+K LK + + + ++E I+++V+H +V
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 270 L-VGYCTFGSQRLLVYEFVPNKTLEFHLHGKD------RPVMNWPTRMKIALGS-ARGLA 321
L + T G L+ L+F L G D + VM +K L A L
Sbjct: 63 LHYAFQTEGKLYLI---------LDF-LRGGDLFTRLSKEVMFTEEDVKFYLAELALALD 112
Query: 322 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPE 381
+LH II+RD+K NILLD+ K+ DFGL+K S+D + + GT Y+APE
Sbjct: 113 HLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAPE 168
Query: 382 YASSGKLTEKSDVFSFGVLLLELITGFRPF---DKADTFA 418
+ T+ +D +SFGVL+ E++TG PF D+ +T
Sbjct: 169 VVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMT 208
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 64/223 (28%), Positives = 100/223 (44%), Gaps = 43/223 (19%)
Query: 216 LLGQGGFGYVHKG-VLTNGKVVAIKQL-KAGSGQGEREFQAEIEIISQVHH-RHLVSLVG 272
+G G G V+K G V+A+KQ+ + G+ + + +++++ + H ++V G
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYG 81
Query: 273 YCTFGS-------------QRLL--VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA 317
Y S +LL + +P L GK M +A+ A
Sbjct: 82 YFITDSDVFICMELMSTCLDKLLKRIQGPIPEDIL-----GK----------MTVAIVKA 126
Query: 318 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGY 377
L YL E +IHRD+K +NILLD S K+ DFG++ +D+ TR G Y
Sbjct: 127 --LHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCAAY 180
Query: 378 LAPEYASSGKLTEK----SDVFSFGVLLLELITGFRPFDKADT 416
+APE K +DV+S G+ L+EL TG P+ T
Sbjct: 181 MAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT 223
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 53/153 (34%), Positives = 74/153 (48%), Gaps = 24/153 (15%)
Query: 273 YCTFGSQRLL--VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR--------GLAY 322
+CTF ++ L V E++ L FH+ R AR GL +
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR----------FDEARARFYAAEIICGLQF 111
Query: 323 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEY 382
LH+ II+RD+K N+LLD K+ADFG+ K +++ + ST GT Y+APE
Sbjct: 112 LHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIAPEI 167
Query: 383 ASSGKLTEKSDVFSFGVLLLELITGFRPFDKAD 415
K E D +SFGVLL E++ G PF D
Sbjct: 168 LKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 64/205 (31%), Positives = 97/205 (47%), Gaps = 25/205 (12%)
Query: 211 FSEANLLGQGGFGYVH--KGVLTNGKVVAIKQLKAGSGQGEREFQ---AEIEIISQVHHR 265
F++ +G G FG V+ + V TN +VVAIK++ Q ++Q E+ + Q+ H
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTN-EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHP 75
Query: 266 HLVSLVGYCTFGSQRLLVYEFV---PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAY 322
+ + G LV E+ + LE H + + I G+ +GLAY
Sbjct: 76 NTIEYKGCYLREHTAWLVMEYCLGSASDILEVH-----KKPLQEVEIAAICHGALQGLAY 130
Query: 323 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEY 382
LH + IHRDIK+ NILL + K+ADFG A ++ V GT ++APE
Sbjct: 131 LHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEV 182
Query: 383 ---ASSGKLTEKSDVFSFGVLLLEL 404
G+ K DV+S G+ +EL
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 67/211 (31%), Positives = 110/211 (52%), Gaps = 25/211 (11%)
Query: 216 LLGQGGFGYVHKGVLT----NGKV-VAIKQLKAG-SGQGEREFQAEIEIISQVHHRHLVS 269
+LG G FG V+KG+ N K+ VAIK L+ S + +E E +++ V ++
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 270 LVGYCTFGSQRLLVYEFVPNKTLEFHL-HGKDR----PVMNWPTRMKIALGSARGLAYLH 324
L+G C S LV + +P L ++ KDR ++NW ++ A+G++YL
Sbjct: 74 LLGIC-LTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLE 126
Query: 325 EDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT--FGYLAPEY 382
E +++HRD+ + N+L+ K+ DFGLA+ LD D G ++A E
Sbjct: 127 E---VRLVHRDLAARNVLVKSPNHVKITDFGLAR-LLDIDETEYHADGGKVPIKWMALES 182
Query: 383 ASSGKLTEKSDVFSFGVLLLELIT-GFRPFD 412
+ T +SDV+S+GV + EL+T G +P+D
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 4e-16
Identities = 66/203 (32%), Positives = 94/203 (46%), Gaps = 19/203 (9%)
Query: 217 LGQGGFGYVHK-GVLTNGKVVAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSLVG 272
LG GGFG V V + + A+K +K + +E EI+ + +H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58
Query: 273 YCTFGSQRLLVY---EFVPNKTLEFHLHGKDRPVMN-WPTRMKIALGSARGLAYLHEDCQ 328
Y TF ++ +Y E+ L L DR + + + R IA YLH
Sbjct: 59 YRTFKDKKY-IYMLMEYCLGGELWTILR--DRGLFDEYTARFYIA-CVVLAFEYLHNR-- 112
Query: 329 PKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKL 388
II+RD+K N+LLD + K+ DFG AK L + T GT Y+APE +
Sbjct: 113 -GIIYRDLKPENLLLDSNGYVKLVDFGFAK-KLKSGQKTWTFC-GTPEYVAPEIILNKGY 169
Query: 389 TEKSDVFSFGVLLLELITGFRPF 411
D +S G+LL EL+TG PF
Sbjct: 170 DFSVDYWSLGILLYELLTGRPPF 192
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (194), Expect = 5e-16
Identities = 58/220 (26%), Positives = 96/220 (43%), Gaps = 55/220 (25%)
Query: 217 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA--------EIEIISQV-HHRH 266
LG G FG V+ G++VAIK++K ++F + E++ + ++ H +
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 267 LVSL-----VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLA 321
+V L + V+E++ + K +P + I +GLA
Sbjct: 60 IVKLKEVFRENDELY-----FVFEYMEGNLYQLMKDRKGKP-FSESVIRSIIYQILQGLA 113
Query: 322 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD----TDTHVSTRVMGTFGY 377
++H+ HRD+K N+L+ K+ADFGLA+ TD +VSTR Y
Sbjct: 114 HIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD-YVSTR-----WY 164
Query: 378 LAPE-------YASSGKLTEKSDVFSFGVLLLELITGFRP 410
APE Y+S D+++ G ++ EL T RP
Sbjct: 165 RAPEILLRSTSYSS------PVDIWALGCIMAELYT-LRP 197
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 5e-16
Identities = 74/312 (23%), Positives = 133/312 (42%), Gaps = 67/312 (21%)
Query: 217 LGQGGFGYVHKGVLTNGK-----------------VVAIKQLKAGSGQGER-EFQAEIEI 258
LG+G FG VH + N + +VA+K L+ + + R +F E++I
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 259 ISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHL---HGKDR-------------- 301
+S++ +++ L+G C ++ E++ N L L H D+
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 302 PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 361
P +++ + + +AL A G+ YL +HRD+ + N L+ ++ K+ADFG++++
Sbjct: 133 PAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 362 DTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFR--PFDKADTFA 418
D + + R + ++A E GK T SDV++FGV L E++ + P+ +
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGE---LT 246
Query: 419 DDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAA-------CIRHSAR 471
D+ +++ A F DQ + Y + R C C R
Sbjct: 247 DEQVIENAGEFFR------------DQGRQVY----LFRPPPCPQGLYELMLQCWSRDCR 290
Query: 472 RRPRMSQIVRAL 483
RP S I L
Sbjct: 291 ERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 6e-16
Identities = 60/174 (34%), Positives = 80/174 (45%), Gaps = 31/174 (17%)
Query: 320 LAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG--- 376
L +H +IHRDIKSANILL + K+ DFG +K T VS V TF
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAAT---VSDDVGRTFCGTP 209
Query: 377 -YLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLA 435
Y+APE ++K+D+FS GVLL EL+T RPFD + M + LA
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN------MEEVMHKTLA---- 259
Query: 436 DGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMPL 489
G +D L E M A + +RRP S+++ NMP+
Sbjct: 260 -GRYDPLPPSISPE--------MQEIVTALLSSDPKRRPSSSKLL-----NMPI 299
|
Length = 496 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 6e-16
Identities = 68/206 (33%), Positives = 100/206 (48%), Gaps = 13/206 (6%)
Query: 216 LLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQ---AEIEIISQVHHRHLVSLV 271
+LG+G FG V L G+ A+K LK + + + E +++ ++ +
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 272 GYCTFGSQRLL--VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQP 329
YCTF ++ L V EF+ L FH+ K R + T + GL +LH
Sbjct: 62 -YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVC--GLQFLHSK--- 115
Query: 330 KIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLT 389
II+RD+K N++LD K+ADFG+ K ++ D ST GT Y+APE K T
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEILQGLKYT 174
Query: 390 EKSDVFSFGVLLLELITGFRPFDKAD 415
D +SFGVLL E++ G PF D
Sbjct: 175 FSVDWWSFGVLLYEMLIGQSPFHGDD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 8e-16
Identities = 53/188 (28%), Positives = 90/188 (47%), Gaps = 18/188 (9%)
Query: 233 GKVVAIKQLKAGSGQGERE---FQAEIEIISQVHHRHLVSLVGYCTFGSQRLL-VYEFVP 288
G VAIK L+ + + E + F+ E + ++++H ++V+L+ L V+E+VP
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 289 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL---DD 345
+TL L + ++ L LA H I+HRD+K NI++
Sbjct: 63 GRTLREVLAADG--ALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGV 117
Query: 346 SFEAKVADFGL------AKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGV 399
AKV DFG+ + + +T V+GT Y APE +T SD++++G+
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177
Query: 400 LLLELITG 407
+ LE +TG
Sbjct: 178 IFLECLTG 185
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 9e-16
Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 217 LGQGGFGYVHKGVLTNGKVVA---IKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSLVG 272
+G G FG V G G A +K+L+A + E+ F E++ +++H +++ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 273 YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRM---KIALGSARGLAYLHEDCQP 329
C LLV EF P L+ +L V + ++A A GL +LH Q
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QA 119
Query: 330 KIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT-FGYLAPEYASS--- 385
IH D+ N L K+ D+GLA D +++ +LAPE
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 386 ----GKLTEKSDVFSFGVLLLELIT-GFRPF 411
T+KS+++S GV + EL T +P+
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWELFTAADQPY 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 53/200 (26%), Positives = 105/200 (52%), Gaps = 16/200 (8%)
Query: 217 LGQGGFGYVHKG-VLTNGKVVAIKQLKAG-SGQGEREFQAEIEIISQVHHRHLVSLVGYC 274
LG G G V+K L +++A+K + + + +++ +E+EI+ + +++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG-A 67
Query: 275 TFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIH 333
F R+ + EF+ +L+ ++ K + +IA+ +GL YL KI+H
Sbjct: 68 FFVENRISICTEFMDGGSLD--VYRK----IPEHVLGRIAVAVVKGLTYL---WSLKILH 118
Query: 334 RDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSD 393
RD+K +N+L++ + K+ DFG++ +++ ++ +GT Y+APE S + SD
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTYVGTNAYMAPERISGEQYGIHSD 175
Query: 394 VFSFGVLLLELITGFRPFDK 413
V+S G+ +EL G P+ +
Sbjct: 176 VWSLGISFMELALGRFPYPQ 195
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 60/218 (27%), Positives = 107/218 (49%), Gaps = 38/218 (17%)
Query: 209 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE-FQA----EIEIISQV 262
D + + N + +G +G V++ G++VA+K+LK E+E F EI I+ ++
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEK---EKEGFPITSLREINILLKL 61
Query: 263 HHRHLVSLVGYCTFGS---QRLLVYEFVPN--KTLEFHLHG-------KDRPVMNWPTRM 310
H ++V+ V GS + +V E+V + K+L + K M
Sbjct: 62 QHPNIVT-VKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVK--------CLM 112
Query: 311 KIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTR 370
L G+A+LH++ I+HRD+K++N+LL++ K+ DFGLA+ T+
Sbjct: 113 LQLL---SGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSP-LKPYTQ 165
Query: 371 VMGTFGYLAPE-YASSGKLTEKSDVFSFGVLLLELITG 407
++ T Y APE + + + D++S G + EL+T
Sbjct: 166 LVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTK 203
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 22/213 (10%)
Query: 217 LGQGGFGYVHKGVLTNGKV---VAIKQLK-AGSGQGERE-FQAEIEIISQVHHRHLVSLV 271
LG+G FG V +G L VA+K +K A + E E F +E + + H +++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 272 GYCTFGSQR------LLVYEFVPNKTLE-FHLHGK--DRPVMNWPTRM--KIALGSARGL 320
G C + +++ F+ + L F L+ + D P PT+M K A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQY-LPTQMLVKFMTDIASGM 125
Query: 321 AYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT-FGYLA 379
YL IHRD+ + N +L+++ VADFGL+K + D + R+ ++A
Sbjct: 126 EYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIA 182
Query: 380 PEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 411
E + T KSDV+SFGV + E+ T G P+
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEIATRGQTPY 215
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 2e-15
Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 18/214 (8%)
Query: 211 FSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLV 268
F L+G G +G V+KG + G++ AIK + +G E E + EI ++ + HHR++
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHRNIA 66
Query: 269 SLVGYCT------FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAY 322
+ G Q LV EF ++ + + I RGL++
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 126
Query: 323 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEY 382
LH Q K+IHRDIK N+LL ++ E K+ DFG++ LD +GT ++APE
Sbjct: 127 LH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ-LDRTVGRRNTFIGTPYWMAPEV 182
Query: 383 ASSGKLTE-----KSDVFSFGVLLLELITGFRPF 411
+ + + KSD++S G+ +E+ G P
Sbjct: 183 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 36/98 (36%), Positives = 55/98 (56%), Gaps = 9/98 (9%)
Query: 319 GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYL 378
G+ LH+ IIHRDIK N+L+D + K+ DFGL+++ L + + +GT YL
Sbjct: 109 GVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGL-----ENKKFVGTPDYL 160
Query: 379 APEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADT 416
APE + SD +S G ++ E + G+ PF A+T
Sbjct: 161 APETILGVGDDKMSDWWSLGCVIFEFLFGYPPFH-AET 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 2e-15
Identities = 65/220 (29%), Positives = 107/220 (48%), Gaps = 17/220 (7%)
Query: 210 NFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLK--AGSGQGEREFQA---EIEIISQVH 263
N+ LLGQG FG V+ + G+ +A KQ++ S + +E A EI+++ +
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 264 HRHLVSLVGYCTFGSQRLLV--YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLA 321
H +V G +++ L E++P +++ L K + K G++
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTRKYTRQILEGMS 120
Query: 322 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST---RVMGTFGYL 378
YLH + I+HRDIK ANIL D + K+ DFG +K L T T V GT ++
Sbjct: 121 YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR-LQTICMSGTGIRSVTGTPYWM 176
Query: 379 APEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFA 418
+PE S K+DV+S G ++E++T P+ + + A
Sbjct: 177 SPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA 216
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 64/216 (29%), Positives = 97/216 (44%), Gaps = 19/216 (8%)
Query: 209 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAG---SGQGEREFQAEIEIISQVHH 264
D+ +G G FG VH + A+K + + E+ E ++ +V H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 265 RHLVSLVGYCTFGSQRLL--VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAY 322
++ L + T QR L + E+VP L +L R + T + A L Y
Sbjct: 61 PFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGR--FSNSTGLFYASEIVCALEY 116
Query: 323 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD-TDTHVSTRVMGTFGYLAPE 381
LH +I++RD+K NILLD K+ DFG AK D T T + GT YLAPE
Sbjct: 117 LHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT-----LCGTPEYLAPE 168
Query: 382 YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTF 417
S + D ++ G+L+ E++ G+ PF + F
Sbjct: 169 VIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF 204
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 67/234 (28%), Positives = 102/234 (43%), Gaps = 71/234 (30%)
Query: 209 DNFSEANLLGQGGFGYVHKGVLTNGKV-VAIKQLKAGSGQGEREFQA---------EIEI 258
D + + +G G +G V T VAIK+L R FQ+ E+ +
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLS-------RPFQSAIHAKRTYRELRL 67
Query: 259 ISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLE-F-------HLHGKDRPVMNWPTRM 310
+ + H +++ L L V F P +LE F HL G D +N +
Sbjct: 68 LKHMDHENVIGL----------LDV--FTPASSLEDFQDVYLVTHLMGAD---LNNIVKC 112
Query: 311 K---------IALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 361
+ + RGL Y+H IIHRD+K +NI +++ E K+ DFGLA+H+
Sbjct: 113 QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169
Query: 362 DTDT-HVSTRVMGTFGYLAPE-------YASSGKLTEKSDVFSFGVLLLELITG 407
D T +V+TR Y APE Y + D++S G ++ EL+TG
Sbjct: 170 DEMTGYVATR-----WYRAPEIMLNWMHY------NQTVDIWSVGCIMAELLTG 212
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 66/234 (28%), Positives = 111/234 (47%), Gaps = 31/234 (13%)
Query: 205 KIATDNFSEANLLGQGGFGYV--------HKGVLTNGKVVAIKQLKAGSGQGE-REFQAE 255
++ D LG+G FG V K VA+K LK+ + + + + +E
Sbjct: 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISE 73
Query: 256 IEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNW---PTRMK 311
+E++ + H+++++L+G CT ++ E+ L +L + P M + PT++
Sbjct: 74 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVP 133
Query: 312 IALGS-----------ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK-- 358
S ARG+ YL K IHRD+ + N+L+ + K+ADFGLA+
Sbjct: 134 EEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 190
Query: 359 HSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 411
H +D + + ++APE T +SDV+SFGVLL E+ T G P+
Sbjct: 191 HHIDYYKKTTNGRL-PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 4e-15
Identities = 62/202 (30%), Positives = 92/202 (45%), Gaps = 11/202 (5%)
Query: 216 LLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQA---EIEIISQVHHRHLVSLV 271
+LG+G FG V L +G++ A+K LK + + + E I+S + ++ +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 272 GYCTFGSQRLL-VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 330
C RL V EFV L FH+ R + A L +LH+
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR--FDEARARFYAAEITSALMFLHDK---G 116
Query: 331 IIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTE 390
II+RD+K N+LLD K+ADFG+ K + ST GT Y+APE
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST-FCGTPDYIAPEILQEMLYGP 175
Query: 391 KSDVFSFGVLLLELITGFRPFD 412
D ++ GVLL E++ G PF+
Sbjct: 176 SVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-15
Identities = 65/233 (27%), Positives = 108/233 (46%), Gaps = 37/233 (15%)
Query: 209 DNFSEANLLGQGGFGYV--------HKGVLTNGKVVAIKQLKAGSGQGE-REFQAEIEII 259
D + LG+G FG V K VA+K LK + + + + +E+E++
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74
Query: 260 SQV-HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNW----------PT 308
+ H+++++L+G CT ++ E+ L +L + P M +
Sbjct: 75 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134
Query: 309 RMKIALGS----ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364
K + ARG+ YL K IHRD+ + N+L+ ++ K+ADFGLA+ + D
Sbjct: 135 TFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNID 191
Query: 365 THVSTRVMGTFG-----YLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 411
+ T T G ++APE T +SDV+SFGVL+ E+ T G P+
Sbjct: 192 YYKKT----TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 7e-15
Identities = 56/220 (25%), Positives = 103/220 (46%), Gaps = 14/220 (6%)
Query: 208 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQ---AEIEIISQVH 263
NF +G+G F V+K + L +G+VVA+K+++ + Q EI+++ Q+
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 264 HRHLVSLVGYCTFGSQRLLVYEFVPN---KTLEFHLHGKDRPVMNWPTRMKIALGSARGL 320
H +++ + ++ +V E + H + R + T K + L
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPE-RTIWKYFVQLCSAL 119
Query: 321 AYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAP 380
++H +I+HRDIK AN+ + + K+ D GL + + T + ++GT Y++P
Sbjct: 120 EHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHSLVGTPYYMSP 175
Query: 381 EYASSGKLTEKSDVFSFGVLLLELITGFRPF--DKADTFA 418
E KSD++S G LL E+ PF DK + ++
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 8e-15
Identities = 59/198 (29%), Positives = 93/198 (46%), Gaps = 23/198 (11%)
Query: 217 LGQGGFGYVHKGVL-TNGKVVAIK--------QLKAGSGQGEREFQAEIEIISQVHHRHL 267
+G+G FG V G L + VA+K LKA +F E I+ Q H ++
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKA-------KFLQEARILKQYSHPNI 55
Query: 268 VSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC 327
V L+G CT +V E V L + P + +++ +A G+ YL
Sbjct: 56 VRLIGVCTQKQPIYIVMELVQGGDFLTFLR-TEGPRLKVKELIQMVENAAAGMEYLESKH 114
Query: 328 QPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF--GYLAPEYASS 385
IHRD+ + N L+ + K++DFG+++ D + ST M + APE +
Sbjct: 115 ---CIHRDLAARNCLVTEKNVLKISDFGMSREEED-GVYASTGGMKQIPVKWTAPEALNY 170
Query: 386 GKLTEKSDVFSFGVLLLE 403
G+ + +SDV+SFG+LL E
Sbjct: 171 GRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 8e-15
Identities = 64/222 (28%), Positives = 106/222 (47%), Gaps = 31/222 (13%)
Query: 217 LGQGGFGYV--------HKGVLTNGKVVAIKQLKA-GSGQGEREFQAEIEIISQV-HHRH 266
LG+G FG V K VA+K LK + + + +E+E++ + H++
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 267 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNW-------PTR-------MKI 312
+++L+G CT ++ E+ L +L + P M++ P +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 313 ALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK--HSLDTDTHVSTR 370
A ARG+ YL K IHRD+ + N+L+ + K+ADFGLA+ H++D +
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 371 VMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 411
+ ++APE T +SDV+SFGVLL E+ T G P+
Sbjct: 197 RL-PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 73/214 (34%), Positives = 99/214 (46%), Gaps = 29/214 (13%)
Query: 210 NFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGEREFQ---AEIEIISQV 262
+F LG G FG V HKG G+ AIK LK ++ Q E I+ ++
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 263 HHRHLVSLVGYCTFGSQRLL--VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGL 320
H +V++ C+F + + + EFV L HL R +P + + L
Sbjct: 76 SHPFIVNM--MCSFQDENRVYFLLEFVVGGELFTHL----RKAGRFPNDVAKFYHAELVL 129
Query: 321 A--YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD-TDTHVSTRVMGTFGY 377
A YLH II+RD+K N+LLD+ KV DFG AK D T T + GT Y
Sbjct: 130 AFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT-----LCGTPEY 181
Query: 378 LAPEYASSGKLTEKSDVFSFGVLLLELITGFRPF 411
LAPE S + D ++ GVLL E I G+ PF
Sbjct: 182 LAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 1e-14
Identities = 58/199 (29%), Positives = 93/199 (46%), Gaps = 9/199 (4%)
Query: 217 LGQGGFGYVHK-GVLTNGKVVAIKQL---KAGSGQGEREFQAEIEIISQVHHRHLVSLVG 272
LG+GGFG V V GK+ A K+L + GE+ E EI+ +V+ +V+L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 273 YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKII 332
+ LV + L++H++ + + + G+ +LH I+
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIV 117
Query: 333 HRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKS 392
+RD+K N+LLDD +++D GLA D T T+ GT GY+APE +
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEPYSYPV 175
Query: 393 DVFSFGVLLLELITGFRPF 411
D F+ G + E++ G PF
Sbjct: 176 DWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 58/229 (25%), Positives = 95/229 (41%), Gaps = 49/229 (21%)
Query: 215 NLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGEREFQA--------------EIEII 259
LG+G +G V K T GK+VAIK++K + E++I+
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 260 SQVHHRHLVSLVG-YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMK------I 312
+++ H +++ LV Y +F+ N ++ + + V++ R+ I
Sbjct: 75 NEIKHENIMGLVDVYVE--------GDFI-NLVMDI-MASDLKKVVDRKIRLTESQVKCI 124
Query: 313 ALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK---------HSLDT 363
L GL LH + +HRD+ ANI ++ K+ADFGLA+
Sbjct: 125 LLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181
Query: 364 DTHVSTRVMG----TFGYLAPE-YASSGKLTEKSDVFSFGVLLLELITG 407
+T M T Y APE + K D++S G + EL+TG
Sbjct: 182 ETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230
|
Length = 335 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 59/216 (27%), Positives = 109/216 (50%), Gaps = 18/216 (8%)
Query: 210 NFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA-EIEIISQVHHRHL 267
NF + LG+G + V+KG T G++VA+K++ + +G EI ++ ++ H ++
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 268 VSLVGYCTFGSQRLLVYEFVPN---KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH 324
V L ++ +LV+E++ K ++ H + L +G+A+ H
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLL---KGIAFCH 117
Query: 325 EDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK-HSLDTDTHVSTRVMGTFGYLAPEYA 383
E+ +++HRD+K N+L++ E K+ADFGLA+ + +T + V T Y AP+
Sbjct: 118 EN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPDVL 172
Query: 384 SSGKLTEKS-DVFSFGVLLLELITG---FRPFDKAD 415
+ S D++S G ++ E+ITG F + D
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED 208
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 64/205 (31%), Positives = 96/205 (46%), Gaps = 16/205 (7%)
Query: 216 LLGQGGFGYVHKGVLT----NGKVVAIKQLKAG----SGQGEREFQAEIEIISQVHHRHL 267
+LG+GG+G V + GK+ A+K LK + + +AE I+ V H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 268 VSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS-ARGLAYLHED 326
V L+ G + L+ E++ L HL +R + L + L +LH
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHL---EREGIFMEDTACFYLSEISLALEHLH-- 117
Query: 327 CQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSG 386
Q II+RD+K NILLD K+ DFGL K S+ T V+ GT Y+APE
Sbjct: 118 -QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFCGTIEYMAPEILMRS 175
Query: 387 KLTEKSDVFSFGVLLLELITGFRPF 411
+ D +S G L+ +++TG PF
Sbjct: 176 GHGKAVDWWSLGALMYDMLTGAPPF 200
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 62/243 (25%), Positives = 100/243 (41%), Gaps = 62/243 (25%)
Query: 207 ATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE-F----QAEIEIIS 260
++ LG+G FG V+K + G+VVA+K++ + E++ F EI+I+
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHN---EKDGFPITALREIKILK 62
Query: 261 QVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPV--MNWP----------- 307
++ H ++V L+ + E + R M P
Sbjct: 63 KLKHPNVVPLID---------MAVERPDK-------SKRKRGSVYMVTPYMDHDLSGLLE 106
Query: 308 -TRMKIALGSAR--------GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA- 357
+K+ + G+ YLHE+ I+HRDIK+ANIL+D+ K+ADFGLA
Sbjct: 107 NPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLAR 163
Query: 358 ---------KHSLDTDTHVSTRVMGTFGYLAPEY-ASSGKLTEKSDVFSFGVLLLELITG 407
K T T ++ T Y PE + T D++ G + E+ T
Sbjct: 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR 223
Query: 408 FRP 410
RP
Sbjct: 224 -RP 225
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 55/194 (28%), Positives = 95/194 (48%), Gaps = 11/194 (5%)
Query: 217 LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGERE-FQAEIEIISQVHHRHLVSLVGYCT 275
LG G FG V+K V+A ++ + E E + EI+I++ H ++V L+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 276 FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRD 335
+ + ++ EF ++ + +RP+ P + + L YLHE+ KIIHRD
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTE-PQIRVVCKQTLEALNYLHEN---KIIHRD 128
Query: 336 IKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTE----- 390
+K+ NIL + K+ADFG++ + T +GT ++APE +
Sbjct: 129 LKAGNILFTLDGDIKLADFGVSAKNTRT-IQRRDSFIGTPYWMAPEVVMCETSKDRPYDY 187
Query: 391 KSDVFSFGVLLLEL 404
K+DV+S G+ L+E+
Sbjct: 188 KADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 3e-14
Identities = 56/202 (27%), Positives = 95/202 (47%), Gaps = 10/202 (4%)
Query: 216 LLGQGGFGYVHKGVLT-NGK---VVAIKQLKAG-SGQGEREFQAEIEIISQVHHRHLVSL 270
+LG G FG + +G L K VAI L+AG S + R F AE + Q H ++V L
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 271 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 330
G T G+ ++V E++ N L+ L K + M + G A G+ YL E
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLR-KHEGQLVAGQLMGMLPGLASGMKYLSE---MG 127
Query: 331 IIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTE 390
+H+ + + +L++ K++ F + + + + APE +
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSS 187
Query: 391 KSDVFSFGVLLLELIT-GFRPF 411
SDV+SFG+++ E+++ G RP+
Sbjct: 188 ASDVWSFGIVMWEVMSYGERPY 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 57/214 (26%), Positives = 105/214 (49%), Gaps = 22/214 (10%)
Query: 210 NFSEANLLGQGGFG--YVHKGVLTNGKVVAIKQ--LKAGSGQGEREFQAEIEIISQVHHR 265
+ +G+G FG Y+ K + V IK+ L + + + E+ +++++ H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCV-IKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 266 HLVSLVGYCTFGSQRLLVYEFVPNKTLEFHL---HG---KDRPVMNWPTRMKIALGSARG 319
++V+ + +V E+ L + G + +++W ++I+LG
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW--FVQISLG---- 113
Query: 320 LAYLHEDCQPKIIHRDIKSANILLD-DSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYL 378
L ++H+ KI+HRDIKS NI L + AK+ DFG+A+ L+ ++ +GT YL
Sbjct: 114 LKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIAR-QLNDSMELAYTCVGTPYYL 169
Query: 379 APEYASSGKLTEKSDVFSFGVLLLELITGFRPFD 412
+PE + K+D++S G +L EL T PF+
Sbjct: 170 SPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 61/198 (30%), Positives = 94/198 (47%), Gaps = 23/198 (11%)
Query: 217 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQ---AEIEIISQVHHRHLVSLVG 272
+G G FG V+ +VVA+K++ Q ++Q E++ + Q+ H + + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 273 YCTFGSQRLLVYEFV---PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQP 329
LV E+ + LE H +P+ I G+ +GLAYLH
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVH----KKPLQEVEI-AAITHGALQGLAYLHSHN-- 141
Query: 330 KIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEY---ASSG 386
+IHRDIK+ NILL + + K+ADFG A S ++ V GT ++APE G
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEG 195
Query: 387 KLTEKSDVFSFGVLLLEL 404
+ K DV+S G+ +EL
Sbjct: 196 QYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 4e-14
Identities = 56/209 (26%), Positives = 100/209 (47%), Gaps = 39/209 (18%)
Query: 217 LGQGGFGYVHKGVL----TNGKVVAIKQLKAGSGQG-ER-EFQAEIEIISQVHHRHLVS- 269
+G+G FG K +L +GK IK++ ER E + E+ ++S + H ++V
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 270 ------------LVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA 317
++ YC G L + + + F + +++W ++ +AL
Sbjct: 65 QESFEENGNLYIVMDYCEGGD---LYKKINAQRGVLF----PEDQILDWFVQICLAL--- 114
Query: 318 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGY 377
++H+ KI+HRDIKS NI L K+ DFG+A+ L++ ++ +GT Y
Sbjct: 115 ---KHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIAR-VLNSTVELARTCIGTPYY 167
Query: 378 LAPEYASSGKLTEKSDVFSFGVLLLELIT 406
L+PE + KSD+++ G +L E+ T
Sbjct: 168 LSPEICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 5e-14
Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 13/208 (6%)
Query: 209 DNFSEANLLGQGGFGYVHKG-VLTNGKVVAIKQLKAGSGQGEREFQA--EIEIISQVHHR 265
D++ + LG+G + V+KG NGK+VA+K ++ +G F A E ++ + H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-PFTAIREASLLKGLKHA 63
Query: 266 HLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA-RGLAYLH 324
++V L LV+E+V ++ P P +K+ L RGL+Y+H
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYVHTDLCQYM---DKHPGGLHPENVKLFLFQLLRGLSYIH 120
Query: 325 EDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPE-YA 383
Q I+HRD+K N+L+ D+ E K+ADFGLA+ + +H + + T Y P+
Sbjct: 121 ---QRYILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDVLL 176
Query: 384 SSGKLTEKSDVFSFGVLLLELITGFRPF 411
S + + D++ G + +E+I G F
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 6e-14
Identities = 61/230 (26%), Positives = 112/230 (48%), Gaps = 25/230 (10%)
Query: 209 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAG-SGQGEREFQAEIEI-ISQVHHR 265
D+ LG+G +G V K + G ++A+K+++A + Q ++ +++I + V
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCP 60
Query: 266 HLVSLVGYCTFGSQRLLVYEFVPNKTLE-FHLHGKDRPV-MNWPTRMKIALGSARGLAYL 323
+ V+ G F + + V + +L+ F+ D+ + + KIA+ + L YL
Sbjct: 61 YTVTFYG-ALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYL 119
Query: 324 HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEY- 382
H + +IHRD+K +N+L++ + + K+ DFG++ + D+ T G Y+APE
Sbjct: 120 HS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL--VDSVAKTIDAGCKPYMAPERI 175
Query: 383 ---ASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPF 429
+ KSDV+S G+ ++EL TG P+D W PF
Sbjct: 176 NPELNQKGYDVKSDVWSLGITMIELATGRFPYDS-----------WKTPF 214
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 7e-14
Identities = 71/253 (28%), Positives = 117/253 (46%), Gaps = 19/253 (7%)
Query: 210 NFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQL--KAGSGQGEREFQA---EIEIISQVH 263
N+ LLG+G FG V+ G+ +A+KQ+ S + +E A EI+++ +
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 264 HRHLVSLVGYCTFGSQRLL--VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLA 321
H +V G ++ L E++P +++ L N R + +G++
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQI--LQGVS 120
Query: 322 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST---RVMGTFGYL 378
YLH + I+HRDIK ANIL D + K+ DFG +K + T T V GT ++
Sbjct: 121 YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR-IQTICMSGTGIKSVTGTPYWM 176
Query: 379 APEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFAD--DSMVDWAKPFLAQGLAD 436
+PE S K+DV+S ++E++T P+ + + A KP L G++D
Sbjct: 177 SPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSD 236
Query: 437 GNFDALVDQKLEE 449
D L +EE
Sbjct: 237 ACRDFLKQIFVEE 249
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 7e-14
Identities = 57/206 (27%), Positives = 99/206 (48%), Gaps = 15/206 (7%)
Query: 209 DNFSEANLLGQGGFGYVHKG-VLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL 267
DNF + +G+G G V + G+ VA+K++ Q E+ I+ H ++
Sbjct: 22 DNFVK---IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 268 VSLVGYCTFGSQRLLVYEFVPNKTL-EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED 326
V + G + +V EF+ L + H + MN + L + L++LH
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIATVCLAVLKALSFLHAQ 134
Query: 327 CQPKIIHRDIKSANILLDDSFEAKVADFGL-AKHSLDTDTHVSTRVMGTFGYLAPEYASS 385
+IHRDIKS +ILL K++DFG A+ S + S ++GT ++APE S
Sbjct: 135 ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPEVISR 189
Query: 386 GKLTEKSDVFSFGVLLLELITGFRPF 411
+ D++S G++++E++ G P+
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 7e-14
Identities = 37/100 (37%), Positives = 61/100 (61%), Gaps = 5/100 (5%)
Query: 311 KIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTR 370
KI++ RGL YL E + KI+HRD+K +NIL++ E K+ DFG++ +D+ ++
Sbjct: 103 KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANS 157
Query: 371 VMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRP 410
+GT Y++PE T +SD++S G+ L+E+ G P
Sbjct: 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 7e-14
Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 209 DNFSEANLLGQGGFGYVH-KGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL 267
DNF + +G+G G V V ++GK+VA+K++ Q E+ I+ H ++
Sbjct: 23 DNFIK---IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 268 VSLVGYCTFGSQRLLVYEFVPNKTL-EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED 326
V + G + +V EF+ L + H + MN + L + L+ LH
Sbjct: 80 VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLKALSVLHAQ 135
Query: 327 CQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSG 386
+IHRDIKS +ILL K++DFG + + ++GT ++APE S
Sbjct: 136 ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQ-VSKEVPRRKSLVGTPYWMAPELISRL 191
Query: 387 KLTEKSDVFSFGVLLLELITGFRPF 411
+ D++S G++++E++ G P+
Sbjct: 192 PYGPEVDIWSLGIMVIEMVDGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 7e-14
Identities = 57/219 (26%), Positives = 107/219 (48%), Gaps = 40/219 (18%)
Query: 217 LGQGGFGYV----HKGVLTNGKVVAIKQL--KAGSGQGEREFQAEIEIISQVHHRHLVS- 269
+G+G +G V H+ T+GK IK+L + S + + + E +++SQ+ H ++V+
Sbjct: 8 VGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 270 -------------LVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS 316
++G+C G +Y + + + + V+ W ++ +AL
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGD----LYHKLKEQKGKLLP---ENQVVEWFVQIAMAL-- 115
Query: 317 ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG 376
YLHE I+HRD+K+ N+ L + KV D G+A+ L+ +++ ++GT
Sbjct: 116 ----QYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIAR-VLENQCDMASTLIGTPY 167
Query: 377 YLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKAD 415
Y++PE S+ KSDV++ G + E+ T F+ D
Sbjct: 168 YMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 23/213 (10%)
Query: 216 LLGQGGFGYVHKGVLTNG--KVVAIKQLKA-----GSGQGERE-----FQAEIEII-SQV 262
LG G FG V+K N ++A+K++ G + ER+ +E+ II Q+
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 263 HHRHLVSLVGYCTF--GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRM--KIALGSAR 318
H ++V Y TF + +V + + L H + + I +
Sbjct: 67 RHPNIVRY--YKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124
Query: 319 GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYL 378
L YLH+ + +I+HRD+ NI+L + + + DFGLAK T V+GT Y
Sbjct: 125 ALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQK--QPESKLTSVVGTILYS 180
Query: 379 APEYASSGKLTEKSDVFSFGVLLLELITGFRPF 411
PE + EK+DV++FG +L ++ T PF
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 65/220 (29%), Positives = 104/220 (47%), Gaps = 17/220 (7%)
Query: 210 NFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLK--AGSGQGEREFQA---EIEIISQVH 263
N+ LLGQG FG V+ G+ +A+KQ++ S + +E A EI+++ +
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 264 HRHLVSLVGYCTFGSQRLL--VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLA 321
H +V G +R L E +P +++ L K + K G++
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTENVTRKYTRQILEGVS 120
Query: 322 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST---RVMGTFGYL 378
YLH + I+HRDIK ANIL D K+ DFG +K L T T V GT ++
Sbjct: 121 YLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKR-LQTICLSGTGMKSVTGTPYWM 176
Query: 379 APEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFA 418
+PE S K+D++S G ++E++T P+ + + A
Sbjct: 177 SPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA 216
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 63/224 (28%), Positives = 99/224 (44%), Gaps = 31/224 (13%)
Query: 211 FSEANLLGQGGFGYVHKGVLT----NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHH 264
F+ +LG+G FG V + L + + VA+K LKA S EF E + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 265 RHLVSLVGYC--TFGSQRLLVYEFVPNKTLEFHLHGK-----------DRPVMNWP--TR 309
+++ L+G + RL + P L F HG + P P T
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPI----PMVILPFMKHGDLHTFLLMSRIGEEPF-TLPLQTL 115
Query: 310 MKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 369
++ + A G+ YL IHRD+ + N +L+++ VADFGL+K D +
Sbjct: 116 VRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQG 172
Query: 370 RVMG-TFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 411
+LA E + T SDV++FGV + E++T G P+
Sbjct: 173 CASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 52/181 (28%), Positives = 86/181 (47%), Gaps = 9/181 (4%)
Query: 232 NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKT 291
GK VA+K++ Q E+ I+ HH ++V + G + +V EF+
Sbjct: 46 TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105
Query: 292 L-EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAK 350
L + H + MN + L R L+YLH +IHRDIKS +ILL K
Sbjct: 106 LTDIVTHTR----MNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIK 158
Query: 351 VADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRP 410
++DFG + + ++GT ++APE S + D++S G++++E+I G P
Sbjct: 159 LSDFGFCAQ-VSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217
Query: 411 F 411
+
Sbjct: 218 Y 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 71.7 bits (175), Expect = 1e-13
Identities = 64/205 (31%), Positives = 100/205 (48%), Gaps = 25/205 (12%)
Query: 211 FSEANLLGQGGFG--YVHKGVLTNGKVVAIKQLKAGSGQGEREFQ---AEIEIISQVHHR 265
F++ +G G FG Y + V TN +VVAIK++ Q ++Q E++ + ++ H
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTN-EVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHP 85
Query: 266 HLVSLVGYCTFGSQRLLVYEFV---PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAY 322
+ + G LV E+ + LE H +P+ I G+ +GLAY
Sbjct: 86 NSIEYKGCYLREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEI-AAITHGALQGLAY 140
Query: 323 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEY 382
LH +IHRDIK+ NILL + + K+ADFG A + ++ V GT ++APE
Sbjct: 141 LHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEV 192
Query: 383 ---ASSGKLTEKSDVFSFGVLLLEL 404
G+ K DV+S G+ +EL
Sbjct: 193 ILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 61/230 (26%), Positives = 103/230 (44%), Gaps = 31/230 (13%)
Query: 209 DNFSEANLLGQGGFGYV--------HKGVLTNGKVVAIKQLK-AGSGQGEREFQAEIEII 259
D LG+G FG V K VA+K LK + + + +E+E++
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71
Query: 260 SQV-HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMN------------- 305
+ H+++++L+G CT ++ E+ L L + P +
Sbjct: 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 306 -WPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK--HSLD 362
+ + A ARG+ YL + IHRD+ + N+L+ + K+ADFGLA+ H +D
Sbjct: 132 SFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDID 188
Query: 363 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 411
S + ++APE T +SDV+SFG+L+ E+ T G P+
Sbjct: 189 YYKKTSNGRL-PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 71/233 (30%), Positives = 114/233 (48%), Gaps = 36/233 (15%)
Query: 205 KIATDNFSEANLLGQGGFGYVHKGV--LTNGKVVAIKQLKAGSGQGERE-FQA----EIE 257
K D F +G+G +G V+K T G++VA+K+++ E+E F EI+
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDT-GELVALKKVRL---DNEKEGFPITAIREIK 58
Query: 258 IISQVHHRHLVSLVGYCTFGSQRL----------LVYEFVPNK---TLEFHL-HGKDRPV 303
I+ Q++HR++V+L T L LV+E++ + LE L H + +
Sbjct: 59 ILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHI 118
Query: 304 MNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 363
++ MK L GL Y H+ +HRDIK +NILL++ + K+ADFGLA+
Sbjct: 119 KSF---MKQLL---EGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSE 169
Query: 364 DTHVSTRVMGTFGYLAPE-YASSGKLTEKSDVFSFGVLLLELITGFRPFDKAD 415
++ T + T Y PE + DV+S G +L EL T +P +A+
Sbjct: 170 ESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTK-KPIFQAN 221
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 71/304 (23%), Positives = 134/304 (44%), Gaps = 59/304 (19%)
Query: 217 LGQGGFGYVH----KGVLTNGK-------------VVAIKQLKAGSGQGER-EFQAEIEI 258
LG+G FG VH +G+ +VA+K L+ + + R +F EI+I
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 259 ISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHL---------HGKDRPVMNWPTR 309
+S++ +++ L+ C ++ E++ N L L D +++ T
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 310 MKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH-VS 368
+ +A A G+ YL +HRD+ + N L+ ++ K+ADFG++++ D + +
Sbjct: 133 IFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 369 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFR--PFDKADTFADDSMVDWA 426
R + +++ E GK T SDV++FGV L E++T + P+ + +D+ +++
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ---LSDEQVIENT 246
Query: 427 KPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAA-------CIRHSARRRPRMSQI 479
F DQ + Y + + A C + C R +A+ RP +I
Sbjct: 247 GEFFR------------DQGRQVY----LPKPALCPDSLYKLMLSCWRRNAKERPSFQEI 290
Query: 480 VRAL 483
L
Sbjct: 291 HATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 70/211 (33%), Positives = 97/211 (45%), Gaps = 23/211 (10%)
Query: 217 LGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGERE---FQAEIEI-ISQVHHRHLV 268
+G+G FG V HK +GK A+K L+ + ++E AE + + V H LV
Sbjct: 3 IGKGSFGKVLLAKHK---ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59
Query: 269 SLVGYCTFGSQRLL--VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIA-LGSARGLAYLHE 325
L + +F + L V ++V L FHL ++R R A + SA L YLH
Sbjct: 60 GL--HYSFQTADKLYFVLDYVNGGELFFHLQ-RERSFPEPRARFYAAEIASA--LGYLHS 114
Query: 326 DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS 385
II+RD+K NILLD + DFGL K ++ ST GT YLAPE
Sbjct: 115 ---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-FCGTPEYLAPEVLRK 170
Query: 386 GKLTEKSDVFSFGVLLLELITGFRPFDKADT 416
D + G +L E++ G PF DT
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT 201
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 59/197 (29%), Positives = 103/197 (52%), Gaps = 20/197 (10%)
Query: 217 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCT 275
+G G +G V+K L G++ A+K +K G Q EI ++ + H ++V+ G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 276 FGSQRLLVYEFVPNKTLE--FHLHGKDRPVMNWPTRMKIAL---GSARGLAYLHEDCQPK 330
+ + E+ +L+ +H+ G P+ + ++IA + +GLAYLH +
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTG---PL----SELQIAYVCRETLQGLAYLHSKGK-- 127
Query: 331 IIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYAS---SGK 387
+HRDIK ANILL D+ + K+ADFG+A T + +GT ++APE A+ +G
Sbjct: 128 -MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS-FIGTPYWMAPEVAAVEKNGG 185
Query: 388 LTEKSDVFSFGVLLLEL 404
+ D+++ G+ +EL
Sbjct: 186 YNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 59/193 (30%), Positives = 92/193 (47%), Gaps = 47/193 (24%)
Query: 217 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA-------EIEIISQVHHRHLV 268
+GQG FG V K ++VA+K++ E E + EI+I+ + H ++V
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLM-----ENEKEGFPITALREIKILQLLKHENVV 74
Query: 269 SLVGYCT--------FGSQRLLVYEF--------VPNKTLEFHLHGKDRPVMNWPTRMKI 312
+L+ C + LV+EF + NK ++F L + MK+
Sbjct: 75 NLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTL-----SEIK--KVMKM 127
Query: 313 ALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK-HSLDTDTH---VS 368
L GL Y+H + KI+HRD+K+ANIL+ K+ADFGLA+ SL ++ +
Sbjct: 128 LLN---GLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181
Query: 369 TRVMGTFGYLAPE 381
RV+ T Y PE
Sbjct: 182 NRVV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 62/242 (25%), Positives = 114/242 (47%), Gaps = 23/242 (9%)
Query: 205 KIATDNFSEANLLGQGGFGYVHK------GVLTNGKVVAIKQLKAGSGQGEREFQAEIEI 258
++ D+F + LG G G V K G++ K++ ++ A Q RE Q +
Sbjct: 1 ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQ----V 56
Query: 259 ISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRM--KIALGS 316
+ + + ++V G + + E + +L+ L R P + K+++
Sbjct: 57 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR----IPEEILGKVSIAV 112
Query: 317 ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG 376
RGLAYL E Q I+HRD+K +NIL++ E K+ DFG++ +D+ ++ +GT
Sbjct: 113 LRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRS 167
Query: 377 YLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLAD 436
Y++PE + +SD++S G+ L+EL G P D A + + +P + +
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD--AKELEAIFGRPVVDGEEGE 225
Query: 437 GN 438
+
Sbjct: 226 PH 227
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 62/235 (26%), Positives = 110/235 (46%), Gaps = 34/235 (14%)
Query: 203 ELKIATDNFSEANLLGQGGFGYVHKGVL------TNGKVVAIKQLK-AGSGQGEREFQAE 255
E+ ++T F E LG+ FG V+KG L + VAIK LK G EF+ E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 256 IEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHL-----HGK------DRPV- 303
+ S++ H ++V L+G T +++ + + L L H D+ V
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 304 --MNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 361
+ + I A G+ +L ++H+D+ + N+L+ D K++D GL +
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175
Query: 362 DTDTHVSTRVMGT----FGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 411
D + ++MG +++PE GK + SD++S+GV+L E+ + G +P+
Sbjct: 176 AADYY---KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 18/214 (8%)
Query: 211 FSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLV 268
F ++G G +G V+KG + G++ AIK + + E E + EI ++ + HHR++
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKYSHHRNIA 76
Query: 269 SLVGYCTFGS------QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAY 322
+ G S Q LV EF ++ + + I RGLA+
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAH 136
Query: 323 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEY 382
LH K+IHRDIK N+LL ++ E K+ DFG++ LD +GT ++APE
Sbjct: 137 LHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ-LDRTVGRRNTFIGTPYWMAPEV 192
Query: 383 ASSGKLTE-----KSDVFSFGVLLLELITGFRPF 411
+ + + +SD++S G+ +E+ G P
Sbjct: 193 IACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 70/224 (31%), Positives = 103/224 (45%), Gaps = 37/224 (16%)
Query: 210 NFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHR 265
+F+ +LG+G FG V KG ++ AIK LK + Q + + V R
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKG---TDELYAIKILKK-----DVIIQDDDVECTMVEKR 52
Query: 266 ---------HLVSLVGYCTFGS-QRL-LVYEFVPNKTLEFHLH--GKDRPVMNWPTRMKI 312
L L + F + RL V E+V L +H+ GK + P +
Sbjct: 53 VLALPGKPPFLTQL--HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKE----PHAVFY 106
Query: 313 ALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM 372
A A GL +LH II+RD+K N++LD K+ADFG+ K ++ +TR
Sbjct: 107 AAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG--KTTRTF 161
Query: 373 -GTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKAD 415
GT Y+APE + + D ++FGVLL E++ G PFD D
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 59/220 (26%), Positives = 110/220 (50%), Gaps = 16/220 (7%)
Query: 210 NFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA--EIEIISQVHHRH 266
++++ +G+G +G V+KG G++VA+K+++ S + A EI ++ ++ H +
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 267 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS-ARGLAYLHE 325
+V L S+ L++EF+ + L+ +L + +K L +G+ + H
Sbjct: 61 IVCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH- 118
Query: 326 DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPE-YAS 384
+++HRD+K N+L+D+ K+ADFGLA+ + V T + T Y APE
Sbjct: 119 --SRRVLHRDLKPQNLLIDNKGVIKLADFGLAR-AFGIPVRVYTHEVVTLWYRAPEVLLG 175
Query: 385 SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD 424
S + + D++S G + E+ T K F DS +D
Sbjct: 176 SPRYSTPVDIWSIGTIFAEMAT------KKPLFHGDSEID 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 6e-13
Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 31/208 (14%)
Query: 217 LGQGGFGYVHKGVL-------TNGKVVAIKQLKAGSGQGER---EFQAEIEIISQVHHRH 266
LGQG F ++KGVL G + + G R F ++SQ+ H+H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 267 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPV-MNWPTRMKIALGSARGLAYLHE 325
LV L G C + ++V E+V L+ LH + V ++W ++ +A A L YL +
Sbjct: 63 LVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119
Query: 326 DCQPKIIHRDIKSANILL---DDSFE----AKVADFGLAKHSLDTDTHVSTRVMGTFGYL 378
K++H ++ NIL+ + K++D G+ L + V ++
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE-----RIPWI 171
Query: 379 APEYASSG--KLTEKSDVFSFGVLLLEL 404
APE +G LT +D +SFG LLE+
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 6e-13
Identities = 66/218 (30%), Positives = 99/218 (45%), Gaps = 34/218 (15%)
Query: 216 LLGQGGFGYVHKGVLTN-GKVVAIKQL---KAGSGQGEREFQAEIEIISQVHHRHLVSLV 271
++G+GGFG V+ + GK+ A+K L + QGE ++ R ++SLV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE---------TLALNERIMLSLV 51
Query: 272 --GYCTFGSQRLLVYEF-VPNKTL---------EFHLHGKDRPVMNWPTRMKIALGSARG 319
G C F + Y F P+K + H H V + A G
Sbjct: 52 STGDCPF--IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILG 109
Query: 320 LAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLA 379
L ++H +++RD+K ANILLD+ +++D GLA H S +GT GY+A
Sbjct: 110 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMA 163
Query: 380 PEYASSGKLTEKS-DVFSFGVLLLELITGFRPFDKADT 416
PE G + S D FS G +L +L+ G PF + T
Sbjct: 164 PEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 6e-13
Identities = 61/221 (27%), Positives = 110/221 (49%), Gaps = 33/221 (14%)
Query: 217 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA-------EIEIISQVHHRHLV 268
+G+G +G V+K G++VA+K+++ E E + EI ++ +++H ++V
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRL-----ETEDEGVPSTAIREISLLKELNHPNIV 61
Query: 269 SLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS-ARGLAYLHEDC 327
L+ ++ LV+EF+ + L+ ++ ++ P +K L +G+AY H
Sbjct: 62 RLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLD-PPLIKSYLYQLLQGIAYCH--- 116
Query: 328 QPKIIHRDIKSANILLDDSFEAKVADFGLAKH---SLDTDTHVSTRVMGTFGYLAPEYAS 384
+++HRD+K N+L+D K+ADFGLA+ + T TH V+ T Y APE
Sbjct: 117 SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH---EVV-TLWYRAPEILL 172
Query: 385 SGKLTEKS-DVFSFGVLLLELITGFRPFDKADTFADDSMVD 424
+ D++S G + E++ RP F DS +D
Sbjct: 173 GSRQYSTPVDIWSIGCIFAEMVNR-RPL-----FPGDSEID 207
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 7e-13
Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 33/213 (15%)
Query: 211 FSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLK-AGSGQGE-----REFQAEIEIISQVH 263
+ E +G+G +G V+K L G+ VA+K+++ S +G RE A ++ +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREI-ALLKQLESFE 59
Query: 264 HRHLVSLVGYCTFGSQR------LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA 317
H ++V L+ C G + LV+E V ++ L +L +P + T +
Sbjct: 60 HPNIVRLLDVCH-GPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQLL 117
Query: 318 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGY 377
RG+ +LH I+HRD+K NIL+ + K+ADFGLA+ + + T V+ T Y
Sbjct: 118 RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR--IYSFEMALTSVVVTLWY 172
Query: 378 LAPE------YASSGKLTEKSDVFSFGVLLLEL 404
APE YA+ D++S G + EL
Sbjct: 173 RAPEVLLQSSYATP------VDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 65/209 (31%), Positives = 90/209 (43%), Gaps = 20/209 (9%)
Query: 216 LLGQGGFGYVHKGVL----TNGKVVAIKQLKAGSGQGEREFQ---AEIEIISQVHHRHLV 268
LLG+G FG V +L GK A+K LK + E E ++ H L
Sbjct: 2 LLGKGTFGKV---ILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLT 58
Query: 269 SLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIA-LGSARGLAYLHED 326
+L Y RL V E+ L FHL ++R R A + SA L YLH
Sbjct: 59 AL-KYSFQTHDRLCFVMEYANGGELFFHL-SRERVFSEDRARFYGAEIVSA--LGYLHSC 114
Query: 327 CQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSG 386
+++RD+K N++LD K+ DFGL K + +D GT YLAPE
Sbjct: 115 ---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGI-SDGATMKTFCGTPEYLAPEVLEDN 170
Query: 387 KLTEKSDVFSFGVLLLELITGFRPFDKAD 415
D + GV++ E++ G PF D
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 29/207 (14%)
Query: 211 FSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQ---AEIEIISQVHHRH 266
FS+ +G G FG V+ + N +VVAIK++ Q ++Q E+ + ++ H +
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 267 LVSLVGYCTFGSQRLLVYEFV---PNKTLEFHLHGKDRPVMNWPTRMKIAL---GSARGL 320
+ G LV E+ + LE H +P+ ++IA G+ +GL
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVH----KKPLQ----EVEIAAVTHGALQGL 128
Query: 321 AYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAP 380
AYLH +IHRD+K+ NILL + K+ DFG A + V GT ++AP
Sbjct: 129 AYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAP 180
Query: 381 EY---ASSGKLTEKSDVFSFGVLLLEL 404
E G+ K DV+S G+ +EL
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 39/94 (41%), Positives = 48/94 (51%), Gaps = 5/94 (5%)
Query: 320 LAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLA 379
L +LH Q II+RDIK NILLD + DFGL+K L + + GT Y+A
Sbjct: 118 LDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMA 174
Query: 380 PEYASSGKLTEKS--DVFSFGVLLLELITGFRPF 411
PE G D +S GVL EL+TG PF
Sbjct: 175 PEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 64/216 (29%), Positives = 100/216 (46%), Gaps = 19/216 (8%)
Query: 208 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQ---AEIEIISQVH 263
NF +LG+G FG V ++ AIK LK + + + E +++
Sbjct: 1 DFNFL--MVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD 58
Query: 264 HRHLVSLVGYCTFGSQRL-LVYEFVPNKTLEFHLH--GKDRPVMNWPTRMKIALGSARGL 320
++ + C RL V E+V L +H+ GK + P + A + GL
Sbjct: 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKE----PQAVFYAAEISVGL 114
Query: 321 AYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM-GTFGYLA 379
+LH II+RD+K N++LD K+ADFG+ K + V+TR GT Y+A
Sbjct: 115 FFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG--VTTRTFCGTPDYIA 169
Query: 380 PEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKAD 415
PE + + D +++GVLL E++ G PFD D
Sbjct: 170 PEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 26/218 (11%)
Query: 210 NFSEANLLGQGGFGYV--------HKGVLTNGKVVAIKQLKAGS----GQGEREFQAEIE 257
NF +LG G +G V H +GK+ A+K LK + + + E +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHD----SGKLYAMKVLKKATIVQKAKTTEHTRTERQ 56
Query: 258 IISQVHHRHLVSLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS 316
++ + + + Y +L L+ +++ L HL ++R ++I G
Sbjct: 57 VLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQ---EVQIYSGE 113
Query: 317 -ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF 375
L +LH + II+RDIK NILLD + + DFGL+K + + + GT
Sbjct: 114 IVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTI 170
Query: 376 GYLAPEYASSGKLTEKS--DVFSFGVLLLELITGFRPF 411
Y+AP+ G D +S GVL+ EL+TG PF
Sbjct: 171 EYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 54/285 (18%), Positives = 114/285 (40%), Gaps = 66/285 (23%)
Query: 224 YVHKGVLTNGKVVAIKQLKA---GSGQGEREFQAEIEIISQVHHRHLVSLVG-------- 272
++KG+ N K V I+ K G + EI+ + ++ +++ + G
Sbjct: 35 SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93
Query: 273 ---------YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYL 323
YCT G R ++ + K L F T++ +A+ +GL L
Sbjct: 94 LPRLSLILEYCTRGYLREVLDK---EKDLSFK------------TKLDMAIDCCKGLYNL 138
Query: 324 HE-DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEY 382
++ +P ++++ S + L+ ++++ K+ GL K + + + Y + +
Sbjct: 139 YKYTNKP---YKNLTSVSFLVTENYKLKIICHGLEK----ILSSPPFKNVNFMVYFSYKM 191
Query: 383 ASS--GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 440
+ + T K D++S GV+L E+ TG PF+ T + + +D
Sbjct: 192 LNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT---------------KEI----YD 232
Query: 441 ALVDQKLEEYDSAEMTRMAACAA-ACIRHSARRRPRMSQIVRALE 484
++++ + C AC H + +RP + +I+ L
Sbjct: 233 LIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 64/250 (25%), Positives = 106/250 (42%), Gaps = 58/250 (23%)
Query: 209 DNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGERE----FQAEIEIIS 260
D+F ++G+G FG V K G + A+K+L+ S E+E +AE +I++
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKK---DTGHIYAMKKLRK-SEMLEKEQVAHVRAERDILA 56
Query: 261 QVHHRHLVSLVGYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR 318
+ + +V L Y +F + L+ E++P + L KD TR IA +
Sbjct: 57 EADNPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEE-ETRFYIA-ETIL 112
Query: 319 GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK---------------HSLDT 363
+ +H + IHRDIK N+LLD K++DFGL H+L +
Sbjct: 113 AIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPS 169
Query: 364 DTHVSTR----------------------VMGTFGYLAPEYASSGKLTEKSDVFSFGVLL 401
+ +GT Y+APE ++ D +S GV++
Sbjct: 170 NFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIM 229
Query: 402 LELITGFRPF 411
E++ G+ PF
Sbjct: 230 YEMLVGYPPF 239
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-12
Identities = 69/208 (33%), Positives = 91/208 (43%), Gaps = 18/208 (8%)
Query: 216 LLGQGGFGYVHKGVL----TNGKVVAIKQLKAGSGQGEREFQ---AEIEIISQVHHRHLV 268
LLG+G FG V +L +GK A+K LK + E E ++ H L
Sbjct: 2 LLGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLT 58
Query: 269 SLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC 327
SL Y RL V E+V L FHL ++R TR A L YLH
Sbjct: 59 SL-KYSFQTKDRLCFVMEYVNGGELFFHL-SRERVFSEDRTRFYGA-EIVSALDYLHSG- 114
Query: 328 QPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGK 387
KI++RD+K N++LD K+ DFGL K + TD GT YLAPE
Sbjct: 115 --KIVYRDLKLENLMLDKDGHIKITDFGLCKEGI-TDAATMKTFCGTPEYLAPEVLEDND 171
Query: 388 LTEKSDVFSFGVLLLELITGFRPFDKAD 415
D + GV++ E++ G PF D
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 65/207 (31%), Positives = 91/207 (43%), Gaps = 13/207 (6%)
Query: 216 LLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGERE---FQAEIEII-SQVHHRHLVSL 270
++G+G FG V +GK A+K L+ +E AE ++ V H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 271 VGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQP 329
Y +++L V +FV L FHL ++R R A A L YLH
Sbjct: 62 -HYSFQTTEKLYFVLDFVNGGELFFHLQ-RERSFPEPRARFYAA-EIASALGYLH---SI 115
Query: 330 KIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLT 389
I++RD+K NILLD + DFGL K + + +T GT YLAPE
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGI-AQSDTTTTFCGTPEYLAPEVIRKQPYD 174
Query: 390 EKSDVFSFGVLLLELITGFRPFDKADT 416
D + G +L E++ G PF D
Sbjct: 175 NTVDWWCLGAVLYEMLYGLPPFYCRDV 201
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 66/218 (30%), Positives = 97/218 (44%), Gaps = 34/218 (15%)
Query: 216 LLGQGGFGYVHKGVLTN-GKVVAIKQL---KAGSGQGEREFQAEIEIISQVHHRHLVSLV 271
++G+GGFG V+ + GK+ A+K L + QGE ++ R ++SLV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE---------TLALNERIMLSLV 51
Query: 272 --GYCTFGSQRLLVYEFVPNKTLEF----------HLHGKDRPVMNWPTRMKIALGSARG 319
G C F + Y F L F H H V + A G
Sbjct: 52 STGDCPF--IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILG 109
Query: 320 LAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLA 379
L ++H +++RD+K ANILLD+ +++D GLA H S +GT GY+A
Sbjct: 110 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMA 163
Query: 380 PEYASSGKLTEKS-DVFSFGVLLLELITGFRPFDKADT 416
PE G + S D FS G +L +L+ G PF + T
Sbjct: 164 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 60/205 (29%), Positives = 102/205 (49%), Gaps = 20/205 (9%)
Query: 209 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL 267
++F +G G +G V+K + G++ AIK +K G+ Q EI ++ H ++
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 268 VSLVGYCTFGSQRLLVYEFVPNKTLE--FHLHGKDRPVMNWPTRMKIALGSA---RGLAY 322
V+ G + + EF +L+ +H+ G P+ + +IA S +GL Y
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG---PL----SESQIAYVSRETLQGLYY 121
Query: 323 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEY 382
LH + +HRDIK ANILL D+ K+ADFG++ T + +GT ++APE
Sbjct: 122 LHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS-FIGTPYWMAPEV 177
Query: 383 AS---SGKLTEKSDVFSFGVLLLEL 404
A+ G + D+++ G+ +EL
Sbjct: 178 AAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 71/281 (25%), Positives = 119/281 (42%), Gaps = 24/281 (8%)
Query: 145 PKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDK----PFPRQSPGMPVGNFKSTFT 200
P P P+ T P T D P P P + S+
Sbjct: 3 PIQPPPGVPLPSTARHTTKSRPRRRPDLTLPLPQRDPSLAVPLPLPPPSSSSSSSSSSSA 62
Query: 201 YEELKIATDNFSE---ANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQG-EREFQAE 255
A + SE N +G G G V+K + G++ A+K + R+ E
Sbjct: 63 SGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICRE 122
Query: 256 IEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALG 315
IEI+ V+H ++V + ++ EF+ +LE ++ + + +A
Sbjct: 123 IEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLAD------VARQ 176
Query: 316 SARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF 375
G+AYLH + I+HRDIK +N+L++ + K+ADFG+++ T ++ V GT
Sbjct: 177 ILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTI 232
Query: 376 GYLAPEYASS----GKLTEKS-DVFSFGVLLLELITGFRPF 411
Y++PE ++ G + D++S GV +LE G PF
Sbjct: 233 AYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 58/205 (28%), Positives = 90/205 (43%), Gaps = 23/205 (11%)
Query: 217 LGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGEREFQ---AEIEIISQVHHRHLVSLVG 272
+GQGG+G V + G++VA+K++K E + E +I++ LV L+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL- 67
Query: 273 YCTFGSQRL-LVYEFVPNKTLEFHLHG----KDRPVMNWPTRMKIALGSARGLAYLHEDC 327
Y + L L E+VP L+ + + M A+ + L Y
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY----- 122
Query: 328 QPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGK 387
IHRD+K N L+D S K+ DFGL+K + + V+G+ Y+APE
Sbjct: 123 ----IHRDLKPENFLIDASGHIKLTDFGLSKGIVT----YANSVVGSPDYMAPEVLRGKG 174
Query: 388 LTEKSDVFSFGVLLLELITGFRPFD 412
D +S G +L E + GF PF
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFS 199
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 5e-12
Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 26/210 (12%)
Query: 217 LGQGGFGYVHKGVL--TNGKVVAIKQLKAGSGQGE-REFQAEIEIISQVHHRHLVSLVGY 273
LG+G +G V+K VL G +A+K+++ + + + E++I+ + ++V G
Sbjct: 9 LGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 274 CTFGSQRLLVYEFVPNKTLE------FHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC 327
+ E++ +L+ G V+ +I +GL +L E+
Sbjct: 68 FFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLR-----RITYAVVKGLKFLKEEH 122
Query: 328 QPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGK 387
IIHRD+K N+L++ + + K+ DFG+ S + ++ +G Y+APE SG
Sbjct: 123 N--IIHRDVKPTNVLVNGNGQVKLCDFGV---SGNLVASLAKTNIGCQSYMAPERIKSGG 177
Query: 388 LTE------KSDVFSFGVLLLELITGFRPF 411
+ +SDV+S G+ +LE+ G P+
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGRYPY 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 5e-12
Identities = 61/211 (28%), Positives = 102/211 (48%), Gaps = 19/211 (9%)
Query: 217 LGQGGFGYVHKGVLTNG---KVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVG 272
+G G FG V G + +G V +K+L+ + Q + +F E + + H +L+ +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 273 YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWP---TRMKIALGSARGLAYLHEDCQP 329
CT + LLV EF P L+ +L + + P T ++A A GL +LH++
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119
Query: 330 KIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV-STRVMGTFGYLAPEYASS--G 386
IH D+ N LL K+ D+GL+ + D +V ++ ++APE G
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179
Query: 387 KL-----TEKSDVFSFGVLLLELIT-GFRPF 411
L T++S+V+S GV + EL G +P+
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWELFELGSQPY 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 9e-12
Identities = 55/197 (27%), Positives = 96/197 (48%), Gaps = 10/197 (5%)
Query: 217 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA-EIEIISQVHHRHLVSLVGYC 274
+GQG G V+ + + G+ VAIKQ+ Q ++E EI ++ + H ++V+ +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNL-QQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 275 TFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHR 334
G + +V E++ +L + M+ + + L +LH + ++IHR
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSN---QVIHR 139
Query: 335 DIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 394
DIKS NILL K+ DFG + ST V GT ++APE + K D+
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 198
Query: 395 FSFGVLLLELITGFRPF 411
+S G++ +E++ G P+
Sbjct: 199 WSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 52/196 (26%), Positives = 93/196 (47%), Gaps = 8/196 (4%)
Query: 217 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCT 275
+GQG G V+ + + G+ VAIKQ+ + EI ++ + + ++V+ +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 276 FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRD 335
G + +V E++ +L + M+ + + L +LH + ++IHRD
Sbjct: 87 VGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALDFLHSN---QVIHRD 140
Query: 336 IKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 395
IKS NILL K+ DFG + ST V GT ++APE + K D++
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIW 199
Query: 396 SFGVLLLELITGFRPF 411
S G++ +E++ G P+
Sbjct: 200 SLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 52/217 (23%), Positives = 102/217 (47%), Gaps = 12/217 (5%)
Query: 210 NFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLK---AGSGQGEREFQAEIEIISQVHHR 265
NF +G+G F V++ L + K VA+K+++ + ++ EI+++ Q++H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 266 HLVSLVGYCTFGSQRLLVYEFVPNKTLE--FHLHGKDRPVMNWPTRMKIALGSARGLAYL 323
+++ + ++ +V E L K + ++ T K + + ++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 324 HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYA 383
H +++HRDIK AN+ + + K+ D GL + + T + ++GT Y++PE
Sbjct: 123 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHSLVGTPYYMSPERI 178
Query: 384 SSGKLTEKSDVFSFGVLLLELITGFRPF--DKADTFA 418
KSD++S G LL E+ PF DK + F+
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFS 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 36/83 (43%), Positives = 53/83 (63%), Gaps = 1/83 (1%)
Query: 330 KIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT-DTHVSTRVMGTFGYLAPEYASSGKL 388
K++HRD+KSANI L + K+ DFG +K D+ V++ GT YLAPE +
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRY 248
Query: 389 TEKSDVFSFGVLLLELITGFRPF 411
++K+D++S GV+L EL+T RPF
Sbjct: 249 SKKADMWSLGVILYELLTLHRPF 271
|
Length = 478 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 51/196 (26%), Positives = 93/196 (47%), Gaps = 8/196 (4%)
Query: 217 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCT 275
+GQG G V + + G+ VAIKQ+ + EI ++ ++ + ++V+ +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 276 FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRD 335
G + +V E++ +L + M+ + + L +LH + ++IHRD
Sbjct: 87 VGDELFVVMEYLAGGSLTDVV---TETCMDEAQIAAVCRECLQALEFLHAN---QVIHRD 140
Query: 336 IKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 395
IKS N+LL K+ DFG + ST V GT ++APE + K D++
Sbjct: 141 IKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIW 199
Query: 396 SFGVLLLELITGFRPF 411
S G++ +E++ G P+
Sbjct: 200 SLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 60/222 (27%), Positives = 109/222 (49%), Gaps = 21/222 (9%)
Query: 210 NFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA--EIEIISQVHHRH 266
NF + +G+G +G V+K G+VVA+K+++ + A EI ++ +++H +
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 267 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED 326
+V L+ ++ LV+EF+ ++ L+ + + P +GLA+ H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 327 CQPKIIHRDIKSANILLDDSFEAKVADFGLAKH---SLDTDTHVSTRVMGTFGYLAPEYA 383
+++HRD+K N+L++ K+ADFGLA+ + T TH V+ T Y APE
Sbjct: 120 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH---EVV-TLWYRAPEIL 172
Query: 384 SSGKL-TEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD 424
K + D++S G + E++T + F DS +D
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVT------RRALFPGDSEID 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 40/98 (40%), Positives = 55/98 (56%), Gaps = 5/98 (5%)
Query: 320 LAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLA 379
L +LH+ I++RD+K NILLD + + DFGL+K +L TD + GT YLA
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANL-TDNKTTNTFCGTTEYLA 164
Query: 380 PEYASSGK-LTEKSDVFSFGVLLLELITGFRPFDKADT 416
PE K T+ D +S GVL+ E+ G+ PF DT
Sbjct: 165 PEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT 202
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 71/271 (26%), Positives = 106/271 (39%), Gaps = 79/271 (29%)
Query: 217 LGQGGFGYVHK----GV--LTNGKVVAIKQLKAGSGQGE-REFQAEIEIISQV-HHRHLV 268
LG+G FG V + G+ + VA+K LK G+ E R +E++I+ + HH ++V
Sbjct: 15 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74
Query: 269 SLVGYCTFGSQRLLVY------------------EFVPNKTLEFHLHGKDRPVMNWPTRM 310
+L+G CT L+V EFVP KT + + +
Sbjct: 75 NLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDL 134
Query: 311 KIALGS------------------------------------------------ARGLAY 322
K L S A+G+ +
Sbjct: 135 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEF 194
Query: 323 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL-DTDTHVSTRVMGTFGYLAPE 381
L K IHRD+ + NILL ++ K+ DFGLA+ D D ++APE
Sbjct: 195 L---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 251
Query: 382 YASSGKLTEKSDVFSFGVLLLELIT-GFRPF 411
T +SDV+SFGVLL E+ + G P+
Sbjct: 252 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 60/210 (28%), Positives = 108/210 (51%), Gaps = 16/210 (7%)
Query: 217 LGQGGFGYVHKG--VLTNGKVVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSLVGY 273
LG+G + V KG LT +VA+K+++ +G E+ ++ + H ++V+L
Sbjct: 13 LGEGTYATVFKGRSKLT-ENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 274 CTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA-RGLAYLHEDCQPKII 332
LV+E++ + ++ + + M+ +KI + RGL+Y H+ KI+
Sbjct: 72 IHTERCLTLVFEYLDSDLKQYLDNCGNLMSMH---NVKIFMFQLLRGLSYCHKR---KIL 125
Query: 333 HRDIKSANILLDDSFEAKVADFGLAK-HSLDTDTHVSTRVMGTFGYLAPE-YASSGKLTE 390
HRD+K N+L+++ E K+ADFGLA+ S+ T T+ + V T Y P+ S + +
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSTEYST 183
Query: 391 KSDVFSFGVLLLELITGFRPFDKADTFADD 420
D++ G +L E+ TG RP T ++
Sbjct: 184 PIDMWGVGCILYEMATG-RPMFPGSTVKEE 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 20/207 (9%)
Query: 208 TDNFSEANLLGQGGFGYV--HKGVLTNGKVVAIKQLK---AGSGQGEREFQAEIEIISQV 262
T+ + + +G G FG V + LT G+ VAIK++ + +R ++ E++++ +
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHL 66
Query: 263 HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAY 322
H +++SL F S +Y + H RP+ + RGL Y
Sbjct: 67 RHENIISLSD--IFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQY-FLYQILRGLKY 123
Query: 323 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT-HVSTRVMGTFGYLAPE 381
+H ++HRD+K +NIL++++ + K+ DFGLA+ T +VSTR Y APE
Sbjct: 124 VH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YRAPE 175
Query: 382 YASS-GKLTEKSDVFSFGVLLLELITG 407
+ K + D++S G + E++ G
Sbjct: 176 IMLTWQKYDVEVDIWSAGCIFAEMLEG 202
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 44/134 (32%), Positives = 66/134 (49%), Gaps = 6/134 (4%)
Query: 282 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANI 341
V E+V L + + R P + A A GL +LH II+RD+K N+
Sbjct: 78 FVMEYVNGGDLMYQIQQVGR--FKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNV 132
Query: 342 LLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLL 401
+LD K+ADFG+ K ++ D + GT Y+APE + + D ++FGVLL
Sbjct: 133 MLDSEGHIKIADFGMCKENM-WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLL 191
Query: 402 LELITGFRPFDKAD 415
E++ G PF+ D
Sbjct: 192 YEMLAGQAPFEGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 63/227 (27%), Positives = 101/227 (44%), Gaps = 34/227 (14%)
Query: 203 ELKIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGERE---FQAE 255
+L++ ++F ++G+G FG V HK ++ +V A+K L + F E
Sbjct: 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHK---SSKQVYAMKLLSKFEMIKRSDSAFFWEE 93
Query: 256 IEIISQVHHRHLVSLVGYCTFGSQRLL--VYEFVPNKTLEFHLHGKDRPVMNWP----TR 309
+I++ + +V L + F + L V E++P L + D P W
Sbjct: 94 RDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIP-EKWARFYTAE 150
Query: 310 MKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA-KHSLDTDTHVS 368
+ +AL + + + IHRD+K N+LLD S K+ADFG K +
Sbjct: 151 VVLALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCD 201
Query: 369 TRVMGTFGYLAPEYASS----GKLTEKSDVFSFGVLLLELITGFRPF 411
T V GT Y++PE S G + D +S GV L E++ G PF
Sbjct: 202 TAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 48/214 (22%)
Query: 217 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA------EIEIISQVHHRHLVS 269
+G+G +G V K G++VAIK+ + E + EI ++ Q+ H +LV+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFV----ESEDDPVIKKIALREIRMLKQLKHPNLVN 64
Query: 270 LVGYCTFGSQRL--LVYEFVPN---KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH 324
L+ F +R LV+E+ + LE + G ++ KI + + + + H
Sbjct: 65 LIE--VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLI-----KKIIWQTLQAVNFCH 117
Query: 325 EDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK----HSLDTDTHVSTRVMGTFGYLAP 380
+ IHRD+K NIL+ + K+ DFG A+ D +V+TR Y AP
Sbjct: 118 ---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAP 169
Query: 381 E-------YASSGKLTEKSDVFSFGVLLLELITG 407
E Y DV++ G + EL+TG
Sbjct: 170 ELLVGDTQYGPP------VDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 64.0 bits (155), Expect = 4e-11
Identities = 49/196 (25%), Positives = 94/196 (47%), Gaps = 8/196 (4%)
Query: 217 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCT 275
+GQG G V+ + + G+ VAI+Q+ + EI ++ + + ++V+ +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 276 FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRD 335
G + +V E++ +L + M+ + + L +LH + ++IHRD
Sbjct: 88 VGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSN---QVIHRD 141
Query: 336 IKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 395
IKS NILL K+ DFG + + + ++GT ++APE + K D++
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQ-ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 396 SFGVLLLELITGFRPF 411
S G++ +E+I G P+
Sbjct: 201 SLGIMAIEMIEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 19/209 (9%)
Query: 216 LLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGERE---FQAEIEII-SQVHHRHL 267
++G+G FG V K ++G A+K L+ + ++E AE ++ + H L
Sbjct: 2 VIGKGSFGKVLLAKRK---SDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFL 58
Query: 268 VSLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED 326
V L Y +++L V ++V L FHL ++R + P A A + YLH
Sbjct: 59 VGL-HYSFQTAEKLYFVLDYVNGGELFFHLQ-RERCFLE-PRARFYAAEVASAIGYLH-- 113
Query: 327 CQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSG 386
II+RD+K NILLD + DFGL K ++ + ST GT YLAPE
Sbjct: 114 -SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-FCGTPEYLAPEVLRKE 171
Query: 387 KLTEKSDVFSFGVLLLELITGFRPFDKAD 415
D + G +L E++ G PF D
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 35/105 (33%), Positives = 62/105 (59%), Gaps = 5/105 (4%)
Query: 311 KIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTR 370
K+++ +GL YL E + KI+HRD+K +NIL++ E K+ DFG++ +D+ ++
Sbjct: 107 KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANS 161
Query: 371 VMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKAD 415
+GT Y++PE + +SD++S G+ L+E+ G P D
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 6e-11
Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 17/205 (8%)
Query: 216 LLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREF---QAEIEIISQV-HHRHLVSL 270
++G+G + V L ++ A+K +K + + Q E + +H LV L
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 271 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRM---KIALGSARGLAYLHEDC 327
S+ V EFV L FH+ + R + R +I+L L +LHE
Sbjct: 62 HSCFQTESRLFFVIEFVSGGDLMFHMQ-RQRKLPEEHARFYSAEISLA----LNFLHER- 115
Query: 328 QPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGK 387
II+RD+K N+LLD K+ D+G+ K + ST GT Y+APE
Sbjct: 116 --GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST-FCGTPNYIAPEILRGED 172
Query: 388 LTEKSDVFSFGVLLLELITGFRPFD 412
D ++ GVL+ E++ G PFD
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 6e-11
Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 33/206 (16%)
Query: 217 LGQGGFGYVHKGVLTNGKVVA------IKQLKAGSGQGEREFQAEIE--IISQVHHRHLV 268
LG+G FG V+ ++ + K VA +K++ G QA E ++S++ H +V
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 269 SLVGYCTFGSQR--LLVYEFVPNKTLEFHLH-----GKDRP---VMNWPTRMKIALGSAR 318
+ +F + ++ E+ + L+ L GK V W ++ +
Sbjct: 66 KF--HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------ 117
Query: 319 GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYL 378
G+ Y+H Q +I+HRD+K+ NI L ++ K+ DFG+++ L ++T GT Y+
Sbjct: 118 GVHYMH---QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRL-LMGSCDLATTFTGTPYYM 172
Query: 379 APEYASSGKLTEKSDVFSFGVLLLEL 404
+PE KSD++S G +L E+
Sbjct: 173 SPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 34/98 (34%), Positives = 55/98 (56%), Gaps = 11/98 (11%)
Query: 318 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM----G 373
RGL Y+H ++HRD+K +N+LL+ + + K+ DFGLA+ + H T +
Sbjct: 117 RGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLAR--IADPEHDHTGFLTEYVA 171
Query: 374 TFGYLAPEYASSGKLTEKS-DVFSFGVLLLELITGFRP 410
T Y APE + K K+ D++S G +L E+++ RP
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RP 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 54/162 (33%), Positives = 75/162 (46%), Gaps = 9/162 (5%)
Query: 253 QAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMK 311
Q E + Q +H LV L S+ V E+V L FH+ + R + R
Sbjct: 43 QTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFY 101
Query: 312 IALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT-DTHVSTR 370
A S L YLHE II+RD+K N+LLD K+ D+G+ K L DT ++
Sbjct: 102 SAEISL-ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TST 155
Query: 371 VMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFD 412
GT Y+APE D ++ GVL+ E++ G PFD
Sbjct: 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 7e-11
Identities = 65/232 (28%), Positives = 112/232 (48%), Gaps = 38/232 (16%)
Query: 209 DNFSEANLLGQGGFGYVHKGV--LTNGKVVAIKQLKAGSGQGEREFQA-------EIEII 259
D + + +G+G +G V+K +TN + +A+K+++ E+E + EI ++
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTN-ETIALKKIRL-----EQEDEGVPSTAIREISLL 55
Query: 260 SQVHHRHLVSL--VGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRM-KIALG 315
++ H ++V L V + +RL LV+E++ L+ H P R+ K L
Sbjct: 56 KEMQHGNIVRLQDVVHS---EKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLY 109
Query: 316 SA-RGLAYLHEDCQPKIIHRDIKSANILLDDSFEA-KVADFGLAKHSLDTDTHVSTRVMG 373
RG+AY H +++HRD+K N+L+D A K+ADFGLA+ + T +
Sbjct: 110 QILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLAR-AFGIPVRTFTHEVV 165
Query: 374 TFGYLAPE-YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD 424
T Y APE S + D++S G + E++ +P F DS +D
Sbjct: 166 TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQ-KPL-----FPGDSEID 211
|
Length = 294 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 7e-11
Identities = 69/267 (25%), Positives = 107/267 (40%), Gaps = 77/267 (28%)
Query: 217 LGQGGFGYVHK------GVLTNGKVVAIKQLKAGSGQGE-REFQAEIEIISQV-HHRHLV 268
LG+G FG V + + + VA+K LK G+ E + E++I+ + HH ++V
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74
Query: 269 SLVG--------------YCTFGSQ----RLLVYEFVP--NKTLEFHLH----GKDRPVM 304
+L+G YC FG+ R F P NK+ GK + +
Sbjct: 75 NLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLD 134
Query: 305 NWPTRMKIALGS------------------------------------ARGLAYLHEDCQ 328
+ + A ARG+ +L
Sbjct: 135 SVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL---AS 191
Query: 329 PKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV---STRVMGTFGYLAPEYASS 385
K IHRD+ + NILL ++ K+ DFGLA+ +V R+ ++APE
Sbjct: 192 RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL--PLKWMAPESIFD 249
Query: 386 GKLTEKSDVFSFGVLLLELIT-GFRPF 411
T +SDV+SFGVLL E+ + G P+
Sbjct: 250 KVYTTQSDVWSFGVLLWEIFSLGASPY 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 8e-11
Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 10/204 (4%)
Query: 217 LGQGGFGYVHKGVLTNG-KVVAIKQLKAGSGQGEREFQ---AEIEIISQVHHRHLVSLVG 272
+G+G FG V + + ++ A+K ++ E AE +++QV+ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 273 YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKII 332
+ LV F+ L HL + R + +R + +A L L + +I
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDL---SRARFY--TAELLCALENLHKFNVI 115
Query: 333 HRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKS 392
+RD+K NILLD + DFGL K ++ D +T GT YLAPE T+
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT-FCGTPEYLAPELLLGHGYTKAV 174
Query: 393 DVFSFGVLLLELITGFRPFDKADT 416
D ++ GVLL E++TG PF +
Sbjct: 175 DWWTLGVLLYEMLTGLPPFYDENV 198
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 9e-11
Identities = 43/167 (25%), Positives = 75/167 (44%), Gaps = 9/167 (5%)
Query: 241 LKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKD 300
+KAG G E I+ ++H ++ L G T+ L+ +P + + +
Sbjct: 122 IKAGQRGGT---ATEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAA 175
Query: 301 RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 360
+ + + I R + YLHE+ +IIHRDIK+ NI ++ + + DFG A
Sbjct: 176 KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFP 232
Query: 361 LDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITG 407
+D + + GT APE + D++S G++L E+ T
Sbjct: 233 VDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 9e-11
Identities = 64/207 (30%), Positives = 94/207 (45%), Gaps = 21/207 (10%)
Query: 216 LLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGEREFQ---AEIEIIS-QVHHRHL 267
+LG+G FG V KG +V AIK LK + + E I++ H L
Sbjct: 2 VLGKGSFGKVMLAELKG---TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFL 58
Query: 268 VSLVGYCTF-GSQRLL-VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHE 325
+L +C F RL V E+V L F + + R +R A L +LH
Sbjct: 59 TAL--HCCFQTKDRLFFVMEYVNGGDLMFQIQ-RSRKFDEPRSRF-YAAEVTLALMFLH- 113
Query: 326 DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS 385
+ +I+RD+K NILLD K+ADFG+ K + +T GT Y+APE
Sbjct: 114 --RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT-FCGTPDYIAPEILQE 170
Query: 386 GKLTEKSDVFSFGVLLLELITGFRPFD 412
+ D ++ GVL+ E++ G PF+
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQPPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 9e-11
Identities = 51/201 (25%), Positives = 92/201 (45%), Gaps = 16/201 (7%)
Query: 217 LGQGGFGYVHKGVLTN-GKVVAIKQLK---AGSGQGEREFQAEIEIISQVHHRHLVSLVG 272
+G+G +G V K ++VA+K+++ G + EI ++ ++ H+++V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLYD 66
Query: 273 YCTFGSQRLLVYEFVPNKTLEF--HLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 330
+ LV+E+ ++ +G ++ +GLA+ H
Sbjct: 67 VLHSDKKLTLVFEYCDQDLKKYFDSCNGD----IDPEIVKSFMFQLLKGLAFCHSH---N 119
Query: 331 IIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTE 390
++HRD+K N+L++ + E K+ADFGLA+ S V+ T Y P+ KL
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYS 178
Query: 391 KS-DVFSFGVLLLELITGFRP 410
S D++S G + EL RP
Sbjct: 179 TSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 17/209 (8%)
Query: 216 LLGQGGFGYV----HKGVLTNGKVVAIKQLKAGS---GQGEREFQAEIEII-SQVHHRHL 267
++G+G FG V HK K A+K L+ + + E+ +E ++ V H L
Sbjct: 2 VIGKGSFGKVLLARHK---AEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFL 58
Query: 268 VSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC 327
V L + V +++ L +HL ++R + P A A L YLH
Sbjct: 59 VGLHFSFQTADKLYFVLDYINGGELFYHLQ-RERCFLE-PRARFYAAEIASALGYLH--- 113
Query: 328 QPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGK 387
I++RD+K NILLD + DFGL K +++ + ST GT YLAPE
Sbjct: 114 SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST-FCGTPEYLAPEVLHKQP 172
Query: 388 LTEKSDVFSFGVLLLELITGFRPFDKADT 416
D + G +L E++ G PF +T
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPFYSRNT 201
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 59/211 (27%), Positives = 107/211 (50%), Gaps = 38/211 (18%)
Query: 217 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA--EIEIISQVHHRHLVSLVGY 273
LG+G + V+KG G++VA+K+++ +G F A E ++ + H ++V+L +
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-PFTAIREASLLKDLKHANIVTL--H 69
Query: 274 CTFGSQRLL--VYEFVPN---KTLEFHLHGKDRPVMNWPTRMKIALGS-ARGLAYLHEDC 327
+++ L V+E++ + ++ G +++ L RGLAY H
Sbjct: 70 DIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLS------MHNVRLFLFQLLRGLAYCH--- 120
Query: 328 QPKIIHRDIKSANILLDDSFEAKVADFGLAK-HSLDTDTHVSTRVMGTFGYLAP------ 380
Q +++HRD+K N+L+ + E K+ADFGLA+ S+ + T+ + V T Y P
Sbjct: 121 QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLWYRPPDVLLGS 178
Query: 381 -EYASSGKLTEKSDVFSFGVLLLELITGFRP 410
EY++S D++ G + E+ TG RP
Sbjct: 179 TEYSTS------LDMWGVGCIFYEMATG-RP 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 68/232 (29%), Positives = 106/232 (45%), Gaps = 35/232 (15%)
Query: 202 EELKIATDNFSEANLLGQGGFGYVHKGVLTN---GKVVAIKQLKAGSGQGEREFQAEIEI 258
E L TD + +G+G +G V+K +TN G + A+K L S E E +AE I
Sbjct: 15 ESLGDPTDTWEIIETIGKGTYGKVYK--VTNKKDGSLAAVKILDPISDVDE-EIEAEYNI 71
Query: 259 ISQV-HHRHLVSLVG------YCTFGSQRLLVYEFVPNKTLEFHLHGK-------DRPVM 304
+ + +H ++V G G Q LV E ++ + G D ++
Sbjct: 72 LQSLPNHPNVVKFYGMFYKADKLV-GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMI 130
Query: 305 NWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364
++ I G+ GL +LH + +IIHRD+K NILL K+ DFG++ T
Sbjct: 131 SY-----ILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 182
Query: 365 THVSTRVMGTFGYLAPEYASSGKLTEKS-----DVFSFGVLLLELITGFRPF 411
+T V GT ++APE + + + S DV+S G+ +EL G P
Sbjct: 183 LRRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 58/200 (29%), Positives = 102/200 (51%), Gaps = 14/200 (7%)
Query: 217 LGQGGFGYVHKG--VLTNGKVVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSLVGY 273
LG+G + V+KG LT+ +VA+K+++ +G E+ ++ + H ++V+L
Sbjct: 14 LGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 274 CTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIH 333
LV+E++ +K L+ +L +N RGL Y H + K++H
Sbjct: 73 IHTEKSLTLVFEYL-DKDLKQYLDDCGN-SINMHNVKLFLFQLLRGLNYCH---RRKVLH 127
Query: 334 RDIKSANILLDDSFEAKVADFGLAK-HSLDTDTHVSTRVMGTFGYLAPE-YASSGKLTEK 391
RD+K N+L+++ E K+ADFGLA+ S+ T T+ + V T Y P+ S + +
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGSTDYSTQ 185
Query: 392 SDVFSFGVLLLELITGFRPF 411
D++ G + E+ TG RP
Sbjct: 186 IDMWGVGCIFYEMSTG-RPL 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 81/358 (22%), Positives = 138/358 (38%), Gaps = 101/358 (28%)
Query: 205 KIATDNFSEANLLGQGGFGYV--------HKGVLTNGKVVAIKQLKAGSGQGE-REFQAE 255
+ D +LG G FG V K ++ VA+K LK G+ E + +E
Sbjct: 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKK--SSCNTVAVKMLKEGATASEHKALMSE 60
Query: 256 IEIISQV-HHRHLVSLVG--------------YCTFGS---------------------Q 279
++I+ + +H ++V+L+G +C +G+ Q
Sbjct: 61 LKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQ 120
Query: 280 RLLVYEFVPNKTLEFHLH-GKDRPVMN-------------------WPTRMKI------A 313
R V ++ + G+ + + W + + + +
Sbjct: 121 RGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYS 180
Query: 314 LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV---STR 370
ARG+ +L K IHRD+ + NILL ++ K+ DFGLA+ +V S R
Sbjct: 181 FQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR 237
Query: 371 VMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPF 429
+ ++APE T +SDV+SFGVLL E+ + G P+ +
Sbjct: 238 L--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE---------- 285
Query: 430 LAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487
Q L DG + E + E+ R+ AC + + RP S +V L G++
Sbjct: 286 FCQRLKDGT-----RMRAPENATPEIYRI---MLACWQGDPKERPTFSALVEIL-GDL 334
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 66/289 (22%), Positives = 118/289 (40%), Gaps = 56/289 (19%)
Query: 217 LGQGGFGYVHKG----VLTNGKV----VAIKQLKAGSGQGEREFQAEIEIISQVHHRHLV 268
LGQG F + KG V G++ V +K L F ++SQ+ H+HLV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 269 SLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 328
G C G + ++V E+V +L+ +L K++ ++N ++++A A L +L +
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLK-KNKNLINISWKLEVAKQLAWALHFLEDK-- 119
Query: 329 PKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT------FGYLAPEY 382
+ H ++ + N+LL + K + K S D +S V+ ++ PE
Sbjct: 120 -GLTHGNVCAKNVLLIREEDRKTGNPPFIKLS---DPGISITVLPKEILLERIPWVPPEC 175
Query: 383 ASSGK-LTEKSDVFSFGVLLLELITGF-RPFDKADTFADDSMVDWAKPFLAQGLADGNFD 440
+ + L+ +D +SFG L E+ +G +P D+
Sbjct: 176 IENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS------------------------ 211
Query: 441 ALVDQKLEEYDSAEM------TRMAACAAACIRHSARRRPRMSQIVRAL 483
+KL+ Y+ T +A C+ + RP I+R L
Sbjct: 212 ---QKKLQFYEDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 65/239 (27%), Positives = 105/239 (43%), Gaps = 52/239 (21%)
Query: 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQA---------EIEI 258
D + + +G G +G V + G VAIK+L R FQ+ E+ +
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKL-------YRPFQSELFAKRAYRELRL 67
Query: 259 ISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLE-FHLHGKDRPVM--NWPTRMKIA-L 314
+ + H +++ L+ F P+ +L+ FH P M + MK L
Sbjct: 68 LKHMKHENVIGLLDV------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKL 115
Query: 315 GSAR----------GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364
R GL Y+H IIHRD+K N+ +++ E K+ DFGLA+ TD
Sbjct: 116 SEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ---TD 169
Query: 365 THVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSM 422
+ ++ V+ T Y APE + T+ D++S G ++ E++TG +P K D M
Sbjct: 170 SEMTGYVV-TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG-KPLFKGHDHLDQLM 226
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 60/220 (27%), Positives = 102/220 (46%), Gaps = 24/220 (10%)
Query: 217 LGQGGFGYVHKG--VLTNGKVVAIKQLKAGSGQGEREFQA--EIEIISQVH---HRHLVS 269
+G+G +G V K + G+ VA+K+++ +G+ E+ ++ + H ++V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 270 LVGYCTFG-----SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH 324
L CT ++ LV+E V ++ L +L P + T + RGL +LH
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 325 EDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYAS 384
+++HRD+K NIL+ S + K+ADFGLA+ + + T V+ T Y APE
Sbjct: 128 SH---RVVHRDLKPQNILVTSSGQIKLADFGLAR--IYSFQMALTSVVVTLWYRAPEVLL 182
Query: 385 SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD 424
D++S G + E+ F + F S VD
Sbjct: 183 QSSYATPVDLWSVGCIFAEM------FRRKPLFRGSSDVD 216
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 23/219 (10%)
Query: 217 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEI-----ISQVHHRHLVSL 270
+G G +G V+K +G VA+K ++ + + E+ + H ++V L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 271 VGYC-TFGSQR----LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHE 325
+ C T + R LV+E V ++ L +L P + T + RGL +LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126
Query: 326 DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS 385
+C I+HRD+K NIL+ + K+ADFGLA+ + + T V+ T Y APE
Sbjct: 127 NC---IVHRDLKPENILVTSGGQVKLADFGLAR--IYSCQMALTPVVVTLWYRAPEVLLQ 181
Query: 386 GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD 424
D++S G + E+ F + F +S D
Sbjct: 182 STYATPVDMWSVGCIFAEM------FRRKPLFCGNSEAD 214
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 63/212 (29%), Positives = 110/212 (51%), Gaps = 20/212 (9%)
Query: 217 LGQGGFGYVHKG--VLTNGKVVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSLVGY 273
LG+G + V KG LT +VA+K+++ +G E+ ++ + H ++V+L
Sbjct: 14 LGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 274 CTFGSQRLLVYEFVPNKTLEFHLH--GKDRPVMNWPTRMKIALGSA-RGLAYLHEDCQPK 330
LV+E++ +K L+ ++ G + N +KI L RGLAY H + K
Sbjct: 73 VHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHN----VKIFLYQILRGLAYCH---RRK 124
Query: 331 IIHRDIKSANILLDDSFEAKVADFGLAK-HSLDTDTHVSTRVMGTFGYLAPE-YASSGKL 388
++HRD+K N+L+++ E K+ADFGLA+ S+ T T+ + V T Y P+ S +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSSEY 182
Query: 389 TEKSDVFSFGVLLLELITGFRPFDKADTFADD 420
+ + D++ G + E+ +G RP T D+
Sbjct: 183 STQIDMWGVGCIFFEMASG-RPLFPGSTVEDE 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 52/217 (23%), Positives = 101/217 (46%), Gaps = 12/217 (5%)
Query: 210 NFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKA---GSGQGEREFQAEIEIISQVHHR 265
NF +G+G F V++ L +G VA+K+++ + + EI+++ Q++H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 266 HLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLH--GKDRPVMNWPTRMKIALGSARGLAYL 323
+++ ++ +V E L + K + ++ T K + L ++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 324 HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYA 383
H +++HRDIK AN+ + + K+ D GL + + T + ++GT Y++PE
Sbjct: 123 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHSLVGTPYYMSPERI 178
Query: 384 SSGKLTEKSDVFSFGVLLLELITGFRPF--DKADTFA 418
KSD++S G LL E+ PF DK + ++
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 30/93 (32%), Positives = 49/93 (52%), Gaps = 9/93 (9%)
Query: 318 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM----G 373
RGL Y+H +IHRD+K +N+L+++ E ++ DFG+A+ L + M
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR-GLSSSPTEHKYFMTEYVA 173
Query: 374 TFGYLAPEYA-SSGKLTEKSDVFSFGVLLLELI 405
T Y APE S + T D++S G + E++
Sbjct: 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 61.8 bits (151), Expect = 2e-10
Identities = 37/104 (35%), Positives = 55/104 (52%), Gaps = 21/104 (20%)
Query: 318 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT----------HV 367
+ L Y+H +IHRD+K +NILL+ K+ADFGLA+ SL +V
Sbjct: 118 KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR-SLSELEENPENPVLTDYV 173
Query: 368 STRVMGTFGYLAPE-YASSGKLTEKSDVFSFGVLLLELITGFRP 410
+TR Y APE S + T+ D++S G +L E++ G +P
Sbjct: 174 ATR-----WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG-KP 211
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 46/135 (34%), Positives = 65/135 (48%), Gaps = 6/135 (4%)
Query: 278 SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIK 337
S+ LV E+V L FH+ + R + R A L +LHE II+RD+K
Sbjct: 69 SRLFLVIEYVNGGDLMFHMQ-RQRKLPEEHARF-YAAEICIALNFLHER---GIIYRDLK 123
Query: 338 SANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSF 397
N+LLD K+ D+G+ K L ST GT Y+APE + D ++
Sbjct: 124 LDNVLLDADGHIKLTDYGMCKEGLGPGDTTST-FCGTPNYIAPEILRGEEYGFSVDWWAL 182
Query: 398 GVLLLELITGFRPFD 412
GVL+ E++ G PFD
Sbjct: 183 GVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 60/218 (27%), Positives = 99/218 (45%), Gaps = 16/218 (7%)
Query: 200 TYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKV--VAIKQLKAGSGQGEREFQ---A 254
+ K+ ++F+ LG G FG V N VAIK+ + +++ +
Sbjct: 21 PKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFS 80
Query: 255 EIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIAL 314
E +I++ ++H V+L G S LV EFV L R +P +
Sbjct: 81 ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKR----FPN--DVGC 134
Query: 315 GSARGLAYLHEDCQP-KIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMG 373
A + + E Q I++RD+K N+LLD K+ DFG AK +DT T+ + G
Sbjct: 135 FYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK-VVDTRTYT---LCG 190
Query: 374 TFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPF 411
T Y+APE + + +D ++ G+ + E++ G PF
Sbjct: 191 TPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 46/180 (25%), Positives = 84/180 (46%), Gaps = 7/180 (3%)
Query: 232 NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKT 291
+G+ VA+K + Q E+ I+ H+++V + G + ++ EF+
Sbjct: 45 SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104
Query: 292 LEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKV 351
L + + R +N + + L YLH +IHRDIKS +ILL K+
Sbjct: 105 LT-DIVSQTR--LNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKL 158
Query: 352 ADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPF 411
+DFG + D ++GT ++APE S + D++S G++++E++ G P+
Sbjct: 159 SDFGFCAQ-ISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPY 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 37/109 (33%), Positives = 57/109 (52%), Gaps = 10/109 (9%)
Query: 303 VMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362
++ W +M + G+ ++HE +++HRDIKS NI L + + K+ DFG A+
Sbjct: 102 ILQWFVQMCL------GVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS 152
Query: 363 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPF 411
+ T V GT Y+ PE + KSD++S G +L EL T PF
Sbjct: 153 PGAYACTYV-GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 67/257 (26%), Positives = 110/257 (42%), Gaps = 35/257 (13%)
Query: 176 SLDSDKPFPRQSPGMPVGNFKSTF-----TYEELKIATDNFSEANLLGQGGFGYV----H 226
SL D FP + NF + + +L++ +++ ++G+G FG V H
Sbjct: 5 SLVLDLDFPALRKNKNIDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRH 64
Query: 227 KGVLTNGKVVAIKQLKAGSGQGERE---FQAEIEIISQVHHRHLVSLVGYCTFGSQRLL- 282
K ++ KV A+K L + F E +I++ + +V L +C F + L
Sbjct: 65 K---SSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL--FCAFQDDKYLY 119
Query: 283 -VYEFVPNKTLEFHLHGKDRP---VMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKS 338
V E++P L + D P + + +AL + + +IHRD+K
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMG---------LIHRDVKP 170
Query: 339 ANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS----GKLTEKSDV 394
N+LLD K+ADFG +T +GT Y++PE S G + D
Sbjct: 171 DNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDW 230
Query: 395 FSFGVLLLELITGFRPF 411
+S GV L E++ G PF
Sbjct: 231 WSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 5e-10
Identities = 60/220 (27%), Positives = 94/220 (42%), Gaps = 28/220 (12%)
Query: 209 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE---FQAEIEIISQVHH 264
+F +L+G+G FG V G + A+K +K + F+ E +I+S +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 265 RHLVSLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRP-----VMNWPTRMKIALGSAR 318
+ L Y L LV E+ P L L+ + + + +A+ S
Sbjct: 61 PWIPQLQ-YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH 119
Query: 319 GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV-STRVMGTFGY 377
+ Y +HRDIK N+L+D + K+ADFG A L + V S +GT Y
Sbjct: 120 QMGY---------VHRDIKPENVLIDRTGHIKLADFGSAA-RLTANKMVNSKLPVGTPDY 169
Query: 378 LAPEYASSGKLTEKS------DVFSFGVLLLELITGFRPF 411
+APE ++ K D +S GV+ E+I G PF
Sbjct: 170 IAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 7e-10
Identities = 34/92 (36%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 318 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA-KHSLDTDTHVSTRVMGTFG 376
RGL YLH I+HRDIK N+L++ + K+ DFGLA D H++ V+ +
Sbjct: 114 RGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY- 169
Query: 377 YLAPE-YASSGKLTEKSDVFSFGVLLLELITG 407
Y APE S T D++S G + EL+
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGR 201
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 7e-10
Identities = 29/88 (32%), Positives = 48/88 (54%), Gaps = 5/88 (5%)
Query: 318 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGY 377
GL YLH +IIHRD+K+ NI ++D + + D G A+ + + + GT
Sbjct: 168 EGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG--LAGTVET 222
Query: 378 LAPEYASSGKLTEKSDVFSFGVLLLELI 405
APE + K K+D++S G++L E++
Sbjct: 223 NAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 7e-10
Identities = 31/90 (34%), Positives = 52/90 (57%), Gaps = 5/90 (5%)
Query: 318 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGY 377
RGL Y+H ++HRD+K +N+LL+ + + K+ DFGLA+ + + ++ V+ T Y
Sbjct: 119 RGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWY 174
Query: 378 LAPE-YASSGKLTEKSDVFSFGVLLLELIT 406
APE + + T DV+S G + EL+
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELLG 204
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 9e-10
Identities = 38/100 (38%), Positives = 57/100 (57%), Gaps = 10/100 (10%)
Query: 318 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT-HVSTRVMGTFG 376
RGL Y+H IIHRD+K +N+ +++ E K+ DFGLA+H+ D T +V+TR
Sbjct: 131 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 182
Query: 377 YLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKAD 415
Y APE + + D++S G ++ EL+TG F D
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 222
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 64/209 (30%), Positives = 90/209 (43%), Gaps = 20/209 (9%)
Query: 216 LLGQGGFGYVHKGVL----TNGKVVAIKQLKAGSGQGEREFQ---AEIEIISQVHHRHLV 268
LLG+G FG V +L G+ A+K L+ + E E ++ H L
Sbjct: 2 LLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 58
Query: 269 SLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIA-LGSARGLAYLHED 326
+L Y RL V E+ L FHL ++R R A + SA L YLH
Sbjct: 59 AL-KYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSA--LEYLHSR 114
Query: 327 CQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSG 386
+++RDIK N++LD K+ DFGL K + +D GT YLAPE
Sbjct: 115 ---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI-SDGATMKTFCGTPEYLAPEVLEDN 170
Query: 387 KLTEKSDVFSFGVLLLELITGFRPFDKAD 415
D + GV++ E++ G PF D
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 17/213 (7%)
Query: 210 NFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGS----GQGEREFQAEIEIISQ 261
NF +LG G +G V GK+ A+K L+ + + + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 262 VHHRHLVSLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA-RG 319
V + + Y +L L+ ++V + HL+ +D + ++ G
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSED---EVRFYSGEIILA 117
Query: 320 LAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLA 379
L +LH + I++RDIK NILLD + DFGL+K L + + GT Y+A
Sbjct: 118 LEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMA 174
Query: 380 PEYA-SSGKLTEKSDVFSFGVLLLELITGFRPF 411
PE G + D +S G+L+ EL+TG PF
Sbjct: 175 PEIIRGKGGHGKAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 53/200 (26%), Positives = 82/200 (41%), Gaps = 17/200 (8%)
Query: 217 LGQGGFGYVH----KGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVG 272
L G G V G KV+ +KA +G EI+I+ + HR +++L+
Sbjct: 100 LTPGSEGEVFVCTKHGDEQRKKVI----VKAVTGGKTPG--REIDILKTISHRAIINLIH 153
Query: 273 YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKII 332
+ S +V +P + + + + I LAYLH II
Sbjct: 154 AYRWKSTVCMV---MPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR---GII 207
Query: 333 HRDIKSANILLDDSFEAKVADFGLA-KHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEK 391
HRD+K+ NI LD+ A + DFG A K DT GT +PE + K
Sbjct: 208 HRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAK 267
Query: 392 SDVFSFGVLLLELITGFRPF 411
+D++S G++L E+
Sbjct: 268 TDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 69/258 (26%), Positives = 111/258 (43%), Gaps = 37/258 (14%)
Query: 176 SLDSDKPFPRQSPGMPVGNFKSTFT-----YEELKIATDNFSEANLLGQGGFGYV----H 226
+L D FP + NF + + +L++ +++ ++G+G FG V H
Sbjct: 5 ALVYDLDFPALRKNKNIDNFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRH 64
Query: 227 KGVLTNGKVVAIKQLKAGSGQGERE---FQAEIEIISQVHHRHLVSLVGYCTFGSQRLL- 282
K + KV A+K L + F E +I++ + +V L + F R L
Sbjct: 65 K---STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL--FYAFQDDRYLY 119
Query: 283 -VYEFVPNKTLEFHLHGKDRP---VMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKS 338
V E++P L + D P + + +AL + + + IHRD+K
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGF---------IHRDVKP 170
Query: 339 ANILLDDSFEAKVADFGLA-KHSLDTDTHVSTRVMGTFGYLAPEYASS----GKLTEKSD 393
N+LLD S K+ADFG K + + T V GT Y++PE S G + D
Sbjct: 171 DNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECD 229
Query: 394 VFSFGVLLLELITGFRPF 411
+S GV L E++ G PF
Sbjct: 230 WWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 62/208 (29%), Positives = 88/208 (42%), Gaps = 17/208 (8%)
Query: 216 LLGQGGFGYVHKGVL----TNGKVVAIKQLKAGSGQGEREFQ---AEIEIISQVHHRHLV 268
LLG+G FG V +L G+ A+K LK + E E ++ H L
Sbjct: 2 LLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 58
Query: 269 SLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC 327
+L Y RL V E+ L FHL ++R R A L YLH
Sbjct: 59 AL-KYSFQTHDRLCFVMEYANGGELFFHL-SRERVFSEDRARFYGA-EIVSALDYLHS-- 113
Query: 328 QPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGK 387
+ +++RD+K N++LD K+ DFGL K + + T GT YLAPE
Sbjct: 114 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDND 172
Query: 388 LTEKSDVFSFGVLLLELITGFRPFDKAD 415
D + GV++ E++ G PF D
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLPFYNQD 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 35/94 (37%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 318 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK-HSLDTDTHVS-TRVMGTF 375
R L Y+H + HRD+K NIL + + K+ DFGLA+ DT T + T + T
Sbjct: 114 RALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 376 GYLAPEYASS--GKLTEKSDVFSFGVLLLELITG 407
Y APE S K T D++S G + E++TG
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG 204
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 7e-09
Identities = 65/251 (25%), Positives = 102/251 (40%), Gaps = 64/251 (25%)
Query: 216 LLGQGGFGYVH----KGVLTNGKVVAIKQLKAGSGQGEREFQ---AEIEIISQVHHRHLV 268
LLG+G G V KG GK+ A+K L + + E EI++ + H L
Sbjct: 8 LLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLP 64
Query: 269 SLVGYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR-------- 318
+L Y +F ++ LV ++ P E + +P ++ AR
Sbjct: 65 TL--YASFQTETYLCLVMDYCPGG--ELFRLLQRQP------GKCLSEEVARFYAAEVLL 114
Query: 319 GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRV------- 371
L YLH I++RD+K NILL +S ++DF L+K S VS +
Sbjct: 115 ALEYLH--LL-GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS 171
Query: 372 ---------------------MGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRP 410
+GT Y+APE S D ++ G+LL E++ G P
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
Query: 411 F---DKADTFA 418
F ++ +TF+
Sbjct: 232 FKGSNRDETFS 242
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 7e-09
Identities = 66/229 (28%), Positives = 97/229 (42%), Gaps = 21/229 (9%)
Query: 198 TFTYEELKIATDNFSEANLLGQGGFGYVHKGVLT--NGKVVAIKQLKAGSGQGEREFQAE 255
T ++ +D + +G+G +G V K VL NG A+K L E E +AE
Sbjct: 7 TIIFDSFPDPSDTWEIIETIGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDIDE-EIEAE 64
Query: 256 IEIISQVH-HRHLVSLVGY-----CTFGSQRLLVYEFVPNKTLEFHLHG--KDRPVMNWP 307
I+ + H ++V G G Q LV E ++ + G K M P
Sbjct: 65 YNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEP 124
Query: 308 TRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 367
I + GL +LH + K IHRD+K NILL K+ DFG++ T
Sbjct: 125 IIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR 181
Query: 368 STRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVLLLELITGFRPF 411
+T V GT ++APE + + DV+S G+ +EL G P
Sbjct: 182 NTSV-GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 25/211 (11%)
Query: 215 NLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGY 273
N++G G FG V++ + + + VAIK++ RE I+ ++H +++ L Y
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELL----IMKNLNHINIIFLKDY 127
Query: 274 CTFGSQRL--------LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS---ARGLAY 322
+ +V EF+P +T+ ++ R P + + L S R LAY
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFL-VKLYSYQLCRALAY 185
Query: 323 LHEDCQPKIIHRDIKSANILLD-DSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPE 381
+H I HRD+K N+L+D ++ K+ DFG AK+ L VS + F Y APE
Sbjct: 186 IHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSY-ICSRF-YRAPE 240
Query: 382 YA-SSGKLTEKSDVFSFGVLLLELITGFRPF 411
+ T D++S G ++ E+I G+ F
Sbjct: 241 LMLGATNYTTHIDLWSLGCIIAEMILGYPIF 271
|
Length = 440 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 38/116 (32%), Positives = 63/116 (54%), Gaps = 17/116 (14%)
Query: 306 WPTRM----KIALGSARGLAYL-HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 360
WP + + + A+G+ +L ++C IHRD+ + N+LL D AK+ DFGLA+
Sbjct: 207 WPLDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDI 262
Query: 361 LDTDTHVSTRVMGT----FGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 411
++ +V V G ++APE T +SDV+S+G+LL E+ + G P+
Sbjct: 263 MNDSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPY 315
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 57/231 (24%), Positives = 98/231 (42%), Gaps = 54/231 (23%)
Query: 211 FSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEI---------EIIS 260
++ +G G +G V + G+ VAIK+L R FQ+EI ++
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKL-------SRPFQSEIFAKRAYRELTLLK 69
Query: 261 QVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGL 320
+ H +++ L+ F S ++ +F+L VM + M+ L G
Sbjct: 70 HMQHENVIGLLD--VFTSAVSG------DEFQDFYL------VMPY---MQTDLQKIMGH 112
Query: 321 AYLHEDCQ---------------PKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365
+ Q IIHRD+K N+ +++ E K+ DFGLA+H+ D
Sbjct: 113 PLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHA---DA 169
Query: 366 HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKAD 415
++ V+ T Y APE + + D++S G ++ E++TG F D
Sbjct: 170 EMTGYVV-TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 52/203 (25%), Positives = 88/203 (43%), Gaps = 19/203 (9%)
Query: 217 LGQGGFGYVHKGVLTNGKVVA---IKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSLVG 272
+G G FG V + VA +K+LKA + E+ EF + + + H +++ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 273 YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRM--KIALGSARGLAYLHEDCQPK 330
C LLV+E+ L+ +L + N + ++A A G+ ++H+
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---N 119
Query: 331 IIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST--RVMGTFGYLAPEYASS--G 386
+H D+ N L KV D+G+ D ++ T +LAPE G
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED-YIETEDDKCVPLRWLAPELVGEFHG 178
Query: 387 KL-----TEKSDVFSFGVLLLEL 404
L T+ S+V++ GV L EL
Sbjct: 179 GLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 54/197 (27%), Positives = 98/197 (49%), Gaps = 15/197 (7%)
Query: 217 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA--EIEIISQVHHRHLVSLVGY 273
LG+G + V+KG+ NG++VA+K + + +G F A E ++ + H ++V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEG-VPFTAIREASLLKGLKHANIVLLHDI 71
Query: 274 CTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA-RGLAYLHEDCQPKII 332
V+E++ ++ + P P +++ + RGLAY+H I+
Sbjct: 72 IHTKETLTFVFEYMHTDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHGQ---HIL 125
Query: 333 HRDIKSANILLDDSFEAKVADFGLAK-HSLDTDTHVSTRVMGTFGYLAPE-YASSGKLTE 390
HRD+K N+L+ E K+ADFGLA+ S+ + T+ S V T Y P+ + +
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGATDYSS 183
Query: 391 KSDVFSFGVLLLELITG 407
D++ G + +E++ G
Sbjct: 184 ALDIWGAGCIFIEMLQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 62/228 (27%), Positives = 99/228 (43%), Gaps = 45/228 (19%)
Query: 209 DNFSEANLLGQGGFGYVHKGVLTNG-KVVAIKQLKAGSGQGERE---FQAEIEI------ 258
++F ++G+G FG V L N KV A+K L E F+ E ++
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 259 --ISQVHH-----RHLVSLVGYCTFGSQRLLVYEF---VPNKTLEFHLHGKDRPVMNWPT 308
I+ +H+ +L ++ Y G L+ +F +P F+L
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYL-----------A 109
Query: 309 RMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 368
M IA+ S L Y +HRDIK NIL+D + ++ADFG ++ T S
Sbjct: 110 EMVIAIDSVHQLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 160
Query: 369 TRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVLLLELITGFRPF 411
+ +GT Y++PE + GK + D +S GV + E++ G PF
Sbjct: 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (134), Expect = 2e-08
Identities = 46/172 (26%), Positives = 73/172 (42%), Gaps = 32/172 (18%)
Query: 255 EIEIISQVH-----HRHLVSLVGYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWP 307
IE + VH + + + L Y + + + +L+ +++ + L F L K+ +
Sbjct: 56 AIEPM--VHQLMKDNPNFIKL--YYSVTTLKGHVLIMDYIKDGDL-FDLLKKEGKLSEAE 110
Query: 308 TRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS-FEAKVADFGLAKHSLDTDTH 366
+ KI L LH+ IIH DIK N+L D + + D+GL K
Sbjct: 111 VK-KIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKI-----IG 161
Query: 367 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSF-----GVLLLELITGFRPFDK 413
+ GT Y +PE K+ + SF GVL EL+TG PF +
Sbjct: 162 TPSCYDGTLDYFSPE-----KIKGHNYDVSFDWWAVGVLTYELLTGKHPFKE 208
|
Length = 267 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 3e-08
Identities = 50/236 (21%), Positives = 97/236 (41%), Gaps = 45/236 (19%)
Query: 216 LLGQGGFGYVHKGV-LTNGKVVAIKQLK---AGSGQGEREFQAEIEIISQVHHRHLVSLV 271
L+G+GG G V+ + VA+K+++ + + ++ F E +I + + H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 272 GYCTFGSQRLLVY---EFVPNKTLEFHL------------HGKDRPVMNWPTRMKIALGS 316
C S VY ++ TL+ L + V + I
Sbjct: 69 SIC---SDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSV---GAFLSIFHKI 122
Query: 317 ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK-----------------H 359
+ Y+H ++HRD+K NILL E + D+G A +
Sbjct: 123 CATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179
Query: 360 SLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKAD 415
+ + +++GT Y+APE +E +D+++ GV+L +++T P+ +
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK 235
|
Length = 932 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 51/213 (23%), Positives = 93/213 (43%), Gaps = 19/213 (8%)
Query: 209 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA--EIEIISQVHHR 265
D + + +G+G +G V+K GK+VA+K+ + + A EI ++ +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 266 -HLVSL-----VGYCTFGSQRLLVYEFVPN---KTLEFHLHGKDRPVMNWPTRMKIALGS 316
++V L V LV+E++ + K ++ + G RP + T
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRP-LPAKTIKSFMYQL 119
Query: 317 ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA-KVADFGLAKHSLDTDTHVSTRVMGTF 375
+G+A+ H+ ++HRD+K N+L+D K+AD GL + + T + T
Sbjct: 120 LKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGR-AFSIPVKSYTHEIVTL 175
Query: 376 GYLAPE-YASSGKLTEKSDVFSFGVLLLELITG 407
Y APE S + D++S G + E+
Sbjct: 176 WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 57/228 (25%), Positives = 96/228 (42%), Gaps = 45/228 (19%)
Query: 209 DNFSEANLLGQGGFGYVHKGVLTNG-KVVAIK------QLKAGSGQGERE-----FQAEI 256
D+F ++G+G FG V + + ++ A+K LK RE +
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 257 EIISQVHH-----RHLVSLVGYCTFGSQRLLVYEF---VPNKTLEFHLHGKDRPVMNWPT 308
+ I+ +H+ +L ++ Y G L+ +F +P F++
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYI-----------A 109
Query: 309 RMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 368
M +A+ S L Y +HRDIK N+LLD + ++ADFG T S
Sbjct: 110 EMVLAIHSIHQLHY---------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS 160
Query: 369 TRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVLLLELITGFRPF 411
+ +GT Y++PE + GK + D +S GV + E++ G PF
Sbjct: 161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 35/227 (15%)
Query: 209 DNFSEANLLGQGGFGYV----HKGVLTNGKVVAI-KQLKAGSGQGEREFQAEIEIISQVH 263
++F L+ G +G V HK + I KQ Q ++ F E +I++
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVF-VERDILTFAE 59
Query: 264 HRHLVSLVGYCTFGSQRLL--VYEFVPN---KTLEFHLHGKDRPVMNWPTRMKIALGSAR 318
+ +VS+ +C+F ++R L V E+V TL ++ + RM A +
Sbjct: 60 NPFVVSM--FCSFETKRHLCMVMEYVEGGDCATLLKNIG----ALPVDMARMYFA-ETVL 112
Query: 319 GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK------------HSLDTDTH 366
L YLH I+HRD+K N+L+ K+ DFGL+K ++ DT
Sbjct: 113 ALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169
Query: 367 --VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPF 411
+ +V GT Y+APE + D ++ G++L E + G PF
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPF 216
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 63/241 (26%), Positives = 101/241 (41%), Gaps = 43/241 (17%)
Query: 209 DNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQL-KAGSGQGER--EFQAEIEIISQVHH 264
++F ++G+G FG V + G V A+K L KA + E+ +AE +I+ +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 265 RHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH 324
+V + L+ EF+P + L KD + T+ IA + + +H
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKD-TLTEEETQFYIA-ETVLAIDSIH 118
Query: 325 EDCQPKIIHRDIKSANILLDDSFEAKVADFGLA---------------KHSLDTD----- 364
Q IHRDIK N+LLD K++DFGL HSL +D
Sbjct: 119 ---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175
Query: 365 --------------THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRP 410
++ +GT Y+APE + D +S GV++ E++ G+ P
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
Query: 411 F 411
F
Sbjct: 236 F 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 45/221 (20%), Positives = 84/221 (38%), Gaps = 38/221 (17%)
Query: 217 LGQGGFGYVHKGVLTNGKVVAIKQ--LKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYC 274
++ K +VA+K+ L + S + + Q EI Q+ H +++ V
Sbjct: 10 FEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68
Query: 275 TFGSQRLLVYEFVPNKTLEFHLHGKDRPVM--NWPTRMK---IAL---GSARGLAYLHED 326
S+ +V + +G ++ ++P + IA L Y+H
Sbjct: 69 IVDSELYVVSPLMA--------YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH-- 118
Query: 327 CQPKIIHRDIKSANILLDDSFEAKVADF---------GLAKHSLDTDTHVSTRVMGTFGY 377
IHR +K+++ILL + ++ G + + S + + +
Sbjct: 119 -SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP---W 174
Query: 378 LAPE--YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADT 416
L+PE + EKSD++S G+ EL G PF D
Sbjct: 175 LSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPF--KDM 213
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 9e-08
Identities = 50/206 (24%), Positives = 94/206 (45%), Gaps = 16/206 (7%)
Query: 209 DNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGEREFQA--EIEIISQV 262
+ F ++G+G +G V HK ++VAIK+ K E + E++++ +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHK---ETKEIVAIKKFKDSEENEEVKETTLRELKMLRTL 57
Query: 263 HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS-ARGLA 321
++V L + LV+E+V LE ++ P P +++ + + +
Sbjct: 58 KQENIVELKEAFRRRGKLYLVFEYVEKNMLELL---EEMPNGVPPEKVRSYIYQLIKAIH 114
Query: 322 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPE 381
+ H++ I+HRDIK N+L+ + K+ DFG A++ + T + T Y +PE
Sbjct: 115 WCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPE 171
Query: 382 YASSGKLTEKSDVFSFGVLLLELITG 407
+ D++S G +L EL G
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 61/228 (26%), Positives = 96/228 (42%), Gaps = 45/228 (19%)
Query: 209 DNFSEANLLGQGGFGYVHKGVLTN-GKVVAIK------QLKAGSGQGERE-----FQAEI 256
D+F ++G+G FG V + N G+V A+K LK RE +
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 257 EIISQVHH-----RHLVSLVGYCTFGSQRLLVYEF---VPNKTLEFHLHGKDRPVMNWPT 308
I+ +H+ +L ++ Y G L+ +F +P F+L
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYL-----------A 109
Query: 309 RMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 368
M +A+ S L Y +HRDIK N+LLD + ++ADFG L T S
Sbjct: 110 EMVLAIDSVHQLGY---------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS 160
Query: 369 TRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVLLLELITGFRPF 411
+GT Y++PE + G+ + D +S GV + E++ G PF
Sbjct: 161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 56/215 (26%), Positives = 92/215 (42%), Gaps = 52/215 (24%)
Query: 217 LGQGGFGYVHKG-VLTNGKVVAIKQLKAGSGQGE-----REFQAEIEIISQVHHRHLVSL 270
+G+G F V K GK AIK +K E RE QA + H +++ L
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQA---LRRLSPHPNILRL 63
Query: 271 VGYCTFGSQRLLVYEFVPNK-TLEFHL---------HGKDRP-----VMNWPTRMKIALG 315
+ ++++ + L F L G+ RP V ++ ++
Sbjct: 64 IE---------VLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQL----- 109
Query: 316 SARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK--HSLDTDT-HVSTRVM 372
+ L ++H + I HRDIK NIL+ D K+ADFG + +S T ++STR
Sbjct: 110 -LKSLDHMH---RNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYISTR-- 162
Query: 373 GTFGYLAPE-YASSGKLTEKSDVFSFGVLLLELIT 406
Y APE + G K D+++ G + E+++
Sbjct: 163 ---WYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 35/100 (35%), Positives = 55/100 (55%), Gaps = 10/100 (10%)
Query: 318 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT-HVSTRVMGTFG 376
RGL Y+H IIHRD+K +N+ +++ E ++ DFGLA+ + D T +V+TR
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----W 180
Query: 377 YLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKAD 415
Y APE + + D++S G ++ EL+ G F D
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND 220
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 49/156 (31%), Positives = 79/156 (50%), Gaps = 19/156 (12%)
Query: 258 IISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLH-GKDRPVMNWPTRMKIALGS 316
++SQV H HL + G C GS+ ++V EFV + L+ L K R + W ++ +A
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQL 126
Query: 317 ARGLAYLHEDCQPKIIHRDIKSANILL-------DDSFEAKVADFGLAKHSLDTDTHVST 369
A L+YL ED ++H ++ + NILL S K++D G++ +L + V
Sbjct: 127 ASALSYL-ED--KNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVE- 182
Query: 370 RVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLEL 404
++APE G L+ +D +SFG LLE+
Sbjct: 183 ----RIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 62/244 (25%), Positives = 105/244 (43%), Gaps = 49/244 (20%)
Query: 209 DNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGERE----FQAEIEIISQVH 263
D+F ++G+G FG V + G + A+K L+ + E+E +AE +I+ +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRK-ADMLEKEQVAHIRAERDILVEAD 59
Query: 264 HRHLVSLVGYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLA 321
+V + + +F +R L+ EF+P + L KD + T+ IA + +
Sbjct: 60 GAWVVKM--FYSFQDKRNLYLIMEFLPGGDMMTLLMKKD-TLSEEATQFYIA-ETVLAID 115
Query: 322 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA---------------KHSLDTD-- 364
+H Q IHRDIK N+LLD K++DFGL H+ +D
Sbjct: 116 AIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFS 172
Query: 365 -----------------THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITG 407
++ +GT Y+APE + D +S GV++ E++ G
Sbjct: 173 FQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
Query: 408 FRPF 411
+ PF
Sbjct: 233 YPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 46/155 (29%), Positives = 76/155 (49%), Gaps = 17/155 (10%)
Query: 258 IISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA 317
++ QV H+H+V L G C + ++V EFV L+ +H K + P + K+A A
Sbjct: 57 MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTT-PWKFKVAKQLA 115
Query: 318 RGLAYLHEDCQPKIIHRDIKSANILL-DDSFEA------KVADFGLAKHSLDTDTHVSTR 370
L+YL ED ++H ++ + NILL + + K++D G+ L V R
Sbjct: 116 SALSYL-ED--KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVE-R 171
Query: 371 VMGTFGYLAPEYASSGK-LTEKSDVFSFGVLLLEL 404
+ ++APE K L+ +D +SFG L E+
Sbjct: 172 I----PWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 5e-07
Identities = 41/147 (27%), Positives = 59/147 (40%), Gaps = 19/147 (12%)
Query: 266 HLVSLVGYCTFGSQRLLVYEFVPNKTLEFH----LHGKDRPVMNWPTRMKIALGSARGLA 321
++V L Y LV + L H L+ + V W M +AL +
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA----- 100
Query: 322 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT-DTHVSTRVMGTFGYLAP 380
LH + I+ RD+ NILLDD ++ F D+ D + Y AP
Sbjct: 101 -LHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YCAP 151
Query: 381 EYASSGKLTEKSDVFSFGVLLLELITG 407
E + TE D +S G +L EL+TG
Sbjct: 152 EVGGISEETEACDWWSLGAILFELLTG 178
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 36/107 (33%), Positives = 56/107 (52%), Gaps = 10/107 (9%)
Query: 318 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK----HSLDTDTHVSTRVMG 373
GL Y+H ++HRD+K N+L++ E K+ DFGLA+ + + + T +
Sbjct: 116 CGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEYVA 171
Query: 374 TFGYLAPEYASSGKLTEKS-DVFSFGVLLLELITGFRPFDKADTFAD 419
T Y APE S + K+ DV+S G +L EL+ G +P K + D
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKDYVD 217
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 59/213 (27%), Positives = 104/213 (48%), Gaps = 33/213 (15%)
Query: 217 LGQGGFGYVHKGVLTNGK---VVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGY 273
+G+G +G+V+K +GK A+KQ++ G+G + EI ++ ++ H ++++L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIE-GTGISMSACR-EIALLRELKHPNVIALQKV 66
Query: 274 CTFGSQR--LLVYEFVPNK---TLEFHLHGK-DRPVMNWPTRMKIAL--GSARGLAYLHE 325
S R L++++ + ++FH K ++ M P M +L G+ YLH
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 326 DCQPKIIHRDIKSANILL----DDSFEAKVADFGLA-------KHSLDTDTHVSTRVMGT 374
+ ++HRD+K ANIL+ + K+AD G A K D D V+ T
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP-----VVVT 178
Query: 375 FGYLAPEYASSGK-LTEKSDVFSFGVLLLELIT 406
F Y APE + T+ D+++ G + EL+T
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 5e-07
Identities = 35/101 (34%), Positives = 56/101 (55%), Gaps = 13/101 (12%)
Query: 317 ARGLAYL-HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT- 374
A+G+++L ++C IHRD+ + NILL K+ DFGLA+ D + V G
Sbjct: 224 AKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLAR---DIRNDSNYVVKGNA 276
Query: 375 ---FGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 411
++APE + T +SDV+S+G+LL E+ + G P+
Sbjct: 277 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY 317
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 33/111 (29%), Positives = 60/111 (54%), Gaps = 10/111 (9%)
Query: 300 DRPVMNWPTRMKIALGSARGLAYL-HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 358
+ P +++ + + A G+ +L ++C +HRD+ + N+L+ + K+ DFGLA+
Sbjct: 232 ESPALSYMDLVGFSYQVANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLAR 287
Query: 359 HSLDTDTHVSTRVMGTF---GYLAPEYASSGKLTEKSDVFSFGVLLLELIT 406
+ ++S TF ++APE + T SDV+SFG+LL E+ T
Sbjct: 288 DIMRDSNYISKG--STFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 65/240 (27%), Positives = 105/240 (43%), Gaps = 49/240 (20%)
Query: 197 STFT----YEELKIATDNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLK---AGSGQG 248
STFT Y++LK +G G G V T G VA+K+L
Sbjct: 15 STFTVLKRYQQLKP----------IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHA 64
Query: 249 EREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLE-FHLHGKDRPVM--N 305
+R ++ E+ ++ V+H++++SL+ F P K+LE F +M N
Sbjct: 65 KRAYR-ELVLLKCVNHKNIISLLNV------------FTPQKSLEEFQDVYLVMELMDAN 111
Query: 306 WPTRMKIALGSAR----------GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 355
+ + L R G+ +LH IIHRD+K +NI++ K+ DFG
Sbjct: 112 LCQVIHMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG 168
Query: 356 LAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKAD 415
LA+ + T+ ++ V+ + Y APE E D++S G ++ EL+ G F D
Sbjct: 169 LAR-TACTNFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD 226
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 32/92 (34%), Positives = 46/92 (50%), Gaps = 11/92 (11%)
Query: 319 GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK---HSLDTDTHVSTRVMGTF 375
G+ +LH IIHRD+K +NI++ K+ DFGLA+ S +V TR
Sbjct: 130 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 182
Query: 376 GYLAPEYASSGKLTEKSDVFSFGVLLLELITG 407
Y APE E D++S G ++ E+I G
Sbjct: 183 -YRAPEVILGMGYKENVDIWSVGCIMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 33/94 (35%), Positives = 52/94 (55%), Gaps = 10/94 (10%)
Query: 317 ARGLAYL-HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF 375
ARG+ +L ++C +HRD+ + N+LL K+ DFGLA+ + +VS TF
Sbjct: 247 ARGMEFLASKNC----VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKG--STF 300
Query: 376 ---GYLAPEYASSGKLTEKSDVFSFGVLLLELIT 406
++APE T SDV+S+G+LL E+ +
Sbjct: 301 LPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 57/213 (26%), Positives = 107/213 (50%), Gaps = 33/213 (15%)
Query: 217 LGQGGFGYVHKGVLTNGKV---VAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVG- 272
+G+G +G+V+K +GK A+KQ++ G+G + EI ++ ++ H +++SL
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIE-GTGISMSACR-EIALLRELKHPNVISLQKV 66
Query: 273 YCTFGSQRL-LVYEFVPNK---TLEFHLHGK-DRPVMNWPTRMKIAL--GSARGLAYLHE 325
+ + +++ L++++ + ++FH K ++ + P M +L G+ YLH
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 126
Query: 326 DCQPKIIHRDIKSANILL----DDSFEAKVADFGLA-------KHSLDTDTHVSTRVMGT 374
+ ++HRD+K ANIL+ + K+AD G A K D D V+ T
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP-----VVVT 178
Query: 375 FGYLAPEYASSGK-LTEKSDVFSFGVLLLELIT 406
F Y APE + T+ D+++ G + EL+T
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 6e-06
Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 13/97 (13%)
Query: 318 RGLAYLHEDCQPKIIHRDIKSANILLD-DSFEAKVADFGLAKHSLDTDTHVS-----TRV 371
RGL Y+H ++HRD+K AN+ ++ + K+ DFGLA+ D H S +
Sbjct: 125 RGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLAR---IVDPHYSHKGYLSEG 178
Query: 372 MGTFGYLAPEYA-SSGKLTEKSDVFSFGVLLLELITG 407
+ T Y +P S T+ D+++ G + E++TG
Sbjct: 179 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 31/86 (36%), Positives = 47/86 (54%), Gaps = 8/86 (9%)
Query: 209 DNFSEANLLGQGGFGYVHK------GVLTNGKVVAIKQLKAGSGQGERE-FQAEIEIISQ 261
DN LG G FG V + G N VA+K LKA + ERE +E++I+S
Sbjct: 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH 97
Query: 262 V-HHRHLVSLVGYCTFGSQRLLVYEF 286
+ H+++V+L+G CT G L++ E+
Sbjct: 98 LGQHKNIVNLLGACTHGGPVLVITEY 123
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 64/263 (24%), Positives = 105/263 (39%), Gaps = 75/263 (28%)
Query: 209 DNFSEANLLGQGGFG---YVHKGVLTNGKVVAIKQLKAGSGQGEREF---QAEIEIISQV 262
++F ++G+G FG V K GK+ A+K L + + +AE +++++
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQK--KDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES 58
Query: 263 HHRHLVSLVGYCTF-GSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWP------TRMKIAL 314
+VSL Y +F +Q L L+ EF+P L L + + TR +A
Sbjct: 59 DSPWVVSL--YYSFQDAQYLYLIMEFLPGGDLMTML-------IKYDTFSEDVTRFYMA- 108
Query: 315 GSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGL------------------ 356
+ +H + IHRDIK NIL+D K++DFGL
Sbjct: 109 ECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQ 165
Query: 357 ---AKHSLDTDTHV--------------------STRVM-----GTFGYLAPEYASSGKL 388
K+ +D V + R+M GT Y+APE
Sbjct: 166 GKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY 225
Query: 389 TEKSDVFSFGVLLLELITGFRPF 411
++ D +S G ++ E + G+ PF
Sbjct: 226 GQECDWWSLGAIMFECLIGWPPF 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 32/92 (34%), Positives = 46/92 (50%), Gaps = 11/92 (11%)
Query: 319 GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK---HSLDTDTHVSTRVMGTF 375
G+ +LH IIHRD+K +NI++ K+ DFGLA+ S +V TR
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 190
Query: 376 GYLAPEYASSGKLTEKSDVFSFGVLLLELITG 407
Y APE E D++S G ++ E+I G
Sbjct: 191 -YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 32/109 (29%), Positives = 54/109 (49%), Gaps = 23/109 (21%)
Query: 330 KIIHRDIKSANILLDDSFE-----------------AKVADFGLAKH-SLDTDTHVSTRV 371
+++HRD+K NI L AK+ DFGL+K+ +++ H
Sbjct: 145 RVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAH---SC 201
Query: 372 MGTFGYLAPEYA--SSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFA 418
+GT Y +PE + +KSD+++ G ++ EL +G PF KA+ F+
Sbjct: 202 VGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFS 250
|
Length = 1021 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 5e-05
Identities = 37/126 (29%), Positives = 65/126 (51%), Gaps = 13/126 (10%)
Query: 283 VYEFVPNKTLEFHLHGKDRPVMNWPTR--MKIALGSARGLAYLHEDCQPKIIHRDIKSAN 340
+Y F+ ++ ++ KDRP++ TR MK L + + Y+H+ K+IHRDIK N
Sbjct: 249 LYSFMYDEAFDW----KDRPLL-KQTRAIMKQLLCA---VEYIHDK---KLIHRDIKLEN 297
Query: 341 ILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVL 400
I L+ + + DFG A +GT +PE + E +D++S G++
Sbjct: 298 IFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLI 357
Query: 401 LLELIT 406
LL++++
Sbjct: 358 LLDMLS 363
|
Length = 501 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 7e-05
Identities = 49/186 (26%), Positives = 85/186 (45%), Gaps = 34/186 (18%)
Query: 236 VAIKQLK---AGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL 292
VAIK+L +R ++ E+ ++ V+H++++SL+ F P K+L
Sbjct: 45 VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNV------------FTPQKSL 91
Query: 293 E-FHLHGKDRPVM--NWPTRMKIALGSAR----------GLAYLHEDCQPKIIHRDIKSA 339
E F +M N +++ L R G+ +LH IIHRD+K +
Sbjct: 92 EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPS 148
Query: 340 NILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGV 399
NI++ K+ DFGLA+ + + + T + T Y APE E D++S G
Sbjct: 149 NIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 206
Query: 400 LLLELI 405
++ E++
Sbjct: 207 IMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 39/140 (27%), Positives = 55/140 (39%), Gaps = 45/140 (32%)
Query: 332 IHRDIKSANILLDDSFEAKVADFGLA-------------------KHSLDTDTHVS---- 368
IHRDIK NIL+D K+ DFGL + S++ S
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 369 --------------TRVM-----GTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFR 409
R + GT Y+APE T+ D +S GV+L E++ G
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242
Query: 410 PFDKADTFADDSM--VDWAK 427
PF ADT A+ + ++W
Sbjct: 243 PF-LADTPAETQLKVINWET 261
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 20/52 (38%), Positives = 32/52 (61%), Gaps = 3/52 (5%)
Query: 317 ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 368
A L YLH + IIHRD+K N+L+ + K+ DFGL+K +L+ + ++
Sbjct: 114 ALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMM 162
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|235899 PRK06975, PRK06975, bifunctional uroporphyrinogen-III synthetase/uroporphyrin-III C-methyltransferase; Reviewed | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 9e-04
Identities = 21/104 (20%), Positives = 29/104 (27%), Gaps = 20/104 (19%)
Query: 5 PPLTSLPAPPETNSTFSPPAPPPSVSAVSAPAPGNLTSPPSSGTPTSGSTVGTRRPSPTR 64
P T+ PAP S S S PA P P + RR
Sbjct: 271 QPATAAPAPS------RMTDTNDSKSVTSQPAAAAAAPAPPPNPPATPPEPPARRGR--- 321
Query: 65 NGYLPPGALAGMVVGVVIGAGIVLAAVGIFLIFYKRRKRKLAAQ 108
+ V+ AAVG + R+ +L +
Sbjct: 322 ---------GSAALWFVVVVLACAAAVGGY--ALNRKVDRLDQE 354
|
Length = 656 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 36/190 (18%), Positives = 47/190 (24%), Gaps = 26/190 (13%)
Query: 5 PPLTSLPAPPETNSTFSPPAPPPSVSAVSAPAPGNLTSPPSSGTPTSGSTVGTRRPSPTR 64
PP T PAP S P P + S P P P + PT
Sbjct: 2704 PPPTPEPAPHALVSATPLPPGPAAARQASPALPAAPAPPAVPAGPATPGGPARPARPPTT 2763
Query: 65 NGYLPPGALAGMVVGVVIGAGIVLAAVGIFLIFYKRRKRKLAAQNLPLKSIFSNVKNDPF 124
G P A G + S+ + ++ P
Sbjct: 2764 AGPPAPAPPAAPAAGP-----------------------PRRLTRPAVASLSESRESLPS 2800
Query: 125 AGKPHHWQQNVSAPSDYQELPKPSLPPSNGPTAPLPTVPVSA---FNEPLSTSGSLDSDK 181
P V AP+ P PT+ PT P L GS+
Sbjct: 2801 PWDPADPPAAVLAPAAALPPAASPAGPLPPPTSAQPTAPPPPPGPPPPSLPLGGSVAPGG 2860
Query: 182 PFPRQSPGMP 191
R+ P
Sbjct: 2861 DVRRRPPSRS 2870
|
Length = 3151 |
| >gnl|CDD|149674 pfam08693, SKG6, Transmembrane alpha-helix domain | Back alignment and domain information |
|---|
Score = 36.2 bits (84), Expect = 0.002
Identities = 12/30 (40%), Positives = 18/30 (60%)
Query: 74 AGMVVGVVIGAGIVLAAVGIFLIFYKRRKR 103
+ VGVVI G++ A + FL + RRK+
Sbjct: 11 VAIAVGVVIPVGVIAAVLLAFLFLWYRRKK 40
|
SKG6/Axl2 are membrane proteins that show polarised intracellular localisation. SKG6_Tmem is the highly conserved transmembrane alpha-helical domain of SKG6 and Axl2 proteins. The full-length fungal protein has a negative regulatory function in cytokinesis. Length = 40 |
| >gnl|CDD|213052 cd12087, TM_EGFR-like, Transmembrane domain of the Epidermal Growth Factor Receptor family of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 35.6 bits (83), Expect = 0.002
Identities = 7/35 (20%), Positives = 17/35 (48%)
Query: 70 PGALAGMVVGVVIGAGIVLAAVGIFLIFYKRRKRK 104
+ + V+G +VL +G+ + ++RR+
Sbjct: 1 RTSKTTSIAAGVVGGLLVLVILGLIVFLFRRRRHI 35
|
PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. They are receptor PTKs (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane (TM) helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. They are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. The TM domain not only serves as a membrane anchor, but also plays an important role in receptor dimerization and optimal activation. Mutations in the TM domain of EGFR family RTKs have been associated with increased breast cancer risk. Length = 38 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 25/90 (27%), Positives = 41/90 (45%), Gaps = 9/90 (10%)
Query: 320 LAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRV------MG 373
L Y+HE I H DIK NI++D + + D+G+A H + H+ G
Sbjct: 139 LEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRG 195
Query: 374 TFGYLAPEYASSGKLTEKSDVFSFGVLLLE 403
T Y + + +T + D+ S G +L+
Sbjct: 196 TLYYAGLDAHNGACVTRRGDLESLGYCMLK 225
|
Length = 294 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.004
Identities = 37/190 (19%), Positives = 49/190 (25%), Gaps = 16/190 (8%)
Query: 5 PPLTSLPAPPETNSTFSPPAPPPSVSAVSAPAPG-NLTSPPSSGTPTSGSTVGTRRPSPT 63
S SP P +AV APA + P+ P S T P P
Sbjct: 2784 TRPAVASLSESRESLPSPWDPADPPAAVLAPAAALPPAASPAGPLPPPTSAQPTA-PPPP 2842
Query: 64 RNGYLPPGALAGMVV--GVVIGAGIVLAAVGIFLIFYKRRKRKLAAQNLPLKSIFSNVKN 121
P L G V G V + + R+LA + +
Sbjct: 2843 PGPPPPSLPLGGSVAPGGDVRRRPPSRSPAAKPAAPARPPVRRLARPAVSRST------- 2895
Query: 122 DPFAGKPHHWQQNVSAPSDYQELPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDK 181
+ FA P + + P P P P P P P P
Sbjct: 2896 ESFALPP-----DQPERPPQPQAPPPPQPQPQPPPPPQPQPPPPPPPRPQPPLAPTTDPA 2950
Query: 182 PFPRQSPGMP 191
S +P
Sbjct: 2951 GAGEPSGAVP 2960
|
Length = 3151 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.004
Identities = 33/126 (26%), Positives = 47/126 (37%), Gaps = 46/126 (36%)
Query: 332 IHRDIKSANILLDDSFEAKVADFGLA-------------------KHSLDTDTH------ 366
IHRDIK NIL+D K+ DFGL + S+D
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 367 ---------------------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELI 405
++ ++GT Y+APE T+ D +S GV+L E++
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 406 TGFRPF 411
G PF
Sbjct: 243 VGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 586 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.98 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.98 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.85 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.82 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.82 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.81 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.8 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.78 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.78 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.77 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.76 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.75 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.73 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.72 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.7 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.69 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.68 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.63 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.59 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.54 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.47 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.41 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.4 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.4 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.33 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.3 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.28 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.22 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.17 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.1 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.1 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.04 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.02 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.94 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.84 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.75 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.75 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.71 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.64 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.59 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.53 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.45 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.44 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.4 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.39 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.34 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.26 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.23 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.15 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.14 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.06 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.05 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.02 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.0 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.95 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.93 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.92 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.83 | |
| PF01102 | 122 | Glycophorin_A: Glycophorin A; InterPro: IPR001195 | 97.77 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.69 | |
| PF04478 | 154 | Mid2: Mid2 like cell wall stress sensor; InterPro: | 97.67 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.64 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.6 | |
| PF08693 | 40 | SKG6: Transmembrane alpha-helix domain; InterPro: | 97.48 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.44 | |
| PTZ00382 | 96 | Variant-specific surface protein (VSP); Provisiona | 97.36 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.35 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.34 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.19 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.14 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.01 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.0 | |
| PLN02236 | 344 | choline kinase | 96.98 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.96 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.92 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.83 | |
| PF02439 | 38 | Adeno_E3_CR2: Adenovirus E3 region protein CR2; In | 96.79 | |
| PF05808 | 162 | Podoplanin: Podoplanin; InterPro: IPR008783 This f | 96.68 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.62 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.53 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.52 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.48 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.4 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.39 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.37 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-60 Score=499.79 Aligned_cols=288 Identities=59% Similarity=1.012 Sum_probs=256.3
Q ss_pred ccccCHHHHHHHhcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 007892 196 KSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCT 275 (586)
Q Consensus 196 ~~~~~~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~ 275 (586)
...|++.|++.+|++|+..+.||+|+||.||+|.+.+|..||||++.....+..++|.+|+++|.+++|||||+|+|||.
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~ 141 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCL 141 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence 34799999999999999999999999999999999999999999987765442556999999999999999999999999
Q ss_pred eCC-eeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeec
Q 007892 276 FGS-QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADF 354 (586)
Q Consensus 276 ~~~-~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DF 354 (586)
+.+ +++||||||+||+|+++|+......++|.+|++||.++|+||+|||+.+.+.|||||||++|||||+++++||+||
T Consensus 142 e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDF 221 (361)
T KOG1187|consen 142 EGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDF 221 (361)
T ss_pred cCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCc
Confidence 988 5999999999999999999866547899999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcc
Q 007892 355 GLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGL 434 (586)
Q Consensus 355 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 434 (586)
|||+.......+..+...||++|+||||+..+.++.|+|||||||+|+||+||+.+.+.........+++|+.+.+.
T Consensus 222 GLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~--- 298 (361)
T KOG1187|consen 222 GLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE--- 298 (361)
T ss_pred cCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH---
Confidence 99976543122222222799999999999999999999999999999999999999987765566779999977664
Q ss_pred cCCChhhhhchhhh--ccCH-HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 435 ADGNFDALVDQKLE--EYDS-AEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 435 ~~~~~~~l~d~~l~--~~~~-~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
++.+.+++|+.+. .+.. .++.++..++.+|++.++.+||+|.||++.|+...
T Consensus 299 -~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 299 -EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred -CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 4588999999985 5554 68899999999999999999999999999997553
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-49 Score=409.05 Aligned_cols=256 Identities=34% Similarity=0.541 Sum_probs=212.1
Q ss_pred CccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchh--HHHHHHHHHHHHhcCCCCcceEEEEEEeCC-eeEEEEEe
Q 007892 210 NFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQG--EREFQAEIEIISQVHHRHLVSLVGYCTFGS-QRLLVYEF 286 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~--~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~-~~~lV~E~ 286 (586)
.+...+.||+|+||+||+|.+.+...||||++....... .++|.+|+.+|.+++|||||+++|+|.... ..+|||||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 344456699999999999999755559999997654333 459999999999999999999999999877 78999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCc-EEecCCCCceeEeCCCC-CeEEeecccccccCCCC
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK-IIHRDIKSANILLDDSF-EAKVADFGLAKHSLDTD 364 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~-ivHrDIk~~NILl~~~~-~~kl~DFGla~~~~~~~ 364 (586)
|++|+|..+|+......+++..+++||.|||+||.|||++ + |||||||+.||||+.++ .+||+|||+++......
T Consensus 122 ~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 122 MPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 9999999999886556799999999999999999999998 6 99999999999999997 99999999998754332
Q ss_pred CcccccccccccccCccccc--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhh
Q 007892 365 THVSTRVMGTFGYLAPEYAS--SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 442 (586)
Q Consensus 365 ~~~~~~~~gt~~y~aPE~~~--~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 442 (586)
...+...||+.|||||++. ...|+.|+|||||||+||||+||+.||....... .... ..
T Consensus 199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~---~~~~---v~------------ 259 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ---VASA---VV------------ 259 (362)
T ss_pred -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH---HHHH---HH------------
Confidence 2233367999999999999 6699999999999999999999999998765311 1110 00
Q ss_pred hchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 443 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 443 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
........+..+...+..++.+||..||.+||++.+|+..|+..+
T Consensus 260 ~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~ 304 (362)
T KOG0192|consen 260 VGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIM 304 (362)
T ss_pred hcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence 011111334447778999999999999999999999999999654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=389.58 Aligned_cols=252 Identities=28% Similarity=0.436 Sum_probs=213.3
Q ss_pred CccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC-eeEEEEEe
Q 007892 210 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS-QRLLVYEF 286 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~-~~~lV~E~ 286 (586)
+++..+.||+|..|+|||+.++ +++.+|+|.+..+. ....+++.+|++++.+.+||+||.++|.|...+ ...|+|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 4555689999999999999976 68999999995543 344578999999999999999999999999988 59999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 366 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 366 (586)
|++|+|+..+... ..+++....+|+.++++||.|||+. .+||||||||+||||+..|+|||||||.++.+.+.
T Consensus 160 MDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred cCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 9999999999654 4489999999999999999999973 29999999999999999999999999999987554
Q ss_pred ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchh
Q 007892 367 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 446 (586)
Q Consensus 367 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 446 (586)
.....+||..|||||.+.++.|+.++||||||++|+|+.+|+.||-... .....|+.- +..+++..
T Consensus 233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~----~~~~~~~~L----------l~~Iv~~p 298 (364)
T KOG0581|consen 233 IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN----PPYLDIFEL----------LCAIVDEP 298 (364)
T ss_pred hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC----CCCCCHHHH----------HHHHhcCC
Confidence 5567889999999999999999999999999999999999999997652 112233321 23444433
Q ss_pred hhccCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 447 LEEYDSA-EMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 447 l~~~~~~-~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
....+.. ...++..++..||++||.+||++.|++++
T Consensus 299 pP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 299 PPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 3344443 67889999999999999999999999863
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-48 Score=402.21 Aligned_cols=255 Identities=31% Similarity=0.480 Sum_probs=218.7
Q ss_pred cCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecC
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVP 288 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 288 (586)
+.+...+.||+|.||.||.|.++....||||.++... ...++|.+|+++|.+|+|+|||+|+|+|..++.++||||||+
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~ 284 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP 284 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence 3344568999999999999999877799999998763 446789999999999999999999999999889999999999
Q ss_pred CCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCccc
Q 007892 289 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 368 (586)
Q Consensus 289 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 368 (586)
.|+|.++|...++..+...+.+.++.|||+|++||+++ ++|||||.++||||+++..+||+|||||+...+......
T Consensus 285 ~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~ 361 (468)
T KOG0197|consen 285 KGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTAS 361 (468)
T ss_pred cCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeec
Confidence 99999999887777899999999999999999999999 999999999999999999999999999996655555455
Q ss_pred ccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhh
Q 007892 369 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 447 (586)
Q Consensus 369 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 447 (586)
....-...|.|||.+..++++.|||||||||+||||+| |+.||......+ +.+.++.|- ++
T Consensus 362 ~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e-----------v~~~le~Gy-------Rl 423 (468)
T KOG0197|consen 362 EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE-----------VLELLERGY-------RL 423 (468)
T ss_pred CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH-----------HHHHHhccC-------cC
Confidence 54555678999999999999999999999999999999 999987654311 111111221 11
Q ss_pred hccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 448 EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 448 ~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
..+..++..+.+++..||+.+|++|||+..+...|+..
T Consensus 424 -p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 424 -PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred -CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence 35666888999999999999999999999999998854
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-46 Score=386.22 Aligned_cols=267 Identities=27% Similarity=0.444 Sum_probs=223.0
Q ss_pred HHHhcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchh-HHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEE
Q 007892 205 KIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQG-EREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 205 ~~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~-~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV 283 (586)
+.+.+...+.++||+|-||.|.++...++..||||+++...... .++|.+||.+|.+|+|||||+|+|+|..++.+++|
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 44556778889999999999999999888999999998875544 48999999999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCC
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 363 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 363 (586)
+|||++|+|.++|..+..+.+.-...++|+.||+.|++||.+. ++|||||.++|||+|.++++||+|||+++.+...
T Consensus 614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccC
Confidence 9999999999999887666666777889999999999999987 9999999999999999999999999999976655
Q ss_pred CCc-ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh--CCCCCCCCCcccchhhhhhhhHHHhhcccCCChh
Q 007892 364 DTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT--GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 440 (586)
Q Consensus 364 ~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt--G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (586)
+.+ ...+.+-...|||+|.+.-++++.++|||+|||+|||+++ ...||.... ++..++-+..++. .+..
T Consensus 691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt---~e~vven~~~~~~----~~~~- 762 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT---DEQVVENAGEFFR----DQGR- 762 (807)
T ss_pred CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh---HHHHHHhhhhhcC----CCCc-
Confidence 543 4456677889999999999999999999999999999865 788987543 2333333322221 1111
Q ss_pred hhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 441 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 441 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
.. ....+.-++..+.+++..||+.|-.+||++++|...|+..
T Consensus 763 ~~----~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 763 QV----VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ce----eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 10 1134455677889999999999999999999999999864
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-47 Score=380.79 Aligned_cols=200 Identities=30% Similarity=0.440 Sum_probs=180.6
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
++|...+.||+|.|++||+|+++ ++..||||.+... .....+.+..|+.||+.++|||||+|+++++.++..|||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 57888889999999999999975 5799999999766 34445667899999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCC------CCeEEeecccccc
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS------FEAKVADFGLAKH 359 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~------~~~kl~DFGla~~ 359 (586)
||+||+|.++|+..+ .+++.+...++.|+|.||++||++ +||||||||.||||+.. -.+||+|||+|+.
T Consensus 90 yC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred eCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 999999999998765 499999999999999999999999 99999999999999764 4689999999998
Q ss_pred cCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 007892 360 SLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKAD 415 (586)
Q Consensus 360 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~ 415 (586)
+.+ .....+.||++-|||||+++.++|+.|+|+||+|+|||++++|+.||+...
T Consensus 165 L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 165 LQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred CCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 753 345567899999999999999999999999999999999999999998544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-46 Score=390.15 Aligned_cols=247 Identities=23% Similarity=0.387 Sum_probs=211.2
Q ss_pred cCccccceecccCcEEEEEEEE-eCCeEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~---~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
..|...+.||+|||..||.++. ..|+.||+|++.+. .....+.+.+||+|.+.|+|||||+++++|++.+..|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4688899999999999999997 78999999999653 2233567889999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
|+|.+++|..+++ .++.+++.+...+..||+.||.|||++ +|||||||..|+||+++.+|||+|||||..+...
T Consensus 98 ELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~- 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD- 171 (592)
T ss_pred EecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCc-
Confidence 9999999999886 566799999999999999999999999 9999999999999999999999999999876533
Q ss_pred CcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhc
Q 007892 365 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 444 (586)
Q Consensus 365 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 444 (586)
.....+.|||+.|+|||++.....+..+||||+|||||-||+|++||+...-. +- +..+..
T Consensus 172 ~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk------et-------------y~~Ik~ 232 (592)
T KOG0575|consen 172 GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK------ET-------------YNKIKL 232 (592)
T ss_pred ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH------HH-------------HHHHHh
Confidence 23446689999999999999999999999999999999999999999865421 10 111110
Q ss_pred hhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 445 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 445 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
.. ..++........+|+..+|+.+|.+||++.+|++
T Consensus 233 ~~-Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 233 NE-YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred cC-cccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 0234455667889999999999999999999996
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=408.74 Aligned_cols=260 Identities=26% Similarity=0.483 Sum_probs=222.5
Q ss_pred HHHhcCccccceecccCcEEEEEEEEe------CCeEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 007892 205 KIATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFG 277 (586)
Q Consensus 205 ~~~~~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~~~~-~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~ 277 (586)
++.+.+.+..+.||+|.||+||+|... +...||||.++..... ...+|++|+++|..++|||||+|+|+|.++
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 344556677799999999999999953 3468999999987665 678999999999999999999999999999
Q ss_pred CeeEEEEEecCCCcHHHHhcCCC------------CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCC
Q 007892 278 SQRLLVYEFVPNKTLEFHLHGKD------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD 345 (586)
Q Consensus 278 ~~~~lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 345 (586)
+..+||+|||..|+|.++|.... ...|+..+.+.||.|||.|++||-++ .+|||||..+|+||.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceecc
Confidence 99999999999999999996421 22388899999999999999999998 8999999999999999
Q ss_pred CCCeEEeecccccccCCCCCcccc-cccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhh
Q 007892 346 SFEAKVADFGLAKHSLDTDTHVST-RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMV 423 (586)
Q Consensus 346 ~~~~kl~DFGla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~ 423 (586)
+..|||+||||++.....+.+... +-+-...||+||.+..++++.+||||||||+|||+++ |+.||..... +..+
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn---~EVI 715 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN---QEVI 715 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch---HHHH
Confidence 999999999999987776655433 4556789999999999999999999999999999999 9999976543 1122
Q ss_pred hhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 424 DWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 424 ~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
+ .+-+..+-..+.+++.++.+|+..||+.+|.+||+++||-..|+..
T Consensus 716 e----------------~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~ 762 (774)
T KOG1026|consen 716 E----------------CIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW 762 (774)
T ss_pred H----------------HHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence 2 2223333367788899999999999999999999999999999864
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-46 Score=370.82 Aligned_cols=243 Identities=28% Similarity=0.404 Sum_probs=204.6
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV 283 (586)
.++|++.++||+|+||+||.++.. +++.+|+|++++.. ....+..++|..||.+++||.||+|+..|.+.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 368999999999999999999965 58999999997653 23346778999999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCC
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 363 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 363 (586)
+||+.||.|..||+.+.. +.+....-++.+|+.||.|||+. +||||||||+|||||.+|+++|+|||||+.....
T Consensus 104 ld~~~GGeLf~hL~~eg~--F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGR--FSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred EeccCCccHHHHHHhcCC--cchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 999999999999976554 88888888999999999999999 9999999999999999999999999999975544
Q ss_pred CCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhh
Q 007892 364 DTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 443 (586)
Q Consensus 364 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 443 (586)
.. ...+.|||+.|||||++.+..|+..+|+|||||+||||++|.+||...+. ..|.+.. .
T Consensus 179 ~~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~------~~~~~~I-------------~ 238 (357)
T KOG0598|consen 179 GD-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV------KKMYDKI-------------L 238 (357)
T ss_pred CC-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH------HHHHHHH-------------h
Confidence 33 33458999999999999999999999999999999999999999976553 2222222 2
Q ss_pred chhhhccCHHHHHHHHHHHHHhhccCCCCCCC
Q 007892 444 DQKLEEYDSAEMTRMAACAAACIRHSARRRPR 475 (586)
Q Consensus 444 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPt 475 (586)
..++...+.-...+..+++...+..||++|..
T Consensus 239 ~~k~~~~p~~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 239 KGKLPLPPGYLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred cCcCCCCCccCCHHHHHHHHHHhccCHHHhcC
Confidence 22222223334467889999999999999964
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-47 Score=363.98 Aligned_cols=258 Identities=26% Similarity=0.425 Sum_probs=213.0
Q ss_pred cCccccceecccCcEEEEEEE-EeCCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEE-EEEeCCe-eEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVG-YCTFGSQ-RLLV 283 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~-~~~g~~vAVK~l~~~--~~~~~~~~~~Ei~il~~l~Hpniv~l~g-~~~~~~~-~~lV 283 (586)
.+|++.++||+|.||+|||++ +.+|..||.|.++-+ +....+++..|+.+|++|+|||||+.++ -+.++.+ ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 346677899999999999999 568999999998754 3344568899999999999999999998 4455555 7899
Q ss_pred EEecCCCcHHHHhcC--CCCCCCChHHHHHHHHHHHHHhHhhhhcCCCc--EEecCCCCceeEeCCCCCeEEeecccccc
Q 007892 284 YEFVPNKTLEFHLHG--KDRPVMNWPTRMKIALGSARGLAYLHEDCQPK--IIHRDIKSANILLDDSFEAKVADFGLAKH 359 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~--~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~--ivHrDIk~~NILl~~~~~~kl~DFGla~~ 359 (586)
||||..|+|...++. +.++.+++.++++++.|++.||.+||... ++ |+||||||.||+|+.+|.|||+||||++.
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 999999999988853 45567999999999999999999999942 34 89999999999999999999999999998
Q ss_pred cCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCCh
Q 007892 360 SLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 439 (586)
Q Consensus 360 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (586)
+... .......+|||.||+||.+....|+.|+||||+||+||||+.-+.||.+.+- .. +.++++++++
T Consensus 178 l~s~-~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~------~~-----L~~KI~qgd~ 245 (375)
T KOG0591|consen 178 LSSK-TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL------LS-----LCKKIEQGDY 245 (375)
T ss_pred hcch-hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH------HH-----HHHHHHcCCC
Confidence 6443 3345568999999999999999999999999999999999999999986532 22 3344556654
Q ss_pred hhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 440 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 440 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
..+.+ ......+.+++..|+..|++.||+...++..+...
T Consensus 246 ~~~p~-------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~ 285 (375)
T KOG0591|consen 246 PPLPD-------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSE 285 (375)
T ss_pred CCCcH-------HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHH
Confidence 43322 34556789999999999999999977777766653
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-46 Score=373.08 Aligned_cols=254 Identities=27% Similarity=0.387 Sum_probs=206.1
Q ss_pred HhcCccccceecccCcEEEEEEEE-eCCeEEEEEEeccCCch-------hHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQ-------GEREFQAEIEIISQVHHRHLVSLVGYCTFGS 278 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~-------~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~ 278 (586)
..+.|.+.+.||.|+||.|-+|.. ++|+.||||++.+.... .....++|++||++|+|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 346688889999999999999995 47999999999654211 2335679999999999999999999999999
Q ss_pred eeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCC---CCeEEeecc
Q 007892 279 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS---FEAKVADFG 355 (586)
Q Consensus 279 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~---~~~kl~DFG 355 (586)
..|||||||.||.|.+.+-.+. .+.+..-..++.|++.||.|||++ ||+||||||+||||..+ ..+||+|||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccc
Confidence 9999999999999999996654 477777788999999999999999 99999999999999766 789999999
Q ss_pred cccccCCCCCcccccccccccccCcccccCCC---CCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhh
Q 007892 356 LAKHSLDTDTHVSTRVMGTFGYLAPEYASSGK---LTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQ 432 (586)
Q Consensus 356 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 432 (586)
||+... ......+.|||+.|.|||++.++. +..|.|+||+||+||-+++|.+||..... +.++.+
T Consensus 325 lAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~--~~sl~e-------- 392 (475)
T KOG0615|consen 325 LAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT--DPSLKE-------- 392 (475)
T ss_pred hhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC--CccHHH--------
Confidence 999864 344567789999999999997654 34588999999999999999999986543 122222
Q ss_pred cccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 433 GLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 433 ~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.+..|.+... + .......++..+++.+||..||++||++.|+++.
T Consensus 393 QI~~G~y~f~--p---~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 393 QILKGRYAFG--P---LQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred HHhcCccccc--C---hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 2222322111 0 1223455778999999999999999999999864
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=367.50 Aligned_cols=260 Identities=28% Similarity=0.451 Sum_probs=205.6
Q ss_pred HHhcCccccceecccCcEEEEEEEEe------CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhc-CCCCcceEEEEEEeC
Q 007892 206 IATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSG-QGEREFQAEIEIISQV-HHRHLVSLVGYCTFG 277 (586)
Q Consensus 206 ~~~~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~ 277 (586)
+..++|++.+.||+|+||.||+|.+. +++.||||+++.... .....+.+|+.+|.++ +||||++++++|...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 44578999999999999999999742 356899999975433 2345789999999999 899999999998764
Q ss_pred C-eeEEEEEecCCCcHHHHhcCCC--------------------------------------------------------
Q 007892 278 S-QRLLVYEFVPNKTLEFHLHGKD-------------------------------------------------------- 300 (586)
Q Consensus 278 ~-~~~lV~E~~~~gsL~~~l~~~~-------------------------------------------------------- 300 (586)
+ ..++||||+++|+|.+++....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4 5789999999999999886432
Q ss_pred ----CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc-ccccccccc
Q 007892 301 ----RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH-VSTRVMGTF 375 (586)
Q Consensus 301 ----~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~ 375 (586)
...+.+.+++.++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++........ ......++.
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 12478889999999999999999998 9999999999999999999999999999865332221 122344678
Q ss_pred cccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhccCHHH
Q 007892 376 GYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAE 454 (586)
Q Consensus 376 ~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~ 454 (586)
.|+|||++.+..++.++|||||||+||||++ |..||...... ..+. ..+..+.. ...+...
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~--~~~~--------~~~~~~~~--------~~~~~~~ 302 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN--EEFC--------QRLKDGTR--------MRAPENA 302 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc--HHHH--------HHHhcCCC--------CCCCCCC
Confidence 8999999998999999999999999999997 99999764321 1111 11111111 0112233
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 455 MTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 455 ~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
...+.+++.+||+.||.+||++.||++.|+..
T Consensus 303 ~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 303 TPEIYRIMLACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 45688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=363.53 Aligned_cols=265 Identities=27% Similarity=0.503 Sum_probs=214.0
Q ss_pred HHHHHHhcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 007892 202 EELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ 279 (586)
Q Consensus 202 ~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~ 279 (586)
+++++..+.+.+...||+|.||+||+|.|.+ .||||+++.... ...+.|+.|+..|++-+|-||+-+.|||.....
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 5566666777788999999999999999864 589999976543 345789999999999999999999999998776
Q ss_pred eEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccc
Q 007892 280 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 359 (586)
Q Consensus 280 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~ 359 (586)
.||.-||+|.+|..|||... ..++..+.+.||.||++|+.|||.+ +|||||||..||||++++.|||+||||+..
T Consensus 463 -AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred -eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceee
Confidence 89999999999999999765 4589999999999999999999999 999999999999999999999999999863
Q ss_pred cCC-CCCcccccccccccccCcccccC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhccc
Q 007892 360 SLD-TDTHVSTRVMGTFGYLAPEYASS---GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLA 435 (586)
Q Consensus 360 ~~~-~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 435 (586)
-.. ........-.|...|||||+++. .+|++.+||||||||+|||+||..||..... +.++ |. +-
T Consensus 538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~---dqIi-fm-------VG 606 (678)
T KOG0193|consen 538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR---DQII-FM-------VG 606 (678)
T ss_pred eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh---hheE-EE-------ec
Confidence 211 11112223457889999999864 5799999999999999999999999983221 1111 11 11
Q ss_pred CCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 007892 436 DGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMP 488 (586)
Q Consensus 436 ~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~~ 488 (586)
.| ..-+++.....++...|.+|+..||..++++||.+.+|+..|+....
T Consensus 607 rG----~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 607 RG----YLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred cc----ccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 11 11122223445677889999999999999999999999998887654
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=364.12 Aligned_cols=268 Identities=24% Similarity=0.327 Sum_probs=218.6
Q ss_pred HHhcCccccceecccCcEEEEEEEE-eCCeEEEEEEeccC---CchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCee
Q 007892 206 IATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAG---SGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQR 280 (586)
Q Consensus 206 ~~~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~---~~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~~~ 280 (586)
..-++|.+++.||+|.|++|++|+. ..++.||||++.+. .......+..|-++|.+| .||.|++|+..|.++..+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 3447899999999999999999995 46899999998653 222234567899999999 799999999999999999
Q ss_pred EEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccccc
Q 007892 281 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 360 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~ 360 (586)
|+|+||++||+|.++|+..+. +++.....++.+|+.||+|||++ |||||||||+|||||+|+++||+|||-|+.+
T Consensus 150 YFvLe~A~nGdll~~i~K~Gs--fde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYGS--FDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEEEecCCCcHHHHHHHhCc--chHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccC
Confidence 999999999999999987654 88888999999999999999998 9999999999999999999999999999976
Q ss_pred CCCCCc----------cc--ccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhH
Q 007892 361 LDTDTH----------VS--TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKP 428 (586)
Q Consensus 361 ~~~~~~----------~~--~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~ 428 (586)
.+.... .. ..++||..|.+||+|.++..+..+|+|+||||||+|+.|.+||...++..
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl---------- 294 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL---------- 294 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH----------
Confidence 443211 11 44899999999999999999999999999999999999999998776411
Q ss_pred HHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh-cCCCCCCCCCCCCC
Q 007892 429 FLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE-GNMPLDDLNEGITP 498 (586)
Q Consensus 429 ~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~-~~~~~~~~~~~~~~ 498 (586)
.+..+++-.. .++...++...+|+.+.|..||.+|++..||-++.- ..+..+++++...|
T Consensus 295 ---------iFqkI~~l~y-~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw~~~PP 355 (604)
T KOG0592|consen 295 ---------IFQKIQALDY-EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENLWQQTPP 355 (604)
T ss_pred ---------HHHHHHHhcc-cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhhhhcCCC
Confidence 1222222111 455666678999999999999999999999987532 12233445554444
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=356.70 Aligned_cols=255 Identities=27% Similarity=0.431 Sum_probs=206.6
Q ss_pred cCccccceecccCcEEEEEEEEeC-CeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC--eeEEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS--QRLLVYE 285 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~~~lV~E 285 (586)
.++...+.||+|.||.||++...+ |..+|||.+...+....+.+.+|+.+|.+++|||||+.+|...... .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 456677999999999999999754 8999999987664444667899999999999999999999855544 5889999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCC-CCCeEEeecccccccCC--
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD-SFEAKVADFGLAKHSLD-- 362 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~-~~~~kl~DFGla~~~~~-- 362 (586)
|+++|+|.+++...+. .+++..+.++..||++||+|||++ +|||||||++||||+. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred ccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999987766 699999999999999999999998 9999999999999999 79999999999987653
Q ss_pred CCCcccccccccccccCcccccCCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhh
Q 007892 363 TDTHVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 441 (586)
Q Consensus 363 ~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (586)
..........||+.|||||++..+. ...++|||||||+++||+||..||.... ....|.-...
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~-----~~~~~~~~ig----------- 236 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF-----EEAEALLLIG----------- 236 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc-----chHHHHHHHh-----------
Confidence 1112234578999999999999643 3459999999999999999999997631 1111111111
Q ss_pred hhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 007892 442 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484 (586)
Q Consensus 442 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~ 484 (586)
.......++........+++..|+..+|.+|||+.++++..-
T Consensus 237 -~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 237 -REDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred -ccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 111111344445677889999999999999999999998654
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-44 Score=362.69 Aligned_cols=270 Identities=23% Similarity=0.308 Sum_probs=214.9
Q ss_pred HHhcCccccceecccCcEEEEEEE-EeCCeEEEEEEeccCCchhH-HHHHHHHHHHHhcC-CCCcceEEEEEEeCC-eeE
Q 007892 206 IATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGE-REFQAEIEIISQVH-HRHLVSLVGYCTFGS-QRL 281 (586)
Q Consensus 206 ~~~~~f~~~~~LG~G~fG~Vyk~~-~~~g~~vAVK~l~~~~~~~~-~~~~~Ei~il~~l~-Hpniv~l~g~~~~~~-~~~ 281 (586)
...++|...++||.|.||.||+|+ ...|..||||+++..-...+ ..-++|+..|++|+ |||||+|.+++.+.+ .++
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 345788889999999999999999 45789999999987644433 34468999999999 999999999999887 899
Q ss_pred EEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccC
Q 007892 282 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 361 (586)
Q Consensus 282 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~ 361 (586)
+|||||+ .+|.+++... +..+++..+..|+.||++||+|+|.+ |+.|||+||+|||+..+..+||+|||||+...
T Consensus 87 fVfE~Md-~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 87 FVFEFMD-CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eeHHhhh-hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccc
Confidence 9999995 5888888776 67799999999999999999999999 99999999999999988899999999999864
Q ss_pred CCCCcccccccccccccCcccc-cCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchh----------hhhhhhHHH
Q 007892 362 DTDTHVSTRVMGTFGYLAPEYA-SSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDS----------MVDWAKPFL 430 (586)
Q Consensus 362 ~~~~~~~~~~~gt~~y~aPE~~-~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~----------~~~~~~~~~ 430 (586)
... -.+.++.|.+|.|||++ +.+.|+.+.|||++|||++||.+-++-|-+.++.+... ..+|..-.-
T Consensus 162 Skp--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 162 SKP--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred cCC--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 433 34678899999999987 56889999999999999999999999888776543221 122322111
Q ss_pred hhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 431 AQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 431 ~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
....-+-.+.....-.+...-.....+.++++.+|+++||.+|||+.|.+++
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 0000011122222222333334467789999999999999999999999875
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=366.14 Aligned_cols=250 Identities=23% Similarity=0.387 Sum_probs=213.3
Q ss_pred cCccccceecccCcEEEEEEE-EeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEec
Q 007892 209 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 287 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~-~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 287 (586)
..|....+||+|.-|.||.+. ..+++.||||++.......++-+.+|+.+|+..+|+|||+++.-|..++++|+|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 457788899999999999998 4468899999998877676778899999999999999999999999999999999999
Q ss_pred CCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcc
Q 007892 288 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 367 (586)
Q Consensus 288 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 367 (586)
++|+|.+.+.. ..|++.++..|+.++++||+|||.+ +|+|||||..||||+.++.+||+|||+|..+..... .
T Consensus 353 ~ggsLTDvVt~---~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-K 425 (550)
T KOG0578|consen 353 EGGSLTDVVTK---TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-K 425 (550)
T ss_pred CCCchhhhhhc---ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC-c
Confidence 99999988854 3499999999999999999999999 999999999999999999999999999987655443 4
Q ss_pred cccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhh
Q 007892 368 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 447 (586)
Q Consensus 368 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 447 (586)
....+||+.|||||++....|+.|.||||||+|++||+-|.+||-..++....-++ ..+|. +.+
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI----------a~ng~------P~l 489 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI----------ATNGT------PKL 489 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHH----------hhcCC------CCc
Confidence 56689999999999999999999999999999999999999999765542211100 01111 111
Q ss_pred hccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 448 EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 448 ~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.........+.+++.+||+.|+.+|+++.|+|++
T Consensus 490 -k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 490 -KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred -CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 2344556789999999999999999999999973
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=349.13 Aligned_cols=261 Identities=24% Similarity=0.364 Sum_probs=212.2
Q ss_pred HhcCccccceecccCcEEEEEEEE-eCCeEEEEEEeccCCchh-HHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQG-EREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~-~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
..+.|++.++||.|.-++||+|+. ..+..||||++.-...+. ...+++|+..|+.++||||++.+..|..+..+|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 346789999999999999999994 467999999997654433 478999999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
.||.+|++.+.+...-...+++..+..|..++++||.|||.+ |.||||||+.||||+.+|.|||+|||....+.+..
T Consensus 104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 999999999999877667799999999999999999999999 99999999999999999999999999987665544
Q ss_pred Cccc---ccccccccccCcccccC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCCh
Q 007892 365 THVS---TRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 439 (586)
Q Consensus 365 ~~~~---~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (586)
.... ...+||++|||||+++. ..|+.|+||||||++.+||.+|+.||....+.. .+...+.+..
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk----------vLl~tLqn~p- 249 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK----------VLLLTLQNDP- 249 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH----------HHHHHhcCCC-
Confidence 2221 45689999999999653 359999999999999999999999998765421 1112222111
Q ss_pred hhhhchhhh-ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 440 DALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 440 ~~l~d~~l~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
..+.-..+. +........+.+++..||+.||.+||+++++++
T Consensus 250 p~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 250 PTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 111100111 222333457899999999999999999999985
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=358.60 Aligned_cols=264 Identities=24% Similarity=0.322 Sum_probs=207.1
Q ss_pred cCccccceecccCcEEEEEEE-EeCCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--CeeEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFG--SQRLLV 283 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~-~~~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~--~~~~lV 283 (586)
+.|+.+++||+|.||.||||+ ..+|+.||+|++..+.. .......+||.||++|+||||++|.+...+. ..+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 567778999999999999999 55799999999976542 2335667999999999999999999999876 689999
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCC
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 363 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 363 (586)
||||++ +|.-++... .-.++..++.-++.|++.||+|||.+ +|+|||||.+|||||++|.+||+|||||+++...
T Consensus 197 FeYMdh-DL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred Eecccc-hhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 999976 555555432 33589999999999999999999999 9999999999999999999999999999987766
Q ss_pred CCcccccccccccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhh----------hhhhhHHHhh
Q 007892 364 DTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSM----------VDWAKPFLAQ 432 (586)
Q Consensus 364 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~----------~~~~~~~~~~ 432 (586)
.....+..+-|.+|.|||++.+. .|+.+.|+||.||||.||+.|++.|.+..+.+.... ..|...-+..
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~ 351 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH 351 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence 66667788899999999999864 699999999999999999999999987665332111 1233111110
Q ss_pred cc---cCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 433 GL---ADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 433 ~~---~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
.. ....+. .++.+.-.......++|+..+|..||.+|.|+.++++
T Consensus 352 ~~~~kp~~~y~----r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 352 ATIFKPQQPYK----RRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccccCCCCccc----chHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 00 000111 1122112233456788999999999999999998875
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=348.87 Aligned_cols=246 Identities=20% Similarity=0.322 Sum_probs=199.7
Q ss_pred cceecccCcEEEEEEEEeCCeEEEEEEeccCCchh---HHHHHHHHHHHHhcCCCCcceEEEEEEe----CCeeEEEEEe
Q 007892 214 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQG---EREFQAEIEIISQVHHRHLVSLVGYCTF----GSQRLLVYEF 286 (586)
Q Consensus 214 ~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~---~~~~~~Ei~il~~l~Hpniv~l~g~~~~----~~~~~lV~E~ 286 (586)
...||+|++|.||+|.+ +|+.||||.++...... .+.|.+|+.+|.+++|||||+++|++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36899999999999998 68999999997653332 3577899999999999999999999977 3467899999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 366 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 366 (586)
+++|+|.+++... ..++|...++++.+++.||.|||... +++||||||+|||+++++.+||+|||+++......
T Consensus 104 ~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 104 CTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred CCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence 9999999999754 35899999999999999999999742 68899999999999999999999999998643321
Q ss_pred ccccccccccccCcccccC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhc
Q 007892 367 VSTRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 444 (586)
Q Consensus 367 ~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 444 (586)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||..... ..+.. .... +...
T Consensus 178 --~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~---~~~~~---~i~~-----~~~~---- 240 (283)
T PHA02988 178 --FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT---KEIYD---LIIN-----KNNS---- 240 (283)
T ss_pred --ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH---HHHHH---HHHh-----cCCC----
Confidence 23468899999999976 6899999999999999999999999975432 11111 1110 0000
Q ss_pred hhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 445 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 445 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
. ..+......+.+++.+||+.||.+||++.||++.|+..
T Consensus 241 --~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 241 --L-KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred --C-CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 0 12223456789999999999999999999999999854
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=391.69 Aligned_cols=258 Identities=31% Similarity=0.510 Sum_probs=216.7
Q ss_pred hcCccccceecccCcEEEEEEEEeC--Ce----EEEEEEeccC-CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCee
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLTN--GK----VVAIKQLKAG-SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR 280 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~~--g~----~vAVK~l~~~-~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~ 280 (586)
.++....+.||+|.||.||.|...+ |. .||||.++.. +.+.+.+|.+|..+|++++|||||+|+|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 4566778899999999999999754 33 4999999776 445667999999999999999999999999999999
Q ss_pred EEEEEecCCCcHHHHhcCC-----CCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecc
Q 007892 281 LLVYEFVPNKTLEFHLHGK-----DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 355 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~-----~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFG 355 (586)
+|++|||.+|+|..+|... ....+...+++.|+.|||+|+.||+++ ++|||||.++|+||+....|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccc
Confidence 9999999999999999764 134688999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCcccc-cccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhc
Q 007892 356 LAKHSLDTDTHVST-RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQG 433 (586)
Q Consensus 356 la~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 433 (586)
||+...+.+..... ..+-...|||||.++++.++.|+|||||||+|||++| |..||...+..+ .+..|
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~--v~~~~-------- 917 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE--VLLDV-------- 917 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH--HHHHH--------
Confidence 99966555443322 2245579999999999999999999999999999999 999998766422 12112
Q ss_pred ccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 434 LADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 434 ~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
...| +| +.+..++..+.+++.+||+.+|++||++..|++.+....
T Consensus 918 ~~gg--------RL-~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 918 LEGG--------RL-DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred HhCC--------cc-CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 1122 12 356677888999999999999999999999999777553
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=397.95 Aligned_cols=259 Identities=27% Similarity=0.511 Sum_probs=214.9
Q ss_pred cCccccceecccCcEEEEEEEE-eCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEec
Q 007892 209 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 287 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 287 (586)
..|...+.||+|+||.||+|+. .+++.||||+++..... ..+|++++++++|||||+++|+|.+.+..++||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 4577889999999999999996 47899999998654322 235688999999999999999999999999999999
Q ss_pred CCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcc
Q 007892 288 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 367 (586)
Q Consensus 288 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 367 (586)
++|+|.++++. ++|.++.+|+.|+++||+|||..+.++|+||||||+|||++.++.+++. ||+......
T Consensus 766 ~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----- 834 (968)
T PLN00113 766 EGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----- 834 (968)
T ss_pred CCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----
Confidence 99999999952 8999999999999999999998777799999999999999999888875 666543321
Q ss_pred cccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhh
Q 007892 368 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 447 (586)
Q Consensus 368 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 447 (586)
.....|+..|||||++.+..++.++|||||||++|||++|+.||+.... ....+++|++... .......++|+.+
T Consensus 835 ~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~----~~~~~~~~~~~~~ 909 (968)
T PLN00113 835 DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCY----SDCHLDMWIDPSI 909 (968)
T ss_pred CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhc----CccchhheeCccc
Confidence 1223688999999999999999999999999999999999999965432 3456777876433 2333445566655
Q ss_pred h---ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 448 E---EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 448 ~---~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
. ....++..++.+++.+|++.+|++||+|.||++.|+...
T Consensus 910 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 910 RGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred cCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 3 345567788999999999999999999999999999764
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=337.19 Aligned_cols=265 Identities=21% Similarity=0.290 Sum_probs=206.6
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
+.|+...++|+|+||.|||++.+ +|+.||||++..... ...+-.++||.+|++++|+|+|.|+.+|.....++||||
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 56788889999999999999976 599999999976533 223456899999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 365 (586)
||+..-|++.-+.. ..++.....+++.|+++|+.|||.+ +||||||||+||||+.++.+||||||+|+.+.. ..
T Consensus 82 ~~dhTvL~eLe~~p--~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pg 155 (396)
T KOG0593|consen 82 YCDHTVLHELERYP--NGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PG 155 (396)
T ss_pred ecchHHHHHHHhcc--CCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-Cc
Confidence 99887665543322 3488888999999999999999999 899999999999999999999999999998764 34
Q ss_pred cccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhh---hHHH---hhcc-cCC
Q 007892 366 HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWA---KPFL---AQGL-ADG 437 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~---~~~~---~~~~-~~~ 437 (586)
...+.++.|.+|.|||.+.+ -.|+...|||++||++.||++|.+-|-+....+ .+.... ..++ .+.+ .+.
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiD--QLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDID--QLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHH--HHHHHHHHHcccCHHHHHHhccCC
Confidence 45678899999999999986 689999999999999999999998887654322 221111 0000 0111 111
Q ss_pred Chhhhhchh------hhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 438 NFDALVDQK------LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 438 ~~~~l~d~~------l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
.|..+.-|. ++.--.....-++++++.||+.||.+|++-+|++.
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 222221111 12111233446899999999999999999999874
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=376.06 Aligned_cols=256 Identities=28% Similarity=0.445 Sum_probs=214.5
Q ss_pred cCccccceecccCcEEEEEEEEeC----CeEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLTN----GKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~~----g~~vAVK~l~~~~~~-~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV 283 (586)
....+.++||.|.||+||+|+++- ...||||.||..... .+++|+.|+.||.+++||||++|.|+.......++|
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 446677999999999999999752 357999999987443 357999999999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCC
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 363 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 363 (586)
.|||+||+|+.+|..++++ +.+.++.-++.+||.|++||-+. ++|||||.++||||+.+..+||+||||++.+.+.
T Consensus 709 TEyMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred hhhhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccC
Confidence 9999999999999888765 99999999999999999999998 9999999999999999999999999999977554
Q ss_pred CCcccccccc--cccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChh
Q 007892 364 DTHVSTRVMG--TFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 440 (586)
Q Consensus 364 ~~~~~~~~~g--t~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (586)
.....+..-| ...|.|||.+...+++.++|||||||++||.++ |.+||=+....+ + +.
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd-----------V--------Ik 845 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-----------V--------IK 845 (996)
T ss_pred CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH-----------H--------HH
Confidence 4222232223 358999999999999999999999999999988 999985433211 1 11
Q ss_pred hhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 441 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 441 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
.+-+.-.-.-+.+++..|.+|++.||++|-.+||++.|||..|....
T Consensus 846 aIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 846 AIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred HHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 11111111356778899999999999999999999999999998654
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=348.15 Aligned_cols=252 Identities=27% Similarity=0.402 Sum_probs=203.8
Q ss_pred CccccceecccCcEEEEEEEE-eCCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEE
Q 007892 210 NFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
.|+..+.||+|+||.||++.. .+|+.||||.+.... ......+.+|+.++.+++|+||+++++++.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 377789999999999999996 478999999986532 2233467899999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 365 (586)
|+++|+|.+++.......+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 99999999888655445689999999999999999999998 99999999999999999999999999998653322
Q ss_pred cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhch
Q 007892 366 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQ 445 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 445 (586)
......|+..|+|||++.+..++.++|||||||+||||++|+.||......... .... . .+..
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~--~~~~-----~---------~~~~ 219 (285)
T cd05631 157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR--EEVD-----R---------RVKE 219 (285)
T ss_pred -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH--HHHH-----H---------Hhhc
Confidence 223457999999999999999999999999999999999999999865431110 0000 0 0000
Q ss_pred hhhccCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 007892 446 KLEEYDSAEMTRMAACAAACIRHSARRRPR-----MSQIVRA 482 (586)
Q Consensus 446 ~l~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----m~evl~~ 482 (586)
....+.......+.+++.+||+.||.+||+ +.++++.
T Consensus 220 ~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 220 DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 011233334567889999999999999997 7888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=357.54 Aligned_cols=249 Identities=24% Similarity=0.366 Sum_probs=206.7
Q ss_pred HhcCccccceecccCcEEEEEEEE-eCCeEEEEEEeccC----Cc-hhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCe
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAG----SG-QGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQ 279 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~----~~-~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~~~ 279 (586)
..++|...+.||+|.||+|++|.. .++..||||+++.. .. .....+.+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 446899999999999999999985 46899999977653 11 23456678999999999 9999999999999999
Q ss_pred eEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCC-CCeEEeeccccc
Q 007892 280 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS-FEAKVADFGLAK 358 (586)
Q Consensus 280 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~-~~~kl~DFGla~ 358 (586)
.++||||+.+|+|.+++.. ...+.+.+..+++.|++.|++|||++ +|+|||||++||||+.+ +++||+|||++.
T Consensus 95 ~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred EEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 9999999999999999976 34488899999999999999999998 99999999999999999 999999999998
Q ss_pred ccCCCCCcccccccccccccCcccccCCC-CC-CcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccC
Q 007892 359 HSLDTDTHVSTRVMGTFGYLAPEYASSGK-LT-EKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLAD 436 (586)
Q Consensus 359 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (586)
... .........+||+.|+|||++.+.. |+ .++||||+||+||-|++|+.||+..+. ....+. +..
T Consensus 170 ~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~------~~l~~k-----i~~ 237 (370)
T KOG0583|consen 170 ISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV------PNLYRK-----IRK 237 (370)
T ss_pred ccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH------HHHHHH-----Hhc
Confidence 764 2333456789999999999999866 75 789999999999999999999987432 111111 111
Q ss_pred CChhhhhchhhhccCHHH-HHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 437 GNFDALVDQKLEEYDSAE-MTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 437 ~~~~~l~d~~l~~~~~~~-~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
+.+ .++... ...+..++.+|+..+|.+|+++.+|+.
T Consensus 238 ~~~---------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 238 GEF---------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred CCc---------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 211 122223 677899999999999999999999994
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=332.55 Aligned_cols=236 Identities=28% Similarity=0.411 Sum_probs=202.8
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhH---HHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGE---REFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~---~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
++|+..+.||.|+||.|.+++.+ +|..+|+|+++...-... +...+|..+|+.+.||++++|++-|.+.+..+|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 56888899999999999999965 688999999976543332 34568999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
||++||.|..+|+..++ ++......+|.+|+.||+|||+. .|++|||||+|||||.+|.+||+|||+|+...+.
T Consensus 124 eyv~GGElFS~Lrk~~r--F~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGR--FSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred eccCCccHHHHHHhcCC--CCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence 99999999999976554 89999999999999999999998 9999999999999999999999999999986443
Q ss_pred CcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhc
Q 007892 365 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 444 (586)
Q Consensus 365 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 444 (586)
.-+.|||+.|+|||.+....+..++|.|+|||++|||+.|..||...++.. .+..++.
T Consensus 198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~-------------------iY~KI~~ 255 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ-------------------IYEKILE 255 (355)
T ss_pred ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH-------------------HHHHHHh
Confidence 456899999999999999999999999999999999999999998766411 1222332
Q ss_pred hhhhccCHHHHHHHHHHHHHhhccCCCCC
Q 007892 445 QKLEEYDSAEMTRMAACAAACIRHSARRR 473 (586)
Q Consensus 445 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~R 473 (586)
..+ .++.-....+.+|+...|+.|-.+|
T Consensus 256 ~~v-~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 256 GKV-KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred Ccc-cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 222 3555566778889999999998888
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=342.70 Aligned_cols=256 Identities=25% Similarity=0.379 Sum_probs=206.3
Q ss_pred hcCccccceecccCcEEEEEEEEe----CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT----NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 282 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~----~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~l 282 (586)
.++|++.+.||+|+||.||+|++. .+..||+|.++.... .....|.+|+.++.+++||||+++++++..++..+|
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 457888999999999999999864 356899999976533 334578999999999999999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCC
Q 007892 283 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 283 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 362 (586)
||||+++|+|.+++.... ..++|..++.++.|++.||+|||+. +++||||||+||||+.++.+||+|||++.....
T Consensus 84 v~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999987543 3589999999999999999999998 999999999999999999999999998765422
Q ss_pred CCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhh
Q 007892 363 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 441 (586)
Q Consensus 363 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (586)
..........++..|+|||++.++.++.++|||||||++|||++ |..||...... .+... +.++.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---~~~~~--------~~~~~--- 225 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---DVIKA--------VEDGF--- 225 (266)
T ss_pred cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHH--------HHCCC---
Confidence 22111122345678999999999999999999999999999875 99999754321 11111 11110
Q ss_pred hhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 442 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 442 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
....+...+..+.+++.+||+.+|.+||++.||++.|+..
T Consensus 226 -----~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 -----RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -----CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0012233456789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=361.41 Aligned_cols=260 Identities=26% Similarity=0.420 Sum_probs=205.6
Q ss_pred HHhcCccccceecccCcEEEEEEEE------eCCeEEEEEEeccCC-chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeC
Q 007892 206 IATDNFSEANLLGQGGFGYVHKGVL------TNGKVVAIKQLKAGS-GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFG 277 (586)
Q Consensus 206 ~~~~~f~~~~~LG~G~fG~Vyk~~~------~~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~ 277 (586)
...++|++.+.||+|+||.||+|+. .++..||||+++... ......+.+|+.+|..+ +||||++++++|..+
T Consensus 32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 3446788899999999999999974 235689999997543 23345788999999999 899999999999999
Q ss_pred CeeEEEEEecCCCcHHHHhcCCC---------------------------------------------------------
Q 007892 278 SQRLLVYEFVPNKTLEFHLHGKD--------------------------------------------------------- 300 (586)
Q Consensus 278 ~~~~lV~E~~~~gsL~~~l~~~~--------------------------------------------------------- 300 (586)
+..++||||+++|+|.+++....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 99999999999999998886422
Q ss_pred ----------------CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 301 ----------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 301 ----------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
...++|..+++++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 12478899999999999999999998 99999999999999999999999999998654322
Q ss_pred Cc-ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhh
Q 007892 365 TH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 442 (586)
Q Consensus 365 ~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 442 (586)
.. ......++..|+|||++.+..++.++|||||||+||||++ |..||..... ......+. . .+.. .
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~--~~~~~~~~----~----~~~~-~- 336 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV--DSKFYKMI----K----EGYR-M- 336 (375)
T ss_pred cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc--hHHHHHHH----H----hCcc-C-
Confidence 21 1122345678999999999999999999999999999998 8899865432 11111111 1 1100 0
Q ss_pred hchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 443 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 443 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
..+.....++.+++.+|++.||.+||+|.||++.|+..
T Consensus 337 ------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 337 ------LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 01112245688999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=346.88 Aligned_cols=262 Identities=25% Similarity=0.433 Sum_probs=205.5
Q ss_pred hcCccccceecccCcEEEEEEEEeC-----------------CeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcce
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLTN-----------------GKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVS 269 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~~-----------------g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~ 269 (586)
.++|.+.++||+|+||.||++.+.+ +..||||.+.... .....+|.+|+++|.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578889999999999999998542 3479999987653 233567999999999999999999
Q ss_pred EEEEEEeCCeeEEEEEecCCCcHHHHhcCCC-----------------CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEE
Q 007892 270 LVGYCTFGSQRLLVYEFVPNKTLEFHLHGKD-----------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKII 332 (586)
Q Consensus 270 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~-----------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iv 332 (586)
++++|...+..+|||||+++++|.+++.... ...++|..+++++.|++.||.|||+. +|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 9999999999999999999999999885421 13478889999999999999999998 999
Q ss_pred ecCCCCceeEeCCCCCeEEeecccccccCCCCC-cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh--CCC
Q 007892 333 HRDIKSANILLDDSFEAKVADFGLAKHSLDTDT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT--GFR 409 (586)
Q Consensus 333 HrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt--G~~ 409 (586)
||||||+||||++++.+||+|||+++....... .......++..|+|||++..+.++.++|||||||++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999986543322 12233456789999999998999999999999999999987 567
Q ss_pred CCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 007892 410 PFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484 (586)
Q Consensus 410 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~ 484 (586)
||..... .....+....+..... ... ...+...+..+.+++.+||+.+|.+||+|.||++.|+
T Consensus 241 p~~~~~~---~~~~~~~~~~~~~~~~-----~~~----~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 241 PYGELTD---EQVIENAGEFFRDQGR-----QVY----LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCcCCH---HHHHHHHHHHhhhccc-----ccc----ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 7765432 2222322222211000 000 0111233467899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=357.67 Aligned_cols=246 Identities=27% Similarity=0.410 Sum_probs=211.5
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
++|...+.||+|.||.||||+-+ +.+.||+|.+.+..+ ...+.+++|++|+++++|||||.++++|+...+.|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888899999999999999954 689999999966533 334678999999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 365 (586)
|+.| +|..+|... ..++++....|+.+++.||.|||++ +|+|||+||.||||+.++.+|+||||+|+... ..+
T Consensus 82 ~a~g-~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~-~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQD--GKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMS-TNT 154 (808)
T ss_pred hhhh-hHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcc-cCc
Confidence 9977 999999644 4599999999999999999999998 99999999999999999999999999999754 356
Q ss_pred cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhch
Q 007892 366 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQ 445 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 445 (586)
.+.+.+.||+.|||||++.++.|+..+|+||||||||||++|++||... ++...++.++. |+
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------si~~Lv~~I~~------------d~ 216 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------SITQLVKSILK------------DP 216 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH------HHHHHHHHHhc------------CC
Confidence 6778889999999999999999999999999999999999999999643 22222222111 11
Q ss_pred hhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 446 KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 446 ~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
. .++.+....++.++...+.+||.+|-+..+++.
T Consensus 217 v--~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 217 V--KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred C--CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 1 345567788999999999999999999999885
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=341.72 Aligned_cols=256 Identities=27% Similarity=0.427 Sum_probs=210.7
Q ss_pred HhcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
..++|++.++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 346789999999999999999998888899999987543 2356889999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 366 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 366 (586)
+++++|.++++......+++.+++.++.|++.||+|||+. +++||||||+|||+++++.+||+|||++....+....
T Consensus 83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 9999999999766556789999999999999999999998 9999999999999999999999999999875443322
Q ss_pred ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhch
Q 007892 367 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQ 445 (586)
Q Consensus 367 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 445 (586)
......++..|+|||++..+.++.++|||||||++|||++ |+.||..... .....+. . .+.. .
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~~~~----~----~~~~----~- 223 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN---SDVMSAL----Q----RGYR----M- 223 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH---HHHHHHH----H----cCCC----C-
Confidence 2233446778999999998899999999999999999998 9999965432 1111111 1 1100 0
Q ss_pred hhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 007892 446 KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 485 (586)
Q Consensus 446 ~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~ 485 (586)
.........+.+++.+|++.+|++||++.+|++.|+.
T Consensus 224 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 224 ---PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ---CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0111233568899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=358.38 Aligned_cols=248 Identities=30% Similarity=0.482 Sum_probs=208.0
Q ss_pred HHHhcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 205 KIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 205 ~~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
++..+....++-||.|..|.||+|++. ++.||||+++. .-..+|..|++|+|+||+.+.|+|...-.+||||
T Consensus 120 eiPFe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~e-------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiM 191 (904)
T KOG4721|consen 120 EIPFEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVRE-------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIM 191 (904)
T ss_pred cCCHHHhhhhhhhccCcccceeeeecc-CceehhHHHhh-------hhhhhHHHHHhccCcceeeEeeeecCCceeEEee
Confidence 444445556788999999999999996 57899998642 2235789999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
|||..|-|...|... ..+.-...+.+..+||.|+.|||.+ +|||||||.-||||..+..|||+|||-++...+..
T Consensus 192 EfCa~GqL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S 266 (904)
T KOG4721|consen 192 EFCAQGQLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS 266 (904)
T ss_pred eccccccHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhhh
Confidence 999999999999654 4588888899999999999999999 99999999999999999999999999998765542
Q ss_pred CcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhc
Q 007892 365 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 444 (586)
Q Consensus 365 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 444 (586)
....++||..|||||++...+.++|.|||||||||||||||..||.+.+... +-| ++-...+.-
T Consensus 267 --TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----IIw-------GVGsNsL~L--- 330 (904)
T KOG4721|consen 267 --TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----IIW-------GVGSNSLHL--- 330 (904)
T ss_pred --hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----eEE-------eccCCcccc---
Confidence 3345789999999999999999999999999999999999999998765321 112 111111111
Q ss_pred hhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 007892 445 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 485 (586)
Q Consensus 445 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~ 485 (586)
..+..++..+.-|+++||+..|+.||+++||+.+|+=
T Consensus 331 ----pvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 331 ----PVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred ----cCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 3566778889999999999999999999999999974
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=338.29 Aligned_cols=252 Identities=29% Similarity=0.448 Sum_probs=205.2
Q ss_pred cCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecC
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVP 288 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 288 (586)
++|+..+.||+|+||.||++.+.++..+|+|.++... ....++.+|+++|++++||||++++++|...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4578889999999999999999888899999986543 335678999999999999999999999999999999999999
Q ss_pred CCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCccc
Q 007892 289 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 368 (586)
Q Consensus 289 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 368 (586)
+|+|.++++... ..++|..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..........
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 83 NGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence 999999987543 2589999999999999999999998 999999999999999999999999999986543322222
Q ss_pred ccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhh
Q 007892 369 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 447 (586)
Q Consensus 369 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 447 (586)
....++..|+|||++....++.++||||||++||||++ |+.||...+. .....+.. .+.. .
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~~~~~~i~--------~~~~--~----- 220 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVVEMIS--------RGFR--L----- 220 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHH--------CCCC--C-----
Confidence 22345668999999998889999999999999999999 8999975442 11111111 1100 0
Q ss_pred hccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 007892 448 EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484 (586)
Q Consensus 448 ~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~ 484 (586)
..+......+.+++.+|++.+|.+||+|.+|++.|.
T Consensus 221 -~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 221 -YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred -CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 011112356899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=338.24 Aligned_cols=256 Identities=28% Similarity=0.460 Sum_probs=209.7
Q ss_pred HhcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
..++|++.+.||+|+||.||+|...+++.||||.++... ....++.+|+.++++++|+||+++++++...+..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 456789999999999999999998888899999987643 3356799999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 366 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 366 (586)
+++++|.+++.......+++..+..++.+++.||.|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999999765555689999999999999999999998 9999999999999999999999999999876432221
Q ss_pred ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhch
Q 007892 367 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQ 445 (586)
Q Consensus 367 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 445 (586)
.......+..|+|||++.+..++.++||||||+++|||++ |+.||..... ..+... +. .+ ..
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~----~~----~~-~~----- 222 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN---AEVLQQ----VD----QG-YR----- 222 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHH----HH----cC-CC-----
Confidence 1111223457999999998899999999999999999999 9999975432 111110 00 00 00
Q ss_pred hhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 007892 446 KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 485 (586)
Q Consensus 446 ~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~ 485 (586)
+ .........+.+++.+|++.+|.+||++.+|++.|+.
T Consensus 223 -~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 223 -M-PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred -C-CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0 1122334678999999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=341.06 Aligned_cols=257 Identities=30% Similarity=0.494 Sum_probs=214.2
Q ss_pred HHhcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEE
Q 007892 206 IATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 206 ~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
...++|...++||.|+||.||+|...+++.+|+|.+.........++.+|+.++.+++|+||+++++++...+..++|||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 34567888999999999999999988899999999987665556789999999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 365 (586)
|+++++|.+++.......+++..++.++.|++.||.|||+. +|+|+||||+||||++++.+||+|||++........
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999999876666789999999999999999999998 899999999999999999999999999986543222
Q ss_pred cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhc
Q 007892 366 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 444 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 444 (586)
......++..|++||++..+.++.++||||||+++|+|++ |+.||..... .....+.. .+ +
T Consensus 160 -~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~---~~~~~~~~--------~~-~----- 221 (261)
T cd05148 160 -LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN---HEVYDQIT--------AG-Y----- 221 (261)
T ss_pred -cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHHH--------hC-C-----
Confidence 1223346778999999998899999999999999999998 8999965442 11111111 00 0
Q ss_pred hhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 007892 445 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 485 (586)
Q Consensus 445 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~ 485 (586)
...........+.+++.+|++.+|.+||++.++++.|+.
T Consensus 222 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 222 --RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred --cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 001122334678899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=360.50 Aligned_cols=245 Identities=31% Similarity=0.454 Sum_probs=208.2
Q ss_pred HHHhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCe
Q 007892 205 KIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQ 279 (586)
Q Consensus 205 ~~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~~~ 279 (586)
....++|.+.++||+|.||+|+++.++ +++.+|||.+++.. ..+.+..+.|..|+...+ ||.|++|+..|...++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 445588999999999999999999976 57899999998874 334566788999988885 9999999999999999
Q ss_pred eEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccc
Q 007892 280 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 359 (586)
Q Consensus 280 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~ 359 (586)
.++||||+.||++..+.+ ...+++.....+|..|+.||+|||++ +|||||||.+|||||.+|.+||+|||||+.
T Consensus 444 l~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccc
Confidence 999999999999544433 34589999999999999999999999 999999999999999999999999999997
Q ss_pred cCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCCh
Q 007892 360 SLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 439 (586)
Q Consensus 360 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (586)
...... ...+.|||+.|||||++.+..|+...|+|+|||+||||+.|+.||.++++. ..+
T Consensus 518 ~m~~g~-~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe-------------------e~F 577 (694)
T KOG0694|consen 518 GMGQGD-RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE-------------------EVF 577 (694)
T ss_pred cCCCCC-ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH-------------------HHH
Confidence 553333 456799999999999999999999999999999999999999999877641 112
Q ss_pred hhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCH
Q 007892 440 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRM 476 (586)
Q Consensus 440 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm 476 (586)
+.|+.... .|+.....+.+.++.++++.+|++|.-+
T Consensus 578 dsI~~d~~-~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 578 DSIVNDEV-RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHhcCCC-CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 22221111 3667778889999999999999999987
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=342.65 Aligned_cols=249 Identities=32% Similarity=0.559 Sum_probs=197.1
Q ss_pred ccceecccCcEEEEEEEEe-----CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 213 EANLLGQGGFGYVHKGVLT-----NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 213 ~~~~LG~G~fG~Vyk~~~~-----~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
..+.||.|.||.||+|.+. .+..|+||.++.... .....|.+|++++.+++||||++++|+|...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999987 257899999966433 3467899999999999999999999999988889999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC-
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT- 365 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~- 365 (586)
+++|+|.++|+......+++..++.|+.|+++||.|||++ +|+|+||+++||||++++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 9999999999887566799999999999999999999998 899999999999999999999999999987632221
Q ss_pred cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhc
Q 007892 366 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 444 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 444 (586)
.......+...|+|||.+....++.++||||||+++|||++ |+.||..... ..+... + .++.
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~---~~~~~~---~-----~~~~------ 222 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN---EEIIEK---L-----KQGQ------ 222 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH---HHHHHH---H-----HTTE------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccc---c-----cccc------
Confidence 22233457789999999998899999999999999999999 7889865432 111111 1 0111
Q ss_pred hhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007892 445 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRAL 483 (586)
Q Consensus 445 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L 483 (586)
....+......+.+++.+||..+|.+||+|.+|++.|
T Consensus 223 --~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 223 --RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp --ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred --cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1112223456688999999999999999999999987
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=363.06 Aligned_cols=262 Identities=28% Similarity=0.450 Sum_probs=211.3
Q ss_pred HHHHhcCccccceecccCcEEEEEEEEeC--C--eE-EEEEEeccC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 007892 204 LKIATDNFSEANLLGQGGFGYVHKGVLTN--G--KV-VAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSLVGYCT 275 (586)
Q Consensus 204 l~~~~~~f~~~~~LG~G~fG~Vyk~~~~~--g--~~-vAVK~l~~~---~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~ 275 (586)
++...++....++||+|.||.||+|.+.. + .. ||||..+.. ......+|.+|+++|++++|||||+++|++.
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 44445666667999999999999999753 2 23 899998852 3455678999999999999999999999999
Q ss_pred eCCeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecc
Q 007892 276 FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 355 (586)
Q Consensus 276 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFG 355 (586)
....+|||||+|+||+|.++|..... .++..++++++.++|.||+|||.+ ++|||||.++|+|++.++.+||+|||
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFG 307 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFG 307 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccc
Confidence 99999999999999999999986554 699999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcc
Q 007892 356 LAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGL 434 (586)
Q Consensus 356 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 434 (586)
|++....... ......-...|+|||.+..+.|+.++|||||||++||+++ |..||.+.... .+..|+
T Consensus 308 Ls~~~~~~~~-~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~---~v~~kI-------- 375 (474)
T KOG0194|consen 308 LSRAGSQYVM-KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY---EVKAKI-------- 375 (474)
T ss_pred cccCCcceee-ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH---HHHHHH--------
Confidence 9876431111 1111234578999999999999999999999999999999 88899866532 111111
Q ss_pred cCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 007892 435 ADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMP 488 (586)
Q Consensus 435 ~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~~ 488 (586)
....+.. ..+...+..+..++.+|+..+|++||+|.+|.+.|+....
T Consensus 376 ~~~~~r~-------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~ 422 (474)
T KOG0194|consen 376 VKNGYRM-------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEK 422 (474)
T ss_pred HhcCccC-------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHh
Confidence 0111111 2333556678888999999999999999999999986643
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=358.44 Aligned_cols=247 Identities=27% Similarity=0.354 Sum_probs=211.1
Q ss_pred cCccccceecccCcEEEEEEEE-eCCeEEEEEEeccCCchh---HHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQG---EREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~---~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
+-|++++.||.|+-|.|-+|++ .+|+.+|||++.+..... ...+.+||-||+.+.|||+++|++++++..++|||.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 4477789999999999999995 479999999997653222 346789999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
||+++|.|+++|-.++. +...+..+++.||+.|+.|||.. +|+||||||+|+|||..+++||+|||+|.... .
T Consensus 92 Eyv~gGELFdylv~kG~--l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~--~ 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGP--LPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEV--P 164 (786)
T ss_pred EecCCchhHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeeccc--C
Confidence 99999999999976654 88999999999999999999998 99999999999999999999999999997643 3
Q ss_pred CcccccccccccccCcccccCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhh
Q 007892 365 THVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 443 (586)
Q Consensus 365 ~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 443 (586)
.....+.||++.|.|||++++.+| +.++||||+|||||.||||++||++++. .. +..++..|.|
T Consensus 165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi------r~-----LLlKV~~G~f---- 229 (786)
T KOG0588|consen 165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI------RV-----LLLKVQRGVF---- 229 (786)
T ss_pred CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH------HH-----HHHHHHcCcc----
Confidence 345667899999999999999888 5799999999999999999999985442 11 2222334444
Q ss_pred chhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 444 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 444 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
+.+.+...+..+|+.+|+..||.+|-|+.||+++
T Consensus 230 -----~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 230 -----EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred -----cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 3456667789999999999999999999999984
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=340.91 Aligned_cols=255 Identities=29% Similarity=0.514 Sum_probs=207.8
Q ss_pred cCccccceecccCcEEEEEEEEeC------CeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 281 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~~------g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~ 281 (586)
++|++.+.||+|+||.||+|.... ...||+|.++.... .....|.+|+.++.+++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468888999999999999998643 25799999875433 33457899999999999999999999999989999
Q ss_pred EEEEecCCCcHHHHhcCCCC--------------CCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCC
Q 007892 282 LVYEFVPNKTLEFHLHGKDR--------------PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF 347 (586)
Q Consensus 282 lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 347 (586)
++|||+++++|.+++..... ..+++.+++.++.|++.||.|||+. +|+||||||+|||+++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 99999999999999865321 4578899999999999999999998 999999999999999999
Q ss_pred CeEEeecccccccCCCCC-cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhh
Q 007892 348 EAKVADFGLAKHSLDTDT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDW 425 (586)
Q Consensus 348 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~ 425 (586)
.+||+|||+++....... .......+++.|+|||++.++.++.++|||||||+||||++ |..||..... ..+..+
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~---~~~~~~ 238 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN---QEVIEM 238 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH
Confidence 999999999986533322 22234457889999999998999999999999999999998 9999975442 111111
Q ss_pred hhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 007892 426 AKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 485 (586)
Q Consensus 426 ~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~ 485 (586)
. ..+ .....+...+..+.+++.+||+.+|.+||++.||++.|+.
T Consensus 239 i--------~~~--------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 239 I--------RSR--------QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred H--------HcC--------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1 111 1112233456789999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=359.11 Aligned_cols=260 Identities=27% Similarity=0.437 Sum_probs=204.6
Q ss_pred HHhcCccccceecccCcEEEEEEEEe------CCeEEEEEEeccCCch-hHHHHHHHHHHHHhc-CCCCcceEEEEEEeC
Q 007892 206 IATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSGQ-GEREFQAEIEIISQV-HHRHLVSLVGYCTFG 277 (586)
Q Consensus 206 ~~~~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~~~~-~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~ 277 (586)
...++|++.+.||+|+||.||+|+.. ++..||||+++..... ....+.+|+++++.+ +|+|||+++++|...
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 34467888999999999999998842 2357999999765333 345688999999999 899999999999999
Q ss_pred CeeEEEEEecCCCcHHHHhcCCC---------------------------------------------------------
Q 007892 278 SQRLLVYEFVPNKTLEFHLHGKD--------------------------------------------------------- 300 (586)
Q Consensus 278 ~~~~lV~E~~~~gsL~~~l~~~~--------------------------------------------------------- 300 (586)
+..++||||+++|+|.+++....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 99999999999999999885321
Q ss_pred -----------CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc-cc
Q 007892 301 -----------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH-VS 368 (586)
Q Consensus 301 -----------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~-~~ 368 (586)
...+++.++++|+.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++........ ..
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 12478889999999999999999998 9999999999999999999999999999865332211 11
Q ss_pred ccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhh
Q 007892 369 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 447 (586)
Q Consensus 369 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 447 (586)
....++..|||||++.+..++.++|||||||+||||++ |+.||....... .... .+ ..+ . ..
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~~----~~----~~~-~----~~-- 334 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFYK----MV----KRG-Y----QM-- 334 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHHH----HH----Hcc-c----Cc--
Confidence 22335678999999998999999999999999999997 999997543211 0000 00 000 0 00
Q ss_pred hccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 448 EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 448 ~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
..+......+.+++.+||+.+|.+||++.+|++.|+..
T Consensus 335 -~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 335 -SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred -cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 01111245788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=322.71 Aligned_cols=248 Identities=27% Similarity=0.407 Sum_probs=213.3
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
++|++.+.||+|.||.||.|+.+ ++-.||+|++.+. ..+..+++++|++|-+.|+||||+++++||.+....||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 67889999999999999999965 5789999998654 2344678999999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
||..+|.|...|.......++......++.|+|.||.|||.. +||||||||+|+|++.++..||+|||-+....
T Consensus 102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--- 175 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP--- 175 (281)
T ss_pred EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC---
Confidence 999999999999877777789999999999999999999998 89999999999999999999999999987543
Q ss_pred CcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhc
Q 007892 365 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 444 (586)
Q Consensus 365 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 444 (586)
.......|||..|++||...+..++.+.|+|++||+.||++.|.+||...... ..+.++..
T Consensus 176 ~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~-------------------etYkrI~k 236 (281)
T KOG0580|consen 176 SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS-------------------ETYKRIRK 236 (281)
T ss_pred CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH-------------------HHHHHHHH
Confidence 33456789999999999999999999999999999999999999999865421 11112211
Q ss_pred hhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 445 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 445 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
-.+ .++........+++.+|+.++|.+|....||++.
T Consensus 237 ~~~-~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 237 VDL-KFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ccc-cCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 111 2445566788999999999999999999999875
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=337.21 Aligned_cols=255 Identities=28% Similarity=0.417 Sum_probs=208.4
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEec
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 287 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 287 (586)
.+|...+.||+|+||.||+|... .++.||+|.++... ....++.+|++++.+++|+||++++++|..++..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45788899999999999999965 48899999987543 33567899999999999999999999999999999999999
Q ss_pred CCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcc
Q 007892 288 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 367 (586)
Q Consensus 288 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 367 (586)
++++|.+++.......+++..++.++.|+++||+|||+. +++||||||+|||+++++.+||+|||++..........
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 999999999766556789999999999999999999998 99999999999999999999999999998654432222
Q ss_pred cccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchh
Q 007892 368 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 446 (586)
Q Consensus 368 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 446 (586)
.....++..|+|||++.+..++.++|||||||+||||++ |..||...+.. ++... +.....
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~------~~~~~-~~~~~~----------- 223 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------QVYEL-LEKGYR----------- 223 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHH-HHCCCC-----------
Confidence 222334668999999998999999999999999999998 99998654321 11111 111000
Q ss_pred hhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 447 LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 447 l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
...+...+..+.+++.+|++.+|.+||++.||++.|+..
T Consensus 224 -~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 224 -MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 012223346789999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=346.98 Aligned_cols=248 Identities=25% Similarity=0.399 Sum_probs=194.7
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
++|+..+.||+|+||.||+|+.. +++.||||++..... .....+.+|++++++++|+||+++++++...+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 34556789999999999999965 689999999865433 3346789999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 366 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 366 (586)
+++++|.... .+.+..+..++.||+.||+|||+. +|+|||||++||||++++.+||+|||+++.......
T Consensus 154 ~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 223 (353)
T PLN00034 154 MDGGSLEGTH------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD- 223 (353)
T ss_pred CCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence 9999986432 356677889999999999999998 999999999999999999999999999986533211
Q ss_pred ccccccccccccCcccccC-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhh
Q 007892 367 VSTRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 441 (586)
Q Consensus 367 ~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (586)
......||..|+|||++.. ...+.++|||||||+||||++|+.||..... .+|....... ..
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~------~~~~~~~~~~--~~----- 290 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ------GDWASLMCAI--CM----- 290 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC------ccHHHHHHHH--hc-----
Confidence 2234579999999998743 2345689999999999999999999974332 1222111000 00
Q ss_pred hhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 442 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 442 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.............+.+++.+||+.||.+||++.||++.
T Consensus 291 ---~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 291 ---SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ---cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00011222344678999999999999999999999975
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=349.81 Aligned_cols=241 Identities=24% Similarity=0.347 Sum_probs=197.2
Q ss_pred ceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecCCC
Q 007892 215 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNK 290 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g 290 (586)
+.||+|+||.||+++.. +|+.||||+++... ......+.+|+.+|.+++||||+++++++...+..+|||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999964 68899999987532 223356788999999999999999999999999999999999999
Q ss_pred cHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCccccc
Q 007892 291 TLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTR 370 (586)
Q Consensus 291 sL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 370 (586)
+|..++... ..+++..+..++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~ 154 (323)
T cd05571 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKT 154 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccccc
Confidence 999988654 3589999999999999999999998 99999999999999999999999999997532222 12234
Q ss_pred ccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhcc
Q 007892 371 VMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEY 450 (586)
Q Consensus 371 ~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~ 450 (586)
.+||+.|+|||++.+..++.++|||||||+||||++|+.||...+.. .+... +..+.. .+
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~~--------~~~~~~---------~~ 214 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFEL--------ILMEEI---------RF 214 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH---HHHHH--------HHcCCC---------CC
Confidence 67999999999999999999999999999999999999999754321 11111 000100 12
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 007892 451 DSAEMTRMAACAAACIRHSARRRP-----RMSQIVR 481 (586)
Q Consensus 451 ~~~~~~~l~~l~~~cl~~dp~~RP-----tm~evl~ 481 (586)
+......+.+++.+||+.||++|| ++.++++
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 233456788999999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=345.12 Aligned_cols=245 Identities=26% Similarity=0.354 Sum_probs=201.3
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
++|+..+.||+|+||.||+|... +++.||||++.... ......+.+|++++.+++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888999999999999999975 68899999986432 123456889999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
||+++|+|.+++... ..+++.....++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 81 EYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence 999999999998654 3488999999999999999999998 9999999999999999999999999999865332
Q ss_pred CcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhc
Q 007892 365 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 444 (586)
Q Consensus 365 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 444 (586)
.....|++.|+|||++.+..++.++|||||||+||||++|+.||...... ....... .+
T Consensus 155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~------~~~~~i~-----~~------- 213 (291)
T cd05612 155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF------GIYEKIL-----AG------- 213 (291)
T ss_pred ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHH-----hC-------
Confidence 22356999999999999888999999999999999999999999764321 1111110 11
Q ss_pred hhhhccCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 007892 445 QKLEEYDSAEMTRMAACAAACIRHSARRRPR-----MSQIVRA 482 (586)
Q Consensus 445 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----m~evl~~ 482 (586)
.+ .++......+.+++.+||+.||.+||+ +.|+++.
T Consensus 214 -~~-~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 214 -KL-EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred -Cc-CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 11 122223456889999999999999995 7777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=338.31 Aligned_cols=268 Identities=20% Similarity=0.264 Sum_probs=204.0
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
++|++.+.||+|+||.||+++.. +++.||||+++... ......+.+|++++.+++|+||++++++|..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46889999999999999999975 57899999987542 2234578899999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 365 (586)
|++++.|..+... ...+++..+..++.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++.......
T Consensus 81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 81 YVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 9999888765532 23588999999999999999999998 999999999999999999999999999987543332
Q ss_pred cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhh-hhH----HHhhcccCCChh
Q 007892 366 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDW-AKP----FLAQGLADGNFD 440 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~-~~~----~~~~~~~~~~~~ 440 (586)
.......|++.|+|||++.+..++.++|||||||+||||++|+.||.............. ..+ .+.....+..+.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 233446789999999999988999999999999999999999999976443111000000 000 000000000010
Q ss_pred hhhchhhh-------ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 441 ALVDQKLE-------EYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 441 ~l~d~~l~-------~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
....+... .+.......+.+++.+||+.||.+||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000 111223456999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=348.16 Aligned_cols=252 Identities=25% Similarity=0.351 Sum_probs=204.7
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
++|++.+.||+|+||.||+|+.. +++.||||+++... ......+.+|++++.+++||||+++++++...+..+|||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46889999999999999999976 58899999987542 223456889999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
||+++++|.+++... ..+.+..+..++.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 999999999999654 3488999999999999999999998 999999999999999999999999999986533
Q ss_pred CcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccc-hhhhhhhhHHHhhcccCCChhhhh
Q 007892 365 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFAD-DSMVDWAKPFLAQGLADGNFDALV 443 (586)
Q Consensus 365 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~ 443 (586)
......||+.|+|||++.+..++.++|||||||+||||++|+.||........ ..+..|... + .
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----------~---~ 218 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET----------L---Q 218 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccc----------c---c
Confidence 23446799999999999999999999999999999999999999976543110 011111100 0 0
Q ss_pred chhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 444 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 444 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.+............+.+++.+||..+|.+||++.||++.
T Consensus 219 ~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 219 RPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000000112234568899999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=334.26 Aligned_cols=252 Identities=29% Similarity=0.448 Sum_probs=205.1
Q ss_pred cCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecC
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVP 288 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 288 (586)
++|.+.+.||+|+||.||+|.+.++..||||.++... ....+|.+|+.++.+++||||++++++|......++||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4577889999999999999998777789999987543 335679999999999999999999999998888999999999
Q ss_pred CCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCccc
Q 007892 289 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 368 (586)
Q Consensus 289 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 368 (586)
+++|.+++..... .+++..++.++.|++.||+|||+. +|+|+||||+|||+++++.+||+|||+++..........
T Consensus 83 ~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 83 NGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred CCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence 9999999865433 589999999999999999999998 999999999999999999999999999986544322222
Q ss_pred ccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhh
Q 007892 369 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 447 (586)
Q Consensus 369 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 447 (586)
....++..|++||++.++.++.++|||||||+||||++ |..||..... ....... ..+..
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~--------~~~~~-------- 219 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN---SETVEKV--------SQGLR-------- 219 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HHHHHHH--------hcCCC--------
Confidence 22345678999999998889999999999999999999 9999975432 1111111 01100
Q ss_pred hccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 007892 448 EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484 (586)
Q Consensus 448 ~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~ 484 (586)
..........+.+++.+||+.+|.+||++.+|++.|+
T Consensus 220 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 220 LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0011123467899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=350.24 Aligned_cols=245 Identities=27% Similarity=0.367 Sum_probs=200.7
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
++|.+.+.||+|+||.||+|+.. +++.||||+++... ......+.+|+.++.+++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57888999999999999999975 58899999986532 123456889999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
||+++|+|.+++... ..+++.....++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++......
T Consensus 98 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 98 EFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred cCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 999999999998654 3478888999999999999999998 99999999999999999999999999998653321
Q ss_pred CcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhc
Q 007892 365 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 444 (586)
Q Consensus 365 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 444 (586)
....|++.|+|||++.+..++.++|||||||+||||++|+.||...... ..... +..+.+
T Consensus 173 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~-----i~~~~~----- 232 (329)
T PTZ00263 173 ----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF------RIYEK-----ILAGRL----- 232 (329)
T ss_pred ----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH------HHHHH-----HhcCCc-----
Confidence 2357999999999999999999999999999999999999999754321 11111 111111
Q ss_pred hhhhccCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 007892 445 QKLEEYDSAEMTRMAACAAACIRHSARRRPR-----MSQIVRA 482 (586)
Q Consensus 445 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----m~evl~~ 482 (586)
.++......+.+++.+||+.||.+||+ +.+++.+
T Consensus 233 ----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 233 ----KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 111223356789999999999999997 5666643
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=337.76 Aligned_cols=255 Identities=26% Similarity=0.489 Sum_probs=208.1
Q ss_pred hcCccccceecccCcEEEEEEEEeC------CeEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCee
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR 280 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~~------g~~vAVK~l~~~~~~-~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~ 280 (586)
.++|.+.+.||+|+||.||+|...+ ++.||||.++..... ....+.+|+++|.+++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3567888999999999999998643 478999999765444 457899999999999999999999999999999
Q ss_pred EEEEEecCCCcHHHHhcCCC------------CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCC
Q 007892 281 LLVYEFVPNKTLEFHLHGKD------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE 348 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 348 (586)
++||||+++++|.+++.... ...+.+..+..++.|++.||.|||+. +|+||||||+|||++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 99999999999999996542 24578999999999999999999998 9999999999999999999
Q ss_pred eEEeecccccccCCCCC-cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhh
Q 007892 349 AKVADFGLAKHSLDTDT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWA 426 (586)
Q Consensus 349 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~ 426 (586)
+||+|||+++....... .......++..|+|||++.++.++.++|||||||++|||++ |..||..... ....++.
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~---~~~~~~~ 237 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN---EEVIECI 237 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHH
Confidence 99999999975433221 12233456788999999999999999999999999999998 9999875442 1122211
Q ss_pred hHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 007892 427 KPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484 (586)
Q Consensus 427 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~ 484 (586)
. .+. ....+......+.+++.+||+.+|.+||++.||++.|+
T Consensus 238 ~--------~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 238 T--------QGR--------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred H--------cCC--------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1 111 11122234467899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=333.50 Aligned_cols=254 Identities=29% Similarity=0.454 Sum_probs=207.0
Q ss_pred hcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEec
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 287 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 287 (586)
.++|++.+.||+|+||.||+|...++..||+|.+..... ....+.+|+.++++++|+||+++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 457888899999999999999988888899999876443 3567999999999999999999999885 45688999999
Q ss_pred CCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcc
Q 007892 288 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 367 (586)
Q Consensus 288 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 367 (586)
++++|.++++......+++.+++.++.+++.||.|||+. +|+||||||+|||+++++.+||+|||++..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 999999999765555689999999999999999999998 89999999999999999999999999998654332222
Q ss_pred cccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchh
Q 007892 368 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 446 (586)
Q Consensus 368 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 446 (586)
.....++..|+|||++....++.++||||||+++|||++ |..||..... ....++. . .+.
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~----~----~~~-------- 220 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---REVLEQV----E----RGY-------- 220 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHH----H----cCC--------
Confidence 222345678999999988899999999999999999999 8999965432 1111111 0 000
Q ss_pred hhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 007892 447 LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 485 (586)
Q Consensus 447 l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~ 485 (586)
...........+.+++.+|+..+|.+||++.++++.|+.
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 221 RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 001222334578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=343.61 Aligned_cols=255 Identities=25% Similarity=0.366 Sum_probs=204.8
Q ss_pred HHhcCccccceecccCcEEEEEEEE-eCCeEEEEEEeccCCc--------------hhHHHHHHHHHHHHhcCCCCcceE
Q 007892 206 IATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSG--------------QGEREFQAEIEIISQVHHRHLVSL 270 (586)
Q Consensus 206 ~~~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~--------------~~~~~~~~Ei~il~~l~Hpniv~l 270 (586)
...++|++.+.||+|.||+|-+|+. .+++.||||++.+... ...+..++||.||++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 3447899999999999999999995 4689999999954321 112478899999999999999999
Q ss_pred EEEEEe--CCeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCC
Q 007892 271 VGYCTF--GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE 348 (586)
Q Consensus 271 ~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 348 (586)
+.+..+ .+..|||+|||..|.+...- .+...+...+..+++.+++.||+|||.+ +||||||||+|+||+++|.
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCc
Confidence 999876 46889999999988875322 1222388999999999999999999999 9999999999999999999
Q ss_pred eEEeecccccccCCCC----CcccccccccccccCcccccCCC----CCCcchHHHHHHHHHHHHhCCCCCCCCCcccch
Q 007892 349 AKVADFGLAKHSLDTD----THVSTRVMGTFGYLAPEYASSGK----LTEKSDVFSFGVLLLELITGFRPFDKADTFADD 420 (586)
Q Consensus 349 ~kl~DFGla~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~ 420 (586)
|||+|||.+....... .....+.+||+.|+|||.+.++. .+.+.||||+||+||.|+.|+.||......
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~--- 325 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL--- 325 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH---
Confidence 9999999997652211 11223468999999999987643 467899999999999999999999755431
Q ss_pred hhhhhhhHHHhhcccCCChhhhhchhhh-ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 007892 421 SMVDWAKPFLAQGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484 (586)
Q Consensus 421 ~~~~~~~~~~~~~~~~~~~~~l~d~~l~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~ 484 (586)
..++.|+...|. ....++-..+.++++++|++||.+|-+..+|..+.-
T Consensus 326 ----------------~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 326 ----------------ELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred ----------------HHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 123445555554 333456678999999999999999999999987654
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=343.21 Aligned_cols=266 Identities=22% Similarity=0.345 Sum_probs=206.5
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
.++|+..+.||+|+||.||+++.. ++..||+|.+..... .....+.+|+++|.+++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 478999999999999999999975 578999999876532 334678999999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 365 (586)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 157 (331)
T cd06649 84 HMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (331)
T ss_pred cCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence 99999999998654 34889999999999999999999852 6999999999999999999999999999765332
Q ss_pred cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhccc----------
Q 007892 366 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLA---------- 435 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~---------- 435 (586)
......|+..|+|||++.+..++.++|||||||+||||++|+.||...+... +.............
T Consensus 158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 233 (331)
T cd06649 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSISPRP 233 (331)
T ss_pred -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccCccc
Confidence 2234579999999999999899999999999999999999999996543211 11100000000000
Q ss_pred ----------------CCChhhhhchhhh----cc-CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007892 436 ----------------DGNFDALVDQKLE----EY-DSAEMTRMAACAAACIRHSARRRPRMSQIVRAL 483 (586)
Q Consensus 436 ----------------~~~~~~l~d~~l~----~~-~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L 483 (586)
......+.+.... .. .......+.+++.+||+.||++||++.||++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0000011111110 00 112346789999999999999999999998753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=363.20 Aligned_cols=250 Identities=22% Similarity=0.313 Sum_probs=203.9
Q ss_pred CccccceecccCcEEEEEEEEe-C-CeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEec
Q 007892 210 NFSEANLLGQGGFGYVHKGVLT-N-GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 287 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~-~-g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 287 (586)
.|.+.+.||+|+||.||++... + ++.||+|.+..........+++|+.+|.+++|||||+++++|..++..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3888999999999999999854 3 5788899876655555567889999999999999999999999999999999999
Q ss_pred CCCcHHHHhcCC--CCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC
Q 007892 288 PNKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365 (586)
Q Consensus 288 ~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 365 (586)
++|+|.++|+.. ....+++.++..++.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999887542 234588889999999999999999998 999999999999999999999999999987543322
Q ss_pred -cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhc
Q 007892 366 -HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 444 (586)
Q Consensus 366 -~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 444 (586)
......+||+.|+|||++.+..++.++|||||||+||||++|+.||..... .+.....+ .+..
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------~~~~~~~~-----~~~~----- 288 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ------REIMQQVL-----YGKY----- 288 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHH-----hCCC-----
Confidence 223456799999999999999999999999999999999999999965432 11111111 1111
Q ss_pred hhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 445 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 445 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
..++......+.+++..||+.+|.+||++.+++.
T Consensus 289 ---~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 289 ---DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ---CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1122233457899999999999999999999874
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=347.19 Aligned_cols=248 Identities=23% Similarity=0.338 Sum_probs=202.0
Q ss_pred HHHhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchh---HHHHHHHHHHHHhcCCCCcceEEEEEEeCCee
Q 007892 205 KIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQG---EREFQAEIEIISQVHHRHLVSLVGYCTFGSQR 280 (586)
Q Consensus 205 ~~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~---~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~ 280 (586)
++..++|+.+..||+|+||.||+++.+ +|..+|+|+|++..... ..-++.|-.||...+++.||+|+..|.+.+.+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 345688999999999999999999965 59999999998764333 34578899999999999999999999999999
Q ss_pred EEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccccc
Q 007892 281 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 360 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~ 360 (586)
||||||++||++..+|...+ .|.......++.+++.|++-||.. |+|||||||+|+|||..|++||+|||||.-+
T Consensus 217 YLiMEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEEEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchh
Confidence 99999999999999997654 488888888999999999999998 9999999999999999999999999998521
Q ss_pred CC----------------------CCCc-----ccc-------------------cccccccccCcccccCCCCCCcchH
Q 007892 361 LD----------------------TDTH-----VST-------------------RVMGTFGYLAPEYASSGKLTEKSDV 394 (586)
Q Consensus 361 ~~----------------------~~~~-----~~~-------------------~~~gt~~y~aPE~~~~~~~s~ksDV 394 (586)
.. .+.. ..+ ..+|||.|||||++.+..|+..+|+
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 11 0000 000 1579999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCccc-chhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCC
Q 007892 395 FSFGVLLLELITGFRPFDKADTFA-DDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRR 473 (586)
Q Consensus 395 wSlGvvL~elltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~R 473 (586)
||||||+||||.|.+||....+.. -..++.|...+-. ........+..++|.+|+. ||.+|
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~f-----------------P~~~~~s~eA~DLI~rll~-d~~~R 433 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKF-----------------PEEVDLSDEAKDLITRLLC-DPENR 433 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccC-----------------CCcCcccHHHHHHHHHHhc-CHHHh
Confidence 999999999999999998776532 1334444322110 1111223678889999999 99999
Q ss_pred CC
Q 007892 474 PR 475 (586)
Q Consensus 474 Pt 475 (586)
..
T Consensus 434 LG 435 (550)
T KOG0605|consen 434 LG 435 (550)
T ss_pred cC
Confidence 87
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=332.77 Aligned_cols=256 Identities=29% Similarity=0.444 Sum_probs=206.9
Q ss_pred hcCccccceecccCcEEEEEEEEeC----CeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLTN----GKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 282 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~~----g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~l 282 (586)
.++|+..+.||+|+||.||+|.+.. ...||||.++... ......|.+|+.++.+++|+||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3578899999999999999999743 3589999987543 2334678999999999999999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCC
Q 007892 283 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 283 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 362 (586)
||||+++++|.+++..... .+++.+++.++.|++.||+|||+. +|+||||||+||||++++.+||+|||+++....
T Consensus 83 v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 83 ITEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEEcCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 9999999999999875433 589999999999999999999998 999999999999999999999999999987642
Q ss_pred CCCc-ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChh
Q 007892 363 TDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 440 (586)
Q Consensus 363 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (586)
.... ......++..|+|||.+.+..++.++||||||+++|||++ |..||..... ..+..+. ..+.
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~--------~~~~-- 225 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN---QDVIKAV--------EDGY-- 225 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH---HHHHHHH--------HcCC--
Confidence 2221 1222345678999999998899999999999999999998 9999864331 1111111 0110
Q ss_pred hhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 441 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 441 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
...........+.+++.+|++.+|.+||++.||++.|+..
T Consensus 226 ------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 ------RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011223346789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=332.91 Aligned_cols=255 Identities=30% Similarity=0.440 Sum_probs=206.7
Q ss_pred hcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEec
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 287 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 287 (586)
.++|.+.+.||+|+||.||+|++.+...||||+++.... ....|.+|++++.+++|+||+++++++. ....++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 467899999999999999999987777899999975332 3467899999999999999999999875 45678999999
Q ss_pred CCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcc
Q 007892 288 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 367 (586)
Q Consensus 288 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 367 (586)
++++|.+++.......+++..++.++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++.........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence 999999999765455689999999999999999999998 99999999999999999999999999997654333222
Q ss_pred cccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchh
Q 007892 368 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 446 (586)
Q Consensus 368 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 446 (586)
.....++..|++||++.++.++.++|||||||++|||++ |..||...... .... . +..+.
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~---~~~~---~-----~~~~~-------- 220 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLD---Q-----VERGY-------- 220 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH---HHHH---H-----HhcCC--------
Confidence 223446778999999998899999999999999999999 88898654321 1100 0 00000
Q ss_pred hhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 447 LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 447 l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
........+..+.+++.+|++.+|.+||++.++++.|+..
T Consensus 221 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 221 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0012233456789999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=353.05 Aligned_cols=264 Identities=26% Similarity=0.408 Sum_probs=223.6
Q ss_pred HHHHHHHhcCccccceecccCcEEEEEEEEeC-CeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 007892 201 YEELKIATDNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ 279 (586)
Q Consensus 201 ~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~ 279 (586)
+++++....+....++||.|.||.||.|+|+. .-.||||.|+.+. ...++|++|+.+|+.++|||+|+|+|+|..+-.
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 35667777778888999999999999999874 5679999998764 447899999999999999999999999999999
Q ss_pred eEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccc
Q 007892 280 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 359 (586)
Q Consensus 280 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~ 359 (586)
.|||.|||.+|+|.++|...++..++--.++.+|.||+.|++||..+ ++|||||.++|+|+.++..|||+||||+++
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhh
Confidence 99999999999999999988888888888999999999999999988 899999999999999999999999999998
Q ss_pred cCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCC
Q 007892 360 SLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGN 438 (586)
Q Consensus 360 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (586)
+............-...|.|||-+..+.++.|+|||+|||+|||+.| |..||-+.+... +.+ ++
T Consensus 415 MtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq---VY~----LL-------- 479 (1157)
T KOG4278|consen 415 MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYG----LL-------- 479 (1157)
T ss_pred hcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH---HHH----HH--------
Confidence 75443322222234568999999999999999999999999999999 999997655311 111 11
Q ss_pred hhhhhchhhh-ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 007892 439 FDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMP 488 (586)
Q Consensus 439 ~~~l~d~~l~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~~ 488 (586)
..... +-+..++..+.+|+.+||+++|.+||++.||-+.||....
T Consensus 480 -----EkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 480 -----EKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred -----hccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 11111 3456778899999999999999999999999999986543
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=332.17 Aligned_cols=256 Identities=28% Similarity=0.431 Sum_probs=209.4
Q ss_pred HHhcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEE
Q 007892 206 IATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 206 ~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
+..++|++.++||+|+||.||+|...+++.||+|.+..... ....+.+|+.++++++|+||+++++++. .+..+++||
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 44578999999999999999999988899999999876543 3568899999999999999999999874 467899999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 365 (586)
|+++++|.+++.......+++.+++.++.|++.||+|||+. +++||||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 99999999998766666789999999999999999999987 999999999999999999999999999976543322
Q ss_pred cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhc
Q 007892 366 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 444 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 444 (586)
.......++..|+|||++..+.++.++|||||||++|||++ |+.||..... ....... ..+..
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~--------~~~~~----- 221 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN---PEVIQNL--------ERGYR----- 221 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh---HHHHHHH--------HcCCC-----
Confidence 22233446778999999998899999999999999999999 9999975432 1111111 01100
Q ss_pred hhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 007892 445 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 485 (586)
Q Consensus 445 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~ 485 (586)
. .........+.+++.+|++.+|++||++++|+..|+.
T Consensus 222 --~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 222 --M-PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred --C-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0 1112234569999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=345.91 Aligned_cols=248 Identities=27% Similarity=0.408 Sum_probs=208.0
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
..|...++||+|.||.||||... .++.||+|++.-... ....++++|+.+|..++++||.+.+|.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 34667789999999999999954 688999999976533 4457899999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 366 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 366 (586)
|.||++.+.|... ..+++..+.-|..+++.||.|||.+ +.+|||||+.||||..+|.+||+|||++.........
T Consensus 93 ~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 93 CGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred hcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence 9999999999543 3357778888999999999999999 9999999999999999999999999999876544333
Q ss_pred ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchh
Q 007892 367 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 446 (586)
Q Consensus 367 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 446 (586)
..+++||+.|||||+++...|+.|+||||||++.+||.+|.+|+....+....-+ +.+-..|.
T Consensus 168 -r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl----------------Ipk~~PP~ 230 (467)
T KOG0201|consen 168 -RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL----------------IPKSAPPR 230 (467)
T ss_pred -cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe----------------ccCCCCCc
Confidence 3678999999999999988999999999999999999999999987665211000 11112222
Q ss_pred hhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 447 LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 447 l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
|+ ......+.+++..||+.+|+.||++.++++
T Consensus 231 L~---~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 231 LD---GDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred cc---cccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 32 245567999999999999999999999985
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=336.82 Aligned_cols=257 Identities=25% Similarity=0.462 Sum_probs=205.0
Q ss_pred HHhcCccccceecccCcEEEEEEEEe------CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 007892 206 IATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGS 278 (586)
Q Consensus 206 ~~~~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~ 278 (586)
+..++|+..+.||+|+||.||+|.+. .+..||||.+..... ....+|.+|+.++.+++|+||++++++|..+.
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 35678999999999999999999853 246799999865432 33457889999999999999999999999999
Q ss_pred eeEEEEEecCCCcHHHHhcCCC--------CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeE
Q 007892 279 QRLLVYEFVPNKTLEFHLHGKD--------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAK 350 (586)
Q Consensus 279 ~~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 350 (586)
..++||||+++++|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+|||+++++.+|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEE
Confidence 9999999999999999986432 12467888999999999999999998 999999999999999999999
Q ss_pred EeecccccccCCCCCc-ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhH
Q 007892 351 VADFGLAKHSLDTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKP 428 (586)
Q Consensus 351 l~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~ 428 (586)
|+|||+++........ ......++..|+|||++.++.++.++|||||||++|||++ |..||..... .....+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~---~~~~~~~-- 234 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN---EQVLRFV-- 234 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHH--
Confidence 9999999765332221 1122345788999999998899999999999999999999 7889865432 1111110
Q ss_pred HHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 007892 429 FLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484 (586)
Q Consensus 429 ~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~ 484 (586)
..+.. ...+......+.+++.+|++.+|.+||++.|+++.|+
T Consensus 235 ------~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 235 ------MEGGL--------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred ------HcCCc--------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 01111 1112233457899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=337.53 Aligned_cols=256 Identities=26% Similarity=0.464 Sum_probs=209.4
Q ss_pred cCccccceecccCcEEEEEEEEe------CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 282 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~l 282 (586)
.+|.+.+.||+|+||.||+|... ++..+++|.++.........+.+|++++++++|+||++++++|...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45788899999999999999843 356799999877666556789999999999999999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCC--------------CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCC
Q 007892 283 VYEFVPNKTLEFHLHGKD--------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE 348 (586)
Q Consensus 283 V~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 348 (586)
||||+++++|.+++.... ...++|..++.++.|++.||+|||++ +|+||||||+|||+++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 999999999999986532 23489999999999999999999998 9999999999999999999
Q ss_pred eEEeecccccccCCCCC-cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhh
Q 007892 349 AKVADFGLAKHSLDTDT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWA 426 (586)
Q Consensus 349 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~ 426 (586)
+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |+.||...... ...+.
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~~- 237 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT---EVIEC- 237 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH-
Confidence 99999999976543322 12233456788999999998999999999999999999999 99998764421 11111
Q ss_pred hHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 427 KPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 427 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
+..+... ......+..+.+++.+||+.+|.+||++.+|++.|+..
T Consensus 238 -------~~~~~~~--------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~ 282 (291)
T cd05094 238 -------ITQGRVL--------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282 (291)
T ss_pred -------HhCCCCC--------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 1111111 11122345789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=336.24 Aligned_cols=247 Identities=24% Similarity=0.393 Sum_probs=211.8
Q ss_pred cCccccceecccCcEEEEEEEE-eCCeEEEEEEeccCCchhH---HHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGE---REFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~---~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
.+|++.+.||+|.||+|-++.. ..|+.||||.++++.-.++ -.+++||+||+.|+||||+.++.+|+..+.+.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 5688889999999999999995 6799999999987654444 45789999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
||..+|.|.+++... ..|++.+..+++.||..|+.|||.+ +++|||||.+|||||+|+++||+||||+..+.+.
T Consensus 133 EYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~- 206 (668)
T KOG0611|consen 133 EYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYADK- 206 (668)
T ss_pred EecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhccc-
Confidence 999999999999654 4599999999999999999999998 9999999999999999999999999999877443
Q ss_pred CcccccccccccccCcccccCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhh
Q 007892 365 THVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 443 (586)
Q Consensus 365 ~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 443 (586)
...+++||++.|.+||.+.+..| .+..|-|||||+||-|+.|..||++.+.. . +.+++..|.+.+
T Consensus 207 -kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk---~--------lvrQIs~GaYrE-- 272 (668)
T KOG0611|consen 207 -KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK---R--------LVRQISRGAYRE-- 272 (668)
T ss_pred -cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH---H--------HHHHhhcccccC--
Confidence 44577999999999999999887 57899999999999999999999976641 1 223344554433
Q ss_pred chhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007892 444 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRAL 483 (586)
Q Consensus 444 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L 483 (586)
...+....-++.+||..+|.+|.|+.+|....
T Consensus 273 --------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 273 --------PETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred --------CCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 22234466789999999999999999998765
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=352.96 Aligned_cols=261 Identities=23% Similarity=0.378 Sum_probs=207.3
Q ss_pred HHhcCccccceecccCcEEEEEEEEeC------CeEEEEEEeccCCc-hhHHHHHHHHHHHHhcC-CCCcceEEEEEEeC
Q 007892 206 IATDNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQLKAGSG-QGEREFQAEIEIISQVH-HRHLVSLVGYCTFG 277 (586)
Q Consensus 206 ~~~~~f~~~~~LG~G~fG~Vyk~~~~~------g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~ 277 (586)
...++|.+.++||+|+||.||+|+... +..||||+++.... ...+.+.+|+++|.++. |||||+++++|...
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 345788999999999999999998531 34799999975433 23457899999999996 99999999999999
Q ss_pred CeeEEEEEecCCCcHHHHhcCCC---------------------------------------------------------
Q 007892 278 SQRLLVYEFVPNKTLEFHLHGKD--------------------------------------------------------- 300 (586)
Q Consensus 278 ~~~~lV~E~~~~gsL~~~l~~~~--------------------------------------------------------- 300 (586)
+..+|||||+++|+|.++|+...
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 99999999999999998886421
Q ss_pred -------------------------------------CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEe
Q 007892 301 -------------------------------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL 343 (586)
Q Consensus 301 -------------------------------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl 343 (586)
...+++..++.++.|+++||+|||+. +|+||||||+|||+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEE
Confidence 12478888999999999999999998 99999999999999
Q ss_pred CCCCCeEEeecccccccCCCCCc-ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchh
Q 007892 344 DDSFEAKVADFGLAKHSLDTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDS 421 (586)
Q Consensus 344 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~ 421 (586)
++++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||+||||++ |..||...... ..
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~--~~ 348 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD--ST 348 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh--HH
Confidence 99999999999999865432221 1223457788999999998999999999999999999997 99998753221 11
Q ss_pred hhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 422 MVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 422 ~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
+... + ..+. ....+......+.+++.+||+.+|++||++.+|++.|+...
T Consensus 349 ~~~~----~----~~~~--------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 349 FYNK----I----KSGY--------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HHHH----H----hcCC--------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 1110 1 0110 00112234567899999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=345.00 Aligned_cols=242 Identities=24% Similarity=0.349 Sum_probs=196.6
Q ss_pred ceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecCCC
Q 007892 215 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNK 290 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g 290 (586)
+.||+|+||.||++... +|+.||+|+++... ......+.+|+.++.+++||||+++++++...+..+|||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999964 68999999987532 223456778999999999999999999999999999999999999
Q ss_pred cHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCccccc
Q 007892 291 TLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTR 370 (586)
Q Consensus 291 sL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 370 (586)
+|..++... ..+++..+..++.|++.||+|||++ +|+||||||+||||++++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 154 (323)
T cd05595 81 ELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKT 154 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccccc
Confidence 999888654 3589999999999999999999998 99999999999999999999999999987532221 12234
Q ss_pred ccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhcc
Q 007892 371 VMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEY 450 (586)
Q Consensus 371 ~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~ 450 (586)
..||+.|+|||++.++.++.++|||||||+||||++|+.||...+.. .+.. ... .+.. .+
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---~~~~---~~~-----~~~~---------~~ 214 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFE---LIL-----MEEI---------RF 214 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH---HHHH---HHh-----cCCC---------CC
Confidence 57999999999999999999999999999999999999999754321 1100 000 0000 12
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 007892 451 DSAEMTRMAACAAACIRHSARRRP-----RMSQIVRA 482 (586)
Q Consensus 451 ~~~~~~~l~~l~~~cl~~dp~~RP-----tm~evl~~ 482 (586)
+......+.+++.+||+.||.+|+ ++.++++.
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 223345688999999999999998 78888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=335.90 Aligned_cols=267 Identities=24% Similarity=0.351 Sum_probs=198.3
Q ss_pred cCccccceecccCcEEEEEEEEe--CCeEEEEEEeccCCc--hhHHHHHHHHHHHHhc---CCCCcceEEEEEEe-----
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT--NGKVVAIKQLKAGSG--QGEREFQAEIEIISQV---HHRHLVSLVGYCTF----- 276 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~--~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l---~Hpniv~l~g~~~~----- 276 (586)
++|++.+.||+|+||.||+|+.. +++.||||.++.... .....+.+|+.++.++ +||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999863 468899999865432 2234566788877766 69999999999863
Q ss_pred CCeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccc
Q 007892 277 GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGL 356 (586)
Q Consensus 277 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGl 356 (586)
....++||||++ ++|.+++.......+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 346789999996 6888888766556689999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccc-hhhhhhhhHH----Hh
Q 007892 357 AKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFAD-DSMVDWAKPF----LA 431 (586)
Q Consensus 357 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~-~~~~~~~~~~----~~ 431 (586)
++..... .......|++.|+|||.+.+..++.++|||||||+||||++|+.||........ ..+.+..... +.
T Consensus 157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 9765332 223445789999999999888999999999999999999999999986543211 0011100000 00
Q ss_pred hc--ccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 432 QG--LADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 432 ~~--~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
+. +....+.......++.........+.+++.+||+.||++||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00 000000000000111111223456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=330.53 Aligned_cols=252 Identities=27% Similarity=0.441 Sum_probs=203.8
Q ss_pred cCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecC
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVP 288 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 288 (586)
.+|++.+.||+|+||.||++.+.++..+|||.+..... ....+.+|++++.+++|+||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 35777899999999999999987777899999865432 34578899999999999999999999999999999999999
Q ss_pred CCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCccc
Q 007892 289 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 368 (586)
Q Consensus 289 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 368 (586)
+++|.+++..... .++|..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...+......
T Consensus 83 ~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 83 NGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 9999999875433 589999999999999999999998 899999999999999999999999999986543322222
Q ss_pred ccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhh
Q 007892 369 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 447 (586)
Q Consensus 369 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 447 (586)
....++..|+|||++.+..++.++|||||||+||||++ |+.||...... ..... +. .+ + . .
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~----~~----~~-~----~--~ 220 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS---EVVES----VS----AG-Y----R--L 220 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH---HHHHH----HH----cC-C----c--C
Confidence 22234457999999998999999999999999999999 89999754321 11110 00 00 0 0 0
Q ss_pred hccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 007892 448 EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484 (586)
Q Consensus 448 ~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~ 484 (586)
..+...+..+.+++.+|+..+|++||+|.||++.|.
T Consensus 221 -~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 221 -YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred -CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 111224557999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=336.77 Aligned_cols=259 Identities=25% Similarity=0.448 Sum_probs=209.1
Q ss_pred HhcCccccceecccCcEEEEEEEEe------CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCee
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR 280 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~ 280 (586)
..++|.+.+.||+|+||.||++... ++..+|+|.+..........+.+|++++.+++|+||++++++|...+..
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 3467899999999999999999852 3467999998776555567899999999999999999999999999999
Q ss_pred EEEEEecCCCcHHHHhcCCC-----------CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCe
Q 007892 281 LLVYEFVPNKTLEFHLHGKD-----------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA 349 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~~-----------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 349 (586)
++||||+++++|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence 99999999999999986432 23489999999999999999999998 99999999999999999999
Q ss_pred EEeecccccccCCCCCc-ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhh
Q 007892 350 KVADFGLAKHSLDTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAK 427 (586)
Q Consensus 350 kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~ 427 (586)
||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||...... .....
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~---~~~~~-- 234 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EVIEC-- 234 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH--
Confidence 99999999865332221 1223446778999999998899999999999999999998 99998754421 11111
Q ss_pred HHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 428 PFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 428 ~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
+..+... .........+.+++.+|++.+|.+||++.||+..|+...
T Consensus 235 ------i~~~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 235 ------ITQGRVL--------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred ------HHcCCcC--------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 1111111 111123356899999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=344.98 Aligned_cols=242 Identities=26% Similarity=0.350 Sum_probs=197.4
Q ss_pred ceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecCCC
Q 007892 215 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNK 290 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g 290 (586)
+.||+|+||.||++... +++.||||++.... ......+.+|+.+|.+++||||+++++++...+..+|||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999964 68999999997542 233457788999999999999999999999999999999999999
Q ss_pred cHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCccccc
Q 007892 291 TLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTR 370 (586)
Q Consensus 291 sL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 370 (586)
+|..++... ..+++.++..++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~ 154 (328)
T cd05593 81 ELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKT 154 (328)
T ss_pred CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccccc
Confidence 999888654 3589999999999999999999998 99999999999999999999999999997533221 12234
Q ss_pred ccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhcc
Q 007892 371 VMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEY 450 (586)
Q Consensus 371 ~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~ 450 (586)
.+||+.|+|||++.+..++.++|||||||+||||++|+.||...+.. ......+ .+.. .+
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~------~~~~~~~-----~~~~---------~~ 214 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELIL-----MEDI---------KF 214 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH------HHHHHhc-----cCCc---------cC
Confidence 67999999999999889999999999999999999999999754321 1111000 0000 12
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 007892 451 DSAEMTRMAACAAACIRHSARRRP-----RMSQIVRA 482 (586)
Q Consensus 451 ~~~~~~~l~~l~~~cl~~dp~~RP-----tm~evl~~ 482 (586)
+......+.+++.+||+.||.+|+ ++.|+++.
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 215 PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 223345688999999999999997 88988864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=329.95 Aligned_cols=257 Identities=28% Similarity=0.466 Sum_probs=210.7
Q ss_pred HHhcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEE
Q 007892 206 IATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 206 ~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
+..++|.+.+.||+|+||.||++.+.+++.||||.+.... ....++.+|+.++++++|+||+++++++......++|||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 4567899999999999999999998888899999987543 335679999999999999999999999998899999999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 365 (586)
|+++++|.+++.......+++.++..++.+++.||.|||++ +|+|+||||+||+|++++.+||+|||+++.......
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 99999999999876656799999999999999999999998 899999999999999999999999999986543222
Q ss_pred cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhc
Q 007892 366 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 444 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 444 (586)
.......++..|+|||.+.+..++.++|||||||++|||++ |+.||..... ........ .+ +.
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~~~~--------~~-~~---- 222 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN---REVLEQVE--------RG-YR---- 222 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH--------cC-CC----
Confidence 12222335568999999998899999999999999999999 9999965432 11111110 00 00
Q ss_pred hhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 007892 445 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 485 (586)
Q Consensus 445 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~ 485 (586)
. ..+...+..+.+++.+|++.+|.+||++.+|++.|+.
T Consensus 223 --~-~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 --M-PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred --C-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0 1112224578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=317.18 Aligned_cols=266 Identities=24% Similarity=0.374 Sum_probs=206.1
Q ss_pred cCccccceecccCcEEEEEEEE-eCCeEEEEEEeccCCchh--HHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQG--EREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~--~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
+.|...+.||+|.||.||+|+. .+|+.||||+++.....+ .....+||..|+.++|+||+.|+++|...+..-||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4577788999999999999994 579999999998764322 3567899999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 365 (586)
||+ .+|+..+..+. ..+.-..+..++.++++||+|||.+ .|+||||||.|+||+.+|.+||+||||++.+...+.
T Consensus 82 fm~-tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred ecc-ccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 995 58888886554 4578888999999999999999999 899999999999999999999999999998765544
Q ss_pred cccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHh-------hcccCC
Q 007892 366 HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLA-------QGLADG 437 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~-------~~~~~~ 437 (586)
. .+..+-|.+|.|||.+.+ ..|+...||||.|||+.||+-|.+-|.+....+ .+....+.+-. +...--
T Consensus 157 ~-~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDid--QL~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 157 I-QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDID--QLSKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred c-cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHH--HHHHHHHHcCCCCcccCccccccc
Confidence 3 333478999999998875 569999999999999999999877665544322 22111111000 000001
Q ss_pred Ch---hhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 438 NF---DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 438 ~~---~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.+ .....+.+...-..+.....+++..++..||.+|.++.|++++
T Consensus 234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11 1111222222334455667999999999999999999999864
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=334.20 Aligned_cols=255 Identities=26% Similarity=0.481 Sum_probs=204.5
Q ss_pred cCccccceecccCcEEEEEEEE-----eCCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVL-----TNGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 282 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~-----~~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~l 282 (586)
++|++.+.||+|+||.||+|++ .+++.||+|.++... .+....+.+|++++++++|+||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 5678889999999999999985 245789999997543 3334678899999999999999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCC---------------CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCC
Q 007892 283 VYEFVPNKTLEFHLHGKD---------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF 347 (586)
Q Consensus 283 V~E~~~~gsL~~~l~~~~---------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 347 (586)
||||+++++|.+++.... ...+++.+.+.++.|++.||+|||++ +|+||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 999999999999885321 23478899999999999999999998 999999999999999999
Q ss_pred CeEEeecccccccCCCCC-cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhh
Q 007892 348 EAKVADFGLAKHSLDTDT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDW 425 (586)
Q Consensus 348 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~ 425 (586)
.+||+|||+++....... .......++..|+|||++.++.++.++|||||||+||||++ |..||..... ..+.+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---~~~~~~ 238 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QEVIEM 238 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH
Confidence 999999999986533221 12233446778999999998899999999999999999998 9999865432 111111
Q ss_pred hhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 007892 426 AKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 485 (586)
Q Consensus 426 ~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~ 485 (586)
.. .+.. ...+......+.+++.+|++.+|.+||++.+|++.|..
T Consensus 239 ~~--------~~~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 VR--------KRQL--------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HH--------cCCc--------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 10 1110 01222334578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=343.32 Aligned_cols=252 Identities=25% Similarity=0.330 Sum_probs=199.6
Q ss_pred CccccceecccCcEEEEEEEEe----CCeEEEEEEeccCC----chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCee
Q 007892 210 NFSEANLLGQGGFGYVHKGVLT----NGKVVAIKQLKAGS----GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQR 280 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~----~g~~vAVK~l~~~~----~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~~~ 280 (586)
+|++.+.||+|+||.||+++.. +++.||+|+++... ......+..|+.++.++ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4788899999999999998853 57899999986432 12234678899999999 599999999999999999
Q ss_pred EEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccccc
Q 007892 281 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 360 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~ 360 (586)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++..
T Consensus 81 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 9999999999999998653 3488999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCCcccccccccccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCCh
Q 007892 361 LDTDTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 439 (586)
Q Consensus 361 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (586)
............||+.|+|||++.+. .++.++|||||||+||||++|+.||......... ........ .
T Consensus 156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~~~~~~~-----~--- 225 (332)
T cd05614 156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ--SEVSRRIL-----K--- 225 (332)
T ss_pred cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH--HHHHHHHh-----c---
Confidence 44333333456799999999999765 4789999999999999999999999754321111 11111100 0
Q ss_pred hhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 007892 440 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRP-----RMSQIVRA 482 (586)
Q Consensus 440 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RP-----tm~evl~~ 482 (586)
.++ .++......+.+++.+||+.||.+|| ++.|+++.
T Consensus 226 ---~~~---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 226 ---CDP---PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred ---CCC---CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 001 12223345678999999999999999 66677654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=328.90 Aligned_cols=254 Identities=31% Similarity=0.455 Sum_probs=206.3
Q ss_pred hcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEec
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 287 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 287 (586)
.++|.+.+.||+|+||.||++.+.++..+|+|.+.... ...+.+.+|+.++++++|+|++++++++. .+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 35688889999999999999998777789999886543 33567889999999999999999999875 45688999999
Q ss_pred CCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcc
Q 007892 288 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 367 (586)
Q Consensus 288 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 367 (586)
++++|.++++......++|..++.++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++.........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 999999999765555689999999999999999999998 89999999999999999999999999997654332222
Q ss_pred cccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchh
Q 007892 368 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 446 (586)
Q Consensus 368 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 446 (586)
.....++..|+|||++.++.++.++|||||||++|||++ |+.||..... .....+.. .+ ..
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~--------~~-~~------ 221 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN---REVLEQVE--------RG-YR------ 221 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH--------cC-CC------
Confidence 223346778999999998999999999999999999999 9999975432 11111110 00 00
Q ss_pred hhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 007892 447 LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 485 (586)
Q Consensus 447 l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~ 485 (586)
.......+..+.+++.+|++.+|.+||++.+|++.|+.
T Consensus 222 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 222 -MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 01122345678999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=341.65 Aligned_cols=241 Identities=25% Similarity=0.325 Sum_probs=194.6
Q ss_pred ecccCcEEEEEEEEe-CCeEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecCCCcH
Q 007892 217 LGQGGFGYVHKGVLT-NGKVVAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL 292 (586)
Q Consensus 217 LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~gsL 292 (586)
||+|+||.||+++.. +++.||+|+++.. .......+.+|+.+|.+++||||++++++|...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999975 5789999998643 223345678899999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCccccccc
Q 007892 293 EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM 372 (586)
Q Consensus 293 ~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 372 (586)
.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...... .......
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 154 (312)
T cd05585 81 FHHLQRE--GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFC 154 (312)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccccc
Confidence 9998654 3489999999999999999999998 99999999999999999999999999998643222 2234467
Q ss_pred ccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhccCH
Q 007892 373 GTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDS 452 (586)
Q Consensus 373 gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~ 452 (586)
||+.|+|||++.+..++.++|||||||+||||++|+.||..... ..+....+. + .+ .++.
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~------~~~~~~~~~-----~--------~~-~~~~ 214 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV------NEMYRKILQ-----E--------PL-RFPD 214 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH------HHHHHHHHc-----C--------CC-CCCC
Confidence 99999999999999999999999999999999999999975432 111111111 0 00 1223
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007892 453 AEMTRMAACAAACIRHSARRRPRMSQIVRAL 483 (586)
Q Consensus 453 ~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L 483 (586)
.....+.+++.+||+.||.+||++..+.+.|
T Consensus 215 ~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 215 GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 3445688999999999999998644333333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=335.06 Aligned_cols=255 Identities=24% Similarity=0.397 Sum_probs=204.2
Q ss_pred cCccccceecccCcEEEEEEEEeC------CeEEEEEEeccCCchh-HHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQLKAGSGQG-EREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 281 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~~------g~~vAVK~l~~~~~~~-~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~ 281 (586)
.+|++.+.||+|+||.||+|...+ ++.||||+++...... ...+.+|+.++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 346677899999999999998643 4789999997654332 356889999999999999999999999999999
Q ss_pred EEEEecCCCcHHHHhcCC--------------CCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCC
Q 007892 282 LVYEFVPNKTLEFHLHGK--------------DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF 347 (586)
Q Consensus 282 lV~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 347 (586)
+++||+++++|.+++... ....+++..+++++.|++.||+|||+. +|+||||||.|||+++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCC
Confidence 999999999999988532 123478889999999999999999998 999999999999999999
Q ss_pred CeEEeecccccccCCCCC-cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhh
Q 007892 348 EAKVADFGLAKHSLDTDT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDW 425 (586)
Q Consensus 348 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~ 425 (586)
.+||+|||+++....... .......+++.|+|||++..+.++.++|||||||+||||++ |..||..... . ++
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~---~~ 235 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---Q---DV 235 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---H---HH
Confidence 999999999886543222 11223446789999999988899999999999999999998 8888865432 1 11
Q ss_pred hhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 007892 426 AKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 485 (586)
Q Consensus 426 ~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~ 485 (586)
... +.+......+......+.+++..|++.+|.+||++.+|+..|+.
T Consensus 236 ~~~-------------i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 IEM-------------IRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHH-------------HHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111 11111112233445668899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=341.59 Aligned_cols=202 Identities=26% Similarity=0.419 Sum_probs=176.3
Q ss_pred HhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
..++|+..+.||+|+||.||++... ++..+|+|.++.... .....+.+|++++.+++|+||++++++|..++..+|||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 3478999999999999999999976 578899998876433 33457899999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
||+++++|.+++... ..+++.....++.+++.||.|||+.+ +|+||||||+|||+++++.+||+|||++......
T Consensus 83 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 83 EHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 999999999998653 34888999999999999999999752 6999999999999999999999999999764332
Q ss_pred CcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 007892 365 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKAD 415 (586)
Q Consensus 365 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~ 415 (586)
......|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 206 (333)
T cd06650 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206 (333)
T ss_pred --ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence 1233568999999999998889999999999999999999999997543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=347.07 Aligned_cols=263 Identities=21% Similarity=0.277 Sum_probs=199.3
Q ss_pred HhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEE
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
..++|++.+.||+|+||.||++... +++.||+|... ...+.+|+++|++++|||||++++++......++|+|
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 3467999999999999999999964 68899999753 2357889999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 365 (586)
++. ++|..++... ..+++.+++.|+.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++.......
T Consensus 164 ~~~-~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 164 RYK-TDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred cCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 995 6788777543 3488999999999999999999998 999999999999999999999999999975433332
Q ss_pred cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccch----hhhhhhhHHHh---hcc---c
Q 007892 366 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADD----SMVDWAKPFLA---QGL---A 435 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~----~~~~~~~~~~~---~~~---~ 435 (586)
.......||+.|+|||++.+..++.++|||||||+||||++|+.||......... .........+. ..+ .
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 3334567999999999999999999999999999999999999887543321111 00000000000 000 0
Q ss_pred CCChhhhhchh-------hh-----ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 436 DGNFDALVDQK-------LE-----EYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 436 ~~~~~~l~d~~-------l~-----~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
...+..+.... .. .........+.+++.+||+.||.+||++.|+++
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00011100000 00 001123457889999999999999999999986
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=332.89 Aligned_cols=255 Identities=27% Similarity=0.465 Sum_probs=206.1
Q ss_pred hcCccccceecccCcEEEEEEEEe------CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 281 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~ 281 (586)
..+|+..++||+|+||.||++... ++..+|+|.++.........|.+|++++.+++|+||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 356788899999999999999742 35689999988766666678999999999999999999999999999999
Q ss_pred EEEEecCCCcHHHHhcCCCC-------------CCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCC
Q 007892 282 LVYEFVPNKTLEFHLHGKDR-------------PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE 348 (586)
Q Consensus 282 lV~E~~~~gsL~~~l~~~~~-------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 348 (586)
+||||+++++|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+|||+++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCC
Confidence 99999999999999865321 3588999999999999999999998 9999999999999999999
Q ss_pred eEEeecccccccCCCCC-cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhh
Q 007892 349 AKVADFGLAKHSLDTDT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWA 426 (586)
Q Consensus 349 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~ 426 (586)
+||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |..||....... ....
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~- 236 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE---AIEC- 236 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH---HHHH-
Confidence 99999999975433221 11223345788999999998999999999999999999998 999986543211 1110
Q ss_pred hHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 007892 427 KPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484 (586)
Q Consensus 427 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~ 484 (586)
...+ .....+...+..+.+++.+||+.+|.+||++.||++.|+
T Consensus 237 -------~~~~--------~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 237 -------ITQG--------RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred -------HHcC--------ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 0000 000111223456889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=325.24 Aligned_cols=250 Identities=28% Similarity=0.408 Sum_probs=206.9
Q ss_pred CccccceecccCcEEEEEEEEe-CCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 210 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
+|...+.||+|+||.||+++.. +++.|++|.+... .......+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999965 6889999998643 334456789999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 366 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 366 (586)
+++++|.++++......+++..++.++.+++.||.|||+. +|+|+||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~- 156 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN- 156 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence 9999999999876556789999999999999999999988 999999999999999999999999999986543322
Q ss_pred ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchh
Q 007892 367 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 446 (586)
Q Consensus 367 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 446 (586)
......|+..|+|||++.++.++.++|||||||++|||++|+.||..... .....+. ..+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~--------~~~~-------- 217 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ---GALILKI--------IRGV-------- 217 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH--------HcCC--------
Confidence 22345688999999999998999999999999999999999999975542 1111110 0111
Q ss_pred hhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 447 LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 447 l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
...........+.+++.+|++.+|++||+|.+|++.
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 218 FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 111222345678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=338.77 Aligned_cols=255 Identities=25% Similarity=0.415 Sum_probs=202.6
Q ss_pred cCccccceecccCcEEEEEEEEe-CCe----EEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGK----VVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 282 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~----~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~l 282 (586)
.+|+..+.||+|+||.||+|++. ++. .||||.++... ....+++.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 56899999999999999999864 333 48999987543 23456789999999999999999999999864 5679
Q ss_pred EEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCC
Q 007892 283 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 283 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 362 (586)
|+||+++|+|.+++.... ..+++..+++++.|++.||+|||+. +|+||||||+||||++++.+||+|||+++....
T Consensus 86 v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccC
Confidence 999999999999987543 3488999999999999999999998 999999999999999999999999999987543
Q ss_pred CCCcc-cccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChh
Q 007892 363 TDTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 440 (586)
Q Consensus 363 ~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (586)
..... .....++..|+|||++.+..++.++|||||||+||||++ |+.||...... .+..+ + ..+..
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~---~~~~~----~----~~~~~- 229 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSI----L----EKGER- 229 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH----H----hCCCC-
Confidence 32221 122335678999999999999999999999999999998 99999754321 11111 1 01100
Q ss_pred hhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 441 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 441 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
+ ..+......+.+++..||..+|.+||++.+|+..|....
T Consensus 230 ------~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 230 ------L-PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred ------C-CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0 011122346889999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=348.10 Aligned_cols=251 Identities=26% Similarity=0.356 Sum_probs=204.1
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
++|.+.+.||+|+||.||+|... +++.||||+++... ......+.+|++++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46889999999999999999975 68999999987532 233467889999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999999999765 4589999999999999999999998 99999999999999999999999999998654332
Q ss_pred ----------------------------CcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 007892 365 ----------------------------THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADT 416 (586)
Q Consensus 365 ----------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~ 416 (586)
........||+.|+|||++.+..++.++|||||||+||||++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 1122345799999999999999999999999999999999999999976542
Q ss_pred ccc-hhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCC-HHHHHHH
Q 007892 417 FAD-DSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPR-MSQIVRA 482 (586)
Q Consensus 417 ~~~-~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPt-m~evl~~ 482 (586)
... ..+..|. ..+ .+. ........+.+++.+|++ +|.+||+ +.|+++.
T Consensus 236 ~~~~~~i~~~~----------~~~------~~p-~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 236 QETYNKIINWK----------ESL------RFP-PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHHHHhccC----------Ccc------cCC-CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 110 0011110 000 000 001134668889999997 9999999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=346.10 Aligned_cols=252 Identities=24% Similarity=0.357 Sum_probs=215.3
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe-eEEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ-RLLV 283 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~-~~lV 283 (586)
.++|...++||+|+||.++..+.+ +++.+++|.+.... ....+...+|+.++++++|||||...+.|.+++. .+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 367888999999999999998854 57899999986543 3334578899999999999999999999999888 8999
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCC
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 363 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 363 (586)
|+|++||+|.+.+....+..+++..+.+++.|++.|+.|||++ +|+|||||+.|||++.+..|||+|||+|+.....
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999999887777899999999999999999999988 9999999999999999999999999999987655
Q ss_pred CCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhh
Q 007892 364 DTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 443 (586)
Q Consensus 364 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 443 (586)
. .....+.||+.||+||.+.+.+|..|+|||||||++|||++-+++|...+.. .++. .++
T Consensus 160 ~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~---~Li~----------------ki~ 219 (426)
T KOG0589|consen 160 D-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS---ELIL----------------KIN 219 (426)
T ss_pred h-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH---HHHH----------------HHh
Confidence 4 2445688999999999999999999999999999999999999999876531 1111 112
Q ss_pred chhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 444 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 444 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.......+......+..++..|++.+|..||++.++|..
T Consensus 220 ~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 220 RGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred hccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 122223445566789999999999999999999999875
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=334.71 Aligned_cols=268 Identities=20% Similarity=0.297 Sum_probs=200.2
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
++|...+.||.|+||.||+|... +++.||+|.++... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56889999999999999999965 68899999986543 22345678999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 366 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 366 (586)
+++ +|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~- 158 (288)
T cd07871 85 LDS-DLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK- 158 (288)
T ss_pred CCc-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence 975 8888876433 3478899999999999999999998 999999999999999999999999999975432221
Q ss_pred ccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhh-hhh----hHHHhhcccCCChh
Q 007892 367 VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMV-DWA----KPFLAQGLADGNFD 440 (586)
Q Consensus 367 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~-~~~----~~~~~~~~~~~~~~ 440 (586)
......|++.|+|||++.+ ..++.++|||||||++|||++|+.||............ ... ...+........+.
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 2233568999999998865 56899999999999999999999999765431110000 000 00000000001111
Q ss_pred hhhchhh-----hccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 441 ALVDQKL-----EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 441 ~l~d~~l-----~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
....+.. ..........+++++..||+.||.+|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 1111110 00011123467899999999999999999999853
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=344.31 Aligned_cols=245 Identities=24% Similarity=0.305 Sum_probs=200.4
Q ss_pred cCccccceecccCcEEEEEEEEeC--CeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLTN--GKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~~--g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV 283 (586)
++|.+.+.||+|+||.||+|.+.+ +..||||++.... ......+.+|+.++..++||||+++++++.+.+..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 578889999999999999998653 3689999986432 22345688999999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCC
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 363 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 363 (586)
|||+++|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++.....
T Consensus 110 ~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 99999999999996543 488999999999999999999998 9999999999999999999999999999864321
Q ss_pred CCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhh
Q 007892 364 DTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 443 (586)
Q Consensus 364 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 443 (586)
.....||+.|+|||++.+..++.++|||||||+||||++|+.||...+... . + +.+..+..
T Consensus 185 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~---~--~------~~i~~~~~---- 245 (340)
T PTZ00426 185 ----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL---I--Y------QKILEGII---- 245 (340)
T ss_pred ----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH---H--H------HHHhcCCC----
Confidence 234579999999999998889999999999999999999999997543210 0 0 00111110
Q ss_pred chhhhccCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 007892 444 DQKLEEYDSAEMTRMAACAAACIRHSARRRP-----RMSQIVRA 482 (586)
Q Consensus 444 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RP-----tm~evl~~ 482 (586)
.++......+.+++.+|++.+|.+|+ ++.++++.
T Consensus 246 -----~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 -----YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -----CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 11222334578999999999999995 78888764
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=350.23 Aligned_cols=256 Identities=23% Similarity=0.279 Sum_probs=202.9
Q ss_pred HHHHhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 007892 204 LKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ 279 (586)
Q Consensus 204 l~~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~ 279 (586)
+....++|+..+.||+|+||.||+++.. +++.||||++... .......+.+|+.++.+++||||+++++++.+++.
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~ 117 (370)
T cd05596 38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY 117 (370)
T ss_pred CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3445578999999999999999999965 5889999998643 22233457889999999999999999999999999
Q ss_pred eEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccc
Q 007892 280 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 359 (586)
Q Consensus 280 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~ 359 (586)
.+|||||+++|+|.+++... .++......++.|++.||+|||+. +|+||||||+||||++++.+||+|||+++.
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 99999999999999988643 377888889999999999999998 999999999999999999999999999986
Q ss_pred cCCCCCcccccccccccccCcccccCC----CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhccc
Q 007892 360 SLDTDTHVSTRVMGTFGYLAPEYASSG----KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLA 435 (586)
Q Consensus 360 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 435 (586)
............+||+.|+|||++.+. .++.++|||||||+||||++|+.||...... ......+
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~----- 260 (370)
T cd05596 192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIM----- 260 (370)
T ss_pred ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH------HHHHHHH-----
Confidence 543322223446799999999998643 4789999999999999999999999764421 1001100
Q ss_pred CCChhhhhchhhh-ccCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 007892 436 DGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARR--RPRMSQIVRA 482 (586)
Q Consensus 436 ~~~~~~l~d~~l~-~~~~~~~~~l~~l~~~cl~~dp~~--RPtm~evl~~ 482 (586)
... ..+. .........+.+++..||+.+|.+ |+++.|+++.
T Consensus 261 ~~~------~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 261 DHK------NSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred cCC------CcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 000 0000 011123467889999999999988 9999999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=340.90 Aligned_cols=242 Identities=27% Similarity=0.407 Sum_probs=195.5
Q ss_pred ceecccCcEEEEEEEEe----CCeEEEEEEeccCC----chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 215 NLLGQGGFGYVHKGVLT----NGKVVAIKQLKAGS----GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~~~----~g~~vAVK~l~~~~----~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
+.||+|+||.||+++.. +++.||||+++... ......+.+|+++|.+++||||++++++|..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 68999999999999853 57899999987532 12234678899999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 366 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 366 (586)
+++++|.+++... ..+.+..+..++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 155 (323)
T cd05584 82 LSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT- 155 (323)
T ss_pred CCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-
Confidence 9999999998654 3477888889999999999999998 999999999999999999999999999975433222
Q ss_pred ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchh
Q 007892 367 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 446 (586)
Q Consensus 367 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 446 (586)
......|++.|+|||++.+..++.++|||||||+||||++|+.||...+.. ....... .+.
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~~~~~~~-----~~~-------- 216 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------KTIDKIL-----KGK-------- 216 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH------HHHHHHH-----cCC--------
Confidence 223457999999999999888999999999999999999999999764421 1111111 111
Q ss_pred hhccCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 007892 447 LEEYDSAEMTRMAACAAACIRHSARRRP-----RMSQIVRA 482 (586)
Q Consensus 447 l~~~~~~~~~~l~~l~~~cl~~dp~~RP-----tm~evl~~ 482 (586)
. ..+......+.+++.+||+.+|.+|| ++.++++.
T Consensus 217 ~-~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 217 L-NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred C-CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 1 11222345688999999999999999 78877653
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=342.78 Aligned_cols=260 Identities=27% Similarity=0.442 Sum_probs=204.3
Q ss_pred HhcCccccceecccCcEEEEEEEEe------CCeEEEEEEeccCCch-hHHHHHHHHHHHHhc-CCCCcceEEEEEEeC-
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSGQ-GEREFQAEIEIISQV-HHRHLVSLVGYCTFG- 277 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~~~~-~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~- 277 (586)
..++|++.+.||+|+||.||+|... +++.||+|+++..... ....+..|++++.++ +|+||++++++|...
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 3467889999999999999999742 2478999998754332 235678899999999 899999999988654
Q ss_pred CeeEEEEEecCCCcHHHHhcCCC---------------------------------------------------------
Q 007892 278 SQRLLVYEFVPNKTLEFHLHGKD--------------------------------------------------------- 300 (586)
Q Consensus 278 ~~~~lV~E~~~~gsL~~~l~~~~--------------------------------------------------------- 300 (586)
...+++|||+++++|.+++....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 56789999999999998885422
Q ss_pred --CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcc-cccccccccc
Q 007892 301 --RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV-STRVMGTFGY 377 (586)
Q Consensus 301 --~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y 377 (586)
...++|..+..++.|++.||+|||+. +|+||||||+||||++++.+||+|||+++......... .....++..|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 12589999999999999999999998 99999999999999999999999999998754332222 2234567789
Q ss_pred cCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHH
Q 007892 378 LAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMT 456 (586)
Q Consensus 378 ~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~ 456 (586)
+|||++.+..++.++|||||||+||||++ |..||...... +.+.. .+..+... ..+.....
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~--~~~~~--------~~~~~~~~--------~~~~~~~~ 303 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID--EEFCR--------RLKEGTRM--------RAPEYATP 303 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc--HHHHH--------HHhccCCC--------CCCccCCH
Confidence 99999999999999999999999999998 99999753321 11111 01111100 11122345
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 457 RMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 457 ~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
.+.+++.+|++.+|++||++.||++.|+...
T Consensus 304 ~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 304 EIYSIMLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 7899999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=327.26 Aligned_cols=254 Identities=26% Similarity=0.411 Sum_probs=202.1
Q ss_pred ccccceecccCcEEEEEEEEeC----CeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe-----
Q 007892 211 FSEANLLGQGGFGYVHKGVLTN----GKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ----- 279 (586)
Q Consensus 211 f~~~~~LG~G~fG~Vyk~~~~~----g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~----- 279 (586)
|.+.+.||+|+||.||+|.+.. +..||||+++... ......+.+|+++++.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5677899999999999999653 3679999987542 2334678999999999999999999999876554
Q ss_pred -eEEEEEecCCCcHHHHhcCC----CCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeec
Q 007892 280 -RLLVYEFVPNKTLEFHLHGK----DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADF 354 (586)
Q Consensus 280 -~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DF 354 (586)
.++|+||+++++|..++... ....+++...+.++.|++.||+|||+. +|+||||||+|||+++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 68999999999999888543 234689999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCCcc-cccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhh
Q 007892 355 GLAKHSLDTDTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQ 432 (586)
Q Consensus 355 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 432 (586)
|+++......... .....++..|+|||++....++.++|||||||++|||++ |..||..... ..+.++.
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---~~~~~~~------ 228 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---HEIYDYL------ 228 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH------
Confidence 9998654433221 122335678999999998899999999999999999999 8899865432 1111111
Q ss_pred cccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 433 GLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 433 ~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
..+. ....+......+.+++.+|++.||.+||++.||++.|+..
T Consensus 229 --~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 229 --RHGN--------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred --HcCC--------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0111 1112233456789999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=335.18 Aligned_cols=261 Identities=27% Similarity=0.441 Sum_probs=208.4
Q ss_pred HHHHhcCccccceecccCcEEEEEEEEeC------CeEEEEEEeccCC-chhHHHHHHHHHHHHhc-CCCCcceEEEEEE
Q 007892 204 LKIATDNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQLKAGS-GQGEREFQAEIEIISQV-HHRHLVSLVGYCT 275 (586)
Q Consensus 204 l~~~~~~f~~~~~LG~G~fG~Vyk~~~~~------g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~ 275 (586)
+.+..++|+..+.||+|+||.||++...+ ...+|+|.+.... ......+.+|++++.++ +|+||++++++|.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 44556778899999999999999998642 3689999987543 23345788999999999 7999999999999
Q ss_pred eCCeeEEEEEecCCCcHHHHhcCC--------------CCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCcee
Q 007892 276 FGSQRLLVYEFVPNKTLEFHLHGK--------------DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANI 341 (586)
Q Consensus 276 ~~~~~~lV~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NI 341 (586)
.++..+++|||+++|+|..+++.. ....+++..++.++.|++.||+|||+. +|+||||||+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeE
Confidence 999999999999999999998642 234689999999999999999999998 999999999999
Q ss_pred EeCCCCCeEEeecccccccCCCCCc-ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccc
Q 007892 342 LLDDSFEAKVADFGLAKHSLDTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFAD 419 (586)
Q Consensus 342 Ll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~ 419 (586)
|+++++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-- 241 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE-- 241 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH--
Confidence 9999999999999999865433221 1122335678999999998899999999999999999998 99998654321
Q ss_pred hhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 420 DSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 420 ~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
.+.. .+. .+. ....+......+.+++.+|++.+|.+||+|.||++.|+..
T Consensus 242 -~~~~----~~~----~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 242 -ELFK----LLK----EGY--------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred -HHHH----HHH----cCC--------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 1111 000 000 0012223345788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=333.50 Aligned_cols=252 Identities=27% Similarity=0.383 Sum_probs=203.4
Q ss_pred CccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEE
Q 007892 210 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
+|+..+.||+|+||.||++... +++.||||++..... .....+.+|+.++.+++|+||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999964 688999999865322 223457789999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 365 (586)
|+++|+|.+++.......+++..+..++.|++.||.|||+. +|+||||||+|||+++++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 99999999888655445689999999999999999999998 999999999999999999999999999976532221
Q ss_pred cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhch
Q 007892 366 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQ 445 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 445 (586)
.....|+..|+|||++.+..++.++|||||||+||||++|+.||....... ....... .+..
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---~~~~~~~-------------~~~~ 219 (285)
T cd05605 158 --IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---KREEVER-------------RVKE 219 (285)
T ss_pred --cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh---HHHHHHH-------------Hhhh
Confidence 233568999999999998899999999999999999999999997543211 0000000 0111
Q ss_pred hhhccCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 007892 446 KLEEYDSAEMTRMAACAAACIRHSARRRP-----RMSQIVRA 482 (586)
Q Consensus 446 ~l~~~~~~~~~~l~~l~~~cl~~dp~~RP-----tm~evl~~ 482 (586)
....+.......+.+++..|++.||.+|| ++.++++.
T Consensus 220 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 220 DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 11123334456788999999999999999 77787654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=335.49 Aligned_cols=259 Identities=26% Similarity=0.424 Sum_probs=207.7
Q ss_pred HhcCccccceecccCcEEEEEEEEe------CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCC
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSG-QGEREFQAEIEIISQV-HHRHLVSLVGYCTFGS 278 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~ 278 (586)
..++|...+.||+|+||.||++... .+..||||+++.... .....+.+|+.+++++ +|+||++++++|...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3467899999999999999999742 345899999876532 3345789999999999 7999999999999999
Q ss_pred eeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccc
Q 007892 279 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 358 (586)
Q Consensus 279 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~ 358 (586)
..++||||+++|+|.++++......+++.+++.++.+++.||+|||+. +|+|+||||+|||+++++.+||+|||+++
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccc
Confidence 999999999999999999765555589999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCc-ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccC
Q 007892 359 HSLDTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLAD 436 (586)
Q Consensus 359 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (586)
........ ......++..|+|||++.++.++.++|||||||++|||++ |..||...... .....+ +. .
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~--~~~~~~----~~----~ 259 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD--SKFYKL----IK----E 259 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch--HHHHHH----HH----c
Confidence 65433221 1222345778999999998999999999999999999998 99998754321 111111 10 1
Q ss_pred CChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 437 GNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 437 ~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
+. . ..........+.+++.+|+..+|++||++.||++.|+..
T Consensus 260 ~~-~-------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 260 GY-R-------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CC-c-------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 10 0 011112245789999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=333.50 Aligned_cols=259 Identities=25% Similarity=0.459 Sum_probs=206.2
Q ss_pred HHhcCccccceecccCcEEEEEEEEeC------CeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 007892 206 IATDNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGS 278 (586)
Q Consensus 206 ~~~~~f~~~~~LG~G~fG~Vyk~~~~~------g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~ 278 (586)
+..++|++.+.||+|+||.||+|...+ +..||||.++.... .....+.+|+.++.+++|+||+++++++...+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 456789999999999999999997542 45899999865432 23456889999999999999999999999999
Q ss_pred eeEEEEEecCCCcHHHHhcCCC--------CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeE
Q 007892 279 QRLLVYEFVPNKTLEFHLHGKD--------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAK 350 (586)
Q Consensus 279 ~~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 350 (586)
..++||||+++|+|.+++.... ...+.+..+..++.|++.||.|||++ +|+||||||+|||+++++.+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEE
Confidence 9999999999999999996422 23456778899999999999999998 999999999999999999999
Q ss_pred EeecccccccCCCCCc-ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhH
Q 007892 351 VADFGLAKHSLDTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKP 428 (586)
Q Consensus 351 l~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~ 428 (586)
|+|||+++........ ......++..|+|||.+.++.++.++|||||||++|||++ |..||...... ....+
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~---~~~~~--- 233 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE---QVLKF--- 233 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH---
Confidence 9999999865332221 1222345778999999998999999999999999999999 78898654321 11111
Q ss_pred HHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 429 FLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 429 ~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
+.+......+......+.+++.+|++.+|++||++.++++.|+..
T Consensus 234 -------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 234 -------------VMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred -------------HHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 111111112223346799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=343.18 Aligned_cols=242 Identities=24% Similarity=0.348 Sum_probs=196.2
Q ss_pred ceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecCCC
Q 007892 215 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNK 290 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g 290 (586)
+.||+|+||.||++... +|+.||||+++... ......+..|++++..++||||+++++++...+..+|||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999964 68899999997532 223456778999999999999999999999999999999999999
Q ss_pred cHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhh-cCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcccc
Q 007892 291 TLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHE-DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 369 (586)
Q Consensus 291 sL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 369 (586)
+|..++... ..+++..+..++.|++.||+|||+ . +|+||||||+||||++++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~ 154 (325)
T cd05594 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMK 154 (325)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-ccc
Confidence 999888644 358999999999999999999997 5 899999999999999999999999999875432222 223
Q ss_pred cccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhc
Q 007892 370 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEE 449 (586)
Q Consensus 370 ~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 449 (586)
...||+.|+|||++.++.++.++|||||||+||||++|+.||...... .+. .... .+.. .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~---~~~---~~i~-----~~~~---------~ 214 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLF---ELIL-----MEEI---------R 214 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH---HHH---HHHh-----cCCC---------C
Confidence 457999999999999999999999999999999999999999754321 111 1000 0000 1
Q ss_pred cCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 007892 450 YDSAEMTRMAACAAACIRHSARRRP-----RMSQIVRA 482 (586)
Q Consensus 450 ~~~~~~~~l~~l~~~cl~~dp~~RP-----tm~evl~~ 482 (586)
++......+.+++.+||+.||.+|+ ++.++++.
T Consensus 215 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 215 FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 2222345688999999999999996 89998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=359.58 Aligned_cols=259 Identities=23% Similarity=0.339 Sum_probs=213.7
Q ss_pred HHHhcCccccceecccCcEEEEEEEEeCC-eEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCCcceEEEE-EEe---C-
Q 007892 205 KIATDNFSEANLLGQGGFGYVHKGVLTNG-KVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGY-CTF---G- 277 (586)
Q Consensus 205 ~~~~~~f~~~~~LG~G~fG~Vyk~~~~~g-~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~-Hpniv~l~g~-~~~---~- 277 (586)
.+...++++.+.|.+|||+.||+++...+ ..||+|++-..+....+.+++||++|++|. |+|||.+++. ... .
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 45566788899999999999999998766 999999998888888899999999999997 9999999993 221 1
Q ss_pred --CeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecc
Q 007892 278 --SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 355 (586)
Q Consensus 278 --~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFG 355 (586)
-+.+|.||||.||.|-++|.......|.+.++++|+.++++|+++||. +.|+|||||||.+||||+.++..||||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCccc
Confidence 357899999999999999976555569999999999999999999998 47889999999999999999999999999
Q ss_pred cccccCCCCCccc--------ccccccccccCcccc---cCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhh
Q 007892 356 LAKHSLDTDTHVS--------TRVMGTFGYLAPEYA---SSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD 424 (586)
Q Consensus 356 la~~~~~~~~~~~--------~~~~gt~~y~aPE~~---~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~ 424 (586)
-+........... -...-|+.|+|||.+ .+..+++|+|||+|||+||-||....||+.....
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l------- 264 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL------- 264 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-------
Confidence 9875322221100 113468999999977 4678999999999999999999999999865331
Q ss_pred hhhHHHhhcccCCChhhhhchhhh-ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 425 WAKPFLAQGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 425 ~~~~~~~~~~~~~~~~~l~d~~l~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
.|++.... ........+|..||..||+.+|.+||++-||+..+..++
T Consensus 265 ----------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~ 312 (738)
T KOG1989|consen 265 ----------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA 312 (738)
T ss_pred ----------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence 12222222 122467789999999999999999999999999887654
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=348.52 Aligned_cols=254 Identities=24% Similarity=0.296 Sum_probs=201.1
Q ss_pred HHHHhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 007892 204 LKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ 279 (586)
Q Consensus 204 l~~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~ 279 (586)
+....++|+..+.||+|+||.||++... +++.||+|.+... .......+.+|+.++..++||||+++++++..++.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 3444578999999999999999999975 5789999998642 22234567899999999999999999999999999
Q ss_pred eEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccc
Q 007892 280 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 359 (586)
Q Consensus 280 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~ 359 (586)
.++||||+++|+|.+++... .+++.....++.|++.||+|||+. +|+||||||+||||++++.+||+|||+++.
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEeccccee
Confidence 99999999999999998543 378888999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCCcccccccccccccCcccccCC----CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhccc
Q 007892 360 SLDTDTHVSTRVMGTFGYLAPEYASSG----KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLA 435 (586)
Q Consensus 360 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 435 (586)
............+||+.|+|||++.+. .++.++|||||||+||||++|+.||...... ....
T Consensus 192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~------~~~~-------- 257 (370)
T cd05621 192 MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV------GTYS-------- 257 (370)
T ss_pred cccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH------HHHH--------
Confidence 543332233456799999999998653 3789999999999999999999999754321 1111
Q ss_pred CCChhhhhchh--hh-ccCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 007892 436 DGNFDALVDQK--LE-EYDSAEMTRMAACAAACIRHSARR--RPRMSQIVRA 482 (586)
Q Consensus 436 ~~~~~~l~d~~--l~-~~~~~~~~~l~~l~~~cl~~dp~~--RPtm~evl~~ 482 (586)
.+++.. +. .........+.+++..|+..++.+ |+++.|++++
T Consensus 258 -----~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 258 -----KIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -----HHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 111111 00 111123456778888999755544 8899998875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=330.96 Aligned_cols=256 Identities=28% Similarity=0.453 Sum_probs=204.0
Q ss_pred HhcCccccceecccCcEEEEEEEEeC------CeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ 279 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~~------g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~ 279 (586)
..++|.+.+.||+|+||.||+|.+.+ +..||+|.+.... ...+..|..|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 35678999999999999999999753 5689999886543 3335678999999999999999999999999899
Q ss_pred eEEEEEecCCCcHHHHhcCCCC-----CCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCC---CeEE
Q 007892 280 RLLVYEFVPNKTLEFHLHGKDR-----PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF---EAKV 351 (586)
Q Consensus 280 ~~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~---~~kl 351 (586)
.++||||+++++|.++++.... ..++|..+++++.|++.||+|||+. +++||||||+|||++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence 9999999999999999865431 3589999999999999999999998 899999999999998654 5999
Q ss_pred eecccccccCCCCCc-ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHH
Q 007892 352 ADFGLAKHSLDTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPF 429 (586)
Q Consensus 352 ~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~ 429 (586)
+|||+++........ .......+..|+|||++.+..++.++|||||||++|||++ |+.||...... .+...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---~~~~~---- 233 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---EVMEF---- 233 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH----
Confidence 999999865322211 1112234568999999998999999999999999999997 99999754321 11110
Q ss_pred HhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 007892 430 LAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484 (586)
Q Consensus 430 ~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~ 484 (586)
+.. ... ...+......+.+++.+|++.+|++||++.+|++.|+
T Consensus 234 ~~~---~~~---------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 234 VTG---GGR---------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHc---CCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 000 000 0122233467889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=330.86 Aligned_cols=256 Identities=26% Similarity=0.467 Sum_probs=207.3
Q ss_pred HhcCccccceecccCcEEEEEEEEeC------CeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ 279 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~~------g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~ 279 (586)
..++|.+.+.||+|+||.||+|...+ +..||+|.+..... .....+.+|+.++.+++|+||+++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 45688899999999999999998643 36899999875532 334578899999999999999999999999999
Q ss_pred eEEEEEecCCCcHHHHhcCCC--------CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEE
Q 007892 280 RLLVYEFVPNKTLEFHLHGKD--------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKV 351 (586)
Q Consensus 280 ~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl 351 (586)
.++||||+++++|.+++.... ...+.|..++.++.|++.||.|||+. +|+||||||+|||++.++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEE
Confidence 999999999999999986432 23478999999999999999999988 9999999999999999999999
Q ss_pred eecccccccCCCCC-cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHH
Q 007892 352 ADFGLAKHSLDTDT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPF 429 (586)
Q Consensus 352 ~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~ 429 (586)
+|||+++....... .......++..|+|||.+..+.++.++|||||||++|||++ |..||..... .....+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~~~~~-- 235 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN---EEVLKFVI-- 235 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH---HHHHHHHh--
Confidence 99999986543322 12233456789999999998889999999999999999998 9999965432 11111110
Q ss_pred HhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 007892 430 LAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484 (586)
Q Consensus 430 ~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~ 484 (586)
.+.. ...+......+.+++.+||+.+|.+||++.+|+..|+
T Consensus 236 ------~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 ------DGGH--------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred ------cCCC--------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 1110 0122223567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=322.41 Aligned_cols=247 Identities=29% Similarity=0.447 Sum_probs=200.3
Q ss_pred ceecccCcEEEEEEEEeCCeEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecCCCcHH
Q 007892 215 NLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLE 293 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~-~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~gsL~ 293 (586)
++||+|+||.||+|...+++.||+|.++..... ....+.+|++++.+++|+||++++++|...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 369999999999999888899999998765433 2347889999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcccccccc
Q 007892 294 FHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMG 373 (586)
Q Consensus 294 ~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~g 373 (586)
+++.... ..+++..++.++.+++.+|.|||+. +++||||||+||++++++.+||+|||++...............+
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 81 SFLRKKK-DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 9886543 3588999999999999999999988 99999999999999999999999999987543322222222345
Q ss_pred cccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhccCH
Q 007892 374 TFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDS 452 (586)
Q Consensus 374 t~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~ 452 (586)
+..|+|||++..+.++.++|||||||++|||++ |..||...... ..... +.. +.. . ....
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~---~~~~~----~~~----~~~-------~-~~~~ 217 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ---QAREQ----VEK----GYR-------M-SCPQ 217 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH---HHHHH----HHc----CCC-------C-CCCC
Confidence 678999999998999999999999999999998 99999654321 11110 100 000 0 1122
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 007892 453 AEMTRMAACAAACIRHSARRRPRMSQIVRALE 484 (586)
Q Consensus 453 ~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~ 484 (586)
.....+.+++.+|+..+|.+||++.||++.|.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 23467899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=358.71 Aligned_cols=258 Identities=25% Similarity=0.327 Sum_probs=206.5
Q ss_pred HHHHHhcCccccceecccCcEEEEEEEE-eCCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC-
Q 007892 203 ELKIATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS- 278 (586)
Q Consensus 203 el~~~~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~- 278 (586)
+.+...++|.+.+.||+|+||+||++.. .+|+.||||++.... ......+.+|+.++..++|+||++++..+...+
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 3444557899999999999999999985 468999999986542 334457889999999999999999988775432
Q ss_pred -------eeEEEEEecCCCcHHHHhcCC--CCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCe
Q 007892 279 -------QRLLVYEFVPNKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA 349 (586)
Q Consensus 279 -------~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 349 (586)
..++||||+++|+|.++++.. ....+.+..+..++.|++.||.|||+. +|+||||||+||||+.++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCE
Confidence 367999999999999988643 234588899999999999999999998 99999999999999999999
Q ss_pred EEeecccccccCCCC-CcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhH
Q 007892 350 KVADFGLAKHSLDTD-THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKP 428 (586)
Q Consensus 350 kl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~ 428 (586)
||+|||+++...... .......+||+.|+|||++.+..++.++|||||||+||||++|+.||..... .++...
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~------~~~~~~ 256 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM------EEVMHK 256 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------HHHHHH
Confidence 999999998654322 1223456799999999999999999999999999999999999999975432 111111
Q ss_pred HHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 429 FLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 429 ~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.+ .+.+ ...+......+.+++..||+.+|.+||++.+|++.
T Consensus 257 ~~-----~~~~--------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 257 TL-----AGRY--------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred Hh-----cCCC--------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11 1111 11223345678999999999999999999999864
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=347.20 Aligned_cols=251 Identities=23% Similarity=0.363 Sum_probs=198.9
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
++|+..+.||+|+||.||+++.. +++.||||+++... ......+.+|+++|..++|+||+++++++.+++..+|||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47889999999999999999965 58899999996532 223456788999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 81 EYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 9999999999986543 489999999999999999999998 99999999999999999999999999987542211
Q ss_pred Cc-------------------------------------ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhC
Q 007892 365 TH-------------------------------------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITG 407 (586)
Q Consensus 365 ~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG 407 (586)
.. .....+||+.|+|||++....++.++|||||||+||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 00 01124699999999999999999999999999999999999
Q ss_pred CCCCCCCCcccc-hhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCC---HHHHHHH
Q 007892 408 FRPFDKADTFAD-DSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPR---MSQIVRA 482 (586)
Q Consensus 408 ~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPt---m~evl~~ 482 (586)
+.||........ ..+..|.. .+ . . .........+.+++.+|+. +|.+|++ +.|+++.
T Consensus 236 ~~Pf~~~~~~~~~~~i~~~~~----------~~---~---~-~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 236 YPPFCSDNPQETYRKIINWKE----------TL---Q---F-PDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCHHHHHHHHHcCCC----------cc---C---C-CCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999976543110 00111100 00 0 0 0001123457788888986 8999998 8888764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=325.83 Aligned_cols=256 Identities=27% Similarity=0.431 Sum_probs=208.7
Q ss_pred HHhcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEE
Q 007892 206 IATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 206 ~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
+..++|+..+.||+|+||.||++.+.++..+|+|.+.... .....+.+|++++++++|+||+++++++.. ...+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 3457899999999999999999998778889999887543 335678999999999999999999999887 77899999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 365 (586)
|+++++|.+++.......+++.+++.++.+++.||.|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 99999999999776556689999999999999999999987 999999999999999999999999999976543322
Q ss_pred cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhc
Q 007892 366 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 444 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 444 (586)
.......++..|+|||++..+.++.++|||||||++|+|++ |+.||..... ..+..+. ..+..
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~~~~--------~~~~~----- 221 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVIRAL--------ERGYR----- 221 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH---HHHHHHH--------hCCCC-----
Confidence 22223346678999999998889999999999999999999 9999975432 1122111 11100
Q ss_pred hhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 007892 445 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 485 (586)
Q Consensus 445 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~ 485 (586)
+ .........+.+++.+|++.+|++||++.+|+..|+.
T Consensus 222 --~-~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 222 --M-PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred --C-CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0 1112234568899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=348.34 Aligned_cols=262 Identities=25% Similarity=0.414 Sum_probs=207.3
Q ss_pred HHHHhcCccccceecccCcEEEEEEEEe------CCeEEEEEEeccCCchh-HHHHHHHHHHHHhcC-CCCcceEEEEEE
Q 007892 204 LKIATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSGQG-EREFQAEIEIISQVH-HRHLVSLVGYCT 275 (586)
Q Consensus 204 l~~~~~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~~~~~-~~~~~~Ei~il~~l~-Hpniv~l~g~~~ 275 (586)
+++..++|.+.+.||+|+||.||+|++. .++.||||+++...... ...+.+|+.+|.++. |||||+++++|.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 4455567888899999999999999864 24689999997653332 347889999999997 999999999999
Q ss_pred eCCeeEEEEEecCCCcHHHHhcCCC-------------------------------------------------------
Q 007892 276 FGSQRLLVYEFVPNKTLEFHLHGKD------------------------------------------------------- 300 (586)
Q Consensus 276 ~~~~~~lV~E~~~~gsL~~~l~~~~------------------------------------------------------- 300 (586)
..+..++||||+++|+|.++++...
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 9999999999999999999986432
Q ss_pred -----------------------------------------CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCc
Q 007892 301 -----------------------------------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSA 339 (586)
Q Consensus 301 -----------------------------------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~ 339 (586)
...++|..++.|+.|+++||+|||+. +|+||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence 12467888899999999999999987 9999999999
Q ss_pred eeEeCCCCCeEEeecccccccCCCCC-cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcc
Q 007892 340 NILLDDSFEAKVADFGLAKHSLDTDT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTF 417 (586)
Q Consensus 340 NILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~ 417 (586)
|||+++++.+||+|||+++....... .......++..|+|||++.+..++.++|||||||+||||++ |..||......
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 99999999999999999986433221 11223457789999999998889999999999999999998 89998654321
Q ss_pred cchhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 418 ADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 418 ~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
. . ....+. .+. .+ ..+......+.+++.+||..+|.+||++.||++.|+..
T Consensus 349 ~--~----~~~~~~----~~~-------~~-~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 349 E--Q----FYNAIK----RGY-------RM-AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred H--H----HHHHHH----cCC-------CC-CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1 0 000010 110 00 11222346789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=333.30 Aligned_cols=266 Identities=22% Similarity=0.335 Sum_probs=197.8
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
.++|.+.+.||+|+||.||+|... +++.||||+++.... .....+.+|+.++++++||||+++++++......++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 368999999999999999999975 688999999875432 223467889999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 365 (586)
|+. ++|.+++.... ..+.+..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 157 (303)
T cd07869 84 YVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS- 157 (303)
T ss_pred CCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence 996 56766665432 3488889999999999999999998 99999999999999999999999999987543221
Q ss_pred cccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhh------------
Q 007892 366 HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQ------------ 432 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~------------ 432 (586)
.......|++.|+|||++.+ ..++.++|||||||+||||++|+.||....... .........+..
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCCChhhccchhhc
Confidence 22234568999999998865 458899999999999999999999997643211 111100000000
Q ss_pred -cccCCChhhhhchhhh-ccC-HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 433 -GLADGNFDALVDQKLE-EYD-SAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 433 -~~~~~~~~~l~d~~l~-~~~-~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
......+.......+. .+. ......+.+++..||+.||.+||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000000000000000 000 011245789999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=344.19 Aligned_cols=202 Identities=25% Similarity=0.393 Sum_probs=175.3
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
++|+..+.||+|+||+||++... +++.||||+++... ......+++|+.++.+++|+||+++++.+.+....+|||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47889999999999999999865 58899999996532 222356788999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 81 EFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred cCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 999999999999654 3589999999999999999999998 99999999999999999999999999997542211
Q ss_pred C----------------------------------cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCC
Q 007892 365 T----------------------------------HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRP 410 (586)
Q Consensus 365 ~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~P 410 (586)
. ......+||+.|+|||++.+..++.++|||||||+||||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 0 011235799999999999999999999999999999999999999
Q ss_pred CCCCC
Q 007892 411 FDKAD 415 (586)
Q Consensus 411 f~~~~ 415 (586)
|....
T Consensus 236 f~~~~ 240 (363)
T cd05628 236 FCSET 240 (363)
T ss_pred CCCCC
Confidence 97644
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=327.08 Aligned_cols=256 Identities=29% Similarity=0.459 Sum_probs=205.3
Q ss_pred hcCccccceecccCcEEEEEEEEe-CC---eEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NG---KVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 282 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g---~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~l 282 (586)
.++|+..+.||+|+||.||+|++. ++ ..+|||.++... ......+..|++++.+++|+||+++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 457888899999999999999975 23 379999987653 3335678999999999999999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCC
Q 007892 283 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 283 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 362 (586)
||||+++++|.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++.....
T Consensus 84 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 84 ITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999986543 4589999999999999999999998 999999999999999999999999999986543
Q ss_pred CCCcccc--cccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCCh
Q 007892 363 TDTHVST--RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 439 (586)
Q Consensus 363 ~~~~~~~--~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (586)
....... ....+..|+|||++..+.++.++|||||||++|||++ |+.||..... . ++.... ..+.
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~---~---~~~~~i-----~~~~- 227 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---H---EVMKAI-----NDGF- 227 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---H---HHHHHH-----hcCC-
Confidence 3222111 1223457999999998889999999999999999998 9999965432 1 111110 0110
Q ss_pred hhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 440 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 440 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
...........+.+++.+|++.+|.+||+|.+|++.|++.
T Consensus 228 -------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 -------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011122345789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=337.23 Aligned_cols=264 Identities=20% Similarity=0.322 Sum_probs=196.8
Q ss_pred CccccceecccCcEEEEEEEEe-CCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC-----CeeE
Q 007892 210 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG-----SQRL 281 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~-----~~~~ 281 (586)
+|++.+.||+|+||.||+|+.. +++.||||+++.. .......+.+|+.++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788899999999999999965 6899999998643 222345688999999999999999999988643 2479
Q ss_pred EEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccC
Q 007892 282 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 361 (586)
Q Consensus 282 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~ 361 (586)
+||||+. ++|.+++... ..+++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELME-SDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCC-CCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 9999995 6888888543 3489999999999999999999998 99999999999999999999999999998643
Q ss_pred CCCC--cccccccccccccCcccccC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHH-------
Q 007892 362 DTDT--HVSTRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFL------- 430 (586)
Q Consensus 362 ~~~~--~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~------- 430 (586)
.... .......|+..|+|||++.+ ..++.++|||||||++|||++|+.||....... ...+....+
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~---~~~~~~~~~~~~~~~~ 231 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH---QLDLITDLLGTPSPET 231 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHHhCCCCHHH
Confidence 2211 12234579999999999875 678999999999999999999999997644211 111100000
Q ss_pred hhcccCCChhhhhchh-------hhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 431 AQGLADGNFDALVDQK-------LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 431 ~~~~~~~~~~~l~d~~-------l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
...+........+... +..........+.+++.+||+.+|.+||++.||++.
T Consensus 232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000000111000 000001123567899999999999999999999964
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=338.49 Aligned_cols=244 Identities=29% Similarity=0.430 Sum_probs=194.3
Q ss_pred ccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHH---HhcCCCCcceEEEEEEeCCeeEEE
Q 007892 211 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEII---SQVHHRHLVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 211 f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il---~~l~Hpniv~l~g~~~~~~~~~lV 283 (586)
|++.+.||+|+||.||+|... +++.||||+++... ......+..|+.++ .+++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567899999999999999965 58999999997532 22234566676655 566799999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCC
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 363 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 363 (586)
|||+++++|..+++. ..+++..+..++.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 999999999988854 3589999999999999999999998 9999999999999999999999999998753322
Q ss_pred CCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhh
Q 007892 364 DTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 443 (586)
Q Consensus 364 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 443 (586)
. ......+|++.|+|||.+.+..++.++|||||||+||||++|+.||...... +...... .+..
T Consensus 155 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~------~~~~~i~-----~~~~---- 218 (324)
T cd05589 155 G-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE------EVFDSIV-----NDEV---- 218 (324)
T ss_pred C-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH------HHHHHHH-----hCCC----
Confidence 2 2233467999999999999999999999999999999999999999754321 1111110 1100
Q ss_pred chhhhccCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 007892 444 DQKLEEYDSAEMTRMAACAAACIRHSARRRPR-----MSQIVR 481 (586)
Q Consensus 444 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----m~evl~ 481 (586)
.++......+.+++.+||+.||.+||+ +.++++
T Consensus 219 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 219 -----RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred -----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 122233456789999999999999994 555554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=346.44 Aligned_cols=251 Identities=22% Similarity=0.296 Sum_probs=195.7
Q ss_pred CccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEE
Q 007892 210 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
.|+..+.||+|+||+||+|+.. +++.||||++.... ......+++|++++.+++|+||+++++++.+.+..+||||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888999999999999999864 57899999996532 2334578899999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC-
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD- 364 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~- 364 (586)
|+++|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 82 YIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 999999999986543 488888889999999999999998 99999999999999999999999999986321000
Q ss_pred ---------------------------------------------CcccccccccccccCcccccCCCCCCcchHHHHHH
Q 007892 365 ---------------------------------------------THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGV 399 (586)
Q Consensus 365 ---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGv 399 (586)
.......+||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 00112357999999999999888999999999999
Q ss_pred HHHHHHhCCCCCCCCCcccc-hhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHH--hhccCCCCCCCH
Q 007892 400 LLLELITGFRPFDKADTFAD-DSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAA--CIRHSARRRPRM 476 (586)
Q Consensus 400 vL~elltG~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~--cl~~dp~~RPtm 476 (586)
+||||++|+.||........ ..+..|.. .+ .. .........+.+++.+ |+..++..||++
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~----------~~------~~-~~~~~~s~~~~dli~~ll~~~~~~~~R~~~ 299 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQLKVINWEN----------TL------HI-PPQVKLSPEAVDLITKLCCSAEERLGRNGA 299 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHHHHHHcccc----------cc------CC-CCCCCCCHHHHHHHHHHccCcccccCCCCH
Confidence 99999999999976543110 01111110 00 00 0001123456667766 556666779999
Q ss_pred HHHHHH
Q 007892 477 SQIVRA 482 (586)
Q Consensus 477 ~evl~~ 482 (586)
.||+..
T Consensus 300 ~~~l~h 305 (381)
T cd05626 300 DDIKAH 305 (381)
T ss_pred HHHhcC
Confidence 999874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=329.46 Aligned_cols=245 Identities=26% Similarity=0.389 Sum_probs=195.5
Q ss_pred ecccCcEEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecCCCcH
Q 007892 217 LGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL 292 (586)
Q Consensus 217 LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~gsL 292 (586)
||+|+||+||++... +++.||||++..... .....+..|++++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999965 688999999865322 2235677899999999999999999999999999999999999999
Q ss_pred HHHhcCC--CCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCccccc
Q 007892 293 EFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTR 370 (586)
Q Consensus 293 ~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 370 (586)
..++... ....+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 9887532 234689999999999999999999998 999999999999999999999999999976543322 2234
Q ss_pred ccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhcc
Q 007892 371 VMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEY 450 (586)
Q Consensus 371 ~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~ 450 (586)
..|++.|+|||++.+..++.++|||||||+||||++|+.||........ ...... .+..... .+
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~-------------~~~~~~~-~~ 220 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQ-------------RILNDSV-TY 220 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHHHHH-------------hhcccCC-CC
Confidence 5789999999999999999999999999999999999999975432110 000000 0000000 12
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 007892 451 DSAEMTRMAACAAACIRHSARRRP-----RMSQIVR 481 (586)
Q Consensus 451 ~~~~~~~l~~l~~~cl~~dp~~RP-----tm~evl~ 481 (586)
+......+.+++.+||+.||.+|| ++.++++
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 221 PDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 233456788999999999999999 6677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=322.73 Aligned_cols=250 Identities=29% Similarity=0.475 Sum_probs=207.5
Q ss_pred hcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEec
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 287 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 287 (586)
.++|+..+.||.|+||.||+|... |+.||||.++.... ....+.+|+.++.+++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 457888899999999999999874 78899999976644 4568899999999999999999999999989999999999
Q ss_pred CCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcc
Q 007892 288 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 367 (586)
Q Consensus 288 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 367 (586)
++++|.+++.......+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 999999999766655799999999999999999999998 999999999999999999999999999986532211
Q ss_pred cccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchh
Q 007892 368 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 446 (586)
Q Consensus 368 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 446 (586)
...++..|+|||++..+.++.++||||||+++|||++ |+.||..... ..+... +. .+..
T Consensus 158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~----~~----~~~~------- 217 (256)
T cd05039 158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPH----VE----KGYR------- 217 (256)
T ss_pred --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHH----Hh----cCCC-------
Confidence 2335678999999998899999999999999999997 9999965432 111111 10 1000
Q ss_pred hhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 007892 447 LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 485 (586)
Q Consensus 447 l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~ 485 (586)
. ..+...+..+.+++.+|++.+|.+||++.||+..|+.
T Consensus 218 ~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 218 M-EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred C-CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 0 1122234678899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=337.09 Aligned_cols=238 Identities=27% Similarity=0.415 Sum_probs=190.2
Q ss_pred ceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeEEEEEecCC
Q 007892 215 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPN 289 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~~~~lV~E~~~~ 289 (586)
+.||+|+||.||+|... +++.||||.++... ......+..|..++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999965 57889999987532 22234456677777654 899999999999999999999999999
Q ss_pred CcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcccc
Q 007892 290 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 369 (586)
Q Consensus 290 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 369 (586)
|+|..++.... .+++.....++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++...... ....
T Consensus 81 g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~ 154 (316)
T cd05592 81 GDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAS 154 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccc
Confidence 99999886543 488899999999999999999998 99999999999999999999999999998643322 2234
Q ss_pred cccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhc
Q 007892 370 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEE 449 (586)
Q Consensus 370 ~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 449 (586)
..+||+.|+|||++.+..++.++|||||||+||||++|+.||...+.. .+. .... .. ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~---~~~---~~i~-----~~---------~~~ 214 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED---ELF---DSIL-----ND---------RPH 214 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH---HHH---HHHH-----cC---------CCC
Confidence 467999999999999889999999999999999999999999764421 111 0000 00 001
Q ss_pred cCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 007892 450 YDSAEMTRMAACAAACIRHSARRRPRMSQ 478 (586)
Q Consensus 450 ~~~~~~~~l~~l~~~cl~~dp~~RPtm~e 478 (586)
++......+.+++.+||+.+|.+||++.+
T Consensus 215 ~~~~~~~~~~~ll~~~l~~~P~~R~~~~~ 243 (316)
T cd05592 215 FPRWISKEAKDCLSKLFERDPTKRLGVDG 243 (316)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCChH
Confidence 22223456788999999999999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=327.93 Aligned_cols=248 Identities=23% Similarity=0.325 Sum_probs=197.7
Q ss_pred ecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecCCCcH
Q 007892 217 LGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL 292 (586)
Q Consensus 217 LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~gsL 292 (586)
||+|+||.||++... +|+.||+|.+.... ......+..|++++.+++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999965 58999999986432 12234566799999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCccccccc
Q 007892 293 EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM 372 (586)
Q Consensus 293 ~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 372 (586)
.+++.......+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++....... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence 9988766656689999999999999999999998 99999999999999999999999999997654322 223456
Q ss_pred ccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhccCH
Q 007892 373 GTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDS 452 (586)
Q Consensus 373 gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~ 452 (586)
|+..|+|||++.+..++.++|||||||+||||++|+.||....... ....+....+ ... ......
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--~~~~~~~~~~-----~~~--------~~~~~~ 220 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--AKEELKRRTL-----EDE--------VKFEHQ 220 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--hHHHHHHHhh-----ccc--------cccccc
Confidence 8999999999998889999999999999999999999997543211 1111111111 000 000011
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 007892 453 AEMTRMAACAAACIRHSARRRPRMSQIVRALE 484 (586)
Q Consensus 453 ~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~ 484 (586)
.....+.+++..||+.||.+||+++|+++.+.
T Consensus 221 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 221 NFTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred cCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 23456889999999999999999988775444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=328.88 Aligned_cols=259 Identities=26% Similarity=0.439 Sum_probs=209.0
Q ss_pred HHhcCccccceecccCcEEEEEEEEeC-----CeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEe-CC
Q 007892 206 IATDNFSEANLLGQGGFGYVHKGVLTN-----GKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTF-GS 278 (586)
Q Consensus 206 ~~~~~f~~~~~LG~G~fG~Vyk~~~~~-----g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~-~~ 278 (586)
+..++|.+.+.||+|+||.||+|.+.+ +..|++|.++.... .....+.+|+.++.+++|+||+++++++.. +.
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 345789999999999999999999766 78899999875533 335678899999999999999999999876 46
Q ss_pred eeEEEEEecCCCcHHHHhcCCCC------CCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEe
Q 007892 279 QRLLVYEFVPNKTLEFHLHGKDR------PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVA 352 (586)
Q Consensus 279 ~~~lV~E~~~~gsL~~~l~~~~~------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~ 352 (586)
..++++||+++++|.+++..... ..+++.+++.++.|++.||+|||+. +++||||||+|||+++++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEEC
Confidence 78899999999999999865322 4589999999999999999999998 99999999999999999999999
Q ss_pred ecccccccCCCCCcc-cccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHH
Q 007892 353 DFGLAKHSLDTDTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFL 430 (586)
Q Consensus 353 DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~ 430 (586)
|||+++.+.....+. .....++..|+|||++.+..++.++|||||||++||+++ |+.||...+. ..+..+..
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~--- 233 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAAYLK--- 233 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHHHHH---
Confidence 999998654433221 223346778999999998889999999999999999999 9999976443 11222211
Q ss_pred hhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 431 AQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 431 ~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
.+. .+ ......+..+.+++.+|++.+|++||++.||++.|+..
T Consensus 234 -----~~~-------~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 234 -----DGY-------RL-AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred -----cCC-------CC-CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 110 00 01122345689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=337.11 Aligned_cols=248 Identities=23% Similarity=0.362 Sum_probs=196.6
Q ss_pred ceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeEEEEEecCC
Q 007892 215 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPN 289 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~~~~lV~E~~~~ 289 (586)
+.||+|+||.||++... +++.||||+++... ......++.|+.++.++ +||||++++++|...+..+|||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999965 58899999997542 22335678899999998 699999999999999999999999999
Q ss_pred CcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcccc
Q 007892 290 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 369 (586)
Q Consensus 290 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 369 (586)
|+|..++... ..+++..+..++.|++.||.|||++ +|+||||||+||||+.++.+||+|||+++...... ....
T Consensus 81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~ 154 (329)
T cd05588 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTS 154 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC-Cccc
Confidence 9999888644 3589999999999999999999998 99999999999999999999999999997532221 1223
Q ss_pred cccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCccc--chhhhhhhhHHHhhcccCCChhhhhchhh
Q 007892 370 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFA--DDSMVDWAKPFLAQGLADGNFDALVDQKL 447 (586)
Q Consensus 370 ~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 447 (586)
..+||+.|+|||++.+..++.++|||||||++|||++|+.||+...... .....+|....+. .+. .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~----~~~--------~ 222 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVIL----EKQ--------I 222 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHH----cCC--------C
Confidence 4679999999999999999999999999999999999999997433211 1112222221111 110 0
Q ss_pred hccCHHHHHHHHHHHHHhhccCCCCCCC------HHHHHH
Q 007892 448 EEYDSAEMTRMAACAAACIRHSARRRPR------MSQIVR 481 (586)
Q Consensus 448 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt------m~evl~ 481 (586)
..+......+.+++.+||+.||.+|++ +.++++
T Consensus 223 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 223 -RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred -CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 122223456889999999999999997 566653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=330.35 Aligned_cols=255 Identities=29% Similarity=0.476 Sum_probs=204.1
Q ss_pred CccccceecccCcEEEEEEEEe------CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEE
Q 007892 210 NFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 282 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~l 282 (586)
+|++.+.||+|+||.||+|+.. ....+++|.+..... .....+.+|+.++.+++||||+++++.|...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999853 235789998875543 334678899999999999999999999999999999
Q ss_pred EEEecCCCcHHHHhcCC----------------------CCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCce
Q 007892 283 VYEFVPNKTLEFHLHGK----------------------DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSAN 340 (586)
Q Consensus 283 V~E~~~~gsL~~~l~~~----------------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~N 340 (586)
|+||+.+++|.+++... ....+++..++.++.|++.||+|||+. +|+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 99999999999987532 123478999999999999999999988 99999999999
Q ss_pred eEeCCCCCeEEeecccccccCCCCCcc-cccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCccc
Q 007892 341 ILLDDSFEAKVADFGLAKHSLDTDTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFA 418 (586)
Q Consensus 341 ILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~ 418 (586)
|||++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-- 235 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-- 235 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH--
Confidence 999999999999999998654332221 222346778999999988889999999999999999998 9999965432
Q ss_pred chhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 419 DDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 419 ~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
..+..+.. . + +. . ..+......+.+++..|++.+|.+||++.||++.|+..
T Consensus 236 -~~~~~~~~----~----~-~~----~---~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 236 -ERLFNLLK----T----G-YR----M---ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred -HHHHHHHh----C----C-CC----C---CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 11222111 0 0 00 0 11222345788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=322.05 Aligned_cols=247 Identities=25% Similarity=0.399 Sum_probs=197.5
Q ss_pred ceecccCcEEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecCCCcH
Q 007892 215 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL 292 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~gsL 292 (586)
+.||+|+||.||+|++. +++.||+|.+.... ......+.+|++++++++|+||++++++|......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999975 68899999876543 33456789999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcc-cccc
Q 007892 293 EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV-STRV 371 (586)
Q Consensus 293 ~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~ 371 (586)
.+++.... ..+++.+++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++....+..... ....
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 81 LTFLRTEG-PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 99986432 3589999999999999999999998 99999999999999999999999999987543221111 0111
Q ss_pred cccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhcc
Q 007892 372 MGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEY 450 (586)
Q Consensus 372 ~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~ 450 (586)
.++..|+|||.+.++.++.++|||||||++|||++ |..||...... .. ...+.. +.. ...
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~---~~----~~~~~~----~~~--------~~~ 217 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ---QT----REAIEQ----GVR--------LPC 217 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH---HH----HHHHHc----CCC--------CCC
Confidence 23457999999999999999999999999999998 88998654321 00 000100 000 012
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 007892 451 DSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484 (586)
Q Consensus 451 ~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~ 484 (586)
+......+.+++.+|++.+|.+||++.||+++|+
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 2233457899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=324.96 Aligned_cols=254 Identities=25% Similarity=0.394 Sum_probs=197.9
Q ss_pred ccccceecccCcEEEEEEEEeCC---eEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC------Ce
Q 007892 211 FSEANLLGQGGFGYVHKGVLTNG---KVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG------SQ 279 (586)
Q Consensus 211 f~~~~~LG~G~fG~Vyk~~~~~g---~~vAVK~l~~~--~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~------~~ 279 (586)
|.+.+.||+|+||.||+|++.+. ..||||.++.. .......+.+|++++.+++|+||++++++|... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 34568999999999999997543 26899988654 233356788999999999999999999988542 24
Q ss_pred eEEEEEecCCCcHHHHhcCC----CCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecc
Q 007892 280 RLLVYEFVPNKTLEFHLHGK----DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 355 (586)
Q Consensus 280 ~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFG 355 (586)
.+++|||+++|+|..++... ....+++...+.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 68999999999998877421 234589999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCCcc-cccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhc
Q 007892 356 LAKHSLDTDTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQG 433 (586)
Q Consensus 356 la~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 433 (586)
+++......... .....+++.|++||++....++.++|||||||++|||++ |+.||..... ..+.+ .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~--------~ 226 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---SEIYD--------Y 226 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHH--------H
Confidence 998754332211 122346678999999998899999999999999999999 8899865332 11111 0
Q ss_pred ccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 434 LADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 434 ~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
+..+... .........+.+++.+||+.+|.+||++.+|++.|+..
T Consensus 227 ~~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 227 LRQGNRL--------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HHcCCCC--------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111110 11122345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=331.36 Aligned_cols=255 Identities=27% Similarity=0.428 Sum_probs=201.3
Q ss_pred cCccccceecccCcEEEEEEEEeC-C--eEEEEEEeccC-CchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLTN-G--KVVAIKQLKAG-SGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~~-g--~~vAVK~l~~~-~~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~~~~lV 283 (586)
++|++.+.||+|+||.||+|++.+ + ..+++|.++.. .....+.+.+|++++.++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578889999999999999999754 3 34788888753 333456789999999999 799999999999999999999
Q ss_pred EEecCCCcHHHHhcCCC--------------CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCe
Q 007892 284 YEFVPNKTLEFHLHGKD--------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA 349 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 349 (586)
+||+++++|.++++... ...+++..++.++.|++.||+|||+. +|+||||||+||||++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 99999999999986532 13488999999999999999999998 99999999999999999999
Q ss_pred EEeecccccccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhH
Q 007892 350 KVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKP 428 (586)
Q Consensus 350 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~ 428 (586)
||+|||++........ ......+..|+|||++.+..++.++|||||||+||||++ |..||...... . +...
T Consensus 159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~---~---~~~~ 230 (297)
T cd05089 159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA---E---LYEK 230 (297)
T ss_pred EECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---H---HHHH
Confidence 9999999864321111 111223557999999998899999999999999999997 99999754321 1 1111
Q ss_pred HHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 429 FLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 429 ~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
.. .+. ....+......+.+++.+|++.+|.+||++.+|++.|+...
T Consensus 231 ~~-----~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 276 (297)
T cd05089 231 LP-----QGY--------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276 (297)
T ss_pred Hh-----cCC--------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00 000 00112223456889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=323.00 Aligned_cols=245 Identities=27% Similarity=0.410 Sum_probs=196.7
Q ss_pred eecccCcEEEEEEEEe---CCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecCCC
Q 007892 216 LLGQGGFGYVHKGVLT---NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNK 290 (586)
Q Consensus 216 ~LG~G~fG~Vyk~~~~---~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g 290 (586)
+||+|+||.||+|.+. +++.+|||+++.... ....++.+|+.++.+++|+||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 6899999999999753 578999999865432 23567899999999999999999999986 45678999999999
Q ss_pred cHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcc--c
Q 007892 291 TLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV--S 368 (586)
Q Consensus 291 sL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~--~ 368 (586)
+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||.|||+++++.+||+|||+++......... .
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 81 PLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 999998643 3589999999999999999999998 99999999999999999999999999998654333211 1
Q ss_pred ccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhh
Q 007892 369 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 447 (586)
Q Consensus 369 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 447 (586)
....++..|+|||.+....++.++|||||||++|||++ |+.||..... ..+.... ..+...
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~i--------~~~~~~------- 217 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG---NEVTQMI--------ESGERM------- 217 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH--------HCCCCC-------
Confidence 22334678999999988889999999999999999998 9999975432 1111111 111110
Q ss_pred hccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 007892 448 EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 485 (586)
Q Consensus 448 ~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~ 485 (586)
..+......+.+++.+|++.+|++||+|.+|++.|++
T Consensus 218 -~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 218 -ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred -CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 1122344568899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=333.76 Aligned_cols=261 Identities=26% Similarity=0.427 Sum_probs=207.9
Q ss_pred HHhcCccccceecccCcEEEEEEEEe--------CCeEEEEEEeccCC-chhHHHHHHHHHHHHhc-CCCCcceEEEEEE
Q 007892 206 IATDNFSEANLLGQGGFGYVHKGVLT--------NGKVVAIKQLKAGS-GQGEREFQAEIEIISQV-HHRHLVSLVGYCT 275 (586)
Q Consensus 206 ~~~~~f~~~~~LG~G~fG~Vyk~~~~--------~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~ 275 (586)
+..++|.+.+.||+|+||.||+++.. ++..||+|.++... ......+.+|+.++..+ +|+||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 44577888999999999999999742 24579999987543 33456789999999999 7999999999999
Q ss_pred eCCeeEEEEEecCCCcHHHHhcCCC--------------CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCcee
Q 007892 276 FGSQRLLVYEFVPNKTLEFHLHGKD--------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANI 341 (586)
Q Consensus 276 ~~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NI 341 (586)
.....++||||+++++|.+++.... ...++|.+++.++.|++.||.|||++ +|+||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence 9999999999999999999986532 23578899999999999999999998 999999999999
Q ss_pred EeCCCCCeEEeecccccccCCCCCcc-cccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccc
Q 007892 342 LLDDSFEAKVADFGLAKHSLDTDTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFAD 419 (586)
Q Consensus 342 Ll~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~ 419 (586)
|+++++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||+||||++ |..||.....
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--- 245 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--- 245 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---
Confidence 99999999999999998654332221 222346678999999998889999999999999999998 7888864321
Q ss_pred hhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 007892 420 DSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMP 488 (586)
Q Consensus 420 ~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~~ 488 (586)
.++.... . .+.. ..........+.+++.+||+.+|.+||+|.||++.|+....
T Consensus 246 ---~~~~~~~-~----~~~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 246 ---EELFKLL-K----EGHR--------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred ---HHHHHHH-H----cCCc--------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 1111111 0 1100 01122345678899999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=346.05 Aligned_cols=251 Identities=23% Similarity=0.342 Sum_probs=196.3
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
++|.+.+.||+|+||.||++... +++.||||++.... ......+++|++++.+++||||+++++++.+.+..+|||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47888999999999999999864 68899999986432 223456888999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
||+++|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 81 EFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 999999999998653 3588888999999999999999998 99999999999999999999999999996332110
Q ss_pred C------------c----------------------------------ccccccccccccCcccccCCCCCCcchHHHHH
Q 007892 365 T------------H----------------------------------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFG 398 (586)
Q Consensus 365 ~------------~----------------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG 398 (586)
. . .....+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 0 0 00124699999999999988999999999999
Q ss_pred HHHHHHHhCCCCCCCCCcccc-hhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCC---CC
Q 007892 399 VLLLELITGFRPFDKADTFAD-DSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARR---RP 474 (586)
Q Consensus 399 vvL~elltG~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~---RP 474 (586)
|+||||++|+.||........ ..+..|... +. +. ........+.+++.+|++ +|.+ |+
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~-------------~~---~p-~~~~~s~~~~dli~~lL~-~~~~r~~r~ 297 (377)
T cd05629 236 AIMFECLIGWPPFCSENSHETYRKIINWRET-------------LY---FP-DDIHLSVEAEDLIRRLIT-NAENRLGRG 297 (377)
T ss_pred hhhhhhhcCCCCCCCCCHHHHHHHHHccCCc-------------cC---CC-CCCCCCHHHHHHHHHHhc-CHhhcCCCC
Confidence 999999999999975443110 011111100 00 00 001123467889999997 6665 46
Q ss_pred CHHHHHHH
Q 007892 475 RMSQIVRA 482 (586)
Q Consensus 475 tm~evl~~ 482 (586)
++.|+++.
T Consensus 298 ~~~~~l~h 305 (377)
T cd05629 298 GAHEIKSH 305 (377)
T ss_pred CHHHHhcC
Confidence 99998864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=336.43 Aligned_cols=241 Identities=26% Similarity=0.372 Sum_probs=194.1
Q ss_pred CccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCC-CCcceEEEEEEeCCeeEEEE
Q 007892 210 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHH-RHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~H-pniv~l~g~~~~~~~~~lV~ 284 (586)
+|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+..|++++..++| ++|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788899999999999999965 47899999987532 2334567889999999976 56888999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
||+++|+|.+++.... .+.+..++.++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 81 EYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 9999999999886543 488999999999999999999998 99999999999999999999999999987532221
Q ss_pred CcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhc
Q 007892 365 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 444 (586)
Q Consensus 365 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 444 (586)
. ......||+.|+|||++.+..++.++|||||||+||||++|+.||...+.. .+... +....
T Consensus 156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~~--------i~~~~------ 217 (324)
T cd05587 156 K-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELFQS--------IMEHN------ 217 (324)
T ss_pred C-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHH--------HHcCC------
Confidence 1 223457999999999999999999999999999999999999999754321 11110 00110
Q ss_pred hhhhccCHHHHHHHHHHHHHhhccCCCCCCCH
Q 007892 445 QKLEEYDSAEMTRMAACAAACIRHSARRRPRM 476 (586)
Q Consensus 445 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm 476 (586)
. .++......+.+++.+||+.+|.+|++.
T Consensus 218 --~-~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 218 --V-SYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred --C-CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 0 1222334568899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=329.53 Aligned_cols=256 Identities=27% Similarity=0.449 Sum_probs=205.0
Q ss_pred HhcCccccceecccCcEEEEEEEEe------CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ 279 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~ 279 (586)
..++|+..+.||+|+||.||++... ++..||+|.+.... .....++.+|+.++.+++||||++++++|..+..
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3567999999999999999999863 46789999987543 2345679999999999999999999999999999
Q ss_pred eEEEEEecCCCcHHHHhcCCC--------------------CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCc
Q 007892 280 RLLVYEFVPNKTLEFHLHGKD--------------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSA 339 (586)
Q Consensus 280 ~~lV~E~~~~gsL~~~l~~~~--------------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~ 339 (586)
.++||||+++++|.+++.... ...+++.+++.++.|++.||+|||+. +++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHh
Confidence 999999999999999986321 12478889999999999999999998 9999999999
Q ss_pred eeEeCCCCCeEEeecccccccCCCCC-cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcc
Q 007892 340 NILLDDSFEAKVADFGLAKHSLDTDT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTF 417 (586)
Q Consensus 340 NILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~ 417 (586)
|||+++++.+||+|||++........ ........+..|+|||.+.++.++.++|||||||++|||++ |..||......
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999875432221 11222345667999999998899999999999999999998 88898644321
Q ss_pred cchhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 007892 418 ADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484 (586)
Q Consensus 418 ~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~ 484 (586)
++... +..+.. ...+......+.+++.+|++.+|.+||++.||++.|+
T Consensus 240 ------~~~~~-----~~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 240 ------EVIYY-----VRDGNV--------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred ------HHHHH-----HhcCCC--------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 11111 111111 1112234467899999999999999999999999997
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=324.18 Aligned_cols=255 Identities=28% Similarity=0.437 Sum_probs=205.1
Q ss_pred cCccccceecccCcEEEEEEEEe----CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT----NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~----~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV 283 (586)
++|++.+.||+|+||.||+|.+. .+..+|+|.++.... .....|.+|+.++.+++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 56888999999999999999864 234799999875432 2346789999999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCC
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 363 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 363 (586)
|||+++++|.+++.... ..+++.+++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 84 TEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999997654 3589999999999999999999998 9999999999999999999999999999876443
Q ss_pred CCcccc--cccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChh
Q 007892 364 DTHVST--RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 440 (586)
Q Consensus 364 ~~~~~~--~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (586)
...... ...++..|++||++.++.++.++|||||||++||+++ |..||...... ....+.. .+. .
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~~~~~--------~~~-~ 227 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVIKAIE--------EGY-R 227 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHHHHHh--------CCC-c
Confidence 322211 1223568999999998899999999999999999887 99999754321 1111110 110 0
Q ss_pred hhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 441 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 441 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
. ......+..+.+++.+|++.+|.+||+|.+|++.|+..
T Consensus 228 ------~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 ------L-PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ------C-CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0 11122345688999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=326.85 Aligned_cols=267 Identities=25% Similarity=0.376 Sum_probs=203.3
Q ss_pred cCccccceecccCcEEEEEEEEe-----CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--CeeE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-----NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG--SQRL 281 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-----~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~--~~~~ 281 (586)
+.|++.+.||+|+||.||++... +++.||||.++.......+.|.+|++++.+++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46888899999999999999853 5789999999876656567899999999999999999999987543 4678
Q ss_pred EEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccC
Q 007892 282 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 361 (586)
Q Consensus 282 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~ 361 (586)
+||||+++++|.+++.... ..++|..++.++.|++.||+|||+. +|+||||||+||||++++.+||+|||+++...
T Consensus 84 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 9999999999999986542 3589999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCc--ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCC-
Q 007892 362 DTDTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGN- 438 (586)
Q Consensus 362 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~- 438 (586)
..... ......++..|+|||++.++.++.++|||||||++|||++|..++..... .|.............
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~ 232 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA-------EFMRMMGNDKQGQMIV 232 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch-------hhhhhcccccccccch
Confidence 33221 11122344569999999988999999999999999999998877543221 000000000000000
Q ss_pred --hhhhhchhhh-ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 439 --FDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 439 --~~~l~d~~l~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
+.+++..... .........+.+++.+||..+|++||+|.||++.|+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 233 YHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0001100000 11223346799999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=337.50 Aligned_cols=243 Identities=24% Similarity=0.375 Sum_probs=192.5
Q ss_pred ceecccCcEEEEEEEEe-CCeEEEEEEeccC---CchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeEEEEEecCC
Q 007892 215 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG---SGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPN 289 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~~~~lV~E~~~~ 289 (586)
+.||+|+||.||++... +++.||+|+++.. .......+..|+.++.++ +||||+++++++...+..+|||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999965 5789999999754 223345677899988877 799999999999999999999999999
Q ss_pred CcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcccc
Q 007892 290 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 369 (586)
Q Consensus 290 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 369 (586)
|+|..++... ..+++..+..++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~~ 154 (329)
T cd05618 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTS 154 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Cccc
Confidence 9999888644 3589999999999999999999998 99999999999999999999999999997532222 1223
Q ss_pred cccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCccc--chhhhhhhhHHHhhcccCCChhhhhchhh
Q 007892 370 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFA--DDSMVDWAKPFLAQGLADGNFDALVDQKL 447 (586)
Q Consensus 370 ~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 447 (586)
...||..|+|||++.+..++.++|||||||++|||++|+.||....... ......|....+. .+. .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~----~~~--------~ 222 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL----EKQ--------I 222 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHh----cCC--------C
Confidence 4679999999999999999999999999999999999999996432211 1111122211111 110 0
Q ss_pred hccCHHHHHHHHHHHHHhhccCCCCCCCH
Q 007892 448 EEYDSAEMTRMAACAAACIRHSARRRPRM 476 (586)
Q Consensus 448 ~~~~~~~~~~l~~l~~~cl~~dp~~RPtm 476 (586)
.++......+.+++.+||+.||.+||+.
T Consensus 223 -~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 223 -RIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred -CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 1233344568899999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=342.38 Aligned_cols=253 Identities=23% Similarity=0.275 Sum_probs=202.0
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
++|.+.+.||+|+||.||++... +|+.||||+++... ......+.+|+.++..++|+||+++++++.+.+..+|||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46889999999999999999965 68899999997542 223456889999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
||+++|+|.+++.... ..+++..+..++.|++.||.|||+. +|+||||||+||||+.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 81 EYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 9999999999987542 3589999999999999999999998 99999999999999999999999999998764433
Q ss_pred CcccccccccccccCccccc------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCC
Q 007892 365 THVSTRVMGTFGYLAPEYAS------SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGN 438 (586)
Q Consensus 365 ~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (586)
........||+.|+|||++. ...++.++|||||||+||||++|+.||...... ......+. ...
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~----~~~ 226 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------KTYNNIMN----FQR 226 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH------HHHHHHHc----CCC
Confidence 33334457999999999986 456789999999999999999999999754321 11111110 000
Q ss_pred hhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 439 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 439 ~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.... .........+.+++..|++ +|.+||++.+++..
T Consensus 227 ~~~~------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 227 FLKF------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred ccCC------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 0000 0111234567889999998 99999999998753
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=324.19 Aligned_cols=254 Identities=24% Similarity=0.363 Sum_probs=203.4
Q ss_pred cCccccceecccCcEEEEEEEE-eCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEec
Q 007892 209 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 287 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 287 (586)
++|++.+.||+|+||.||+|+. .+++.||+|++..........+++|+.++.+++|+||+++++++..++..++|+||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 5788899999999999999996 468899999997655555567889999999999999999999999999999999999
Q ss_pred CCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcc
Q 007892 288 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 367 (586)
Q Consensus 288 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 367 (586)
++++|.++++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||++........ .
T Consensus 89 ~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~ 162 (267)
T cd06646 89 GGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-K 162 (267)
T ss_pred CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc-c
Confidence 999999988643 3588999999999999999999998 999999999999999999999999999986532221 1
Q ss_pred cccccccccccCccccc---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhc
Q 007892 368 STRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 444 (586)
Q Consensus 368 ~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 444 (586)
.....|+..|+|||.+. ...++.++|||||||++|||++|+.||........ ...+. ...+ ..
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~--~~~~~---------~~~~---~~ 228 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LFLMS---------KSNF---QP 228 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh--heeee---------cCCC---CC
Confidence 23346889999999884 45578899999999999999999999864432110 00000 0000 00
Q ss_pred hhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007892 445 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRAL 483 (586)
Q Consensus 445 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L 483 (586)
+... ........+.+++.+||+.+|++||++.+|++.|
T Consensus 229 ~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 229 PKLK-DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCc-cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1110 1112345788999999999999999999999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=325.55 Aligned_cols=265 Identities=27% Similarity=0.388 Sum_probs=203.2
Q ss_pred ccccceecccCcEEEEEEEE-----eCCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--CeeEE
Q 007892 211 FSEANLLGQGGFGYVHKGVL-----TNGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFG--SQRLL 282 (586)
Q Consensus 211 f~~~~~LG~G~fG~Vyk~~~-----~~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~--~~~~l 282 (586)
|...+.||+|+||+||++.. .+++.||+|.++.... .....|.+|+++|++++||||++++++|... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 47889999999999988653 3577899999876533 3456788999999999999999999998764 35789
Q ss_pred EEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCC
Q 007892 283 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 283 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 362 (586)
||||+++++|.+++... .+++.+++.++.|++.||.|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 86 v~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred EecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 99999999999998643 489999999999999999999998 999999999999999999999999999986543
Q ss_pred CCCc--ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChh
Q 007892 363 TDTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 440 (586)
Q Consensus 363 ~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (586)
.... ......++..|++||.+..+.++.++|||||||++|||++|..||....... ..+..+... ......+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~----~~~~~~~~ 234 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQG----QMTVVRLI 234 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhccccc----ccchhhhh
Confidence 2211 1122345667999999998899999999999999999999999986543211 111111100 00001111
Q ss_pred hhhchhhh-ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 441 ALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 441 ~l~d~~l~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
.+++.... ..+...+..+.+++.+|++.+|.+||++.+|++.|+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 235 ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 11111111 12233456799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=321.44 Aligned_cols=251 Identities=25% Similarity=0.374 Sum_probs=202.5
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc-----hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-----QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 282 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~-----~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~l 282 (586)
++|...+.||+|+||.||++... +++.||+|.+..... .....+.+|++++.+++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57889999999999999999964 689999999864321 123468889999999999999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCC
Q 007892 283 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 283 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 362 (586)
|+||+++++|.+++... ..+++.....++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 82 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 99999999999988654 3488889999999999999999998 999999999999999999999999999976533
Q ss_pred CCCccc--ccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChh
Q 007892 363 TDTHVS--TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 440 (586)
Q Consensus 363 ~~~~~~--~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (586)
...... ....|+..|+|||++.+..++.++|||||||++|||++|+.||....... ...+. . ...
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~---~----~~~--- 223 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA---AIFKI---A----TQP--- 223 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH---HHHHH---h----ccC---
Confidence 221111 23568889999999998889999999999999999999999997543211 00000 0 000
Q ss_pred hhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 441 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 441 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.....+......+.+++.+|++.+|.+||++.||++.
T Consensus 224 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 224 -----TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -----CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0011223344568899999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=336.14 Aligned_cols=237 Identities=27% Similarity=0.383 Sum_probs=191.7
Q ss_pred ceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeEEEEEecCC
Q 007892 215 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPN 289 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~~~~lV~E~~~~ 289 (586)
+.||+|+||.||+++.. +++.||||+++... ......+..|+.++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999965 57899999987532 22345677888888876 699999999999999999999999999
Q ss_pred CcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcccc
Q 007892 290 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 369 (586)
Q Consensus 290 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 369 (586)
|+|..++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~ 154 (320)
T cd05590 81 GDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTS 154 (320)
T ss_pred chHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cccc
Confidence 9999988654 3488999999999999999999998 99999999999999999999999999987532222 2233
Q ss_pred cccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhc
Q 007892 370 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEE 449 (586)
Q Consensus 370 ~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 449 (586)
...||+.|+|||++.+..++.++|||||||+||||++|+.||...+.. .+. .... .+.. .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~---~~~---~~i~-----~~~~---------~ 214 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED---DLF---EAIL-----NDEV---------V 214 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHH---HHHh-----cCCC---------C
Confidence 467999999999999889999999999999999999999999764421 111 1111 1110 1
Q ss_pred cCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 007892 450 YDSAEMTRMAACAAACIRHSARRRPRMS 477 (586)
Q Consensus 450 ~~~~~~~~l~~l~~~cl~~dp~~RPtm~ 477 (586)
++......+.+++.+||+.||.+||++.
T Consensus 215 ~~~~~~~~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 215 YPTWLSQDAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHCCCCC
Confidence 1222345688999999999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=326.63 Aligned_cols=254 Identities=26% Similarity=0.427 Sum_probs=200.8
Q ss_pred cCccccceecccCcEEEEEEEEe-CCe----EEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGK----VVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 282 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~----~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~l 282 (586)
++|++.+.||+|+||.||+|.+. +++ .|++|.+..... ....++..|+.++.+++||||+++++++. +...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 46778899999999999999964 343 478888764432 23467888999999999999999999986 456788
Q ss_pred EEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCC
Q 007892 283 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 283 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 362 (586)
++||+++|+|.+++.... ..++|..++.|+.|++.||+|||+. +++||||||+|||+++++.+||+|||+++....
T Consensus 86 i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 999999999999997543 3589999999999999999999998 899999999999999999999999999986543
Q ss_pred CCCc-ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChh
Q 007892 363 TDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 440 (586)
Q Consensus 363 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (586)
.... ......++..|++||++.++.++.++|||||||++|||++ |..||...... .+.++. ..+...
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---~~~~~~--------~~~~~~ 230 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH---EVPDLL--------EKGERL 230 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH--------HCCCcC
Confidence 3222 2233457789999999998999999999999999999998 99999765421 111111 111100
Q ss_pred hhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 441 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 441 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
. ........+.+++.+|+..+|.+||++.|+++.|+..
T Consensus 231 --~------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~ 268 (279)
T cd05111 231 --A------QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRM 268 (279)
T ss_pred --C------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 0 0111234578889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=336.47 Aligned_cols=242 Identities=26% Similarity=0.375 Sum_probs=194.5
Q ss_pred ceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeEEEEEecCC
Q 007892 215 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPN 289 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~~~~lV~E~~~~ 289 (586)
+.||+|+||.||+|+.. +++.||||+++... ......+..|++++..+ +||||+++++++...+..+|||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999975 47899999987542 22345677899999876 799999999999999999999999999
Q ss_pred CcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcccc
Q 007892 290 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 369 (586)
Q Consensus 290 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 369 (586)
++|..++... ..+++..+..++.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++....... ...
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~ 154 (321)
T cd05591 81 GDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTT 154 (321)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc-ccc
Confidence 9999888644 3488999999999999999999998 999999999999999999999999999975432222 233
Q ss_pred cccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhc
Q 007892 370 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEE 449 (586)
Q Consensus 370 ~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 449 (586)
...|++.|+|||++.+..++.++|||||||+||||++|+.||...... .+.. ... .+.. .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~---~~~~---~i~-----~~~~---------~ 214 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED---DLFE---SIL-----HDDV---------L 214 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH---HHHH---HHH-----cCCC---------C
Confidence 467999999999999889999999999999999999999999765421 1111 111 1100 1
Q ss_pred cCHHHHHHHHHHHHHhhccCCCCCC-------CHHHHHHH
Q 007892 450 YDSAEMTRMAACAAACIRHSARRRP-------RMSQIVRA 482 (586)
Q Consensus 450 ~~~~~~~~l~~l~~~cl~~dp~~RP-------tm~evl~~ 482 (586)
++......+.+++..||+.||.+|| ++.++++.
T Consensus 215 ~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 215 YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 1112335688999999999999999 67777643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=335.53 Aligned_cols=241 Identities=26% Similarity=0.380 Sum_probs=194.9
Q ss_pred CccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeEEEE
Q 007892 210 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
+|...+.||+|+||.||+|+.. +++.||||.++... ......+..|..++..+ +|++|+++++++...+..+|||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788899999999999999965 57899999987542 22234567788888877 5899999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
||+++|+|.+++.... .+++.+++.++.|++.||+|||+. +|+||||||+||||++++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 81 EYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 9999999998886543 488999999999999999999998 99999999999999999999999999997533221
Q ss_pred CcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhc
Q 007892 365 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 444 (586)
Q Consensus 365 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 444 (586)
......+||+.|+|||++.++.++.++|||||||+||||++|+.||...+. ..+... .. ...
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~~~~---i~-----~~~------ 217 (323)
T cd05616 156 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQS---IM-----EHN------ 217 (323)
T ss_pred -CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH---HHHHHH---HH-----hCC------
Confidence 123346799999999999999999999999999999999999999976442 111111 00 110
Q ss_pred hhhhccCHHHHHHHHHHHHHhhccCCCCCCCH
Q 007892 445 QKLEEYDSAEMTRMAACAAACIRHSARRRPRM 476 (586)
Q Consensus 445 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm 476 (586)
. .++......+.+++.+|++.+|.+|++.
T Consensus 218 --~-~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 218 --V-AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred --C-CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 0 1223345678899999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=333.10 Aligned_cols=258 Identities=28% Similarity=0.429 Sum_probs=205.3
Q ss_pred hcCccccceecccCcEEEEEEEEe--------CCeEEEEEEeccCC-chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeC
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT--------NGKVVAIKQLKAGS-GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFG 277 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~--------~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~ 277 (586)
.++|.+.+.||+|+||.||++... ++..+|+|.++... .....++.+|++++.++ +|+||++++++|...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 467999999999999999999853 23579999997643 23446788999999999 799999999999999
Q ss_pred CeeEEEEEecCCCcHHHHhcCCC--------------CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEe
Q 007892 278 SQRLLVYEFVPNKTLEFHLHGKD--------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL 343 (586)
Q Consensus 278 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl 343 (586)
+..++||||+++++|.+++.... ...++|.++++++.|++.||+|||+. +++||||||+|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence 99999999999999999997532 13589999999999999999999988 99999999999999
Q ss_pred CCCCCeEEeecccccccCCCCCcc-cccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchh
Q 007892 344 DDSFEAKVADFGLAKHSLDTDTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDS 421 (586)
Q Consensus 344 ~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~ 421 (586)
+.++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~----- 248 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV----- 248 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-----
Confidence 999999999999997653322111 112234568999999998889999999999999999998 8889864332
Q ss_pred hhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 422 MVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 422 ~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
.+.... +. .+.. ...+......+.+++.+|+..+|.+||+|.+|++.|+.+.
T Consensus 249 -~~~~~~-~~----~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 249 -EELFKL-LK----EGHR--------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred -HHHHHH-HH----cCCC--------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 111110 10 1100 0122234467889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=321.55 Aligned_cols=258 Identities=20% Similarity=0.323 Sum_probs=207.0
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
++|++.+.||+|+||.||+|+.. +++.||||.++.. .......+.+|++++++++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57889999999999999999964 6899999987542 2233457889999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCC--CCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCC
Q 007892 285 EFVPNKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 285 E~~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 362 (586)
||+++++|.+++... ....+++..++.++.|+++||.|||++ +|+|+||||+||||+.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999887532 234578889999999999999999998 999999999999999999999999999886543
Q ss_pred CCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhh
Q 007892 363 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 442 (586)
Q Consensus 363 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 442 (586)
... ......|+..|+|||++.+..++.++||||||+++|||++|+.||..... ....+.... .......
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~~~-----~~~~~~~- 227 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLCQKI-----EQCDYPP- 227 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHHHHH-----hcCCCCC-
Confidence 221 12234688899999999888899999999999999999999999865332 111221110 0111100
Q ss_pred hchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 443 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 443 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
.........+.+++.+||..+|.+||++.+|++.|++.
T Consensus 228 ------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 228 ------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred ------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 11123446789999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=320.91 Aligned_cols=249 Identities=28% Similarity=0.432 Sum_probs=202.6
Q ss_pred hcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEe-CCeeEEEEEe
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF-GSQRLLVYEF 286 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~-~~~~~lV~E~ 286 (586)
.++|...+.||+|+||.||++... |..||+|.++... ....+.+|+.++++++|+|++++++++.. ++..++|+||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 357888899999999999999874 7789999986543 24578999999999999999999997654 5678999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 366 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 366 (586)
+++++|.+++.......+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 9999999999766666689999999999999999999998 99999999999999999999999999987543221
Q ss_pred ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhch
Q 007892 367 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQ 445 (586)
Q Consensus 367 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 445 (586)
....++..|+|||++....++.++|||||||++|||++ |+.||..... ..+..+ +.. +..
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~---~~~~~~----~~~----~~~------ 217 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPR----VEK----GYK------ 217 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH----Hhc----CCC------
Confidence 22345678999999998889999999999999999998 9999864331 111111 111 100
Q ss_pred hhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 007892 446 KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 485 (586)
Q Consensus 446 ~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~ 485 (586)
.......+..+.+++.+|++.+|++||++.++++.|+.
T Consensus 218 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 218 --MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred --CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 01122334678899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=338.35 Aligned_cols=260 Identities=27% Similarity=0.426 Sum_probs=219.6
Q ss_pred HHHHhcCccccceecccCcEEEEEEEEeC---C--eEEEEEEeccC-CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 007892 204 LKIATDNFSEANLLGQGGFGYVHKGVLTN---G--KVVAIKQLKAG-SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG 277 (586)
Q Consensus 204 l~~~~~~f~~~~~LG~G~fG~Vyk~~~~~---g--~~vAVK~l~~~-~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~ 277 (586)
+++..+.....++||.|-||.||+|++.+ | -.||||..+.+ .....+.|++|.-+|++++|||||+|+|+|.+
T Consensus 384 yel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e- 462 (974)
T KOG4257|consen 384 YELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE- 462 (974)
T ss_pred ceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-
Confidence 44555666777999999999999999643 2 35899998875 44456789999999999999999999999985
Q ss_pred CeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccc
Q 007892 278 SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 357 (586)
Q Consensus 278 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla 357 (586)
...|||||.++-|.|..+|+.+. ..++......++.||+.+|+|||+. ++|||||..+|||+...-.|||+||||+
T Consensus 463 ~P~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLS 538 (974)
T KOG4257|consen 463 QPMWIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLS 538 (974)
T ss_pred cceeEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchh
Confidence 57899999999999999998654 4588889999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccC
Q 007892 358 KHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLAD 436 (586)
Q Consensus 358 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (586)
+...+.......+..-...|||||.+.-.+++.++|||.|||++||++. |..||......+. ...+++
T Consensus 539 R~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV-----------I~~iEn 607 (974)
T KOG4257|consen 539 RYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV-----------IGHIEN 607 (974)
T ss_pred hhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce-----------EEEecC
Confidence 9988777666666667789999999999999999999999999999988 9999986543221 112223
Q ss_pred CChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 437 GNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 437 ~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
|.. ...+.+++..|..++.+||..+|.+||++.||...|....
T Consensus 608 GeR--------lP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~ 650 (974)
T KOG4257|consen 608 GER--------LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL 650 (974)
T ss_pred CCC--------CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence 321 1356778889999999999999999999999999998654
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=343.36 Aligned_cols=261 Identities=23% Similarity=0.272 Sum_probs=204.0
Q ss_pred HHHHHHHhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 007892 201 YEELKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSLVGYCTF 276 (586)
Q Consensus 201 ~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~ 276 (586)
+.++....++|++.+.||+|+||.||++... +++.||+|++... .......+.+|+.++..++||||+++++++..
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3455666789999999999999999999975 5789999998642 12234567889999999999999999999999
Q ss_pred CCeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccc
Q 007892 277 GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGL 356 (586)
Q Consensus 277 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGl 356 (586)
++..++||||+++|+|.+++... .++...+..++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 99999999999999999988643 378888889999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCcccccCC----CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhh
Q 007892 357 AKHSLDTDTHVSTRVMGTFGYLAPEYASSG----KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQ 432 (586)
Q Consensus 357 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 432 (586)
++.............+||+.|+|||++... .++.++|||||||+||||++|+.||...+.. ......+.
T Consensus 189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~- 261 (371)
T cd05622 189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMN- 261 (371)
T ss_pred eeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH------HHHHHHHc-
Confidence 987544333333456799999999998653 3789999999999999999999999754421 11111110
Q ss_pred cccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHHH
Q 007892 433 GLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARR--RPRMSQIVRAL 483 (586)
Q Consensus 433 ~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~--RPtm~evl~~L 483 (586)
......+ .........+.+++.+|+..++.+ |+++.||++..
T Consensus 262 ---~~~~~~~------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 262 ---HKNSLTF------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred ---CCCcccC------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 0000000 011123456788899999854443 78999998764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=320.61 Aligned_cols=252 Identities=29% Similarity=0.480 Sum_probs=203.8
Q ss_pred cCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecC
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVP 288 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 288 (586)
.+|+..+.||+|+||.||++.+.++..+|||.+..... ...+|.+|++++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 46778899999999999999987788999999875433 34678999999999999999999999999999999999999
Q ss_pred CCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCccc
Q 007892 289 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 368 (586)
Q Consensus 289 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 368 (586)
+++|.+++.... ..+.+..+..++.+++.+|+|||+. +++||||||+||+++.++.+||+|||++...........
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 83 HGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 999999987543 3478999999999999999999998 899999999999999999999999999876543322212
Q ss_pred ccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhh
Q 007892 369 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 447 (586)
Q Consensus 369 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 447 (586)
....++..|+|||++.++.++.++|||||||++|||++ |+.||..... ..+.+. +..+. ....
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~~--------~~~~~--~~~~--- 222 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN---SEVVET--------INAGF--RLYK--- 222 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHH--------HhCCC--CCCC---
Confidence 22335678999999998899999999999999999998 9999975332 111111 01110 0001
Q ss_pred hccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 007892 448 EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484 (586)
Q Consensus 448 ~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~ 484 (586)
+......+.+++.+||+.+|.+||++.||++.|.
T Consensus 223 ---~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 223 ---PRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ---CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1112457899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=327.60 Aligned_cols=250 Identities=28% Similarity=0.407 Sum_probs=201.2
Q ss_pred ccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 211 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 211 f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
|+..+.||+|+||.||++... +++.||||.+..... .....+.+|+.++.+++|+||+.+++.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 677789999999999999965 688999999865422 2234577899999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 366 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 366 (586)
+++++|.+++.......+++.+++.++.|++.||.|||+. +|+||||||+|||+++++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT- 157 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence 9999999998665555689999999999999999999988 999999999999999999999999999876432221
Q ss_pred ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchh
Q 007892 367 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 446 (586)
Q Consensus 367 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 446 (586)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||......... ..+ . .+.+..
T Consensus 158 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~--~~~-~-------------~~~~~~ 220 (285)
T cd05630 158 -IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR--EEV-E-------------RLVKEV 220 (285)
T ss_pred -ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH--HHH-H-------------hhhhhh
Confidence 12347999999999999999999999999999999999999999754321100 000 0 000000
Q ss_pred hhccCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 007892 447 LEEYDSAEMTRMAACAAACIRHSARRRPR-----MSQIVR 481 (586)
Q Consensus 447 l~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----m~evl~ 481 (586)
...+.......+.+++..||+.||.+||+ +.|+++
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 221 QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 01122233456889999999999999999 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=321.67 Aligned_cols=258 Identities=24% Similarity=0.354 Sum_probs=206.4
Q ss_pred HHHHHhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeE
Q 007892 203 ELKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 281 (586)
Q Consensus 203 el~~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~ 281 (586)
|++.+++++.....||+|+||.||+|... ++..||+|.+........+.+.+|+.++++++|+||++++++|..++..+
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 35567788888899999999999999965 57789999988766666778999999999999999999999999999999
Q ss_pred EEEEecCCCcHHHHhcCCCCCCC--ChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCC-CCCeEEeeccccc
Q 007892 282 LVYEFVPNKTLEFHLHGKDRPVM--NWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD-SFEAKVADFGLAK 358 (586)
Q Consensus 282 lV~E~~~~gsL~~~l~~~~~~~l--~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~-~~~~kl~DFGla~ 358 (586)
+|+||+++++|.+++..... .+ ++..++.++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||++.
T Consensus 82 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EEEecCCCCCHHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 99999999999999875422 24 7888899999999999999998 9999999999999976 6799999999987
Q ss_pred ccCCCCCcccccccccccccCcccccCCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccC
Q 007892 359 HSLDTDTHVSTRVMGTFGYLAPEYASSGK--LTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLAD 436 (586)
Q Consensus 359 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (586)
....... ......|+..|+|||++..+. ++.++|||||||++|+|++|+.||...+.. ....|....
T Consensus 158 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~---~~~~~~~~~------- 226 (268)
T cd06624 158 RLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP---QAAMFKVGM------- 226 (268)
T ss_pred ecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh---hhhHhhhhh-------
Confidence 6533221 122345889999999987644 789999999999999999999999654321 111111100
Q ss_pred CChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 437 GNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 437 ~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.......+......+.+++.+||+.+|.+||++.||++.
T Consensus 227 -------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 227 -------FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred -------hccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 000112233345678899999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=319.00 Aligned_cols=257 Identities=22% Similarity=0.373 Sum_probs=208.9
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
++|++.+.||+|+||.||+|... +|+.||+|.++.. .......+.+|++++++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999976 7899999988642 2223567889999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCC--CCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCC
Q 007892 285 EFVPNKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 285 E~~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 362 (586)
||+++++|..++... ....+++.+++.++.++++||.|||+. +|+||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999888542 234589999999999999999999998 999999999999999999999999999876533
Q ss_pred CCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhh
Q 007892 363 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 442 (586)
Q Consensus 363 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 442 (586)
... ......++..|+|||++.+..++.++|||||||++|+|++|+.||..... ...++... +..+.+.
T Consensus 159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~-----~~~~~~~-- 226 (267)
T cd08224 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKK-----IEKCDYP-- 226 (267)
T ss_pred CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHHhh-----hhcCCCC--
Confidence 221 12334688899999999988899999999999999999999999965431 11111111 1111111
Q ss_pred hchhhhccC-HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 443 VDQKLEEYD-SAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 443 ~d~~l~~~~-~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
..+ ......+.+++.+|+..+|.+||++.+|++.|+..
T Consensus 227 ------~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 227 ------PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred ------CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 111 13445788999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=339.78 Aligned_cols=263 Identities=21% Similarity=0.285 Sum_probs=199.1
Q ss_pred CccccceecccCcEEEEEEEE-eCCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC-----eeE
Q 007892 210 NFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS-----QRL 281 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~--~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~-----~~~ 281 (586)
+|+..+.||+|+||.||++.. .+++.||||++... .......+.+|+++|..++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478889999999999999996 46899999998653 2233467889999999999999999999998766 789
Q ss_pred EEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccC
Q 007892 282 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 361 (586)
Q Consensus 282 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~ 361 (586)
+|+||+. ++|..++... ..+++..+..++.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9999996 5677777443 3589999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCcccccccccccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhh-h---------h-----
Q 007892 362 DTDTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMV-D---------W----- 425 (586)
Q Consensus 362 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~-~---------~----- 425 (586)
...........++..|+|||++.+. .++.++|||||||++|||++|+.||...........+ + +
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 3333333445689999999998764 5799999999999999999999999765432111000 0 0
Q ss_pred -hhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 426 -AKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 426 -~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
....+....... ... ..+..........+.+++.+||+.||.+||++.|+++.
T Consensus 235 ~~~~~~~~~~~~~---~~~-~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 235 GARAHILRGPHKP---PSL-PVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHhCCCCC---Cch-HHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000000000 000 00001112234568899999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=327.63 Aligned_cols=262 Identities=24% Similarity=0.431 Sum_probs=203.2
Q ss_pred hcCccccceecccCcEEEEEEEEeC---------------CeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLTN---------------GKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLV 271 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~~---------------g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~ 271 (586)
.++|++.+.||+|+||.||+++..+ ...||||.++... ......|.+|++++.+++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3578889999999999999987542 2358999987653 23345789999999999999999999
Q ss_pred EEEEeCCeeEEEEEecCCCcHHHHhcCCC----------CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCcee
Q 007892 272 GYCTFGSQRLLVYEFVPNKTLEFHLHGKD----------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANI 341 (586)
Q Consensus 272 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NI 341 (586)
+++...+..++||||+++++|.+++.... ...+.|..+++++.|++.||+|||+. +++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 99999999999999999999999885432 12478899999999999999999998 999999999999
Q ss_pred EeCCCCCeEEeecccccccCCCCC-cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh--CCCCCCCCCccc
Q 007892 342 LLDDSFEAKVADFGLAKHSLDTDT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT--GFRPFDKADTFA 418 (586)
Q Consensus 342 Ll~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt--G~~Pf~~~~~~~ 418 (586)
|+++++.+||+|||++........ .......++..|+|||++..+.++.++|||||||++|||++ |..||.....
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~-- 238 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD-- 238 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh--
Confidence 999999999999999976533221 12223345778999999998999999999999999999998 6678765432
Q ss_pred chhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 007892 419 DDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484 (586)
Q Consensus 419 ~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~ 484 (586)
..........+... +.. . ....+...+..+.+++.+|++.+|.+||+|.+|++.|+
T Consensus 239 -~~~~~~~~~~~~~~---~~~--~----~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 239 -EQVIENTGEFFRNQ---GRQ--I----YLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred -HHHHHHHHHhhhhc---ccc--c----cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 11111111111000 000 0 00111123457999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=334.64 Aligned_cols=262 Identities=27% Similarity=0.370 Sum_probs=218.4
Q ss_pred CccccCHHHHHHHhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCcceE
Q 007892 195 FKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSL 270 (586)
Q Consensus 195 ~~~~~~~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~~~~Ei~il~~l~Hpniv~l 270 (586)
+.++-.++-.....+.|+.-++||+||||.||-++.+ +|+.+|+|++.+. ..+++...++|-.||.+++.+.||.|
T Consensus 171 FlQWK~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVsl 250 (591)
T KOG0986|consen 171 FLQWKWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSL 250 (591)
T ss_pred HHHHHHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEE
Confidence 3333444444555577999999999999999999965 5999999998553 23445677899999999999999999
Q ss_pred EEEEEeCCeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeE
Q 007892 271 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAK 350 (586)
Q Consensus 271 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 350 (586)
-..|+..+.++||+..|+||+|..||...+.+.+++...+.+|.+|+.||++||.. +||+|||||+|||||+.|+++
T Consensus 251 aYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvR 327 (591)
T KOG0986|consen 251 AYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVR 327 (591)
T ss_pred eeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeE
Confidence 99999999999999999999999999988888899999999999999999999998 999999999999999999999
Q ss_pred EeecccccccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHH
Q 007892 351 VADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFL 430 (586)
Q Consensus 351 l~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 430 (586)
|+|+|||..+.+...+ ...+||.+|||||+++.+.|+...|.|+|||+||||+.|+.||..... .+.|
T Consensus 328 ISDLGLAvei~~g~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke-----Kvk~----- 395 (591)
T KOG0986|consen 328 ISDLGLAVEIPEGKPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE-----KVKR----- 395 (591)
T ss_pred eeccceEEecCCCCcc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh-----hhhH-----
Confidence 9999999987665543 334899999999999999999999999999999999999999975432 1111
Q ss_pred hhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 007892 431 AQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMS 477 (586)
Q Consensus 431 ~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~ 477 (586)
..++..+-..-+.++....++...+....|..||.+|..-+
T Consensus 396 ------eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 396 ------EEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred ------HHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 11222222222356777778899999999999999997543
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=331.47 Aligned_cols=260 Identities=26% Similarity=0.447 Sum_probs=205.3
Q ss_pred HHhcCccccceecccCcEEEEEEEEe--------CCeEEEEEEeccCC-chhHHHHHHHHHHHHhc-CCCCcceEEEEEE
Q 007892 206 IATDNFSEANLLGQGGFGYVHKGVLT--------NGKVVAIKQLKAGS-GQGEREFQAEIEIISQV-HHRHLVSLVGYCT 275 (586)
Q Consensus 206 ~~~~~f~~~~~LG~G~fG~Vyk~~~~--------~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~ 275 (586)
...++|.+.+.||+|+||.||+++.. ....||+|+++... ......+..|++++.++ +||||++++++|.
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 34467888999999999999999742 24579999987543 23356788999999999 6999999999999
Q ss_pred eCCeeEEEEEecCCCcHHHHhcCCC--------------CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCcee
Q 007892 276 FGSQRLLVYEFVPNKTLEFHLHGKD--------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANI 341 (586)
Q Consensus 276 ~~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NI 341 (586)
..+..++||||+++|+|.+++.... ...++|.++++++.|++.||.|||++ +|+||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Ni 165 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNV 165 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeE
Confidence 9999999999999999999986432 23589999999999999999999998 999999999999
Q ss_pred EeCCCCCeEEeecccccccCCCCCcc-cccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccc
Q 007892 342 LLDDSFEAKVADFGLAKHSLDTDTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFAD 419 (586)
Q Consensus 342 Ll~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~ 419 (586)
|+++++.+||+|||+++......... .....++..|+|||++.++.++.++|||||||++|||++ |..||.....
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~--- 242 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV--- 242 (314)
T ss_pred EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH---
Confidence 99999999999999998654322211 112234567999999998899999999999999999999 8899865432
Q ss_pred hhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 420 DSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 420 ~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
..+... +. .+.. ...+......+.+++.+|++.+|.+||++.||++.|+...
T Consensus 243 ~~~~~~----~~----~~~~--------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 243 EELFKL----LR----EGHR--------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred HHHHHH----HH----cCCC--------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 111111 10 1100 0112233456889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=318.42 Aligned_cols=248 Identities=29% Similarity=0.497 Sum_probs=204.5
Q ss_pred ceecccCcEEEEEEEEeC----CeEEEEEEeccCCchh-HHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecCC
Q 007892 215 NLLGQGGFGYVHKGVLTN----GKVVAIKQLKAGSGQG-EREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPN 289 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~~~~----g~~vAVK~l~~~~~~~-~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~ 289 (586)
+.||+|+||.||+|.... +..|+||.+....... ...+.+|++++.+++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999999764 7889999997654433 67889999999999999999999999999999999999999
Q ss_pred CcHHHHhcCCC-------CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCC
Q 007892 290 KTLEFHLHGKD-------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 290 gsL~~~l~~~~-------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 362 (586)
++|.+++.... ...+++..+..++.|+++||+|||++ +|+||||||+|||+++++.+||+|||++.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999997642 35689999999999999999999998 999999999999999999999999999987654
Q ss_pred CCC-cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChh
Q 007892 363 TDT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 440 (586)
Q Consensus 363 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (586)
... .......++..|+|||.+....++.++|||||||++|||++ |..||..... ..+.... ..+
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~--------~~~--- 223 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---EEVLEYL--------RKG--- 223 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHH--------HcC---
Confidence 321 22234567889999999998899999999999999999999 6999976532 1111110 111
Q ss_pred hhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 007892 441 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484 (586)
Q Consensus 441 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~ 484 (586)
............+.+++.+|++.+|.+||++.|+++.|+
T Consensus 224 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 224 -----YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -----CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 001122333567899999999999999999999999884
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=324.09 Aligned_cols=253 Identities=26% Similarity=0.394 Sum_probs=201.4
Q ss_pred HHhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeC------
Q 007892 206 IATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFG------ 277 (586)
Q Consensus 206 ~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~------ 277 (586)
.+.+.|+..+.||+|+||.||+|... +++.||+|++.... .....+..|+.++.++ +|+||++++++|...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35577888899999999999999965 57899999986543 3456788999999998 699999999998753
Q ss_pred CeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccc
Q 007892 278 SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 357 (586)
Q Consensus 278 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla 357 (586)
...++||||+++++|.+++.......+++..+..++.|++.||+|||+. +|+|||||++|||+++++.+||+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 4578999999999999999765555689999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCccccc-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhh
Q 007892 358 KHSLDTDTHVSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQ 432 (586)
Q Consensus 358 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 432 (586)
+....... ......|+..|+|||++. ...++.++|||||||+||||++|..||....... .+.. ..
T Consensus 159 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~-----~~~~--~~- 229 (272)
T cd06637 159 AQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-----ALFL--IP- 229 (272)
T ss_pred eecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-----HHHH--Hh-
Confidence 76433221 223467899999999986 3458889999999999999999999996543211 1100 00
Q ss_pred cccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 433 GLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 433 ~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
......+ ........+.+++.+||..+|.+||++.||++
T Consensus 230 ---~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 230 ---RNPAPRL-------KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred ---cCCCCCC-------CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0000000 11123356889999999999999999999986
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=326.48 Aligned_cols=250 Identities=26% Similarity=0.379 Sum_probs=200.4
Q ss_pred ccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 211 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 211 f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
|+..+.||+|+||+||++... +++.||+|.+..... .....+.+|+++|.+++|+||+.+.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667789999999999999964 688999999865422 2234578899999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 366 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 366 (586)
+++++|.+++.......+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-- 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence 9999999988765555699999999999999999999998 99999999999999999999999999997643221
Q ss_pred ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchh
Q 007892 367 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 446 (586)
Q Consensus 367 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 446 (586)
......|+..|+|||++.+..++.++|+|||||++|||++|..||....... ....+... ....
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~--~~~~~~~~-----~~~~--------- 220 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV--KREEVDRR-----VLET--------- 220 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHh-----hhcc---------
Confidence 1234578999999999998899999999999999999999999997543211 11111100 0000
Q ss_pred hhccCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 007892 447 LEEYDSAEMTRMAACAAACIRHSARRRPR-----MSQIVR 481 (586)
Q Consensus 447 l~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----m~evl~ 481 (586)
...+.......+.+++..|++.+|.+||+ +.+++.
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 221 EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 00122233456789999999999999999 556654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=330.28 Aligned_cols=254 Identities=28% Similarity=0.459 Sum_probs=200.7
Q ss_pred cCccccceecccCcEEEEEEEEe-CCe--EEEEEEeccCC-chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGK--VVAIKQLKAGS-GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~--~vAVK~l~~~~-~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~~~~lV 283 (586)
++|++.+.||+|+||.||+|.+. ++. .+|+|.++... ......+.+|++++.++ +|+||+++++++..++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 57888899999999999999964 343 46888776532 33456788999999999 899999999999999999999
Q ss_pred EEecCCCcHHHHhcCCC--------------CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCe
Q 007892 284 YEFVPNKTLEFHLHGKD--------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA 349 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 349 (586)
|||+++++|.++++... ...+++.+++.++.|++.||+|||+. +|+||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence 99999999999986432 23588999999999999999999998 99999999999999999999
Q ss_pred EEeecccccccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhH
Q 007892 350 KVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKP 428 (586)
Q Consensus 350 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~ 428 (586)
||+|||+++...... ......++..|+|||++.+..++.++|||||||+||||++ |..||...... .....
T Consensus 164 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~--- 235 (303)
T cd05088 164 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYEK--- 235 (303)
T ss_pred EeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---HHHHH---
Confidence 999999986421111 1111224567999999988889999999999999999998 99999654321 11111
Q ss_pred HHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 429 FLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 429 ~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
. . .+. .. .........+.+++.+|++.+|.+||++.++++.|+..
T Consensus 236 ~-~----~~~-------~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 236 L-P----QGY-------RL-EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred H-h----cCC-------cC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 0 000 00 11112345688999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=321.15 Aligned_cols=257 Identities=21% Similarity=0.331 Sum_probs=206.6
Q ss_pred cCccccceecccCcEEEEEEEE-eCCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
++|++.+.||+|+||.||++.. .+++.||||.+.... .....++.+|+.++.+++|+||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999995 478999999876432 223457889999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCC--CCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCC
Q 007892 285 EFVPNKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 285 E~~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 362 (586)
||+++++|.+++... ....+++..++.++.++++||.|||+. +|+|+||||+|||++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988632 234589999999999999999999998 999999999999999999999999999876533
Q ss_pred CCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhh
Q 007892 363 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 442 (586)
Q Consensus 363 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 442 (586)
... ......|+..|+|||++.+..++.++||||||+++|||++|..||..... ....+.... ....
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~-----~~~~---- 224 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKI-----EQCD---- 224 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc----hHHHHhhhh-----hcCC----
Confidence 221 12335688999999999988899999999999999999999999964332 111111110 0000
Q ss_pred hchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 007892 443 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 485 (586)
Q Consensus 443 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~ 485 (586)
.+.+ ........+.+++.+|++.+|.+||+|.+|++.|+.
T Consensus 225 -~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~ 264 (267)
T cd08229 225 -YPPL--PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR 264 (267)
T ss_pred -CCCC--CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence 0100 112344578899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=343.81 Aligned_cols=201 Identities=25% Similarity=0.325 Sum_probs=172.6
Q ss_pred CccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEE
Q 007892 210 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
.|+..+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++.+++|+|||+++++|.+++..+||||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999964 57899999986532 2234568899999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC-
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD- 364 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~- 364 (586)
|+++|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+||||+.++.+||+|||++.......
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 82 YIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 99999999998654 3478888889999999999999998 99999999999999999999999999975321000
Q ss_pred ---------------------------------------------CcccccccccccccCcccccCCCCCCcchHHHHHH
Q 007892 365 ---------------------------------------------THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGV 399 (586)
Q Consensus 365 ---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGv 399 (586)
.......+||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00112357999999999999899999999999999
Q ss_pred HHHHHHhCCCCCCCCC
Q 007892 400 LLLELITGFRPFDKAD 415 (586)
Q Consensus 400 vL~elltG~~Pf~~~~ 415 (586)
+||||++|+.||...+
T Consensus 237 il~elltG~~Pf~~~~ 252 (382)
T cd05625 237 ILYEMLVGQPPFLAQT 252 (382)
T ss_pred HHHHHHhCCCCCCCCC
Confidence 9999999999997654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=333.67 Aligned_cols=241 Identities=27% Similarity=0.408 Sum_probs=195.1
Q ss_pred ceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeEEEEEecCC
Q 007892 215 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPN 289 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~~~~lV~E~~~~ 289 (586)
+.||+|+||.||++... +++.||||+++... ......+..|++++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999975 47899999997542 22345677899999888 699999999999999999999999999
Q ss_pred CcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcccc
Q 007892 290 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 369 (586)
Q Consensus 290 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 369 (586)
|+|..++.... .+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++...... ....
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (318)
T cd05570 81 GDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTS 154 (318)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cccc
Confidence 99998886543 489999999999999999999998 99999999999999999999999999987532222 1223
Q ss_pred cccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhc
Q 007892 370 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEE 449 (586)
Q Consensus 370 ~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 449 (586)
..+|+..|+|||++.+..++.++|||||||++|||++|+.||...+. ..+.. ... .... .
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~---~~~~~---~i~-----~~~~---------~ 214 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE---DELFQ---SIL-----EDEV---------R 214 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH---HHHHH---HHH-----cCCC---------C
Confidence 45799999999999999999999999999999999999999975432 11111 100 1100 1
Q ss_pred cCHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHH
Q 007892 450 YDSAEMTRMAACAAACIRHSARRRPRM-----SQIVR 481 (586)
Q Consensus 450 ~~~~~~~~l~~l~~~cl~~dp~~RPtm-----~evl~ 481 (586)
++......+.+++.+||+.||.+||++ .++++
T Consensus 215 ~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 215 YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 222334568899999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=338.19 Aligned_cols=238 Identities=28% Similarity=0.368 Sum_probs=193.3
Q ss_pred ceecccCcEEEEEEEE----eCCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecC
Q 007892 215 NLLGQGGFGYVHKGVL----TNGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVP 288 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~~----~~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 288 (586)
+.||+|+||.||++.. .+|+.||||+++.... .....+..|+++|.+++||||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999875 3578999999975322 223456789999999999999999999999999999999999
Q ss_pred CCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCccc
Q 007892 289 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 368 (586)
Q Consensus 289 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 368 (586)
+|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||||++++.+||+|||+++....... ..
T Consensus 82 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~~ 155 (318)
T cd05582 82 GGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KA 155 (318)
T ss_pred CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-ce
Confidence 99999998643 3589999999999999999999998 999999999999999999999999999986533221 22
Q ss_pred ccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhh
Q 007892 369 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLE 448 (586)
Q Consensus 369 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 448 (586)
....|++.|+|||.+.+..++.++|||||||+||||++|+.||...... .... ... ... .
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~---~~~~---~i~-----~~~--------~- 215 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK---ETMT---MIL-----KAK--------L- 215 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH---HHHH---HHH-----cCC--------C-
Confidence 3467999999999999888999999999999999999999999754321 1111 000 000 0
Q ss_pred ccCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 007892 449 EYDSAEMTRMAACAAACIRHSARRRPRMSQ 478 (586)
Q Consensus 449 ~~~~~~~~~l~~l~~~cl~~dp~~RPtm~e 478 (586)
..+......+.+++.+||+.||.+||++.+
T Consensus 216 ~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 216 GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 122223456789999999999999999665
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=319.56 Aligned_cols=246 Identities=27% Similarity=0.439 Sum_probs=195.9
Q ss_pred eecccCcEEEEEEEEe---CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecCCCc
Q 007892 216 LLGQGGFGYVHKGVLT---NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKT 291 (586)
Q Consensus 216 ~LG~G~fG~Vyk~~~~---~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~gs 291 (586)
.||+|+||.||+|++. .+..||||.+..... .....|.+|+.++++++|+||++++++|. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999864 356799999876533 23457899999999999999999999986 457889999999999
Q ss_pred HHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCccc--c
Q 007892 292 LEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS--T 369 (586)
Q Consensus 292 L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~--~ 369 (586)
|.+++... ...+++..+++++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++.......... .
T Consensus 81 L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 81 LNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred HHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 99998643 24589999999999999999999998 999999999999999999999999999986533322111 1
Q ss_pred cccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhh
Q 007892 370 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLE 448 (586)
Q Consensus 370 ~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 448 (586)
...++..|+|||++....++.++|||||||++|||++ |..||...... ..... +. .+.. .
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~----~~----~~~~--------~ 217 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP---EVMSF----IE----QGKR--------L 217 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHH----HH----CCCC--------C
Confidence 1223578999999988889999999999999999996 99999754321 11111 11 1100 0
Q ss_pred ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 007892 449 EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 485 (586)
Q Consensus 449 ~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~ 485 (586)
..+......+.+++.+||..+|++||++.+|.+.|+.
T Consensus 218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 1223345678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=319.12 Aligned_cols=250 Identities=21% Similarity=0.331 Sum_probs=204.2
Q ss_pred CccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEec
Q 007892 210 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 287 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 287 (586)
+|+..+.||+|+||.||++... +++.||+|.++... ....+.+.+|+.++++++|+||+++++++..++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999965 68899999986432 233467889999999999999999999999999999999999
Q ss_pred CCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcc
Q 007892 288 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 367 (586)
Q Consensus 288 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 367 (586)
++++|.+++.......+++...+.++.|++.||.|||++ +|+|+||||+|||+++++.++|+|||++........ .
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~ 156 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-Y 156 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc-c
Confidence 999999988655555688999999999999999999998 999999999999999999999999999976543221 2
Q ss_pred cccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhh
Q 007892 368 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 447 (586)
Q Consensus 368 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 447 (586)
.....|+..|+|||++.+..++.++||||||+++|+|++|..||...+.. ..... +..+.+.
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~~~~~-----~~~~~~~------- 218 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK------NLILK-----VCQGSYK------- 218 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH------HHHHH-----HhcCCCC-------
Confidence 23456899999999999888999999999999999999999999754321 11100 1111111
Q ss_pred hccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 448 EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 448 ~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
..+......+.+++.+||+.+|.+||++.+|+..
T Consensus 219 -~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 -PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1122234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=332.06 Aligned_cols=240 Identities=28% Similarity=0.391 Sum_probs=191.8
Q ss_pred ceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeEEEEEecCC
Q 007892 215 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPN 289 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~~~~lV~E~~~~ 289 (586)
+.||+|+||+||+|... +++.||||.++... ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999975 47899999987542 12234566778888764 899999999999999999999999999
Q ss_pred CcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcccc
Q 007892 290 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 369 (586)
Q Consensus 290 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 369 (586)
|+|..++... ..+++.++..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 154 (316)
T cd05619 81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KTC 154 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-cee
Confidence 9999998643 3488999999999999999999998 999999999999999999999999999875322221 223
Q ss_pred cccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhc
Q 007892 370 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEE 449 (586)
Q Consensus 370 ~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 449 (586)
...||+.|+|||++.+..++.++|||||||+||||++|+.||...+. ..+.... ..+ .+ .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---~~~~~~i--------~~~------~~---~ 214 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE---EELFQSI--------RMD------NP---C 214 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH---HHHHHHH--------HhC------CC---C
Confidence 46799999999999988999999999999999999999999975432 1111110 000 00 1
Q ss_pred cCHHHHHHHHHHHHHhhccCCCCCCCHH-HHH
Q 007892 450 YDSAEMTRMAACAAACIRHSARRRPRMS-QIV 480 (586)
Q Consensus 450 ~~~~~~~~l~~l~~~cl~~dp~~RPtm~-evl 480 (586)
++......+.+++.+||+.+|.+||++. ++.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 215 YPRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred CCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 1222335678999999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=344.33 Aligned_cols=251 Identities=22% Similarity=0.276 Sum_probs=195.7
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
.+|++.+.||+|+||.||+++.. +++.||||++.... ......+.+|+++|.+++|+||+++++.+.+++..+|||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36889999999999999999964 58899999986432 122456789999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCC-
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT- 363 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~- 363 (586)
||+++|+|.+++... ..+++.....++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+|..+...
T Consensus 81 E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 81 DYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 999999999998654 3478888889999999999999998 9999999999999999999999999998532100
Q ss_pred -----------------------------------------CCcccccccccccccCcccccCCCCCCcchHHHHHHHHH
Q 007892 364 -----------------------------------------DTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLL 402 (586)
Q Consensus 364 -----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ 402 (586)
........+||+.|||||++.+..++.++|||||||+||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 000112357999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCcccc-hhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCC---CHHH
Q 007892 403 ELITGFRPFDKADTFAD-DSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRP---RMSQ 478 (586)
Q Consensus 403 elltG~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RP---tm~e 478 (586)
||++|+.||........ ..+..|.. . +..+ ........+.+++.+|+ .+|.+|+ ++.|
T Consensus 236 ell~G~~Pf~~~~~~~~~~~i~~~~~----------~---~~~~----~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~e 297 (376)
T cd05598 236 EMLVGQPPFLADTPAETQLKVINWET----------T---LHIP----SQAKLSREASDLILRLC-CGAEDRLGKNGADE 297 (376)
T ss_pred ehhhCCCCCCCCCHHHHHHHHhccCc----------c---ccCC----CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHH
Confidence 99999999976543111 00111100 0 0000 01112345666777766 4999999 8888
Q ss_pred HHHH
Q 007892 479 IVRA 482 (586)
Q Consensus 479 vl~~ 482 (586)
++..
T Consensus 298 ll~h 301 (376)
T cd05598 298 IKAH 301 (376)
T ss_pred HhCC
Confidence 8764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=324.35 Aligned_cols=262 Identities=26% Similarity=0.439 Sum_probs=206.0
Q ss_pred hcCccccceecccCcEEEEEEEEeC-----------------CeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcce
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLTN-----------------GKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVS 269 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~~-----------------g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~ 269 (586)
.++|++.+.||+|+||.||++...+ +..||+|.+..... .....+.+|++++.+++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4678889999999999999998542 24689999876533 34567899999999999999999
Q ss_pred EEEEEEeCCeeEEEEEecCCCcHHHHhcCCC---------CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCce
Q 007892 270 LVGYCTFGSQRLLVYEFVPNKTLEFHLHGKD---------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSAN 340 (586)
Q Consensus 270 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~N 340 (586)
++++|..++..++|+||+++++|..++.... ...+++..++.++.|++.||+|||+. +|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 9999999999999999999999999986543 12589999999999999999999998 99999999999
Q ss_pred eEeCCCCCeEEeecccccccCCCCC-cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh--CCCCCCCCCcc
Q 007892 341 ILLDDSFEAKVADFGLAKHSLDTDT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT--GFRPFDKADTF 417 (586)
Q Consensus 341 ILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt--G~~Pf~~~~~~ 417 (586)
||+++++.++|+|||+++....... .......++..|+|||++..+.++.++|||||||++|||++ |..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 9999999999999999986543322 12234456789999999998899999999999999999998 6778865332
Q ss_pred cchhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 007892 418 ADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484 (586)
Q Consensus 418 ~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~ 484 (586)
.....+....+ ......... ......+..+.+++.+|++.+|.+||++.||++.|+
T Consensus 240 --~~~~~~~~~~~----~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 --QQVIENAGHFF----RDDGRQIYL-----PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred --HHHHHHHHhcc----ccccccccC-----CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 11212111110 000000000 112223457899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=319.05 Aligned_cols=248 Identities=27% Similarity=0.415 Sum_probs=201.5
Q ss_pred ceecccCcEEEEEEEEeC--C--eEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecCC
Q 007892 215 NLLGQGGFGYVHKGVLTN--G--KVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPN 289 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~~~~--g--~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~ 289 (586)
+.||+|+||.||+|.+.+ + ..||||.+..... ...+.+.+|+.++++++|+||+++++++.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999753 2 3699999987665 556789999999999999999999999988 888999999999
Q ss_pred CcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc--c
Q 007892 290 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH--V 367 (586)
Q Consensus 290 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~--~ 367 (586)
++|.+++.......++|...+.++.|++.||+|||+. +++|+||||+|||++.++.+||+|||+++........ .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 9999999765435689999999999999999999998 9999999999999999999999999999876443221 1
Q ss_pred cccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchh
Q 007892 368 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 446 (586)
Q Consensus 368 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 446 (586)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||...... .+.... .. ... .
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~---~~----~~~-------~ 219 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS---QILKKI---DK----EGE-------R 219 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH---Hh----cCC-------c
Confidence 123457789999999998899999999999999999998 99999654321 111110 00 000 0
Q ss_pred hhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 007892 447 LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484 (586)
Q Consensus 447 l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~ 484 (586)
...+...+..+.+++.+|++.+|.+||++.+|++.|.
T Consensus 220 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 220 -LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0112233467899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=332.99 Aligned_cols=240 Identities=28% Similarity=0.389 Sum_probs=192.0
Q ss_pred ceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeEEEEEecCC
Q 007892 215 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPN 289 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~~~~lV~E~~~~ 289 (586)
+.||+|+||.||+|+.. +|+.||||+++... ......+..|..++..+ +||||+++++++.+.+..+|||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999975 58899999997532 22344567788888764 899999999999999999999999999
Q ss_pred CcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcccc
Q 007892 290 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 369 (586)
Q Consensus 290 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 369 (586)
|+|..++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (316)
T cd05620 81 GDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRAS 154 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Ccee
Confidence 9999988654 3488999999999999999999998 99999999999999999999999999987532211 2234
Q ss_pred cccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhc
Q 007892 370 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEE 449 (586)
Q Consensus 370 ~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 449 (586)
..+||+.|+|||++.+..++.++|||||||+||||++|+.||...+. ..+... +..+ .+ .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~---~~~~~~--------~~~~------~~---~ 214 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE---DELFES--------IRVD------TP---H 214 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHH--------HHhC------CC---C
Confidence 56799999999999999999999999999999999999999975432 111110 0000 00 1
Q ss_pred cCHHHHHHHHHHHHHhhccCCCCCCCHH-HHH
Q 007892 450 YDSAEMTRMAACAAACIRHSARRRPRMS-QIV 480 (586)
Q Consensus 450 ~~~~~~~~l~~l~~~cl~~dp~~RPtm~-evl 480 (586)
++......+.+++.+||+.||.+||++. +++
T Consensus 215 ~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 215 YPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1222345678899999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=334.33 Aligned_cols=240 Identities=27% Similarity=0.397 Sum_probs=190.5
Q ss_pred ceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHH-HHHhcCCCCcceEEEEEEeCCeeEEEEEecCC
Q 007892 215 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIE-IISQVHHRHLVSLVGYCTFGSQRLLVYEFVPN 289 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~-il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~ 289 (586)
+.||+|+||+||+|+.. +|+.||||++.... ......+..|.. ++..++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999975 68999999986532 122234445544 56789999999999999999999999999999
Q ss_pred CcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcccc
Q 007892 290 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 369 (586)
Q Consensus 290 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 369 (586)
|+|..++... ..+.+..+..++.|++.||.|||++ +|+||||||+||||++++.+||+|||+++...... ....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (323)
T cd05575 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTS 154 (323)
T ss_pred CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cccc
Confidence 9999988653 3588899999999999999999998 99999999999999999999999999997543222 2234
Q ss_pred cccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhc
Q 007892 370 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEE 449 (586)
Q Consensus 370 ~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 449 (586)
...||+.|+|||++.+..++.++|||||||+||||++|+.||...+. .+.....+ .+ .+ .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~------~~~~~~i~-----~~--------~~-~ 214 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT------AEMYDNIL-----NK--------PL-R 214 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH------HHHHHHHH-----cC--------CC-C
Confidence 46799999999999999999999999999999999999999975432 11111111 11 11 1
Q ss_pred cCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 007892 450 YDSAEMTRMAACAAACIRHSARRRPRMSQIV 480 (586)
Q Consensus 450 ~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl 480 (586)
........+.+++.+||+.||.+||++.+.+
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (323)
T cd05575 215 LKPNISVSARHLLEGLLQKDRTKRLGAKDDF 245 (323)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHhCCCCCCCH
Confidence 1122355688999999999999999986433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=332.44 Aligned_cols=243 Identities=24% Similarity=0.346 Sum_probs=193.2
Q ss_pred ceecccCcEEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeEEEEEecCC
Q 007892 215 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPN 289 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~~~~lV~E~~~~ 289 (586)
+.||+|+||.||++... +++.||||+++.... .....+..|+.++.++ +|+||+++++++...+..+|||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999965 578999999975422 2335678899999988 699999999999999999999999999
Q ss_pred CcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcccc
Q 007892 290 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 369 (586)
Q Consensus 290 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 369 (586)
|+|..++... ..+++..+..++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (327)
T cd05617 81 GDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTS 154 (327)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Ccee
Confidence 9999888643 3489999999999999999999998 99999999999999999999999999997532222 1223
Q ss_pred cccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhc
Q 007892 370 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEE 449 (586)
Q Consensus 370 ~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 449 (586)
..+||+.|+|||++.+..++.++|||||||+||||++|+.||............++....+. .... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~------------~~~~-~ 221 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL------------EKPI-R 221 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH------------hCCC-C
Confidence 46799999999999999999999999999999999999999975432111122222111111 0000 1
Q ss_pred cCHHHHHHHHHHHHHhhccCCCCCCCH
Q 007892 450 YDSAEMTRMAACAAACIRHSARRRPRM 476 (586)
Q Consensus 450 ~~~~~~~~l~~l~~~cl~~dp~~RPtm 476 (586)
++......+.+++.+||+.||.+|+++
T Consensus 222 ~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 222 IPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 222334567899999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=331.57 Aligned_cols=261 Identities=20% Similarity=0.236 Sum_probs=196.5
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
..+|.+.+.||+|+||.||++... .++.||||.... ..+.+|+++|++|+|+|||++++++..++..+||||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999975 478899996432 3467899999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC-
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT- 365 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~- 365 (586)
+. ++|..++.... ..++|.+++.|+.|++.||.|||++ +||||||||+||||+.++.+||+|||+++.......
T Consensus 242 ~~-~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 242 YR-SDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred cC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 95 68877775432 3589999999999999999999998 999999999999999999999999999986533221
Q ss_pred cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcc-c----chhhhhhhhHHHhhcccCCChh
Q 007892 366 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTF-A----DDSMVDWAKPFLAQGLADGNFD 440 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~-~----~~~~~~~~~~~~~~~~~~~~~~ 440 (586)
.......||..|+|||++.+..++.++|||||||+||||++|..|+...... . ...+....... ......+.
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~---~~~~~~~~ 393 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQA---QVHVDEFP 393 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhh---ccccccCC
Confidence 1223457999999999999999999999999999999999988765432211 0 01111111100 00000000
Q ss_pred -----hhhchh--------hhccC-------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 441 -----ALVDQK--------LEEYD-------SAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 441 -----~l~d~~--------l~~~~-------~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.+.... ...+. ......+.+++.+||+.||.+||++.||++.
T Consensus 394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000000 00000 0112367889999999999999999999975
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=322.14 Aligned_cols=251 Identities=24% Similarity=0.292 Sum_probs=210.0
Q ss_pred cCccccceecccCcEEEEEEEEeC-CeEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
+.|+..+.||+|.-|+||++.+.+ +..+|+|++.+... +.....+.|-+||+.++||.|+.|++.++.+...||||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 457778999999999999999875 58999999976543 33346678999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCC--
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD-- 362 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~-- 362 (586)
|||+||+|...++.+....++...+..+|.+++-||+|||.. |||+|||||+||||.++|++.|+||.|+.....
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 999999999999999999999999999999999999999998 999999999999999999999999998753210
Q ss_pred -------------------------------CCC----------------------cccccccccccccCcccccCCCCC
Q 007892 363 -------------------------------TDT----------------------HVSTRVMGTFGYLAPEYASSGKLT 389 (586)
Q Consensus 363 -------------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~s 389 (586)
... ..+...+||-.|+|||++.+...+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 000 011235799999999999999999
Q ss_pred CcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhh-ccCHHHHHHHHHHHHHhhcc
Q 007892 390 EKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRH 468 (586)
Q Consensus 390 ~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~-~~~~~~~~~l~~l~~~cl~~ 468 (586)
.++|+|+|||+||||+.|..||.+.+.. ..+..++-..+. ......+..+.+||.+.|.+
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~-------------------~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvK 374 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNK-------------------ETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVK 374 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCch-------------------hhHHHHhcCCCcCCCCCcchhHHHHHHHHHhcc
Confidence 9999999999999999999999887642 123334434343 22235667899999999999
Q ss_pred CCCCCCC----HHHHHH
Q 007892 469 SARRRPR----MSQIVR 481 (586)
Q Consensus 469 dp~~RPt----m~evl~ 481 (586)
||.+|.. +.||-+
T Consensus 375 dP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 375 DPSKRLGSKRGAAEIKR 391 (459)
T ss_pred ChhhhhccccchHHhhc
Confidence 9999998 777654
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=315.35 Aligned_cols=247 Identities=28% Similarity=0.440 Sum_probs=200.2
Q ss_pred ceecccCcEEEEEEEEeCCeEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecCCCcHH
Q 007892 215 NLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLE 293 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~-~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~gsL~ 293 (586)
++||+|+||.||++.+.+++.||+|.++..... ....+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999877999999998765443 4568999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCccc-cccc
Q 007892 294 FHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS-TRVM 372 (586)
Q Consensus 294 ~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~-~~~~ 372 (586)
+++.... ..+++..++.++.+++.+|+|||++ +++||||||+||||+.++.+||+|||+++.......... ....
T Consensus 81 ~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 81 TFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 9986543 3578999999999999999999998 899999999999999999999999999976432211111 1223
Q ss_pred ccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhccC
Q 007892 373 GTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYD 451 (586)
Q Consensus 373 gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~ 451 (586)
++..|+|||++.++.++.++|||||||++|||++ |..||...... ...... ..+. .+ ..+
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~---~~~~~~--------~~~~-------~~-~~~ 217 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ---QTRERI--------ESGY-------RM-PAP 217 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH---HHHHHH--------hcCC-------CC-CCC
Confidence 4567999999998899999999999999999999 88888654321 111110 0000 00 112
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 007892 452 SAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484 (586)
Q Consensus 452 ~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~ 484 (586)
......+.+++.+|++.+|.+||++.||++.|+
T Consensus 218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 233457899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=321.51 Aligned_cols=255 Identities=25% Similarity=0.440 Sum_probs=205.7
Q ss_pred cCccccceecccCcEEEEEEEEe------CCeEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 281 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~~~~-~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~ 281 (586)
++|+....||+|+||.||+|+.. +.+.|++|.+...... ....+.+|++++.+++|+||++++++|.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 67888999999999999999964 2467999988665433 3467999999999999999999999999989999
Q ss_pred EEEEecCCCcHHHHhcCCCC-------CCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeec
Q 007892 282 LVYEFVPNKTLEFHLHGKDR-------PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADF 354 (586)
Q Consensus 282 lV~E~~~~gsL~~~l~~~~~-------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DF 354 (586)
+||||+++++|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999975441 2589999999999999999999998 8999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhc
Q 007892 355 GLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQG 433 (586)
Q Consensus 355 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 433 (586)
|+++..............++..|++||.+.+..++.++|||||||++|+|++ |..||..... ...+.+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~~~~~------- 231 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEVLNRL------- 231 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHHHHHH-------
Confidence 9987543332222233456788999999988889999999999999999999 8889864332 1111111
Q ss_pred ccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 007892 434 LADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484 (586)
Q Consensus 434 ~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~ 484 (586)
..+.... ......+..+.+++.+|++.+|.+||++.|++..|.
T Consensus 232 -~~~~~~~-------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 232 -QAGKLEL-------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred -HcCCcCC-------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 0111100 111223457899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=321.29 Aligned_cols=255 Identities=29% Similarity=0.466 Sum_probs=203.2
Q ss_pred cCccccceecccCcEEEEEEEEeC-C---eEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLTN-G---KVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~~-g---~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV 283 (586)
..|++.+.||+|+||.||+|.+.. + ..||||.++... .....+|..|+.++.+++||||+++++++..+...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 357788999999999999999753 3 369999987642 33356899999999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCC
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 363 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 363 (586)
|||+++++|.+++.... ..+++.+++.++.|++.||.|||+. +++|+||||+|||++.++.+||+|||++......
T Consensus 84 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 84 TEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 99999999999987543 3589999999999999999999998 9999999999999999999999999998765332
Q ss_pred CCcc-cc-cc--cccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCC
Q 007892 364 DTHV-ST-RV--MGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGN 438 (586)
Q Consensus 364 ~~~~-~~-~~--~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (586)
.... .. .. ..+..|+|||++..+.++.++|||||||++|||++ |..||..... .....+.. . ...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~---~~~~~~i~----~---~~~ 229 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---QDVINAIE----Q---DYR 229 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH---HHHHHHHH----c---CCc
Confidence 2111 11 11 12457999999998999999999999999999886 9999975432 12222211 0 000
Q ss_pred hhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 439 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 439 ~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
+ ....+.+..+.+++..|++.+|.+||+|.+|+..|+..
T Consensus 230 --------~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 230 --------L-PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred --------C-CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 11123345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=328.43 Aligned_cols=267 Identities=19% Similarity=0.304 Sum_probs=198.9
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
++|...+.||+|+||.||+|+.. +++.||||.++.... .....+.+|++++.+++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57889999999999999999965 578899999875432 2234678899999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 366 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 366 (586)
+++ +|..++.... ..+++..+..++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 159 (309)
T cd07872 86 LDK-DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK- 159 (309)
T ss_pred CCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence 975 7777765432 3478899999999999999999998 999999999999999999999999999975432221
Q ss_pred ccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhh-----hHHHhhcccCCChh
Q 007892 367 VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWA-----KPFLAQGLADGNFD 440 (586)
Q Consensus 367 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~ 440 (586)
......++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+........ ...+........+.
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 2233468899999998864 56899999999999999999999999765432111111000 00000000000000
Q ss_pred hhhchh-----hhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 441 ALVDQK-----LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 441 ~l~d~~-----l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
....+. +..........+.+++.+||+.||.+||++.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000 00011123456789999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=307.62 Aligned_cols=266 Identities=24% Similarity=0.343 Sum_probs=212.5
Q ss_pred HHHHhcCccccceecccCcEEEEEEE-EeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC----
Q 007892 204 LKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS---- 278 (586)
Q Consensus 204 l~~~~~~f~~~~~LG~G~fG~Vyk~~-~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~---- 278 (586)
+.+..++|.+.++||+|||..||+++ +.+++.+|+|++.....++.+..++|++..++++|||++++++++..+.
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 44566889999999999999999999 6688999999998888777889999999999999999999998885543
Q ss_pred -eeEEEEEecCCCcHHHHhcCC--CCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecc
Q 007892 279 -QRLLVYEFVPNKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 355 (586)
Q Consensus 279 -~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFG 355 (586)
..||+++|...|+|.+++... .+..+++.+.++|+.++++||++||+. .+.++||||||.|||+.+.+.++|.|||
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEecc
Confidence 489999999999999988643 334699999999999999999999997 4569999999999999999999999999
Q ss_pred cccccCCCCCccc--------ccccccccccCcccccC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhh
Q 007892 356 LAKHSLDTDTHVS--------TRVMGTFGYLAPEYASS---GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD 424 (586)
Q Consensus 356 la~~~~~~~~~~~--------~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~ 424 (586)
.+....-...... .....|..|.|||.+.- ...++++|||||||+||+|+.|..||+..-. ..+++.-
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-~GgSlaL 253 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-QGGSLAL 253 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-cCCeEEE
Confidence 9875432111000 11246889999999864 4578999999999999999999999986544 2222211
Q ss_pred hhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 425 WAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 425 ~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
++.++.+.- .......+.+.+++++|++.||.+||++.+++..++..
T Consensus 254 --------Av~n~q~s~-------P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 254 --------AVQNAQISI-------PNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred --------eeecccccc-------CCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 111111111 11112456799999999999999999999999998754
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=334.45 Aligned_cols=259 Identities=28% Similarity=0.447 Sum_probs=201.4
Q ss_pred hcCccccceecccCcEEEEEEEE------eCCeEEEEEEeccCCch-hHHHHHHHHHHHHhc-CCCCcceEEEEEEeC-C
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVL------TNGKVVAIKQLKAGSGQ-GEREFQAEIEIISQV-HHRHLVSLVGYCTFG-S 278 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~------~~g~~vAVK~l~~~~~~-~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~-~ 278 (586)
.++|++.+.||+|+||.||+|+. .+++.||||+++..... ....+.+|+.+|.++ +|+||++++++|... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 46788999999999999999973 34689999999764332 345788999999999 689999999988654 4
Q ss_pred eeEEEEEecCCCcHHHHhcCCC----------------------------------------------------------
Q 007892 279 QRLLVYEFVPNKTLEFHLHGKD---------------------------------------------------------- 300 (586)
Q Consensus 279 ~~~lV~E~~~~gsL~~~l~~~~---------------------------------------------------------- 300 (586)
..++||||+++|+|.++++...
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 6789999999999999886432
Q ss_pred -------CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc-cccccc
Q 007892 301 -------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH-VSTRVM 372 (586)
Q Consensus 301 -------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~ 372 (586)
...++|..+..++.|+++||+|||++ +|+||||||+|||+++++.+||+|||++......... ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 12368888999999999999999998 9999999999999999999999999999865332211 112234
Q ss_pred ccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhccC
Q 007892 373 GTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYD 451 (586)
Q Consensus 373 gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~ 451 (586)
++..|+|||++.+..++.++|||||||+||||++ |..||...... .... ..+..+... ..+
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~--------~~~~~~~~~--------~~~ 304 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFC--------RRLKEGTRM--------RAP 304 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--HHHH--------HHHhccCCC--------CCC
Confidence 5678999999998899999999999999999997 99998654321 0000 001111100 011
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 452 SAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 452 ~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
......+.+++..|++.+|.+||++.||++.|+...
T Consensus 305 ~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 305 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 112346889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=321.47 Aligned_cols=255 Identities=25% Similarity=0.397 Sum_probs=204.3
Q ss_pred hcCccccceecccCcEEEEEEEEeCC----eEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLTNG----KVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 282 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~~g----~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~l 282 (586)
.++|.+.+.||+|+||.||+|.+.+. ..||||...... ....+.+.+|+.++++++|+||++++++|.. ...++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 35688889999999999999996542 468999887654 3445688999999999999999999999875 56789
Q ss_pred EEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCC
Q 007892 283 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 283 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 362 (586)
||||+++++|.+++.... ..+++..++.++.+++.||+|||+. +++||||||+|||++.++.+||+|||+++....
T Consensus 84 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 84 VMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 999999999999996543 3589999999999999999999988 999999999999999999999999999986544
Q ss_pred CCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhh
Q 007892 363 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 441 (586)
Q Consensus 363 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (586)
..........++..|+|||.+....++.++|||||||++|||++ |..||...... ....+. ..+..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~~--------~~~~~-- 226 (270)
T cd05056 160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIGRI--------ENGER-- 226 (270)
T ss_pred ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHH--------HcCCc--
Confidence 33222233345568999999988889999999999999999996 99999755421 111111 01100
Q ss_pred hhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 442 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 442 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
+ .........+.+++.+|+..+|.+||++.++++.|+..
T Consensus 227 -----~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 227 -----L-PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred -----C-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 11123345789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=325.60 Aligned_cols=265 Identities=23% Similarity=0.362 Sum_probs=204.0
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
++|++.+.||+|+||.||++... ++..+|+|.++.... .....+.+|++++.+++||||++++++|..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46889999999999999999965 578899999875432 2345688999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 366 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 366 (586)
+++++|.++++.. ..+++..+..++.|+++||.|||+.+ +|+||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 154 (308)
T cd06615 81 MDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 154 (308)
T ss_pred cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence 9999999999654 44889999999999999999999742 89999999999999999999999999987643321
Q ss_pred ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccC----------
Q 007892 367 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLAD---------- 436 (586)
Q Consensus 367 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~---------- 436 (586)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||...+... ...+...........
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 155 -ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred -cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCcccccCCC
Confidence 234578999999999988889999999999999999999999996543211 111110000000000
Q ss_pred ------CChhhhhchhhh----ccC-HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007892 437 ------GNFDALVDQKLE----EYD-SAEMTRMAACAAACIRHSARRRPRMSQIVRAL 483 (586)
Q Consensus 437 ------~~~~~l~d~~l~----~~~-~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L 483 (586)
....++.+.... ..+ ......+.+++.+||+.+|.+||++.||++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 000011111110 000 11345688999999999999999999999763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=344.40 Aligned_cols=270 Identities=21% Similarity=0.310 Sum_probs=196.5
Q ss_pred HHHHHHhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCC------CCcceEEEEE
Q 007892 202 EELKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHH------RHLVSLVGYC 274 (586)
Q Consensus 202 ~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~H------pniv~l~g~~ 274 (586)
+++....++|++.++||+|+||+||+|+.. .++.||||+++... ...+++..|++++.+++| .+|+++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 455566789999999999999999999964 57899999996532 223456677887777654 4588999988
Q ss_pred EeC-CeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCC------
Q 007892 275 TFG-SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF------ 347 (586)
Q Consensus 275 ~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~------ 347 (586)
... ...+||||++ +++|.+++... ..+.+..+..|+.||+.||+|||.++ +||||||||+||||+.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCcccccc
Confidence 764 4678999988 77888887644 35899999999999999999999732 899999999999998765
Q ss_pred ----------CeEEeecccccccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcc
Q 007892 348 ----------EAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTF 417 (586)
Q Consensus 348 ----------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~ 417 (586)
.+||+|||++.... ......+||+.|+|||++.+..++.++|||||||+||||++|+.||+..+..
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred cccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 49999999886422 2234567999999999999999999999999999999999999999865432
Q ss_pred cchhhh---------hhhhHHHh----hcc-cCCChhhhhchh-h----h---ccCHHHHHHHHHHHHHhhccCCCCCCC
Q 007892 418 ADDSMV---------DWAKPFLA----QGL-ADGNFDALVDQK-L----E---EYDSAEMTRMAACAAACIRHSARRRPR 475 (586)
Q Consensus 418 ~~~~~~---------~~~~~~~~----~~~-~~~~~~~l~d~~-l----~---~~~~~~~~~l~~l~~~cl~~dp~~RPt 475 (586)
.....+ .|...... ..+ ..+.+....++. + . .........+++|+..||+.||.+||+
T Consensus 352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t 431 (467)
T PTZ00284 352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN 431 (467)
T ss_pred HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence 111111 11110000 000 000000000000 0 0 000112346789999999999999999
Q ss_pred HHHHHH
Q 007892 476 MSQIVR 481 (586)
Q Consensus 476 m~evl~ 481 (586)
+.|+++
T Consensus 432 a~e~L~ 437 (467)
T PTZ00284 432 ARQMTT 437 (467)
T ss_pred HHHHhc
Confidence 999997
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=316.92 Aligned_cols=247 Identities=28% Similarity=0.456 Sum_probs=198.2
Q ss_pred ceecccCcEEEEEEEEeC----CeEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecCC
Q 007892 215 NLLGQGGFGYVHKGVLTN----GKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPN 289 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~~~~----g~~vAVK~l~~~~~~-~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~ 289 (586)
++||+|+||.||+|.+.. +..||+|.+...... ...++.+|+.+++++.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999998532 268999998765442 4567899999999999999999999886 4568999999999
Q ss_pred CcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCccc-
Q 007892 290 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS- 368 (586)
Q Consensus 290 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~- 368 (586)
++|.+++.... .+++..++.++.|++.||+|||+. +++|+||||+|||++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 99999997543 589999999999999999999988 899999999999999999999999999986543332211
Q ss_pred -ccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchh
Q 007892 369 -TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 446 (586)
Q Consensus 369 -~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 446 (586)
....++..|+|||.+.+..++.++|||||||++|||++ |..||...+. ..+..+.. .+...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~--------~~~~~------ 217 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLE--------SGERL------ 217 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHH--------cCCcC------
Confidence 11224568999999998899999999999999999998 9999975432 22222211 11000
Q ss_pred hhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 447 LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 447 l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
..+......+.+++.+|+..+|.+||++.+|++.|++.
T Consensus 218 --~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 218 --PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred --CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 11122345788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=316.87 Aligned_cols=250 Identities=24% Similarity=0.365 Sum_probs=202.9
Q ss_pred CccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEe-CCeeEEEEE
Q 007892 210 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTF-GSQRLLVYE 285 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~-~~~~~lV~E 285 (586)
+|++.+.||+|+||.||++... +++.||||.+.... ......+.+|++++++++|+|++++++.+.. ....++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788899999999999999965 57889999986532 2334578899999999999999999988764 446789999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 365 (586)
|+++++|.+++.......+++.++..++.+++.||+|||+. +|+||||||+|||+++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~- 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC- 156 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence 99999999999765555689999999999999999999998 99999999999999999999999999998653322
Q ss_pred cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhch
Q 007892 366 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQ 445 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 445 (586)
.......+++.|+|||++.+..++.++|||||||++|||++|+.||...+. ..+..... .+
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~------~~~~~~~~-----~~-------- 217 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM------NSLVYRII-----EG-------- 217 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHH-----hc--------
Confidence 223345689999999999999999999999999999999999999975432 11111111 11
Q ss_pred hhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 446 KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 446 ~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.+..........+.+++.+|++.+|.+||++.++++.
T Consensus 218 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 218 KLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1111223345678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=320.59 Aligned_cols=248 Identities=28% Similarity=0.469 Sum_probs=195.2
Q ss_pred ceecccCcEEEEEEEEeC-Ce--EEEEEEeccCC-chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeEEEEEecCC
Q 007892 215 NLLGQGGFGYVHKGVLTN-GK--VVAIKQLKAGS-GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPN 289 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~~~~-g~--~vAVK~l~~~~-~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~~~~lV~E~~~~ 289 (586)
+.||+|+||.||+|++.+ +. .+++|.++... ......+.+|++++.++ +||||++++++|...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 469999999999999754 33 57888887532 34456788999999999 799999999999999999999999999
Q ss_pred CcHHHHhcCCC--------------CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecc
Q 007892 290 KTLEFHLHGKD--------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 355 (586)
Q Consensus 290 gsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFG 355 (586)
|+|.+++.... ...+++.+++.++.|++.||+|||+. +++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 99999986432 13478999999999999999999997 99999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcc
Q 007892 356 LAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGL 434 (586)
Q Consensus 356 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 434 (586)
++....... .......+..|+|||++....++.++|||||||+||||++ |..||..... ...... .
T Consensus 158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~---~~~~~~---~----- 224 (270)
T cd05047 158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYEK---L----- 224 (270)
T ss_pred Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH---HHHHHH---H-----
Confidence 986322111 1111223567999999988899999999999999999997 9999965432 111110 0
Q ss_pred cCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 435 ADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 435 ~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
..+. .+ .........+.+++.+|++.+|.+||++.+|+..|+..
T Consensus 225 ~~~~-------~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 225 PQGY-------RL-EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred hCCC-------CC-CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 0000 00 11122345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=316.14 Aligned_cols=251 Identities=30% Similarity=0.483 Sum_probs=204.5
Q ss_pred ccccceecccCcEEEEEEEEeC-----CeEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 211 FSEANLLGQGGFGYVHKGVLTN-----GKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 211 f~~~~~LG~G~fG~Vyk~~~~~-----g~~vAVK~l~~~~~~-~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
|++.+.||.|+||.||+++..+ +..||+|.++..... ....+..|+.++.+++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4567899999999999999754 378999999766543 4678999999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
||+++++|.+++.......+++.++..++.|++.||+|||+. +++|+||||+||++++++.++|+|||+++......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999999765444489999999999999999999998 99999999999999999999999999998765443
Q ss_pred CcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhh
Q 007892 365 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 443 (586)
Q Consensus 365 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 443 (586)
........+++.|+|||.+....++.++||||||++++||++ |+.||..... ..+.... ..+..
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~--------~~~~~---- 222 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEVLEYL--------KKGYR---- 222 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH--------hcCCC----
Confidence 322222337789999999988889999999999999999998 8888875322 1111111 01110
Q ss_pred chhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007892 444 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRAL 483 (586)
Q Consensus 444 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L 483 (586)
..........+.+++.+|+..+|.+||++.|+++.|
T Consensus 223 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 ----LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ----CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 011222456789999999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=321.65 Aligned_cols=255 Identities=25% Similarity=0.406 Sum_probs=202.7
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCe----EEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGK----VVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 281 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~----~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~ 281 (586)
.++|+..+.||+|+||.||+|.+. +++ .||||.++.... ....++.+|+.++..++|+||++++++|.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 357888999999999999999853 444 489999875433 335678899999999999999999999975 4577
Q ss_pred EEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccC
Q 007892 282 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 361 (586)
Q Consensus 282 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~ 361 (586)
+++||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 85 l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 9999999999999986543 3589999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCcc-cccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCCh
Q 007892 362 DTDTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 439 (586)
Q Consensus 362 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (586)
...... .....++..|++||.+.+..++.++|||||||+||||++ |..||..... ..+..+.. .+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~--------~~~~ 229 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---REIPDLLE--------KGER 229 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHH--------CCCc
Confidence 322211 112235678999999998899999999999999999998 9999975432 12222211 1100
Q ss_pred hhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 440 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 440 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
. .........+.+++.+||+.||++||++.++++.|+..
T Consensus 230 ~--------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~ 268 (279)
T cd05109 230 L--------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268 (279)
T ss_pred C--------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 0 11122345688999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=333.58 Aligned_cols=246 Identities=25% Similarity=0.381 Sum_probs=193.1
Q ss_pred ceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHH-HHHHhcCCCCcceEEEEEEeCCeeEEEEEecCC
Q 007892 215 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEI-EIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPN 289 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei-~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~ 289 (586)
+.||+|+||.||+++.. +++.||+|++.... ......+..|. .++..++|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999965 57889999986532 12223444444 456788999999999999999999999999999
Q ss_pred CcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcccc
Q 007892 290 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 369 (586)
Q Consensus 290 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 369 (586)
++|.+++... ..+.+.....++.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~~ 154 (325)
T cd05602 81 GELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TTS 154 (325)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-Ccc
Confidence 9999998653 3477888888999999999999998 999999999999999999999999999975432221 234
Q ss_pred cccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhc
Q 007892 370 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEE 449 (586)
Q Consensus 370 ~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 449 (586)
..+||+.|+|||++.+..++.++|||||||+||||++|+.||...... .+.. ... ...+ .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~---~i~-------------~~~~-~ 214 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EMYD---NIL-------------NKPL-Q 214 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH---HHHH---HHH-------------hCCc-C
Confidence 467999999999999999999999999999999999999999754321 1111 111 0001 1
Q ss_pred cCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 450 YDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 450 ~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
+.......+.+++..|++.+|.+||++.+.+..+...
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~ 251 (325)
T cd05602 215 LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNH 251 (325)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcC
Confidence 1223345688999999999999999988666555443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=335.54 Aligned_cols=244 Identities=27% Similarity=0.375 Sum_probs=192.4
Q ss_pred ceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHH-HHHhcCCCCcceEEEEEEeCCeeEEEEEecCC
Q 007892 215 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIE-IISQVHHRHLVSLVGYCTFGSQRLLVYEFVPN 289 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~-il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~ 289 (586)
+.||+|+||.||+++.. +|+.||||++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999964 68999999986532 222344555554 56779999999999999999999999999999
Q ss_pred CcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcccc
Q 007892 290 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 369 (586)
Q Consensus 290 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 369 (586)
|+|..++... ..+++..+..++.||+.||+|||+. +|+||||||+||||++++.+||+|||+++...... ....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~ 154 (325)
T cd05604 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTT 154 (325)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCcc
Confidence 9999888643 3588999999999999999999998 99999999999999999999999999997532221 1234
Q ss_pred cccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhc
Q 007892 370 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEE 449 (586)
Q Consensus 370 ~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 449 (586)
..+|++.|+|||++.+..++.++|||||||+||||++|+.||...+.. +.....+ .+ .+ .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~~~~~~~-----~~--------~~-~ 214 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA------EMYDNIL-----HK--------PL-V 214 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH------HHHHHHH-----cC--------Cc-c
Confidence 567999999999999999999999999999999999999999754321 1111111 00 01 1
Q ss_pred cCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 007892 450 YDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484 (586)
Q Consensus 450 ~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~ 484 (586)
........+.+++..|++.+|.+||++++.++.+.
T Consensus 215 ~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~ 249 (325)
T cd05604 215 LRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQ 249 (325)
T ss_pred CCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHh
Confidence 11123456788999999999999999875554443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=332.03 Aligned_cols=255 Identities=22% Similarity=0.270 Sum_probs=196.9
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
++|++.+.||+|+||.||+++.. +++.||||++... .......+.+|+.++..++|+||+++++++..++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47889999999999999999965 5889999998642 1223456889999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
||+++|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||||+.++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred ecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 999999999998643 23588899999999999999999998 99999999999999999999999999997654433
Q ss_pred CcccccccccccccCcccccC-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCCh
Q 007892 365 THVSTRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 439 (586)
Q Consensus 365 ~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (586)
.......+||+.|+|||++.. +.++.++|||||||+||||++|+.||..... .+.....+.. ...+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~------~~~~~~i~~~---~~~~ 227 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNH---KEHF 227 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH------HHHHHHHHcC---CCcc
Confidence 333334579999999999863 4578899999999999999999999975432 1111111100 0000
Q ss_pred hhhhchhhhccCHHHHHHHHHHHHHhhccCC--CCCCCHHHHHHH
Q 007892 440 DALVDQKLEEYDSAEMTRMAACAAACIRHSA--RRRPRMSQIVRA 482 (586)
Q Consensus 440 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp--~~RPtm~evl~~ 482 (586)
. +..........+.+++.+|+..++ ..|+++.++++.
T Consensus 228 -~-----~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 228 -Q-----FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred -c-----CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0 001111134456777777765433 348899988875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=318.65 Aligned_cols=250 Identities=22% Similarity=0.382 Sum_probs=199.0
Q ss_pred cCccccceecccCcEEEEEEEE-eCCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 209 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
++|+..++||+|+||.||+|+. .+++.||+|.+.... ......+.+|++++.+++||||++++++|...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 4678889999999999999985 468899999986542 33346789999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 366 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 366 (586)
+++++|..+. .+++..+..++.|++.||.|||+. +|+|+||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--- 148 (279)
T cd06619 81 MDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--- 148 (279)
T ss_pred CCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---
Confidence 9999997553 367888899999999999999998 9999999999999999999999999999765332
Q ss_pred ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccch-hhhhhhhHHHhhcccCCChhhhhch
Q 007892 367 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADD-SMVDWAKPFLAQGLADGNFDALVDQ 445 (586)
Q Consensus 367 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~d~ 445 (586)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||......... ....+... +.... .+
T Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-----~~~~~-----~~ 218 (279)
T cd06619 149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC-----IVDED-----PP 218 (279)
T ss_pred cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHH-----HhccC-----CC
Confidence 223457899999999999889999999999999999999999999754321110 00011000 00000 00
Q ss_pred hhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 446 KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 446 ~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.+. .......+.+++.+|++.+|.+||++.|+++.
T Consensus 219 ~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 219 VLP--VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCC--CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 110 11123468899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=322.11 Aligned_cols=262 Identities=24% Similarity=0.419 Sum_probs=203.3
Q ss_pred hcCccccceecccCcEEEEEEEEe-----------------CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcce
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-----------------NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVS 269 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-----------------~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~ 269 (586)
.++|++.+.||+|+||.||++... ++..||||.+.... ......|.+|+.+|.+++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 356889999999999999998532 24579999987653 334568999999999999999999
Q ss_pred EEEEEEeCCeeEEEEEecCCCcHHHHhcCCCC---------CCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCce
Q 007892 270 LVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDR---------PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSAN 340 (586)
Q Consensus 270 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~N 340 (586)
+++++..++..++||||+++++|.+++..... ..+++.+++.++.|++.||+|||+. +|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence 99999999999999999999999999865321 2477889999999999999999998 99999999999
Q ss_pred eEeCCCCCeEEeecccccccCCCCCc-ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh--CCCCCCCCCcc
Q 007892 341 ILLDDSFEAKVADFGLAKHSLDTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT--GFRPFDKADTF 417 (586)
Q Consensus 341 ILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt--G~~Pf~~~~~~ 417 (586)
||+++++.+||+|||+++........ ......++..|++||+...+.++.++|||||||+||||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 99999999999999999865332211 1223345678999999988899999999999999999998 77888654321
Q ss_pred cchhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 007892 418 ADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484 (586)
Q Consensus 418 ~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~ 484 (586)
.........+... +. .... ..+......+.+++.+||+.+|.+||+|.||++.|+
T Consensus 241 ---~~~~~~~~~~~~~---~~--~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 ---QVIENTGEFFRDQ---GR--QVYL----PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred ---HHHHHHHHHHhhc---cc--cccC----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1111111111000 00 0000 111223467889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=315.97 Aligned_cols=251 Identities=23% Similarity=0.362 Sum_probs=205.6
Q ss_pred CccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 210 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
+|+..+.||.|+||.||.+... +++.+++|.+.... .....++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4788899999999999998854 58899999876432 33356788999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 366 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 366 (586)
+++++|.+++.......+++.++..++.|++.||.|||+. +++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999999765455689999999999999999999988 999999999999999999999999999986543332
Q ss_pred ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchh
Q 007892 367 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 446 (586)
Q Consensus 367 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 446 (586)
......|+..|+|||++.+..++.++||||||+++|||++|..||...... +...... .+.+.
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~-----~~~~~------ 219 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL------NLVVKIV-----QGNYT------ 219 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHH-----cCCCC------
Confidence 223456899999999998888899999999999999999999999754321 1111111 11111
Q ss_pred hhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007892 447 LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRAL 483 (586)
Q Consensus 447 l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L 483 (586)
.........+.+++.+|++.+|.+||++.++++.+
T Consensus 220 --~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 220 --PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred --CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 11123345688999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=331.03 Aligned_cols=241 Identities=25% Similarity=0.380 Sum_probs=194.1
Q ss_pred CccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeeEEEE
Q 007892 210 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~~~~~lV~ 284 (586)
+|+..+.||+|+||.||++... +|+.||||++.... ....+.+..|+.++..+. |++|+++++++...+..+|||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4777899999999999999965 68899999987532 223456778899998885 577888999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
||+++|+|.+++.... .+++.+++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 81 Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 81 EYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 9999999999986543 489999999999999999999998 99999999999999999999999999997543221
Q ss_pred CcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhc
Q 007892 365 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 444 (586)
Q Consensus 365 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 444 (586)
.......||+.|+|||++.++.++.++|||||||+||||++|+.||..... ..+... .. ..
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~~~---i~-----~~------- 216 (323)
T cd05615 156 -VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---DELFQS---IM-----EH------- 216 (323)
T ss_pred -ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHH---HH-----hC-------
Confidence 122345699999999999988999999999999999999999999976442 111111 01 00
Q ss_pred hhhhccCHHHHHHHHHHHHHhhccCCCCCCCH
Q 007892 445 QKLEEYDSAEMTRMAACAAACIRHSARRRPRM 476 (586)
Q Consensus 445 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm 476 (586)
.. .++......+.+++.+|++.+|.+|++.
T Consensus 217 -~~-~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 217 -NV-SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred -CC-CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 00 1222334567899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=342.98 Aligned_cols=249 Identities=25% Similarity=0.404 Sum_probs=208.9
Q ss_pred CccccceecccCcEEEEEEEEeC--C--eEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 210 NFSEANLLGQGGFGYVHKGVLTN--G--KVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~~--g--~~vAVK~l~~~~~~-~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
.....++||+|.||.|++|.|.. | ..||||+++.+... ...+|++|+.+|.+|+|+|+++|||+..+ ...+|||
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 34456899999999999999763 4 36899999887655 56799999999999999999999999987 7788999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
|+++.|+|.+.|+......|-...+..++.|||.|+.||..+ ++|||||..+||||-..-.|||+||||.+.+...+
T Consensus 190 ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred hhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 999999999999886666788889999999999999999998 99999999999999988899999999999876544
Q ss_pred Ccc--cccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhh
Q 007892 365 THV--STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 441 (586)
Q Consensus 365 ~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (586)
.+. .....-.+.|+|||.++..+++.++|||+|||+||||++ |..||.+-.... +.+.++
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q-----------IL~~iD------ 329 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ-----------ILKNID------ 329 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH-----------HHHhcc------
Confidence 332 223445678999999999999999999999999999999 889997665421 111111
Q ss_pred hhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 442 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 442 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
+..+-..++.+.+++.++++.||.++|.+||++..|.+
T Consensus 330 --~~erLpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 330 --AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred --ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 11122456778899999999999999999999999973
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=323.77 Aligned_cols=250 Identities=22% Similarity=0.375 Sum_probs=204.7
Q ss_pred cCccccceecccCcEEEEEEEE-eCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEec
Q 007892 209 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 287 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 287 (586)
.+|+..+.||+|+||.||+|+. .+++.||+|.+..........+.+|+.+++.+.|+||++++++|..+...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 5788889999999999999995 468899999997665555677899999999999999999999999999999999999
Q ss_pred CCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcc
Q 007892 288 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 367 (586)
Q Consensus 288 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 367 (586)
++++|.+++.. ..+++.+++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++........ .
T Consensus 100 ~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~ 172 (296)
T cd06654 100 AGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (296)
T ss_pred CCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc-c
Confidence 99999999854 2478999999999999999999998 999999999999999999999999999876433221 1
Q ss_pred cccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhh
Q 007892 368 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 447 (586)
Q Consensus 368 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 447 (586)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||....... .+..+. ..+. +.+
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~--~~~~~~--------~~~~------~~~ 236 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--ALYLIA--------TNGT------PEL 236 (296)
T ss_pred cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH--hHHHHh--------cCCC------CCC
Confidence 233468899999999998889999999999999999999999997544311 111110 0000 000
Q ss_pred hccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 448 EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 448 ~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.........+.+++.+|+..+|.+||++.+|++.
T Consensus 237 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 237 -QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred -CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 1122334568899999999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=330.77 Aligned_cols=261 Identities=26% Similarity=0.424 Sum_probs=206.3
Q ss_pred HHhcCccccceecccCcEEEEEEEEeC--------CeEEEEEEeccCC-chhHHHHHHHHHHHHhc-CCCCcceEEEEEE
Q 007892 206 IATDNFSEANLLGQGGFGYVHKGVLTN--------GKVVAIKQLKAGS-GQGEREFQAEIEIISQV-HHRHLVSLVGYCT 275 (586)
Q Consensus 206 ~~~~~f~~~~~LG~G~fG~Vyk~~~~~--------g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~ 275 (586)
+...+|.+.+.||+|+||.||++.... +..||+|.++... .....++.+|++++.++ +|+||++++++|.
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 344568889999999999999997421 2368999887543 23356889999999999 7999999999999
Q ss_pred eCCeeEEEEEecCCCcHHHHhcCCC--------------CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCcee
Q 007892 276 FGSQRLLVYEFVPNKTLEFHLHGKD--------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANI 341 (586)
Q Consensus 276 ~~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NI 341 (586)
.++..++++||+++|+|.+++.... ...+.|.+++.++.|++.||+|||++ +|+||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 165 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNV 165 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceE
Confidence 9999999999999999999986432 23588999999999999999999998 999999999999
Q ss_pred EeCCCCCeEEeecccccccCCCCCcc-cccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccc
Q 007892 342 LLDDSFEAKVADFGLAKHSLDTDTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFAD 419 (586)
Q Consensus 342 Ll~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~ 419 (586)
||+.++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||+||||++ |..||.....
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--- 242 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV--- 242 (334)
T ss_pred EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH---
Confidence 99999999999999998654322111 122334567999999998999999999999999999998 8899865432
Q ss_pred hhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 007892 420 DSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMP 488 (586)
Q Consensus 420 ~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~~ 488 (586)
.++..... .+. ...........+.+++.+|++.+|.+||+|.||++.|+....
T Consensus 243 ---~~~~~~~~-----~~~--------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 243 ---EELFKLLK-----EGH--------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred ---HHHHHHHH-----cCC--------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 11111110 110 001122334578899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=322.07 Aligned_cols=239 Identities=26% Similarity=0.391 Sum_probs=189.2
Q ss_pred eecccCcEEEEEEEEeC-------------------------CeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceE
Q 007892 216 LLGQGGFGYVHKGVLTN-------------------------GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSL 270 (586)
Q Consensus 216 ~LG~G~fG~Vyk~~~~~-------------------------g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l 270 (586)
+||+|+||.||+|.+.. ...||+|.+..........|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999998531 13589999876544445678899999999999999999
Q ss_pred EEEEEeCCeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCC---
Q 007892 271 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF--- 347 (586)
Q Consensus 271 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~--- 347 (586)
+++|......+|||||+++|+|..++... ...+++..++.++.|+++||+|||+. +|+||||||+||||+.++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999888643 34588999999999999999999998 999999999999997643
Q ss_pred ----CeEEeecccccccCCCCCcccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHH-hCCCCCCCCCcccchh
Q 007892 348 ----EAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELI-TGFRPFDKADTFADDS 421 (586)
Q Consensus 348 ----~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~ell-tG~~Pf~~~~~~~~~~ 421 (586)
.+||+|||++...... ....++..|+|||++.+ ..++.++|||||||++|||+ +|+.||.......
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--- 229 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE--- 229 (274)
T ss_pred CccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH---
Confidence 3799999998643221 22357788999998865 56899999999999999995 6999987543211
Q ss_pred hhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 007892 422 MVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484 (586)
Q Consensus 422 ~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~ 484 (586)
...+ +.. .. ..+......+.+++.+||+.+|.+||+|.+|++.|.
T Consensus 230 ~~~~----~~~-------------~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 KERF----YEK-------------KH-RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHH----HHh-------------cc-CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1111 000 00 011112246889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=331.89 Aligned_cols=237 Identities=26% Similarity=0.400 Sum_probs=188.5
Q ss_pred ceecccCcEEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHH-HHHhcCCCCcceEEEEEEeCCeeEEEEEecCC
Q 007892 215 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIE-IISQVHHRHLVSLVGYCTFGSQRLLVYEFVPN 289 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~-il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~ 289 (586)
++||+|+||.||+|+.. +++.||||++..... .....+.+|+. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999975 588999999865321 22334555554 67889999999999999999999999999999
Q ss_pred CcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcccc
Q 007892 290 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 369 (586)
Q Consensus 290 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 369 (586)
++|..++... ..+.+.....++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (321)
T cd05603 81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTS 154 (321)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cccc
Confidence 9999888643 3478888899999999999999998 99999999999999999999999999987532222 2234
Q ss_pred cccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhc
Q 007892 370 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEE 449 (586)
Q Consensus 370 ~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 449 (586)
..+||+.|+|||++.+..++.++|||||||+||||++|+.||...+. ..+.... ....+ .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i-------------~~~~~-~ 214 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV------SQMYDNI-------------LHKPL-Q 214 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH------HHHHHHH-------------hcCCC-C
Confidence 46799999999999988999999999999999999999999975432 1111111 11111 1
Q ss_pred cCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 007892 450 YDSAEMTRMAACAAACIRHSARRRPRMS 477 (586)
Q Consensus 450 ~~~~~~~~l~~l~~~cl~~dp~~RPtm~ 477 (586)
.+......+.+++.+||+.+|.+||+..
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 215 LPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 2223345688999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=322.59 Aligned_cols=266 Identities=23% Similarity=0.304 Sum_probs=196.4
Q ss_pred CccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCch--hHHHHHHHHHHHHhc---CCCCcceEEEEEEe-----CC
Q 007892 210 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ--GEREFQAEIEIISQV---HHRHLVSLVGYCTF-----GS 278 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~--~~~~~~~Ei~il~~l---~Hpniv~l~g~~~~-----~~ 278 (586)
+|+..+.||+|+||.||+|... +++.||+|.++..... ....+.+|++++.++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999965 6889999998754222 234566777777765 69999999998864 24
Q ss_pred eeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccc
Q 007892 279 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 358 (586)
Q Consensus 279 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~ 358 (586)
..++||||+++ +|..++.......+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccc
Confidence 57899999975 888888765556689999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccc-hhhhhhhhH----HHhhc
Q 007892 359 HSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFAD-DSMVDWAKP----FLAQG 433 (586)
Q Consensus 359 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~-~~~~~~~~~----~~~~~ 433 (586)
...... ......|+..|+|||++.+..++.++|||||||++|||++|+.||........ ..+..+... .+...
T Consensus 157 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 157 IYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 653221 22345689999999999988999999999999999999999999975432110 001110000 00000
Q ss_pred --ccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 434 --LADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 434 --~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
.....+.......+..........+.+++.+||+.||.+||++.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000000000011111233456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=314.80 Aligned_cols=249 Identities=26% Similarity=0.399 Sum_probs=204.8
Q ss_pred cCccccceecccCcEEEEEEEEeC-CeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEec
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 287 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 287 (586)
++|+..+.||.|+||.||+|...+ ++.|++|.+..... ..++.+|++++++++|+||+++++++......++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 678889999999999999999765 78999999875432 678999999999999999999999999999999999999
Q ss_pred CCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcc
Q 007892 288 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 367 (586)
Q Consensus 288 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 367 (586)
++++|.+++.... ..+++..+..++.|++.||.|||+. +|+|+||+|+||++++++.+||+|||++........ .
T Consensus 81 ~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (256)
T cd06612 81 GAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-K 155 (256)
T ss_pred CCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-c
Confidence 9999999986433 4589999999999999999999998 999999999999999999999999999986543321 2
Q ss_pred cccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhh
Q 007892 368 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 447 (586)
Q Consensus 368 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 447 (586)
.....++..|++||++.+..++.++|||||||++|+|++|+.||........ .... .... ...+
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~--~~~~---------~~~~-----~~~~ 219 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA--IFMI---------PNKP-----PPTL 219 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh--hhhh---------ccCC-----CCCC
Confidence 2345588999999999988999999999999999999999999975443110 0000 0000 0000
Q ss_pred hccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 448 EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 448 ~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
..+......+.+++.+|++.+|.+||++.||++
T Consensus 220 -~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 220 -SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred -CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 112233456899999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=333.32 Aligned_cols=255 Identities=20% Similarity=0.263 Sum_probs=197.4
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
++|.+.+.||+|+||.||+++.. +++.||||.+.... ......+.+|+.++..++|+||+++++++...+..+|||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57889999999999999999965 57889999986531 222345788999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
||+++|+|..++.... ..+++..+..++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 81 Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred eCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999999997532 3588889999999999999999998 99999999999999999999999999998654433
Q ss_pred CcccccccccccccCcccccC-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCCh
Q 007892 365 THVSTRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 439 (586)
Q Consensus 365 ~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (586)
........|++.|+|||++.+ +.++.++|||||||+||||++|+.||...+.. +........ ...+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~---~~~~ 227 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNH---EERF 227 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH------HHHHHHHcC---CCcc
Confidence 323334579999999999875 56889999999999999999999999754321 111111000 0000
Q ss_pred hhhhchhhhccCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 007892 440 DALVDQKLEEYDSAEMTRMAACAAACIRHSARR--RPRMSQIVRA 482 (586)
Q Consensus 440 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~--RPtm~evl~~ 482 (586)
.+..........+.+++.+|+..++++ |+++.+++++
T Consensus 228 ------~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 228 ------QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ------cCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 001111123456788888888865544 4577777654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=316.79 Aligned_cols=248 Identities=25% Similarity=0.433 Sum_probs=200.1
Q ss_pred CccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCch---------hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 007892 210 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ---------GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ 279 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~---------~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~ 279 (586)
+|.+.+.||+|+||.||+|... +++.||+|.+...... ....+.+|++++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3667789999999999999864 5789999988654221 12467889999999999999999999999999
Q ss_pred eEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccc
Q 007892 280 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 359 (586)
Q Consensus 280 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~ 359 (586)
.++|+||+++++|..++... ..+++..+..++.|++.||+|||+. +++||||||+|||+++++.+||+|||+++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 99999999999999999654 3488899999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCCc-----ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcc
Q 007892 360 SLDTDTH-----VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGL 434 (586)
Q Consensus 360 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 434 (586)
....... ......|+..|+|||++.++.++.++|||||||++|+|++|+.||....... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~----------- 222 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ--AIF----------- 222 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH--HHH-----------
Confidence 5422111 1123458899999999998889999999999999999999999997543210 000
Q ss_pred cCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 435 ADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 435 ~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
.+........+......+.+++.+||+.+|.+||++.||++
T Consensus 223 ------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 223 ------KIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ------HHhccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 00000111222334567889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=332.03 Aligned_cols=255 Identities=21% Similarity=0.266 Sum_probs=196.9
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
++|.+.+.||+|+||.||+++.. +++.||+|++.... ......+.+|+.++..++|+||+++++++.+.+..+|||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47889999999999999999975 47789999986421 122345888999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
||+++|+|.+++.... ..+++..+..++.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 81 ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred eccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 9999999999997532 3488999999999999999999998 99999999999999999999999999997654333
Q ss_pred CcccccccccccccCccccc-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCCh
Q 007892 365 THVSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 439 (586)
Q Consensus 365 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (586)
.......+||+.|+|||++. .+.++.++|||||||+||||++|+.||..... .+........ ...+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~---~~~~ 227 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNH---KERF 227 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH------HHHHHHHhCC---Cccc
Confidence 33334467999999999986 35688999999999999999999999975432 1111111100 0000
Q ss_pred hhhhchhhhccCHHHHHHHHHHHHHhhccCCC--CCCCHHHHHHH
Q 007892 440 DALVDQKLEEYDSAEMTRMAACAAACIRHSAR--RRPRMSQIVRA 482 (586)
Q Consensus 440 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~--~RPtm~evl~~ 482 (586)
............+.+++.+|+..++. .|+++.|+++.
T Consensus 228 ------~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 ------QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ------cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00011112345677788887755444 37888888865
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=313.92 Aligned_cols=268 Identities=21% Similarity=0.260 Sum_probs=202.0
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchh--HHHHHHHHHHHHhcCCCCcceEEEEEEe--CCeeEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQG--EREFQAEIEIISQVHHRHLVSLVGYCTF--GSQRLLV 283 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~--~~~~~~Ei~il~~l~Hpniv~l~g~~~~--~~~~~lV 283 (586)
+.|+.++.|++|.||.||+|+.. +++.||+|+++...... --.-++||.+|.+++|||||.+-.+... -+..|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 45677899999999999999954 68999999998754221 1245789999999999999999888764 3578999
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCC
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 363 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 363 (586)
||||+. +|...++... +.+...+..-+..|+++||+|||.+ .|+|||||++|+|+.+.|.+||+|||||+.+...
T Consensus 156 Me~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred HHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 999965 7888887654 4577888888999999999999998 8999999999999999999999999999987655
Q ss_pred CCcccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhh----------hhhhhHHHhh
Q 007892 364 DTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSM----------VDWAKPFLAQ 432 (586)
Q Consensus 364 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~----------~~~~~~~~~~ 432 (586)
. ...+..+-|.+|.|||.+.+ ..|+...|+||+|||+.||+++++-|.+....+.... ..|..-....
T Consensus 231 ~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 231 L-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred c-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 3 33466788999999999876 4699999999999999999999998877654332111 1222110000
Q ss_pred cccCCChhhhhchhhh-ccCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 433 GLADGNFDALVDQKLE-EYDSA-EMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 433 ~~~~~~~~~l~d~~l~-~~~~~-~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.+..-.+....-..+. .|... ....-.+++...|..||.+|-|+.|.++.
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 0000011111111111 22211 23456788899999999999999998763
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=322.48 Aligned_cols=266 Identities=26% Similarity=0.378 Sum_probs=203.0
Q ss_pred cCccccceecccCcEEEEEEEE-----eCCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--Cee
Q 007892 209 DNFSEANLLGQGGFGYVHKGVL-----TNGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFG--SQR 280 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~-----~~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~--~~~ 280 (586)
..|+..+.||+|+||.||++.+ .++..||+|.++... ......+.+|++++++++|+||++++++|... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3467889999999999999984 357889999987553 33346789999999999999999999999875 567
Q ss_pred EEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccccc
Q 007892 281 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 360 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~ 360 (586)
++||||+++++|.+++.... ..++|.+++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccccc
Confidence 89999999999999986543 3589999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCCc--ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccch----hhhhhhhHHHhhcc
Q 007892 361 LDTDTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADD----SMVDWAKPFLAQGL 434 (586)
Q Consensus 361 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~----~~~~~~~~~~~~~~ 434 (586)
...... ......++..|+|||++.+..++.++|||||||++|||++++.|+......... ....+........+
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL 239 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence 433221 122345677899999998888999999999999999999987765321110000 00000000000000
Q ss_pred cCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 435 ADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 435 ~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
..+. ...........+.+++.+|++.+|.+||++.+|++.|+..
T Consensus 240 ~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 240 EEGK--------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HcCc--------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0110 0011223456799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=315.81 Aligned_cols=250 Identities=22% Similarity=0.359 Sum_probs=204.7
Q ss_pred CccccceecccCcEEEEEEEEe-CCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 210 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
+|+..+.||+|+||.||++... +|+.||+|.+... ......++.+|+.++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788899999999999999964 6889999998643 223345789999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 366 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 366 (586)
+++++|.+++.......+++.+++.++.|++.||.|||+. +++|+||+|+|||++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE- 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence 9999999998765545688999999999999999999998 999999999999999999999999999976533221
Q ss_pred ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchh
Q 007892 367 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 446 (586)
Q Consensus 367 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 446 (586)
......|+..|+|||++.++.++.++|||||||++++|++|+.||...+. .+.....+ .+..
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~-----~~~~------- 218 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------KNLVLKII-----RGSY------- 218 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------HHHHHHHh-----cCCC-------
Confidence 22334688899999999988999999999999999999999999975432 11111111 1111
Q ss_pred hhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 447 LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 447 l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
..........+.+++.+|++.+|.+||+|.+|++.
T Consensus 219 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 219 -PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred -CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11222335578999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=331.45 Aligned_cols=263 Identities=23% Similarity=0.309 Sum_probs=197.2
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC------
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS------ 278 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~------ 278 (586)
.++|+..+.||+|+||.||++... +|+.||||++... .......+.+|+.++..++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 478999999999999999999964 5889999998653 2233457889999999999999999999986543
Q ss_pred eeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccc
Q 007892 279 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 358 (586)
Q Consensus 279 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~ 358 (586)
..++||||+++ +|...++. .+++..+..++.|++.||.|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred eeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 46899999976 45555532 378888999999999999999998 99999999999999999999999999997
Q ss_pred ccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhh--------------
Q 007892 359 HSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD-------------- 424 (586)
Q Consensus 359 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~-------------- 424 (586)
..... .......||..|+|||.+.+..++.++|||||||+||||++|+.||...+... .+..
T Consensus 172 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~ 247 (359)
T cd07876 172 TACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID--QWNKVIEQLGTPSAEFMN 247 (359)
T ss_pred ccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCcHHHHH
Confidence 54322 12234578999999999999999999999999999999999999998654211 0000
Q ss_pred hhhHHHhhccc------CCChhhhhc----hhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 425 WAKPFLAQGLA------DGNFDALVD----QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 425 ~~~~~~~~~~~------~~~~~~l~d----~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.....+..... ...+.++.. +............+.+++.+||+.||++||++.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000000 000000000 00001111224568899999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=316.83 Aligned_cols=252 Identities=25% Similarity=0.381 Sum_probs=192.7
Q ss_pred ceecccCcEEEEEEEEeC---CeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecCCC
Q 007892 215 NLLGQGGFGYVHKGVLTN---GKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNK 290 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~~~~---g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g 290 (586)
+.||+|+||.||+|.+.+ +..+|+|.++.... .....+.+|+.++.+++||||++++++|.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 369999999999998643 45799999876543 33457889999999999999999999999989999999999999
Q ss_pred cHHHHhcCCC---CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcc
Q 007892 291 TLEFHLHGKD---RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 367 (586)
Q Consensus 291 sL~~~l~~~~---~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 367 (586)
+|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999986432 23467788889999999999999998 99999999999999999999999999997543332211
Q ss_pred -cccccccccccCcccccCC-------CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCC
Q 007892 368 -STRVMGTFGYLAPEYASSG-------KLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGN 438 (586)
Q Consensus 368 -~~~~~gt~~y~aPE~~~~~-------~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (586)
.....++..|+|||++... .++.++|||||||++|||++ |+.||....... ...+. + .+.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~~-------~-~~~ 226 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTYT-------V-REQ 226 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHHH-------h-hcc
Confidence 2234578889999998642 35789999999999999996 999997543211 11110 0 001
Q ss_pred hhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 007892 439 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484 (586)
Q Consensus 439 ~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~ 484 (586)
...+.++.+. ......+.+++..|+ .+|.+||++.||++.|+
T Consensus 227 ~~~~~~~~~~---~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 227 QLKLPKPRLK---LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred cCCCCCCccC---CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1111112211 112345777889998 68999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=317.39 Aligned_cols=240 Identities=26% Similarity=0.428 Sum_probs=190.5
Q ss_pred ceecccCcEEEEEEEEeC-------------CeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeE
Q 007892 215 NLLGQGGFGYVHKGVLTN-------------GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 281 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~~~~-------------g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~ 281 (586)
+.||+|+||.||+|++.+ ...|++|.+..........|.+|+.++..++||||++++++|......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2358999887655555567889999999999999999999999999999
Q ss_pred EEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCC-------eEEeec
Q 007892 282 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE-------AKVADF 354 (586)
Q Consensus 282 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~-------~kl~DF 354 (586)
+||||+++++|..++.... ..+++..+++++.|+++||+|||+. +|+||||||+||||+.++. +|++||
T Consensus 81 lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999998886543 3489999999999999999999998 9999999999999987654 899999
Q ss_pred ccccccCCCCCcccccccccccccCccccc-CCCCCCcchHHHHHHHHHHHH-hCCCCCCCCCcccchhhhhhhhHHHhh
Q 007892 355 GLAKHSLDTDTHVSTRVMGTFGYLAPEYAS-SGKLTEKSDVFSFGVLLLELI-TGFRPFDKADTFADDSMVDWAKPFLAQ 432 (586)
Q Consensus 355 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDVwSlGvvL~ell-tG~~Pf~~~~~~~~~~~~~~~~~~~~~ 432 (586)
|++...... ....++..|+|||++. +..++.++|||||||+||||+ .|..||........ . .+.
T Consensus 157 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~----~---~~~-- 222 (262)
T cd05077 157 GIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK----E---RFY-- 222 (262)
T ss_pred CCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH----H---HHH--
Confidence 998754322 2345788999999986 467899999999999999998 58888865332110 0 000
Q ss_pred cccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 007892 433 GLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484 (586)
Q Consensus 433 ~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~ 484 (586)
.+.+. ........+.+++.+||+.||.+||++.+|++.|+
T Consensus 223 ---~~~~~---------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 ---EGQCM---------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred ---hcCcc---------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 00000 00112346789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=318.14 Aligned_cols=249 Identities=27% Similarity=0.385 Sum_probs=203.6
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
++|+..+.||.|+||.||+|... +++.||+|.+.... ......+.+|+++++.++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46788899999999999999965 58899999986543 33346788999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 366 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 366 (586)
+++++|.+++... .+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||+++...... .
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~ 153 (274)
T cd06609 81 CGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-S 153 (274)
T ss_pred eCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc-c
Confidence 9999999998654 689999999999999999999998 89999999999999999999999999998764332 2
Q ss_pred ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchh
Q 007892 367 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 446 (586)
Q Consensus 367 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 446 (586)
......++..|+|||++.+..++.++|||||||+||||++|+.||...+... ... .+..+.. +.
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~---~~~--------~~~~~~~-----~~ 217 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR---VLF--------LIPKNNP-----PS 217 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH---HHH--------HhhhcCC-----CC
Confidence 2234568889999999998889999999999999999999999997544210 000 0001100 01
Q ss_pred hhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 447 LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 447 l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
+.. ......+.+++.+||..+|++||++++|++.
T Consensus 218 ~~~--~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 218 LEG--NKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred Ccc--cccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 110 0134568889999999999999999999873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=331.03 Aligned_cols=251 Identities=26% Similarity=0.333 Sum_probs=210.1
Q ss_pred hcCccccceecccCcEEEEEEEEeC-CeEEEEEEeccCCch---hHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeeEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQ---GEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLL 282 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~~---~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~~~~~l 282 (586)
.+.|++.+.||+|.||.||+++... |+.+|+|.+.+.... ....+.+|+.||+++. |||||.++++++.....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 3568888999999999999999765 999999999765432 3468999999999998 9999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCC----CCCeEEeeccccc
Q 007892 283 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD----SFEAKVADFGLAK 358 (586)
Q Consensus 283 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~----~~~~kl~DFGla~ 358 (586)
|||++.||.|.+.+... .+++.....++.|++.++.|||+. +|+||||||+|+|+.. ++.+|++|||++.
T Consensus 114 vmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 99999999999998766 388999999999999999999998 9999999999999953 3579999999999
Q ss_pred ccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCC
Q 007892 359 HSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGN 438 (586)
Q Consensus 359 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (586)
.... .......+||+.|+|||++....|+...||||+||++|.|++|..||.......... .+..+.
T Consensus 188 ~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-----------~i~~~~ 254 (382)
T KOG0032|consen 188 FIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-----------AILRGD 254 (382)
T ss_pred EccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-----------HHHcCC
Confidence 8655 345567899999999999999999999999999999999999999998765321100 111222
Q ss_pred hhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 439 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 439 ~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
++ .. ...-......+.+++..|+..||.+|+++.+++++
T Consensus 255 ~~-f~----~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 255 FD-FT----SEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CC-CC----CCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 20 00 02223345678899999999999999999999984
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=338.05 Aligned_cols=202 Identities=25% Similarity=0.401 Sum_probs=174.9
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
++|+..+.||+|+||.||++... +++.||||+++... ......+++|+.++.+++|+||+++++.+.+.+..+|||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999965 58899999986432 223456788999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
||+++|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 81 EFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred eCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 999999999998654 3488999999999999999999998 99999999999999999999999999987542211
Q ss_pred C----------------------------------cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCC
Q 007892 365 T----------------------------------HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRP 410 (586)
Q Consensus 365 ~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~P 410 (586)
. ......+||+.|+|||++.+..++.++|||||||+||||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 0 011235799999999999999999999999999999999999999
Q ss_pred CCCCC
Q 007892 411 FDKAD 415 (586)
Q Consensus 411 f~~~~ 415 (586)
|....
T Consensus 236 f~~~~ 240 (360)
T cd05627 236 FCSET 240 (360)
T ss_pred CCCCC
Confidence 97654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=320.45 Aligned_cols=252 Identities=25% Similarity=0.380 Sum_probs=202.3
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEec
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 287 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 287 (586)
++|++.+.||.|+||.||+|... +++.|++|.+..........+.+|+.++++++|+||+++++++..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 67888999999999999999975 48899999998766566678899999999999999999999999999999999999
Q ss_pred CCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcc
Q 007892 288 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 367 (586)
Q Consensus 288 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 367 (586)
++++|..++.... ..+++..+..++.|++.+|+|||+. +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 92 ~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~ 166 (292)
T cd06644 92 PGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QR 166 (292)
T ss_pred CCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc-cc
Confidence 9999988875433 3589999999999999999999998 99999999999999999999999999987543221 12
Q ss_pred cccccccccccCccccc-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhh
Q 007892 368 STRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 442 (586)
Q Consensus 368 ~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 442 (586)
.....++..|+|||++. ...++.++|||||||++|||++|+.||...... .....+. ....
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~~~~~---------~~~~--- 232 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--RVLLKIA---------KSEP--- 232 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH--HHHHHHh---------cCCC---
Confidence 23356888999999984 345688999999999999999999999654321 0011100 0000
Q ss_pred hchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 443 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 443 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
+.. ..+......+.+++.+||..+|++||++.||++.
T Consensus 233 --~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 233 --PTL-SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred --ccC-CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000 1122334568899999999999999999999863
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=320.12 Aligned_cols=250 Identities=24% Similarity=0.373 Sum_probs=200.4
Q ss_pred ccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecCC
Q 007892 211 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPN 289 (586)
Q Consensus 211 f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~ 289 (586)
|+..+.||+|+||.||+|... ++..+++|.+..........+.+|++++..++|+||++++++|..++..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 566788999999999999975 4788999998766555567789999999999999999999999999999999999999
Q ss_pred CcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcccc
Q 007892 290 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 369 (586)
Q Consensus 290 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 369 (586)
++|..++.... ..+++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||++....... ....
T Consensus 87 ~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~ 161 (282)
T cd06643 87 GAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRD 161 (282)
T ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-cccc
Confidence 99998876533 3589999999999999999999998 99999999999999999999999999997643322 1223
Q ss_pred cccccccccCccccc-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhc
Q 007892 370 RVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 444 (586)
Q Consensus 370 ~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 444 (586)
...++..|+|||++. +..++.++|||||||++|||++|+.||...... ....... ......+
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~~---------~~~~~~~-- 228 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM--RVLLKIA---------KSEPPTL-- 228 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH--HHHHHHh---------hcCCCCC--
Confidence 356899999999984 345788999999999999999999999754321 1111110 0000000
Q ss_pred hhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 445 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 445 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
..+......+.+++.+||+.+|.+||++.+|++.
T Consensus 229 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 229 ----AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ----CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1112234568899999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=315.68 Aligned_cols=249 Identities=29% Similarity=0.430 Sum_probs=193.5
Q ss_pred ceecccCcEEEEEEEEeC----CeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEe-CCeeEEEEEecC
Q 007892 215 NLLGQGGFGYVHKGVLTN----GKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTF-GSQRLLVYEFVP 288 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~~~~----g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~-~~~~~lV~E~~~ 288 (586)
+.||+|+||.||+|.+.+ ...||+|.+.... ......+.+|+.+++.++||||++++++|.. ++..++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 469999999999998642 4579999985432 3345678899999999999999999998864 556789999999
Q ss_pred CCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc--
Q 007892 289 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH-- 366 (586)
Q Consensus 289 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~-- 366 (586)
+++|.+++.... ..+.+..++.++.|+++||.|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 81 HGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 999999987543 3467888899999999999999998 9999999999999999999999999999764332211
Q ss_pred -ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhc
Q 007892 367 -VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITG-FRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 444 (586)
Q Consensus 367 -~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 444 (586)
......++..|+|||++....++.++|||||||++|||++| ..||...+. ..+..+. . .+..
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~---~-----~~~~----- 220 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---FDITVYL---L-----QGRR----- 220 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHH---h-----cCCC-----
Confidence 11233467789999999888999999999999999999995 556654322 1111111 0 1100
Q ss_pred hhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 445 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 445 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
...+...+..+.+++..||+.+|++||++.||++.|+..
T Consensus 221 ---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 221 ---LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred ---CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 011112245688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=314.67 Aligned_cols=238 Identities=28% Similarity=0.444 Sum_probs=191.6
Q ss_pred ceecccCcEEEEEEEEeCCe-----------EEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEE
Q 007892 215 NLLGQGGFGYVHKGVLTNGK-----------VVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~~~~g~-----------~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV 283 (586)
+.||+|+||.||+|.+.+.. .|++|.+...... ...|.+|+.+|++++|+||++++++|.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999976432 5788887655433 6788999999999999999999999988 778999
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCC-------CeEEeeccc
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF-------EAKVADFGL 356 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~-------~~kl~DFGl 356 (586)
|||+++|+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+
T Consensus 79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999875432 589999999999999999999998 999999999999999887 799999999
Q ss_pred ccccCCCCCcccccccccccccCcccccCC--CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhc
Q 007892 357 AKHSLDTDTHVSTRVMGTFGYLAPEYASSG--KLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQG 433 (586)
Q Consensus 357 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 433 (586)
+..... .....++..|+|||++... .++.++|||||||++|||++ |..||....... ...+..
T Consensus 155 a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~---~~~~~~------ 220 (259)
T cd05037 155 PITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE---KERFYQ------ 220 (259)
T ss_pred cccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh---HHHHHh------
Confidence 986533 1234467789999999876 78999999999999999999 577876543211 111100
Q ss_pred ccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 007892 434 LADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484 (586)
Q Consensus 434 ~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~ 484 (586)
.... +. ......+.+++.+|+..+|.+||++.+|++.|+
T Consensus 221 --~~~~-------~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 --DQHR-------LP---MPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred --cCCC-------CC---CCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000 00 001167889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=318.94 Aligned_cols=248 Identities=29% Similarity=0.521 Sum_probs=198.3
Q ss_pred ceecccCcEEEEEEEEeC-------CeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 215 NLLGQGGFGYVHKGVLTN-------GKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~~~~-------g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
+.||+|+||.||+|+..+ ++.||||.+.... ......+.+|++++++++||||++++++|...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 469999999999998643 2579999886543 23356788999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCC-----CCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCC-----CeEEeeccc
Q 007892 287 VPNKTLEFHLHGK-----DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF-----EAKVADFGL 356 (586)
Q Consensus 287 ~~~gsL~~~l~~~-----~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~-----~~kl~DFGl 356 (586)
+++++|.+++... ....++|.+++.++.|++.||.|||+. +++|+||||+|||++.++ .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999998643 224588999999999999999999988 899999999999999877 899999999
Q ss_pred ccccCCCCCc-ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcc
Q 007892 357 AKHSLDTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGL 434 (586)
Q Consensus 357 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 434 (586)
++........ ......++..|+|||++.++.++.++|||||||++|||++ |+.||...... ....+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~~~~~-------- 226 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EVLQHV-------- 226 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HHHHHH--------
Confidence 9765332211 1223345778999999999999999999999999999998 99999754321 111111
Q ss_pred cCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 007892 435 ADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484 (586)
Q Consensus 435 ~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~ 484 (586)
..+. .. ......+..+.+++.+||+.+|.+||++.+|++.|+
T Consensus 227 ~~~~-------~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 227 TAGG-------RL-QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred hcCC-------cc-CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 0100 00 122234567889999999999999999999999986
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=341.98 Aligned_cols=264 Identities=23% Similarity=0.356 Sum_probs=193.3
Q ss_pred HhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--------
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG-------- 277 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~-------- 277 (586)
..++|...+.||+|+||.||+|+.. +++.||||++.... ....+|+.+|++++|+|||++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3467999999999999999999974 58899999886432 2345799999999999999999887432
Q ss_pred CeeEEEEEecCCCcHHHHhcC--CCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCC-CeEEeec
Q 007892 278 SQRLLVYEFVPNKTLEFHLHG--KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF-EAKVADF 354 (586)
Q Consensus 278 ~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~-~~kl~DF 354 (586)
...++||||+++ +|.+++.. .....+++..+..++.|++.||+|||+. +|+||||||+||||+.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecc
Confidence 135689999985 56555532 2334689999999999999999999998 999999999999998654 7999999
Q ss_pred ccccccCCCCCcccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHH----
Q 007892 355 GLAKHSLDTDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPF---- 429 (586)
Q Consensus 355 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~---- 429 (586)
|+++...... ......||+.|+|||++.+ ..++.++|||||||+||||++|.+||...... +.+.......
T Consensus 216 Gla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~--~~~~~i~~~~~~p~ 291 (440)
T PTZ00036 216 GSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV--DQLVRIIQVLGTPT 291 (440)
T ss_pred ccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCC
Confidence 9998654322 2234578999999999865 46899999999999999999999999765431 1111110000
Q ss_pred ---Hh---hcccCCChhhhhchhhh-ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 430 ---LA---QGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 430 ---~~---~~~~~~~~~~l~d~~l~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
+. ..+..-.+..+....+. .++......+++++.+||+.||.+||++.|+++.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00 00000000001111111 1222334678999999999999999999999853
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=319.76 Aligned_cols=256 Identities=26% Similarity=0.376 Sum_probs=205.6
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
++|++.+.||+|+||.||++... +++.||+|++.... ......+.+|++++..++|+||+++++++...+..+|||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 56778899999999999999965 58899999886543 23356889999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 366 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 366 (586)
+++++|.+++... ..+++.....++.+++.+|.|||+.. +|+||||||+|||+++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-- 158 (284)
T cd06620 85 MDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-- 158 (284)
T ss_pred CCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--
Confidence 9999999988653 35899999999999999999999742 79999999999999999999999999987542221
Q ss_pred ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccc-----hhhhhhhhHHHhhcccCCChhh
Q 007892 367 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFAD-----DSMVDWAKPFLAQGLADGNFDA 441 (586)
Q Consensus 367 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 441 (586)
.....|+..|+|||++.++.++.++|||||||++|+|++|+.||.......+ ..+.++.....
T Consensus 159 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----------- 226 (284)
T cd06620 159 -ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV----------- 226 (284)
T ss_pred -cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh-----------
Confidence 2345789999999999888999999999999999999999999986543211 11112221111
Q ss_pred hhchhhhccCH-HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 007892 442 LVDQKLEEYDS-AEMTRMAACAAACIRHSARRRPRMSQIVRALE 484 (586)
Q Consensus 442 l~d~~l~~~~~-~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~ 484 (586)
......... .....+.+++.+|++.||.+||++.||++++.
T Consensus 227 --~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 227 --QEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred --hccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 111111111 24457889999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=355.27 Aligned_cols=258 Identities=20% Similarity=0.302 Sum_probs=203.1
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
++|++.++||+|+||.||+|+.. +|+.||||++..... .....|.+|++++++++||||++++++|.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57899999999999999999965 588999999875422 22457899999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCC---------CCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecc
Q 007892 285 EFVPNKTLEFHLHGK---------DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 355 (586)
Q Consensus 285 E~~~~gsL~~~l~~~---------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFG 355 (586)
||++|++|.+++... ....+++..+++++.|+++||+|||+. +|+||||||+||||+.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 999999999988632 113466778899999999999999998 99999999999999999999999999
Q ss_pred cccccCCCC-----------------CcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCccc
Q 007892 356 LAKHSLDTD-----------------THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFA 418 (586)
Q Consensus 356 la~~~~~~~-----------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~ 418 (586)
+++...... .......+||+.|||||++.+..++.++|||||||+||||++|+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 998652110 011123579999999999999999999999999999999999999997643211
Q ss_pred chhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHhcC
Q 007892 419 DDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRP-RMSQIVRALEGN 486 (586)
Q Consensus 419 ~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RP-tm~evl~~L~~~ 486 (586)
.. +. . .+.++.......+.+..+.+++.+|++.||.+|+ ++.++++.|+..
T Consensus 239 ---i~-~~-----~--------~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 239 ---IS-YR-----D--------VILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred ---hh-hh-----h--------hccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00 00 0 0000000000123345688999999999999996 567777777654
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=315.28 Aligned_cols=247 Identities=28% Similarity=0.468 Sum_probs=200.8
Q ss_pred cCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecC
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVP 288 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 288 (586)
++|.+.+.||+|+||.||++.. +++.||+|.++... ....+.+|+.++.+++|+||+++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4688889999999999999985 67889999986542 245788999999999999999999998754 5789999999
Q ss_pred CCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCccc
Q 007892 289 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 368 (586)
Q Consensus 289 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 368 (586)
+++|.+++.......+++..++.++.|++.||.|||+. +++||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---- 154 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---- 154 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence 99999999766555689999999999999999999988 99999999999999999999999999987543211
Q ss_pred ccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhh
Q 007892 369 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 447 (586)
Q Consensus 369 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 447 (586)
.....+..|+|||++.++.++.++|||||||++|||++ |+.||...... ++... +. .+.. .
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~~~-~~----~~~~---~---- 216 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK------EVKEC-VE----KGYR---M---- 216 (254)
T ss_pred CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH------HHHHH-Hh----CCCC---C----
Confidence 12234568999999998899999999999999999998 99999754321 11110 11 1100 0
Q ss_pred hccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 007892 448 EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 485 (586)
Q Consensus 448 ~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~ 485 (586)
......+..+.+++.+|++.+|.+||++.+|+..|+.
T Consensus 217 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 217 -EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1112234678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=323.77 Aligned_cols=251 Identities=24% Similarity=0.315 Sum_probs=203.3
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCch---hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ---GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~---~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
++|+..+.||+|+||.||++... +++.||+|.+...... ..+.+.+|++++.+++|+||+++++++..+...++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 46888999999999999999976 4899999998764322 3457889999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
||+.+++|.+++.......+++..+..++.|+++||+|||+. +++|+||||+||||+.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 999999999999765556789999999999999999999998 99999999999999999999999999987543211
Q ss_pred Cc----------------------------ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 007892 365 TH----------------------------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADT 416 (586)
Q Consensus 365 ~~----------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~ 416 (586)
.. ......|+..|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 10 11234688999999999988899999999999999999999999975542
Q ss_pred ccchhhhhhhhHHHhhcccCCChhhhhchhhh-ccCHHHHHHHHHHHHHhhccCCCCCCC----HHHHHH
Q 007892 417 FADDSMVDWAKPFLAQGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPR----MSQIVR 481 (586)
Q Consensus 417 ~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~-~~~~~~~~~l~~l~~~cl~~dp~~RPt----m~evl~ 481 (586)
.. .+. .+.+.... .........+.+++.+|++.+|++||+ +.|++.
T Consensus 238 ~~--~~~-----------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 238 DE--TFS-----------------NILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HH--HHH-----------------HHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 11 110 01111111 111114567999999999999999999 666655
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=315.38 Aligned_cols=250 Identities=26% Similarity=0.450 Sum_probs=200.8
Q ss_pred CccccceecccCcEEEEEEEEeCCeEEEEEEeccCCc------hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEE
Q 007892 210 NFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSG------QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~------~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV 283 (586)
+|...+.||+|+||.||+|...+++.+|||.++.... .....+.+|++++++++|+||++++++|.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4677899999999999999988899999999865321 1224688999999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCC
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 363 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 363 (586)
+||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+|+||||+|||+++++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 81 MEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 99999999999996543 478999999999999999999998 8999999999999999999999999998754221
Q ss_pred C-----CcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCC
Q 007892 364 D-----THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGN 438 (586)
Q Consensus 364 ~-----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (586)
. ........|+..|+|||++.+..++.++|||||||++|||++|+.||...+... ..... ....+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~~~~~-------~~~~~~ 226 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA--AMFYI-------GAHRGL 226 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH--HHHHh-------hhccCC
Confidence 1 111223568999999999998889999999999999999999999997543211 00000 000000
Q ss_pred hhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 439 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 439 ~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
. ...+......+.+++.+||+.+|.+||++.||+.
T Consensus 227 ~--------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 M--------PRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred C--------CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 1112223456889999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=317.50 Aligned_cols=253 Identities=25% Similarity=0.367 Sum_probs=201.4
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEec
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 287 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 287 (586)
++|...+.||+|+||.||+|+.. +++.||+|.++.........+.+|+.++..++||||+++++++...+..++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 56777899999999999999864 58899999987665555567889999999999999999999999999999999999
Q ss_pred CCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcc
Q 007892 288 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 367 (586)
Q Consensus 288 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 367 (586)
++++|.+++.... .+++.+++.++.|++.||.|||+. +|+|+||||+|||++.++.+||+|||++....... ..
T Consensus 89 ~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~ 162 (267)
T cd06645 89 GGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AK 162 (267)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-cc
Confidence 9999999886543 489999999999999999999998 99999999999999999999999999987653221 12
Q ss_pred cccccccccccCccccc---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhc
Q 007892 368 STRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 444 (586)
Q Consensus 368 ~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 444 (586)
.....|+..|+|||++. .+.++.++|||||||++|||++|..||........ +... ....+. .
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~--~~~~---------~~~~~~---~ 228 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LFLM---------TKSNFQ---P 228 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh--HHhh---------hccCCC---C
Confidence 23456899999999874 45688999999999999999999999865432110 0000 000000 0
Q ss_pred hhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 445 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 445 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
+... ........+.+++.+|++.+|++||++.+|++.
T Consensus 229 ~~~~-~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 229 PKLK-DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred Cccc-ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 0000 001123457899999999999999999998853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=317.75 Aligned_cols=266 Identities=20% Similarity=0.283 Sum_probs=199.0
Q ss_pred CccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 210 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
+|+..+.||+|+||.||+|+.. +++.||||.++... ......+.+|+.++.+++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999975 68899999986542 22246788999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCC-CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC
Q 007892 287 VPNKTLEFHLHGKD-RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365 (586)
Q Consensus 287 ~~~gsL~~~l~~~~-~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 365 (586)
++ ++|.+++.... ...+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||++...... .
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP-V 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCC-c
Confidence 97 57887775433 25689999999999999999999998 9999999999999999999999999999754322 1
Q ss_pred cccccccccccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHH-------HhhcccCC
Q 007892 366 HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPF-------LAQGLADG 437 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~-------~~~~~~~~ 437 (586)
.......+++.|+|||++.+. .++.++|||||||++|||++|+.||....... .+......+ +.......
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID--QLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhcchhhH
Confidence 222334578899999988654 57899999999999999999999997654311 111100000 00000000
Q ss_pred Chhhh----hchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 438 NFDAL----VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 438 ~~~~l----~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.+... ....+.........++.+++.+||+.||.+||++.+|+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000 0011111111234567899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=313.23 Aligned_cols=249 Identities=29% Similarity=0.461 Sum_probs=200.9
Q ss_pred ccccceecccCcEEEEEEEEeC-CeEEEEEEeccCCchhHH--HHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEec
Q 007892 211 FSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGER--EFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 287 (586)
Q Consensus 211 f~~~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~~~~~--~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 287 (586)
|++.+.||+|+||+||++.... ++.||+|++......... ....|+.++.+++|+||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 5678999999999999999764 678999999876544332 3456999999999999999999999999999999999
Q ss_pred CCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcc
Q 007892 288 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 367 (586)
Q Consensus 288 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 367 (586)
++++|.+++. ....+++..++.++.|+++||.+||+. +|+|+||||+|||+++++.++|+|||++.... .....
T Consensus 81 ~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~ 154 (260)
T PF00069_consen 81 PGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNEN 154 (260)
T ss_dssp TTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSE
T ss_pred cccccccccc--ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-ccccc
Confidence 9999999997 234589999999999999999999998 99999999999999999999999999997541 22223
Q ss_pred cccccccccccCccccc-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchh
Q 007892 368 STRVMGTFGYLAPEYAS-SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 446 (586)
Q Consensus 368 ~~~~~gt~~y~aPE~~~-~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 446 (586)
.....++..|+|||++. +..++.++||||||+++|+|++|..||....... ....... .....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~---~~~~~~~-------------~~~~~ 218 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD---QLEIIEK-------------ILKRP 218 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH---HHHHHHH-------------HHHTH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchh---hhhhhhh-------------ccccc
Confidence 34567899999999998 8889999999999999999999999998652111 1111100 00000
Q ss_pred hh-ccC--HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 447 LE-EYD--SAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 447 l~-~~~--~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
+. ... ......+.+++..||+.||.+||++.++++
T Consensus 219 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 219 LPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 10 000 011278999999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=321.06 Aligned_cols=249 Identities=22% Similarity=0.369 Sum_probs=204.8
Q ss_pred cCccccceecccCcEEEEEEEE-eCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEec
Q 007892 209 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 287 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 287 (586)
.+|...+.||+|+||.||+++. .+++.||+|.+........+.+.+|+.+++.++|+||++++++|..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 6788899999999999999996 468999999997665555677899999999999999999999999999999999999
Q ss_pred CCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcc
Q 007892 288 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 367 (586)
Q Consensus 288 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 367 (586)
++++|.+++.. ..+++.+++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 99 ~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~-~~ 171 (297)
T cd06656 99 AGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SK 171 (297)
T ss_pred CCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCc-cC
Confidence 99999998853 3488999999999999999999998 99999999999999999999999999987643322 12
Q ss_pred cccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhh
Q 007892 368 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 447 (586)
Q Consensus 368 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 447 (586)
.....+++.|+|||.+.+..++.++|||||||++|+|++|..||...+.... +... ...+ . +.+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~--~~~~--------~~~~-~-----~~~ 235 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYLI--------ATNG-T-----PEL 235 (297)
T ss_pred cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh--eeee--------ccCC-C-----CCC
Confidence 2345688999999999988899999999999999999999999976443110 0000 0000 0 000
Q ss_pred hccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 448 EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 448 ~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
.........+.+++.+||+.+|.+||++.+|++
T Consensus 236 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 236 -QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred -CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 112233456788999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=319.32 Aligned_cols=240 Identities=24% Similarity=0.431 Sum_probs=191.4
Q ss_pred ceecccCcEEEEEEEEeC--------CeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 215 NLLGQGGFGYVHKGVLTN--------GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~~~~--------g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
+.||+|+||.||+|.... ...||+|.+..........+.+|+.++..++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998642 235888888665545556789999999999999999999999998999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCC--------eEEeeccccc
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE--------AKVADFGLAK 358 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~--------~kl~DFGla~ 358 (586)
+++|+|..+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +|++|||++.
T Consensus 81 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 81 VKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999999997543 3589999999999999999999998 9999999999999987765 6999999986
Q ss_pred ccCCCCCcccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCC-CCCCCCCcccchhhhhhhhHHHhhcccC
Q 007892 359 HSLDTDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGF-RPFDKADTFADDSMVDWAKPFLAQGLAD 436 (586)
Q Consensus 359 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~-~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (586)
..... ....++..|+|||++.+ ..++.++|||||||++|||++|. .||....... .... .
T Consensus 157 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~---~~~~----~------ 218 (258)
T cd05078 157 TVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK---KLQF----Y------ 218 (258)
T ss_pred ccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH---HHHH----H------
Confidence 54321 23467889999999986 45899999999999999999985 5655433211 0000 0
Q ss_pred CChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 007892 437 GNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484 (586)
Q Consensus 437 ~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~ 484 (586)
... ..++......+.+++.+||+.+|++||++.+|++.|+
T Consensus 219 -------~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 219 -------EDR-HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -------Hcc-ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 0122223356899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=319.56 Aligned_cols=247 Identities=26% Similarity=0.398 Sum_probs=201.2
Q ss_pred CccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEec
Q 007892 210 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 287 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 287 (586)
.|+..+.||+|+||.||+|.+. +++.||+|.++... ......+.+|++++++++|+||++++++|..+...++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4666788999999999999864 57899999987543 233457899999999999999999999999999999999999
Q ss_pred CCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcc
Q 007892 288 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 367 (586)
Q Consensus 288 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 367 (586)
++++|.+++.. ..+.+..+..++.|++.||.|||++ +++|+||+|+||++++++.+||+|||++........ .
T Consensus 85 ~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06642 85 GGGSALDLLKP---GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K 157 (277)
T ss_pred CCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch-h
Confidence 99999998854 3488999999999999999999998 999999999999999999999999999976543221 2
Q ss_pred cccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhh
Q 007892 368 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 447 (586)
Q Consensus 368 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 447 (586)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||....... ...+ + ..+ ..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~~----~----~~~--------~~ 218 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR---VLFL----I----PKN--------SP 218 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh---HHhh----h----hcC--------CC
Confidence 223468889999999998889999999999999999999999986543211 1100 0 000 00
Q ss_pred hccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 448 EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 448 ~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
..........+.+++.+|++.+|.+||+|.+|++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 219 PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 11222344668899999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=325.55 Aligned_cols=264 Identities=16% Similarity=0.261 Sum_probs=195.9
Q ss_pred ccceeccc--CcEEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEec
Q 007892 213 EANLLGQG--GFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 287 (586)
Q Consensus 213 ~~~~LG~G--~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 287 (586)
+.++||+| +|++||++... +|+.||||+++... ......+.+|+++++.++||||++++++|..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 78999999864 68999999997542 223456788999999999999999999999999999999999
Q ss_pred CCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc-
Q 007892 288 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH- 366 (586)
Q Consensus 288 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~- 366 (586)
++|+|.+++.......+++..++.++.|++.||+|||+. +|+||||||+|||++.++.++++||+.+.........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999998655445689999999999999999999998 9999999999999999999999999875443221110
Q ss_pred -----ccccccccccccCcccccC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHh--------
Q 007892 367 -----VSTRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLA-------- 431 (586)
Q Consensus 367 -----~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~-------- 431 (586)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||....... .........+.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~ 236 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLNGTVPCLLDTTTI 236 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--HHHHHhcCCccccccccch
Confidence 1122356778999999976 458999999999999999999999997532110 00000000000
Q ss_pred --hcc--------cCCChhhhh---------c-hhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 432 --QGL--------ADGNFDALV---------D-QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 432 --~~~--------~~~~~~~l~---------d-~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
..+ .+..+.... . .....+.......+.+++.+||+.||.+||++.||++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 000 000000000 0 0000122233457889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=321.28 Aligned_cols=249 Identities=20% Similarity=0.373 Sum_probs=204.5
Q ss_pred cCccccceecccCcEEEEEEEE-eCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEec
Q 007892 209 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 287 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 287 (586)
.+|+..+.||.|+||.||+|.. .+++.||||.+..........+.+|+.+++.++|+||+++++++..++..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688999999999999999985 468999999987665555678899999999999999999999999999999999999
Q ss_pred CCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcc
Q 007892 288 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 367 (586)
Q Consensus 288 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 367 (586)
++++|..++.. ..+++.++..++.+++.||+|||+. +++||||||+|||++.++.+||+|||++........ .
T Consensus 99 ~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~ 171 (296)
T cd06655 99 AGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-K 171 (296)
T ss_pred CCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc-c
Confidence 99999998853 2489999999999999999999998 999999999999999999999999999876433222 2
Q ss_pred cccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhh
Q 007892 368 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 447 (586)
Q Consensus 368 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 447 (586)
.....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.... +..+ . .... +.+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~--~~~~----~-----~~~~-----~~~ 235 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYLI----A-----TNGT-----PEL 235 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHH----H-----hcCC-----ccc
Confidence 2335688999999999988899999999999999999999999976543111 1000 0 0000 000
Q ss_pred hccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 448 EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 448 ~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
.........+.+++.+||..+|.+||++.+|+.
T Consensus 236 -~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 236 -QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred -CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 112223456888999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=319.08 Aligned_cols=266 Identities=28% Similarity=0.450 Sum_probs=197.5
Q ss_pred ccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHh--cCCCCcceEEEEEEeCC----eeEEEE
Q 007892 211 FSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQ--VHHRHLVSLVGYCTFGS----QRLLVY 284 (586)
Q Consensus 211 f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~--l~Hpniv~l~g~~~~~~----~~~lV~ 284 (586)
..+.++||+|.||.||||++. ++.||||++.. +..+.|++|-+|.+. ++|+||++++++-..+. +++||+
T Consensus 212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred hhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 444578999999999999995 48999999854 446788988888875 57999999999877665 889999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhc------CCCcEEecCCCCceeEeCCCCCeEEeeccccc
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED------CQPKIIHRDIKSANILLDDSFEAKVADFGLAK 358 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~------~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~ 358 (586)
||.++|+|.++|..+ .++|....+|+.-+++||+|||+. ..|.|+|||||++||||.+|+.+.|+|||||.
T Consensus 288 ~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 288 EFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred eeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 999999999999654 599999999999999999999976 36789999999999999999999999999998
Q ss_pred ccCCCCCc-ccccccccccccCcccccCCC-CC-----CcchHHHHHHHHHHHHhCCCCCCC--CCccc--------chh
Q 007892 359 HSLDTDTH-VSTRVMGTFGYLAPEYASSGK-LT-----EKSDVFSFGVLLLELITGFRPFDK--ADTFA--------DDS 421 (586)
Q Consensus 359 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~s-----~ksDVwSlGvvL~elltG~~Pf~~--~~~~~--------~~~ 421 (586)
.+...... ..-..+||..|||||++.+.. +. .+.||||+|.|||||++.-.-++. ..+.. ...
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP 444 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP 444 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence 76543221 222368999999999997532 22 368999999999999996544421 11100 000
Q ss_pred hhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCCC
Q 007892 422 MVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMPL 489 (586)
Q Consensus 422 ~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~~~ 489 (586)
-.+-.+.++.+ .+....+.+.- .....+..+.+.+..||.+|++-|.|+.=|.+.+....-+
T Consensus 445 t~e~mq~~VV~---kK~RP~~p~~W---~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 445 TLEEMQELVVR---KKQRPKIPDAW---RKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred CHHHHHHHHHh---hccCCCChhhh---hcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 11111111111 00000111110 1114566799999999999999999999888888765433
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=317.77 Aligned_cols=253 Identities=24% Similarity=0.407 Sum_probs=202.3
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
++|++.+.||+|+||.||++... +++.||+|.++... ......+.+|++++.+++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46788899999999999999976 68999999986542 23346788999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCC-CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC
Q 007892 287 VPNKTLEFHLHGKD-RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365 (586)
Q Consensus 287 ~~~gsL~~~l~~~~-~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 365 (586)
+++++|..++.... ...+++..+..++.+++.||.|||+.+ +|+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence 99999998886532 235899999999999999999999643 8999999999999999999999999999765322
Q ss_pred cccccccccccccCcccccCCC------CCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCCh
Q 007892 366 HVSTRVMGTFGYLAPEYASSGK------LTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 439 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~~~~------~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (586)
......++..|+|||++.+.. ++.++|||||||+||||++|+.||...... ....- +
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~-------------~ 219 (286)
T cd06622 157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA---NIFAQ-------------L 219 (286)
T ss_pred -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh---hHHHH-------------H
Confidence 223345888999999986543 588999999999999999999999653321 11100 0
Q ss_pred hhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 440 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 440 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
..+.+......+......+.+++.+|++.+|.+||++.+++..
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 220 SAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred HHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 1111111122333456778899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=311.50 Aligned_cols=249 Identities=24% Similarity=0.400 Sum_probs=202.9
Q ss_pred CccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 210 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
+|+..+.||+|+||.||++... +++.+|||.+.... ......+.+|++++++++|+||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4788899999999999999864 67899999986542 23356788999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCC-CCeEEeecccccccCCCCC
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS-FEAKVADFGLAKHSLDTDT 365 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~-~~~kl~DFGla~~~~~~~~ 365 (586)
+++++|.+++.......+++..++.++.+++++|+|||++ +|+|+||||+||+++++ +.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS- 156 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence 9999999999766556689999999999999999999998 99999999999999855 468999999998654322
Q ss_pred cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhch
Q 007892 366 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQ 445 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 445 (586)
......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+.. ....+. . .+...
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~~~~~---~-----~~~~~----- 219 (256)
T cd08220 157 -KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP---ALVLKI---M-----SGTFA----- 219 (256)
T ss_pred -cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH---HHHHHH---H-----hcCCC-----
Confidence 223356889999999999888999999999999999999999999754421 111111 0 01110
Q ss_pred hhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 446 KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 446 ~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.........+.+++.+||+.+|.+||++.|+++.
T Consensus 220 ---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 220 ---PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ---CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1122234568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=329.87 Aligned_cols=266 Identities=20% Similarity=0.284 Sum_probs=197.6
Q ss_pred HhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeC------
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFG------ 277 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~------ 277 (586)
..++|+..+.||+|+||.||++... .++.||||.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 3478999999999999999999854 58899999987542 22345678899999999999999999988643
Q ss_pred CeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccc
Q 007892 278 SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 357 (586)
Q Consensus 278 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla 357 (586)
...++||||+++ +|.+.+.. .+++..+..++.|+++||.|||+. +|+||||||+||||+.++.+||+|||++
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCccc
Confidence 356899999975 56555532 378889999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchh-hh--------hh---
Q 007892 358 KHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDS-MV--------DW--- 425 (586)
Q Consensus 358 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~-~~--------~~--- 425 (586)
+..... .......||..|+|||++.+..++.++|||||||+||||++|+.||...+...... .. ++
T Consensus 167 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (355)
T cd07874 167 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_pred ccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 864322 22234578999999999998899999999999999999999999997654211100 00 00
Q ss_pred hhHHHhhcccC-CCh-----hhhhchhh----hccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 426 AKPFLAQGLAD-GNF-----DALVDQKL----EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 426 ~~~~~~~~~~~-~~~-----~~l~d~~l----~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
..+.+...... ..+ .......+ ..........+.+++.+||+.||++||++.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000000000 000 00000000 01112234568899999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=317.65 Aligned_cols=269 Identities=25% Similarity=0.362 Sum_probs=205.6
Q ss_pred cCccccceecccCcEEEEEEEEe-----CCeEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCee
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-----NGKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTF--GSQR 280 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-----~g~~vAVK~l~~~~~~-~~~~~~~Ei~il~~l~Hpniv~l~g~~~~--~~~~ 280 (586)
+.|...+.||+|+||.||++++. +++.||||.++..... ....|.+|++++++++|+||+++++++.. +...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45777799999999999999864 3689999999765443 45789999999999999999999999987 5578
Q ss_pred EEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccccc
Q 007892 281 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 360 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~ 360 (586)
++||||+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+|+||||+|||++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 99999999999999997543 2589999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCc--ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCC
Q 007892 361 LDTDTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGN 438 (586)
Q Consensus 361 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (586)
...... ......++..|++||++....++.++||||||+++|||++|..|+....... ..++...... .....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~----~~~~~~~~~~-~~~~~ 234 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEF----LRMIGIAQGQ-MIVTR 234 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchh----cccccccccc-ccHHH
Confidence 432211 1112345567999999988899999999999999999999999986532211 0000000000 00000
Q ss_pred hhhhhchhhh-ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 439 FDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 439 ~~~l~d~~l~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
+..++..... .........+.+++.+|++.+|.+||+|.||+++|+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 235 LLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 0011111000 11223346799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=311.16 Aligned_cols=251 Identities=25% Similarity=0.376 Sum_probs=203.2
Q ss_pred cCccccceecccCcEEEEEEEE-eCCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~--~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
++|++.++||+|.|+.||++.. .+|+.+|+|++... +..+.+++.+|+.|.+.|+|||||+|..-+.+...+|||||
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 5677789999999999999885 46899999987543 33467889999999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeC---CCCCeEEeecccccccCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD---DSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~---~~~~~kl~DFGla~~~~~ 362 (586)
+|.|++|..-+-.. ...++...-..+.||+.+|.|+|.+ +|||||+||.|+||. ...-+||+|||+|..+.
T Consensus 91 ~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~- 164 (355)
T KOG0033|consen 91 LVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN- 164 (355)
T ss_pred cccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeC-
Confidence 99999997665332 3466777788999999999999999 999999999999994 34569999999999876
Q ss_pred CCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhh
Q 007892 363 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 442 (586)
Q Consensus 363 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 442 (586)
+...-...+||++|||||++...+|+..+|||+.|||||-|+.|.+||-+.+... +.+.+..+.++.
T Consensus 165 -~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r-----------lye~I~~g~yd~- 231 (355)
T KOG0033|consen 165 -DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-----------LYEQIKAGAYDY- 231 (355)
T ss_pred -CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH-----------HHHHHhccccCC-
Confidence 3334456789999999999999999999999999999999999999997643211 222222333321
Q ss_pred hchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 443 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 443 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
++ .+-....+...+++.+||..||.+|-|+.|.++.
T Consensus 232 -~~---~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 232 -PS---PEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred -CC---cccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 11 1122334567889999999999999999998753
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=316.64 Aligned_cols=254 Identities=26% Similarity=0.416 Sum_probs=203.1
Q ss_pred cCccccceecccCcEEEEEEEEeC-Ce----EEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLTN-GK----VVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 282 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~~-g~----~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~l 282 (586)
++|+..+.||+|+||.||+|.+.+ |. .||+|.++.... .....+.+|+.++.+++|+||++++++|.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 567888999999999999999643 32 689998876543 334678899999999999999999999987 78899
Q ss_pred EEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCC
Q 007892 283 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 283 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 362 (586)
||||+++|+|.++++.... .+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 86 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 9999999999999976433 489999999999999999999997 999999999999999999999999999987543
Q ss_pred CCCccc-ccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChh
Q 007892 363 TDTHVS-TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 440 (586)
Q Consensus 363 ~~~~~~-~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (586)
...... ....++..|+|||.+..+.++.++|||||||++|||++ |+.||..... ..+..+. ..+..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~--------~~~~~- 229 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA---VEIPDLL--------EKGER- 229 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH---HHHHHHH--------hCCCC-
Confidence 322211 11224568999999988899999999999999999998 9999976432 1111111 01100
Q ss_pred hhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 441 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 441 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
...+......+.+++.+||..+|.+||++.++++.|+..
T Consensus 230 -------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 230 -------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 011112334678899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=314.35 Aligned_cols=253 Identities=24% Similarity=0.419 Sum_probs=201.0
Q ss_pred CccccceecccCcEEEEEEEEeC--CeEEEEEEeccCC----------chhHHHHHHHHHHHHh-cCCCCcceEEEEEEe
Q 007892 210 NFSEANLLGQGGFGYVHKGVLTN--GKVVAIKQLKAGS----------GQGEREFQAEIEIISQ-VHHRHLVSLVGYCTF 276 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~~--g~~vAVK~l~~~~----------~~~~~~~~~Ei~il~~-l~Hpniv~l~g~~~~ 276 (586)
+|+..+.||+|+||.||+|.+.. ++.+|||.+.... .....++.+|+.++.+ ++|+||++++++|..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778999999999999999765 6889999875321 1223457788888875 799999999999999
Q ss_pred CCeeEEEEEecCCCcHHHHhcC--CCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeec
Q 007892 277 GSQRLLVYEFVPNKTLEFHLHG--KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADF 354 (586)
Q Consensus 277 ~~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DF 354 (586)
++..++||||+++++|.+++.. .....+++..++.++.|++.||.|||+.. +|+|+|||++|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999888743 22345889999999999999999999632 7999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcc
Q 007892 355 GLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGL 434 (586)
Q Consensus 355 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 434 (586)
|++....... ......|+..|++||++.++.++.++||||||+++|||++|+.||...+.. ......
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~------~~~~~~----- 225 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML------SLATKI----- 225 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH------HHHHHH-----
Confidence 9998654332 233456899999999999888999999999999999999999999654321 111110
Q ss_pred cCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 007892 435 ADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484 (586)
Q Consensus 435 ~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~ 484 (586)
..+.+... ........+.+++.+|++.||.+||++.||..+|+
T Consensus 226 ~~~~~~~~-------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 226 VEAVYEPL-------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred hhccCCcC-------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 01111100 01123456889999999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=313.97 Aligned_cols=248 Identities=25% Similarity=0.391 Sum_probs=204.0
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
..|+..+.||.|+||.||+|... ++..||||.++... ......+.+|+.++++++|+||++++++|..+...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35677789999999999999965 58899999987543 34456788999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 366 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 366 (586)
+++++|.+++.. ..+++.....++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06640 84 LGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-
Confidence 999999999864 2478889999999999999999998 999999999999999999999999999976543322
Q ss_pred ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchh
Q 007892 367 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 446 (586)
Q Consensus 367 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 446 (586)
......++..|+|||++.+..++.++|||||||++|||++|..||....... ... ....+ .
T Consensus 157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~--------~~~~~--------~ 217 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR---VLF--------LIPKN--------N 217 (277)
T ss_pred ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh---Hhh--------hhhcC--------C
Confidence 2233468889999999998889999999999999999999999997543211 000 00000 0
Q ss_pred hhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 447 LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 447 l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
...........+.+++.+||+.+|.+||++.+|+..
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 218 PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 112334456778999999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=331.53 Aligned_cols=263 Identities=21% Similarity=0.277 Sum_probs=197.2
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeC------C
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFG------S 278 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~------~ 278 (586)
.++|...+.||+|+||.||++... .++.||||++.... ......+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 478999999999999999999964 57899999986532 23345778899999999999999999987543 3
Q ss_pred eeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccc
Q 007892 279 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 358 (586)
Q Consensus 279 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~ 358 (586)
..++||||+++ +|...+.. .+++..+..++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 57999999975 56666532 378889999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhh-----------
Q 007892 359 HSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAK----------- 427 (586)
Q Consensus 359 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~----------- 427 (586)
..... .......||..|+|||++.+..++.++|||||||+||||++|+.||...+.... +.....
T Consensus 175 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~ 250 (364)
T cd07875 175 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ--WNKVIEQLGTPCPEFMK 250 (364)
T ss_pred ccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCCHHHHH
Confidence 64322 122345789999999999999999999999999999999999999976543211 000000
Q ss_pred ---HHHhhccc------CCChhhhhchhhh----ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 428 ---PFLAQGLA------DGNFDALVDQKLE----EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 428 ---~~~~~~~~------~~~~~~l~d~~l~----~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
+.+..... .-.+..+....+. .........+.+++.+|++.||.+|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000 0000011000000 1111123568899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=310.93 Aligned_cols=248 Identities=25% Similarity=0.428 Sum_probs=201.4
Q ss_pred CccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC-----chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEE
Q 007892 210 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-----GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-----~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV 283 (586)
+|+..+.||+|+||.||+|+.. +++.|++|.+.... ....+.+.+|++++++++|+||+++++++..+...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3677899999999999999976 78999999986533 22346788999999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCC
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 363 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 363 (586)
+||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 81 LELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 9999999999998654 3488999999999999999999998 9999999999999999999999999998765332
Q ss_pred CCcccccccccccccCcccccCCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhh
Q 007892 364 DTHVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 442 (586)
Q Consensus 364 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 442 (586)
. ......|+..|++||.+.... ++.++|+|||||++|+|++|+.||...... .....+.. ...
T Consensus 156 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~--------~~~---- 219 (258)
T cd06632 156 S--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV--AAVFKIGR--------SKE---- 219 (258)
T ss_pred c--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH--HHHHHHHh--------ccc----
Confidence 2 223456889999999987766 899999999999999999999999754321 11111100 000
Q ss_pred hchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 443 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 443 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
+...+......+.+++.+|++.+|.+||++.++++.
T Consensus 220 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 220 ----LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred ----CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 111222234667889999999999999999999863
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=310.86 Aligned_cols=254 Identities=25% Similarity=0.381 Sum_probs=206.2
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
.++|+..+.||.|+||.||++... +++.+++|.+..........+.+|++++++++||||+++++++..++..+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 367889999999999999999964 5788999999876555667899999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 366 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 366 (586)
+++++|.+++.... ..+++.++..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||++....... .
T Consensus 82 ~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~ 156 (262)
T cd06613 82 CGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-A 156 (262)
T ss_pred CCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh-h
Confidence 99999999886542 3588999999999999999999998 99999999999999999999999999987653321 1
Q ss_pred ccccccccccccCcccccCC---CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhh
Q 007892 367 VSTRVMGTFGYLAPEYASSG---KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 443 (586)
Q Consensus 367 ~~~~~~gt~~y~aPE~~~~~---~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 443 (586)
......++..|+|||.+... .++.++|||||||++|||++|+.||....... ...... ...+.
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~--~~~~~~---------~~~~~--- 222 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR--ALFLIS---------KSNFP--- 222 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH---------hccCC---
Confidence 22335688899999999776 88999999999999999999999997544211 111000 00000
Q ss_pred chhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 444 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 444 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
...+ .........+.+++.+|+..+|.+||++.+|+.
T Consensus 223 ~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 223 PPKL-KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred Cccc-cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0001 112234567899999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=332.68 Aligned_cols=264 Identities=20% Similarity=0.233 Sum_probs=198.7
Q ss_pred hcCccccceecccCcEEEEEEEEe---CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT---NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~---~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
..+|.+.+.||+|+||.||++... .++.||||.+... ..+.+|+++|.+++|||||++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 357999999999999999999853 3578999988643 34568999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
|++. ++|..++.. ...+++.+++.|+.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 166 e~~~-~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 166 PKYK-CDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred hhcC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 9995 677777743 34589999999999999999999998 99999999999999999999999999997654332
Q ss_pred Cc-ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccch-hhhhhhhHHHhhc--ccCCC--
Q 007892 365 TH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADD-SMVDWAKPFLAQG--LADGN-- 438 (586)
Q Consensus 365 ~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~--~~~~~-- 438 (586)
.. ......||+.|+|||++....++.++|||||||+||||++|+.||......... .+....+..-... +....
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 21 223467999999999999999999999999999999999999999765432111 1111000000000 00000
Q ss_pred -h----hhhhchhhhcc-------CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 439 -F----DALVDQKLEEY-------DSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 439 -~----~~l~d~~l~~~-------~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
+ ..........+ .......+.+++..||+.||.+||++.|++..
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 00000000000 01123467889999999999999999999975
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=319.75 Aligned_cols=264 Identities=21% Similarity=0.326 Sum_probs=199.2
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
++|...+.||+|+||.||+|... +++.||+|.++... ......+.+|+.++.+++|+||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56888999999999999999865 57899999986543 22345678899999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 366 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 366 (586)
++ ++|..++.... ..+++..+..++.|+++||+|||+. +|+|+||||+|||+++++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 159 (301)
T cd07873 86 LD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 159 (301)
T ss_pred cc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence 97 58888776543 3588999999999999999999998 999999999999999999999999999975432221
Q ss_pred ccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHH--------hhcccCC
Q 007892 367 VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFL--------AQGLADG 437 (586)
Q Consensus 367 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~--------~~~~~~~ 437 (586)
......+++.|+|||.+.+ ..++.++|||||||+||||++|+.||...+... ........+ .......
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCChhhchhhhccc
Confidence 1223457889999998865 457889999999999999999999997654311 111100000 0000000
Q ss_pred Ch-----hhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 438 NF-----DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 438 ~~-----~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
.+ .......+..........+.+++.+||+.||.+||++.||++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00 000001111111223456789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=319.06 Aligned_cols=196 Identities=23% Similarity=0.328 Sum_probs=160.3
Q ss_pred cceecccCcEEEEEEEEe---CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCeeEEEEEecC
Q 007892 214 ANLLGQGGFGYVHKGVLT---NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF--GSQRLLVYEFVP 288 (586)
Q Consensus 214 ~~~LG~G~fG~Vyk~~~~---~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~--~~~~~lV~E~~~ 288 (586)
.++||+|+||.||+|+.. +++.||+|.++... ....+.+|+.+|++++||||+++++++.. +...++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999964 46789999986542 23467889999999999999999998854 456789999996
Q ss_pred CCcHHHHhcCC-------CCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEe----CCCCCeEEeecccc
Q 007892 289 NKTLEFHLHGK-------DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL----DDSFEAKVADFGLA 357 (586)
Q Consensus 289 ~gsL~~~l~~~-------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl----~~~~~~kl~DFGla 357 (586)
+ +|.+++... ....+++..+..++.|++.||.|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 4 676665421 123488889999999999999999998 99999999999999 45678999999999
Q ss_pred cccCCCCCc--ccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 007892 358 KHSLDTDTH--VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKAD 415 (586)
Q Consensus 358 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~ 415 (586)
+........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 865432221 2234678999999999876 458999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=323.56 Aligned_cols=193 Identities=23% Similarity=0.330 Sum_probs=165.0
Q ss_pred HHhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 206 IATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 206 ~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
....+|.+.+.||+|+||.||+|+.. +++.||+|..... ....|+.++.+++|+||+++++++......++|+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 44568999999999999999999975 4678999975432 2356899999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
||+. ++|.+++... ...++|..++.|+.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 137 e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 137 PHYS-SDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred EccC-CcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 9995 5777777543 34589999999999999999999998 99999999999999999999999999997532221
Q ss_pred CcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCC
Q 007892 365 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPF 411 (586)
Q Consensus 365 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf 411 (586)
......||..|+|||++.+..++.++|||||||+||||+++..++
T Consensus 212 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 --AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred --ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 223456999999999999999999999999999999999965554
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=310.81 Aligned_cols=255 Identities=24% Similarity=0.382 Sum_probs=206.1
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
++|++.+.||.|+||.||+|... ++..+|+|++.... ......+.+|+++++.++|+||+++++.+..++..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47889999999999999999954 67899999986543 23456889999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCC-CCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC
Q 007892 287 VPNKTLEFHLHGKDR-PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 365 (586)
+++++|.+++..... ..+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999875432 4689999999999999999999998 999999999999999999999999999886554332
Q ss_pred c---ccccccccccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhh
Q 007892 366 H---VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 441 (586)
Q Consensus 366 ~---~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (586)
. ......|+..|++||++... .++.++|||||||++|||++|+.||....... ....+.. .
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~~--------~----- 222 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLMLTLQ--------N----- 222 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHHHHhc--------C-----
Confidence 2 22345689999999998876 78999999999999999999999997544311 1111100 0
Q ss_pred hhchhhhc--cCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 442 LVDQKLEE--YDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 442 l~d~~l~~--~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
..+.+.. ........+.+++..|++.+|.+||++.||++.
T Consensus 223 -~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 223 -DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred -CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0011110 012345678899999999999999999999863
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=315.09 Aligned_cols=265 Identities=22% Similarity=0.305 Sum_probs=202.7
Q ss_pred CccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 210 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
+|++.+.||+|+||.||+|... +|+.||||++.... ......+.+|+.++++++|+||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778899999999999999964 68999999987643 23346789999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 366 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 366 (586)
+ +++|.+++.... ..+++.+++.++.|+++||+|||+. +|+|+||||+||+++.++.++|+|||++.........
T Consensus 81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 9 999999886544 4589999999999999999999998 9999999999999999999999999999876443322
Q ss_pred ccccccccccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhh--------cccCC
Q 007892 367 VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQ--------GLADG 437 (586)
Q Consensus 367 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--------~~~~~ 437 (586)
......|+..|+|||.+.+. .++.++|||||||++|||++|..+|...... ....+....+.. .....
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI---EQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH---HHHHHHHHHcCCCChHHHhhccCcc
Confidence 23345689999999998654 4689999999999999999998888654321 111111000000 00000
Q ss_pred Chhhhhc-----hhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 438 NFDALVD-----QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 438 ~~~~l~d-----~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.+..+.. ..+.....+....+.+++.+|++.+|.+||+++++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000 00111112234788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=313.81 Aligned_cols=269 Identities=22% Similarity=0.289 Sum_probs=203.9
Q ss_pred hcCccccceecccCcEEEEEEEE-eCCeEEEEEEeccCCch--hHHHHHHHHHHHHhcCCCC-cceEEEEEEeCC-----
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQ--GEREFQAEIEIISQVHHRH-LVSLVGYCTFGS----- 278 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~--~~~~~~~Ei~il~~l~Hpn-iv~l~g~~~~~~----- 278 (586)
...|...++||+|.||+||+|+. .+|+.||+|++.....+ ......+|+.+|.+|+|+| ||+|++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 34566778899999999999995 47899999999765442 2346689999999999999 999999998877
Q ss_pred -eeEEEEEecCCCcHHHHhcCCCC--CCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecc
Q 007892 279 -QRLLVYEFVPNKTLEFHLHGKDR--PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 355 (586)
Q Consensus 279 -~~~lV~E~~~~gsL~~~l~~~~~--~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFG 355 (586)
..+|||||+ .-+|..++..... ..++...+..++.|+++||+|||++ +|+||||||+||||+++|.+||+|||
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence 788999999 5588888876543 3577788999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccc----------hhhhh
Q 007892 356 LAKHSLDTDTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFAD----------DSMVD 424 (586)
Q Consensus 356 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~----------~~~~~ 424 (586)
+|+...-.. ...+..++|..|.|||++.+. .|+...||||+|||+.||++++.-|.+....+. .+...
T Consensus 166 lAra~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 166 LARAFSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred hHHHhcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence 999654222 234567899999999999876 799999999999999999999888876654221 11122
Q ss_pred hhhHHHhhcccCCChhhhhchh-hhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 425 WAKPFLAQGLADGNFDALVDQK-LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 425 ~~~~~~~~~~~~~~~~~l~d~~-l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
|..-........ .+...-.+. +............+++..||+.+|.+|.++...+.+
T Consensus 245 Wp~v~~~~~~k~-~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 245 WPGVSSLPDYKA-PFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccccccccc-cCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 321100000000 111111000 001111111478899999999999999999999875
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=316.85 Aligned_cols=253 Identities=24% Similarity=0.379 Sum_probs=204.1
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
.++|++.+.||.|+||.||++... +++.||+|.+..........|.+|++++++++|+||+++++++..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 366888899999999999999975 5889999999776655567899999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 366 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 366 (586)
+++++|..++.... ..+++..+..++.|++.||.|||+. +|+|+||||+|||++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~- 158 (280)
T cd06611 84 CDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ- 158 (280)
T ss_pred cCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc-
Confidence 99999999886533 3589999999999999999999998 999999999999999999999999999875433221
Q ss_pred ccccccccccccCccccc-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhh
Q 007892 367 VSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 441 (586)
Q Consensus 367 ~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (586)
......++..|++||++. ...++.++|||||||++|||++|+.||...+.. ..+..+ ..+..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~--~~~~~~---------~~~~~-- 225 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM--RVLLKI---------LKSEP-- 225 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH--HHHHHH---------hcCCC--
Confidence 223356899999999875 345778999999999999999999999754321 111111 01100
Q ss_pred hhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 442 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 442 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
+.+ ..+......+.+++.+||+.+|.+||++.+|++.
T Consensus 226 ---~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 226 ---PTL-DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ---CCc-CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 000 1112234568889999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=321.34 Aligned_cols=251 Identities=21% Similarity=0.308 Sum_probs=213.2
Q ss_pred cCccccceecccCcEEEEEEEE-eCCeEEEEEEeccCCchh--HHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQG--EREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~--~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
+-|.+.+.||+|.|..|-++++ -.|..||||++.+..... ...+.+|+..|+.++|||||+||.+......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 4577778999999999999984 479999999997754333 3568899999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEe-CCCCCeEEeecccccccCCCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL-DDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl-~~~~~~kl~DFGla~~~~~~~ 364 (586)
+-++|+|.+++..++. .+.+....+++.||+.|+.|||.. .+|||||||+||.+ .+-|-|||.|||++..+...
T Consensus 98 LGD~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG- 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG- 172 (864)
T ss_pred ecCCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc-
Confidence 9999999999976543 488888899999999999999998 89999999999987 55689999999999876543
Q ss_pred CcccccccccccccCcccccCCCCC-CcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhh
Q 007892 365 THVSTRVMGTFGYLAPEYASSGKLT-EKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 443 (586)
Q Consensus 365 ~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 443 (586)
...++.||+..|-|||++.+..|+ ++.||||||||||.|++|+.||...+.. ..+..++
T Consensus 173 -~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS-------------------ETLTmIm 232 (864)
T KOG4717|consen 173 -KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS-------------------ETLTMIM 232 (864)
T ss_pred -chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch-------------------hhhhhhh
Confidence 345678999999999999998886 5789999999999999999999877642 2233455
Q ss_pred chhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHhc
Q 007892 444 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR--ALEG 485 (586)
Q Consensus 444 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~--~L~~ 485 (586)
|-.. ..+.....++.++|..||..||.+|.+.++|+. +|+.
T Consensus 233 DCKY-tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~ 275 (864)
T KOG4717|consen 233 DCKY-TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQA 275 (864)
T ss_pred cccc-cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccC
Confidence 5444 355667788999999999999999999999985 4443
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=318.37 Aligned_cols=263 Identities=24% Similarity=0.361 Sum_probs=204.2
Q ss_pred cCHHHHHHHhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEE-
Q 007892 199 FTYEELKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCT- 275 (586)
Q Consensus 199 ~~~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~- 275 (586)
+.++.+..+.++|+..+.||+|+||.||++... +++.+|+|+++... .....+.+|+.++.++ +|+||++++++|.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 334566677899999999999999999999864 57899999886532 2245788999999999 6999999999884
Q ss_pred ----eCCeeEEEEEecCCCcHHHHhcCC--CCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCe
Q 007892 276 ----FGSQRLLVYEFVPNKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA 349 (586)
Q Consensus 276 ----~~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 349 (586)
.++..++||||+++++|.++++.. ....+++..+..++.|++.||.|||+. +|+||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCE
Confidence 345689999999999999887532 234588999999999999999999998 99999999999999999999
Q ss_pred EEeecccccccCCCCCcccccccccccccCcccccC-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhh
Q 007892 350 KVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD 424 (586)
Q Consensus 350 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~ 424 (586)
||+|||+++....... ......|+..|+|||++.. ..++.++|||||||++|||++|+.||....... .+..
T Consensus 164 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~--~~~~ 240 (286)
T cd06638 164 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR--ALFK 240 (286)
T ss_pred EEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH--HHhh
Confidence 9999999976533221 2233468999999999853 457889999999999999999999997543211 0000
Q ss_pred hhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007892 425 WAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRAL 483 (586)
Q Consensus 425 ~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L 483 (586)
+ .......+. .+......+.+++.+|++.+|.+||++.||++.+
T Consensus 241 ~---------~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 241 I---------PRNPPPTLH------QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred c---------cccCCCccc------CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 0 000000000 1111234688999999999999999999999764
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=312.15 Aligned_cols=264 Identities=24% Similarity=0.331 Sum_probs=220.7
Q ss_pred CHHHHHHHhcCccccceecccCcEEEEEEEEeC------CeEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCcceEEE
Q 007892 200 TYEELKIATDNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVG 272 (586)
Q Consensus 200 ~~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~~------g~~vAVK~l~~~~~~-~~~~~~~Ei~il~~l~Hpniv~l~g 272 (586)
...|+.+..++++...++-+|.||.||+|.|.+ .+.|-||.++....+ ....|+.|..++..+.|||+..+.+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 356788888899999999999999999997653 356778888776444 3457889999999999999999999
Q ss_pred EEEeC-CeeEEEEEecCCCcHHHHhcC------CCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCC
Q 007892 273 YCTFG-SQRLLVYEFVPNKTLEFHLHG------KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD 345 (586)
Q Consensus 273 ~~~~~-~~~~lV~E~~~~gsL~~~l~~------~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 345 (586)
+|.++ ...+++|.++.-|+|..+|.. +..+.+...+...++.|++.|++|||.+ +|||.||.++|++||+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehh
Confidence 99775 467889999999999999861 2335677788899999999999999998 9999999999999999
Q ss_pred CCCeEEeecccccccCCCCCccccc-ccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhh
Q 007892 346 SFEAKVADFGLAKHSLDTDTHVSTR-VMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMV 423 (586)
Q Consensus 346 ~~~~kl~DFGla~~~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~ 423 (586)
..++||+|-.|++.+...+.+.... .-....||+||.+....|+.++|||||||+||||+| |+.||...++++...
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~-- 509 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEH-- 509 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHH--
Confidence 9999999999999988887775543 335668999999999999999999999999999999 999999888754211
Q ss_pred hhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 007892 424 DWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 485 (586)
Q Consensus 424 ~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~ 485 (586)
+ +.|...-..+.+++.++..++..||+..|++||+++|++..|.+
T Consensus 510 -----y------------lkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 510 -----Y------------LKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred -----H------------HhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 1 12221113456788899999999999999999999999998863
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=313.49 Aligned_cols=252 Identities=25% Similarity=0.362 Sum_probs=190.0
Q ss_pred ceecccCcEEEEEEEEeC---CeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecCCC
Q 007892 215 NLLGQGGFGYVHKGVLTN---GKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNK 290 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~~~~---g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g 290 (586)
+.||+|+||.||+|...+ ...+|+|.+.... ......|.+|+.+++.++|+||++++++|......++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999998644 3578888876543 233457889999999999999999999999999999999999999
Q ss_pred cHHHHhcCCCC---CCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc-
Q 007892 291 TLEFHLHGKDR---PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH- 366 (586)
Q Consensus 291 sL~~~l~~~~~---~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~- 366 (586)
+|.+++..... ....+...+.++.|++.||+|||+. +|+||||||+||||++++.+||+|||++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999865432 2356788899999999999999998 9999999999999999999999999998754322211
Q ss_pred ccccccccccccCcccccC-------CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCC
Q 007892 367 VSTRVMGTFGYLAPEYASS-------GKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGN 438 (586)
Q Consensus 367 ~~~~~~gt~~y~aPE~~~~-------~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (586)
......++..|+|||++.. ..++.++|||||||++|||++ |..||....... . +...+..+.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~-------~~~~~~~~~ 227 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ---V-------LKQVVREQD 227 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH---H-------HHHHhhccC
Confidence 1123346678999998743 356889999999999999999 788886543211 0 001111111
Q ss_pred hhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 007892 439 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484 (586)
Q Consensus 439 ~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~ 484 (586)
..+.++. ........+.+++..|+ .||.+||++.||++.|.
T Consensus 228 -~~~~~~~---~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 228 -IKLPKPQ---LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred -ccCCCCc---ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1111111 12223455667778888 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=316.84 Aligned_cols=262 Identities=24% Similarity=0.346 Sum_probs=205.4
Q ss_pred cCHHHHHHHhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEEe
Q 007892 199 FTYEELKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTF 276 (586)
Q Consensus 199 ~~~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~ 276 (586)
+...++..+.++|...+.||+|+||.||++... +++.+|+|.+..... ....+.+|+.++.++ +|+||++++++|..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 445666777899999999999999999999964 688999999865432 245778899999999 79999999999875
Q ss_pred C-----CeeEEEEEecCCCcHHHHhcCC--CCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCe
Q 007892 277 G-----SQRLLVYEFVPNKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA 349 (586)
Q Consensus 277 ~-----~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 349 (586)
. +..++||||+++++|.++++.. ....+.+..++.++.|++.||+|||+. +|+||||||+|||+++++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCE
Confidence 4 3579999999999999888632 234589999999999999999999998 99999999999999999999
Q ss_pred EEeecccccccCCCCCcccccccccccccCcccccCC-----CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhh
Q 007892 350 KVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSG-----KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD 424 (586)
Q Consensus 350 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~ 424 (586)
||+|||++........ ......|+..|+|||++..+ .++.++|||||||++|||++|+.||...... ..+..
T Consensus 168 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~--~~~~~ 244 (291)
T cd06639 168 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV--KTLFK 244 (291)
T ss_pred EEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH--HHHHH
Confidence 9999999886533221 12234688999999998643 3689999999999999999999999754321 11111
Q ss_pred hhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 425 WAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 425 ~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
+. .+....+ .........+.+++.+|++.+|++||++.|+++.
T Consensus 245 ~~---------~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 245 IP---------RNPPPTL------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred Hh---------cCCCCCC------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11 0000000 0112233568999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=314.57 Aligned_cols=266 Identities=21% Similarity=0.304 Sum_probs=202.0
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
++|+..+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++.+++|+||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999976 58999999986432 2234567899999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 365 (586)
|++++.|..++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 81 YCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred ccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 99999998877543 3489999999999999999999998 999999999999999999999999999986543321
Q ss_pred cccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHH---Hh---hcccCCC
Q 007892 366 HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPF---LA---QGLADGN 438 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~---~~---~~~~~~~ 438 (586)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||......+ .+..+.... .. ..+....
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD--QLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCChHHhhhccccc
Confidence 1223457889999999875 567899999999999999999999997654321 111111000 00 0000000
Q ss_pred h-hhhhchhhh------ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 439 F-DALVDQKLE------EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 439 ~-~~l~d~~l~------~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
+ ..+..+... .........+.+++.+||+.+|++||++.|++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0 000001000 0111234678899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=312.71 Aligned_cols=252 Identities=23% Similarity=0.352 Sum_probs=189.6
Q ss_pred ceecccCcEEEEEEEEeCC---eEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecCCC
Q 007892 215 NLLGQGGFGYVHKGVLTNG---KVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNK 290 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~~~~g---~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g 290 (586)
++||+|+||.||+|...++ ..+++|.++... ......|.+|+.+++.++||||++++++|......++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999986543 356677766543 234568999999999999999999999999999999999999999
Q ss_pred cHHHHhcCCC--CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC-Ccc
Q 007892 291 TLEFHLHGKD--RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD-THV 367 (586)
Q Consensus 291 sL~~~l~~~~--~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~-~~~ 367 (586)
+|.++++... ...+.+..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 9999997542 23466777889999999999999998 89999999999999999999999999986432211 112
Q ss_pred cccccccccccCcccccC-------CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCCh
Q 007892 368 STRVMGTFGYLAPEYASS-------GKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 439 (586)
Q Consensus 368 ~~~~~gt~~y~aPE~~~~-------~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (586)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||...... ++....+. +..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~~-----~~~ 226 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR------EVLNHVIK-----DQQ 226 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHh-----hcc
Confidence 234568899999998853 245789999999999999997 56788643321 11111111 111
Q ss_pred hhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 007892 440 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484 (586)
Q Consensus 440 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~ 484 (586)
..+.++.+. ......+.+++..|+ .+|.+||++.||++.|.
T Consensus 227 ~~~~~~~~~---~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 227 VKLFKPQLE---LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cccCCCccC---CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 112222222 112345777888899 67999999999999884
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=310.79 Aligned_cols=249 Identities=26% Similarity=0.388 Sum_probs=194.5
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc-----hhHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCee
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-----QGEREFQAEIEIISQVHHRHLVSLVGYCTF--GSQR 280 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~-----~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~--~~~~ 280 (586)
.+|...+.||+|+||.||++... +++.||+|++..... .....+.+|+.++++++|+||+++++++.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888999999999999999964 588999999864321 223468889999999999999999998875 3567
Q ss_pred EEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccccc
Q 007892 281 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 360 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~ 360 (586)
++++||+++++|.+++.... .+++...+.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 89999999999999986543 488999999999999999999987 9999999999999999999999999998754
Q ss_pred CCCCC--cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCC
Q 007892 361 LDTDT--HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGN 438 (586)
Q Consensus 361 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (586)
..... .......++..|+|||++.+..++.++|||||||++|||++|+.||....... . .... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~-----~-~~~~----~~~~- 225 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA-----A-IFKI----ATQP- 225 (266)
T ss_pred ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH-----H-HHHH----hcCC-
Confidence 32111 11123458899999999998889999999999999999999999997543210 0 0000 0000
Q ss_pred hhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 439 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 439 ~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
....++......+..++ .|+..+|.+||+|+||++
T Consensus 226 -------~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 -------TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred -------CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 00112222334455666 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=317.40 Aligned_cols=266 Identities=25% Similarity=0.361 Sum_probs=205.1
Q ss_pred HhcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhc--CCCCcceEEEEEEeC----Cee
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQV--HHRHLVSLVGYCTFG----SQR 280 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l--~Hpniv~l~g~~~~~----~~~ 280 (586)
...+..+.+.||+|.||+||+|.++ |..||||++... +++.+.+|.+|++.+ +|+||+.+++.-..+ .++
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hhheeEEEEEecCccccceeecccc-CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 3456788899999999999999995 688999998643 467888999998864 899999999876543 378
Q ss_pred EEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhc-----CCCcEEecCCCCceeEeCCCCCeEEeecc
Q 007892 281 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED-----CQPKIIHRDIKSANILLDDSFEAKVADFG 355 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~-----~~~~ivHrDIk~~NILl~~~~~~kl~DFG 355 (586)
|||.+|.++|+|.++|.. ..++-...++++..+|.||+|||.. ..|.|.|||||+.||||.+++.+.|+|+|
T Consensus 285 wLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 999999999999999965 4589999999999999999999964 57899999999999999999999999999
Q ss_pred cccccCCCCC---cccccccccccccCcccccCCC----C--CCcchHHHHHHHHHHHHhC----------CCCCCCCCc
Q 007892 356 LAKHSLDTDT---HVSTRVMGTFGYLAPEYASSGK----L--TEKSDVFSFGVLLLELITG----------FRPFDKADT 416 (586)
Q Consensus 356 la~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~----~--s~ksDVwSlGvvL~elltG----------~~Pf~~~~~ 416 (586)
||........ ...+..+||-.|||||++.... + -..+||||||.||||+... +.||.+.-+
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 9976543321 2235578999999999996432 1 1368999999999998752 457765443
Q ss_pred ccchhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 417 FADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 417 ~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
.+.+..+..+ .+-...++..++.+. .....+..|.++++.||..+|.-|-|+=-|-+.|....
T Consensus 442 -~DPs~eeMrk-----VVCv~~~RP~ipnrW--~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 442 -SDPSFEEMRK-----VVCVQKLRPNIPNRW--KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred -CCCCHHHHhc-----ceeecccCCCCCccc--ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 2223322211 111222222222222 24567888999999999999999999988888887654
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=309.31 Aligned_cols=251 Identities=27% Similarity=0.465 Sum_probs=202.4
Q ss_pred CccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCch--hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 210 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ--GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~--~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
+|...+.||+|+||.||+|... +++.|++|.++..... ....+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778899999999999999965 6889999998765443 567889999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 366 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 366 (586)
+++++|.+++... ..+++..+..|+.+++.||.|||+. +|+|+||+++||++++++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 81 CSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 9999999998654 3478999999999999999999998 9999999999999999999999999999876443332
Q ss_pred ccc---cccccccccCcccccCCC---CCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChh
Q 007892 367 VST---RVMGTFGYLAPEYASSGK---LTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 440 (586)
Q Consensus 367 ~~~---~~~gt~~y~aPE~~~~~~---~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (586)
... ...++..|++||++.+.. ++.++||||||+++|||++|+.||...+. .|...+... .+.
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~-------~~~~~~~~~---~~~-- 223 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN-------EFQIMFHVG---AGH-- 223 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc-------hHHHHHHHh---cCC--
Confidence 211 356788999999998766 88999999999999999999999975431 111110000 000
Q ss_pred hhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 441 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 441 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
.+.+. ........+.+++.+|++.+|.+||++.|++.
T Consensus 224 ---~~~~~-~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 ---KPPIP-DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ---CCCCC-cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00011 11122456789999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=329.76 Aligned_cols=240 Identities=24% Similarity=0.327 Sum_probs=186.1
Q ss_pred ecccCcEEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHHHHHhc---CCCCcceEEEEEEeCCeeEEEEEecCC
Q 007892 217 LGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQV---HHRHLVSLVGYCTFGSQRLLVYEFVPN 289 (586)
Q Consensus 217 LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l---~Hpniv~l~g~~~~~~~~~lV~E~~~~ 289 (586)
||+|+||.||+|+.. +++.||||++..... .....+..|..++.++ +||||+++++++...+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999965 588999999864321 1223445677777665 699999999999999999999999999
Q ss_pred CcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcccc
Q 007892 290 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 369 (586)
Q Consensus 290 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 369 (586)
|+|..++... ..+++..+..++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++...... ....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~ 154 (330)
T cd05586 81 GELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTN 154 (330)
T ss_pred ChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCcc
Confidence 9999888654 3488999999999999999999998 99999999999999999999999999997543222 1234
Q ss_pred cccccccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhh
Q 007892 370 RVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLE 448 (586)
Q Consensus 370 ~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 448 (586)
..+||..|+|||++.+. .++.++|||||||+||||++|+.||...+.. ..... +..+.. .+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~------~~~~~-----i~~~~~------~~~ 217 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ------QMYRN-----IAFGKV------RFP 217 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH------HHHHH-----HHcCCC------CCC
Confidence 46799999999998754 4899999999999999999999999754321 11110 011110 000
Q ss_pred ccCHHHHHHHHHHHHHhhccCCCCCCC----HHHHHH
Q 007892 449 EYDSAEMTRMAACAAACIRHSARRRPR----MSQIVR 481 (586)
Q Consensus 449 ~~~~~~~~~l~~l~~~cl~~dp~~RPt----m~evl~ 481 (586)
.......+.+++.+||+.+|.+||+ +.|+++
T Consensus 218 --~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 218 --KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred --CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 0112356788999999999999995 555544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=313.28 Aligned_cols=254 Identities=25% Similarity=0.406 Sum_probs=198.4
Q ss_pred ccccceecccCcEEEEEEEEe----CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC------
Q 007892 211 FSEANLLGQGGFGYVHKGVLT----NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS------ 278 (586)
Q Consensus 211 f~~~~~LG~G~fG~Vyk~~~~----~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~------ 278 (586)
|.+.+.||+|+||.||+|.+. +++.||||+++... ....+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566789999999999999864 36889999987542 233567889999999999999999999886542
Q ss_pred eeEEEEEecCCCcHHHHhcCC----CCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeec
Q 007892 279 QRLLVYEFVPNKTLEFHLHGK----DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADF 354 (586)
Q Consensus 279 ~~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DF 354 (586)
..++++||+++|+|..++... ....+++...+.++.|++.||+|||+. +|+||||||+|||+++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 247899999999998877432 122478889999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCCc-ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhh
Q 007892 355 GLAKHSLDTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQ 432 (586)
Q Consensus 355 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 432 (586)
|+++........ ......++..|++||.+....++.++|||||||++|||++ |+.||...+. ..+..+..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~~~----- 229 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNYLI----- 229 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHHHH-----
Confidence 999865332211 1122345678999999998889999999999999999999 8899875432 11111110
Q ss_pred cccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 433 GLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 433 ~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
.+.. + .........+.+++.+|++.+|.+||++.||++.|++.
T Consensus 230 ---~~~~-------~-~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 230 ---KGNR-------L-KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ---cCCc-------C-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0000 0 11122345799999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=319.90 Aligned_cols=255 Identities=28% Similarity=0.454 Sum_probs=200.7
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCe----EEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGK----VVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 281 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~----~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~ 281 (586)
.++|+..+.||+|+||.||+|++. +|. .||+|.+..... ....++.+|+.++.+++|+||++++|+|... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 356788899999999999999864 343 578998875433 2234788999999999999999999999754 567
Q ss_pred EEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccC
Q 007892 282 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 361 (586)
Q Consensus 282 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~ 361 (586)
+++||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++...
T Consensus 85 ~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccccc
Confidence 9999999999999986543 3488999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCc-ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCCh
Q 007892 362 DTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 439 (586)
Q Consensus 362 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (586)
..... ......++..|+|||++.+..++.++|||||||++|||++ |..||..... ....++.. .+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~---~~~~~~~~--------~~~~ 229 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT---REIPDLLE--------KGER 229 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH--------CCCC
Confidence 32221 1122345778999999998899999999999999999997 9999965432 11222211 1100
Q ss_pred hhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 440 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 440 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
+ .........+.+++..|+..+|++||+|.+|++.|+..
T Consensus 230 -------~-~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 230 -------L-PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred -------C-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 01112234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=315.15 Aligned_cols=259 Identities=25% Similarity=0.375 Sum_probs=203.7
Q ss_pred CHHHHHHHhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEEe-
Q 007892 200 TYEELKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTF- 276 (586)
Q Consensus 200 ~~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~- 276 (586)
++.++..+.+.|+..+.||.|+||.||+|... +++.||+|.+.... ....++..|+.++.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 34556667788999999999999999999964 57899999986543 2345788899999998 69999999999853
Q ss_pred -----CCeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEE
Q 007892 277 -----GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKV 351 (586)
Q Consensus 277 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl 351 (586)
....+++|||+++|+|.+++.......+++..++.++.|++.||.|||+. +|+|+||||+||++++++.++|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEE
Confidence 45789999999999999988765555688888999999999999999998 9999999999999999999999
Q ss_pred eecccccccCCCCCcccccccccccccCccccc-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhh
Q 007892 352 ADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWA 426 (586)
Q Consensus 352 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~ 426 (586)
+|||++........ ......|++.|+|||.+. ...++.++|||||||++|||++|..||.............
T Consensus 163 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~-- 239 (282)
T cd06636 163 VDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP-- 239 (282)
T ss_pred eeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHh--
Confidence 99999875432221 123356899999999875 3468889999999999999999999996543211100000
Q ss_pred hHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 427 KPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 427 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
...... .........+.+++.+||+.||.+||++.||++
T Consensus 240 --------------~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 240 --------------RNPPPK--LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred --------------hCCCCC--CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000000 011123457899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=355.04 Aligned_cols=259 Identities=22% Similarity=0.339 Sum_probs=199.6
Q ss_pred HHhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCee
Q 007892 206 IATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTF--GSQR 280 (586)
Q Consensus 206 ~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~--~~~~ 280 (586)
...++|.+.+.||+|+||+||++... .++.||+|.+.... ......|..|+.+|.+|+|||||+++++|.. ....
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34478999999999999999999965 57789999986532 2334678899999999999999999998865 3568
Q ss_pred EEEEEecCCCcHHHHhcCC--CCCCCChHHHHHHHHHHHHHhHhhhhcCC----CcEEecCCCCceeEeCCC--------
Q 007892 281 LLVYEFVPNKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDCQ----PKIIHRDIKSANILLDDS-------- 346 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~----~~ivHrDIk~~NILl~~~-------- 346 (586)
+|||||+++++|.++|... ....+++..++.|+.||+.||.|||..+. .+||||||||+||||+.+
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 8999999999999988642 22458999999999999999999998521 259999999999999642
Q ss_pred ---------CCeEEeecccccccCCCCCcccccccccccccCcccccC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 007892 347 ---------FEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVLLLELITGFRPFDKAD 415 (586)
Q Consensus 347 ---------~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvvL~elltG~~Pf~~~~ 415 (586)
..+||+|||+++..... .......||+.|+|||++.+ ..++.++||||||||||||++|+.||....
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~--s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIE--SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred ccccccCCCCceEEccCCcccccccc--ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 34899999999865322 12234579999999999854 458999999999999999999999997543
Q ss_pred cccchhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHhc
Q 007892 416 TFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR--ALEG 485 (586)
Q Consensus 416 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~--~L~~ 485 (586)
.. ..+... + ..+ +.+. .......+.+|+..||+.+|.+||++.|++. .|..
T Consensus 248 ~~-----~qli~~-l----k~~-------p~lp--i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~ 300 (1021)
T PTZ00266 248 NF-----SQLISE-L----KRG-------PDLP--IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN 300 (1021)
T ss_pred cH-----HHHHHH-H----hcC-------CCCC--cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhh
Confidence 21 111110 0 000 0000 0112356889999999999999999999984 4543
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=314.03 Aligned_cols=265 Identities=24% Similarity=0.355 Sum_probs=204.7
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
++|+..+.||+|+||.||+|... +++.||||.++... ......+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 46888999999999999999976 57899999986532 2234678999999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 365 (586)
|++++.|..++... ..+++.++..++.+++.||.|||+. +|+|+||+++||++++++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 81 YVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred cCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 99998887666432 3489999999999999999999998 999999999999999999999999999987654433
Q ss_pred cccccccccccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHH--------hhcccC
Q 007892 366 HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFL--------AQGLAD 436 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~--------~~~~~~ 436 (586)
.......++..|+|||++.+. .++.++||||||++||+|++|+.||......+ .+. .....+ .....+
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID--QLY-LIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH-HHHHHhCCCCHHHhhhcccC
Confidence 233446788999999999887 88999999999999999999999997543211 110 000000 000000
Q ss_pred CChh-----hhhchh-hh-ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 437 GNFD-----ALVDQK-LE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 437 ~~~~-----~l~d~~-l~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
..+. ...+.. .. .++......+.+++.+||..+|++||++++|++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000 000000 01 222334677999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=309.20 Aligned_cols=253 Identities=22% Similarity=0.366 Sum_probs=202.3
Q ss_pred CccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCeeEEEE
Q 007892 210 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTF--GSQRLLVY 284 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~--~~~~~lV~ 284 (586)
+|+..+.||.|+||.||++... +++.||+|.+.... ......+..|++++++++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4778899999999999999854 67899999986532 2334578899999999999999999998864 45678999
Q ss_pred EecCCCcHHHHhcCC--CCCCCChHHHHHHHHHHHHHhHhhhhcC--CCcEEecCCCCceeEeCCCCCeEEeeccccccc
Q 007892 285 EFVPNKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDC--QPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 360 (586)
Q Consensus 285 E~~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~--~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~ 360 (586)
||+++++|.+++... ....+++..++.++.+++.||.|||..+ ..+|+|+||||+|||+++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999988643 2346899999999999999999999322 239999999999999999999999999999875
Q ss_pred CCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChh
Q 007892 361 LDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 440 (586)
Q Consensus 361 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (586)
..... ......++..|++||++....++.++||||||+++|+|++|+.||...+. ..+... +..+.
T Consensus 161 ~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~--------~~~~~-- 226 (265)
T cd08217 161 GHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQLASK--------IKEGK-- 226 (265)
T ss_pred cCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---HHHHHH--------HhcCC--
Confidence 43322 12335689999999999988899999999999999999999999976542 111111 11111
Q ss_pred hhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 441 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 441 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
...........+.+++.+|++.+|.+||++.+|++.
T Consensus 227 ------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 227 ------FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 112333445678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=314.41 Aligned_cols=266 Identities=22% Similarity=0.333 Sum_probs=200.3
Q ss_pred CccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 210 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
+|+..+.||.|+||.||+|+.. +++.||||.++... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 5888999999999999999965 68899999986543 22235788999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 366 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 366 (586)
+. ++|..++.......+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence 95 6888888766566789999999999999999999998 999999999999999999999999999876432221
Q ss_pred ccccccccccccCcccccCCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhh------c---c--
Q 007892 367 VSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQ------G---L-- 434 (586)
Q Consensus 367 ~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~------~---~-- 434 (586)
......++..|+|||++.+.. ++.++|||||||++|||+||+.||...... ..+.......-.. . +
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRIFRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCChhhhhhhhHHHH
Confidence 223345788999999887544 688999999999999999999999754421 1111111000000 0 0
Q ss_pred cCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 435 ADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 435 ~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
....+.......+..........+.+++.+|++.||.+||++.|++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000000000111111111223567899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=316.91 Aligned_cols=196 Identities=23% Similarity=0.329 Sum_probs=159.7
Q ss_pred cceecccCcEEEEEEEEeC---CeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCeeEEEEEecC
Q 007892 214 ANLLGQGGFGYVHKGVLTN---GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF--GSQRLLVYEFVP 288 (586)
Q Consensus 214 ~~~LG~G~fG~Vyk~~~~~---g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~--~~~~~lV~E~~~ 288 (586)
..+||+|+||.||+|+..+ +..||+|.+.... ....+.+|+++|++++||||+++++++.. +...++||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 3689999999999999653 4789999986543 23467889999999999999999998854 457789999997
Q ss_pred CCcHHHHhcCC-------CCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEe----CCCCCeEEeecccc
Q 007892 289 NKTLEFHLHGK-------DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL----DDSFEAKVADFGLA 357 (586)
Q Consensus 289 ~gsL~~~l~~~-------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl----~~~~~~kl~DFGla 357 (586)
+ +|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 666655321 123478888999999999999999998 99999999999999 56678999999999
Q ss_pred cccCCCCCc--ccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 007892 358 KHSLDTDTH--VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKAD 415 (586)
Q Consensus 358 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~ 415 (586)
+........ ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 865433221 1234578999999999876 458999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=310.30 Aligned_cols=250 Identities=22% Similarity=0.376 Sum_probs=202.8
Q ss_pred CccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 210 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
+|...+.||+|+||.||++... +|..||+|.+.... ......+.+|++++++++|+||+++++.|......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999975 57899999986532 23345788999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCC-CeEEeecccccccCCCCC
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF-EAKVADFGLAKHSLDTDT 365 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~-~~kl~DFGla~~~~~~~~ 365 (586)
+++++|.+++.......+++..++.++.|++.||.|||+. +|+|+||||+|||+++++ .+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 9999999999765555689999999999999999999998 999999999999998875 469999999976543221
Q ss_pred cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhch
Q 007892 366 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQ 445 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 445 (586)
......|++.|+|||++.+..++.++|||||||++|||++|+.||...+. .++..... .+.+
T Consensus 158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~-----~~~~------ 219 (257)
T cd08225 158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKIC-----QGYF------ 219 (257)
T ss_pred -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHh-----cccC------
Confidence 22334688999999999888899999999999999999999999965432 11211111 1111
Q ss_pred hhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 446 KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 446 ~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
..........+.+++.+|++.+|.+||++.||++.
T Consensus 220 --~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 220 --APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred --CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11112233568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=306.64 Aligned_cols=252 Identities=25% Similarity=0.374 Sum_probs=208.2
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
++|+..+.||+|+||.||+++.. +++.|+||++..... .....+.+|+.++.+++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 46888999999999999999976 489999999876544 3457899999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhh-cCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHE-DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 365 (586)
+++++|.+++... ..+++..++.++.|+++||+|||+ . +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 81 MDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 9999999999654 458999999999999999999999 7 999999999999999999999999999986543322
Q ss_pred cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhch
Q 007892 366 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQ 445 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 445 (586)
. .....++..|+|||.+....++.++||||||+++|+|++|+.||..........+..+. ...
T Consensus 156 ~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~----------------~~~ 218 (264)
T cd06623 156 Q-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI----------------CDG 218 (264)
T ss_pred c-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHH----------------hcC
Confidence 2 23456889999999999889999999999999999999999999765421111111111 111
Q ss_pred hhhccCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 446 KLEEYDSA-EMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 446 ~l~~~~~~-~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
........ ....+.+++.+|+..+|.+||++.||++.
T Consensus 219 ~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 219 PPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11122222 45679999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=308.47 Aligned_cols=250 Identities=24% Similarity=0.340 Sum_probs=196.7
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC-----chhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--Cee
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-----GQGEREFQAEIEIISQVHHRHLVSLVGYCTFG--SQR 280 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-----~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~--~~~ 280 (586)
++|...+.||+|+||.||+|... +++.||||.+.... ......+.+|+.++.+++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57888999999999999999965 58899999885322 12235788899999999999999999988763 467
Q ss_pred EEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccccc
Q 007892 281 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 360 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~ 360 (586)
++||||+++++|.+++... ..+++...++++.|++.||+|||+. +|+|+||||+|||++.++.+||+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 8999999999999998644 3478888999999999999999998 8999999999999999999999999998754
Q ss_pred CCCCC--cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCC
Q 007892 361 LDTDT--HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGN 438 (586)
Q Consensus 361 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (586)
..... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||....... .. ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-----~~-~~~~-------- 222 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-----AI-FKIA-------- 222 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-----HH-HHHh--------
Confidence 32111 11233568899999999988889999999999999999999999996532210 00 0000
Q ss_pred hhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 439 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 439 ~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
..+.....+......+.+++.+|+. +|++||++.||++.
T Consensus 223 ----~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 223 ----TQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred ----cCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0000112233445667888899985 89999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=313.47 Aligned_cols=267 Identities=19% Similarity=0.310 Sum_probs=197.5
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~-~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
++|+..+.||+|+||.||+|... +++.||||.+...... ....+.+|++++++++|+||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67889999999999999999975 6889999998654322 234577899999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 366 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 366 (586)
+.+ +|.+++..... .+.+.....++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 85 ~~~-~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~ 158 (291)
T cd07844 85 LDT-DLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS-K 158 (291)
T ss_pred CCC-CHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC-c
Confidence 985 89888865443 588999999999999999999998 99999999999999999999999999987542211 1
Q ss_pred ccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhh------hHHHhhc-----c
Q 007892 367 VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWA------KPFLAQG-----L 434 (586)
Q Consensus 367 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~------~~~~~~~-----~ 434 (586)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||............-|. ...+... .
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 1222356889999999875 45889999999999999999999999754421100000000 0000000 0
Q ss_pred cCCChhhhhchhhhcc--CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 435 ADGNFDALVDQKLEEY--DSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 435 ~~~~~~~l~d~~l~~~--~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
............+... .......+.+++.+||+.+|.+||++.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000000000111100 0111256789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=317.41 Aligned_cols=268 Identities=25% Similarity=0.373 Sum_probs=201.3
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCch--hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ--GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~--~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
++|+..+.||+|+||.||+|... +++.||+|++...... ....+.+|++++.+++|+||++++++|..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999976 5889999998653222 24578899999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 365 (586)
|++++.|..+.... ..++|.+++.++.|+++||+|||+. +|+|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 154 (286)
T cd07846 81 FVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 154 (286)
T ss_pred cCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence 99999998877543 2389999999999999999999998 99999999999999999999999999998654332
Q ss_pred cccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccc-hhhhhhhhHHHhh---cccCC-Ch
Q 007892 366 HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFAD-DSMVDWAKPFLAQ---GLADG-NF 439 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~-~~~~~~~~~~~~~---~~~~~-~~ 439 (586)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ..+..+...+... ..... ..
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence 22234568899999999875 4578899999999999999999999965432110 0001100000000 00000 00
Q ss_pred hhhhchhh------hccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 440 DALVDQKL------EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 440 ~~l~d~~l------~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.....+.. ..........+.+++.+||+.+|.+||++.+|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00000000 00111234678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=314.85 Aligned_cols=265 Identities=24% Similarity=0.316 Sum_probs=201.1
Q ss_pred CccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCch-----hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEE
Q 007892 210 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ-----GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~-----~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV 283 (586)
+|...+.||+|+||.||+|... +++.||||.++..... ....+..|++++.+++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777899999999999999965 6889999999765332 234677899999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCC
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 363 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 363 (586)
|||+ +++|..++.... ..+++..++.++.|+++||.|||++ +|+|+||||+|||++.++.+||+|||+++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9999 999999997644 3589999999999999999999998 9999999999999999999999999999865433
Q ss_pred CCcccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHH-------Hhh--c
Q 007892 364 DTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPF-------LAQ--G 433 (586)
Q Consensus 364 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~-------~~~--~ 433 (586)
.. ......++..|+|||.+.+ ..++.++|||||||++|||++|..||....... .+......+ +.. .
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 156 NR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID--QLGKIFEALGTPTEENWPGVTS 232 (298)
T ss_pred Cc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH--HHHHHHHHcCCCchhhhhhccc
Confidence 22 1223456788999998854 467899999999999999999988876543211 110000000 000 0
Q ss_pred c-cCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 434 L-ADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 434 ~-~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
. ............+..........+.+++.+|++.+|.+||++.||++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0 000000000001111222345678999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=311.27 Aligned_cols=253 Identities=27% Similarity=0.397 Sum_probs=200.9
Q ss_pred HhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCC------
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGS------ 278 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~------ 278 (586)
.+++|+..+.||+|+||.||+|... +++.+++|.+..... ....+.+|+.++.++ +|+||++++++|....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4688999999999999999999975 578999999876543 346789999999999 6999999999997644
Q ss_pred eeEEEEEecCCCcHHHHhcCCC--CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccc
Q 007892 279 QRLLVYEFVPNKTLEFHLHGKD--RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGL 356 (586)
Q Consensus 279 ~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGl 356 (586)
..++||||+++++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999998886533 45689999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCcccccC-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHh
Q 007892 357 AKHSLDTDTHVSTRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLA 431 (586)
Q Consensus 357 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 431 (586)
+....... .......|+..|+|||++.. ..++.++|||||||+||+|++|+.||...... ..+...
T Consensus 160 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~------ 230 (275)
T cd06608 160 SAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--RALFKI------ 230 (275)
T ss_pred ceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--HHHHHh------
Confidence 87643322 12233568999999998753 34678999999999999999999999643321 111110
Q ss_pred hcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 432 QGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 432 ~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
..+... .+ .........+.+++.+||..||.+||++.||++
T Consensus 231 ---~~~~~~-----~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 231 ---PRNPPP-----TL-KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ---hccCCC-----CC-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 001000 00 112224567889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=310.69 Aligned_cols=254 Identities=24% Similarity=0.400 Sum_probs=199.1
Q ss_pred CccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCch----------hHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 007892 210 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ----------GEREFQAEIEIISQVHHRHLVSLVGYCTFGS 278 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~----------~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~ 278 (586)
+|...+.||.|+||.||+|... +|+.||||.++..... ..+.+.+|+.++.+++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667889999999999999854 6889999988542111 1235788999999999999999999999999
Q ss_pred eeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccc
Q 007892 279 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 358 (586)
Q Consensus 279 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~ 358 (586)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 999999999999999998665 3588999999999999999999998 99999999999999999999999999997
Q ss_pred ccCCCCCc-ccccccccccccCcccccCCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhccc
Q 007892 359 HSLDTDTH-VSTRVMGTFGYLAPEYASSGK--LTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLA 435 (586)
Q Consensus 359 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 435 (586)
........ ......|+..|+|||++.... ++.++||||||+++|||++|..||...+.. ..+.+. .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~----~----- 225 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI--AAMFKL----G----- 225 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH--HHHHHh----h-----
Confidence 64332211 123456889999999987654 889999999999999999999999643321 011100 0
Q ss_pred CCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 436 DGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 436 ~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.......++. .........+.+++.+|++.+|.+||++.||++.
T Consensus 226 ~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 226 NKRSAPPIPP---DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ccccCCcCCc---cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 0000000100 1112335678899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=309.55 Aligned_cols=253 Identities=25% Similarity=0.420 Sum_probs=205.0
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
++|+..+.||+|+||.||++... +++.||+|.+..... ....++.+|++++++++||||++++++|...+..++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36778899999999999999976 588999999876533 3456789999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhh-cCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHE-DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 365 (586)
+++++|.+++.... ..+++..+.+++.|++.+|+|||+ . +++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 81 MDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred cCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 99999999987543 458889999999999999999998 6 999999999999999999999999999875432211
Q ss_pred cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhch
Q 007892 366 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQ 445 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 445 (586)
....++..|++||++.+..++.++||||||+++|+|++|+.||...+.. .....+.....+ ..
T Consensus 157 ---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~-------------~~ 219 (265)
T cd06605 157 ---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP-PDGIFELLQYIV-------------NE 219 (265)
T ss_pred ---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-cccHHHHHHHHh-------------cC
Confidence 1266889999999999889999999999999999999999999755321 112222222111 11
Q ss_pred hhhccCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 446 KLEEYDSA-EMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 446 ~l~~~~~~-~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
........ ....+.+++.+|+..+|.+||++.|++..
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 220 PPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 01111111 45568899999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=318.76 Aligned_cols=248 Identities=21% Similarity=0.328 Sum_probs=200.0
Q ss_pred ccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecCC
Q 007892 211 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPN 289 (586)
Q Consensus 211 f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~ 289 (586)
|.....||+|+||.||++... +++.||+|.+..........+.+|+.++..++||||+++++++..++..++|+||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 333457999999999999964 6889999999765555566788999999999999999999999999999999999999
Q ss_pred CcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcccc
Q 007892 290 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 369 (586)
Q Consensus 290 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 369 (586)
++|..++.. ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....... ....
T Consensus 103 ~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~ 175 (297)
T cd06659 103 GALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRK 175 (297)
T ss_pred CCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc-cccc
Confidence 999988743 3489999999999999999999998 99999999999999999999999999987543322 1223
Q ss_pred cccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhc
Q 007892 370 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEE 449 (586)
Q Consensus 370 ~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 449 (586)
...|+..|+|||++.+..++.++|||||||++|||++|+.||...... ....... ... .... .
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~~~~~~--------~~~-----~~~~-~ 238 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV---QAMKRLR--------DSP-----PPKL-K 238 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHh--------ccC-----CCCc-c
Confidence 456899999999999889999999999999999999999999754321 1111100 000 0000 0
Q ss_pred cCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 450 YDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 450 ~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
........+.+++.+|++.+|.+||++.+|++.
T Consensus 239 ~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 239 NAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 111223457889999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=317.09 Aligned_cols=255 Identities=20% Similarity=0.259 Sum_probs=202.0
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
++|+..+.||+|+||.||++... .++.||||.+..... .....+.+|++++..++|+||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888999999999999999965 478999999876532 22457889999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
||+++++|.+++... ..+++..+..++.+++.||.|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 81 EYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 999999999999654 3589999999999999999999998 99999999999999999999999999987421100
Q ss_pred --------------CcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHH
Q 007892 365 --------------THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFL 430 (586)
Q Consensus 365 --------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 430 (586)
........++..|+|||++....++.++|+|||||+||||++|..||...... ++.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~~~~~~~ 229 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ELFGQVI 229 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHH
Confidence 00112245788999999998888999999999999999999999999754321 1111110
Q ss_pred hhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 007892 431 AQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 485 (586)
Q Consensus 431 ~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~ 485 (586)
.+.. ..+. ........+.+++.+||+.+|.+||++.++.+.|+.
T Consensus 230 -----~~~~---~~~~---~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 230 -----SDDI---EWPE---GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred -----hccc---CCCC---ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 0000 0000 011234568999999999999999998777777764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=318.26 Aligned_cols=248 Identities=23% Similarity=0.361 Sum_probs=199.9
Q ss_pred ccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecCC
Q 007892 211 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPN 289 (586)
Q Consensus 211 f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~ 289 (586)
|.....||+|+||.||++... ++..||||.+..........+.+|+.++.+++|+||+++++.+..++..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 333467999999999999864 5889999998765555566789999999999999999999999999999999999999
Q ss_pred CcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcccc
Q 007892 290 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 369 (586)
Q Consensus 290 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 369 (586)
++|.+++.. ..+++.++..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++........ ...
T Consensus 104 ~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~ 176 (292)
T cd06658 104 GALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRK 176 (292)
T ss_pred CcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCc
Confidence 999998853 2488999999999999999999998 999999999999999999999999999875433221 223
Q ss_pred cccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhc
Q 007892 370 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEE 449 (586)
Q Consensus 370 ~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 449 (586)
...|+..|+|||++.+..++.++|||||||++|||++|+.||....... .+.. +. ..+...+.
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~~-----~~---------~~~~~~~~- 239 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ--AMRR-----IR---------DNLPPRVK- 239 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-----HH---------hcCCCccc-
Confidence 4568999999999988889999999999999999999999997543211 0000 00 00111111
Q ss_pred cCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 450 YDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 450 ~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
........+.+++..|+..+|.+||++.||++.
T Consensus 240 ~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 240 DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 111233467889999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=302.15 Aligned_cols=250 Identities=28% Similarity=0.425 Sum_probs=205.4
Q ss_pred CccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecC
Q 007892 210 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVP 288 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 288 (586)
+|...+.||+|+||.||++... +++.+++|++..........+.+|++++++++|+||+++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4677899999999999999975 688999999977655556789999999999999999999999999999999999999
Q ss_pred CCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCccc
Q 007892 289 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 368 (586)
Q Consensus 289 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 368 (586)
+++|.+++.... ..+++..+..++.+++.+|.|||+. +++|+||+|+||++++++.++|+|||++........ .
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 154 (253)
T cd05122 81 GGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R 154 (253)
T ss_pred CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence 999999986643 4589999999999999999999997 999999999999999999999999999986544322 3
Q ss_pred ccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhh
Q 007892 369 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLE 448 (586)
Q Consensus 369 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 448 (586)
....++..|++||++....++.++||||||+++|+|++|+.||....... ...... ......+
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~--------~~~~~~~------ 217 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK---ALFKIA--------TNGPPGL------ 217 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH---HHHHHH--------hcCCCCc------
Confidence 44568899999999998889999999999999999999999997543210 000000 0000000
Q ss_pred ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 449 EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 449 ~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.........+.+++.+|++.+|.+||++.||++.
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 218 RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred CcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0111124578999999999999999999999863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=323.70 Aligned_cols=263 Identities=21% Similarity=0.306 Sum_probs=196.4
Q ss_pred HhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeC------
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFG------ 277 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~------ 277 (586)
..++|...+.||+|+||.||+|... +++.||||++..... .....+.+|+.+|++++|+||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4578999999999999999999964 678999999865422 2335677899999999999999999987543
Q ss_pred CeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccc
Q 007892 278 SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 357 (586)
Q Consensus 278 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla 357 (586)
...++++|++ +++|..++.. ..+++..+..++.|++.||.|||+. +|+||||||+||||++++.+||+|||++
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccc
Confidence 3568999988 7889887753 3489999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhH------HH
Q 007892 358 KHSLDTDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKP------FL 430 (586)
Q Consensus 358 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~------~~ 430 (586)
+..... .....|+..|+|||++.+ ..++.++|||||||+||||++|+.||...+.. ..+..+... .+
T Consensus 166 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~ 239 (343)
T cd07878 166 RQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI--DQLKRIMEVVGTPSPEV 239 (343)
T ss_pred eecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCCHHH
Confidence 865332 234568999999999876 56899999999999999999999999764421 111111000 00
Q ss_pred hhcccCCChhhhhc-------hhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 431 AQGLADGNFDALVD-------QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 431 ~~~~~~~~~~~l~d-------~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
...+........+. ..+..........+.+++.+|++.||.+||++.|++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000000 00000001122357899999999999999999999964
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=309.69 Aligned_cols=247 Identities=27% Similarity=0.399 Sum_probs=201.2
Q ss_pred CccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEec
Q 007892 210 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 287 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 287 (586)
-|+..+.||+|+||.||+|... +++.||||.+.... ......+.+|+.++.+++|+||+++++++..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3667889999999999999864 68899999986543 233457889999999999999999999999999999999999
Q ss_pred CCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcc
Q 007892 288 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 367 (586)
Q Consensus 288 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 367 (586)
++++|..++.. ..+++..+..++.+++.+|.|||+. +++|+||||+||++++++.++|+|||++....... ..
T Consensus 85 ~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~ 157 (277)
T cd06641 85 GGGSALDLLEP---GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IK 157 (277)
T ss_pred CCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccch-hh
Confidence 99999998854 3489999999999999999999998 99999999999999999999999999987653322 12
Q ss_pred cccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhh
Q 007892 368 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 447 (586)
Q Consensus 368 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 447 (586)
.....++..|++||++.+..++.++|||||||++|+|++|..||...... .+... + ..+. .
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~-~----~~~~--------~ 218 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM------KVLFL-I----PKNN--------P 218 (277)
T ss_pred hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH------HHHHH-H----hcCC--------C
Confidence 23346888999999999888999999999999999999999999653321 11100 0 0110 0
Q ss_pred hccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 448 EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 448 ~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
..........+.+++.+|++.+|.+||++.++++.
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 219 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11222334568899999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=310.06 Aligned_cols=247 Identities=24% Similarity=0.437 Sum_probs=199.6
Q ss_pred CccccceecccCcEEEEEEEE-eCCeEEEEEEeccCC-chhHHHHHHHHHHHHhcC---CCCcceEEEEEEeCCeeEEEE
Q 007892 210 NFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGS-GQGEREFQAEIEIISQVH---HRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~---Hpniv~l~g~~~~~~~~~lV~ 284 (586)
.|+..+.||+|+||.||+|.. .+++.||||.++... .....++.+|+.++++++ |+|+++++++|..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999996 468999999986542 334567889999999997 999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
||+++++|.+++... .+++...+.++.+++.||.|||+. +|+|+||+|+||++++++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 82 EYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred ecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 999999999988543 589999999999999999999998 99999999999999999999999999998764433
Q ss_pred CcccccccccccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhh
Q 007892 365 THVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 443 (586)
Q Consensus 365 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 443 (586)
. ......|+..|+|||++.++ .++.++|||||||++|+|++|..||....... ...+ +... .
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~---~~~~--------~~~~-----~ 218 (277)
T cd06917 156 S-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR---AMML--------IPKS-----K 218 (277)
T ss_pred c-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh---hhhc--------cccC-----C
Confidence 2 22335689999999998754 46899999999999999999999997543211 1110 0000 0
Q ss_pred chhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 444 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 444 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
.+.+.. ......+.+++.+|++.+|.+||++.|+++
T Consensus 219 ~~~~~~--~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 219 PPRLED--NGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCCCc--ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 011110 013457889999999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=307.44 Aligned_cols=258 Identities=26% Similarity=0.333 Sum_probs=202.4
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--CeeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFG--SQRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~--~~~~lV~ 284 (586)
++|...+.||.|++|.||++... +++.||+|.+..... .....+.+|++++++++|+||++++++|... +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888999999999999999974 588999999875433 3456789999999999999999999998653 4689999
Q ss_pred EecCCCcHHHHhcC--CCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCC
Q 007892 285 EFVPNKTLEFHLHG--KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 285 E~~~~gsL~~~l~~--~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 362 (586)
||+++++|.+++.. .....+++.....++.|++.||.|||+. +++|+||+++||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999887653 2234578889999999999999999998 999999999999999999999999999875432
Q ss_pred CCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcc--cchhhhhhhhHHHhhcccCCChh
Q 007892 363 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTF--ADDSMVDWAKPFLAQGLADGNFD 440 (586)
Q Consensus 363 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 440 (586)
.. .....++..|++||.+.+..++.++|||||||++|||++|..||...... ....+..|... ....
T Consensus 158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------~~~~ 226 (287)
T cd06621 158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN--------MPNP 226 (287)
T ss_pred cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc--------CCch
Confidence 22 12345788999999999899999999999999999999999999865321 11122222111 0000
Q ss_pred hhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 441 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 441 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.+.+.. .........+.+++.+||+.+|.+||++.||++.
T Consensus 227 ~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 227 ELKDEP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred hhccCC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 110000 0011234678999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=299.17 Aligned_cols=251 Identities=24% Similarity=0.373 Sum_probs=201.3
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc-----h---hHHHHHHHHHHHHhcC-CCCcceEEEEEEeC
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-----Q---GEREFQAEIEIISQVH-HRHLVSLVGYCTFG 277 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~-----~---~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~ 277 (586)
-++|...+.||+|..+.|-++..+ +|+.+|+|++..... + -.+.-++|+.||+++. ||||+.|.++++..
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 356778899999999999998854 688999999854321 1 1234567999999985 99999999999999
Q ss_pred CeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccc
Q 007892 278 SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 357 (586)
Q Consensus 278 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla 357 (586)
...++|+|.|+.|.|.++|...- .+++.+..+|+.|+..|++|||.+ .||||||||+|||+|++.++||+|||++
T Consensus 96 sF~FlVFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred chhhhhhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEecccee
Confidence 99999999999999999996543 488999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCcccccCC------CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHh
Q 007892 358 KHSLDTDTHVSTRVMGTFGYLAPEYASSG------KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLA 431 (586)
Q Consensus 358 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 431 (586)
+.+... ......|||++|+|||.+.+. .|+...|+|++||++|-|+.|..||--.... +..
T Consensus 171 ~~l~~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm-----------lML 237 (411)
T KOG0599|consen 171 CQLEPG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM-----------LML 237 (411)
T ss_pred eccCCc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH-----------HHH
Confidence 987543 345678999999999988653 4778999999999999999999998422110 011
Q ss_pred hcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 432 QGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 432 ~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
+.+.+|.+.-- . ..-.+......+++.+||+.||.+|-|.+|+++
T Consensus 238 R~ImeGkyqF~-s----peWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 238 RMIMEGKYQFR-S----PEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHHhcccccC-C----cchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 12222322110 0 111234566889999999999999999999985
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=299.82 Aligned_cols=250 Identities=25% Similarity=0.436 Sum_probs=197.9
Q ss_pred ccccceecccCcEEEEEEEEe-CCeEEEEEEeccC-CchhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeeEEEEEec
Q 007892 211 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG-SGQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLLVYEFV 287 (586)
Q Consensus 211 f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~-~~~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~~~~~lV~E~~ 287 (586)
.+.+..||.|..|.||+++.. .|...|||.+... +......++..++++.+-+ +|.||+++|||..+...++.||.|
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 444578999999999999965 5899999999664 3444467788888888776 999999999999999999999998
Q ss_pred CCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcc
Q 007892 288 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 367 (586)
Q Consensus 288 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 367 (586)
..+++.+|..-. ..+++.-+-++...+++||.||.+++ +|||||+||+|||||+.|++||||||++..+.+...+
T Consensus 174 -s~C~ekLlkrik-~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh- 248 (391)
T KOG0983|consen 174 -STCAEKLLKRIK-GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH- 248 (391)
T ss_pred -HHHHHHHHHHhc-CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccccc-
Confidence 445666665433 34777777789999999999999986 9999999999999999999999999999887666554
Q ss_pred cccccccccccCcccccC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhc
Q 007892 368 STRVMGTFGYLAPEYASS---GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 444 (586)
Q Consensus 368 ~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 444 (586)
++..|.+.|||||.+.- .+|+-++|||||||.|+||.||+.||...+..- +.+.. .+ + + ..
T Consensus 249 -trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF-e~ltk----vl-----n----~-eP 312 (391)
T KOG0983|consen 249 -TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF-EVLTK----VL-----N----E-EP 312 (391)
T ss_pred -ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH-HHHHH----HH-----h----c-CC
Confidence 45679999999999853 478999999999999999999999998755311 11100 00 0 0 01
Q ss_pred hhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 445 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 445 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
+.|. ........+++++..||++|+.+||...+++++
T Consensus 313 P~L~-~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 313 PLLP-GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCCC-cccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 2222 222256779999999999999999999998864
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=312.47 Aligned_cols=244 Identities=28% Similarity=0.394 Sum_probs=200.4
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
++|++.+.||+|+||.||++... +++.||+|.+.... ......+.+|++++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888999999999999999965 58999999986532 223456889999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+|+||+|+||||++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 999999999998654 3588999999999999999999998 9999999999999999999999999999875433
Q ss_pred CcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhc
Q 007892 365 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 444 (586)
Q Consensus 365 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 444 (586)
.....|++.|+|||.+.+...+.++||||||+++|+|++|+.||...... .... . +..+.
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~-------~-~~~~~------ 214 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI---QIYE-------K-ILEGK------ 214 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HHHH-------H-HhcCC------
Confidence 23456899999999998888999999999999999999999999754420 0000 0 00111
Q ss_pred hhhhccCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 007892 445 QKLEEYDSAEMTRMAACAAACIRHSARRRP-----RMSQIVR 481 (586)
Q Consensus 445 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RP-----tm~evl~ 481 (586)
. .++......+.+++.+||+.+|.+|+ ++.|+++
T Consensus 215 --~-~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 215 --V-RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred --c-cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 0 12222346788999999999999999 6666654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=310.50 Aligned_cols=253 Identities=25% Similarity=0.385 Sum_probs=206.3
Q ss_pred HhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEE
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
..++|+..+.||+|+||.||+|... +++.|++|.++.... ....+.+|++++.+++|+||+++++++......++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4567888899999999999999976 688999999976544 46678899999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 365 (586)
|+++++|.+++.... ..+++..+..++.+++.||.|||+. +|+|+||+|+||+++.++.+||+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~- 170 (286)
T cd06614 96 YMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK- 170 (286)
T ss_pred ccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccch-
Confidence 999999999997654 3699999999999999999999997 99999999999999999999999999987543222
Q ss_pred cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhch
Q 007892 366 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQ 445 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 445 (586)
.......++..|++||++.+..++.++|||||||+||+|++|+.||...+... ....+. ......+
T Consensus 171 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~--~~~~~~---------~~~~~~~--- 236 (286)
T cd06614 171 SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR--ALFLIT---------TKGIPPL--- 236 (286)
T ss_pred hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH---------hcCCCCC---
Confidence 12233457889999999988889999999999999999999999997544311 111100 0000000
Q ss_pred hhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 446 KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 446 ~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.........+.+++.+|++.+|.+||++.+|++.
T Consensus 237 ---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 237 ---KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred ---cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0111234568899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=312.90 Aligned_cols=258 Identities=22% Similarity=0.383 Sum_probs=207.5
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEec
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 287 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 287 (586)
++|...+.||+|+||.||++... +++.||+|.+........+.+.+|+.++++++||||++++++|...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 67888999999999999999854 67899999987554445567899999999999999999999999999999999999
Q ss_pred CCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcc
Q 007892 288 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 367 (586)
Q Consensus 288 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 367 (586)
++++|.+++... .+++.++..++.+++.||.|||+. +++||||||+||+++.++.+||+|||++........ .
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~ 171 (293)
T cd06647 99 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 171 (293)
T ss_pred CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-c
Confidence 999999998542 478999999999999999999998 999999999999999999999999999876543322 2
Q ss_pred cccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhh
Q 007892 368 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 447 (586)
Q Consensus 368 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 447 (586)
.....|++.|++||.+..+.++.++|||||||++|+|++|+.||...+.... +..+. ..+. +..
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~--~~~~~--------~~~~------~~~ 235 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYLIA--------TNGT------PEL 235 (293)
T ss_pred cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh--eeehh--------cCCC------CCC
Confidence 2334688899999999888899999999999999999999999976543110 00000 0000 000
Q ss_pred hccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HhcCCCCC
Q 007892 448 EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA--LEGNMPLD 490 (586)
Q Consensus 448 ~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~--L~~~~~~~ 490 (586)
.........+.+++.+||+.+|.+||++.+++.+ ++...++.
T Consensus 236 -~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~ 279 (293)
T cd06647 236 -QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLS 279 (293)
T ss_pred -CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcccc
Confidence 1112234568899999999999999999999974 44444443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=313.01 Aligned_cols=260 Identities=24% Similarity=0.336 Sum_probs=197.3
Q ss_pred CccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC-----eeEEE
Q 007892 210 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS-----QRLLV 283 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~-----~~~lV 283 (586)
.|...+++|.|.||.||+|++. +++.||||+...+.. .-.+|+++|+++.|||||+|+.+|.... ...||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4667799999999999999965 478999999865432 3346999999999999999998886532 22489
Q ss_pred EEecCCCcHHHHhcC--CCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCC-CCeEEeeccccccc
Q 007892 284 YEFVPNKTLEFHLHG--KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS-FEAKVADFGLAKHS 360 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~--~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~-~~~kl~DFGla~~~ 360 (586)
|||||. +|...++. ..+..++...+.-+..|+.+||+|||+. +|+||||||.|+|+|.+ |.+||||||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999976 67666653 2234577777788999999999999997 99999999999999976 89999999999987
Q ss_pred CCCCCcccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhh---cc--
Q 007892 361 LDTDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQ---GL-- 434 (586)
Q Consensus 361 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~---~~-- 434 (586)
...... ..+..|..|.|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+... .+.++..++-+-.. .+
T Consensus 177 ~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~--~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 177 VKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS--VDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred ccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH--HHHHHHHHHHhCCCCHHHHhh
Confidence 554433 45668889999999875 5799999999999999999999999987543 34444433211110 00
Q ss_pred -----cCCChhhhhchhhhc-cCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 435 -----ADGNFDALVDQKLEE-YDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 435 -----~~~~~~~l~d~~l~~-~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
.+-.+..+....+.. +......+.++++.+++..+|.+|.++.|++.
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 011112222222211 34455678999999999999999999999875
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=305.70 Aligned_cols=252 Identities=22% Similarity=0.383 Sum_probs=201.2
Q ss_pred CccccceecccCcEEEEEEEE-eCCeEEEEEEeccCCc------hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEE
Q 007892 210 NFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSG------QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 282 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~------~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~l 282 (586)
+|+..+.||+|+||.||++.. .+++.||+|.+..... .....+++|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999985 5688999999864321 123578899999999999999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCC-CeEEeecccccccC
Q 007892 283 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF-EAKVADFGLAKHSL 361 (586)
Q Consensus 283 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~-~~kl~DFGla~~~~ 361 (586)
||||+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++ .+||+|||++....
T Consensus 81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 99999999999998653 3588999999999999999999998 999999999999998775 59999999987654
Q ss_pred CCCCc---ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCC
Q 007892 362 DTDTH---VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGN 438 (586)
Q Consensus 362 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (586)
..... ......|+..|+|||.+.+..++.++||||||+++|+|++|..||.......... ...... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~---~~~~~~----~~-- 226 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA---LIFKIA----SA-- 226 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH---HHHHHh----cc--
Confidence 32211 1223568899999999988889999999999999999999999996543211111 100000 00
Q ss_pred hhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 439 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 439 ~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
......+......+.+++.+|++.+|.+||++.|++.
T Consensus 227 ------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 227 ------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0001233345567889999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=308.07 Aligned_cols=261 Identities=22% Similarity=0.274 Sum_probs=195.4
Q ss_pred ccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcC-CCCcceEEEEEEeC--CeeEEEEE
Q 007892 211 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVH-HRHLVSLVGYCTFG--SQRLLVYE 285 (586)
Q Consensus 211 f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~--~~~~lV~E 285 (586)
|+..+.||+|+||.||+|... +++.||||+++.... .......+|+.++.++. |+||++++++|.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 566789999999999999964 688999999875422 22334557899999985 99999999999987 88999999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 365 (586)
|+++ +|.+++.... ..++|.+++.++.|++.||+|||+. +|+||||||+||++++ +.+||+|||+++.......
T Consensus 81 ~~~~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 81 LMDM-NLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred cCCc-cHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 9974 7766665432 4589999999999999999999998 9999999999999999 9999999999986533222
Q ss_pred cccccccccccccCccccc-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHh-------hccc--
Q 007892 366 HVSTRVMGTFGYLAPEYAS-SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLA-------QGLA-- 435 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~-~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~-------~~~~-- 435 (586)
.....++..|+|||++. ++.++.++|||||||+||||++|..||...+.. ..+.+....+. +...
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07831 155 --YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL---DQIAKIHDVLGTPDAEVLKKFRKS 229 (282)
T ss_pred --cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH---HHHHHHHHHcCCCCHHHHHhhccc
Confidence 12345788999999764 456789999999999999999999999765431 11222111110 0000
Q ss_pred ---CCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 436 ---DGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 436 ---~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
...+.......+..........+.+++.+||+.+|.+||++.++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000111111111122346789999999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=307.49 Aligned_cols=250 Identities=25% Similarity=0.373 Sum_probs=205.8
Q ss_pred HHhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHH---HHHHHHHHHHhcCCCCcceEEEEEEeCCeeE
Q 007892 206 IATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGER---EFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 281 (586)
Q Consensus 206 ~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~---~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~ 281 (586)
+..++|...++||+|.||+|-+++.+ .|+.+|+|++++..-.... .-+.|-.+|+..+||.+..|...|...+.+|
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC 244 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC 244 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence 34578999999999999999999954 6999999999876433333 3457889999999999999998999999999
Q ss_pred EEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccC
Q 007892 282 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 361 (586)
Q Consensus 282 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~ 361 (586)
+||||+.||.|..||... ..+++.....+-..|+.||.|||++ +||+||||.+|.|||.||++||+|||||+...
T Consensus 245 FVMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc
Confidence 999999999999999654 4578877778889999999999998 99999999999999999999999999998643
Q ss_pred CCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhh
Q 007892 362 DTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 441 (586)
Q Consensus 362 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (586)
.. .......|||+.|+|||++....|+...|.|.+||++|||+||++||...+... +.+.
T Consensus 320 ~~-g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k---LFeL---------------- 379 (516)
T KOG0690|consen 320 KY-GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK---LFEL---------------- 379 (516)
T ss_pred cc-cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH---HHHH----------------
Confidence 32 234466899999999999999999999999999999999999999998765421 1111
Q ss_pred hhchhhhccCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 007892 442 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPR-----MSQIVR 481 (586)
Q Consensus 442 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----m~evl~ 481 (586)
++-..+ .++.....+...++...|.+||.+|.. ++||.+
T Consensus 380 Il~ed~-kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 380 ILMEDL-KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred HHhhhc-cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 110011 355566677888899999999999973 455543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=335.05 Aligned_cols=250 Identities=27% Similarity=0.432 Sum_probs=205.2
Q ss_pred cccceecccCcEEEEEEEE-eCCe----EEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEE
Q 007892 212 SEANLLGQGGFGYVHKGVL-TNGK----VVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 212 ~~~~~LG~G~fG~Vyk~~~-~~g~----~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
...++||.|.||+||||.+ ..|+ .||+|.+..... +...+|++|+-+|.+|+||||++|+|+|.... ..||.+
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 3468999999999999995 3443 689999866543 44578999999999999999999999998765 889999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 365 (586)
||+.|+|.+|++.+ +..+.-...+.|..|||+||.|||++ ++|||||.++||||..-..+||.|||+++.......
T Consensus 778 ~mP~G~LlDyvr~h-r~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREH-RDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred hcccchHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 99999999999864 34588889999999999999999998 999999999999999999999999999998765444
Q ss_pred cccc-cccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhh
Q 007892 366 HVST-RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 443 (586)
Q Consensus 366 ~~~~-~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 443 (586)
.... ...-.+.|||-|.+....|+.++|||||||++|||+| |..||+.....+ +..++ +.|.
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e-------I~dll----e~ge----- 917 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE-------IPDLL----EKGE----- 917 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-------hhHHH----hccc-----
Confidence 3322 2234568999999999999999999999999999999 999998765321 11111 1111
Q ss_pred chhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 007892 444 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 485 (586)
Q Consensus 444 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~ 485 (586)
+| ..+..+...+..++.+||..|+..||+++++...+..
T Consensus 918 --RL-sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 918 --RL-SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred --cC-CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 11 3455667788999999999999999999999887764
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=310.18 Aligned_cols=248 Identities=23% Similarity=0.345 Sum_probs=201.3
Q ss_pred CccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecC
Q 007892 210 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVP 288 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 288 (586)
.|...+.||+|+||.||++... +++.|++|.++.........+.+|+.++.+++|+||+++++++...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 3455679999999999999964 688999999876554555678899999999999999999999999999999999999
Q ss_pred CCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCccc
Q 007892 289 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 368 (586)
Q Consensus 289 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 368 (586)
+++|.+++.. ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++....... ...
T Consensus 100 ~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-~~~ 172 (285)
T cd06648 100 GGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-PRR 172 (285)
T ss_pred CCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCC-ccc
Confidence 9999999865 3489999999999999999999998 99999999999999999999999999987543322 122
Q ss_pred ccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhh
Q 007892 369 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLE 448 (586)
Q Consensus 369 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 448 (586)
....|+..|+|||.+.+..++.++|||||||++|||++|+.||...+.. .+..... .+. .+.+
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~------~~~~~~~-----~~~-----~~~~- 235 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL------QAMKRIR-----DNL-----PPKL- 235 (285)
T ss_pred ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH------HHHHHHH-----hcC-----CCCC-
Confidence 3356899999999999888999999999999999999999999754321 1111110 000 0000
Q ss_pred ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 449 EYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 449 ~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
.........+.+++.+||+.+|.+||++.++++
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 236 KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred cccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 111123457899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=309.07 Aligned_cols=250 Identities=24% Similarity=0.402 Sum_probs=193.3
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHH-HHhcCCCCcceEEEEEEeCCeeEEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEI-ISQVHHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~~~~~Ei~i-l~~l~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
++|++.+.||+|+||.||+++.. +|+.||+|+++... ......+..|+.+ ++.++|+||+++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47888999999999999999975 68999999987643 2334456666665 556789999999999999999999999
Q ss_pred ecCCCcHHHHhcCC--CCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCC
Q 007892 286 FVPNKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 363 (586)
Q Consensus 286 ~~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 363 (586)
|++ ++|..++... ....+++..++.++.|++.||+|||+++ +++||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 6777666432 2346899999999999999999999853 7999999999999999999999999999865332
Q ss_pred CCcccccccccccccCcccccC----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCCh
Q 007892 364 DTHVSTRVMGTFGYLAPEYASS----GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 439 (586)
Q Consensus 364 ~~~~~~~~~gt~~y~aPE~~~~----~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (586)
. ......|+..|+|||.+.+ ..++.++|+|||||+||||++|+.||...... ...+..
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~--------------- 219 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-FQQLKQ--------------- 219 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-HHHHHH---------------
Confidence 1 2233568899999998864 45688999999999999999999999643210 000000
Q ss_pred hhhhchhhhccC-HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 440 DALVDQKLEEYD-SAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 440 ~~l~d~~l~~~~-~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
.+.......+ ......+.+++.+||..+|.+||++.+|+.
T Consensus 220 --~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 220 --VVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred --HHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000000111 123456889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=310.65 Aligned_cols=268 Identities=21% Similarity=0.291 Sum_probs=200.5
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCch--hHHHHHHHHHHHHhcCCCCcceEEEEEEeC--CeeEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ--GEREFQAEIEIISQVHHRHLVSLVGYCTFG--SQRLLV 283 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~--~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~--~~~~lV 283 (586)
++|+..+.||+|+||.||+|... +++.||+|.++..... ....+.+|++++.+++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 56888899999999999999976 5889999999754322 223567899999999999999999999877 889999
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCC
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 363 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 363 (586)
|||+++ +|.+++.... ..+++..++.++.|++.||+|||+. +|+|+||||+|||+++++.+||+|||++......
T Consensus 85 ~e~~~~-~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 85 MEYVEH-DLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred ehhcCc-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 999974 8888886543 3589999999999999999999998 9999999999999999999999999999865443
Q ss_pred CCcccccccccccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchh-hh---------hhhhHHHhh
Q 007892 364 DTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDS-MV---------DWAKPFLAQ 432 (586)
Q Consensus 364 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~-~~---------~~~~~~~~~ 432 (586)
.. ......++..|+|||++.+. .++.++|+|||||++|||++|..||.......... +. .|..-....
T Consensus 160 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 160 LK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred cc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 21 12334578899999998754 46899999999999999999999997544211100 00 111000000
Q ss_pred cccCCChhhhhchhhh-ccCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 433 GLADGNFDALVDQKLE-EYDSA-EMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 433 ~~~~~~~~~l~d~~l~-~~~~~-~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
......+.......+. .+... ....+.+++.+|++.+|++||++.|++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000111111111111 12222 35668899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=309.09 Aligned_cols=265 Identities=20% Similarity=0.295 Sum_probs=199.6
Q ss_pred ccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEec
Q 007892 211 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 287 (586)
Q Consensus 211 f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 287 (586)
|+..+.||.|++|.||+|... +|+.||||++..... .....+.+|++++++++|+||+++++++..++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999964 689999999865432 22356889999999999999999999999999999999999
Q ss_pred CCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcc
Q 007892 288 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 367 (586)
Q Consensus 288 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 367 (586)
+ ++|.+++.......+++..++.++.|+++||+|||+. +++||||+|+|||++.++.+||+|||+++....... .
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~ 155 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-T 155 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-c
Confidence 5 6899888765545689999999999999999999998 999999999999999999999999999975432211 1
Q ss_pred cccccccccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHH---hhc----ccCCC-
Q 007892 368 STRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFL---AQG----LADGN- 438 (586)
Q Consensus 368 ~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~---~~~----~~~~~- 438 (586)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||...... ..+....+... ... .....
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI--DQLFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChHHhhhhhhchhh
Confidence 2233568899999988654 5789999999999999999999999765431 11111111000 000 00000
Q ss_pred ---hhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 439 ---FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 439 ---~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
+.......+..........+.+++.+|++.+|.+||++.||++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000001111122233578899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=309.34 Aligned_cols=268 Identities=20% Similarity=0.275 Sum_probs=196.2
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~-~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
+++|...+.||+|+||.||+|... +++.||+|.+...... ....+.+|++++++++|+||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 468999999999999999999864 6889999998654322 23467889999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 365 (586)
|+. ++|..++.... ..+.+..+..++.|++.||.|||.. +|+|+||||+|||++.++.+||+|||+++.......
T Consensus 84 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 84 YMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred ccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 996 56665554332 3478888899999999999999998 999999999999999999999999999975432221
Q ss_pred cccccccccccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhH---------HHhh--c
Q 007892 366 HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKP---------FLAQ--G 433 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~---------~~~~--~ 433 (586)
......+++.|+|||++.+. .++.++|||||||+||||++|+.||.............|... .+.. .
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07870 159 -TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN 237 (291)
T ss_pred -CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence 12334578999999998753 578899999999999999999999975443111111111000 0000 0
Q ss_pred ccCCChhhhhchhhhc--cCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 434 LADGNFDALVDQKLEE--YDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 434 ~~~~~~~~l~d~~l~~--~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
.....+.......+.. ........+.+++.+|++.||.+||++.|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000000000000 00012356789999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=330.28 Aligned_cols=252 Identities=24% Similarity=0.375 Sum_probs=204.0
Q ss_pred cCccccceecccCcEEEEEEEEeC-CeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEec
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 287 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 287 (586)
+-|.++..||.|+||.|||++.++ +-..|-|.|........++|.-||+||..+.||+||+|++.|...+.+|++.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 345667889999999999999765 4455678887777777889999999999999999999999999999999999999
Q ss_pred CCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcc
Q 007892 288 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 367 (586)
Q Consensus 288 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 367 (586)
.||-.+..+-.-+ ..|...++..++.+++.||.|||++ +|||||||+.|||++-+|.++|+|||.+..... ....
T Consensus 112 ~GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qk 186 (1187)
T KOG0579|consen 112 GGGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQK 186 (1187)
T ss_pred CCchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh-HHhh
Confidence 9999987775444 4589999999999999999999999 999999999999999999999999999754211 1223
Q ss_pred cccccccccccCcccccC-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhh
Q 007892 368 STRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 442 (586)
Q Consensus 368 ~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 442 (586)
...+.||++|||||++++ .+|+.++||||||++|.||..+.+|-...++.. .+...+ ...
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR--VllKia---------KSe---- 251 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--VLLKIA---------KSE---- 251 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH--HHHHHh---------hcC----
Confidence 345789999999998764 579999999999999999999999987655421 111111 000
Q ss_pred hchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 443 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 443 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.|.| --+......+.+++..||..+|+.||++.|++++
T Consensus 252 -PPTL-lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 252 -PPTL-LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred -CCcc-cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 1111 1233445678999999999999999999999853
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=311.29 Aligned_cols=264 Identities=18% Similarity=0.241 Sum_probs=195.9
Q ss_pred CccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 210 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
+|+..+.||+|+||.||+|+.. +|+.||+|.++.... .....+.+|++++++++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778899999999999999975 688999999865322 2235678899999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 366 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 366 (586)
+++ +|.+++.... ..+++..++.++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 154 (284)
T cd07839 81 CDQ-DLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR- 154 (284)
T ss_pred CCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-
Confidence 975 6777665432 3489999999999999999999998 999999999999999999999999999986433221
Q ss_pred ccccccccccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhh-----------HHHhhcc
Q 007892 367 VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAK-----------PFLAQGL 434 (586)
Q Consensus 367 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~-----------~~~~~~~ 434 (586)
......++..|+|||++.+. .++.++|||||||++|||++|..||....... ....... +.+.+..
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHHHHHHHHhCCCChHHhHHhhhcc
Confidence 12334678899999998764 47899999999999999999999865433211 0000000 0000000
Q ss_pred cCCChhhhhchhh--hccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 435 ADGNFDALVDQKL--EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 435 ~~~~~~~l~d~~l--~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
....+.. ..... ..........+.+++.+||+.||.+||++.|+++.
T Consensus 233 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 233 DYKPYPM-YPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccccCC-CCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0000000 00000 01112234678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=327.16 Aligned_cols=244 Identities=27% Similarity=0.385 Sum_probs=198.9
Q ss_pred CccccceecccCcEEEEEEEE-eCCeEEEEEEeccCCch---hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEE
Q 007892 210 NFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQ---GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~---~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
-|...+.||.|+||.||.++. .+.+.||||++....++ ...++..||..|.+|+|||+|...|+|..+...|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 377789999999999999995 46789999999665443 35688999999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 365 (586)
|| -|+-.+.|.... +.|...++..|+.+.+.||+|||+. +.||||||+.||||++.|.|||+|||.|.....
T Consensus 107 YC-lGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P--- 178 (948)
T KOG0577|consen 107 YC-LGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP--- 178 (948)
T ss_pred HH-hccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc---
Confidence 99 456666665433 4588889999999999999999999 899999999999999999999999999876433
Q ss_pred cccccccccccccCccccc---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhh
Q 007892 366 HVSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 442 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 442 (586)
...++|||.|||||++. .|.|+-|+|||||||+..||.-.++|+...+.. ..+...+ ..
T Consensus 179 --AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM--SALYHIA---------QN----- 240 (948)
T KOG0577|consen 179 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIA---------QN----- 240 (948)
T ss_pred --hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH--HHHHHHH---------hc-----
Confidence 35578999999999874 588999999999999999999999997654421 1111111 10
Q ss_pred hchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 443 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 443 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
-.|.|. ..+....++.++..||++-|.+|||..++++
T Consensus 241 esPtLq--s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 241 ESPTLQ--SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CCCCCC--CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 112222 2334567899999999999999999998864
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=331.91 Aligned_cols=268 Identities=17% Similarity=0.234 Sum_probs=188.0
Q ss_pred hcCccccceecccCcEEEEEEEEeC--CeEEEEE------------------EeccCCchhHHHHHHHHHHHHhcCCCCc
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLTN--GKVVAIK------------------QLKAGSGQGEREFQAEIEIISQVHHRHL 267 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~~--g~~vAVK------------------~l~~~~~~~~~~~~~Ei~il~~l~Hpni 267 (586)
.++|++.+.||+|+||+||++.+.. +..+++| .++. .......+.+|+++|.+++|+||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCCCc
Confidence 4789999999999999999987542 2222222 1111 11224568899999999999999
Q ss_pred ceEEEEEEeCCeeEEEEEecCCCcHHHHhcCCC---CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeC
Q 007892 268 VSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKD---RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD 344 (586)
Q Consensus 268 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~ 344 (586)
|++++++...+..++|+|++. ++|..++.... ...........|+.|++.||+|||++ +||||||||+||||+
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 999999999999999999985 45655554321 11233456778999999999999998 999999999999999
Q ss_pred CCCCeEEeecccccccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCC-CCCCCCcccchhhh
Q 007892 345 DSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFR-PFDKADTFADDSMV 423 (586)
Q Consensus 345 ~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~-Pf~~~~~~~~~~~~ 423 (586)
.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||+||||++|.. ||..........+.
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 99999999999998765443333445679999999999999999999999999999999999875 44433221111111
Q ss_pred hhhhHH-------------HhhcccCCChh---hhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 424 DWAKPF-------------LAQGLADGNFD---ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 424 ~~~~~~-------------~~~~~~~~~~~---~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
...... +.+.+....+. ..+...+.. ......+.+++.+||+.||.+||++.|++..
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRN--LGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHh--cCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 111000 00000000000 000000000 0122456778999999999999999999864
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=306.51 Aligned_cols=270 Identities=20% Similarity=0.290 Sum_probs=204.1
Q ss_pred HhcCccccceecccCcEEEEEEEEe-CCeEEEEEEecc--CCchhHHHHHHHHHHHHhcCCCCcceEEEEEEe-----CC
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKA--GSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF-----GS 278 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~--~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~-----~~ 278 (586)
....|...+.||+|.||.|+++... +|+.||||++.. ......+...+|+.+|++++|+||+.+++.+.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3455666789999999999999964 689999999873 233344567889999999999999999998865 35
Q ss_pred eeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccc
Q 007892 279 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 358 (586)
Q Consensus 279 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~ 358 (586)
..|+|+|+| ..+|...++... .+.......+..|+++||.|+|+. +|+||||||+|+|++.+..+||+|||||+
T Consensus 100 DvYiV~elM-etDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecccccee
Confidence 789999999 678988886543 488889999999999999999998 99999999999999999999999999999
Q ss_pred ccCCC-CCcccccccccccccCccccc-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhh----hHHHhh
Q 007892 359 HSLDT-DTHVSTRVMGTFGYLAPEYAS-SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWA----KPFLAQ 432 (586)
Q Consensus 359 ~~~~~-~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~----~~~~~~ 432 (586)
..... .....+.++.|.+|.|||.+. ...|+...||||.||||.||++|+.-|-+.+......+.-.. .+....
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence 76432 122336678899999999875 568999999999999999999999999877653322221100 000001
Q ss_pred cccCCChhhhhch-------hhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 433 GLADGNFDALVDQ-------KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 433 ~~~~~~~~~l~d~-------~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.+........+.. .....-.......++++.+||..||.+|+|++|.++.
T Consensus 254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1111111111110 0011112334568899999999999999999999874
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=305.60 Aligned_cols=266 Identities=22% Similarity=0.332 Sum_probs=200.3
Q ss_pred CccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEec
Q 007892 210 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 287 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~-~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 287 (586)
+|+..+.||.|++|.||+|+.. +|+.||||.++..... ....+.+|++++++++|+||++++++|...+..+|||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5788999999999999999975 5889999998765332 2456778999999999999999999999999999999999
Q ss_pred CCCcHHHHhcCCC-CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc
Q 007892 288 PNKTLEFHLHGKD-RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 366 (586)
Q Consensus 288 ~~gsL~~~l~~~~-~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 366 (586)
++ +|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 7877775433 34589999999999999999999988 999999999999999999999999999975432211
Q ss_pred ccccccccccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccch-hhhh---------hhhHHHhhccc
Q 007892 367 VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADD-SMVD---------WAKPFLAQGLA 435 (586)
Q Consensus 367 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~-~~~~---------~~~~~~~~~~~ 435 (586)
......++..|++||++.+. .++.++|||||||++|||++|+.||......... .... |..-.....+
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 234 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY- 234 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh-
Confidence 12334578899999988654 5789999999999999999999999765431100 0000 0000000000
Q ss_pred CCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 436 DGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 436 ~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
...+....+.............+.+++.+|++.+|.+||++.||++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000011111111122233567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=326.64 Aligned_cols=245 Identities=27% Similarity=0.400 Sum_probs=204.0
Q ss_pred ceecccCcEEEEEEEEeC-CeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecCCCcHH
Q 007892 215 NLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLE 293 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~gsL~ 293 (586)
-+||+|.||+||.|+..+ ...+|||.+........+-+.+||.+.++|+|.|||+.+|.|.+++...+.||-++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 369999999999999654 5679999997776666778999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCC--ChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeC-CCCCeEEeecccccccCCCCCccccc
Q 007892 294 FHLHGKDRPVM--NWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD-DSFEAKVADFGLAKHSLDTDTHVSTR 370 (586)
Q Consensus 294 ~~l~~~~~~~l--~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~ 370 (586)
..|..+=++ + ++.++..+..||++||.|||++ .|||||||-.||||+ -.|.+||+|||-++.+..- .....+
T Consensus 661 sLLrskWGP-lKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~TET 735 (1226)
T KOG4279|consen 661 SLLRSKWGP-LKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCTET 735 (1226)
T ss_pred HHHHhccCC-CccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccC-Cccccc
Confidence 999765332 4 6677788899999999999999 999999999999995 5789999999999986443 334566
Q ss_pred ccccccccCcccccCCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhh
Q 007892 371 VMGTFGYLAPEYASSGK--LTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLE 448 (586)
Q Consensus 371 ~~gt~~y~aPE~~~~~~--~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 448 (586)
+.||..|||||++..|. |+.++|||||||++.||.||++||.....-. + ..+.-|-+ ..-.
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq-------A-----AMFkVGmy-----KvHP 798 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ-------A-----AMFKVGMY-----KVHP 798 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh-------H-----hhhhhcce-----ecCC
Confidence 78999999999998764 8899999999999999999999997644210 0 00111111 1122
Q ss_pred ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 449 EYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 449 ~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
..+.+...+..+++.+|+..||.+||++.++++
T Consensus 799 ~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 799 PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 567778889999999999999999999999885
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=300.46 Aligned_cols=250 Identities=24% Similarity=0.379 Sum_probs=205.9
Q ss_pred CccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 210 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
+|...+.||.|+||.||++... +++.||+|++..... .....+.+|++++++++|+|++++++.+..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999975 588999999876533 4456789999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCC--CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 287 VPNKTLEFHLHGKD--RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 287 ~~~gsL~~~l~~~~--~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
+++++|.+++.... ...+++.++..++.+++.||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999987643 35689999999999999999999998 99999999999999999999999999998654432
Q ss_pred CcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhc
Q 007892 365 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 444 (586)
Q Consensus 365 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 444 (586)
.......|++.|+|||.+....++.++||||||+++|+|++|+.||...... ...... ....
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~-----~~~~------ 219 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL------ELALKI-----LKGQ------ 219 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH------HHHHHH-----hcCC------
Confidence 2233457889999999999888999999999999999999999999654321 111110 0111
Q ss_pred hhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 445 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 445 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
+...+......+.+++.+|+..+|.+||++.||++.
T Consensus 220 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 220 --YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred --CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111222334578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=310.15 Aligned_cols=246 Identities=25% Similarity=0.363 Sum_probs=195.6
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
+.|+..+.||+|+||.||+|+.. +++.||+|.+..... .....+.+|++++.+++||||++++++|...+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888899999999999999965 688999999864322 23357889999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
||++ |+|.+.+.... ..+++..+..++.|++.||.|||+. +|+||||+|+||++++++.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 95 EYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred HhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 9997 46655554332 3589999999999999999999998 9999999999999999999999999998754322
Q ss_pred CcccccccccccccCccccc---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhh
Q 007892 365 THVSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 441 (586)
Q Consensus 365 ~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (586)
....++..|+|||++. .+.++.++|||||||++|||++|+.||...+... .... + .....
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~---~~~~----~----~~~~~-- 231 (307)
T cd06607 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALYH----I----AQNDS-- 231 (307)
T ss_pred ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH---HHHH----H----hcCCC--
Confidence 2346888999999874 4668899999999999999999999996543211 0000 0 00000
Q ss_pred hhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 442 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 442 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
+. .........+.+++.+||+.+|.+||+|.+|+..
T Consensus 232 ---~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 232 ---PT--LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred ---CC--CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 0112234578999999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=306.45 Aligned_cols=264 Identities=21% Similarity=0.296 Sum_probs=200.1
Q ss_pred ccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--CeeEEEEE
Q 007892 211 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFG--SQRLLVYE 285 (586)
Q Consensus 211 f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~--~~~~lV~E 285 (586)
|++.+.||.|+||.||+|+.. +++.||||.+.... ......+.+|++++.+++|+|++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567789999999999999976 48899999997653 22345788999999999999999999999988 78999999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 365 (586)
|+++ +|..++.... ..+++..++.++.|+++||+|||+. +++|+||||+|||+++++.+||+|||++........
T Consensus 81 ~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred cccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 9975 8888776543 4689999999999999999999998 999999999999999999999999999987654432
Q ss_pred cccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhh----c---c---
Q 007892 366 HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQ----G---L--- 434 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~----~---~--- 434 (586)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ........... . +
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE---QLEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCchhhccccccc
Confidence 22334457889999998764 457899999999999999999999997654311 11111000000 0 0
Q ss_pred ---cCCChhhhhchhhh-ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 435 ---ADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 435 ---~~~~~~~l~d~~l~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
............+. .+...+...+.+++.+|++.+|.+||++.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000000111111 1111135678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=320.94 Aligned_cols=255 Identities=23% Similarity=0.395 Sum_probs=207.2
Q ss_pred HHHHhcCccccceecccCcEEEEEEEEeCCeEEEEEEecc--CCchhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCee
Q 007892 204 LKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKA--GSGQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQR 280 (586)
Q Consensus 204 l~~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~--~~~~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~~~~ 280 (586)
+.+....|++.++||+||-+.||++...+.+.+|+|++.. .+.+...-|+.|+.+|.+|+ |.+||+|++|-..++.+
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 3444566888999999999999999988888899888643 35556678999999999996 99999999999999999
Q ss_pred EEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccccc
Q 007892 281 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 360 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~ 360 (586)
||||||- ..+|..+|..+......| .+..+..|++.++.++|++ ||||.||||.|+|+-.. .+||+|||+|...
T Consensus 436 YmvmE~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVkG-~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 436 YMVMECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVKG-RLKLIDFGIANAI 509 (677)
T ss_pred EEEeecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEee-eEEeeeechhccc
Confidence 9999985 568999998776665667 6778999999999999999 99999999999999764 7999999999987
Q ss_pred CCCCCc-ccccccccccccCcccccCC-----------CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhH
Q 007892 361 LDTDTH-VSTRVMGTFGYLAPEYASSG-----------KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKP 428 (586)
Q Consensus 361 ~~~~~~-~~~~~~gt~~y~aPE~~~~~-----------~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~ 428 (586)
....+. .....+||+.||+||.+... +.+.++||||||||||+|+.|+.||..... .|+
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-------~~a-- 580 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-------QIA-- 580 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-------HHH--
Confidence 655443 34567899999999998543 256899999999999999999999975332 222
Q ss_pred HHhhcccCCChhhhhchhhh-ccCHHHH-HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 429 FLAQGLADGNFDALVDQKLE-EYDSAEM-TRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 429 ~~~~~~~~~~~~~l~d~~l~-~~~~~~~-~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.+..+.|+..+ +|+.--. ..++++++.||..||.+||+..+||+.
T Consensus 581 ---------Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 581 ---------KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ---------HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 23456666543 3322111 229999999999999999999999974
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=309.03 Aligned_cols=268 Identities=19% Similarity=0.274 Sum_probs=197.7
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
++|+..+.||+|+||.||+|... +|+.||||.+..... .....+.+|++++++++|+||+++++++..+...++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57889999999999999999965 688999999865322 223578899999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCC-CCCeEEeecccccccCCCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD-SFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~-~~~~kl~DFGla~~~~~~~ 364 (586)
|++ ++|..++.......+++.....++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~- 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP- 156 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCC-
Confidence 996 5777777554444467888889999999999999998 9999999999999985 567999999999764322
Q ss_pred CcccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchh-hhhhhhHHHhhcccC----CC
Q 007892 365 THVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDS-MVDWAKPFLAQGLAD----GN 438 (586)
Q Consensus 365 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~----~~ 438 (586)
........+++.|+|||++.+ ..++.++|||||||++|+|++|+.||......+... ...+......+.+.. ..
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 112233467889999999865 457899999999999999999999997644311100 000000000000000 00
Q ss_pred h----hhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 439 F----DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 439 ~----~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
+ .......+..........+.+++.+|++.+|.+||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 000001111112223456889999999999999999999986
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=306.17 Aligned_cols=247 Identities=25% Similarity=0.315 Sum_probs=202.5
Q ss_pred CccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEE
Q 007892 210 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
+|+..+.||.|+||.||++... +++.||+|.+.... ....+.+.+|++++++++||||+++++++..+...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5788899999999999999975 58899999986532 2335688999999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 365 (586)
|+.+++|.+++... ..+++..+..++.|+++||.|||+. +|+|+||||+|||+++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999999998654 4588999999999999999999998 99999999999999999999999999987654332
Q ss_pred cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhch
Q 007892 366 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQ 445 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 445 (586)
......|+..|+|||++....++.++|+||||+++|+|++|..||...... ..++..... ..
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~----~~--------- 216 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT----IRDQIRAKQ----ET--------- 216 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc----HHHHHHHHh----cc---------
Confidence 223356888999999999888999999999999999999999999865431 111111100 00
Q ss_pred hhhccCHHHHHHHHHHHHHhhccCCCCCCCH--HHHH
Q 007892 446 KLEEYDSAEMTRMAACAAACIRHSARRRPRM--SQIV 480 (586)
Q Consensus 446 ~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm--~evl 480 (586)
.....+......+.+++.+|++.+|.+||++ +|++
T Consensus 217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 217 ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 0012233344778999999999999999999 6554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=305.38 Aligned_cols=241 Identities=27% Similarity=0.374 Sum_probs=192.4
Q ss_pred ecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecCCCcH
Q 007892 217 LGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL 292 (586)
Q Consensus 217 LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~gsL 292 (586)
||+|+||+||++... +|+.||+|.+.... ......+..|+++|++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999854 68899999986432 22344667899999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCccccccc
Q 007892 293 EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM 372 (586)
Q Consensus 293 ~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 372 (586)
.+++.......+++.+++.++.|++.||.|||+. +++||||+|+|||+++++.+||+|||++...... .......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC--Ccccccc
Confidence 9999766555689999999999999999999998 9999999999999999999999999998765331 1222345
Q ss_pred ccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhccCH
Q 007892 373 GTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDS 452 (586)
Q Consensus 373 gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~ 452 (586)
++..|++||++.++.++.++|||||||++|+|++|+.||.......... . +.+... .....+..
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~-----~~~~~~---------~~~~~~~~ 219 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE--E-----LKRRTL---------EMAVEYPD 219 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH--H-----HHhccc---------cccccCCc
Confidence 7889999999988889999999999999999999999997654311100 0 000000 00012223
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHH
Q 007892 453 AEMTRMAACAAACIRHSARRRPRMSQ 478 (586)
Q Consensus 453 ~~~~~l~~l~~~cl~~dp~~RPtm~e 478 (586)
.....+.+++.+||+.+|.+||+..+
T Consensus 220 ~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 220 KFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred cCCHHHHHHHHHHccCChhHccCCCc
Confidence 33567889999999999999994444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=310.29 Aligned_cols=269 Identities=21% Similarity=0.258 Sum_probs=196.7
Q ss_pred CccccceecccCcEEEEEEEEe---CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--CeeE
Q 007892 210 NFSEANLLGQGGFGYVHKGVLT---NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFG--SQRL 281 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~---~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~--~~~~ 281 (586)
.|++.+.||+|+||.||+|... +++.||||.+.... ......+.+|+.++.+++||||++++++|.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4778899999999999999965 47899999997643 23345678899999999999999999999988 7899
Q ss_pred EEEEecCCCcHHHHhcCC---CCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCC----CCCeEEeec
Q 007892 282 LVYEFVPNKTLEFHLHGK---DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD----SFEAKVADF 354 (586)
Q Consensus 282 lV~E~~~~gsL~~~l~~~---~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~----~~~~kl~DF 354 (586)
+||||+++ +|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999976 555555322 123578889999999999999999998 8999999999999999 899999999
Q ss_pred ccccccCCCCC--cccccccccccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccc-------hhhhh
Q 007892 355 GLAKHSLDTDT--HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFAD-------DSMVD 424 (586)
Q Consensus 355 Gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~-------~~~~~ 424 (586)
|+++....... .......+++.|+|||++.+. .++.++|||||||+||||++|+.||........ ..+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986543322 122345688999999988654 578999999999999999999999976543220 01111
Q ss_pred hhhHH-------HhhcccCCChhhhhc---------hhhh-ccCH--HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 425 WAKPF-------LAQGLADGNFDALVD---------QKLE-EYDS--AEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 425 ~~~~~-------~~~~~~~~~~~~l~d---------~~l~-~~~~--~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
+...+ +........+....+ ..+. .+.. .....+.+++.+||+.+|.+||++.||++.
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 10000 000000000000000 0000 0001 234568999999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=310.28 Aligned_cols=248 Identities=24% Similarity=0.372 Sum_probs=196.8
Q ss_pred CccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEE
Q 007892 210 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
.|...+.||+|+||.||+++.. ++..||+|.+..... .....+.+|++++++++|+|+++++++|..++..++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3777899999999999999964 688999999864322 223578899999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 365 (586)
|+++ +|.+.+... ...++|.++..++.+++.||.|||+. +|+||||+|+||++++++.+||+|||++......
T Consensus 106 ~~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (317)
T cd06635 106 YCLG-SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-- 178 (317)
T ss_pred CCCC-CHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence 9975 676666433 23489999999999999999999998 9999999999999999999999999998754321
Q ss_pred cccccccccccccCccccc---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhh
Q 007892 366 HVSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 442 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 442 (586)
....|++.|+|||++. .+.++.++|||||||++|||++|+.||...+.. .....+.. .+.
T Consensus 179 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~~~--------~~~---- 241 (317)
T cd06635 179 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIAQ--------NES---- 241 (317)
T ss_pred ---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH--HHHHHHHh--------ccC----
Confidence 2346889999999973 467899999999999999999999998654321 01111100 000
Q ss_pred hchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 007892 443 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 485 (586)
Q Consensus 443 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~ 485 (586)
...........+.+++.+|++.+|.+||++.+|++.+..
T Consensus 242 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 242 ----PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred ----CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 001112234568899999999999999999999987653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=298.00 Aligned_cols=251 Identities=27% Similarity=0.418 Sum_probs=206.0
Q ss_pred CccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--CeeEEEE
Q 007892 210 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFG--SQRLLVY 284 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~--~~~~lV~ 284 (586)
+|...+.||+|++|.||+|... +++.|++|.+..... .....+.+|++++++++|+||+++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4777899999999999999976 688999999876543 3456889999999999999999999999988 8899999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
||+++++|.+++.... .+++..++.++.+++.+|+|||+. +++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999987544 689999999999999999999997 99999999999999999999999999998764433
Q ss_pred Cc-ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhh
Q 007892 365 TH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 443 (586)
Q Consensus 365 ~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 443 (586)
.. ......++..|++||.+.....+.++||||||++||+|++|+.||...+. .....|. +...
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~-------~~~~------ 219 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN---PMAALYK-------IGSS------ 219 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---hHHHHHh-------cccc------
Confidence 21 12345688999999999988899999999999999999999999976541 0111110 0000
Q ss_pred chhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 444 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 444 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
......+......+.+++.+|++.+|.+||++.|+++.
T Consensus 220 -~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 220 -GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred -CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 00112233335779999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=297.77 Aligned_cols=247 Identities=27% Similarity=0.438 Sum_probs=203.6
Q ss_pred CccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 210 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
+|+..+.||+|+||.||+++.. +++.|+||.+..... .....+.+|++++.+++|+|++++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999865 578999999976644 3456789999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 366 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 366 (586)
+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 9999999998654 4589999999999999999999998 9999999999999999999999999999876443322
Q ss_pred ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchh
Q 007892 367 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 446 (586)
Q Consensus 367 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 446 (586)
.....++..|+|||++.+..++.++|||+||+++|+|++|+.||...... ...|.. .....
T Consensus 156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~----~~~~~~-------~~~~~------- 216 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM----AALFRI-------VQDDH------- 216 (254)
T ss_pred -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH----HHHHHH-------hccCC-------
Confidence 23356889999999998888899999999999999999999999754321 111110 00000
Q ss_pred hhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 447 LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 447 l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
...+......+.+++.+|+..+|++||++.|++.
T Consensus 217 -~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 217 -PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred -CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 0122233467889999999999999999999984
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=307.99 Aligned_cols=254 Identities=25% Similarity=0.434 Sum_probs=195.8
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeeEEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~~~~~lV~E 285 (586)
++|...+.||+|+||.||++... +++.||||.+.... ......+.+|+.++.++. |+||+++++++...+..+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 35566789999999999999965 58899999986543 234567889999999996 9999999999999999999999
Q ss_pred ecCCCcHH---HHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCC
Q 007892 286 FVPNKTLE---FHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 286 ~~~~gsL~---~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 362 (586)
|+.. +|. .++.......+++.....++.++++||+|||+.+ +|+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 9864 443 3333333456899999999999999999999743 899999999999999999999999999976543
Q ss_pred CCCcccccccccccccCcccccCC---CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCCh
Q 007892 363 TDTHVSTRVMGTFGYLAPEYASSG---KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 439 (586)
Q Consensus 363 ~~~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (586)
... .....|+..|+|||++... .++.++|||||||++|||++|+.||..... ...- +.+.. .+.
T Consensus 161 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~----~~~~~-~~~- 227 (288)
T cd06616 161 SIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQ----LTQVV-KGD- 227 (288)
T ss_pred CCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHH----Hhhhc-CCC-
Confidence 221 1334688999999999766 689999999999999999999999975431 1110 00000 000
Q ss_pred hhhhchhhh-ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 440 DALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 440 ~~l~d~~l~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.+.+. .........+.+++.+|++.+|.+||++.+|++.
T Consensus 228 ----~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 ----PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred ----CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01111 1112345678999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=308.16 Aligned_cols=267 Identities=20% Similarity=0.236 Sum_probs=196.0
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCe-----
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQ----- 279 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~~~----- 279 (586)
++|+..+.||+|+||.||+|... +++.||||.++.... .....+.+|+.++.++. |+||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999965 689999999765432 22357888999999995 6999999999987665
Q ss_pred eEEEEEecCCCcHHHHhcCCC---CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCC-CCCeEEeecc
Q 007892 280 RLLVYEFVPNKTLEFHLHGKD---RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD-SFEAKVADFG 355 (586)
Q Consensus 280 ~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~-~~~~kl~DFG 355 (586)
.++||||+++ +|.+++.... ...+++..++.++.||++||.|||+. +|+||||||+|||++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999986 7877775432 24589999999999999999999998 9999999999999998 8899999999
Q ss_pred cccccCCCCCcccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHH---h
Q 007892 356 LAKHSLDTDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFL---A 431 (586)
Q Consensus 356 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~---~ 431 (586)
+++...... .......+++.|+|||++.+ ..++.++|||||||+||||++|..||....... .+........ .
T Consensus 157 ~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~ 233 (295)
T cd07837 157 LGRAFSIPV-KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ--QLLHIFKLLGTPTE 233 (295)
T ss_pred cceecCCCc-cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHHHhCCCCh
Confidence 997643221 11223457889999998865 457999999999999999999999997543211 0000000000 0
Q ss_pred hcc----cCCC---hhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 432 QGL----ADGN---FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 432 ~~~----~~~~---~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
+.+ .... +.......+..........+.+++.+||+.+|.+||++.|++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000 0000 00000000111112244668899999999999999999999853
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=308.74 Aligned_cols=269 Identities=25% Similarity=0.292 Sum_probs=199.6
Q ss_pred HHhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC----
Q 007892 206 IATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGS---- 278 (586)
Q Consensus 206 ~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~---- 278 (586)
...++|++.+.||+|+||.||+|+.. +|+.||||.++.... .....+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45578999999999999999999975 588999999975432 23356788999999999999999999987654
Q ss_pred ------eeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEe
Q 007892 279 ------QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVA 352 (586)
Q Consensus 279 ------~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~ 352 (586)
..++|+||+++ +|...+... ...+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeC
Confidence 78999999986 666666543 33589999999999999999999998 99999999999999999999999
Q ss_pred ecccccccCCCCCcccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHh
Q 007892 353 DFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLA 431 (586)
Q Consensus 353 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 431 (586)
|||++...............++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... .+..... ...
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~--~~~~~~~-~~~ 235 (302)
T cd07864 159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA--QLELISR-LCG 235 (302)
T ss_pred cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHH-HhC
Confidence 999998754433222233456788999998864 457899999999999999999999997544211 1111100 000
Q ss_pred h-------cccCCC-h-----hhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 432 Q-------GLADGN-F-----DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 432 ~-------~~~~~~-~-----~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
. .+.... + ..................+.+++.+||+.+|.+||++.+|+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 000000 0 0000000000011124678999999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=313.49 Aligned_cols=268 Identities=23% Similarity=0.362 Sum_probs=198.4
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccC--CchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeC--CeeE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFG--SQRL 281 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~--~~~~ 281 (586)
.++|+..+.||+|+||.||+|... +++.||||++... .......+.+|+.++.++ +|+||++++++|... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 467888999999999999999975 5889999988542 222345677899999999 999999999998653 3679
Q ss_pred EEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccC
Q 007892 282 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 361 (586)
Q Consensus 282 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~ 361 (586)
+||||++ ++|..++... .++|..+..++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++...
T Consensus 86 lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred EEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 9999997 5888888653 588999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCC----cccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchh-hhhhhhH-------
Q 007892 362 DTDT----HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDS-MVDWAKP------- 428 (586)
Q Consensus 362 ~~~~----~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~-~~~~~~~------- 428 (586)
.... .......|+..|+|||++.+ ..++.++|||||||++|||++|+.||.......... +..+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 3322 12234578999999998754 567899999999999999999999997543211100 0000000
Q ss_pred HHhhcccCCChhhhhc---hhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 429 FLAQGLADGNFDALVD---QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 429 ~~~~~~~~~~~~~l~d---~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.+........+..+.. ..+..........+.+++.+|++.+|.+||++.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000000000000 00011111235678999999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=303.46 Aligned_cols=243 Identities=25% Similarity=0.356 Sum_probs=197.9
Q ss_pred ecccCcEEEEEEEEeC-CeEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecCCCcH
Q 007892 217 LGQGGFGYVHKGVLTN-GKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL 292 (586)
Q Consensus 217 LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~gsL 292 (586)
||.|+||.||+++..+ |+.|++|.+..... .....+.+|++++.+++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999764 89999999865433 3346788999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC-------
Q 007892 293 EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT------- 365 (586)
Q Consensus 293 ~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~------- 365 (586)
.+++.... .+++..++.++.|++.||+|||+. +|+|+||+|+|||+++++.+||+|||++........
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99987544 589999999999999999999998 999999999999999999999999999876433211
Q ss_pred cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhch
Q 007892 366 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQ 445 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 445 (586)
.......++..|++||.+.....+.++||||||+++|||++|..||...... .... .. ..+..
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~~---~~-----~~~~~------ 218 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE---EIFQ---NI-----LNGKI------ 218 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---HHHH---HH-----hcCCc------
Confidence 1223456888999999998888999999999999999999999999754421 1111 10 01111
Q ss_pred hhhccCHH--HHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 007892 446 KLEEYDSA--EMTRMAACAAACIRHSARRRPRMSQIVRALE 484 (586)
Q Consensus 446 ~l~~~~~~--~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~ 484 (586)
..... ....+.+++.+|++.+|.+||++.+|.+.|+
T Consensus 219 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 219 ---EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred ---CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 01111 2567899999999999999999977777766
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=322.15 Aligned_cols=199 Identities=31% Similarity=0.428 Sum_probs=174.3
Q ss_pred CccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcC-C-----CCcceEEEEEEeCCeeEE
Q 007892 210 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-H-----RHLVSLVGYCTFGSQRLL 282 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~-H-----pniv~l~g~~~~~~~~~l 282 (586)
+|.+.+.||+|.||.|.||+.. +++.||||++++.. .-.++-..|+.||.+|+ | -|+|++++||...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 6888999999999999999954 69999999998753 23456678999999997 4 489999999999999999
Q ss_pred EEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCC--CCeEEeeccccccc
Q 007892 283 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS--FEAKVADFGLAKHS 360 (586)
Q Consensus 283 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~--~~~kl~DFGla~~~ 360 (586)
|+|.+ .-+|.++|+.+.-..++...+..|+.||+.||.+||+. +|||+||||+||||.+- ..+||+|||.+...
T Consensus 266 VfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99998 66999999988888899999999999999999999998 99999999999999653 47999999999864
Q ss_pred CCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcc
Q 007892 361 LDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTF 417 (586)
Q Consensus 361 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~ 417 (586)
... . ..+.-+..|.|||++.+.+|+.+.|||||||||.||++|.+-|.+.++.
T Consensus 342 ~q~---v-ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~ 394 (586)
T KOG0667|consen 342 SQR---V-YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEY 394 (586)
T ss_pred CCc---c-eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHH
Confidence 322 1 2566788999999999999999999999999999999998778766553
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=306.07 Aligned_cols=247 Identities=26% Similarity=0.391 Sum_probs=208.4
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEec
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 287 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 287 (586)
+-|.++++||+|+||.|||+.++ .|++||||.+-.. .+.+++..||.||+++..|++|+.+|.+.....+|+|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 34777899999999999999965 6999999987544 34678999999999999999999999998889999999999
Q ss_pred CCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcc
Q 007892 288 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 367 (586)
Q Consensus 288 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 367 (586)
..|++.+.+... ++.|.+.++..|+...++||+|||.. +-||||||+.||||+.+|.+||+|||.+..+.+... .
T Consensus 111 GAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA-K 185 (502)
T KOG0574|consen 111 GAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA-K 185 (502)
T ss_pred CCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHH-h
Confidence 999999988654 45799999999999999999999998 789999999999999999999999999987655443 3
Q ss_pred cccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhh
Q 007892 368 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 447 (586)
Q Consensus 368 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 447 (586)
..++.||+.|||||++..-.|+.++||||||++..||..|++||.+..+... +-.+.....
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA-------------------IFMIPT~PP 246 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA-------------------IFMIPTKPP 246 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce-------------------eEeccCCCC
Confidence 4568899999999999988899999999999999999999999986654211 000111111
Q ss_pred h--ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 448 E--EYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 448 ~--~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
. .-+..-..++-++++.||-+.|++|-|+.++++
T Consensus 247 PTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 247 PTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 1 223445578999999999999999999998875
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=305.30 Aligned_cols=266 Identities=23% Similarity=0.316 Sum_probs=199.8
Q ss_pred ccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeeEEEEEec
Q 007892 211 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLLVYEFV 287 (586)
Q Consensus 211 f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~~~~~lV~E~~ 287 (586)
|.+.+.||+|+||.||+|+.. +++.|+||++..... .......+|+..+.+++ |+||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567789999999999999976 478899999865432 22334567999999999 999999999999999999999999
Q ss_pred CCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcc
Q 007892 288 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 367 (586)
Q Consensus 288 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 367 (586)
+++|.+++.......+++..++.++.|++.+|.|||++ +|+|+||+|+||++++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-- 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence 88998888766545689999999999999999999998 999999999999999999999999999986543222
Q ss_pred cccccccccccCccccc-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccch-hhh---------hhhhHHHhhcccC
Q 007892 368 STRVMGTFGYLAPEYAS-SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADD-SMV---------DWAKPFLAQGLAD 436 (586)
Q Consensus 368 ~~~~~gt~~y~aPE~~~-~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~-~~~---------~~~~~~~~~~~~~ 436 (586)
.....++..|+|||++. ...++.++|+||||++++||++|+.||......+.. ... .|...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 23356888999999875 445789999999999999999999999655431110 000 1111100000000
Q ss_pred CChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 437 GNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 437 ~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
..+.......+..........+.+++.+|++.+|++||++.||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000011111111111224679999999999999999999999863
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=305.22 Aligned_cols=242 Identities=24% Similarity=0.342 Sum_probs=187.7
Q ss_pred eecccCcEEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHHHHHh---cCCCCcceEEEEEEeCCeeEEEEEecC
Q 007892 216 LLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQ---VHHRHLVSLVGYCTFGSQRLLVYEFVP 288 (586)
Q Consensus 216 ~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~---l~Hpniv~l~g~~~~~~~~~lV~E~~~ 288 (586)
.||+|+||.||++... +++.||||.+..... .....+.+|..++.. .+|+||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999964 588999999865422 222334455544443 479999999999999999999999999
Q ss_pred CCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCccc
Q 007892 289 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 368 (586)
Q Consensus 289 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 368 (586)
+++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++....... .
T Consensus 81 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~ 152 (279)
T cd05633 81 GGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---P 152 (279)
T ss_pred CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---c
Confidence 99999988654 3489999999999999999999998 89999999999999999999999999987543222 2
Q ss_pred ccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhh
Q 007892 369 TRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 447 (586)
Q Consensus 369 ~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 447 (586)
....|+..|+|||.+.. ..++.++|||||||+||||++|+.||..........+... . .. ...
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~----~----~~------~~~-- 216 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM----T----LT------VNV-- 216 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH----h----hc------CCc--
Confidence 23468999999999864 5589999999999999999999999975432111110000 0 00 000
Q ss_pred hccCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 007892 448 EEYDSAEMTRMAACAAACIRHSARRRP-----RMSQIVRA 482 (586)
Q Consensus 448 ~~~~~~~~~~l~~l~~~cl~~dp~~RP-----tm~evl~~ 482 (586)
..+......+.+++..||+.||.+|| +++|++++
T Consensus 217 -~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 217 -ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred -CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 12233456788999999999999999 59988775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=300.10 Aligned_cols=248 Identities=27% Similarity=0.403 Sum_probs=203.6
Q ss_pred CccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 210 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
+|++.+.||+|+||.||++... +++.+|+|.+.... ......+.+|++++++++|+||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999854 67899999987542 23345778899999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCC--CCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 287 VPNKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 287 ~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
+++++|..++... ....+++..++.++.+++.||+|||+. +++|+||+|.||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999988552 234589999999999999999999998 9999999999999999999999999999876443
Q ss_pred CcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhc
Q 007892 365 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 444 (586)
Q Consensus 365 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 444 (586)
......++..|++||++.+..++.++|+||||+++|||++|+.||...+.. .+.. .+..+.+.
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~--------~~~~~~~~---- 219 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---DLRY--------KVQRGKYP---- 219 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH--------HHhcCCCC----
Confidence 222345888999999999889999999999999999999999999755421 1111 01111111
Q ss_pred hhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 445 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 445 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.........+.+++.+|++.+|.+||++.||++.
T Consensus 220 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 220 ----PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred ----CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 2223445679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=303.98 Aligned_cols=251 Identities=25% Similarity=0.341 Sum_probs=196.9
Q ss_pred CccccceecccCcEEEEEEEE----eCCeEEEEEEeccCCc----hhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCee
Q 007892 210 NFSEANLLGQGGFGYVHKGVL----TNGKVVAIKQLKAGSG----QGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQR 280 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~----~~g~~vAVK~l~~~~~----~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~~~ 280 (586)
+|++.+.||.|+||.||++.. .+|+.||+|+++.... ...+.+.+|+.++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999986 3688999999875322 2235678899999999 599999999999998999
Q ss_pred EEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccccc
Q 007892 281 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 360 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~ 360 (586)
++||||+++++|.+++... ..+.+..+..++.|++.||.|||+. +++||||||+|||+++++.+||+|||++...
T Consensus 81 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 81 HLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 9999999999999998654 3488889999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCCcccccccccccccCcccccCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCC
Q 007892 361 LDTDTHVSTRVMGTFGYLAPEYASSG--KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGN 438 (586)
Q Consensus 361 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (586)
............|+..|+|||++..+ .++.++||||||++||+|++|..||...... .....+......
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~------- 226 (290)
T cd05613 156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILK------- 226 (290)
T ss_pred ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhc-------
Confidence 43332222345689999999998753 4688999999999999999999999643321 111222111100
Q ss_pred hhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 007892 439 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRP-----RMSQIVR 481 (586)
Q Consensus 439 ~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RP-----tm~evl~ 481 (586)
....++......+.+++.+|++.+|.+|| ++.+++.
T Consensus 227 -------~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 227 -------SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred -------cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 00012233446788999999999999997 5555543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=312.90 Aligned_cols=266 Identities=21% Similarity=0.294 Sum_probs=198.9
Q ss_pred HhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC------
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG------ 277 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~------ 277 (586)
..++|+..+.||+|+||.||++... +++.||||.+... .......+.+|+.++.+++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3478999999999999999999964 6899999998643 223345677899999999999999999988643
Q ss_pred CeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccc
Q 007892 278 SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 357 (586)
Q Consensus 278 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla 357 (586)
...++||||+. ++|.+.+... +++..+..++.|++.||+|||.. +|+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccc
Confidence 34689999996 4777777432 88889999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccch-hh--------hhhhh-
Q 007892 358 KHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADD-SM--------VDWAK- 427 (586)
Q Consensus 358 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~-~~--------~~~~~- 427 (586)
+...... ......++..|+|||.+.+..++.++|||||||+||+|++|+.||...+..... .+ .+|..
T Consensus 166 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 166 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred eeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 8653321 123346889999999999999999999999999999999999999765421100 00 00000
Q ss_pred --HHHhhccc------CCChhhhhchhhh-----ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 428 --PFLAQGLA------DGNFDALVDQKLE-----EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 428 --~~~~~~~~------~~~~~~l~d~~l~-----~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
..+..... ...+..+....+. .........+.+++.+||+.||++||++.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000 0011111111110 0112345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=312.67 Aligned_cols=264 Identities=19% Similarity=0.318 Sum_probs=197.1
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeC-----Cee
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFG-----SQR 280 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~-----~~~ 280 (586)
.++|++.++||+|+||.||+|+.. +|+.||||+++... ......+.+|+.++.+++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999854 68999999986432 23345678899999999999999999987654 357
Q ss_pred EEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccccc
Q 007892 281 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 360 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~ 360 (586)
++|+||+.+ +|..++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 84 ~lv~e~~~~-~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELMET-DLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhccc-CHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeec
Confidence 899999965 77777643 3489999999999999999999998 9999999999999999999999999999765
Q ss_pred CCCCCc--ccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCC
Q 007892 361 LDTDTH--VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADG 437 (586)
Q Consensus 361 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (586)
...... ......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...+... ...+....+... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~-~~~ 232 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTP-SQE 232 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCC-CHH
Confidence 332211 1233568999999998754 568999999999999999999999997543211 111110000000 000
Q ss_pred Chhhhhchhh---------------hccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 438 NFDALVDQKL---------------EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 438 ~~~~l~d~~l---------------~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.+..+.+... ..........+.+++.+||+.+|.+||++.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0111111000 00111234568899999999999999999999986
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=300.15 Aligned_cols=241 Identities=25% Similarity=0.309 Sum_probs=195.9
Q ss_pred ecccCcEEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecCCCcH
Q 007892 217 LGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL 292 (586)
Q Consensus 217 LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~gsL 292 (586)
||.|+||.||+++.. +++.||+|.+..... .....+.+|+.++++++|+||+++++++.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 799999999999975 488999999865432 2346789999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCccccccc
Q 007892 293 EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM 372 (586)
Q Consensus 293 ~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 372 (586)
.+++... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++...... ......
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~ 153 (262)
T cd05572 81 WTILRDR--GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFC 153 (262)
T ss_pred HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccccc
Confidence 9999654 3488999999999999999999997 99999999999999999999999999998764432 223356
Q ss_pred ccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhch-hhhccC
Q 007892 373 GTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQ-KLEEYD 451 (586)
Q Consensus 373 gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~-~l~~~~ 451 (586)
|+..|++||.+....++.++|+||||+++|+|++|..||...... ..++... +.+. ....++
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~-------------~~~~~~~~~~~ 216 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED----PMEIYND-------------ILKGNGKLEFP 216 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----HHHHHHH-------------HhccCCCCCCC
Confidence 889999999998888999999999999999999999999765420 1111111 1100 000222
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 007892 452 SAEMTRMAACAAACIRHSARRRPR-----MSQIVR 481 (586)
Q Consensus 452 ~~~~~~l~~l~~~cl~~dp~~RPt-----m~evl~ 481 (586)
......+.+++.+||+.+|.+||+ +.|+++
T Consensus 217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 233567999999999999999999 666665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=298.20 Aligned_cols=250 Identities=23% Similarity=0.354 Sum_probs=198.0
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccC-----CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--Cee
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG-----SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG--SQR 280 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~-----~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~--~~~ 280 (586)
.+|++.+.||+|+||.||+|... +++.||+|.+... .......+++|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57889999999999999999964 5889999987432 123345788999999999999999999998764 467
Q ss_pred EEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccccc
Q 007892 281 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 360 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~ 360 (586)
++|+||+++++|.+++.... .+++....+++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 89999999999999886433 478899999999999999999998 9999999999999999999999999999864
Q ss_pred CCCCC--cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCC
Q 007892 361 LDTDT--HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGN 438 (586)
Q Consensus 361 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (586)
..... .......|+..|+|||++.+..++.++|||||||+||||++|+.||....... ..... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~--------~---- 222 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA--AIFKI--------A---- 222 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH--HHHHH--------H----
Confidence 32111 11123568999999999998889999999999999999999999997543211 01000 0
Q ss_pred hhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 439 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 439 ~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
..+.....+......+.+++.+|+.. +.+||+..+++..
T Consensus 223 ----~~~~~~~~p~~~~~~~~~~i~~~l~~-~~~r~~~~~~~~~ 261 (264)
T cd06653 223 ----TQPTKPMLPDGVSDACRDFLKQIFVE-EKRRPTAEFLLRH 261 (264)
T ss_pred ----cCCCCCCCCcccCHHHHHHHHHHhcC-cccCccHHHHhcC
Confidence 00001123344556789999999995 6999999988753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=300.07 Aligned_cols=263 Identities=23% Similarity=0.315 Sum_probs=197.8
Q ss_pred ccccceecccCcEEEEEEEEeC-CeEEEEEEeccCCch--hHHHHHHHHHHHHhc---CCCCcceEEEEEEeCCe-----
Q 007892 211 FSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQ--GEREFQAEIEIISQV---HHRHLVSLVGYCTFGSQ----- 279 (586)
Q Consensus 211 f~~~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~~--~~~~~~~Ei~il~~l---~Hpniv~l~g~~~~~~~----- 279 (586)
|++.+.||+|+||.||+|+... ++.||||.++..... ....+.+|+.++.++ +|+||++++++|...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5678899999999999999764 899999999743222 234567788887766 59999999999988776
Q ss_pred eEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccc
Q 007892 280 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 359 (586)
Q Consensus 280 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~ 359 (586)
.+++|||+.+ +|.+++.......+++..++.++.|+++||.|||+. +|+|+||+++|||++.++.+||+|||++..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCccee
Confidence 8999999974 788888665445689999999999999999999998 899999999999999999999999999976
Q ss_pred cCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHh---hccc-
Q 007892 360 SLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLA---QGLA- 435 (586)
Q Consensus 360 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~- 435 (586)
...... .....++..|+|||++.+..++.++|||||||++|||++|+.||...... +.+..+...... ..+.
T Consensus 157 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 157 YSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA--DQLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred ccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH--HHHHHHHHHcCCCChHhcCC
Confidence 533221 12345788999999999889999999999999999999999998754321 111111110000 0000
Q ss_pred -----CCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 436 -----DGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 436 -----~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
...+..................+.+++.+||+.||.+||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000011111111122234567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=303.59 Aligned_cols=255 Identities=25% Similarity=0.314 Sum_probs=201.4
Q ss_pred CccccceecccCcEEEEEEEEe----CCeEEEEEEeccCCc----hhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCee
Q 007892 210 NFSEANLLGQGGFGYVHKGVLT----NGKVVAIKQLKAGSG----QGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQR 280 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~----~g~~vAVK~l~~~~~----~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~~~ 280 (586)
+|+..+.||+|+||.||+++.. +++.||||.++.... .....+.+|+.++.++ +|+||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4777899999999999999853 567899999865321 2234678899999999 599999999999999999
Q ss_pred EEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccccc
Q 007892 281 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 360 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~ 360 (586)
++||||+++++|..++... ..+++.....++.|++++|.|||+. +++||||||.|||++.++.++|+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 9999999999999988643 3488999999999999999999988 9999999999999999999999999998865
Q ss_pred CCCCCcccccccccccccCcccccCCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCC
Q 007892 361 LDTDTHVSTRVMGTFGYLAPEYASSGK--LTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGN 438 (586)
Q Consensus 361 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (586)
............|+..|++||.+.+.. .+.++||||||+++|||++|..||....... ....+..... ..
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~-----~~- 227 (288)
T cd05583 156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRIL-----KS- 227 (288)
T ss_pred ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHH-----cc-
Confidence 443332233356899999999987665 7889999999999999999999996433211 1111111111 00
Q ss_pred hhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 007892 439 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 485 (586)
Q Consensus 439 ~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~ 485 (586)
....+......+.+++.+||+.+|++||++.++.+.|+-
T Consensus 228 --------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 --------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred --------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 001122234567899999999999999999999888774
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=304.78 Aligned_cols=243 Identities=22% Similarity=0.361 Sum_probs=197.4
Q ss_pred ceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecCCCcHH
Q 007892 215 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLE 293 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~gsL~ 293 (586)
..||+|+||.||++... +++.||||.+..........+.+|+.++++++|+||+++++++..++..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 57999999999999874 68999999987655555667899999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcccccccc
Q 007892 294 FHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMG 373 (586)
Q Consensus 294 ~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~g 373 (586)
+++.. ..+++.....++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||++....... .......|
T Consensus 106 ~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~ 178 (292)
T cd06657 106 DIVTH---TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLVG 178 (292)
T ss_pred HHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccc-cccccccc
Confidence 88743 2478999999999999999999998 99999999999999999999999999987653322 12233568
Q ss_pred cccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhccCHH
Q 007892 374 TFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSA 453 (586)
Q Consensus 374 t~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~ 453 (586)
++.|++||++.+..++.++|||||||++|||++|..||...... ....... .. ....+. ....
T Consensus 179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~---~~~~~~~----~~---------~~~~~~-~~~~ 241 (292)
T cd06657 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIR----DN---------LPPKLK-NLHK 241 (292)
T ss_pred CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHH----hh---------CCcccC-Cccc
Confidence 89999999998888999999999999999999999999754321 1111110 00 001111 1112
Q ss_pred HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 454 EMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 454 ~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
....+.+++.+||+.+|.+||++.+|++
T Consensus 242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 242 VSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 3446788999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=305.97 Aligned_cols=264 Identities=18% Similarity=0.229 Sum_probs=195.6
Q ss_pred ccceecccCcEEEEEEEEeCCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecCCC
Q 007892 213 EANLLGQGGFGYVHKGVLTNGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNK 290 (586)
Q Consensus 213 ~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~--~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g 290 (586)
+.+.+|.|+++.||++.. +++.||||+++.. .......+.+|++++++++|+||+++++++...+..+++|||++++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 345556666666666665 6899999998754 3334567999999999999999999999999999999999999999
Q ss_pred cHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC-----
Q 007892 291 TLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT----- 365 (586)
Q Consensus 291 sL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~----- 365 (586)
+|.+++.......+++.....++.|+++||+|||++ +|+||||||+|||++.++.+||+|||++........
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 999999765445688999999999999999999998 999999999999999999999999999875432211
Q ss_pred -cccccccccccccCcccccC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhccc-------
Q 007892 366 -HVSTRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLA------- 435 (586)
Q Consensus 366 -~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~------- 435 (586)
.......++..|+|||++.. ..++.++|||||||++|||++|+.||....... .+.+-........+.
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhhh
Confidence 11123457788999999875 358899999999999999999999997643211 111100000000000
Q ss_pred CCChhh----hhch-----hhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 436 DGNFDA----LVDQ-----KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 436 ~~~~~~----l~d~-----~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
...... ..++ ............+.+++.+||+.+|.+||++.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000000 0000 0012233445678899999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=302.36 Aligned_cols=259 Identities=19% Similarity=0.231 Sum_probs=184.5
Q ss_pred hcCccccceecccCcEEEEEEEEeC----CeEEEEEEeccCCchhHH-----------HHHHHHHHHHhcCCCCcceEEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLTN----GKVVAIKQLKAGSGQGER-----------EFQAEIEIISQVHHRHLVSLVG 272 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~~----g~~vAVK~l~~~~~~~~~-----------~~~~Ei~il~~l~Hpniv~l~g 272 (586)
.+.|.+.++||+|+||.||+|.+.+ +..+|+|........... ....+...+..++|+||+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3679999999999999999999754 345666654322211111 1122334455678999999999
Q ss_pred EEEeCC----eeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCC
Q 007892 273 YCTFGS----QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE 348 (586)
Q Consensus 273 ~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 348 (586)
++.... ..++++|++.. ++.+.+... ...++..+..|+.|++.||+|||+. +|+||||||+|||++.++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCc
Confidence 776543 34677777643 555555332 2357788899999999999999998 9999999999999999999
Q ss_pred eEEeecccccccCCCCCc------ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhh
Q 007892 349 AKVADFGLAKHSLDTDTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSM 422 (586)
Q Consensus 349 ~kl~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~ 422 (586)
+||+|||+++........ ......||+.|+|||++.+..++.++|||||||+||||++|+.||...... ..+
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~--~~~ 242 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN--GNL 242 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc--hHH
Confidence 999999999865432211 112246999999999999999999999999999999999999999765321 111
Q ss_pred hhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 007892 423 VDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484 (586)
Q Consensus 423 ~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~ 484 (586)
..-...-+ +..+....+. .......+.+++..|++.+|.+||++.+|++.|+
T Consensus 243 ~~~~~~~~--------~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 243 IHAAKCDF--------IKRLHEGKIK--IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHhHHHH--------HHHhhhhhhc--cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 11110000 0111111111 1123467899999999999999999999998763
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=303.44 Aligned_cols=267 Identities=22% Similarity=0.287 Sum_probs=194.7
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC-------
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGS------- 278 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~------- 278 (586)
++|+..+.||+|+||.||+|... +++.||||.+..... .....+.+|+.++++++||||++++++|....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 57999999999999999999965 689999999864322 22345678999999999999999999987654
Q ss_pred -eeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccc
Q 007892 279 -QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 357 (586)
Q Consensus 279 -~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla 357 (586)
..++||||+.+ +|.+.+.... ..+++.+++.++.|++.||+|||++ +|+|+||||+|||++.++.+||+|||++
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 45999999965 7777775433 3589999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCc---ccccccccccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhh----HH
Q 007892 358 KHSLDTDTH---VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAK----PF 429 (586)
Q Consensus 358 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~----~~ 429 (586)
......... ......++..|+|||++.+. .++.++||||||+++|||++|+.||...+............ +.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 865332211 12234678899999988764 47889999999999999999999997654321111111000 00
Q ss_pred Hhhccc----------CCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 430 LAQGLA----------DGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 430 ~~~~~~----------~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
+..... .......+...+. .......+.+++.+||+.+|.+||++.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~--~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLK--PYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcc--cccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 000000 0000000011111 00112456789999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=300.44 Aligned_cols=265 Identities=21% Similarity=0.273 Sum_probs=200.6
Q ss_pred ccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCch--hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEec
Q 007892 211 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ--GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 287 (586)
Q Consensus 211 f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~--~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 287 (586)
|+..+.||.|++|.||++... +++.+++|.++..... ....+..|++++++++|+||+++++++..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 556789999999999999965 6889999998654332 3467888999999999999999999999999999999999
Q ss_pred CCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcc
Q 007892 288 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 367 (586)
Q Consensus 288 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 367 (586)
++ +|.+++.... ..+++..++.++.+++.||.|||+. +|+|+||||+|||+++++.+||+|||++....... ..
T Consensus 81 ~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~ 154 (283)
T cd05118 81 DT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RP 154 (283)
T ss_pred CC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cc
Confidence 75 7877776543 4589999999999999999999998 99999999999999999999999999997664433 12
Q ss_pred cccccccccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhh-hh-------hhHHHhhcccCC-
Q 007892 368 STRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMV-DW-------AKPFLAQGLADG- 437 (586)
Q Consensus 368 ~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~-~~-------~~~~~~~~~~~~- 437 (586)
.....++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+........ .. ....+.+.....
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence 2334578899999998776 7899999999999999999999999765432110000 00 000000000000
Q ss_pred -ChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 438 -NFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 438 -~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
.+....+.............+.+++.+||+.+|.+||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00000000111122334678999999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=305.37 Aligned_cols=254 Identities=25% Similarity=0.429 Sum_probs=195.2
Q ss_pred HhcCccccceecccCcEEEEEEEEeC-CeEEEEEEeccCCc-hhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeeEEE
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSG-QGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~~~~~lV 283 (586)
..++|...+.||+|+||.||+|...+ ++.||||.++.... .....+..|+.++.++. |+||++++++|..+...++|
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 44678889999999999999999864 89999999975432 33456777888777775 99999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCC
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 363 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 363 (586)
|||+.+ +|..++.... ..+++..+..++.++++||+|||+.+ +|+||||+|+|||+++++.+||+|||++......
T Consensus 93 ~e~~~~-~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 93 MELMST-CLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred eeccCc-CHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 999854 6666554432 36899999999999999999999732 8999999999999999999999999999765432
Q ss_pred CCcccccccccccccCcccccCCC----CCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCCh
Q 007892 364 DTHVSTRVMGTFGYLAPEYASSGK----LTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 439 (586)
Q Consensus 364 ~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (586)
.. .....++..|+|||++.+.. ++.++||||||++||||++|+.||...... .+.+..+ + .+..
T Consensus 169 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~----~-----~~~~ 236 (296)
T cd06618 169 KA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-FEVLTKI----L-----QEEP 236 (296)
T ss_pred Cc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-HHHHHHH----h-----cCCC
Confidence 22 22335788999999987554 889999999999999999999999653210 0111110 1 0000
Q ss_pred hhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 440 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 440 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.. . .........+.+++.+||+.+|.+||++.+|++.
T Consensus 237 ~~-----~-~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 237 PS-----L-PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CC-----C-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 0 0111234568999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=323.09 Aligned_cols=244 Identities=24% Similarity=0.376 Sum_probs=193.7
Q ss_pred ccceecccCcEEEEEEEEe-CCeEEEEEEeccC----CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe--eEEEEE
Q 007892 213 EANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG----SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ--RLLVYE 285 (586)
Q Consensus 213 ~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~--~~lV~E 285 (586)
...+||+|.|-+||||... +|..||--.++.. +....+.|..|+++|+.|+|+|||+++.++.+... .-+|.|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3478999999999999964 5777874433221 22334789999999999999999999999987655 678999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCC-CCCeEEeecccccccCCCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD-SFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~-~~~~kl~DFGla~~~~~~~ 364 (586)
.|..|+|..|+....+ ++...+..|+.||++||.|||++ .|+|||||||..||||+. .|.|||+|+|||......
T Consensus 124 L~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s- 199 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS- 199 (632)
T ss_pred cccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc-
Confidence 9999999999976654 88889999999999999999997 789999999999999975 589999999999875332
Q ss_pred CcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhc
Q 007892 365 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 444 (586)
Q Consensus 365 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 444 (586)
....+.|||.|||||... ..|++..||||||++++||+|+..||..-...+ . +.+++..|....
T Consensus 200 --~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A-----Q-----IYKKV~SGiKP~--- 263 (632)
T KOG0584|consen 200 --HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA-----Q-----IYKKVTSGIKPA--- 263 (632)
T ss_pred --ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHH-----H-----HHHHHHcCCCHH---
Confidence 224488999999999887 789999999999999999999999997543211 1 111112222111
Q ss_pred hhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 445 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 445 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
.+..-...++.++|..||.. ..+||++.|+|.
T Consensus 264 ----sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 264 ----ALSKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ----HhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 11111235688999999999 999999999986
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=307.94 Aligned_cols=262 Identities=19% Similarity=0.279 Sum_probs=193.3
Q ss_pred ceeccc--CcEEEEEEEEe-CCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecCC
Q 007892 215 NLLGQG--GFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPN 289 (586)
Q Consensus 215 ~~LG~G--~fG~Vyk~~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~ 289 (586)
..||+| +||+||++... +|+.||||++..... ...+.+.+|+.++..++||||++++++|..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 99999999964 789999999875432 2245788999999999999999999999999999999999999
Q ss_pred CcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcc--
Q 007892 290 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV-- 367 (586)
Q Consensus 290 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~-- 367 (586)
++|.+++.......+++..+..++.|++.||+|||+. +|+||||||+||||+.++.+|++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999998765555689999999999999999999988 99999999999999999999999998654322111100
Q ss_pred ----cccccccccccCcccccCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhH---------HHh-
Q 007892 368 ----STRVMGTFGYLAPEYASSG--KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKP---------FLA- 431 (586)
Q Consensus 368 ----~~~~~gt~~y~aPE~~~~~--~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~---------~~~- 431 (586)
.....++..|+|||++.++ .++.++|||||||++|||++|+.||....... .+...... .+.
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--MLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--HHHHHhcCCCCCCccccccch
Confidence 0112356679999999764 47899999999999999999999997543211 11100000 000
Q ss_pred --hc-----------ccCCCh-----hhhhchhhh-ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 432 --QG-----------LADGNF-----DALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 432 --~~-----------~~~~~~-----~~l~d~~l~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
.. +.+... ..+.+..+. .........+.+++.+||+.||.+||++.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00 000000 000111111 122345577899999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=311.96 Aligned_cols=268 Identities=19% Similarity=0.299 Sum_probs=199.6
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEe----CCeeE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTF----GSQRL 281 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~----~~~~~ 281 (586)
++|+..+.||+|+||.||+|+.. +|+.||+|++..... .....+.+|+.+|.+++|+||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 68999999999999999999965 589999999865422 234567789999999999999999988753 35679
Q ss_pred EEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccC
Q 007892 282 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 361 (586)
Q Consensus 282 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~ 361 (586)
+||||+. ++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 85 lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 85 VVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 9999995 6898888654 3489999999999999999999998 99999999999999999999999999997653
Q ss_pred CCCCc---ccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhh----hhHHHhhc
Q 007892 362 DTDTH---VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDW----AKPFLAQG 433 (586)
Q Consensus 362 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~----~~~~~~~~ 433 (586)
..... ......|+..|+|||.+.. ..++.++|||||||++|||++|+.||...+.........- ....+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~ 238 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence 32211 1234578999999998865 4689999999999999999999999976543111000000 00000000
Q ss_pred ccCCChhhhhch-------hhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 434 LADGNFDALVDQ-------KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 434 ~~~~~~~~l~d~-------~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.....+....+. .+..........+.+++.+|++.+|.+||++.+++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000111111110 0011112345779999999999999999999999874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=305.20 Aligned_cols=268 Identities=24% Similarity=0.292 Sum_probs=196.6
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCch--hHHHHHHHHHHHHhcCCCCcceEEEEEEeC--CeeEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ--GEREFQAEIEIISQVHHRHLVSLVGYCTFG--SQRLL 282 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~--~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~--~~~~l 282 (586)
.++|+..+.||+|+||.||+|... +|+.||+|.++..... ....+.+|+.++.+++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 367999999999999999999975 5899999998654322 123567899999999999999999998765 46799
Q ss_pred EEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCC
Q 007892 283 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 283 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 362 (586)
||||+.+ +|.+++.... ..+++.++..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||++.....
T Consensus 86 v~e~~~~-~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEecCCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 9999965 7777775432 4589999999999999999999998 999999999999999999999999999986543
Q ss_pred CCCcccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccch-hhhhhhh-------HHHhhc
Q 007892 363 TDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADD-SMVDWAK-------PFLAQG 433 (586)
Q Consensus 363 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~-~~~~~~~-------~~~~~~ 433 (586)
... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||......... .+..+.. +.+...
T Consensus 161 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07845 161 PAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL 239 (309)
T ss_pred ccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence 321 1223346788999999865 45789999999999999999999999754431110 0001000 000000
Q ss_pred ccCCChhhhhchh---hhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 434 LADGNFDALVDQK---LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 434 ~~~~~~~~l~d~~---l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
-..+.+ .+.... +..........+.+++..|++.||++||++.||++.
T Consensus 240 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 240 PLVGKF-TLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccccc-cccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000 000000 000001124567889999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=297.30 Aligned_cols=244 Identities=23% Similarity=0.264 Sum_probs=190.1
Q ss_pred ceecccCcEEEEEEEEe-CCeEEEEEEeccCCch---hHHHHHHHHHHH-HhcCCCCcceEEEEEEeCCeeEEEEEecCC
Q 007892 215 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ---GEREFQAEIEII-SQVHHRHLVSLVGYCTFGSQRLLVYEFVPN 289 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~---~~~~~~~Ei~il-~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~ 289 (586)
+.||.|+||.||+|... +++.||||.+...... ....+..|..++ ...+|+||+++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56999999999999964 5889999998654321 223445555544 445899999999999999999999999999
Q ss_pred CcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcccc
Q 007892 290 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 369 (586)
Q Consensus 290 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 369 (586)
++|..++... ..+++..+..++.|++.||.|||+. +|+||||+|+|||+++++.+||+|||+++.... ..
T Consensus 82 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~ 151 (260)
T cd05611 82 GDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NK 151 (260)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----cc
Confidence 9999998654 3488899999999999999999998 999999999999999999999999999875432 23
Q ss_pred cccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhc
Q 007892 370 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEE 449 (586)
Q Consensus 370 ~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 449 (586)
...|+..|++||.+.+..++.++||||||++||||++|..||...+.. . ...... .+... .. ..
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~---~~~~~~-----~~~~~--~~---~~ 215 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD---A---VFDNIL-----SRRIN--WP---EE 215 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH---H---HHHHHH-----hcccC--CC---Cc
Confidence 346888999999998888999999999999999999999999754321 1 111100 00000 00 01
Q ss_pred cCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 007892 450 YDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484 (586)
Q Consensus 450 ~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~ 484 (586)
........+.+++.+||+.+|.+||++.++.+.|.
T Consensus 216 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 216 VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred ccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 11234567899999999999999998876665554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=298.52 Aligned_cols=241 Identities=25% Similarity=0.362 Sum_probs=187.5
Q ss_pred eecccCcEEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHH---HHHhcCCCCcceEEEEEEeCCeeEEEEEecC
Q 007892 216 LLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIE---IISQVHHRHLVSLVGYCTFGSQRLLVYEFVP 288 (586)
Q Consensus 216 ~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~---il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 288 (586)
.||+|+||.||++... +++.||+|.+..... .....+..|.. ++...+||||+.+++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 588999999865321 22223444444 3444579999999999999999999999999
Q ss_pred CCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCccc
Q 007892 289 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 368 (586)
Q Consensus 289 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 368 (586)
+++|.+++... ..+++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||++....... .
T Consensus 81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~ 152 (278)
T cd05606 81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---P 152 (278)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---C
Confidence 99999988643 3599999999999999999999998 89999999999999999999999999987543322 2
Q ss_pred ccccccccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhh
Q 007892 369 TRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 447 (586)
Q Consensus 369 ~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 447 (586)
....|+..|+|||++.++ .++.++|||||||+||||++|+.||.......... .... . ...+.
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~-~~~~---~----------~~~~~-- 216 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRM---T----------LTMAV-- 216 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH-HHHH---h----------hccCC--
Confidence 234689999999998754 68999999999999999999999997653211100 0000 0 00000
Q ss_pred hccCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 007892 448 EEYDSAEMTRMAACAAACIRHSARRRP-----RMSQIVR 481 (586)
Q Consensus 448 ~~~~~~~~~~l~~l~~~cl~~dp~~RP-----tm~evl~ 481 (586)
..+......+.+++.+|+..+|.+|| ++.++++
T Consensus 217 -~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 217 -ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred -CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 12222356789999999999999999 8999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=314.64 Aligned_cols=246 Identities=24% Similarity=0.326 Sum_probs=208.1
Q ss_pred HhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchh--HHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEE
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQG--EREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~--~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV 283 (586)
....|.+...||+|.|++|.+++.. .+..||+|.+.+..... .+.+.+|+++|..|+|||||+|+.+......+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 4467899999999999999999964 58899999997764333 35688999999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCC
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 363 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 363 (586)
|||+.+|.++++|...++ +.......++.|+..+++|||.+ .|||||||++||||+.+.++||+|||++..+.
T Consensus 134 ~eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-- 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD-- 206 (596)
T ss_pred EEeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec--
Confidence 999999999999987665 66678888999999999999999 89999999999999999999999999998774
Q ss_pred CCcccccccccccccCcccccCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhh
Q 007892 364 DTHVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 442 (586)
Q Consensus 364 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 442 (586)
........+|++.|.|||++.+..| ++.+|+||+||+||-|++|.+||++..... +
T Consensus 207 ~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~-----------------------L 263 (596)
T KOG0586|consen 207 YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE-----------------------L 263 (596)
T ss_pred ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc-----------------------c
Confidence 3445677899999999999998765 689999999999999999999998654311 1
Q ss_pred hchhhh---ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 443 VDQKLE---EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 443 ~d~~l~---~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
-++.+. ..+.-....+.++++++|-.+|.+|+++.+|.+.
T Consensus 264 r~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 264 RPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred cchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 111111 1222334567889999999999999999999764
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=308.02 Aligned_cols=269 Identities=20% Similarity=0.317 Sum_probs=197.2
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeC------C
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFG------S 278 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~------~ 278 (586)
.++|...+.||+|+||.||+|+.. +|+.||||+++... ......+.+|+.++.+++|+||++++++|... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 378999999999999999999964 68999999986532 22235678999999999999999999998754 3
Q ss_pred eeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccc
Q 007892 279 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 358 (586)
Q Consensus 279 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~ 358 (586)
..++|+||+.+ +|..++. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred eEEEEeccccc-CHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 46899999964 6766552 2488999999999999999999998 89999999999999999999999999997
Q ss_pred ccCCCCCcccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhh----hhHHHhhc
Q 007892 359 HSLDTDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDW----AKPFLAQG 433 (586)
Q Consensus 359 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~----~~~~~~~~ 433 (586)
..... .....++..|+|||.+.+ ..++.++|||||||+||||++|+.||...+.........+ ..+.+.+.
T Consensus 166 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07879 166 HADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK 241 (342)
T ss_pred CCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 64221 123467889999999876 4689999999999999999999999976542110000000 00000011
Q ss_pred ccCCChhhhhc-------hhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HhcCCC
Q 007892 434 LADGNFDALVD-------QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA--LEGNMP 488 (586)
Q Consensus 434 ~~~~~~~~l~d-------~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~--L~~~~~ 488 (586)
+........+. ..+..........+.+++.+||+.||.+||++.||+.. +++...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 11110011000 00000011234568899999999999999999999954 665433
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=300.68 Aligned_cols=248 Identities=22% Similarity=0.333 Sum_probs=202.7
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccC---CchhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeeEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG---SGQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~~~~~lV 283 (586)
++|...+.||+|+||.||+++.. +++.||+|++... .......+..|++++.+++ |+||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888999999999999999975 6899999998653 2233467889999999998 99999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCC
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 363 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 363 (586)
|||+++++|.+++.... .+++..++.|+.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 81 LEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 99999999999996543 599999999999999999999998 9999999999999999999999999998865433
Q ss_pred CC-------------------cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhh
Q 007892 364 DT-------------------HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD 424 (586)
Q Consensus 364 ~~-------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~ 424 (586)
.. .......++..|++||.+....++.++||||||+++++|++|+.||....... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~ 232 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL---TFQ 232 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH---HHH
Confidence 21 11223467899999999988889999999999999999999999998654210 000
Q ss_pred hhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCH----HHHHH
Q 007892 425 WAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRM----SQIVR 481 (586)
Q Consensus 425 ~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm----~evl~ 481 (586)
.+.+ ....++......+.+++.+||+.+|.+||++ .|+++
T Consensus 233 ----------------~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 233 ----------------KILK-LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred ----------------HHHh-cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0000 0002223335678999999999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=308.88 Aligned_cols=270 Identities=19% Similarity=0.291 Sum_probs=200.0
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC-----Cee
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG-----SQR 280 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~-----~~~ 280 (586)
++|...+.||+|+||.||+++.. +++.||||.+... .......+.+|+.++.+++|+||+++++++... ...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 57889999999999999999964 6899999998653 222345677899999999999999999988654 347
Q ss_pred EEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccccc
Q 007892 281 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 360 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~ 360 (586)
+|||||+. ++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 85 YIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred EEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 99999996 6888887543 3589999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCCcccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchh-hhhhhh---HHHhhccc
Q 007892 361 LDTDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDS-MVDWAK---PFLAQGLA 435 (586)
Q Consensus 361 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~-~~~~~~---~~~~~~~~ 435 (586)
.... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||...+...... +..... +-....+.
T Consensus 159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07858 159 SEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR 237 (337)
T ss_pred CCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcC
Confidence 4332 12233567889999998864 568999999999999999999999997543211000 000000 00000000
Q ss_pred CCChhhhh-------chhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--Hhc
Q 007892 436 DGNFDALV-------DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA--LEG 485 (586)
Q Consensus 436 ~~~~~~l~-------d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~--L~~ 485 (586)
.......+ +.............+.+++.+||+.+|.+||++.|+++. |+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 238 NEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred chhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 11111100 011111112345678999999999999999999999976 554
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=306.96 Aligned_cols=267 Identities=21% Similarity=0.304 Sum_probs=202.1
Q ss_pred CccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC-----eeE
Q 007892 210 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS-----QRL 281 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~-----~~~ 281 (586)
+|.+.+.||.|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999975 48899999987643 334467899999999999999999999998765 789
Q ss_pred EEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccC
Q 007892 282 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 361 (586)
Q Consensus 282 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~ 361 (586)
+||||++ ++|..++.... .+++..++.++.+++.||+|||+. +|+||||||.|||++.++.++|+|||++....
T Consensus 81 lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999997 47888886543 689999999999999999999998 99999999999999999999999999998754
Q ss_pred CCCC--cccccccccccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccch-hhhhhhhHHHhhc---c
Q 007892 362 DTDT--HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADD-SMVDWAKPFLAQG---L 434 (586)
Q Consensus 362 ~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~---~ 434 (586)
.... .......++..|+|||++.+. .++.++||||||+++|+|++|+.||......... .+..+......+. .
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 4321 122345688899999999877 7899999999999999999999999765431100 0000000000000 0
Q ss_pred cCCChhhhhc-------hhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 435 ADGNFDALVD-------QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 435 ~~~~~~~l~d-------~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
........+. ..+..........+.+++.+||+.+|.+||++.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0000000000 00111112245678999999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=294.03 Aligned_cols=248 Identities=23% Similarity=0.260 Sum_probs=192.3
Q ss_pred HHHHHhcCcccccee--cccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCC
Q 007892 203 ELKIATDNFSEANLL--GQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGS 278 (586)
Q Consensus 203 el~~~~~~f~~~~~L--G~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~ 278 (586)
+.....++|.+.+.+ |+|+||.||+++.. ++..+|+|.+...... . .|+.....+ +|+||+++++++...+
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~--~e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN---A--IEPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc---h--hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence 344445677777776 99999999999964 6788999998653211 1 122222222 6999999999999999
Q ss_pred eeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCC-CeEEeecccc
Q 007892 279 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF-EAKVADFGLA 357 (586)
Q Consensus 279 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~-~~kl~DFGla 357 (586)
..++||||+++++|.+++.... .++|.++..++.|+++||.|||+. +|+||||||+|||++.++ .++|+|||++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 9999999999999999986543 689999999999999999999998 899999999999999988 9999999998
Q ss_pred cccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCC
Q 007892 358 KHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADG 437 (586)
Q Consensus 358 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (586)
+..... ....|+..|+|||++.+..++.++|||||||++|||++|+.||...... ......|...
T Consensus 158 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~--------- 222 (267)
T PHA03390 158 KIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESLLKR--------- 222 (267)
T ss_pred eecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHHHHh---------
Confidence 764322 2245889999999999889999999999999999999999999844321 1111222111
Q ss_pred ChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCC-HHHHHH
Q 007892 438 NFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPR-MSQIVR 481 (586)
Q Consensus 438 ~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPt-m~evl~ 481 (586)
..... .........+.+++.+||+.+|.+||+ +.|+++
T Consensus 223 -----~~~~~-~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 223 -----QQKKL-PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred -----hcccC-CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 00000 112234567899999999999999995 688874
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=295.97 Aligned_cols=249 Identities=20% Similarity=0.318 Sum_probs=195.6
Q ss_pred CccccceecccCcEEEEEEEEeC-CeEEEEEEeccC-----CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEE
Q 007892 210 NFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAG-----SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~-----~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV 283 (586)
+|.+.+.||+|+||.||++.... +..+++|.++.. .......+..|+.++.+++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47788999999999999998643 444555655432 222344677899999999999999999999998999999
Q ss_pred EEecCCCcHHHHhcC--CCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccC
Q 007892 284 YEFVPNKTLEFHLHG--KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 361 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~--~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~ 361 (586)
|||+++++|.+++.. .....+++..++.++.|++.||.|||+. +++|+||||+||+++++ .+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~~-~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKNN-LLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeecC-CEeecccCceeecC
Confidence 999999999988864 2335689999999999999999999998 99999999999999864 69999999997654
Q ss_pred CCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhh
Q 007892 362 DTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 441 (586)
Q Consensus 362 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (586)
.... ......|+..|+|||++.+..++.++|+||||+++|+|++|+.||..... ......
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~------------- 216 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVLR------------- 216 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHH-------------
Confidence 3322 22335688899999999888889999999999999999999999964331 111111
Q ss_pred hhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 442 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 442 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
+........+......+.+++.+|++.+|++||++.|+++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 217 IVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred HHcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 01111112233445678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=299.49 Aligned_cols=244 Identities=25% Similarity=0.381 Sum_probs=192.8
Q ss_pred ccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 211 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 211 f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
|...+.||+|+||.||+|+.. +++.|++|++..... .....+.+|++++++++|+|++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666788999999999999964 688999999864322 2335688899999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 366 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 366 (586)
+. ++|.+.+.... ..+++.+++.++.|++.+|.|||+. +|+|+||||+||++++++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 103 CL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 96 56666665432 3589999999999999999999998 999999999999999999999999999864322
Q ss_pred ccccccccccccCccccc---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhh
Q 007892 367 VSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 443 (586)
Q Consensus 367 ~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 443 (586)
.....|+..|+|||++. .+.++.++|||||||++|||++|..||...+... ...+. . ......
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~---~~~~~---~-----~~~~~~-- 239 (313)
T cd06633 174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALYHI---A-----QNDSPT-- 239 (313)
T ss_pred -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHH---H-----hcCCCC--
Confidence 22356889999999984 4668899999999999999999999987644211 11110 0 000000
Q ss_pred chhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 444 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 444 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.........+.+++.+||+.+|.+||++.++++.
T Consensus 240 -----~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 240 -----LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -----CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111223458889999999999999999999964
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=302.08 Aligned_cols=269 Identities=23% Similarity=0.269 Sum_probs=194.4
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCch--hHHHHHHHHHHHHhcCCCCcceEEEEEEeCC------
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ--GEREFQAEIEIISQVHHRHLVSLVGYCTFGS------ 278 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~--~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~------ 278 (586)
.++|++.+.||.|+||.||+|+.. +++.||||++...... ....+.+|++++.+++|+||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999965 5889999998643222 2346788999999999999999999875433
Q ss_pred --eeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccc
Q 007892 279 --QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGL 356 (586)
Q Consensus 279 --~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGl 356 (586)
..++|+||+.+ +|...+... ...+++..+..++.|+++||+|||+. +|+|+||||+|||+++++.+||+|||+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCcc
Confidence 46899999965 566665543 34599999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCC----------cccccccccccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhh-h
Q 007892 357 AKHSLDTDT----------HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMV-D 424 (586)
Q Consensus 357 a~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~-~ 424 (586)
++....... ...+...+++.|+|||++.+. .++.++|||||||++|||++|+.||............ .
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 976433211 111234678899999988654 5899999999999999999999999754432110000 0
Q ss_pred hh-------hHHHh--hcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 425 WA-------KPFLA--QGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 425 ~~-------~~~~~--~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
.. .+.+. .............+.+..........+.+++.+||+.+|.+||++.|++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 00 00000 00000000000111111111112256889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=329.17 Aligned_cols=262 Identities=27% Similarity=0.468 Sum_probs=211.6
Q ss_pred HHHHhcCccccceecccCcEEEEEEEEeC--------CeEEEEEEeccCCch-hHHHHHHHHHHHHhc-CCCCcceEEEE
Q 007892 204 LKIATDNFSEANLLGQGGFGYVHKGVLTN--------GKVVAIKQLKAGSGQ-GEREFQAEIEIISQV-HHRHLVSLVGY 273 (586)
Q Consensus 204 l~~~~~~f~~~~~LG~G~fG~Vyk~~~~~--------g~~vAVK~l~~~~~~-~~~~~~~Ei~il~~l-~Hpniv~l~g~ 273 (586)
+++..+++.+.+.||+|.||.|++|.... ...||||.++..... ..+.+..|+++|..+ +|+||+.|+|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 44555666667799999999999998531 357999999876443 456899999999998 59999999999
Q ss_pred EEeCCeeEEEEEecCCCcHHHHhcCCC------C--------CCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCc
Q 007892 274 CTFGSQRLLVYEFVPNKTLEFHLHGKD------R--------PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSA 339 (586)
Q Consensus 274 ~~~~~~~~lV~E~~~~gsL~~~l~~~~------~--------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~ 339 (586)
|...+..++|.||+..|+|..+|.... . ..+.....+.++.|||.|++||++. ++|||||.++
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaR 447 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAAR 447 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhh
Confidence 999999999999999999999997654 0 1388889999999999999999998 8999999999
Q ss_pred eeEeCCCCCeEEeecccccccCCCCCcccccccc--cccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCc
Q 007892 340 NILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMG--TFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADT 416 (586)
Q Consensus 340 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~ 416 (586)
||||.++..+||+||||++...+........-.| ...|||||.+....|+.|+|||||||+||||++ |..||.....
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~ 527 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP 527 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence 9999999999999999999765544433222222 446999999999999999999999999999999 9999965221
Q ss_pred ccchhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 417 FADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 417 ~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
...+.++ +.+|.. ...+..+..++.++++.||+.+|++||++.|+++.|+..
T Consensus 528 --~~~l~~~--------l~~G~r--------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 528 --TEELLEF--------LKEGNR--------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred --HHHHHHH--------HhcCCC--------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 1122222 112221 123445567888999999999999999999999999973
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=306.35 Aligned_cols=272 Identities=20% Similarity=0.289 Sum_probs=201.8
Q ss_pred CHHHHHHHhcCccccceecccCcEEEEEEEE-eCCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 007892 200 TYEELKIATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTF 276 (586)
Q Consensus 200 ~~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~ 276 (586)
...++....++|.+.+.||+|+||.||+|.. .+++.||||+++... ......+.+|++++.+++|+||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 3456777889999999999999999999985 468999999987542 2224567889999999999999999998864
Q ss_pred C------CeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeE
Q 007892 277 G------SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAK 350 (586)
Q Consensus 277 ~------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 350 (586)
. ...+++++++ +++|.+++... .+++..+..++.|+++||+|||+. +|+||||||+||++++++.+|
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEE
Confidence 3 3467888876 78998877542 489999999999999999999998 999999999999999999999
Q ss_pred EeecccccccCCCCCcccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccch-hhhhh---
Q 007892 351 VADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADD-SMVDW--- 425 (586)
Q Consensus 351 l~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~-~~~~~--- 425 (586)
|+|||+++.... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+..... .+..+
T Consensus 161 l~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (345)
T cd07877 161 ILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 236 (345)
T ss_pred Eecccccccccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999999876432 1233568899999998865 56889999999999999999999999654321100 00000
Q ss_pred hhHHHhhcccCCChhhhh-------chhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 426 AKPFLAQGLADGNFDALV-------DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 426 ~~~~~~~~~~~~~~~~l~-------d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
..+.+...+........+ .....+........+.+++.+|++.+|.+||++.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 237 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000011111111000000 000001111234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=300.63 Aligned_cols=247 Identities=24% Similarity=0.352 Sum_probs=194.9
Q ss_pred CccccceecccCcEEEEEEEEe-CCeEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEE
Q 007892 210 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
.|...+.||+|+||.||+|+.. +++.||||.+... ......++.+|++++++++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3666789999999999999965 5788999998642 22234568889999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 365 (586)
|+. |+|.+++.... ..+++.++..++.+++.||.|||+. +++||||||+|||++.++.+||+|||++......
T Consensus 96 ~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 168 (308)
T cd06634 96 YCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (308)
T ss_pred ccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence 996 57776664333 3488999999999999999999998 9999999999999999999999999998764322
Q ss_pred cccccccccccccCccccc---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhh
Q 007892 366 HVSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 442 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 442 (586)
....++..|+|||++. .+.++.++|||||||++|||++|+.||...+.. .....+. .+..
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~---------~~~~--- 231 (308)
T cd06634 169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIA---------QNES--- 231 (308)
T ss_pred ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH--HHHHHHh---------hcCC---
Confidence 2346888999999974 356889999999999999999999998654321 1111111 0000
Q ss_pred hchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 007892 443 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484 (586)
Q Consensus 443 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~ 484 (586)
+. .........+.+++.+||+.+|.+||++.+|++...
T Consensus 232 --~~--~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 232 --PA--LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred --CC--cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 00 011223456889999999999999999999997644
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=330.82 Aligned_cols=252 Identities=27% Similarity=0.430 Sum_probs=192.5
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEe---------
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTF--------- 276 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~--------- 276 (586)
..+|++.++||+||||.|||++.+ ||+.||||+|.... ...-..+.+|+..|++|+|||||+.+..+.+
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 356888899999999999999965 89999999986553 2334578899999999999999997641100
Q ss_pred ---------------------------------------------------------------------C----------
Q 007892 277 ---------------------------------------------------------------------G---------- 277 (586)
Q Consensus 277 ---------------------------------------------------------------------~---------- 277 (586)
+
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 0
Q ss_pred -------------------------------CeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhc
Q 007892 278 -------------------------------SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED 326 (586)
Q Consensus 278 -------------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~ 326 (586)
..+||-||||+..+|.++++.+.... .-...++++.+|+.||.|+|+.
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHHhC
Confidence 12478899999988888886543211 3567789999999999999999
Q ss_pred CCCcEEecCCCCceeEeCCCCCeEEeecccccccC------CC-----------CCcccccccccccccCcccccCC---
Q 007892 327 CQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL------DT-----------DTHVSTRVMGTFGYLAPEYASSG--- 386 (586)
Q Consensus 327 ~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~------~~-----------~~~~~~~~~gt~~y~aPE~~~~~--- 386 (586)
+||||||||.|||||.+..|||+|||||+... +. .....+..+||.-|+|||++.+.
T Consensus 717 ---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 717 ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred ---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 99999999999999999999999999998621 00 11123557899999999999754
Q ss_pred CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhh
Q 007892 387 KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACI 466 (586)
Q Consensus 387 ~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl 466 (586)
+|+.|.|+|||||||+||+. ||...-+ +......+..+.+..- .++..+....-..++.+++
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~y---PF~TsME----------Ra~iL~~LR~g~iP~~-----~~f~~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEMLY---PFGTSME----------RASILTNLRKGSIPEP-----ADFFDPEHPEEASLIRWLL 855 (1351)
T ss_pred cccchhhhHHHHHHHHHHhc---cCCchHH----------HHHHHHhcccCCCCCC-----cccccccchHHHHHHHHHh
Confidence 59999999999999999996 5654321 1222233333332211 2345556667788999999
Q ss_pred ccCCCCCCCHHHHHH
Q 007892 467 RHSARRRPRMSQIVR 481 (586)
Q Consensus 467 ~~dp~~RPtm~evl~ 481 (586)
++||.+|||+.|+|.
T Consensus 856 ~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLN 870 (1351)
T ss_pred cCCCccCCCHHHHhh
Confidence 999999999999975
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=302.88 Aligned_cols=265 Identities=23% Similarity=0.294 Sum_probs=196.1
Q ss_pred cCcc-ccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchh--------------HHHHHHHHHHHHhcCCCCcceEEE
Q 007892 209 DNFS-EANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQG--------------EREFQAEIEIISQVHHRHLVSLVG 272 (586)
Q Consensus 209 ~~f~-~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~--------------~~~~~~Ei~il~~l~Hpniv~l~g 272 (586)
++|. ..+.||.|+||.||+|... +++.||||.++...... ...+.+|++++.+++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3454 3577999999999999965 68999999986543221 125778999999999999999999
Q ss_pred EEEeCCeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEe
Q 007892 273 YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVA 352 (586)
Q Consensus 273 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~ 352 (586)
++..++..++||||+. ++|.+++... ..+++.....++.|++.||.|||+. +|+|+|||++|||++.++.+||+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEEC
Confidence 9999999999999996 6888888543 3488999999999999999999998 99999999999999999999999
Q ss_pred ecccccccCCCC-------------CcccccccccccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCccc
Q 007892 353 DFGLAKHSLDTD-------------THVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFA 418 (586)
Q Consensus 353 DFGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~ 418 (586)
|||++....... ........++..|+|||++.+. .++.++|||||||++|||++|..||...+...
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~ 241 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID 241 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999997654110 1111223568899999998764 47899999999999999999999997654321
Q ss_pred chhhhhhhhHHHhhc----ccC----C---ChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 419 DDSMVDWAKPFLAQG----LAD----G---NFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 419 ~~~~~~~~~~~~~~~----~~~----~---~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
. .......+... +.. . .+..................+.+++..|++.+|.+||++.||+..
T Consensus 242 --~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 242 --Q-LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred --H-HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 1 11110000000 000 0 000001111111112234568899999999999999999999964
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=294.23 Aligned_cols=262 Identities=23% Similarity=0.301 Sum_probs=199.2
Q ss_pred ccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEec
Q 007892 211 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 287 (586)
Q Consensus 211 f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 287 (586)
|+..+.||+|+||.||+|+.. +++.||+|.+.... ......+..|+.++++++|+||+++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 556788999999999999976 48999999987653 222457788999999999999999999999999999999999
Q ss_pred CCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcc
Q 007892 288 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 367 (586)
Q Consensus 288 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 367 (586)
+ ++|.+++.... ..+++..+..++.++++||+|||+. +|+||||+|+||++++++.+||+|||+++....... .
T Consensus 81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~ 154 (282)
T cd07829 81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-T 154 (282)
T ss_pred C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-c
Confidence 7 58999987543 3589999999999999999999998 999999999999999999999999999986543322 1
Q ss_pred cccccccccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHH-----------hhcc-
Q 007892 368 STRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFL-----------AQGL- 434 (586)
Q Consensus 368 ~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~-----------~~~~- 434 (586)
.....++..|+|||.+... .++.++|||||||++|||++|+.||....... ...+....+ ....
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID---QLFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH---HHHHHHHHhCCCcHHHHHhhccccc
Confidence 2234567789999998766 88999999999999999999999997644211 111000000 0000
Q ss_pred cCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 435 ADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 435 ~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
....+..................+.+++.+||+.+|.+||++.+|+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00011111111110111112467999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=307.29 Aligned_cols=266 Identities=21% Similarity=0.277 Sum_probs=194.5
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC----------
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG---------- 277 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~---------- 277 (586)
.+|...+.||.|+||.||+|... +|+.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 67899999999999999999964 5889999998766555567789999999999999999999776543
Q ss_pred ----CeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeC-CCCCeEEe
Q 007892 278 ----SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD-DSFEAKVA 352 (586)
Q Consensus 278 ----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~-~~~~~kl~ 352 (586)
...++||||++ ++|..++.. ..+.+.....++.|++.||.|||+. +|+||||||+|||++ +++.+||+
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEEC
Confidence 35789999997 588877743 2488999999999999999999998 999999999999997 45678999
Q ss_pred ecccccccCCCCCcc--cccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHH
Q 007892 353 DFGLAKHSLDTDTHV--STRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPF 429 (586)
Q Consensus 353 DFGla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~ 429 (586)
|||+++......... .....++..|+|||.+.. ..++.++|||||||++|||++|+.||................+.
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999997643221111 123457889999998754 56888999999999999999999999765432111100000000
Q ss_pred H----hhcccCCChhhhh------chhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 430 L----AQGLADGNFDALV------DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 430 ~----~~~~~~~~~~~l~------d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
. ...........+. ...+..........+.+++..|++.||.+||++.||+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0 0000000000000 00000111123356889999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=283.65 Aligned_cols=250 Identities=23% Similarity=0.334 Sum_probs=201.7
Q ss_pred HhcCcccc-ceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCCcceEEEEEEe----CCe
Q 007892 207 ATDNFSEA-NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGYCTF----GSQ 279 (586)
Q Consensus 207 ~~~~f~~~-~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~----~~~ 279 (586)
.+++|++. ++||-|-.|.|-.+..+ +++.+|+|+|... ...++|+++..... |||||++++++.. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 34566553 67999999999999865 6889999998643 45688999988875 9999999999865 345
Q ss_pred eEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCC---CCCeEEeeccc
Q 007892 280 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD---SFEAKVADFGL 356 (586)
Q Consensus 280 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~---~~~~kl~DFGl 356 (586)
+++|||+|+||.|...+..++...+.+.+...|+.||+.|+.|||+. +|.||||||+|+|... |..+||+|||+
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccccc
Confidence 67899999999999999988888899999999999999999999998 9999999999999954 56799999999
Q ss_pred ccccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccC
Q 007892 357 AKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLAD 436 (586)
Q Consensus 357 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (586)
|+..... ....+-+.|+.|.|||++...+|+...|+||+||++|-|++|.+||.......- .+-....+..
T Consensus 211 AK~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai-------spgMk~rI~~ 281 (400)
T KOG0604|consen 211 AKETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-------SPGMKRRIRT 281 (400)
T ss_pred ccccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC-------ChhHHhHhhc
Confidence 9975432 233456889999999999999999999999999999999999999986554210 0111112222
Q ss_pred CChhhhhchhhhccCHH----HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 437 GNFDALVDQKLEEYDSA----EMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 437 ~~~~~l~d~~l~~~~~~----~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
|.+ +|+.. ..+...++++.+|+.+|.+|.|+.|++..
T Consensus 282 gqy---------~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 282 GQY---------EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred cCc---------cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 322 23333 33567788999999999999999999864
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=328.05 Aligned_cols=145 Identities=28% Similarity=0.374 Sum_probs=130.7
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
++|.+.++||+|+||.||+|... +++.||||+++... ......+.+|+.++..++|+||+++++++...+..+|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 67899999999999999999976 68899999987543 222467889999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccc
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 358 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~ 358 (586)
||+.+++|..++.... .+.+...+.|+.||+.||+|||.. +||||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999986543 488899999999999999999998 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=294.54 Aligned_cols=256 Identities=25% Similarity=0.382 Sum_probs=196.6
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeEEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
++.+.+..||.|.||+|+|-.++ .|+..|||++..... ....+|+.|.+...+- ++||||+++|.+..++..|+.||
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 34445678999999999999865 699999999987654 3446788888876665 69999999999999999999999
Q ss_pred ecCCCcHHH---HhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCC
Q 007892 286 FVPNKTLEF---HLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 286 ~~~~gsL~~---~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 362 (586)
.|+ -+|+. +.+......+++.-+-+|......||.||.+.. +||||||||+|||||..|.+||||||++..+.+
T Consensus 144 LMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 144 LMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred HHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 995 34443 333334456888888899999999999999875 899999999999999999999999999987644
Q ss_pred CCCcccccccccccccCcccccC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChh
Q 007892 363 TDTHVSTRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 440 (586)
Q Consensus 363 ~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (586)
.- ..+.-.|...|||||.+.. ..|+-++||||||++|||+.||..||+..+. +.+..... ..|...
T Consensus 221 Si--AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~V-----v~gdpp 288 (361)
T KOG1006|consen 221 SI--AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQV-----VIGDPP 288 (361)
T ss_pred HH--HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHH-----HcCCCC
Confidence 32 3355679999999999853 3489999999999999999999999986542 11111111 112211
Q ss_pred hhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 441 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 441 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.+... ....+....|+.++..|+.+|-..||...++.++
T Consensus 289 ~l~~~---~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 289 ILLFD---KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred eecCc---ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 11110 1112345678999999999999999999988753
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=304.00 Aligned_cols=265 Identities=22% Similarity=0.305 Sum_probs=197.2
Q ss_pred HHhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC----
Q 007892 206 IATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS---- 278 (586)
Q Consensus 206 ~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~---- 278 (586)
...++|+..+.||+|+||.||++... +++.||||++.... ......+.+|+++|.+++|+||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 34678999999999999999999854 68999999986432 222356889999999999999999999987643
Q ss_pred --eeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccc
Q 007892 279 --QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGL 356 (586)
Q Consensus 279 --~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGl 356 (586)
..++||||+ +++|..++.. ..+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~ 164 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 164 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccc
Confidence 458999999 7789888753 3489999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccc-hhhhhhh---hHHHh
Q 007892 357 AKHSLDTDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFAD-DSMVDWA---KPFLA 431 (586)
Q Consensus 357 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~-~~~~~~~---~~~~~ 431 (586)
+...... .....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.... ....... ...+.
T Consensus 165 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (343)
T cd07880 165 ARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV 240 (343)
T ss_pred ccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 9764321 123457889999999875 4588999999999999999999999975542110 0000000 00000
Q ss_pred hcccCCChhhhhc-------hhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 432 QGLADGNFDALVD-------QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 432 ~~~~~~~~~~l~d-------~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
..+.......... ..+..........+.+++.+|++.||.+||++.+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 241 QKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1111111111100 0011111223446889999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=299.65 Aligned_cols=264 Identities=20% Similarity=0.278 Sum_probs=192.0
Q ss_pred CccccceecccCcEEEEEEEEe-C--CeEEEEEEeccC--CchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeC----Ce
Q 007892 210 NFSEANLLGQGGFGYVHKGVLT-N--GKVVAIKQLKAG--SGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFG----SQ 279 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~-~--g~~vAVK~l~~~--~~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~----~~ 279 (586)
+|.+.+.||+|+||.||+++.. . +..||||++... .......+.+|++++.++ +|+||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778899999999999999965 3 678999998643 222345678899999999 599999999976543 35
Q ss_pred eEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccc
Q 007892 280 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 359 (586)
Q Consensus 280 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~ 359 (586)
.++++||+. ++|..++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 678889885 6888888543 4589999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCCc---ccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccc-------------hhh
Q 007892 360 SLDTDTH---VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFAD-------------DSM 422 (586)
Q Consensus 360 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~-------------~~~ 422 (586)
....... ......|+..|+|||++.+ ..++.++|||||||++|+|++|..||...+.... ..+
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL 234 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 5432211 1233568999999998765 4689999999999999999999999976442110 000
Q ss_pred hhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 423 VDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 423 ~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
..+..+....... .........+..........+.+++.+|++.+|.+||++.|++.
T Consensus 235 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 235 SRIGSPKAQNYIR--SLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HhhhhhhHHHHHH--hccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000000 00000000011111112456889999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=314.57 Aligned_cols=269 Identities=25% Similarity=0.375 Sum_probs=204.0
Q ss_pred ccccceecccCcEEEEEEEE-eCCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC------eeEE
Q 007892 211 FSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS------QRLL 282 (586)
Q Consensus 211 f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~------~~~l 282 (586)
+...+.||+|+||.||+|+. ..|+.||||.++... ....+...+|+++|++|+|+|||++++.-.... ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 34457899999999999995 479999999997643 233456789999999999999999988765433 5579
Q ss_pred EEEecCCCcHHHHhcCC-CCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEe--CCCC--CeEEeecccc
Q 007892 283 VYEFVPNKTLEFHLHGK-DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL--DDSF--EAKVADFGLA 357 (586)
Q Consensus 283 V~E~~~~gsL~~~l~~~-~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl--~~~~--~~kl~DFGla 357 (586)
|||||.+|+|...|..- +...|+..+.+.+..++..||.|||++ +||||||||.||++ ..+| -.||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 99999999999999764 345799999999999999999999998 99999999999998 3334 4799999999
Q ss_pred cccCCCCCcccccccccccccCccccc-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhh----
Q 007892 358 KHSLDTDTHVSTRVMGTFGYLAPEYAS-SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQ---- 432 (586)
Q Consensus 358 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~---- 432 (586)
+...+.. ..+.++||..|++||... .+.|+..+|.|||||++||++||.+||..........-+.|.. +.+
T Consensus 172 rel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~--~tkkp~~ 247 (732)
T KOG4250|consen 172 RELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHI--ITKKPSG 247 (732)
T ss_pred ccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhh--hccCCCc
Confidence 9875543 556789999999999998 4889999999999999999999999998655432222222211 111
Q ss_pred ------cccCCChhh--hhchhhhccCHHHHHHHHHHHHHhhccCCCCCC--CHHHHHHHHhcCC
Q 007892 433 ------GLADGNFDA--LVDQKLEEYDSAEMTRMAACAAACIRHSARRRP--RMSQIVRALEGNM 487 (586)
Q Consensus 433 ------~~~~~~~~~--l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RP--tm~evl~~L~~~~ 487 (586)
...+|.++. .+. ...........++-..+..++..++++|- ...+....+..++
T Consensus 248 v~i~~~~~eNgpv~~s~~lP-~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL 311 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLP-QPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL 311 (732)
T ss_pred eeEeeecccCCceeeeccCC-CcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence 011111111 010 01133445556778888889999999999 6666665555443
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=301.39 Aligned_cols=268 Identities=21% Similarity=0.289 Sum_probs=198.4
Q ss_pred HHHHhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEe-CCe
Q 007892 204 LKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTF-GSQ 279 (586)
Q Consensus 204 l~~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~-~~~ 279 (586)
+...+++|+..+.||+|+||.||++... +++.||||++... .......+.+|++++.+++||||++++++|.. ...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3446788999999999999999999855 7899999988543 22234678899999999999999999998866 567
Q ss_pred eEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccc
Q 007892 280 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 359 (586)
Q Consensus 280 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~ 359 (586)
.++|+||+ +++|..++... .+.+.....++.|+++||.|||+. +|+||||||+|||+++++.+||+|||++..
T Consensus 85 ~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccc
Confidence 88999998 56888887532 378888889999999999999998 999999999999999999999999999875
Q ss_pred cCCCCCcccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccc-hhhhhhhhH---HHhhcc
Q 007892 360 SLDTDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFAD-DSMVDWAKP---FLAQGL 434 (586)
Q Consensus 360 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~-~~~~~~~~~---~~~~~~ 434 (586)
.... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ..+.++... -+.+.+
T Consensus 158 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 158 QDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred cCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 4221 123457889999998865 5689999999999999999999999975442110 001111000 000000
Q ss_pred cCCChhhhh-chhhh-ccC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 435 ADGNFDALV-DQKLE-EYD-----SAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 435 ~~~~~~~l~-d~~l~-~~~-----~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
..+....++ .-... ..+ ......+.+++.+|++.+|++||++.+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000 00000 001 1234678999999999999999999999765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=338.38 Aligned_cols=256 Identities=28% Similarity=0.401 Sum_probs=205.8
Q ss_pred HHhcCccccceecccCcEEEEEEE-EeCCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEE
Q 007892 206 IATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 282 (586)
Q Consensus 206 ~~~~~f~~~~~LG~G~fG~Vyk~~-~~~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~l 282 (586)
..+-+++..+.||.|.||.||-|. +.+|...|||.++-... .....+.+|..+|..|+|||+|+.+|+-.+.+..+|
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 344567788999999999999999 55799999999865433 334567899999999999999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCC
Q 007892 283 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 283 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 362 (586)
.||||.+|+|.+.+.... ..++.....+-.|++.||+|||++ |||||||||.||||+.+|-+|++|||.|.....
T Consensus 1312 FMEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecC
Confidence 999999999999985432 245555556788999999999999 999999999999999999999999999987654
Q ss_pred CCCc---ccccccccccccCcccccCCC---CCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccC
Q 007892 363 TDTH---VSTRVMGTFGYLAPEYASSGK---LTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLAD 436 (586)
Q Consensus 363 ~~~~---~~~~~~gt~~y~aPE~~~~~~---~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (586)
.... .....+||+-|||||++.+-. -..++||||||||++||+||++||...+. +|+. +..+..
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------e~aI---My~V~~ 1456 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------EWAI---MYHVAA 1456 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------hhHH---HhHHhc
Confidence 4211 224578999999999997533 45689999999999999999999987654 3542 222223
Q ss_pred CChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 007892 437 GNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484 (586)
Q Consensus 437 ~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~ 484 (586)
|... .++......=.+++..||+.||.+|.++.|+++.--
T Consensus 1457 gh~P--------q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f 1496 (1509)
T KOG4645|consen 1457 GHKP--------QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAF 1496 (1509)
T ss_pred cCCC--------CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhc
Confidence 3222 344446677789999999999999999998887643
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=286.01 Aligned_cols=266 Identities=23% Similarity=0.401 Sum_probs=203.7
Q ss_pred HHHHHHHhcCccccceecccCcEEEEEEE-EeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCC
Q 007892 201 YEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGS 278 (586)
Q Consensus 201 ~~el~~~~~~f~~~~~LG~G~fG~Vyk~~-~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~~ 278 (586)
++++-.-+ .++||+|.|+.|--++ +.+|+.+|||++.+........+.+|++++.+.+ |+||+.|+.||+++.
T Consensus 75 F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 75 FEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred HHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 45555444 3789999999999988 6789999999998887777888999999999996 999999999999999
Q ss_pred eeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCC---CeEEeecc
Q 007892 279 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF---EAKVADFG 355 (586)
Q Consensus 279 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~---~~kl~DFG 355 (586)
..|||||-|.||.|..|++.. ..+++.+..++..+|+.||.+||.+ +|.||||||+|||-.+.. -+|||||.
T Consensus 150 ~FYLVfEKm~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfD 224 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFD 224 (463)
T ss_pred eEEEEEecccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccc
Confidence 999999999999999999654 5699999999999999999999999 999999999999996554 47999998
Q ss_pred cccccCCC------CCcccccccccccccCccccc-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhh
Q 007892 356 LAKHSLDT------DTHVSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD 424 (586)
Q Consensus 356 la~~~~~~------~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~ 424 (586)
|..-.... .+....+-+|+..|||||+.. .-.|+.+.|.||||||||-|++|..||.+.-..+ ..
T Consensus 225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d----CG 300 (463)
T KOG0607|consen 225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD----CG 300 (463)
T ss_pred cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc----CC
Confidence 87532111 112223467999999999763 3468999999999999999999999997643311 22
Q ss_pred hhhHHHhhcccCCChhhhhchhhhccCHHHH----HHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 425 WAKPFLAQGLADGNFDALVDQKLEEYDSAEM----TRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 425 ~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~----~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
|.+--.-+.-.+..|..|-+... +|+..++ .+..+++...+-.++.+|.++.+++.
T Consensus 301 WdrGe~Cr~CQ~~LFesIQEGkY-eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 301 WDRGEVCRVCQNKLFESIQEGKY-EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ccCCCccHHHHHHHHHHHhccCC-cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 32111000000011111222221 3444444 34567777888899999999999987
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=311.40 Aligned_cols=260 Identities=25% Similarity=0.396 Sum_probs=213.2
Q ss_pred HHHHHHHhcCccccceecccCcEEEEEEE-EeCCeEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEEe--
Q 007892 201 YEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTF-- 276 (586)
Q Consensus 201 ~~el~~~~~~f~~~~~LG~G~fG~Vyk~~-~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~-- 276 (586)
++.+...++-|++.+.||.|.+|+||+++ .++++.+|||++.... ...+++..|.+||+.+ +|||++.++|++..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 44445566789999999999999999999 4578999999987654 3356888899999988 69999999999864
Q ss_pred ---CCeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEee
Q 007892 277 ---GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVAD 353 (586)
Q Consensus 277 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~D 353 (586)
++++|||||||.+|+..+++++.....+.|..+..|+..++.||.+||.+ .++|||||-.||||+.++.|||+|
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvD 166 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVD 166 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEee
Confidence 57899999999999999999877777899999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCCCcccccccccccccCcccccCC-----CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhH
Q 007892 354 FGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSG-----KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKP 428 (586)
Q Consensus 354 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~ 428 (586)
||++..+. .......+..||+.|||||++... .|+..+|+||||++..||--|.+|+.+.-+.. .
T Consensus 167 FGvSaQld-sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr---------a 236 (953)
T KOG0587|consen 167 FGVSAQLD-STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR---------A 236 (953)
T ss_pred eeeeeeee-cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh---------h
Confidence 99987643 233445567899999999999653 47789999999999999999999987654311 1
Q ss_pred HHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 429 FLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 429 ~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
++ . +..-..+.| ..+..-.+.+.++|..||.+|..+||++.+++++
T Consensus 237 LF-~------IpRNPPPkL-krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 237 LF-L------IPRNPPPKL-KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred hc-c------CCCCCCccc-cchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 00 0 000011111 3456667889999999999999999999998864
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=325.58 Aligned_cols=258 Identities=25% Similarity=0.305 Sum_probs=212.1
Q ss_pred CHHHHHHHhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 007892 200 TYEELKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCT 275 (586)
Q Consensus 200 ~~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~ 275 (586)
...+++...++|.++++||+|+||.|..++++ .+++||.|++.++. ......|.+|-++|..-+.+=||+|+..|.
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 35678888899999999999999999999975 58999999998753 223457899999999999999999999999
Q ss_pred eCCeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecc
Q 007892 276 FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 355 (586)
Q Consensus 276 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFG 355 (586)
+...+|||||||+||+|-.+|...+ .++......++..|.-||.-||+. |+|||||||.|||||..|++||+|||
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccch
Confidence 9999999999999999999997665 577877888899999999999998 99999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccccCccccc----C-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHH
Q 007892 356 LAKHSLDTDTHVSTRVMGTFGYLAPEYAS----S-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFL 430 (586)
Q Consensus 356 la~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 430 (586)
-|-.+.....-.+...+|||.|++||++. + +.|+..+|+||+||++|||+.|..||.. +++++--.
T Consensus 221 sClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa------dslveTY~--- 291 (1317)
T KOG0612|consen 221 SCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA------DSLVETYG--- 291 (1317)
T ss_pred hHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH------HHHHHHHH---
Confidence 99877655555566678999999999985 2 6799999999999999999999999964 34443322
Q ss_pred hhcccCCChhhhhchhhh-ccC--HHHHHHHHHHHHHhhccCCCCCCC---HHHHHHH
Q 007892 431 AQGLADGNFDALVDQKLE-EYD--SAEMTRMAACAAACIRHSARRRPR---MSQIVRA 482 (586)
Q Consensus 431 ~~~~~~~~~~~l~d~~l~-~~~--~~~~~~l~~l~~~cl~~dp~~RPt---m~evl~~ 482 (586)
.|++..-. .|+ .+......++|.+.+.. +..|.. +.++-.+
T Consensus 292 ----------KIm~hk~~l~FP~~~~VSeeakdLI~~ll~~-~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 292 ----------KIMNHKESLSFPDETDVSEEAKDLIEALLCD-REVRLGRNGIEDIKNH 338 (1317)
T ss_pred ----------HHhchhhhcCCCcccccCHHHHHHHHHHhcC-hhhhcccccHHHHHhC
Confidence 33333111 233 34556777888877754 677777 7777653
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=302.58 Aligned_cols=265 Identities=23% Similarity=0.341 Sum_probs=198.3
Q ss_pred HhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe----
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ---- 279 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~---- 279 (586)
..++|+..+.||+|+||.||+|... +++.||||++.... ......+.+|+.++++++|+||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3578999999999999999999975 57899999986532 2233567789999999999999999988766554
Q ss_pred --eEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccc
Q 007892 280 --RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 357 (586)
Q Consensus 280 --~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla 357 (586)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||++
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccc
Confidence 89999998 6789888864 3589999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccch-hhhhh---hhHHHhh
Q 007892 358 KHSLDTDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADD-SMVDW---AKPFLAQ 432 (586)
Q Consensus 358 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~-~~~~~---~~~~~~~ 432 (586)
...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||........- .+.+. ..+.+..
T Consensus 166 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (343)
T cd07851 166 RHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQ 241 (343)
T ss_pred cccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Confidence 865332 233467889999999865 36789999999999999999999999754431100 00000 0000111
Q ss_pred cccCCChhhhhch-------hhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 433 GLADGNFDALVDQ-------KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 433 ~~~~~~~~~l~d~-------~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.+........+.. ............+.+++.+||+.+|.+||++.||++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 242 KISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred hccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 1111111111110 0011111225678999999999999999999999863
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=294.54 Aligned_cols=242 Identities=27% Similarity=0.385 Sum_probs=199.7
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCch---hHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ---GEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLL 282 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~---~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~~~~l 282 (586)
..+|..+.+||+|+||+|-++.-+ ..+.+|||+|+++.-. +.+--..|-.+|... +-|.+++|..++..-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 357888999999999999999865 3578999999876322 122234566677665 46889999999999999999
Q ss_pred EEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCC
Q 007892 283 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 283 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 362 (586)
||||+.||+|-.+++.-++ +.++..+.+|.+||-||-+||++ +||+||||..|||||.+|++||+|||+++.-.-
T Consensus 428 VMEyvnGGDLMyhiQQ~Gk--FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVGK--FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred EEEEecCchhhhHHHHhcc--cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccccc
Confidence 9999999999999976544 78888999999999999999999 999999999999999999999999999986433
Q ss_pred CCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhh
Q 007892 363 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 442 (586)
Q Consensus 363 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 442 (586)
.. ....+.+||+.|+|||.+...+|+..+|+|||||+||||+.|+.||++.++. ..+..+
T Consensus 503 ~~-~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~-------------------elF~aI 562 (683)
T KOG0696|consen 503 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-------------------ELFQAI 562 (683)
T ss_pred CC-cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH-------------------HHHHHH
Confidence 22 2345689999999999999999999999999999999999999999987641 112233
Q ss_pred hchhhhccCHHHHHHHHHHHHHhhccCCCCCCC
Q 007892 443 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPR 475 (586)
Q Consensus 443 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPt 475 (586)
.+... .|+.....+.+.+++..+...|.+|..
T Consensus 563 ~ehnv-syPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 563 MEHNV-SYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred HHccC-cCcccccHHHHHHHHHHhhcCCccccC
Confidence 33332 467777788899999999999999864
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=283.73 Aligned_cols=236 Identities=29% Similarity=0.352 Sum_probs=193.4
Q ss_pred ecccCcEEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecCCCcH
Q 007892 217 LGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL 292 (586)
Q Consensus 217 LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~gsL 292 (586)
||+|+||.||++... +++.||+|.+..... .....+..|++++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999975 488999999876432 2345788999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCccccccc
Q 007892 293 EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM 372 (586)
Q Consensus 293 ~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 372 (586)
.+++.... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....... .......
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~ 154 (250)
T cd05123 81 FSHLSKEG--RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFC 154 (250)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCc
Confidence 99996543 489999999999999999999997 99999999999999999999999999997654332 1223456
Q ss_pred ccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhccCH
Q 007892 373 GTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDS 452 (586)
Q Consensus 373 gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~ 452 (586)
++..|++||.+.+...+.++|+||||+++|||++|+.||...+. ..+.... . .. .+ .++.
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~---~-----~~--------~~-~~~~ 214 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKI---L-----KD--------PL-RFPE 214 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHH---h-----cC--------CC-CCCC
Confidence 88899999999888899999999999999999999999975442 1111110 0 00 00 1222
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHH
Q 007892 453 AEMTRMAACAAACIRHSARRRPRMSQ 478 (586)
Q Consensus 453 ~~~~~l~~l~~~cl~~dp~~RPtm~e 478 (586)
.....+.+++.+|+..+|.+||++.+
T Consensus 215 ~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 215 FLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 23567889999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=302.04 Aligned_cols=260 Identities=22% Similarity=0.305 Sum_probs=184.7
Q ss_pred HhcCccccceecccCcEEEEEEEE-----------------eCCeEEEEEEeccCCchhHHHH--------------HHH
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVL-----------------TNGKVVAIKQLKAGSGQGEREF--------------QAE 255 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~-----------------~~g~~vAVK~l~~~~~~~~~~~--------------~~E 255 (586)
..++|++.++||+|+||.||+|.+ .+++.||||+++.......++| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 457899999999999999999974 2356899999876543323333 347
Q ss_pred HHHHHhcCCCCc-----ceEEEEEEe--------CCeeEEEEEecCCCcHHHHhcCCCC---------------------
Q 007892 256 IEIISQVHHRHL-----VSLVGYCTF--------GSQRLLVYEFVPNKTLEFHLHGKDR--------------------- 301 (586)
Q Consensus 256 i~il~~l~Hpni-----v~l~g~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~--------------------- 301 (586)
+.++.+++|.++ +++++||.. .+..+|||||+++++|.++|+....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777788876554 778888754 3568999999999999999875321
Q ss_pred -CCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcccccccccccccCc
Q 007892 302 -PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAP 380 (586)
Q Consensus 302 -~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aP 380 (586)
..++|..+..++.|++.+|.|||+. +|+||||||+|||++.++.+||+|||+++..............+++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 1346778889999999999999998 899999999999999999999999999976433222122223458899999
Q ss_pred ccccCCC----------------------CCCcchHHHHHHHHHHHHhCCC-CCCCCCcccc------hhhhhhhhHHHh
Q 007892 381 EYASSGK----------------------LTEKSDVFSFGVLLLELITGFR-PFDKADTFAD------DSMVDWAKPFLA 431 (586)
Q Consensus 381 E~~~~~~----------------------~s~ksDVwSlGvvL~elltG~~-Pf~~~~~~~~------~~~~~~~~~~~~ 431 (586)
|.+.... ...+.||||+||+||||++|.. ||.....+.. ..+..|..
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~---- 455 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM---- 455 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh----
Confidence 9875432 1235799999999999999886 7754332111 11112210
Q ss_pred hcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCC---CCCCCHHHHHHH
Q 007892 432 QGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSA---RRRPRMSQIVRA 482 (586)
Q Consensus 432 ~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp---~~RPtm~evl~~ 482 (586)
.....++ . ...........+++.+||..++ .+|+++.|++++
T Consensus 456 --~~~~~~~------~-~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 456 --YKGQKYD------F-SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred --hcccCCC------c-ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 0011110 0 1112234567888999998765 789999999864
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=272.24 Aligned_cols=238 Identities=28% Similarity=0.329 Sum_probs=194.5
Q ss_pred CcEEEEEEEEe-CCeEEEEEEeccCCchh-HHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecCCCcHHHHhcC
Q 007892 221 GFGYVHKGVLT-NGKVVAIKQLKAGSGQG-EREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHG 298 (586)
Q Consensus 221 ~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~-~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~ 298 (586)
+||.||+|+.. +|+.+|+|++....... ...+.+|++.+++++|+||+++++++......++++||+++++|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999986 48999999997765544 67899999999999999999999999999999999999999999999865
Q ss_pred CCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCccccccccccccc
Q 007892 299 KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYL 378 (586)
Q Consensus 299 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~ 378 (586)
... +++..++.++.+++.+|.|||+. +|+|+||+|+||++++++.++|+|||++....... ......++..|+
T Consensus 81 ~~~--~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~ 153 (244)
T smart00220 81 RGR--LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYM 153 (244)
T ss_pred ccC--CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCC
Confidence 433 88999999999999999999998 99999999999999999999999999998754432 223456888999
Q ss_pred CcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHH
Q 007892 379 APEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRM 458 (586)
Q Consensus 379 aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l 458 (586)
+||.+....++.++|||+||+++++|++|..||..... ...+.++.. .+.... ..........+
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~~~~~~~--------~~~~~~------~~~~~~~~~~~ 217 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLELFKKIG--------KPKPPF------PPPEWKISPEA 217 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHh--------ccCCCC------ccccccCCHHH
Confidence 99999988899999999999999999999999975321 112222111 110000 00000034678
Q ss_pred HHHHHHhhccCCCCCCCHHHHHH
Q 007892 459 AACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 459 ~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
.+++.+|+..+|.+||++.++++
T Consensus 218 ~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 218 KDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHccCCchhccCHHHHhh
Confidence 99999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=299.26 Aligned_cols=240 Identities=23% Similarity=0.282 Sum_probs=196.6
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeEEEEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
++.|.....||.|+|+.|-++... +++..+||++... ..+..+|+.++.+. +|+||+++.+.|.++.+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 467777888999999999999854 6889999999765 23456678777776 69999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEe-CCCCCeEEeecccccccCCCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL-DDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl-~~~~~~kl~DFGla~~~~~~~ 364 (586)
.+.++-|.+.+..... +. .++..|+.+|+.++.|||++ +||||||||+|||+ ++.++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~~~~--~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPE--FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred hccccHHHHHHHhcch--hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 9999998888755433 22 67778999999999999998 99999999999999 68899999999999876443
Q ss_pred CcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhc
Q 007892 365 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 444 (586)
Q Consensus 365 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 444 (586)
...-+-|..|.|||++....|++++|+||||++||+|++|+.||...... .. +...+..+
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~e--------i~~~i~~~------- 529 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IE--------IHTRIQMP------- 529 (612)
T ss_pred ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HH--------HHHhhcCC-------
Confidence 23346788999999999999999999999999999999999999865431 00 11111111
Q ss_pred hhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 445 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 445 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.+.........+|+.+||+.||.+||+|.|+...
T Consensus 530 ----~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 530 ----KFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred ----ccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 2334556778899999999999999999998753
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=276.28 Aligned_cols=220 Identities=21% Similarity=0.178 Sum_probs=176.6
Q ss_pred cCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecCCCcHHHHhcC
Q 007892 220 GGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHG 298 (586)
Q Consensus 220 G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~ 298 (586)
|.||.||+++.. +++.||+|.+.... .+..|...+....||||+++++++...+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999964 68899999987542 334455555666799999999999999999999999999999998865
Q ss_pred CCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCccccccccccccc
Q 007892 299 KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYL 378 (586)
Q Consensus 299 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~ 378 (586)
.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++...... .....++..|+
T Consensus 79 ~~--~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~ 149 (237)
T cd05576 79 FL--NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYC 149 (237)
T ss_pred hc--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCcccc
Confidence 43 489999999999999999999998 9999999999999999999999999988654322 12234677899
Q ss_pred CcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHH
Q 007892 379 APEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRM 458 (586)
Q Consensus 379 aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l 458 (586)
|||++..+.++.++|||||||++|||++|+.||....... .. ...+ ..+......+
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----~~----------~~~~---------~~~~~~~~~~ 205 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----NT----------HTTL---------NIPEWVSEEA 205 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----cc----------cccc---------CCcccCCHHH
Confidence 9999988889999999999999999999998875322100 00 0000 1112234568
Q ss_pred HHHHHHhhccCCCCCCCHH
Q 007892 459 AACAAACIRHSARRRPRMS 477 (586)
Q Consensus 459 ~~l~~~cl~~dp~~RPtm~ 477 (586)
.+++.+|++.||.+||++.
T Consensus 206 ~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 206 RSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHHccCCHHHhcCCC
Confidence 8999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=307.98 Aligned_cols=262 Identities=21% Similarity=0.218 Sum_probs=172.4
Q ss_pred HhcCccccceecccCcEEEEEEEEeC-----CeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEE------EE
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLTN-----GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGY------CT 275 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~~-----g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~------~~ 275 (586)
..++|+..+.||+|+||.||+|++.+ +..||||++...... +.+..| .+.+..+.+++.++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 45789999999999999999999754 689999988643211 111111 1122222222222111 34
Q ss_pred eCCeeEEEEEecCCCcHHHHhcCCCCC------------------CCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCC
Q 007892 276 FGSQRLLVYEFVPNKTLEFHLHGKDRP------------------VMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIK 337 (586)
Q Consensus 276 ~~~~~~lV~E~~~~gsL~~~l~~~~~~------------------~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk 337 (586)
.+...+|||||+.+++|.++++..... ......+..|+.|++.||+|||+. +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 567889999999999999988654311 011233557899999999999998 99999999
Q ss_pred CceeEeCC-CCCeEEeecccccccCCCCCcccccccccccccCcccccCC----------------------CCCCcchH
Q 007892 338 SANILLDD-SFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSG----------------------KLTEKSDV 394 (586)
Q Consensus 338 ~~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~ksDV 394 (586)
|+||||++ ++.+||+|||+++..............+++.|||||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 57999999999986544444445567899999999965321 24457799
Q ss_pred HHHHHHHHHHHhCCCCCCCCCcc-------cchhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhc
Q 007892 395 FSFGVLLLELITGFRPFDKADTF-------ADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIR 467 (586)
Q Consensus 395 wSlGvvL~elltG~~Pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~ 467 (586)
|||||+||||+++..+++..... ....+..|..... .....++ ....+ ..........+|+.+||+
T Consensus 363 wSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~-----~~~~~~~-~~~~~-~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVE-----PRASPDL-RRGFE-VLDLDGGAGWELLKSMMR 435 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhc-----cccchhh-hhhhh-hccccchHHHHHHHHHcc
Confidence 99999999999987765432100 0011122211100 0000000 00000 000112235689999999
Q ss_pred cCCCCCCCHHHHHHH
Q 007892 468 HSARRRPRMSQIVRA 482 (586)
Q Consensus 468 ~dp~~RPtm~evl~~ 482 (586)
.||++||++.|++++
T Consensus 436 ~dP~kR~ta~e~L~H 450 (566)
T PLN03225 436 FKGRQRISAKAALAH 450 (566)
T ss_pred CCcccCCCHHHHhCC
Confidence 999999999999974
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=288.39 Aligned_cols=253 Identities=28% Similarity=0.442 Sum_probs=192.7
Q ss_pred cCccccceecccCcEEEEEEE-EeCCeEEEEEEeccCCch---hH----HHHHHHHHHHHhcCCCCcceEEEEEEeC-Ce
Q 007892 209 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQ---GE----REFQAEIEIISQVHHRHLVSLVGYCTFG-SQ 279 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~-~~~g~~vAVK~l~~~~~~---~~----~~~~~Ei~il~~l~Hpniv~l~g~~~~~-~~ 279 (586)
++|-.+++||+|||+.|||+. +...+.||||+-..+..+ .. +-..+|..|...|.||.||++++|+..+ +.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 346677899999999999998 455788999986443222 11 1245799999999999999999999754 56
Q ss_pred eEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCC---CCCeEEeeccc
Q 007892 280 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD---SFEAKVADFGL 356 (586)
Q Consensus 280 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~---~~~~kl~DFGl 356 (586)
.|-|+|||+|.+|+.+|..+ +.+++.+...|++||+.||.||.+. .++|||-||||.||||-+ -|.+||.||||
T Consensus 543 FCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred ceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 78999999999999999644 5699999999999999999999986 789999999999999954 47899999999
Q ss_pred ccccCCCCC------cccccccccccccCcccccCC----CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhh
Q 007892 357 AKHSLDTDT------HVSTRVMGTFGYLAPEYASSG----KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWA 426 (586)
Q Consensus 357 a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~----~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~ 426 (586)
++.+.+... .......||.+|++||.+.-+ +++.|.||||+|||+|.++.|+.||...... ..+....
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ--QdILqeN 697 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ--QDILQEN 697 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH--HHHHhhh
Confidence 998654322 223456899999999988543 5789999999999999999999999865431 1111110
Q ss_pred hHHHhhcccCCChhhhhchhhhccC--HHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 007892 427 KPFLAQGLADGNFDALVDQKLEEYD--SAEMTRMAACAAACIRHSARRRPRMSQIV 480 (586)
Q Consensus 427 ~~~~~~~~~~~~~~~l~d~~l~~~~--~~~~~~l~~l~~~cl~~dp~~RPtm~evl 480 (586)
.++...--.|+ .....+..++|.+||+..-++|-...|+.
T Consensus 698 --------------TIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 698 --------------TILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred --------------chhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 00100000111 22335678899999999999987765543
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=291.27 Aligned_cols=244 Identities=24% Similarity=0.357 Sum_probs=194.7
Q ss_pred cceecccCcEEEEEEEEe-CCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecCCC
Q 007892 214 ANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNK 290 (586)
Q Consensus 214 ~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g 290 (586)
.+.||.|.||+||-|+++ +|+.||||++.+- ....+..+++|+.||++++||.||.|...|+..+..++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 478999999999999965 7999999999654 3344678999999999999999999999999999999999999665
Q ss_pred cHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCC---CCeEEeecccccccCCCCCcc
Q 007892 291 TLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS---FEAKVADFGLAKHSLDTDTHV 367 (586)
Q Consensus 291 sL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~---~~~kl~DFGla~~~~~~~~~~ 367 (586)
-|+-.|. .....|+...-..++.||+.||.|||.+ +|+|+||||+||||.+. -.+||||||+|+...+. ..
T Consensus 649 MLEMILS-sEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk--sF 722 (888)
T KOG4236|consen 649 MLEMILS-SEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK--SF 722 (888)
T ss_pred HHHHHHH-hhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchh--hh
Confidence 5555554 4445588877788899999999999998 99999999999999653 36999999999987553 34
Q ss_pred cccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhh
Q 007892 368 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 447 (586)
Q Consensus 368 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 447 (586)
...++||+.|+|||+++.+.|...-|+||.|||+|--++|..||..+.... +.+.+..+. ..+
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn-------------dQIQNAaFM--yPp-- 785 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN-------------DQIQNAAFM--YPP-- 785 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh-------------HHhhccccc--cCC--
Confidence 456899999999999999999999999999999999999999998654321 111111111 000
Q ss_pred hccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 448 EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 448 ~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
+--.+.....++++...|+..-++|-+..+-+.
T Consensus 786 -~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 786 -NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred -CchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 111233456788888888888888888776553
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=307.06 Aligned_cols=315 Identities=24% Similarity=0.336 Sum_probs=227.2
Q ss_pred ccccceecccCcE-EEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeEEEEEecC
Q 007892 211 FSEANLLGQGGFG-YVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVP 288 (586)
Q Consensus 211 f~~~~~LG~G~fG-~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~~~~lV~E~~~ 288 (586)
|...+++|.|.-| .||+|.. +|+.||||++-.. .....++||..|+.- +|||||++++.-.+...+||+.|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 4555778999876 5799998 5789999998543 234567899999988 4999999987777778899999999
Q ss_pred CCcHHHHhcCC--CCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCC-----CCCeEEeecccccccC
Q 007892 289 NKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD-----SFEAKVADFGLAKHSL 361 (586)
Q Consensus 289 ~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~-----~~~~kl~DFGla~~~~ 361 (586)
..+|.+++... +.....-...+.+..|+++||++||+. +||||||||.||||+. ..+++|+|||+|+.+.
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 67999999773 222222234567889999999999996 9999999999999965 3579999999999876
Q ss_pred CCCCcc--cccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCC
Q 007892 362 DTDTHV--STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGN 438 (586)
Q Consensus 362 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (586)
...... .....||-+|+|||.+....-+.++||||||||+|..++ |.+||...-..+ .++ ..++
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-~NI------------l~~~ 729 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-ANI------------LTGN 729 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-hhh------------hcCc
Confidence 544332 335679999999999998888889999999999999999 599997543211 111 1111
Q ss_pred hhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH------------HHHhcCCCC-----------------
Q 007892 439 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIV------------RALEGNMPL----------------- 489 (586)
Q Consensus 439 ~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl------------~~L~~~~~~----------------- 489 (586)
+.- + .|+. ..++ ...++|.+|++.+|..||++.+|+ +.|+..-..
T Consensus 730 ~~L-~--~L~~-~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~Fl~dvSDRvE~e~r~~~s~lL~~le 803 (903)
T KOG1027|consen 730 YTL-V--HLEP-LPDC--EAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRLSFLRDVSDRVEKENRDSPSELLRALE 803 (903)
T ss_pred cce-e--eecc-CchH--HHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHHHHHHhhhhhhhhhhccCchHHHHhhc
Confidence 110 0 0111 1111 678899999999999999999996 223221110
Q ss_pred --------CCCCCCCCCCCccccCCCCCCCCCchh-----cHHHHHHHHhhhhccccCCCcccCCCCCCCCCCCCC
Q 007892 490 --------DDLNEGITPGHSTIYGSYGGSDYNSMQ-----YREDMKKFRKIALESVELGSSDYSGLTSDYGQNPPS 552 (586)
Q Consensus 490 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 552 (586)
.+|.+.+.+........++...+++.. .+|..+++|+++.+.++..+..++|+..+|--++|-
T Consensus 804 ~~~~~vv~~~W~~kl~~~~~~~l~kyR~Yk~~svrDLLR~iRNk~hHyrELp~~v~ellG~vPdgF~~YFt~RFP~ 879 (903)
T KOG1027|consen 804 AGARVVVSGDWTEKLDKTFMDNLRKYRSYKGSSVRDLLRAIRNKKHHYRELPPEVRELLGDVPDGFDLYFTKRFPN 879 (903)
T ss_pred cCCceEecCchhhhhCHHHHHHHHHhcCcccccHHHHHHHHHhhhhhhhhcCHHHHHhcCCCCcHHHHHHHHhhhH
Confidence 122222222222223345555566654 677788999999999998888888988888777763
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=271.15 Aligned_cols=203 Identities=26% Similarity=0.345 Sum_probs=167.5
Q ss_pred cCccccceecccCcEEEEEEEEeC-----CeEEEEEEeccCCchh--HHHHHHHHHHHHhcCCCCcceEEEEEEe-CCee
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLTN-----GKVVAIKQLKAGSGQG--EREFQAEIEIISQVHHRHLVSLVGYCTF-GSQR 280 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~~-----g~~vAVK~l~~~~~~~--~~~~~~Ei~il~~l~Hpniv~l~g~~~~-~~~~ 280 (586)
..|+....||+|.||.|||++-.+ .+.+|+|+++...... ....-+|+.+++.++|+||+.|+.++.. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 568888999999999999997332 2479999997653322 2456789999999999999999998877 7788
Q ss_pred EEEEEecCCCcHHHHhcCC---CCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCC----CCeEEee
Q 007892 281 LLVYEFVPNKTLEFHLHGK---DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS----FEAKVAD 353 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~---~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~----~~~kl~D 353 (586)
+|+|||.+. +|...++.. ....++......|+.||+.|+.|||++ -|+||||||.||||..+ |.|||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeec
Confidence 999999976 555555432 224578888889999999999999999 79999999999999877 8999999
Q ss_pred cccccccCCCCCc--ccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 007892 354 FGLAKHSLDTDTH--VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKAD 415 (586)
Q Consensus 354 FGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~ 415 (586)
|||++.+.+.-.. ....++-|+.|.|||.+.+ ..|+.+.|||+.|||+.||++-.+-|....
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 9999987655433 2356789999999999876 469999999999999999999988886543
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-32 Score=285.51 Aligned_cols=210 Identities=24% Similarity=0.341 Sum_probs=174.0
Q ss_pred ccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhH---HHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 211 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGE---REFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 211 f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~---~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
|..++.||-|.||+|.++... +...+|.|.|.+.+...+ .-.++|-+||..-+.+-||+|+.-|.+.+.+|+||||
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY 710 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 710 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence 777889999999999999844 467899999976543333 3567899999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCC----
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD---- 362 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~---- 362 (586)
++||++-.+|...+ .+.+.....++.++..|+++.|.. |+|||||||.|||||.+|++||.|||||.-+.-
T Consensus 711 IPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 711 IPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred cCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceecccc
Confidence 99999999886544 477777777888999999999998 999999999999999999999999999962110
Q ss_pred ----CCCccc---------------------------------ccccccccccCcccccCCCCCCcchHHHHHHHHHHHH
Q 007892 363 ----TDTHVS---------------------------------TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELI 405 (586)
Q Consensus 363 ----~~~~~~---------------------------------~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ell 405 (586)
...|.. -..+||+.|+|||++....|+..+|+||.|||||||+
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML 865 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence 000000 0147999999999999999999999999999999999
Q ss_pred hCCCCCCCCCcccch-hhhhh
Q 007892 406 TGFRPFDKADTFADD-SMVDW 425 (586)
Q Consensus 406 tG~~Pf~~~~~~~~~-~~~~~ 425 (586)
.|+.||....+.... .+..|
T Consensus 866 ~g~~pf~~~tp~~tq~kv~nw 886 (1034)
T KOG0608|consen 866 VGQPPFLADTPGETQYKVINW 886 (1034)
T ss_pred hCCCCccCCCCCcceeeeeeh
Confidence 999999877654432 34445
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-33 Score=289.44 Aligned_cols=243 Identities=24% Similarity=0.314 Sum_probs=200.2
Q ss_pred hcCccccceecccCcEEEEEEEEeCCe-EEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLTNGK-VVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~~g~-~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV 283 (586)
..+++.+..||-||||.|-+....... .+|+|++++.. ....+.+..|-.||...+.|.||+||--|.+....|++
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 345666778999999999998875543 38999987642 22234567899999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCC
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 363 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 363 (586)
||-|-||.|...|... ..++..+...++..+++|++|||.+ +||+|||||+|+|||.+|-+||.|||+|+.....
T Consensus 499 mEaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 499 MEACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HHhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 9999999999999544 4588888889999999999999999 9999999999999999999999999999987543
Q ss_pred CCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhh
Q 007892 364 DTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 443 (586)
Q Consensus 364 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 443 (586)
...-++|||+.|.|||++.+...+.++|.|+||+++|||++|.+||...++...-++ +..+ ++.+
T Consensus 574 --~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~-------ILkG-----id~i- 638 (732)
T KOG0614|consen 574 --RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNL-------ILKG-----IDKI- 638 (732)
T ss_pred --CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHH-------HHhh-----hhhh-
Confidence 344568999999999999999999999999999999999999999998776321111 1111 1111
Q ss_pred chhhhccCHHHHHHHHHHHHHhhccCCCCCCC
Q 007892 444 DQKLEEYDSAEMTRMAACAAACIRHSARRRPR 475 (586)
Q Consensus 444 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPt 475 (586)
.++........++++..++.+|.+|..
T Consensus 639 -----~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 639 -----EFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred -----hcccccchhHHHHHHHHHhcCcHhhhc
Confidence 455556667888999999999999886
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-32 Score=264.03 Aligned_cols=250 Identities=23% Similarity=0.354 Sum_probs=199.1
Q ss_pred HhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccC---CchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeE
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG---SGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRL 281 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~~~~ 281 (586)
..++|.+.++||+|+|.+|..+.+. +.+.+|+|++++. ...+..-.+.|-.+..+. +||.+|-|..+|..+..++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 3478999999999999999999965 5789999999764 223334556677777665 7999999999999999999
Q ss_pred EEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccC
Q 007892 282 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 361 (586)
Q Consensus 282 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~ 361 (586)
+|.||++||+|-.|++.+. .++++....+..+|.-||.|||++ |||+||||..|||||..|.+||.|+|+|+...
T Consensus 328 fvieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCC
Confidence 9999999999999886554 488888888899999999999999 99999999999999999999999999999754
Q ss_pred CCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcc-cchhhhhhhhHHHhhcccCCChh
Q 007892 362 DTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTF-ADDSMVDWAKPFLAQGLADGNFD 440 (586)
Q Consensus 362 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 440 (586)
... ....+++||+.|+|||.+.+..|....|+|+|||+++||+.|+.||+-.... .+.+..++....+. +
T Consensus 403 ~~g-d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvil----e---- 473 (593)
T KOG0695|consen 403 GPG-DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVIL----E---- 473 (593)
T ss_pred CCC-cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHh----h----
Confidence 332 3445689999999999999999999999999999999999999999853311 12233333222221 1
Q ss_pred hhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCC
Q 007892 441 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPR 475 (586)
Q Consensus 441 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPt 475 (586)
..+ ..+.....+...+++.-|++||.+|..
T Consensus 474 ----kqi-riprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 474 ----KQI-RIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred ----hcc-cccceeehhhHHHHHHhhcCCcHHhcC
Confidence 111 223334456677888999999998863
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-32 Score=250.86 Aligned_cols=207 Identities=25% Similarity=0.414 Sum_probs=169.8
Q ss_pred HHHHhcCccccceecccCcEEEEEEEE-eCCeEEEEEEeccC-CchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCee
Q 007892 204 LKIATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAG-SGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQR 280 (586)
Q Consensus 204 l~~~~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~-~~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~~~ 280 (586)
+++..++......||+|++|.|-+-++ .+|+..|||.+... ..+....++.|+++..+. .+|.+|.++|........
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 445556666678999999999999885 47999999999764 334456788899987775 699999999999999999
Q ss_pred EEEEEecCCCcHHHHhcC--CCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccc
Q 007892 281 LLVYEFVPNKTLEFHLHG--KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 358 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~ 358 (586)
++.||.|. .+|+.+-.. +.+..+++.-+-+||..+.+||.|||++. .+||||+||+||||+.+|++||||||++.
T Consensus 121 wIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence 99999995 455433221 23456888889999999999999999985 89999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCcccccC----CCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 007892 359 HSLDTDTHVSTRVMGTFGYLAPEYASS----GKLTEKSDVFSFGVLLLELITGFRPFDKAD 415 (586)
Q Consensus 359 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~ksDVwSlGvvL~elltG~~Pf~~~~ 415 (586)
.+.+... .+-..|.-.|||||.+.. ..|+-|+||||||+.+.||.+++.||+...
T Consensus 198 ~L~dSiA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 198 YLVDSIA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred eehhhhH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 7655432 222458889999998853 368999999999999999999999997543
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-32 Score=271.34 Aligned_cols=266 Identities=22% Similarity=0.331 Sum_probs=203.4
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcC--CCC----cceEEEEEEeCCee
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVH--HRH----LVSLVGYCTFGSQR 280 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~--Hpn----iv~l~g~~~~~~~~ 280 (586)
+++|.+...||+|.||.|-.+... .+..||||+++.-.+. .+..+-|+++|+++. .|+ +|.+.++|...++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 678999999999999999999964 3689999999765433 345667999999994 233 77888889999999
Q ss_pred EEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeC----------------
Q 007892 281 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD---------------- 344 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~---------------- 344 (586)
|+|+|.+ |-++.++|..++...++...+..|+.|++++++|||+. +++|-||||+|||+.
T Consensus 167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCccce
Confidence 9999998 77899999888878899999999999999999999998 999999999999993
Q ss_pred ----CCCCeEEeecccccccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccch
Q 007892 345 ----DSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADD 420 (586)
Q Consensus 345 ----~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~ 420 (586)
++..+||+|||.|....... ..++.|..|.|||++.+-.++..+||||+||||+||++|..-|...+..+-.
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHL 318 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHL 318 (415)
T ss_pred eccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHH
Confidence 13468999999998643222 4567899999999999999999999999999999999999988765521110
Q ss_pred hhhhh--------------hhHHHhhc-------ccCCChhhhhchh--hh---ccCHHHHHHHHHHHHHhhccCCCCCC
Q 007892 421 SMVDW--------------AKPFLAQG-------LADGNFDALVDQK--LE---EYDSAEMTRMAACAAACIRHSARRRP 474 (586)
Q Consensus 421 ~~~~~--------------~~~~~~~~-------~~~~~~~~l~d~~--l~---~~~~~~~~~l~~l~~~cl~~dp~~RP 474 (586)
.+.+- +..++..+ -..+......+.. |. .....+...|.+|+..||..||.+|+
T Consensus 319 aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~Ri 398 (415)
T KOG0671|consen 319 AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRI 398 (415)
T ss_pred HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccc
Confidence 01000 01111000 0001111111111 11 23345667799999999999999999
Q ss_pred CHHHHHHH
Q 007892 475 RMSQIVRA 482 (586)
Q Consensus 475 tm~evl~~ 482 (586)
|++|+++.
T Consensus 399 Tl~EAL~H 406 (415)
T KOG0671|consen 399 TLREALSH 406 (415)
T ss_pred cHHHHhcC
Confidence 99999864
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=240.12 Aligned_cols=201 Identities=24% Similarity=0.360 Sum_probs=167.7
Q ss_pred CccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 210 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
+|...++||+|.||+||||+.. .++.||+|+++-+.. ......++||-+|+.+.|+|||+|+++...+...-||+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4666789999999999999954 588999999865432 2245788999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 366 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 366 (586)
|. .+|..+...-+ ..++......++.|+++||.++|++ ++.||||||.|.||+.+|++||+||||++.+.-.-..
T Consensus 83 cd-qdlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvrc 157 (292)
T KOG0662|consen 83 CD-QDLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC 157 (292)
T ss_pred hh-HHHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence 94 46776665443 3488888999999999999999998 8999999999999999999999999999976543322
Q ss_pred ccccccccccccCcccccCC-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCc
Q 007892 367 VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELIT-GFRPFDKADT 416 (586)
Q Consensus 367 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~ 416 (586)
....+-|..|.+|.++.+. -|+...|+||-||++.||.. |++-|.+.+.
T Consensus 158 -ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dv 208 (292)
T KOG0662|consen 158 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV 208 (292)
T ss_pred -eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH
Confidence 2334678999999998765 58899999999999999988 6555655543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-29 Score=256.02 Aligned_cols=266 Identities=24% Similarity=0.344 Sum_probs=197.4
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcC-----C---CCcceEEEEEEe---
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-----H---RHLVSLVGYCTF--- 276 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~-----H---pniv~l~g~~~~--- 276 (586)
.+|...++||-|.|++||++... +.+.||+|+.+... .-.+....||.+|++++ | .+||+|+++|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 67889999999999999999954 56799999987542 22356778999999984 2 469999999976
Q ss_pred -CCeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCC---------
Q 007892 277 -GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS--------- 346 (586)
Q Consensus 277 -~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~--------- 346 (586)
+.+.|||+|++ |.+|..++...+.+.++...+.+|+.||+.||.|||..| +|||-||||+||||-.+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~~~~~ 233 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPAKDAR 233 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchhhhhh
Confidence 56889999999 778888888888888999999999999999999999999 99999999999999300
Q ss_pred --------------------------------------------------------------------------------
Q 007892 347 -------------------------------------------------------------------------------- 346 (586)
Q Consensus 347 -------------------------------------------------------------------------------- 346 (586)
T Consensus 234 ~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~ 313 (590)
T KOG1290|consen 234 EAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNE 313 (590)
T ss_pred hhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccc
Confidence
Q ss_pred -----------------------------------------------------------------------------CCe
Q 007892 347 -----------------------------------------------------------------------------FEA 349 (586)
Q Consensus 347 -----------------------------------------------------------------------------~~~ 349 (586)
.++
T Consensus 314 ~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~v 393 (590)
T KOG1290|consen 314 STVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRV 393 (590)
T ss_pred cchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeE
Confidence 013
Q ss_pred EEeecccccccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcc----cchhhhhh
Q 007892 350 KVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTF----ADDSMVDW 425 (586)
Q Consensus 350 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~----~~~~~~~~ 425 (586)
||+|||-|...... .+.-.-|..|.|||++.+..|+..+|||||+|+++||+||..-|+..... +++.+...
T Consensus 394 KIaDlGNACW~~kh----FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i 469 (590)
T KOG1290|consen 394 KIADLGNACWVHKH----FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALI 469 (590)
T ss_pred EEeeccchhhhhhh----hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHH
Confidence 44444444332111 11223466799999999999999999999999999999999988754321 22222211
Q ss_pred h-------hHHHhhcc-------cCCChhh--------hhchhhh--ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 426 A-------KPFLAQGL-------ADGNFDA--------LVDQKLE--EYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 426 ~-------~~~~~~~~-------~~~~~~~--------l~d~~l~--~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
. +.+...+. ..|.++. +.+-..+ ++..++...+.+++.-||+.+|++||++.+.++
T Consensus 470 ~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~ 549 (590)
T KOG1290|consen 470 MELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLK 549 (590)
T ss_pred HHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhc
Confidence 1 11111100 1111111 1111112 678899999999999999999999999999986
Q ss_pred H
Q 007892 482 A 482 (586)
Q Consensus 482 ~ 482 (586)
.
T Consensus 550 h 550 (590)
T KOG1290|consen 550 H 550 (590)
T ss_pred C
Confidence 3
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-29 Score=240.44 Aligned_cols=211 Identities=35% Similarity=0.523 Sum_probs=184.3
Q ss_pred ecccCcEEEEEEEEeC-CeEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecCCCcHHH
Q 007892 217 LGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEF 294 (586)
Q Consensus 217 LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~~-~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~gsL~~ 294 (586)
||+|.+|.||++...+ ++.++||++...... ....+.+|++.+.++.|++|+++++++......++++||+++++|..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999764 889999998765433 34679999999999999999999999999899999999999999999
Q ss_pred HhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCC-CCCeEEeecccccccCCCCCcccccccc
Q 007892 295 HLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD-SFEAKVADFGLAKHSLDTDTHVSTRVMG 373 (586)
Q Consensus 295 ~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~g 373 (586)
++.... ..+++..+..++.+++++|++||+. +++|+||++.||+++. ++.++|+|||++........ ......+
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~ 155 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVG 155 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccC
Confidence 986542 3588999999999999999999998 9999999999999999 89999999999986543321 1233557
Q ss_pred cccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhccCH
Q 007892 374 TFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDS 452 (586)
Q Consensus 374 t~~y~aPE~~~~~-~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~ 452 (586)
...|++||.+... ..+.+.|+|+||+++++|
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------ 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------ 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence 8899999999877 888999999999999999
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007892 453 AEMTRMAACAAACIRHSARRRPRMSQIVRAL 483 (586)
Q Consensus 453 ~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L 483 (586)
..+.+++..|++.+|.+||++.++++.|
T Consensus 188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ---PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ---HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3578889999999999999999998754
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-32 Score=255.02 Aligned_cols=266 Identities=25% Similarity=0.365 Sum_probs=192.0
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccC-Cchh-HHHHHHHHHHHHhcCCCCcceEEEEEEe--------C
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG-SGQG-EREFQAEIEIISQVHHRHLVSLVGYCTF--------G 277 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~-~~~~-~~~~~~Ei~il~~l~Hpniv~l~g~~~~--------~ 277 (586)
..|....+||+|.||+||+++.. .|+.||+|++-.. .+.+ -....+|+.+|..|.|+|++.|+..|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 34556678999999999999965 4788898876332 2222 2456789999999999999999998854 2
Q ss_pred CeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccc
Q 007892 278 SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 357 (586)
Q Consensus 278 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla 357 (586)
...+|||++|+. +|.-.|.. ....++..++.+++.++..||.|+|.. .|+|||+|+.|+||+.++.+||+|||++
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn-~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSN-RKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcC-ccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccc
Confidence 347899999965 56555532 224588899999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCC---cccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhh----------
Q 007892 358 KHSLDTDT---HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMV---------- 423 (586)
Q Consensus 358 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~---------- 423 (586)
+.+..... ...+..+-|..|+.||.+.+ ..|+.+.|||.-|||+.||+||.+-+..........++
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 76543322 22345677999999998876 46899999999999999999998888765432211111
Q ss_pred hhhh---HHHhhc-----ccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 424 DWAK---PFLAQG-----LADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 424 ~~~~---~~~~~~-----~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
-|.. -.+.+. +-.+.++. +..++..|-. ....++++..++..||.+|+.+.|++..
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rk-v~n~~kp~~k--d~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRK-VKNRLKPYVK--DDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhh-hhhhcccccC--ChhHHHHHHHHhccCcccCcchHhhhch
Confidence 1110 000011 11111111 1111111111 1256788999999999999999999864
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-30 Score=241.90 Aligned_cols=260 Identities=20% Similarity=0.326 Sum_probs=197.1
Q ss_pred hcCccccceecccCcEEEEEEE-EeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCC--eeEEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGS--QRLLV 283 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~-~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~~--~~~lV 283 (586)
.++|++.+++|+|.|++||.|. ..+.+.++||+++.- ....+.+|+.||..|. ||||++|++...+.. ...||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4679999999999999999999 456789999999864 3567899999999998 999999999987644 55799
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCC-CCeEEeecccccccCC
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS-FEAKVADFGLAKHSLD 362 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~-~~~kl~DFGla~~~~~ 362 (586)
+||++|.+..... +.+....+...+.++++||.|||+. ||+|||+||.|++||.. -.++|+|+|||.++-.
T Consensus 114 FE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 9999998887654 3477778889999999999999999 99999999999999865 4699999999987644
Q ss_pred CCCcccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcc-------
Q 007892 363 TDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGL------- 434 (586)
Q Consensus 363 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~------- 434 (586)
... ....+.+..|--||.+.. ..|+..-|+|||||+|..|+..+.||-.... .-+.++..++-+....+
T Consensus 186 ~~e--YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d-N~DQLVkIakVLGt~el~~Yl~KY 262 (338)
T KOG0668|consen 186 GKE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD-NYDQLVKIAKVLGTDELYAYLNKY 262 (338)
T ss_pred Cce--eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC-CHHHHHHHHHHhChHHHHHHHHHH
Confidence 322 223456677899998865 5688899999999999999999999864332 23455554432211111
Q ss_pred ---cCCChhhhhchhh----hcc----CH-HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 435 ---ADGNFDALVDQKL----EEY----DS-AEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 435 ---~~~~~~~l~d~~l----~~~----~~-~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
-+..+..++.... ..| +. -...+.++++...|+.|-.+|+|++|.+.
T Consensus 263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 263 QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 1112222222111 011 01 11256889999999999999999999875
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=242.29 Aligned_cols=199 Identities=33% Similarity=0.421 Sum_probs=173.8
Q ss_pred ccccceecccCcEEEEEEEEeC-CeEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecC
Q 007892 211 FSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVP 288 (586)
Q Consensus 211 f~~~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~~-~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 288 (586)
|...+.||.|++|.||++...+ ++.+|+|.+...... ....+.+|++.+.+++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5567899999999999999875 889999999766544 56789999999999999999999999999899999999999
Q ss_pred CCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCccc
Q 007892 289 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 368 (586)
Q Consensus 289 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 368 (586)
+++|.+++...... +++..+..++.+++.+|.+||+. +++|+||++.||+++.++.++|+|||++...........
T Consensus 81 ~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 81 GGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred CCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence 99999998754322 78999999999999999999998 999999999999999999999999999987644321122
Q ss_pred ccccccccccCcccc-cCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 007892 369 TRVMGTFGYLAPEYA-SSGKLTEKSDVFSFGVLLLELITGFRPFDK 413 (586)
Q Consensus 369 ~~~~gt~~y~aPE~~-~~~~~s~ksDVwSlGvvL~elltG~~Pf~~ 413 (586)
....++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 345678899999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=261.59 Aligned_cols=196 Identities=25% Similarity=0.371 Sum_probs=167.5
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhH--------HHHHHHHHHHHhcC---CCCcceEEEEEEe
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGE--------REFQAEIEIISQVH---HRHLVSLVGYCTF 276 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~--------~~~~~Ei~il~~l~---Hpniv~l~g~~~~ 276 (586)
.+|...+.||.|+||.|++++++ +...|+||.+.+.+-... -.+-.||.||..|+ |+||++++.+|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 45888999999999999999975 567899999876432211 12336999999998 9999999999999
Q ss_pred CCeeEEEEEec-CCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecc
Q 007892 277 GSQRLLVYEFV-PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 355 (586)
Q Consensus 277 ~~~~~lV~E~~-~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFG 355 (586)
++.+||++|-- ++-+|.+++..+. .|++.+...|+.|++-|+++||+. +|||||||-+||.++.+|-+||+|||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeecc
Confidence 99999999975 4567889997654 499999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccccCcccccCCCC-CCcchHHHHHHHHHHHHhCCCCCC
Q 007892 356 LAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVLLLELITGFRPFD 412 (586)
Q Consensus 356 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvvL~elltG~~Pf~ 412 (586)
.+....... ...++||.+|.|||++.+.+| ....|||+||++||-++....||.
T Consensus 716 saa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 716 SAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred chhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 987643322 244689999999999998877 566899999999999999888885
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-29 Score=243.17 Aligned_cols=268 Identities=22% Similarity=0.294 Sum_probs=190.8
Q ss_pred ccccceecccCcEEEEEEEE-eCCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC-----CeeEE
Q 007892 211 FSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG-----SQRLL 282 (586)
Q Consensus 211 f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~--~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~-----~~~~l 282 (586)
.+-.+.||-|.||.||..+. ++|+.||+|++-+- +...-+.+.+|+.+|.-++|.|++.+++...-. .++|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 34457899999999999985 47999999987542 222345678899999999999999988766433 24567
Q ss_pred EEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCC
Q 007892 283 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 283 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 362 (586)
+.|.| ..+|...+-. .+.++-....-+..||++||+|||+. +|.||||||.|.|++.|..+|||||||++....
T Consensus 135 ~TELm-QSDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 135 LTELM-QSDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHH-Hhhhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccch
Confidence 77777 4466555532 34477777777899999999999998 999999999999999999999999999997655
Q ss_pred CCCcccccccccccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhh-hhhh-HH--HhhcccCC
Q 007892 363 TDTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMV-DWAK-PF--LAQGLADG 437 (586)
Q Consensus 363 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~-~~~~-~~--~~~~~~~~ 437 (586)
.+....+..+-|-.|.|||.+++. .|+.+.||||.|||+.||+..+.-|....+.....++ +... +. -++...+|
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 444445566788999999999874 6999999999999999999998888776653322221 1100 00 00011122
Q ss_pred Chhhhhchh--------hhcc--CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 007892 438 NFDALVDQK--------LEEY--DSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484 (586)
Q Consensus 438 ~~~~l~d~~--------l~~~--~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~ 484 (586)
....++... |-.. +...-.+-+.+...++..||++|-+..+.+..+-
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 111111111 1111 1122234567778899999999999888876653
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-29 Score=264.79 Aligned_cols=253 Identities=24% Similarity=0.373 Sum_probs=203.6
Q ss_pred HhcCccccceecccCcEEEEEEEE-eCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEE
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
..++|.....+|.|.||.|||++. ..++..|||.++........-+++|+-++...+|+|||.++|-+...+..+++||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 347888999999999999999995 4689999999998888888889999999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 365 (586)
||.+|+|++.-|.. ..+++.++..++...++||+|||+. +=+|||||-.|||+++.+.+|++|||.+..+...-
T Consensus 93 ycgggslQdiy~~T--gplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati- 166 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATI- 166 (829)
T ss_pred ecCCCcccceeeec--ccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhh-
Confidence 99999999887654 3588899999999999999999998 88999999999999999999999999986543221
Q ss_pred cccccccccccccCcccc---cCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhh
Q 007892 366 HVSTRVMGTFGYLAPEYA---SSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 442 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~---~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 442 (586)
.....+.||+.|||||+. +.+.|..++|||++|+...||---+.|....-+.. .+ ++.. ...++
T Consensus 167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr--~l------~LmT---kS~~q-- 233 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR--AL------FLMT---KSGFQ-- 233 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH--HH------HHhh---ccCCC--
Confidence 233457899999999976 45779999999999999999988777754332211 00 0000 00010
Q ss_pred hchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 007892 443 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIV 480 (586)
Q Consensus 443 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl 480 (586)
.+.++ ....-...+.++++.|+..+|++||+++-++
T Consensus 234 -pp~lk-Dk~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 234 -PPTLK-DKTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred -CCccc-CCccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 11121 2233345688999999999999999988665
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=253.00 Aligned_cols=270 Identities=22% Similarity=0.250 Sum_probs=201.3
Q ss_pred HHHhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcC------CCCcceEEEEEEeC
Q 007892 205 KIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVH------HRHLVSLVGYCTFG 277 (586)
Q Consensus 205 ~~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~------Hpniv~l~g~~~~~ 277 (586)
+.....|.+....|+|-|++|.+|... -|+.||||+|.++.. ....=+.|++||.+|+ .-|+++|+-.|...
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 334467888888999999999999954 478999999987632 2345568999999996 35899999999999
Q ss_pred CeeEEEEEecCCCcHHHHhcCCCC-CCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCC-CCeEEeecc
Q 007892 278 SQRLLVYEFVPNKTLEFHLHGKDR-PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS-FEAKVADFG 355 (586)
Q Consensus 278 ~~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~-~~~kl~DFG 355 (586)
+++|||||-+ .-+|.+.|...+. -.|.......++.|+.-||..|... +|+|.||||.|||+++. ..+||||||
T Consensus 507 nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 507 NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCc
Confidence 9999999987 5688898876543 3477788889999999999999875 99999999999999865 568999999
Q ss_pred cccccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccc-hhhhhhhhHHHhhcc
Q 007892 356 LAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFAD-DSMVDWAKPFLAQGL 434 (586)
Q Consensus 356 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~-~~~~~~~~~~~~~~~ 434 (586)
.|-...+... +.+.-+..|.|||++.+-.|+...|+||.||+||||+||+.-|-+...-.. .-..+...++-...+
T Consensus 583 SA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Kml 659 (752)
T KOG0670|consen 583 SASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKML 659 (752)
T ss_pred cccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHh
Confidence 9976544332 334455679999999999999999999999999999999998865432110 001111111111111
Q ss_pred cCCCh-------------------------------------hh-h-hchhhhccCHHHHHHHHHHHHHhhccCCCCCCC
Q 007892 435 ADGNF-------------------------------------DA-L-VDQKLEEYDSAEMTRMAACAAACIRHSARRRPR 475 (586)
Q Consensus 435 ~~~~~-------------------------------------~~-l-~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPt 475 (586)
..+.| .. + -.+.+.+........|.+|+..||..||++|-+
T Consensus 660 RKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit 739 (752)
T KOG0670|consen 660 RKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRIT 739 (752)
T ss_pred hhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCC
Confidence 11110 00 0 011223344556678999999999999999999
Q ss_pred HHHHHHH
Q 007892 476 MSQIVRA 482 (586)
Q Consensus 476 m~evl~~ 482 (586)
..|.|.+
T Consensus 740 ~nqAL~H 746 (752)
T KOG0670|consen 740 VNQALKH 746 (752)
T ss_pred HHHHhcC
Confidence 9988753
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-27 Score=276.41 Aligned_cols=195 Identities=15% Similarity=0.188 Sum_probs=139.2
Q ss_pred hcCC-CCcceEEEEE-------EeCCeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEE
Q 007892 261 QVHH-RHLVSLVGYC-------TFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKII 332 (586)
Q Consensus 261 ~l~H-pniv~l~g~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iv 332 (586)
.++| .||++++++| ......++++||+ +++|.++|... ...+++.+++.|+.||++||+|||++ +|+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---gIv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQ---GIV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 4455 5888888887 2234567789987 66999999643 34589999999999999999999998 999
Q ss_pred ecCCCCceeEeCCC-------------------CCeEEeecccccccCCCCC---------------ccccccccccccc
Q 007892 333 HRDIKSANILLDDS-------------------FEAKVADFGLAKHSLDTDT---------------HVSTRVMGTFGYL 378 (586)
Q Consensus 333 HrDIk~~NILl~~~-------------------~~~kl~DFGla~~~~~~~~---------------~~~~~~~gt~~y~ 378 (586)
||||||+||||+.. +.+||+|||+++....... ......+||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 99999999999653 4556666666653211000 0011246889999
Q ss_pred CcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHH
Q 007892 379 APEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRM 458 (586)
Q Consensus 379 aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l 458 (586)
|||++.+..++.++|||||||+||||++|..|+..... .+..+.. ....+.. ......+
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~~~-------------~~~~~~~----~~~~~~~ 241 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSLRH-------------RVLPPQI----LLNWPKE 241 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHHHH-------------hhcChhh----hhcCHHH
Confidence 99999999999999999999999999999888653211 0111100 0011110 1122345
Q ss_pred HHHHHHhhccCCCCCCCHHHHHH
Q 007892 459 AACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 459 ~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
..++.+||+.+|.+||+|.||++
T Consensus 242 ~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 242 ASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHHhCCCChhhCcChHHHhh
Confidence 67888999999999999999986
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.9e-27 Score=228.98 Aligned_cols=263 Identities=23% Similarity=0.303 Sum_probs=190.8
Q ss_pred cCccccceecccCcEEEEEEEE-eCCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC------Ce
Q 007892 209 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG------SQ 279 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~--~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~------~~ 279 (586)
.+|.....+|.|.- .|..+.. -.++.||+|++... .....+...+|..++..++|+||++++.++.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 34666677888887 5555542 25788999987543 223345677899999999999999999998653 35
Q ss_pred eEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccc
Q 007892 280 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 359 (586)
Q Consensus 280 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~ 359 (586)
.|+||||| ..+|...++- .++-.++..|..|++.|++|||+. +|+||||||+||++..+..+||.|||+++.
T Consensus 96 ~y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcc
Confidence 68999999 5577776652 266678889999999999999998 999999999999999999999999999986
Q ss_pred cCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccc------------hh----hh
Q 007892 360 SLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFAD------------DS----MV 423 (586)
Q Consensus 360 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~------------~~----~~ 423 (586)
.... -..+.++.|..|.|||++.+-.|.+.+||||+||++.||++|+.-|.+.+..+. .+ +.
T Consensus 168 e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 168 EDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred cCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence 4222 356778899999999999888899999999999999999999988875443221 00 00
Q ss_pred hhhhHHHhh--cccCCChhhhhchhh-h---ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 424 DWAKPFLAQ--GLADGNFDALVDQKL-E---EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 424 ~~~~~~~~~--~~~~~~~~~l~d~~l-~---~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.-++-++.. ....-.+.+++...+ . +.+.-......+++.+||-.+|++|-+..++|++
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 011111110 000011222221111 0 1222334457889999999999999999999875
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.5e-27 Score=236.64 Aligned_cols=268 Identities=23% Similarity=0.341 Sum_probs=197.0
Q ss_pred HHHHhcCccccceecccCcEEEEEEEEe----CCeEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCC
Q 007892 204 LKIATDNFSEANLLGQGGFGYVHKGVLT----NGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGS 278 (586)
Q Consensus 204 l~~~~~~f~~~~~LG~G~fG~Vyk~~~~----~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~~ 278 (586)
+....+.|..+++||+|.|++||++++. ..+.||+|.+...+. ...+.+|+++|..+. +.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3444567899999999999999999954 367899999865432 356899999999996 999999999999999
Q ss_pred eeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCC-CCCeEEeecccc
Q 007892 279 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD-SFEAKVADFGLA 357 (586)
Q Consensus 279 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~-~~~~kl~DFGla 357 (586)
+..+|+||++.....+++.. ++..++..++..+++||.++|.+ |||||||||+|+|.+. .+.-.|+|||||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred eeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhH
Confidence 99999999999998888743 66788889999999999999998 9999999999999975 467799999998
Q ss_pred cccCCC------------------C---------------C----------cccccccccccccCccccc-CCCCCCcch
Q 007892 358 KHSLDT------------------D---------------T----------HVSTRVMGTFGYLAPEYAS-SGKLTEKSD 393 (586)
Q Consensus 358 ~~~~~~------------------~---------------~----------~~~~~~~gt~~y~aPE~~~-~~~~s~ksD 393 (586)
...... . . .......||+||.|||++. ....+.+.|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 711000 0 0 0001156999999999885 567889999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHH----------Hhhc--ccC-CC----------hhhh-hchh---
Q 007892 394 VFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPF----------LAQG--LAD-GN----------FDAL-VDQK--- 446 (586)
Q Consensus 394 VwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~----------~~~~--~~~-~~----------~~~l-~d~~--- 446 (586)
|||.|||++-+++++.||-.... +.+.+.+.+.-+ +... +.+ .+ ++.+ ....
T Consensus 261 iws~GVI~Lslls~~~PFf~a~d-d~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~ 339 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKD-DADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS 339 (418)
T ss_pred eeeccceeehhhccccccccCcc-ccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence 99999999999999999975432 112222211000 0000 000 01 1111 0000
Q ss_pred ----hh--ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 447 ----LE--EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 447 ----l~--~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
++ ....-....+.+++.+|++.||.+|-++++.|+.
T Consensus 340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 11 1112223468899999999999999999998864
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-27 Score=225.34 Aligned_cols=251 Identities=19% Similarity=0.329 Sum_probs=185.4
Q ss_pred cCccccceecccCcEEEEEEEEeC-CeEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCcceEEEE-EEeCCeeEEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGY-CTFGSQRLLVYE 285 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l-~Hpniv~l~g~-~~~~~~~~lV~E 285 (586)
+.|.+.+.||+|.||.+-++.++. .+.+++|.+... ....++|.+|...--.| .|.||+.-+++ |...+.+.+++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 668888999999999999999764 678888987543 34467899999876666 49999988764 455667779999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEe-C-CCCCeEEeecccccccCCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL-D-DSFEAKVADFGLAKHSLDT 363 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl-~-~~~~~kl~DFGla~~~~~~ 363 (586)
|++.|+|...+.. ..+.+....+++.|++.||.|||++ .+||||||.+|||| + +..++||||||+.+....
T Consensus 103 ~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~- 175 (378)
T KOG1345|consen 103 FAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT- 175 (378)
T ss_pred cCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCc-
Confidence 9999999987754 3477778889999999999999999 99999999999999 3 345899999999875321
Q ss_pred CCcccccccccccccCcccccC---C--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCC
Q 007892 364 DTHVSTRVMGTFGYLAPEYASS---G--KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGN 438 (586)
Q Consensus 364 ~~~~~~~~~gt~~y~aPE~~~~---~--~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (586)
....+.-+..|.+||.... + ...+.+|||.||+++|.++||..||.. ...++....+|..- .+ +.
T Consensus 176 ---tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk-a~~~d~~Y~~~~~w--~~----rk 245 (378)
T KOG1345|consen 176 ---TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK-ASIMDKPYWEWEQW--LK----RK 245 (378)
T ss_pred ---eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh-hhccCchHHHHHHH--hc----cc
Confidence 1122345677999997643 2 346789999999999999999999984 44456666666431 11 11
Q ss_pred hhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 439 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 439 ~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
. +.+...-.....++..+.++-+.+++++|=...++-++
T Consensus 246 ~-----~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 246 N-----PALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred C-----ccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 1 11211111123456667788888999998555555443
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-25 Score=209.80 Aligned_cols=166 Identities=19% Similarity=0.182 Sum_probs=125.2
Q ss_pred CcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcccc
Q 007892 290 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 369 (586)
Q Consensus 290 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 369 (586)
|+|.++++.. ...++|.+++.|+.|+++||.|||++ + ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----- 63 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ----- 63 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc-----
Confidence 6888988753 34599999999999999999999998 4 999999999999999 99998653321
Q ss_pred cccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhc
Q 007892 370 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEE 449 (586)
Q Consensus 370 ~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 449 (586)
..|++.|||||++.++.++.++|||||||+||||++|+.||....... ..+..+.. ... ... +....
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~~~~----~~~-~~~------~~~~~ 130 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEILLN----GMP-ADD------PRDRS 130 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHHHHH----Hhc-cCC------ccccc
Confidence 258999999999999999999999999999999999999996543211 11111111 000 000 00000
Q ss_pred cCHHHH--HHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 007892 450 YDSAEM--TRMAACAAACIRHSARRRPRMSQIVRALEG 485 (586)
Q Consensus 450 ~~~~~~--~~l~~l~~~cl~~dp~~RPtm~evl~~L~~ 485 (586)
...... ..+.+++.+|++.+|.+||++.|+++.+..
T Consensus 131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 111122 268999999999999999999999998864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=6e-25 Score=229.29 Aligned_cols=164 Identities=21% Similarity=0.214 Sum_probs=129.3
Q ss_pred HhcCccccceecccCcEEEEEEEEe--CCeEEEEEEeccC-----CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLT--NGKVVAIKQLKAG-----SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ 279 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~--~g~~vAVK~l~~~-----~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~ 279 (586)
..++|.+.+.||+|+||+||+|++. +++.||||++... .....+.|.+|+++|.+++|+|++..+.. .+.
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~ 92 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGK 92 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCC
Confidence 3467999999999999999999864 5788899987533 12234578999999999999999854322 245
Q ss_pred eEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCC-CCceeEeCCCCCeEEeeccccc
Q 007892 280 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDI-KSANILLDDSFEAKVADFGLAK 358 (586)
Q Consensus 280 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDI-k~~NILl~~~~~~kl~DFGla~ 358 (586)
.+|||||++|++|... ... . ...++.+++++|.|||+. +|+|||| ||+|||++.++.+||+|||+++
T Consensus 93 ~~LVmE~~~G~~L~~~-~~~-----~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~ 160 (365)
T PRK09188 93 DGLVRGWTEGVPLHLA-RPH-----G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLAS 160 (365)
T ss_pred cEEEEEccCCCCHHHh-Ccc-----c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence 7999999999999632 111 1 146788999999999998 9999999 9999999999999999999999
Q ss_pred ccCCCCCcc-------cccccccccccCcccccC
Q 007892 359 HSLDTDTHV-------STRVMGTFGYLAPEYASS 385 (586)
Q Consensus 359 ~~~~~~~~~-------~~~~~gt~~y~aPE~~~~ 385 (586)
......... .+..++++.|+|||++..
T Consensus 161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 764433111 145678999999999864
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.4e-24 Score=219.59 Aligned_cols=259 Identities=21% Similarity=0.269 Sum_probs=196.4
Q ss_pred CccccceecccCcEEEEEEEEeCC--eEEEEEEeccCCchhHHHHHHHHHHHHhcCC----CCcceEEEEE-EeCCeeEE
Q 007892 210 NFSEANLLGQGGFGYVHKGVLTNG--KVVAIKQLKAGSGQGEREFQAEIEIISQVHH----RHLVSLVGYC-TFGSQRLL 282 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~~g--~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~H----pniv~l~g~~-~~~~~~~l 282 (586)
+|.+.+.||+|+||.||++..... ..+|+|............+..|+.++..+.. .++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999996553 5788888765433333378889999998873 6899999888 47778899
Q ss_pred EEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCC-----CCeEEeecccc
Q 007892 283 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS-----FEAKVADFGLA 357 (586)
Q Consensus 283 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~-----~~~kl~DFGla 357 (586)
||+.+ |.+|.++........++..+.++|+.|++.+|++||+. |++||||||.|+++... ..+.|.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99988 88999987655556799999999999999999999998 99999999999999754 46999999999
Q ss_pred c--ccCCCCCc----c---cccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhH
Q 007892 358 K--HSLDTDTH----V---STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKP 428 (586)
Q Consensus 358 ~--~~~~~~~~----~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~ 428 (586)
+ .+...... . .....||..|.++....+...+.+.|+||++.++.||+.|..||........ .......
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~--~~~~~~~ 252 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL--KSKFEKD 252 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch--HHHHHHH
Confidence 8 43222211 1 1234599999999999999999999999999999999999999965443211 1110000
Q ss_pred HHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 429 FLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 429 ~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
........ +....+..+..+...+-..+...+|....+...|+...
T Consensus 253 ---------~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~ 298 (322)
T KOG1164|consen 253 ---------PRKLLTDR----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVF 298 (322)
T ss_pred ---------hhhhcccc----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence 00000000 11223345666666677789999999999998887653
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-22 Score=204.90 Aligned_cols=259 Identities=28% Similarity=0.373 Sum_probs=197.5
Q ss_pred ccccceecccCcEEEEEEEEeCCeEEEEEEeccCCch---hHHHHHHHHHHHHhcCCC-CcceEEEEEEeCCeeEEEEEe
Q 007892 211 FSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQ---GEREFQAEIEIISQVHHR-HLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 211 f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~---~~~~~~~Ei~il~~l~Hp-niv~l~g~~~~~~~~~lV~E~ 286 (586)
|...+.||.|+||.||++... ..+++|.+...... ....+.+|+.++..+.|+ +|+++++++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566789999999999999986 78899998765433 367899999999999988 799999999777778999999
Q ss_pred cCCCcHHHHhcCCCC-CCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCC-CeEEeecccccccCCCC
Q 007892 287 VPNKTLEFHLHGKDR-PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF-EAKVADFGLAKHSLDTD 364 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~-~~kl~DFGla~~~~~~~ 364 (586)
+.+++|.+++..... ..+.......++.+++.++.|+|.. +++||||||+|||++... .++++|||+++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999966654322 2588889999999999999999998 899999999999999988 79999999998554433
Q ss_pred Cc-----ccccccccccccCcccccC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcc-cchhhhhhhhHHHhhccc
Q 007892 365 TH-----VSTRVMGTFGYLAPEYASS---GKLTEKSDVFSFGVLLLELITGFRPFDKADTF-ADDSMVDWAKPFLAQGLA 435 (586)
Q Consensus 365 ~~-----~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~ 435 (586)
.. ......|+..|++||.+.. ..+....|+|++|++++++++|..||...... ........ +.....
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~----~~~~~~ 232 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKI----ILELPT 232 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHH----HHhcCC
Confidence 22 2356789999999999987 57899999999999999999999997655421 00111111 100000
Q ss_pred CCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 436 DGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 436 ~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
. ....... ..........+.+++..|+..+|..|.++.+....
T Consensus 233 ~-~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 233 P-SLASPLS---PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred c-ccccccC---ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0 0000000 00002223568889999999999999999987764
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-24 Score=206.38 Aligned_cols=247 Identities=21% Similarity=0.349 Sum_probs=191.7
Q ss_pred ccceecccCcEEEEEEEEeCCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecCCC
Q 007892 213 EANLLGQGGFGYVHKGVLTNGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNK 290 (586)
Q Consensus 213 ~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~--~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g 290 (586)
+.-+|.+...|+.|+|++..+ .+++|+++.. .....++|.+|.-.|+.+.||||+.++|.|...-...++..||+.|
T Consensus 194 l~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence 345688899999999999754 4556777543 3333478999999999999999999999999999999999999999
Q ss_pred cHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCccccc
Q 007892 291 TLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTR 370 (586)
Q Consensus 291 sL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 370 (586)
+|...||....-..+-.+..++++++++|++|||+. .|-|.---|.+..|+||++..++|. ++-.++... ...
T Consensus 273 slynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris-mad~kfsfq-----e~g 345 (448)
T KOG0195|consen 273 SLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQ-----EVG 345 (448)
T ss_pred HHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee-cccceeeee-----ccc
Confidence 999999998877788899999999999999999986 3344444688999999999988774 222222111 112
Q ss_pred ccccccccCcccccCCCCC---CcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhh
Q 007892 371 VMGTFGYLAPEYASSGKLT---EKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 447 (586)
Q Consensus 371 ~~gt~~y~aPE~~~~~~~s---~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 447 (586)
....+.||+||.++..+-+ +.+|+|||.++||||.|...||.+..+.+..-.+. -+.++
T Consensus 346 r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia-----------leglr------- 407 (448)
T KOG0195|consen 346 RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA-----------LEGLR------- 407 (448)
T ss_pred cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh-----------hcccc-------
Confidence 3457899999999876543 57999999999999999999998766532211111 00111
Q ss_pred hccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 007892 448 EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 485 (586)
Q Consensus 448 ~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~ 485 (586)
...+......+.+++.-|++.||.+||.+..|+-.||.
T Consensus 408 v~ippgis~hm~klm~icmnedpgkrpkfdmivpilek 445 (448)
T KOG0195|consen 408 VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEK 445 (448)
T ss_pred ccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence 13455666789999999999999999999999999885
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.9e-22 Score=196.35 Aligned_cols=201 Identities=22% Similarity=0.331 Sum_probs=170.9
Q ss_pred cCccccceecccCcEEEEEEE-EeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeeEEEEEe
Q 007892 209 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~-~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
-+|.+.++||+|.||..+.|+ +-+++.||||.--.. ...-+++.|....+.|. .++|..++.|..++..-.||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 468889999999999999999 558899999974222 22346888888888885 79999999888888888999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCC-----CCCeEEeecccccccC
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD-----SFEAKVADFGLAKHSL 361 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~-----~~~~kl~DFGla~~~~ 361 (586)
+ |-+|+++++-.++ .++..+.+.||.|++.-++|+|++ .+|+|||||+|+||.. ...+.|+|||+|+.+.
T Consensus 106 L-GPSLEDLFD~CgR-~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCGR-RFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred h-CcCHHHHHHHhcC-cccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 8 8899888765554 489999999999999999999999 8999999999999963 3468999999999987
Q ss_pred CCCCcc------cccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 007892 362 DTDTHV------STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADT 416 (586)
Q Consensus 362 ~~~~~~------~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~ 416 (586)
+..+.. .....||..||+--...+...+.+.|+-|||-|++..|-|.+||.+...
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 766532 1235699999999999999999999999999999999999999987653
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.2e-22 Score=195.00 Aligned_cols=173 Identities=12% Similarity=0.131 Sum_probs=135.0
Q ss_pred HHHhcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHH---------HHHHHHHHHhcCCCCcceEEEEEE
Q 007892 205 KIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGERE---------FQAEIEIISQVHHRHLVSLVGYCT 275 (586)
Q Consensus 205 ~~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~---------~~~Ei~il~~l~Hpniv~l~g~~~ 275 (586)
....++|+..++||.|+||.||+... ++..+|||.+.......+.. +.+|+..+.+++|++|..+..++.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 44568899999999999999999665 57789999997553333322 689999999999999999988865
Q ss_pred eC--------CeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCC
Q 007892 276 FG--------SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF 347 (586)
Q Consensus 276 ~~--------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 347 (586)
.. +..+|||||++|.+|.++.. ++. ....+++.+|..||.. +++||||||+||+++.++
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g 172 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG 172 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC
Confidence 43 35789999999999987631 222 3456899999999998 999999999999999988
Q ss_pred CeEEeecccccccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHH
Q 007892 348 EAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELI 405 (586)
Q Consensus 348 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ell 405 (586)
++|+|||......+.... -.++....+..++|+|+|||.|..+.
T Consensus 173 -i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999988754322111 11344445667999999999987664
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.7e-22 Score=188.01 Aligned_cols=260 Identities=22% Similarity=0.285 Sum_probs=195.7
Q ss_pred HhcCccccceecccCcEEEEEEE-EeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCC-CCcceEEEEEEeCCeeEEEE
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHH-RHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~-~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~H-pniv~l~g~~~~~~~~~lV~ 284 (586)
..++|..++.||.|+||.+|.|. ..+|..||||.-..... .-++.-|..+...|+| ..|..+..|..+...-.|||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 44789999999999999999999 56899999998654433 3467889999999975 67888888888888889999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCC---CCCeEEeecccccccC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD---SFEAKVADFGLAKHSL 361 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~---~~~~kl~DFGla~~~~ 361 (586)
|.+ |-+|++.+.-..+ .++..+.+-+|-|++.-++|+|.+ ++|||||||.|+|..- ...+.|+||||++.+.
T Consensus 91 dLL-GPsLEdLfnfC~R-~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCSR-RFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred ecc-CccHHHHHHHHhh-hhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 998 8899888765443 488889999999999999999999 8999999999999964 3578999999999876
Q ss_pred CCCC--cc----cccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhccc
Q 007892 362 DTDT--HV----STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLA 435 (586)
Q Consensus 362 ~~~~--~~----~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 435 (586)
+..+ |+ .....||..|.+--...+-..+.+.|+-|+|.+|..+.-|..||.+..........+ ...
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyE---kI~----- 237 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYE---KIS----- 237 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHH---HHH-----
Confidence 5433 22 234679999999888888888999999999999999999999998765422111111 111
Q ss_pred CCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCH---HHHHHHHhc
Q 007892 436 DGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRM---SQIVRALEG 485 (586)
Q Consensus 436 ~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm---~evl~~L~~ 485 (586)
+..... .++......+.++.-.+.-|-..--++-|.. .++.+.|-.
T Consensus 238 EkK~s~----~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr 286 (341)
T KOG1163|consen 238 EKKMST----PIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR 286 (341)
T ss_pred HhhcCC----CHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence 111111 1112222334456666777887777888874 455555543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.4e-23 Score=229.49 Aligned_cols=252 Identities=23% Similarity=0.255 Sum_probs=184.9
Q ss_pred CccccceecccCcEEEEEEEEeCCeEEEEEEeccC-CchhHHHHHHHHHH--HHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 210 NFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAG-SGQGEREFQAEIEI--ISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~-~~~~~~~~~~Ei~i--l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
+|...+.||.+.|=+|.+|+.+.|. |+||++-+. .....+.|.++++- ...++|||.+.+.-+-......|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5777899999999999999998887 788887443 34445555554443 4455899999988776666677888888
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccC-CCCC
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL-DTDT 365 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~-~~~~ 365 (586)
+ ..+|.+.| ..++.+...+...|+.|+++||..+|.. +|+|+|||.+||||+.-+.+.|+||.-.+-.. ..+.
T Consensus 103 v-khnLyDRl--STRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 103 V-KHNLYDRL--STRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred H-hhhhhhhh--ccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 8 45888888 4567788899999999999999999998 99999999999999999999999998766321 1111
Q ss_pred c-ccc----cccccccccCcccccCC-----------CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhH
Q 007892 366 H-VST----RVMGTFGYLAPEYASSG-----------KLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKP 428 (586)
Q Consensus 366 ~-~~~----~~~gt~~y~aPE~~~~~-----------~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~ 428 (586)
. ..+ +...-.+|+|||.+... ..+++.||||+||+++||++ |+++|...+- ..+
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL------~aY--- 247 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL------LAY--- 247 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH------HhH---
Confidence 1 111 11223489999987531 26788999999999999998 7888864321 111
Q ss_pred HHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 429 FLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 429 ~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
..+. +......|+... ...+.+++..|++.||.+|.++.++|+.-.|..
T Consensus 248 ------r~~~-~~~~e~~Le~Ie---d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~ 296 (1431)
T KOG1240|consen 248 ------RSGN-ADDPEQLLEKIE---DVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLV 296 (1431)
T ss_pred ------hccC-ccCHHHHHHhCc---CccHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence 0111 111112222111 125788999999999999999999999877654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.9e-23 Score=227.18 Aligned_cols=253 Identities=21% Similarity=0.238 Sum_probs=187.3
Q ss_pred cccceecccCcEEEEEEEEe-CCeEEEEEEeccC--CchhHH----HHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 212 SEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGER----EFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 212 ~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~----~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
...+++|.|.+|.|+..... ..+.++.|..... ....++ .+..|+.+-..++|+|++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 35688999999988777643 3344444433210 111122 2556888888899999988777776666665669
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
|||++ +|...+... ..+...++.-++.|++.||+|||+. +|.|||||++|+|++.++.+||+|||.+..+.-..
T Consensus 401 E~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred hcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 99999 999888654 2477778888999999999999998 99999999999999999999999999987654322
Q ss_pred ---CcccccccccccccCcccccCCCCCC-cchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChh
Q 007892 365 ---THVSTRVMGTFGYLAPEYASSGKLTE-KSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 440 (586)
Q Consensus 365 ---~~~~~~~~gt~~y~aPE~~~~~~~s~-ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (586)
.+.....+|+..|+|||.+....|+. ..||||.||++..|++|+.||......+... .+ . ...-.
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-~~--------~--~~~~~ 543 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-KT--------N--NYSDQ 543 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-hh--------h--ccccc
Confidence 25667789999999999999988876 5799999999999999999998765433211 00 0 00000
Q ss_pred hhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 441 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 441 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
.-+..-........+.+...++.++|+.+|.+|-+|.+|++
T Consensus 544 ~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 544 RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00111111233455677899999999999999999999985
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-21 Score=187.67 Aligned_cols=139 Identities=15% Similarity=0.142 Sum_probs=107.8
Q ss_pred cceecccCcEEEEEEEEeCCeEEEEEEeccCCch--h------------------------HHHHHHHHHHHHhcCCCCc
Q 007892 214 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQ--G------------------------EREFQAEIEIISQVHHRHL 267 (586)
Q Consensus 214 ~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~--~------------------------~~~~~~Ei~il~~l~Hpni 267 (586)
...||+|+||.||+|...+|+.||||+++..... . ......|+.+|.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999888999999999754211 0 0122359999999988776
Q ss_pred ceEEEEEEeCCeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhh-hhcCCCcEEecCCCCceeEeCCC
Q 007892 268 VSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYL-HEDCQPKIIHRDIKSANILLDDS 346 (586)
Q Consensus 268 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yL-H~~~~~~ivHrDIk~~NILl~~~ 346 (586)
.....+.. ...+|||||+++++|...+.. ...+++.+...++.|++.+|.|| |+. +|+||||||+|||+++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~~- 153 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYHD- 153 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEEC-
Confidence 43332222 234899999999877654322 23588899999999999999999 676 9999999999999984
Q ss_pred CCeEEeeccccccc
Q 007892 347 FEAKVADFGLAKHS 360 (586)
Q Consensus 347 ~~~kl~DFGla~~~ 360 (586)
+.++|+|||++...
T Consensus 154 ~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 GKLYIIDVSQSVEH 167 (190)
T ss_pred CcEEEEEccccccC
Confidence 68999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-20 Score=179.86 Aligned_cols=186 Identities=17% Similarity=0.099 Sum_probs=140.7
Q ss_pred ccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhH----HHHHHHHHHHHhcC-CCCcceEEEEEEeCCeeEEEEEec
Q 007892 213 EANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGE----REFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLLVYEFV 287 (586)
Q Consensus 213 ~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~----~~~~~Ei~il~~l~-Hpniv~l~g~~~~~~~~~lV~E~~ 287 (586)
....|++|+||+||.+.- .+..++.+.+........ ..+++|+++|.+|+ |+++++++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 457899999999997665 677788777765433211 25789999999995 5889999886 3468999999
Q ss_pred CCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCC-CCceeEeCCCCCeEEeecccccccCCCCCc
Q 007892 288 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDI-KSANILLDDSFEAKVADFGLAKHSLDTDTH 366 (586)
Q Consensus 288 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDI-k~~NILl~~~~~~kl~DFGla~~~~~~~~~ 366 (586)
.|.+|...+.. ....++.+++.+|.+||.. +|+|||| ||.|||++.++.++|+|||++.........
T Consensus 81 ~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 81 AGAAMYQRPPR---------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred cCccHHhhhhh---------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 99998754321 1135778999999999998 9999999 799999999999999999999854432210
Q ss_pred ----c--------cccccccccccCcccccCC-CCC-CcchHHHHHHHHHHHHhCCCCCCCCC
Q 007892 367 ----V--------STRVMGTFGYLAPEYASSG-KLT-EKSDVFSFGVLLLELITGFRPFDKAD 415 (586)
Q Consensus 367 ----~--------~~~~~gt~~y~aPE~~~~~-~~s-~ksDVwSlGvvL~elltG~~Pf~~~~ 415 (586)
. .....+++.|+.|+...-. ..+ ...+.++.|..+|.++|++.++-.+.
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 1123478888998865322 223 46788999999999999998875544
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=181.21 Aligned_cols=139 Identities=14% Similarity=0.096 Sum_probs=110.5
Q ss_pred cceecccCcEEEEEEEEeCCeEEEEEEeccCCch---------------------h-----HHHHHHHHHHHHhcCCCCc
Q 007892 214 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQ---------------------G-----EREFQAEIEIISQVHHRHL 267 (586)
Q Consensus 214 ~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~---------------------~-----~~~~~~Ei~il~~l~Hpni 267 (586)
...||+|+||.||+|+..+|+.||||+++..... . ...+..|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999878999999998765211 0 1123579999999999987
Q ss_pred ceEEEEEEeCCeeEEEEEecCCCcHHHH-hcCCCCCCCChHHHHHHHHHHHHHhHhhhh-cCCCcEEecCCCCceeEeCC
Q 007892 268 VSLVGYCTFGSQRLLVYEFVPNKTLEFH-LHGKDRPVMNWPTRMKIALGSARGLAYLHE-DCQPKIIHRDIKSANILLDD 345 (586)
Q Consensus 268 v~l~g~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~~ivHrDIk~~NILl~~ 345 (586)
.....+... ..+|||||++++++... +.. ..++..+...++.+++.+|.+||. . +|+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-
Confidence 554444332 24899999998865433 322 236778889999999999999999 7 999999999999999
Q ss_pred CCCeEEeecccccccC
Q 007892 346 SFEAKVADFGLAKHSL 361 (586)
Q Consensus 346 ~~~~kl~DFGla~~~~ 361 (586)
++.++|+|||++....
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 7899999999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.5e-20 Score=184.53 Aligned_cols=232 Identities=19% Similarity=0.286 Sum_probs=148.8
Q ss_pred CccccceecccCcEEEEEEEEeC-CeEEEEEEeccCC---chhHHHHHHHHHHHHhcCC----------CCcceEEEEEE
Q 007892 210 NFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGS---GQGEREFQAEIEIISQVHH----------RHLVSLVGYCT 275 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~H----------pniv~l~g~~~ 275 (586)
.+...+.||.|+|+.||.+++.. |+.+|||...... ....+++++|.-.+..+.+ -.++-.++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 35567899999999999999764 8999999974332 2334567777655555322 12222222211
Q ss_pred ---------eC--C------eeEEEEEecCCCcHHHHhc---CC--CCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEe
Q 007892 276 ---------FG--S------QRLLVYEFVPNKTLEFHLH---GK--DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIH 333 (586)
Q Consensus 276 ---------~~--~------~~~lV~E~~~~gsL~~~l~---~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH 333 (586)
.. . ..+++|+-+ -++|.+.+. .. ....+....++.+..|+++.+++||.. ||||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEe
Confidence 11 1 225667766 567776643 11 112344556777889999999999999 9999
Q ss_pred cCCCCceeEeCCCCCeEEeecccccccCCCCCcccccccccccccCcccccCC--------CCCCcchHHHHHHHHHHHH
Q 007892 334 RDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSG--------KLTEKSDVFSFGVLLLELI 405 (586)
Q Consensus 334 rDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~s~ksDVwSlGvvL~ell 405 (586)
+|||++|+|++.+|.++|+||+......... .. ...+..|.+||..... .++.+.|.|+||++||.|+
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~---~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRY---RC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEE---EG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCcee---ec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 9999999999999999999999876532211 11 3355779999976432 4788999999999999999
Q ss_pred hCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCC
Q 007892 406 TGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRR 473 (586)
Q Consensus 406 tG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~R 473 (586)
||+.||+........ +| ....+. +.++.+..++..+|+.+|.+|
T Consensus 245 C~~lPf~~~~~~~~~---~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADP---EW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTS---GG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCccccc---cc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999865432211 11 222344 677889999999999999987
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.2e-21 Score=204.11 Aligned_cols=233 Identities=27% Similarity=0.306 Sum_probs=182.7
Q ss_pred eecccCcEEEEEEE----EeCCeEEEEEEeccCCchh--HHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeeEEEEEecC
Q 007892 216 LLGQGGFGYVHKGV----LTNGKVVAIKQLKAGSGQG--EREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLLVYEFVP 288 (586)
Q Consensus 216 ~LG~G~fG~Vyk~~----~~~g~~vAVK~l~~~~~~~--~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~~~~~lV~E~~~ 288 (586)
.+|+|.||.|++.. ...|..+|.|.+++..... ......|..++..++ ||.+|++...+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999865 3347788999886543211 114456888899987 9999999999999999999999999
Q ss_pred CCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCccc
Q 007892 289 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 368 (586)
Q Consensus 289 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 368 (586)
+|.|..++... ..+...........++-+++++|.. +|+|||+|++||+++.+|.+|+.|||+.+...+....
T Consensus 81 gg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKE--VMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-- 153 (612)
T ss_pred cchhhhccccC--CchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc--
Confidence 99998888543 3356666667778889999999998 9999999999999999999999999999876543322
Q ss_pred ccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhh
Q 007892 369 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLE 448 (586)
Q Consensus 369 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 448 (586)
|||..|||||++. .....+|.||||++.+||+||..||.. +-.. .|....+
T Consensus 154 ---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------~~~~-------------~Il~~~~- 204 (612)
T KOG0603|consen 154 ---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------DTMK-------------RILKAEL- 204 (612)
T ss_pred ---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------HHHH-------------HHhhhcc-
Confidence 8999999999998 567799999999999999999999975 1111 1111111
Q ss_pred ccCHHHHHHHHHHHHHhhccCCCCCCCHH--HHHHHHh
Q 007892 449 EYDSAEMTRMAACAAACIRHSARRRPRMS--QIVRALE 484 (586)
Q Consensus 449 ~~~~~~~~~l~~l~~~cl~~dp~~RPtm~--evl~~L~ 484 (586)
.++.+.......++..++..+|.+|.-.. .+.+.++
T Consensus 205 ~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~ 242 (612)
T KOG0603|consen 205 EMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQ 242 (612)
T ss_pred CCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhc
Confidence 35666777788888999999999998663 4444444
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.6e-19 Score=172.71 Aligned_cols=138 Identities=18% Similarity=0.192 Sum_probs=107.3
Q ss_pred ccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhc-----CCCCcceEEEEEEeCC---e-eE
Q 007892 211 FSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-----HHRHLVSLVGYCTFGS---Q-RL 281 (586)
Q Consensus 211 f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l-----~Hpniv~l~g~~~~~~---~-~~ 281 (586)
+...++||+|+||.||. .-.++.. +||++........+.+.+|+.++.++ .||||++++|++..+. . ..
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34467899999999996 2223444 68988765445567899999999999 5799999999998863 3 33
Q ss_pred EEEEe--cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHh-HhhhhcCCCcEEecCCCCceeEeCC----CCCeEEeec
Q 007892 282 LVYEF--VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGL-AYLHEDCQPKIIHRDIKSANILLDD----SFEAKVADF 354 (586)
Q Consensus 282 lV~E~--~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL-~yLH~~~~~~ivHrDIk~~NILl~~----~~~~kl~DF 354 (586)
+|+|| +++++|.+++... .+++. ..++.+++.++ +|||++ +|+||||||+|||++. ++.++|+||
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 78999 5679999999542 24444 35677888888 899998 9999999999999974 347999995
Q ss_pred cccc
Q 007892 355 GLAK 358 (586)
Q Consensus 355 Gla~ 358 (586)
+.+.
T Consensus 154 ~G~~ 157 (210)
T PRK10345 154 IGES 157 (210)
T ss_pred CCCc
Confidence 5443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.5e-19 Score=202.87 Aligned_cols=201 Identities=24% Similarity=0.252 Sum_probs=161.0
Q ss_pred HHHHHHhcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcC---CCCcceEEEEEEeCC
Q 007892 202 EELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH---HRHLVSLVGYCTFGS 278 (586)
Q Consensus 202 ~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~---Hpniv~l~g~~~~~~ 278 (586)
.+++...+.|.+.+.||+|+||.||+|...+|+.||+|.-+.......- -=.+++.||+ -+.|..+...+...+
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfY---I~~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFY---ICLQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeee---ehHHHHHhhchhhhcchHHHHHHHccCC
Confidence 3556677889999999999999999999888999999998776544221 1122333333 234555555555677
Q ss_pred eeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeC-------CCCCeEE
Q 007892 279 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD-------DSFEAKV 351 (586)
Q Consensus 279 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~-------~~~~~kl 351 (586)
..+||+||.+.|+|.+++. ..+.++|...+.++.|+++.+++||.. +|||+||||.|+||. +...++|
T Consensus 768 ~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred cceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEE
Confidence 8889999999999999997 556799999999999999999999998 999999999999994 2346899
Q ss_pred eecccccccCC-CCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCC
Q 007892 352 ADFGLAKHSLD-TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRP 410 (586)
Q Consensus 352 ~DFGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~P 410 (586)
+|||.+..+.- .+......+++|-.+-++|...+..++...|.|.|..+++-||.|+.-
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 99999865321 222344567889999999999999999999999999999999999753
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.4e-19 Score=190.79 Aligned_cols=216 Identities=24% Similarity=0.390 Sum_probs=163.6
Q ss_pred HHhcCCCCcceEEEEEEeCCeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCC
Q 007892 259 ISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKS 338 (586)
Q Consensus 259 l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~ 338 (586)
|+.+.|.|+.+++|.|.++...++|.+||..|+|.+.+... ...++|.-...++.++++||+|||.- +-..|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeeecc
Confidence 35678999999999999999999999999999999999763 44599999999999999999999976 2339999999
Q ss_pred ceeEeCCCCCeEEeecccccccCCC-CCcccccccccccccCcccccCCC-------CCCcchHHHHHHHHHHHHhCCCC
Q 007892 339 ANILLDDSFEAKVADFGLAKHSLDT-DTHVSTRVMGTFGYLAPEYASSGK-------LTEKSDVFSFGVLLLELITGFRP 410 (586)
Q Consensus 339 ~NILl~~~~~~kl~DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~-------~s~ksDVwSlGvvL~elltG~~P 410 (586)
.|+++|..+.+||+|||+.....+. .........-..-|.|||.+.... .+.+.||||||++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 9999999999999999998765421 001111122445799999987631 46789999999999999999999
Q ss_pred CCCCCcccc-hhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 411 FDKADTFAD-DSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 411 f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
|+......+ +.++.+.+. .......|.+.... +....+..++..||..+|.+||++.+|-..++...
T Consensus 158 ~~~~~~~~~~~eii~~~~~---------~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKK---------GGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred cccccccCChHHHHHHHHh---------cCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 987543222 223333211 01111222222111 34447999999999999999999999999988653
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.1e-18 Score=167.98 Aligned_cols=134 Identities=20% Similarity=0.273 Sum_probs=113.7
Q ss_pred ceecccCcEEEEEEEEeCCeEEEEEEeccCCch--------hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 215 NLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQ--------GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~--------~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
+.||+|++|.||+|.. +|..|+||........ ....+.+|+.++.+++|++|.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 6678899986543211 123577899999999999998877777777888999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccc
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 359 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~ 359 (586)
++|++|.+++... .+ .+..++.+++.+|.+||.. +++|+|++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988542 22 7889999999999999998 999999999999999 78899999999864
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.7e-18 Score=171.81 Aligned_cols=141 Identities=14% Similarity=0.133 Sum_probs=110.8
Q ss_pred CccccceecccCcEEEEEEE--EeCCeEEEEEEeccCCch------------------------hHHHHHHHHHHHHhcC
Q 007892 210 NFSEANLLGQGGFGYVHKGV--LTNGKVVAIKQLKAGSGQ------------------------GEREFQAEIEIISQVH 263 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~--~~~g~~vAVK~l~~~~~~------------------------~~~~~~~Ei~il~~l~ 263 (586)
.|.+.+.||+|+||.||+|. ..+|+.||||+++..... ....+..|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48889999999999999998 568999999998754210 1123568999999997
Q ss_pred CC--CcceEEEEEEeCCeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCc-EEecCCCCce
Q 007892 264 HR--HLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK-IIHRDIKSAN 340 (586)
Q Consensus 264 Hp--niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~-ivHrDIk~~N 340 (586)
+. .+.+++++ ...+|||||+++++|...+... ..+...+...++.|++.+|++||.. + |+||||||+|
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~N 179 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYN 179 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhh
Confidence 53 34445443 2358999999998886654222 2355556778999999999999998 8 9999999999
Q ss_pred eEeCCCCCeEEeeccccccc
Q 007892 341 ILLDDSFEAKVADFGLAKHS 360 (586)
Q Consensus 341 ILl~~~~~~kl~DFGla~~~ 360 (586)
||++ ++.++|+|||++...
T Consensus 180 Ili~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EEEE-CCCEEEEEChhhhcc
Confidence 9999 789999999998753
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=4e-18 Score=164.68 Aligned_cols=145 Identities=18% Similarity=0.136 Sum_probs=113.7
Q ss_pred HHHHHHhcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCc----------------------hhHHHHHHHHHHH
Q 007892 202 EELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSG----------------------QGEREFQAEIEII 259 (586)
Q Consensus 202 ~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~----------------------~~~~~~~~Ei~il 259 (586)
.++......|...+.||+|+||.||++...+|+.||||++..... .....+..|+.++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 345555445888899999999999999988899999998754321 0112366789999
Q ss_pred HhcCCCC--cceEEEEEEeCCeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCC
Q 007892 260 SQVHHRH--LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIK 337 (586)
Q Consensus 260 ~~l~Hpn--iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk 337 (586)
.++.|.+ +...++. ...++||||+++++|...... .....++.+++.++.++|+. +|+|||||
T Consensus 88 ~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~ 152 (198)
T cd05144 88 KALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKH---GIIHGDLS 152 (198)
T ss_pred HHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHC---CCCcCCCC
Confidence 9998874 4445442 345899999999999765421 23567889999999999997 99999999
Q ss_pred CceeEeCCCCCeEEeecccccccC
Q 007892 338 SANILLDDSFEAKVADFGLAKHSL 361 (586)
Q Consensus 338 ~~NILl~~~~~~kl~DFGla~~~~ 361 (586)
|+||||++++.++|+|||++....
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCC
Confidence 999999999999999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.1e-18 Score=189.13 Aligned_cols=137 Identities=22% Similarity=0.306 Sum_probs=112.5
Q ss_pred hcCccccceecccCcEEEEEEEEeCCeEEEEEE-eccC-Cc------hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQ-LKAG-SG------QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ 279 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~-l~~~-~~------~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~ 279 (586)
...|...+.||+|+||.||+|.+.+.. +++|+ +... .. .....+.+|++++.+++|++++..+.++.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 345567899999999999999976544 33443 2211 11 123468899999999999999998888888788
Q ss_pred eEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccc
Q 007892 280 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 359 (586)
Q Consensus 280 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~ 359 (586)
.+|||||+++++|.+++. ....++.+++.+|.|||+. +|+||||||+|||+ +++.++|+|||+++.
T Consensus 411 ~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 899999999999998874 4567899999999999998 99999999999999 577999999999975
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.7e-18 Score=162.97 Aligned_cols=130 Identities=22% Similarity=0.299 Sum_probs=106.7
Q ss_pred eecccCcEEEEEEEEeCCeEEEEEEeccCCch--------hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEec
Q 007892 216 LLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQ--------GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 287 (586)
Q Consensus 216 ~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~--------~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 287 (586)
.||+|+||.||+|.+ +|..|+||........ ....+.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 5678999986543211 1245778999999999887665555666677789999999
Q ss_pred CCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccc
Q 007892 288 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 359 (586)
Q Consensus 288 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~ 359 (586)
+|++|.+.+..... .++.+++.+|.+||+. +++|+|++|.|||++ ++.++|+|||+++.
T Consensus 80 ~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND---------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH---------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999988743211 7899999999999998 999999999999999 78999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.5e-18 Score=191.25 Aligned_cols=210 Identities=24% Similarity=0.316 Sum_probs=142.9
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEec
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 287 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 287 (586)
++|..+++|..|+||.||..+++ ..+.+|+|+=+.+ .+.+- |+.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq~------lilRn--ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN------LILRN--ILTFAGNPFVV------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcccccc------hhhhc--cccccCCccee-------------------
Confidence 67889999999999999999876 3678888542221 11110 23233333333
Q ss_pred CCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC---
Q 007892 288 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD--- 364 (586)
Q Consensus 288 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~--- 364 (586)
|+-...+...+. ++. +++.+++|||+. +|+|||+|+.|.||+.-|++|+.||||.+......
T Consensus 136 --gDc~tllk~~g~--lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 --GDCATLLKNIGP--LPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred --chhhhhcccCCC--Ccc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 232233322221 221 227789999998 99999999999999999999999999987532211
Q ss_pred ---------Cc--ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhc
Q 007892 365 ---------TH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQG 433 (586)
Q Consensus 365 ---------~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 433 (586)
++ ....++||+.|.|||++....|...+|+|++|+|+||.+.|..||..+.+.. .+..++..
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee------lfg~visd- 273 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------LFGQVISD- 273 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH------HHhhhhhh-
Confidence 11 1234789999999999999999999999999999999999999998765421 11111110
Q ss_pred ccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 007892 434 LADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMS 477 (586)
Q Consensus 434 ~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~ 477 (586)
+..+. +-+.....+..+++.+.|+.+|..|--..
T Consensus 274 --~i~wp--------E~dea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 274 --DIEWP--------EEDEALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred --hcccc--------ccCcCCCHHHHHHHHHHHHhChHhhcccc
Confidence 00000 12333446788889999999999997544
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.1e-18 Score=182.52 Aligned_cols=171 Identities=25% Similarity=0.386 Sum_probs=129.4
Q ss_pred eeEEEEEecCCCcHHHHhcC-CCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccc
Q 007892 279 QRLLVYEFVPNKTLEFHLHG-KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 357 (586)
Q Consensus 279 ~~~lV~E~~~~gsL~~~l~~-~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla 357 (586)
..++.|++|.-.+|.+||.+ ......+|...+.++.|++.|++| + +.+|||+||.||+...+..+||.||||.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 46789999999999999964 344567888999999999999999 5 8999999999999999989999999998
Q ss_pred cccCCCC-----CcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHh
Q 007892 358 KHSLDTD-----THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLA 431 (586)
Q Consensus 358 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~ 431 (586)
....... ....+...||..||+||.+.+..|+.|+|||+||++|+||+. =...|+.... .
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t--------------~ 469 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIAT--------------L 469 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHh--------------h
Confidence 7654443 223456789999999999999999999999999999999997 2233322111 1
Q ss_pred hcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 007892 432 QGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMS 477 (586)
Q Consensus 432 ~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~ 477 (586)
..+.++.+... .+.+++ .-..++.+++...|.+||++.
T Consensus 470 ~d~r~g~ip~~---~~~d~p-----~e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 470 TDIRDGIIPPE---FLQDYP-----EEYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred hhhhcCCCChH---HhhcCc-----HHHHHHHHhcCCCcccCchHH
Confidence 11223332210 111222 235678999999999999433
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.7e-16 Score=144.44 Aligned_cols=135 Identities=20% Similarity=0.146 Sum_probs=115.8
Q ss_pred ccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCC--CCcceEEEEEEeCCeeEEEEEecCCC
Q 007892 213 EANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHH--RHLVSLVGYCTFGSQRLLVYEFVPNK 290 (586)
Q Consensus 213 ~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~H--pniv~l~g~~~~~~~~~lV~E~~~~g 290 (586)
+.+.||+|.++.||++...+ ..++||....... ...+.+|+.++..++| .++.++++++...+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35789999999999999855 7899999866543 5678999999999976 58999999988888899999999988
Q ss_pred cHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccc
Q 007892 291 TLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 359 (586)
Q Consensus 291 sL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~ 359 (586)
.+..+ ++.....++.+++++|++||.....+++|+||+++|||+++++.++++|||++..
T Consensus 79 ~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77543 5567778899999999999986545799999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1e-16 Score=161.57 Aligned_cols=197 Identities=23% Similarity=0.266 Sum_probs=139.1
Q ss_pred CCCCcceEEEEEEeC---------------------------CeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHH
Q 007892 263 HHRHLVSLVGYCTFG---------------------------SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALG 315 (586)
Q Consensus 263 ~Hpniv~l~g~~~~~---------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ 315 (586)
.|||||++.++|.+. ...||||... ..+|..+|..+. .+.....-|+.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC---CchHHHHHHHHH
Confidence 499999998876432 3467888876 458888886554 445556668899
Q ss_pred HHHHhHhhhhcCCCcEEecCCCCceeEe--CCCC--CeEEeecccccccCCCCC-----cccccccccccccCcccccC-
Q 007892 316 SARGLAYLHEDCQPKIIHRDIKSANILL--DDSF--EAKVADFGLAKHSLDTDT-----HVSTRVMGTFGYLAPEYASS- 385 (586)
Q Consensus 316 ia~gL~yLH~~~~~~ivHrDIk~~NILl--~~~~--~~kl~DFGla~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~- 385 (586)
+++|+.|||.+ +|.|||+|+.|||| |+|. .+.|+|||+|-......- ...-..-|...-||||+...
T Consensus 350 lLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 350 LLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 99999999999 99999999999998 4554 468999999853221110 01112347788999998753
Q ss_pred -CC----CCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHH
Q 007892 386 -GK----LTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAA 460 (586)
Q Consensus 386 -~~----~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~ 460 (586)
|+ .-.|+|.|+.|.+.||++....||..... +..+. ..+. ...|...+...+..+.+
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe-m~L~~--------------r~Yq---e~qLPalp~~vpp~~rq 488 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE-MLLDT--------------RTYQ---ESQLPALPSRVPPVARQ 488 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccch-heech--------------hhhh---hhhCCCCcccCChHHHH
Confidence 22 23599999999999999999999976322 11111 1111 12223345556677899
Q ss_pred HHHHhhccCCCCCCCHHHHHHHHh
Q 007892 461 CAAACIRHSARRRPRMSQIVRALE 484 (586)
Q Consensus 461 l~~~cl~~dp~~RPtm~evl~~L~ 484 (586)
++...|+.||.+|++..-....|.
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHHH
Confidence 999999999999999765555554
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.5e-16 Score=150.38 Aligned_cols=135 Identities=18% Similarity=0.196 Sum_probs=98.9
Q ss_pred cceecccCcEEEEEEEEeCCeEEEEEEeccCCchh---HHH---------------------HHHHHHHHHhcCCCC--c
Q 007892 214 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQG---ERE---------------------FQAEIEIISQVHHRH--L 267 (586)
Q Consensus 214 ~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~---~~~---------------------~~~Ei~il~~l~Hpn--i 267 (586)
.+.||+|+||.||+|...+|+.||||+++...... ... ...|...+.++.+.+ +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46899999999999998889999999987542211 111 135666676665443 4
Q ss_pred ceEEEEEEeCCeeEEEEEecCCCcHHHH-hcCCCCCCCChHHHHHHHHHHHHHhHhhhh-cCCCcEEecCCCCceeEeCC
Q 007892 268 VSLVGYCTFGSQRLLVYEFVPNKTLEFH-LHGKDRPVMNWPTRMKIALGSARGLAYLHE-DCQPKIIHRDIKSANILLDD 345 (586)
Q Consensus 268 v~l~g~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~~ivHrDIk~~NILl~~ 345 (586)
.+++++ ...+|||||++++.+... +.... .. .+...++.+++.++.+||. . +|+||||||+|||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-
Confidence 445443 246899999999544211 11110 11 5677899999999999998 6 999999999999999
Q ss_pred CCCeEEeeccccccc
Q 007892 346 SFEAKVADFGLAKHS 360 (586)
Q Consensus 346 ~~~~kl~DFGla~~~ 360 (586)
++.++|+|||++...
T Consensus 150 ~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 DGKVYIIDVPQAVEI 164 (187)
T ss_pred CCcEEEEECcccccc
Confidence 889999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.5e-15 Score=148.36 Aligned_cols=135 Identities=19% Similarity=0.207 Sum_probs=105.0
Q ss_pred cceec-ccCcEEEEEEEEeCCeEEEEEEeccCC-------------chhHHHHHHHHHHHHhcCCCCc--ceEEEEEEeC
Q 007892 214 ANLLG-QGGFGYVHKGVLTNGKVVAIKQLKAGS-------------GQGEREFQAEIEIISQVHHRHL--VSLVGYCTFG 277 (586)
Q Consensus 214 ~~~LG-~G~fG~Vyk~~~~~g~~vAVK~l~~~~-------------~~~~~~~~~Ei~il~~l~Hpni--v~l~g~~~~~ 277 (586)
...|| .||.|+||+.... +..++||.+.... ......+.+|++++.+|+|++| +..++++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 36788 8999999999875 6678898875321 1223457889999999998875 7777775543
Q ss_pred C----eeEEEEEecCC-CcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEe
Q 007892 278 S----QRLLVYEFVPN-KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVA 352 (586)
Q Consensus 278 ~----~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~ 352 (586)
. ..+||+||+++ .+|.+++... .++.. .+.+++.+|.+||+. ||+||||||.|||++.++.++|+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEE
Confidence 2 22599999997 6898887542 23332 357899999999998 99999999999999998899999
Q ss_pred ecccccc
Q 007892 353 DFGLAKH 359 (586)
Q Consensus 353 DFGla~~ 359 (586)
|||.+..
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9999875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.1e-16 Score=177.93 Aligned_cols=254 Identities=22% Similarity=0.295 Sum_probs=188.2
Q ss_pred CccccceecccCcEEEEEEEEeC--CeEEEEEEeccCC--chhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeeEEEE
Q 007892 210 NFSEANLLGQGGFGYVHKGVLTN--GKVVAIKQLKAGS--GQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~~--g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~~~~~lV~ 284 (586)
.|...+.||+|.|+.|-...... ...+|+|.+.... .........|..+-..+. |.|++++++.....+..+++.
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 34555679999999998887543 3456777665443 222234445788877787 999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhh-hcCCCcEEecCCCCceeEeCCCC-CeEEeecccccccCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH-EDCQPKIIHRDIKSANILLDDSF-EAKVADFGLAKHSLD 362 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH-~~~~~~ivHrDIk~~NILl~~~~-~~kl~DFGla~~~~~ 362 (586)
+|..++++...+...+...++....-.+..|+..+|.|+| +. ++.||||||+|.+++..+ ..|++|||+|..+..
T Consensus 101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred CcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 9999999988873233324566667788999999999999 66 899999999999999999 999999999987765
Q ss_pred --CCCcccccccc-cccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCC
Q 007892 363 --TDTHVSTRVMG-TFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGN 438 (586)
Q Consensus 363 --~~~~~~~~~~g-t~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (586)
.........+| ++.|+|||...+ .......|+||.|+++.-+++|..|++...... .....|...- +.
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~~~~-------~~ 249 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWKSNK-------GR 249 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeecccc-------cc
Confidence 22333445678 999999999987 456788999999999999999999998765432 2233332210 00
Q ss_pred hhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 439 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 439 ~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
+. ............++...++..++..|.+.+++..
T Consensus 250 ~~-------~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 250 FT-------QLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cc-------cCccccCChhhhhcccccccCCchhccccccccc
Confidence 00 0111222344667778888899999999887753
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.54 E-value=2.2e-14 Score=154.67 Aligned_cols=141 Identities=23% Similarity=0.256 Sum_probs=101.9
Q ss_pred cceecccCcEEEEEEEEeCCeEEEEEEeccCCchh----------------------------------------HHHHH
Q 007892 214 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQG----------------------------------------EREFQ 253 (586)
Q Consensus 214 ~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~----------------------------------------~~~~~ 253 (586)
.+.||.|++|.||+|++.+|+.||||+.+.+.... +-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 46799999999999999999999999987642111 01345
Q ss_pred HHHHHHHhcC----CCCcceEEEEEE-eCCeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHH-HhHhhhhcC
Q 007892 254 AEIEIISQVH----HRHLVSLVGYCT-FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR-GLAYLHEDC 327 (586)
Q Consensus 254 ~Ei~il~~l~----Hpniv~l~g~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~-gL~yLH~~~ 327 (586)
.|+..+.++. |.+-+.+-.++. ..+..+|||||++|++|.+.+..... .. .+.+++..++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql~~~- 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQVLRD- 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHHHhC-
Confidence 5666666652 333344333332 34567999999999999877643211 12 23456666666 46788887
Q ss_pred CCcEEecCCCCceeEeCCCCCeEEeecccccccC
Q 007892 328 QPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 361 (586)
Q Consensus 328 ~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~ 361 (586)
+++|+|+||.||+++.++.++|+|||++....
T Consensus 277 --g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 --GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred --CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999997653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.1e-13 Score=145.70 Aligned_cols=247 Identities=22% Similarity=0.264 Sum_probs=179.6
Q ss_pred cCccccceecc--cCcEEEEEEEE---eCCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCee
Q 007892 209 DNFSEANLLGQ--GGFGYVHKGVL---TNGKVVAIKQLKAGSG--QGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQR 280 (586)
Q Consensus 209 ~~f~~~~~LG~--G~fG~Vyk~~~---~~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~~~~ 280 (586)
..|.....+|. |.+|.||.+.. .++..+|+|.-+.... +....=.+|+....+++ |+|.++....+..++..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34667788999 99999999987 3578899998543322 22223345677777775 99999988888888999
Q ss_pred EEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHH----HhHhhhhcCCCcEEecCCCCceeEeCCC-CCeEEeecc
Q 007892 281 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR----GLAYLHEDCQPKIIHRDIKSANILLDDS-FEAKVADFG 355 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~----gL~yLH~~~~~~ivHrDIk~~NILl~~~-~~~kl~DFG 355 (586)
++-.|++ +.+|..+.+... ..++....+.+..+... ||.++|.. .++|-|+|+.||++..+ ...+++|||
T Consensus 194 fiqtE~~-~~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 194 FIQTELC-GESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeeeccc-cchhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcc
Confidence 9999988 478877776543 23555666677777777 99999998 99999999999999999 889999999
Q ss_pred cccccCCCCCc----ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHh
Q 007892 356 LAKHSLDTDTH----VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLA 431 (586)
Q Consensus 356 la~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 431 (586)
+...+.+.... ...+..|...|++||.++ +.++.++|+|+||.++++..+|......... ..|.. +
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~------~~W~~--~- 338 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKN------SSWSQ--L- 338 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCC------CCccc--c-
Confidence 99877655422 223346888999999887 6789999999999999999998776543311 12321 0
Q ss_pred hcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 007892 432 QGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIV 480 (586)
Q Consensus 432 ~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl 480 (586)
..+ + +-+ ++......++...+..+++.++..|++.+.+.
T Consensus 339 ---r~~-~--ip~----e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 339 ---RQG-Y--IPL----EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred ---ccc-c--Cch----hhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 000 0 111 22222233455588999999999999877664
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.41 E-value=1e-12 Score=143.73 Aligned_cols=144 Identities=19% Similarity=0.198 Sum_probs=97.4
Q ss_pred cCccccceecccCcEEEEEEEEeC-CeEEEEEEeccCCchh---------------------------------------
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQG--------------------------------------- 248 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~~~--------------------------------------- 248 (586)
..|+. +.||.|++|.||+|++.+ |+.||||+++++-...
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45776 789999999999999987 9999999997542110
Q ss_pred -HHHHHHHHHHHHhcC----CCCcceEEEEEEe-CCeeEEEEEecCCCcHHHH--hcCCCCCCCChHHHHHHHHHHHH-H
Q 007892 249 -EREFQAEIEIISQVH----HRHLVSLVGYCTF-GSQRLLVYEFVPNKTLEFH--LHGKDRPVMNWPTRMKIALGSAR-G 319 (586)
Q Consensus 249 -~~~~~~Ei~il~~l~----Hpniv~l~g~~~~-~~~~~lV~E~~~~gsL~~~--l~~~~~~~l~~~~~~~ia~~ia~-g 319 (586)
+-+|.+|+..+.++. +.+.+.+-.++.+ ....+|||||++|+.|.+. +...+ .+.. .++...+. -
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g---~d~~---~la~~~v~~~ 272 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG---TDMK---LLAERGVEVF 272 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC---CCHH---HHHHHHHHHH
Confidence 012445665555553 4444554444443 5678899999999999764 22211 2222 22222222 1
Q ss_pred hHhhhhcCCCcEEecCCCCceeEeCCCC----CeEEeecccccccCC
Q 007892 320 LAYLHEDCQPKIIHRDIKSANILLDDSF----EAKVADFGLAKHSLD 362 (586)
Q Consensus 320 L~yLH~~~~~~ivHrDIk~~NILl~~~~----~~kl~DFGla~~~~~ 362 (586)
+..++.. |++|+|+||.|||++.++ .++++|||++.....
T Consensus 273 ~~Qif~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 273 FTQVFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 2334445 999999999999999888 999999999976533
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.1e-12 Score=122.83 Aligned_cols=131 Identities=18% Similarity=0.076 Sum_probs=97.5
Q ss_pred cceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcc-eEEEEEEeCCeeEEEEEecCCCcH
Q 007892 214 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLV-SLVGYCTFGSQRLLVYEFVPNKTL 292 (586)
Q Consensus 214 ~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv-~l~g~~~~~~~~~lV~E~~~~gsL 292 (586)
.+.|+.|.++.||++... ++.|+||....... ....+..|+.++..+.+.+++ +++.+. ....++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 367899999999999874 77899998755432 234568899999998765554 454433 3345799999999887
Q ss_pred HHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcC--CCcEEecCCCCceeEeCCCCCeEEeecccccc
Q 007892 293 EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC--QPKIIHRDIKSANILLDDSFEAKVADFGLAKH 359 (586)
Q Consensus 293 ~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~--~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~ 359 (586)
.... . ....++.+++++|+.||... ...++|+|+++.||+++ ++.++|+|||.+..
T Consensus 79 ~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 5420 1 11245678999999999873 22369999999999999 56899999999853
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.40 E-value=4.3e-13 Score=132.85 Aligned_cols=210 Identities=19% Similarity=0.288 Sum_probs=142.4
Q ss_pred HHHHHHHHHHHhcCCCCcceEEEEEEeCC-----eeEEEEEecCCCcHHHHhcCC--CCCCCChHHHHHHHHHHHHHhHh
Q 007892 250 REFQAEIEIISQVHHRHLVSLVGYCTFGS-----QRLLVYEFVPNKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAY 322 (586)
Q Consensus 250 ~~~~~Ei~il~~l~Hpniv~l~g~~~~~~-----~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~y 322 (586)
...+.-++-|-++.|-|||+++.|+.+.. ...++.|||.-|+|..+|+.. ....+......+|+-||+.||.|
T Consensus 112 ek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~y 191 (458)
T KOG1266|consen 112 EKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSY 191 (458)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhh
Confidence 34444556677778999999999986543 457899999999999999753 33457777788999999999999
Q ss_pred hhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCC---CCcccccccccccccCcccccCCCCCCcchHHHHHH
Q 007892 323 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT---DTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGV 399 (586)
Q Consensus 323 LH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGv 399 (586)
||+ |.|.|+|+++..+-|++..++-+||.---........ .........+-++|.+||+=..-..+..+|||+||.
T Consensus 192 Lhs-~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgm 270 (458)
T KOG1266|consen 192 LHS-CDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGM 270 (458)
T ss_pred hhc-cCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhH
Confidence 998 6899999999999999999988887422111000000 000111234678999999877677788999999999
Q ss_pred HHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 007892 400 LLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQI 479 (586)
Q Consensus 400 vL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~ev 479 (586)
..+||..|..--..... ...++-........++++ .-..++..|++-.|..||+|+++
T Consensus 271 cAlemailEiq~tnseS---~~~~ee~ia~~i~~len~-------------------lqr~~i~kcl~~eP~~rp~ar~l 328 (458)
T KOG1266|consen 271 CALEMAILEIQSTNSES---KVEVEENIANVIIGLENG-------------------LQRGSITKCLEGEPNGRPDARLL 328 (458)
T ss_pred HHHHHHHheeccCCCcc---eeehhhhhhhheeeccCc-------------------cccCcCcccccCCCCCCcchhhh
Confidence 99999887542111100 000010000000111111 12345678999999999999998
Q ss_pred HHH
Q 007892 480 VRA 482 (586)
Q Consensus 480 l~~ 482 (586)
+.+
T Consensus 329 lfH 331 (458)
T KOG1266|consen 329 LFH 331 (458)
T ss_pred hcC
Confidence 643
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.2e-11 Score=131.60 Aligned_cols=166 Identities=18% Similarity=0.253 Sum_probs=125.8
Q ss_pred EeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecCCCcHHHHhcCCCCCCCChHHH
Q 007892 230 LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR 309 (586)
Q Consensus 230 ~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~ 309 (586)
..++..|.|+..+..........++-++.|+.++||||++++..+...+..|||.|-+. -|..++... .....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-----~~~~v 106 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-----GKEEV 106 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-----HHHHH
Confidence 34678888888877666445567888999999999999999999999999999999884 344455332 24456
Q ss_pred HHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcccccccccccccCcccccCCCCC
Q 007892 310 MKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLT 389 (586)
Q Consensus 310 ~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s 389 (586)
...+.||+.||.+||++| +++|++|.-..|+|+..|+.||++|-++........ ......---.|..|+.+....
T Consensus 107 ~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--
Confidence 667899999999999887 899999999999999999999999998865332221 011111122456666544222
Q ss_pred CcchHHHHHHHHHHHHhC
Q 007892 390 EKSDVFSFGVLLLELITG 407 (586)
Q Consensus 390 ~ksDVwSlGvvL~elltG 407 (586)
-..|.|-|||+++|++.|
T Consensus 182 ~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cchhhhhHHHHHHHHhCc
Confidence 346999999999999999
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.5e-12 Score=139.20 Aligned_cols=249 Identities=19% Similarity=0.205 Sum_probs=179.7
Q ss_pred HHhcCccccceecccCcEEEEEEEEe--CCeEEEEEEeccCCchhHHHH--HHHHHHHHhcC-CCCcceEEEEEEeCCee
Q 007892 206 IATDNFSEANLLGQGGFGYVHKGVLT--NGKVVAIKQLKAGSGQGEREF--QAEIEIISQVH-HRHLVSLVGYCTFGSQR 280 (586)
Q Consensus 206 ~~~~~f~~~~~LG~G~fG~Vyk~~~~--~g~~vAVK~l~~~~~~~~~~~--~~Ei~il~~l~-Hpniv~l~g~~~~~~~~ 280 (586)
.-..+|.++..||.|.|+.|++...+ ++..+++|.+.+.......++ ..|+-+...+. |.|+++.+..+....+.
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 34467999999999999999998744 578999999887655544443 35777777764 89999987777777788
Q ss_pred EEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCC-CCeEEeecccccc
Q 007892 281 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS-FEAKVADFGLAKH 359 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~-~~~kl~DFGla~~ 359 (586)
++-.|||.++++...+ .-...++...++++..+++.++.++|+. .++|+|+||+||++.++ +..++.|||++..
T Consensus 342 ~ip~e~~~~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred cCchhhhcCcchhhhh--HHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccc
Confidence 8999999999987666 2234577888899999999999999988 89999999999999886 8899999999864
Q ss_pred cCCCCCcccccccccccc-cCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCC
Q 007892 360 SLDTDTHVSTRVMGTFGY-LAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGN 438 (586)
Q Consensus 360 ~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (586)
+.-. .......+..| .+++.+....+..+.|+|+||.-+.|.++|..-- .+.+.|.. +..+
T Consensus 417 ~~~~---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls--------~~~~~~~~------i~~~- 478 (524)
T KOG0601|consen 417 LAFS---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLS--------ESGVQSLT------IRSG- 478 (524)
T ss_pred ccee---cccccccccccccchhhccccccccccccccccccccccccCcccC--------ccccccee------eecc-
Confidence 2111 11111123334 3566666777889999999999999999985421 11222211 1111
Q ss_pred hhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 007892 439 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 485 (586)
Q Consensus 439 ~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~ 485 (586)
.+...+.. ...+..+++.++..++..||.+.++..+.+-
T Consensus 479 -------~~p~~~~~-~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 479 -------DTPNLPGL-KLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred -------cccCCCch-HHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 11111111 1456677888999999999998887766543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.28 E-value=3.9e-11 Score=117.17 Aligned_cols=143 Identities=20% Similarity=0.250 Sum_probs=111.2
Q ss_pred cceecccCcEEEEEEEEeCCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCC--CCcceEEEEEEeCC---eeEEEEEec
Q 007892 214 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHH--RHLVSLVGYCTFGS---QRLLVYEFV 287 (586)
Q Consensus 214 ~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~H--pniv~l~g~~~~~~---~~~lV~E~~ 287 (586)
.+.|+.|.++.||++...+|+.++||....... .....+..|++++..+.+ .++.+++.++.... ..++||||+
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 367899999999999987778899999765432 134578999999999975 34677888776542 568999999
Q ss_pred CCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcC----------------------------------------
Q 007892 288 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC---------------------------------------- 327 (586)
Q Consensus 288 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~---------------------------------------- 327 (586)
+|.++...+.. ..++...+..++.++++.|.+||+..
T Consensus 83 ~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 83 DGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 99988765531 23677777888888888888888521
Q ss_pred -------------CCcEEecCCCCceeEeCC--CCCeEEeecccccc
Q 007892 328 -------------QPKIIHRDIKSANILLDD--SFEAKVADFGLAKH 359 (586)
Q Consensus 328 -------------~~~ivHrDIk~~NILl~~--~~~~kl~DFGla~~ 359 (586)
...++|+|+++.|||++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 56689999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.22 E-value=2e-10 Score=109.86 Aligned_cols=135 Identities=16% Similarity=0.142 Sum_probs=97.2
Q ss_pred ceecccCcEEEEEEEEeC-------CeEEEEEEeccCC----------------------chhHHHHH----HHHHHHHh
Q 007892 215 NLLGQGGFGYVHKGVLTN-------GKVVAIKQLKAGS----------------------GQGEREFQ----AEIEIISQ 261 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~~~~-------g~~vAVK~l~~~~----------------------~~~~~~~~----~Ei~il~~ 261 (586)
..||.|--+.||.|...+ +..+|||+.+... ......+. +|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 578999999999998543 4789999874321 01122333 79999999
Q ss_pred cCC--CCcceEEEEEEeCCeeEEEEEecCCCcHH-HHhcCCCCCCCChHHHHHHHHHHHHHhHhh-hhcCCCcEEecCCC
Q 007892 262 VHH--RHLVSLVGYCTFGSQRLLVYEFVPNKTLE-FHLHGKDRPVMNWPTRMKIALGSARGLAYL-HEDCQPKIIHRDIK 337 (586)
Q Consensus 262 l~H--pniv~l~g~~~~~~~~~lV~E~~~~gsL~-~~l~~~~~~~l~~~~~~~ia~~ia~gL~yL-H~~~~~~ivHrDIk 337 (586)
+.. -++..++++ ...+|||||+.+..+. ..|.. ..++..+...+..+++.+|..| |.. +|||+||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence 863 455566643 4567999999765432 12211 1244455667889999999998 776 99999999
Q ss_pred CceeEeCCCCCeEEeeccccccc
Q 007892 338 SANILLDDSFEAKVADFGLAKHS 360 (586)
Q Consensus 338 ~~NILl~~~~~~kl~DFGla~~~ 360 (586)
+.|||+++ +.+.|+|||.+...
T Consensus 153 ~~NIL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 153 EYNMLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred HHHEEEEC-CcEEEEECCCceeC
Confidence 99999974 57999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.17 E-value=3.4e-10 Score=104.56 Aligned_cols=143 Identities=19% Similarity=0.218 Sum_probs=104.6
Q ss_pred ccceecccCcEEEEEEEEeCCeEEEEEEeccC--------CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 213 EANLLGQGGFGYVHKGVLTNGKVVAIKQLKAG--------SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 213 ~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~--------~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
...+|-+|+-+.|+++.+ .|+.+.||.--.. ........++|+.+|.+++--.|.--.-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 467899999999999998 4677777763221 1122356778999999987545444333566666667999
Q ss_pred EecCC-CcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCC---CeEEeecccccc
Q 007892 285 EFVPN-KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF---EAKVADFGLAKH 359 (586)
Q Consensus 285 E~~~~-gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~---~~kl~DFGla~~ 359 (586)
||+++ .++.+++...............++..|-..+.-||.+ +|||+||..+||+|..++ .+.++||||+..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 4677777554433333344467888999999999998 999999999999996543 458999999854
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.2e-09 Score=101.58 Aligned_cols=131 Identities=20% Similarity=0.249 Sum_probs=98.4
Q ss_pred ceecccCcEEEEEEEEeCCeEEEEEEeccCCc----h----hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 215 NLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSG----Q----GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~----~----~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
..+++|+-..+|.+.+.+. .+++|.-..... . ....-++|+.+|.++.--.|..-+=|..+.....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~-~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGL-PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccCc-ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 3578999999999977543 466665322211 1 123456799999998755544434455666777899999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccc
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 359 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~ 359 (586)
++|-.|.+.+... +..++..+-.-+.-||.. +|||+||.++||+|..+. +.++||||+..
T Consensus 81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA---------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc---------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888554 256777888888999998 999999999999998874 99999999974
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.4e-11 Score=138.10 Aligned_cols=247 Identities=19% Similarity=0.219 Sum_probs=164.5
Q ss_pred HhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEE
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 282 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~l 282 (586)
..+.|.+.+-+-.|.|+.++.+.-. .|...+.|...... .+..+..+.+-.++...+||-+++...-+.-....+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 3356666677778888888776632 24334444332221 1112333444444444556666655444344567789
Q ss_pred EEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCC
Q 007892 283 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 283 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 362 (586)
|++|+.+++|...||... +.+..-....+..+...++|||.. .++|||++|.|+|+..++..++.|||+......
T Consensus 882 ~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred hhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccccc
Confidence 999999999999987654 344333344556677889999987 699999999999999999999999984321110
Q ss_pred C------------------------------CCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 007892 363 T------------------------------DTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFD 412 (586)
Q Consensus 363 ~------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~ 412 (586)
. +........||+.|++||.+.+......+|+|++|++|+|.++|..||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 0 0011123569999999999999999999999999999999999999998
Q ss_pred CCCcccchhhhhhhhHHHhhcccCCChhhhhchhhh--ccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 007892 413 KADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLE--EYDSAEMTRMAACAAACIRHSARRRPRMS 477 (586)
Q Consensus 413 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~--~~~~~~~~~l~~l~~~cl~~dp~~RPtm~ 477 (586)
...+.. .++.+...... .-......+...++...+..++.+|-.|.
T Consensus 1037 a~tpq~-------------------~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1037 AETPQQ-------------------IFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred Ccchhh-------------------hhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 655421 11111111111 22333445667777888888999888776
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.04 E-value=7.2e-09 Score=109.06 Aligned_cols=167 Identities=17% Similarity=0.209 Sum_probs=126.5
Q ss_pred cEEEEEEEE-eCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEE----eCCeeEEEEEecCC-CcHHHH
Q 007892 222 FGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCT----FGSQRLLVYEFVPN-KTLEFH 295 (586)
Q Consensus 222 fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~----~~~~~~lV~E~~~~-gsL~~~ 295 (586)
-.+.||++. .||..|++|++..+..+.......-+++++++.|.|+|.+..++. .+..++|||+|.++ ++|.+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 467889884 489999999995544444434456688999999999999988876 24578899999987 455544
Q ss_pred hcCC-------------CCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCC
Q 007892 296 LHGK-------------DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 296 l~~~-------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 362 (586)
-... ......+..++.++.|+..||.++|+. |+.-+-|.+.+||++.+.+++|...|+......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 3211 123467788999999999999999998 899999999999999999999988887765433
Q ss_pred CCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCC
Q 007892 363 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFR 409 (586)
Q Consensus 363 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~ 409 (586)
... |-+. --.+-|.=.||.+|+.|.||..
T Consensus 446 d~~---------------~~le---~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 446 DPT---------------EPLE---SQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCC---------------cchh---HHhhhhHHHHHHHHHHHhhccc
Confidence 321 1111 1236788899999999999954
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.02 E-value=5.3e-09 Score=105.45 Aligned_cols=141 Identities=16% Similarity=0.049 Sum_probs=101.1
Q ss_pred ceecccCcEEEEEEEEeCCeEEEEEEeccCCch-----------hHHHHHHHHHHHHhcCCCC--cceEEEEEEe-----
Q 007892 215 NLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQ-----------GEREFQAEIEIISQVHHRH--LVSLVGYCTF----- 276 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~-----------~~~~~~~Ei~il~~l~Hpn--iv~l~g~~~~----- 276 (586)
+.+-.-....|++..+ +|+.|.||+....... ....+.+|...+.+|...+ ...++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444444455777766 6788999976433211 1114778999999885433 3445556543
Q ss_pred CCeeEEEEEecCCC-cHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCC-------CCC
Q 007892 277 GSQRLLVYEFVPNK-TLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD-------SFE 348 (586)
Q Consensus 277 ~~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~-------~~~ 348 (586)
....+||+|++++. +|.+++........+...+..++.+++..+.-||.. ||+|+|++++||||+. ++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCce
Confidence 23568999999986 798887532223345567778999999999999998 9999999999999975 468
Q ss_pred eEEeecccccc
Q 007892 349 AKVADFGLAKH 359 (586)
Q Consensus 349 ~kl~DFGla~~ 359 (586)
+.|+||+.++.
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998853
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.94 E-value=7.5e-09 Score=98.64 Aligned_cols=125 Identities=21% Similarity=0.265 Sum_probs=82.3
Q ss_pred EEEEEEEeCCeEEEEEEeccCCc--------------------------hhHHHHHHHHHHHHhcCCC--CcceEEEEEE
Q 007892 224 YVHKGVLTNGKVVAIKQLKAGSG--------------------------QGEREFQAEIEIISQVHHR--HLVSLVGYCT 275 (586)
Q Consensus 224 ~Vyk~~~~~g~~vAVK~l~~~~~--------------------------~~~~~~~~Ei~il~~l~Hp--niv~l~g~~~ 275 (586)
.||.|...+|..+|||+.+.... ......++|++.|.++..- ++.+++.+-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999998999999999754210 0112456899999999865 455665442
Q ss_pred eCCeeEEEEEecC--CCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHh-hhhcCCCcEEecCCCCceeEeCCCCCeEEe
Q 007892 276 FGSQRLLVYEFVP--NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAY-LHEDCQPKIIHRDIKSANILLDDSFEAKVA 352 (586)
Q Consensus 276 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~y-LH~~~~~~ivHrDIk~~NILl~~~~~~kl~ 352 (586)
...|||||++ |..+..+.... ++......++.+++..+.. +|.. +|||+||...|||++++ .+.|+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE-
T ss_pred ---CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEE
Confidence 3469999998 65554433221 1134456677888886665 4666 99999999999999988 99999
Q ss_pred eccccccc
Q 007892 353 DFGLAKHS 360 (586)
Q Consensus 353 DFGla~~~ 360 (586)
|||.+...
T Consensus 149 Df~qav~~ 156 (188)
T PF01163_consen 149 DFGQAVDS 156 (188)
T ss_dssp -GTTEEET
T ss_pred ecCcceec
Confidence 99988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.84 E-value=6.2e-08 Score=99.75 Aligned_cols=258 Identities=20% Similarity=0.225 Sum_probs=157.5
Q ss_pred ccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCcceEEEE------EEeCC-eeEEEE
Q 007892 213 EANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGY------CTFGS-QRLLVY 284 (586)
Q Consensus 213 ~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l-~Hpniv~l~g~------~~~~~-~~~lV~ 284 (586)
..+.||+|+-+.+|-.-.- +..| -|+......-...+ .+..|... .||-+-.-+.+ .-.+. ..-++|
T Consensus 15 ~gr~LgqGgea~ly~l~e~-~d~V-AKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV-RDQV-AKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecchh-hchh-heeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 3478999999999964321 2233 36654433222222 23334444 35543331111 11112 245677
Q ss_pred EecCCCc-HHHHhc----CCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccc
Q 007892 285 EFVPNKT-LEFHLH----GKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 359 (586)
Q Consensus 285 E~~~~gs-L~~~l~----~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~ 359 (586)
..+.+.. +..++. ...-+..+|.-.++++..++.+.+-||+. |.+-+|+.++|+|+.+++.|.|.|-.-...
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceee
Confidence 7776642 222221 12235689999999999999999999998 899999999999999999999998654332
Q ss_pred cCCCCCcccccccccccccCccccc-----CCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCcccchhhhhhhhHHHhhc
Q 007892 360 SLDTDTHVSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVLLLELITG-FRPFDKADTFADDSMVDWAKPFLAQG 433 (586)
Q Consensus 360 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvvL~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~ 433 (586)
.. +......-+|...|.+||.-. +-.-+...|.|.|||+|++|+.| ++||.+.....+.. ..+...
T Consensus 167 ~~--ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap------~p~E~~ 238 (637)
T COG4248 167 NA--NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAP------NPLETD 238 (637)
T ss_pred cc--CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCC------Ccchhh
Confidence 21 122223356889999999754 33456789999999999999985 99998654322110 001111
Q ss_pred ccCCChhhhhchhhh------ccC-HHHHHHHHHHHHHhhccC--CCCCCCHHHHHHHHhcC
Q 007892 434 LADGNFDALVDQKLE------EYD-SAEMTRMAACAAACIRHS--ARRRPRMSQIVRALEGN 486 (586)
Q Consensus 434 ~~~~~~~~l~d~~l~------~~~-~~~~~~l~~l~~~cl~~d--p~~RPtm~evl~~L~~~ 486 (586)
+..|.+..-.|.... ..+ .-.+..+..+..+|+... +.-||+++.++..|...
T Consensus 239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al 300 (637)
T COG4248 239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL 300 (637)
T ss_pred hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence 222222222221111 122 223356777788888654 56899999999888653
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.7e-07 Score=90.19 Aligned_cols=138 Identities=14% Similarity=0.111 Sum_probs=104.2
Q ss_pred ecccCcEEEEEEEEeCCeEEEEEEeccCC------chhHHHHHHHHHHHHhcCC--CCcceEEEEEEe-----CCeeEEE
Q 007892 217 LGQGGFGYVHKGVLTNGKVVAIKQLKAGS------GQGEREFQAEIEIISQVHH--RHLVSLVGYCTF-----GSQRLLV 283 (586)
Q Consensus 217 LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~------~~~~~~~~~Ei~il~~l~H--pniv~l~g~~~~-----~~~~~lV 283 (586)
-|+||.+-|++-.+. |+.+-||+-...- ...+..|.+|+..|.+|.. -.+.+++ ++.. ....+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 477999999997774 4568888865221 2356789999999999863 2344555 4432 1245799
Q ss_pred EEecCC-CcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCC--eEEeecccccc
Q 007892 284 YEFVPN-KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE--AKVADFGLAKH 359 (586)
Q Consensus 284 ~E~~~~-gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~--~kl~DFGla~~ 359 (586)
+|-+.| -+|.+++........+...+..++.++++.|.-||.. ++.|+|+.+.|||++.++. ++++||--++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997764 5788888655444567777889999999999999998 9999999999999986666 99999976653
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.75 E-value=2.5e-09 Score=116.30 Aligned_cols=152 Identities=22% Similarity=0.349 Sum_probs=107.4
Q ss_pred HHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC--------cccccccccccccCcccccC
Q 007892 314 LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT--------HVSTRVMGTFGYLAPEYASS 385 (586)
Q Consensus 314 ~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~ 385 (586)
.+++.||.|+|.. .++||++|.|++|.++.++..||+.|+++........ ...--..-...|.|||++..
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 4455899999986 4999999999999999999999999999865433111 11111224557999999999
Q ss_pred CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHh
Q 007892 386 GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAAC 465 (586)
Q Consensus 386 ~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~c 465 (586)
...+.++|+|||||++|.+..|..+........ ...... ....+-....+..+.+.++.+.+.++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~----~~~~~~-----------~~~~~~~~~~~s~~~p~el~~~l~k~ 248 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGL----LSYSFS-----------RNLLNAGAFGYSNNLPSELRESLKKL 248 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCc----chhhhh-----------hcccccccccccccCcHHHHHHHHHH
Confidence 889999999999999999996555433222110 000000 01111122245567788899999999
Q ss_pred hccCCCCCCCHHHHHHH
Q 007892 466 IRHSARRRPRMSQIVRA 482 (586)
Q Consensus 466 l~~dp~~RPtm~evl~~ 482 (586)
+..+...||++.++...
T Consensus 249 l~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 249 LNGDSAVRPTLDLLLSI 265 (700)
T ss_pred hcCCcccCcchhhhhcc
Confidence 99999999988877543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.1e-07 Score=92.36 Aligned_cols=106 Identities=21% Similarity=0.239 Sum_probs=84.1
Q ss_pred HHHHHHHHHHHHhcCC--CCcceEEEEEEeC----CeeEEEEEecCCC-cHHHHhcCCCCCCCChHHHHHHHHHHHHHhH
Q 007892 249 EREFQAEIEIISQVHH--RHLVSLVGYCTFG----SQRLLVYEFVPNK-TLEFHLHGKDRPVMNWPTRMKIALGSARGLA 321 (586)
Q Consensus 249 ~~~~~~Ei~il~~l~H--pniv~l~g~~~~~----~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~ 321 (586)
.....+|...+.+|.. =.....+++.... ...+||+|++++. +|.+++..... ++......++.+++..+.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence 3467788998888853 3345566666552 2457999999984 79888865333 556677889999999999
Q ss_pred hhhhcCCCcEEecCCCCceeEeCCCC---CeEEeecccccc
Q 007892 322 YLHEDCQPKIIHRDIKSANILLDDSF---EAKVADFGLAKH 359 (586)
Q Consensus 322 yLH~~~~~~ivHrDIk~~NILl~~~~---~~kl~DFGla~~ 359 (586)
-||+. +|+|+|+++.|||++.+. .+.|+||+.++.
T Consensus 133 ~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 133 KLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999 999999999999998886 899999998875
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.1e-07 Score=103.74 Aligned_cols=141 Identities=21% Similarity=0.261 Sum_probs=95.4
Q ss_pred ceecccCcEEEEEEEEeCCeEEEEEEeccCCch----------------------------------------hHHHHHH
Q 007892 215 NLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQ----------------------------------------GEREFQA 254 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~----------------------------------------~~~~~~~ 254 (586)
+-|+.++-|.||+|++.+|+.||||+...+-.. .+-++..
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 679999999999999999999999998764211 0112445
Q ss_pred HHHHHHhcC----CCCcceEEEEEE-eCCeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHH-hHhhhhcCC
Q 007892 255 EIEIISQVH----HRHLVSLVGYCT-FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARG-LAYLHEDCQ 328 (586)
Q Consensus 255 Ei~il~~l~----Hpniv~l~g~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~g-L~yLH~~~~ 328 (586)
|...+.++. ...-+++=.+|+ ..+...|+|||++|-.+.+...-+. ..++.. .|+..++++ +..+-.+
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k---~ia~~~~~~f~~q~~~d-- 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRK---ELAELLVRAFLRQLLRD-- 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHH---HHHHHHHHHHHHHHHhc--
Confidence 555555552 222333333443 3678899999999988877632222 234433 333333333 2333334
Q ss_pred CcEEecCCCCceeEeCCCCCeEEeecccccccCC
Q 007892 329 PKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 329 ~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 362 (586)
+++|.|..|.||+++.++++.+.|||+.....+
T Consensus 285 -gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 -GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred -CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 899999999999999999999999999876543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.59 E-value=3.9e-07 Score=89.75 Aligned_cols=135 Identities=19% Similarity=0.151 Sum_probs=94.4
Q ss_pred ccccceecccCcEEEEEEEEeCCeEEEEEEeccCCc----------------------hhHHHHHHHHHHHHhcCCC--C
Q 007892 211 FSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSG----------------------QGEREFQAEIEIISQVHHR--H 266 (586)
Q Consensus 211 f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~----------------------~~~~~~~~Ei~il~~l~Hp--n 266 (586)
..+.+.||-|--+.||.|....|..+|||.=+.... ......++|.++|.+|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 556789999999999999999999999997432210 1123456899999998644 5
Q ss_pred cceEEEEEEeCCeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCC
Q 007892 267 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS 346 (586)
Q Consensus 267 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 346 (586)
+.+.++ .+...+||||++|-.|...-- ..-+... |+..|+.-+.-+-.. ||||+|+..=|||+++|
T Consensus 173 VP~P~~----~nRHaVvMe~ieG~eL~~~r~----~~en~~~---il~~il~~~~~~~~~---GiVHGDlSefNIlV~~d 238 (304)
T COG0478 173 VPKPIA----WNRHAVVMEYIEGVELYRLRL----DVENPDE---ILDKILEEVRKAYRR---GIVHGDLSEFNILVTED 238 (304)
T ss_pred CCCccc----cccceeeeehcccceeecccC----cccCHHH---HHHHHHHHHHHHHHc---CccccCCchheEEEecC
Confidence 555543 245679999999877643221 1122233 334444444333344 89999999999999999
Q ss_pred CCeEEeecccccc
Q 007892 347 FEAKVADFGLAKH 359 (586)
Q Consensus 347 ~~~kl~DFGla~~ 359 (586)
|.+.|+||--+..
T Consensus 239 g~~~vIDwPQ~v~ 251 (304)
T COG0478 239 GDIVVIDWPQAVP 251 (304)
T ss_pred CCEEEEeCccccc
Confidence 9999999977654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.5e-06 Score=85.70 Aligned_cols=138 Identities=17% Similarity=0.184 Sum_probs=86.6
Q ss_pred ceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCC--cceEEEEEEeCCeeEEEEEecCCCc-
Q 007892 215 NLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH--LVSLVGYCTFGSQRLLVYEFVPNKT- 291 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpn--iv~l~g~~~~~~~~~lV~E~~~~gs- 291 (586)
..||+|..+.||+. .|..+++|...... ......+|.+++..+..-. +.+.++++...+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57999999999984 24567788875432 3456789999999986443 4677888877777889999999863
Q ss_pred HHHH---------------------hcCCCCCCCChHHHHH-HHH----------HHHH-HhHhhhhc-CCCcEEecCCC
Q 007892 292 LEFH---------------------LHGKDRPVMNWPTRMK-IAL----------GSAR-GLAYLHED-CQPKIIHRDIK 337 (586)
Q Consensus 292 L~~~---------------------l~~~~~~~l~~~~~~~-ia~----------~ia~-gL~yLH~~-~~~~ivHrDIk 337 (586)
+... ||.-.........+.. +.. .+.. ...+|... ..+.++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 2111 2221111111111110 000 0011 11222211 13467899999
Q ss_pred CceeEeCCCCCeEEeeccccc
Q 007892 338 SANILLDDSFEAKVADFGLAK 358 (586)
Q Consensus 338 ~~NILl~~~~~~kl~DFGla~ 358 (586)
+.||++++++ +.|+||+.+.
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCcEEEcCCC-cEEEechhcC
Confidence 9999999887 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.45 E-value=2.3e-06 Score=83.81 Aligned_cols=142 Identities=18% Similarity=0.179 Sum_probs=86.0
Q ss_pred cceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCC--CcceEEEEEEe---CCeeEEEEEecC
Q 007892 214 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHR--HLVSLVGYCTF---GSQRLLVYEFVP 288 (586)
Q Consensus 214 ~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hp--niv~l~g~~~~---~~~~~lV~E~~~ 288 (586)
++.|+.|..+.||+....+ ..+++|..... .....+..|+.++..+... .+.+++.++.. ....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4679999999999999877 58889986544 4567888999999888533 35677765533 345689999999
Q ss_pred CCcHHH----------------H---hcCC--CCCCCChHH---------HHHH------------HHHHHH-HhHhhhh
Q 007892 289 NKTLEF----------------H---LHGK--DRPVMNWPT---------RMKI------------ALGSAR-GLAYLHE 325 (586)
Q Consensus 289 ~gsL~~----------------~---l~~~--~~~~l~~~~---------~~~i------------a~~ia~-gL~yLH~ 325 (586)
+..+.. . ||.. ......+.. .... ...+.. .+..++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988877 1 1111 111111111 0000 111222 2333332
Q ss_pred c----CCCcEEecCCCCceeEeC-CCCCeEEeeccccc
Q 007892 326 D----CQPKIIHRDIKSANILLD-DSFEAKVADFGLAK 358 (586)
Q Consensus 326 ~----~~~~ivHrDIk~~NILl~-~~~~~kl~DFGla~ 358 (586)
. ....++|+|+.+.|||++ +++.+-|+||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1 234799999999999999 66666799998875
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.44 E-value=2.7e-06 Score=82.24 Aligned_cols=140 Identities=17% Similarity=0.224 Sum_probs=96.3
Q ss_pred HHHhcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHH---------HHHHHHHHhcCC---CCcceEEE
Q 007892 205 KIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREF---------QAEIEIISQVHH---RHLVSLVG 272 (586)
Q Consensus 205 ~~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~---------~~Ei~il~~l~H---pniv~l~g 272 (586)
.+...+|...+++-......|.+-.. +|+.+++|..+......++.| .+++..+.++.. -.+..++.
T Consensus 27 ~i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 27 KILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 44557888888888888888888776 568889998876544444333 345555555532 22223222
Q ss_pred EEE-----eCCeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCC
Q 007892 273 YCT-----FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF 347 (586)
Q Consensus 273 ~~~-----~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 347 (586)
++. .....+|+|||++|-.|.+... ++. .++..+..++.-||.. |++|+|+.|+|+++++++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~~ 172 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNNG 172 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECCc
Confidence 222 2245578999999988865432 221 3456677889999998 999999999999999664
Q ss_pred CeEEeecccccc
Q 007892 348 EAKVADFGLAKH 359 (586)
Q Consensus 348 ~~kl~DFGla~~ 359 (586)
++++||+.-+.
T Consensus 173 -i~iID~~~k~~ 183 (229)
T PF06176_consen 173 -IRIIDTQGKRM 183 (229)
T ss_pred -EEEEECccccc
Confidence 99999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.40 E-value=3e-08 Score=106.84 Aligned_cols=192 Identities=20% Similarity=0.159 Sum_probs=136.0
Q ss_pred HHHHhcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCC-cceEEEEEEeCCeeEE
Q 007892 204 LKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH-LVSLVGYCTFGSQRLL 282 (586)
Q Consensus 204 l~~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpn-iv~l~g~~~~~~~~~l 282 (586)
++..+..+...+.+++|.+++++|.+-...+...++.+... ....-++++|.+++||| .+.-++-+..+...++
T Consensus 237 lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i 311 (829)
T KOG0576|consen 237 LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWI 311 (829)
T ss_pred ccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccch
Confidence 33444455556778999999999987433344445554332 45566899999999999 6666666776778889
Q ss_pred EEEecCCC-cHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccC
Q 007892 283 VYEFVPNK-TLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 361 (586)
Q Consensus 283 V~E~~~~g-sL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~ 361 (586)
+++++..+ +-..... .....+...+...+...-+++|+|||+. .=+||| |||..+ ...|..||+....+.
T Consensus 312 ~~~i~s~~rs~~~~~~-~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~ 382 (829)
T KOG0576|consen 312 PMRICSTGRSSALEMT-VSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLT 382 (829)
T ss_pred hhhhhcCCccccccCC-hhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccC
Confidence 99999877 2111110 0011233334455666677899999976 348999 887766 578999999987664
Q ss_pred CCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCC
Q 007892 362 DTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPF 411 (586)
Q Consensus 362 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf 411 (586)
... ......+++.++|||+...+.+..+.|+|++|+--.++--|-.|-
T Consensus 383 ~~~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 383 RTM--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ccc--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 433 345567999999999999999999999999998777777776653
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.39 E-value=9.3e-07 Score=96.26 Aligned_cols=142 Identities=20% Similarity=0.234 Sum_probs=91.2
Q ss_pred cceecccCcEEEEEEEEeCCeEEEEEEeccCCchh-------------------------------------HHHHHHHH
Q 007892 214 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQG-------------------------------------EREFQAEI 256 (586)
Q Consensus 214 ~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~-------------------------------------~~~~~~Ei 256 (586)
.+.||.-..|.||+|++++|+.||||+-++.-... +-+|..|+
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 36799999999999999999999999976542110 11345555
Q ss_pred HHHHhc----CCCC---cceEEEEE-EeCCeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCC
Q 007892 257 EIISQV----HHRH---LVSLVGYC-TFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 328 (586)
Q Consensus 257 ~il~~l----~Hpn---iv~l~g~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~ 328 (586)
+-..++ .|-+ -|.+=.++ .....+.|+||||+|.-+.+...- ....++-..+.. .+.++ |++.-..
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i-~~~gi~~~~i~~---~l~~~--~~~qIf~ 319 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI-DKRGISPHDILN---KLVEA--YLEQIFK 319 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH-HHcCCCHHHHHH---HHHHH--HHHHHHh
Confidence 554444 3555 12222223 234678999999999877544221 112255444333 33332 2222222
Q ss_pred CcEEecCCCCceeEeC----CCCCeEEeecccccccC
Q 007892 329 PKIIHRDIKSANILLD----DSFEAKVADFGLAKHSL 361 (586)
Q Consensus 329 ~~ivHrDIk~~NILl~----~~~~~kl~DFGla~~~~ 361 (586)
.|++|+|-.|.|||++ .++++.+-|||+.....
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 3899999999999998 36789999999987643
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.34 E-value=4.9e-06 Score=82.91 Aligned_cols=139 Identities=17% Similarity=0.125 Sum_probs=85.6
Q ss_pred eecccCc-EEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeeEEEEEecCCCcHH
Q 007892 216 LLGQGGF-GYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLLVYEFVPNKTLE 293 (586)
Q Consensus 216 ~LG~G~f-G~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~~~~~lV~E~~~~gsL~ 293 (586)
.|-.|.. ..||+.... +..+.||+..... ...+.+|++++..+. +--+.++++++...+..++|||+++|.+|.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3444544 889998764 4677888865432 346778999998884 444567787777666788999999998775
Q ss_pred HHh-------------------cCCCCC--CCC--hHHHHHHHHH--------------------HHHHhHhhhh----c
Q 007892 294 FHL-------------------HGKDRP--VMN--WPTRMKIALG--------------------SARGLAYLHE----D 326 (586)
Q Consensus 294 ~~l-------------------~~~~~~--~l~--~~~~~~ia~~--------------------ia~gL~yLH~----~ 326 (586)
... |..... .+. +..++..... +...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 331 211110 111 0011100000 1111122211 1
Q ss_pred CCCcEEecCCCCceeEeCCCCCeEEeeccccc
Q 007892 327 CQPKIIHRDIKSANILLDDSFEAKVADFGLAK 358 (586)
Q Consensus 327 ~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~ 358 (586)
..+.++|+|+.+.|||++++..+.|+||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 23569999999999999998778899999875
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.26 E-value=3.6e-06 Score=80.51 Aligned_cols=103 Identities=21% Similarity=0.181 Sum_probs=81.5
Q ss_pred HHHHHHHHhcCC-CCcceEEEEEEeCCeeEEEEEecCCCcHHHHhc-CCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCc
Q 007892 253 QAEIEIISQVHH-RHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLH-GKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 330 (586)
Q Consensus 253 ~~Ei~il~~l~H-pniv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~-~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ 330 (586)
..|.-+|+.+++ +++.+++|+|- .++|.||+..+.+...-. -..-...+|..|.+||.++++.+.+|++...-.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458889999986 69999999993 367999998775532100 001123689999999999999999999854436
Q ss_pred EEecCCCCceeEeCCCCCeEEeecccccc
Q 007892 331 IIHRDIKSANILLDDSFEAKVADFGLAKH 359 (586)
Q Consensus 331 ivHrDIk~~NILl~~~~~~kl~DFGla~~ 359 (586)
+.-.|++++|+-+++++++|++|...+..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 88899999999999999999999987653
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.7e-05 Score=92.90 Aligned_cols=146 Identities=17% Similarity=0.259 Sum_probs=93.2
Q ss_pred cceecccCcEEEEEEEEeCC---eEEEEEEeccCCc-hhHHHHHHHHHHHHhcC-CCCc--ceEEEEEEeC---CeeEEE
Q 007892 214 ANLLGQGGFGYVHKGVLTNG---KVVAIKQLKAGSG-QGEREFQAEIEIISQVH-HRHL--VSLVGYCTFG---SQRLLV 283 (586)
Q Consensus 214 ~~~LG~G~fG~Vyk~~~~~g---~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~-Hpni--v~l~g~~~~~---~~~~lV 283 (586)
.+.|+.|.+..+|+....++ ..+++|+...... .....+.+|+++|..+. |.++ .+++++|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 57789999999999887654 4677777543321 23457889999999995 6665 7888888764 467899
Q ss_pred EEecCCCcHHH-----------------------HhcCCCCC---------CCChH--HHHHHH---------------H
Q 007892 284 YEFVPNKTLEF-----------------------HLHGKDRP---------VMNWP--TRMKIA---------------L 314 (586)
Q Consensus 284 ~E~~~~gsL~~-----------------------~l~~~~~~---------~l~~~--~~~~ia---------------~ 314 (586)
|||++|..+.+ .||..... ...+. ++.++. -
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99998864321 12221111 01111 111110 1
Q ss_pred HHHHHhHhhhhcCC--------CcEEecCCCCceeEeCC-CCC-eEEeecccccc
Q 007892 315 GSARGLAYLHEDCQ--------PKIIHRDIKSANILLDD-SFE-AKVADFGLAKH 359 (586)
Q Consensus 315 ~ia~gL~yLH~~~~--------~~ivHrDIk~~NILl~~-~~~-~kl~DFGla~~ 359 (586)
.+...+.+|..+.. +.+||+|+++.|||++. +.. +-|.||.++..
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 12334567754321 35999999999999985 334 57899998764
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.15 E-value=2.3e-05 Score=76.74 Aligned_cols=151 Identities=17% Similarity=0.184 Sum_probs=96.4
Q ss_pred CHHHHHHHhcCccccc---eecccCcEEEEEEEEeCCeEEEEEEeccCCchh-------------------HH-----HH
Q 007892 200 TYEELKIATDNFSEAN---LLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQG-------------------ER-----EF 252 (586)
Q Consensus 200 ~~~el~~~~~~f~~~~---~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~-------------------~~-----~~ 252 (586)
+++.+....+...+.. .|..|--..||+|.-.++..+|||+.+...... .+ ..
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 3444444444444444 455677789999998789999999986532111 11 12
Q ss_pred HHHHHHHHhcC--CCCcceEEEEEEeCCeeEEEEEecCCCcH-HHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCC
Q 007892 253 QAEIEIISQVH--HRHLVSLVGYCTFGSQRLLVYEFVPNKTL-EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQP 329 (586)
Q Consensus 253 ~~Ei~il~~l~--Hpniv~l~g~~~~~~~~~lV~E~~~~gsL-~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~ 329 (586)
.+|+.-|.++. +=.+.+-+++. .-.|||||+...-+ .-.|.. . .+...+...+..++++.+.-|-..+
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD--v-~~e~~e~~~~~~~~v~~~~~l~~~a-- 186 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD--V-PLELEEAEGLYEDVVEYMRRLYKEA-- 186 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc--C-CcCchhHHHHHHHHHHHHHHHHHhc--
Confidence 45777777774 33334444333 33699999965411 111111 1 1222245566777888887776643
Q ss_pred cEEecCCCCceeEeCCCCCeEEeeccccccc
Q 007892 330 KIIHRDIKSANILLDDSFEAKVADFGLAKHS 360 (586)
Q Consensus 330 ~ivHrDIk~~NILl~~~~~~kl~DFGla~~~ 360 (586)
++||+||..=|||+. ++.+.|+|||-+...
T Consensus 187 ~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 187 GLVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred CcccccchhhheEEE-CCeEEEEECcccccc
Confidence 899999999999999 779999999988654
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.14 E-value=2.8e-05 Score=74.40 Aligned_cols=125 Identities=27% Similarity=0.453 Sum_probs=91.2
Q ss_pred cCccccceecccCc-EEEEEEEEeCCeEEEEEEeccCC-----------c----------hhHHHHHHHHHHHHhcC---
Q 007892 209 DNFSEANLLGQGGF-GYVHKGVLTNGKVVAIKQLKAGS-----------G----------QGEREFQAEIEIISQVH--- 263 (586)
Q Consensus 209 ~~f~~~~~LG~G~f-G~Vyk~~~~~g~~vAVK~l~~~~-----------~----------~~~~~~~~Ei~il~~l~--- 263 (586)
.+++..+.||.|.- |.|||+.+ +|+.+|+|.++... . .-...|..|.....+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67888999999999 99999998 57899999943210 0 00124778888888885
Q ss_pred CCCc--ceEEEEEEeCC------------------eeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhh
Q 007892 264 HRHL--VSLVGYCTFGS------------------QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYL 323 (586)
Q Consensus 264 Hpni--v~l~g~~~~~~------------------~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yL 323 (586)
+.++ |+++||..-.. .+.||.||++... .+ ..+-+.++.+-|..|
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~----~~~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PL----QIRDIPQMLRDLKIL 180 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------cc----chhHHHHHHHHHHHH
Confidence 4566 99999984331 2357888876543 11 123355667778889
Q ss_pred hhcCCCcEEecCCCCceeEeCCCCCeEEeecccc
Q 007892 324 HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 357 (586)
Q Consensus 324 H~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla 357 (586)
|.. +|+-+|+|+.|.. .-||+|||.+
T Consensus 181 ~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHC---CeeeccCcccccc-----CCEEEecccC
Confidence 987 9999999999997 4599999864
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.06 E-value=2.7e-05 Score=72.28 Aligned_cols=127 Identities=20% Similarity=0.237 Sum_probs=86.6
Q ss_pred ccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcce-EEEEEEeCCeeEEEEEecCCCc
Q 007892 213 EANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVS-LVGYCTFGSQRLLVYEFVPNKT 291 (586)
Q Consensus 213 ~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~-l~g~~~~~~~~~lV~E~~~~gs 291 (586)
..+.|++|++|.||+|.+.+ ..+|+|.-+.++ ....+..|+++|..+.--++.. ++.|-. ..+.|||+.|-.
T Consensus 26 v~~~L~KG~~s~Vyl~~~~~-~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~ 98 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWRG-GEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRP 98 (201)
T ss_pred hhhhhhcccccEEEEeeccC-ceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcc
Confidence 34789999999999999965 578888866543 3568999999999998666654 433332 235599999888
Q ss_pred HHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCC-C-ceeEeCCCCCeEEeecccccc
Q 007892 292 LEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIK-S-ANILLDDSFEAKVADFGLAKH 359 (586)
Q Consensus 292 L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk-~-~NILl~~~~~~kl~DFGla~~ 359 (586)
|..+-... +- +-...++..-.-|-.. ||-|+.|. | .||++.+ ..+.|+||.-|..
T Consensus 99 L~~~~~~~-----~r----k~l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~-~~~~iIDFd~At~ 155 (201)
T COG2112 99 LGKLEIGG-----DR----KHLLRVLEKAYKLDRL---GIEHGELSRPWKNVLVND-RDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhcc-----cH----HHHHHHHHHHHHHHHh---ccchhhhcCCceeEEecC-CcEEEEEccchhh
Confidence 86654321 12 2233444443334444 88899887 3 4555544 4899999998863
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.05 E-value=6.3e-05 Score=77.41 Aligned_cols=79 Identities=11% Similarity=0.071 Sum_probs=58.6
Q ss_pred ccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCC---CCcceEEEEEEeC---CeeEEEE
Q 007892 211 FSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHH---RHLVSLVGYCTFG---SQRLLVY 284 (586)
Q Consensus 211 f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~H---pniv~l~g~~~~~---~~~~lV~ 284 (586)
....+.||.|..+.||+....+++ +.||..+.. .....|..|.+.|..|.- -.+.+++++|..+ +..+|||
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQGN-PMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred hheeeecCCccceeEEEEEcCCCC-EEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 344578999999999998766664 566764431 123588999999998853 3678888888653 6689999
Q ss_pred EecCCCcH
Q 007892 285 EFVPNKTL 292 (586)
Q Consensus 285 E~~~~gsL 292 (586)
|++++.++
T Consensus 93 E~i~G~~~ 100 (297)
T PRK10593 93 ERLRGVSV 100 (297)
T ss_pred eccCCEec
Confidence 99998754
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.02 E-value=3.7e-05 Score=76.22 Aligned_cols=139 Identities=19% Similarity=0.210 Sum_probs=77.9
Q ss_pred ceecccCcE-EEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCC---CcceEEEEEEeC---CeeEEEEEec
Q 007892 215 NLLGQGGFG-YVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHR---HLVSLVGYCTFG---SQRLLVYEFV 287 (586)
Q Consensus 215 ~~LG~G~fG-~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hp---niv~l~g~~~~~---~~~~lV~E~~ 287 (586)
+.|+.||.. .||+. +..+++|..... .....+.+|+++|..+... .+.++++.+... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 567877776 58875 235677865432 2345788999999888532 344445444332 2347899999
Q ss_pred CCCcHHHH------------------hcCCCCCC--C-------------ChHHHH--HHH-------HHHHHH-hH-hh
Q 007892 288 PNKTLEFH------------------LHGKDRPV--M-------------NWPTRM--KIA-------LGSARG-LA-YL 323 (586)
Q Consensus 288 ~~gsL~~~------------------l~~~~~~~--l-------------~~~~~~--~ia-------~~ia~g-L~-yL 323 (586)
+|.++... ||...... . .|.... .+. .+.+.. ++ ++
T Consensus 77 ~G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 156 (235)
T cd05155 77 EGETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALWEAAL 156 (235)
T ss_pred cCCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHHHHHh
Confidence 98766321 22211100 0 121110 000 011111 11 11
Q ss_pred hh--cCCCcEEecCCCCceeEeCCCCCeEEeecccccc
Q 007892 324 HE--DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 359 (586)
Q Consensus 324 H~--~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~ 359 (586)
+. ...+.++|+|+.+.|||++++...-|+||+.+..
T Consensus 157 ~~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 157 RAPWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred cccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 11 1234599999999999998775567999998753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.00 E-value=0.00013 Score=70.33 Aligned_cols=132 Identities=21% Similarity=0.266 Sum_probs=92.3
Q ss_pred ccceecccCcEEEEEEEEeCCeEEEEEEeccCC----------------chhHHHHHHHHHHHHhcC------CCCcceE
Q 007892 213 EANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGS----------------GQGEREFQAEIEIISQVH------HRHLVSL 270 (586)
Q Consensus 213 ~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~----------------~~~~~~~~~Ei~il~~l~------Hpniv~l 270 (586)
....||+|+.-.||.- ++.....||++.... ....++.++|+.-...+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 3568999999999974 445556788887655 122456667777666665 8899999
Q ss_pred EEEEEeCCeeEEEEEecCC------CcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeC
Q 007892 271 VGYCTFGSQRLLVYEFVPN------KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD 344 (586)
Q Consensus 271 ~g~~~~~~~~~lV~E~~~~------gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~ 344 (586)
+|+...+...-+|+|.+.+ -+|.+++.... ++. .. ...+-.-..||-++ .|+.+||+|.||++.
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~---~~~-~~---~~~L~~f~~~l~~~---~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG---LTE-EL---RQALDEFKRYLLDH---HIVIRDLNPHNIVVQ 152 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC---ccH-HH---HHHHHHHHHHHHHc---CCeecCCCcccEEEE
Confidence 9999999999999998753 35777774332 443 22 22333445677766 899999999999995
Q ss_pred CC---C-CeEEee-ccc
Q 007892 345 DS---F-EAKVAD-FGL 356 (586)
Q Consensus 345 ~~---~-~~kl~D-FGl 356 (586)
.+ . .+.|+| ||-
T Consensus 153 ~~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 153 RRDSGEFRLVLIDGLGE 169 (199)
T ss_pred ecCCCceEEEEEeCCCC
Confidence 33 2 577777 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.95 E-value=8.2e-05 Score=73.54 Aligned_cols=140 Identities=21% Similarity=0.238 Sum_probs=82.5
Q ss_pred cceecccCcEEEEEEEEeC--CeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCC-cceEEEEEEeCCeeEEEEEecCCC
Q 007892 214 ANLLGQGGFGYVHKGVLTN--GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH-LVSLVGYCTFGSQRLLVYEFVPNK 290 (586)
Q Consensus 214 ~~~LG~G~fG~Vyk~~~~~--g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpn-iv~l~g~~~~~~~~~lV~E~~~~g 290 (586)
.+.|..|-...+|+....+ ++.|++|+...... ...+..+|+.++..+...+ ..++++.+. ..+||||++|.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence 3567888889999998764 57888897654322 1223457888998885433 444544432 23799999987
Q ss_pred cHHHH-----------------hcCCCCC---------CC-ChHHHHHHHH----------------------HHHHHhH
Q 007892 291 TLEFH-----------------LHGKDRP---------VM-NWPTRMKIAL----------------------GSARGLA 321 (586)
Q Consensus 291 sL~~~-----------------l~~~~~~---------~l-~~~~~~~ia~----------------------~ia~gL~ 321 (586)
++... +|..... .. -|..+..+.. .+...+.
T Consensus 78 ~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 157 (235)
T cd05157 78 TLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEIS 157 (235)
T ss_pred cCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHH
Confidence 65321 1211111 11 1222111111 1111111
Q ss_pred hh----hhc-CCCcEEecCCCCceeEeCC-CCCeEEeeccccc
Q 007892 322 YL----HED-CQPKIIHRDIKSANILLDD-SFEAKVADFGLAK 358 (586)
Q Consensus 322 yL----H~~-~~~~ivHrDIk~~NILl~~-~~~~kl~DFGla~ 358 (586)
.| ... ....++|+|+.+.|||+++ +..+.|+||..|.
T Consensus 158 ~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 158 WLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 11 111 2347999999999999998 5789999998875
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.93 E-value=5.9e-05 Score=75.80 Aligned_cols=138 Identities=15% Similarity=0.128 Sum_probs=80.1
Q ss_pred eecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCc-ceEEEEEEeCCeeEEEEEecCCCcHHH
Q 007892 216 LLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL-VSLVGYCTFGSQRLLVYEFVPNKTLEF 294 (586)
Q Consensus 216 ~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpni-v~l~g~~~~~~~~~lV~E~~~~gsL~~ 294 (586)
.+..|-.+.+|+.. .+++.+++|........-..+..+|..++..+....+ .++++++. .++||||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 35567778999887 4567788887654322211245789999998864333 34444432 368999999876532
Q ss_pred -----------------HhcCCCC--CCCChHHH-HHHHHHH---------HHHhHhhhhc-----CCCcEEecCCCCce
Q 007892 295 -----------------HLHGKDR--PVMNWPTR-MKIALGS---------ARGLAYLHED-----CQPKIIHRDIKSAN 340 (586)
Q Consensus 295 -----------------~l~~~~~--~~l~~~~~-~~ia~~i---------a~gL~yLH~~-----~~~~ivHrDIk~~N 340 (586)
.||.... ..++...+ .....++ ...+..+-.. ..+.++|+|+.+.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1232221 11222211 1111111 1112222111 13368999999999
Q ss_pred eEeCCCCCeEEeecccccc
Q 007892 341 ILLDDSFEAKVADFGLAKH 359 (586)
Q Consensus 341 ILl~~~~~~kl~DFGla~~ 359 (586)
||+++++ +.|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999876 78999998853
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.00017 Score=76.74 Aligned_cols=76 Identities=20% Similarity=0.153 Sum_probs=54.3
Q ss_pred cceecccCcEEEEEEEEeCC-eEEEEEEeccC-----C--chhHHHHHHHHHHHHhcC---CCCcceEEEEEEeCCeeEE
Q 007892 214 ANLLGQGGFGYVHKGVLTNG-KVVAIKQLKAG-----S--GQGEREFQAEIEIISQVH---HRHLVSLVGYCTFGSQRLL 282 (586)
Q Consensus 214 ~~~LG~G~fG~Vyk~~~~~g-~~vAVK~l~~~-----~--~~~~~~~~~Ei~il~~l~---Hpniv~l~g~~~~~~~~~l 282 (586)
.+.||.|.+..||++...+| +.|+||.-... . ......+..|.+.|..+. -.++.+++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 36799999999999998877 58999985321 1 123456677888888763 2456677655 3456789
Q ss_pred EEEecCCCc
Q 007892 283 VYEFVPNKT 291 (586)
Q Consensus 283 V~E~~~~gs 291 (586)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998744
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.83 E-value=9.7e-05 Score=75.77 Aligned_cols=141 Identities=16% Similarity=0.143 Sum_probs=86.4
Q ss_pred cceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCC--cceEEEE------EEeCCeeEEEEE
Q 007892 214 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH--LVSLVGY------CTFGSQRLLVYE 285 (586)
Q Consensus 214 ~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpn--iv~l~g~------~~~~~~~~lV~E 285 (586)
.+.|..|-...+|+....+ ..+++|+... .....+..|+.++..+.+.+ +.+++.. ....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 4667778778999987644 4688898754 23456777888888885332 4444431 233456689999
Q ss_pred ecCCCcHHH--------------HhcCC----CC-----CCCChHHHHH----------HHHHHHHHhHhhhh----cCC
Q 007892 286 FVPNKTLEF--------------HLHGK----DR-----PVMNWPTRMK----------IALGSARGLAYLHE----DCQ 328 (586)
Q Consensus 286 ~~~~gsL~~--------------~l~~~----~~-----~~l~~~~~~~----------ia~~ia~gL~yLH~----~~~ 328 (586)
|++|..+.. .||.. .. ....|..... ....+...+.++.. ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999866421 11110 00 1123322210 11112334444443 123
Q ss_pred CcEEecCCCCceeEeCCCCCeEEeeccccc
Q 007892 329 PKIIHRDIKSANILLDDSFEAKVADFGLAK 358 (586)
Q Consensus 329 ~~ivHrDIk~~NILl~~~~~~kl~DFGla~ 358 (586)
.+++|+|+.+.|||++++..+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999998777899999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane | Back alignment and domain information |
|---|
Probab=97.77 E-value=1.2e-05 Score=69.99 Aligned_cols=20 Identities=25% Similarity=0.396 Sum_probs=15.1
Q ss_pred CCCCCcccceEehhhHHHHH
Q 007892 67 YLPPGALAGMVVGVVIGAGI 86 (586)
Q Consensus 67 ~l~~~~~~~~vvgv~~~~~~ 86 (586)
.++.++++|||+||++|+++
T Consensus 60 ~fs~~~i~~Ii~gv~aGvIg 79 (122)
T PF01102_consen 60 RFSEPAIIGIIFGVMAGVIG 79 (122)
T ss_dssp SSS-TCHHHHHHHHHHHHHH
T ss_pred CccccceeehhHHHHHHHHH
Confidence 77788999999998877543
|
Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00026 Score=72.87 Aligned_cols=139 Identities=23% Similarity=0.298 Sum_probs=84.6
Q ss_pred ceecccCcEEEEEEEEeC-------CeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCc-ceEEEEEEeCCeeEEEEEe
Q 007892 215 NLLGQGGFGYVHKGVLTN-------GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL-VSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~~~~-------g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpni-v~l~g~~~~~~~~~lV~E~ 286 (586)
+.|..|--..||+....+ ++.+++|+..... ....+..+|++++..+...++ .++++++. + .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhe
Confidence 556677778999988655 4788899876543 223466788888888863333 45555553 2 358999
Q ss_pred cCCCcHHHH-----------------hcCCCCCC---------CChHHHHH--------------------------HHH
Q 007892 287 VPNKTLEFH-----------------LHGKDRPV---------MNWPTRMK--------------------------IAL 314 (586)
Q Consensus 287 ~~~gsL~~~-----------------l~~~~~~~---------l~~~~~~~--------------------------ia~ 314 (586)
++|..+... ||...... .-|..+.+ +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 988766421 22211110 00111101 011
Q ss_pred HHHHHhHhhhh------cCCCcEEecCCCCceeEeCCC----CCeEEeeccccc
Q 007892 315 GSARGLAYLHE------DCQPKIIHRDIKSANILLDDS----FEAKVADFGLAK 358 (586)
Q Consensus 315 ~ia~gL~yLH~------~~~~~ivHrDIk~~NILl~~~----~~~kl~DFGla~ 358 (586)
.+..-+.+|.. .....++|+|+.+.|||++++ +.++|+||..|.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 12222334432 234579999999999999885 789999999885
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF04478 Mid2: Mid2 like cell wall stress sensor; InterPro: IPR007567 This family represents a region near the C terminus of Mid2, which contains a transmembrane region | Back alignment and domain information |
|---|
Probab=97.67 E-value=1e-05 Score=72.33 Aligned_cols=37 Identities=35% Similarity=0.516 Sum_probs=17.3
Q ss_pred CCCCCCC---cccceEehhhHHHHHHHHHHHHHHHHHhhhhh
Q 007892 65 NGYLPPG---ALAGMVVGVVIGAGIVLAAVGIFLIFYKRRKR 103 (586)
Q Consensus 65 ~~~l~~~---~~~~~vvgv~~~~~~~~~~~~~~~~~~rrr~~ 103 (586)
++||+.. .++|++|||.++ ++|++++++||||+|+||
T Consensus 40 ssGlS~knknIVIGvVVGVGg~--ill~il~lvf~~c~r~kk 79 (154)
T PF04478_consen 40 SSGLSSKNKNIVIGVVVGVGGP--ILLGILALVFIFCIRRKK 79 (154)
T ss_pred CCCCCcCCccEEEEEEecccHH--HHHHHHHhheeEEEeccc
Confidence 3455543 355555554332 333444444445544444
|
The remainder of the protein sequence is serine-rich and of low complexity, and is therefore impossible to align accurately. Mid2 is thought to act as a mechanosensor of cell wall stress. The C-terminal cytoplasmic region of Mid2 is known to interact with Rom2, a guanine nucleotide exchange factor (GEF) for Rho1, which is part of the cell wall integrity signalling pathway []. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00075 Score=70.02 Aligned_cols=156 Identities=15% Similarity=0.161 Sum_probs=85.6
Q ss_pred cCHHHHHHHhcCccc-----cceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCC--cceEE
Q 007892 199 FTYEELKIATDNFSE-----ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH--LVSLV 271 (586)
Q Consensus 199 ~~~~el~~~~~~f~~-----~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpn--iv~l~ 271 (586)
.+.+++....+.|.. .+.|+.|....+|+....+| .+++|+... .....+..|+.++..|...+ +.+.+
T Consensus 7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i 82 (319)
T PRK05231 7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPV 82 (319)
T ss_pred CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcce
Confidence 344555444445543 35566777789999887655 578898752 12344445666666653212 23333
Q ss_pred E------EEEeCCeeEEEEEecCCCcHHH--------------HhcCCCC---------CCCCh-HHHHHH---------
Q 007892 272 G------YCTFGSQRLLVYEFVPNKTLEF--------------HLHGKDR---------PVMNW-PTRMKI--------- 312 (586)
Q Consensus 272 g------~~~~~~~~~lV~E~~~~gsL~~--------------~l~~~~~---------~~l~~-~~~~~i--------- 312 (586)
. +....+..++++||++|..+.. .||.... ..+.| .....-
T Consensus 83 ~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (319)
T PRK05231 83 ARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQ 162 (319)
T ss_pred eCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhH
Confidence 2 1233566789999999864310 1121110 01112 221111
Q ss_pred ---HHH-HHHHhHhhhh----cCCCcEEecCCCCceeEeCCCCCeEEeeccccc
Q 007892 313 ---ALG-SARGLAYLHE----DCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 358 (586)
Q Consensus 313 ---a~~-ia~gL~yLH~----~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~ 358 (586)
..+ +...++.+.. ....++||+|+.+.|||++++...-|+||+.+.
T Consensus 163 ~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 163 AALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred HHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 111 1112233321 134489999999999999977555799999885
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.001 Score=68.71 Aligned_cols=156 Identities=17% Similarity=0.194 Sum_probs=89.9
Q ss_pred CHHHHHHHhcCccc-----cceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCC--CcceEEE
Q 007892 200 TYEELKIATDNFSE-----ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHR--HLVSLVG 272 (586)
Q Consensus 200 ~~~el~~~~~~f~~-----~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hp--niv~l~g 272 (586)
+.++|....+.|.+ .+.|+.|.-..+|+....+| .+++|+..... ....+..|++++..|... .+.+++.
T Consensus 8 ~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~ 84 (307)
T TIGR00938 8 SDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVK 84 (307)
T ss_pred CHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCcccc
Confidence 34555554445543 45577777789999876555 57788765432 234556677777777422 2344443
Q ss_pred EE------EeCCeeEEEEEecCCCcHH--------------HHhcCCCC----------CCCChHHHHH-----------
Q 007892 273 YC------TFGSQRLLVYEFVPNKTLE--------------FHLHGKDR----------PVMNWPTRMK----------- 311 (586)
Q Consensus 273 ~~------~~~~~~~lV~E~~~~gsL~--------------~~l~~~~~----------~~l~~~~~~~----------- 311 (586)
.. ...+..++++||++|..+. -.+|.... ..-.|.....
T Consensus 85 t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~ 164 (307)
T TIGR00938 85 SRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEA 164 (307)
T ss_pred CCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCH
Confidence 21 2245678999999885431 01221100 0112221110
Q ss_pred -HHHHHHHHhHhhhh----cCCCcEEecCCCCceeEeCCCCCeEEeeccccc
Q 007892 312 -IALGSARGLAYLHE----DCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 358 (586)
Q Consensus 312 -ia~~ia~gL~yLH~----~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~ 358 (586)
....+.+.++++.. ....+++|+|+.+.||++++++.+.|+||+.+.
T Consensus 165 ~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 165 HMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 01122334555532 234589999999999999988767899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ] | Back alignment and domain information |
|---|
Probab=97.48 E-value=4.5e-05 Score=52.20 Aligned_cols=30 Identities=40% Similarity=0.848 Sum_probs=20.2
Q ss_pred ccceEehhhHHHHHHHHHHHHHHHHHhhhh
Q 007892 73 LAGMVVGVVIGAGIVLAAVGIFLIFYKRRK 102 (586)
Q Consensus 73 ~~~~vvgv~~~~~~~~~~~~~~~~~~rrr~ 102 (586)
.++|.+|+++.+++++++++++||++|||+
T Consensus 10 ~vaIa~~VvVPV~vI~~vl~~~l~~~~rR~ 39 (40)
T PF08693_consen 10 TVAIAVGVVVPVGVIIIVLGAFLFFWYRRK 39 (40)
T ss_pred eEEEEEEEEechHHHHHHHHHHhheEEecc
Confidence 456777777777777777767676555554
|
This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis []. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.00053 Score=79.48 Aligned_cols=196 Identities=18% Similarity=0.188 Sum_probs=131.4
Q ss_pred HHHHHHHHHhcCCCCcceEEEEEEeCCeeE----EEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcC
Q 007892 252 FQAEIEIISQVHHRHLVSLVGYCTFGSQRL----LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC 327 (586)
Q Consensus 252 ~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~----lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~ 327 (586)
..-|++.+.++.|+|++.+++|..+....- +..|++..-++..++.... .++..+.+.+..++.+||.|+|..
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~~h~~- 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAYLHSL- 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHHHHHh-
Confidence 345777888889999999998876644332 4457777777877775443 477788888999999999999987
Q ss_pred CCcEEecCCCCc---eeEeCCCCCeEEe--ecccccccCCCCCcccccccccccccCcccccCCCCCC--cchHHHHHHH
Q 007892 328 QPKIIHRDIKSA---NILLDDSFEAKVA--DFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTE--KSDVFSFGVL 400 (586)
Q Consensus 328 ~~~ivHrDIk~~---NILl~~~~~~kl~--DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~--ksDVwSlGvv 400 (586)
...|.=+..+ +...+.++.+.+. ||+..+...+.... ....-...+.++|......++. ..|+|.+|..
T Consensus 306 --~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~--~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 306 --SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS--FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred --ccceeEEecccccccccCccceeecchhhhcccccCCCcccc--hhhcCccccccccccccccchhhhhhHHHHHHHH
Confidence 4555544444 4444566667777 88888765443322 1122344577788776555444 4799999999
Q ss_pred HHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 007892 401 LLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIV 480 (586)
Q Consensus 401 L~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl 480 (586)
+..+..|..+-..... +...+.. .....+......|+..+.++|+...+++
T Consensus 382 ~~~~~~~~~i~~~~~~--------------------------~~~~l~~---~~~~~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKSAV--------------------------PVSLLDV---LSTSELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred HhhhhhcCcccccccc--------------------------hhhhhcc---ccchhhhhhhhhhcchhhhhccchhhhh
Confidence 9999998654221110 0011110 0111456677889999999999999998
Q ss_pred HHH
Q 007892 481 RAL 483 (586)
Q Consensus 481 ~~L 483 (586)
...
T Consensus 433 ~~~ 435 (1351)
T KOG1035|consen 433 THP 435 (1351)
T ss_pred hch
Confidence 754
|
|
| >PTZ00382 Variant-specific surface protein (VSP); Provisional | Back alignment and domain information |
|---|
Probab=97.36 E-value=9.2e-05 Score=62.26 Aligned_cols=29 Identities=31% Similarity=0.424 Sum_probs=19.8
Q ss_pred CCCCCCCCCcccceEehhhHHHHHHHHHH
Q 007892 63 TRNGYLPPGALAGMVVGVVIGAGIVLAAV 91 (586)
Q Consensus 63 ~~~~~l~~~~~~~~vvgv~~~~~~~~~~~ 91 (586)
+.+++|+.|+++||+||+++++++|++++
T Consensus 58 t~~~~ls~gaiagi~vg~~~~v~~lv~~l 86 (96)
T PTZ00382 58 ANRSGLSTGAIAGISVAVVAVVGGLVGFL 86 (96)
T ss_pred cCCCCcccccEEEEEeehhhHHHHHHHHH
Confidence 33468999999999998875544343333
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0011 Score=67.59 Aligned_cols=141 Identities=18% Similarity=0.253 Sum_probs=74.7
Q ss_pred ccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcC---CCCcceEEEEEEeCCeeEEEEEec
Q 007892 211 FSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH---HRHLVSLVGYCTFGSQRLLVYEFV 287 (586)
Q Consensus 211 f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~---Hpniv~l~g~~~~~~~~~lV~E~~ 287 (586)
....+.|+.|....+|+.. .+++.+.||.-. ......|..|.+-|+.|. --.+.+++++....+..+||+||+
T Consensus 19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 3445779999999999987 567888999865 233457888999998884 345778888888777889999999
Q ss_pred CCCcH--------H---HHhcC-CCCC-------------------CCChHH-----HHHHHHHH--------------H
Q 007892 288 PNKTL--------E---FHLHG-KDRP-------------------VMNWPT-----RMKIALGS--------------A 317 (586)
Q Consensus 288 ~~gsL--------~---~~l~~-~~~~-------------------~l~~~~-----~~~ia~~i--------------a 317 (586)
+.+.. - ..||. .... .-+|.+ |+.-..+. .
T Consensus 95 ~~~~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~~l~ 174 (288)
T PF03881_consen 95 EMGSPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELERLV 174 (288)
T ss_dssp ------CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHHHHH
T ss_pred cCCCCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHHHHH
Confidence 87611 0 12233 1110 123322 11111111 1
Q ss_pred HH-hHhhhhc-CCCcEEecCCCCceeEeCCCCCeEEeecc
Q 007892 318 RG-LAYLHED-CQPKIIHRDIKSANILLDDSFEAKVADFG 355 (586)
Q Consensus 318 ~g-L~yLH~~-~~~~ivHrDIk~~NILl~~~~~~kl~DFG 355 (586)
.. ...|+.. -.|-++|+||-+.|++.+.++.+.|.|=.
T Consensus 175 ~~~~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DPa 214 (288)
T PF03881_consen 175 ERLPSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDPA 214 (288)
T ss_dssp HHHHHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S--
T ss_pred HHHHHHhcCCCCCceeeEcCccccceeecCCCCceeeccc
Confidence 11 1223321 25679999999999999999989998844
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.002 Score=65.48 Aligned_cols=31 Identities=26% Similarity=0.483 Sum_probs=25.9
Q ss_pred CcEEecCCCCceeEeCCCCC-eEEeecccccc
Q 007892 329 PKIIHRDIKSANILLDDSFE-AKVADFGLAKH 359 (586)
Q Consensus 329 ~~ivHrDIk~~NILl~~~~~-~kl~DFGla~~ 359 (586)
+.++|+|+++.|||+++++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999997555 46999998854
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0041 Score=64.11 Aligned_cols=145 Identities=18% Similarity=0.279 Sum_probs=82.5
Q ss_pred cceecccCcEEEEEEEEeCCeEEEEEEec-cCCchhHHHHHHHHHHHHhcCC--CCcceEEEEEEeCC--eeEEEEEecC
Q 007892 214 ANLLGQGGFGYVHKGVLTNGKVVAIKQLK-AGSGQGEREFQAEIEIISQVHH--RHLVSLVGYCTFGS--QRLLVYEFVP 288 (586)
Q Consensus 214 ~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~-~~~~~~~~~~~~Ei~il~~l~H--pniv~l~g~~~~~~--~~~lV~E~~~ 288 (586)
.+.+..|---.+|.... .++.++|.+-. .......+...+|..+|..+.- --+...+++|.++. ..+.||+|++
T Consensus 30 v~~~~~G~sn~t~~~~~-~~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ve 108 (321)
T COG3173 30 VEEISGGWSNDTFRLGD-TGQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVE 108 (321)
T ss_pred eeeccCCcccceEEEec-CCceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEec
Confidence 34443333333444433 36777777211 1222334567788888888753 23445677887766 6689999998
Q ss_pred CCcHHHHh---------------------cCC---------------CCCCCChHHHHHHHH--------HHHHHhHhhh
Q 007892 289 NKTLEFHL---------------------HGK---------------DRPVMNWPTRMKIAL--------GSARGLAYLH 324 (586)
Q Consensus 289 ~gsL~~~l---------------------~~~---------------~~~~l~~~~~~~ia~--------~ia~gL~yLH 324 (586)
|..+...+ |.- .++...|...++.+. ....-..||+
T Consensus 109 Ge~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~ 188 (321)
T COG3173 109 GEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLE 188 (321)
T ss_pred ceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHH
Confidence 84332211 110 011112222221110 1122244554
Q ss_pred hcC-----CCcEEecCCCCceeEeCCCCCeEEeecccccc
Q 007892 325 EDC-----QPKIIHRDIKSANILLDDSFEAKVADFGLAKH 359 (586)
Q Consensus 325 ~~~-----~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~ 359 (586)
.+. .+.++|+|+.+.||+|+++..+=|.||+++..
T Consensus 189 ~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 189 ANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred hcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 432 34699999999999999988899999999875
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.00052 Score=69.61 Aligned_cols=135 Identities=20% Similarity=0.203 Sum_probs=92.2
Q ss_pred CccccceecccCcEEEEEEEEeCCeEEEEEEeccCC------------------ch----hHHHHHHHHHHHHhcC-CCC
Q 007892 210 NFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGS------------------GQ----GEREFQAEIEIISQVH-HRH 266 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~------------------~~----~~~~~~~Ei~il~~l~-Hpn 266 (586)
-++..+.||-|.-+.||.+...+|+..++|.-.... .. ..-...+|+..|+.|. |..
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 367789999999999999999889999888632110 00 1123456888888885 332
Q ss_pred -cceEEEEEEeCCeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCC
Q 007892 267 -LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD 345 (586)
Q Consensus 267 -iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 345 (586)
+.+.++ .+..++|||++.+..|...-+- .+.+++..-+++ -+--|-.+ |+||+|+.-=||+|++
T Consensus 173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v-----~d~~~ly~~lm~---~Iv~la~~---GlIHgDFNEFNimv~d 237 (465)
T KOG2268|consen 173 PVPKPID----HNRHCVVMELVDGYPLRQVRHV-----EDPPTLYDDLMG---LIVRLANH---GLIHGDFNEFNIMVKD 237 (465)
T ss_pred CCCCccc----ccceeeHHHhhcccceeeeeec-----CChHHHHHHHHH---HHHHHHHc---CceecccchheeEEec
Confidence 333333 3456799999999888654432 233333333332 23344455 9999999999999999
Q ss_pred CCCeEEeecccccc
Q 007892 346 SFEAKVADFGLAKH 359 (586)
Q Consensus 346 ~~~~kl~DFGla~~ 359 (586)
+..++++||--+..
T Consensus 238 d~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 238 DDKIVVIDFPQMVS 251 (465)
T ss_pred CCCEEEeechHhhc
Confidence 99999999976543
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.00024 Score=83.91 Aligned_cols=159 Identities=12% Similarity=0.007 Sum_probs=110.3
Q ss_pred HHHHHHHHHhcCCCCcceEEEEEEe--CCeeEEEEEecCCCcHHHHhcCCCC--CCCChHHHHHHHHHHHHHhHhhhhcC
Q 007892 252 FQAEIEIISQVHHRHLVSLVGYCTF--GSQRLLVYEFVPNKTLEFHLHGKDR--PVMNWPTRMKIALGSARGLAYLHEDC 327 (586)
Q Consensus 252 ~~~Ei~il~~l~Hpniv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~--~~l~~~~~~~ia~~ia~gL~yLH~~~ 327 (586)
...|.+.++...|+++.....-... ....+.+++|+.+|.+...+-.... +.++..-......+......-+|...
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 3455556666788888776544432 3455789999999999988864322 22322222222222244445555442
Q ss_pred CC--cEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHH
Q 007892 328 QP--KIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELI 405 (586)
Q Consensus 328 ~~--~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ell 405 (586)
+. --+|+++|.-|.+|..+.++|++++||.+.. ...........+++.|+.++....-+++.++|+|..|+.+|++.
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIk-np~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIK-NPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred cCCccchhhhhhhhccceecCCccccccccccccc-CchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 22 3689999999999999999999999999832 22222334456888899999998888999999999999999998
Q ss_pred hCCCCC
Q 007892 406 TGFRPF 411 (586)
Q Consensus 406 tG~~Pf 411 (586)
-|..+|
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 887665
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0052 Score=64.24 Aligned_cols=74 Identities=16% Similarity=0.126 Sum_probs=48.2
Q ss_pred eecccCcEEEEEEEEeCC-eEEEEEEeccCC-------chhHHHHHHHHHHHHhcC--CCCcceEEEEEEeCCeeEEEEE
Q 007892 216 LLGQGGFGYVHKGVLTNG-KVVAIKQLKAGS-------GQGEREFQAEIEIISQVH--HRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 216 ~LG~G~fG~Vyk~~~~~g-~~vAVK~l~~~~-------~~~~~~~~~Ei~il~~l~--Hpniv~l~g~~~~~~~~~lV~E 285 (586)
.||.|....||++...+| +.|+||.-.... ........-|.+.|.... .|..|.-+ |+.+.+...+|||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~v-y~~D~e~~~~vME 80 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRI-FHFDTEMAVTVME 80 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeE-EEEccccceehHh
Confidence 589999999999998654 689999853211 122344556777776664 45444433 3334566679999
Q ss_pred ecCCC
Q 007892 286 FVPNK 290 (586)
Q Consensus 286 ~~~~g 290 (586)
+++..
T Consensus 81 dL~~~ 85 (370)
T TIGR01767 81 DLSHH 85 (370)
T ss_pred hCccc
Confidence 99653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.011 Score=62.27 Aligned_cols=139 Identities=20% Similarity=0.228 Sum_probs=82.5
Q ss_pred ceecccCcEEEEEEEEeC-----CeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcc-eEEEEEEeCCeeEEEEEecC
Q 007892 215 NLLGQGGFGYVHKGVLTN-----GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLV-SLVGYCTFGSQRLLVYEFVP 288 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~~~~-----g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv-~l~g~~~~~~~~~lV~E~~~ 288 (586)
..|-.|-...+|+..+.+ ++.|++|+....... .-+..+|+.++..+..-++. ++++++..+ .|+||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~-~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVEL-FFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCe-eechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 456567788999987543 367889987654322 22346789999888644443 556655332 5899998
Q ss_pred CCcHHHH-----------------hcCCCC---C-CCChHHHHHHHHH-----------------HHHHhHhh----hh-
Q 007892 289 NKTLEFH-----------------LHGKDR---P-VMNWPTRMKIALG-----------------SARGLAYL----HE- 325 (586)
Q Consensus 289 ~gsL~~~-----------------l~~~~~---~-~l~~~~~~~ia~~-----------------ia~gL~yL----H~- 325 (586)
+.+|... +|.... . ..-|.+..++..+ +...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7666321 222211 1 1123332222211 11112222 21
Q ss_pred cCCCcEEecCCCCceeEeCC-CCCeEEeeccccc
Q 007892 326 DCQPKIIHRDIKSANILLDD-SFEAKVADFGLAK 358 (586)
Q Consensus 326 ~~~~~ivHrDIk~~NILl~~-~~~~kl~DFGla~ 358 (586)
.....++|+|+++.|||+++ ++.+.|+||..+.
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 12346899999999999986 4689999998875
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.0064 Score=62.89 Aligned_cols=139 Identities=16% Similarity=0.198 Sum_probs=93.2
Q ss_pred ccceecccCcEEEEEEEEeCCeEEEEEEeccCC----------------------chhH----HHHHHHHHHHHhcCCCC
Q 007892 213 EANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGS----------------------GQGE----REFQAEIEIISQVHHRH 266 (586)
Q Consensus 213 ~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~----------------------~~~~----~~~~~Ei~il~~l~Hpn 266 (586)
+...|..|--..||.++-.+|..+|||+.+..- .... -....|+.-|.+|+.-.
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 346788899999999999999999999975320 0011 12346888888886433
Q ss_pred cceEEEEEEeCCeeEEEEEecCCCcH-HHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCC
Q 007892 267 LVSLVGYCTFGSQRLLVYEFVPNKTL-EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD 345 (586)
Q Consensus 267 iv~l~g~~~~~~~~~lV~E~~~~gsL-~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 345 (586)
|.----.. -....|||+|+..... .-.|. .-.++...+..+-.+++.-+.-|-..| ++||.||.-=|+|+.+
T Consensus 228 IP~PePIl--Lk~hVLVM~FlGrdgw~aPkLK---d~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyhd 300 (520)
T KOG2270|consen 228 IPCPEPIL--LKNHVLVMEFLGRDGWAAPKLK---DASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHD 300 (520)
T ss_pred CCCCCcee--eecceEeeeeccCCCCcCcccc---cccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEEC
Confidence 22110000 0234699999953221 11121 123555567777788888888888888 8999999999999876
Q ss_pred CCCeEEeecccccc
Q 007892 346 SFEAKVADFGLAKH 359 (586)
Q Consensus 346 ~~~~kl~DFGla~~ 359 (586)
+ .+.|+|.+-+..
T Consensus 301 G-~lyiIDVSQSVE 313 (520)
T KOG2270|consen 301 G-KLYIIDVSQSVE 313 (520)
T ss_pred C-EEEEEEcccccc
Confidence 5 789999887754
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.0085 Score=61.76 Aligned_cols=30 Identities=37% Similarity=0.433 Sum_probs=26.1
Q ss_pred CCcEEecCCCCceeEeCCCCCeEEeeccccc
Q 007892 328 QPKIIHRDIKSANILLDDSFEAKVADFGLAK 358 (586)
Q Consensus 328 ~~~ivHrDIk~~NILl~~~~~~kl~DFGla~ 358 (586)
..+++|+|+.+.|||++. +.+.|+||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 357999999999999988 578999999775
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.018 Score=61.28 Aligned_cols=73 Identities=14% Similarity=0.137 Sum_probs=49.4
Q ss_pred cceecccCcEEEEEEEEeCCeEEEEEEeccCCc-------hhHHHHHHHHHHHHhcC---CCCcceEEEEEEeCCeeEEE
Q 007892 214 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSG-------QGEREFQAEIEIISQVH---HRHLVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 214 ~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~-------~~~~~~~~Ei~il~~l~---Hpniv~l~g~~~~~~~~~lV 283 (586)
.+.||.|....||+.... ++.|+||+-..... .....-..|.+.|..+. ..++.+++.+|. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 578999999999998764 55688998542111 11223334466666553 347888888886 456789
Q ss_pred EEecCC
Q 007892 284 YEFVPN 289 (586)
Q Consensus 284 ~E~~~~ 289 (586)
|||+++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999977
|
|
| >PF02439 Adeno_E3_CR2: Adenovirus E3 region protein CR2; InterPro: IPR003470 Early region 3 (E3) of human adenoviruses (Ads) codes for proteins that appear to control viral interactions with the host [] | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.00072 Score=45.44 Aligned_cols=17 Identities=29% Similarity=0.690 Sum_probs=10.5
Q ss_pred cccceEehhhHHHHHHH
Q 007892 72 ALAGMVVGVVIGAGIVL 88 (586)
Q Consensus 72 ~~~~~vvgv~~~~~~~~ 88 (586)
..+|||+||++|+++++
T Consensus 4 s~IaIIv~V~vg~~iii 20 (38)
T PF02439_consen 4 STIAIIVAVVVGMAIII 20 (38)
T ss_pred chhhHHHHHHHHHHHHH
Confidence 34677788777654333
|
This region called CR1 (conserved region 1) [] is found three times in Human adenovirus 19 (a subgroup D adenovirus) 49 kDa protein in the E3 region. CR1 is also found in the 20.1 Kd protein of subgroup B adenoviruses. The function of this 80 amino acid region is unknown. This region is probably a divergent immunoglobulin domain. |
| >PF05808 Podoplanin: Podoplanin; InterPro: IPR008783 This family consists of several mammalian podoplanin-like proteins which are thought to control specifically the unique shape of podocytes [] | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.00034 Score=63.20 Aligned_cols=29 Identities=24% Similarity=0.486 Sum_probs=0.0
Q ss_pred CCCCCCCCCcccceEehhhHHHHHHHHHH
Q 007892 63 TRNGYLPPGALAGMVVGVVIGAGIVLAAV 91 (586)
Q Consensus 63 ~~~~~l~~~~~~~~vvgv~~~~~~~~~~~ 91 (586)
..++||+.++++||||||++|+++|.+++
T Consensus 121 ~ek~GL~T~tLVGIIVGVLlaIG~igGII 149 (162)
T PF05808_consen 121 VEKDGLSTVTLVGIIVGVLLAIGFIGGII 149 (162)
T ss_dssp -----------------------------
T ss_pred cccCCcceeeeeeehhhHHHHHHHHhhee
Confidence 34679999999999999998766544443
|
; GO: 0016021 integral to membrane; PDB: 3IET_X. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.022 Score=59.32 Aligned_cols=140 Identities=22% Similarity=0.335 Sum_probs=83.9
Q ss_pred ceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCC------cceEEEEE--EeCC--eeEEEE
Q 007892 215 NLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH------LVSLVGYC--TFGS--QRLLVY 284 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpn------iv~l~g~~--~~~~--~~~lV~ 284 (586)
..|.. .-..||+....+|+. ++|+.... ....++..|+..|..|.-.+ |..+=|-. ...+ ..+-++
T Consensus 32 ~~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf 107 (331)
T COG2334 32 RGLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALF 107 (331)
T ss_pred ccccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEE
Confidence 33444 567799998877776 88887665 44567778888888774211 22222211 1123 677899
Q ss_pred EecCCCcHHH-----H----------hcC--CC--------CCCCChHH-------------HHHHHHHHHHHhHhhhhc
Q 007892 285 EFVPNKTLEF-----H----------LHG--KD--------RPVMNWPT-------------RMKIALGSARGLAYLHED 326 (586)
Q Consensus 285 E~~~~gsL~~-----~----------l~~--~~--------~~~l~~~~-------------~~~ia~~ia~gL~yLH~~ 326 (586)
+|++|..+.. + ||. .+ .....|.. ......++...+..+.+.
T Consensus 108 ~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~ 187 (331)
T COG2334 108 EYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLAR 187 (331)
T ss_pred EecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhh
Confidence 9999887762 0 111 11 11234430 011223333344444432
Q ss_pred ----CCCc---EEecCCCCceeEeCCCCC-eEEeeccccc
Q 007892 327 ----CQPK---IIHRDIKSANILLDDSFE-AKVADFGLAK 358 (586)
Q Consensus 327 ----~~~~---ivHrDIk~~NILl~~~~~-~kl~DFGla~ 358 (586)
.... +||+|+.+.|||++.+.. +.++||+-|.
T Consensus 188 ~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 188 LPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred chhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 1223 999999999999999875 8899999885
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.0085 Score=58.22 Aligned_cols=121 Identities=21% Similarity=0.251 Sum_probs=59.9
Q ss_pred CeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCc-ceEEEEEEeCCeeEEEEEecCCCcHHHH----------------
Q 007892 233 GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL-VSLVGYCTFGSQRLLVYEFVPNKTLEFH---------------- 295 (586)
Q Consensus 233 g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpni-v~l~g~~~~~~~~~lV~E~~~~gsL~~~---------------- 295 (586)
.+.|+||+..... ...-....|..+++.+..-++ .++++++. +. +|+||+++..|...
T Consensus 2 ~~~~~~Ri~g~~t-~~~idr~~E~~~~~~l~~~g~~p~~~~~~~--~g--~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~ 76 (211)
T PF01633_consen 2 PEKYLVRIPGEGT-ENFIDRENENEALKLLSEAGLGPKIIYFFE--NG--RVEEFIEGRTLSPEDFRNPEILKRIAKLLA 76 (211)
T ss_dssp TSEEEEEEEESCG-CSHHHHHHHHHHHHHHHHTTSSS-EEEEET--TE--EEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCCc-ccccCHHHHHHHHHHHHHcCCCCeEEEEcC--CC--cEEEEecccccChhhccChHHHHHHHHHHH
Confidence 3578888876653 334566788999988864444 55665543 22 57799977665321
Q ss_pred -hcCC-----CCCCCChHHHHHH----------------------HHHHHHHhHhhhh---c--CCCcEEecCCCCceeE
Q 007892 296 -LHGK-----DRPVMNWPTRMKI----------------------ALGSARGLAYLHE---D--CQPKIIHRDIKSANIL 342 (586)
Q Consensus 296 -l~~~-----~~~~l~~~~~~~i----------------------a~~ia~gL~yLH~---~--~~~~ivHrDIk~~NIL 342 (586)
||.. .....-|.....+ ...+.+-+..+.. . ...-++|+||.+.|||
T Consensus 77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil 156 (211)
T PF01633_consen 77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL 156 (211)
T ss_dssp HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence 1110 0111112222222 0111122222221 0 1125789999999999
Q ss_pred e-CCCCCeEEeeccccc
Q 007892 343 L-DDSFEAKVADFGLAK 358 (586)
Q Consensus 343 l-~~~~~~kl~DFGla~ 358 (586)
+ +.++.++|+||..|.
T Consensus 157 ~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 157 INNKDGEVKLIDFEYAG 173 (211)
T ss_dssp ETSSSSCEEE--GTT-E
T ss_pred eccCCCeEEEecHHHHh
Confidence 9 888999999998875
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.0086 Score=63.42 Aligned_cols=75 Identities=19% Similarity=0.200 Sum_probs=50.1
Q ss_pred cceecccCcEEEEEEEEeC-CeEEEEEEeccCC------chhHHHHHHHHHHHHhcC--CCCcceEEEEEEeCCeeEEEE
Q 007892 214 ANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGS------GQGEREFQAEIEIISQVH--HRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 214 ~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~------~~~~~~~~~Ei~il~~l~--Hpniv~l~g~~~~~~~~~lV~ 284 (586)
.+.||.|.-..||++...+ ++.|+||.-.... ........-|.+.|+.+. .|..|.-+ |+.+.....+||
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~v-y~~D~e~~~~vM 112 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKV-YLFDSVMNCCVM 112 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeE-EEECcHHhhHHH
Confidence 4689999999999999753 5679999853211 122355666778887764 45444433 333456677899
Q ss_pred EecCC
Q 007892 285 EFVPN 289 (586)
Q Consensus 285 E~~~~ 289 (586)
|+++.
T Consensus 113 EdL~~ 117 (409)
T PRK12396 113 EDLSD 117 (409)
T ss_pred HhCcc
Confidence 99865
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.04 Score=57.44 Aligned_cols=71 Identities=11% Similarity=0.071 Sum_probs=46.2
Q ss_pred cCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCC--Ccce---EEE--EEEeCCeeEEEEEecCCCc
Q 007892 220 GGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHR--HLVS---LVG--YCTFGSQRLLVYEFVPNKT 291 (586)
Q Consensus 220 G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hp--niv~---l~g--~~~~~~~~~lV~E~~~~gs 291 (586)
+.-..||+....++..+++|+..... ....++..|++.+..|... .++. .-| +...++..+.++++++|..
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 45578999988788889999875332 3456777888888777421 1222 112 2233567788999998764
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.022 Score=59.56 Aligned_cols=139 Identities=17% Similarity=0.258 Sum_probs=80.8
Q ss_pred ceecccCcEEEEEEEEeC----CeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCc-ceEEEEEEeCCeeEEEEEecCC
Q 007892 215 NLLGQGGFGYVHKGVLTN----GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL-VSLVGYCTFGSQRLLVYEFVPN 289 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~~~~----g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpni-v~l~g~~~~~~~~~lV~E~~~~ 289 (586)
+.|..|=...+|+....+ +..|+||+....... .-+-.+|+.++..+..-++ .++++++. ++ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence 456557778899887543 237889987654332 2344678889988865444 45666653 22 58999987
Q ss_pred CcHHH-----------------HhcCCCCC----CCChHHHHHHHHHH----------------------HHHhHhhhh-
Q 007892 290 KTLEF-----------------HLHGKDRP----VMNWPTRMKIALGS----------------------ARGLAYLHE- 325 (586)
Q Consensus 290 gsL~~-----------------~l~~~~~~----~l~~~~~~~ia~~i----------------------a~gL~yLH~- 325 (586)
..|.. .||..... .--|..+.++..++ ..-+..+..
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 66521 12322111 11233322222111 111111111
Q ss_pred ----cCCCcEEecCCCCceeEeCC-CCCeEEeeccccc
Q 007892 326 ----DCQPKIIHRDIKSANILLDD-SFEAKVADFGLAK 358 (586)
Q Consensus 326 ----~~~~~ivHrDIk~~NILl~~-~~~~kl~DFGla~ 358 (586)
....-++|+|+.+.|||+++ ++.++++||..|.
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 11224789999999999974 5789999999874
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.039 Score=66.14 Aligned_cols=141 Identities=18% Similarity=0.219 Sum_probs=80.1
Q ss_pred ceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcC-------CCCcceEE-----EEEEe-CC--e
Q 007892 215 NLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-------HRHLVSLV-----GYCTF-GS--Q 279 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~-------Hpniv~l~-----g~~~~-~~--~ 279 (586)
+.|+ |..-.+|+....+|+.+++|+..... ....+..|...|..|. .|.+++-. ..+.. ++ .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~--~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSE--PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCcc--chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 4564 45688899888788889999987643 2334444555665442 23333311 11111 22 4
Q ss_pred eEEEEEecCCCcHHHH-----------------hc----CCC----CCCCChHH-----------------HHHHHHHHH
Q 007892 280 RLLVYEFVPNKTLEFH-----------------LH----GKD----RPVMNWPT-----------------RMKIALGSA 317 (586)
Q Consensus 280 ~~lV~E~~~~gsL~~~-----------------l~----~~~----~~~l~~~~-----------------~~~ia~~ia 317 (586)
.+-+|+|++|..|... || ... ...+.|.. ...++.+++
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 5678999999777541 11 011 11233422 112222222
Q ss_pred HHhH-----hhhhcCCCcEEecCCCCceeEeCCCC--CeE-Eeecccccc
Q 007892 318 RGLA-----YLHEDCQPKIIHRDIKSANILLDDSF--EAK-VADFGLAKH 359 (586)
Q Consensus 318 ~gL~-----yLH~~~~~~ivHrDIk~~NILl~~~~--~~k-l~DFGla~~ 359 (586)
..+. .| ......+||+|+.+.|||++.+. ++. |+|||.+..
T Consensus 188 ~~~~~~v~p~l-~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 188 ARFERNVAPRL-AALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHH-hcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 2221 12 12344799999999999999875 555 999998864
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.038 Score=57.10 Aligned_cols=32 Identities=16% Similarity=0.321 Sum_probs=28.4
Q ss_pred CCcEEecCCCCceeEeCCCCCeEEeecccccc
Q 007892 328 QPKIIHRDIKSANILLDDSFEAKVADFGLAKH 359 (586)
Q Consensus 328 ~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~ 359 (586)
..+++|+|+.+.|||+++++.+.|+||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 34799999999999999998999999998864
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 586 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-71 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-70 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-47 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-46 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-43 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-43 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-42 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-41 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-29 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-28 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-28 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-24 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-24 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 9e-24 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-23 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-23 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-23 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-23 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-23 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-23 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-23 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 9e-23 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-22 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-22 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-22 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-22 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-22 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-22 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-22 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-22 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-22 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-22 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-22 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-22 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-22 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-22 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-22 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-22 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-21 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-21 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-21 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-21 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-21 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-21 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-21 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-21 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-21 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-21 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-21 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-21 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-21 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-21 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-21 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-21 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-20 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-20 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-20 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-20 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-20 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-20 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-20 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-20 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-20 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-20 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-20 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-20 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-20 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-20 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-20 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-20 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-19 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-19 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-19 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-19 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-19 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-19 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-19 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-19 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-19 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-19 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-19 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-19 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-19 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-19 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-19 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-19 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 7e-19 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 8e-19 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-19 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-19 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-19 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 8e-19 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 9e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 9e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-18 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-18 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-18 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-18 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-18 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-18 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-18 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-18 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-18 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-18 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-18 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-18 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-18 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-18 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-18 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-18 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-18 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-18 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-18 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-18 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-18 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-18 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-18 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-18 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-18 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-18 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-18 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-18 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-18 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-18 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-18 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-18 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-18 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-18 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-18 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-18 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-18 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-18 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-18 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-18 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-18 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-18 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-18 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-18 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-18 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-18 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-18 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 7e-18 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 7e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-18 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-18 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 8e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 8e-18 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 8e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-18 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-18 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 8e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 9e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 9e-18 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 9e-18 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 9e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 9e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 9e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 9e-18 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-17 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-17 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-17 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-17 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-17 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 6e-17 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 6e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-17 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-17 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-17 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-17 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-17 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-17 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 8e-17 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 8e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 8e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 9e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 9e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-16 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-16 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-16 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-16 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-16 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-16 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-16 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-16 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-16 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-16 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-16 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-16 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-16 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-16 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-16 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-16 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-16 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-16 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-16 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-16 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 8e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-16 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 8e-16 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 9e-16 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-16 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-16 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-16 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-15 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-15 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-15 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-15 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-15 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-15 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-15 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-15 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-15 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-15 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-15 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-15 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-15 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-15 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-15 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-15 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-15 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-15 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-15 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-15 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-15 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-15 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-15 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-15 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-15 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-15 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-15 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-15 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 8e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 8e-15 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-15 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-15 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 8e-15 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 9e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-15 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 9e-15 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-14 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-14 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-14 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-14 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-14 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-14 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-14 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-14 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-14 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-14 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-14 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-14 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-14 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-14 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-14 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-14 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-14 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-14 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-14 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-14 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-14 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 7e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 8e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 8e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-13 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-13 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-13 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-13 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-13 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 8e-13 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 8e-13 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 8e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-13 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 9e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 9e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-12 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-12 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 8e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-11 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-11 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 8e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 8e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 9e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 9e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 7e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 7e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 7e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 8e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 8e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 8e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-09 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-09 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 9e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 9e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 9e-09 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 8e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 9e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-07 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 7e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 8e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 9e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 9e-07 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 9e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-06 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-06 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-06 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 4e-06 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 4e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-06 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 5e-06 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 6e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 9e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-05 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 1e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 552 bits (1424), Expect = 0.0
Identities = 152/316 (48%), Positives = 209/316 (66%), Gaps = 11/316 (3%)
Query: 186 QSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGS 245
+ P + +G K F+ EL++A+DNFS N+LG+GGFG V+KG L +G +VA+K+LK
Sbjct: 8 EDPEVHLGQLK-RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEER 66
Query: 246 GQG-EREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGK--DRP 302
QG E +FQ E+E+IS HR+L+ L G+C ++RLLVY ++ N ++ L + +P
Sbjct: 67 TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP 126
Query: 303 VMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362
++WP R +IALGSARGLAYLH+ C PKIIHRD+K+ANILLD+ FEA V DFGLAK
Sbjct: 127 PLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 186
Query: 363 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDS- 421
DTHV+T V GT G++APEY S+GK +EK+DVF +GV+LLELITG R FD A DD
Sbjct: 187 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246
Query: 422 -MVDWAKPFLAQGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQI 479
++DW K L + +ALVD L+ Y E+ ++ A C + S RP+MS++
Sbjct: 247 MLLDWVKGL----LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302
Query: 480 VRALEGNMPLDDLNEG 495
VR LEG+ + E
Sbjct: 303 VRMLEGDGLAERWEEW 318
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 515 bits (1330), Expect = 0.0
Identities = 120/325 (36%), Positives = 180/325 (55%), Gaps = 11/325 (3%)
Query: 171 LSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVL 230
+ + S ++ S V +L+ AT+NF L+G G FG V+KGVL
Sbjct: 1 MGSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL 60
Query: 231 TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNK 290
+G VA+K+ S QG EF+ EIE +S H HLVSL+G+C ++ +L+Y+++ N
Sbjct: 61 RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENG 120
Query: 291 TLEFHLHGKDRPV--MNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE 348
L+ HL+G D P M+W R++I +G+ARGL YLH IIHRD+KS NILLD++F
Sbjct: 121 NLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFV 177
Query: 349 AKVADFGLAKHSLDTD-THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITG 407
K+ DFG++K + D TH+ST V GT GY+ PEY G+LTEKSDV+SFGV+L E++
Sbjct: 178 PKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCA 237
Query: 408 FRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACI 466
++ ++ +WA G + +VD L + + + A C+
Sbjct: 238 RSAIVQSLPREMVNLAEWAVESHNN----GQLEQIVDPNLADKIRPESLRKFGDTAVKCL 293
Query: 467 RHSARRRPRMSQIVRALEGNMPLDD 491
S+ RP M ++ LE + L +
Sbjct: 294 ALSSEDRPSMGDVLWKLEYALRLQE 318
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 497 bits (1282), Expect = e-175
Identities = 111/312 (35%), Positives = 183/312 (58%), Gaps = 23/312 (7%)
Query: 186 QSPGMPVGNFKSTFTYEELKIATDNFSE------ANLLGQGGFGYVHKGVLTNGKVVAIK 239
+S + F +F++ ELK T+NF E N +G+GGFG V+KG + N VA+K
Sbjct: 3 KSLEVSDTRFH-SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVK 60
Query: 240 QLKAG----SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFH 295
+L A + + +++F EI+++++ H +LV L+G+ + G LVY ++PN +L
Sbjct: 61 KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 296 LHGKD-RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADF 354
L D P ++W R KIA G+A G+ +LHE+ IHRDIKSANILLD++F AK++DF
Sbjct: 121 LSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDF 177
Query: 355 GLAKHS-LDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDK 413
GLA+ S T +++R++GT Y+APE G++T KSD++SFGV+LLE+ITG D+
Sbjct: 178 GLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDE 236
Query: 414 ADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRR 473
++D + + + +D+K+ + DS + M + A+ C+ +R
Sbjct: 237 --HREPQLLLDIKEEIEDEE---KTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKR 291
Query: 474 PRMSQIVRALEG 485
P + ++ + L+
Sbjct: 292 PDIKKVQQLLQE 303
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 288 bits (740), Expect = 1e-93
Identities = 73/319 (22%), Positives = 122/319 (38%), Gaps = 31/319 (9%)
Query: 197 STFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEI 256
E L + + +G FG V K L + VA+K Q + + E+
Sbjct: 12 VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSW-QNEYEV 69
Query: 257 EIISQVHHRHLVSLVGYCTFGS----QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKI 312
+ + H +++ +G G+ L+ F +L L V++W I
Sbjct: 70 YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK---ANVVSWNELCHI 126
Query: 313 ALGSARGLAYLHED-------CQPKIIHRDIKSANILLDDSFEAKVADFGLAK-HSLDTD 364
A ARGLAYLHED +P I HRDIKS N+LL ++ A +ADFGLA
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 365 THVSTRVMGTFGYLAPEYASSG-----KLTEKSDVFSFGVLLLELITGFRPFDKADTFAD 419
+ +GT Y+APE + D+++ G++L EL + D D
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP---VD 243
Query: 420 DSMVDWAKPFLAQGLADGNFDALVDQKL-----EEYDSAEMTR-MAACAAACIRHSARRR 473
+ M+ + + + + +V +K + + + C H A R
Sbjct: 244 EYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEAR 303
Query: 474 PRMSQIVRALEGNMPLDDL 492
+ + L ++
Sbjct: 304 LSAGCVGERITQMQRLTNI 322
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 5e-74
Identities = 69/338 (20%), Positives = 132/338 (39%), Gaps = 50/338 (14%)
Query: 199 FTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEI 258
E + DN L+G+G +G V+KG L + + VA+K + + F E I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNI 58
Query: 259 --ISQVHHRHLVSLVGYCTFGS-----QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMK 311
+ + H ++ + + + LLV E+ PN +L +L +W + +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS---LHTSDWVSSCR 115
Query: 312 IALGSARGLAYLHED------CQPKIIHRDIKSANILLDDSFEAKVADFGLAK------- 358
+A RGLAYLH + +P I HRD+ S N+L+ + ++DFGL+
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 359 HSLDTDTHVSTRVMGTFGYLAPEYASS-------GKLTEKSDVFSFGVLLLELITGFRPF 411
+ + + +GT Y+APE ++ D+++ G++ E+
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR---- 231
Query: 412 DKADTFADDSMVDWAKPFLAQGLADGNF----DALVDQKL-------EEYDSAEMTRMAA 460
D F +S+ ++ F + F + +K + +S + +
Sbjct: 232 -CTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKE 290
Query: 461 CAAACIRHSARRRPRMSQIVRALEGNMPLDDLNEGITP 498
C A R + M + + N+ ++P
Sbjct: 291 TIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSP 328
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 2e-68
Identities = 77/313 (24%), Positives = 134/313 (42%), Gaps = 29/313 (9%)
Query: 178 DSDKPFPRQS-PGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVV 236
P P F+ +++ I + + +G G FG VH+ +G V
Sbjct: 5 HHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDV 63
Query: 237 AIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEF 294
A+K L + EF E+ I+ ++ H ++V +G T +V E++ +L
Sbjct: 64 AVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYR 123
Query: 295 HLHGKD-RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVAD 353
LH R ++ R+ +A A+G+ YLH P I+HR++KS N+L+D + KV D
Sbjct: 124 LLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCD 182
Query: 354 FGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDK 413
FGL++ + S GT ++APE EKSDV+SFGV+L EL T +P+
Sbjct: 183 FGLSR-LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN 241
Query: 414 ADTFADDSMVDWAK--PFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSAR 471
+ + V + + + ++ ++ + C +
Sbjct: 242 LNPAQVVAAVGFKCKRLEIPRN---------LNPQVAAI----IEG-------CWTNEPW 281
Query: 472 RRPRMSQIVRALE 484
+RP + I+ L
Sbjct: 282 KRPSFATIMDLLR 294
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 4e-67
Identities = 89/307 (28%), Positives = 140/307 (45%), Gaps = 53/307 (17%)
Query: 200 TYEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGE-------RE 251
+A + +G+GGFG VHKG + + VVAIK L G +GE +E
Sbjct: 10 KSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQE 69
Query: 252 FQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMK 311
FQ E+ I+S ++H ++V L G + +V EFVP L L K P + W +++
Sbjct: 70 FQREVFIMSNLNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHP-IKWSVKLR 126
Query: 312 IALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE-----AKVADFGLAKHSLDTDTH 366
+ L A G+ Y+ + P I+HRD++S NI L E AKVADFGL++ S+ +
Sbjct: 127 LMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS--- 182
Query: 367 VSTRVMGTFGYLAPE--YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD 424
+ ++G F ++APE A TEK+D +SF ++L ++TG PFD+ +
Sbjct: 183 -VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IK 237
Query: 425 WAKPFLAQGL-------ADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMS 477
+ +GL + + C ++RP S
Sbjct: 238 FINMIREEGLRPTIPEDCPPRLRNV------------IEL-------CWSGDPKKRPHFS 278
Query: 478 QIVRALE 484
IV+ L
Sbjct: 279 YIVKELS 285
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 9e-65
Identities = 87/291 (29%), Positives = 133/291 (45%), Gaps = 45/291 (15%)
Query: 201 YEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIIS 260
Y+E+++ ++G+G FG V K K VAIKQ++ S + F E+ +S
Sbjct: 7 YKEIEVE-------EVVGRGAFGVVCKAKW-RAKDVAIKQIE--SESERKAFIVELRQLS 56
Query: 261 QVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDR-PVMNWPTRMKIALGSARG 319
+V+H ++V L G C + LV E+ +L LHG + P M L ++G
Sbjct: 57 RVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQG 114
Query: 320 LAYLHEDCQPKIIHRDIKSANILLDDSFE-AKVADFGLAKHSLDTDTHVSTRVMGTFGYL 378
+AYLH +IHRD+K N+LL K+ DFG A T G+ ++
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI----QTHMTNNKGSAAWM 170
Query: 379 APEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWA-----KPFLAQG 433
APE +EK DVFS+G++L E+IT +PFD+ A + WA +P L +
Sbjct: 171 APEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA--FRIMWAVHNGTRPPLIKN 228
Query: 434 LADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484
L ++L MTR C +RP M +IV+ +
Sbjct: 229 L-PKPIESL------------MTR-------CWSKDPSQRPSMEEIVKIMT 259
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 2e-63
Identities = 80/298 (26%), Positives = 121/298 (40%), Gaps = 48/298 (16%)
Query: 201 YEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAG----SGQGEREFQAEI 256
+ EL + ++G GGFG V++ G VA+K + Q + E
Sbjct: 6 FAELTLE-------EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEA 57
Query: 257 EIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS 316
++ + + H ++++L G C LV EF L L GK P + A+
Sbjct: 58 KLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIP---PDILVNWAVQI 114
Query: 317 ARGLAYLHEDCQPKIIHRDIKSANILLDDSFE--------AKVADFGLAKHSLDTDTHVS 368
ARG+ YLH++ IIHRD+KS+NIL+ E K+ DFGLA+ T
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK--- 171
Query: 369 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAK- 427
G + ++APE + ++ SDV+S+GVLL EL+TG PF D A V K
Sbjct: 172 MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKL 231
Query: 428 -PFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484
+ + + M C RP + I+ L
Sbjct: 232 ALPIPST---------CPEPFAKL----MED-------CWNPDPHSRPSFTNILDQLT 269
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 2e-63
Identities = 63/293 (21%), Positives = 111/293 (37%), Gaps = 44/293 (15%)
Query: 201 YEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAG--SGQGEREFQAEIEI 258
+++L L + G + KG G + +K LK S + R+F E
Sbjct: 9 FKQLNFL-------TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPR 60
Query: 259 ISQVHHRHLVSLVGYCTFGSQRLL--VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS 316
+ H +++ ++G C + ++P +L LH V++ +K AL
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120
Query: 317 ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG 376
ARG+A+LH +P I + S ++++D+ A+++ + + S M
Sbjct: 121 ARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPA 173
Query: 377 YLAPE---YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAK--PFLA 431
++APE +D++SF VLL EL+T PF V P +
Sbjct: 174 WVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIP 233
Query: 432 QGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484
G+ + L M C+ +RP+ IV LE
Sbjct: 234 PGI-SPHVSKL------------MKI-------CMNEDPAKRPKFDMIVPILE 266
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 1e-62
Identities = 74/318 (23%), Positives = 120/318 (37%), Gaps = 56/318 (17%)
Query: 217 LGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCT 275
LG+G FG K G+V+ +K+L + +R F E++++ + H +++ +G
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 276 FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRD 335
+ + E++ TL + D W R+ A A G+AYLH IIHRD
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQ-YPWSQRVSFAKDIASGMAYLH---SMNIIHRD 133
Query: 336 IKSANILLDDSFEAKVADFGLAKHSLDTDTH-------------VSTRVMGTFGYLAPEY 382
+ S N L+ ++ VADFGLA+ +D T V+G ++APE
Sbjct: 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193
Query: 383 ASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 442
+ EK DVFSFG++L E+I D
Sbjct: 194 INGRSYDEKVDVFSFGIVLCEIIGRVNADP--------------------DYLPRTMDFG 233
Query: 443 VDQKLEEYDSAEMTRMAAC-------AAACIRHSARRRPRMSQIVRALE-------GNMP 488
++ + + C C +RP ++ LE G++P
Sbjct: 234 LNVR----GFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLP 289
Query: 489 LDDLNEGITPGHSTIYGS 506
L E + G Y
Sbjct: 290 LGPQLEQLDRGFWETYRR 307
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 8e-62
Identities = 71/329 (21%), Positives = 125/329 (37%), Gaps = 49/329 (14%)
Query: 172 STSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLT 231
+ SL S + FPR++ +++ +E I + L+G+G FG V+ G
Sbjct: 3 EMNLSLLSARSFPRKAS-------QTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRW- 54
Query: 232 NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPN 289
+G+V AI+ + + + F+ E+ Q H ++V +G C ++
Sbjct: 55 HGEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKG 113
Query: 290 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA 349
+TL + + V++ +IA +G+ YLH I+H+D+KS N+ D+ +
Sbjct: 114 RTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYDN-GKV 168
Query: 350 KVADFGLAKHSLDTDTHVSTRVM----GTFGYLAPEYASSGKL---------TEKSDVFS 396
+ DFGL S + G +LAPE ++ SDVF+
Sbjct: 169 VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFA 228
Query: 397 FGVLLLELITGFRPFDKADTFADDSMVDW-AKPFLAQGLADGNFDALVDQKLEEYDSAEM 455
G + EL PF A + KP L+Q + +
Sbjct: 229 LGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDI------------L 276
Query: 456 TRMAACAAACIRHSARRRPRMSQIVRALE 484
C RP ++++ LE
Sbjct: 277 LF-------CWAFEQEERPTFTKLMDMLE 298
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 2e-61
Identities = 76/297 (25%), Positives = 136/297 (45%), Gaps = 39/297 (13%)
Query: 200 TYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAG--SGQGEREFQAEIE 257
++ +I + +G G FG V+KG +G V A+K L + Q + F+ E+
Sbjct: 15 AADDWEIPDGQITVGQRIGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVG 72
Query: 258 IISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA 317
++ + H +++ +GY T Q +V ++ +L HLH + + IA +A
Sbjct: 73 VLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTA 130
Query: 318 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK-HSLDTDTHVSTRVMGTFG 376
RG+ YLH IIHRD+KS NI L + K+ DFGLA S + +H ++ G+
Sbjct: 131 RGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187
Query: 377 YLAPE---YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWA------K 427
++APE S + +SDV++FG++L EL+TG P+ + +
Sbjct: 188 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR---DQIIEMVGRGSLS 244
Query: 428 PFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484
P L++ ++ ++++ M C++ RP +I+ +E
Sbjct: 245 PDLSKVRSN------CPKRMKRL----MAE-------CLKKKRDERPSFPRILAEIE 284
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 5e-58
Identities = 63/300 (21%), Positives = 120/300 (40%), Gaps = 45/300 (15%)
Query: 215 NLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEI--ISQVHHRHLVSLVG 272
+G+G +G V +G G+ VA+K + + E+ + E E+ + H +++ +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 273 YCTFGS----QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED-- 326
Q L+ + +L +L ++ + ++I L A GLA+LH +
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 327 ---CQPKIIHRDIKSANILLDDSFEAKVADFGLAK---HSLDTDTHVSTRVMGTFGYLAP 380
+P I HRD+KS NIL+ + + +AD GLA S + + +GT Y+AP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 381 E------YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGL 434
E ++ D+++FG++L E+ + D+ PF
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE--------DYKPPFYDVVP 238
Query: 435 ADGNFD----ALVDQKL------EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484
D +F+ + + + +T +A C + R +I + L
Sbjct: 239 NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 5e-57
Identities = 64/348 (18%), Positives = 125/348 (35%), Gaps = 54/348 (15%)
Query: 167 FNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVH 226
+ P + L G+P+ +G+G +G V
Sbjct: 4 YIPPGESLRDLIEQSQSSGSGSGLPL------LVQR---TIAKQIQMVKQIGKGRYGEVW 54
Query: 227 KGVLTNGKVVAIKQLKAGSGQGEREFQAEIEI--ISQVHHRHLVSLVGYCTFGS----QR 280
G G+ VA+K E + E EI + H +++ + G+ Q
Sbjct: 55 MGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110
Query: 281 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED-----CQPKIIHRD 335
L+ ++ N +L +L ++ + +K+A S GL +LH + +P I HRD
Sbjct: 111 YLITDYHENGSLYDYLK---STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRD 167
Query: 336 IKSANILLDDSFEAKVADFGLAK---HSLDTDTHVSTRVMGTFGYLAPE------YASSG 386
+KS NIL+ + +AD GLA + +GT Y+ PE +
Sbjct: 168 LKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHF 227
Query: 387 KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 446
+ +D++SFG++L E+ + ++ P+ +D +++ + +
Sbjct: 228 QSYIMADMYSFGLILWEVARRCVSGGIVE--------EYQLPYHDLVPSDPSYEDMREIV 279
Query: 447 LEE----------YDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484
+ + +M C H+ R ++ + L
Sbjct: 280 CIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 188 bits (478), Expect = 9e-55
Identities = 68/300 (22%), Positives = 124/300 (41%), Gaps = 45/300 (15%)
Query: 215 NLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEI--ISQVHHRHLVSLVG 272
+G+G FG V +G G+ VA+K + + ER + E EI + H +++ +
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIA 103
Query: 273 YCT----FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED-- 326
+Q LV ++ + +L +L+ R + +K+AL +A GLA+LH +
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIV 160
Query: 327 ---CQPKIIHRDIKSANILLDDSFEAKVADFGLAK---HSLDTDTHVSTRVMGTFGYLAP 380
+P I HRD+KS NIL+ + +AD GLA + DT +GT Y+AP
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 381 E------YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGL 434
E + +++D+++ G++ E+ + + P+
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY--------QLPYYDLVP 272
Query: 435 ADGNFDAL----VDQKL------EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484
+D + + + +QKL + MA C + R +I + L
Sbjct: 273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 9e-49
Identities = 66/281 (23%), Positives = 114/281 (40%), Gaps = 45/281 (16%)
Query: 217 LGQGGFGYVHKGVLTNGKV-VAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSLVGYC 274
+G+G FG V G L VA+K + + +F E I+ Q H ++V L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 275 TFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHR 334
T +V E V L + + T +++ +A G+ YL IHR
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARL-RVKTLLQMVGDAAAGMEYLESK---CCIHR 237
Query: 335 DIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGY--LAPEYASSGKLTEKS 392
D+ + N L+ + K++DFG+++ D + ++ + APE + G+ + +S
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEAD-GVYAASGGLRQVPVKWTAPEALNYGRYSSES 296
Query: 393 DVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEE-Y 450
DV+SFG+LL E + G P+ L+ N + +E+
Sbjct: 297 DVWSFGILLWETFSLGASPY--------------------PNLS--NQQTR--EFVEKGG 332
Query: 451 DSAEMTRMAACAAA-------CIRHSARRRPRMSQIVRALE 484
+ C A C + +RP S I + L+
Sbjct: 333 ---RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQ 370
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 1e-44
Identities = 70/287 (24%), Positives = 122/287 (42%), Gaps = 36/287 (12%)
Query: 217 LGQGGFGYVHKGVLT-----NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLV 271
LG+G FG V G+VVA+K+L+ + + R+F+ EIEI+ + H ++V
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 272 GYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQP 329
G C +R L+ E++P +L +L K + ++ ++ +G+ YL
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTK--- 133
Query: 330 KIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF--GYLAPEYASSGK 387
+ IHRD+ + NIL+++ K+ DFGL K + G + APE + K
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK 193
Query: 388 LTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLA--DGNFDALVDQ 445
+ SDV+SFGV+L EL T+ + S A+ G + +
Sbjct: 194 FSVASDVWSFGVVLYELF----------TYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243
Query: 446 KLEE-YDSAEMTRMAACAAA-------CIRHSARRRPRMSQIVRALE 484
L+ + R C C ++ +RP + ++
Sbjct: 244 LLKNNG---RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 287
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-44
Identities = 77/286 (26%), Positives = 123/286 (43%), Gaps = 35/286 (12%)
Query: 217 LGQGGFGYVHKGVLT-----NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLV 271
LG+G FG V G +VA+KQL+ +R+FQ EI+I+ +H +V
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 272 GYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQP 329
G ++ LV E++P+ L L + R ++ + + +G+ YL
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRARLDASRLLLYSSQICKGMEYLGSR--- 146
Query: 330 KIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF--GYLAPEYASSGK 387
+ +HRD+ + NIL++ K+ADFGLAK + R G + APE S
Sbjct: 147 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 206
Query: 388 LTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 446
+ +SDV+SFGV+L EL T + + F + P L++ + +
Sbjct: 207 FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR----------LLEL 256
Query: 447 LEE-YDSAEMTRMAACAAA-------CIRHSARRRPRMSQIVRALE 484
LEE + AC A C S + RP S + L+
Sbjct: 257 LEEGQ---RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLD 299
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 3e-44
Identities = 69/232 (29%), Positives = 101/232 (43%), Gaps = 13/232 (5%)
Query: 181 KPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQ 240
P P P E LK+ LG G FG V VA+K
Sbjct: 167 VPCMSSKPQKPWEKDAWEIPRESLKLE-------KKLGAGQFGEVWMATYNKHTKVAVKT 219
Query: 241 LKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKD 300
+K GS F AE ++ + H LV L T ++ EF+ +L L +
Sbjct: 220 MKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDE 277
Query: 301 RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 360
P + + A G+A++ + IHRD+++ANIL+ S K+ADFGLA+
Sbjct: 278 GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVI 334
Query: 361 LDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 411
D + + APE + G T KSDV+SFG+LL+E++T G P+
Sbjct: 335 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY 386
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 4e-44
Identities = 70/287 (24%), Positives = 123/287 (42%), Gaps = 36/287 (12%)
Query: 217 LGQGGFGYVHKGVLT-----NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLV 271
LG+G FG V G+VVA+K+L+ + + R+F+ EIEI+ + H ++V
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 272 GYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQP 329
G C +R L+ E++P +L +L K + ++ ++ +G+ YL
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTK--- 164
Query: 330 KIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF--GYLAPEYASSGK 387
+ IHRD+ + NIL+++ K+ DFGL K + + G + APE + K
Sbjct: 165 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK 224
Query: 388 LTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLA--DGNFDALVDQ 445
+ SDV+SFGV+L EL T+ + S A+ G + +
Sbjct: 225 FSVASDVWSFGVVLYELF----------TYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274
Query: 446 KLEE-YDSAEMTRMAACAAA-------CIRHSARRRPRMSQIVRALE 484
L+ + R C C ++ +RP + ++
Sbjct: 275 LLKNNG---RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 318
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 9e-44
Identities = 78/314 (24%), Positives = 135/314 (42%), Gaps = 44/314 (14%)
Query: 181 KPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKV-VAIK 239
P P+++ G + +E + + + + LG G +G V++GV + VA+K
Sbjct: 195 YPAPKRNKPTIYGVSPNYDKWE---MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK 251
Query: 240 QLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGK 299
LK + + E EF E ++ ++ H +LV L+G CT ++ EF+ L +L
Sbjct: 252 TLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC 310
Query: 300 DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 359
+R ++ + +A + + YL + IHR++ + N L+ ++ KVADFGL++
Sbjct: 311 NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRL 367
Query: 360 SLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFA 418
+ APE + K + KSDV++FGVLL E+ T G P+
Sbjct: 368 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY------- 420
Query: 419 DDSMVDWAKPFLAQGLADGNFDALVDQKLEE-YDSAEMTRMAACAAA-------CIRHSA 470
G+ V + LE+ Y M R C C + +
Sbjct: 421 -------------PGIDLSQ----VYELLEKDY---RMERPEGCPEKVYELMRACWQWNP 460
Query: 471 RRRPRMSQIVRALE 484
RP ++I +A E
Sbjct: 461 SDRPSFAEIHQAFE 474
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-43
Identities = 64/235 (27%), Positives = 104/235 (44%), Gaps = 20/235 (8%)
Query: 181 KPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQ 240
KP + F + +G+G FG V G G VA+K
Sbjct: 169 KPKVMEGTVAAQ----DEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKC 223
Query: 241 LKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGK 299
+K + + F AE +++Q+ H +LV L+G L +V E++ +L +L +
Sbjct: 224 IKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR 281
Query: 300 DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 359
R V+ +K +L + YL + +HRD+ + N+L+ + AKV+DFGL K
Sbjct: 282 GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKE 338
Query: 360 --SLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 411
S + + APE K + KSDV+SFG+LL E+ + G P+
Sbjct: 339 ASSTQDTGKLPVKWT------APEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 387
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-43
Identities = 59/202 (29%), Positives = 93/202 (46%), Gaps = 18/202 (8%)
Query: 217 LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF 276
LG G FG V G VA+K +K GS E EF E + + ++ H LV G C+
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 277 GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDI 336
+V E++ N L +L + +++ G+A+L + IHRD+
Sbjct: 75 EYPIYIVTEYISNGCLLNYLR-SHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDL 130
Query: 337 KSANILLDDSFEAKVADFGLAKHSLDTDTHVST------RVMGTFGYLAPEYASSGKLTE 390
+ N L+D KV+DFG+ ++ LD S + APE K +
Sbjct: 131 AARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS------APEVFHYFKYSS 184
Query: 391 KSDVFSFGVLLLELIT-GFRPF 411
KSDV++FG+L+ E+ + G P+
Sbjct: 185 KSDVWAFGILMWEVFSLGKMPY 206
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-43
Identities = 69/198 (34%), Positives = 100/198 (50%), Gaps = 6/198 (3%)
Query: 215 NLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYC 274
LGQG FG V G VAIK LK G+ E F E +++ ++ H LV L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 275 TFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHR 334
+ +V E++ +L L G+ + P + +A A G+AY+ +HR
Sbjct: 249 S-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 304
Query: 335 DIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 394
D+++ANIL+ ++ KVADFGLA+ D + + APE A G+ T KSDV
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 395 FSFGVLLLELIT-GFRPF 411
+SFG+LL EL T G P+
Sbjct: 365 WSFGILLTELTTKGRVPY 382
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-43
Identities = 64/202 (31%), Positives = 104/202 (51%), Gaps = 12/202 (5%)
Query: 217 LGQGGFGYVHKGVLTNGKV---VAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSLVG 272
LG G FG V +GV K VAIK LK G+ + + E E +I+ Q+ + ++V L+G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 273 YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKII 332
C +LV E L L GK + ++ + G+ YL E +
Sbjct: 78 VCQ-AEALMLVMEMAGGGPLHKFLVGKREEI-PVSNVAELLHQVSMGMKYLEEK---NFV 132
Query: 333 HRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF--GYLAPEYASSGKLTE 390
HRD+ + N+LL + AK++DFGL+K D++ + R G + + APE + K +
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 192
Query: 391 KSDVFSFGVLLLELIT-GFRPF 411
+SDV+S+GV + E ++ G +P+
Sbjct: 193 RSDVWSYGVTMWEALSYGQKPY 214
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-43
Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 16/217 (7%)
Query: 199 FTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEI 258
F + +G+G FG V G G VA+K +K + + F AE +
Sbjct: 11 FYRSGWALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASV 67
Query: 259 ISQVHHRHLVSLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA 317
++Q+ H +LV L+G L +V E++ +L +L + R V+ +K +L
Sbjct: 68 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 127
Query: 318 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK--HSLDTDTHVSTRVMGTF 375
+ YL + +HRD+ + N+L+ + AKV+DFGL K S + +
Sbjct: 128 EAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT--- 181
Query: 376 GYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 411
APE K + KSDV+SFG+LL E+ + G P+
Sbjct: 182 ---APEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 215
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 4e-43
Identities = 58/201 (28%), Positives = 100/201 (49%), Gaps = 11/201 (5%)
Query: 217 LGQGGFGYVHKGVLTNGKV----VAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSLV 271
LG+G FG V++GV TN K VA+K K + +F +E I+ + H H+V L+
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 272 GYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKI 331
G ++ E P L +L +++ + T + +L + +AYL
Sbjct: 80 GIIE-EEPTWIIMELYPYGELGHYLE-RNKNSLKVLTLVLYSLQICKAMAYLESI---NC 134
Query: 332 IHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEK 391
+HRDI NIL+ K+ DFGL+++ D D + ++ +++PE + + T
Sbjct: 135 VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTA 194
Query: 392 SDVFSFGVLLLELIT-GFRPF 411
SDV+ F V + E+++ G +PF
Sbjct: 195 SDVWMFAVCMWEILSFGKQPF 215
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 5e-43
Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 217 LGQGGFGYVHKGVLT----NGKV-VAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSL 270
LG G FG V+KG+ K+ VAIK+L+ + E E +++ V + H+ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 271 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 330
+G C S L+ + +P L ++ + + + + + A+G+ YL + +
Sbjct: 83 LGICL-TSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLEDR---R 137
Query: 331 IIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT---FGYLAPEYASSGK 387
++HRD+ + N+L+ K+ DFGLAK + G ++A E
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--GGKVPIKWMALESILHRI 195
Query: 388 LTEKSDVFSFGVLLLELIT-GFRPFD 412
T +SDV+S+GV + EL+T G +P+D
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKPYD 221
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 6e-43
Identities = 67/196 (34%), Positives = 99/196 (50%), Gaps = 6/196 (3%)
Query: 217 LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF 276
LG G FG V G VA+K LK GS + F AE ++ Q+ H+ LV L T
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVT- 78
Query: 277 GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDI 336
++ E++ N +L L + + +A A G+A++ E IHRD+
Sbjct: 79 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 135
Query: 337 KSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 396
++ANIL+ D+ K+ADFGLA+ D + + APE + G T KSDV+S
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 397 FGVLLLELIT-GFRPF 411
FG+LL E++T G P+
Sbjct: 196 FGILLTEIVTHGRIPY 211
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 6e-43
Identities = 65/204 (31%), Positives = 103/204 (50%), Gaps = 13/204 (6%)
Query: 217 LGQGGFGYVHKGVLTNGKV-----VAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSL 270
+G G FG V+KG+L VAIK LKAG + +R +F E I+ Q H +++ L
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 271 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 330
G + +++ E++ N L+ L + + + + G A G+ YL
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGMKYLANM---N 167
Query: 331 IIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGY--LAPEYASSGKL 388
+HRD+ + NIL++ + KV+DFGL++ D T G APE S K
Sbjct: 168 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF 227
Query: 389 TEKSDVFSFGVLLLELIT-GFRPF 411
T SDV+SFG+++ E++T G RP+
Sbjct: 228 TSASDVWSFGIVMWEVMTYGERPY 251
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 6e-43
Identities = 67/196 (34%), Positives = 102/196 (52%), Gaps = 6/196 (3%)
Query: 217 LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF 276
+G G FG VH G N VAIK ++ G+ E +F E E++ ++ H LV L G C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 277 GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDI 336
+ LV EF+ + L +L R + T + + L G+AYL E +IHRD+
Sbjct: 75 QAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDL 130
Query: 337 KSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 396
+ N L+ ++ KV+DFG+ + LD ST + +PE S + + KSDV+S
Sbjct: 131 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 190
Query: 397 FGVLLLELIT-GFRPF 411
FGVL+ E+ + G P+
Sbjct: 191 FGVLMWEVFSEGKIPY 206
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-42
Identities = 56/201 (27%), Positives = 100/201 (49%), Gaps = 11/201 (5%)
Query: 217 LGQGGFGYVHKGVLTNGK----VVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSLV 271
+G+G FG VH+G+ + + VAIK K + R +F E + Q H H+V L+
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 272 GYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKI 331
G T + ++ E L L + ++ + + A + LAYL +
Sbjct: 83 GVIT-ENPVWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYLESK---RF 137
Query: 332 IHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEK 391
+HRDI + N+L+ + K+ DFGL+++ D+ + +++ ++APE + + T
Sbjct: 138 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 197
Query: 392 SDVFSFGVLLLELIT-GFRPF 411
SDV+ FGV + E++ G +PF
Sbjct: 198 SDVWMFGVCMWEILMHGVKPF 218
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 1e-42
Identities = 69/287 (24%), Positives = 116/287 (40%), Gaps = 36/287 (12%)
Query: 217 LGQGGFGYVHKGVLT-----NGKVVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSL 270
LG+G FG V G+ VA+K LK SG + + EIEI+ ++H ++V
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 271 VGYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 328
G CT L+ EF+P+ +L+ +L K++ +N ++K A+ +G+ YL
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLP-KNKNKINLKQQLKYAVQICKGMDYLGSR-- 145
Query: 329 PKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF--GYLAPEYASSG 386
+ +HRD+ + N+L++ + K+ DFGL K + + + + APE
Sbjct: 146 -QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS 204
Query: 387 KLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQ 445
K SDV+SFGV L EL+T D + + + +
Sbjct: 205 KFYIASDVWSFGVTLHELLTYC----DSDSSPMALFLKMIGPTHGQMTVTR------LVN 254
Query: 446 KLEE-YDSAEMTRMAACAAA-------CIRHSARRRPRMSQIVRALE 484
L+E + C C R ++ E
Sbjct: 255 TLKEGK---RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFE 298
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-42
Identities = 63/220 (28%), Positives = 100/220 (45%), Gaps = 18/220 (8%)
Query: 199 FTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEI 258
Y +I + + LG G FG V G VAIK +K GS E EF E ++
Sbjct: 14 LGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKV 72
Query: 259 ISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR 318
+ + H LV L G CT ++ E++ N L +L + R +++
Sbjct: 73 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCE 131
Query: 319 GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST------RVM 372
+ YL + +HRD+ + N L++D KV+DFGL+++ LD + S R
Sbjct: 132 AMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS 188
Query: 373 GTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 411
PE K + KSD+++FGVL+ E+ + G P+
Sbjct: 189 ------PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY 222
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-42
Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 14/203 (6%)
Query: 217 LGQGGFGYVHKGVLTNGKV---VAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLV 271
LG G FG V KG KV VA+K LK + E AE ++ Q+ + ++V ++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 272 GYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKI 331
G C +LV E L +L + + +++ + G+ YL E
Sbjct: 85 GICE-AESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEES---NF 138
Query: 332 IHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF--GYLAPEYASSGKLT 389
+HRD+ + N+LL AK++DFGL+K + + + G + + APE + K +
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 198
Query: 390 EKSDVFSFGVLLLELIT-GFRPF 411
KSDV+SFGVL+ E + G +P+
Sbjct: 199 SKSDVWSFGVLMWEAFSYGQKPY 221
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-42
Identities = 68/239 (28%), Positives = 107/239 (44%), Gaps = 19/239 (7%)
Query: 181 KPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGK----VV 236
P + P V F + I ++G G FG V G L V
Sbjct: 24 DPHTFEDPTQTVHEFAKELDATNISID-------KVVGAGEFGEVCSGRLKLPSKKEISV 76
Query: 237 AIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFH 295
AIK LK G + +R +F E I+ Q H +++ L G T ++V E++ N +L+
Sbjct: 77 AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 296 LHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 355
L K + + G A G+ YL + +HRD+ + NIL++ + KV+DFG
Sbjct: 137 LR-KHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFG 192
Query: 356 LAKHSLDTDTHVSTRVMGTFGYL--APEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 411
L + D T G +PE + K T SDV+S+G++L E+++ G RP+
Sbjct: 193 LGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-42
Identities = 63/204 (30%), Positives = 105/204 (51%), Gaps = 20/204 (9%)
Query: 217 LGQGGFGYVHKGVLTNGKV-VAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCT 275
LG G +G V++GV + VA+K LK + + E EF E ++ ++ H +LV L+G CT
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 276 FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRD 335
++ EF+ L +L +R ++ + +A + + YL + IHRD
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRD 136
Query: 336 IKSANILLDDSFEAKVADFGLAKHSLDTDTHVST-------RVMGTFGYLAPEYASSGKL 388
+ + N L+ ++ KVADFGL++ + DT+ + + APE + K
Sbjct: 137 LAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWT------APESLAYNKF 189
Query: 389 TEKSDVFSFGVLLLELIT-GFRPF 411
+ KSDV++FGVLL E+ T G P+
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSPY 213
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 3e-42
Identities = 77/294 (26%), Positives = 117/294 (39%), Gaps = 61/294 (20%)
Query: 215 NLLGQGGFGYVHKGVLTNGK----VVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVS 269
++G+G FG V+ G L + A+K L + GE +F E I+ H +++S
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 270 LVGYCTFG-SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 328
L+G C L+V ++ + L + + + L A+G+ YL
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAKGMKYLASK-- 147
Query: 329 PKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYL------APEY 382
K +HRD+ + N +LD+ F KVADFGLA+ D + + V G A E
Sbjct: 148 -KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY---SVHNKTGAKLPVKWMALES 203
Query: 383 ASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 441
+ K T KSDV+SFGVLL EL+T G P+ + FD
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMTRGAPPY--------------------PDVN--TFDI 241
Query: 442 LVDQKLEE-YDSAEMTRMAA---CAAA-------CIRHSARRRPRMSQIVRALE 484
L + R+ C C A RP S++V +
Sbjct: 242 T--VYLLQGR------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 287
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 4e-42
Identities = 69/239 (28%), Positives = 110/239 (46%), Gaps = 19/239 (7%)
Query: 181 KPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLT---NGKV-V 236
+P + PG +F + I ++G G G V G L V V
Sbjct: 28 EPHTYEEPGRAGRSFTREIEASRIHIE-------KIIGSGDSGEVCYGRLRVPGQRDVPV 80
Query: 237 AIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFH 295
AIK LKAG + +R +F +E I+ Q H +++ L G T G ++V E++ N +L+
Sbjct: 81 AIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTF 140
Query: 296 LHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 355
L D + + G G+ YL + +HRD+ + N+L+D + KV+DFG
Sbjct: 141 LRTHDGQF-TIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFG 196
Query: 356 LAKHSLDTDTHVSTRVMGTFGYL--APEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 411
L++ D T G APE + + SDV+SFGV++ E++ G RP+
Sbjct: 197 LSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY 255
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 6e-42
Identities = 78/286 (27%), Positives = 118/286 (41%), Gaps = 36/286 (12%)
Query: 217 LGQGGFGYVHKGVLTN-----GKVVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSL 270
LG+G FG V G++VA+K LKA +G R ++ EI+I+ ++H H++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 271 VGYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 328
G C LV E+VP +L +L + + A G+AYLH
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLP-RHSI--GLAQLLLFAQQICEGMAYLHAQ-- 153
Query: 329 PKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF--GYLAPEYASSG 386
IHRD+ + N+LLD+ K+ DFGLAK + + R G + APE
Sbjct: 154 -HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 212
Query: 387 KLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQ 445
K SDV+SFGV L EL+T F + + + + + + +
Sbjct: 213 KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR----------LTE 262
Query: 446 KLEEYDSAEMTRMAACAAA-------CIRHSARRRPRMSQIVRALE 484
LE + R C A C A RP ++ L+
Sbjct: 263 LLER--GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILK 306
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 7e-42
Identities = 70/290 (24%), Positives = 117/290 (40%), Gaps = 53/290 (18%)
Query: 215 NLLGQGGFGYVHKGVLTNGK----VVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVS 269
++G+G FG V+ G + AIK L + + F E ++ ++H ++++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 270 LVGYCTFGS-QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 328
L+G ++ ++ + L + + + L ARG+ YL E
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIR-SPQRNPTVKDLISFGLQVARGMEYLAEQ-- 143
Query: 329 PKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYL-----APEYA 383
K +HRD+ + N +LD+SF KVADFGLA+ LD + + + L A E
Sbjct: 144 -KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQ--HRHARLPVKWTALESL 200
Query: 384 SSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 442
+ + T KSDV+SFGVLL EL+T G P+ + + FD
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLTRGAPPY--------------------RHID--PFDLT 238
Query: 443 VDQKLEE-YDSAEMTRMAACAAA-------CIRHSARRRPRMSQIVRALE 484
L + + + C + C RP +V +E
Sbjct: 239 --HFLAQGR---RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVE 283
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 7e-42
Identities = 72/298 (24%), Positives = 117/298 (39%), Gaps = 19/298 (6%)
Query: 126 GKPHHWQQNVSAPSDYQELPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPR 185
HH S + P P + + S + + S +
Sbjct: 7 MGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHI 66
Query: 186 QSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGK----VVAIKQL 241
+ + + ++ ++G+G FG V+ G L + A+K L
Sbjct: 67 DLSALN-PELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL 125
Query: 242 KAGSGQGER-EFQAEIEIISQVHHRHLVSLVGYCT-FGSQRLLVYEFVPNKTLEFHLHGK 299
+ GE +F E I+ H +++SL+G C L+V ++ + L +
Sbjct: 126 NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-N 184
Query: 300 DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 359
+ + L A+G+ +L K +HRD+ + N +LD+ F KVADFGLA+
Sbjct: 185 ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD 241
Query: 360 SLDTDTHVSTRVMGTFGYL-----APEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 411
D + T L A E + K T KSDV+SFGVLL EL+T G P+
Sbjct: 242 MYDKEFDSVHN--KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 297
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 3e-41
Identities = 69/198 (34%), Positives = 100/198 (50%), Gaps = 6/198 (3%)
Query: 215 NLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYC 274
LGQG FG V G VAIK LK G+ E F E +++ ++ H LV L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 275 TFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHR 334
+ +V E++ +L L G+ + P + +A A G+AY+ +HR
Sbjct: 332 S-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 387
Query: 335 DIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 394
D+++ANIL+ ++ KVADFGLA+ D + + APE A G+ T KSDV
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 447
Query: 395 FSFGVLLLELIT-GFRPF 411
+SFG+LL EL T G P+
Sbjct: 448 WSFGILLTELTTKGRVPY 465
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-41
Identities = 65/267 (24%), Positives = 119/267 (44%), Gaps = 11/267 (4%)
Query: 151 PSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATDN 210
P LP++P A NE S + + + + + + +I +
Sbjct: 332 PQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRER 391
Query: 211 FSEANLLGQGGFGYVHKGVLTNGK----VVAIKQLKAGSGQGER-EFQAEIEIISQVHHR 265
+G+G FG VH+G+ + + VAIK K + R +F E + Q H
Sbjct: 392 IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 451
Query: 266 HLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHE 325
H+V L+G T + ++ E L L + ++ + + A + LAYL
Sbjct: 452 HIVKLIGVIT-ENPVWIIMELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTALAYLES 509
Query: 326 DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS 385
+ +HRDI + N+L+ + K+ DFGL+++ D+ + +++ ++APE +
Sbjct: 510 K---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 566
Query: 386 GKLTEKSDVFSFGVLLLELIT-GFRPF 411
+ T SDV+ FGV + E++ G +PF
Sbjct: 567 RRFTSASDVWMFGVCMWEILMHGVKPF 593
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 4e-41
Identities = 81/337 (24%), Positives = 134/337 (39%), Gaps = 26/337 (7%)
Query: 98 YKRRKRKLAAQNLPLKSIFSNV--------KNDPFAGKPHHWQQNVSAPSDYQELPKPSL 149
Y + K +P + F + S+ S+ P+L
Sbjct: 211 YLISQDKAGKYCIPEGTKFDTLWQLVEYLKLKADGLIYCLKEACPNSSASNASGAAAPTL 270
Query: 150 PPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATD 209
P + ++ + + + PR P EELK
Sbjct: 271 PAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKL 330
Query: 210 NFSEANL------LGQGGFGYVHKGVLTNGKV---VAIKQLKAGSGQGER-EFQAEIEII 259
NL LG G FG V +GV K VAIK LK G+ + + E E +I+
Sbjct: 331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIM 390
Query: 260 SQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARG 319
Q+ + ++V L+G C +LV E L L R + ++ + G
Sbjct: 391 HQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLV-GKREEIPVSNVAELLHQVSMG 448
Query: 320 LAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGY-- 377
+ YL E +HR++ + N+LL + AK++DFGL+K D++ + R G +
Sbjct: 449 MKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 505
Query: 378 LAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDK 413
APE + K + +SDV+S+GV + E ++ G +P+ K
Sbjct: 506 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 542
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 7e-41
Identities = 68/302 (22%), Positives = 120/302 (39%), Gaps = 68/302 (22%)
Query: 217 LGQGGFGYVHKGVLTNGK------VVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSL 270
LG+G FG V N +VA+K LK + ++FQ E E+++ + H H+V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 271 VGYCTFGSQRLLVYEFVPN--------------KTLEFHLHGKDRPVMNWPTRMKIALGS 316
G C G ++V+E++ + L + + + + IA
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 317 ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG 376
A G+ YL +HRD+ + N L+ + K+ DFG+++ TD + +G
Sbjct: 143 ASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY----RVGGHT 195
Query: 377 YL-----APEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFL 430
L PE K T +SDV+SFGV+L E+ T G +P+
Sbjct: 196 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW------------------- 236
Query: 431 AQGLADGNFDALVDQKLEE-YDSAEMTRMAACAAA-------CIRHSARRRPRMSQIVRA 482
L+ N + + + + + + R C C + ++R + +I +
Sbjct: 237 -FQLS--NTEVI--ECITQGR---VLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKI 288
Query: 483 LE 484
L
Sbjct: 289 LH 290
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 7e-41
Identities = 65/205 (31%), Positives = 102/205 (49%), Gaps = 15/205 (7%)
Query: 217 LGQGGFGYVHKGVLT----NGKV-VAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSL 270
LG G FG VHKGV + K+ V IK ++ SG+ + I + H H+V L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 271 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 330
+G C GS LV +++P +L H+ + R + + + A+G+ YL E
Sbjct: 81 LGLCP-GSSLQLVTQYLPLGSLLDHVR-QHRGALGPQLLLNWGVQIAKGMYYLEEH---G 135
Query: 331 IIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF--GYLAPEYASSGKL 388
++HR++ + N+LL + +VADFG+A L D ++A E GK
Sbjct: 136 MVHRNLAARNVLLKSPSQVQVADFGVAD-LLPPDDKQLLYSEAKTPIKWMALESIHFGKY 194
Query: 389 TEKSDVFSFGVLLLELIT-GFRPFD 412
T +SDV+S+GV + EL+T G P+
Sbjct: 195 THQSDVWSYGVTVWELMTFGAEPYA 219
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 9e-41
Identities = 58/206 (28%), Positives = 86/206 (41%), Gaps = 15/206 (7%)
Query: 217 LGQGGFGYVHKGVLTNGKV----VAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVS 269
LG G FG V +G VA+K LK + +F E+ + + HR+L+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 270 LVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQP 329
L G +V E P +L L K + T + A+ A G+ YL
Sbjct: 86 LYGVVL-TPPMKMVTELAPLGSLLDRLR-KHQGHFLLGTLSRYAVQVAEGMGYLESK--- 140
Query: 330 KIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGY--LAPEYASSGK 387
+ IHRD+ + N+LL K+ DFGL + D H + + APE +
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 200
Query: 388 LTEKSDVFSFGVLLLELIT-GFRPFD 412
+ SD + FGV L E+ T G P+
Sbjct: 201 FSHASDTWMFGVTLWEMFTYGQEPWI 226
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 1e-40
Identities = 60/254 (23%), Positives = 92/254 (36%), Gaps = 21/254 (8%)
Query: 184 PRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLK 242
G F + I ++ LG+GGF YV L +G A+K++
Sbjct: 4 SHHHHHHSSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRIL 63
Query: 243 AGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR----LLVYEFVPNKTLEFHLHG 298
Q E Q E ++ +H +++ LV YC L+ F TL +
Sbjct: 64 CHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIER 123
Query: 299 KDRPVMNWPTR--MKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGL 356
+ + LG RGL +H HRD+K NILL D + + D G
Sbjct: 124 LKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGS 180
Query: 357 AKHSLDTDTHVSTRVM--------GTFGYLAPE---YASSGKLTEKSDVFSFGVLLLELI 405
+ + T Y APE S + E++DV+S G +L ++
Sbjct: 181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMM 240
Query: 406 TGFRPFDKADTFAD 419
G P+D D
Sbjct: 241 FGEGPYDMVFQKGD 254
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 3e-40
Identities = 58/205 (28%), Positives = 101/205 (49%), Gaps = 15/205 (7%)
Query: 217 LGQGGFGYVHKGVLT----NGKV-VAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSL 270
LG G FG V+KG+ K+ VAIK+L+ + E E +++ V + H+ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 271 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 330
+G C S L+ + +P L ++ + + + + + A+G+ YL + +
Sbjct: 83 LGICL-TSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLEDR---R 137
Query: 331 IIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF--GYLAPEYASSGKL 388
++HRD+ + N+L+ K+ DFGLAK L + G ++A E
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAK-LLGAEEKEYHAEGGKVPIKWMALESILHRIY 196
Query: 389 TEKSDVFSFGVLLLELIT-GFRPFD 412
T +SDV+S+GV + EL+T G +P+D
Sbjct: 197 THQSDVWSYGVTVWELMTFGSKPYD 221
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 5e-40
Identities = 66/216 (30%), Positives = 108/216 (50%), Gaps = 28/216 (12%)
Query: 217 LGQGGFGYVHKGVLTNGK------VVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVS 269
LGQG FG V++GV VAIK + + ER EF E ++ + + H+V
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 270 LVGYCTFGSQRLLVYEFVPNKTLEFHL-----HGKDRPVMNWPTR---MKIALGSARGLA 321
L+G + G L++ E + L+ +L + PV+ P+ +++A A G+A
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 322 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYL--- 378
YL+ + K +HRD+ + N ++ + F K+ DFG+ + +TD + G G L
Sbjct: 153 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----RKGGKGLLPVR 205
Query: 379 --APEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 411
+PE G T SDV+SFGV+L E+ T +P+
Sbjct: 206 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY 241
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 8e-40
Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 29/214 (13%)
Query: 217 LGQGGFGYVHKGVLTNGKV--------VAIKQLKAGSGQGEREFQAEIEIISQVHHRHLV 268
LGQG F + KGV V +K L F ++S++ H+HLV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 269 SLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 328
G C G + +LV EFV +L+ +L K++ +N ++++A A + +L E+
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAAAMHFLEEN-- 132
Query: 329 PKIIHRDIKSANILLDDSFE--------AKVADFGLAKHSLDTD-THVSTRVMGTFGYLA 379
+IH ++ + NILL + K++D G++ L D +
Sbjct: 133 -TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWV------P 185
Query: 380 PEYASSGKL-TEKSDVFSFGVLLLELIT-GFRPF 411
PE + K +D +SFG L E+ + G +P
Sbjct: 186 PECIENPKNLNLATDKWSFGTTLWEICSGGDKPL 219
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-39
Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 19/206 (9%)
Query: 216 LLGQGGFGYVHKGV-LTNGKVVAIKQ--LKAGSGQGEREFQAEIEIISQVHHRHLVSLVG 272
+G+G F V+KG+ VA + + + + F+ E E++ + H ++V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 273 YCTFGSQ---RLLVY-EFVPNKTLEFHL--HGKDRPVMNWPTRMKIALGSARGLAYLHED 326
+ +++ E + + TL+ +L M +GL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHT- 147
Query: 327 CQPKIIHRDIKSANILLDDSF-EAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS 385
P IIHRD+K NI + K+ D GLA + V+GT ++APE
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK--RASFAKA-VIGTPEFMAPEMYEE 204
Query: 386 GKLTEKSDVFSFGVLLLELITGFRPF 411
E DV++FG+ +LE+ T P+
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSEYPY 229
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-39
Identities = 65/220 (29%), Positives = 98/220 (44%), Gaps = 32/220 (14%)
Query: 217 LGQGGFGYVHKGVLTNGK------VVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSL 270
LG+G FG V N +VA+K LK S ++FQ E E+++ + H+H+V
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 271 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR-------------MKIALGSA 317
G CT G L+V+E++ + L L + +A A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 318 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGY 377
G+ YL +HRD+ + N L+ K+ DFG+++ TD RV G
Sbjct: 169 AGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY---YRVGGR-TM 221
Query: 378 L-----APEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 411
L PE K T +SDV+SFGV+L E+ T G +P+
Sbjct: 222 LPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW 261
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 6e-39
Identities = 67/303 (22%), Positives = 113/303 (37%), Gaps = 69/303 (22%)
Query: 217 LGQGGFGYVHKGVLTNGK------VVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVS 269
LG+ FG V+KG L VAIK LK + R EF+ E + +++ H ++V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 270 LVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR--------------MKIALG 315
L+G T +++ + + L L + T + +
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 316 SARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF 375
A G+ YL ++H+D+ + N+L+ D K++D GL + D + +
Sbjct: 137 IAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYY----KLLGN 189
Query: 376 GYL-----APEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPF 429
L APE GK + SD++S+GV+L E+ + G +P+
Sbjct: 190 SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY------------------ 231
Query: 430 LAQGLADGNFDALVDQKLEE-YDSAEMTRMAACAAA-------CIRHSARRRPRMSQIVR 481
G + N D + + + + C A C RRPR I
Sbjct: 232 --CGYS--NQDVV--EMIRNRQ---VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHS 282
Query: 482 ALE 484
L
Sbjct: 283 RLR 285
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 6e-39
Identities = 60/229 (26%), Positives = 109/229 (47%), Gaps = 27/229 (11%)
Query: 209 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL 267
+F E L+G GGFG V K +GK IK++K + + E++ ++++ H ++
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK----YNNEKAEREVKALAKLDHVNI 66
Query: 268 VSLVGY-------------CTFGSQRLLVY---EFVPNKTLEFHLHGKDRPVMNWPTRMK 311
V G + S+ ++ EF TLE + + ++ ++
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 312 IALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRV 371
+ +G+ Y+H K+I+RD+K +NI L D+ + K+ DFGL SL D +
Sbjct: 127 LFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVT-SLKNDGKRTRSK 182
Query: 372 MGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFAD 419
GT Y++PE SS ++ D+++ G++L EL+ F+ + F D
Sbjct: 183 -GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTD 230
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-38
Identities = 60/221 (27%), Positives = 108/221 (48%), Gaps = 35/221 (15%)
Query: 215 NLLGQGGFGYVHKGVLTNGKV---VAIKQLKAGSGQGER-EFQAEIEIISQV-HHRHLVS 269
+++G+G FG V K + + AIK++K + + + +F E+E++ ++ HH ++++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 270 LVGYCTFGSQRLLVYEFVPN--------------KTLEFHLHGKDRPVMNWPTRMKIALG 315
L+G C L E+ P+ F + ++ + A
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 316 SARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF 375
ARG+ YL + + IHRD+ + NIL+ +++ AK+ADFGL++ + +V T
Sbjct: 151 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK----TM 200
Query: 376 GYL-----APEYASSGKLTEKSDVFSFGVLLLELIT-GFRP 410
G L A E + T SDV+S+GVLL E+++ G P
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-38
Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 10/205 (4%)
Query: 216 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGE---REFQAEIEIISQVHHRHLVSLV 271
LG GG V+ VAIK + + E + F+ E+ SQ+ H+++VS++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 272 GYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKI 331
LV E++ TL ++ ++ T + G+ + H+ +I
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIE--SHGPLSVDTAINFTNQILDGIKHAHDM---RI 132
Query: 332 IHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEK 391
+HRDIK NIL+D + K+ DFG+AK +T + V+GT Y +PE A E
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDEC 192
Query: 392 SDVFSFGVLLLELITGFRPFDKADT 416
+D++S G++L E++ G PF+ +T
Sbjct: 193 TDIYSIGIVLYEMLVGEPPFN-GET 216
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-38
Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 28/216 (12%)
Query: 217 LGQGGFGYVHKGVLTNGK------VVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVS 269
LG G FG V++G ++ VA+K L + + +F E IIS+ +H+++V
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 270 LVGYCTFGSQRLLVYEFVPNKTLEFHL-----HGKDRPVMNWPTRMKIALGSARGLAYLH 324
+G R ++ E + L+ L + + +A A G YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 325 EDCQPKIIHRDIKSANILLDDSFE---AKVADFGLAKHSLDTDTHVSTRVMGTFGYL--- 378
E+ IHRDI + N LL AK+ DFG+A+ + G L
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY----RKGGCAMLPVK 210
Query: 379 --APEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 411
PE G T K+D +SFGVLL E+ + G+ P+
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 246
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 4e-38
Identities = 64/257 (24%), Positives = 106/257 (41%), Gaps = 29/257 (11%)
Query: 177 LDSDKPFPRQSPGM-PVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGK- 234
+ S S G+ P G+ + E++ I + +LG+G FG V +G L
Sbjct: 1 MGSSHHHHHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDG 60
Query: 235 ---VVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCT-----FGSQRLLVY 284
VA+K +K S + EF +E + H +++ L+G C + +++
Sbjct: 61 TSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVIL 120
Query: 285 EFVPNKTL-EF---HLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSAN 340
F+ L + + T +K + A G+ YL +HRD+ + N
Sbjct: 121 PFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARN 177
Query: 341 ILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYL-----APEYASSGKLTEKSDVF 395
+L D VADFGL+K D + G + A E + T KSDV+
Sbjct: 178 CMLRDDMTVCVADFGLSKKIYSGDYYRQ----GRIAKMPVKWIAIESLADRVYTSKSDVW 233
Query: 396 SFGVLLLELIT-GFRPF 411
+FGV + E+ T G P+
Sbjct: 234 AFGVTMWEIATRGMTPY 250
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 9e-38
Identities = 58/217 (26%), Positives = 91/217 (41%), Gaps = 29/217 (13%)
Query: 217 LGQGGFGYVHKGVLTNGK----VVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSL 270
LG+G FG V + L VA+K LKA + EF E + + H H+ L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 271 VGYCT------FGSQRLLVYEFVPNKTL-EF---HLHGKDRPVMNWPTRMKIALGSARGL 320
VG +++ F+ + L F G++ + T ++ + A G+
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 321 AYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYL-- 378
YL IHRD+ + N +L + VADFGL++ D + G L
Sbjct: 151 EYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQ----GCASKLPV 203
Query: 379 ---APEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 411
A E + T SDV++FGV + E++T G P+
Sbjct: 204 KWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY 240
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-37
Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 32/217 (14%)
Query: 215 NLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSGQGER-EFQAEIEIISQV-HHRH 266
LG G FG V + VA+K LK+ + E+ +E++I+S + H +
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 267 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR------------MKIAL 314
+V+L+G CT G L++ E+ L L K R + P + +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 315 GSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 374
A+G+A+L IHRD+ + N+LL + AK+ DFGLA+ ++ ++
Sbjct: 172 QVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK----G 224
Query: 375 FGYL-----APEYASSGKLTEKSDVFSFGVLLLELIT 406
L APE T +SDV+S+G+LL E+ +
Sbjct: 225 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 7e-37
Identities = 55/240 (22%), Positives = 98/240 (40%), Gaps = 14/240 (5%)
Query: 178 DSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVV 236
P P + Y L NF +G+G F V++ L +G V
Sbjct: 5 SQGMQGPPVPQFQPQKALRPDMGYNTL----ANFRIEKKIGRGQFSEVYRAACLLDGVPV 60
Query: 237 AIKQLKAGSGQGEREFQA---EIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLE 293
A+K+++ + EI+++ Q++H +++ ++ +V E L
Sbjct: 61 ALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLS 120
Query: 294 FHL--HGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKV 351
+ K + ++ T K + L ++H +++HRDIK AN+ + + K+
Sbjct: 121 RMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKL 177
Query: 352 ADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPF 411
D GL + T + V GT Y++PE KSD++S G LL E+ PF
Sbjct: 178 GDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 236
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 8e-37
Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 9/201 (4%)
Query: 216 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYC 274
+LG+G +G V+ G L+N +AIK++ + + EI + + H+++V +G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 275 TFGSQRLLVYEFVPNKTLEFHLHGKDRPV-MNWPTRMKIALGSARGLAYLHEDCQPKIIH 333
+ + E VP +L L K P+ N T GL YLH++ +I+H
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145
Query: 334 RDIKSANILLD-DSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPE--YASSGKLTE 390
RDIK N+L++ S K++DFG +K + T GT Y+APE +
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGYGK 204
Query: 391 KSDVFSFGVLLLELITGFRPF 411
+D++S G ++E+ TG PF
Sbjct: 205 AADIWSLGCTIIEMATGKPPF 225
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 8e-37
Identities = 58/240 (24%), Positives = 104/240 (43%), Gaps = 51/240 (21%)
Query: 208 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH 266
+F E +LGQG FG V K + + AIK+++ + +E+ +++ ++H++
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 267 LVSLVGYCTFGSQRL---------------LVYEFVPNKTLEFHLHGKDRP-----VMNW 306
+V Y + +R + E+ N TL +H ++
Sbjct: 64 VVRY--YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 307 PTRMK-IALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK------- 358
+ I L+Y+H IIHRD+K NI +D+S K+ DFGLAK
Sbjct: 122 ---FRQILEA----LSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLD 171
Query: 359 -------HSLDTDTHVSTRVMGTFGYLAPE-YASSGKLTEKSDVFSFGVLLLELITGFRP 410
+ + ++++ + GT Y+A E +G EK D++S G++ E+I F
Sbjct: 172 ILKLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFST 230
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 9e-37
Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 28/216 (12%)
Query: 217 LGQGGFGYVHKGVLTNGK------VVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVS 269
LG G FG V++G ++ VA+K L + + +F E IIS+ +H+++V
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 270 LVGYCTFGSQRLLVYEFVPNKTLEFHL-----HGKDRPVMNWPTRMKIALGSARGLAYLH 324
+G R ++ E + L+ L + + +A A G YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 325 EDCQPKIIHRDIKSANILLDDSFE---AKVADFGLAKHSLDTDTHVSTRVMGTFGYL--- 378
E+ IHRDI + N LL AK+ DFG+A+ + G L
Sbjct: 199 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY----RKGGCAMLPVK 251
Query: 379 --APEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 411
PE G T K+D +SFGVLL E+ + G+ P+
Sbjct: 252 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 287
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 9e-37
Identities = 61/224 (27%), Positives = 100/224 (44%), Gaps = 41/224 (18%)
Query: 217 LGQGGFGYVHKGVLTNGK------VVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVS 269
LG+G FG V K + K VA+K LK + E + +E ++ QV+H H++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 270 LVGYCTFGSQRLLVYEFVPN----------------------KTLEFHLHGKDRPVMNWP 307
L G C+ LL+ E+ L D +
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 308 TRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 367
+ A ++G+ YL E K++HRD+ + NIL+ + + K++DFGL++ + D++V
Sbjct: 151 DLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 368 STRVMGTFGYL-----APEYASSGKLTEKSDVFSFGVLLLELIT 406
+ G + A E T +SDV+SFGVLL E++T
Sbjct: 208 K----RSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 1e-36
Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 18/215 (8%)
Query: 205 KIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLK----AGSGQGEREFQAEIEII 259
+ A ++F LG+G FG V+ + ++A+K L +G + + E+EI
Sbjct: 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQ 63
Query: 260 SQVHHRHLVSLVGYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA 317
S + H +++ L Y F L+ E+ P T+ L K T I A
Sbjct: 64 SHLRHPNILRL--YGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFDEQRTATYITE-LA 119
Query: 318 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGY 377
L+Y H ++IHRDIK N+LL + E K+ADFG + H+ + + GT Y
Sbjct: 120 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D-LCGTLDY 173
Query: 378 LAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFD 412
L PE EK D++S GVL E + G PF+
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-36
Identities = 65/282 (23%), Positives = 122/282 (43%), Gaps = 29/282 (10%)
Query: 209 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQL-KAGSGQGEREF-QAEIEIISQVHHR 265
+++ +G G +G K ++GK++ K+L + E++ +E+ ++ ++ H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 266 HLVSLVG-YCTFGSQRL-LVYEFVPNKTLEFHL--HGKDRPVMNWPTRMKIALGSARGLA 321
++V + L +V E+ L + K+R ++ +++ L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 322 YLHE--DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLA 379
H D ++HRD+K AN+ LD K+ DFGLA+ L+ DT + +GT Y++
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR-ILNHDTSFAKTFVGTPYYMS 184
Query: 380 PEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 439
PE + EKSD++S G LL EL PF A + + LA + +G F
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT-AFSQKE----------LAGKIREGKF 233
Query: 440 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481
++ S E+ + + RP + +I+
Sbjct: 234 R-----RIPYRYSDELNEI---ITRMLNLKDYHRPSVEEILE 267
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 60/247 (24%), Positives = 93/247 (37%), Gaps = 22/247 (8%)
Query: 176 SLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGK 234
S + QSPG +S F +F + LG G +G V K +G+
Sbjct: 32 SFRGEASETLQSPGYDPSRPESFFQ--------QSFQRLSRLGHGSYGEVFKVRSKEDGR 83
Query: 235 VVAIKQLKAGSGQGEREFQ---AEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPNK 290
+ A+K+ + +G ++ AE+ +V H V L G L E
Sbjct: 84 LYAVKRSMS-PFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GP 141
Query: 291 TLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAK 350
+L+ H + + LA+LH ++H D+K ANI L K
Sbjct: 142 SLQQHCE-AWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCK 197
Query: 351 VADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRP 410
+ DFGL L T + G Y+APE G +DVFS G+ +LE+
Sbjct: 198 LGDFGLLVE-LGTAGAGEVQE-GDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNMEL 254
Query: 411 FDKADTF 417
+ +
Sbjct: 255 PHGGEGW 261
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 16/211 (7%)
Query: 216 LLGQGGFGYVHKGV-LTNGKVVAIKQLK---AGSGQGEREFQAEIEIISQVHHRHLVSL- 270
+LG GG VH L + + VA+K L+ A F+ E + + ++H +V++
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 271 -VGYCTFGSQRL--LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC 327
G + L +V E+V TL +H M +++ + + L + H++
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNFSHQN- 135
Query: 328 QPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV--STRVMGTFGYLAPEYASS 385
IIHRD+K ANI++ + KV DFG+A+ D+ V + V+GT YL+PE A
Sbjct: 136 --GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 386 GKLTEKSDVFSFGVLLLELITGFRPFDKADT 416
+ +SDV+S G +L E++TG PF D+
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFT-GDS 223
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-36
Identities = 60/244 (24%), Positives = 99/244 (40%), Gaps = 25/244 (10%)
Query: 185 RQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQ--LK 242
S G+ +G F + + + +S +G GG V + + ++ AIK L+
Sbjct: 6 HHSSGVDLGTENLYF--QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLE 63
Query: 243 AGSGQGEREFQAEIEIISQV--HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKD 300
Q ++ EI ++++ H ++ L Y +V E N L L K
Sbjct: 64 EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKK 122
Query: 301 RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH- 359
++ R + +H+ I+H D+K AN L+ D K+ DFG+A
Sbjct: 123 S--IDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQM 176
Query: 360 SLDTDTHVSTRVMGTFGYLAPE-----------YASSGKLTEKSDVFSFGVLLLELITGF 408
DT + V +GT Y+ PE S K++ KSDV+S G +L + G
Sbjct: 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
Query: 409 RPFD 412
PF
Sbjct: 237 TPFQ 240
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 64/311 (20%), Positives = 118/311 (37%), Gaps = 77/311 (24%)
Query: 217 LGQGGFGYVHKGVLTNGK------VVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVS 269
+G+G FG V + +VA+K LK + + +FQ E ++++ + ++V
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 270 LVGYCTFGSQRLLVYEFVPN----------------------KTLEFHLHGKDRPVMNWP 307
L+G C G L++E++ + + P ++
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 308 TRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 367
++ IA A G+AYL E K +HRD+ + N L+ ++ K+ADFGL+++ D +
Sbjct: 175 EQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY- 230
Query: 368 STRVMGTFGYL-----APEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDS 421
+ PE + T +SDV+++GV+L E+ + G +P+
Sbjct: 231 ---KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY---------- 277
Query: 422 MVDWAKPFLAQGLADGN-FDALVDQKLEEYDSAEMTRMAACAAA-------CIRHSARRR 473
G+A + D + + C C R
Sbjct: 278 ----------YGMAHEEVIYYVRDGNI-------LACPENCPLELYNLMRLCWSKLPADR 320
Query: 474 PRMSQIVRALE 484
P I R L+
Sbjct: 321 PSFCSIHRILQ 331
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-36
Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 36/219 (16%)
Query: 217 LGQGGFGYVHKGVLTNGK--------VVAIKQLKAGSGQGER-EFQAEIEIISQV-HHRH 266
LG+G FG V VA+K LK + + + + +E+E++ + H++
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 267 LVSLVGYCTFGSQRLLVYEFVPN--------------KTLEFHLHGKDRPVMNWPTRMKI 312
+++L+G CT ++ E+ + ++ M + +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 313 ALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM 372
ARG+ YL K IHRD+ + N+L+ ++ K+ADFGLA+ + D +
Sbjct: 163 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK---- 215
Query: 373 GTFGYL-----APEYASSGKLTEKSDVFSFGVLLLELIT 406
T G L APE T +SDV+SFGVL+ E+ T
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 5e-36
Identities = 57/219 (26%), Positives = 94/219 (42%), Gaps = 36/219 (16%)
Query: 217 LGQGGFGYVHKGVLTNGK------VVAIKQLKAGSGQGER-EFQAEIEIISQV-HHRHLV 268
LG G FG V + VA+K LK + ER +E++++S + +H ++V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 269 SLVGYCTFGSQRLLVYEFVPN----------------KTLEFHLHGKDRPVMNWPTRMKI 312
+L+G CT G L++ E+ + D ++ +
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 313 ALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM 372
+ A+G+A+L IHRD+ + NILL K+ DFGLA+ + +V
Sbjct: 151 SYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK--- 204
Query: 373 GTFGYL-----APEYASSGKLTEKSDVFSFGVLLLELIT 406
L APE + T +SDV+S+G+ L EL +
Sbjct: 205 -GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 5e-36
Identities = 49/208 (23%), Positives = 85/208 (40%), Gaps = 12/208 (5%)
Query: 216 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGE---REFQAEIEIISQVHHRHLVSLV 271
L+G+GG G V++ ++VA+K + Q E ++ H+V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 272 GYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKI 331
+ Q + + L L + + + P + I L H
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAML--RRQGPLAPPRAVAIVRQIGSALDAAHAA---GA 155
Query: 332 IHRDIKSANILLDDSFEAKVADFGLAKHSLDTD-THVSTRVMGTFGYLAPEYASSGKLTE 390
HRD+K NIL+ A + DFG+A + D T + +GT Y+APE S T
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYMAPERFSESHATY 214
Query: 391 KSDVFSFGVLLLELITGFRPFDKADTFA 418
++D+++ +L E +TG P+ D +
Sbjct: 215 RADIYALTCVLYECLTGSPPYQ-GDQLS 241
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-36
Identities = 63/300 (21%), Positives = 108/300 (36%), Gaps = 52/300 (17%)
Query: 209 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE-FQAEIEIISQVHHRH 266
+F LG+GGFG V + + AIK+++ + + RE E++ ++++ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 267 LVSLVGY---------CTFGSQRLLVY---EFVPNKTL-EFHLHGKDRPVMNWPTRMKIA 313
+V S ++ +Y + + L ++ + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 314 LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS----- 368
L A + +LH ++HRD+K +NI KV DFGL ++D D
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVT-AMDQDEEEQTVLTP 180
Query: 369 -------TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDS 421
T +GT Y++PE + K D+FS G++L EL+ PF
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME----- 232
Query: 422 MVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481
+ + + F L QK M + S RP I+
Sbjct: 233 -----RVRTLTDVRNLKFPPLFTQK-----YPCEYVM---VQDMLSPSPMERPEAINIIE 279
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 7e-36
Identities = 47/208 (22%), Positives = 93/208 (44%), Gaps = 9/208 (4%)
Query: 209 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA---EIEIISQVHH 264
+ + +G+G FG +G+ IK++ S +E + E+ +++ + H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINI-SRMSSKEREESRREVAVLANMKH 82
Query: 265 RHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH 324
++V +V ++ L ++ + + + + L ++H
Sbjct: 83 PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 325 EDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYAS 384
+ KI+HRDIKS NI L ++ DFG+A+ L++ ++ +GT YL+PE
Sbjct: 143 D---RKILHRDIKSQNIFLTKDGTVQLGDFGIAR-VLNSTVELARACIGTPYYLSPEICE 198
Query: 385 SGKLTEKSDVFSFGVLLLELITGFRPFD 412
+ KSD+++ G +L EL T F+
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLKHAFE 226
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 9e-36
Identities = 60/218 (27%), Positives = 95/218 (43%), Gaps = 35/218 (16%)
Query: 217 LGQGGFGYVHKGVLTN------GKVVAIKQLKAGSGQGER-EFQAEIEIISQV-HHRHLV 268
LG+G FG V + + VA+K LK G+ E +E++I+ + HH ++V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 269 SLVGYCT-FGSQRLLVYEFVPNKTL--------------EFHLHGKDRPVMNWPTRMKIA 313
+L+G CT G +++ EF L + + + + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 314 LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMG 373
A+G+ +L K IHRD+ + NILL + K+ DFGLA+ +V
Sbjct: 155 FQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK---- 207
Query: 374 TFGYL-----APEYASSGKLTEKSDVFSFGVLLLELIT 406
L APE T +SDV+SFGVLL E+ +
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 56/224 (25%), Positives = 95/224 (42%), Gaps = 41/224 (18%)
Query: 217 LGQGGFGYVHKGVLTNGK------VVAIKQLKAGSGQGER-EFQAEIEIISQV-HHRHLV 268
LG G FG V VA+K LK + ER +E+++++Q+ H ++V
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 269 SLVGYCTFGSQRLLVYEFVPN------------KTLEFHLHGKDRPVMNWPTR------- 309
+L+G CT L++E+ K E + +++ +
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 310 --MKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 367
+ A A+G+ +L +HRD+ + N+L+ K+ DFGLA+ + +V
Sbjct: 173 DLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229
Query: 368 STRVMGTFGYL-----APEYASSGKLTEKSDVFSFGVLLLELIT 406
L APE G T KSDV+S+G+LL E+ +
Sbjct: 230 VR----GNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 36/219 (16%)
Query: 217 LGQGGFGYVHKGVLTNGK--------VVAIKQLKAGSGQGER-EFQAEIEIISQV-HHRH 266
LG+G FG V VA+K LK + + + + +E+E++ + H++
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 267 LVSLVGYCTFGSQRLLVYEFVPN--------------KTLEFHLHGKDRPVMNWPTRMKI 312
+++L+G CT ++ E+ + ++ M + +
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 313 ALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM 372
ARG+ YL K IHRD+ + N+L+ ++ K+ADFGLA+ + D +
Sbjct: 209 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK---- 261
Query: 373 GTFGYL-----APEYASSGKLTEKSDVFSFGVLLLELIT 406
T G L APE T +SDV+SFGVL+ E+ T
Sbjct: 262 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 61/257 (23%), Positives = 110/257 (42%), Gaps = 25/257 (9%)
Query: 186 QSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAG 244
S G G +S F + +++ +L +GGF +V++ + +G+ A+K+L +
Sbjct: 5 GSLGGASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN 64
Query: 245 SGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQR--------LLVYEFVPNKTLEFH 295
+ R E+ + ++ H ++V + G + LL+ E + +EF
Sbjct: 65 EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFL 124
Query: 296 LHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 355
+ R ++ T +KI + R + ++H +P IIHRD+K N+LL + K+ DFG
Sbjct: 125 KKMESRGPLSCDTVLKIFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFG 183
Query: 356 LA---KHSLDTDTHVSTRVM--------GTFGYLAPE---YASSGKLTEKSDVFSFGVLL 401
A H D R + T Y PE S+ + EK D+++ G +L
Sbjct: 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCIL 243
Query: 402 LELITGFRPFDKADTFA 418
L PF+
Sbjct: 244 YLLCFRQHPFEDGAKLR 260
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-35
Identities = 63/206 (30%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 216 LLGQGGFGYVHKGV-LTNGKVVAIK-----QLKAGSGQGEREFQAEIEIISQVHHRHLVS 269
LLG+G F V++ + G VAIK + +G +R Q E++I Q+ H ++
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYK-AGMVQR-VQNEVKIHCQLKHPSILE 75
Query: 270 LVGYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIA-LGSARGLAYLHED 326
L Y F LV E N + +L + +P R + + G+ YLH
Sbjct: 76 LYNY--FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI--ITGMLYLH-- 129
Query: 327 CQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSG 386
I+HRD+ +N+LL + K+ADFGLA L + GT Y++PE A+
Sbjct: 130 -SHGILHRDLTLSNLLLTRNMNIKIADFGLATQ-LKMPHEKHYTLCGTPNYISPEIATRS 187
Query: 387 KLTEKSDVFSFGVLLLELITGFRPFD 412
+SDV+S G + L+ G PFD
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGRPPFD 213
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-35
Identities = 68/216 (31%), Positives = 95/216 (43%), Gaps = 20/216 (9%)
Query: 205 KIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLK----AGSGQGEREFQAEIEII 259
K D+F LG+G FG V+ N ++A+K L G + + EIEI
Sbjct: 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ-LRREIEIQ 68
Query: 260 SQVHHRHLVSLVGYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIA-LGS 316
S + H +++ + Y F ++ L+ EF P L L K + + L
Sbjct: 69 SHLRHPNILRM--YNYFHDRKRIYLMLEFAPRGELYKELQ-KHGRFDEQRSATFMEELAD 125
Query: 317 ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG 376
A L Y HE K+IHRDIK N+L+ E K+ADFG + H+ GT
Sbjct: 126 A--LHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC---GTLD 177
Query: 377 YLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFD 412
YL PE EK D++ GVL E + G PFD
Sbjct: 178 YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-35
Identities = 63/281 (22%), Positives = 100/281 (35%), Gaps = 37/281 (13%)
Query: 148 SLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIA 207
L P + G+ D DK + + V Y LK
Sbjct: 9 GLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRI----YSILK-- 62
Query: 208 TDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQ--LKAGSGQGEREFQAEIEIISQVHH- 264
+G GG V + + ++ AIK L+ Q ++ EI ++++
Sbjct: 63 --------QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 114
Query: 265 -RHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYL 323
++ L Y +V E N L L K ++ R + +
Sbjct: 115 SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTI 171
Query: 324 HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH-SLDTDTHVSTRVMGTFGYLAPE- 381
H+ I+H D+K AN L+ D K+ DFG+A DT + V +G Y+ PE
Sbjct: 172 HQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEA 227
Query: 382 ----------YASSGKLTEKSDVFSFGVLLLELITGFRPFD 412
S K++ KSDV+S G +L + G PF
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 6e-35
Identities = 58/219 (26%), Positives = 96/219 (43%), Gaps = 36/219 (16%)
Query: 217 LGQGGFGYVHKGVLTNGK--------VVAIKQLKAGSGQGER-EFQAEIEIISQV-HHRH 266
LG+G FG V VA+K LK+ + + + + +E+E++ + H++
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 267 LVSLVGYCTFGSQRLLVYEFVPN--------------KTLEFHLHGKDRPVMNWPTRMKI 312
+++L+G CT ++ E+ ++ ++ +
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 313 ALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM 372
A ARG+ YL K IHRD+ + N+L+ + K+ADFGLA+ D +
Sbjct: 197 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK---- 249
Query: 373 GTFGYL-----APEYASSGKLTEKSDVFSFGVLLLELIT 406
T G L APE T +SDV+SFGVLL E+ T
Sbjct: 250 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 8e-35
Identities = 54/238 (22%), Positives = 93/238 (39%), Gaps = 26/238 (10%)
Query: 205 KIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQL-KAGSGQGEREFQAEIEIISQV 262
+ + +++LGQG V +G G + AIK + E E++ ++
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 263 HHRHLVSLVGYCTF----GSQRLLVYEFVPNKTLEFHLHGKDRPV-MNWPTRMKIALGSA 317
+H+++V L + ++L+ EF P +L L + + +
Sbjct: 65 NHKNIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122
Query: 318 RGLAYLHEDCQPKIIHRDIKSANILL----DDSFEAKVADFGLAKHSLDTDTHVSTRVMG 373
G+ +L E+ I+HR+IK NI+ D K+ DFG A+ L+ D + G
Sbjct: 123 GGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-LEDDEQFVSLY-G 177
Query: 374 TFGYLAPE--------YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMV 423
T YL P+ K D++S GV TG PF + + V
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 57/227 (25%), Positives = 93/227 (40%), Gaps = 23/227 (10%)
Query: 202 EELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQ--LKAGSGQGEREFQAEIEII 259
E + + +S +G GG V + + ++ AIK L+ Q ++ EI +
Sbjct: 2 ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 61
Query: 260 SQV--HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA 317
+++ H ++ L Y +V E N L L K ++ R
Sbjct: 62 NKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKS--IDPWERKSYWKNML 118
Query: 318 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH-SLDTDTHVSTRVMGTFG 376
+ +H+ I+H D+K AN L+ D K+ DFG+A DT + V +GT
Sbjct: 119 EAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVN 174
Query: 377 YLAPE-----------YASSGKLTEKSDVFSFGVLLLELITGFRPFD 412
Y+ PE S K++ KSDV+S G +L + G PF
Sbjct: 175 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 221
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-34
Identities = 63/262 (24%), Positives = 106/262 (40%), Gaps = 22/262 (8%)
Query: 158 PLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLL 217
P P P A ++ G+ + P + + +S Y + L
Sbjct: 2 PAPADPGKAGVPGVAAPGAPAAAPPAKEIPE--VLVDPRSRRRYVRGR----------FL 49
Query: 218 GQGGFGYVHKGV-LTNGKVVAIKQL---KAGSGQGEREFQAEIEIISQVHHRHLVSLVGY 273
G+GGF + +V A K + + EI I + H+H+V G+
Sbjct: 50 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 109
Query: 274 CTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIH 333
+V E ++L LH + + + R G YLH + ++IH
Sbjct: 110 FEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RNRVIH 164
Query: 334 RDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSD 393
RD+K N+ L++ E K+ DFGLA ++ D + GT Y+APE S + + D
Sbjct: 165 RDLKLGNLFLNEDLEVKIGDFGLATK-VEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVD 223
Query: 394 VFSFGVLLLELITGFRPFDKAD 415
V+S G ++ L+ G PF+ +
Sbjct: 224 VWSIGCIMYTLLVGKPPFETSC 245
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 7e-34
Identities = 43/205 (20%), Positives = 80/205 (39%), Gaps = 22/205 (10%)
Query: 216 LLGQGGFGYVHKGV--LTNGKVVAIKQLKAGSGQGERE-FQAEIEIISQVHHRHLVSL-- 270
+ GG G+++ + NG+ V +K L + AE + +++V H +V +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 271 VGYCTFGSQRLLVY---EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC 327
T + Y E+V ++L+ K + + L L+YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEILPALSYLHSI- 201
Query: 328 QPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGK 387
+++ D+K NI+L + + K+ D G + GT G+ APE
Sbjct: 202 --GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY-----LYGTPGFQAPEIVR-TG 252
Query: 388 LTEKSDVFSFGVLLLELITGFRPFD 412
T +D+++ G L L +
Sbjct: 253 PTVATDIYTVGRTLAALTLDLPTRN 277
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 10/205 (4%)
Query: 216 LLGQGGFGYVHKGV-LTNGKVVAIKQL---KAGSGQGEREFQAEIEIISQVHHRHLVSLV 271
LG+GGF + +V A K + + EI I + H+H+V
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 272 GYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKI 331
G+ +V E ++L LH + + + R G YLH + ++
Sbjct: 82 GFFEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RNRV 136
Query: 332 IHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEK 391
IHRD+K N+ L++ E K+ DFGLA ++ D + GT Y+APE S + +
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATK-VEYDGERKKVLCGTPNYIAPEVLSKKGHSFE 195
Query: 392 SDVFSFGVLLLELITGFRPFDKADT 416
DV+S G ++ L+ G PF+ +
Sbjct: 196 VDVWSIGCIMYTLLVGKPPFETSCL 220
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 54/238 (22%), Positives = 93/238 (39%), Gaps = 26/238 (10%)
Query: 205 KIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQL-KAGSGQGEREFQAEIEIISQV 262
+ + +++LGQG V +G G + AIK + E E++ ++
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 263 HHRHLVSLVGYCTF----GSQRLLVYEFVPNKTLEFHLHGKDRPV-MNWPTRMKIALGSA 317
+H+++V L + ++L+ EF P +L L + + +
Sbjct: 65 NHKNIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122
Query: 318 RGLAYLHEDCQPKIIHRDIKSANILL----DDSFEAKVADFGLAKHSLDTDTHVSTRVMG 373
G+ +L E+ I+HR+IK NI+ D K+ DFG A+ L+ D + G
Sbjct: 123 GGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-LEDDEQFVSLY-G 177
Query: 374 TFGYLAPE--------YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMV 423
T YL P+ K D++S GV TG PF + + V
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 8e-33
Identities = 46/224 (20%), Positives = 92/224 (41%), Gaps = 37/224 (16%)
Query: 217 LGQGGFGYVHKGVLTNGKVVAIKQL-----------------KAGSGQGEREFQAEIEII 259
L QG F + + K A+K+ K +F+ E++II
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 260 SQVHHRHLVSLVGYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS- 316
+ + + + ++ + ++YE++ N ++ N+ + I +
Sbjct: 98 TDIKNEYCLTC--EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155
Query: 317 -----ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRV 371
+Y+H + I HRD+K +NIL+D + K++DFG +++ +D S
Sbjct: 156 IIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS--- 210
Query: 372 MGTFGYLAPEYASSGKLT---EKSDVFSFGVLLLELITGFRPFD 412
GT+ ++ PE S + + K D++S G+ L + PF
Sbjct: 211 RGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS 253
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 59/270 (21%), Positives = 101/270 (37%), Gaps = 21/270 (7%)
Query: 148 SLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIA 207
S S+G L ++ S S L P + G+ + YE +
Sbjct: 2 SGSVSSGQAHSLASLA----KTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEY-REE 56
Query: 208 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH 266
+ +G+G FG VH+ G A+K+++ E E+ + +
Sbjct: 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRL-----EVFRVEELVACAGLSSPR 111
Query: 267 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED 326
+V L G G + E + +L + K + + + GL YLH
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYYLGQALEGLEYLHTR 169
Query: 327 CQPKIIHRDIKSANILLD-DSFEAKVADFGLAKHSLDTDTHVSTR----VMGTFGYLAPE 381
+I+H D+K+ N+LL D A + DFG A S + GT ++APE
Sbjct: 170 ---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226
Query: 382 YASSGKLTEKSDVFSFGVLLLELITGFRPF 411
K D++S ++L ++ G P+
Sbjct: 227 VVMGKPCDAKVDIWSSCCMMLHMLNGCHPW 256
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 2e-32
Identities = 71/221 (32%), Positives = 99/221 (44%), Gaps = 17/221 (7%)
Query: 208 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE-FQAEIEIISQVHHR 265
+ LG GGFGYV + + G+ VAIKQ + RE + EI+I+ +++H
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 266 HLVSLV------GYCTFGSQRLLVYEFVPNKTLEFHLHGKDRP-VMNWPTRMKIALGSAR 318
++VS LL E+ L +L+ + + + +
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 319 GLAYLHEDCQPKIIHRDIKSANILLDDSFEA---KVADFGLAKHSLDTDTHVSTRVMGTF 375
L YLHE+ +IIHRD+K NI+L + K+ D G AK LD + V GT
Sbjct: 133 ALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE-LDQGELCTEFV-GTL 187
Query: 376 GYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADT 416
YLAPE K T D +SFG L E ITGFRPF
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ 228
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 5e-32
Identities = 67/222 (30%), Positives = 99/222 (44%), Gaps = 41/222 (18%)
Query: 208 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE-FQAEIEIISQVHHR 265
+ F++ +G+G FG V KG+ KVVAIK + + E E Q EI ++SQ
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 266 HLVSLVG-------------YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKI 312
++ G Y GS + + L+ +I
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLD---------------ETQI 121
Query: 313 AL---GSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 369
A +GL YLH + K IHRDIK+AN+LL + E K+ADFG+A DT +T
Sbjct: 122 ATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT 178
Query: 370 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPF 411
+GT ++APE K+D++S G+ +EL G P
Sbjct: 179 -FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPH 219
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 5e-32
Identities = 47/295 (15%), Positives = 90/295 (30%), Gaps = 32/295 (10%)
Query: 145 PKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGMPV--GNFKSTFTYE 202
P+ S + + P +++ L L P +
Sbjct: 3 PQMSSLGTVDAPNFIVGNP---WDDKL-IFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKT 58
Query: 203 ELKIATDNFSEANLLGQGGFGYVHKGV------LTNGKVVAIKQLKAGSGQGEREFQAEI 256
E ++ + +LLG+G F V++ N + +K K + +
Sbjct: 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLM 118
Query: 257 EIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRP---VMNWPTRMKIA 313
E + + F + +LV E TL ++ VM + A
Sbjct: 119 ERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178
Query: 314 LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA-----------KVADFGLAK--HS 360
+ + +H+ +IIH DIK N +L + F + D G +
Sbjct: 179 MRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235
Query: 361 LDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKAD 415
T + + T G+ E S+ + D F + ++ G K +
Sbjct: 236 FPKGTIFTAKC-ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNE 289
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-31
Identities = 80/301 (26%), Positives = 127/301 (42%), Gaps = 31/301 (10%)
Query: 130 HWQQNVSAPSDYQELPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPG 189
+ + P E+P+ + P F E + S PF
Sbjct: 107 QNFLSHTGPDLIPEVPRQLVTNCTQRLEQGP--CKDLFQELTRLTHEYLSVAPFADYLDS 164
Query: 190 MPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAG- 244
+ F E + + F + +LG+GGFG V + GK+ A K+L+
Sbjct: 165 IYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKR 221
Query: 245 --SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ-RL-LVYEFVPNKTLEFHLHGKD 300
+GE E +I+ +V+ R +VSL + ++ L LV + L+FH++
Sbjct: 222 IKKRKGEAMALNEKQILEKVNSRFVVSL--AYAYETKDALCLVLTLMNGGDLKFHIYHMG 279
Query: 301 RPVMNWPTRMK-----IALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 355
+ R I G L LH + +I++RD+K NILLDD +++D G
Sbjct: 280 QAGFPEA-RAVFYAAEICCG----LEDLHRE---RIVYRDLKPENILLDDHGHIRISDLG 331
Query: 356 LAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKAD 415
LA H + T + RV GT GY+APE + + T D ++ G LL E+I G PF +
Sbjct: 332 LAVHVPEGQT-IKGRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389
Query: 416 T 416
Sbjct: 390 K 390
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-31
Identities = 72/273 (26%), Positives = 109/273 (39%), Gaps = 28/273 (10%)
Query: 162 VPVSAFNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGG 221
F L + PF + F E + D F + +LG+GG
Sbjct: 138 AGDGLFQPLLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGG 197
Query: 222 FGYV----HKGVLTNGKVVAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSLVGYC 274
FG V K GK+ A K+L +G + E +I+++VH R +VSL
Sbjct: 198 FGEVFACQMKA---TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL--AY 252
Query: 275 TFGSQ-RL-LVYEFVPNKTLEFHLHGKDRPVMNWP-TRMK-----IALGSARGLAYLHED 326
F ++ L LV + + +H++ D + R I G L +LH+
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG----LEHLHQR 308
Query: 327 CQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSG 386
II+RD+K N+LLDD +++D GLA T GT G++APE
Sbjct: 309 ---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLLGE 364
Query: 387 KLTEKSDVFSFGVLLLELITGFRPFDKADTFAD 419
+ D F+ GV L E+I PF +
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGPFRARGEKVE 397
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 64/240 (26%), Positives = 110/240 (45%), Gaps = 39/240 (16%)
Query: 202 EELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE-FQAEIEII 259
+ ++ + +G+G +G V+K V +G+++A+K++++ + E++ +++++
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV 74
Query: 260 -SQVHHRHLVSLVG-------------YCTFGSQRLL--VYEFVPNKTLEFHLHGKDRPV 303
++V G + + VY + + E L
Sbjct: 75 MRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEIL------- 127
Query: 304 MNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 363
KI L + + L +L E KIIHRDIK +NILLD S K+ DFG++ L
Sbjct: 128 ------GKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ-L-V 177
Query: 364 DTHVSTRVMGTFGYLAPE----YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFAD 419
D+ TR G Y+APE AS +SDV+S G+ L EL TG P+ K ++ D
Sbjct: 178 DSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD 237
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 57/254 (22%), Positives = 101/254 (39%), Gaps = 25/254 (9%)
Query: 168 NEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATD---NFSEANLLGQGGFGY 224
+ +SG + QS + FK+ + D +G+G G
Sbjct: 3 HHHHHSSGVDLGTENLYFQSGVVTHEQFKAA--LRMVVDQGDPRLLLDSYVKIGEGSTGI 60
Query: 225 VHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 283
V +G+ VA+K + Q E+ I+ H ++V + G + ++
Sbjct: 61 VCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVL 120
Query: 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMK------IALGSARGLAYLHEDCQPKIIHRDIK 337
EF+ G +++ R+ + + LAYLH +IHRDIK
Sbjct: 121 MEFLQG--------GALTDIVS-QVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIK 168
Query: 338 SANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSF 397
S +ILL K++DFG + V GT ++APE S + D++S
Sbjct: 169 SDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLYATEVDIWSL 227
Query: 398 GVLLLELITGFRPF 411
G++++E++ G P+
Sbjct: 228 GIMVIEMVDGEPPY 241
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 5e-31
Identities = 60/268 (22%), Positives = 107/268 (39%), Gaps = 39/268 (14%)
Query: 205 KIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREF-QAEIEIISQV 262
++ D+F + + LG G G V K +G V+A K + R E++++ +
Sbjct: 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 88
Query: 263 HHRHLVSLVG-------------YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR 309
+ ++V G + GS ++ + + E L
Sbjct: 89 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQIL------------- 133
Query: 310 MKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT--DTHV 367
K+++ +GL YL E KI+HRD+K +NIL++ E K+ DFG++ +D+ ++ V
Sbjct: 134 GKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV 191
Query: 368 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAK 427
GT Y++PE + +SD++S G+ L+E+ G P D + M
Sbjct: 192 -----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQV 246
Query: 428 PFLAQGLADGNFDALVDQKLEEYDSAEM 455
A DS
Sbjct: 247 EGDAAETPPRPRTPGRPLNKFGMDSRPP 274
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-31
Identities = 53/237 (22%), Positives = 100/237 (42%), Gaps = 38/237 (16%)
Query: 204 LKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGERE-FQAEIEII-S 260
+++ D+ LG+G +G V K +G+++A+K+++A E++ +++I
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61
Query: 261 QVHHRHLVSLVG-------------YCTFGSQRLLVYEFVPNKTL-EFHLHGKDRPVMNW 306
V V+ G + +T+ E L
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDIL---------- 111
Query: 307 PTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 366
KIA+ + L +LH + +IHRD+K +N+L++ + K+ DFG++ + L D
Sbjct: 112 ---GKIAVSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGY-L-VDDV 164
Query: 367 VSTRVMGTFGYLAPE----YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFAD 419
G Y+APE + + KSD++S G+ ++EL P+D T
Sbjct: 165 AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ 221
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-31
Identities = 46/242 (19%), Positives = 80/242 (33%), Gaps = 46/242 (19%)
Query: 208 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLK-AGSGQGEREFQ-AEIEIISQV-H 263
T F E +G G FG V K V +G + AIK+ K +G + + E+ + +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 264 HRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHL--HGKDRPVMNWPTRMKIALGSARGLA 321
H H+V L+ E+ +L + + + + L RGL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 322 YLHEDCQPKIIHRDIKSANILLD-------------------DSFEAKVADFGLAKHSLD 362
Y+H ++H DIK +NI + + K+ D G
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 363 TDTHVSTRVMGTFGYLAPE-------YASSGKLTEKSDVFSFGVLLLELITGFRPFDKAD 415
G +LA E + K+D+F+ + ++ D
Sbjct: 187 PQVEE-----GDSRFLANEVLQENYTH------LPKADIFALALTVVCAAGAEPLPRNGD 235
Query: 416 TF 417
+
Sbjct: 236 QW 237
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-31
Identities = 52/225 (23%), Positives = 96/225 (42%), Gaps = 43/225 (19%)
Query: 208 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH 266
+ + LG G FG V+K G + A K ++ S + ++ EIEI++ H +
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 267 LVSLVG-------------YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIA 313
+V L+G +C G+ ++ + E I
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIM-LELDRGLTEPQ----------------IQ 120
Query: 314 L---GSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTR 370
+ L +LH +IIHRD+K+ N+L+ + ++ADFG++ +L T +
Sbjct: 121 VVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS- 176
Query: 371 VMGTFGYLAPEYASSGKLTE-----KSDVFSFGVLLLELITGFRP 410
+GT ++APE + + K+D++S G+ L+E+ P
Sbjct: 177 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 52/219 (23%), Positives = 92/219 (42%), Gaps = 36/219 (16%)
Query: 208 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH 266
++ +GQG G V+ + + G+ VAI+Q+ + EI ++ + + +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 267 LVSLVG-------------YCTFGSQRLLVYEFVPNKTL-EFHLHGKDRPVMNWPTRMKI 312
+V+ + Y GS + + V + E + +
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGS----LTDVVTETCMDEGQI-------------AAV 121
Query: 313 ALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM 372
+ L +LH + ++IHRDIKS NILL K+ DFG + ST V
Sbjct: 122 CRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV- 177
Query: 373 GTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPF 411
GT ++APE + K D++S G++ +E+I G P+
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 63/219 (28%), Positives = 95/219 (43%), Gaps = 36/219 (16%)
Query: 208 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH 266
+ F LG+G +G V+K + G++VAIKQ+ +E EI I+ Q H
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85
Query: 267 LVSLVG-------------YCTFGSQRLL-VYEFVPNKTLEFHLHGKDRPVMNWPTRMKI 312
+V G YC GS + + E + I
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGS--VSDIIRLRNKTLTEDEI-------------ATI 130
Query: 313 ALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM 372
+ +GL YLH + IHRDIK+ NILL+ AK+ADFG+A DT +T +
Sbjct: 131 LQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI- 186
Query: 373 GTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPF 411
GT ++APE +D++S G+ +E+ G P+
Sbjct: 187 GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPY 225
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 64/233 (27%), Positives = 103/233 (44%), Gaps = 50/233 (21%)
Query: 208 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHR 265
F L+G G +G V+KG + G++ AIK + +G E E + EI ++ + HHR
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHR 81
Query: 266 HLVSLVG-------------------YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNW 306
++ + G +C GS L+ N E
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW----------- 130
Query: 307 PTRMKIAL---GSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 363
IA RGL++LH+ K+IHRDIK N+LL ++ E K+ DFG++ T
Sbjct: 131 -----IAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 182
Query: 364 DTHVSTRVMGTFGYLAPEYASSGKLTE-----KSDVFSFGVLLLELITGFRPF 411
+T +GT ++APE + + + KSD++S G+ +E+ G P
Sbjct: 183 VGRRNT-FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 7e-30
Identities = 56/224 (25%), Positives = 99/224 (44%), Gaps = 26/224 (11%)
Query: 205 KIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-H 263
+ +F ++LG G G + + + + VA+K++ + E++++ +
Sbjct: 20 IVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLLRESDE 76
Query: 264 HRHLVSLVGYCTFGSQRL--LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLA 321
H +++ +CT ++ + E TL+ ++ KD + + + GLA
Sbjct: 77 HPNVIRY--FCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPI-TLLQQTTSGLA 132
Query: 322 YLHEDCQPKIIHRDIKSANILLDDSFE-----AKVADFGLAKHSLDTDTHVSTR---VMG 373
+LH I+HRD+K NIL+ A ++DFGL K L H +R V G
Sbjct: 133 HLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK-LAVGRHSFSRRSGVPG 188
Query: 374 TFGYLAPEY---ASSGKLTEKSDVFSFGVLLLELIT-GFRPFDK 413
T G++APE T D+FS G + +I+ G PF K
Sbjct: 189 TEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK 232
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 59/225 (26%), Positives = 96/225 (42%), Gaps = 30/225 (13%)
Query: 209 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE-FQAEIEIISQVHHRH 266
D++ ++G G V + VAIK++ Q + EI+ +SQ HH +
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 267 LVSLVG-------------YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIA 313
+VS + GS ++ V + V++ T I
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHK-------SGVLDESTIATIL 127
Query: 314 LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMG 373
GL YLH++ IHRD+K+ NILL + ++ADFG++ +V
Sbjct: 128 REVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRK 184
Query: 374 TF-G---YLAPEYASSGKL-TEKSDVFSFGVLLLELITGFRPFDK 413
TF G ++APE + K+D++SFG+ +EL TG P+ K
Sbjct: 185 TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHK 229
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 65/312 (20%), Positives = 119/312 (38%), Gaps = 39/312 (12%)
Query: 129 HHWQQNVSAPSDYQELPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSP 188
HH + + S + + + + ++ L P +
Sbjct: 4 HHHHHSSGVDL----GTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRT 59
Query: 189 GMPVGNFKST---FTYEELKIATDNFSE------ANLLGQGGFGYVHKGV-LTNGKVVAI 238
+ + F + + + +LG G FG VHK G +A
Sbjct: 60 SALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAA 119
Query: 239 KQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL------ 292
K +K + + E + EI +++Q+ H +L+ L + +LV E+V L
Sbjct: 120 KIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIID 179
Query: 293 -EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA-- 349
++L D + MK G+ ++H+ I+H D+K NIL +
Sbjct: 180 ESYNLTELDTILF-----MKQICE---GIRHMHQM---YILHLDLKPENILCVNRDAKQI 228
Query: 350 KVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFR 409
K+ DFGLA+ + GT +LAPE + ++ +D++S GV+ L++G
Sbjct: 229 KIIDFGLARR-YKPREKLKVNF-GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLS 286
Query: 410 PF---DKADTFA 418
PF + A+T
Sbjct: 287 PFLGDNDAETLN 298
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-29
Identities = 64/290 (22%), Positives = 109/290 (37%), Gaps = 32/290 (11%)
Query: 146 KPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELK 205
KP P + ++ G + K + V + + + ++
Sbjct: 92 KPCEPTAPVLIPGDERKRRRGYDVD--EQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVE 149
Query: 206 IATDNFSE----ANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIIS 260
I D+ + LG G FG VH+ G A K + + + EI+ +S
Sbjct: 150 IKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMS 209
Query: 261 QVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL-------EFHLHGKDRPVMNWPTRMKIA 313
+ H LV+L ++ +++YEF+ L + + M+
Sbjct: 210 VLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY-----MRQV 264
Query: 314 LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA--KVADFGLAKHSLDTDTHVSTRV 371
GL ++HE+ +H D+K NI+ K+ DFGL H LD V
Sbjct: 265 CK---GLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH-LDPKQSVKVTT 317
Query: 372 MGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPF---DKADTFA 418
GT + APE A + +D++S GVL L++G PF + +T
Sbjct: 318 -GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR 366
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 63/263 (23%), Positives = 100/263 (38%), Gaps = 55/263 (20%)
Query: 178 DSDKPFPRQSPGMPVGNFKSTFTYEELKIA------TDNFSEANLLGQGGFGYVHKGV-L 230
+ F MP G + ++ FS+ +G G FG V+ +
Sbjct: 17 TENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDV 76
Query: 231 TNGKVVAIKQLKAGSGQGEREF---QAEIEIISQVHHRHLVSLVG-------------YC 274
N +VVAIK++ Q ++ E+ + ++ H + + G YC
Sbjct: 77 RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC 136
Query: 275 TFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIAL---GSARGLAYLHEDCQPKI 331
+ LL E E IA G+ +GLAYLH +
Sbjct: 137 LGSASDLL--EVHKKPLQEVE----------------IAAVTHGALQGLAYLHSH---NM 175
Query: 332 IHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTE- 390
IHRD+K+ NILL + K+ DFG A ++ +GT ++APE + +
Sbjct: 176 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS-----FVGTPYWMAPEVILAMDEGQY 230
Query: 391 --KSDVFSFGVLLLELITGFRPF 411
K DV+S G+ +EL P
Sbjct: 231 DGKVDVWSLGITCIELAERKPPL 253
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 26/242 (10%), Positives = 47/242 (19%), Gaps = 43/242 (17%)
Query: 216 LLGQGGFGYVHKGV-LTNGKVVAIKQL---KAGSGQGEREFQAEIEIISQVHHRHLVSLV 271
L G V + + A+K S +++
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 272 GYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS--------------- 316
V + D V N+ M A
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 317 ---------------ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 361
R A L ++H N+ + + D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWK-- 243
Query: 362 DTDTHVSTRVMGTFGYLAPEYASSGKL--TEKSDVFSFGVLLLELITGFRPFDKADTFAD 419
Y E+ ++ T + + G+ + + F PF
Sbjct: 244 --VGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK 301
Query: 420 DS 421
S
Sbjct: 302 GS 303
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-29
Identities = 63/265 (23%), Positives = 108/265 (40%), Gaps = 31/265 (11%)
Query: 178 DSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSE----ANLLGQGGFGYVHKGV-LTN 232
D P + + + +++ + + LG G FG VH+ V
Sbjct: 17 KYDGPKINDYDK-FYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKAT 75
Query: 233 GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL 292
G+V K + + + EI I++Q+HH L++L + +L+ EF+ L
Sbjct: 76 GRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL 135
Query: 293 -------EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD 345
++ + + M+ A GL ++HE I+H DIK NI+ +
Sbjct: 136 FDRIAAEDYKMSEAEVINY-----MRQACE---GLKHMHEH---SIVHLDIKPENIMCET 184
Query: 346 SFEA--KVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLE 403
+ K+ DFGLA L+ D V T + APE + +D+++ GVL
Sbjct: 185 KKASSVKIIDFGLATK-LNPDEIVKVTT-ATAEFAAPEIVDREPVGFYTDMWAIGVLGYV 242
Query: 404 LITGFRPF---DKADTFADDSMVDW 425
L++G PF D +T + DW
Sbjct: 243 LLSGLSPFAGEDDLETLQNVKRCDW 267
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 40/233 (17%), Positives = 78/233 (33%), Gaps = 48/233 (20%)
Query: 208 TDNFSEANLLGQG--GFGYVHKGV-LTNGKVVAIKQ--LKAGSGQGEREFQAEIEIISQV 262
+ ++G+G V+ G+ V +++ L+A S + Q E+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 263 HHRHLVSLVG-------------YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR 309
+H ++V + +GS + L+ + E
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA-------------- 129
Query: 310 MKIAL---GSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 366
IA G + L Y+H +HR +K+++IL+ + ++ +
Sbjct: 130 --IAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQR 184
Query: 367 VSTRVM------GTFGYLAPEYASSGKL--TEKSDVFSFGVLLLELITGFRPF 411
+L+PE KSD++S G+ EL G PF
Sbjct: 185 QRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 237
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 53/236 (22%), Positives = 95/236 (40%), Gaps = 40/236 (16%)
Query: 202 EELKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGERE-FQAEIEII 259
+ + ++ +G G G V K G V+A+KQ++ + E + +++++
Sbjct: 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77
Query: 260 -SQVHHRHLVSLVG-------------YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMN 305
++V G + + + + E L
Sbjct: 78 LKSHDCPYIVQCFGTFITNTDVFIAMELMGTCA--EKLKKRMQGPIPERIL--------- 126
Query: 306 WPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365
K+ + + L YL E + +IHRD+K +NILLD+ + K+ DFG++ L D
Sbjct: 127 ----GKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGR-L-VDD 178
Query: 366 HVSTRVMGTFGYLAPE-----YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADT 416
R G Y+APE + ++DV+S G+ L+EL TG P+ T
Sbjct: 179 KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT 234
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-28
Identities = 71/274 (25%), Positives = 109/274 (39%), Gaps = 37/274 (13%)
Query: 162 VPVSAFNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYE-ELKIATDNFSEANLLGQG 220
VP F + F + F E + + ++FS ++G+G
Sbjct: 141 VPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRG 200
Query: 221 GFGYV----HKGVLTNGKVVAIKQLKAG---SGQGEREFQAEIEIISQVH---HRHLVSL 270
GFG V GK+ A+K L QGE E ++S V +V +
Sbjct: 201 GFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCM 257
Query: 271 VGYCTFGSQ-RL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMK-----IALGSARGLAYL 323
F + +L + + + L +HL M+ I LG L ++
Sbjct: 258 --SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA---DMRFYAAEIILG----LEHM 308
Query: 324 HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYA 383
H +++RD+K ANILLD+ +++D GLA H V GT GY+APE
Sbjct: 309 HNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGYMAPEVL 362
Query: 384 SSGKLTEKS-DVFSFGVLLLELITGFRPFDKADT 416
G + S D FS G +L +L+ G PF + T
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-28
Identities = 55/237 (23%), Positives = 97/237 (40%), Gaps = 43/237 (18%)
Query: 209 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHL 267
+ +LG G G V G+ VA+K++ EI+++++ H ++
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNV 71
Query: 268 VSLVGYCTFGSQRL--LVYEFVPNKTL-----EFHLHGKDRPVMNWPTRMKIALGSARGL 320
+ YC+ + R + E N L ++ ++ + + + A G+
Sbjct: 72 IRY--YCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 321 AYLHEDCQPKIIHRDIKSANILLD-------------DSFEAKVADFGLAKHSLDTDTHV 367
A+LH KIIHRD+K NIL+ ++ ++DFGL K LD+
Sbjct: 129 AHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK-LDSGQSS 184
Query: 368 STRVM----GTFGYLAPE-------YASSGKLTEKSDVFSFGVLLLELIT-GFRPFD 412
+ GT G+ APE + +LT D+FS G + +++ G PF
Sbjct: 185 FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 64/252 (25%), Positives = 100/252 (39%), Gaps = 25/252 (9%)
Query: 177 LDSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYV----HKGVLTN 232
+D PR G + K ++F +LG+G F V
Sbjct: 1 MDGTAAEPRPGAGSLQHAQPPP---QPRKKRPEDFKFGKILGEGSFSTVVLARELA---T 54
Query: 233 GKVVAIKQLKAGSGQGEREFQ---AEIEIISQVHHRHLVSLVGYCTFGSQRLL--VYEFV 287
+ AIK L+ E + E +++S++ H V L Y TF L +
Sbjct: 55 SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL--YFTFQDDEKLYFGLSYA 112
Query: 288 PNKTLEFHLHGKDRPVMNWPTRMKIA-LGSARGLAYLHEDCQPKIIHRDIKSANILLDDS 346
N L ++ K TR A + SA L YLH IIHRD+K NILL++
Sbjct: 113 KNGELLKYIR-KIGSFDETCTRFYTAEIVSA--LEYLHGK---GIIHRDLKPENILLNED 166
Query: 347 FEAKVADFGLAKHSLDTDTHVSTRVM-GTFGYLAPEYASSGKLTEKSDVFSFGVLLLELI 405
++ DFG AK GT Y++PE + + SD+++ G ++ +L+
Sbjct: 167 MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 226
Query: 406 TGFRPFDKADTF 417
G PF + +
Sbjct: 227 AGLPPFRAGNEY 238
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-27
Identities = 62/242 (25%), Positives = 104/242 (42%), Gaps = 32/242 (13%)
Query: 188 PGMPVGNFKST---FTYEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQL-- 241
PG + + +T F I +D + +LG+G FG V G+ A+K +
Sbjct: 2 PGSMMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISK 61
Query: 242 -KAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKD 300
+ + E++++ Q+ H +++ L + LV E L F D
Sbjct: 62 RQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL-F-----D 115
Query: 301 RPVMNWP-------TRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL---DDSFEAK 350
+ ++ L G+ Y+H++ KI+HRD+K N+LL +
Sbjct: 116 EIISRKRFSEVDAARIIRQVLS---GITYMHKN---KIVHRDLKPENLLLESKSKDANIR 169
Query: 351 VADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRP 410
+ DFGL+ H + +GT Y+APE G EK DV+S GV+L L++G P
Sbjct: 170 IIDFGLSTHFEASKKM--KDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPP 226
Query: 411 FD 412
F+
Sbjct: 227 FN 228
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 4e-27
Identities = 60/251 (23%), Positives = 95/251 (37%), Gaps = 39/251 (15%)
Query: 181 KPFPRQSPGMPVGNFKST---FTYEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVV 236
+ G+ ++T F + ++ + LG G +G V
Sbjct: 6 HHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVER 65
Query: 237 AIKQL-KAGSGQGERE-FQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEF 294
AIK + K E+ ++ + H +++ L + LV E L F
Sbjct: 66 AIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL-F 124
Query: 295 HLHGKDRPVMNWPTR-----------MKIALGSARGLAYLHEDCQPKIIHRDIKSANILL 343
D + R +K L G+ YLH+ I+HRD+K N+LL
Sbjct: 125 -----DEII----HRMKFNEVDAAVIIKQVLS---GVTYLHKH---NIVHRDLKPENLLL 169
Query: 344 ---DDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVL 400
+ K+ DFGL+ + +GT Y+APE K EK DV+S GV+
Sbjct: 170 ESKEKDALIKIVDFGLSAVFENQKKM--KERLGTAYYIAPE-VLRKKYDEKCDVWSIGVI 226
Query: 401 LLELITGFRPF 411
L L+ G+ PF
Sbjct: 227 LFILLAGYPPF 237
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 49/224 (21%), Positives = 90/224 (40%), Gaps = 27/224 (12%)
Query: 208 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH 266
+ + A LG+G FG VH+ V ++ K K +K G + + EI I++ HR+
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRN 62
Query: 267 LVSLVGYCTFGSQRLLVYEFVPNKTL-------EFHLHGKDRPVMNWPTRMKIALGSARG 319
++ L + ++++EF+ + F L+ ++ +
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSY-----VHQVCE---A 114
Query: 320 LAYLHEDCQPKIIHRDIKSANILLDDSFEA--KVADFGLAKHSLDTDTHVSTRVMGTFGY 377
L +LH I H DI+ NI+ + K+ +FG A+ L + Y
Sbjct: 115 LQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ-LKPGDNFRLLF-TAPEY 169
Query: 378 LAPEYASSGKLTEKSDVFSFGVLLLELITGFRPF---DKADTFA 418
APE ++ +D++S G L+ L++G PF
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIE 213
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-27
Identities = 39/330 (11%), Positives = 84/330 (25%), Gaps = 64/330 (19%)
Query: 129 HHWQQNVSAPSDYQELPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSP 188
HH + + Y + P + P V ++ + SL S + P
Sbjct: 3 HHHHHSSGRENLYFQGPGDVVIEELFNRIPQANVRTTSEYMQSAAD-SLVSTSLWNTGQP 61
Query: 189 GMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQ 247
+S +LGQ + G+ +
Sbjct: 62 F----RVESELGERPR-----TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP 112
Query: 248 GERE----------------------------FQAEIEIISQVHHRHLVSLVGYC--TFG 277
F +++ + ++ + +
Sbjct: 113 PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWV 172
Query: 278 SQRLLVYEFVPNKTLEF----HLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIH 333
R +Y + + F H + R+++ L R LA LH ++H
Sbjct: 173 LSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVH 229
Query: 334 RDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS-------- 385
++ +I+LD + F + G+ PE +
Sbjct: 230 TYLRPVDIVLDQRGGVFLTGFEHLVRD-----GARVVSSVSRGFEPPELEARRATISYHR 284
Query: 386 ---GKLTEKSDVFSFGVLLLELITGFRPFD 412
+T D ++ G+++ + P
Sbjct: 285 DRRTLMTFSFDAWALGLVIYWIWCADLPIT 314
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 61/222 (27%), Positives = 94/222 (42%), Gaps = 33/222 (14%)
Query: 217 LGQGGFGYVHKGV-LTNGKVVAIK-----QLKAGSGQGERE-FQAEIEIISQVHHRHLVS 269
LG G F V K + G A K Q +A RE + E+ I+ QV H ++++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 270 LVGYCTFGSQRLLVYEFVPNKTL------EFHLHGKDRPVMNWPTRMKIALGSARGLAYL 323
L + +L+ E V L + L ++ +K L G+ YL
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-----IKQILD---GVNYL 131
Query: 324 HEDCQPKIIHRDIKSANILL----DDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLA 379
H KI H D+K NI+L K+ DFGLA ++ GT ++A
Sbjct: 132 HTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE-IEDGVEFKNIF-GTPEFVA 186
Query: 380 PEYASSGKLTEKSDVFSFGVLLLELITGFRPF---DKADTFA 418
PE + L ++D++S GV+ L++G PF K +T A
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 228
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 27/243 (11%), Positives = 61/243 (25%), Gaps = 43/243 (17%)
Query: 216 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGE---REFQAEIEIISQ---------- 261
+LGQ + G+ + ++ + E+ +
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 262 ------------VHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHL---------HGKD 300
V ++ ++ F ++ +L H
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 301 RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 360
+ R+++ L R LA LH ++H ++ +I+LD + F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 361 LDTDTHVSTRVMGTFGYLAPE-----YASSGKLTEKSDVFSFGVLLLELITGFRPFDKAD 415
+ R A +T D ++ G+ + + P
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDA 321
Query: 416 TFA 418
Sbjct: 322 ALG 324
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 38/214 (17%)
Query: 216 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYC 274
+LG G F V GK+ A+K +K + + EI ++ ++ H ++V+L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 275 TFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS-------------ARGLA 321
+ LV + V L F DR + G +
Sbjct: 76 ESTTHYYLVMQLVSGGEL-F-----DRIL---------ERGVYTEKDASLVIQQVLSAVK 120
Query: 322 YLHEDCQPKIIHRDIKSANILL---DDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYL 378
YLHE+ I+HRD+K N+L +++ + + DFGL+K + + GT GY+
Sbjct: 121 YLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME---QNGIMSTACGTPGYV 174
Query: 379 APEYASSGKLTEKSDVFSFGVLLLELITGFRPFD 412
APE + ++ D +S GV+ L+ G+ PF
Sbjct: 175 APEVLAQKPYSKAVDCWSIGVITYILLCGYPPFY 208
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 35/179 (19%), Positives = 63/179 (35%), Gaps = 15/179 (8%)
Query: 245 SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL-EFHLHGKDRPV 303
S +I + ++ V + + + + + L ++
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160
Query: 304 MNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK----- 358
+ I + A + +LH ++HRD+K +NI KV DFGL
Sbjct: 161 REHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217
Query: 359 ------HSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPF 411
+ T +GT Y++PE + K D+FS G++L EL+ F
Sbjct: 218 EEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ 276
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 9e-05
Identities = 15/62 (24%), Positives = 32/62 (51%), Gaps = 2/62 (3%)
Query: 209 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE-FQAEIEIISQVHHRH 266
+F +G+GGFG V + + AIK+++ + + RE E++ ++++ H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 267 LV 268
+V
Sbjct: 66 IV 67
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-26
Identities = 59/221 (26%), Positives = 95/221 (42%), Gaps = 36/221 (16%)
Query: 208 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQL-KAGSGQGERE-FQAEIEIISQVHH 264
+ ++ +LG+G FG V K + A+K + KA + + E+E++ ++ H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 265 RHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR-----------MKIA 313
+++ L S +V E L F D + R +K
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGEL-F-----DEII----KRKRFSEHDAARIIKQV 130
Query: 314 LGSARGLAYLHEDCQPKIIHRDIKSANILL---DDSFEAKVADFGLAKHSLDTDTHVSTR 370
G+ Y+H+ I+HRD+K NILL + + K+ DFGL+
Sbjct: 131 FS---GITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKD 182
Query: 371 VMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPF 411
+GT Y+APE G EK DV+S GV+L L++G PF
Sbjct: 183 RIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPF 222
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 60/212 (28%), Positives = 91/212 (42%), Gaps = 31/212 (14%)
Query: 217 LGQGGFGYVHKGV-LTNGKVVAIKQL-KAGSGQGEREFQAEIEIISQVHHRHLVSLVGYC 274
LG G FG VH ++G IK + K S + +AEIE++ + H +++ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 275 TFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR-----------MKIALGSARGLAYL 323
+V E L +R V MK + LAY
Sbjct: 90 EDYHNMYIVMETCEGGEL-L-----ERIVSAQARGKALSEGYVAELMKQMMN---ALAYF 140
Query: 324 HEDCQPKIIHRDIKSANILLDDSFEA---KVADFGLAKHSLDTDTHVSTRVMGTFGYLAP 380
H ++H+D+K NIL D+ K+ DFGLA+ +D H + GT Y+AP
Sbjct: 141 HSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL-FKSDEHSTNAA-GTALYMAP 195
Query: 381 EYASSGKLTEKSDVFSFGVLLLELITGFRPFD 412
E +T K D++S GV++ L+TG PF
Sbjct: 196 EVF-KRDVTFKCDIWSAGVVMYFLLTGCLPFT 226
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 62/233 (26%), Positives = 101/233 (43%), Gaps = 26/233 (11%)
Query: 205 KIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGEREFQ---AEIE 257
+ D+F +G+G FG V K+ A+K + E + E++
Sbjct: 11 DVNFDHFEILRAIGKGSFGKVCIVQKND---TKKMYAMKYMNKQKCVERNEVRNVFKELQ 67
Query: 258 IISQVHHRHLVSLVGYCTF-GSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIA-L 314
I+ + H LV+L + +F + + +V + + L +HL ++ ++ I L
Sbjct: 68 IMQGLEHPFLVNL--WYSFQDEEDMFMVVDLLLGGDLRYHL-QQNVHFKEETVKLFICEL 124
Query: 315 GSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 374
A L YL +IIHRD+K NILLD+ + DF +A + + GT
Sbjct: 125 VMA--LDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGT 177
Query: 375 FGYLAPEYASSGKLTEKS---DVFSFGVLLLELITGFRPFDKADTFADDSMVD 424
Y+APE SS K S D +S GV EL+ G RP+ + + +V
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH 230
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-26
Identities = 61/232 (26%), Positives = 92/232 (39%), Gaps = 47/232 (20%)
Query: 208 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLK-------------AGSGQGEREFQ 253
+++ + LG G +G V AIK +K + E
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 254 AEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR---- 309
EI ++ + H +++ L LV EF L F ++ + R
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL-F-----EQII----NRHKFD 144
Query: 310 -------MKIALGSARGLAYLHEDCQPKIIHRDIKSANILL---DDSFEAKVADFGLAKH 359
MK L G+ YLH+ I+HRDIK NILL + K+ DFGL+
Sbjct: 145 ECDAANIMKQILS---GICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSF 198
Query: 360 SLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPF 411
+ + +GT Y+APE K EK DV+S GV++ L+ G+ PF
Sbjct: 199 F--SKDYKLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPPF 247
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 4e-26
Identities = 69/299 (23%), Positives = 119/299 (39%), Gaps = 37/299 (12%)
Query: 137 APSDYQELPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGMPVGNFK 196
A + + LP + L P + N D+ +G
Sbjct: 22 ARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPED 81
Query: 197 STFTYEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIK-------QLKAGSGQG 248
+ K + +++G+G V + V G A+K +L +
Sbjct: 82 ELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEE 141
Query: 249 ERE-FQAEIEIISQVH-HRHLVSLVGYCTFGSQRLLVYEFVPNKTLEF-------HLHGK 299
RE + E I+ QV H H+++L+ S LV++ + L F L K
Sbjct: 142 VREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL-FDYLTEKVALSEK 200
Query: 300 DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 359
+ + M+ L +++LH + I+HRD+K NILLDD+ + +++DFG + H
Sbjct: 201 ETRSI-----MRSLLE---AVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCH 249
Query: 360 SLDTDTHVSTRVMGTFGYLAPE------YASSGKLTEKSDVFSFGVLLLELITGFRPFD 412
L+ + GT GYLAPE + ++ D+++ GV+L L+ G PF
Sbjct: 250 -LEPGEKLRELC-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFW 306
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 58/240 (24%), Positives = 102/240 (42%), Gaps = 21/240 (8%)
Query: 187 SPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIK-----Q 240
SPG+ G ++ + D + ++G+G F V + + G+ A+K +
Sbjct: 2 SPGISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAK 61
Query: 241 LKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKD 300
+ G + + E I + H H+V L+ + +V+EF+ L F + +
Sbjct: 62 FTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRA 121
Query: 301 RPVMNWPTR-----MKIALGSARGLAYLHEDCQPKIIHRDIKSANILL---DDSFEAKVA 352
+ M+ L L Y H++ IIHRD+K +LL ++S K+
Sbjct: 122 DAGFVYSEAVASHYMRQILE---ALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLG 175
Query: 353 DFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFD 412
FG+A ++ RV GT ++APE + DV+ GV+L L++G PF
Sbjct: 176 GFGVAIQLGESGLVAGGRV-GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY 234
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 56/222 (25%), Positives = 93/222 (41%), Gaps = 33/222 (14%)
Query: 217 LGQGGFGYVHKGV-LTNGKVVAIK-----QLKAGSGQGERE-FQAEIEIISQVHHRHLVS 269
LG G F V K GK A K +L + RE + E+ I+ ++ H ++++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 270 LVGYCTFGSQRLLVYEFVPNKTL------EFHLHGKDRPVMNWPTRMKIALGSARGLAYL 323
L + +L+ E V L + L + +K L G+ YL
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF-----LKQILD---GVHYL 124
Query: 324 HEDCQPKIIHRDIKSANILL----DDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLA 379
H +I H D+K NI+L + K+ DFG+A ++ GT ++A
Sbjct: 125 HSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK-IEAGNEFKNIF-GTPEFVA 179
Query: 380 PEYASSGKLTEKSDVFSFGVLLLELITGFRPF---DKADTFA 418
PE + L ++D++S GV+ L++G PF K +T
Sbjct: 180 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLT 221
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-26
Identities = 60/220 (27%), Positives = 95/220 (43%), Gaps = 33/220 (15%)
Query: 217 LGQGGFGYVHKGV-LTNGKVVAIKQL--KAGSGQGERE------FQAEIEIISQVHHRHL 267
LG G G V K VAI+ + + + RE + EIEI+ +++H +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 268 VSLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR----GLAY 322
+ + F ++ +V E + L F D+ V N + + Y
Sbjct: 203 IKIKN--FFDAEDYYIVLELMEGGEL-F-----DKVVGNKRLKEATCKLYFYQMLLAVQY 254
Query: 323 LHEDCQPKIIHRDIKSANILL---DDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLA 379
LHE+ IIHRD+K N+LL ++ K+ DFG +K L + + T GT YLA
Sbjct: 255 LHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-LGETSLMRTLC-GTPTYLA 309
Query: 380 PE---YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADT 416
PE + D +S GV+L ++G+ PF + T
Sbjct: 310 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 349
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 33/221 (14%)
Query: 217 LGQGGFGYVHKGV-LTNGKVVAIKQL-KAGSGQGERE-FQAEIEIISQV-HHRHLVSLVG 272
LG+G F V + + + G+ A K L K GQ R EI ++ +++L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 273 YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR---------MKIALGSARGLAYL 323
S+ +L+ E+ + F + +K L G+ YL
Sbjct: 97 VYENTSEIILILEYAAGGEI-F-----SLCLPELAEMVSENDVIRLIKQILE---GVYYL 147
Query: 324 HEDCQPKIIHRDIKSANILLDDSFEA---KVADFGLAKHSLDTDTHVSTRVMGTFGYLAP 380
H++ I+H D+K NILL + K+ DFG+++ + + + GT YLAP
Sbjct: 148 HQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK-IGHACELREIM-GTPEYLAP 202
Query: 381 EYASSGKLTEKSDVFSFGVLLLELITGFRPF---DKADTFA 418
E + +T +D+++ G++ L+T PF D +T+
Sbjct: 203 EILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYL 243
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-26
Identities = 54/247 (21%), Positives = 85/247 (34%), Gaps = 54/247 (21%)
Query: 217 LGQGGFGYVHKGV-LTNGKVVAIK-----QLKAGSGQGEREFQAEIEIISQVHHRHLVSL 270
+GQG +G V + + AIK +++ + + + E+ ++ ++HH ++ L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 271 VG-------------YCTFGS--QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALG 315
C G +L V+ + I
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 316 SAR-----------------------GLAYLHEDCQPKIIHRDIKSANILL--DDSFEAK 350
L YLH I HRDIK N L + SFE K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIK 210
Query: 351 VADFGLAKHSLDTDTHVSTRVM---GTFGYLAPE--YASSGKLTEKSDVFSFGVLLLELI 405
+ DFGL+K + + GT ++APE ++ K D +S GVLL L+
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270
Query: 406 TGFRPFD 412
G PF
Sbjct: 271 MGAVPFP 277
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 57/234 (24%), Positives = 104/234 (44%), Gaps = 28/234 (11%)
Query: 202 EELKIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGS--GQGERE-FQA 254
+++++ ++F ++G+G FG V K KV A+K L + E F+
Sbjct: 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFRE 123
Query: 255 EIEIISQVHHRHLVSLVGYCTF-GSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKI 312
E +++ + + +L + F L LV ++ L L + + R +
Sbjct: 124 ERDVLVNGDSKWITTL--HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYL 181
Query: 313 A-LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRV 371
A + A + +H Q +HRDIK NIL+D + ++ADFG ++ T S+
Sbjct: 182 AEMVIA--IDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA 236
Query: 372 MGTFGYLAPE-----YASSGKLTEKSDVFSFGVLLLELITGFRPF---DKADTF 417
+GT Y++PE G+ + D +S GV + E++ G PF +T+
Sbjct: 237 VGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY 290
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 63/242 (26%), Positives = 102/242 (42%), Gaps = 36/242 (14%)
Query: 184 PRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQL- 241
S G F+ TF + ++ +LG+G FG V K + A+K +
Sbjct: 5 HHHSSGRENLYFQGTFA--------ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVIN 56
Query: 242 -KAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEF------ 294
+ + E+E++ ++ H +++ L S +V E L F
Sbjct: 57 KASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL-FDEIIKR 115
Query: 295 -HLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL---DDSFEAK 350
D + +K G+ Y+H+ I+HRD+K NILL + + K
Sbjct: 116 KRFSEHDAARI-----IKQVFS---GITYMHKH---NIVHRDLKPENILLESKEKDCDIK 164
Query: 351 VADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRP 410
+ DFGL+ +T + R+ GT Y+APE G EK DV+S GV+L L++G P
Sbjct: 165 IIDFGLSTC-FQQNTKMKDRI-GTAYYIAPEVL-RGTYDEKCDVWSAGVILYILLSGTPP 221
Query: 411 FD 412
F
Sbjct: 222 FY 223
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 61/222 (27%), Positives = 94/222 (42%), Gaps = 33/222 (14%)
Query: 217 LGQGGFGYVHKGV-LTNGKVVAIK-----QLKAGSGQGERE-FQAEIEIISQVHHRHLVS 269
LG G F V K + G A K Q +A RE + E+ I+ QV H ++++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 270 LVGYCTFGSQRLLVYEFVPNKTL------EFHLHGKDRPVMNWPTRMKIALGSARGLAYL 323
L + +L+ E V L + L ++ +K L G+ YL
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-----IKQILD---GVNYL 131
Query: 324 HEDCQPKIIHRDIKSANILL----DDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLA 379
H KI H D+K NI+L K+ DFGLA ++ GT ++A
Sbjct: 132 HTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE-IEDGVEFKNIF-GTPEFVA 186
Query: 380 PEYASSGKLTEKSDVFSFGVLLLELITGFRPF---DKADTFA 418
PE + L ++D++S GV+ L++G PF K +T A
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 228
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 59/231 (25%), Positives = 96/231 (41%), Gaps = 33/231 (14%)
Query: 208 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIK-----QLKAGSGQGERE-FQAEIEIIS 260
D + LG G F V K + G A K + K+ RE + E+ I+
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 261 QVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL------EFHLHGKDRPVMNWPTRMKIAL 314
++ H ++++L + +L+ E V L + L ++ +K L
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF-----LKQIL 124
Query: 315 GSARGLAYLHEDCQPKIIHRDIKSANILL----DDSFEAKVADFGLAKHSLDTDTHVSTR 370
G+ YLH +I H D+K NI+L K+ DFGLA +D
Sbjct: 125 N---GVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK-IDFGNEFKNI 177
Query: 371 VMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPF---DKADTFA 418
GT ++APE + L ++D++S GV+ L++G PF K +T A
Sbjct: 178 F-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 227
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 6e-25
Identities = 84/356 (23%), Positives = 133/356 (37%), Gaps = 55/356 (15%)
Query: 87 VLAAVGIFLIFYKRRKRKLAAQNLPLKSIFSNV----------KNDPFAGKPHHW----- 131
+L G F+ YK R + + + PL + FS + + F + W
Sbjct: 28 LLKNDGTFI-GYKERPQDVDQREAPLNN-FSVAQCQLMKTERPRPNTFIIRCLQWTTVIE 85
Query: 132 -QQNVSAPSDYQELPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGM 190
+V P + +E ++G P SG+ + + +
Sbjct: 86 RTFHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKH-- 143
Query: 191 PVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSG 246
++ + F LLG+G FG V K G+ A+K LK
Sbjct: 144 --------------RVTMNEFEYLKLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVI 186
Query: 247 QGEREF---QAEIEIISQVHHRHLVSLVGYCTFGSQ-RL-LVYEFVPNKTLEFHLHGKDR 301
+ E E ++ H L +L +F + RL V E+ L FHL ++R
Sbjct: 187 VAKDEVAHTLTENRVLQNSRHPFLTAL--KYSFQTHDRLCFVMEYANGGELFFHLS-RER 243
Query: 302 PVMNWPTRMKIA-LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 360
R A + SA L YLH + +++RD+K N++LD K+ DFGL K
Sbjct: 244 VFSEDRARFYGAEIVSA--LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEG 299
Query: 361 LDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADT 416
+ + T GT YLAPE D + GV++ E++ G PF D
Sbjct: 300 IKDGATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 354
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 57/217 (26%), Positives = 89/217 (41%), Gaps = 34/217 (15%)
Query: 216 LLGQGGFGYVHKGV-LTNGKVVAIKQLK----AGSGQGEREFQAEIEIISQVHHRHLVSL 270
LLG+G +G V + + A+K LK GE + EI+++ ++ H++++ L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 271 --VGYCTFGSQRLLVYEFVPNKTLE-FHLHGKDRPVMNWPTRMKIALGSAR--------G 319
V Y + +V E+ E D R + A G
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEML-----DSVPEK---RFPVC--QAHGYFCQLIDG 121
Query: 320 LAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA--KHSLDTDTHVSTRVMGTFGY 377
L YLH I+H+DIK N+LL K++ G+A H D T G+ +
Sbjct: 122 LEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT-SQGSPAF 177
Query: 378 LAPEYASSGKLTE--KSDVFSFGVLLLELITGFRPFD 412
PE A+ K D++S GV L + TG PF+
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 59/222 (26%), Positives = 95/222 (42%), Gaps = 31/222 (13%)
Query: 208 TDNFSEA----NLLGQGGFGYVHKGV-LTNGKVVAIKQL--KAGSGQGEREFQAEIEIIS 260
+ FS+ LG+G F V + V T G A K + K S + ++ + E I
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 261 QVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEF-------HLHGKDRPVMNWPTRMKIA 313
++ H ++V L S LV++ V L F D ++
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL-FEDIVAREFYSEADASHC-----IQQI 114
Query: 314 LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA---KVADFGLAKHSLDTDTHVSTR 370
L +AY H + I+HR++K N+LL + K+ADFGLA ++
Sbjct: 115 LE---SIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE-VNDSEAWHGF 167
Query: 371 VMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFD 412
GT GYL+PE ++ D+++ GV+L L+ G+ PF
Sbjct: 168 A-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW 208
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 60/237 (25%), Positives = 98/237 (41%), Gaps = 30/237 (12%)
Query: 202 EELKIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGS--GQGERE-FQA 254
+E+++ D+F ++G+G F V K G+V A+K + +GE F+
Sbjct: 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFRE 110
Query: 255 EIEIISQVHHRHLVSLVGYCTFGSQRLL--VYEFVPNKTLEFHLHGKDRPVMNWPTRMKI 312
E +++ R + L + F + L V E+ L L + R +
Sbjct: 111 ERDVLVNGDRRWITQL--HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYL 168
Query: 313 A-LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRV 371
A + A + +H + +HRDIK NILLD ++ADFG T S
Sbjct: 169 AEIVMA--IDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVA 223
Query: 372 MGTFGYLAPE-------YASSGKLTEKSDVFSFGVLLLELITGFRPF---DKADTFA 418
+GT YL+PE +G + D ++ GV E+ G PF A+T+
Sbjct: 224 VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYG 280
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 56/221 (25%), Positives = 85/221 (38%), Gaps = 46/221 (20%)
Query: 217 LGQGGFGYVHKGV-LTNGKVVAIK-----QLKAGSGQGEREFQA---EIEIISQVHHRHL 267
LG G FG+V V K V +K ++ + + EI I+S+V H ++
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 268 VSLVGYCTFGSQRLLVYEFVPNKT-----LEFHLHGK---DRPVMNWPTRMKIALGS--- 316
+ + + N+ +E H G + R+ L S
Sbjct: 92 IKV-------------LDIFENQGFFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIF 136
Query: 317 ---ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMG 373
+ YL IIHRDIK NI++ + F K+ DFG A + L+ T G
Sbjct: 137 RQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY-LERGKLFYTFC-G 191
Query: 374 TFGYLAPEYASSGKLTE--KSDVFSFGVLLLELITGFRPFD 412
T Y APE G + +++S GV L L+ PF
Sbjct: 192 TIEYCAPEVL-MGNPYRGPELEMWSLGVTLYTLVFEENPFC 231
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 70/225 (31%), Positives = 109/225 (48%), Gaps = 26/225 (11%)
Query: 205 KIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGS--GQGEREFQAEIEI 258
K F +LGQG FG V ++ A+K LK + + + E +I
Sbjct: 20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 259 ISQVHHRHLVSLVGYCTFGSQ-RL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMK----- 311
+ +V+H +V L + F ++ +L L+ +F+ L L + VM +K
Sbjct: 80 LVEVNHPFIVKL--HYAFQTEGKLYLILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAE 134
Query: 312 IALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRV 371
+AL L +LH II+RD+K NILLD+ K+ DFGL+K S+D + +
Sbjct: 135 LALA----LDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-F 186
Query: 372 MGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADT 416
GT Y+APE + T+ +D +SFGVL+ E++TG PF D
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR 231
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 61/220 (27%), Positives = 95/220 (43%), Gaps = 33/220 (15%)
Query: 217 LGQGGFGYVHKGV-LTNGKVVAIKQL--KAGSGQGERE------FQAEIEIISQVHHRHL 267
LG G G V K VAIK + + + RE + EIEI+ +++H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 268 VSLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR----GLAY 322
+ + F ++ +V E + L F D+ V N + + Y
Sbjct: 78 IKIKN--FFDAEDYYIVLELMEGGEL-F-----DKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 323 LHEDCQPKIIHRDIKSANILL---DDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLA 379
LHE+ IIHRD+K N+LL ++ K+ DFG +K L + + T GT YLA
Sbjct: 130 LHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-LGETSLMRTLC-GTPTYLA 184
Query: 380 PE---YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADT 416
PE + D +S GV+L ++G+ PF + T
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 53/207 (25%), Positives = 83/207 (40%), Gaps = 26/207 (12%)
Query: 217 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCT 275
+G+G +G V V A K++ + F+ EIEI+ + H +++ L
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 276 FGSQRLLVYEFVPNKTLEF-------HLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 328
+ LV E L F D + MK L +AY H+
Sbjct: 77 DNTDIYLVMELCTGGEL-FERVVHKRVFRESDAARI-----MKDVLS---AVAYCHKL-- 125
Query: 329 PKIIHRDIKSANILL---DDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS 385
+ HRD+K N L K+ DFGLA + T+V GT Y++P+
Sbjct: 126 -NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR-FKPGKMMRTKV-GTPYYVSPQ-VLE 181
Query: 386 GKLTEKSDVFSFGVLLLELITGFRPFD 412
G + D +S GV++ L+ G+ PF
Sbjct: 182 GLYGPECDEWSAGVMMYVLLCGYPPFS 208
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-24
Identities = 59/221 (26%), Positives = 92/221 (41%), Gaps = 40/221 (18%)
Query: 217 LGQGGFGYVHKGV-LTNGKVVAIK--------QLKAGSGQGERE-FQAEIEIISQV-HHR 265
LG+G V + + K A+K A Q RE E++I+ +V H
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 266 HLVSLVGYCTFGSQRLLVYEFVPNKTLEF-------HLHGKD-RPVMNWPTRMKIALGSA 317
+++ L + LV++ + L F L K+ R +M + L
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGEL-FDYLTEKVTLSEKETRKIM------RALLE-- 135
Query: 318 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGY 377
+ LH+ I+HRD+K NILLDD K+ DFG + LD + GT Y
Sbjct: 136 -VICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ-LDPGEKLREVC-GTPSY 189
Query: 378 LAPE------YASSGKLTEKSDVFSFGVLLLELITGFRPFD 412
LAPE + ++ D++S GV++ L+ G PF
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW 230
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 63/248 (25%), Positives = 96/248 (38%), Gaps = 65/248 (26%)
Query: 216 LLGQGGFGYVHKGV-LTNGKVVAIK-----QLKAGSGQGEREFQA--------------- 254
+G+G +G V + A+K +L +G R
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 255 ------EIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV--PNKT-----LEFHLHGKDR 301
EI I+ ++ H ++V L E + PN+ E G
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKL-------------VEVLDDPNEDHLYMVFELVNQG--- 123
Query: 302 PVMNWPTRMKIALGSAR--------GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVAD 353
PVM PT ++ AR G+ YLH KIIHRDIK +N+L+ + K+AD
Sbjct: 124 PVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIAD 180
Query: 354 FGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLT---EKSDVFSFGVLLLELITGFRP 410
FG++ +D +S V GT ++APE S + + DV++ GV L + G P
Sbjct: 181 FGVSNEFKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
Query: 411 FDKADTFA 418
F
Sbjct: 240 FMDERIMC 247
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 67/235 (28%), Positives = 108/235 (45%), Gaps = 20/235 (8%)
Query: 193 GNFKSTFTYEELKIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQL-KAGSGQ 247
G+ +++ KI + F +LG+GG+G V GK+ A+K L KA +
Sbjct: 1 GSSETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR 60
Query: 248 GEREF---QAEIEIISQVHHRHLVSLVGYCTFGSQ-RL-LVYEFVPNKTLEFHLHGKDRP 302
++ +AE I+ +V H +V L F + +L L+ E++ L L ++
Sbjct: 61 NAKDTAHTKAERNILEEVKHPFIVDL--IYAFQTGGKLYLILEYLSGGELFMQLE-REGI 117
Query: 303 VMNWPTRMKIA-LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 361
M +A + A L +LH+ II+RD+K NI+L+ K+ DFGL K S+
Sbjct: 118 FMEDTACFYLAEISMA--LGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172
Query: 362 DTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADT 416
T T GT Y+APE D +S G L+ +++TG PF +
Sbjct: 173 HDGTVTHT-FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR 226
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-23
Identities = 51/213 (23%), Positives = 90/213 (42%), Gaps = 34/213 (15%)
Query: 217 LGQGGFGYVHKGV-LTNGKVVAIKQL--KAGSGQGEREFQAEIEIISQVHHRHLVSLVGY 273
LG+G F V + V + G+ A + K S + ++ + E I + H ++V L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 274 CTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR-----------MKIALGSARGLAY 322
+ L+++ V L F + V R ++ L + +
Sbjct: 79 ISEEGHHYLIFDLVTGGEL-F-----EDIV----AREYYSEADASHCIQQILE---AVLH 125
Query: 323 LHEDCQPKIIHRDIKSANILL---DDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLA 379
H+ ++HR++K N+LL K+ADFGLA ++ + GT GYL+
Sbjct: 126 CHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIE-VEGEQQAWFGFAGTPGYLS 181
Query: 380 PEYASSGKLTEKSDVFSFGVLLLELITGFRPFD 412
PE + D+++ GV+L L+ G+ PF
Sbjct: 182 PEVLRKDPYGKPVDLWACGVILYILLVGYPPFW 214
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 62/226 (27%), Positives = 96/226 (42%), Gaps = 30/226 (13%)
Query: 202 EELKIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLK----AGSGQGEREFQ 253
+L++ +++ ++G+G FG V HK KV A+K L F
Sbjct: 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAF-FW 117
Query: 254 AEIEIISQVHHRHLVSLVGYCTFGSQRLL--VYEFVPNKTLEFHLHGKDRPVMNWPTRMK 311
E +I++ + +V L + F R L V E++P L + + V R
Sbjct: 118 EERDIMAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFY 173
Query: 312 IA-LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTR 370
A + A L +H IHRD+K N+LLD S K+ADFG ++ + V
Sbjct: 174 TAEVVLA--LDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK-MNKEGMVRCD 227
Query: 371 VM-GTFGYLAPE----YASSGKLTEKSDVFSFGVLLLELITGFRPF 411
GT Y++PE G + D +S GV L E++ G PF
Sbjct: 228 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 64/248 (25%), Positives = 101/248 (40%), Gaps = 35/248 (14%)
Query: 182 PFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQ 240
P G S F +DN+ LG+G F V + V T G A K
Sbjct: 2 PHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI 61
Query: 241 L--KAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHG 298
+ K S + ++ + E I ++ H ++V L S LV++ V L F
Sbjct: 62 INTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL-F---- 116
Query: 299 KDRPVMNWPTR-----------MKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF 347
+ V R ++ L +AY H + I+HR++K N+LL
Sbjct: 117 -EDIV----AREFYSEADASHCIQQILE---SIAYCHSN---GIVHRNLKPENLLLASKA 165
Query: 348 EA---KVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLEL 404
+ K+ADFGLA ++ GT GYL+PE ++ D+++ GV+L L
Sbjct: 166 KGAAVKLADFGLAIE-VNDSEAWHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILYIL 223
Query: 405 ITGFRPFD 412
+ G+ PF
Sbjct: 224 LVGYPPFW 231
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 4e-23
Identities = 59/218 (27%), Positives = 93/218 (42%), Gaps = 37/218 (16%)
Query: 216 LLGQGGFGYVHKGV-LTNGKVVAIK-----QLKAGSGQGEREFQAEIEIISQVHHRHLVS 269
LG+G +G V V + VA+K + ++E I I ++H ++V
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVVK 69
Query: 270 LVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR--------GLA 321
G+ G+ + L E+ L F DR + M A+ G+
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGEL-F-----DRIEPD--IGMPEP--DAQRFFHQLMAGVV 119
Query: 322 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD--TDTHVSTRVMGTFGYLA 379
YLH I HRDIK N+LLD+ K++DFGLA + ++ GT Y+A
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVA 175
Query: 380 PEYASSGKL--TEKSDVFSFGVLLLELITGFRPFDKAD 415
PE + E DV+S G++L ++ G P+D+
Sbjct: 176 PELL-KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 7e-23
Identities = 63/279 (22%), Positives = 103/279 (36%), Gaps = 51/279 (18%)
Query: 150 PPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATD 209
S+G + + + +++ + G F E
Sbjct: 6 HHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESE----- 60
Query: 210 NFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLV 268
LG+G V++ K A+K LK ++ + EI ++ ++ H +++
Sbjct: 61 -------LGRGATSIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLSHPNII 111
Query: 269 SLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS------------ 316
L ++ LV E V L F DR V G
Sbjct: 112 KLKEIFETPTEISLVLELVTGGEL-F-----DRIV---------EKGYYSERDAADAVKQ 156
Query: 317 -ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA---KVADFGLAKHSLDTDTHVSTRVM 372
+AYLHE+ I+HRD+K N+L K+ADFGL+K ++ + T
Sbjct: 157 ILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI-VEHQVLMKTVC- 211
Query: 373 GTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPF 411
GT GY APE + D++S G++ L+ GF PF
Sbjct: 212 GTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPF 250
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 64/231 (27%), Positives = 107/231 (46%), Gaps = 27/231 (11%)
Query: 193 GNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKG--VLTNGKVVAIKQL---KAGSGQ 247
GN ++ E+ I N+ +G+G F V +LT G+ VAIK + +
Sbjct: 1 GNSIASCADEQPHI--GNYRLLKTIGKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTS 57
Query: 248 GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL--LVYEFVPNKTLEFHLHGKDRPVMN 305
++ F+ E+ I+ ++H ++V L + +++ L+ E+ + +L R M
Sbjct: 58 LQKLFR-EVRIMKILNHPNIVKL--FEVIETEKTLYLIMEYASGGEVFDYLVAHGR--MK 112
Query: 306 WPTRMKIA--LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 363
+ SA + Y H Q +I+HRD+K+ N+LLD K+ADFG +
Sbjct: 113 EKEARSKFRQIVSA--VQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV- 166
Query: 364 DTHVSTRVMGTFGYLAPEYASSGKLTE--KSDVFSFGVLLLELITGFRPFD 412
+ G Y APE GK + + DV+S GV+L L++G PFD
Sbjct: 167 GGKLDAFC-GAPPYAAPELF-QGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 59/218 (27%), Positives = 93/218 (42%), Gaps = 37/218 (16%)
Query: 216 LLGQGGFGYVHKGV-LTNGKVVAIK-----QLKAGSGQGEREFQAEIEIISQVHHRHLVS 269
LG+G +G V V + VA+K + ++E I I ++H ++V
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVVK 69
Query: 270 LVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR--------GLA 321
G+ G+ + L E+ L F DR + M A+ G+
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGEL-F-----DRIEPD--IGMPEP--DAQRFFHQLMAGVV 119
Query: 322 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD--TDTHVSTRVMGTFGYLA 379
YLH I HRDIK N+LLD+ K++DFGLA + ++ GT Y+A
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVA 175
Query: 380 PEYASSGKL--TEKSDVFSFGVLLLELITGFRPFDKAD 415
PE + E DV+S G++L ++ G P+D+
Sbjct: 176 PELL-KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 4e-22
Identities = 63/226 (27%), Positives = 91/226 (40%), Gaps = 30/226 (13%)
Query: 205 KIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGEREF---QAEIE 257
K+ ++F LLG+G FG V K G+ A+K L+ + E E
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESR 57
Query: 258 IISQVHHRHLVSLVGYCTFGSQ-RL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMK---- 311
++ H L +L F + RL V E+ L FHL + R +
Sbjct: 58 VLQNTRHPFLTAL--KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE---RARFYGA 112
Query: 312 -IALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTR 370
I L YLH +++RDIK N++LD K+ DFGL K + + T
Sbjct: 113 EIVSA----LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT- 164
Query: 371 VMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADT 416
GT YLAPE D + GV++ E++ G PF D
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 99.7 bits (248), Expect = 4e-22
Identities = 69/307 (22%), Positives = 116/307 (37%), Gaps = 40/307 (13%)
Query: 128 PHHWQQNVSAPSDYQELPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQS 187
Q ++ L + N P P + + + + P +
Sbjct: 263 GISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERA-KIGQGTKAPEEK 321
Query: 188 PGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKA 243
+ F + + +K+ +F+ +LG+G FG V KG ++ A+K LK
Sbjct: 322 TANTISKFDNNGNRDRMKL--TDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKK 376
Query: 244 GSGQGEREF---QAEIEIISQV-HHRHLVSLVGYCTFGSQ-RL-LVYEFVPNKTLEFHLH 297
+ + E +++ L L + F + RL V E+V L +H+
Sbjct: 377 DVVIQDDDVECTMVEKRVLALPGKPPFLTQL--HSCFQTMDRLYFVMEYVNGGDLMYHIQ 434
Query: 298 GKDRPVMNWPTRMKIALGSAR--------GLAYLHEDCQPKIIHRDIKSANILLDDSFEA 349
R A GL +L II+RD+K N++LD
Sbjct: 435 QVGR----------FKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHI 481
Query: 350 KVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFR 409
K+ADFG+ K ++ T GT Y+APE + + D ++FGVLL E++ G
Sbjct: 482 KIADFGMCKENIWDGVTTKT-FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 540
Query: 410 PFDKADT 416
PF+ D
Sbjct: 541 PFEGEDE 547
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 6e-22
Identities = 64/229 (27%), Positives = 90/229 (39%), Gaps = 32/229 (13%)
Query: 205 KIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGEREFQ---AEIE 257
D F LG G FG V HK +G A+K L ++ + E
Sbjct: 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 258 IISQVHHRHLVSLVGYCTFGSQRLL--VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIA-L 314
I+ V+ LV L +F L V E+V + HL + R A +
Sbjct: 94 ILQAVNFPFLVKL--EFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQI 150
Query: 315 GSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM-G 373
YLH +I+RD+K N+L+D +V DFG AK T + G
Sbjct: 151 VLT--FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCG 200
Query: 374 TFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSM 422
T LAPE S + D ++ GVL+ E+ G+ PF FAD +
Sbjct: 201 TPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF-----FADQPI 244
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 8e-22
Identities = 61/228 (26%), Positives = 109/228 (47%), Gaps = 33/228 (14%)
Query: 209 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGERE---FQA--EIEIISQVH 263
+ + + +G+G +G V+K + G++VA+K+++ + E E A EI ++ ++H
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDA---EDEGIPSTAIREISLLKELH 77
Query: 264 HRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYL 323
H ++VSL+ LV+EF+ K L+ L + RG+A+
Sbjct: 78 HPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDENKTG-LQDSQIKIYLYQLLRGVAHC 135
Query: 324 HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPE-- 381
H+ +I+HRD+K N+L++ K+ADFGLA+ + V+ T Y AP+
Sbjct: 136 HQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVL 191
Query: 382 -----YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD 424
Y++S D++S G + E+ITG +P F + D
Sbjct: 192 MGSKKYSTS------VDIWSIGCIFAEMITG-KPL-----FPGVTDDD 227
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 9e-22
Identities = 78/297 (26%), Positives = 123/297 (41%), Gaps = 59/297 (19%)
Query: 150 PPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATD 209
P + V + + S D K + + +Y + K+
Sbjct: 5 PRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKV--- 61
Query: 210 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLV 268
+G G FG V++ L +G++VAIK++ Q +R E++I+ ++ H ++V
Sbjct: 62 -------IGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 110
Query: 269 SLVGYCTFGSQRL------LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA----- 317
L + ++ LV ++VP +T+ V +R K L
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVP-ETVY--------RVARHYSRAKQTLPVIYVKLY 161
Query: 318 -----RGLAYLHEDCQPKIIHRDIKSANILLD-DSFEAKVADFGLAKHSLDTDTHVS--- 368
R LAY+H I HRDIK N+LLD D+ K+ DFG AK + + +VS
Sbjct: 162 MYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 218
Query: 369 TRVMGTFGYLAPEY-ASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD 424
+R Y APE + T DV+S G +L EL+ G +P F DS VD
Sbjct: 219 SRY-----YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI-----FPGDSGVD 264
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 65/253 (25%), Positives = 102/253 (40%), Gaps = 58/253 (22%)
Query: 193 GNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREF 252
+ Y K+ +G G FG V + L VAIK++ Q +R
Sbjct: 34 TGEQREIAYTNCKV----------IGNGSFGVVFQAKLVESDEVAIKKVL----QDKRFK 79
Query: 253 QAEIEIISQVHHRHLVSLVGYCTFGSQRL------LVYEFVPNKTLEFHLHGKDRPVMNW 306
E++I+ V H ++V L + + LV E+VP +T+
Sbjct: 80 NRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP-ETV--------YRASRH 130
Query: 307 PTRMKIALGSA----------RGLAYLHEDCQPKIIHRDIKSANILLD-DSFEAKVADFG 355
++K + R LAY+H I HRDIK N+LLD S K+ DFG
Sbjct: 131 YAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFG 187
Query: 356 LAKH--SLDTDTH-VSTRVMGTFGYLAPE-YASSGKLTEKSDVFSFGVLLLELITGFRPF 411
AK + + + + +R Y APE + T D++S G ++ EL+ G +P
Sbjct: 188 SAKILIAGEPNVSYICSRY-----YRAPELIFGATNYTTNIDIWSTGCVMAELMQG-QPL 241
Query: 412 DKADTFADDSMVD 424
F +S +D
Sbjct: 242 -----FPGESGID 249
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 60/279 (21%), Positives = 95/279 (34%), Gaps = 70/279 (25%)
Query: 165 SAFNEPLS--TSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGF 222
S +PL + P + Y LLG+GGF
Sbjct: 1 SMLTKPLQGPPAPPGTPTPPPGGKDREAFEAE------YRLGP----------LLGKGGF 44
Query: 223 GYVHKGV-LTNGKVVAIKQL------KAGSGQGEREFQAEIEIISQVH----HRHLVSLV 271
G V G LT+ VAIK + E+ ++ +V H ++ L
Sbjct: 45 GTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL- 103
Query: 272 GYCTFGSQRLLVYEFVPNKT-----LEFHLHGK---DRPVMNWPTRMKIALGSAR----- 318
++ + LE L + D + +R
Sbjct: 104 ------------LDWFETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGP--SRCFFGQ 147
Query: 319 ---GLAYLHEDCQPKIIHRDIKSANILLD-DSFEAKVADFGLAKHSLDTDTHVSTRVMGT 374
+ + H ++HRDIK NIL+D AK+ DFG +L D + GT
Sbjct: 148 VVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSG--ALLHDEPYTDFD-GT 201
Query: 375 FGYLAPEYASSGKLT-EKSDVFSFGVLLLELITGFRPFD 412
Y PE+ S + + V+S G+LL +++ G PF+
Sbjct: 202 RVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE 240
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 94.1 bits (235), Expect = 1e-21
Identities = 52/229 (22%), Positives = 100/229 (43%), Gaps = 33/229 (14%)
Query: 209 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE---FQA--EIEIISQV 262
+ + +G+G +G V K ++VA+K+++ + E A EI ++ ++
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD---DDEGVPSSALREICLLKEL 58
Query: 263 HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAY 322
H+++V L + LV+EF + L+ + + ++ +GL +
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSCNGD-LDPEIVKSFLFQLLKGLGF 116
Query: 323 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPE- 381
H ++HRD+K N+L++ + E K+A+FGLA+ S V+ T Y P+
Sbjct: 117 CHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDV 172
Query: 382 ------YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD 424
Y++S D++S G + EL RP F + + D
Sbjct: 173 LFGAKLYSTS------IDMWSAGCIFAELANAGRPL-----FPGNDVDD 210
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 2e-21
Identities = 66/224 (29%), Positives = 108/224 (48%), Gaps = 27/224 (12%)
Query: 205 KIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGEREFQ---AEIE 257
K + +F LG G FG V + NG+ A+K LK ++ + E
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERL 58
Query: 258 IISQVHHRHLVSLVGYCTF-GSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIA-L 314
++S V H ++ + + TF +Q++ ++ +++ L L K + N + A +
Sbjct: 59 MLSIVTHPFIIRM--WGTFQDAQQIFMIMDYIEGGELFSLLR-KSQRFPNPVAKFYAAEV 115
Query: 315 GSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM-G 373
A L YLH II+RD+K NILLD + K+ DFG AK+ D T + G
Sbjct: 116 CLA--LEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCG 165
Query: 374 TFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTF 417
T Y+APE S+ + D +SFG+L+ E++ G+ PF ++T
Sbjct: 166 TPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM 209
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-21
Identities = 65/260 (25%), Positives = 102/260 (39%), Gaps = 45/260 (17%)
Query: 188 PGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG 246
PG + + E + D F + GQG FG V G G VAIK++
Sbjct: 2 PGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR 61
Query: 247 QGEREFQAEIEIISQVHHRHLVSL------VGYCTFGSQRL-LVYEFVPNKTLEFHLHGK 299
RE Q ++ ++ +HH ++V L +G L +V E+VP+ LH
Sbjct: 62 FRNRELQ-IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDT-----LH-- 113
Query: 300 DRPVMNWPTRMKIALGSA----------RGLAYLHEDCQPKIIHRDIKSANILLD-DSFE 348
R ++A R + LH + HRDIK N+L++
Sbjct: 114 --RCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGT 170
Query: 349 AKVADFGLAKHSLDTDTHVS---TRVMGTFGYLAPEY-ASSGKLTEKSDVFSFGVLLLEL 404
K+ DFG AK ++ +V+ +R Y APE + T D++S G + E+
Sbjct: 171 LKLCDFGSAKKLSPSEPNVAYICSRY-----YRAPELIFGNQHYTTAVDIWSVGCIFAEM 225
Query: 405 ITGFRPFDKADTFADDSMVD 424
+ G P F D+
Sbjct: 226 MLG-EPI-----FRGDNSAG 239
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 54/224 (24%), Positives = 89/224 (39%), Gaps = 50/224 (22%)
Query: 216 LLGQGGFGYVHKGV-LTNGKVVAIKQL------KAGSGQGEREFQAEIEIISQVHHR--H 266
LLG GGFG V+ G+ +++ VAIK + G E+ ++ +V
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 267 LVSLVGYCTFGSQRLLVYEFVPNKT-----LEFHLHGK---DRPVMNWPTRMKIALGSAR 318
++ L ++ LE + D ++ L AR
Sbjct: 110 VIRL-------------LDWFERPDSFVLILERPEPVQDLFDFITER--GALQEEL--AR 152
Query: 319 --------GLAYLHEDCQPKIIHRDIKSANILLD-DSFEAKVADFGLAKHSLDTDTHVST 369
+ + H ++HRDIK NIL+D + E K+ DFG +L DT +
Sbjct: 153 SFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSG--ALLKDTVYTD 207
Query: 370 RVMGTFGYLAPEYASSGKLT-EKSDVFSFGVLLLELITGFRPFD 412
GT Y PE+ + + V+S G+LL +++ G PF+
Sbjct: 208 FD-GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 250
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 3e-21
Identities = 65/213 (30%), Positives = 96/213 (45%), Gaps = 34/213 (15%)
Query: 216 LLGQGGFGYVHKGV-LTNGKVVAIKQL---KAGSGQGEREFQAEIEIISQVHHRHLVSLV 271
LG G FG V G G VA+K L K S + + EI+ + H H++ L
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL- 76
Query: 272 GYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR--------GLA 321
Y + +V E+V L F D + R++ AR +
Sbjct: 77 -YQVISTPTDFFMVMEYVSGGEL-F-----DYICKH--GRVEEM--EARRLFQQILSAVD 125
Query: 322 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPE 381
Y H + ++HRD+K N+LLD AK+ADFGL+ ++ +D G+ Y APE
Sbjct: 126 YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLS--NMMSDGEFLRTSCGSPNYAAPE 180
Query: 382 YASSGKLTE--KSDVFSFGVLLLELITGFRPFD 412
SG+L + D++S GV+L L+ G PFD
Sbjct: 181 VI-SGRLYAGPEVDIWSCGVILYALLCGTLPFD 212
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 64/228 (28%), Positives = 108/228 (47%), Gaps = 26/228 (11%)
Query: 205 KIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGEREF----QAEI 256
K+ +NF +LG G +G V GK+ A+K LK + + + + E
Sbjct: 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 109
Query: 257 EIISQV-HHRHLVSLVGYCTFGSQ-RL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIA 313
+++ + LV+L + F ++ +L L+ +++ L HL + ++ +
Sbjct: 110 QVLEHIRQSPFLVTL--HYAFQTETKLHLILDYINGGELFTHLS-QRERFTEHEVQIYVG 166
Query: 314 -LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM 372
+ A L +LH+ II+RDIK NILLD + + DFGL+K + +T +
Sbjct: 167 EIVLA--LEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC 221
Query: 373 GTFGYLAPE---YASSGKLTEKS-DVFSFGVLLLELITGFRPFDKADT 416
GT Y+AP+ SG +K+ D +S GVL+ EL+TG PF
Sbjct: 222 GTIEYMAPDIVRGGDSGH--DKAVDWWSLGVLMYELLTGASPFTVDGE 267
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 4e-21
Identities = 67/285 (23%), Positives = 101/285 (35%), Gaps = 49/285 (17%)
Query: 150 PPSNGPTAPLPT-VPVSAFNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIAT 208
P P P P P P P+Q P V KS ++ I
Sbjct: 5 SQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHV---KSGLQIKKNAIID 61
Query: 209 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRH 266
D + +LG G G V + + A+K L+ + + E+E+ + H
Sbjct: 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPH 116
Query: 267 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHL-----HGK---DRPVMNWPTR--------- 309
+V +V VYE + + G R
Sbjct: 117 IVRIVD----------VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 166
Query: 310 MKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA---KVADFGLAKHSLDTDTH 366
MK +G A + YLH I HRD+K N+L K+ DFG AK +
Sbjct: 167 MKS-IGEA--IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSHNS 219
Query: 367 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPF 411
++T T Y+APE K + D++S GV++ L+ G+ PF
Sbjct: 220 LTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 263
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 6e-21
Identities = 57/217 (26%), Positives = 89/217 (41%), Gaps = 44/217 (20%)
Query: 216 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYC 274
+G G FG ++VA+K ++ G+ E Q EI + H ++V
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN-VQREIINHRSLRHPNIVRF---- 81
Query: 275 TFGSQRLLVYEFVPNKT-----LEFHLHGK--DRPVMNWPTRMKIALGSAR--------G 319
E + T +E+ G+ +R R AR G
Sbjct: 82 ---------KEVILTPTHLAIIMEYASGGELYERICNA--GRFSED--EARFFFQQLLSG 128
Query: 320 LAYLHEDCQPKIIHRDIKSANILLDDSFEA--KVADFGLAKHSLDTDTHVSTRVMGTFGY 377
++Y H +I HRD+K N LLD S K+ DFG +K S+ + + V GT Y
Sbjct: 129 VSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTV-GTPAY 183
Query: 378 LAPEYASSGKLTE--KSDVFSFGVLLLELITGFRPFD 412
+APE + + +DV+S GV L ++ G PF+
Sbjct: 184 IAPEVL-LRQEYDGKIADVWSCGVTLYVMLVGAYPFE 219
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 8e-21
Identities = 63/229 (27%), Positives = 107/229 (46%), Gaps = 31/229 (13%)
Query: 209 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE---FQA--EIEIISQV 262
+ + + LG+G F V+K ++VAIK++K G ++ A EI+++ ++
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 263 HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAY 322
H +++ L+ S LV++F+ LE + + L + +GL Y
Sbjct: 70 SHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLV-LTPSHIKAYMLMTLQGLEY 127
Query: 323 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPE- 381
LH+ I+HRD+K N+LLD++ K+ADFGLAK + + +V+ T Y APE
Sbjct: 128 LHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-TRWYRAPEL 183
Query: 382 ------YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD 424
Y D+++ G +L EL+ PF DS +D
Sbjct: 184 LFGARMYGVG------VDMWAVGCILAELLLR-VPF-----LPGDSDLD 220
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 8e-21
Identities = 56/252 (22%), Positives = 101/252 (40%), Gaps = 39/252 (15%)
Query: 216 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGY 273
+LG+G V + L + A+K ++ G E+E++ Q HR+++ L+ +
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 274 CTFGSQRLLVYEFVPNKTLEFHLHGKD-------RPVMNWPTRMKIALGSARGLAYLHED 326
+ LV+E + ++ H+H + V+ +A L +LH
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ-----DVA----SALDFLHN- 129
Query: 327 CQPKIIHRDIKSANILL---DDSFEAKVADFGLAK--HSLDTDTHVSTRVM----GTFGY 377
I HRD+K NIL + K+ DF L + +ST + G+ Y
Sbjct: 130 --KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187
Query: 378 LAPE-----YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQ 432
+APE + ++ D++S GV+L L++G+ PF A P
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247
Query: 433 GLAD----GNFD 440
L + G ++
Sbjct: 248 MLFESIQEGKYE 259
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 8e-21
Identities = 69/262 (26%), Positives = 109/262 (41%), Gaps = 48/262 (18%)
Query: 180 DKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAI 238
S G+ +G F + + + L+G+G +G V K G++VAI
Sbjct: 2 GHHHHHHSSGVDLGTENLYFQ------SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAI 55
Query: 239 KQLKAGSGQGERE---FQA--EIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLE 293
K+ + + A EI+++ Q+ H +LV+L+ C + LV+EFV + T+
Sbjct: 56 KKFLESD---DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV-DHTIL 111
Query: 294 FHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVAD 353
L +++ K G+ + H IIHRDIK NIL+ S K+ D
Sbjct: 112 DDLELFPNG-LDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCD 167
Query: 354 FGLAKH---SLDTDTH-VSTRVMGTFGYLAPE-------YASSGKLTEKSDVFSFGVLLL 402
FG A+ + V+TR Y APE Y + DV++ G L+
Sbjct: 168 FGFARTLAAPGEVYDDEVATR-----WYRAPELLVGDVKYGKA------VDVWAIGCLVT 216
Query: 403 ELITGFRPFDKADTFADDSMVD 424
E+ G P F DS +D
Sbjct: 217 EMFMG-EPL-----FPGDSDID 232
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 8e-21
Identities = 55/228 (24%), Positives = 102/228 (44%), Gaps = 33/228 (14%)
Query: 209 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGERE---FQA--EIEIISQVH 263
+ + +G+G +G V+K G+ A+K+++ E E EI I+ ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEK---EDEGIPSTTIREISILKELK 58
Query: 264 HRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYL 323
H ++V L + +LV+E + + L+ L + + T L G+AY
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYC 116
Query: 324 HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPE-- 381
H+ +++HRD+K N+L++ E K+ADFGLA+ + ++ T Y AP+
Sbjct: 117 HDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVL 172
Query: 382 -----YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD 424
Y+++ D++S G + E++ G P F S D
Sbjct: 173 MGSKKYSTT------IDIWSVGCIFAEMVNG-TPL-----FPGVSEAD 208
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 9e-21
Identities = 53/243 (21%), Positives = 89/243 (36%), Gaps = 51/243 (20%)
Query: 196 KSTFTYEELKIATDNFSE-----ANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGE 249
++ + ++ +LG G G V + G+ A+K L
Sbjct: 11 GLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD-----S 65
Query: 250 REFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHL-----HGK---D 300
+ + E++ Q H+V ++ VYE + + + G
Sbjct: 66 PKARQEVDHHWQASGGPHIVCILD----------VYENMHHGKRCLLIIMECMEGGELFS 115
Query: 301 RPVMNWPTR---------MKIALGSARGLAYLHEDCQPKIIHRDIKSANILL---DDSFE 348
R M+ +G+A + +LH I HRD+K N+L +
Sbjct: 116 RIQERGDQAFTEREAAEIMRD-IGTA--IQFLHSH---NIAHRDVKPENLLYTSKEKDAV 169
Query: 349 AKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGF 408
K+ DFG AK T + T T Y+APE K + D++S GV++ L+ GF
Sbjct: 170 LKLTDFGFAKE--TTQNALQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGF 226
Query: 409 RPF 411
PF
Sbjct: 227 PPF 229
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 9e-21
Identities = 57/234 (24%), Positives = 96/234 (41%), Gaps = 44/234 (18%)
Query: 209 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE---FQA--EIEIISQV 262
+ + + +G+G +G V K G++VAIK+ + A EI ++ Q+
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE---DDPVIKKIALREIRMLKQL 59
Query: 263 HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMK-IALGSARGLA 321
H +LV+L+ + LV+E+ + T+ L +K I + + +
Sbjct: 60 KHPNLVNLLEVFRRKRRLHLVFEYC-DHTVLHEL--DRYQRGVPEHLVKSITWQTLQAVN 116
Query: 322 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH---SLDTDTH-VSTRVMGTFGY 377
+ H+ IHRD+K NIL+ K+ DFG A+ D V+TR Y
Sbjct: 117 FCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR-----WY 168
Query: 378 LAPE-------YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD 424
+PE Y DV++ G + EL++G P + S VD
Sbjct: 169 RSPELLVGDTQYGPP------VDVWAIGCVFAELLSG-VPL-----WPGKSDVD 210
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 50/213 (23%), Positives = 87/213 (40%), Gaps = 38/213 (17%)
Query: 217 LGQGGFGYVHKGV-LTNGKVVAIKQL-KAGSGQGEREFQAEIEIISQV-HHRHLVSLVGY 273
LG+G F K V + + A+K + K ++E I + H ++V L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKE----ITALKLCEGHPNIVKLHEV 74
Query: 274 CTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR-----------MKIALGSARGLAY 322
LV E + L F +R + M+ + +++
Sbjct: 75 FHDQLHTFLVMELLNGGEL-F-----ERIK----KKKHFSETEASYIMRKLVS---AVSH 121
Query: 323 LHEDCQPKIIHRDIKSANILL---DDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLA 379
+H+ ++HRD+K N+L +D+ E K+ DFG A+ + + T T Y A
Sbjct: 122 MHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAA 177
Query: 380 PEYASSGKLTEKSDVFSFGVLLLELITGFRPFD 412
PE + E D++S GV+L +++G PF
Sbjct: 178 PELLNQNGYDESCDLWSLGVILYTMLSGQVPFQ 210
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 69/228 (30%), Positives = 103/228 (45%), Gaps = 33/228 (14%)
Query: 205 KIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGEREF---QAEIE 257
K+ ++F +LG+G FG V K + AIK LK + + E
Sbjct: 13 KLKIEDFILHKMLGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKR 69
Query: 258 IISQV-HHRHLVSLVGYCTFGSQ-RL-LVYEFVPNKTLEFHLHGKDR-PVMNWPTRMK-- 311
++S H L + +CTF ++ L V E++ L +H+ + + +R
Sbjct: 70 VLSLAWEHPFLTHM--FCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDL----SRATFY 123
Query: 312 ---IALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 368
I LG L +LH I++RD+K NILLD K+ADFG+ K ++ D +
Sbjct: 124 AAEIILG----LQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN 176
Query: 369 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADT 416
T GT Y+APE K D +SFGVLL E++ G PF D
Sbjct: 177 T-FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE 223
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 47/234 (20%), Positives = 86/234 (36%), Gaps = 46/234 (19%)
Query: 202 EELKIATDNFSEA----NLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEI 256
++L + F++ +G G + + + A+K + E I
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE----I 66
Query: 257 EIISQ-VHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALG 315
EI+ + H ++++L G +V E + L D+ +
Sbjct: 67 EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL-L-----DKIL---------RQK 111
Query: 316 S-------------ARGLAYLHEDCQPKIIHRDIKSANILL----DDSFEAKVADFGLAK 358
+ + YLH ++HRD+K +NIL + ++ DFG AK
Sbjct: 112 FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168
Query: 359 HSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFD 412
+ + T T ++APE D++S GVLL ++TG+ PF
Sbjct: 169 QLRAENGLLMTPC-YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFA 221
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 62/227 (27%), Positives = 99/227 (43%), Gaps = 31/227 (13%)
Query: 205 KIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGEREF---QAEIE 257
++ +F+ +LG+G FG V KG ++ A+K LK + + E
Sbjct: 16 RMKLTDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKR 72
Query: 258 IISQV-HHRHLVSLVGYCTFGSQ-RL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMK--- 311
+++ L L + F + RL V E+V L +H+ R
Sbjct: 73 VLALPGKPPFLTQL--HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP---HAVFYA 127
Query: 312 --IALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 369
IA+G L +L II+RD+K N++LD K+ADFG+ K ++ T
Sbjct: 128 AEIAIG----LFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT 180
Query: 370 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADT 416
GT Y+APE + + D ++FGVLL E++ G PF+ D
Sbjct: 181 -FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 226
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 3e-20
Identities = 19/205 (9%), Positives = 52/205 (25%), Gaps = 39/205 (19%)
Query: 216 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGE---REFQAEIEIISQVHHRHLVSLV 271
G + + + VA+ + + +E + +S++ + ++
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 272 GYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKI 331
+ L+V E++ +L+ P ++ A H +
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVADTSPSP----VGAIRAMQSLAAAADAAHRA---GV 150
Query: 332 IHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEK 391
+ + + + +A + +
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAY---------------------PATMPDA-------NPQ 182
Query: 392 SDVFSFGVLLLELITGFRPFDKADT 416
D+ G L L+ P +A
Sbjct: 183 DDIRGIGASLYALLVNRWPLPEAGV 207
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 69/262 (26%), Positives = 114/262 (43%), Gaps = 29/262 (11%)
Query: 166 AFNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYV 225
++P + P P S + +G + +F ++G+G FG V
Sbjct: 1 GISQPQEPELMNANPAPPPAPSQQINLGPSSNP------HAKPSDFHFLKVIGKGSFGKV 54
Query: 226 ----HKGVLTNGKVVAIKQLKAGSGQGEREF---QAEIEIISQ-VHHRHLVSLVGYCTFG 277
HK A+K L+ + ++E +E ++ + V H LV L + +F
Sbjct: 55 LLARHKA---EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL--HFSFQ 109
Query: 278 SQ-RL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIA-LGSARGLAYLHEDCQPKIIHR 334
+ +L V +++ L +HL ++R + R A + SA L YLH I++R
Sbjct: 110 TADKLYFVLDYINGGELFYHLQ-RERCFLEPRARFYAAEIASA--LGYLHSL---NIVYR 163
Query: 335 DIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 394
D+K NILLD + DFGL K +++ ++ ST GT YLAPE D
Sbjct: 164 DLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST-FCGTPEYLAPEVLHKQPYDRTVDW 222
Query: 395 FSFGVLLLELITGFRPFDKADT 416
+ G +L E++ G PF +T
Sbjct: 223 WCLGAVLYEMLYGLPPFYSRNT 244
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 5e-20
Identities = 56/275 (20%), Positives = 107/275 (38%), Gaps = 50/275 (18%)
Query: 168 NEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHK 227
+ G+L++ P + S Y + LG+G +G V+K
Sbjct: 3 HHHHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRI----------TKLGEGTYGEVYK 52
Query: 228 GV-LTNGKVVAIKQLKAGSGQGERE---FQA--EIEIISQVHHRHLVSLVGYCTFGSQRL 281
+ + VAIK+++ E E A E+ ++ ++ HR+++ L +
Sbjct: 53 AIDTVTNETVAIKRIRLEH---EEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109
Query: 282 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANI 341
L++E+ L+ ++ P ++ G+ + H + +HRD+K N+
Sbjct: 110 LIFEYA-ENDLKKYMD--KNPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNL 163
Query: 342 LLDDSFEA-----KVADFGLAKHSLDTDTHVSTRVMGTFGYLAPE-------YASSGKLT 389
LL S + K+ DFGLA+ + ++ T Y PE Y++S
Sbjct: 164 LLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRPPEILLGSRHYSTS---- 218
Query: 390 EKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD 424
D++S + E++ P F DS +D
Sbjct: 219 --VDIWSIACIWAEMLMK-TPL-----FPGDSEID 245
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 6e-20
Identities = 64/221 (28%), Positives = 108/221 (48%), Gaps = 31/221 (14%)
Query: 207 ATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGE-----REFQAEIEIIS 260
++ F + LG G + V+KG+ T G VA+K++K S +G RE I ++
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIRE----ISLMK 58
Query: 261 QVHHRHLVSLVGYCTFGSQRLLVYEFVPN---KTLEFHLHGKDRPVMNWPTRMKIALGSA 317
++ H ++V L ++ LV+EF+ N K ++ G +
Sbjct: 59 ELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 318 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGY 377
+GLA+ HE+ KI+HRD+K N+L++ + K+ DFGLA+ S+ V+ T Y
Sbjct: 119 QGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWY 174
Query: 378 LAPE-------YASSGKLTEKSDVFSFGVLLLELITGFRPF 411
AP+ Y++S D++S G +L E+ITG +P
Sbjct: 175 RAPDVLMGSRTYSTS------IDIWSCGCILAEMITG-KPL 208
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 9e-20
Identities = 56/229 (24%), Positives = 104/229 (45%), Gaps = 35/229 (15%)
Query: 209 DNFSEANLLGQGGFGYVHKG-VLTNGKVVAIKQLKAGSGQGE-----REFQAEIEIISQV 262
+ + + + LG+G + V+KG +VA+K+++ +G RE + ++ +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIRE----VSLLKDL 57
Query: 263 HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAY 322
H ++V+L LV+E++ +K L+ +L +N RGLAY
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNI-INMHNVKLFLFQLLRGLAY 115
Query: 323 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPE- 381
H + K++HRD+K N+L+++ E K+ADFGLA+ V+ T Y P+
Sbjct: 116 CH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDI 171
Query: 382 ------YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD 424
Y++ D++ G + E+ TG RP F ++ +
Sbjct: 172 LLGSTDYSTQ------IDMWGVGCIFYEMATG-RPL-----FPGSTVEE 208
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 64/223 (28%), Positives = 99/223 (44%), Gaps = 23/223 (10%)
Query: 205 KIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGEREF---QAEIE 257
+ +F ++G+G + V K ++ A+K +K + + Q E
Sbjct: 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDEDIDWVQTEKH 61
Query: 258 IISQV-HHRHLVSLVGYCTFGSQ-RL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIA- 313
+ Q +H LV L + F ++ RL V E+V L FH+ + R + R A
Sbjct: 62 VFEQASNHPFLVGL--HSCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAE 118
Query: 314 LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMG 373
+ A L YLHE II+RD+K N+LLD K+ D+G+ K L ST G
Sbjct: 119 ISLA--LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCG 172
Query: 374 TFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADT 416
T Y+APE D ++ GVL+ E++ G PFD +
Sbjct: 173 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGS 215
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 1e-19
Identities = 63/299 (21%), Positives = 103/299 (34%), Gaps = 82/299 (27%)
Query: 190 MPVGNFKSTFTYEELK--IATDNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQL 241
+P+ Y+ K D LG+G FG V + + VA+K L
Sbjct: 1 LPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML 60
Query: 242 KAGSGQGER-EFQAEIEIISQV-HHRHLVSLVGYCT-FGSQRLLVYEFVPNKTLEFHLHG 298
K G+ E +E++I+ + HH ++V+L+G CT G +++ EF L +L
Sbjct: 61 KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 120
Query: 299 KDRPVMNWPTRMKIALGSARGLAYLHED-------------------------------C 327
K + + T+ + + D
Sbjct: 121 KRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 180
Query: 328 QPKIIHRDIKSANILLDDSFE------------------------------AKVADFGLA 357
P+ +++D + L+ SF+ K+ DFGLA
Sbjct: 181 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 240
Query: 358 KHSLDTDTHVSTRVMGTFGYL-----APEYASSGKLTEKSDVFSFGVLLLELIT-GFRP 410
+ +V L APE T +SDV+SFGVLL E+ + G P
Sbjct: 241 RDIYKDPDYVRKGD----ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 66/261 (25%), Positives = 109/261 (41%), Gaps = 25/261 (9%)
Query: 167 FNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYV- 225
++ P + + + + +S L + +F ++G+G + V
Sbjct: 12 YDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGL--QDFDLLRVIGRGSYAKVL 69
Query: 226 ---HKGVLTNGKVVAIKQLKAGSGQGEREF---QAEIEIISQV-HHRHLVSLVGYCTFGS 278
K ++ A++ +K + + Q E + Q +H LV L + F +
Sbjct: 70 LVRLKK---TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL--HSCFQT 124
Query: 279 Q-RL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIA-LGSARGLAYLHEDCQPKIIHRD 335
+ RL V E+V L FH+ + R + R A + A L YLHE II+RD
Sbjct: 125 ESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEISLA--LNYLHER---GIIYRD 178
Query: 336 IKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 395
+K N+LLD K+ D+G+ K L ST GT Y+APE D +
Sbjct: 179 LKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIAPEILRGEDYGFSVDWW 237
Query: 396 SFGVLLLELITGFRPFDKADT 416
+ GVL+ E++ G PFD +
Sbjct: 238 ALGVLMFEMMAGRSPFDIVGS 258
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 2e-19
Identities = 67/213 (31%), Positives = 95/213 (44%), Gaps = 34/213 (15%)
Query: 216 LLGQGGFGYVHKGV-LTNGKVVAIKQL---KAGSGQGEREFQAEIEIISQVHHRHLVSLV 271
LG G FG V G G VA+K L K S + + EI+ + H H++ L
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL- 81
Query: 272 GYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR--------GLA 321
Y + +V E+V L F D N R+ +R G+
Sbjct: 82 -YQVISTPSDIFMVMEYVSGGEL-F-----DYICKN--GRLDEKE--SRRLFQQILSGVD 130
Query: 322 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPE 381
Y H + ++HRD+K N+LLD AK+ADFGL+ D + T G+ Y APE
Sbjct: 131 YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFLRTSC-GSPNYAAPE 185
Query: 382 YASSGKLTE--KSDVFSFGVLLLELITGFRPFD 412
SG+L + D++S GV+L L+ G PFD
Sbjct: 186 VI-SGRLYAGPEVDIWSSGVILYALLCGTLPFD 217
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 60/241 (24%), Positives = 99/241 (41%), Gaps = 44/241 (18%)
Query: 207 ATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEI------EI- 258
AT + +G G +G V+K +G VA+K ++ + + E+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPN---GGGGGGGLPISTVREVA 63
Query: 259 ----ISQVHHRHLVSL----VGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTR 309
+ H ++V L T ++ LV+E V ++ L +L P + T
Sbjct: 64 LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETI 122
Query: 310 MKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 369
+ RGL +LH + I+HRD+K NIL+ K+ADFGLA+ ++
Sbjct: 123 KDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLAR-IYSYQMALTP 178
Query: 370 RVMGTFGYLAPE------YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMV 423
V+ T Y APE YA+ D++S G + E+ +P F +S
Sbjct: 179 VVV-TLWYRAPEVLLQSTYATP------VDMWSVGCIFAEMFRR-KPL-----FCGNSEA 225
Query: 424 D 424
D
Sbjct: 226 D 226
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 62/229 (27%), Positives = 95/229 (41%), Gaps = 67/229 (29%)
Query: 216 LLGQGGFGYVHKGV-LTNGKVVAIK-----QLKAGS--GQGEREFQAEIEIISQVHHRHL 267
LG+G FG V + VA+K LK + ERE I + + H H+
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVERE----ISYLKLLRHPHI 71
Query: 268 VSLVGYCTFGSQRLLVYEFVPNKT-----LEF-------HL--HGKDRPVMNWPTRMKIA 313
+ L Y+ + T +E+ ++ RM
Sbjct: 72 IKL-------------YDVITTPTDIVMVIEYAGGELFDYIVEKK----------RMTED 108
Query: 314 LGSAR--------GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365
R + Y H + KI+HRD+K N+LLDD+ K+ADFGL+ ++ TD
Sbjct: 109 E--GRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLS--NIMTDG 161
Query: 366 HVSTRVMGTFGYLAPEYASSGKLTE--KSDVFSFGVLLLELITGFRPFD 412
+ G+ Y APE +GKL + DV+S G++L ++ G PFD
Sbjct: 162 NFLKTSCGSPNYAAPEVI-NGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 69/230 (30%), Positives = 98/230 (42%), Gaps = 37/230 (16%)
Query: 205 KIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGEREF---QAEIE 257
++ DNF +LG+G FG V K G + A+K LK + + E
Sbjct: 19 RLGIDNFEFIRVLGKGSFGKVMLARVKE---TGDLYAVKVLKKDVILQDDDVECTMTEKR 75
Query: 258 IISQV-HHRHLVSLVGYCTFGSQ-RL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIAL 314
I+S +H L L +C F + RL V EFV L FH+ R
Sbjct: 76 ILSLARNHPFLTQL--FCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR----------FDE 123
Query: 315 GSAR--------GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 366
AR L +LH+ II+RD+K N+LLD K+ADFG+ K +
Sbjct: 124 ARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT 180
Query: 367 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADT 416
+T GT Y+APE D ++ GVLL E++ G PF+ +
Sbjct: 181 TATFC-GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE 229
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 5e-19
Identities = 61/246 (24%), Positives = 104/246 (42%), Gaps = 67/246 (27%)
Query: 209 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE---FQA--EIEIISQV 262
+ + +GQG FG V K G+ VA+K++ + E+E A EI+I+ +
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN---EKEGFPITALREIKILQLL 73
Query: 263 HHRHLVSLVGYCTFGSQRL--------LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIAL 314
H ++V+L+ C + LV++F E L G +++ + +
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDF-----CEHDLAG----LLS---NVLVKF 121
Query: 315 GSA----------RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA------- 357
+ GL Y+H + KI+HRD+K+AN+L+ K+ADFGLA
Sbjct: 122 TLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178
Query: 358 KHSLDTDTHVSTRVMGTFGYLAPE-------YASSGKLTEKSDVFSFGVLLLELITGFRP 410
+ T+ RV+ T Y PE Y D++ G ++ E+ T P
Sbjct: 179 NSQPNRYTN---RVV-TLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTR-SP 227
Query: 411 FDKADT 416
+ +T
Sbjct: 228 IMQGNT 233
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 57/224 (25%), Positives = 99/224 (44%), Gaps = 37/224 (16%)
Query: 209 DNFSEANLLGQGGFGYVHKG--VLTNGKVVAIKQLKAGSGQGERE---FQA--EIEI--- 258
+ +G+G +G V K + G+ VA+K+++ + E E+ +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT---GEEGMPLSTIREVAVLRH 67
Query: 259 ISQVHHRHLVSL----VGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIA 313
+ H ++V L T +L LV+E V ++ L +L P + T +
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMM 126
Query: 314 LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMG 373
RGL +LH +++HRD+K NIL+ S + K+ADFGLA+ +++ V+
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQMALTSVVV- 181
Query: 374 TFGYLAPE------YASSGKLTEKSDVFSFGVLLLELITGFRPF 411
T Y APE YA+ D++S G + E+ +P
Sbjct: 182 TLWYRAPEVLLQSSYATP------VDLWSVGCIFAEMFRR-KPL 218
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 3e-17
Identities = 57/247 (23%), Positives = 99/247 (40%), Gaps = 53/247 (21%)
Query: 197 STFTYEELKIATDNFSEANLLGQGGFGYVHKGV---LTNGKVVAIKQLKAGSGQGEREFQ 253
F YE K+ G+G +G+V+K + K A+KQ++
Sbjct: 20 DLFEYEGCKV-----------GRGTYGHVYKAKRKDGKDDKDYALKQIEGTG----ISMS 64
Query: 254 A--EIEIISQVHHRHLVSLVGYCTFGSQRL--LVYEFVPN---KTLEFHLHGKDRP---V 303
A EI ++ ++ H +++SL + R L++++ + ++FH K
Sbjct: 65 ACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQ 124
Query: 304 MNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA----KVADFGLAKH 359
+ + G+ YLH + ++HRD+K ANIL+ K+AD G A+
Sbjct: 125 LPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
Query: 360 ---SLDTDTHVSTRVMGTFGYLAPE-------YASSGKLTEKSDVFSFGVLLLELITGFR 409
L + V+ TF Y APE Y T+ D+++ G + EL+T
Sbjct: 182 FNSPLKPLADLDPVVV-TFWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTS-E 233
Query: 410 PFDKADT 416
P
Sbjct: 234 PIFHCRQ 240
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 57/278 (20%), Positives = 102/278 (36%), Gaps = 75/278 (26%)
Query: 193 GNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGERE 251
G S+ Y K LG G FG V + +GK A+K++ +
Sbjct: 1 GLETSSKKYSLGKT----------LGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPR 45
Query: 252 FQA-EIEIISQVHHRHLVSL--VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPT 308
++ E++I+ + H +++ L Y T + + L +G + +
Sbjct: 46 YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIV 105
Query: 309 R---------------------MKIALGSA----------------RGLAYLHEDCQPKI 331
+K + S R + ++H I
Sbjct: 106 NPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGI 162
Query: 332 IHRDIKSANILLD-DSFEAKVADFGLAKHSLDTDTHVS---TRVMGTFGYLAPE-YASSG 386
HRDIK N+L++ K+ DFG AK + ++ V+ +R Y APE +
Sbjct: 163 CHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPELMLGAT 217
Query: 387 KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD 424
+ T D++S G + ELI G +P F+ ++ +D
Sbjct: 218 EYTPSIDLWSIGCVFGELILG-KPL-----FSGETSID 249
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 50/234 (21%), Positives = 86/234 (36%), Gaps = 51/234 (21%)
Query: 208 TDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQL--KAGSGQGEREFQA---------EI 256
++ + G +G V GV + G VAIK++ G+ EI
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 257 EIISQVHHRHLVSLVGYCTFGSQRL-----LVYEFVPNKTLEFHLHGKDRPVMNWPTRMK 311
+++ HH +++ L + LV E + L V++ +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTEL-----MRTDLAQ----VIHDQ---R 128
Query: 312 IALGSA----------RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 361
I + GL LHE ++HRD+ NILL D+ + + DF LA+
Sbjct: 129 IVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDT 185
Query: 362 DTDT---HVSTRVMGTFGYLAPEY-ASSGKLTEKSDVFSFGVLLLELITGFRPF 411
+V+ R Y APE T+ D++S G ++ E+ +
Sbjct: 186 ADANKTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR-KAL 233
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 5e-16
Identities = 57/234 (24%), Positives = 88/234 (37%), Gaps = 37/234 (15%)
Query: 216 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEI-------------ISQ 261
LG G F V + N VA+K ++ E AE EI
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE---AAEDEIKLLQRVNDADNTKEDS 82
Query: 262 VHHRHLVSLVGYCTF----GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA 317
+ H++ L+ + G ++V+E + L + R + +I+
Sbjct: 83 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRG-IPLIYVKQISKQLL 141
Query: 318 RGLAYLHEDCQPKIIHRDIKSANILLDDS------FEAKVADFGLAKHSLDTDTHVSTRV 371
GL Y+H C IIH DIK N+L++ + K+AD G A D H + +
Sbjct: 142 LGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW---YDEHYTNSI 196
Query: 372 MGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITG---FRPFDKADTFADDSM 422
Y +PE +D++S L+ ELITG F P + DD
Sbjct: 197 QTRE-YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 52/231 (22%), Positives = 98/231 (42%), Gaps = 44/231 (19%)
Query: 201 YEELKIA---TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEI 256
YE + D++ LG+G + V + + +TN + V +K LK +++ + EI
Sbjct: 25 YESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREI 81
Query: 257 EIISQV-HHRHLVSLVGYCTFGSQR----LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMK 311
+I+ + ++++L LV+E V N + + T
Sbjct: 82 KILENLRGGPNIITL--ADIVKDPVSRTPALVFEHVNNTDF--------KQLYQTLTDYD 131
Query: 312 IA------LGSARGLAYLHEDCQPKIIHRDIKSANILLD-DSFEAKVADFGLAK--HSLD 362
I L + L Y H I+HRD+K N+++D + + ++ D+GLA+ H
Sbjct: 132 IRFYMYEIL---KALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185
Query: 363 TDTH-VSTRVMGTFGYLAPEYASSGKLTEKS-DVFSFGVLLLELITGFRPF 411
V++R + PE ++ + S D++S G +L +I PF
Sbjct: 186 EYNVRVASRY-----FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 6e-15
Identities = 51/240 (21%), Positives = 82/240 (34%), Gaps = 66/240 (27%)
Query: 194 NFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREF 252
+ KS ++ I D + +LG G G V + + A+K L+ +
Sbjct: 3 HVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKA 57
Query: 253 QAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHL-----HG---KDRPV 303
+ E+E+ + H+V +V VYE + + G R
Sbjct: 58 RREVELHWRASQCPHIVRIVD----------VYENLYAGRKCLLIVMECLDGGELFSRIQ 107
Query: 304 MNWPTR---------MKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA---KV 351
MK +G A + YLH I HRD+K N+L K+
Sbjct: 108 DRGDQAFTEREASEIMKS-IGEA--IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKL 161
Query: 352 ADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPF 411
DFG AK + Y + D++S GV++ L+ G+ PF
Sbjct: 162 TDFGFAKETTGE------------KY-----------DKSCDMWSLGVIMYILLCGYPPF 198
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 9e-15
Identities = 55/228 (24%), Positives = 93/228 (40%), Gaps = 58/228 (25%)
Query: 208 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA---------EIE 257
+ +G G +G V + +G+ VAIK+L R FQ+ E+
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL-------SRPFQSEIFAKRAYRELL 75
Query: 258 IISQVHHRHLVSLVGYCTFGSQRL------LVYEFVPNKTLEFHLHGKDRPVMNWPTRMK 311
++ + H +++ L+ T S LV F ++ L M
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPF-----MQTDLQ----------KIMG 120
Query: 312 IALGSA----------RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 361
+ +GL Y+H ++HRD+K N+ +++ E K+ DFGLA+H+
Sbjct: 121 LKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177
Query: 362 DTDTH-VSTRVMGTFGYLAPEYA-SSGKLTEKSDVFSFGVLLLELITG 407
T V TR Y APE S + D++S G ++ E++TG
Sbjct: 178 AEMTGYVVTRW-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 220
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 8e-14
Identities = 57/226 (25%), Positives = 89/226 (39%), Gaps = 53/226 (23%)
Query: 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQA---------EIE 257
+ +G G G V + VAIK+L R FQ E+
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL-------SRPFQNQTHAKRAYRELV 76
Query: 258 IISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLE--------FHLHGKD-RPVMN--- 305
++ V+H++++ L+ F P K+LE L + V+
Sbjct: 77 LMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMEL 124
Query: 306 WPTRMKIALGSA-RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364
RM L G+ +LH IIHRD+K +NI++ K+ DFGLA+ + +
Sbjct: 125 DHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 181
Query: 365 T---HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITG 407
+V TR Y APE E D++S G ++ E+I G
Sbjct: 182 MMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 54/220 (24%), Positives = 89/220 (40%), Gaps = 41/220 (18%)
Query: 208 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA---------EIE 257
+ +G G G V + VAIK+L R FQ E+
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL-------SRPFQNQTHAKRAYRELV 113
Query: 258 IISQVHHRHLVSLVGYCTFGSQRL------LVYEFVPNKTLEFHLHGKDRPVMNWPTRMK 311
++ V+H++++SL+ T LV E ++ +L + + RM
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL-----MDANLCQVIQMEL-DHERMS 167
Query: 312 IALGSA-RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT---HV 367
L G+ +LH IIHRD+K +NI++ K+ DFGLA+ + + +V
Sbjct: 168 YLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 224
Query: 368 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITG 407
TR Y APE E D++S G ++ E++
Sbjct: 225 VTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMVRH 259
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 11/96 (11%)
Query: 318 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT-HVSTRVMGTFG 376
+GL Y+H IIHRD+K N+ +++ E K+ DFGLA+ + T +V TR
Sbjct: 139 KGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW----- 190
Query: 377 YLAPEYA-SSGKLTEKSDVFSFGVLLLELITGFRPF 411
Y APE + + T+ D++S G ++ E+ITG +
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITG-KTL 225
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 55/231 (23%), Positives = 100/231 (43%), Gaps = 52/231 (22%)
Query: 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQA---------EIE 257
++ + +G+G +G V N VAIK++ F+ EI+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIK 77
Query: 258 IISQVHHRHLVSLVGYCTFGSQRL-----LVYEFVPNKTLEFHLHG--KDRPVMNWPTRM 310
I+ + H +++ + + +V + +E L+ K + + N
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDL-----METDLYKLLKTQHLSNDHICY 132
Query: 311 KI--ALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH-- 366
+ L RGL Y+H ++HRD+K +N+LL+ + + K+ DFGLA+ + H
Sbjct: 133 FLYQIL---RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 186
Query: 367 -----VSTRVMGTFGYLAPEYA-SSGKLTEKSDVFSFGVLLLELITGFRPF 411
V+TR Y APE +S T+ D++S G +L E+++ RP
Sbjct: 187 FLTEYVATR-----WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 231
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 56/210 (26%), Positives = 92/210 (43%), Gaps = 28/210 (13%)
Query: 216 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREF--QA--EIEIISQVHHR----- 265
++G+G FG V K + VA+K ++ E+ F QA EI I+ + +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRN-----EKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 266 -HLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH 324
+++ ++ TF + + +E + E K + R K A + L LH
Sbjct: 159 MNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVR-KFAHSILQCLDALH 217
Query: 325 EDCQPKIIHRDIKSANILL--DDSFEAKVADFGLAKHSLDTD-THVSTRVMGTFGYLAPE 381
+ +IIH D+K NILL KV DFG + + T++ +R F Y APE
Sbjct: 218 ---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSR----F-YRAPE 269
Query: 382 YASSGKLTEKSDVFSFGVLLLELITGFRPF 411
+ D++S G +L EL+TG+
Sbjct: 270 VILGARYGMPIDMWSLGCILAELLTGYPLL 299
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 37/96 (38%), Positives = 56/96 (58%), Gaps = 11/96 (11%)
Query: 318 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT-HVSTRVMGTFG 376
RGL Y+H IIHRD+K +N+ +++ E K+ DFGLA+H+ D T +V+TR
Sbjct: 143 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW----- 194
Query: 377 YLAPEYA-SSGKLTEKSDVFSFGVLLLELITGFRPF 411
Y APE + + D++S G ++ EL+TG R
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG-RTL 229
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 67.2 bits (163), Expect = 3e-12
Identities = 46/249 (18%), Positives = 73/249 (29%), Gaps = 61/249 (24%)
Query: 206 IATDNFSEANLLGQGGFGYVHKGVLTNG----KVVAIKQLKAGSG---QGEREFQAEIEI 258
+ T+ +G+G FG V + + + K++AI+ +G + E EI I
Sbjct: 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 259 ISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKT--------------------------- 291
++ L V T G L V
Sbjct: 77 SKELSL--LSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134
Query: 292 ------LEFHLHGKD-----RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSAN 340
LEF G D + + T I LA + HRD+ N
Sbjct: 135 DQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGN 192
Query: 341 ILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAP--EYASSGKLTEKSDVFSFG 398
+LL + K+ K S + + G +Y S + VF
Sbjct: 193 VLLKKTSLKKLHYTLNGKSST----------IPSCGLQVSIIDYTLSRLERDGIVVFCDV 242
Query: 399 VLLLELITG 407
+ +L TG
Sbjct: 243 SMDEDLFTG 251
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 6e-12
Identities = 43/228 (18%), Positives = 88/228 (38%), Gaps = 44/228 (19%)
Query: 217 LGQGGFGYVHKGV---------LTNGKVVAIKQLKAGSGQGEREF-----QAEIEIISQV 262
+ G +++ + ++K L A G+ E A+ +++
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVNKW 108
Query: 263 HHRHLVSLVG---YCTFGSQ----RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALG 315
+ L+ FG R LV + ++L+ L + V++ + +++A
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 316 SARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKV--ADFGLAKHSLDTDTHVSTR--- 370
L +LHE+ +H ++ + NI +D +++V A +G A + HV+
Sbjct: 168 LLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGS 224
Query: 371 ---VMGTFGYLAPEYAS----SGK-LTEKSDVFSFGVLLLELITGFRP 410
G E+ S G + +SD+ S G +L+ + GF P
Sbjct: 225 RSPHEGD-----LEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 7e-12
Identities = 52/207 (25%), Positives = 85/207 (41%), Gaps = 24/207 (11%)
Query: 215 NLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA---EIEIISQVHHR----- 265
+L+G+G FG V K + VAIK +K + E+ ++ ++
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 266 -HLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH 324
++V L + F + LV+E + + + R V TR K A L +L
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTR-KFAQQMCTALLFLA 174
Query: 325 EDCQPKIIHRDIKSANILL--DDSFEAKVADFGLAKHSLDT-DTHVSTRVMGTFGYLAPE 381
+ IIH D+K NILL K+ DFG + ++ +R F Y +PE
Sbjct: 175 TP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSR----F-YRSPE 228
Query: 382 YASSGKLTEKSDVFSFGVLLLELITGF 408
D++S G +L+E+ TG
Sbjct: 229 VLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 9e-12
Identities = 47/250 (18%), Positives = 85/250 (34%), Gaps = 57/250 (22%)
Query: 172 STSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGV-L 230
+ SGS + + P + + ++ D + +L+G G +G+V +
Sbjct: 19 TVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQI---PDRYEIRHLIGTGSYGHVCEAYDK 75
Query: 231 TNGKVVAIKQLKAGSGQGEREFQA---------EIEIISQVHHRHLVSLVGYCTFGSQRL 281
+VVAIK++ R F+ EI I+++++H H+V ++
Sbjct: 76 LEKRVVAIKKI-------LRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEK 128
Query: 282 -----LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA----------RGLAYLHED 326
+V E + + R + L G+ Y+H
Sbjct: 129 FDELYVVLEI-----ADSDFKK----LF----RTPVYLTELHIKTLLYNLLVGVKYVHS- 174
Query: 327 CQPKIIHRDIKSANILLDDSFEAKVADFGLA------KHSLDTDTHVSTRVMGTFGYLAP 380
I+HRD+K AN L++ KV DFGLA ++
Sbjct: 175 --AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPH 232
Query: 381 EYASSGKLTE 390
+LT
Sbjct: 233 TKNLKRQLTG 242
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 57/269 (21%), Positives = 89/269 (33%), Gaps = 73/269 (27%)
Query: 217 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH--------HRHL 267
LG G F V + K VA+K +K+ E EI ++ V +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNREMV 103
Query: 268 VSLVGYCTF----GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYL 323
V L+ G+ +V+E + + L++ + + + P KI +GL YL
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQG-LPLPCVKKIIQQVLQGLDYL 162
Query: 324 HEDCQPKIIHRDIKSANILL---------------------------------------- 343
H C+ IIH DIK NILL
Sbjct: 163 HTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNF 220
Query: 344 ---------DDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 394
+ + K+AD G A H + + T Y + E +D+
Sbjct: 221 LVNPLEPKNAEKLKVKIADLGNACW---VHKHFTEDIQ-TRQYRSLEVLIGSGYNTPADI 276
Query: 395 FSFGVLLLELITG---FRPFDKADTFADD 420
+S + EL TG F P + D+
Sbjct: 277 WSTACMAFELATGDYLFEPHSGEEYTRDE 305
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 45/231 (19%), Positives = 86/231 (37%), Gaps = 48/231 (20%)
Query: 216 LLGQGGFGYVHKGVLTNGK------VVAIKQLKAGSGQGEREFQ-----AEIEIISQVHH 264
+GQGGFG ++ + + + +K + +G E + A+ E I +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 265 RHLVSLVGYCT---FGSQ-------RLLVYEFVPNKTLE--FHLHGKDRPVMNWPTRMKI 312
+ +G G R ++ + L+ + + K + T +++
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAK---RFSRKTVLQL 157
Query: 313 ALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKV--ADFGLAKHSLDTDTHV--- 367
+L L Y+HE +H DIK++N+LL+ +V D+GLA H
Sbjct: 158 SLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYA 214
Query: 368 ---STRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVLLLELITGFRP 410
GT E+ S + + D+ G +++ +TG P
Sbjct: 215 ADPKRCHDGT-----IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 28/103 (27%), Positives = 49/103 (47%), Gaps = 18/103 (17%)
Query: 318 RGLAYLHEDCQPKIIHRDIKSANILLDDSF-EAKVADFGLAKHSLDTDTH-------VST 369
RGL Y+H ++HRD+K AN+ ++ K+ DFGLA+ +H + T
Sbjct: 131 RGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 370 RVMGTFGYLAPE-YASSGKLTEKSDVFSFGVLLLELITGFRPF 411
+ Y +P S T+ D+++ G + E++TG +
Sbjct: 188 K-----WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KTL 224
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 48/209 (22%), Positives = 79/209 (37%), Gaps = 49/209 (23%)
Query: 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQA---------EIE 257
DN+ +L+G+G +GYV+ K VAIK++ R F+ EI
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV-------NRMFEDLIDCKRILREIT 77
Query: 258 IISQVHHRHLVSLVGYCTFGSQRL-----LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKI 312
I++++ +++ L +V E + L + + I
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEI-----ADSDLKK----LF----KTPI 124
Query: 313 ALGSA----------RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH-SL 361
L G ++HE IIHRD+K AN LL+ KV DFGLA+ +
Sbjct: 125 FLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181
Query: 362 DTDTHVSTRVMGTFGYLAPEYASSGKLTE 390
+ DT++ + +LT
Sbjct: 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTS 210
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 52/229 (22%), Positives = 85/229 (37%), Gaps = 47/229 (20%)
Query: 216 LLGQGGFGYVHKGV-LTNGKVVAIKQLK---AGSGQGEREFQ-----AEIEIISQVHHRH 266
+G GGFG ++ + A +K +G E + A+ + I + R
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 267 LVSLVGYCTF----------GSQRLLVYEFVPNKTLE--FHLHGKDRPVMNWPTRMKIAL 314
+ +G F S R +V E + L+ +G T +++ +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGT----FKKSTVLQLGI 158
Query: 315 GSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKV--ADFGLAKHSLDTDTHV----- 367
L Y+HE+ +H DIK+AN+LL +V AD+GL+ H
Sbjct: 159 RMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQEN 215
Query: 368 -STRVMGTFGYLAPEYAS----SGK-LTEKSDVFSFGVLLLELITGFRP 410
GT E+ S G L+ +SDV G +L + G P
Sbjct: 216 PRKGHNGT-----IEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 35/109 (32%), Positives = 52/109 (47%), Gaps = 24/109 (22%)
Query: 318 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT------------ 365
R + LH +IHRD+K +N+L++ + + KV DFGLA+ ++
Sbjct: 123 RAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 366 --HVSTRVMGTFGYLAPEY-ASSGKLTEKSDVFSFGVLLLELITGFRPF 411
V+TR Y APE +S K + DV+S G +L EL RP
Sbjct: 180 VEFVATR-----WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR-RPI 222
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 64.1 bits (155), Expect = 9e-11
Identities = 68/420 (16%), Positives = 118/420 (28%), Gaps = 120/420 (28%)
Query: 93 IFLIFYKRRKRKLAAQNLP--LKSIFSNVKNDPFAGKPHH--------W-----QQNV-- 135
I +F +++ KSI S + D W Q+ +
Sbjct: 21 ILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQ 80
Query: 136 -----SAPSDYQELPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGM 190
+Y+ L P P+ + T + L + + R P
Sbjct: 81 KFVEEVLRINYKFLMSPIKTEQRQPS--MMTRMYIEQRDRLYNDNQVFAKYNVSRLQP-- 136
Query: 191 PVGNFKSTFTYEELKIATDNFSEANLL---GQGGFGYVHKGVLTNGKVVAIKQLKAGSGQ 247
Y +L+ A A + G G G K + A+ + Q
Sbjct: 137 ----------YLKLRQALLELRPAKNVLIDGVLGSG---KTWV------ALDVCLSYKVQ 177
Query: 248 GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL-----LVYEFVPNKTLEFHLHGKDRP 302
+ +F+ ++ + C L L+Y+ PN T D
Sbjct: 178 CKMDFKI-----------FWLN-LKNCNSPETVLEMLQKLLYQIDPNWT-----SRSDHS 220
Query: 303 VMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVAD-FGL-AKHS 360
N R+ R L + + ++ ++L + AK + F L K
Sbjct: 221 S-NIKLRIHSIQAELRRL----------LKSKPYENCLLVLLNVQNAKAWNAFNLSCK-- 267
Query: 361 LDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSF--GVLLLELITGFRPFD---KAD 415
++TR +L+ + L S + LL RP D +
Sbjct: 268 ----ILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVL 323
Query: 416 TFADDSMVDWAKPFL----AQGLADG----------NFDAL---VDQKLEEYDSAEMTRM 458
T P A+ + DG N D L ++ L + AE +M
Sbjct: 324 TTN---------PRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKM 374
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 9e-11
Identities = 64/244 (26%), Positives = 94/244 (38%), Gaps = 84/244 (34%)
Query: 216 LLGQGGFGYV-----HKGVLTNGKVVAIKQLKAGSGQGEREFQA---EIEIISQVHHR-- 265
LG+G FG V HK G+ VA+K +K +R +A EI+++ ++
Sbjct: 21 TLGEGAFGKVVECIDHK---AGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDP 73
Query: 266 ----HLVSLVGY-------C-TFGSQRLLVYEFV-PNKTLEFHLHGKDRPVMNWPTRMKI 312
V ++ + C F L Y+F+ N L F L R K+
Sbjct: 74 NSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDH---------IR-KM 123
Query: 313 ALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA-------------------KVAD 353
A + + +LH K+ H D+K NIL S KV D
Sbjct: 124 AYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180
Query: 354 FGLAKHSLDTDTH---VSTRVMGTFGYLAPE------YASSGKLTEKSDVFSFGVLLLEL 404
FG A + D + H VSTR Y APE + ++ DV+S G +L+E
Sbjct: 181 FGSA--TYDDEHHSTLVSTRH-----YRAPEVILALGW------SQPCDVWSIGCILIEY 227
Query: 405 ITGF 408
GF
Sbjct: 228 YLGF 231
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 54/232 (23%), Positives = 87/232 (37%), Gaps = 60/232 (25%)
Query: 216 LLGQGGFGYVHKGV--LTNGKVVAIKQLKAGSGQGEREFQA---EIEIISQVHHR----- 265
LG+G FG V + + VA+K ++ + +A EI ++ ++ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENK 81
Query: 266 -HLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH 324
V + + F + +E + T EF +P R +A L +LH
Sbjct: 82 FLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVR-HMAYQLCHALRFLH 140
Query: 325 EDCQPKIIHRDIKSANILLDDSFEA-------------------KVADFGLAKHSLDTDT 365
E ++ H D+K NIL +S +VADFG A + D +
Sbjct: 141 E---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHEH 195
Query: 366 H---VSTRVMGTFGYLAPE------YASSGKLTEKSDVFSFGVLLLELITGF 408
H V+TR Y PE + + DV+S G +L E GF
Sbjct: 196 HTTIVATRH-----YRPPEVILELGW------AQPCDVWSIGCILFEYYRGF 236
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 6e-10
Identities = 51/238 (21%), Positives = 87/238 (36%), Gaps = 68/238 (28%)
Query: 216 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA---EIEIISQV-----HHRH 266
+G G FG V + N K A+K ++ ++ ++ E +I+ ++ ++ +
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNN 97
Query: 267 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRM--KIALGSARGLAYLH 324
+V G + L++E + E + + L YL
Sbjct: 98 IVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGF---HIEDIKLYCIEILKALNYLR 154
Query: 325 EDCQPKIIHRDIKSANILLDDSFEA-------------------------KVADFGLAKH 359
+ + H D+K NILLDD + K+ DFG A
Sbjct: 155 KM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA-- 209
Query: 360 SLDTDTH---VSTRVMGTFGYLAPE------YASSGKLTEKSDVFSFGVLLLELITGF 408
+ +D H ++TR Y APE + SD++SFG +L EL TG
Sbjct: 210 TFKSDYHGSIINTR----Q-YRAPEVILNLGW------DVSSDMWSFGCVLAELYTGS 256
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 9e-10
Identities = 52/212 (24%), Positives = 80/212 (37%), Gaps = 32/212 (15%)
Query: 217 LGQGGFGYVHKGV-LTNGKVVAIKQ--LKAGSGQGEREFQ-----AEIEIISQVHHRHLV 268
+G G FG ++ G + G+ VAIK +K Q E + I +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRW---- 72
Query: 269 SLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 328
G ++V E + +LE + R + T + +A + Y+H
Sbjct: 73 ----CGAEGDYNVMVMELL-GPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSKN- 125
Query: 329 PKIIHRDIKSANILL---DDSFEAKVADFGLAKHSLD--TDTHVSTR----VMGTFGYLA 379
IHRD+K N L+ + DFGLAK D T H+ R + GT Y A
Sbjct: 126 --FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY-A 182
Query: 380 PEYASSGK-LTEKSDVFSFGVLLLELITGFRP 410
G + + D+ S G +L+ G P
Sbjct: 183 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 49/213 (23%), Positives = 83/213 (38%), Gaps = 32/213 (15%)
Query: 217 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHH-RHLVSLVGYC 274
+G+G FG + +G L N + VAIK S + + E + + ++ +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 275 TFGSQRLLVYEFV-PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIH 333
G +LV + + P+ LE L R + T A + +HE +++
Sbjct: 76 QEGLHNVLVIDLLGPS--LEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHEKS---LVY 129
Query: 334 RDIKSANILLDDSFEAK-----VADFGLAKHSLDTDT--HVSTR----VMGTFGYLAPEY 382
RDIK N L+ V DFG+ K D T H+ R + GT Y
Sbjct: 130 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT-----ARY 184
Query: 383 AS----SGK-LTEKSDVFSFGVLLLELITGFRP 410
S G+ + + D+ + G + + + G P
Sbjct: 185 MSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 51/213 (23%), Positives = 85/213 (39%), Gaps = 32/213 (15%)
Query: 217 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHH-RHLVSLVGYC 274
+G G FG + G L + VAIK S + E Q+ + + +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLGSGDGIPQVYYFG 74
Query: 275 TFGSQRLLVYEFV-PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIH 333
G +V E + P+ LE DR + T + IA+ + Y+H +I+
Sbjct: 75 PCGKYNAMVLELLGPS--LEDLFDLCDR-TFSLKTVLMIAIQLISRMEYVHSKN---LIY 128
Query: 334 RDIKSANILL---DDSFEAKV--ADFGLAKHSLDTDT--HVSTR----VMGTFGYLAPEY 382
RD+K N L+ + + + DF LAK +D +T H+ R + GT Y
Sbjct: 129 RDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGT-----ARY 183
Query: 383 AS----SGK-LTEKSDVFSFGVLLLELITGFRP 410
S GK + + D+ + G + + + G P
Sbjct: 184 MSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 28/115 (24%), Positives = 48/115 (41%), Gaps = 25/115 (21%)
Query: 318 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGY 377
+ + YLH ++HRD+K +NILL+ KVADFGL++ ++ + +
Sbjct: 120 KVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 378 LAPEYASSGKLTE--------------------KS-DVFSFGVLLLELITGFRPF 411
LT+ K D++S G +L E++ G +P
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG-KPI 230
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 49/206 (23%), Positives = 87/206 (42%), Gaps = 20/206 (9%)
Query: 217 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGYC 274
+G G FG ++ G + + VAIK + + E +I + + ++ +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 275 TFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHR 334
G +LV + + +LE + R ++ T + +A + ++H +HR
Sbjct: 73 VEGDYNVLVMDLL-GPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKS---FLHR 127
Query: 335 DIKSANILL---DDSFEAKVADFGLAKHSLDTDT--HVSTR----VMGTFGYLAPEYASS 385
DIK N L+ + + + DFGLAK DT T H+ R + GT Y A
Sbjct: 128 DIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY-ASVNTHL 186
Query: 386 GK-LTEKSDVFSFGVLLLELITGFRP 410
G + + D+ S G +L+ + G P
Sbjct: 187 GIEQSRRDDLESLGYVLMYFLRGSLP 212
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 586 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.82 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.68 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.42 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.28 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.14 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.09 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.8 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.73 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.61 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.5 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.49 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.47 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.26 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.21 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.09 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.07 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.02 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 97.78 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.74 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.6 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.52 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.43 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.41 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.4 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.3 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 97.28 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.24 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 97.22 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.03 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.81 | |
| 2k9y_A | 41 | Ephrin type-A receptor 2; receptor tyrosine kinase | 96.16 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.08 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 95.98 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.39 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.47 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 92.14 | |
| 2l34_A | 33 | TYRO protein tyrosine kinase-binding protein; immu | 91.19 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 90.85 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 90.81 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 88.82 | |
| 2l34_A | 33 | TYRO protein tyrosine kinase-binding protein; immu | 87.09 | |
| 2klu_A | 70 | T-cell surface glycoprotein CD4; cell membrane, di | 86.72 | |
| 1iij_A | 35 | ERBB-2 receptor protein-tyrosine kinase; alpha-hel | 86.22 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 86.0 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 83.65 | |
| 2l8s_A | 54 | Integrin alpha-1; transmembrane region, detergent | 81.54 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 81.4 | |
| 2knc_B | 79 | Integrin beta-3; transmembrane signaling, protein | 81.15 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-57 Score=463.18 Aligned_cols=257 Identities=25% Similarity=0.465 Sum_probs=215.3
Q ss_pred hcCccccceecccCcEEEEEEEEe------CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 281 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~ 281 (586)
.++|.+.+.||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 467889999999999999999864 47899999998877777789999999999999999999999999999999
Q ss_pred EEEEecCCCcHHHHhcCCC-----------CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeE
Q 007892 282 LVYEFVPNKTLEFHLHGKD-----------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAK 350 (586)
Q Consensus 282 lV~E~~~~gsL~~~l~~~~-----------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 350 (586)
||||||++|+|.++|+... ...++|.++++|+.||+.||+|||++ +||||||||+||||++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEE
Confidence 9999999999999997532 34699999999999999999999998 999999999999999999999
Q ss_pred EeecccccccCCCCCc-ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhH
Q 007892 351 VADFGLAKHSLDTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKP 428 (586)
Q Consensus 351 l~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~ 428 (586)
|+|||+++........ ......||+.|||||++.++.|+.++|||||||+||||+| |+.||..... ..+...
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~~~--- 242 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEVIEC--- 242 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHHHH---
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH---
Confidence 9999999865443322 2334679999999999999999999999999999999999 9999976542 111111
Q ss_pred HHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 429 FLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 429 ~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
+ ..+ .....+...+..+.+++.+||+.||.+||+|.||++.|+..
T Consensus 243 -i----~~~--------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 243 -I----TQG--------RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp -H----HHT--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -H----HcC--------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1 111 11123344556789999999999999999999999999864
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-56 Score=463.78 Aligned_cols=257 Identities=28% Similarity=0.467 Sum_probs=209.3
Q ss_pred hcCccccceecccCcEEEEEEEEe------CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 281 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~ 281 (586)
.++|.+.++||+|+||+||+|++. +++.||||+++.......++|++|+++|++++|||||+++|+|.+.+..+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 467888899999999999999864 47899999998877777789999999999999999999999999999999
Q ss_pred EEEEecCCCcHHHHhcCCC-------------CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCC
Q 007892 282 LVYEFVPNKTLEFHLHGKD-------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE 348 (586)
Q Consensus 282 lV~E~~~~gsL~~~l~~~~-------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 348 (586)
||||||++|+|.++|+... ...++|.++++|+.||++||+|||++ +||||||||+||||++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCc
Confidence 9999999999999997542 23599999999999999999999998 9999999999999999999
Q ss_pred eEEeecccccccCCCCC-cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhh
Q 007892 349 AKVADFGLAKHSLDTDT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWA 426 (586)
Q Consensus 349 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~ 426 (586)
+||+|||+++....... ......+||+.|||||++.+..++.++|||||||+||||+| |+.||..... ..+...
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~~~- 272 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN---TEAIDC- 272 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH---HHHHHH-
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH---HHHHHH-
Confidence 99999999987644332 23455789999999999999999999999999999999999 9999976542 111111
Q ss_pred hHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 427 KPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 427 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
+.+ +. ....+...+..+.+++.+||+.||.+||+|.||++.|+..
T Consensus 273 ---i~~----g~--------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l 317 (329)
T 4aoj_A 273 ---ITQ----GR--------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317 (329)
T ss_dssp ---HHH----TC--------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred ---HHc----CC--------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 111 10 0123334556789999999999999999999999999865
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-56 Score=458.39 Aligned_cols=256 Identities=25% Similarity=0.423 Sum_probs=212.5
Q ss_pred cCccccceecccCcEEEEEEEEe------CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 281 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~ 281 (586)
+++++.++||+|+||+||+|++. +++.||||+++... ....++|++|+.+|++++|||||+++|+|.+.+..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 45677799999999999999963 46899999997643 334578999999999999999999999999999999
Q ss_pred EEEEecCCCcHHHHhcCCC--------------CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCC
Q 007892 282 LVYEFVPNKTLEFHLHGKD--------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF 347 (586)
Q Consensus 282 lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 347 (586)
||||||++|+|.++|+... ...++|.++++|+.|||+||+|||++ +||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCC
Confidence 9999999999999996532 23589999999999999999999998 999999999999999999
Q ss_pred CeEEeecccccccCCCCC-cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhh
Q 007892 348 EAKVADFGLAKHSLDTDT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDW 425 (586)
Q Consensus 348 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~ 425 (586)
.+||+|||+++.....+. ...+..+||+.|||||++.++.|+.++|||||||+||||+| |+.||..... ..+...
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---~~~~~~ 259 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVVEM 259 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---HHHHHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH---HHHHHH
Confidence 999999999987543322 23455689999999999999999999999999999999998 8999976542 122221
Q ss_pred hhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 426 AKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 426 ~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
+..+.. ...+.+++..+.+++.+||+.||.+||+|.||++.|+.-
T Consensus 260 --------i~~~~~--------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 260 --------IRNRQV--------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp --------HHTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred --------HHcCCC--------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111211 122334566789999999999999999999999999853
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-56 Score=454.04 Aligned_cols=260 Identities=28% Similarity=0.453 Sum_probs=206.3
Q ss_pred HHhcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEE
Q 007892 206 IATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 206 ~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV 283 (586)
+..++|.+.++||+|+||+||+|++.+ .||||+++... ....+.|++|+.+|++++|||||+++|+|.. +..+||
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV 109 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV 109 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence 445788889999999999999998753 58999987543 3445789999999999999999999999865 568999
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCC
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 363 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 363 (586)
||||+||+|.++|+... ..++|.++++|+.|||+||+|||++ +||||||||+||||++++.+||+|||+|+.....
T Consensus 110 mEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp EECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred EEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 99999999999997643 3599999999999999999999998 9999999999999999999999999999875432
Q ss_pred C-CcccccccccccccCcccccC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCCh
Q 007892 364 D-THVSTRVMGTFGYLAPEYASS---GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 439 (586)
Q Consensus 364 ~-~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (586)
. .......+||+.|||||++.+ +.|+.++|||||||+||||+||+.||...... . .....+...
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~---~---~~~~~~~~~------ 253 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR---D---QIIFMVGRG------ 253 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH---H---HHHHHHHTT------
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH---H---HHHHHHhcC------
Confidence 2 233455789999999999863 46899999999999999999999999764421 1 111111111
Q ss_pred hhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 440 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 440 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
...+.+.....+++..+.+++.+||+.||.+||+|.||++.|+..
T Consensus 254 --~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 254 --YASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp --CCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred --CCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111222233344566789999999999999999999999988753
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-55 Score=453.73 Aligned_cols=250 Identities=21% Similarity=0.363 Sum_probs=205.3
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.|++|+++|++|+|||||++++++.+++..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 78999999999999999999975 68999999997543 2335678999999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 365 (586)
||+||+|.++|.......+++.+.+.|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+..... .
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-V 179 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH-H
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC-c
Confidence 99999999999876666789999999999999999999998 9999999999999999999999999999865321 1
Q ss_pred cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhch
Q 007892 366 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQ 445 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 445 (586)
...+..+||+.|||||++.+..|+.++|||||||+||||++|+.||..... .+.....+ .+.+
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i~-----~~~~------ 242 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM------KNLVLKII-----SGSF------ 242 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHH-----HTCC------
T ss_pred ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHHHH-----cCCC------
Confidence 233457899999999999999999999999999999999999999976542 11111111 1111
Q ss_pred hhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 446 KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 446 ~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
..........+.+|+.+||+.||.+||++.|+++
T Consensus 243 --~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 243 --PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1122233457889999999999999999999986
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-54 Score=445.62 Aligned_cols=249 Identities=21% Similarity=0.349 Sum_probs=209.3
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEec
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 287 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 287 (586)
+.|+..++||+|+||+||+|+.. +|+.||||+++.......+.+.+|+++|++++|||||+++++|.+++..|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999975 68999999997655555667899999999999999999999999999999999999
Q ss_pred CCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcc
Q 007892 288 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 367 (586)
Q Consensus 288 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 367 (586)
++|+|.+++... .+++.++..|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+...... ..
T Consensus 154 ~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~ 226 (346)
T 4fih_A 154 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PR 226 (346)
T ss_dssp TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CC
T ss_pred CCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCC-Cc
Confidence 999999998642 489999999999999999999998 99999999999999999999999999998764432 23
Q ss_pred cccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhh
Q 007892 368 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 447 (586)
Q Consensus 368 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 447 (586)
....+||+.|||||++.+..|+.++|||||||+||||++|+.||....... +... +... ..+.+
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~~----i~~~---------~~~~~ 290 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMKM----IRDN---------LPPRL 290 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHH----HHHS---------SCCCC
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHHH----HHcC---------CCCCC
Confidence 456789999999999999999999999999999999999999997654311 1110 1110 00011
Q ss_pred hccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 448 EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 448 ~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
.........+.+|+.+||+.||.+||++.|+++
T Consensus 291 -~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 291 -KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp -SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111223456889999999999999999999987
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=446.71 Aligned_cols=267 Identities=26% Similarity=0.416 Sum_probs=218.9
Q ss_pred cCHHHHHHHhcCccccceecccCcEEEEEEEEeC------CeEEEEEEeccCCch-hHHHHHHHHHHHHhcCC-CCcceE
Q 007892 199 FTYEELKIATDNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHH-RHLVSL 270 (586)
Q Consensus 199 ~~~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~~------g~~vAVK~l~~~~~~-~~~~~~~Ei~il~~l~H-pniv~l 270 (586)
+...++++..++|++.+.||+|+||+||+|.+.. ++.||||+++..... ..+.|.+|+.+|.++.| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 4456677888999999999999999999999653 368999999776443 35679999999999964 999999
Q ss_pred EEEEEeC-CeeEEEEEecCCCcHHHHhcCCC--------------CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecC
Q 007892 271 VGYCTFG-SQRLLVYEFVPNKTLEFHLHGKD--------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRD 335 (586)
Q Consensus 271 ~g~~~~~-~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrD 335 (586)
+|+|... +..+||||||++|+|.++|+... ...++|.+++.|+.|||+||+|||++ +|||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCc
Confidence 9999764 56899999999999999997532 24589999999999999999999998 999999
Q ss_pred CCCceeEeCCCCCeEEeecccccccCCCCC-cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCC
Q 007892 336 IKSANILLDDSFEAKVADFGLAKHSLDTDT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDK 413 (586)
Q Consensus 336 Ik~~NILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~ 413 (586)
|||+||||++++.+||+|||+|+....... ......+||+.|||||++.++.|+.++|||||||+||||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999997654433 23455789999999999999999999999999999999998 9999976
Q ss_pred CCcccchhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 414 ADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 414 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
.... ..+. ..+.+ +. ....+......+.+++..||+.||.+||+|.||++.|+..
T Consensus 291 ~~~~--~~~~----~~i~~----g~--------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 291 VKID--EEFC----RRLKE----GT--------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp CCCS--HHHH----HHHHH----TC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCHH--HHHH----HHHHc----CC--------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 4421 1111 11111 11 0122333456788999999999999999999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-53 Score=439.82 Aligned_cols=252 Identities=19% Similarity=0.243 Sum_probs=206.5
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
.+.|...++||+|+||.||+|+.. +|+.||||+++.... +.+|+.+|++++|||||+++++|.+++..||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 356888899999999999999975 589999999975432 34799999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCC-CeEEeecccccccCCCCC
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF-EAKVADFGLAKHSLDTDT 365 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~-~~kl~DFGla~~~~~~~~ 365 (586)
|+||+|.++|+... .+++.++..|+.||+.||+|||++ +||||||||+||||+.++ .+||+|||+|+.......
T Consensus 132 ~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 132 LEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp CTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred cCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 99999999997543 599999999999999999999998 999999999999999987 699999999987643321
Q ss_pred c----ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhh
Q 007892 366 H----VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 441 (586)
Q Consensus 366 ~----~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (586)
. .....+||+.|||||++.+..|+.++|||||||+||||++|+.||....... +.. ... .+.
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~---~i~-----~~~--- 272 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP---LCL---KIA-----SEP--- 272 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC---CHH---HHH-----HSC---
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HHH---HHH-----cCC---
Confidence 1 2234689999999999999999999999999999999999999997654321 110 000 000
Q ss_pred hhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 442 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 442 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
+.+..++......+.+++.+||+.||.+||++.||++.|...
T Consensus 273 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 273 ---PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp ---CGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 111123344556789999999999999999999999888654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-54 Score=439.64 Aligned_cols=269 Identities=22% Similarity=0.287 Sum_probs=202.3
Q ss_pred cCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC----eeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS----QRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~----~~~lV~ 284 (586)
.+|.+.++||+|+||+||+|++ +|+.||||+++.... ....+..|+.++.+++|||||+++|+|.+.+ ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 3577889999999999999998 689999999965421 1223345666677899999999999998754 579999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcC-----CCcEEecCCCCceeEeCCCCCeEEeecccccc
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC-----QPKIIHRDIKSANILLDDSFEAKVADFGLAKH 359 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~-----~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~ 359 (586)
|||++|+|.++|+.. .++|..+++|+.|+++||+|||+++ .++||||||||+||||+.++.+||+|||+++.
T Consensus 81 Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 999999999999754 4899999999999999999999862 46899999999999999999999999999987
Q ss_pred cCCCCCc---ccccccccccccCcccccCC------CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccc----hhhhhhh
Q 007892 360 SLDTDTH---VSTRVMGTFGYLAPEYASSG------KLTEKSDVFSFGVLLLELITGFRPFDKADTFAD----DSMVDWA 426 (586)
Q Consensus 360 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~----~~~~~~~ 426 (586)
....... .....+||+.|||||++.+. .++.++|||||||+||||+||..||........ .....+.
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 6443322 22346899999999999754 467899999999999999999888764332110 0000111
Q ss_pred hHHHhhcccCCChhhhhchhhh--ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 427 KPFLAQGLADGNFDALVDQKLE--EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 427 ~~~~~~~~~~~~~~~l~d~~l~--~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
...+...+..+.+ ++.+. ....+....+.+++.+||+.||.+||||.||++.|+..
T Consensus 238 ~~~~~~~~~~~~~----rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 238 VEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp HHHHHHHHTTSCC----CCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHhcccC----CCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 1111111111111 11221 12345667899999999999999999999999999864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-53 Score=447.98 Aligned_cols=249 Identities=21% Similarity=0.349 Sum_probs=210.1
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEec
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 287 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 287 (586)
+.|+..++||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||+++++|.+++..|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56999999999999999999975 68999999997766556677899999999999999999999999999999999999
Q ss_pred CCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcc
Q 007892 288 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 367 (586)
Q Consensus 288 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 367 (586)
+||+|.+++... .+++.++..|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+...... ..
T Consensus 231 ~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-~~ 303 (423)
T 4fie_A 231 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PR 303 (423)
T ss_dssp TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-CC
T ss_pred CCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCC-cc
Confidence 999999998643 489999999999999999999998 99999999999999999999999999998764432 23
Q ss_pred cccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhh
Q 007892 368 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 447 (586)
Q Consensus 368 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 447 (586)
....+||+.|||||++.+..|+.++|||||||+||||++|+.||....... +... +... ..+.+
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~~----i~~~---------~~~~~ 367 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMKM----IRDN---------LPPRL 367 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHH----HHHS---------CCCCC
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHHH----HHcC---------CCCCC
Confidence 456789999999999999999999999999999999999999997654311 1110 1110 00111
Q ss_pred hccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 448 EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 448 ~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
. ........+.+|+.+||+.||.+||++.|+++
T Consensus 368 ~-~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 368 K-NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp S-CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred c-ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1 11223456889999999999999999999987
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=427.22 Aligned_cols=247 Identities=26% Similarity=0.408 Sum_probs=197.5
Q ss_pred ccccceecccCcEEEEEEEEe-CCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEe----CCeeEEE
Q 007892 211 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTF----GSQRLLV 283 (586)
Q Consensus 211 f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~----~~~~~lV 283 (586)
|++.++||+|+||+||+|++. +++.||||++... .....+.|.+|+++|++|+|||||+++++|.. ....+||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 356678999999999999975 5889999999643 33345679999999999999999999999865 3457899
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCC-CCCeEEeecccccccCC
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD-SFEAKVADFGLAKHSLD 362 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~-~~~~kl~DFGla~~~~~ 362 (586)
||||++|+|.++|... ..+++..+..|+.||+.||+|||++ .++||||||||+||||+. ++.+||+|||+|+....
T Consensus 108 mEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 9999999999999754 3599999999999999999999987 224999999999999984 78999999999986432
Q ss_pred CCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhh
Q 007892 363 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 442 (586)
Q Consensus 363 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 442 (586)
......+||+.|||||++. +.|+.++|||||||+||||+||+.||...... ..+. +.+..+....
T Consensus 185 ---~~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~--~~~~--------~~i~~~~~~~- 249 (290)
T 3fpq_A 185 ---SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIY--------RRVTSGVKPA- 249 (290)
T ss_dssp ---TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHH--------HHHTTTCCCG-
T ss_pred ---CccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH--HHHH--------HHHHcCCCCC-
Confidence 2335578999999999887 46999999999999999999999999754321 1111 1111111111
Q ss_pred hchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 443 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 443 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
.++......+.+++.+||+.||.+||++.|+++
T Consensus 250 ------~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 250 ------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111112346889999999999999999999986
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-53 Score=433.66 Aligned_cols=247 Identities=20% Similarity=0.308 Sum_probs=208.0
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
++|++.+.||+|+||+||+|+.. +|+.||||++... .....+.+.+|+++|++++|||||++++++.+++..||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999965 6899999999643 2233567899999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
|||+||+|.++|.... .+++.+...++.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+......
T Consensus 112 Ey~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 9999999999997543 499999999999999999999998 99999999999999999999999999999764332
Q ss_pred -CcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhh
Q 007892 365 -THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 443 (586)
Q Consensus 365 -~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 443 (586)
.......+||+.|||||++.+..|+.++|||||||+||||++|+.||...+.. +.....+ .+.+
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~~~~~i~-----~~~~---- 251 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG------LIFAKII-----KLEY---- 251 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHH-----HTCC----
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHH-----cCCC----
Confidence 23345679999999999999999999999999999999999999999764421 1111111 1111
Q ss_pred chhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 007892 444 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIV 480 (586)
Q Consensus 444 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl 480 (586)
.++......+.+++.+||+.||.+||++.|++
T Consensus 252 -----~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 -----DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp -----CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred -----CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 12233445788999999999999999999874
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=416.00 Aligned_cols=249 Identities=24% Similarity=0.356 Sum_probs=193.2
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
++|++.+.||+|+||+||+|+.. +|+.||||+++... ......+.+|+++|++++|||||++++++.+.+..+|||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999964 68999999996542 233467899999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
||+ +|+|.+++.... .+++.+...++.|++.||+|||++ +|+||||||+||||++++.+||+|||+|+...+..
T Consensus 93 Ey~-~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp ECC-CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred eCC-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 999 689999886543 599999999999999999999998 99999999999999999999999999998654322
Q ss_pred CcccccccccccccCcccccCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhh
Q 007892 365 THVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 443 (586)
Q Consensus 365 ~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 443 (586)
.....+||+.|||||++.+..+ +.++|||||||+||||++|+.||..... ........ .+.+
T Consensus 167 --~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~------~~~~~~i~-----~~~~---- 229 (275)
T 3hyh_A 167 --FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI------PVLFKNIS-----NGVY---- 229 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH-----HTCC----
T ss_pred --ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHH-----cCCC----
Confidence 3345789999999999998776 5799999999999999999999975432 11111111 1111
Q ss_pred chhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHhc
Q 007892 444 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR--ALEG 485 (586)
Q Consensus 444 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~--~L~~ 485 (586)
.++......+.+++.+||+.||.+|||+.|+++ .++.
T Consensus 230 -----~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 230 -----TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp -----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred -----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 122233456889999999999999999999997 4543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-52 Score=424.33 Aligned_cols=247 Identities=28% Similarity=0.353 Sum_probs=197.5
Q ss_pred cCccccceecccCcEEEEEEEEe----CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT----NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 282 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~----~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~l 282 (586)
++|++.+.||+|+||+||+|+.. .++.||||+++... ......+.+|+++|++++|||||++++++.+++..||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999863 46899999996542 1223468899999999999999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCC
Q 007892 283 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 283 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 362 (586)
|||||+||+|.++|.... .+++.++..++.|++.||+|||++ +||||||||+||||+.++.+||+|||+|+...+
T Consensus 104 vmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 999999999999997543 599999999999999999999998 999999999999999999999999999986543
Q ss_pred CCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhh
Q 007892 363 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 442 (586)
Q Consensus 363 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 442 (586)
... .....+||+.|||||++.+..|+.++|||||||+||||+||+.||...+.. +.....+. +.
T Consensus 179 ~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~------~~~~~i~~-----~~---- 242 (304)
T 3ubd_A 179 HEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK------ETMTMILK-----AK---- 242 (304)
T ss_dssp --C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH-----CC----
T ss_pred CCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH------HHHHHHHc-----CC----
Confidence 332 234578999999999999999999999999999999999999999765421 11111111 11
Q ss_pred hchhhhccCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 007892 443 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPR-----MSQIVR 481 (586)
Q Consensus 443 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----m~evl~ 481 (586)
+ .++......+.+++.+||+.||.+||+ ++|+++
T Consensus 243 ----~-~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 243 ----L-GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp ----C-CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred ----C-CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 1 122334567889999999999999998 456664
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=413.66 Aligned_cols=249 Identities=22% Similarity=0.353 Sum_probs=189.1
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC--------
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGS-------- 278 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~-------- 278 (586)
++|++.+.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|+++|++|+|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46899999999999999999975 689999999975443 33467899999999999999999999987644
Q ss_pred ----eeEEEEEecCCCcHHHHhcCCCC-CCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEee
Q 007892 279 ----QRLLVYEFVPNKTLEFHLHGKDR-PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVAD 353 (586)
Q Consensus 279 ----~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~D 353 (586)
..|||||||++|+|.+++..... ....+..++.|+.||+.||+|||++ +||||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999976543 2356677889999999999999998 999999999999999999999999
Q ss_pred cccccccCCCCCc-----------ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhh
Q 007892 354 FGLAKHSLDTDTH-----------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSM 422 (586)
Q Consensus 354 FGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~ 422 (586)
||+|+........ ..+..+||+.|||||++.+..|+.++|||||||+||||++ ||..... .
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~-----~ 233 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME-----R 233 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH-----H
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH-----H
Confidence 9999875432211 1234689999999999999999999999999999999996 7753211 0
Q ss_pred hhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 423 VDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 423 ~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
... + ..+....+.. ........+.+++.+||+.||.+||++.||++
T Consensus 234 ~~~----~-~~~~~~~~p~--------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 234 VRT----L-TDVRNLKFPP--------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHH----H-HHHHTTCCCH--------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHH----H-HHHhcCCCCC--------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000 0 0011111111 11222345678999999999999999999987
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=402.93 Aligned_cols=289 Identities=51% Similarity=0.861 Sum_probs=245.2
Q ss_pred ccCHHHHHHHhcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 007892 198 TFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTF 276 (586)
Q Consensus 198 ~~~~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~-~~~~~~~Ei~il~~l~Hpniv~l~g~~~~ 276 (586)
.|++.++....++|+..+.||+|+||.||+|...+|+.||||++...... ....+.+|+.++.+++||||++++++|..
T Consensus 19 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 98 (326)
T 3uim_A 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT 98 (326)
T ss_dssp ECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECC
T ss_pred eecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEec
Confidence 68889999999999999999999999999999888999999999765322 23378999999999999999999999999
Q ss_pred CCeeEEEEEecCCCcHHHHhcCCC--CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeec
Q 007892 277 GSQRLLVYEFVPNKTLEFHLHGKD--RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADF 354 (586)
Q Consensus 277 ~~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DF 354 (586)
.+..++||||+++|+|.+++.... ...++|..+..|+.|++.||+|||+.+.++|+||||||+||||++++.+||+||
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Df 178 (326)
T 3uim_A 99 PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 178 (326)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCC
T ss_pred CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccC
Confidence 999999999999999999997653 345999999999999999999999987779999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc--ccchhhhhhhhHHHhh
Q 007892 355 GLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADT--FADDSMVDWAKPFLAQ 432 (586)
Q Consensus 355 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~--~~~~~~~~~~~~~~~~ 432 (586)
|+++..............||+.|+|||++.++.++.++|||||||+||||++|+.||..... .....+.+|....
T Consensus 179 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--- 255 (326)
T 3uim_A 179 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL--- 255 (326)
T ss_dssp SSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT---
T ss_pred ccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH---
Confidence 99987655555555566799999999999988999999999999999999999999963221 1223445554433
Q ss_pred cccCCChhhhhchhhh-ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCCCC
Q 007892 433 GLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMPLD 490 (586)
Q Consensus 433 ~~~~~~~~~l~d~~l~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~~~~ 490 (586)
+....+..+.+..+. .+.......+.+++.+||+.||.+||++.||+++|++.....
T Consensus 256 -~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~ 313 (326)
T 3uim_A 256 -LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAE 313 (326)
T ss_dssp -TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSS
T ss_pred -hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhh
Confidence 334455566666665 677888999999999999999999999999999999865443
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=399.29 Aligned_cols=282 Identities=41% Similarity=0.711 Sum_probs=241.2
Q ss_pred HHHHHHHhcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCee
Q 007892 201 YEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR 280 (586)
Q Consensus 201 ~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~ 280 (586)
+.++...+++|+..+.||+|+||.||+|++.+++.||||++........+.+.+|+.++.+++||||++++++|...+..
T Consensus 31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp CSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred HHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 34455677899999999999999999999888999999999877666778899999999999999999999999999999
Q ss_pred EEEEEecCCCcHHHHhcCCCC--CCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccc
Q 007892 281 LLVYEFVPNKTLEFHLHGKDR--PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 358 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~~~--~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~ 358 (586)
++||||+++|+|.+++..... ..++|..++.++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccc
Confidence 999999999999999976542 3589999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCC-CcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCC
Q 007892 359 HSLDTD-THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADG 437 (586)
Q Consensus 359 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (586)
...... ........||+.|+|||++.++.++.++|||||||+||||++|+.||.............|..... ..+
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~----~~~ 263 (321)
T 2qkw_B 188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH----NNG 263 (321)
T ss_dssp ECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHH----TTT
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcc----ccc
Confidence 654322 223344569999999999998999999999999999999999999998776655556666654432 234
Q ss_pred Chhhhhchhhh-ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCCC
Q 007892 438 NFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMPL 489 (586)
Q Consensus 438 ~~~~l~d~~l~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~~~ 489 (586)
.+..++++.+. ....+....+.+++.+||+.||.+||++.||++.|+....+
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 44555555554 56778889999999999999999999999999999976543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=410.84 Aligned_cols=268 Identities=20% Similarity=0.308 Sum_probs=201.4
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEe------CCe
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTF------GSQ 279 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~------~~~ 279 (586)
++|++.+.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|+++|++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 67999999999999999999975 689999999975432 234578899999999999999999999764 357
Q ss_pred eEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccc
Q 007892 280 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 359 (586)
Q Consensus 280 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~ 359 (586)
.|||||||+ |+|.+++... ..+++.++..|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+.
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeee
Confidence 899999995 6799998654 4599999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCC---CcccccccccccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhh-hhhhHH---Hh
Q 007892 360 SLDTD---THVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMV-DWAKPF---LA 431 (586)
Q Consensus 360 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~-~~~~~~---~~ 431 (586)
+.... .......+||+.|||||++.+. .++.++|||||||+||||++|+.||...+.......+ ...... ..
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~ 287 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVI 287 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGT
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 54322 2233567899999999998765 5799999999999999999999999865532111000 000000 00
Q ss_pred hcccCCChhhhhch-------hhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 432 QGLADGNFDALVDQ-------KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 432 ~~~~~~~~~~l~d~-------~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
...........+.. .+..........+++|+.+||+.||.+|||+.|++++
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp C-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000000000000 0000111223568899999999999999999999873
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=398.49 Aligned_cols=201 Identities=23% Similarity=0.354 Sum_probs=172.7
Q ss_pred HHHhcCccccceecccCcEEEEEEEEe----CCeEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCe
Q 007892 205 KIATDNFSEANLLGQGGFGYVHKGVLT----NGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQ 279 (586)
Q Consensus 205 ~~~~~~f~~~~~LG~G~fG~Vyk~~~~----~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~~ 279 (586)
....+.|++.+.||+|+||+||+|+.+ .++.||||++.... ....+.+|+++|.++ +|||||++++++.+.+.
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 345678999999999999999999864 46899999986543 345688999999998 69999999999999999
Q ss_pred eEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCC-CCeEEeeccccc
Q 007892 280 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS-FEAKVADFGLAK 358 (586)
Q Consensus 280 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~-~~~kl~DFGla~ 358 (586)
.+||||||++|+|.+++. .+++.+...++.|++.||+|||++ +||||||||+||||+.+ +.+||+|||+|+
T Consensus 95 ~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 999999999999999983 388999999999999999999998 99999999999999876 799999999998
Q ss_pred ccCCCCC---------------------------cccccccccccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCC
Q 007892 359 HSLDTDT---------------------------HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRP 410 (586)
Q Consensus 359 ~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvL~elltG~~P 410 (586)
...+... ...+..+||+.|||||++.+. .|+.++||||+||+||||++|+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 6543221 112345799999999999765 589999999999999999999999
Q ss_pred CCCCC
Q 007892 411 FDKAD 415 (586)
Q Consensus 411 f~~~~ 415 (586)
|....
T Consensus 247 f~~~~ 251 (361)
T 4f9c_A 247 FYKAS 251 (361)
T ss_dssp SSCCS
T ss_pred CCCCC
Confidence 96543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=421.45 Aligned_cols=253 Identities=23% Similarity=0.339 Sum_probs=209.5
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
.++|++.+.||+|+||.||+|+.. +|+.||||+++.........+++|+++|++|+|||||+|++++.+.+..+|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 368999999999999999999975 6899999999876666667899999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCC--CCeEEeecccccccCCCC
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS--FEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~--~~~kl~DFGla~~~~~~~ 364 (586)
|+||+|.++|.... ..+++.++..++.||+.||+|||++ +|+||||||+||||+.+ +.+||+|||+++.+....
T Consensus 236 ~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 236 MSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred cCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 99999999986432 3589999999999999999999998 99999999999999854 899999999999764332
Q ss_pred CcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhc
Q 007892 365 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 444 (586)
Q Consensus 365 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 444 (586)
.....+||+.|||||++.+..|+.++|||||||+||||++|+.||...... ... .... .+.+. +.+
T Consensus 312 --~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~---~~~---~~i~-----~~~~~-~~~ 377 (573)
T 3uto_A 312 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---ETL---RNVK-----SCDWN-MDD 377 (573)
T ss_dssp --EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHH---HHHH-----TTCCC-CCS
T ss_pred --ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHH---HHHH-----hCCCC-CCc
Confidence 234568999999999999999999999999999999999999999765431 111 1111 11100 001
Q ss_pred hhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 445 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 445 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
... ......+.+|+.+||+.||.+||++.|++++
T Consensus 378 ~~~----~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 378 SAF----SGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp GGG----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccc----cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111 1223567899999999999999999999873
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=416.64 Aligned_cols=249 Identities=24% Similarity=0.363 Sum_probs=200.9
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHH---HHHHHHhcCCCCcceEEEEEEeCCee
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQA---EIEIISQVHHRHLVSLVGYCTFGSQR 280 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~---Ei~il~~l~Hpniv~l~g~~~~~~~~ 280 (586)
.++|++.++||+|+||+||+|+.. +|+.||||++++.. ......+.+ ++.++..++|||||+|++++.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 478999999999999999999975 58999999996431 122233344 45666777999999999999999999
Q ss_pred EEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccccc
Q 007892 281 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 360 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~ 360 (586)
|||||||+||+|.++|.... .+++.....++.||+.||+|||++ +||||||||+||||+.+|.+||+|||+|+..
T Consensus 268 ylVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeec
Confidence 99999999999999997543 499999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCcccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCCh
Q 007892 361 LDTDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 439 (586)
Q Consensus 361 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (586)
.... ....+||+.|||||++.. ..|+.++|||||||+||||++|+.||..........+. ...+
T Consensus 343 ~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~---~~i~--------- 407 (689)
T 3v5w_A 343 SKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---RMTL--------- 407 (689)
T ss_dssp SSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHH---HHHH---------
T ss_pred CCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---Hhhc---------
Confidence 4432 345689999999999975 47999999999999999999999999764432111111 1000
Q ss_pred hhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 007892 440 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPR-----MSQIVR 481 (586)
Q Consensus 440 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----m~evl~ 481 (586)
...+ .++......+.+++.+||+.||.+|++ +.||++
T Consensus 408 ----~~~~-~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 408 ----TMAV-ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp ----HCCC-CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ----CCCC-CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 0000 233334567899999999999999998 688864
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=375.51 Aligned_cols=258 Identities=27% Similarity=0.410 Sum_probs=213.2
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
.++|...+.||+|+||.||+|... +++.||||++........+.|.+|++++.+++||||++++++|.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 367899999999999999999975 5899999999777667778899999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 366 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 366 (586)
+++++|.+++.... ..+++.+++.|+.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++........
T Consensus 89 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 89 IKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp CTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 99999999997643 3589999999999999999999998 9999999999999999999999999999865433221
Q ss_pred c-------------cccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhc
Q 007892 367 V-------------STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQG 433 (586)
Q Consensus 367 ~-------------~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 433 (586)
. .....||+.|+|||++.+..++.++|||||||+||||++|..||............
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~---------- 234 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL---------- 234 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB----------
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh----------
Confidence 1 11457999999999999999999999999999999999999998754432111000
Q ss_pred ccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 434 LADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 434 ~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
......+. ..+......+.+++.+||+.||.+||++.||++.|+..
T Consensus 235 ----~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l 280 (310)
T 3s95_A 235 ----NVRGFLDR---YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280 (310)
T ss_dssp ----CHHHHHHH---TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----hhhccccc---cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 01111111 11223345688999999999999999999999999865
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=367.11 Aligned_cols=280 Identities=38% Similarity=0.672 Sum_probs=233.2
Q ss_pred cccCHHHHHHHhcCcccc------ceecccCcEEEEEEEEeCCeEEEEEEeccCC----chhHHHHHHHHHHHHhcCCCC
Q 007892 197 STFTYEELKIATDNFSEA------NLLGQGGFGYVHKGVLTNGKVVAIKQLKAGS----GQGEREFQAEIEIISQVHHRH 266 (586)
Q Consensus 197 ~~~~~~el~~~~~~f~~~------~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~----~~~~~~~~~Ei~il~~l~Hpn 266 (586)
..|++.++..++++|... +.||+|+||.||+|.. +++.||||++.... ....+.+.+|+.++.+++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 368999999999999887 9999999999999987 67899999986532 234568999999999999999
Q ss_pred cceEEEEEEeCCeeEEEEEecCCCcHHHHhcCCC-CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCC
Q 007892 267 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKD-RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD 345 (586)
Q Consensus 267 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 345 (586)
|+++++++...+..++||||+++++|.+++.... ...++|..++.++.|++.||.|||+. +|+||||||+||||+.
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE 168 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcC
Confidence 9999999999999999999999999999986432 34689999999999999999999998 9999999999999999
Q ss_pred CCCeEEeecccccccCCCCC-cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhh
Q 007892 346 SFEAKVADFGLAKHSLDTDT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD 424 (586)
Q Consensus 346 ~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~ 424 (586)
++.+||+|||+++....... .......||+.|+|||.+.+ .++.++|||||||+||||++|+.||...... ..+..
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~ 245 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP--QLLLD 245 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS--SBTTH
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch--HHHHH
Confidence 99999999999986543322 22344679999999998874 6899999999999999999999999865432 22222
Q ss_pred hhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 425 WAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 425 ~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
+..... .....+...++..+..........+.+++.+||+.+|.+||++.+|++.|+..
T Consensus 246 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 246 IKEEIE---DEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp HHHHHH---TTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHhh---hhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 222111 11234555666666667788889999999999999999999999999999865
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=384.30 Aligned_cols=258 Identities=26% Similarity=0.439 Sum_probs=212.4
Q ss_pred hcCccccceecccCcEEEEEEEEe--------CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhc-CCCCcceEEEEEEeC
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT--------NGKVVAIKQLKAGSG-QGEREFQAEIEIISQV-HHRHLVSLVGYCTFG 277 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~--------~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~ 277 (586)
.++|.+.+.||+|+||.||+|.+. ++..||||+++.... .....+.+|+.+|.++ +||||++++++|...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 478999999999999999999863 356899999976543 3346799999999999 899999999999999
Q ss_pred CeeEEEEEecCCCcHHHHhcCCC--------------CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEe
Q 007892 278 SQRLLVYEFVPNKTLEFHLHGKD--------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL 343 (586)
Q Consensus 278 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl 343 (586)
+..+|||||+++|+|.+++.... ...+++.+++.++.|++.||+|||++ +|+||||||+||||
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence 99999999999999999997543 23589999999999999999999998 99999999999999
Q ss_pred CCCCCeEEeecccccccCCCCC-cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchh
Q 007892 344 DDSFEAKVADFGLAKHSLDTDT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDS 421 (586)
Q Consensus 344 ~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~ 421 (586)
+.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||+||||++ |+.||...... .
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~---~ 313 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---E 313 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---G
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH---H
Confidence 9999999999999986544332 22334567889999999999999999999999999999999 99999764421 1
Q ss_pred hhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 422 MVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 422 ~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
+... +. .+. ....+......+.+++.+||+.+|.+||++.||++.|+...
T Consensus 314 ~~~~----~~----~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 314 LFKL----LK----EGH--------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp HHHH----HH----TTC--------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHH----Hh----cCC--------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111 11 110 01122334557899999999999999999999999998754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=376.76 Aligned_cols=265 Identities=29% Similarity=0.428 Sum_probs=206.1
Q ss_pred CHHHHHHHhcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 007892 200 TYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFG 277 (586)
Q Consensus 200 ~~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~ 277 (586)
...++.+..++|++.+.||+|+||.||+|+. +|+.||||++..... .....+.+|+++|.+++||||+++++++...
T Consensus 28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 3p86_A 28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 106 (309)
T ss_dssp ----CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred CcccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 3344556668899999999999999999987 688999999876543 3346789999999999999999999999999
Q ss_pred CeeEEEEEecCCCcHHHHhcCCCC-CCCChHHHHHHHHHHHHHhHhhhhcCCCc--EEecCCCCceeEeCCCCCeEEeec
Q 007892 278 SQRLLVYEFVPNKTLEFHLHGKDR-PVMNWPTRMKIALGSARGLAYLHEDCQPK--IIHRDIKSANILLDDSFEAKVADF 354 (586)
Q Consensus 278 ~~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~--ivHrDIk~~NILl~~~~~~kl~DF 354 (586)
+..++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+. + |+||||||+||||+.++.+||+||
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Df 183 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDF 183 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCC
Confidence 999999999999999999976432 2389999999999999999999998 7 999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcc
Q 007892 355 GLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGL 434 (586)
Q Consensus 355 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 434 (586)
|+++...... .......||+.|+|||++.+..++.++|||||||+||||++|+.||...... ....... ..
T Consensus 184 g~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~---~~~~~~~----~~- 254 (309)
T 3p86_A 184 GLSRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA---QVVAAVG----FK- 254 (309)
T ss_dssp C------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH---HHHHHHH----HS-
T ss_pred CCCccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHH----hc-
Confidence 9997543321 2234467999999999999999999999999999999999999999765431 1111100 00
Q ss_pred cCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 435 ADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 435 ~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
.. ....+......+.+++.+||+.+|.+||++.||++.|+...
T Consensus 255 -~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~ 297 (309)
T 3p86_A 255 -CK---------RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297 (309)
T ss_dssp -CC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CC---------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00 00122334456889999999999999999999999998654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=369.96 Aligned_cols=251 Identities=21% Similarity=0.372 Sum_probs=209.1
Q ss_pred hcCccccceecccCcEEEEEEEE-eCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
.++|+..+.||+|+||.||+|.. .+++.||||++........+.+.+|+.++.+++||||++++++|..++..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 36799999999999999999995 46899999999766555677899999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 366 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 366 (586)
+++|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+||||+.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 171 (297)
T 3fxz_A 99 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (297)
T ss_dssp CTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-
Confidence 9999999999653 489999999999999999999998 999999999999999999999999999986543322
Q ss_pred ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchh
Q 007892 367 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 446 (586)
Q Consensus 367 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 446 (586)
......||+.|+|||++.+..++.++|||||||+||||++|+.||...+... .+. ........ .
T Consensus 172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~----~~~~~~~~----------~ 235 (297)
T 3fxz_A 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--ALY----LIATNGTP----------E 235 (297)
T ss_dssp CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHH----HHHHHCSC----------C
T ss_pred ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHH----HHHhCCCC----------C
Confidence 2345679999999999999999999999999999999999999997654311 000 00000000 0
Q ss_pred hhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 447 LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 447 l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
+ ..+......+.+++.+||+.||.+||++.|+++.
T Consensus 236 ~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 236 L-QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp C-SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred C-CCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0 1122234568899999999999999999999873
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=371.57 Aligned_cols=261 Identities=22% Similarity=0.316 Sum_probs=216.7
Q ss_pred ccCHHHHHHHhcC----------ccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCC
Q 007892 198 TFTYEELKIATDN----------FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH 266 (586)
Q Consensus 198 ~~~~~el~~~~~~----------f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpn 266 (586)
.|++++++.+++. |...+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++.+++|||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 5788898888765 777789999999999999976 69999999998776666788999999999999999
Q ss_pred cceEEEEEEeCCeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCC
Q 007892 267 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS 346 (586)
Q Consensus 267 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 346 (586)
|++++++|...+..++||||+++++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||||+.+
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLD 177 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCC
Confidence 99999999999999999999999999999864 3489999999999999999999998 99999999999999999
Q ss_pred CCeEEeecccccccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhh
Q 007892 347 FEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWA 426 (586)
Q Consensus 347 ~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~ 426 (586)
+.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||+||||++|+.||...... .....
T Consensus 178 ~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~---~~~~~- 252 (321)
T 2c30_A 178 GRVKLSDFGFCAQISKDV-PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV---QAMKR- 252 (321)
T ss_dssp CCEEECCCTTCEECCSSS-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHH-
T ss_pred CcEEEeeeeeeeecccCc-cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH-
Confidence 999999999998654322 2234567999999999999999999999999999999999999999754421 11111
Q ss_pred hHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 427 KPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 427 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
+... ..+.+. ........+.+++.+||+.||.+||++.||++.
T Consensus 253 ---~~~~---------~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 253 ---LRDS---------PPPKLK-NSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp ---HHHS---------SCCCCT-TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ---HhcC---------CCCCcC-ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1100 000000 011223568899999999999999999999874
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=365.32 Aligned_cols=256 Identities=30% Similarity=0.462 Sum_probs=212.8
Q ss_pred HhcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
..++|+..+.||+|+||.||+|...+++.||||++..... ..+.+.+|++++.+++||||+++++++.+.+..++||||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred ChhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 3467999999999999999999998899999999976543 356899999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 366 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 366 (586)
+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 87 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 87 MEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp CTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence 99999999996543 3589999999999999999999998 9999999999999999999999999999865443322
Q ss_pred ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhch
Q 007892 367 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQ 445 (586)
Q Consensus 367 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 445 (586)
......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... ..... +. .+
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~---~~~~~----~~----~~-------- 223 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVED----IS----TG-------- 223 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHH----HH----TT--------
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH---HHHHH----Hh----cC--------
Confidence 3334557888999999998999999999999999999999 99999764421 11111 00 00
Q ss_pred hhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 446 KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 446 ~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
.....+......+.+++..||+.+|.+||++.|+++.|+..
T Consensus 224 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 224 FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 00011222345688999999999999999999999999864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=375.18 Aligned_cols=257 Identities=28% Similarity=0.430 Sum_probs=209.1
Q ss_pred hcCccccceecccCcEEEEEEEEe----CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT----NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 282 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~----~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~l 282 (586)
.++|.+.+.||+|+||.||+|.+. .+..||||+++... ....+.|.+|+.+|.+++||||++++++|.+++..+|
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 467999999999999999999974 45579999997653 3345679999999999999999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCC
Q 007892 283 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 283 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 362 (586)
||||+++++|.+++.... ..+++.+++.|+.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++....
T Consensus 128 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp EEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred EeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 999999999999996543 3589999999999999999999998 999999999999999999999999999987644
Q ss_pred CCCc--ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCCh
Q 007892 363 TDTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 439 (586)
Q Consensus 363 ~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (586)
.... ......+|+.|+|||++.+..++.++|||||||+||||++ |+.||...... .+.... ..+
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~~~--------~~~-- 270 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR---DVISSV--------EEG-- 270 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHHHHH--------HTT--
T ss_pred CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHH--------HcC--
Confidence 3221 2233456788999999998999999999999999999999 99999764421 111110 010
Q ss_pred hhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 440 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 440 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
.....+......+.+++..||+.||.+||++.||++.|+...
T Consensus 271 ------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~ 312 (325)
T 3kul_A 271 ------YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312 (325)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 000122334567899999999999999999999999998754
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=364.70 Aligned_cols=257 Identities=26% Similarity=0.397 Sum_probs=213.6
Q ss_pred HhcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
..++|++.+.||+|+||.||+|.+.++..||||+++.... ...++.+|++++.+++||||++++++|...+..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 4578999999999999999999998888999999976543 356799999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 366 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 366 (586)
+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 85 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 85 ISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp CTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred cCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 99999999986542 3489999999999999999999998 9999999999999999999999999999876544433
Q ss_pred ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhch
Q 007892 367 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQ 445 (586)
Q Consensus 367 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 445 (586)
......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... .. .. + ..+.
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~---~~-~----~~~~------- 222 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE---VV---LK-V----SQGH------- 222 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HH---HH-H----HTTC-------
T ss_pred cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH---HH---HH-H----HcCC-------
Confidence 3344557788999999998899999999999999999999 999997654311 10 00 0 0000
Q ss_pred hhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 446 KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 446 ~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
....+......+.+++..||+.+|.+||++.||++.|+...
T Consensus 223 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 223 -RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp -CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred -CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 00111122356889999999999999999999999999764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=397.87 Aligned_cols=261 Identities=27% Similarity=0.428 Sum_probs=215.8
Q ss_pred HHHHHhcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEE
Q 007892 203 ELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 282 (586)
Q Consensus 203 el~~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~l 282 (586)
++++..++|.+.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+.+|.+++|||||+++++|. .+..+|
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l 259 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI 259 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence 3455678899999999999999999999888999999998654 34678999999999999999999999987 567899
Q ss_pred EEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCC
Q 007892 283 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 283 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 362 (586)
||||+++|+|.++|.......+++..++.++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++....
T Consensus 260 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp EECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 99999999999999765444688999999999999999999998 999999999999999999999999999987543
Q ss_pred CCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhh
Q 007892 363 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 441 (586)
Q Consensus 363 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (586)
..........++..|+|||++..+.++.++|||||||+||||++ |+.||..... ..+... +....
T Consensus 337 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~---~~~~~~----i~~~~------- 402 (454)
T 1qcf_A 337 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVIRA----LERGY------- 402 (454)
T ss_dssp HHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHH----HHHTC-------
T ss_pred CceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH---HHHHHH----HHcCC-------
Confidence 22222233456789999999998999999999999999999999 9999975432 111111 11100
Q ss_pred hhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 442 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 442 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
....+...+..+.+++.+||+.||.+||+|.+|++.|+...
T Consensus 403 -----~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 403 -----RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred -----CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 00122334567899999999999999999999999999764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=380.45 Aligned_cols=268 Identities=26% Similarity=0.419 Sum_probs=216.9
Q ss_pred ccCHHHHHHHhcCccccceecccCcEEEEEEEEe------CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhc-CCCCcce
Q 007892 198 TFTYEELKIATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSG-QGEREFQAEIEIISQV-HHRHLVS 269 (586)
Q Consensus 198 ~~~~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l-~Hpniv~ 269 (586)
.+...++++..++|.+.+.||+|+||.||+|++. +++.||||+++.... ...+.+.+|++++.++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 3556778888999999999999999999999853 357999999976543 3346799999999999 7999999
Q ss_pred EEEEEEeCCe-eEEEEEecCCCcHHHHhcCCCC-----------------------------------------------
Q 007892 270 LVGYCTFGSQ-RLLVYEFVPNKTLEFHLHGKDR----------------------------------------------- 301 (586)
Q Consensus 270 l~g~~~~~~~-~~lV~E~~~~gsL~~~l~~~~~----------------------------------------------- 301 (586)
++++|...+. .++||||+++|+|.++++....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999987654 8999999999999999976532
Q ss_pred -----------------CCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 302 -----------------PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 302 -----------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
..+++..++.|+.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 1288999999999999999999998 99999999999999999999999999998654332
Q ss_pred -CcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhh
Q 007892 365 -THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 442 (586)
Q Consensus 365 -~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 442 (586)
........||+.|+|||++.+..++.++|||||||+||||++ |+.||...... ..+... +.. +
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~----~~~----~----- 312 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFCRR----LKE----G----- 312 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS--HHHHHH----HHH----T-----
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh--HHHHHH----HHc----C-----
Confidence 223345678999999999999999999999999999999998 99999765431 111111 100 0
Q ss_pred hchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 443 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 443 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
.....+......+.+++.+||+.||.+||++.||+++|+..
T Consensus 313 ---~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 313 ---TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 00012222345688999999999999999999999999864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=373.41 Aligned_cols=249 Identities=23% Similarity=0.338 Sum_probs=207.4
Q ss_pred HhcCccccceecccCcEEEEEEEE-eCCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEE
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~--~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV 283 (586)
..++|.+.+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+.+|++++||||+++++++...+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 346899999999999999999997 47899999999654 233456788999999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCC
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 363 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 363 (586)
|||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 93 ~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp ECCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred EECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 99999999999986543 489999999999999999999998 9999999999999999999999999999865432
Q ss_pred CCcccccccccccccCcccccCCCCC-CcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhh
Q 007892 364 DTHVSTRVMGTFGYLAPEYASSGKLT-EKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 442 (586)
Q Consensus 364 ~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 442 (586)
......+||+.|+|||++.+..+. .++|||||||+||||++|+.||...+.. ....... .+.+
T Consensus 168 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~i~-----~~~~--- 231 (328)
T 3fe3_A 168 --GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK------ELRERVL-----RGKY--- 231 (328)
T ss_dssp --CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHH-----HCCC---
T ss_pred --CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHH-----hCCC---
Confidence 233556899999999999887765 7999999999999999999999765421 1111111 1110
Q ss_pred hchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 443 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 443 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
..+......+.+++.+||+.||.+||++.|+++.
T Consensus 232 ------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 232 ------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1222234568899999999999999999999874
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=365.92 Aligned_cols=261 Identities=24% Similarity=0.354 Sum_probs=208.0
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV 283 (586)
.++|++.+.||+|+||.||+|+.. +++.||||.+..... .....+.+|+.++.+++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 367999999999999999999965 688999999854332 3346789999999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCC
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 363 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 363 (586)
|||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++.....
T Consensus 90 ~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 99999999999996543 589999999999999999999998 9999999999999999999999999999876544
Q ss_pred CCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhh
Q 007892 364 DTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 443 (586)
Q Consensus 364 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 443 (586)
.........||+.|+|||.+.+..++.++|||||||+||||++|+.||...... ......+ .. ....
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~----~~-~~~~-- 231 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV------SIAIKHI----QD-SVPN-- 231 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH------HHHHHHH----SS-CCCC--
T ss_pred cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHh----hc-cCCC--
Confidence 333344567999999999999999999999999999999999999999765421 1111111 01 1100
Q ss_pred chhhhccCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHhcCCC
Q 007892 444 DQKLEEYDSAEMTRMAACAAACIRHSARRRP-RMSQIVRALEGNMP 488 (586)
Q Consensus 444 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RP-tm~evl~~L~~~~~ 488 (586)
.........+..+.+++.+|++.||.+|| ++.++.+.|+....
T Consensus 232 --~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 232 --VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp --HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred --cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 01122333456789999999999999999 99999999997643
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=395.47 Aligned_cols=261 Identities=26% Similarity=0.405 Sum_probs=218.1
Q ss_pred HHHHhcCccccceecccCcEEEEEEEEeC-CeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEE
Q 007892 204 LKIATDNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 282 (586)
Q Consensus 204 l~~~~~~f~~~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~l 282 (586)
+++..++|.+.+.||+|+||.||+|++.. +..||||.++.... ..++|.+|+.+|.+++|||||+++++|......+|
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 293 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence 34456789999999999999999999875 88999999976543 46789999999999999999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCC
Q 007892 283 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 283 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 362 (586)
||||+++|+|.++|.......+++..++.|+.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++....
T Consensus 294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 99999999999999876666799999999999999999999998 999999999999999999999999999987644
Q ss_pred CCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhh
Q 007892 363 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 441 (586)
Q Consensus 363 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (586)
..........++..|+|||++..+.++.++|||||||+||||++ |+.||...+.. .+... +....
T Consensus 371 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~---~~~~~----~~~~~------- 436 (495)
T 1opk_A 371 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYEL----LEKDY------- 436 (495)
T ss_dssp CCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHH----HHTTC-------
T ss_pred CceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HHcCC-------
Confidence 33323334456789999999999999999999999999999999 99999765431 11111 11100
Q ss_pred hhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 442 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 442 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
....+......+.+++.+||+.||.+||+|.||++.|+...
T Consensus 437 -----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 437 -----RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred -----CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 00122334567899999999999999999999999999653
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=371.62 Aligned_cols=274 Identities=24% Similarity=0.330 Sum_probs=208.7
Q ss_pred HHhcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC----eeE
Q 007892 206 IATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS----QRL 281 (586)
Q Consensus 206 ~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~----~~~ 281 (586)
...++|++.+.||+|+||.||+|++. ++.||||++.... .....+..|+.+|.+++|||||+++++|.... ..+
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 34578999999999999999999875 7999999996543 23445667999999999999999999998754 469
Q ss_pred EEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcC-------CCcEEecCCCCceeEeCCCCCeEEeec
Q 007892 282 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC-------QPKIIHRDIKSANILLDDSFEAKVADF 354 (586)
Q Consensus 282 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~-------~~~ivHrDIk~~NILl~~~~~~kl~DF 354 (586)
+||||+++|+|.+++... .++|..++.|+.|++.||+|||+.+ .++|+||||||+||||+.++.+||+||
T Consensus 99 lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp EEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred EEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence 999999999999999653 3899999999999999999999751 348999999999999999999999999
Q ss_pred ccccccCCCCCc-ccccccccccccCcccccCC-----CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhh--
Q 007892 355 GLAKHSLDTDTH-VSTRVMGTFGYLAPEYASSG-----KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWA-- 426 (586)
Q Consensus 355 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~-- 426 (586)
|+++........ ......||+.|+|||++.+. .++.++|||||||+||||++|+.||.............+.
T Consensus 176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 255 (322)
T 3soc_A 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ 255 (322)
T ss_dssp TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence 999865443322 23346799999999999863 5567899999999999999999999865432211111100
Q ss_pred ---hHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 427 ---KPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 427 ---~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
...+............+... .........+.+++.+||+.||.+||++.||++.|+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 256 HPSLEDMQEVVVHKKKRPVLRDY--WQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGG--GGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCchhhhhhhhhcccCCCCcccc--ccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00000000011110001100 01234567799999999999999999999999999864
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=368.18 Aligned_cols=257 Identities=26% Similarity=0.401 Sum_probs=210.2
Q ss_pred HHhcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEE
Q 007892 206 IATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 206 ~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
+..++|+..+.||+|+||.||+|.+.++..||||+++.... ...++.+|++++.+++|+||++++++|...+..++|||
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 44578999999999999999999998889999999976543 35679999999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 365 (586)
|+++++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++.......
T Consensus 100 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 100 YMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp CCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred ccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 999999999997532 3489999999999999999999998 999999999999999999999999999986544332
Q ss_pred cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhc
Q 007892 366 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 444 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 444 (586)
.......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... ... . +.+ +.
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~---~~~---~-~~~----~~------ 238 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---TAE---H-IAQ----GL------ 238 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHH---H-HHT----TC------
T ss_pred ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH---HHH---H-Hhc----cc------
Confidence 22333457788999999998899999999999999999998 999997654311 111 0 100 00
Q ss_pred hhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 445 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 445 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
....+......+.+++.+||+.+|.+||++.||++.|+..
T Consensus 239 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 239 --RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp --CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 0011122235688999999999999999999999999864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=375.28 Aligned_cols=264 Identities=25% Similarity=0.456 Sum_probs=215.4
Q ss_pred HHHHHHhcCccccceecccCcEEEEEEEEeC------CeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEE
Q 007892 202 EELKIATDNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYC 274 (586)
Q Consensus 202 ~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~~------g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~ 274 (586)
.++....++|.+.+.||+|+||.||+|+..+ ++.||||+++.... .....|.+|+.++.+++||||++++++|
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3455667899999999999999999999753 48999999976543 3356799999999999999999999999
Q ss_pred EeCCeeEEEEEecCCCcHHHHhcCCC----------------------CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEE
Q 007892 275 TFGSQRLLVYEFVPNKTLEFHLHGKD----------------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKII 332 (586)
Q Consensus 275 ~~~~~~~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iv 332 (586)
.+.+..++||||+++|+|.+++.... ...+++.+++.|+.|++.||.|||++ +|+
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~iv 196 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV 196 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 99999999999999999999997532 15689999999999999999999998 999
Q ss_pred ecCCCCceeEeCCCCCeEEeecccccccCCCCC-cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCC
Q 007892 333 HRDIKSANILLDDSFEAKVADFGLAKHSLDTDT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRP 410 (586)
Q Consensus 333 HrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~P 410 (586)
||||||+||||+.++.+||+|||+++....... .......||+.|+|||.+.++.++.++|||||||+||||++ |+.|
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence 999999999999999999999999976533221 12234568899999999998899999999999999999999 9999
Q ss_pred CCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 411 FDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 411 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
|..... ..+... +..+.. ...+......+.+++.+||+.||.+||++.+|++.|+...
T Consensus 277 ~~~~~~---~~~~~~--------~~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~ 334 (343)
T 1luf_A 277 YYGMAH---EEVIYY--------VRDGNI--------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 334 (343)
T ss_dssp TTTSCH---HHHHHH--------HHTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCh---HHHHHH--------HhCCCc--------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence 975432 111111 111111 1122334457899999999999999999999999999764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=381.17 Aligned_cols=257 Identities=28% Similarity=0.438 Sum_probs=199.4
Q ss_pred hcCccccceecccCcEEEEEEEEe----CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT----NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 282 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~----~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~l 282 (586)
.++|.+.+.||+|+||.||+|++. ++..||||+++... ....+.|.+|+.+|.+++||||++++++|...+..+|
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 467999999999999999999965 46789999997653 3345689999999999999999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCC
Q 007892 283 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 283 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 362 (586)
||||+++|+|.++++... ..+++.+++.|+.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++....
T Consensus 124 v~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 999999999999997543 3589999999999999999999998 999999999999999999999999999987644
Q ss_pred CCCcc--cccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCCh
Q 007892 363 TDTHV--STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 439 (586)
Q Consensus 363 ~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (586)
..... .....+++.|+|||++.+..++.++|||||||+||||++ |+.||..... ..+... +. .+
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~---~~~~~~----i~----~~-- 266 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---QDVIKA----VD----EG-- 266 (373)
T ss_dssp --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH---HHHHHH----HH----TT--
T ss_pred CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH----HH----cC--
Confidence 32221 122345778999999999999999999999999999998 9999975432 111111 00 10
Q ss_pred hhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 440 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 440 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
............+.+++.+||+.||.+||+|.||++.|+...
T Consensus 267 ------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 267 ------YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp ------EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 000122234567899999999999999999999999998753
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=365.37 Aligned_cols=260 Identities=27% Similarity=0.404 Sum_probs=218.8
Q ss_pred HHHHhcCccccceecccCcEEEEEEEEeC-CeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEE
Q 007892 204 LKIATDNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 282 (586)
Q Consensus 204 l~~~~~~f~~~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~l 282 (586)
+++..++|.+.+.||+|+||.||+|.... ++.||||.+.... ...+.+.+|++++++++||||++++++|...+..++
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 86 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence 44566889999999999999999999764 8899999997643 345789999999999999999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCC
Q 007892 283 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 283 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 362 (586)
||||+++++|.+++.......+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 87 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp EEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred EEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 99999999999999876667799999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhh
Q 007892 363 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 441 (586)
Q Consensus 363 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (586)
..........+++.|+|||++.+..++.++||||||+++|+|++ |..||...+.. .+.... ....
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~---~~~~~~----~~~~------- 229 (288)
T 3kfa_A 164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYELL----EKDY------- 229 (288)
T ss_dssp SSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHHH----HTTC-------
T ss_pred CccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----hccC-------
Confidence 44444445667889999999998999999999999999999999 99999765431 111111 0000
Q ss_pred hhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 442 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 442 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
....+......+.+++.+||+.||.+||++.||++.|+..
T Consensus 230 -----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 230 -----RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 0012223346789999999999999999999999999864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=387.64 Aligned_cols=265 Identities=20% Similarity=0.255 Sum_probs=213.5
Q ss_pred cCHHHHHHHhcCccccceecccCcEEEEEEEEeC-CeEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEE
Q 007892 199 FTYEELKIATDNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYC 274 (586)
Q Consensus 199 ~~~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l~Hpniv~l~g~~ 274 (586)
+.+.+++...++|++.++||+|+||+||+|++.+ ++.||||+++.... .....+++|+.++.+++||||++++++|
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3456777888999999999999999999999764 78999999965321 1123488999999999999999999999
Q ss_pred EeCCeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeec
Q 007892 275 TFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADF 354 (586)
Q Consensus 275 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DF 354 (586)
.+.+..+||||||++|+|.++|... ...+++..+..++.|++.||+|||+. +||||||||+||||+.++.+||+||
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred eeCCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcch
Confidence 9999999999999999999999763 23589999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccccCccccc-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHH
Q 007892 355 GLAKHSLDTDTHVSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPF 429 (586)
Q Consensus 355 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~ 429 (586)
|+++.............+||+.|+|||++. .+.++.++|||||||+||||++|+.||...+... .. ...
T Consensus 220 Gla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~---~~---~~i 293 (437)
T 4aw2_A 220 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE---TY---GKI 293 (437)
T ss_dssp TTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH---HHH
T ss_pred hhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH---HH---Hhh
Confidence 999876555444445578999999999987 5679999999999999999999999997654311 10 000
Q ss_pred HhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 007892 430 LAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARR--RPRMSQIVRA 482 (586)
Q Consensus 430 ~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~--RPtm~evl~~ 482 (586)
+... ...............+.+++.+||..++++ ||++.||++.
T Consensus 294 ~~~~---------~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 294 MNHK---------ERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HTHH---------HHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred hhcc---------ccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 0000 000000111123456888999999888888 9999999873
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=368.92 Aligned_cols=249 Identities=23% Similarity=0.351 Sum_probs=207.2
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV 283 (586)
.++|+..+.||+|+||.||+++.. +|+.||||+++.. .......+.+|+.+|.+++||||+++++++...+..+||
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 468999999999999999999975 5899999999653 223356788999999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCC
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 363 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 363 (586)
|||+++|+|..++... ..+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 84 ~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 84 MEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 9999999999998654 3489999999999999999999998 9999999999999999999999999999864322
Q ss_pred CCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhh
Q 007892 364 DTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 443 (586)
Q Consensus 364 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 443 (586)
. ......+||+.|+|||++.+..++.++|||||||+||||++|+.||...+.. ......+..
T Consensus 159 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~~~----------- 220 (337)
T 1o6l_A 159 G-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFELILME----------- 220 (337)
T ss_dssp T-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHC-----------
T ss_pred C-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH------HHHHHHHcC-----------
Confidence 2 2234568999999999999999999999999999999999999999754321 111111110
Q ss_pred chhhhccCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 007892 444 DQKLEEYDSAEMTRMAACAAACIRHSARRRP-----RMSQIVRA 482 (586)
Q Consensus 444 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RP-----tm~evl~~ 482 (586)
.+ .++......+.+++.+||+.||.+|| ++.||+++
T Consensus 221 --~~-~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 221 --EI-RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --CC-CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --CC-CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 00 12233446788999999999999999 89999864
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=362.88 Aligned_cols=260 Identities=29% Similarity=0.432 Sum_probs=213.8
Q ss_pred HHHHHhcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEE
Q 007892 203 ELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 282 (586)
Q Consensus 203 el~~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~l 282 (586)
++++..++|++.+.||+|+||.||+|...+++.||||.++... .....+.+|++++.+++||||+++++++. .+..++
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 84 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYI 84 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEE
Confidence 3455668899999999999999999999888899999997654 33578999999999999999999999987 456899
Q ss_pred EEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCC
Q 007892 283 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 283 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 362 (586)
||||+++++|.+++.......+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 99999999999999654333589999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhh
Q 007892 363 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 441 (586)
Q Consensus 363 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (586)
..........++..|+|||.+.++.++.++|||||||+||||++ |+.||...... .+... +. .+.
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~----~~----~~~--- 227 (279)
T 1qpc_A 162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVIQN----LE----RGY--- 227 (279)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHH----HH----TTC---
T ss_pred cccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH---HHHHH----Hh----ccc---
Confidence 43333344567889999999998899999999999999999999 99999754321 11111 11 110
Q ss_pred hhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 442 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 442 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
....+......+.+++..|++.+|.+||++.+|++.|+..
T Consensus 228 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 228 -----RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 0011223345789999999999999999999999999864
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=383.42 Aligned_cols=253 Identities=27% Similarity=0.418 Sum_probs=209.9
Q ss_pred HHHhcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC-eeEEE
Q 007892 205 KIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS-QRLLV 283 (586)
Q Consensus 205 ~~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~-~~~lV 283 (586)
.+..++|.+.+.||+|+||.||+|.+. |+.||||+++... ..+.|.+|+.+|.+++|||||+++++|.... ..+||
T Consensus 189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv 265 (450)
T 1k9a_A 189 ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 265 (450)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred ccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence 345578999999999999999999984 7899999998654 4568999999999999999999999988765 78999
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCC
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 363 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 363 (586)
|||+++|+|.+++.......+++..++.++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 266 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp EECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 9999999999999876655689999999999999999999998 9999999999999999999999999999854321
Q ss_pred CCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhh
Q 007892 364 DTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 442 (586)
Q Consensus 364 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 442 (586)
.....++..|+|||.+.++.++.++|||||||+||||++ |+.||....... +... +. .+.
T Consensus 343 ----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~~----i~----~~~---- 403 (450)
T 1k9a_A 343 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR----VE----KGY---- 403 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HHHH----HH----TTC----
T ss_pred ----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HH----cCC----
Confidence 122357889999999999999999999999999999998 999997654311 1111 11 110
Q ss_pred hchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 443 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 443 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
....+...+..+.+++.+||+.||.+||++.||++.|+..
T Consensus 404 ----~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 404 ----KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 0012334456789999999999999999999999999864
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=390.42 Aligned_cols=260 Identities=30% Similarity=0.438 Sum_probs=209.1
Q ss_pred HHHHhcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEE
Q 007892 204 LKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 204 l~~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV 283 (586)
+++..++|.+.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+.+|.+++||||++++++|.. +..+||
T Consensus 179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv 256 (452)
T 1fmk_A 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 256 (452)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred cccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence 344567899999999999999999999888899999998654 335689999999999999999999999976 678999
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCC
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 363 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 363 (586)
|||+++|+|.++|.......+++.+++.|+.|++.||+|||++ +|+||||||+||||++++.+||+|||+++.....
T Consensus 257 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred ehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 9999999999999754445689999999999999999999998 9999999999999999999999999999876443
Q ss_pred CCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhh
Q 007892 364 DTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 442 (586)
Q Consensus 364 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 442 (586)
.........++..|+|||.+..+.++.++|||||||+||||++ |+.||...... .+... + ..+..
T Consensus 334 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~~~~~----i----~~~~~--- 399 (452)
T 1fmk_A 334 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQ----V----ERGYR--- 399 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHH----H----HTTCC---
T ss_pred ceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHH----H----HcCCC---
Confidence 3223334457889999999999999999999999999999999 99999754321 11111 1 11100
Q ss_pred hchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 443 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 443 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
...+...+..+.+++.+||+.||.+||++.+|++.|+...
T Consensus 400 -----~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 400 -----MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred -----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 0122334567899999999999999999999999999764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=375.81 Aligned_cols=261 Identities=27% Similarity=0.434 Sum_probs=213.9
Q ss_pred HHhcCccccceecccCcEEEEEEEEe--------CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhc-CCCCcceEEEEEE
Q 007892 206 IATDNFSEANLLGQGGFGYVHKGVLT--------NGKVVAIKQLKAGSG-QGEREFQAEIEIISQV-HHRHLVSLVGYCT 275 (586)
Q Consensus 206 ~~~~~f~~~~~LG~G~fG~Vyk~~~~--------~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~ 275 (586)
+..++|.+.+.||+|+||.||+|+.. .+..||||+++.... .....+.+|++++.++ +||||++++++|.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 34578999999999999999999963 236899999976543 3346789999999999 8999999999999
Q ss_pred eCCeeEEEEEecCCCcHHHHhcCCC--------------CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCcee
Q 007892 276 FGSQRLLVYEFVPNKTLEFHLHGKD--------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANI 341 (586)
Q Consensus 276 ~~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NI 341 (586)
..+..++||||+++|+|.+++.... ...+++.+++.|+.|++.||+|||+. +|+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceE
Confidence 9999999999999999999997543 24589999999999999999999998 999999999999
Q ss_pred EeCCCCCeEEeecccccccCCCCC-cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccc
Q 007892 342 LLDDSFEAKVADFGLAKHSLDTDT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFAD 419 (586)
Q Consensus 342 Ll~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~ 419 (586)
||+.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||+||||++ |..||.....
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~--- 299 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--- 299 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH---
Confidence 999999999999999986544322 22334567899999999999999999999999999999999 9999975442
Q ss_pred hhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 007892 420 DSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMP 488 (586)
Q Consensus 420 ~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~~ 488 (586)
..+... +. .+. ....+......+.+++.+||+.||.+||++.||++.|+....
T Consensus 300 ~~~~~~----~~----~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 352 (382)
T 3tt0_A 300 EELFKL----LK----EGH--------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352 (382)
T ss_dssp HHHHHH----HH----TTC--------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHH----HH----cCC--------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111111 11 110 001222334578999999999999999999999999997653
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=357.87 Aligned_cols=261 Identities=24% Similarity=0.365 Sum_probs=203.0
Q ss_pred hcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHh--cCCCCcceEEEEEEeC----CeeE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQ--VHHRHLVSLVGYCTFG----SQRL 281 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~--l~Hpniv~l~g~~~~~----~~~~ 281 (586)
.++|++.+.||+|+||.||+|+. +++.||||++... ....+..|.+++.. ++||||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46899999999999999999998 6899999998653 34566777887777 7899999999997653 4578
Q ss_pred EEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhh--------hcCCCcEEecCCCCceeEeCCCCCeEEee
Q 007892 282 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH--------EDCQPKIIHRDIKSANILLDDSFEAKVAD 353 (586)
Q Consensus 282 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH--------~~~~~~ivHrDIk~~NILl~~~~~~kl~D 353 (586)
+||||+++|+|.++++. ..+++..+++|+.|++.||+||| +. +|+||||||+||||+.++.+||+|
T Consensus 83 lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECC
T ss_pred EehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEee
Confidence 99999999999999953 35899999999999999999999 66 999999999999999999999999
Q ss_pred cccccccCCCCCcc---cccccccccccCcccccCC------CCCCcchHHHHHHHHHHHHhC----------CCCCCCC
Q 007892 354 FGLAKHSLDTDTHV---STRVMGTFGYLAPEYASSG------KLTEKSDVFSFGVLLLELITG----------FRPFDKA 414 (586)
Q Consensus 354 FGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~s~ksDVwSlGvvL~elltG----------~~Pf~~~ 414 (586)
||+++......... .....||+.|+|||++.+. .++.++|||||||+||||++| +.||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 99997654433221 2334799999999999876 455799999999999999999 7787654
Q ss_pred CcccchhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 415 DTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 415 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
..... ....+.. .+.. ......+.. ..+.......+.+++.+||+.||.+||++.||++.|+..
T Consensus 237 ~~~~~-~~~~~~~-~~~~---~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 237 VPNDP-SFEDMRK-VVCV---DQQRPNIPN---RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCSSC-CHHHHHH-HHTT---SCCCCCCCG---GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCc-chhhhhH-HHhc---cCCCCCCCh---hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 33211 1111111 1100 110000000 012345677899999999999999999999999999853
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=362.49 Aligned_cols=257 Identities=25% Similarity=0.402 Sum_probs=198.5
Q ss_pred HHhcCccccceecccCcEEEEEEEEeC----CeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCee
Q 007892 206 IATDNFSEANLLGQGGFGYVHKGVLTN----GKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR 280 (586)
Q Consensus 206 ~~~~~f~~~~~LG~G~fG~Vyk~~~~~----g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~ 280 (586)
+..++|++.+.||+|+||.||+|.... +..||||.++.... ...+.+.+|+.++.+++||||+++++++. ++..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 90 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 90 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence 445789999999999999999999743 56799999876433 33567899999999999999999999985 5678
Q ss_pred EEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccccc
Q 007892 281 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 360 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~ 360 (586)
++||||+++++|.+++.... ..+++..++.++.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++..
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccccccc
Confidence 89999999999999997543 3589999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCCh
Q 007892 361 LDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 439 (586)
Q Consensus 361 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (586)
............+++.|+|||.+.+..++.++|||||||+||||++ |..||...... ...... ..+.
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~---~~~~~i--------~~~~- 234 (281)
T 1mp8_A 167 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRI--------ENGE- 234 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHH--------HTTC-
T ss_pred CcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH---HHHHHH--------HcCC-
Confidence 5443333344567889999999998899999999999999999997 99999765431 111111 0110
Q ss_pred hhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 440 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 440 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
....+......+.+++.+||+.||.+||++.||++.|+..
T Consensus 235 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 235 -------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0112233456788999999999999999999999999864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=366.33 Aligned_cols=267 Identities=24% Similarity=0.378 Sum_probs=207.2
Q ss_pred hcCccccceecccCcEEEEEEEE-----eCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--Cee
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVL-----TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG--SQR 280 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~-----~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~--~~~ 280 (586)
.++|++.+.||+|+||.||+|++ .+++.||||++........+.+.+|+++|.+++||||++++++|... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46799999999999999999985 25889999999877666677899999999999999999999999653 458
Q ss_pred EEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccccc
Q 007892 281 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 360 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~ 360 (586)
++||||+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++..
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred EEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 99999999999999997543 3489999999999999999999998 9999999999999999999999999999875
Q ss_pred CCCCC--cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCC-
Q 007892 361 LDTDT--HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADG- 437 (586)
Q Consensus 361 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~- 437 (586)
..... .......++..|+|||.+.+..++.++|||||||+||||++|..||...... ...+.. ......
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~----~~~~~~----~~~~~~~ 236 (295)
T 3ugc_A 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIG----NDKQGQM 236 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH----HHHHHC----TTCCTHH
T ss_pred cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH----HHhhhc----Cccccch
Confidence 43322 1223345778899999999999999999999999999999999998643210 000000 000000
Q ss_pred ---Chhhhhc-hhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 438 ---NFDALVD-QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 438 ---~~~~l~d-~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
.....+. ......+......+.+++.+||+.||.+||++.||++.|+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 237 IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0000000 001122334456799999999999999999999999999864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=380.89 Aligned_cols=258 Identities=24% Similarity=0.393 Sum_probs=210.5
Q ss_pred HHhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEE
Q 007892 206 IATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 206 ~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV 283 (586)
+..++|.+.+.||+|+||.||+|.+. +++.||||.++.... .....|.+|+.+|.+++||||++++++|...+..+||
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 44578999999999999999999986 689999999876532 2345788999999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCC
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 363 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 363 (586)
|||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 191 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp EECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 99999999999997532 3489999999999999999999998 9999999999999999999999999999864332
Q ss_pred CCccc-ccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhh
Q 007892 364 DTHVS-TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 441 (586)
Q Consensus 364 ~~~~~-~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (586)
..... ....++..|+|||.+..+.++.++|||||||+||||++ |..||...... ....+ +. .+..
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~---~~~~~----~~----~~~~-- 333 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ---QTREF----VE----KGGR-- 333 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH---HHHHH----HH----TTCC--
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HH----cCCC--
Confidence 21111 12346778999999998999999999999999999998 99999764421 11111 11 1100
Q ss_pred hhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 442 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 442 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
...+...+..+.+++.+||+.||.+||++.+|++.|+..
T Consensus 334 ------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 334 ------LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 012223445788999999999999999999999999854
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=378.42 Aligned_cols=258 Identities=27% Similarity=0.420 Sum_probs=209.3
Q ss_pred hcCccccceecccCcEEEEEEEEe------CCeEEEEEEeccC-CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCee
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAG-SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR 280 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~-~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~ 280 (586)
.++|.+.+.||+|+||.||+|++. +++.||||+++.. .......+.+|+.++.+++||||++++++|......
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467999999999999999999953 4678999999654 334456789999999999999999999999999999
Q ss_pred EEEEEecCCCcHHHHhcCCC-----CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCC---CeEEe
Q 007892 281 LLVYEFVPNKTLEFHLHGKD-----RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF---EAKVA 352 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~---~~kl~ 352 (586)
+|||||+++|+|.+++.... ...+++.+++.|+.|++.||+|||++ +|+||||||+||||+.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999997532 24589999999999999999999998 999999999999999554 59999
Q ss_pred ecccccccCCCC-CcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHH
Q 007892 353 DFGLAKHSLDTD-THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFL 430 (586)
Q Consensus 353 DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~ 430 (586)
|||+++...... ........||+.|+|||++.++.++.++|||||||+||||++ |..||..... ..+....
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~---~~~~~~i---- 299 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVLEFV---- 299 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHH----
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH----
Confidence 999997542211 122334568999999999999999999999999999999998 9999976542 1111111
Q ss_pred hhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 431 AQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 431 ~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
..+. ....+......+.+++.+||+.+|.+||++.||++.|+...
T Consensus 300 ----~~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 300 ----TSGG--------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp ----HTTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----HcCC--------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 0110 00122233456889999999999999999999999998654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=370.54 Aligned_cols=252 Identities=25% Similarity=0.339 Sum_probs=206.3
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCch------hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCee
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ------GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR 280 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~------~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~ 280 (586)
.+.|.+.+.||+|+||.||+++.. +|+.||||+++..... ....+.+|+.+|.+++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467999999999999999999975 5899999999764322 357899999999999999999999999999999
Q ss_pred EEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCC----CeEEeeccc
Q 007892 281 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF----EAKVADFGL 356 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~----~~kl~DFGl 356 (586)
+|||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||||++++ .+||+|||+
T Consensus 91 ~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 9999999999999999653 4599999999999999999999998 999999999999998876 799999999
Q ss_pred ccccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccC
Q 007892 357 AKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLAD 436 (586)
Q Consensus 357 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (586)
++...... .....+||+.|+|||++.+..++.++|||||||+||+|++|..||...... .+ ..... .
T Consensus 166 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~---~~---~~~i~-----~ 232 (361)
T 2yab_A 166 AHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ET---LANIT-----A 232 (361)
T ss_dssp CEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HH---HHHHH-----T
T ss_pred ceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HH---HHHHH-----h
Confidence 98754422 234567999999999999999999999999999999999999999764421 11 11110 1
Q ss_pred CChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 437 GNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 437 ~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
+.+. .+.. +.......+.+++..||..||.+||++.|+++.
T Consensus 233 ~~~~--~~~~---~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 233 VSYD--FDEE---FFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp TCCC--CCHH---HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cCCC--CCch---hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1110 0000 001123568899999999999999999999863
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=366.66 Aligned_cols=252 Identities=24% Similarity=0.368 Sum_probs=203.3
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++.+++||||+++++++.+++..+|||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 68999999999999999999976 689999999865432 2345788999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC-C
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD-T 365 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~-~ 365 (586)
+++++|.+++... ..+++.++..++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++...... .
T Consensus 87 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 87 CSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp CTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred CCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 9999999999654 3489999999999999999999998 99999999999999999999999999998653222 2
Q ss_pred cccccccccccccCcccccCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhc
Q 007892 366 HVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 444 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 444 (586)
.......||+.|+|||++.+..+ +.++|||||||+||||++|+.||...... ......|... ... .
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~~~~~~--------~~~---~- 228 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDWKEK--------KTY---L- 228 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT-SHHHHHHHTT--------CTT---S-
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH-HHHHHHHhcc--------ccc---C-
Confidence 22345679999999999987665 78999999999999999999999765431 1122222110 000 0
Q ss_pred hhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 445 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 445 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.........+.+++.+||+.||.+||++.||++.
T Consensus 229 ----~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 229 ----NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----CccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0011223467889999999999999999999864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=361.88 Aligned_cols=264 Identities=21% Similarity=0.289 Sum_probs=202.0
Q ss_pred hcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
.++|++.+.||+|+||.||+|+..+|+.||||+++.... .....+.+|++++.+++||||+++++++...+..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 378999999999999999999998899999999965432 224678899999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 365 (586)
|+++ +|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 100 ~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 173 (311)
T 3niz_A 100 FMEK-DLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPV- 173 (311)
T ss_dssp CCSE-EHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC-
T ss_pred CCCC-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCc-
Confidence 9985 7777776533 4589999999999999999999998 99999999999999999999999999998654322
Q ss_pred cccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhh---
Q 007892 366 HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA--- 441 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 441 (586)
.......||+.|+|||++.+ ..++.++|||||||+||||++|+.||....... .+..... .+.. .....+..
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i~~-~~~~-~~~~~~~~~~~ 249 (311)
T 3niz_A 174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD--QLPKIFS-ILGT-PNPREWPQVQE 249 (311)
T ss_dssp C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT--HHHHHHH-HHCC-CCTTTSGGGTT
T ss_pred ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHH-HHCC-CChHHhhhhhc
Confidence 22344578999999999876 568999999999999999999999997654321 1111110 0000 00000000
Q ss_pred ---h--------hchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 442 ---L--------VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 442 ---l--------~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
. ...............+.+++.+||+.||.+||++.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0 000000111122356889999999999999999999997
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=382.90 Aligned_cols=257 Identities=23% Similarity=0.284 Sum_probs=210.5
Q ss_pred HHHHHHHhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 007892 201 YEELKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTF 276 (586)
Q Consensus 201 ~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~ 276 (586)
+.+++...++|++.+.||+|+||.||+|+.. +++.||||+++... ......+.+|+.++..++|||||+++++|.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 4566777889999999999999999999976 58899999986521 1122358899999999999999999999999
Q ss_pred CCeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccc
Q 007892 277 GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGL 356 (586)
Q Consensus 277 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGl 356 (586)
.+..+|||||+++|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccce
Confidence 99999999999999999999653 488999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCcccccCCC----CCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhh
Q 007892 357 AKHSLDTDTHVSTRVMGTFGYLAPEYASSGK----LTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQ 432 (586)
Q Consensus 357 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 432 (586)
++.............+||+.|+|||++.+.. ++.++|||||||+||||++|+.||...+.. ....
T Consensus 215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~----- 283 (410)
T 3v8s_A 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYS----- 283 (410)
T ss_dssp CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHH-----
T ss_pred eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh------hHHH-----
Confidence 9876544433345678999999999997654 889999999999999999999999765421 1111
Q ss_pred cccCCChhhhhchhhh-ccC--HHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 007892 433 GLADGNFDALVDQKLE-EYD--SAEMTRMAACAAACIRHSARR--RPRMSQIVRA 482 (586)
Q Consensus 433 ~~~~~~~~~l~d~~l~-~~~--~~~~~~l~~l~~~cl~~dp~~--RPtm~evl~~ 482 (586)
.++..... .++ ......+.+++.+||+.+|.+ ||++.||+++
T Consensus 284 --------~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 284 --------KIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp --------HHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred --------HHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 11111100 111 123456889999999999988 9999999975
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=366.37 Aligned_cols=260 Identities=27% Similarity=0.435 Sum_probs=213.0
Q ss_pred HHHhcCccccceecccCcEEEEEEEEe------CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 007892 205 KIATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFG 277 (586)
Q Consensus 205 ~~~~~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~ 277 (586)
....++|.+.+.||+|+||.||+|... +++.||||+++.... ...+.+.+|+.++.+++||||++++++|...
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 98 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD 98 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence 344678999999999999999999862 358899999976533 3456789999999999999999999999999
Q ss_pred CeeEEEEEecCCCcHHHHhcCCCC----------------------CCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecC
Q 007892 278 SQRLLVYEFVPNKTLEFHLHGKDR----------------------PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRD 335 (586)
Q Consensus 278 ~~~~lV~E~~~~gsL~~~l~~~~~----------------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrD 335 (586)
+..++||||+++++|.+++..... ..+++.+++.++.|++.||+|||++ +|+|||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~d 175 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRD 175 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccc
Confidence 999999999999999999975432 3488999999999999999999998 999999
Q ss_pred CCCceeEeCCCCCeEEeecccccccCCCCCc-ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCC
Q 007892 336 IKSANILLDDSFEAKVADFGLAKHSLDTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDK 413 (586)
Q Consensus 336 Ik~~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~ 413 (586)
|||+||||+.++.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||+||||++ |+.||..
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 255 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999866443322 2233457889999999998899999999999999999999 9999976
Q ss_pred CCcccchhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 414 ADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 414 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
.... .+... +. .+. ....+......+.+++.+||+.||.+||++.||++.|+..
T Consensus 256 ~~~~---~~~~~----~~----~~~--------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 256 IPPE---RLFNL----LK----TGH--------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp CCGG---GHHHH----HH----TTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCHH---HHHHH----hh----cCC--------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 5431 11111 10 110 0112223446789999999999999999999999999864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=359.25 Aligned_cols=272 Identities=21% Similarity=0.268 Sum_probs=213.8
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC--eeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS--QRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~~~lV~ 284 (586)
++|.+.++||+|+||.||+|+.. +++.||||+++... ....+.+.+|+++|.+++||||+++++++.... ..+|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 67999999999999999999976 48999999997543 233567889999999999999999999998765 779999
Q ss_pred EecCCCcHHHHhcCCCC-CCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEe----CCCCCeEEeecccccc
Q 007892 285 EFVPNKTLEFHLHGKDR-PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL----DDSFEAKVADFGLAKH 359 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl----~~~~~~kl~DFGla~~ 359 (586)
||+++++|.+++..... ..+++.+++.|+.|++.||+|||+. +|+||||||+|||| +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 99999999999976433 3389999999999999999999998 99999999999999 7888899999999987
Q ss_pred cCCCCCcccccccccccccCccccc--------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHh
Q 007892 360 SLDTDTHVSTRVMGTFGYLAPEYAS--------SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLA 431 (586)
Q Consensus 360 ~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 431 (586)
...... .....||+.|+|||++. +..++.++|||||||+||||++|+.||....... ...+.....+.
T Consensus 166 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~ 241 (319)
T 4euu_A 166 LEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR--RNKEVMYKIIT 241 (319)
T ss_dssp CCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGG--GCHHHHHHHHH
T ss_pred cCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccc--hhHHHHHHHhc
Confidence 544322 23457999999999886 5788999999999999999999999997543211 11111111111
Q ss_pred hcc----------cCCChhhhhc-hhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 432 QGL----------ADGNFDALVD-QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 432 ~~~----------~~~~~~~l~d-~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
... ..+.++-.-+ +....+.......+.+++.+||+.||.+||++.|+++....+.
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 110 0000000000 0111455677888999999999999999999999999998653
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=398.47 Aligned_cols=261 Identities=30% Similarity=0.436 Sum_probs=214.7
Q ss_pred HHHHHhcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEE
Q 007892 203 ELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 282 (586)
Q Consensus 203 el~~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~l 282 (586)
++++..++|++.+.||+|+||.||+|.+.++..||||+++... ...++|.+|+++|.+++|+|||+++++|.+ +..+|
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~l 338 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 338 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceE
Confidence 3445667899999999999999999999888899999998654 335689999999999999999999999976 67899
Q ss_pred EEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCC
Q 007892 283 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 283 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 362 (586)
||||+++|+|.++|.......+++.+++.|+.||+.||+|||++ +|+||||||+||||++++.+||+|||+++....
T Consensus 339 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 339 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp EECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred eeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 99999999999999754445689999999999999999999998 999999999999999999999999999986543
Q ss_pred CCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhh
Q 007892 363 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 441 (586)
Q Consensus 363 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (586)
..........++..|+|||++..+.++.++|||||||+||||++ |+.||...... .+... + ..+..
T Consensus 416 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~---~~~~~----i----~~~~~-- 482 (535)
T 2h8h_A 416 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQ----V----ERGYR-- 482 (535)
T ss_dssp HHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH---HHHHH----H----HTTCC--
T ss_pred CceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----H----HcCCC--
Confidence 22222233457789999999999999999999999999999999 99999754321 11111 1 11100
Q ss_pred hhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 442 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 442 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
...+......+.+++.+||+.||.+||++.+|++.|+...
T Consensus 483 ------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 483 ------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred ------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 0122334567889999999999999999999999999754
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=362.67 Aligned_cols=259 Identities=19% Similarity=0.235 Sum_probs=208.4
Q ss_pred hcCccccceecccCcEEEEEEEE-eCCeEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeEEEEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
.++|.+.+.||+|+||.||+|+. .+|+.||||++..... ...+.+|+.++.++ +||||+++++++..++..+||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46799999999999999999996 4789999999875432 24688999999999 89999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCC-----eEEeeccccccc
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE-----AKVADFGLAKHS 360 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~-----~kl~DFGla~~~ 360 (586)
|+ +++|.+++... ...+++..++.|+.|++.||+|||+. +|+||||||+||||+.++. +||+|||+++..
T Consensus 86 ~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 86 LL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred eC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 99 99999998754 34699999999999999999999998 9999999999999998887 999999999875
Q ss_pred CCCCCc------ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcc
Q 007892 361 LDTDTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGL 434 (586)
Q Consensus 361 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 434 (586)
...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||............... ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i---~~~~- 236 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKI---GDTK- 236 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHH---HHHH-
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHH---Hhhh-
Confidence 443321 124567999999999999999999999999999999999999999875432211111110 0000
Q ss_pred cCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 435 ADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 435 ~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
.. ..........+ .+.+++..|++.+|.+||++.+|++.|+..
T Consensus 237 -------~~-~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 237 -------RA-TPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp -------HH-SCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred -------cc-CCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 00 00000011122 799999999999999999999999999854
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=369.17 Aligned_cols=263 Identities=24% Similarity=0.436 Sum_probs=212.0
Q ss_pred HHHHhcCccccceecccCcEEEEEEEEe------CCeEEEEEEeccCC-chhHHHHHHHHHHHHhc-CCCCcceEEEEEE
Q 007892 204 LKIATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGS-GQGEREFQAEIEIISQV-HHRHLVSLVGYCT 275 (586)
Q Consensus 204 l~~~~~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~ 275 (586)
++...++|...+.||+|+||.||+|... ++..||||+++... ......+.+|+.+|.++ +||||++++++|.
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 3445688999999999999999999962 45689999997542 23346789999999999 8999999999999
Q ss_pred eCCeeEEEEEecCCCcHHHHhcCCCC---------------------CCCChHHHHHHHHHHHHHhHhhhhcCCCcEEec
Q 007892 276 FGSQRLLVYEFVPNKTLEFHLHGKDR---------------------PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHR 334 (586)
Q Consensus 276 ~~~~~~lV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHr 334 (586)
..+..+|||||+++|+|.+++..... ..+++..++.++.|++.||+|||+. +|+||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~ 196 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR 196 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence 99999999999999999999976532 2479999999999999999999998 99999
Q ss_pred CCCCceeEeCCCCCeEEeecccccccCCCCC-cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCC
Q 007892 335 DIKSANILLDDSFEAKVADFGLAKHSLDTDT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFD 412 (586)
Q Consensus 335 DIk~~NILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~ 412 (586)
||||+||||+.++.+||+|||+++....... .......||+.|+|||.+.++.++.++|||||||+||||++ |..||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 9999999999999999999999986543322 22344568889999999998999999999999999999998 999997
Q ss_pred CCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 413 KADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 413 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
..... ..+... +..... ...+......+.+++.+||+.||.+||++.||++.|+...
T Consensus 277 ~~~~~--~~~~~~----~~~~~~------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 333 (344)
T 1rjb_A 277 GIPVD--ANFYKL----IQNGFK------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 333 (344)
T ss_dssp TCCCS--HHHHHH----HHTTCC------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred cCCcH--HHHHHH----HhcCCC------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 65421 111111 111000 0122233467899999999999999999999999999764
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=366.68 Aligned_cols=255 Identities=24% Similarity=0.407 Sum_probs=201.4
Q ss_pred cCccccceecccCcEEEEEEEEe-CCe----EEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGK----VVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 282 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~----~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~l 282 (586)
++|+..+.||+|+||.||+|++. +++ .||+|.++... ....+.|.+|+.++.+++||||++++++|..+. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 67999999999999999999964 343 46888885432 344578999999999999999999999998754 789
Q ss_pred EEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCC
Q 007892 283 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 283 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 362 (586)
|+||+++|+|.+++.... ..+++..++.|+.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++....
T Consensus 94 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 999999999999997643 3589999999999999999999998 999999999999999999999999999987543
Q ss_pred CCCc-ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChh
Q 007892 363 TDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 440 (586)
Q Consensus 363 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (586)
.... ......||+.|+|||++.++.++.++|||||||+||||++ |+.||....... +... +. .+.
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~----~~----~~~-- 236 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSI----LE----KGE-- 236 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHH----HH----TTC--
T ss_pred CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---HHHH----HH----cCC--
Confidence 3322 2233457889999999999999999999999999999999 999997654311 1111 10 000
Q ss_pred hhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 441 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 441 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
....+......+.+++.+||+.+|.+||+|.||++.|+...
T Consensus 237 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 237 ------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp ------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred ------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 00122234457889999999999999999999999998653
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=376.85 Aligned_cols=251 Identities=22% Similarity=0.319 Sum_probs=193.1
Q ss_pred cCcccc-ceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEEe----CCeeE
Q 007892 209 DNFSEA-NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTF----GSQRL 281 (586)
Q Consensus 209 ~~f~~~-~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~----~~~~~ 281 (586)
++|... ++||+|+||+||++... +|+.||||+++.. ..+.+|++++.++ +||||++++++|.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 556665 78999999999999975 5889999999642 4677899988554 89999999999875 55789
Q ss_pred EEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCC---CCCeEEeeccccc
Q 007892 282 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD---SFEAKVADFGLAK 358 (586)
Q Consensus 282 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~---~~~~kl~DFGla~ 358 (586)
|||||+++|+|.+++.......+++.++..|+.||+.||.|||+. +|+||||||+||||+. ++.+||+|||+++
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 999999999999999876666799999999999999999999998 9999999999999987 7899999999998
Q ss_pred ccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccch-hhhhhhhHHHhhcccCC
Q 007892 359 HSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADD-SMVDWAKPFLAQGLADG 437 (586)
Q Consensus 359 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~ 437 (586)
...... .....+||+.|+|||++.+..++.++|||||||+||||++|+.||......... .+... +. .+
T Consensus 213 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~----i~----~~ 282 (400)
T 1nxk_A 213 ETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR----IR----MG 282 (400)
T ss_dssp ECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHH----HH----HT
T ss_pred ccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHH----HH----cC
Confidence 653322 234567999999999999999999999999999999999999999765432210 01110 00 01
Q ss_pred ChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 438 NFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 438 ~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.+. ...+. .......+.+++.+||+.||.+||++.||++.
T Consensus 283 ~~~-~~~~~----~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 283 QYE-FPNPE----WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp CCC-CCTTT----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccc-CCCcc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000 00000 11234568899999999999999999999984
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=362.96 Aligned_cols=261 Identities=26% Similarity=0.424 Sum_probs=213.6
Q ss_pred HHHhcCccccceecccCcEEEEEEEE------eCCeEEEEEEeccCCc-hhHHHHHHHHHHHHhc-CCCCcceEEEEEEe
Q 007892 205 KIATDNFSEANLLGQGGFGYVHKGVL------TNGKVVAIKQLKAGSG-QGEREFQAEIEIISQV-HHRHLVSLVGYCTF 276 (586)
Q Consensus 205 ~~~~~~f~~~~~LG~G~fG~Vyk~~~------~~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~ 276 (586)
....++|...+.||+|+||.||+|++ .+++.||||+++.... ...+.+.+|+.++.++ +||||++++++|..
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 34557899999999999999999985 2467999999976543 3356789999999999 89999999999999
Q ss_pred CCeeEEEEEecCCCcHHHHhcCCCC----------------CCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCce
Q 007892 277 GSQRLLVYEFVPNKTLEFHLHGKDR----------------PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSAN 340 (586)
Q Consensus 277 ~~~~~lV~E~~~~gsL~~~l~~~~~----------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~N 340 (586)
.+..++||||+++|+|.+++..... ..+++..++.++.|++.||.|||++ +|+||||||+|
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~N 175 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 175 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccce
Confidence 9999999999999999999976442 2489999999999999999999998 99999999999
Q ss_pred eEeCCCCCeEEeecccccccCCCCCc-ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCccc
Q 007892 341 ILLDDSFEAKVADFGLAKHSLDTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFA 418 (586)
Q Consensus 341 ILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~ 418 (586)
|||+.++.+||+|||+++........ ......|++.|+|||++.+..++.++|||||||+||||++ |+.||......
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~- 254 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD- 254 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch-
Confidence 99999999999999999876443322 2334567889999999998999999999999999999999 99999765421
Q ss_pred chhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 419 DDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 419 ~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
...... +..... ..........+.+++.+||+.||.+||++.||++.|+..
T Consensus 255 -~~~~~~----~~~~~~------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 255 -SKFYKM----IKEGFR------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp -HHHHHH----HHHTCC------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -hHHHHH----hccCCC------------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 111111 111000 011222345789999999999999999999999999865
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=355.28 Aligned_cols=256 Identities=30% Similarity=0.453 Sum_probs=212.0
Q ss_pred HhcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
..++|...+.||+|+||.||+|...+++.||||+++.... ..+.+.+|++++.+++||||+++++++...+..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 3467999999999999999999998899999999976543 356899999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 366 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 366 (586)
+++++|.+++.... ..+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 85 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 85 MEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp CTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccccc
Confidence 99999999997543 3589999999999999999999998 9999999999999999999999999999865433222
Q ss_pred ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhch
Q 007892 367 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQ 445 (586)
Q Consensus 367 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 445 (586)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ..... +. .+.
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~----i~----~~~------- 222 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVED----IS----TGF------- 222 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHH----HH----TTC-------
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH---HHHHH----Hh----cCC-------
Confidence 2234557889999999998899999999999999999999 89999764321 11111 00 110
Q ss_pred hhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 446 KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 446 ~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
....+......+.+++.+||+.+|.+||++.|+++.|+..
T Consensus 223 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 223 -RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0011122345688999999999999999999999999864
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=363.78 Aligned_cols=252 Identities=21% Similarity=0.318 Sum_probs=206.7
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
.++|.+.+.||+|+||.||+|+.. +++.||+|.++... .....+.+|+.+|.+++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 468999999999999999999975 58899999987543 3456789999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCC--CCCeEEeecccccccCCCC
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD--SFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~--~~~~kl~DFGla~~~~~~~ 364 (586)
+++++|.+++.... ..+++.+++.++.|++.||.|||++ +|+||||||+|||++. ++.+||+|||+++......
T Consensus 83 ~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 83 ISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 99999999996543 3589999999999999999999998 9999999999999987 7899999999998764332
Q ss_pred CcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhc
Q 007892 365 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 444 (586)
Q Consensus 365 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 444 (586)
......||+.|+|||++.+..++.++|||||||+||||++|..||...... ........... .+. .
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~~---~~~---~ 224 (321)
T 1tki_A 159 --NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIENIMNAEY---TFD---E 224 (321)
T ss_dssp --EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCC---CCC---H
T ss_pred --ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH------HHHHHHHcCCC---CCC---h
Confidence 234467999999999999888999999999999999999999999764421 11111111000 000 0
Q ss_pred hhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 445 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 445 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
... ......+.+++.+||+.||.+||++.|+++.
T Consensus 225 ~~~----~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 225 EAF----KEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHH----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhh----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 000 1123568899999999999999999999973
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=353.86 Aligned_cols=253 Identities=29% Similarity=0.461 Sum_probs=196.3
Q ss_pred hcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCc----hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSG----QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~----~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV 283 (586)
.++|+..+.||+|+||.||+|.+ .++.||||+++.... ...+.+++|++++.+++||||++++++|...+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 46899999999999999999997 488999999865432 2246789999999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCC--------CCCeEEeecc
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD--------SFEAKVADFG 355 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~--------~~~~kl~DFG 355 (586)
|||+++++|.+++.. ..+++..++.++.|++.||+|||++...+|+||||||+|||++. ++.+||+|||
T Consensus 85 ~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 999999999999853 35899999999999999999999982223999999999999986 6789999999
Q ss_pred cccccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhccc
Q 007892 356 LAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLA 435 (586)
Q Consensus 356 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 435 (586)
+++...... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||....... . .+ ...
T Consensus 162 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~-~~--~~~----- 227 (271)
T 3dtc_A 162 LAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA---V-AY--GVA----- 227 (271)
T ss_dssp C----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH---H-HH--HHH-----
T ss_pred ccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H-HH--hhh-----
Confidence 998653322 234569999999999998899999999999999999999999997644211 0 00 000
Q ss_pred CCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 007892 436 DGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 485 (586)
Q Consensus 436 ~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~ 485 (586)
.... ....+......+.+++.+||+.||.+||++.||++.|+.
T Consensus 228 ~~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 228 MNKL-------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp TSCC-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred cCCC-------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 0000 001223334678999999999999999999999999984
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=353.73 Aligned_cols=261 Identities=17% Similarity=0.207 Sum_probs=211.1
Q ss_pred hcCccccceecccCcEEEEEEEE-eCCeEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeEEEEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
.++|.+.+.||+|+||.||+|+. .+++.||||++.... ....+.+|+.++.++ +|+|++++++++......++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 46799999999999999999996 578999999986543 234688999999999 79999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCC-----eEEeeccccccc
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE-----AKVADFGLAKHS 360 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~-----~kl~DFGla~~~ 360 (586)
|+ +++|.+++.... ..+++..++.|+.|++.||+|||++ +|+||||||+||||+.++. +||+|||+++..
T Consensus 87 ~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 87 LL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 99 999999997543 3489999999999999999999998 9999999999999987766 999999999876
Q ss_pred CCCCCc------ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcc
Q 007892 361 LDTDTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGL 434 (586)
Q Consensus 361 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 434 (586)
...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||.................
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~------ 235 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE------ 235 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH------
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHh------
Confidence 543221 23456799999999999999999999999999999999999999987543222111111100
Q ss_pred cCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 435 ADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 435 ~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
..............+..+.+++..|++.+|.+||++.+|++.|+...
T Consensus 236 ------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~ 282 (298)
T 1csn_A 236 ------KKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 282 (298)
T ss_dssp ------HHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred ------hccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence 00000011111233467899999999999999999999999998653
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=372.63 Aligned_cols=250 Identities=27% Similarity=0.387 Sum_probs=201.1
Q ss_pred HHhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCee
Q 007892 206 IATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQR 280 (586)
Q Consensus 206 ~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~~~ 280 (586)
...++|++.+.||+|+||.||+|+.. +|+.||||+++... ......+.+|+.+|.++ +||||+++++++...+..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 34578999999999999999999975 58999999997532 22345678999999998 699999999999999999
Q ss_pred EEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccccc
Q 007892 281 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 360 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~ 360 (586)
+|||||+++|+|..++... ..+++..+..++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++..
T Consensus 100 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 9999999999999999654 3489999999999999999999998 9999999999999999999999999999864
Q ss_pred CCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChh
Q 007892 361 LDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 440 (586)
Q Consensus 361 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (586)
... .......+||+.|+|||++.+..++.++|||||||+||||++|+.||...+.. +.....+
T Consensus 175 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~---------- 237 (353)
T 3txo_A 175 ICN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED------DLFEAIL---------- 237 (353)
T ss_dssp CC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHH----------
T ss_pred ccC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH------HHHHHHH----------
Confidence 322 22334568999999999999888999999999999999999999999765431 1111111
Q ss_pred hhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCH------HHHHH
Q 007892 441 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRM------SQIVR 481 (586)
Q Consensus 441 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm------~evl~ 481 (586)
...+ .++......+.+++.+||+.||.+||++ .||++
T Consensus 238 ---~~~~-~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 238 ---NDEV-VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ---HCCC-CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ---cCCC-CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1111 1223344568899999999999999998 77765
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=362.86 Aligned_cols=252 Identities=23% Similarity=0.329 Sum_probs=205.6
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCch------hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCee
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ------GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR 280 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~------~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~ 280 (586)
.++|...+.||+|+||.||++... +|+.||||.++..... ....+.+|+.+|.+++||||+++++++......
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 356999999999999999999975 5899999998654321 357899999999999999999999999999999
Q ss_pred EEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCC----CeEEeeccc
Q 007892 281 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF----EAKVADFGL 356 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~----~~kl~DFGl 356 (586)
++||||+++++|.+++... ..+++..++.++.|++.||.|||+. +|+||||||+||||+.++ .+||+|||+
T Consensus 90 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 9999999999999999643 4589999999999999999999998 999999999999999887 899999999
Q ss_pred ccccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccC
Q 007892 357 AKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLAD 436 (586)
Q Consensus 357 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (586)
++...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||...... ... ...... .
T Consensus 165 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~---~~~~~~---~ 233 (326)
T 2y0a_A 165 AHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETL---ANVSAV---N 233 (326)
T ss_dssp CEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHH---HHHHHT---C
T ss_pred CeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH---HHH---HHHHhc---C
Confidence 98754322 223467999999999999999999999999999999999999999754321 110 000000 0
Q ss_pred CChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 437 GNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 437 ~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
..+. +. ........+.+++.+||+.||.+||++.|+++.
T Consensus 234 ~~~~---~~----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 234 YEFE---DE----YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp CCCC---HH----HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCcC---cc----ccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000 00 001123568899999999999999999999874
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=368.04 Aligned_cols=264 Identities=25% Similarity=0.401 Sum_probs=198.0
Q ss_pred HHHHHhcCccccceecccCcEEEEEEEEeCC----eEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 007892 203 ELKIATDNFSEANLLGQGGFGYVHKGVLTNG----KVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTF 276 (586)
Q Consensus 203 el~~~~~~f~~~~~LG~G~fG~Vyk~~~~~g----~~vAVK~l~~~--~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~ 276 (586)
++.+..++|++.+.||+|+||.||+|++... ..||||+++.. .....+.+.+|++++++++||||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 3445567899999999999999999996543 27999999764 33446789999999999999999999999987
Q ss_pred CCee------EEEEEecCCCcHHHHhcCCC----CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCC
Q 007892 277 GSQR------LLVYEFVPNKTLEFHLHGKD----RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS 346 (586)
Q Consensus 277 ~~~~------~lV~E~~~~gsL~~~l~~~~----~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 346 (586)
.... ++||||+++|+|.+++.... ...+++..++.|+.|++.||+|||+. +|+||||||+||||+++
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAED 173 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTT
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCC
Confidence 7655 89999999999999885422 22589999999999999999999998 99999999999999999
Q ss_pred CCeEEeecccccccCCCCC-cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhh
Q 007892 347 FEAKVADFGLAKHSLDTDT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVD 424 (586)
Q Consensus 347 ~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~ 424 (586)
+.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||....... +..
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~ 250 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---IYN 250 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---HHH
Confidence 9999999999986543322 12233457889999999999999999999999999999999 999997654311 111
Q ss_pred hhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 007892 425 WAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMP 488 (586)
Q Consensus 425 ~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~~ 488 (586)
. +...............+.+++.+||+.||.+||++.+|++.|+....
T Consensus 251 ~----------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 251 Y----------------LIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp H----------------HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H----------------HhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0 01011111223344678999999999999999999999999997653
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=353.51 Aligned_cols=251 Identities=22% Similarity=0.338 Sum_probs=206.8
Q ss_pred hcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--CeeEEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFG--SQRLLV 283 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~--~~~~lV 283 (586)
.++|.+.+.||+|+||.||+|++. ++.||||+++... ....+.|.+|+.++.+++||||++++++|... ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 367899999999999999999984 8899999997653 33456799999999999999999999999887 778999
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCc--EEecCCCCceeEeCCCCCeEEeecccccccC
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK--IIHRDIKSANILLDDSFEAKVADFGLAKHSL 361 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~--ivHrDIk~~NILl~~~~~~kl~DFGla~~~~ 361 (586)
|||+++|+|.+++.......+++..++.++.|++.||+|||+. + |+||||||+|||++.++.++|+|||+.....
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 9999999999999876666799999999999999999999997 6 9999999999999999999999999875422
Q ss_pred CCCCcccccccccccccCcccccCCCCCC---cchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCC
Q 007892 362 DTDTHVSTRVMGTFGYLAPEYASSGKLTE---KSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGN 438 (586)
Q Consensus 362 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~---ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (586)
. ....||+.|+|||.+.+..++. ++|||||||++|||++|+.||....... ........ +.
T Consensus 165 ~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~----~~ 228 (271)
T 3kmu_A 165 S------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME------IGMKVALE----GL 228 (271)
T ss_dssp C------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH------HHHHHHHS----CC
T ss_pred c------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH------HHHHHHhc----CC
Confidence 1 2346899999999998765554 7999999999999999999997544211 11111100 00
Q ss_pred hhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 439 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 439 ~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
....+......+.+++..||+.||.+||++.||++.|+..
T Consensus 229 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 229 --------RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 0012223445689999999999999999999999999864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=370.31 Aligned_cols=251 Identities=23% Similarity=0.367 Sum_probs=201.7
Q ss_pred HhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeE
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRL 281 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~~~~ 281 (586)
..++|++.++||+|+||.||+++.. +++.||||+++.... .....+..|+.+|.++ +|||||+++++|...+..+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 3468999999999999999999976 578999999975422 2234578899999887 8999999999999999999
Q ss_pred EEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccC
Q 007892 282 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 361 (586)
Q Consensus 282 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~ 361 (586)
|||||+++|+|..++... ..+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 130 lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 999999999999998754 3489999999999999999999998 99999999999999999999999999998633
Q ss_pred CCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccch--hhhhhhhHHHhhcccCCCh
Q 007892 362 DTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADD--SMVDWAKPFLAQGLADGNF 439 (586)
Q Consensus 362 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 439 (586)
... ......+||+.|+|||++.+..++.++|||||||+||||++|+.||......... ...++...
T Consensus 205 ~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~----------- 272 (396)
T 4dc2_A 205 RPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ----------- 272 (396)
T ss_dssp CTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHH-----------
T ss_pred cCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHH-----------
Confidence 222 2345578999999999999999999999999999999999999999754321110 01111111
Q ss_pred hhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCH
Q 007892 440 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRM 476 (586)
Q Consensus 440 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm 476 (586)
.+....+ .++......+.+++.+||+.||.+||++
T Consensus 273 -~i~~~~~-~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 273 -VILEKQI-RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp -HHHHCCC-CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred -HHhcccc-CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1111111 2333445678999999999999999985
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=367.93 Aligned_cols=270 Identities=16% Similarity=0.254 Sum_probs=206.6
Q ss_pred hcCccccceeccc--CcEEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEE
Q 007892 208 TDNFSEANLLGQG--GFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 282 (586)
Q Consensus 208 ~~~f~~~~~LG~G--~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~l 282 (586)
.++|++.+.||+| +||.||+|+.. +|+.||||+++... ......+.+|+.++++++|||||+++++|...+..+|
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3679999999999 99999999976 68999999997543 3334678899999999999999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCC
Q 007892 283 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 283 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 362 (586)
||||+++|+|.+++.......+++..+..|+.|++.||+|||++ +|+||||||+||||+.++.+||+|||++.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 99999999999999876556699999999999999999999998 999999999999999999999999999865422
Q ss_pred CCC------cccccccccccccCcccccC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcc
Q 007892 363 TDT------HVSTRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGL 434 (586)
Q Consensus 363 ~~~------~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 434 (586)
... .......||+.|+|||++.+ ..++.++|||||||+||||++|+.||....... .+.......+...+
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~ 258 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLNGTVPCLL 258 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTT--HHHHC---------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHhcCCCCccc
Confidence 111 11223478999999999987 579999999999999999999999997654321 11110000000000
Q ss_pred ------------------cCCChhhhh----------chhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 435 ------------------ADGNFDALV----------DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 435 ------------------~~~~~~~l~----------d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
....+...+ +.....+.......+.+++.+||+.||.+||++.|+++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 000000000 000001223344678999999999999999999999864
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=366.69 Aligned_cols=265 Identities=25% Similarity=0.463 Sum_probs=215.4
Q ss_pred HHHHHHHhcCccccceecccCcEEEEEEEEe------CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEE
Q 007892 201 YEELKIATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGY 273 (586)
Q Consensus 201 ~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~ 273 (586)
.+++++..++|.+.+.||+|+||.||+|+.. +++.||||.+..... .....+.+|+.++.+++||||++++++
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 3455667789999999999999999999864 367899999976533 334578999999999999999999999
Q ss_pred EEeCCeeEEEEEecCCCcHHHHhcCCC--------CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCC
Q 007892 274 CTFGSQRLLVYEFVPNKTLEFHLHGKD--------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD 345 (586)
Q Consensus 274 ~~~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 345 (586)
+...+..++||||+++|+|.+++.... ...+++..++.++.|++.||.|||++ +|+||||||+||||+.
T Consensus 97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~ 173 (322)
T 1p4o_A 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAE 173 (322)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECT
T ss_pred EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcC
Confidence 999999999999999999999986421 24578999999999999999999998 9999999999999999
Q ss_pred CCCeEEeecccccccCCCCC-cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhh
Q 007892 346 SFEAKVADFGLAKHSLDTDT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMV 423 (586)
Q Consensus 346 ~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~ 423 (586)
++.+||+|||+++....... .......|++.|+|||++.++.++.++|||||||+||||++ |+.||..... ..+.
T Consensus 174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~ 250 (322)
T 1p4o_A 174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---EQVL 250 (322)
T ss_dssp TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---HHHH
T ss_pred CCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH---HHHH
Confidence 99999999999986533222 12234467889999999998999999999999999999999 8999976432 1111
Q ss_pred hhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 424 DWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 424 ~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
.. + ..+. +..........+.+++.+||+.||.+||++.||++.|+..+
T Consensus 251 ~~----~----~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 251 RF----V----MEGG--------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp HH----H----HTTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HH----H----HcCC--------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 11 0 0111 11122234456889999999999999999999999999764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=356.92 Aligned_cols=249 Identities=22% Similarity=0.314 Sum_probs=197.0
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCch--------------------------hHHHHHHHHHHHH
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ--------------------------GEREFQAEIEIIS 260 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~--------------------------~~~~~~~Ei~il~ 260 (586)
.++|.+.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|+++|.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 468999999999999999999965 6899999998654311 1246889999999
Q ss_pred hcCCCCcceEEEEEEe--CCeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCC
Q 007892 261 QVHHRHLVSLVGYCTF--GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKS 338 (586)
Q Consensus 261 ~l~Hpniv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~ 338 (586)
+++||||+++++++.+ .+..++||||+++++|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp 165 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKP 165 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCH
Confidence 9999999999999987 5688999999999999876532 3589999999999999999999998 999999999
Q ss_pred ceeEeCCCCCeEEeecccccccCCCCCcccccccccccccCcccccCCC---CCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 007892 339 ANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGK---LTEKSDVFSFGVLLLELITGFRPFDKAD 415 (586)
Q Consensus 339 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~ksDVwSlGvvL~elltG~~Pf~~~~ 415 (586)
+||||+.++.+||+|||+++....... ......||+.|+|||.+.+.. ++.++|||||||+||||++|+.||....
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 999999999999999999987544322 234467999999999998655 4788999999999999999999997543
Q ss_pred cccchhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 416 TFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 416 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
. ..+.......... + .........+.+++.+||+.||.+||++.||++
T Consensus 245 ~------~~~~~~~~~~~~~---~---------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 245 I------MCLHSKIKSQALE---F---------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp H------HHHHHHHHHCCCC---C---------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred H------HHHHHHHhcccCC---C---------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 2 1111111110000 0 001123356889999999999999999999975
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=361.69 Aligned_cols=250 Identities=20% Similarity=0.322 Sum_probs=198.4
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC--------
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS-------- 278 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~-------- 278 (586)
++|+..+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|+.+|++++||||++++++|.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 57999999999999999999986 78999999997543 334578999999999999999999999986644
Q ss_pred -------------------------------------------------eeEEEEEecCCCcHHHHhcCCCC-CCCChHH
Q 007892 279 -------------------------------------------------QRLLVYEFVPNKTLEFHLHGKDR-PVMNWPT 308 (586)
Q Consensus 279 -------------------------------------------------~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~ 308 (586)
..++||||+++++|.+++..... ....+..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 27899999999999999976533 3356677
Q ss_pred HHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC-----------cccccccccccc
Q 007892 309 RMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT-----------HVSTRVMGTFGY 377 (586)
Q Consensus 309 ~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~-----------~~~~~~~gt~~y 377 (586)
++.++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++....... .......||+.|
T Consensus 166 ~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 899999999999999998 999999999999999999999999999987654321 122345799999
Q ss_pred cCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHH
Q 007892 378 LAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTR 457 (586)
Q Consensus 378 ~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~ 457 (586)
+|||++.+..++.++|||||||+||||++|..|+.... ... .......+ ..........
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~--------~~~-----~~~~~~~~--------~~~~~~~~~~ 301 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV--------RII-----TDVRNLKF--------PLLFTQKYPQ 301 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH--------HHH-----HHHHTTCC--------CHHHHHHCHH
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH--------HHH-----HHhhccCC--------CcccccCChh
Confidence 99999999999999999999999999999876642110 000 00001111 1111233456
Q ss_pred HHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 458 MAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 458 l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
+.+++.+||+.||.+||++.||++.
T Consensus 302 ~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 302 EHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHccCCCCcCCCHHHHhhc
Confidence 7899999999999999999999874
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=361.17 Aligned_cols=245 Identities=27% Similarity=0.383 Sum_probs=205.2
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV 283 (586)
.++|++.+.||+|+||.||+++.. +|+.||||+++... ....+.+.+|+.++..++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 367999999999999999999975 68999999996532 22346788999999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCC
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 363 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 363 (586)
|||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 85 ~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp ECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred EeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 99999999999997543 489999999999999999999998 9999999999999999999999999999865332
Q ss_pred CCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhh
Q 007892 364 DTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 443 (586)
Q Consensus 364 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 443 (586)
....+||+.|+|||++.+..++.++|||||||+||||++|+.||...+.. ......+.
T Consensus 160 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~i~~------------ 217 (318)
T 1fot_A 160 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------KTYEKILN------------ 217 (318)
T ss_dssp ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHH------------
T ss_pred ----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHh------------
Confidence 23467999999999999999999999999999999999999999764421 11111111
Q ss_pred chhhhccCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 007892 444 DQKLEEYDSAEMTRMAACAAACIRHSARRRP-----RMSQIVR 481 (586)
Q Consensus 444 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RP-----tm~evl~ 481 (586)
..+ .++......+.+++.+||+.||.+|| ++.||++
T Consensus 218 -~~~-~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 218 -AEL-RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp -CCC-CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCC-CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 111 12223345788999999999999999 8888885
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=378.58 Aligned_cols=264 Identities=21% Similarity=0.233 Sum_probs=210.6
Q ss_pred cCHHHHHHHhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEE
Q 007892 199 FTYEELKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYC 274 (586)
Q Consensus 199 ~~~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l~Hpniv~l~g~~ 274 (586)
+.+.+++...++|++.+.||+|+||.||+++.. +|+.||||+++.... .....+++|+.++.+++||||++++++|
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 345677778899999999999999999999975 689999999965321 1223578999999999999999999999
Q ss_pred EeCCeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeec
Q 007892 275 TFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADF 354 (586)
Q Consensus 275 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DF 354 (586)
.+.+..+|||||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||||+.++.+||+||
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeec
Confidence 99999999999999999999997532 3589999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccccCccccc-------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhh
Q 007892 355 GLAKHSLDTDTHVSTRVMGTFGYLAPEYAS-------SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAK 427 (586)
Q Consensus 355 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~ 427 (586)
|+++.............+||+.|+|||++. .+.++.++|||||||+||||++|+.||...+... ...
T Consensus 207 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~ 280 (412)
T 2vd5_A 207 GSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE------TYG 280 (412)
T ss_dssp TTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHH
T ss_pred hhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH------HHH
Confidence 999876544433344568999999999987 4678999999999999999999999997654211 111
Q ss_pred HHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCC---CCHHHHHHH
Q 007892 428 PFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRR---PRMSQIVRA 482 (586)
Q Consensus 428 ~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~R---Ptm~evl~~ 482 (586)
..+... ..+ .+..........+.+++.+||+ +|.+| |++.||+++
T Consensus 281 ~i~~~~------~~~---~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 281 KIVHYK------EHL---SLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHHTHH------HHC---CCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred HHHhcc------cCc---CCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 100000 000 0001112334678999999999 99888 689998763
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=366.78 Aligned_cols=253 Identities=23% Similarity=0.381 Sum_probs=205.7
Q ss_pred HhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEE
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV 283 (586)
..++|.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++.+++||||++++++|.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3467999999999999999999975 58999999997543 23346788999999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCC---CCeEEeeccccccc
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS---FEAKVADFGLAKHS 360 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~---~~~kl~DFGla~~~ 360 (586)
|||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||||+.+ +.+||+|||+++..
T Consensus 107 ~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp ECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred EecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 9999999999998654 4589999999999999999999998 99999999999999765 45999999999876
Q ss_pred CCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChh
Q 007892 361 LDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 440 (586)
Q Consensus 361 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (586)
.... ......||+.|+|||++.+..++.++|||||||+||||++|+.||...+. ..+.. ... .+.+.
T Consensus 182 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~---~~~~~---~i~-----~~~~~ 248 (362)
T 2bdw_A 182 NDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLYA---QIK-----AGAYD 248 (362)
T ss_dssp TTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---HHH-----HTCCC
T ss_pred cCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHH---HHH-----hCCCC
Confidence 4332 22346799999999999998999999999999999999999999976442 11111 111 11110
Q ss_pred hhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 441 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 441 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
...+.. ......+.+++.+||+.||.+||++.|+++.
T Consensus 249 -~~~~~~----~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 249 -YPSPEW----DTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -CCTTGG----GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -CCcccc----cCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000001 1223568899999999999999999999864
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=367.51 Aligned_cols=267 Identities=18% Similarity=0.233 Sum_probs=206.9
Q ss_pred HhcCccccceecccCcEEEEEEEEeC------CeEEEEEEeccCCchhH-----------HHHHHHHHHHHhcCCCCcce
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQLKAGSGQGE-----------REFQAEIEIISQVHHRHLVS 269 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~~------g~~vAVK~l~~~~~~~~-----------~~~~~Ei~il~~l~Hpniv~ 269 (586)
..++|.+.+.||+|+||.||+|.+.+ ++.||||++........ ..+..|+..+.+++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34689999999999999999999765 47899999876543211 12334566677788999999
Q ss_pred EEEEEEeC----CeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeC-
Q 007892 270 LVGYCTFG----SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD- 344 (586)
Q Consensus 270 l~g~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~- 344 (586)
++++|... ...+|||||+ +++|.+++... ...+++..++.|+.|++.||+|||+. +|+||||||+||||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEES
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEec
Confidence 99999774 4579999999 99999999764 24599999999999999999999998 999999999999998
Q ss_pred -CCCCeEEeecccccccCCCCCc------ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcc
Q 007892 345 -DSFEAKVADFGLAKHSLDTDTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTF 417 (586)
Q Consensus 345 -~~~~~kl~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~ 417 (586)
.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||+||||++|+.||.....
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~- 266 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK- 266 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT-
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc-
Confidence 8899999999999865432211 11335699999999999999999999999999999999999999985332
Q ss_pred cchhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 418 ADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 418 ~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
......+...... ..+..+++..+. ....+..+.+++..|++.+|.+||++.+|++.|+...
T Consensus 267 -~~~~~~~~~~~~~-----~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~ 328 (364)
T 3op5_A 267 -DPKYVRDSKIRYR-----ENIASLMDKCFP--AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL 328 (364)
T ss_dssp -CHHHHHHHHHHHH-----HCHHHHHHHHSC--TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred -CHHHHHHHHHHhh-----hhHHHHHHHhcc--cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence 2222222221111 123334444332 1123457889999999999999999999999998653
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=362.40 Aligned_cols=259 Identities=26% Similarity=0.442 Sum_probs=210.9
Q ss_pred HhcCccccceecccCcEEEEEEEEe--------CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhc-CCCCcceEEEEEEe
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLT--------NGKVVAIKQLKAGSG-QGEREFQAEIEIISQV-HHRHLVSLVGYCTF 276 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~--------~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~ 276 (586)
..++|.+.+.||+|+||.||+|... +++.||||+++.... .....+.+|+.++.++ +||||++++++|..
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 4578999999999999999999863 467899999976543 3356789999999999 89999999999999
Q ss_pred CCeeEEEEEecCCCcHHHHhcCCCC--------------CCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeE
Q 007892 277 GSQRLLVYEFVPNKTLEFHLHGKDR--------------PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANIL 342 (586)
Q Consensus 277 ~~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NIL 342 (586)
.+..++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+|||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEE
Confidence 9999999999999999999976432 3489999999999999999999998 9999999999999
Q ss_pred eCCCCCeEEeecccccccCCCCCc-ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccch
Q 007892 343 LDDSFEAKVADFGLAKHSLDTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADD 420 (586)
Q Consensus 343 l~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~ 420 (586)
|+.++.+||+|||+++........ ......+++.|+|||++.+..++.++|||||||+||||++ |+.||..... .
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~ 266 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---E 266 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH---H
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH---H
Confidence 999999999999999865443321 2233457889999999998899999999999999999999 9999975432 1
Q ss_pred hhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 421 SMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 421 ~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
.+... +.. +. ....+......+.+++.+||+.+|.+||++.||++.|+...
T Consensus 267 ~~~~~----~~~----~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 267 ELFKL----LKE----GH--------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317 (334)
T ss_dssp HHHHH----HHH----TC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHH----Hhc----CC--------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11111 111 00 00122233457889999999999999999999999999764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=359.80 Aligned_cols=267 Identities=27% Similarity=0.425 Sum_probs=216.1
Q ss_pred cCHHHHHHHhcCccccceecccCcEEEEEEEEe------CCeEEEEEEeccCCch-hHHHHHHHHHHHHhc-CCCCcceE
Q 007892 199 FTYEELKIATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSGQ-GEREFQAEIEIISQV-HHRHLVSL 270 (586)
Q Consensus 199 ~~~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~~~~-~~~~~~~Ei~il~~l-~Hpniv~l 270 (586)
+...++....++|.+.+.||+|+||.||+|.+. +++.||||+++..... ..+.+.+|+.++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 455677778899999999999999999999852 4689999999765433 346789999999999 79999999
Q ss_pred EEEEEeCC-eeEEEEEecCCCcHHHHhcCCCC--------------CCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecC
Q 007892 271 VGYCTFGS-QRLLVYEFVPNKTLEFHLHGKDR--------------PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRD 335 (586)
Q Consensus 271 ~g~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrD 335 (586)
+++|...+ ..++||||+++++|.+++..... ..+++..++.++.|++.||.|||+. +|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence 99998755 48999999999999999976543 2278999999999999999999998 999999
Q ss_pred CCCceeEeCCCCCeEEeecccccccCCCCC-cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCC
Q 007892 336 IKSANILLDDSFEAKVADFGLAKHSLDTDT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDK 413 (586)
Q Consensus 336 Ik~~NILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~ 413 (586)
|||+||||+.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||+||||++ |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999986544322 22344568899999999999999999999999999999998 9999976
Q ss_pred CCcccchhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 414 ADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 414 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
.... ..+... +.. +. ....+......+.+++.+||+.||.+||++.||++.|+..
T Consensus 254 ~~~~--~~~~~~----~~~----~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 254 VKID--EEFCRR----LKE----GT--------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp CCCS--HHHHHH----HHH----TC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cchh--HHHHHH----hcc----Cc--------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 4421 111111 110 00 0011222345688999999999999999999999999865
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=363.89 Aligned_cols=253 Identities=21% Similarity=0.362 Sum_probs=203.6
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccC-----CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG-----SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 281 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~-----~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~ 281 (586)
.+.|++.+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+.++.+++||||++++++|...+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 357999999999999999999975 6899999998532 1224578999999999999999999999999999999
Q ss_pred EEEEecCCCcHHHHhcCC--CCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCC---eEEeeccc
Q 007892 282 LVYEFVPNKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE---AKVADFGL 356 (586)
Q Consensus 282 lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~---~kl~DFGl 356 (586)
|||||+++++|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+||||+.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999998877542 233589999999999999999999998 9999999999999976654 99999999
Q ss_pred ccccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccC
Q 007892 357 AKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLAD 436 (586)
Q Consensus 357 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (586)
++...... ......+||+.|+|||++.+..++.++|||||||+||||++|+.||..... .+. .... .
T Consensus 180 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~---~~i~-----~ 246 (351)
T 3c0i_A 180 AIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLF---EGII-----K 246 (351)
T ss_dssp CEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHH---HHHH-----H
T ss_pred eeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHH---HHHH-----c
Confidence 98764432 223456799999999999999999999999999999999999999975321 111 1111 0
Q ss_pred CChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 437 GNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 437 ~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
+.+. .++... ......+.+++.+||+.||.+||++.|+++
T Consensus 247 ~~~~--~~~~~~---~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 247 GKYK--MNPRQW---SHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp TCCC--CCHHHH---TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCC--CCcccc---ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1100 000000 112356889999999999999999999986
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=369.44 Aligned_cols=253 Identities=24% Similarity=0.363 Sum_probs=207.9
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
.++|.+.+.||+|+||.||+|... +|+.||+|++..........+.+|+.+|.+++||||++++++|.+....+|||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 367999999999999999999975 6889999999876655667899999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCC--CCCeEEeecccccccCCCC
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD--SFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~--~~~~kl~DFGla~~~~~~~ 364 (586)
+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||||+. ++.+||+|||+++......
T Consensus 130 ~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 130 LSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp CCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 99999999986543 3589999999999999999999998 9999999999999974 5789999999998764332
Q ss_pred CcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhc
Q 007892 365 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 444 (586)
Q Consensus 365 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 444 (586)
......||+.|+|||++.+..++.++|||||||+||||++|+.||...... .... ......+ .+ +
T Consensus 206 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~---~i~~~~~---~~----~ 270 (387)
T 1kob_A 206 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETLQ---NVKRCDW---EF----D 270 (387)
T ss_dssp --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHH---HHHHCCC---CC----C
T ss_pred --ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH---HHHH---HHHhCCC---CC----C
Confidence 223457999999999999999999999999999999999999999765421 1111 1000000 00 0
Q ss_pred hhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 445 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 445 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
. .........+.+++.+||+.||.+||++.|+++.
T Consensus 271 ~---~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 271 E---DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp S---STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred c---cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0 1111234568899999999999999999999864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=367.08 Aligned_cols=249 Identities=26% Similarity=0.345 Sum_probs=205.2
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
++|.+.+.||+|+||.||++... +++.||||++.... ....+.+.+|+.+|.+++|||||+++++|.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 67999999999999999999975 57899999986432 233567889999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
||+.+|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++.....
T Consensus 95 e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE- 168 (384)
T ss_dssp CCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred ecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCC-
Confidence 999999999999754 3599999999999999999999998 9999999999999999999999999999865432
Q ss_pred CcccccccccccccCcccccC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhh
Q 007892 365 THVSTRVMGTFGYLAPEYASS---GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 441 (586)
Q Consensus 365 ~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (586)
......+||+.|+|||++.. ..++.++|||||||+||||++|+.||..........+.....
T Consensus 169 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~-------------- 233 (384)
T 4fr4_A 169 -TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE-------------- 233 (384)
T ss_dssp -CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH--------------
T ss_pred -CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh--------------
Confidence 22345689999999999964 458999999999999999999999997544322111111110
Q ss_pred hhchhhhccCHHHHHHHHHHHHHhhccCCCCCCC-HHHHHH
Q 007892 442 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPR-MSQIVR 481 (586)
Q Consensus 442 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPt-m~evl~ 481 (586)
.....++......+.+++.+||+.||.+||+ +.+|++
T Consensus 234 ---~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 234 ---TTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ---HCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ---hcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0011233334567899999999999999998 777764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=357.92 Aligned_cols=245 Identities=22% Similarity=0.301 Sum_probs=194.2
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc--hhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
++|+..++||+|+||+||+|+.. +|+.||||++..... .....+..|+..+.++ +|+||++++++|.+++..+|||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 67999999999999999999986 689999999865432 2334555666666665 8999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
||+ +++|.+++.... ..++|..++.|+.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 137 e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp ECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred ecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 999 678888876543 3599999999999999999999998 99999999999999999999999999998653322
Q ss_pred CcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhc
Q 007892 365 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 444 (586)
Q Consensus 365 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 444 (586)
......||+.|+|||++.+ .++.++|||||||+||||++|..|+..... |. .+..+....
T Consensus 212 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~--------~~------~~~~~~~~~--- 271 (311)
T 3p1a_A 212 --AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG--------WQ------QLRQGYLPP--- 271 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH--------HH------HHTTTCCCH---
T ss_pred --CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH--------HH------HHhccCCCc---
Confidence 2344569999999999875 799999999999999999999776643211 11 001111111
Q ss_pred hhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 445 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 445 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
. +.......+.+++.+||+.||.+||++.||++.
T Consensus 272 -~---~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 272 -E---FTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp -H---HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -c---cccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 1 111234568999999999999999999999863
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=362.98 Aligned_cols=208 Identities=26% Similarity=0.354 Sum_probs=182.8
Q ss_pred cCHHHHHHHhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcC-----CCCcceEEE
Q 007892 199 FTYEELKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-----HRHLVSLVG 272 (586)
Q Consensus 199 ~~~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~-----Hpniv~l~g 272 (586)
|++.+.....++|.+.++||+|+||.||+|+.. +++.||||+++.. ......+..|++++.+++ ||||+++++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 344445556789999999999999999999974 6889999999743 334567888999999996 999999999
Q ss_pred EEEeCCeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCC-------
Q 007892 273 YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD------- 345 (586)
Q Consensus 273 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~------- 345 (586)
++...+..+|||||+ +++|.+++.......+++..+..++.|++.||+|||+. +|+||||||+||||+.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~ 179 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSL 179 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccc
Confidence 999999999999999 99999999876666799999999999999999999998 9999999999999975
Q ss_pred ------------------CCCeEEeecccccccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhC
Q 007892 346 ------------------SFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITG 407 (586)
Q Consensus 346 ------------------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG 407 (586)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||+||||++|
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 255 (360)
T 3llt_A 180 ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255 (360)
T ss_dssp EEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred cchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHC
Confidence 789999999999864332 2346799999999999999999999999999999999999
Q ss_pred CCCCCCCC
Q 007892 408 FRPFDKAD 415 (586)
Q Consensus 408 ~~Pf~~~~ 415 (586)
+.||....
T Consensus 256 ~~pf~~~~ 263 (360)
T 3llt_A 256 SLLFRTHE 263 (360)
T ss_dssp SCSCCCSS
T ss_pred CCCCCCCc
Confidence 99998654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=352.52 Aligned_cols=251 Identities=34% Similarity=0.603 Sum_probs=202.4
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhH-------HHHHHHHHHHHhcCCCCcceEEEEEEeCCee
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGE-------REFQAEIEIISQVHHRHLVSLVGYCTFGSQR 280 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~-------~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~ 280 (586)
++|+..+.||+|+||.||+|+.. +++.||||++........ +.+.+|+.++.+++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 67999999999999999999974 689999999865432211 67899999999999999999999986554
Q ss_pred EEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCc--EEecCCCCceeEeCCCCC-----eEEee
Q 007892 281 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK--IIHRDIKSANILLDDSFE-----AKVAD 353 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~--ivHrDIk~~NILl~~~~~-----~kl~D 353 (586)
++||||+++++|.+++.... ..+++..++.++.|++.||+|||++ + |+||||||+||||+.++. +||+|
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 69999999999988886543 4589999999999999999999998 7 999999999999988776 99999
Q ss_pred cccccccCCCCCcccccccccccccCcccc--cCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHh
Q 007892 354 FGLAKHSLDTDTHVSTRVMGTFGYLAPEYA--SSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLA 431 (586)
Q Consensus 354 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 431 (586)
||+++.... ......||+.|+|||.+ ....++.++|||||||+||||++|+.||....... ..+......
T Consensus 173 fg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~~~~~ 244 (287)
T 4f0f_A 173 FGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IKFINMIRE 244 (287)
T ss_dssp CTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH----HHHHHHHHH
T ss_pred CCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH----HHHHHHHhc
Confidence 999975432 23446799999999998 45567899999999999999999999997654311 111111000
Q ss_pred hcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 007892 432 QGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 485 (586)
Q Consensus 432 ~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~ 485 (586)
.. . ....+......+.+++.+||+.||.+||++.||++.|+.
T Consensus 245 ~~-----~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 245 EG-----L-------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp SC-----C-------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred cC-----C-------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 00 0 002223345678999999999999999999999999985
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=365.35 Aligned_cols=246 Identities=24% Similarity=0.324 Sum_probs=202.4
Q ss_pred cCccccceecccCcEEEEEEEE-eCCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
++|.+.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.+|+.++||||+++++++...+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 6799999999999999999997 468999999986431 122357889999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
||+ +|+|.+++... ..+++.++..++.|++.||.|||+. +|+||||||+||||++++.+||+|||+++......
T Consensus 89 E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 89 EYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp CCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred ECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 999 78888888654 3489999999999999999999998 99999999999999999999999999998654332
Q ss_pred CcccccccccccccCcccccCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhh
Q 007892 365 THVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 443 (586)
Q Consensus 365 ~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 443 (586)
.....+||+.|+|||.+.+..+ +.++|||||||+||||++|+.||....... + .+.+..+.+
T Consensus 163 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---~--------~~~i~~~~~---- 225 (336)
T 3h4j_B 163 --FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN---L--------FKKVNSCVY---- 225 (336)
T ss_dssp --TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT---C--------BCCCCSSCC----
T ss_pred --ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH---H--------HHHHHcCCC----
Confidence 2345679999999999987776 789999999999999999999997543211 0 001111110
Q ss_pred chhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 444 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 444 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
..+......+.+++.+||+.||.+||++.||++.
T Consensus 226 -----~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 226 -----VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp -----CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred -----CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 1222234568899999999999999999999873
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=361.52 Aligned_cols=249 Identities=26% Similarity=0.381 Sum_probs=196.3
Q ss_pred hcCccccceecccCcEEEEEEEE----eCCeEEEEEEeccCC----chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVL----TNGKVVAIKQLKAGS----GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ 279 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~----~~g~~vAVK~l~~~~----~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~ 279 (586)
.++|++.+.||+|+||.||+++. .+|+.||||+++... ......+.+|+.+|.+++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46899999999999999999997 478999999997642 2234567899999999999999999999999999
Q ss_pred eEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccc
Q 007892 280 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 359 (586)
Q Consensus 280 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~ 359 (586)
.+|||||+++++|.+++... ..+.+..+..++.|++.||.|||++ +|+||||||+||||+.++.+||+|||+++.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 99999999999999999654 3488999999999999999999998 999999999999999999999999999975
Q ss_pred cCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCCh
Q 007892 360 SLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 439 (586)
Q Consensus 360 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (586)
..... ......+||+.|+|||++.+..++.++|||||||+||||++|+.||...... ......+.
T Consensus 171 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~-------- 235 (327)
T 3a62_A 171 SIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK------KTIDKILK-------- 235 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHH--------
T ss_pred cccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHh--------
Confidence 43222 2234467999999999999999999999999999999999999999764421 11111111
Q ss_pred hhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 007892 440 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRP-----RMSQIVRA 482 (586)
Q Consensus 440 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RP-----tm~evl~~ 482 (586)
..+ .++......+.+++.+||+.||.+|| ++.|++++
T Consensus 236 -----~~~-~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 236 -----CKL-NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp -----TCC-CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred -----CCC-CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 000 12223345788999999999999999 77788763
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=366.91 Aligned_cols=250 Identities=26% Similarity=0.374 Sum_probs=204.6
Q ss_pred HHHhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCe
Q 007892 205 KIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQ 279 (586)
Q Consensus 205 ~~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~~ 279 (586)
....++|.+.+.||+|+||.||+|+.. +|+.||||+++... ......+..|..++.++ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 445688999999999999999999975 58999999997532 23345678899999987 89999999999999999
Q ss_pred eEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccc
Q 007892 280 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 359 (586)
Q Consensus 280 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~ 359 (586)
.+|||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++.
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 999999999999999996543 489999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCCh
Q 007892 360 SLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 439 (586)
Q Consensus 360 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (586)
..... ......+||+.|+|||++.+..++.++|||||||+||||++|+.||...+.. .+.. .... +.
T Consensus 168 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~---~i~~-----~~- 234 (345)
T 1xjd_A 168 NMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELFH---SIRM-----DN- 234 (345)
T ss_dssp CCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHHH-----CC-
T ss_pred cccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH---HHHH---HHHh-----CC-
Confidence 43222 2234578999999999999999999999999999999999999999764421 1111 1100 00
Q ss_pred hhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHH-HHH
Q 007892 440 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMS-QIV 480 (586)
Q Consensus 440 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~-evl 480 (586)
..++......+.+++.+||+.||.+||++. ||+
T Consensus 235 --------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 235 --------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp --------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred --------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 012223345788999999999999999997 665
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=360.52 Aligned_cols=249 Identities=24% Similarity=0.376 Sum_probs=201.2
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~~~~lV 283 (586)
++|+..+.||+|+||.||+++.. +++.||||+++... ......+.+|+.++.++ +||||+++++++...+..+||
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 67999999999999999999976 58999999997542 23345688999999988 899999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCC
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 363 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 363 (586)
|||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 89 ~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 9999999999998654 3489999999999999999999998 9999999999999999999999999999864322
Q ss_pred CCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccch--hhhhhhhHHHhhcccCCChhh
Q 007892 364 DTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADD--SMVDWAKPFLAQGLADGNFDA 441 (586)
Q Consensus 364 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 441 (586)
. ......+||+.|+|||++.+..++.++|||||||+||||++|+.||......... ....+... .
T Consensus 164 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~------------~ 230 (345)
T 3a8x_A 164 G-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ------------V 230 (345)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHH------------H
T ss_pred C-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHH------------H
Confidence 2 2234568999999999999999999999999999999999999999753321110 00111110 0
Q ss_pred hhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCH
Q 007892 442 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRM 476 (586)
Q Consensus 442 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm 476 (586)
+....+ .++......+.+++.+||+.||.+||++
T Consensus 231 i~~~~~-~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 231 ILEKQI-RIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp HHHCCC-CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred HHcCCC-CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 111111 2233345678899999999999999995
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=352.13 Aligned_cols=256 Identities=26% Similarity=0.375 Sum_probs=204.5
Q ss_pred HhcCccccceecccCcEEEEEEEEeC----CeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeE
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLTN----GKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 281 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~~----g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~ 281 (586)
..++|...+.||+|+||.||+|++.+ +..||||.+.... ....+.+.+|+.++.+++||||+++++++.. +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 34789999999999999999999653 3469999987653 3345689999999999999999999999865 4568
Q ss_pred EEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccC
Q 007892 282 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 361 (586)
Q Consensus 282 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~ 361 (586)
+||||+++++|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 89 ~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 9999999999999996532 3589999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChh
Q 007892 362 DTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 440 (586)
Q Consensus 362 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (586)
...........+++.|+|||.+.+..++.++|||||||+||||++ |+.||....... .... +.. +.
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~~----~~~----~~-- 231 (281)
T 3cc6_A 165 DEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIGV----LEK----GD-- 231 (281)
T ss_dssp --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHHH----HHH----TC--
T ss_pred cccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHHH----Hhc----CC--
Confidence 443333344567889999999998899999999999999999998 999997544311 1111 000 00
Q ss_pred hhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 441 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 441 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
....+......+.+++.+||+.||.+||++.||++.|+..
T Consensus 232 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 232 ------RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 0011222345688999999999999999999999999864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=373.76 Aligned_cols=254 Identities=20% Similarity=0.305 Sum_probs=205.0
Q ss_pred HhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEE
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV 283 (586)
..++|++.+.||+|+||.||+|... +|+.||+|++..... .....+.+|+.+|.+++|||||++++++.+.+..+||
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 3467999999999999999999964 689999999976542 2345789999999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeC---CCCCeEEeeccccccc
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD---DSFEAKVADFGLAKHS 360 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~---~~~~~kl~DFGla~~~ 360 (586)
|||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||||+ +++.+||+|||+++..
T Consensus 89 ~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 89 FDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp ECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 9999999999988754 3489999999999999999999998 999999999999998 5678999999999865
Q ss_pred CCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChh
Q 007892 361 LDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 440 (586)
Q Consensus 361 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (586)
.... .......||+.|+|||++.+..++.++|||||||+||+|++|..||...+.. .+.. ... .+.+.
T Consensus 164 ~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~---~~~~---~i~-----~~~~~ 231 (444)
T 3soa_A 164 EGEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH---RLYQ---QIK-----AGAYD 231 (444)
T ss_dssp CTTC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHH---HHH-----HTCCC
T ss_pred cCCC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH---HHHH---HHH-----hCCCC
Confidence 4332 2234567999999999999999999999999999999999999999754421 1111 100 11110
Q ss_pred hhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 441 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 441 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
...+ ........+.+++..||+.||.+||++.|+++.
T Consensus 232 -~~~~----~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 232 -FPSP----EWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp -CCTT----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -CCcc----ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0000 011234568899999999999999999999873
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=364.15 Aligned_cols=255 Identities=27% Similarity=0.433 Sum_probs=203.3
Q ss_pred cCccccceecccCcEEEEEEEEe-CCe----EEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGK----VVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 282 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~----~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~l 282 (586)
++|+..+.||+|+||.||+|++. +++ .||+|.+.... ......+.+|+.++.+++||||++++++|. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 67899999999999999999964 344 38888875443 233456788999999999999999999986 466889
Q ss_pred EEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCC
Q 007892 283 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 283 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 362 (586)
||||+++|+|.+++... ...+++..++.|+.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++....
T Consensus 92 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 99999999999999754 23589999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCc-ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChh
Q 007892 363 TDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 440 (586)
Q Consensus 363 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (586)
.... ......|+..|+|||++.++.++.++|||||||+||||++ |+.||....... +.... . .+..
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~----~----~~~~- 235 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---VPDLL----E----KGER- 235 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---HHHHH----H----TTCB-
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---HHHHH----H----cCCC-
Confidence 3322 2344568889999999999999999999999999999999 999998654311 11111 0 1100
Q ss_pred hhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 441 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 441 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
...+......+.+++.+||+.||.+||++.||++.|+...
T Consensus 236 -------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 236 -------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp -------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred -------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0111122345788999999999999999999999998764
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=364.02 Aligned_cols=245 Identities=25% Similarity=0.314 Sum_probs=205.2
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
++|+..+.||+|+||.||+++.. +|+.||||+++... ....+.+.+|+.+|.+++||||+++++++.+.+..+|||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 67999999999999999999975 68999999986532 223467889999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 9999999999997543 489999999999999999999998 9999999999999999999999999999865332
Q ss_pred CcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhc
Q 007892 365 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 444 (586)
Q Consensus 365 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 444 (586)
....+||+.|+|||++.+..++.++|||||||+||||++|+.||...... +...... .+
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~-----~~------- 253 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI------QIYEKIV-----SG------- 253 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHH-----HC-------
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH------HHHHHHH-----cC-------
Confidence 23467999999999999999999999999999999999999999764421 1111111 11
Q ss_pred hhhhccCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 007892 445 QKLEEYDSAEMTRMAACAAACIRHSARRRPR-----MSQIVRA 482 (586)
Q Consensus 445 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----m~evl~~ 482 (586)
.+ .++......+.+++.+||+.||.+||+ +.||++.
T Consensus 254 -~~-~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 254 -KV-RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp -CC-CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CC-CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 11 122233457899999999999999998 8888753
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=363.81 Aligned_cols=252 Identities=23% Similarity=0.362 Sum_probs=198.9
Q ss_pred HhcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCC--CCcceEEEEEEeCCeeEE
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHH--RHLVSLVGYCTFGSQRLL 282 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~H--pniv~l~g~~~~~~~~~l 282 (586)
..++|++.+.||+|+||.||++...+++.||||++.... ......+.+|+.+|.+++| +||+++++++..++..+|
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 346799999999999999999998889999999986543 3334678999999999976 999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCC
Q 007892 283 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 283 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 362 (586)
||| +.+++|.+++... ..+++.++..|+.|++.||+|||+. +|+||||||+||||+ ++.+||+|||+++....
T Consensus 87 v~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EEC-CCSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred EEe-CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 999 5688999999764 3589999999999999999999998 999999999999997 56899999999987644
Q ss_pred CCCc-ccccccccccccCcccccC-----------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHH
Q 007892 363 TDTH-VSTRVMGTFGYLAPEYASS-----------GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFL 430 (586)
Q Consensus 363 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 430 (586)
.... .....+||+.|+|||++.+ ..++.++|||||||+||||++|+.||..... ....
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~------ 229 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN----QISK------ 229 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS----HHHH------
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh----HHHH------
Confidence 3322 2345679999999999864 6789999999999999999999999975322 0000
Q ss_pred hhcccCCChhhhhchhhh-ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007892 431 AQGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRAL 483 (586)
Q Consensus 431 ~~~~~~~~~~~l~d~~l~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L 483 (586)
+..++++... .++......+.+++.+||+.||.+||++.||++..
T Consensus 230 --------~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 230 --------LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp --------HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred --------HHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 0111221111 22222345688999999999999999999999753
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=364.58 Aligned_cols=251 Identities=24% Similarity=0.354 Sum_probs=205.2
Q ss_pred HHhcCccccceecccCcEEEEEEEEeC-CeEEEEEEeccCC---chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCee
Q 007892 206 IATDNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGS---GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQR 280 (586)
Q Consensus 206 ~~~~~f~~~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~~~ 280 (586)
...++|++.+.||+|+||.||+|+... ++.||||+++... ......+..|..+|..+ +||||+++++++...+..
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 345789999999999999999999764 7899999997532 23346788999999988 799999999999999999
Q ss_pred EEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccccc
Q 007892 281 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 360 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~ 360 (586)
+|||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++..
T Consensus 97 ~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 99999999999999997543 489999999999999999999998 9999999999999999999999999999864
Q ss_pred CCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChh
Q 007892 361 LDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 440 (586)
Q Consensus 361 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (586)
.... ......+||+.|+|||++.+..++.++|||||||+||||++|+.||...+.. +.....+
T Consensus 172 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~---------- 234 (353)
T 2i0e_A 172 IWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQSIM---------- 234 (353)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHH----------
T ss_pred ccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH------HHHHHHH----------
Confidence 3222 2234568999999999999999999999999999999999999999764421 1111111
Q ss_pred hhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 007892 441 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPR-----MSQIVRA 482 (586)
Q Consensus 441 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----m~evl~~ 482 (586)
...+ .++......+.+++.+||+.||.+||+ +.||+++
T Consensus 235 ---~~~~-~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 235 ---EHNV-AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp ---HCCC-CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred ---hCCC-CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1111 123334567899999999999999995 5777653
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=350.45 Aligned_cols=255 Identities=28% Similarity=0.434 Sum_probs=208.2
Q ss_pred hcCccccc-eecccCcEEEEEEEEe---CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEE
Q 007892 208 TDNFSEAN-LLGQGGFGYVHKGVLT---NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 282 (586)
Q Consensus 208 ~~~f~~~~-~LG~G~fG~Vyk~~~~---~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~l 282 (586)
.++|.+.+ .||+|+||.||+|++. +++.||||+++.... ...+.+.+|++++.+++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 45666666 9999999999999853 578899999977533 3456799999999999999999999999 5567899
Q ss_pred EEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCC
Q 007892 283 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 283 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 362 (586)
||||+++++|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++....
T Consensus 87 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 99999999999999643 34589999999999999999999998 999999999999999999999999999987643
Q ss_pred CCCcc--cccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCCh
Q 007892 363 TDTHV--STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 439 (586)
Q Consensus 363 ~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (586)
..... .....||+.|+|||++.+..++.++|||||||++|||++ |+.||..... ..+.... ..+.
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~i--------~~~~- 230 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAFI--------EQGK- 230 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHHHHH--------HTTC-
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHH--------hcCC-
Confidence 33221 223457889999999998899999999999999999998 9999976543 1111111 0111
Q ss_pred hhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 440 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 440 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
....+......+.+++..||+.+|.+||++.||++.|+..
T Consensus 231 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 231 -------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp -------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0122233456789999999999999999999999999865
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=358.04 Aligned_cols=269 Identities=25% Similarity=0.368 Sum_probs=206.4
Q ss_pred cCccccceecccCcEEEEEEEE-----eCCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--Cee
Q 007892 209 DNFSEANLLGQGGFGYVHKGVL-----TNGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFG--SQR 280 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~-----~~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~--~~~ 280 (586)
+.|+..+.||+|+||.||+|++ .+++.||||+++... ......+.+|+.++.+++||||++++++|... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 5588899999999999999984 368999999997543 33457899999999999999999999999876 668
Q ss_pred EEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccccc
Q 007892 281 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 360 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~ 360 (586)
++||||+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++..
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccccc
Confidence 99999999999999985433 3489999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCC--cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCC
Q 007892 361 LDTDT--HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGN 438 (586)
Q Consensus 361 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (586)
..... .......||..|+|||.+.+..++.++|||||||++|||++|..|+..... .......+.... .....
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~-~~~~~ 251 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA----LFLKMIGPTHGQ-MTVTR 251 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH----HHHHHHCSCCGG-GHHHH
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh----HHhhccCCcccc-cCHHH
Confidence 44332 223345688899999999989999999999999999999999998643211 000000000000 00000
Q ss_pred hhhhhc-hhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 439 FDALVD-QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 439 ~~~l~d-~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
+...+. ......+......+.+++.+||+.||.+||++.||++.|+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 252 LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 000000 001122334456799999999999999999999999999853
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=368.22 Aligned_cols=248 Identities=25% Similarity=0.339 Sum_probs=198.4
Q ss_pred cccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecCCC
Q 007892 212 SEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNK 290 (586)
Q Consensus 212 ~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g 290 (586)
...+.||+|+||.||+|... +|+.||||+++.......+.+.+|+++|.+++||||++++++|...+..+|||||++++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 33678999999999999974 68999999998776666778999999999999999999999999999999999999999
Q ss_pred cHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEe--CCCCCeEEeecccccccCCCCCccc
Q 007892 291 TLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL--DDSFEAKVADFGLAKHSLDTDTHVS 368 (586)
Q Consensus 291 sL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl--~~~~~~kl~DFGla~~~~~~~~~~~ 368 (586)
+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||| ++++.+||+|||+++...... ..
T Consensus 172 ~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~~ 245 (373)
T 2x4f_A 172 ELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KL 245 (373)
T ss_dssp EEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--BC
T ss_pred cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--cc
Confidence 9998886432 3489999999999999999999998 99999999999999 667899999999998764332 22
Q ss_pred ccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhh
Q 007892 369 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLE 448 (586)
Q Consensus 369 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 448 (586)
...+||+.|+|||++.++.++.++|||||||+||||++|+.||...... +.....+...+. +.....
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~i~~~~~~------~~~~~~- 312 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA------ETLNNILACRWD------LEDEEF- 312 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCCC------SCSGGG-
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhccCC------CChhhh-
Confidence 3457999999999999999999999999999999999999999765421 111111111000 000111
Q ss_pred ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 449 EYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 449 ~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
......+.+++.+||+.||.+||++.|+++
T Consensus 313 ---~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 313 ---QDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp ---TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---ccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 122356889999999999999999999997
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=348.49 Aligned_cols=265 Identities=18% Similarity=0.280 Sum_probs=201.0
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
++|+..+.||+|+||+||+|... +++.||||+++.... .....+.+|+.++.+++||||+++++++.+++..+||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999975 588999999975432 334678899999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 365 (586)
|++++.+..+... ...+++..+..++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++......
T Consensus 82 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 155 (292)
T 3o0g_A 82 FCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV- 155 (292)
T ss_dssp CCSEEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-
T ss_pred cCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcc-
Confidence 9986544444432 23589999999999999999999998 99999999999999999999999999998653322
Q ss_pred cccccccccccccCcccccCCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhh-
Q 007892 366 HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV- 443 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~- 443 (586)
.......||+.|+|||++.+.. ++.++|||||||+||||++|..||....... ..+..... .+.. .....+..+.
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~-~~~~~i~~-~~~~-~~~~~~~~~~~ 232 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQLKRIFR-LLGT-PTEEQWPSMTK 232 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH-HHHHHHHH-HHCC-CCTTTCTTGGG
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH-HHHHHHHH-HhCC-CChhhhhhhcc
Confidence 2234457899999999998765 8999999999999999999988864433211 11111110 0000 0000000000
Q ss_pred ------------chhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 444 ------------DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 444 ------------d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
...+..........+.+++.+||+.||.+||++.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000011222344678899999999999999999999863
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=363.20 Aligned_cols=252 Identities=24% Similarity=0.321 Sum_probs=190.7
Q ss_pred HhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEE
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
..++|++.+.||+|+||.||+|+.. +++.||||+++... ..+.+.+|+++|.+++||||++++++|...+..+||||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4578999999999999999999986 47899999997643 34678899999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCC---CCCeEEeecccccccCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD---SFEAKVADFGLAKHSLD 362 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~---~~~~kl~DFGla~~~~~ 362 (586)
|+++++|.+++... ..+++.+++.++.|++.||.|||+. +|+||||||+||||+. ++.+||+|||+++....
T Consensus 129 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 129 LVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp CCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred eCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 99999999999654 3489999999999999999999998 9999999999999975 88999999999986533
Q ss_pred CCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhh
Q 007892 363 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 442 (586)
Q Consensus 363 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 442 (586)
. .......||+.|+|||++.+..++.++|||||||+||||++|+.||...... ..+. .... ..... .
T Consensus 204 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~---~~i~-----~~~~~-~ 270 (349)
T 2w4o_A 204 Q--VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD--QFMF---RRIL-----NCEYY-F 270 (349)
T ss_dssp -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH--HHHH---HHHH-----TTCCC-C
T ss_pred c--cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc--HHHH---HHHH-----hCCCc-c
Confidence 2 2234467999999999999999999999999999999999999999754421 1011 0101 11110 0
Q ss_pred hchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 443 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 443 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.. .........+.+++.+||+.||.+||++.|+++.
T Consensus 271 ~~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 271 IS----PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp CT----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CC----chhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 1112234568899999999999999999999874
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=354.39 Aligned_cols=251 Identities=25% Similarity=0.413 Sum_probs=204.8
Q ss_pred hcCccccceecccCcEEEEEEEEeC-C-------eEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLTN-G-------KVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ 279 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~~-g-------~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~ 279 (586)
.++|.+.+.||+|+||.||+|+... + ..||+|.+........+.+.+|+.++.+++||||++++++|...+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 4679999999999999999999653 3 5799999977666667889999999999999999999999999999
Q ss_pred eEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCC--------eEE
Q 007892 280 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE--------AKV 351 (586)
Q Consensus 280 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~--------~kl 351 (586)
.++||||+++++|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+||||+.++. +||
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred CEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeee
Confidence 999999999999999997543 3489999999999999999999998 9999999999999998887 999
Q ss_pred eecccccccCCCCCcccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCC-CCCCCCcccchhhhhhhhHH
Q 007892 352 ADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFR-PFDKADTFADDSMVDWAKPF 429 (586)
Q Consensus 352 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~-Pf~~~~~~~~~~~~~~~~~~ 429 (586)
+|||++..... .....|++.|+|||.+.+ ..++.++|||||||+||||++|.. ||...... .....
T Consensus 163 ~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---~~~~~---- 230 (289)
T 4fvq_A 163 SDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ---RKLQF---- 230 (289)
T ss_dssp CCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHHH----
T ss_pred ccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH---HHHHH----
Confidence 99999975422 233568999999999987 779999999999999999999654 44433211 11110
Q ss_pred HhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 007892 430 LAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMP 488 (586)
Q Consensus 430 ~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~~ 488 (586)
... .. ..+......+.+++.+||+.||.+||++.||++.|+....
T Consensus 231 ~~~---~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 231 YED---RH-----------QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HHT---TC-----------CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred hhc---cC-----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 000 00 0111123457899999999999999999999999997654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=355.10 Aligned_cols=260 Identities=30% Similarity=0.527 Sum_probs=197.8
Q ss_pred HhcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
..++|...+.||+|+||.||+|+.. ..||||+++... ....+.|.+|+.+|++++||||+++++++. ....++||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~lv~ 98 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVT 98 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEEEE
Confidence 3478999999999999999999854 359999987543 334567999999999999999999999764 56689999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
||+++++|.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 99 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 99 QWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp ECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred EecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccccccc
Confidence 9999999999996543 4589999999999999999999998 99999999999999999999999999997643321
Q ss_pred -CcccccccccccccCccccc---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChh
Q 007892 365 -THVSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 440 (586)
Q Consensus 365 -~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (586)
........||+.|+|||.+. ...++.++|||||||++|||++|+.||...... ..+.... .. +.
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~----~~----~~-- 242 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIEMV----GR----GS-- 242 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH--HHHHHHH----HH----TS--
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH--HHHHHHh----cc----cc--
Confidence 22234467999999999986 567889999999999999999999999764421 1111111 11 11
Q ss_pred hhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 441 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 441 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
..+.+.......+..+.+++.+||+.+|.+||++.||++.|+...
T Consensus 243 --~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 243 --LSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp --CCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred --cCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 111111223344567999999999999999999999999998753
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=351.31 Aligned_cols=264 Identities=22% Similarity=0.322 Sum_probs=200.9
Q ss_pred cCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCch--hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQ--GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~--~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
++|+..+.||+|+||.||+|+..+|+.||||++...... ....+.+|++++.+++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 578999999999999999999988999999998654322 236788999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 366 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 366 (586)
+++ +|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++...... .
T Consensus 82 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-R 155 (288)
T ss_dssp CSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred cCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc-c
Confidence 975 8888886543 3589999999999999999999998 99999999999999999999999999998653222 1
Q ss_pred ccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhh---
Q 007892 367 VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL--- 442 (586)
Q Consensus 367 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l--- 442 (586)
......||+.|+|||++.+ ..++.++|||||||+||||++|+.||...... +.+..... .+.. .....+...
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~-~~~~-~~~~~~~~~~~~ 231 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA--DQLMRIFR-ILGT-PNSKNWPNVTEL 231 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHH-HHCC-CCTTTSTTGGGS
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHH-HHCC-CChhhchhhhcc
Confidence 2234578999999999975 45899999999999999999999999765421 11111100 0000 000000000
Q ss_pred --hch--------hhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 443 --VDQ--------KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 443 --~d~--------~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.++ ....+.......+.+++.+||+.||.+||++.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000 0111122334578899999999999999999999863
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=352.05 Aligned_cols=270 Identities=23% Similarity=0.352 Sum_probs=204.2
Q ss_pred HHHHHhcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhc--CCCCcceEEEEEEeC---
Q 007892 203 ELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQV--HHRHLVSLVGYCTFG--- 277 (586)
Q Consensus 203 el~~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l--~Hpniv~l~g~~~~~--- 277 (586)
.-....++|++.+.||+|+||.||+|+.. ++.||||++... ....+..|.+++..+ +||||+++++++...
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred cccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 34445578999999999999999999975 899999998643 234555666666554 899999999999887
Q ss_pred -CeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcC-----CCcEEecCCCCceeEeCCCCCeEE
Q 007892 278 -SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC-----QPKIIHRDIKSANILLDDSFEAKV 351 (586)
Q Consensus 278 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~-----~~~ivHrDIk~~NILl~~~~~~kl 351 (586)
...++||||+++|+|.+++... .+++..++.++.|++.||+|||+.+ .++|+||||||+||||+.++.+||
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred CCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 7889999999999999999653 4899999999999999999999752 348999999999999999999999
Q ss_pred eecccccccCCCCCcc---cccccccccccCcccccCCCCCCc------chHHHHHHHHHHHHhC----------CCCCC
Q 007892 352 ADFGLAKHSLDTDTHV---STRVMGTFGYLAPEYASSGKLTEK------SDVFSFGVLLLELITG----------FRPFD 412 (586)
Q Consensus 352 ~DFGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~k------sDVwSlGvvL~elltG----------~~Pf~ 412 (586)
+|||+++......... .....||+.|+|||++.+.....+ +|||||||+||||++| +.||.
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 9999997654332221 124579999999999987776665 9999999999999999 55655
Q ss_pred CCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 413 KADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 413 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
...... .....+... + ............ ....+....+.+++.+||+.||.+||++.||++.|+...
T Consensus 264 ~~~~~~-~~~~~~~~~-~----~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 330 (337)
T 3mdy_A 264 DLVPSD-PSYEDMREI-V----CIKKLRPSFPNR--WSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330 (337)
T ss_dssp TTSCSS-CCHHHHHHH-H----TTSCCCCCCCGG--GGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhcCCC-CchhhhHHH-H----hhhccCcccccc--chhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence 433211 111111110 0 000000000000 112356788999999999999999999999999998754
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=362.03 Aligned_cols=269 Identities=25% Similarity=0.325 Sum_probs=212.6
Q ss_pred hcCccccceecccCcEEEEEEEE-----eCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEE--eCCee
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVL-----TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCT--FGSQR 280 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~-----~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~--~~~~~ 280 (586)
.++|++.+.||+|+||.||++++ .+++.||||++........+.+.+|++++.+++|+||+++++++. .....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 36799999999999999999985 368899999998776666778999999999999999999999987 45668
Q ss_pred EEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccccc
Q 007892 281 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 360 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~ 360 (586)
++||||+++++|.+++.... ..+++..++.|+.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++..
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceec
Confidence 89999999999999986532 2489999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCc--ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCC
Q 007892 361 LDTDTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGN 438 (586)
Q Consensus 361 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (586)
...... ......||..|+|||++.+..++.++|||||||+||||++|+.||...... ....+.. ......
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~---~~~~~~~-----~~~~~~ 249 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE---FLRMMGC-----ERDVPA 249 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH---HHHHCC---------CCH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccch---hhhhccc-----cccccc
Confidence 433321 223456888999999999889999999999999999999999998643210 0000000 000000
Q ss_pred hhh---hhchhh-hccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 007892 439 FDA---LVDQKL-EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMP 488 (586)
Q Consensus 439 ~~~---l~d~~l-~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~~ 488 (586)
... .+.... ...+......+.+++.+||+.||.+||++.||++.|+....
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 250 LSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred HHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 001 111111 12334455679999999999999999999999999997643
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=365.98 Aligned_cols=256 Identities=25% Similarity=0.332 Sum_probs=206.9
Q ss_pred hcCccccceecccCcEEEEEEEE----eCCeEEEEEEeccCC----chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCC
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVL----TNGKVVAIKQLKAGS----GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGS 278 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~----~~g~~vAVK~l~~~~----~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~ 278 (586)
.++|.+.+.||+|+||.||+++. .+++.||||+++... ......+.+|+++|.++ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36899999999999999999997 368999999986532 12345677899999999 6999999999999999
Q ss_pred eeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccc
Q 007892 279 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 358 (586)
Q Consensus 279 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~ 358 (586)
..+|||||+++++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 9999999999999999997543 489999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCcccccC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccC
Q 007892 359 HSLDTDTHVSTRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLAD 436 (586)
Q Consensus 359 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (586)
.............+||+.|+|||++.+ ..++.++|||||||+||||++|+.||....... ....+....+..
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~---- 281 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN--SQAEISRRILKS---- 281 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC--CHHHHHHHHHHC----
T ss_pred ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc--hHHHHHHHHhcc----
Confidence 754444444455689999999999985 347899999999999999999999997544321 111111111100
Q ss_pred CChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHHh
Q 007892 437 GNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRP-----RMSQIVRALE 484 (586)
Q Consensus 437 ~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RP-----tm~evl~~L~ 484 (586)
...++......+.+++.+||+.||.+|| ++.||++..-
T Consensus 282 ----------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 282 ----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp ----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred ----------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence 0122333446788999999999999999 9999987653
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=358.42 Aligned_cols=257 Identities=28% Similarity=0.437 Sum_probs=202.9
Q ss_pred hcCccccceecccCcEEEEEEEEeC-----CeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLTN-----GKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 281 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~~-----g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~ 281 (586)
.++|...+.||+|+||.||+|.+.. +..||||.++.... .....+.+|+.++.+++||||+++++++...+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 4678888999999999999999653 24699999976533 33457899999999999999999999999999999
Q ss_pred EEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccC
Q 007892 282 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 361 (586)
Q Consensus 282 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~ 361 (586)
|||||+++++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 123 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 9999999999999997543 4589999999999999999999998 99999999999999999999999999998754
Q ss_pred CCCCc--ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCC
Q 007892 362 DTDTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGN 438 (586)
Q Consensus 362 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (586)
..... ......+++.|+|||.+.+..++.++|||||||+||||++ |+.||..... ..+... + ..+.
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~~~~~~----~----~~~~ 267 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---HEVMKA----I----NDGF 267 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHH----H----HTTC
T ss_pred cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH---HHHHHH----H----HCCC
Confidence 33221 1223346789999999999999999999999999999999 9999975432 111111 1 0110
Q ss_pred hhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 439 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 439 ~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
....+......+.+++.+||+.+|.+||++.||++.|+...
T Consensus 268 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 268 --------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp --------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred --------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00112234467899999999999999999999999998654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=388.54 Aligned_cols=255 Identities=28% Similarity=0.428 Sum_probs=203.8
Q ss_pred hcCccccc-eecccCcEEEEEEEEe---CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEE
Q 007892 208 TDNFSEAN-LLGQGGFGYVHKGVLT---NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 282 (586)
Q Consensus 208 ~~~f~~~~-~LG~G~fG~Vyk~~~~---~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~l 282 (586)
.+++.+.+ .||+|+||.||+|.+. ++..||||+++... ....++|.+|+++|.+++|||||+++++|.. +..+|
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l 412 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 412 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEE
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEE
Confidence 34555555 7999999999999875 45689999997653 3356789999999999999999999999976 56899
Q ss_pred EEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCC
Q 007892 283 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 283 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 362 (586)
||||+++|+|.++|... ...+++..++.|+.||+.||+|||++ +|+||||||+||||++++.+||+|||+++....
T Consensus 413 v~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 413 VMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp EEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred EEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 99999999999999754 34589999999999999999999998 999999999999999999999999999987643
Q ss_pred CCCccc--ccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCCh
Q 007892 363 TDTHVS--TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 439 (586)
Q Consensus 363 ~~~~~~--~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (586)
...... ....+++.|+|||++.++.++.++|||||||+||||++ |+.||...... .+.... ..+.
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~~~i--------~~~~- 556 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFI--------EQGK- 556 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH---HHHHHH--------HTTC-
T ss_pred CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHHHH--------HcCC-
Confidence 322211 22346689999999999999999999999999999998 99999765431 111111 1111
Q ss_pred hhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 440 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 440 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
....+......+.+++..||+.+|.+||++.+|++.|+..
T Consensus 557 -------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 557 -------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp -------CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred -------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 0122334556789999999999999999999999999864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=354.19 Aligned_cols=259 Identities=20% Similarity=0.285 Sum_probs=201.6
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV 283 (586)
.++|.+.+.||+|+||.||+|... +++.||||++..... .....+.+|+.++.+++||||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 378999999999999999999975 689999999975432 2246789999999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCC
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 363 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 363 (586)
|||+++++|.+++... ..+++..++.++.|++.||.|||+. +|+||||||+||||+.++.+||+|||++......
T Consensus 113 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 9999999999999754 3489999999999999999999998 9999999999999999999999999999876544
Q ss_pred CCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhh
Q 007892 364 DTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 443 (586)
Q Consensus 364 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 443 (586)
.........|++.|+|||.+.+..++.++||||||++||||++|+.||...... .....+....
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~--------- 251 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAI--------- 251 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCC---------
T ss_pred ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCC---------
Confidence 333334567999999999999999999999999999999999999999754321 1111111100
Q ss_pred chhhhccCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHhcCCC
Q 007892 444 DQKLEEYDSAEMTRMAACAAACIRHSARRRP-RMSQIVRALEGNMP 488 (586)
Q Consensus 444 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RP-tm~evl~~L~~~~~ 488 (586)
+............+.+++.+||+.||.+|| ++.++++.|+....
T Consensus 252 -~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 252 -PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp -CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred -CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 001112223345688999999999999999 99999999997754
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=368.23 Aligned_cols=250 Identities=22% Similarity=0.355 Sum_probs=198.8
Q ss_pred hcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCC--chhHHHHHHHHHHHHhcC--CCCcceEEEEEEeCCeeEEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGS--GQGEREFQAEIEIISQVH--HRHLVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~--Hpniv~l~g~~~~~~~~~lV 283 (586)
.++|.+.+.||+|+||.||++...+++.||||++.... ......+++|+.+|.+++ |+||+++++++...+..+||
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 35699999999999999999998889999999986543 334568999999999996 59999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCC
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 363 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 363 (586)
|| +.+++|.+++.... .+++.++..|+.||+.||.|||+. +|+||||||+||||+ ++.+||+|||+++.....
T Consensus 135 ~E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp EE-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred Ee-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 99 56899999997643 588999999999999999999998 999999999999996 578999999999876433
Q ss_pred CCc-ccccccccccccCcccccC-----------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHh
Q 007892 364 DTH-VSTRVMGTFGYLAPEYASS-----------GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLA 431 (586)
Q Consensus 364 ~~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 431 (586)
... .....+||+.|+|||++.+ ..++.++|||||||+||||++|+.||...... ....
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~~~~----- 277 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKL----- 277 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----HHHH-----
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----HHHH-----
Confidence 222 2345679999999999865 46899999999999999999999999753320 0111
Q ss_pred hcccCCChhhhhchhhh-ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 432 QGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 432 ~~~~~~~~~~l~d~~l~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
..++++... .++......+.+++.+||+.||.+||++.||++.
T Consensus 278 --------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 278 --------HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp --------HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --------HHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 111111111 1222224568899999999999999999999974
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=377.81 Aligned_cols=249 Identities=23% Similarity=0.355 Sum_probs=196.9
Q ss_pred HhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEE
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 282 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~l 282 (586)
..++|++.+.||+|+||.||+|... +|+.||||+++.. .......+.+|+.+|.+++||||++++++|...+..+|
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 3467999999999999999999965 6889999999753 22334567889999999999999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhh-cCCCcEEecCCCCceeEeCCCCCeEEeecccccccC
Q 007892 283 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHE-DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 361 (586)
Q Consensus 283 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~ 361 (586)
||||+++|+|.+++... ..+++..+..++.|++.||+|||+ . +|+||||||+||||+.++.+||+|||+++...
T Consensus 226 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp EECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 99999999999998654 358999999999999999999998 6 89999999999999999999999999998643
Q ss_pred CCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhh
Q 007892 362 DTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 441 (586)
Q Consensus 362 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (586)
... ......+||+.|+|||++.+..++.++|||||||+||||++|+.||...+.. .+. ......
T Consensus 301 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~---~~i~~~--------- 364 (446)
T 4ejn_A 301 KDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLF---ELILME--------- 364 (446)
T ss_dssp C------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HHHHHC---------
T ss_pred CCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHH---HHHHhC---------
Confidence 322 2234578999999999999999999999999999999999999999765421 111 111110
Q ss_pred hhchhhhccCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 007892 442 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRP-----RMSQIVR 481 (586)
Q Consensus 442 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RP-----tm~evl~ 481 (586)
.+ .++......+.+++.+||+.||.+|| ++.|+++
T Consensus 365 ----~~-~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 365 ----EI-RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ----CC-CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ----CC-CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 00 12223346788999999999999999 9999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=362.42 Aligned_cols=261 Identities=26% Similarity=0.424 Sum_probs=210.6
Q ss_pred HHHhcCccccceecccCcEEEEEEEEeC------CeEEEEEEeccCCc-hhHHHHHHHHHHHHhc-CCCCcceEEEEEEe
Q 007892 205 KIATDNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQLKAGSG-QGEREFQAEIEIISQV-HHRHLVSLVGYCTF 276 (586)
Q Consensus 205 ~~~~~~f~~~~~LG~G~fG~Vyk~~~~~------g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~ 276 (586)
+...++|...+.||+|+||.||+|.... ++.||||.++.... .....+.+|+.++.++ +||||++++++|..
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 3445789999999999999999999642 24799999976543 3456789999999999 89999999999999
Q ss_pred CCeeEEEEEecCCCcHHHHhcCCC------------CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeC
Q 007892 277 GSQRLLVYEFVPNKTLEFHLHGKD------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD 344 (586)
Q Consensus 277 ~~~~~lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~ 344 (586)
.+..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+||||+
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLT 198 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEE
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEEC
Confidence 999999999999999999986431 24589999999999999999999998 999999999999999
Q ss_pred CCCCeEEeecccccccCCCCC-cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhh
Q 007892 345 DSFEAKVADFGLAKHSLDTDT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSM 422 (586)
Q Consensus 345 ~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~ 422 (586)
.++.+||+|||+++....... .......|++.|+|||.+.+..++.++|||||||+||||++ |..||...... ..+
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~ 276 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN--SKF 276 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS--HHH
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh--HHH
Confidence 999999999999986543322 22334567889999999998999999999999999999999 99999764421 111
Q ss_pred hhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 423 VDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 423 ~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
... +..... ...+......+.+++.+||+.||.+||++.||++.|+..
T Consensus 277 ~~~----~~~~~~------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 277 YKL----VKDGYQ------------MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp HHH----HHHTCC------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHH----HhcCCC------------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 111 111000 011222345788999999999999999999999999854
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=361.93 Aligned_cols=260 Identities=23% Similarity=0.267 Sum_probs=201.4
Q ss_pred HHHHhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccC-----CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 007892 204 LKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG-----SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG 277 (586)
Q Consensus 204 l~~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~-----~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~ 277 (586)
+....++|.+.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++.+++||||++++++|.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 4556678999999999999999999974 5789999998643 234457899999999999999999999999999
Q ss_pred CeeEEEEEecCCCcHHHHhcCCC--------------------------------------CCCCChHHHHHHHHHHHHH
Q 007892 278 SQRLLVYEFVPNKTLEFHLHGKD--------------------------------------RPVMNWPTRMKIALGSARG 319 (586)
Q Consensus 278 ~~~~lV~E~~~~gsL~~~l~~~~--------------------------------------~~~l~~~~~~~ia~~ia~g 319 (586)
+..+|||||+++|+|.+++.... ...+++..+..|+.|++.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999999885210 1123566788899999999
Q ss_pred hHhhhhcCCCcEEecCCCCceeEeCCCC--CeEEeecccccccCCCCC---cccccccccccccCcccccC--CCCCCcc
Q 007892 320 LAYLHEDCQPKIIHRDIKSANILLDDSF--EAKVADFGLAKHSLDTDT---HVSTRVMGTFGYLAPEYASS--GKLTEKS 392 (586)
Q Consensus 320 L~yLH~~~~~~ivHrDIk~~NILl~~~~--~~kl~DFGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~s~ks 392 (586)
|+|||+. +|+||||||+||||+.++ .+||+|||+++....... .......||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 9999998 999999999999998766 899999999986533221 12345679999999999975 6789999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCC
Q 007892 393 DVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARR 472 (586)
Q Consensus 393 DVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~ 472 (586)
|||||||+||||++|+.||....... .....+.... . ...+... .....+.+++.+||+.||.+
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~------~~~~~~~~~~---~---~~~~~~~----~~~~~~~~li~~~l~~~p~~ 321 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDAD------TISQVLNKKL---C---FENPNYN----VLSPLARDLLSNLLNRNVDE 321 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCC---C---TTSGGGG----GSCHHHHHHHHHHSCSCTTT
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHH------HHHHHHhccc---c---cCCcccc----cCCHHHHHHHHHHcCCChhH
Confidence 99999999999999999997654311 1111111100 0 0011111 12356889999999999999
Q ss_pred CCCHHHHHHH
Q 007892 473 RPRMSQIVRA 482 (586)
Q Consensus 473 RPtm~evl~~ 482 (586)
||++.|+++.
T Consensus 322 Rps~~~~l~h 331 (345)
T 3hko_A 322 RFDAMRALQH 331 (345)
T ss_dssp SCCHHHHHHS
T ss_pred CCCHHHHhcC
Confidence 9999999873
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=355.33 Aligned_cols=253 Identities=31% Similarity=0.486 Sum_probs=198.8
Q ss_pred cCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecC
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVP 288 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 288 (586)
++|++.+.||+|+||.||+|++. ++.||||++... ...+.|.+|+++|.+++||||++++++|. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 67889999999999999999974 789999998653 34568999999999999999999999886 45789999999
Q ss_pred CCcHHHHhcCCCC-CCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCC-eEEeecccccccCCCCCc
Q 007892 289 NKTLEFHLHGKDR-PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE-AKVADFGLAKHSLDTDTH 366 (586)
Q Consensus 289 ~gsL~~~l~~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~-~kl~DFGla~~~~~~~~~ 366 (586)
+++|.+++..... ..+.+..++.++.|+++||+|||+.+..+|+||||||+||||+.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999976543 34788999999999999999999943238999999999999988876 799999999754322
Q ss_pred ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchh
Q 007892 367 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 446 (586)
Q Consensus 367 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 446 (586)
.....||+.|+|||++.+..++.++|||||||+||||++|+.||...... .....|.. ..+..
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~-------~~~~~------- 222 (307)
T 2eva_A 160 -MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP--AFRIMWAV-------HNGTR------- 222 (307)
T ss_dssp ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS--HHHHHHHH-------HTTCC-------
T ss_pred -cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc--HHHHHHHH-------hcCCC-------
Confidence 23346999999999999999999999999999999999999999754321 11111110 01110
Q ss_pred hhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 447 LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 447 l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
..........+.+++.+||+.||.+||++.||++.|+...
T Consensus 223 -~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 223 -PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp -CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred -CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 0111223456889999999999999999999999998654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=355.70 Aligned_cols=266 Identities=28% Similarity=0.384 Sum_probs=207.9
Q ss_pred CccccceecccCcEEEEEEEEe-----CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--CeeE
Q 007892 210 NFSEANLLGQGGFGYVHKGVLT-----NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFG--SQRL 281 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~-----~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~--~~~~ 281 (586)
.|++.+.||+|+||.||++.+. +++.||||+++.... .....+.+|+++|.+++||||+++++++.+. ...+
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 3588999999999999998753 688999999976543 3356789999999999999999999999884 6789
Q ss_pred EEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccC
Q 007892 282 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 361 (586)
Q Consensus 282 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~ 361 (586)
+||||+++++|.+++... .+++..++.++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++...
T Consensus 112 lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 999999999999999654 389999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCC--cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCCh
Q 007892 362 DTDT--HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 439 (586)
Q Consensus 362 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (586)
.... .......|+..|+|||++.+..++.++|||||||++|||++|+.||...... ......+...... ...+
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~----~~~~ 260 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTK-FLELIGIAQGQMT----VLRL 260 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH-HHHHHCSCCHHHH----HHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchh-hhhhhcccccchh----HHHH
Confidence 4332 1233456888999999999889999999999999999999999998643210 0000001000000 0001
Q ss_pred hhhhchhhh-ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 440 DALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 440 ~~l~d~~l~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
...++.... ..+......+.+++.+||+.||.+||++.||++.|+..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 261 TELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 111111111 23344556799999999999999999999999999864
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=360.41 Aligned_cols=264 Identities=19% Similarity=0.237 Sum_probs=200.2
Q ss_pred hcCccccceecccCcEEEEEEEEe----CCeEEEEEEeccCCchh-----------HHHHHHHHHHHHhcCCCCcceEEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT----NGKVVAIKQLKAGSGQG-----------EREFQAEIEIISQVHHRHLVSLVG 272 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~----~g~~vAVK~l~~~~~~~-----------~~~~~~Ei~il~~l~Hpniv~l~g 272 (586)
.++|.+.+.||+|+||.||+|... ++..||||++....... ...+.+|+.++..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367999999999999999999975 56789999987654321 124667889999999999999999
Q ss_pred EEEe----CCeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCC-
Q 007892 273 YCTF----GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF- 347 (586)
Q Consensus 273 ~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~- 347 (586)
++.. ....+|||||+ +++|.+++.... .+++.+++.|+.|++.||+|||+. +|+||||||+||||+.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSST
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCC
Confidence 9988 67889999999 999999997544 699999999999999999999998 999999999999998877
Q ss_pred -CeEEeecccccccCCCCC------cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccch
Q 007892 348 -EAKVADFGLAKHSLDTDT------HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADD 420 (586)
Q Consensus 348 -~~kl~DFGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~ 420 (586)
.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||+||||++|+.||..... ..
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~--~~ 267 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLK--DP 267 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT--CH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccc--cc
Confidence 999999999986533211 112445799999999999999999999999999999999999999964321 11
Q ss_pred hhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 421 SMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 421 ~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
.........+.. .+...+..... .......+.+++.+||+.||.+||++.+|++.|+..
T Consensus 268 ~~~~~~~~~~~~-----~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 268 VAVQTAKTNLLD-----ELPQSVLKWAP--SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HHHHHHHHHHHH-----TTTHHHHHHSC--TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred HHHHHHHHhhcc-----cccHHHHhhcc--ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 111111110100 00000000000 013345799999999999999999999999999865
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=379.87 Aligned_cols=255 Identities=27% Similarity=0.404 Sum_probs=210.9
Q ss_pred HHhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeE
Q 007892 206 IATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 281 (586)
Q Consensus 206 ~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~ 281 (586)
+..++|...+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+++|.+++|||||++++++.+.+..+
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 34577999999999999999999975 68999999986531 233567889999999999999999999999999999
Q ss_pred EEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccC
Q 007892 282 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 361 (586)
Q Consensus 282 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~ 361 (586)
|||||+++|+|.+++.......+++..++.++.||+.||+|||++ +||||||||+||||+.++.+||+|||+++...
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 999999999999999876666699999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhh
Q 007892 362 DTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 441 (586)
Q Consensus 362 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (586)
... .....+||+.|+|||++.+..++.++|||||||+||||++|+.||.......... ..... +
T Consensus 338 ~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~--~i~~~-i----------- 401 (576)
T 2acx_A 338 EGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE--EVERL-V----------- 401 (576)
T ss_dssp TTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH--HHHHH-H-----------
T ss_pred cCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH--HHHHH-h-----------
Confidence 332 2234589999999999999999999999999999999999999998654321111 11000 0
Q ss_pred hhchhhhccCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 007892 442 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRP-----RMSQIVR 481 (586)
Q Consensus 442 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RP-----tm~evl~ 481 (586)
......++......+.+++.+||+.||.+|| ++.||++
T Consensus 402 --~~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 402 --KEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp --HHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred --hcccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 0000123333456789999999999999999 7888875
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=352.63 Aligned_cols=267 Identities=23% Similarity=0.303 Sum_probs=202.7
Q ss_pred HhcCccccceecccCcEEEEEEEE-eCCeEEEEEEeccCCc-----hhHHHHHHHHHHHHhcC---CCCcceEEEEEEeC
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSG-----QGEREFQAEIEIISQVH---HRHLVSLVGYCTFG 277 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~-----~~~~~~~~Ei~il~~l~---Hpniv~l~g~~~~~ 277 (586)
..++|++.+.||+|+||.||+|+. .+++.||||++..... .....+.+|+.++.+++ ||||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 457899999999999999999996 4689999999864321 12346777888877764 99999999999876
Q ss_pred C-----eeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEe
Q 007892 278 S-----QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVA 352 (586)
Q Consensus 278 ~-----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~ 352 (586)
. ..++||||+. ++|.+++.......+++..+..|+.|++.||+|||++ +|+||||||+||||+.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEe
Confidence 5 4789999997 5999999877666699999999999999999999998 89999999999999999999999
Q ss_pred ecccccccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhh
Q 007892 353 DFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQ 432 (586)
Q Consensus 353 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 432 (586)
|||+++...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||....... .+..... .+..
T Consensus 163 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~i~~-~~~~ 237 (308)
T 3g33_A 163 DFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGKIFD-LIGL 237 (308)
T ss_dssp SCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH--HHHHHHH-HHCC
T ss_pred eCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHH-HhCC
Confidence 999998654322 2345679999999999999999999999999999999999999997654311 1111110 0000
Q ss_pred ----ccc------CCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 433 ----GLA------DGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 433 ----~~~------~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.+. .+.+.......+.....+....+.+++.+||+.||.+||++.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 000 00000000000111112234578899999999999999999999863
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=345.96 Aligned_cols=250 Identities=22% Similarity=0.313 Sum_probs=204.4
Q ss_pred hcCccccceecccCcEEEEEEEEeC-CeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
.++|.+.+.||+|+||.||+|.... +..||+|++........+.+.+|++++.+++||||++++++|...+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 4679999999999999999999764 678999999776556678899999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEe---CCCCCeEEeecccccccCCC
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL---DDSFEAKVADFGLAKHSLDT 363 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl---~~~~~~kl~DFGla~~~~~~ 363 (586)
+++++|.+++... ..+++..++.|+.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||++......
T Consensus 88 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 88 CTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp CCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 9999999888654 3489999999999999999999998 99999999999999 78899999999999865433
Q ss_pred CCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhh
Q 007892 364 DTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 443 (586)
Q Consensus 364 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 443 (586)
. ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||...... ... .... .+... ..
T Consensus 163 ~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~---~~~~-----~~~~~-~~ 227 (277)
T 3f3z_A 163 K--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS---EVM---LKIR-----EGTFT-FP 227 (277)
T ss_dssp S--CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HHHH-----HCCCC-CC
T ss_pred c--chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHH---HHH---HHHH-----hCCCC-CC
Confidence 2 2234579999999999875 4999999999999999999999999764421 111 0000 01000 00
Q ss_pred chhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 444 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 444 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
.... ......+.+++.+||+.||.+||++.|+++
T Consensus 228 ~~~~----~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 228 EKDW----LNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred chhh----hcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 012457889999999999999999999985
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=344.70 Aligned_cols=260 Identities=20% Similarity=0.277 Sum_probs=206.1
Q ss_pred hcCccccceecccCcEEEEEEEE-eCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEE-EeCCeeEEEEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYC-TFGSQRLLVYE 285 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~-~~~~~~~lV~E 285 (586)
.++|.+.+.||+|+||.||+|+. .+++.||||++...... ..+.+|+.++.+++|++++..+++| ..++..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 47899999999999999999996 57899999998654332 4688999999999988876666655 56778899999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEe---CCCCCeEEeecccccccCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL---DDSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl---~~~~~~kl~DFGla~~~~~ 362 (586)
|+ +++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||| ++++.+||+|||+++....
T Consensus 86 ~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred ec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 99 999999987433 3589999999999999999999998 99999999999999 4888999999999987654
Q ss_pred CCCc------ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccC
Q 007892 363 TDTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLAD 436 (586)
Q Consensus 363 ~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (586)
.... ......||+.|+|||.+.+..++.++|||||||+||||++|+.||..................
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------- 233 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK------- 233 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH-------
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccc-------
Confidence 3321 124567999999999999999999999999999999999999999865432211111111000
Q ss_pred CChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 437 GNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 437 ~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
.............+..+.+++.+||+.||.+||++.+|++.|+..
T Consensus 234 -----~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 234 -----KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp -----HHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred -----ccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 000000011122345789999999999999999999999999865
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=346.29 Aligned_cols=260 Identities=20% Similarity=0.272 Sum_probs=202.7
Q ss_pred hcCccccceecccCcEEEEEEEE-eCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEE-EeCCeeEEEEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYC-TFGSQRLLVYE 285 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~-~~~~~~~lV~E 285 (586)
.++|++.+.||+|+||.||+|+. .+++.||||++..... ...+.+|+.++.+++|++++..+++| ...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 47899999999999999999996 5789999998755432 23588899999999988877766666 56778899999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEe---CCCCCeEEeecccccccCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL---DDSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl---~~~~~~kl~DFGla~~~~~ 362 (586)
|+ +++|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||| ++++.+||+|||+++....
T Consensus 86 ~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 86 LL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp CC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred cc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 99 999999987433 3489999999999999999999998 99999999999999 7889999999999987544
Q ss_pred CCC------cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccC
Q 007892 363 TDT------HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLAD 436 (586)
Q Consensus 363 ~~~------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (586)
... .......||+.|+|||.+.+..++.++|||||||+||||++|+.||.................
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-------- 232 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE-------- 232 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH--------
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhc--------
Confidence 332 122346799999999999999999999999999999999999999986543222111111000
Q ss_pred CChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 437 GNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 437 ~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
..............+..+.+++..||+.||.+||++.+|++.|+..
T Consensus 233 ----~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 233 ----KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp ----HHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred ----ccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 0000000011112245789999999999999999999999999865
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=356.05 Aligned_cols=262 Identities=26% Similarity=0.404 Sum_probs=200.1
Q ss_pred HHHHHhcCccccceecccCcEEEEEEEEe----CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 007892 203 ELKIATDNFSEANLLGQGGFGYVHKGVLT----NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTF 276 (586)
Q Consensus 203 el~~~~~~f~~~~~LG~G~fG~Vyk~~~~----~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~ 276 (586)
++.+..++|.+.+.||+|+||.||+|.+. .++.||||.++... ....+.+.+|+.++.+++||||++++++|..
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 44456678999999999999999999865 34589999987543 3334678999999999999999999999987
Q ss_pred CCe-----eEEEEEecCCCcHHHHhcC----CCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCC
Q 007892 277 GSQ-----RLLVYEFVPNKTLEFHLHG----KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF 347 (586)
Q Consensus 277 ~~~-----~~lV~E~~~~gsL~~~l~~----~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 347 (586)
.+. .++||||+++++|.+++.. .....+++..++.++.|++.||.|||+. +|+||||||+||||+.++
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDM 184 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTS
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCC
Confidence 553 4899999999999998843 2335699999999999999999999998 999999999999999999
Q ss_pred CeEEeecccccccCCCCC-cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhh
Q 007892 348 EAKVADFGLAKHSLDTDT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDW 425 (586)
Q Consensus 348 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~ 425 (586)
.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||+||||++ |..||...... .+...
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~ 261 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH---EMYDY 261 (313)
T ss_dssp CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHH
T ss_pred cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH---HHHHH
Confidence 999999999986543322 12233457889999999999999999999999999999999 89999765431 11111
Q ss_pred hhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 426 AKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 426 ~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
. . .+ .....+......+.+++.+||+.+|.+||++.+|++.|+..
T Consensus 262 ~---~-----~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 262 L---L-----HG--------HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp H---H-----TT--------CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred H---H-----cC--------CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 0 11 00112223345789999999999999999999999999864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=361.24 Aligned_cols=251 Identities=22% Similarity=0.288 Sum_probs=193.9
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEec
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 287 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 287 (586)
++|.+.+.||+|+||.||+++.. +++.||||++...... ...+++|+.++++++||||+++++++...+..++||||+
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS-CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc-cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 67999999999999999999976 6899999999765433 357889999999999999999999999999999999999
Q ss_pred CCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCC--eEEeecccccccCCCCC
Q 007892 288 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE--AKVADFGLAKHSLDTDT 365 (586)
Q Consensus 288 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~--~kl~DFGla~~~~~~~~ 365 (586)
++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||||+.++. +||+|||+++.....
T Consensus 99 ~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~-- 171 (361)
T 3uc3_A 99 SGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-- 171 (361)
T ss_dssp CSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccccc--
Confidence 9999999986543 489999999999999999999998 9999999999999987765 999999999743222
Q ss_pred cccccccccccccCcccccCCCCCCc-chHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhc
Q 007892 366 HVSTRVMGTFGYLAPEYASSGKLTEK-SDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 444 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~~~~~s~k-sDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 444 (586)
.......||+.|+|||++.+..++.+ +|||||||+||||++|+.||....... .........+.
T Consensus 172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~~~~~------------- 236 (361)
T 3uc3_A 172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR--DYRKTIQRILS------------- 236 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC--CHHHHHHHHHT-------------
T ss_pred CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhc-------------
Confidence 12234579999999999988877665 899999999999999999997654321 11111111110
Q ss_pred hhhh-ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 445 QKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 445 ~~l~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.... .........+.+++.+||+.||.+||++.|++++
T Consensus 237 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 237 VKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp TCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 0000 0011223568899999999999999999999974
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=359.79 Aligned_cols=255 Identities=25% Similarity=0.388 Sum_probs=195.4
Q ss_pred cCccccceecccCcEEEEEEEE-eCCeEEEEEEeccCCch---hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe----e
Q 007892 209 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQ---GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ----R 280 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~---~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~----~ 280 (586)
++|++.+.||+|+||.||+++. .+++.||||+++..... ....+.+|+.++.+++||||+++++++..... .
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 6899999999999999999996 47899999999765322 23578899999999999999999999876543 3
Q ss_pred EEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccccc
Q 007892 281 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 360 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~ 360 (586)
++||||+++++|.++++... .+++.+++.++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++..
T Consensus 92 ~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred EEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 89999999999999996543 489999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCCc--ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCC
Q 007892 361 LDTDTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGN 438 (586)
Q Consensus 361 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (586)
...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||...... ......+. ...
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~----~~~ 236 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVR----EDP 236 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHH----CCC
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhc----CCC
Confidence 433221 223457999999999999999999999999999999999999999765431 11111110 110
Q ss_pred hhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH-HHHh
Q 007892 439 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIV-RALE 484 (586)
Q Consensus 439 ~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl-~~L~ 484 (586)
.. +. .........+.+++.+||+.||.+||++.+++ +.|.
T Consensus 237 ~~----~~--~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 277 (311)
T 3ork_A 237 IP----PS--ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 277 (311)
T ss_dssp CC----HH--HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred CC----cc--cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHH
Confidence 00 00 11112345688999999999999999766655 4444
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=351.43 Aligned_cols=257 Identities=26% Similarity=0.373 Sum_probs=205.7
Q ss_pred HHHhcCccccc-eecccCcEEEEEEEEe---CCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 007892 205 KIATDNFSEAN-LLGQGGFGYVHKGVLT---NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGS 278 (586)
Q Consensus 205 ~~~~~~f~~~~-~LG~G~fG~Vyk~~~~---~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~ 278 (586)
....++|.+.+ .||+|+||.||+|.+. +++.||||+++.... ...+.+.+|+.++.+++||||+++++++ ..+
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 90 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence 34456788887 9999999999999753 368899999976432 2356899999999999999999999999 567
Q ss_pred eeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccc
Q 007892 279 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 358 (586)
Q Consensus 279 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~ 358 (586)
..++||||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 789999999999999999764 3489999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCcc--cccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhccc
Q 007892 359 HSLDTDTHV--STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLA 435 (586)
Q Consensus 359 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 435 (586)
......... .....+++.|+|||.+.+..++.++||||||++||||++ |+.||...... .+.... .
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~--------~ 234 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTAML--------E 234 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHH--------H
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH--------H
Confidence 764433221 223456789999999998889999999999999999999 99999765421 111111 0
Q ss_pred CCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 436 DGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 436 ~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
.+. ....+......+.+++.+||+.||.+||++.||++.|+..
T Consensus 235 ~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 235 KGE--------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp TTC--------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred cCC--------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111 0112233456789999999999999999999999999864
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=355.21 Aligned_cols=261 Identities=24% Similarity=0.344 Sum_probs=206.5
Q ss_pred HHhcCccccceecccCcEEEEEEEE-eCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEe----CCee
Q 007892 206 IATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF----GSQR 280 (586)
Q Consensus 206 ~~~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~----~~~~ 280 (586)
+..++|++.+.||+|+||.||++.. .+++.||||++........+.+.+|++++.+++||||++++++|.. ....
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 4457899999999999999999997 5789999999977666667789999999999999999999999973 3477
Q ss_pred EEEEEecCCCcHHHHhcCC--CCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccc
Q 007892 281 LLVYEFVPNKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 358 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~ 358 (586)
++||||+++++|.+++... ....+++.+++.++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 8999999999999988642 335689999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCCCc--------ccccccccccccCcccccCCC---CCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhh
Q 007892 359 HSLDTDTH--------VSTRVMGTFGYLAPEYASSGK---LTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAK 427 (586)
Q Consensus 359 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~ 427 (586)
........ ......||+.|+|||.+.... ++.++|||||||+||||++|+.||........ .+...
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~-- 259 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVALA-- 259 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHHH--
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhHH--
Confidence 64321110 012345799999999987554 68999999999999999999999953211100 00000
Q ss_pred HHHhhcccCCChhhhhchhhh-ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 428 PFLAQGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 428 ~~~~~~~~~~~~~~l~d~~l~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
+. . ... .........+.+++.+||+.||.+||++.||++.|+...
T Consensus 260 --~~----~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 260 --VQ----N---------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp --HH----C---------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred --hh----c---------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 00 0 000 111223457899999999999999999999999999764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=350.05 Aligned_cols=266 Identities=23% Similarity=0.328 Sum_probs=209.9
Q ss_pred HHHHHhcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHh--cCCCCcceEEEEEEeCC--
Q 007892 203 ELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQ--VHHRHLVSLVGYCTFGS-- 278 (586)
Q Consensus 203 el~~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~--l~Hpniv~l~g~~~~~~-- 278 (586)
.-....++|.+.+.||+|+||.||+|+. +|+.||||++... ....+.+|++++.. ++||||+++++++....
T Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 36 VQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred ecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 3455567899999999999999999998 5899999998643 35678889999988 78999999999998876
Q ss_pred --eeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhh--------hcCCCcEEecCCCCceeEeCCCCC
Q 007892 279 --QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH--------EDCQPKIIHRDIKSANILLDDSFE 348 (586)
Q Consensus 279 --~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH--------~~~~~~ivHrDIk~~NILl~~~~~ 348 (586)
..++||||+++|+|.+++... .+++..++.++.|++.||+||| +. +|+||||||+||||+.++.
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~ 185 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGT 185 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSC
T ss_pred cceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCC
Confidence 789999999999999999653 4899999999999999999999 65 9999999999999999999
Q ss_pred eEEeecccccccCCCCCc---ccccccccccccCcccccCCC------CCCcchHHHHHHHHHHHHhC----------CC
Q 007892 349 AKVADFGLAKHSLDTDTH---VSTRVMGTFGYLAPEYASSGK------LTEKSDVFSFGVLLLELITG----------FR 409 (586)
Q Consensus 349 ~kl~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~s~ksDVwSlGvvL~elltG----------~~ 409 (586)
+||+|||+++........ ......||+.|+|||++.+.. ++.++|||||||+||||++| +.
T Consensus 186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~ 265 (342)
T 1b6c_B 186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 265 (342)
T ss_dssp EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence 999999999865443322 224457999999999998652 34689999999999999999 77
Q ss_pred CCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 410 PFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 410 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
||....... .....+..... ...+...+... -...+....+.+++.+||+.||.+||++.||++.|+..
T Consensus 266 p~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 266 PYYDLVPSD-PSVEEMRKVVC-----EQKLRPNIPNR--WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp TTTTTSCSS-CCHHHHHHHHT-----TSCCCCCCCGG--GGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CccccCcCc-ccHHHHHHHHH-----HHHhCCCCccc--ccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 886543311 12222221111 11111101000 12345677899999999999999999999999999865
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=347.45 Aligned_cols=248 Identities=27% Similarity=0.420 Sum_probs=202.0
Q ss_pred HhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEE
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 282 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~l 282 (586)
+.++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|+.++.+++||||++++++|.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3478999999999999999999976 46799999985432 1224678999999999999999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCC
Q 007892 283 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 283 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 362 (586)
||||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||||+.++.+||+|||++.....
T Consensus 87 v~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp EECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 99999999999998654 3489999999999999999999998 999999999999999999999999999865432
Q ss_pred CCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhh
Q 007892 363 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 442 (586)
Q Consensus 363 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 442 (586)
. ......|++.|+|||.+.+..++.++||||||++||||++|+.||....... . ... +..
T Consensus 162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~---~~~-~~~---------- 221 (279)
T 3fdn_A 162 S---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE---T---YKR-ISR---------- 221 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---H---HHH-HHH----------
T ss_pred c---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH---H---HHH-HHh----------
Confidence 2 2244579999999999999999999999999999999999999997544211 0 000 000
Q ss_pred hchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 443 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 443 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
....++......+.+++.+||+.||.+||++.||++.
T Consensus 222 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 222 ---VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp ---TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred ---CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0001222234568899999999999999999999974
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=364.93 Aligned_cols=255 Identities=29% Similarity=0.439 Sum_probs=195.5
Q ss_pred CccccceecccCcEEEEEEEEeC--C--eEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEe-CCeeEEE
Q 007892 210 NFSEANLLGQGGFGYVHKGVLTN--G--KVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTF-GSQRLLV 283 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~~--g--~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~-~~~~~lV 283 (586)
.|...+.||+|+||.||+|++.+ + ..||||.++... ....+.|.+|+.++++++||||++++++|.. ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 46778999999999999999642 2 468999986543 3445789999999999999999999999865 4578999
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCC
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 363 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 363 (586)
|||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 170 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccccc
Confidence 99999999999997543 4588999999999999999999998 9999999999999999999999999999865433
Q ss_pred CCc---ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCCh
Q 007892 364 DTH---VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 439 (586)
Q Consensus 364 ~~~---~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (586)
... ......+++.|+|||++.+..++.++|||||||+||||++ |..||....... +..+ +. .+.
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~----~~----~~~- 313 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVY----LL----QGR- 313 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHH----HH----TTC-
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHH----HH----cCC-
Confidence 211 2233467889999999999999999999999999999999 677886554321 1111 00 110
Q ss_pred hhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 440 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 440 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
....+......+.+++.+||+.||.+||++.||++.|+...
T Consensus 314 -------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~ 354 (373)
T 3c1x_A 314 -------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 354 (373)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00112223456889999999999999999999999998653
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=347.13 Aligned_cols=265 Identities=20% Similarity=0.295 Sum_probs=199.8
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCch--hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ--GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~--~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
++|+..+.||+|+||.||+|... +|+.||||++...... ..+.+.+|+.++.+++||||++++++|...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 67999999999999999999976 4899999998654332 24578899999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 365 (586)
|+++++|..++... ..+++..+..++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++.......
T Consensus 83 ~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 157 (311)
T 4agu_A 83 YCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD 157 (311)
T ss_dssp CCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred eCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence 99999999888654 3489999999999999999999998 999999999999999999999999999986543222
Q ss_pred cccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhh-------cccCC
Q 007892 366 HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQ-------GLADG 437 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~-------~~~~~ 437 (586)
......||..|+|||++.+ ..++.++|||||||+||||++|+.||.......... .....+.. .+...
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 233 (311)
T 4agu_A 158 -YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLY---LIRKTLGDLIPRHQQVFSTN 233 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCSCCHHHHHHHHTC
T ss_pred -ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhcccccccccccccc
Confidence 2334579999999999875 678999999999999999999999997655321111 11000000 00000
Q ss_pred C-hhh--hhch----hhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 438 N-FDA--LVDQ----KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 438 ~-~~~--l~d~----~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
. +.. +.++ .+..........+.+++.+||+.||.+||++.||++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0 000 0000 0000011234568899999999999999999999964
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=353.12 Aligned_cols=252 Identities=25% Similarity=0.338 Sum_probs=205.9
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCch------hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCee
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ------GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR 280 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~------~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~ 280 (586)
.++|.+.+.||+|+||.||+|+.. +|+.||||.++..... ....+.+|+.++.+++||||+++++++...+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 367999999999999999999975 5899999998654321 357899999999999999999999999999999
Q ss_pred EEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCC----CeEEeeccc
Q 007892 281 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF----EAKVADFGL 356 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~----~~kl~DFGl 356 (586)
++||||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 9999999999999999754 3589999999999999999999998 999999999999999887 799999999
Q ss_pred ccccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccC
Q 007892 357 AKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLAD 436 (586)
Q Consensus 357 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (586)
++...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||...... +...... .
T Consensus 166 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~i~-----~ 232 (321)
T 2a2a_A 166 AHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANIT-----S 232 (321)
T ss_dssp CEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHH-----T
T ss_pred ceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHH-----h
Confidence 98754332 223457999999999999999999999999999999999999999754321 1111100 1
Q ss_pred CChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 437 GNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 437 ~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.... .+... .......+.+++.+||+.||.+||++.|+++.
T Consensus 233 ~~~~--~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 233 VSYD--FDEEF---FSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp TCCC--CCHHH---HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred cccc--cChhh---hcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1000 00000 01123468899999999999999999999874
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=359.66 Aligned_cols=247 Identities=24% Similarity=0.350 Sum_probs=200.0
Q ss_pred cCccccceecccCcEEEEEEEE-eCCeEEEEEEeccCCch---hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQ---GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~---~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
+.|...+.||+|+||.||+|+. .+++.||||++...... ..+.+.+|+++|.+++||||++++++|...+..+|||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588999999999999999996 47899999999754322 2357889999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
||+. |+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++....
T Consensus 134 e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~-- 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 206 (348)
T ss_dssp ECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred ecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC--
Confidence 9997 6777776533 24589999999999999999999998 999999999999999999999999999986532
Q ss_pred CcccccccccccccCccccc---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhh
Q 007892 365 THVSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 441 (586)
Q Consensus 365 ~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (586)
.....||+.|+|||++. .+.++.++|||||||+||||++|+.||...... ........ .. .
T Consensus 207 ---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~------~~~~~~~~----~~-~-- 270 (348)
T 1u5q_A 207 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQ----NE-S-- 270 (348)
T ss_dssp ---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHH----SC-C--
T ss_pred ---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHh----cC-C--
Confidence 23457999999999984 577999999999999999999999999754421 11111110 00 0
Q ss_pred hhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007892 442 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRAL 483 (586)
Q Consensus 442 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L 483 (586)
+.+ ........+.+++.+||+.||.+||++.||++..
T Consensus 271 ---~~~--~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 271 ---PAL--QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp ---CCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred ---CCC--CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 000 1112235688999999999999999999998743
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=366.89 Aligned_cols=252 Identities=23% Similarity=0.360 Sum_probs=197.0
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHHH-HHhcCCCCcceEEEEEEeCCeeEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEI-ISQVHHRHLVSLVGYCTFGSQRLL 282 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~i-l~~l~Hpniv~l~g~~~~~~~~~l 282 (586)
.++|++.+.||+|+||.||+++.. +++.||||+++.... .....+..|..+ +..++||||+++++++...+..+|
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 367999999999999999999976 578999999975432 223456677776 567899999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCC
Q 007892 283 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 283 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 362 (586)
||||+++|+|.+++... ..+.+..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++....
T Consensus 117 v~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 99999999999999654 3488999999999999999999998 999999999999999999999999999986433
Q ss_pred CCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhh
Q 007892 363 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 442 (586)
Q Consensus 363 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 442 (586)
.. ......+||+.|+|||++.+..++.++|||||||+||||++|+.||...+.. +.....+
T Consensus 192 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~------------ 252 (373)
T 2r5t_A 192 HN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EMYDNIL------------ 252 (373)
T ss_dssp CC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH------HHHHHHH------------
T ss_pred CC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHH------------
Confidence 22 2334578999999999999999999999999999999999999999754321 1111111
Q ss_pred hchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 007892 443 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 485 (586)
Q Consensus 443 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~ 485 (586)
...+ .++......+.+++.+||+.||.+||++.+.++.+..
T Consensus 253 -~~~~-~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~ 293 (373)
T 2r5t_A 253 -NKPL-QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKS 293 (373)
T ss_dssp -HSCC-CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHT
T ss_pred -hccc-CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhC
Confidence 1111 1222334568899999999999999998655544443
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=387.70 Aligned_cols=246 Identities=27% Similarity=0.402 Sum_probs=198.4
Q ss_pred ceecccCcEEEEEEEEe---CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecCC
Q 007892 215 NLLGQGGFGYVHKGVLT---NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPN 289 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~~~---~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~ 289 (586)
+.||+|+||.||+|.+. .++.||||+++... ....++|.+|+++|.+++|||||+++++|.. +..+|||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999764 46789999997643 2346789999999999999999999999964 568899999999
Q ss_pred CcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC--cc
Q 007892 290 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT--HV 367 (586)
Q Consensus 290 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~--~~ 367 (586)
|+|.+++... ..+++..++.|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+++....... ..
T Consensus 454 g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 454 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence 9999999654 4589999999999999999999998 999999999999999999999999999987644332 22
Q ss_pred cccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchh
Q 007892 368 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 446 (586)
Q Consensus 368 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 446 (586)
.....+|+.|+|||++.+..++.++|||||||+||||++ |+.||...... .+... + ..+.
T Consensus 529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~~~----i----~~~~-------- 589 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTAM----L----EKGE-------- 589 (635)
T ss_dssp ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHH----H----HTTC--------
T ss_pred ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----H----HcCC--------
Confidence 233457889999999999999999999999999999998 99999765431 11111 1 1111
Q ss_pred hhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 007892 447 LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 485 (586)
Q Consensus 447 l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~ 485 (586)
....+......+.+++..||+.||.+||++.+|++.|+.
T Consensus 590 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 590 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 012233445678999999999999999999999999985
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=344.13 Aligned_cols=251 Identities=24% Similarity=0.376 Sum_probs=204.0
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++.+++||||+++++++...+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 478999999999999999999975 58899999986542 333467889999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCC---eEEeecccccccC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE---AKVADFGLAKHSL 361 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~---~kl~DFGla~~~~ 361 (586)
||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||||+.++. +||+|||++....
T Consensus 85 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 999999998888654 3489999999999999999999998 9999999999999976655 9999999997654
Q ss_pred CCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhh
Q 007892 362 DTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 441 (586)
Q Consensus 362 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (586)
... ......||+.|+|||++.+..++.++||||||++||+|++|+.||...... .... ... .+.+.
T Consensus 160 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~~~---~~~-----~~~~~- 225 (284)
T 3kk8_A 160 DSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYA---QIK-----AGAYD- 225 (284)
T ss_dssp SSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHH-----HTCCC-
T ss_pred cCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh---HHHH---HHH-----hcccc-
Confidence 332 223467999999999999999999999999999999999999999764421 1111 100 01000
Q ss_pred hhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 442 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 442 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
...+ ........+.+++.+||+.||.+||++.|+++
T Consensus 226 ~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 226 YPSP----EWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp CCTT----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCch----hhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0000 01122356889999999999999999999997
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=349.93 Aligned_cols=251 Identities=27% Similarity=0.419 Sum_probs=200.2
Q ss_pred HhcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC-CeeEEEEE
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG-SQRLLVYE 285 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~-~~~~lV~E 285 (586)
..++|+..+.||+|+||.||++.. .|+.||||+++... ..+.+.+|+.++.+++||||+++++++... +..++|||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred ChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 357899999999999999999987 58899999997543 356799999999999999999999997654 46899999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 365 (586)
|+++++|.+++.......+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 170 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 170 (278)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence 99999999999755444488999999999999999999998 9999999999999999999999999999754322
Q ss_pred cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhc
Q 007892 366 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 444 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 444 (586)
.....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .+... + ..+.
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~~----~----~~~~------ 231 (278)
T 1byg_A 171 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPR----V----EKGY------ 231 (278)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHH----H----TTTC------
T ss_pred --ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----H----hcCC------
Confidence 123457889999999998999999999999999999998 99999765421 11110 1 0110
Q ss_pred hhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 445 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 445 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
....+......+.+++..||+.||.+||++.||++.|+..
T Consensus 232 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 232 --KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 0012223446789999999999999999999999999864
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=371.72 Aligned_cols=251 Identities=25% Similarity=0.359 Sum_probs=207.3
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
++|.+.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+.+|+.++||||+++++++...+..+|||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 67999999999999999999976 68999999996532 123467899999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++......
T Consensus 96 E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 96 EYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp ECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 999999999999654 3589999999999999999999998 99999999999999999999999999998754322
Q ss_pred CcccccccccccccCcccccCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhh
Q 007892 365 THVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 443 (586)
Q Consensus 365 ~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 443 (586)
.....+||+.|+|||++.+..+ +.++|||||||+||||++|+.||...... ...... ..+.+
T Consensus 171 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~------~~~~~i-----~~~~~---- 233 (476)
T 2y94_A 171 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP------TLFKKI-----CDGIF---- 233 (476)
T ss_dssp --CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH------HHHHHH-----HTTCC----
T ss_pred --cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH------HHHHHH-----hcCCc----
Confidence 2345679999999999988765 68999999999999999999999764421 111111 11111
Q ss_pred chhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHhcC
Q 007892 444 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR--ALEGN 486 (586)
Q Consensus 444 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~--~L~~~ 486 (586)
..+......+.+++.+||+.||.+||++.||++ .+...
T Consensus 234 -----~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 234 -----YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred -----CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 111222356889999999999999999999997 45543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=347.67 Aligned_cols=256 Identities=29% Similarity=0.439 Sum_probs=202.1
Q ss_pred cCccccceecccCcEEEEEEEEeC----CeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEe-CCeeEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLTN----GKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTF-GSQRLL 282 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~~----g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~-~~~~~l 282 (586)
..|.+.+.||+|+||.||+|++.+ ...||||.++.... .....+.+|+.++++++||||++++++|.. ++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 458888999999999999999643 23689999876443 334678999999999999999999999754 557799
Q ss_pred EEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCC
Q 007892 283 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 283 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 362 (586)
||||+++++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 105 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccc
Confidence 999999999999997543 4589999999999999999999998 999999999999999999999999999986543
Q ss_pred CCC---cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCC
Q 007892 363 TDT---HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGN 438 (586)
Q Consensus 363 ~~~---~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (586)
... .......||+.|+|||.+.+..++.++|||||||++|||++ |.+||....... ..... . .+.
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~~~~---~-----~~~ 249 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYL---L-----QGR 249 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HHHHH---H-----TTC
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HHHHH---h-----cCC
Confidence 321 12234567889999999999999999999999999999999 556665443211 11110 0 000
Q ss_pred hhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 439 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 439 ~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
....+......+.+++.+||+.+|.+||++.||++.|+...
T Consensus 250 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 290 (298)
T 3f66_A 250 --------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 290 (298)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00111223456889999999999999999999999998753
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=354.42 Aligned_cols=264 Identities=22% Similarity=0.316 Sum_probs=190.5
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
.++|+..+.||+|+||.||+|... +|+.||||+++.... .....+.+|+.++.+++||||+++++++..++..+||||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 367889999999999999999964 589999999975432 234678899999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCC----CCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccC
Q 007892 286 FVPNKTLEFHLHGK----DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 361 (586)
Q Consensus 286 ~~~~gsL~~~l~~~----~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~ 361 (586)
|++ ++|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 5888887542 224589999999999999999999998 99999999999999999999999999998653
Q ss_pred CCCCcccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhh--------
Q 007892 362 DTDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQ-------- 432 (586)
Q Consensus 362 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~-------- 432 (586)
... .......||+.|+|||++.+ ..++.++|||||||+||||++|+.||....... ........+..
T Consensus 160 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~ 235 (317)
T 2pmi_A 160 IPV-NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE---QLKLIFDIMGTPNESLWPS 235 (317)
T ss_dssp SCC-CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCTTTCGG
T ss_pred CCc-ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCChhHhhh
Confidence 322 12234578999999999976 468999999999999999999999997654311 11111000000
Q ss_pred -----c----c---cCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 433 -----G----L---ADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 433 -----~----~---~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
. + ....+...+.+.. .......+.+++.+||+.||.+||++.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 236 VTKLPKYNPNIQQRPPRDLRQVLQPHT---KEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GGGCTTCCTTCCCCCCCCSHHHHGGGC---SSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhcccccccccchhHHHhhcccc---cccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0 0 0000111111111 11223568999999999999999999999863
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=349.76 Aligned_cols=256 Identities=21% Similarity=0.356 Sum_probs=206.2
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCeeEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTF--GSQRLL 282 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~--~~~~~l 282 (586)
.++|++.+.||+|+||.||++... +++.||||.+.... ....+.+.+|+.++.+++||||++++++|.. ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 367999999999999999999975 68999999997543 2345678999999999999999999998854 568899
Q ss_pred EEEecCCCcHHHHhcCC--CCCCCChHHHHHHHHHHHHHhHhhhhcCCCc-----EEecCCCCceeEeCCCCCeEEeecc
Q 007892 283 VYEFVPNKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDCQPK-----IIHRDIKSANILLDDSFEAKVADFG 355 (586)
Q Consensus 283 V~E~~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~-----ivHrDIk~~NILl~~~~~~kl~DFG 355 (586)
||||+++++|.+++... ....+++..++.++.|++.||+|||+. + |+||||||+|||++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 99999999999998643 234589999999999999999999998 6 9999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhccc
Q 007892 356 LAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLA 435 (586)
Q Consensus 356 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 435 (586)
+++...... .......|++.|+|||.+.+..++.++||||||++||||++|+.||..... ..+... +.
T Consensus 162 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~--------i~ 229 (279)
T 2w5a_A 162 LARILNHDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELAGK--------IR 229 (279)
T ss_dssp HHHHC---C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHH--------HH
T ss_pred hheeecccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---HHHHHH--------Hh
Confidence 998653322 222345799999999999988999999999999999999999999976542 111111 01
Q ss_pred CCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 436 DGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 436 ~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
.+.+ ...+......+.+++.+||+.||.+||++.||++.+...
T Consensus 230 ~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 230 EGKF--------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp HTCC--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred hccc--------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 1111 112223345789999999999999999999999987644
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=358.09 Aligned_cols=252 Identities=18% Similarity=0.206 Sum_probs=204.8
Q ss_pred HHHhcCccccceecccCcEEEEEEE------EeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcC---CCCcceEEEEEE
Q 007892 205 KIATDNFSEANLLGQGGFGYVHKGV------LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH---HRHLVSLVGYCT 275 (586)
Q Consensus 205 ~~~~~~f~~~~~LG~G~fG~Vyk~~------~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~---Hpniv~l~g~~~ 275 (586)
+...++|.+.++||+|+||.||+|+ ..+++.||||+++... ..++..|++++.+++ |+||+++++++.
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 3455789999999999999999994 4568899999997643 457888889888887 999999999999
Q ss_pred eCCeeEEEEEecCCCcHHHHhcCC---CCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCC-------
Q 007892 276 FGSQRLLVYEFVPNKTLEFHLHGK---DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD------- 345 (586)
Q Consensus 276 ~~~~~~lV~E~~~~gsL~~~l~~~---~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~------- 345 (586)
..+..+|||||+++|+|.++++.. ....++|..++.|+.|++.||+|||+. +||||||||+||||+.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC--
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccc
Confidence 999999999999999999999642 345699999999999999999999998 9999999999999998
Q ss_pred ----CCCeEEeecccccccCC-CCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccch
Q 007892 346 ----SFEAKVADFGLAKHSLD-TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADD 420 (586)
Q Consensus 346 ----~~~~kl~DFGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~ 420 (586)
++.+||+|||+++.... .........+||+.|+|||++.+..++.++|||||||+||||++|+.||......
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--- 291 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG--- 291 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT---
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC---
Confidence 89999999999975431 2223345578999999999999999999999999999999999999999643321
Q ss_pred hhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCC-CCHHHHHHHHhcC
Q 007892 421 SMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRR-PRMSQIVRALEGN 486 (586)
Q Consensus 421 ~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~R-Ptm~evl~~L~~~ 486 (586)
.|. ....+ ..+. ....+.+++..|++.+|.+| |++.++.+.|+..
T Consensus 292 ---~~~--------~~~~~--------~~~~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 292 ---ECK--------PEGLF--------RRLP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp ---EEE--------ECSCC--------TTCS--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred ---cee--------echhc--------cccC--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 010 00011 1111 13456788999999999888 5788888888754
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=362.94 Aligned_cols=273 Identities=21% Similarity=0.263 Sum_probs=212.9
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC--eeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS--QRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~~~lV~ 284 (586)
++|.+.+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|+++|.+++||||+++++++...+ ..+|||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 67999999999999999999976 48999999997543 233567889999999999999999999998755 679999
Q ss_pred EecCCCcHHHHhcCCCC-CCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEe----CCCCCeEEeecccccc
Q 007892 285 EFVPNKTLEFHLHGKDR-PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL----DDSFEAKVADFGLAKH 359 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl----~~~~~~kl~DFGla~~ 359 (586)
||+++|+|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+|||| +.++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 99999999999976432 3389999999999999999999998 99999999999999 7788899999999987
Q ss_pred cCCCCCcccccccccccccCcccccC--------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHh
Q 007892 360 SLDTDTHVSTRVMGTFGYLAPEYASS--------GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLA 431 (586)
Q Consensus 360 ~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 431 (586)
..... ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||........ ..+.....+.
T Consensus 166 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~--~~~~~~~~~~ 241 (396)
T 4eut_A 166 LEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--NKEVMYKIIT 241 (396)
T ss_dssp CCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT--CHHHHHHHHH
T ss_pred ccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc--hHHHHHHHhc
Confidence 54322 2234679999999999864 5678899999999999999999999975432111 1111111111
Q ss_pred hcc----------cCCChhhhhc-hhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 007892 432 QGL----------ADGNFDALVD-QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMP 488 (586)
Q Consensus 432 ~~~----------~~~~~~~l~d-~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~~ 488 (586)
... ..+.++-.-+ +............+.+++.+||+.||.+||++.|+++.|+....
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 100 0000000000 01113457778889999999999999999999999999987643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=344.88 Aligned_cols=249 Identities=26% Similarity=0.378 Sum_probs=184.2
Q ss_pred hcCccccceecccCcEEEEEEEE-eCCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV 283 (586)
.++|.+.+.||+|+||.||+|+. .+|+.||||.+.... ....+.+.+|+.++.+++||||+++++++...+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 36799999999999999999997 468999999986432 12246789999999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCC
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 363 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 363 (586)
|||+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 99999999999987542 4589999999999999999999998 9999999999999999999999999999865432
Q ss_pred CCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhh
Q 007892 364 DTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 443 (586)
Q Consensus 364 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 443 (586)
.. ......||+.|+|||.+.+..++.++||||||++||||++|+.||........ + . .+....+
T Consensus 166 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~--------~-~~~~~~~---- 229 (278)
T 3cok_A 166 HE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT--L--------N-KVVLADY---- 229 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------------CCSSCC----
T ss_pred CC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH--H--------H-HHhhccc----
Confidence 21 22345799999999999988999999999999999999999999976543110 0 0 0000000
Q ss_pred chhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 444 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 444 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
..+......+.+++.+||+.||.+||++.||++
T Consensus 230 -----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 230 -----EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp -----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -----CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 111223456889999999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=354.83 Aligned_cols=255 Identities=28% Similarity=0.452 Sum_probs=203.8
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeE--EEEEEeccC-CchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKV--VAIKQLKAG-SGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~--vAVK~l~~~-~~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~~~~lV 283 (586)
++|.+.+.||+|+||.||+|+.. ++.. ||||.++.. .....+.+.+|++++.++ +||||+++++++...+..+||
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 67899999999999999999964 5664 499998753 233446789999999999 899999999999999999999
Q ss_pred EEecCCCcHHHHhcCCC--------------CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCe
Q 007892 284 YEFVPNKTLEFHLHGKD--------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA 349 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 349 (586)
|||+++++|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||||+.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 99999999999997643 24689999999999999999999998 99999999999999999999
Q ss_pred EEeecccccccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhH
Q 007892 350 KVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKP 428 (586)
Q Consensus 350 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~ 428 (586)
||+|||+++..... .......+++.|+|||++.+..++.++|||||||+||||++ |+.||...... .+...
T Consensus 182 kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~~~~--- 253 (327)
T 1fvr_A 182 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYEK--- 253 (327)
T ss_dssp EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHH---
T ss_pred EEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH---HHHHH---
Confidence 99999999743211 11233457889999999998889999999999999999998 99999765421 11110
Q ss_pred HHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 429 FLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 429 ~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
+ ..+. ....+......+.+++.+||+.+|.+||++.||++.|+...
T Consensus 254 -~----~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 299 (327)
T 1fvr_A 254 -L----PQGY--------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 299 (327)
T ss_dssp -G----GGTC--------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -h----hcCC--------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0 0110 00112233457899999999999999999999999998653
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=345.29 Aligned_cols=245 Identities=22% Similarity=0.299 Sum_probs=200.1
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccC--CchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeEEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~~~~lV 283 (586)
.++|++.+.||+|+||.||+|+.. +++.||||+++.. .......+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 367999999999999999999976 6899999999764 234456788999999999 899999999999999999999
Q ss_pred EEecCCCcHHHHhcCCC--CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCC----------------
Q 007892 284 YEFVPNKTLEFHLHGKD--RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD---------------- 345 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~--~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~---------------- 345 (586)
|||+++++|.+++.... ...+++..++.|+.|++.||+|||++ +|+||||||+||||+.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999996532 24589999999999999999999998 9999999999999984
Q ss_pred ---CCCeEEeecccccccCCCCCcccccccccccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchh
Q 007892 346 ---SFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDS 421 (586)
Q Consensus 346 ---~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~ 421 (586)
...+||+|||++...... ....||+.|+|||.+.+. .++.++|||||||+||||++|..++.....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~----- 236 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSP-----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ----- 236 (289)
T ss_dssp ---CCCEEECCCTTCEETTCS-----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH-----
T ss_pred cCCceEEEEcccccccccCCc-----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH-----
Confidence 447999999999875432 224599999999999865 567899999999999999999887643221
Q ss_pred hhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 422 MVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 422 ~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
... + ..+. +...+......+.+++.+||+.||.+||++.|+++.
T Consensus 237 ~~~-----~----~~~~--------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 237 WHE-----I----RQGR--------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp HHH-----H----HTTC--------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHH-----H----HcCC--------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 111 0 0111 111222234578899999999999999999999864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=341.91 Aligned_cols=253 Identities=24% Similarity=0.370 Sum_probs=205.4
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++.+++||||+++++++.+++..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 367999999999999999999976 68999999986543 3345788999999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC-
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD- 364 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~- 364 (586)
|+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||||+.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 86 YCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp CCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred ecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 99999999998643 3589999999999999999999998 99999999999999999999999999997643222
Q ss_pred CcccccccccccccCcccccCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhh
Q 007892 365 THVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 443 (586)
Q Consensus 365 ~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 443 (586)
........|++.|+|||.+.+..+ +.++||||||+++|||++|+.||...... ......|... ... .
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~--------~~~---~ 228 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDWKEK--------KTY---L 228 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT-SHHHHHHHTT--------CTT---S
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH-HHHHHHhhhc--------ccc---c
Confidence 122344679999999999987665 78999999999999999999999765431 1122222110 000 0
Q ss_pred chhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 444 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 444 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
... ......+.+++.+||+.||.+||++.||++.
T Consensus 229 -~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 229 -NPW----KKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp -TTG----GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -Cch----hhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 001 1223467899999999999999999999863
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=356.04 Aligned_cols=259 Identities=27% Similarity=0.417 Sum_probs=205.5
Q ss_pred HhcCccccceecccCcEEEEEEEE------eCCeEEEEEEeccC-CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVL------TNGKVVAIKQLKAG-SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ 279 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~------~~g~~vAVK~l~~~-~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~ 279 (586)
..++|.+.+.||+|+||.||+|++ .+++.||||.+... .......+.+|+.++.+++||||+++++++...+.
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 347899999999999999999983 24678999999754 33445688999999999999999999999999999
Q ss_pred eEEEEEecCCCcHHHHhcCCCC-----CCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCC---CCCeEE
Q 007892 280 RLLVYEFVPNKTLEFHLHGKDR-----PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD---SFEAKV 351 (586)
Q Consensus 280 ~~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~---~~~~kl 351 (586)
.++||||+++++|.+++..... ..+++..++.++.|++.||.|||+. +|+||||||+||||+. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999976432 3589999999999999999999998 9999999999999984 456999
Q ss_pred eecccccccCCCCC-cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHH
Q 007892 352 ADFGLAKHSLDTDT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPF 429 (586)
Q Consensus 352 ~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~ 429 (586)
+|||+++....... .......|++.|+|||.+.++.++.++|||||||+||||++ |+.||..... ..+..+..
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~~~-- 259 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVLEFVT-- 259 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHHH--
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH---HHHHHHHh--
Confidence 99999975433221 22234568999999999998999999999999999999998 9999975432 11111110
Q ss_pred HhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 430 LAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 430 ~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
.+.. ..........+.+++.+||+.||.+||++.||++.|+...
T Consensus 260 ------~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 260 ------SGGR--------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp ------TTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------cCCC--------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 1100 0112233457889999999999999999999999998653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=355.69 Aligned_cols=256 Identities=25% Similarity=0.405 Sum_probs=200.5
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCe----EEEEEEeccC-CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGK----VVAIKQLKAG-SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 281 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~----~vAVK~l~~~-~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~ 281 (586)
.++|+..+.||+|+||.||+|++. +++ .||+|.+... .......+.+|+.++.+++||||++++++|..+. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 367999999999999999999964 344 4688887543 3345678999999999999999999999998754 78
Q ss_pred EEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccC
Q 007892 282 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 361 (586)
Q Consensus 282 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~ 361 (586)
+|+||+.+|+|.+++.... ..+++..++.|+.|++.||.|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 93 ~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 9999999999999987643 3589999999999999999999998 99999999999999999999999999998754
Q ss_pred CCCCc-ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCCh
Q 007892 362 DTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 439 (586)
Q Consensus 362 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (586)
..... ......+|+.|+|||.+.+..++.++|||||||+||||++ |+.||....... +... +. .+.
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~----~~----~~~- 236 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSI----LE----KGE- 236 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHH----HH----TTC-
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHH----HH----cCC-
Confidence 33221 2233457889999999999999999999999999999999 999997654321 1111 10 010
Q ss_pred hhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 440 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 440 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
....+......+.+++.+||+.||.+||++.||++.|+...
T Consensus 237 -------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 237 -------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp -------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 00122233456889999999999999999999999998754
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=353.47 Aligned_cols=250 Identities=23% Similarity=0.315 Sum_probs=180.5
Q ss_pred cceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeeEEEEEecCCCc
Q 007892 214 ANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLLVYEFVPNKT 291 (586)
Q Consensus 214 ~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~~~~~lV~E~~~~gs 291 (586)
.+.||+|+||.||+|+.. +++.||||++... ....+.+|+.++.++. ||||++++++|.+....+|||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999975 5899999999643 3567889999999997 9999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCC---CeEEeecccccccCCCCCccc
Q 007892 292 LEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF---EAKVADFGLAKHSLDTDTHVS 368 (586)
Q Consensus 292 L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~---~~kl~DFGla~~~~~~~~~~~ 368 (586)
|.+++... ..+++.++..|+.|++.||+|||++ +|+||||||+||||+.++ .+||+|||+++...... ...
T Consensus 93 L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~~~ 166 (325)
T 3kn6_A 93 LFERIKKK--KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPL 166 (325)
T ss_dssp HHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-Ccc
Confidence 99999764 4599999999999999999999998 999999999999997665 89999999998654332 223
Q ss_pred ccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccc-hhhhhhhhHHHhhcccCCChhhhhchhh
Q 007892 369 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFAD-DSMVDWAKPFLAQGLADGNFDALVDQKL 447 (586)
Q Consensus 369 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~d~~l 447 (586)
...+||+.|+|||++.+..++.++|||||||+||||++|+.||........ ....+... .+..+.+.. ...
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-----~i~~~~~~~-~~~-- 238 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMK-----KIKKGDFSF-EGE-- 238 (325)
T ss_dssp -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHH-----HHTTTCCCC-CSH--
T ss_pred cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHH-----HHHcCCCCC-Ccc--
Confidence 446789999999999999999999999999999999999999986543211 11111111 111111100 000
Q ss_pred hccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 448 EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 448 ~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
........+.+++.+||+.||.+||++.||++.
T Consensus 239 --~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 239 --AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp --HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred --cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 001234578899999999999999999999853
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=354.26 Aligned_cols=258 Identities=21% Similarity=0.312 Sum_probs=205.2
Q ss_pred HHHHhcCcccc-ceecccCcEEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCC
Q 007892 204 LKIATDNFSEA-NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGS 278 (586)
Q Consensus 204 l~~~~~~f~~~-~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~~ 278 (586)
.+...+.|.+. +.||+|+||.||+|+.. +++.||||+++... ......+.+|+.++.++. ||||+++++++...+
T Consensus 23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~ 102 (327)
T 3lm5_A 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS 102 (327)
T ss_dssp HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence 34445667776 89999999999999976 58999999987532 334678999999999995 799999999999999
Q ss_pred eeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCC---CCCeEEeecc
Q 007892 279 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD---SFEAKVADFG 355 (586)
Q Consensus 279 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~---~~~~kl~DFG 355 (586)
..++||||+++|+|.+++.......+++.+++.++.|++.||+|||+. +|+||||||+||||+. ++.+||+|||
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Dfg 179 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFG 179 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeCc
Confidence 999999999999999999766666799999999999999999999998 9999999999999988 7899999999
Q ss_pred cccccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhccc
Q 007892 356 LAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLA 435 (586)
Q Consensus 356 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 435 (586)
+++...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||....... .... +.+.
T Consensus 180 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~-----i~~~-- 248 (327)
T 3lm5_A 180 MSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE--TYLN-----ISQV-- 248 (327)
T ss_dssp GCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH-----HHHT--
T ss_pred cccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--HHHH-----HHhc--
Confidence 998754322 2234679999999999999999999999999999999999999997654311 1000 0000
Q ss_pred CCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 436 DGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 436 ~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
...+ ...........+.+++.+||+.||.+||++.|+++.
T Consensus 249 ~~~~-------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 249 NVDY-------SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp CCCC-------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred cccc-------CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 0000 001112234568899999999999999999999864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=344.91 Aligned_cols=255 Identities=26% Similarity=0.357 Sum_probs=202.7
Q ss_pred CccccceecccCcEEEEEEEEeC----CeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCee-EEE
Q 007892 210 NFSEANLLGQGGFGYVHKGVLTN----GKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR-LLV 283 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~~----g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~-~lV 283 (586)
.|...++||+|+||.||+|.+.+ +..||||.+..... ...+.+.+|+.++++++||||++++++|...+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 35566899999999999999643 23799999976443 3456789999999999999999999999876655 899
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCC
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 363 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 363 (586)
|||+.+++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 102 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp ECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred EecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 9999999999999763 34589999999999999999999998 9999999999999999999999999999865432
Q ss_pred CC---cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCC-CCCCcccchhhhhhhhHHHhhcccCCCh
Q 007892 364 DT---HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPF-DKADTFADDSMVDWAKPFLAQGLADGNF 439 (586)
Q Consensus 364 ~~---~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (586)
.. .......++..|+|||.+.+..++.++|||||||++|||++|..|+ ...+. ..+..... .+.
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~---~~~~~~~~--------~~~- 245 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP---FDLTHFLA--------QGR- 245 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG---GGHHHHHH--------TTC-
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH---HHHHHHhh--------cCC-
Confidence 21 1223456889999999999999999999999999999999965554 43322 11111110 000
Q ss_pred hhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 440 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 440 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
....+......+.+++.+||+.||.+||++.||++.|+...
T Consensus 246 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 286 (298)
T 3pls_A 246 -------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV 286 (298)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00112223457889999999999999999999999998653
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=373.87 Aligned_cols=254 Identities=27% Similarity=0.392 Sum_probs=207.9
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV 283 (586)
.++|...+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+.+|.+++||||+++++++...+..+||
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 477999999999999999999975 58999999996532 22346788999999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCC--CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccC
Q 007892 284 YEFVPNKTLEFHLHGKD--RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 361 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~--~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~ 361 (586)
|||+++|+|.+++.... ...+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999987543 45699999999999999999999998 99999999999999999999999999998754
Q ss_pred CCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhh
Q 007892 362 DTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 441 (586)
Q Consensus 362 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (586)
.... .....+||+.|+|||++.+..++.++|||||||+||||++|+.||....... ....+....+.
T Consensus 341 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~--~~~~~~~~i~~---------- 407 (543)
T 3c4z_A 341 AGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKELKQRVLE---------- 407 (543)
T ss_dssp TTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC--CHHHHHHHHHH----------
T ss_pred CCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch--hHHHHHHHHhh----------
Confidence 3322 2334689999999999999999999999999999999999999998654211 11111111111
Q ss_pred hhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHH
Q 007892 442 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRM-----SQIVR 481 (586)
Q Consensus 442 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm-----~evl~ 481 (586)
... .++......+.+++.+||+.||.+||++ .||++
T Consensus 408 ---~~~-~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 408 ---QAV-TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp ---CCC-CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred ---ccc-CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 000 2333345678899999999999999975 56653
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=346.47 Aligned_cols=247 Identities=26% Similarity=0.416 Sum_probs=204.9
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEe----------
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF---------- 276 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~---------- 276 (586)
.++|+..+.||+|+||.||+|... +++.||||+++... ..+.+|++++.+++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 367999999999999999999986 68999999997653 357789999999999999999998864
Q ss_pred ------CCeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeE
Q 007892 277 ------GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAK 350 (586)
Q Consensus 277 ------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 350 (586)
....++||||+++++|.+++.......+++..++.++.|++.||.|||+. +|+||||||+||||++++.+|
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCEE
Confidence 34578999999999999999765555699999999999999999999998 999999999999999999999
Q ss_pred EeecccccccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHH
Q 007892 351 VADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFL 430 (586)
Q Consensus 351 l~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 430 (586)
|+|||+++...... ......|++.|+|||.+.+..++.++|||||||+||||++|..||.... .+...
T Consensus 163 l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--------~~~~~-- 230 (284)
T 2a19_B 163 IGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--------KFFTD-- 230 (284)
T ss_dssp ECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--------HHHHH--
T ss_pred ECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--------HHHHH--
Confidence 99999998764432 2234569999999999999999999999999999999999998864211 11110
Q ss_pred hhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 431 AQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 431 ~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
+..+.+ .......+.+++.+||+.||.+||++.||++.|+...
T Consensus 231 ---~~~~~~-----------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 231 ---LRDGII-----------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp ---HHTTCC-----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred ---hhcccc-----------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 011111 1112345788999999999999999999999998653
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=348.84 Aligned_cols=264 Identities=22% Similarity=0.351 Sum_probs=199.1
Q ss_pred cCcccc-ceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeEEEEE
Q 007892 209 DNFSEA-NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 209 ~~f~~~-~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
+.|.+. +.||+|+||.||+|+.. +++.||||++..........+.+|+++|.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 567774 78999999999999954 6899999999876666677899999999995 79999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCC---eEEeecccccccCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE---AKVADFGLAKHSLD 362 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~---~kl~DFGla~~~~~ 362 (586)
|+++++|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||||+.++. +||+|||+++....
T Consensus 92 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 92 KMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp CCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred cCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 99999999999654 3489999999999999999999998 9999999999999988766 99999999976432
Q ss_pred CCC------cccccccccccccCcccccC-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHh
Q 007892 363 TDT------HVSTRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLA 431 (586)
Q Consensus 363 ~~~------~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 431 (586)
... ......+||+.|+|||++.. ..++.++|||||||+||||++|+.||........ .|......
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~ 242 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDC----GWDRGEAC 242 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCS----CC----CC
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccc----cccccccc
Confidence 211 11223569999999999875 5689999999999999999999999986543211 11100000
Q ss_pred hcccCCChhhhhchhhhccCH----HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 432 QGLADGNFDALVDQKLEEYDS----AEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 432 ~~~~~~~~~~l~d~~l~~~~~----~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.......+..+..... .++. .....+.+++.+||+.||.+||++.|+++.
T Consensus 243 ~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 243 PACQNMLFESIQEGKY-EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHHHHCCC-CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhHHHHHHHHHhccCc-ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0000000000000000 1111 123568999999999999999999999874
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=360.85 Aligned_cols=261 Identities=15% Similarity=0.248 Sum_probs=206.4
Q ss_pred cCccccceecccCcEEEEEEEEeC---------CeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcce----------
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLTN---------GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVS---------- 269 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~~---------g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~---------- 269 (586)
++|.+.+.||+|+||.||+|+... ++.||||++... ..+.+|++++.+++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 679999999999999999999763 789999998754 46889999999999999988
Q ss_pred -----EEEEEEe-CCeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEe
Q 007892 270 -----LVGYCTF-GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL 343 (586)
Q Consensus 270 -----l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl 343 (586)
+++++.. +...+|||||+ +++|.+++.......+++.+++.|+.|++.||+|||++ +|+||||||+||||
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFV 192 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEE
Confidence 6788877 67889999999 99999999865445699999999999999999999998 99999999999999
Q ss_pred CCCC--CeEEeecccccccCCCCCc------ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 007892 344 DDSF--EAKVADFGLAKHSLDTDTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKAD 415 (586)
Q Consensus 344 ~~~~--~~kl~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~ 415 (586)
+.++ .+||+|||+++........ ......||+.|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9998 9999999999865432211 1133579999999999999999999999999999999999999998654
Q ss_pred cccchhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 416 TFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 416 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
.. ...+..+...+... ...+.+.... .......+.+++.+||+.||.+||++.||++.|+...
T Consensus 273 ~~-~~~~~~~~~~~~~~------~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 335 (352)
T 2jii_A 273 PN-TEDIMKQKQKFVDK------PGPFVGPCGH--WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL 335 (352)
T ss_dssp TC-HHHHHHHHHHHHHS------CCCEECTTSC--EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred cC-HHHHHHHHHhccCC------hhhhhhhccc--cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence 21 11222221111100 0011111100 0112356899999999999999999999999998653
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=348.41 Aligned_cols=258 Identities=21% Similarity=0.336 Sum_probs=197.5
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
++|++.+.||+|+||.||+|... +|+.||||+++.. .......+.+|+.++.+++||||++++++|...+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 57999999999999999999964 6899999999753 2334567899999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcC--CCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCC
Q 007892 285 EFVPNKTLEFHLHG--KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 285 E~~~~gsL~~~l~~--~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 362 (586)
||+++++|.+++.. .....+++..++.++.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999998864 2234589999999999999999999998 999999999999999999999999999986543
Q ss_pred CCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhh
Q 007892 363 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 442 (586)
Q Consensus 363 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 442 (586)
.. .......|++.|+|||++.+..++.++|||||||+||||++|+.||...... ...+.... ....+..+
T Consensus 189 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~-----~~~~~~~~ 258 (310)
T 2wqm_A 189 KT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKI-----EQCDYPPL 258 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHHHHHH-----HTTCSCCC
T ss_pred CC-ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHHHHHh-----hcccCCCC
Confidence 22 1223457899999999999999999999999999999999999999754321 11111111 11111110
Q ss_pred hchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 443 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 443 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
........+.+++.+||+.||.+||++.+|++.|+..
T Consensus 259 -------~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l 295 (310)
T 2wqm_A 259 -------PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295 (310)
T ss_dssp -------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0112345688999999999999999999999999865
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=345.62 Aligned_cols=250 Identities=26% Similarity=0.407 Sum_probs=207.3
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
.+.|...+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++.+++||||+++++++......++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 356999999999999999999964 68899999996543 3446789999999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 365 (586)
|+++++|.+++.. ..+++..++.++.|++.||.|||+. +|+||||||+||||+.++.+||+|||++........
T Consensus 101 ~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 174 (303)
T 3a7i_A 101 YLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 174 (303)
T ss_dssp CCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred eCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence 9999999999854 3589999999999999999999998 999999999999999999999999999986543322
Q ss_pred cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhch
Q 007892 366 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQ 445 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 445 (586)
......|++.|+|||++.+..++.++|||||||+||||++|+.||...... ..... +.. +.
T Consensus 175 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~----~~~----~~------- 235 (303)
T 3a7i_A 175 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM---KVLFL----IPK----NN------- 235 (303)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHH----HHH----SC-------
T ss_pred -ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH---HHHHH----hhc----CC-------
Confidence 223457999999999999999999999999999999999999999754421 11111 000 00
Q ss_pred hhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007892 446 KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRAL 483 (586)
Q Consensus 446 ~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L 483 (586)
...........+.+++.+||+.||.+||++.||++..
T Consensus 236 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 236 -PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp -CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred -CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 0011222345688999999999999999999998753
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=362.21 Aligned_cols=254 Identities=24% Similarity=0.363 Sum_probs=193.1
Q ss_pred HHhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC--------chhHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 007892 206 IATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--------GQGEREFQAEIEIISQVHHRHLVSLVGYCTF 276 (586)
Q Consensus 206 ~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--------~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~ 276 (586)
...++|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|+.+|.+++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 34688999999999999999999975 57899999986532 111235889999999999999999999985
Q ss_pred CCeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCC---CCeEEee
Q 007892 277 GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS---FEAKVAD 353 (586)
Q Consensus 277 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~---~~~kl~D 353 (586)
.+..+|||||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||||+.+ +.+||+|
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred cCceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEee
Confidence 45689999999999999988654 4599999999999999999999998 99999999999999654 4599999
Q ss_pred cccccccCCCCCcccccccccccccCcccccC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHH
Q 007892 354 FGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS---GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFL 430 (586)
Q Consensus 354 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 430 (586)
||+++..... ......+||+.|+|||++.+ ..++.++|||||||+||||++|+.||....... .+....
T Consensus 286 FG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~i---- 357 (419)
T 3i6u_A 286 FGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQI---- 357 (419)
T ss_dssp SSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHHH----
T ss_pred cccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHHH----
Confidence 9999875432 23345679999999999853 678889999999999999999999997644211 111110
Q ss_pred hhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 431 AQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 431 ~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
..+.+.. ..... ......+.+++.+||+.||.+||++.|+++.
T Consensus 358 ----~~~~~~~-~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 358 ----TSGKYNF-IPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp ----HTTCCCC-CHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ----hcCCCCC-Cchhh----cccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 1111100 00000 1123568899999999999999999999874
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=348.29 Aligned_cols=250 Identities=22% Similarity=0.379 Sum_probs=202.8
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
.++|.+.+.||+|+||.||+++.. +|+.||||+++.........+.+|+.++.+++||||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 467999999999999999999975 6899999999876555556789999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEe---CCCCCeEEeecccccccCCC
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL---DDSFEAKVADFGLAKHSLDT 363 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl---~~~~~~kl~DFGla~~~~~~ 363 (586)
+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+ ++++.+||+|||+++.....
T Consensus 88 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 162 (304)
T 2jam_A 88 VSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162 (304)
T ss_dssp CCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred CCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence 9999999988653 3489999999999999999999998 99999999999999 78899999999999754322
Q ss_pred CCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhh
Q 007892 364 DTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 443 (586)
Q Consensus 364 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 443 (586)
......|++.|+|||.+.+..++.++|||||||++|||++|+.||...... .+. .. +. .+.+. ..
T Consensus 163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~---~~-i~----~~~~~-~~ 227 (304)
T 2jam_A 163 ---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES---KLF---EK-IK----EGYYE-FE 227 (304)
T ss_dssp ---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHH---HH-HH----HCCCC-CC
T ss_pred ---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHH---HH-HH----cCCCC-CC
Confidence 223457999999999999999999999999999999999999999764321 111 11 10 11000 00
Q ss_pred chhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 444 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 444 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
. .........+.+++.+||+.||.+||++.|+++
T Consensus 228 ~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 228 S----PFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp T----TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred c----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 111223456889999999999999999999997
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=356.44 Aligned_cols=242 Identities=24% Similarity=0.327 Sum_probs=202.1
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCch--------hHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ--------GEREFQAEIEIISQVHHRHLVSLVGYCTFGS 278 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~--------~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~ 278 (586)
.++|...+.||+|+||.||+|+.. +++.||||+++..... ....+.+|+.+|.+++||||++++++|...+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 467999999999999999999964 6899999999765321 2346778999999999999999999999999
Q ss_pred eeEEEEEecCCC-cHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccc
Q 007892 279 QRLLVYEFVPNK-TLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 357 (586)
Q Consensus 279 ~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla 357 (586)
..++||||+.+| +|.+++.... .+++..+..|+.|++.||+|||++ +|+||||||+||||+.++.+||+|||++
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccc
Confidence 999999999777 9999986543 499999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCcccccCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccC
Q 007892 358 KHSLDTDTHVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLAD 436 (586)
Q Consensus 358 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (586)
+...... ......||+.|+|||++.+..+ +.++|||||||+||||++|+.||....... .
T Consensus 178 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----------------~ 238 (335)
T 3dls_A 178 AYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV-----------------E 238 (335)
T ss_dssp EECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT-----------------T
T ss_pred eECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH-----------------h
Confidence 8754332 2334679999999999988776 789999999999999999999996532100 0
Q ss_pred CChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 437 GNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 437 ~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.. . ..+......+.+++.+||+.||.+||++.||++.
T Consensus 239 ~~--------~-~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 239 AA--------I-HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp TC--------C-CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred hc--------c-CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 0 0011123468899999999999999999999985
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=369.03 Aligned_cols=263 Identities=21% Similarity=0.272 Sum_probs=197.2
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC------C
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG------S 278 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~------~ 278 (586)
.++|+..+.||+|+||.||+|... +++.||||++... .......+.+|+.+|++++|||||++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 478999999999999999999965 5899999999754 333456788999999999999999999999654 4
Q ss_pred eeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccc
Q 007892 279 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 358 (586)
Q Consensus 279 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~ 358 (586)
..+|||||++++ |.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp EEEEEEECCSEE-HHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred eEEEEEeCCCCC-HHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 579999999765 5555532 389999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhh------------
Q 007892 359 HSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWA------------ 426 (586)
Q Consensus 359 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~------------ 426 (586)
..... ...+..+||+.|+|||++.+..++.++|||||||+||||++|+.||...+... .+....
T Consensus 213 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~--~~~~i~~~lg~p~~~~~~ 288 (464)
T 3ttj_A 213 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID--QWNKVIEQLGTPCPEFMK 288 (464)
T ss_dssp ----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCSCCHHHHT
T ss_pred ecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCHHHHH
Confidence 65332 22345789999999999999999999999999999999999999998655321 111000
Q ss_pred ------hHHHhhc--ccCCChhhhhchhhh----ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 427 ------KPFLAQG--LADGNFDALVDQKLE----EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 427 ------~~~~~~~--~~~~~~~~l~d~~l~----~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
+.++... .....+..+....+. .........+.+++.+||+.||.+|||+.|++++
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 000011111111110 1112235678999999999999999999999874
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=343.33 Aligned_cols=251 Identities=25% Similarity=0.364 Sum_probs=202.0
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc------hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCee
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG------QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR 280 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~------~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~ 280 (586)
.++|.+.+.||+|+||.||+++.. +++.||||.++.... .....+.+|+.++.+++||||+++++++...+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 367999999999999999999976 589999999865422 1357899999999999999999999999999999
Q ss_pred EEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCC----CeEEeeccc
Q 007892 281 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF----EAKVADFGL 356 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~----~~kl~DFGl 356 (586)
++||||+++++|.+++... ..+++..++.++.|++.||.|||+. +|+||||||+|||++.++ .+||+|||+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 9999999999999998653 3589999999999999999999998 999999999999998877 899999999
Q ss_pred ccccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccC
Q 007892 357 AKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLAD 436 (586)
Q Consensus 357 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (586)
+....... ......|++.|+|||++.+..++.++||||||++||||++|+.||....... .+..+ ..
T Consensus 159 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~---------~~ 225 (283)
T 3bhy_A 159 AHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE--TLTNI---------SA 225 (283)
T ss_dssp CEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHH---------HT
T ss_pred ceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH--HHHHh---------Hh
Confidence 98654322 2234569999999999999999999999999999999999999997644211 01000 00
Q ss_pred CChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 437 GNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 437 ~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
.... .+.. ........+.+++.+||+.||.+||++.|+++
T Consensus 226 ~~~~--~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 226 VNYD--FDEE---YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp TCCC--CCHH---HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cccC--Ccch---hcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 0000 0000 00112356889999999999999999999987
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=354.86 Aligned_cols=271 Identities=23% Similarity=0.388 Sum_probs=198.4
Q ss_pred hcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHH--HHhcCCCCcceEEEEEEe-----CCee
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEI--ISQVHHRHLVSLVGYCTF-----GSQR 280 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~i--l~~l~Hpniv~l~g~~~~-----~~~~ 280 (586)
.++|++.+.||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++|+||+++++++.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 47899999999999999999987 68999999996532 3445555554 445899999999986643 2356
Q ss_pred EEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcC------CCcEEecCCCCceeEeCCCCCeEEeec
Q 007892 281 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC------QPKIIHRDIKSANILLDDSFEAKVADF 354 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~------~~~ivHrDIk~~NILl~~~~~~kl~DF 354 (586)
+|||||+++|+|.+++.... .++..++.|+.|++.||+|||+.+ .++|+||||||+||||+.++.+||+||
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF 164 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF 164 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred EEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeec
Confidence 89999999999999996543 589999999999999999999863 338999999999999999999999999
Q ss_pred ccccccCCCC-------CcccccccccccccCcccccC-------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccch
Q 007892 355 GLAKHSLDTD-------THVSTRVMGTFGYLAPEYASS-------GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADD 420 (586)
Q Consensus 355 Gla~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-------~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~ 420 (586)
|+++...... ........||+.|+|||++.+ ..++.++|||||||+||||++|..||.........
T Consensus 165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~ 244 (336)
T 3g2f_A 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244 (336)
T ss_dssp TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence 9998654322 112234579999999999986 45677999999999999999998877543321111
Q ss_pred hhhhhhhHH--------HhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 421 SMVDWAKPF--------LAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 421 ~~~~~~~~~--------~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
.. .+.... +............+.... .........+.+++.+||+.||.+||++.||++.|+..+
T Consensus 245 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 245 QM-AFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW-KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CC-TTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC-CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH-hhhcccCCCchHHHHHhhhcccccCCCCCccc-ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 00 000000 000000000000000000 122346678999999999999999999999999999765
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=366.41 Aligned_cols=193 Identities=26% Similarity=0.370 Sum_probs=154.0
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeC-----Cee
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFG-----SQR 280 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~-----~~~ 280 (586)
++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+|.+++|||||+++++|... ...
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 68999999999999999999965 68999999986532 23346788999999999999999999999543 568
Q ss_pred EEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccccc
Q 007892 281 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 360 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~ 360 (586)
||||||+ +++|..++... ..+++..+..|+.||+.||+|||+. +||||||||+||||+.++.+||+|||+++..
T Consensus 133 ~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp EEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred EEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhc
Confidence 9999998 57898888654 4599999999999999999999998 9999999999999999999999999999875
Q ss_pred CCCCC--------------------------cccccccccccccCcccc-cCCCCCCcchHHHHHHHHHHHHhC
Q 007892 361 LDTDT--------------------------HVSTRVMGTFGYLAPEYA-SSGKLTEKSDVFSFGVLLLELITG 407 (586)
Q Consensus 361 ~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~ksDVwSlGvvL~elltG 407 (586)
..... ...+..+||+.|+|||++ ....++.++|||||||+||||++|
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 42211 123446789999999976 566799999999999999999994
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=354.87 Aligned_cols=251 Identities=21% Similarity=0.337 Sum_probs=200.8
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeEEEEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
.++|++.+.||+|+||.||++... +|+.||||+++.... .+.+|+++|.++ +||||+++++++.+++..+||||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 467999999999999999999975 589999999976532 345788889888 79999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCC----CCeEEeecccccccC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS----FEAKVADFGLAKHSL 361 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~----~~~kl~DFGla~~~~ 361 (586)
|+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||+.++ +.+||+|||+++...
T Consensus 97 ~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 97 LMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp CCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 99999999998654 3589999999999999999999998 99999999999998443 359999999998754
Q ss_pred CCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhh
Q 007892 362 DTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 441 (586)
Q Consensus 362 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (586)
.... .....+||+.|+|||++.+..++.++|||||||+||||++|+.||....... ..+...... .+.+.
T Consensus 172 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~~~~i~-----~~~~~- 241 (342)
T 2qr7_A 172 AENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT---PEEILARIG-----SGKFS- 241 (342)
T ss_dssp CTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC---HHHHHHHHH-----HCCCC-
T ss_pred CCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC---HHHHHHHHc-----cCCcc-
Confidence 4322 2344679999999999988889999999999999999999999997543211 111111111 11110
Q ss_pred hhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 442 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 442 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
+.. .+.......+.+++.+||+.||.+||++.||++
T Consensus 242 ~~~----~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 242 LSG----GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp CCS----TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cCc----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000 111223456889999999999999999999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=345.18 Aligned_cols=250 Identities=24% Similarity=0.322 Sum_probs=197.7
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
++|.+.+.||+|+||.||++... +++.||||++.... ....+.+.+|+++|.+++||||++++++|...+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 67999999999999999999975 58899999986543 33467899999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCC--CCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEe---CCCCCeEEeecccccccC
Q 007892 287 VPNKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL---DDSFEAKVADFGLAKHSL 361 (586)
Q Consensus 287 ~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl---~~~~~~kl~DFGla~~~~ 361 (586)
+++++|.+++... ....+++..++.|+.|++.||+|||+. +|+||||||+|||| +.++.+||+|||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999888542 234589999999999999999999998 99999999999999 456789999999998654
Q ss_pred CCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhh
Q 007892 362 DTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 441 (586)
Q Consensus 362 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (586)
... ......||+.|+|||.+. +.++.++|||||||+||||++|+.||....... ..... .. ....+
T Consensus 179 ~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~---~~~~~---~~---~~~~~-- 244 (285)
T 3is5_A 179 SDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE---VQQKA---TY---KEPNY-- 244 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH---HH---CCCCC--
T ss_pred Ccc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH---HHhhh---cc---CCccc--
Confidence 322 234467999999999986 578999999999999999999999997654211 11100 00 00000
Q ss_pred hhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 442 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 442 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
..........+.+++.+||+.||.+||++.||++
T Consensus 245 ------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 245 ------AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ------CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ------ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000012356789999999999999999999986
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=355.60 Aligned_cols=266 Identities=24% Similarity=0.373 Sum_probs=209.4
Q ss_pred hcCccccceecccCcEEEEEEEE-----eCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC--ee
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVL-----TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS--QR 280 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~-----~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~~ 280 (586)
.++|++.+.||+|+||.||++.+ .+++.||||++........+.+.+|++++.+++||||++++++|...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 36789999999999999999984 368999999998776666788999999999999999999999987654 67
Q ss_pred EEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccccc
Q 007892 281 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 360 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~ 360 (586)
++||||+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp EEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 89999999999999997643 3589999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCc--ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCccc-----chhhhhhhhHHHhhc
Q 007892 361 LDTDTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFA-----DDSMVDWAKPFLAQG 433 (586)
Q Consensus 361 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~-----~~~~~~~~~~~~~~~ 433 (586)
...... ......++..|+|||.+.+..++.++|||||||+||||++|..||....... ......+....+
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 272 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL--- 272 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH---
T ss_pred cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH---
Confidence 443221 1233457788999999998889999999999999999999999986421100 000000000000
Q ss_pred ccCCChhhhhchhh-hccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 434 LADGNFDALVDQKL-EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 434 ~~~~~~~~l~d~~l-~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
...+.... ...+......+.+++.+||+.||.+||++.||++.|+..
T Consensus 273 ------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 273 ------IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp ------HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred ------HHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 01111000 012233456789999999999999999999999999854
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=342.76 Aligned_cols=245 Identities=27% Similarity=0.405 Sum_probs=204.3
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
++|.+.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++.+++||||+++++++...+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 67999999999999999999976 57899999986432 223467899999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
||+++++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~- 167 (284)
T 2vgo_A 94 EFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL- 167 (284)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred EeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence 9999999999986543 489999999999999999999998 9999999999999999999999999999764332
Q ss_pred CcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhc
Q 007892 365 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 444 (586)
Q Consensus 365 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 444 (586)
......|++.|+|||++.+..++.++||||||+++|||++|+.||...... +...... ...
T Consensus 168 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~-----~~~------ 228 (284)
T 2vgo_A 168 --RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT------ETHRRIV-----NVD------ 228 (284)
T ss_dssp --CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHH-----TTC------
T ss_pred --ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh------HHHHHHh-----ccc------
Confidence 223457999999999999999999999999999999999999999764421 1111111 000
Q ss_pred hhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 445 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 445 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
. .++......+.+++.+||+.||.+||++.||++
T Consensus 229 --~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 229 --L-KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp --C-CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --c-CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 0 122223456889999999999999999999986
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=359.13 Aligned_cols=267 Identities=22% Similarity=0.348 Sum_probs=192.9
Q ss_pred HhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccC--CchhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCC--ee
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGS--QR 280 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~~--~~ 280 (586)
..++|++.+.||+|+||.||+|... +|+.||||++... .......+.+|+.+|.++. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4578999999999999999999964 6899999998653 2334467789999999997 999999999997654 68
Q ss_pred EEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccccc
Q 007892 281 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 360 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~ 360 (586)
+||||||+ ++|..++.. ..+++..+..++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++..
T Consensus 87 ~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 99999997 689888865 3589999999999999999999998 9999999999999999999999999999865
Q ss_pred CCC--------------------CCcccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccc
Q 007892 361 LDT--------------------DTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFAD 419 (586)
Q Consensus 361 ~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~ 419 (586)
... .....+..+||+.|+|||++.+ ..++.++|||||||+||||++|+.||...+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 239 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 321 1112344689999999999976 6799999999999999999999999986543211
Q ss_pred hhhhhhhh------HHHhhcccCCC----------------------hhhhhchhhh-ccCHHHHHHHHHHHHHhhccCC
Q 007892 420 DSMVDWAK------PFLAQGLADGN----------------------FDALVDQKLE-EYDSAEMTRMAACAAACIRHSA 470 (586)
Q Consensus 420 ~~~~~~~~------~~~~~~~~~~~----------------------~~~l~d~~l~-~~~~~~~~~l~~l~~~cl~~dp 470 (586)
+..... ......+.... +..+...... .........+.+++.+||+.||
T Consensus 240 --~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP 317 (388)
T 3oz6_A 240 --LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP 317 (388)
T ss_dssp --HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred --HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence 100000 00000000000 0000000000 0011224568899999999999
Q ss_pred CCCCCHHHHHHH
Q 007892 471 RRRPRMSQIVRA 482 (586)
Q Consensus 471 ~~RPtm~evl~~ 482 (586)
.+||++.|++++
T Consensus 318 ~~R~t~~e~l~H 329 (388)
T 3oz6_A 318 NKRISANDALKH 329 (388)
T ss_dssp GGSCCHHHHTTS
T ss_pred ccCCCHHHHhCC
Confidence 999999999875
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=356.08 Aligned_cols=258 Identities=23% Similarity=0.359 Sum_probs=189.9
Q ss_pred HHHHhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCCcceEEEEEEe-----
Q 007892 204 LKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGYCTF----- 276 (586)
Q Consensus 204 l~~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~----- 276 (586)
+.....+|++.++||+|+||.||+|+.. +++.||||++........+.+.+|+.++.++. ||||+++++++..
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 102 (337)
T 3ll6_A 23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES 102 (337)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence 3445578999999999999999999975 68999999997776666778999999999996 9999999999953
Q ss_pred ---CCeeEEEEEecCCCcHHHHhcC-CCCCCCChHHHHHHHHHHHHHhHhhhhcCCCc--EEecCCCCceeEeCCCCCeE
Q 007892 277 ---GSQRLLVYEFVPNKTLEFHLHG-KDRPVMNWPTRMKIALGSARGLAYLHEDCQPK--IIHRDIKSANILLDDSFEAK 350 (586)
Q Consensus 277 ---~~~~~lV~E~~~~gsL~~~l~~-~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~--ivHrDIk~~NILl~~~~~~k 350 (586)
....++||||+. |+|.+++.. .....+++.+++.|+.|++.||+|||+. + |+||||||+||||+.++.+|
T Consensus 103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 103 DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEE
T ss_pred ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEE
Confidence 345789999995 788887754 2234599999999999999999999998 7 99999999999999999999
Q ss_pred EeecccccccCCCCCc-----------ccccccccccccCcccc---cCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 007892 351 VADFGLAKHSLDTDTH-----------VSTRVMGTFGYLAPEYA---SSGKLTEKSDVFSFGVLLLELITGFRPFDKADT 416 (586)
Q Consensus 351 l~DFGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~ 416 (586)
|+|||+++........ ......||+.|+|||++ .+..++.++|||||||+||||++|+.||.....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 9999999875432211 11135699999999998 566789999999999999999999999975432
Q ss_pred ccchhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 417 FADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 417 ~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
.. .. .+.+.. .........+.+++.+||+.||.+||++.||++.|+...
T Consensus 259 ~~---~~------------~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 259 LR---IV------------NGKYSI-------PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307 (337)
T ss_dssp ----------------------CCC-------CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH---hh------------cCcccC-------CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11 00 000000 000111234778999999999999999999999998653
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=343.35 Aligned_cols=253 Identities=25% Similarity=0.362 Sum_probs=200.9
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEec
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 287 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 287 (586)
+.|....+||+|+||.||+|... +++.||||.+..........+.+|+.++.+++||||++++++|...+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 44566679999999999999964 57899999998766666678999999999999999999999999999999999999
Q ss_pred CCCcHHHHhcCCC-CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCC-CCCeEEeecccccccCCCCC
Q 007892 288 PNKTLEFHLHGKD-RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD-SFEAKVADFGLAKHSLDTDT 365 (586)
Q Consensus 288 ~~gsL~~~l~~~~-~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~-~~~~kl~DFGla~~~~~~~~ 365 (586)
++++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||||+. ++.+||+|||+++......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~- 177 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN- 177 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence 9999999997643 23467888999999999999999998 9999999999999987 8999999999998654322
Q ss_pred cccccccccccccCcccccCCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhh
Q 007892 366 HVSTRVMGTFGYLAPEYASSGK--LTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 443 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~~~~--~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 443 (586)
.......|++.|+|||++.++. ++.++|||||||+||||++|+.||....... ...+... . .
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~-~-~----------- 241 (295)
T 2clq_A 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ---AAMFKVG-M-F----------- 241 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH---HHHHHHH-H-H-----------
T ss_pred CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh---HHHHhhc-c-c-----------
Confidence 1223457999999999997654 8899999999999999999999996533211 0000000 0 0
Q ss_pred chhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 444 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 444 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
......+......+.+++.+||+.||.+||++.|+++.
T Consensus 242 -~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 242 -KVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp -CCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred -cccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00011223344578899999999999999999999863
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=365.47 Aligned_cols=260 Identities=20% Similarity=0.274 Sum_probs=207.1
Q ss_pred hcCccccceecccCcEEEEEEEE-eCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCC-CCcceEEEEEEeCCeeEEEEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHH-RHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~H-pniv~l~g~~~~~~~~~lV~E 285 (586)
.++|.+.++||+|+||.||+|+. .+++.||||+++..... .++..|++++..++| ++|..+..++...+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 47899999999999999999996 46899999998654332 358899999999986 666677777788889999999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEe---CCCCCeEEeecccccccCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL---DDSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl---~~~~~~kl~DFGla~~~~~ 362 (586)
|+ +++|.+++.... ..+++.+++.|+.||+.||+|||++ +||||||||+|||| +.++.+||+|||+++....
T Consensus 84 ~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred CC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 99 999999997433 3599999999999999999999998 99999999999999 6889999999999987654
Q ss_pred CCCc------ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccC
Q 007892 363 TDTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLAD 436 (586)
Q Consensus 363 ~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (586)
.... ......||+.|+|||++.+..++.++|||||||+||||++|+.||................. .
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~---~---- 231 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE---K---- 231 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHH---H----
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhh---c----
Confidence 3321 12356799999999999999999999999999999999999999987554222221111110 0
Q ss_pred CChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 437 GNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 437 ~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
.+...+. .........+.+++..||+.+|.+||++.+|++.|+..
T Consensus 232 -~~~~~~~----~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 232 -KVATSIE----ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp -HHHSCHH----HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred -cccccHH----HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 0000111 11112245789999999999999999999999998764
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=352.62 Aligned_cols=248 Identities=22% Similarity=0.349 Sum_probs=205.0
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV 283 (586)
.++|.+.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++.+++|+||++++++|.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 367999999999999999999976 47899999986542 23456788999999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCC
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 363 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 363 (586)
|||+++++|.+++... ..+++.+++.++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 120 ~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 120 LELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp ECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 9999999999988653 3589999999999999999999998 9999999999999999999999999999865432
Q ss_pred CCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhh
Q 007892 364 DTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 443 (586)
Q Consensus 364 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 443 (586)
. .......|++.|+|||++.+..++.++|||||||+||||++|+.||...... +....... +.+
T Consensus 195 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~-----~~~---- 258 (335)
T 2owb_A 195 G-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ETYLRIKK-----NEY---- 258 (335)
T ss_dssp T-CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHH-----TCC----
T ss_pred c-ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH------HHHHHHhc-----CCC----
Confidence 2 2234467999999999999889999999999999999999999999754321 11110000 000
Q ss_pred chhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 444 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 444 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
..+......+.+++.+||+.||.+||++.||++
T Consensus 259 -----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 259 -----SIPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred -----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111223356888999999999999999999997
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=344.07 Aligned_cols=248 Identities=22% Similarity=0.350 Sum_probs=205.0
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
++|...+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++.+++||||+++++++...+..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 67899999999999999999976 47899999986542 234567889999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
||+++++|.+++... ..+++.+++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 95 e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 95 ELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp ECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred ecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 999999999988653 3589999999999999999999998 99999999999999999999999999998654222
Q ss_pred CcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhc
Q 007892 365 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 444 (586)
Q Consensus 365 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 444 (586)
.......|++.|+|||.+.+..++.++||||||++||||++|+.||...... +...... .+..
T Consensus 170 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~-----~~~~----- 232 (294)
T 2rku_A 170 -ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ETYLRIK-----KNEY----- 232 (294)
T ss_dssp -CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHH-----TTCC-----
T ss_pred -cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHh-----hccC-----
Confidence 2233467999999999999889999999999999999999999999764421 1000000 0000
Q ss_pred hhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 445 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 445 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
..+......+.+++.+||+.||.+||++.|+++.
T Consensus 233 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 233 ----SIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ----CCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1112233568899999999999999999999973
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=355.75 Aligned_cols=263 Identities=21% Similarity=0.347 Sum_probs=195.6
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchh-HHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQG-EREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~-~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
++|...+.||+|+||.||+|+.. +++.||||+++...... ...+.+|+.+|.+++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999976 68899999996543221 12456799999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 366 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 366 (586)
++ |+|.+++.... ..+++..+..++.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++...... .
T Consensus 82 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~ 155 (324)
T 3mtl_A 82 LD-KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-K 155 (324)
T ss_dssp CS-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred cc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc-c
Confidence 97 58888876543 3589999999999999999999998 99999999999999999999999999997643322 2
Q ss_pred ccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhch
Q 007892 367 VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQ 445 (586)
Q Consensus 367 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 445 (586)
......||+.|+|||++.+ ..++.++|||||||+||||++|+.||...... .........+... ....+..+...
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~-~~~~~~~~~~~ 231 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE---EQLHFIFRILGTP-TEETWPGILSN 231 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCC-CTTTSTTGGGC
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCC-ChHhchhhhcc
Confidence 2334578999999999876 56899999999999999999999999865431 1111111111000 00000000000
Q ss_pred --------------hhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 446 --------------KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 446 --------------~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
.+..........+.+++.+||+.||.+||++.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000111123356889999999999999999999987
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=351.64 Aligned_cols=258 Identities=23% Similarity=0.392 Sum_probs=206.3
Q ss_pred HHHHHHhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc--------hhHHHHHHHHHHHHhc-CCCCcceEE
Q 007892 202 EELKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--------QGEREFQAEIEIISQV-HHRHLVSLV 271 (586)
Q Consensus 202 ~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~--------~~~~~~~~Ei~il~~l-~Hpniv~l~ 271 (586)
.......++|.+.+.||+|+||.||+|++. +|+.||||++..... ...+.+.+|+.++.++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 334555678999999999999999999986 689999999865431 1134678999999999 799999999
Q ss_pred EEEEeCCeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEE
Q 007892 272 GYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKV 351 (586)
Q Consensus 272 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl 351 (586)
++|...+..+|||||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||||+.++.+||
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEE
Confidence 9999999999999999999999998643 3589999999999999999999998 9999999999999999999999
Q ss_pred eecccccccCCCCCcccccccccccccCcccccC------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhh
Q 007892 352 ADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS------GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDW 425 (586)
Q Consensus 352 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~ 425 (586)
+|||++....... ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||...... .....
T Consensus 242 ~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~~~~~ 316 (365)
T 2y7j_A 242 SDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI---LMLRM 316 (365)
T ss_dssp CCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH
T ss_pred EecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH---HHHHH
Confidence 9999998754332 2344679999999999863 35889999999999999999999999754321 11110
Q ss_pred hhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 426 AKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 426 ~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
+. .+.+. ...+.... ....+.+++.+||+.||.+||++.||++.
T Consensus 317 ----i~----~~~~~-~~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 317 ----IM----EGQYQ-FSSPEWDD----RSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp ----HH----HTCCC-CCHHHHSS----SCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ----HH----hCCCC-CCCccccc----CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00 01100 00000111 23468899999999999999999999873
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=339.93 Aligned_cols=248 Identities=24% Similarity=0.339 Sum_probs=196.4
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV 283 (586)
.++|.+.+.||+|+||.||+|... +|+.||||++.... ......+.+|+.++.+++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 468999999999999999999976 68999999986532 22346789999999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCC
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 363 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 363 (586)
|||+++++|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred EeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 99999999999986543 489999999999999999999998 9999999999999999999999999999865432
Q ss_pred CCcccccccccccccCcccccCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhh
Q 007892 364 DTHVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 442 (586)
Q Consensus 364 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 442 (586)
. ......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||..... ..+... +.. +.
T Consensus 165 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~----~~~----~~---- 227 (276)
T 2h6d_A 165 E--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV---PTLFKK----IRG----GV---- 227 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHH----HHH----CC----
T ss_pred c--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH---HHHHHH----hhc----Cc----
Confidence 2 2234568999999999987665 6899999999999999999999975432 111111 000 00
Q ss_pred hchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 443 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 443 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
...+......+.+++.+||+.||.+||++.||++.
T Consensus 228 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 228 -----FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -----ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 01122234568899999999999999999999974
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=353.50 Aligned_cols=266 Identities=23% Similarity=0.294 Sum_probs=203.3
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcC--------CCCcceEEEEEE----
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVH--------HRHLVSLVGYCT---- 275 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~--------Hpniv~l~g~~~---- 275 (586)
++|.+.++||+|+||.||+|+.. +++.||||+++.. ......+.+|+.+|.+++ |+||+++++++.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 68999999999999999999864 5889999999754 334567889999999985 788999999987
Q ss_pred eCCeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCC--------
Q 007892 276 FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF-------- 347 (586)
Q Consensus 276 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~-------- 347 (586)
.+...+|||||+ +++|.+++.......+++..++.|+.|++.||+|||+++ +|+||||||+||||+.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~~ 192 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAA 192 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred CCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhhh
Confidence 455789999999 555555555444456999999999999999999999864 799999999999998775
Q ss_pred -----------------------------------------CeEEeecccccccCCCCCcccccccccccccCcccccCC
Q 007892 348 -----------------------------------------EAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSG 386 (586)
Q Consensus 348 -----------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 386 (586)
.+||+|||+++..... .....||+.|+|||++.+.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~~ 268 (397)
T 1wak_A 193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIGS 268 (397)
T ss_dssp HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHTS
T ss_pred hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcCC
Confidence 7999999999865332 2345799999999999999
Q ss_pred CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHh-----------h-c-----c-cCCChhhh------
Q 007892 387 KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLA-----------Q-G-----L-ADGNFDAL------ 442 (586)
Q Consensus 387 ~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~-----------~-~-----~-~~~~~~~l------ 442 (586)
.++.++|||||||+||||++|+.||............+....... . . + ..+.+..+
T Consensus 269 ~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (397)
T 1wak_A 269 GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPW 348 (397)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCC
T ss_pred CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCc
Confidence 999999999999999999999999986543221111110000000 0 0 0 00000000
Q ss_pred --hchhhh--ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 443 --VDQKLE--EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 443 --~d~~l~--~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.+.... .........+.+++.+||+.||.+||++.||++.
T Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 349 GLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred chhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 000001 3467778889999999999999999999999863
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=347.30 Aligned_cols=258 Identities=26% Similarity=0.388 Sum_probs=198.3
Q ss_pred hcCccccceecccCcEEEEEEEEeC--C--eEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCee
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLTN--G--KVVAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR 280 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~~--g--~~vAVK~l~~~---~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~ 280 (586)
.++|++.+.||+|+||.||+|++.. + ..||||+++.. .....+.+.+|+.++.+++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 3679999999999999999998642 3 36899998754 2334568899999999999999999999998754 8
Q ss_pred EEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccccc
Q 007892 281 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 360 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~ 360 (586)
++|+||+++++|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccc
Confidence 89999999999999986532 3488999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCc--ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCC
Q 007892 361 LDTDTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADG 437 (586)
Q Consensus 361 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (586)
...... ......+++.|+|||++.+..++.++||||||++||||++ |+.||...... .+... ... .+
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~---~~~----~~ 241 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QILHK---IDK----EG 241 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHH---HHT----SC
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH---HHHHH---HHc----cC
Confidence 443322 2234567889999999998889999999999999999999 99999765421 11111 100 00
Q ss_pred ChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 007892 438 NFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMP 488 (586)
Q Consensus 438 ~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~~ 488 (586)
.. ..........+.+++.+||+.||.+||++.+|++.|+...+
T Consensus 242 ~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 242 ER--------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp CC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CC--------CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 00 01122334678999999999999999999999999997654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=355.05 Aligned_cols=267 Identities=22% Similarity=0.339 Sum_probs=204.8
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
.++|++.+.||+|+||.||++... +++.||+|++.... ......+.+|+.++.+++||||++++++|..++..+||||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 367999999999999999999976 68999999997653 3335678999999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 365 (586)
|+++++|.+++.... .+++..+..|+.+++.||.|||+.+ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 112 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 185 (360)
T ss_dssp CCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred CCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence 999999999996543 4899999999999999999999842 7999999999999999999999999999754221
Q ss_pred cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhh-----------hh--------
Q 007892 366 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD-----------WA-------- 426 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~-----------~~-------- 426 (586)
......||+.|+|||++.+..++.++|||||||+||||++|+.||............. +.
T Consensus 186 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (360)
T 3eqc_A 186 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264 (360)
T ss_dssp -C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred -cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence 2234579999999999999999999999999999999999999997654211100000 00
Q ss_pred hHHHhhcccCCChhhhhchhhh----c-cCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 427 KPFLAQGLADGNFDALVDQKLE----E-YDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 427 ~~~~~~~~~~~~~~~l~d~~l~----~-~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
..+............+++.... . ........+.+++.+||+.||.+||++.|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ---------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0000000000011111111111 0 11123456899999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=353.35 Aligned_cols=275 Identities=22% Similarity=0.301 Sum_probs=201.5
Q ss_pred CHHHHHHHhcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCch-----------hHHHHHHHHHHHHhcCCCCcc
Q 007892 200 TYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQ-----------GEREFQAEIEIISQVHHRHLV 268 (586)
Q Consensus 200 ~~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~-----------~~~~~~~Ei~il~~l~Hpniv 268 (586)
...++....++|.+.+.||+|+||.||+|...+|+.||||++...... ..+.+.+|+.++.+++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 456788889999999999999999999999888999999998543221 136789999999999999999
Q ss_pred eEEEEEEeC-----CeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEe
Q 007892 269 SLVGYCTFG-----SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL 343 (586)
Q Consensus 269 ~l~g~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl 343 (586)
++++++... ...++||||+. |+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILL 167 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEE
Confidence 999998542 36799999997 6777777643 34589999999999999999999998 99999999999999
Q ss_pred CCCCCeEEeecccccccCCCCCcccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccch-h
Q 007892 344 DDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADD-S 421 (586)
Q Consensus 344 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~-~ 421 (586)
+.++.+||+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 245 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNK 245 (362)
T ss_dssp CTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred cCCCCEEEEecCcccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99999999999999754322 22344679999999999876 67999999999999999999999999865421110 0
Q ss_pred hhh------------hhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 422 MVD------------WAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 422 ~~~------------~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
+.. |..+.....+. .....................+.+++.+||+.||.+||++.|+++.
T Consensus 246 i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 246 IVEVVGTPKIEDVVMFSSPSARDYLR-NSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHCCCCHHHHHHTSCHHHHHHTT-TCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHcCCCChHHhhhccchhhhHHHH-hhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 000 00000000000 0000000000111112234568899999999999999999999974
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=341.34 Aligned_cols=248 Identities=25% Similarity=0.390 Sum_probs=198.3
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEe----CCeeE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTF----GSQRL 281 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~----~~~~~ 281 (586)
..|.+.+.||+|+||.||+|... ++..||+|.+... .......+.+|+.++.+++||||++++++|.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 34778889999999999999975 5789999998654 23345678999999999999999999999875 35678
Q ss_pred EEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCc--EEecCCCCceeEeC-CCCCeEEeeccccc
Q 007892 282 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK--IIHRDIKSANILLD-DSFEAKVADFGLAK 358 (586)
Q Consensus 282 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~--ivHrDIk~~NILl~-~~~~~kl~DFGla~ 358 (586)
+||||+++++|.+++... ..+++..++.|+.|++.||.|||+. + |+||||||+||||+ +++.+||+|||++.
T Consensus 106 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 999999999999999653 3489999999999999999999998 6 99999999999997 78999999999997
Q ss_pred ccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCC
Q 007892 359 HSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGN 438 (586)
Q Consensus 359 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (586)
..... ......||+.|+|||++. +.++.++|||||||+||+|++|+.||...... ..... . +..+.
T Consensus 181 ~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~---~-----~~~~~ 246 (290)
T 1t4h_A 181 LKRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYR---R-----VTSGV 246 (290)
T ss_dssp GCCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHHH---H-----HTTTC
T ss_pred ccccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH--HHHHH---H-----HhccC
Confidence 54332 234457999999999887 56999999999999999999999999754321 11111 0 01111
Q ss_pred hhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 439 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 439 ~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
... .++......+.+++.+||+.||.+||++.||++.
T Consensus 247 ~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 247 KPA-------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp CCG-------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred Ccc-------ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 100 1111123468899999999999999999999863
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=342.72 Aligned_cols=251 Identities=25% Similarity=0.361 Sum_probs=196.8
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc--------hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--------QGEREFQAEIEIISQVHHRHLVSLVGYCTFGS 278 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~--------~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~ 278 (586)
.++|.+.+.||+|+||.||+|+.. +++.||||++..... .....+.+|+++|.+++||||+++++++..+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 467999999999999999999975 588999999865321 12245889999999999999999999987654
Q ss_pred eeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCC---eEEeecc
Q 007892 279 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE---AKVADFG 355 (586)
Q Consensus 279 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~---~kl~DFG 355 (586)
.++||||+++++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||||+.++. +||+|||
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred -eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 89999999999999998653 4589999999999999999999998 9999999999999987654 9999999
Q ss_pred cccccCCCCCcccccccccccccCccccc---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhh
Q 007892 356 LAKHSLDTDTHVSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQ 432 (586)
Q Consensus 356 la~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 432 (586)
+++..... .......||+.|+|||++. ...++.++|||||||+||||++|+.||....... .+.... .
T Consensus 163 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~----~- 233 (322)
T 2ycf_A 163 HSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQI----T- 233 (322)
T ss_dssp TCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHH----H-
T ss_pred cceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHH----H-
Confidence 99865332 2234467999999999973 5678999999999999999999999997654311 111111 0
Q ss_pred cccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 433 GLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 433 ~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
.+.+.. . +.. .......+.+++.+||+.||.+||++.|+++
T Consensus 234 ---~~~~~~-~-~~~---~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 234 ---SGKYNF-I-PEV---WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp ---HTCCCC-C-HHH---HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---hCcccc-C-chh---hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 011000 0 000 0112456889999999999999999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=351.62 Aligned_cols=256 Identities=26% Similarity=0.413 Sum_probs=199.9
Q ss_pred HHHHHhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEEe----
Q 007892 203 ELKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTF---- 276 (586)
Q Consensus 203 el~~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~---- 276 (586)
++....++|++.+.||+|+||.||+|+.. +++.||||++.... .....+.+|+.++.++ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 34445688999999999999999999974 68999999987543 3356889999999999 79999999999987
Q ss_pred --CCeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeec
Q 007892 277 --GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADF 354 (586)
Q Consensus 277 --~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DF 354 (586)
.+..++||||+++++|.+++.......+++..++.++.|++.||.|||+. +|+||||||+||||+.++.+||+||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Df 173 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDF 173 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCC
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeC
Confidence 46789999999999999999765555689999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccccCccccc-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHH
Q 007892 355 GLAKHSLDTDTHVSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPF 429 (586)
Q Consensus 355 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~ 429 (586)
|++....... .......|++.|+|||++. ...++.++|||||||+||||++|+.||....... .+..
T Consensus 174 g~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~----- 245 (326)
T 2x7f_A 174 GVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR--ALFL----- 245 (326)
T ss_dssp TTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHH-----
T ss_pred cCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH--HHHH-----
Confidence 9998653321 1223457999999999987 5678999999999999999999999997544211 0000
Q ss_pred HhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 430 LAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 430 ~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
+.. ... +.+ ........+.+++.+||..||.+||++.||++
T Consensus 246 ~~~----~~~-----~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 246 IPR----NPA-----PRL--KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHH----SCC-----CCC--SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hhc----Ccc-----ccC--CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 000 000 000 11122356889999999999999999999997
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=350.43 Aligned_cols=266 Identities=24% Similarity=0.392 Sum_probs=200.9
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
.++|+..+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+.++.+++||||++++++|...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 367999999999999999999976 489999999865433 23456889999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 104 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 104 EFVDHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp ECCSEEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred ecCCcchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 9999999998875443 489999999999999999999998 99999999999999999999999999997654322
Q ss_pred CcccccccccccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhh----------HHHhh-
Q 007892 365 THVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAK----------PFLAQ- 432 (586)
Q Consensus 365 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~----------~~~~~- 432 (586)
.......|++.|+|||++.+. .++.++|||||||+||||++|+.||....... .+..... ..+..
T Consensus 179 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 179 -EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID--QLYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCCHHHHHHHHHC
T ss_pred -cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHHHHhCCCChhhhhHhhhc
Confidence 223345799999999999865 78999999999999999999999997654321 1111100 00000
Q ss_pred c-ccCCChhhhhchh-hhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 433 G-LADGNFDALVDQK-LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 433 ~-~~~~~~~~l~d~~-l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
. .....+..+.... ...........+.+++.+||+.||.+||++.||++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 0000000000000 00111223567899999999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=364.52 Aligned_cols=241 Identities=13% Similarity=0.161 Sum_probs=189.8
Q ss_pred hcCccccceecccCcEEEEEEEE-eCCeEEEEEEeccC---CchhHHHHHHHH---HHHHhcCCCCcceEE-------EE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAG---SGQGEREFQAEI---EIISQVHHRHLVSLV-------GY 273 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~---~~~~~~~~~~Ei---~il~~l~Hpniv~l~-------g~ 273 (586)
.++|.+.+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+ .+|++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788999999999999999995 56899999999743 334457889999 555566899999998 66
Q ss_pred EEeCCe-----------------eEEEEEecCCCcHHHHhcCCCC-----CCCChHHHHHHHHHHHHHhHhhhhcCCCcE
Q 007892 274 CTFGSQ-----------------RLLVYEFVPNKTLEFHLHGKDR-----PVMNWPTRMKIALGSARGLAYLHEDCQPKI 331 (586)
Q Consensus 274 ~~~~~~-----------------~~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~ia~~ia~gL~yLH~~~~~~i 331 (586)
+...+. .+|||||+ +|+|.+++..... ..++|..++.|+.|++.||+|||++ +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 665432 78999999 6899999875321 2234688889999999999999998 99
Q ss_pred EecCCCCceeEeCCCCCeEEeecccccccCCCCCcccccccccccccCcccccCC-----------CCCCcchHHHHHHH
Q 007892 332 IHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSG-----------KLTEKSDVFSFGVL 400 (586)
Q Consensus 332 vHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~ksDVwSlGvv 400 (586)
+||||||+||||+.++.+||+|||+++.... .....+| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999985322 2344568 999999999877 89999999999999
Q ss_pred HHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 007892 401 LLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIV 480 (586)
Q Consensus 401 L~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl 480 (586)
||||++|+.||........ .. .+.. .. ......+.+++.+||+.||.+||++.|++
T Consensus 303 l~elltg~~Pf~~~~~~~~---~~----------------~~~~-~~----~~~~~~~~~li~~~L~~dp~~Rpt~~e~l 358 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGG---SE----------------WIFR-SC----KNIPQPVRALLEGFLRYPKEDRLLPLQAM 358 (377)
T ss_dssp HHHHHHSSCCC------CC---SG----------------GGGS-SC----CCCCHHHHHHHHHHTCSSGGGCCCHHHHH
T ss_pred HHHHHHCCCCCcccccccc---hh----------------hhhh-hc----cCCCHHHHHHHHHHcCCCchhCCCHHHHh
Confidence 9999999999975443110 00 0000 00 11235688999999999999999999998
Q ss_pred H
Q 007892 481 R 481 (586)
Q Consensus 481 ~ 481 (586)
+
T Consensus 359 ~ 359 (377)
T 3byv_A 359 E 359 (377)
T ss_dssp T
T ss_pred h
Confidence 6
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=353.27 Aligned_cols=266 Identities=19% Similarity=0.291 Sum_probs=206.4
Q ss_pred hcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchh-----------------HHHHHHHHHHHHhcCCCCcceE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQG-----------------EREFQAEIEIISQVHHRHLVSL 270 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~-----------------~~~~~~Ei~il~~l~Hpniv~l 270 (586)
.++|.+.+.||+|+||.||+|.. +++.||||++....... ...+.+|+.++.+++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999999 89999999986432111 1789999999999999999999
Q ss_pred EEEEEeCCeeEEEEEecCCCcHHHH------hcCCCCCCCChHHHHHHHHHHHHHhHhhhh-cCCCcEEecCCCCceeEe
Q 007892 271 VGYCTFGSQRLLVYEFVPNKTLEFH------LHGKDRPVMNWPTRMKIALGSARGLAYLHE-DCQPKIIHRDIKSANILL 343 (586)
Q Consensus 271 ~g~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~~ivHrDIk~~NILl 343 (586)
++++.+.+..++||||+++++|.++ +.......+++..++.++.|++.||.|||+ . +|+||||||+||||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEE
Confidence 9999999999999999999999998 655445679999999999999999999998 7 99999999999999
Q ss_pred CCCCCeEEeecccccccCCCCCcccccccccccccCcccccCC-CCCC-cchHHHHHHHHHHHHhCCCCCCCCCcccchh
Q 007892 344 DDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSG-KLTE-KSDVFSFGVLLLELITGFRPFDKADTFADDS 421 (586)
Q Consensus 344 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~ 421 (586)
+.++.+||+|||++...... ......|+..|+|||.+.+. .++. ++|||||||++|||++|+.||...... ..
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~ 260 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--VE 260 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--HH
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--HH
Confidence 99999999999999865332 33456799999999999877 6666 999999999999999999999865431 11
Q ss_pred hhhhhhHHHhh-cccC-CChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 422 MVDWAKPFLAQ-GLAD-GNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 422 ~~~~~~~~~~~-~~~~-~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
+.......... .... .....+...............+.+++.+||+.||.+||++.|+++.
T Consensus 261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11111000000 0000 0000000000001113344678999999999999999999999873
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=351.01 Aligned_cols=264 Identities=18% Similarity=0.265 Sum_probs=193.3
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCch--hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ--GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~--~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
.++|++.+.||+|+||.||+|+.. +++.||||+++..... ....+.+|+.+|.+++||||+++++++..++..+|||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 468999999999999999999965 6899999999754332 2356789999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEe-----CCCCCeEEeecccccc
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL-----DDSFEAKVADFGLAKH 359 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl-----~~~~~~kl~DFGla~~ 359 (586)
||++ |+|.+++.... .+++..+..|+.|++.||+|||++ +|+||||||+|||| ++++.+||+|||+++.
T Consensus 113 e~~~-~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 113 EYAE-NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp ECCS-EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred ecCC-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 9997 59999886543 489999999999999999999998 99999999999999 4555699999999986
Q ss_pred cCCCCCcccccccccccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHh-------
Q 007892 360 SLDTDTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLA------- 431 (586)
Q Consensus 360 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~------- 431 (586)
..... .......||+.|+|||++.+. .++.++|||||||+||||++|+.||....... .+.........
T Consensus 187 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~ 263 (329)
T 3gbz_A 187 FGIPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID--QLFKIFEVLGLPDDTTWP 263 (329)
T ss_dssp HC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCTTTST
T ss_pred cCCcc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH--HHHHHHHHhCCCchhhhh
Confidence 53322 223445789999999999864 48999999999999999999999997654311 11111100000
Q ss_pred -----hcccCCChhhhhchhhh-ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 432 -----QGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 432 -----~~~~~~~~~~l~d~~l~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
..+. ..+.......+. .........+.+++.+||+.||.+||++.|+++
T Consensus 264 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 264 GVTALPDWK-QSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TGGGSTTCC-TTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhh-hhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000 000000000000 011112356789999999999999999999987
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=342.42 Aligned_cols=255 Identities=21% Similarity=0.309 Sum_probs=201.4
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC----chhHHHHHHHHHHHHhcCCCCcceEEEEEE--eCCee
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS----GQGEREFQAEIEIISQVHHRHLVSLVGYCT--FGSQR 280 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~--~~~~~ 280 (586)
.++|.+.+.||+|+||.||++... +++.||||+++... ......+.+|+.++.+++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 368999999999999999999964 68899999986532 234578999999999999999999999984 45578
Q ss_pred EEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccccc
Q 007892 281 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 360 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~ 360 (586)
++||||++++ |.+++.......+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999877 66666655556799999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCC-CcccccccccccccCcccccCCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCC
Q 007892 361 LDTD-THVSTRVMGTFGYLAPEYASSGK--LTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADG 437 (586)
Q Consensus 361 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (586)
.... ........|++.|+|||++.+.. ++.++|||||||+||||++|+.||...... ....... .+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~i~-----~~ 228 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY------KLFENIG-----KG 228 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHH-----HC
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH------HHHHHHh-----cC
Confidence 4322 22233456999999999997643 478999999999999999999999764321 1111100 01
Q ss_pred ChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHhcC
Q 007892 438 NFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR--ALEGN 486 (586)
Q Consensus 438 ~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~--~L~~~ 486 (586)
.+ ..+......+.+++.+||+.||.+||++.|+++ .++..
T Consensus 229 ~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 229 SY---------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp CC---------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred CC---------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 00 112233456889999999999999999999996 45544
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=357.03 Aligned_cols=200 Identities=25% Similarity=0.355 Sum_probs=175.6
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhc------CCCCcceEEEEEEeCCee
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQV------HHRHLVSLVGYCTFGSQR 280 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l------~Hpniv~l~g~~~~~~~~ 280 (586)
..+|++.+.||+|+||.||+|... +++.||||+++.. ......+.+|+.++..+ +|+||++++++|...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 357999999999999999999865 5899999999754 23346788899998887 577999999999999999
Q ss_pred EEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCC--eEEeeccccc
Q 007892 281 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE--AKVADFGLAK 358 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~--~kl~DFGla~ 358 (586)
+|||||+. ++|.+++.......+++..+..|+.|++.||+|||+. +|+||||||+||||+.++. +||+|||+++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999996 6888888776666799999999999999999999998 9999999999999999887 9999999997
Q ss_pred ccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 007892 359 HSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADT 416 (586)
Q Consensus 359 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~ 416 (586)
..... ....+||+.|+|||++.+..++.++|||||||+||||++|+.||...+.
T Consensus 251 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 251 YEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp ETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 64322 2345799999999999999999999999999999999999999986553
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=358.24 Aligned_cols=199 Identities=27% Similarity=0.345 Sum_probs=167.8
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeC-----Ce
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFG-----SQ 279 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~-----~~ 279 (586)
.++|.+.+.||+|+||.||+|+.. +++.||||+++... ......+.+|+.+|.+++|+||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 368999999999999999999975 58899999997542 23346789999999999999999999999776 57
Q ss_pred eEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccc
Q 007892 280 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 359 (586)
Q Consensus 280 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~ 359 (586)
.+|||||+. ++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++.
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 899999986 6999998654 4599999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCC---------------------cccccccccccccCcccc-cCCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 007892 360 SLDTDT---------------------HVSTRVMGTFGYLAPEYA-SSGKLTEKSDVFSFGVLLLELITGFRPFD 412 (586)
Q Consensus 360 ~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~s~ksDVwSlGvvL~elltG~~Pf~ 412 (586)
...... ...+..+||+.|+|||++ ....++.++|||||||+||||++|..||.
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 543221 123557899999999986 56679999999999999999998766654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=342.94 Aligned_cols=257 Identities=20% Similarity=0.291 Sum_probs=200.6
Q ss_pred cCccccceecccCcEEEEEEEE-eCCeEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCCcceEEEEEEe--CCeeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGYCTF--GSQRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~--~~~~~lV~ 284 (586)
++|++.+.||+|+||.||+|+. .+++.||||+++... ...+.+|+.+|.+++ ||||+++++++.. ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 6799999999999999999986 468999999997533 567899999999997 9999999999988 66789999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCC-CeEEeecccccccCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF-EAKVADFGLAKHSLDT 363 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~-~~kl~DFGla~~~~~~ 363 (586)
||+++++|.+++.. +++..+..++.|++.||+|||++ +|+||||||+||||+.++ .+||+|||+++.....
T Consensus 113 e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 113 EHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp ECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred eccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 99999999998843 88999999999999999999998 999999999999999776 8999999999865433
Q ss_pred CCcccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHH--------Hhhc-
Q 007892 364 DTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPF--------LAQG- 433 (586)
Q Consensus 364 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~--------~~~~- 433 (586)
.. .....|+..|+|||++.+ ..++.++|||||||+||||++|+.||...... ...+....... +...
T Consensus 185 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~-~~~l~~~~~~~~~~~~~~~~~~~~ 261 (330)
T 3nsz_A 185 QE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVRIAKVLGTEDLYDYIDKYN 261 (330)
T ss_dssp CC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH-HHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred Cc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch-HHHHHHHHHhcCCchhhhHHHHhc
Confidence 22 234578999999999876 67999999999999999999999999654321 11111111000 0000
Q ss_pred -------------ccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 434 -------------LADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 434 -------------~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.....+...... .........+.+++.+||+.||.+||++.|+++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 262 IELDPRFNDILGRHSRKRWERFVHS---ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp CCCCTHHHHHHCCCCCCCGGGGCCT---TTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccccchhhhhhhccccchhhhccc---cccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000001111110 0111134678999999999999999999999973
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=341.43 Aligned_cols=251 Identities=26% Similarity=0.397 Sum_probs=200.3
Q ss_pred HhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEE
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
..++|+..+.||+|+||.||+|... +|+.||||.+.... ....+.+|+.++.+++||||+++++++...+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4578999999999999999999976 48999999997643 34678999999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 365 (586)
|+++++|.+++... ...+++..++.++.+++.||.|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 105 ~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 105 YCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp CCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred cCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 99999999998632 24589999999999999999999998 999999999999999999999999999976543322
Q ss_pred cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhch
Q 007892 366 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQ 445 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 445 (586)
......|++.|+|||.+.+..++.++|||||||+||||++|+.||....... .. + . +.... ...+
T Consensus 181 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~-~--~-~~~~~-~~~~------ 245 (314)
T 3com_A 181 -KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR---AI-F--M-IPTNP-PPTF------ 245 (314)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH---HH-H--H-HHHSC-CCCC------
T ss_pred -ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH---HH-H--H-HhcCC-Cccc------
Confidence 2234579999999999999999999999999999999999999997544211 00 0 0 00000 0000
Q ss_pred hhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 446 KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 446 ~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
.........+.+++.+||+.||.+||++.||++
T Consensus 246 ---~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 246 ---RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ---SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ---CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 011122356889999999999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=382.25 Aligned_cols=250 Identities=24% Similarity=0.358 Sum_probs=205.9
Q ss_pred HHhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccC---CchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCee
Q 007892 206 IATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG---SGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQR 280 (586)
Q Consensus 206 ~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~~~ 280 (586)
...++|++.+.||+|+||.||+|+.. +++.||||+++.. .......+..|..+|..+ +|+||+++++++.+.+..
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 44578999999999999999999975 5789999999753 122345678899999987 699999999999999999
Q ss_pred EEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccccc
Q 007892 281 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 360 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~ 360 (586)
+|||||+++|+|.++|.... .+++..+..++.||+.||+|||++ +||||||||+||||+.++.+||+|||+++..
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 99999999999999997543 489999999999999999999998 9999999999999999999999999999864
Q ss_pred CCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChh
Q 007892 361 LDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 440 (586)
Q Consensus 361 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (586)
.... ......+||+.|+|||++.+..++.++|||||||+||||++|+.||...+.. +.....
T Consensus 493 ~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~------~~~~~i----------- 554 (674)
T 3pfq_A 493 IWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQSI----------- 554 (674)
T ss_dssp CCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHH-----------
T ss_pred ccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH------HHHHHH-----------
Confidence 3322 2345578999999999999999999999999999999999999999765421 111111
Q ss_pred hhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHH
Q 007892 441 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRM-----SQIVR 481 (586)
Q Consensus 441 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm-----~evl~ 481 (586)
+...+ .++......+.+++..||+.||.+||++ .||++
T Consensus 555 --~~~~~-~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 555 --MEHNV-AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp --HSSCC-CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred --HhCCC-CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 11111 2333445678999999999999999997 66664
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=356.69 Aligned_cols=252 Identities=12% Similarity=0.104 Sum_probs=183.7
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHHHHHhc--CCCCcceEE-------EEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQV--HHRHLVSLV-------GYCT 275 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l--~Hpniv~l~-------g~~~ 275 (586)
.+|...+.||+|+||.||+|++. +|+.||||+++.... .....+++|+.++..| +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45888999999999999999975 789999999987543 2345678886555555 699988855 4444
Q ss_pred eC-----------------CeeEEEEEecCCCcHHHHhcCCCCCCCChHHH------HHHHHHHHHHhHhhhhcCCCcEE
Q 007892 276 FG-----------------SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR------MKIALGSARGLAYLHEDCQPKII 332 (586)
Q Consensus 276 ~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~------~~ia~~ia~gL~yLH~~~~~~iv 332 (586)
.. ...+|||||++ |+|.+++..... .+.+..+ +.|+.|++.||+|||++ +|+
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~iv 216 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQSK---GLV 216 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCc
Confidence 33 33799999998 899999975432 3566677 78889999999999998 999
Q ss_pred ecCCCCceeEeCCCCCeEEeecccccccCCCCCcccccccccccccCcccccC--CCCCCcchHHHHHHHHHHHHhCCCC
Q 007892 333 HRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVLLLELITGFRP 410 (586)
Q Consensus 333 HrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvvL~elltG~~P 410 (586)
||||||+||||+.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||+||||++|+.|
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999865321 124557799999999987 6799999999999999999999999
Q ss_pred CCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhh-ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 411 FDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 411 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
|......... .|... .........+. .........+.+++.+||+.||.+||++.|+++
T Consensus 293 f~~~~~~~~~---~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 293 FGLVTPGIKG---SWKRP---------SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TTBCCTTCTT---CCCBC---------CTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCcCccccc---chhhh---------hhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9876432111 11100 00000000000 111133457889999999999999999999975
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=345.50 Aligned_cols=252 Identities=23% Similarity=0.373 Sum_probs=198.8
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
.++|++.+.||+|+||.||+|... +++.||+|++..........+.+|+.++.+++||||+++++++...+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 478999999999999999999986 4889999999876666678899999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 366 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 366 (586)
+++++|.+++.... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...... ..
T Consensus 98 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~ 172 (302)
T 2j7t_A 98 CPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-LQ 172 (302)
T ss_dssp CTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-HH
T ss_pred CCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc-cc
Confidence 99999998886432 3489999999999999999999998 9999999999999999999999999997532111 01
Q ss_pred ccccccccccccCcccc-----cCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhh
Q 007892 367 VSTRVMGTFGYLAPEYA-----SSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 441 (586)
Q Consensus 367 ~~~~~~gt~~y~aPE~~-----~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (586)
......|++.|+|||++ ....++.++|||||||++|||++|+.||....... ..... .. +....
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~----~~-----~~~~~ 241 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--VLLKI----AK-----SDPPT 241 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHH----HH-----SCCCC
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH--HHHHH----hc-----cCCcc
Confidence 12335689999999998 46778999999999999999999999997654211 11111 00 00000
Q ss_pred hhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 442 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 442 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
+ ..+......+.+++.+||+.||.+||++.||++
T Consensus 242 ~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 242 L------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp C------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred c------CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0 011122356889999999999999999999886
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=341.52 Aligned_cols=265 Identities=20% Similarity=0.311 Sum_probs=205.9
Q ss_pred hcCccccceecccCcEEEEEEEE--eCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCC------CcceEEEEEEeCCe
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVL--TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHR------HLVSLVGYCTFGSQ 279 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~--~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hp------niv~l~g~~~~~~~ 279 (586)
.++|++.+.||+|+||.||+|.. .+++.||||+++... .....+.+|+.++.+++|+ +|+++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 36899999999999999999986 368999999997542 3356788999999998765 49999999999999
Q ss_pred eEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCC--------------
Q 007892 280 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD-------------- 345 (586)
Q Consensus 280 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~-------------- 345 (586)
.++||||+ +++|.+++.......+++..+..++.|++.||+|||++ +|+||||||+||||+.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999 88999999776656789999999999999999999998 9999999999999987
Q ss_pred -----CCCeEEeecccccccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccch
Q 007892 346 -----SFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADD 420 (586)
Q Consensus 346 -----~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~ 420 (586)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||+||||++|+.||...+.....
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 243 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred cccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 678999999999864322 23457999999999999999999999999999999999999999865432111
Q ss_pred hhhhhh-----hHHHhhcccCCC------------------hhhhhchhh--hccCHHHHHHHHHHHHHhhccCCCCCCC
Q 007892 421 SMVDWA-----KPFLAQGLADGN------------------FDALVDQKL--EEYDSAEMTRMAACAAACIRHSARRRPR 475 (586)
Q Consensus 421 ~~~~~~-----~~~~~~~~~~~~------------------~~~l~d~~l--~~~~~~~~~~l~~l~~~cl~~dp~~RPt 475 (586)
...... ...+.. ..... ......+.. ..........+.+++.+||+.||.+||+
T Consensus 244 ~~~~~~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 322 (339)
T 1z57_A 244 AMMERILGPLPKHMIQK-TRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT 322 (339)
T ss_dssp HHHHHHHCSCCHHHHHH-CSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHhCCCCHHHHhh-ccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence 110000 000000 00000 000000000 0123455678999999999999999999
Q ss_pred HHHHHHH
Q 007892 476 MSQIVRA 482 (586)
Q Consensus 476 m~evl~~ 482 (586)
+.||++.
T Consensus 323 ~~ell~h 329 (339)
T 1z57_A 323 LREALKH 329 (339)
T ss_dssp HHHHTTS
T ss_pred HHHHhcC
Confidence 9999853
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=348.64 Aligned_cols=265 Identities=20% Similarity=0.265 Sum_probs=199.1
Q ss_pred cCccccceecccCcEEEEEEEE-eCCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEe--------C
Q 007892 209 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTF--------G 277 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~--------~ 277 (586)
++|++.+.||+|+||.||+|+. .+|+.||||++..... .....+.+|+.++.+++||||++++++|.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 6799999999999999999997 4689999999865432 224578899999999999999999999987 4
Q ss_pred CeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccc
Q 007892 278 SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 357 (586)
Q Consensus 278 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla 357 (586)
+..+|||||+++ +|...+.... ..+++.++..|+.|++.||+|||+. +|+||||||+||||+.++.+||+|||++
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccCC-CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 468999999975 6666665433 3489999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCC---CcccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhc
Q 007892 358 KHSLDTD---THVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQG 433 (586)
Q Consensus 358 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 433 (586)
+...... ........||+.|+|||++.+ ..++.++|||||||+||||++|+.||....... ......... ..
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~-~~ 247 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH---QLALISQLC-GS 247 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHH-CC
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHh-CC
Confidence 8654222 122344678999999999876 458999999999999999999999998654321 111110000 00
Q ss_pred ccCCChhhhhchhh---------hccC-H------HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 434 LADGNFDALVDQKL---------EEYD-S------AEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 434 ~~~~~~~~l~d~~l---------~~~~-~------~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.....+.......+ .... . .....+.+++.+||+.||.+||++.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 00000000000000 0000 0 012458899999999999999999999974
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=349.96 Aligned_cols=268 Identities=25% Similarity=0.335 Sum_probs=198.8
Q ss_pred HHhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchh-----HHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 007892 206 IATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQG-----EREFQAEIEIISQVHHRHLVSLVGYCTFGSQ 279 (586)
Q Consensus 206 ~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~-----~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~ 279 (586)
...++|...+.||+|+||.||+|+.. +|+.||||+++...... .+.+.+|+.++.+++||||++++++|...+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999975 58999999987532211 2467899999999999999999999999999
Q ss_pred eEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccc
Q 007892 280 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 359 (586)
Q Consensus 280 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~ 359 (586)
.++||||+++ +|..++.... ..+++..+..++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++.
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred eEEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 9999999986 8888876533 4588999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCCcccccccccccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCC
Q 007892 360 SLDTDTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGN 438 (586)
Q Consensus 360 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (586)
..... .......||+.|+|||++.+. .++.++|||||||+||||++|..||...... ..+........ . .....
T Consensus 162 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~--~~~~~i~~~~~-~-~~~~~ 236 (346)
T 1ua2_A 162 FGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL--DQLTRIFETLG-T-PTEEQ 236 (346)
T ss_dssp TTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHC-C-CCTTT
T ss_pred ccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHcC-C-CChhh
Confidence 54332 223446799999999999754 5899999999999999999999999765431 11111110000 0 00000
Q ss_pred hh---hhhc---------hhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007892 439 FD---ALVD---------QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRAL 483 (586)
Q Consensus 439 ~~---~l~d---------~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L 483 (586)
+. .+.+ ..+..........+.+++.+||+.||.+||++.|+++.-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 00 0000 000011122346789999999999999999999999753
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=349.40 Aligned_cols=265 Identities=21% Similarity=0.289 Sum_probs=194.5
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC------
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS------ 278 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~------ 278 (586)
.++|...+.||+|+||.||+|... +++.||||++.... ......+.+|+.++++++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 368999999999999999999965 68999999997542 233467889999999999999999999997654
Q ss_pred eeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccc
Q 007892 279 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 358 (586)
Q Consensus 279 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~ 358 (586)
..++||||+++ +|.+++.. .+++..+..++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred ceEEEEEcCCC-CHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 78999999975 77777753 388999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchh-hhh-------------
Q 007892 359 HSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDS-MVD------------- 424 (586)
Q Consensus 359 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~-~~~------------- 424 (586)
..... .......||+.|+|||++.+..++.++|||||||+||||++|+.||...+...... +..
T Consensus 176 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 176 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred ccccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 65322 12344679999999999999999999999999999999999999998654311000 000
Q ss_pred --hhhHHHhh--cccCCChhhhhchhhh----ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 425 --WAKPFLAQ--GLADGNFDALVDQKLE----EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 425 --~~~~~~~~--~~~~~~~~~l~d~~l~----~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
....++.. ......+..+....+. .........+.+++.+||+.||.+||++.|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00000000 0000111111111110 1112345679999999999999999999999973
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=367.28 Aligned_cols=250 Identities=23% Similarity=0.367 Sum_probs=204.6
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV 283 (586)
.++|+..+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+.+|.+++||||++++++|...+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 367999999999999999999976 68999999986542 33467899999999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEe---CCCCCeEEeeccccccc
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL---DDSFEAKVADFGLAKHS 360 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl---~~~~~~kl~DFGla~~~ 360 (586)
|||+.+|+|.+++.... .+++..+..|+.|++.||.|||++ +|+||||||+|||| +.++.+||+|||+++..
T Consensus 105 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp ECCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 99999999999886543 489999999999999999999998 99999999999999 56789999999999875
Q ss_pred CCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChh
Q 007892 361 LDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 440 (586)
Q Consensus 361 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (586)
.... ......||+.|+|||++.+ .++.++|||||||+||+|++|+.||...... .+.... ..+.+.
T Consensus 180 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i--------~~~~~~ 245 (484)
T 3nyv_A 180 EASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY---DILKKV--------EKGKYT 245 (484)
T ss_dssp CCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH--------HHCCCC
T ss_pred cccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH---HHHHHH--------HcCCCC
Confidence 4332 2344679999999999875 7999999999999999999999999765431 111110 011110
Q ss_pred hhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 441 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 441 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
. ..+.. ......+.+++.+||+.+|.+||++.|+++
T Consensus 246 ~-~~~~~----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 246 F-ELPQW----KKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp C-CSGGG----GGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C-CCccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 0 00011 123456889999999999999999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=366.14 Aligned_cols=250 Identities=23% Similarity=0.351 Sum_probs=198.0
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
.+.|+..+.||+|+||.||+|+.. ++..||||++.... ......+.+|+.+|++++|||||+++++|......+|||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 356999999999999999999975 68899999987543 233567899999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCC---CCCeEEeecccccccC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD---SFEAKVADFGLAKHSL 361 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~---~~~~kl~DFGla~~~~ 361 (586)
||+++|+|.+++... ..+++..+..|+.|++.||.|||+. +|+||||||+||||+. ++.+||+|||+++...
T Consensus 116 e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 116 ECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 999999999888654 3489999999999999999999998 9999999999999976 4559999999998754
Q ss_pred CCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhh
Q 007892 362 DTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 441 (586)
Q Consensus 362 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (586)
... .....+||+.|+|||++. +.++.++|||||||+||+|++|+.||...... .+ ..... .+.+.
T Consensus 191 ~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~---~~~i~-----~~~~~- 255 (494)
T 3lij_A 191 NQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ---EI---LRKVE-----KGKYT- 255 (494)
T ss_dssp TTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH---HHHHH-----HTCCC-
T ss_pred CCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HH---HHHHH-----hCCCC-
Confidence 332 234467999999999987 57999999999999999999999999765421 11 11111 11100
Q ss_pred hhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 442 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 442 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
...+.. ......+.+++.+||+.||.+||++.|+++
T Consensus 256 ~~~~~~----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 256 FDSPEW----KNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp CCSGGG----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCchhc----ccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 000111 122356889999999999999999999985
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=346.52 Aligned_cols=265 Identities=25% Similarity=0.380 Sum_probs=187.3
Q ss_pred HHHhcCccccceecccCcEEEEEEEE-eCCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEE
Q 007892 205 KIATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 282 (586)
Q Consensus 205 ~~~~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~l 282 (586)
.+..++|.+.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.++.+++||||+++++++...+..++
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 34568899999999999999999985 468899999986543 2334678899999999999999999999999999999
Q ss_pred EEEecCCCcHHHHhcC------CCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccc
Q 007892 283 VYEFVPNKTLEFHLHG------KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGL 356 (586)
Q Consensus 283 V~E~~~~gsL~~~l~~------~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGl 356 (586)
||||+++++|.+++.. .....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 9999999999998863 1234589999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCC----cccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHh
Q 007892 357 AKHSLDTDT----HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLA 431 (586)
Q Consensus 357 a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 431 (586)
+........ .......||+.|+|||++.+ ..++.++|||||||+||||++|+.||........ .. ..+.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~----~~~~ 241 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV--LM----LTLQ 241 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--HH----HHHT
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH--HH----HHhc
Confidence 876543211 12234579999999999875 5689999999999999999999999986543211 00 0000
Q ss_pred hcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 432 QGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 432 ~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.. .........+. .........+.+++.+||+.||.+||++.||++.
T Consensus 242 ~~-~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 242 ND-PPSLETGVQDK---EMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp SS-CCCTTC--------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cC-CCccccccccc---hhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00 00000000011 1111223568899999999999999999999863
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=344.16 Aligned_cols=266 Identities=23% Similarity=0.349 Sum_probs=203.7
Q ss_pred HhcCccccceecccCcEEEEEEEE--eCCeEEEEEEeccCCc--hhHHHHHHHHHHHHhc---CCCCcceEEEEEE----
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVL--TNGKVVAIKQLKAGSG--QGEREFQAEIEIISQV---HHRHLVSLVGYCT---- 275 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~--~~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l---~Hpniv~l~g~~~---- 275 (586)
..++|++.+.||+|+||.||+|.. .+|+.||||+++.... .....+.+|+.++.++ +||||++++++|.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999997 4688999999864322 1123566788877766 8999999999997
Q ss_pred -eCCeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeec
Q 007892 276 -FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADF 354 (586)
Q Consensus 276 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DF 354 (586)
.....++||||++ |+|.+++.......+++..++.++.|++.||.|||+. +|+||||||+||||+.++.+||+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecC
Confidence 4567889999997 6999999776666699999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHh---
Q 007892 355 GLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLA--- 431 (586)
Q Consensus 355 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--- 431 (586)
|+++..... .......|+..|+|||++.+..++.++|||||||+||||++|+.||....... .+.... ..+.
T Consensus 165 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~i~-~~~~~~~ 239 (326)
T 1blx_A 165 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QLGKIL-DVIGLPG 239 (326)
T ss_dssp CSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHH-HHHCCCC
T ss_pred cccccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHH-HHcCCCC
Confidence 999765322 22344678999999999999999999999999999999999999998654311 111100 0000
Q ss_pred -hcccC------CChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 432 -QGLAD------GNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 432 -~~~~~------~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
..+.. ..+.......+..+.......+.+++.+||+.||.+||++.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000 000000001111222334567889999999999999999999985
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=365.04 Aligned_cols=251 Identities=24% Similarity=0.324 Sum_probs=200.6
Q ss_pred HhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc-------------hhHHHHHHHHHHHHhcCCCCcceEEE
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-------------QGEREFQAEIEIISQVHHRHLVSLVG 272 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~-------------~~~~~~~~Ei~il~~l~Hpniv~l~g 272 (586)
..++|.+.+.||+|+||.||+|+.. +++.||||+++.... ...+.+.+|+.+|.+++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3478999999999999999999975 578999999875431 23467899999999999999999999
Q ss_pred EEEeCCeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCC---Ce
Q 007892 273 YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF---EA 349 (586)
Q Consensus 273 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~---~~ 349 (586)
+|......+|||||+++|+|.+++... ..+++..++.|+.|++.||+|||+. +|+||||||+||||+.++ .+
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccE
Confidence 999999999999999999999888654 3489999999999999999999998 999999999999998775 69
Q ss_pred EEeecccccccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHH
Q 007892 350 KVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPF 429 (586)
Q Consensus 350 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~ 429 (586)
||+|||+++...... ......||+.|+|||++. +.++.++|||||||+||+|++|+.||...... .+.. ..
T Consensus 189 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~---~i 259 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ---DIIK---KV 259 (504)
T ss_dssp EECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HH
T ss_pred EEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHH---HH
Confidence 999999998754332 234467999999999987 56999999999999999999999999765431 1111 10
Q ss_pred HhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 430 LAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 430 ~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
..+.+.. ..+.. ......+.+++.+||+.||.+||++.|+++
T Consensus 260 -----~~~~~~~-~~~~~----~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 260 -----EKGKYYF-DFNDW----KNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp -----HHCCCCC-CHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -----HcCCCCC-Ccccc----CCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0111000 00000 112356889999999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=364.99 Aligned_cols=250 Identities=23% Similarity=0.346 Sum_probs=201.2
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
++|++.+.||+|+||.||+|+.. +++.||||++... .......+.+|+++|.+++||||+++++++......++|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 67999999999999999999975 6899999998542 22345788999999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeC---CCCCeEEeecccccccCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD---DSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~---~~~~~kl~DFGla~~~~~ 362 (586)
|+.+|+|.+++... ..+++..+..|+.|++.||.|||++ +|+||||||+||||+ .++.+||+|||+++....
T Consensus 102 ~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 102 LYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp CCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred cCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 99999999888654 3489999999999999999999998 999999999999995 556899999999986543
Q ss_pred CCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhh
Q 007892 363 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 442 (586)
Q Consensus 363 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 442 (586)
.. .....+||+.|+|||++.+ .++.++|||||||+||+|++|+.||...... .+. .... .+.+..
T Consensus 177 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~---~~i~-----~~~~~~- 241 (486)
T 3mwu_A 177 NT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DIL---KRVE-----TGKYAF- 241 (486)
T ss_dssp C------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HHHH-----HTCCCS-
T ss_pred CC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH---HHHH-----hCCCCC-
Confidence 22 2344679999999999875 6999999999999999999999999765421 111 1111 111100
Q ss_pred hchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 443 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 443 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
..+.. ......+.+++.+||+.||.+||++.|+++.
T Consensus 242 ~~~~~----~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 242 DLPQW----RTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp CSGGG----GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCccc----CCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00011 1223568899999999999999999999974
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=337.95 Aligned_cols=251 Identities=23% Similarity=0.342 Sum_probs=203.0
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc---------hhHHHHHHHHHHHHhcC-CCCcceEEEEEEe
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---------QGEREFQAEIEIISQVH-HRHLVSLVGYCTF 276 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~---------~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~ 276 (586)
.++|...+.||+|+||.||+|... +|+.||||+++.... ...+.+.+|++++.++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 368999999999999999999975 689999999965431 12356789999999996 9999999999999
Q ss_pred CCeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccc
Q 007892 277 GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGL 356 (586)
Q Consensus 277 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGl 356 (586)
.+..++||||+++++|.+++... ..+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~ 170 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGF 170 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccc
Confidence 99999999999999999999653 3589999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCccccc------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHH
Q 007892 357 AKHSLDTDTHVSTRVMGTFGYLAPEYAS------SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFL 430 (586)
Q Consensus 357 a~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 430 (586)
+....... ......|++.|+|||++. ...++.++||||||++||||++|+.||...... . ......
T Consensus 171 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~---~~~~~~ 242 (298)
T 1phk_A 171 SCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM---L---MLRMIM 242 (298)
T ss_dssp CEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---H---HHHHHH
T ss_pred hhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH---H---HHHHHh
Confidence 98654322 223457999999999885 456899999999999999999999999754321 1 111111
Q ss_pred hhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 431 AQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 431 ~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
. +.+. ...+.. ......+.+++.+||+.||.+||++.|+++
T Consensus 243 ~-----~~~~-~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 243 S-----GNYQ-FGSPEW----DDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp H-----TCCC-CCTTTG----GGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred c-----CCcc-cCcccc----cccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1 1100 000111 123456889999999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=351.86 Aligned_cols=262 Identities=22% Similarity=0.314 Sum_probs=197.0
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC------
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS------ 278 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~------ 278 (586)
.++|...+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+.+|.+++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 367999999999999999999974 68999999986532 233467889999999999999999999997653
Q ss_pred eeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccc
Q 007892 279 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 358 (586)
Q Consensus 279 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~ 358 (586)
..++||||+ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 459999999 8899999865 3489999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhh------HHHh
Q 007892 359 HSLDTDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAK------PFLA 431 (586)
Q Consensus 359 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~------~~~~ 431 (586)
..... ....+||+.|+|||++.+ ..++.++|||||||+||||++|+.||...+... .+..... ..+.
T Consensus 177 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 177 QADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD--QLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp ECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHHHH
T ss_pred ccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCHHHH
Confidence 65322 244678999999999876 679999999999999999999999998654321 1100000 0000
Q ss_pred hcccCCChhhhh-------chhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 432 QGLADGNFDALV-------DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 432 ~~~~~~~~~~l~-------d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
+.+........+ ...+..........+.+++.+||+.||.+||++.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 000000000000 001111222335678999999999999999999999984
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=341.26 Aligned_cols=253 Identities=21% Similarity=0.326 Sum_probs=186.6
Q ss_pred HhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchh--HHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEE
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQG--EREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~--~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV 283 (586)
..++|+..+.||+|+||.||+|... +|+.||||+++...... .+.+.++..+++.++||||+++++++..++..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 4578999999999999999999974 78999999997653222 23445555667888999999999999999999999
Q ss_pred EEecCCCcHHHHhcC--CCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccC
Q 007892 284 YEFVPNKTLEFHLHG--KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 361 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~--~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~ 361 (586)
|||++ |+|.+++.. .....+++..++.|+.|++.||+|||+++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99997 577766643 23356999999999999999999999863 79999999999999999999999999998654
Q ss_pred CCCCcccccccccccccCcccc----cCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCC
Q 007892 362 DTDTHVSTRVMGTFGYLAPEYA----SSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADG 437 (586)
Q Consensus 362 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (586)
... ......||+.|+|||++ ....++.++|||||||++|||++|+.||....... ..+... +. ..
T Consensus 162 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~----~~----~~ 230 (290)
T 3fme_A 162 DDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF-QQLKQV----VE----EP 230 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH-HHHHHH----HH----SC
T ss_pred ccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH-HHHHHH----hc----cC
Confidence 322 22334699999999996 55678999999999999999999999997533210 111110 10 00
Q ss_pred ChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 438 NFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 438 ~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
. ...........+.+++.+||+.||.+||++.||++
T Consensus 231 ~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 231 S--------PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp C--------CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C--------CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 0 00111123456889999999999999999999987
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=351.91 Aligned_cols=266 Identities=23% Similarity=0.312 Sum_probs=196.6
Q ss_pred HHHHhcCccccceecccCcEEEEEEEE-eCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC-----
Q 007892 204 LKIATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG----- 277 (586)
Q Consensus 204 l~~~~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~----- 277 (586)
++...++|...+.||+|+||.||+|+. .+|+.||||++..... ...+|+++|++++|||||+++++|...
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 345568899999999999999999996 4689999999865432 234799999999999999999998543
Q ss_pred ---------------------------------CeeEEEEEecCCCcHHHHhcC--CCCCCCChHHHHHHHHHHHHHhHh
Q 007892 278 ---------------------------------SQRLLVYEFVPNKTLEFHLHG--KDRPVMNWPTRMKIALGSARGLAY 322 (586)
Q Consensus 278 ---------------------------------~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~ia~~ia~gL~y 322 (586)
...++||||++ ++|.+.+.. .....+++..+..++.|++.||+|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 34789999998 577666643 233469999999999999999999
Q ss_pred hhhcCCCcEEecCCCCceeEeC-CCCCeEEeecccccccCCCCCcccccccccccccCcccccCC-CCCCcchHHHHHHH
Q 007892 323 LHEDCQPKIIHRDIKSANILLD-DSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVL 400 (586)
Q Consensus 323 LH~~~~~~ivHrDIk~~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvv 400 (586)
||+. +|+||||||+||||+ +++.+||+|||+++....... .....||..|+|||.+.+. .++.++|||||||+
T Consensus 157 LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 157 IHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 9998 999999999999997 688999999999986543322 2345789999999998764 48999999999999
Q ss_pred HHHHHhCCCCCCCCCcccchhhhhhhhHH-------Hh---hcccCCChhhhhchhhh-ccCHHHHHHHHHHHHHhhccC
Q 007892 401 LLELITGFRPFDKADTFADDSMVDWAKPF-------LA---QGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHS 469 (586)
Q Consensus 401 L~elltG~~Pf~~~~~~~~~~~~~~~~~~-------~~---~~~~~~~~~~l~d~~l~-~~~~~~~~~l~~l~~~cl~~d 469 (586)
||||++|+.||...... +.+....... +. .......+..+...... .++......+.+++.+||+.|
T Consensus 232 l~ell~g~~pf~~~~~~--~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 309 (383)
T 3eb0_A 232 FGELILGKPLFSGETSI--DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE 309 (383)
T ss_dssp HHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred HHHHHhCCCCCCCCChH--HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence 99999999999865431 1111111100 00 00000000000001111 122334566899999999999
Q ss_pred CCCCCCHHHHHH
Q 007892 470 ARRRPRMSQIVR 481 (586)
Q Consensus 470 p~~RPtm~evl~ 481 (586)
|.+||++.|+++
T Consensus 310 P~~R~t~~e~l~ 321 (383)
T 3eb0_A 310 PDLRINPYEAMA 321 (383)
T ss_dssp GGGSCCHHHHHT
T ss_pred hhhCCCHHHHhc
Confidence 999999999985
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=377.48 Aligned_cols=259 Identities=24% Similarity=0.403 Sum_probs=207.0
Q ss_pred HHHHhcCccccceecccCcEEEEEEEEeC----CeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 007892 204 LKIATDNFSEANLLGQGGFGYVHKGVLTN----GKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGS 278 (586)
Q Consensus 204 l~~~~~~f~~~~~LG~G~fG~Vyk~~~~~----g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~ 278 (586)
+.+..++|.+.+.||+|+||.||+|.+.. +..||||.++.... ...+.|.+|+.+|.+++||||++++++|. ++
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 463 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 463 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence 34456789999999999999999999742 56899999876433 33467999999999999999999999985 46
Q ss_pred eeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccc
Q 007892 279 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 358 (586)
Q Consensus 279 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~ 358 (586)
..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred ceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCe
Confidence 6899999999999999997543 3589999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCC
Q 007892 359 HSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADG 437 (586)
Q Consensus 359 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (586)
..............+++.|+|||++.+..++.++|||||||+||||++ |..||...... .+..... .+
T Consensus 540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---~~~~~i~--------~~ 608 (656)
T 2j0j_A 540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRIE--------NG 608 (656)
T ss_dssp SCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHH--------HT
T ss_pred ecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHH--------cC
Confidence 765444333344567889999999998899999999999999999997 99999765421 1111110 00
Q ss_pred ChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 438 NFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 438 ~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
.....+......+.+++.+||+.||.+||++.||++.|+..
T Consensus 609 --------~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 609 --------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp --------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 00012233456788999999999999999999999999864
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=356.57 Aligned_cols=260 Identities=24% Similarity=0.336 Sum_probs=194.4
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC----C--eeE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG----S--QRL 281 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~----~--~~~ 281 (586)
.+|...+.||+|+||.||+|++. +|+.||||++.... +.+.+|+++|++++|||||+++++|... + ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46889999999999999999985 58999999986543 2345799999999999999999998542 2 356
Q ss_pred EEEEecCCCcHHHHhcC--CCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCC-CCeEEeeccccc
Q 007892 282 LVYEFVPNKTLEFHLHG--KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS-FEAKVADFGLAK 358 (586)
Q Consensus 282 lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~-~~~kl~DFGla~ 358 (586)
|||||+++ +|...+.. .....+++..+..++.||++||+|||++ +|+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 89999986 55444432 2335699999999999999999999998 99999999999999955 568999999998
Q ss_pred ccCCCCCcccccccccccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHH-------H
Q 007892 359 HSLDTDTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPF-------L 430 (586)
Q Consensus 359 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~-------~ 430 (586)
....... .....||+.|+|||++.+. .++.++|||||||+||||++|+.||...... +.+....... +
T Consensus 206 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~--~~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 206 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV--DQLVEIIKVLGTPTREQI 281 (420)
T ss_dssp ECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCSCCHHHH
T ss_pred hcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHH
Confidence 7543322 2346789999999998764 7999999999999999999999999865431 2222221110 0
Q ss_pred hhcccCCChhhhhchhh-----h-ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 431 AQGLADGNFDALVDQKL-----E-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 431 ~~~~~~~~~~~l~d~~l-----~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
... ...+.....+.+ . .+.......+.+|+.+||+.||.+||++.|++++
T Consensus 282 ~~~--~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 282 REM--NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHH--CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred Hhh--ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 000 000000000000 0 1222334678999999999999999999999863
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=352.98 Aligned_cols=263 Identities=24% Similarity=0.329 Sum_probs=197.0
Q ss_pred cCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe------eEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ------RLL 282 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~------~~l 282 (586)
.+|...+.||+|+||.||+|+...+..||+|++..... ...+|+++|++++||||++++++|...+. .+|
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 56999999999999999999988777799998865432 23469999999999999999999965433 789
Q ss_pred EEEecCCCcHHHHhc-CCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeC-CCCCeEEeeccccccc
Q 007892 283 VYEFVPNKTLEFHLH-GKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD-DSFEAKVADFGLAKHS 360 (586)
Q Consensus 283 V~E~~~~gsL~~~l~-~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~-~~~~~kl~DFGla~~~ 360 (586)
||||++++.+....+ ......+++..+..++.|++.||+|||+. +|+||||||+||||+ .++.+||+|||+++..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 999998765544332 12234689999999999999999999998 999999999999999 7999999999999875
Q ss_pred CCCCCcccccccccccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHH----------
Q 007892 361 LDTDTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPF---------- 429 (586)
Q Consensus 361 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~---------- 429 (586)
..... .....||+.|+|||++.+. .++.++|||||||+||||++|+.||...... +.+.......
T Consensus 193 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 193 IAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI--DQLVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp CTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCHHHHHH
T ss_pred cCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHHHh
Confidence 43322 2345789999999998764 5899999999999999999999999865431 1222111100
Q ss_pred HhhcccCCChhhhhchhhh-ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 430 LAQGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 430 ~~~~~~~~~~~~l~d~~l~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.........+..+....+. .+.......+.+++.+||+.||.+||++.|++++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0000000011111000111 1222344678999999999999999999999874
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=345.93 Aligned_cols=259 Identities=22% Similarity=0.365 Sum_probs=200.7
Q ss_pred cCHHHHHHHhcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCC--chhHHHHHHHHHHHHhcC--CCCcceEEEEE
Q 007892 199 FTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGS--GQGEREFQAEIEIISQVH--HRHLVSLVGYC 274 (586)
Q Consensus 199 ~~~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~--Hpniv~l~g~~ 274 (586)
+.+..+....++|++.+.||+|+||.||++...+++.||||++.... ......+.+|+.++.+++ |+||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 33344556678899999999999999999998889999999986543 334568899999999997 59999999999
Q ss_pred EeCCeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeec
Q 007892 275 TFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADF 354 (586)
Q Consensus 275 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DF 354 (586)
...+..++||| +.+++|.+++... ..+++..++.++.|++.||.|||+. +|+||||||+||||++ +.+||+||
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Df 170 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDF 170 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCC
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeec
Confidence 99999999999 5689999999754 3589999999999999999999998 9999999999999965 79999999
Q ss_pred ccccccCCCCCc-ccccccccccccCcccccC-----------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhh
Q 007892 355 GLAKHSLDTDTH-VSTRVMGTFGYLAPEYASS-----------GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSM 422 (586)
Q Consensus 355 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~ 422 (586)
|+++........ ......|++.|+|||.+.+ ..++.++|||||||+||||++|+.||...... .
T Consensus 171 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~----~ 246 (313)
T 3cek_A 171 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----I 246 (313)
T ss_dssp SSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH----H
T ss_pred cccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH----H
Confidence 999865433221 2234579999999999875 47888999999999999999999999754321 0
Q ss_pred hhhhhHHHhhcccCCChhhhhchhhh-ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 423 VDWAKPFLAQGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 423 ~~~~~~~~~~~~~~~~~~~l~d~~l~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.... .+++.... .++......+.+++.+||+.||.+||++.||++.
T Consensus 247 -~~~~-------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 247 -SKLH-------------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp -HHHH-------------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -HHHH-------------HHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 0111 11111111 1222224568899999999999999999999974
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=344.19 Aligned_cols=269 Identities=21% Similarity=0.322 Sum_probs=204.9
Q ss_pred cCccccceecccCcEEEEEEEE-eCCeEEEEEEeccCCchhHHHHHHHHHHHHhcC-----------CCCcceEEEEEEe
Q 007892 209 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-----------HRHLVSLVGYCTF 276 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~-----------Hpniv~l~g~~~~ 276 (586)
++|.+.+.||+|+||.||+|+. .+++.||||++... ......+.+|+.++.+++ |+||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 6799999999999999999996 46899999999753 234567889999999886 8999999999986
Q ss_pred CC----eeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeC------CC
Q 007892 277 GS----QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD------DS 346 (586)
Q Consensus 277 ~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~------~~ 346 (586)
.+ ..++||||+ +++|.+++.......+++..++.|+.|++.||+|||+++ +|+||||||+||||+ .+
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTE
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcCc
Confidence 54 788999999 999999998765566999999999999999999999853 799999999999994 44
Q ss_pred CCeEEeecccccccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccc----hhh
Q 007892 347 FEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFAD----DSM 422 (586)
Q Consensus 347 ~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~----~~~ 422 (586)
+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||+||||++|+.||........ ..+
T Consensus 175 ~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 250 (373)
T 1q8y_A 175 IQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 250 (373)
T ss_dssp EEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred ceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence 58999999999865332 2345799999999999999999999999999999999999999986542111 011
Q ss_pred hhhhh-------HHHhh---------------cccCCC---hhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 007892 423 VDWAK-------PFLAQ---------------GLADGN---FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMS 477 (586)
Q Consensus 423 ~~~~~-------~~~~~---------------~~~~~~---~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~ 477 (586)
..... .++.. .+.... ...+... ...++......+.+++.+||+.||.+||++.
T Consensus 251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 329 (373)
T 1q8y_A 251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE-KYKFSKDEAKEISDFLSPMLQLDPRKRADAG 329 (373)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHH-TTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhh-cccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence 11000 00000 000000 0011111 1135677888999999999999999999999
Q ss_pred HHHH--HHhcC
Q 007892 478 QIVR--ALEGN 486 (586)
Q Consensus 478 evl~--~L~~~ 486 (586)
||++ .+.+.
T Consensus 330 ell~hp~f~~~ 340 (373)
T 1q8y_A 330 GLVNHPWLKDT 340 (373)
T ss_dssp HHHTCGGGTTC
T ss_pred HHhhChhhhcc
Confidence 9997 44443
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=347.00 Aligned_cols=265 Identities=20% Similarity=0.284 Sum_probs=201.4
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEeC-----Cee
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFG-----SQR 280 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~-~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~-----~~~ 280 (586)
.++|+..+.||+|+||.||+|... +++.||||++...... ....+.+|+.+|.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 367999999999999999999965 6889999999754333 346789999999999999999999999764 367
Q ss_pred EEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccccc
Q 007892 281 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 360 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~ 360 (586)
++||||+. ++|.+++... .+++..+..|+.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++..
T Consensus 106 ~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 99999997 5898888643 489999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCCc--ccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHh------
Q 007892 361 LDTDTH--VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLA------ 431 (586)
Q Consensus 361 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~------ 431 (586)
...... ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||........ +.... ..+.
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~i~-~~~~~~~~~~ 255 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ--LNHIL-GILGSPSQED 255 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH--HHHHH-HHHCSCCHHH
T ss_pred CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH--HHHHH-HHhCCCCHHH
Confidence 432221 1244689999999998754 5589999999999999999999999976553221 11100 0000
Q ss_pred -hcccCCChhhhhch-------hhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 432 -QGLADGNFDALVDQ-------KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 432 -~~~~~~~~~~l~d~-------~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
..+........... ............+.+++.+||+.||.+||++.|+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000000 0001112234568899999999999999999999974
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=340.42 Aligned_cols=265 Identities=20% Similarity=0.282 Sum_probs=200.4
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeC-----Cee
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFG-----SQR 280 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~-----~~~ 280 (586)
.++|.+.+.||+|+||.||+|+.. +|+.||||+++.... .....+.+|+.++.+++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 368999999999999999999975 689999999975433 3345788999999999999999999998764 678
Q ss_pred EEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccccc
Q 007892 281 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 360 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~ 360 (586)
++||||+. ++|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++..
T Consensus 90 ~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 99999997 689888865 3489999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCCc---------ccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHH
Q 007892 361 LDTDTH---------VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFL 430 (586)
Q Consensus 361 ~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 430 (586)
...... ......||+.|+|||++.. ..++.++|||||||+||||++|+.||...+... .+.. ....+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~-~~~~~ 239 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH--QLLL-IFGII 239 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHH-HHHHH
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HHHH-HHHHh
Confidence 432211 1123578999999998754 778999999999999999999999998654211 1100 00000
Q ss_pred hhcc--------cCCChhhhhc-------hhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 431 AQGL--------ADGNFDALVD-------QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 431 ~~~~--------~~~~~~~l~d-------~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.... ........+. ..+..........+.+++.+||+.||.+||++.||++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000 0000000000 00111112334678899999999999999999999973
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=346.41 Aligned_cols=273 Identities=20% Similarity=0.254 Sum_probs=192.6
Q ss_pred HHHHHHhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe-
Q 007892 202 EELKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ- 279 (586)
Q Consensus 202 ~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~- 279 (586)
.+.....++|.+.+.||+|+||.||+|+.. +|+.||||++...... ...+.+|+..+..++||||++++++|...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF-RNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC-CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc-cHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 466777899999999999999999999975 6899999998654322 3456778888999999999999999976433
Q ss_pred ------eEEEEEecCCCcHHHHhc-CCCCCCCChHHHHHHHHHHHHHhHhhh--hcCCCcEEecCCCCceeEeCC-CCCe
Q 007892 280 ------RLLVYEFVPNKTLEFHLH-GKDRPVMNWPTRMKIALGSARGLAYLH--EDCQPKIIHRDIKSANILLDD-SFEA 349 (586)
Q Consensus 280 ------~~lV~E~~~~gsL~~~l~-~~~~~~l~~~~~~~ia~~ia~gL~yLH--~~~~~~ivHrDIk~~NILl~~-~~~~ 349 (586)
.++||||++++.+..... ......+++..+..++.|++.||.||| +. +|+||||||+||||+. ++.+
T Consensus 95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEE
T ss_pred cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcE
Confidence 789999998754332221 123445889999999999999999999 76 9999999999999996 8999
Q ss_pred EEeecccccccCCCCCcccccccccccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhH
Q 007892 350 KVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKP 428 (586)
Q Consensus 350 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~ 428 (586)
||+|||+++....... .....||+.|+|||++.+. .++.++|||||||+||||++|+.||...... ..+..+.+.
T Consensus 172 kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--~~~~~~~~~ 247 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA--GQLHEIVRV 247 (360)
T ss_dssp EECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHH
T ss_pred EEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH--HHHHHHHHH
Confidence 9999999987543322 2345789999999998655 4899999999999999999999999875431 111111110
Q ss_pred -------HHhhccc-CCChhhh------hchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 429 -------FLAQGLA-DGNFDAL------VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 429 -------~~~~~~~-~~~~~~l------~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.+..... ...++.. ....+..........+.+++.+||+.||.+||++.||++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000000 0000000 0000112222345789999999999999999999999974
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=342.97 Aligned_cols=263 Identities=22% Similarity=0.282 Sum_probs=195.1
Q ss_pred cCccccceecccCcEEEEEEEEeC-CeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEE------------
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCT------------ 275 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~------------ 275 (586)
++|...+.||+|+||.||+|.... ++.||||++........+.+.+|+.++.+++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 679999999999999999999764 8999999998766666778999999999999999999999873
Q ss_pred --eCCeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeC-CCCCeEEe
Q 007892 276 --FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD-DSFEAKVA 352 (586)
Q Consensus 276 --~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~-~~~~~kl~ 352 (586)
.....++||||++ |+|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+||||+ +++.+||+
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEEC
T ss_pred ccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEc
Confidence 3467899999997 699999854 3488999999999999999999998 999999999999997 56799999
Q ss_pred ecccccccCCCCC--cccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHH
Q 007892 353 DFGLAKHSLDTDT--HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPF 429 (586)
Q Consensus 353 DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~ 429 (586)
|||+++....... .......++..|+|||.+.. ..++.++|||||||+||||++|+.||....... .+.......
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~~~~~~~ 241 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE--QMQLILESI 241 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHS
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhc
Confidence 9999986543211 12234567999999998865 678999999999999999999999998654311 110000000
Q ss_pred ------HhhcccCCChhhhhchh-------hhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 430 ------LAQGLADGNFDALVDQK-------LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 430 ------~~~~~~~~~~~~l~d~~-------l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
..+.+. ..+...+... +..........+.+++.+||+.||.+||++.|+++
T Consensus 242 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 242 PVVHEEDRQELL-SVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp CCCCHHHHHHHH-TTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCCchhhhhhhh-hcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 000000 0000000000 00111223467899999999999999999999987
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=353.35 Aligned_cols=201 Identities=24% Similarity=0.331 Sum_probs=155.0
Q ss_pred cCccc-cceecccCcEEEEEEEEe---CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCeeEE
Q 007892 209 DNFSE-ANLLGQGGFGYVHKGVLT---NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF--GSQRLL 282 (586)
Q Consensus 209 ~~f~~-~~~LG~G~fG~Vyk~~~~---~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~--~~~~~l 282 (586)
+.|.+ .++||+|+||.||+|++. +++.||||++..... ...+.+|+.+|.+++|||||+++++|.. ....+|
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 34655 458999999999999976 478999999975432 3468899999999999999999999965 678899
Q ss_pred EEEecCCCcHHHHhcCC-------CCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEe----CCCCCeEE
Q 007892 283 VYEFVPNKTLEFHLHGK-------DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL----DDSFEAKV 351 (586)
Q Consensus 283 V~E~~~~gsL~~~l~~~-------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl----~~~~~~kl 351 (586)
||||+.+ +|.+++... ....+++..+..|+.||+.||+|||+. +|+||||||+|||| +.++.+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999964 776666421 123489999999999999999999998 99999999999999 67889999
Q ss_pred eecccccccCCCCC--cccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 007892 352 ADFGLAKHSLDTDT--HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKAD 415 (586)
Q Consensus 352 ~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~ 415 (586)
+|||+++....... ......+||+.|+|||++.+ ..++.++|||||||+||||++|+.||....
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 99999987543221 22345679999999999987 458999999999999999999999997544
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=348.29 Aligned_cols=261 Identities=24% Similarity=0.375 Sum_probs=202.8
Q ss_pred HHHHHHhcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 007892 202 EELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ 279 (586)
Q Consensus 202 ~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~ 279 (586)
.++.+..++|.+.+.||+|+||.||+|...+ .||||.++... ....+.+.+|+.++.+++|+||+++++++...+.
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 3455566889999999999999999998754 48999986542 2223567889999999999999999999999999
Q ss_pred eEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccc
Q 007892 280 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 359 (586)
Q Consensus 280 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~ 359 (586)
.++||||+++++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++ ++.+||+|||+++.
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSI 178 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred eEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccc
Confidence 999999999999999996543 4589999999999999999999998 999999999999998 67999999999875
Q ss_pred cCCCC----CcccccccccccccCcccccC---------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhh
Q 007892 360 SLDTD----THVSTRVMGTFGYLAPEYASS---------GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWA 426 (586)
Q Consensus 360 ~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~ 426 (586)
..... ........|++.|+|||.+.. ..++.++|||||||+||||++|+.||...... ... +
T Consensus 179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~-~- 253 (319)
T 2y4i_B 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE---AII-W- 253 (319)
T ss_dssp ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH---HHH-H-
T ss_pred cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH-H-
Confidence 43211 112233468999999999874 45788999999999999999999999754421 111 0
Q ss_pred hHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 427 KPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 427 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
. + ..+.... +. .......+.+++.+||+.||.+||++.+|++.|+...
T Consensus 254 -~-~----~~~~~~~-----~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~ 301 (319)
T 2y4i_B 254 -Q-M----GTGMKPN-----LS--QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301 (319)
T ss_dssp -H-H----HTTCCCC-----CC--CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred -H-h----ccCCCCC-----CC--cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 0 0 0111000 00 1112345889999999999999999999999999764
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=343.33 Aligned_cols=202 Identities=26% Similarity=0.307 Sum_probs=174.2
Q ss_pred HhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcC-CC-----CcceEEEEEEeCCe
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HR-----HLVSLVGYCTFGSQ 279 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~-Hp-----niv~l~g~~~~~~~ 279 (586)
..++|.+.+.||+|+||.||+|+.. +++.||||+++.. .....++..|+.++..++ |+ +|+++++++...+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 3578999999999999999999975 6889999999753 233567788999998885 55 49999999999999
Q ss_pred eEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeC--CCCCeEEeecccc
Q 007892 280 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD--DSFEAKVADFGLA 357 (586)
Q Consensus 280 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~--~~~~~kl~DFGla 357 (586)
.+|||||+. ++|.+++.......+++..+..++.|++.||.|||.+ ..+|+||||||+||||+ .++.+||+|||++
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred eEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 999999996 5999998876656699999999999999999999952 23899999999999994 4788999999999
Q ss_pred cccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 007892 358 KHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKAD 415 (586)
Q Consensus 358 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~ 415 (586)
+..... .....||+.|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus 209 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 209 CQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp EETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 875332 234679999999999999999999999999999999999999998654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=349.67 Aligned_cols=262 Identities=21% Similarity=0.312 Sum_probs=185.1
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeC------C
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFG------S 278 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~------~ 278 (586)
.++|...+.||+|+||.||+|... +|+.||||++.... ......+.+|+.+|++++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 378999999999999999999964 68999999986542 23356788999999999999999999999654 5
Q ss_pred eeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccc
Q 007892 279 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 358 (586)
Q Consensus 279 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~ 358 (586)
..++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||||+.++.+||+|||+++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred eEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 679999999 7899888854 3589999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhH------HHh
Q 007892 359 HSLDTDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKP------FLA 431 (586)
Q Consensus 359 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~------~~~ 431 (586)
..... .....||..|+|||++.+ ..++.++|||||||+||||++|+.||...+... .+...... .+.
T Consensus 181 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~l~~i~~~~g~p~~~~~ 254 (367)
T 2fst_X 181 HTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID--QLKLILRLVGTPGAELL 254 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCCHHHH
T ss_pred ccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHH
Confidence 64322 244679999999999876 679999999999999999999999998655311 11110000 000
Q ss_pred hcccCCChhhhhch-------hhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 432 QGLADGNFDALVDQ-------KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 432 ~~~~~~~~~~l~d~-------~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
..+........+.. .+..........+.+++.+||+.||.+||++.|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 00000000111100 0000111223568899999999999999999999974
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=338.17 Aligned_cols=262 Identities=21% Similarity=0.325 Sum_probs=201.7
Q ss_pred hcCccccceecccCcEEEEEEEEe-C-CeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCC------cceEEEEEEeCCe
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-N-GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH------LVSLVGYCTFGSQ 279 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~-g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpn------iv~l~g~~~~~~~ 279 (586)
.++|.+.+.||+|+||.||+|... + ++.||||+++.. ......+.+|+.++.+++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 378999999999999999999974 3 478999999753 234567889999999997665 9999999999999
Q ss_pred eEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEe----------------
Q 007892 280 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL---------------- 343 (586)
Q Consensus 280 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl---------------- 343 (586)
.+|||||+ +++|.+++.......+++.+++.|+.|++.||+|||++ +|+||||||+||||
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccccccc
Confidence 99999999 56666666655555699999999999999999999998 99999999999999
Q ss_pred ---CCCCCeEEeecccccccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccch
Q 007892 344 ---DDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADD 420 (586)
Q Consensus 344 ---~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~ 420 (586)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||+||||++|+.||.......
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-- 246 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE-- 246 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--
T ss_pred ccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--
Confidence 56789999999999864332 234579999999999999999999999999999999999999998654311
Q ss_pred hhhhhhhHHHh-------hcccCCC--------h------hhhh----chhh--hccCHHHHHHHHHHHHHhhccCCCCC
Q 007892 421 SMVDWAKPFLA-------QGLADGN--------F------DALV----DQKL--EEYDSAEMTRMAACAAACIRHSARRR 473 (586)
Q Consensus 421 ~~~~~~~~~~~-------~~~~~~~--------~------~~l~----d~~l--~~~~~~~~~~l~~l~~~cl~~dp~~R 473 (586)
........+. ....... + ...+ .+.. ..........+.+++.+||+.||.+|
T Consensus 247 -~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 247 -HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp -HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred -HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 1111000000 0000000 0 0000 0000 01223456689999999999999999
Q ss_pred CCHHHHHH
Q 007892 474 PRMSQIVR 481 (586)
Q Consensus 474 Ptm~evl~ 481 (586)
|++.||++
T Consensus 326 pt~~e~l~ 333 (355)
T 2eu9_A 326 ITLAEALL 333 (355)
T ss_dssp CCHHHHTT
T ss_pred cCHHHHhc
Confidence 99999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=341.43 Aligned_cols=256 Identities=21% Similarity=0.276 Sum_probs=176.6
Q ss_pred hcCccccc-eecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEe----CCeeE
Q 007892 208 TDNFSEAN-LLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF----GSQRL 281 (586)
Q Consensus 208 ~~~f~~~~-~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~----~~~~~ 281 (586)
.++|.+.+ +||+|+||.||+|... +|+.||||++... .....+....+..+.||||+++++++.. +...+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 46788854 6999999999999976 6899999998653 2222333344667799999999999976 44578
Q ss_pred EEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCC---CCCeEEeeccccc
Q 007892 282 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD---SFEAKVADFGLAK 358 (586)
Q Consensus 282 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~---~~~~kl~DFGla~ 358 (586)
|||||+++|+|.+++.......+++.+++.++.|++.||.|||++ +|+||||||+||||+. ++.+||+|||+++
T Consensus 103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 999999999999999877666799999999999999999999998 9999999999999976 4559999999998
Q ss_pred ccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCC
Q 007892 359 HSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGN 438 (586)
Q Consensus 359 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (586)
..... ......||+.|+|||++.+..++.++|||||||+||||++|+.||......... ..+. ..+..+.
T Consensus 180 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~-----~~~~~~~ 249 (336)
T 3fhr_A 180 ETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS--PGMK-----RRIRLGQ 249 (336)
T ss_dssp EC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------------
T ss_pred ecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh--hhHH-----Hhhhccc
Confidence 65322 223457899999999999889999999999999999999999999755431100 0000 0000000
Q ss_pred hhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHhc
Q 007892 439 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR--ALEG 485 (586)
Q Consensus 439 ~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~--~L~~ 485 (586)
+ .... .........+.+++.+||+.||.+||++.|+++ .+..
T Consensus 250 ~-~~~~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 250 Y-GFPN----PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp --CCCT----TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred c-ccCc----hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 0 0000 011223456889999999999999999999998 4443
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=355.50 Aligned_cols=251 Identities=23% Similarity=0.303 Sum_probs=188.7
Q ss_pred cCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeEEEEEec
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFV 287 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~~~~lV~E~~ 287 (586)
+.|...+.||+|+||+||.+...+|+.||||++... ....+.+|+.+|.++ +|||||++++++..++..+|||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 345667889999999998776678999999998653 245678999999987 8999999999999999999999999
Q ss_pred CCCcHHHHhcCCCCCC-----CChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCC-------------CCe
Q 007892 288 PNKTLEFHLHGKDRPV-----MNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS-------------FEA 349 (586)
Q Consensus 288 ~~gsL~~~l~~~~~~~-----l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~-------------~~~ 349 (586)
. |+|.+++....... ..+..++.|+.|++.||+|||+. +|+||||||+||||+.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence 5 69999997653211 13345678999999999999998 99999999999999653 589
Q ss_pred EEeecccccccCCCCCc---ccccccccccccCcccccC-------CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCccc
Q 007892 350 KVADFGLAKHSLDTDTH---VSTRVMGTFGYLAPEYASS-------GKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFA 418 (586)
Q Consensus 350 kl~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~ 418 (586)
||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||+||||++ |+.||.......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 99999999876543322 1234579999999999975 678999999999999999999 999997543211
Q ss_pred chhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 419 DDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 419 ~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
.. .+.......... ..........+.+++.+||+.||.+||++.||++
T Consensus 248 ----~~----i~~~~~~~~~~~-------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 ----SN----IIRGIFSLDEMK-------CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ----HH----HHHTCCCCCCCT-------TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----HH----HhcCCCCccccc-------ccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 11 111111100000 0123456678999999999999999999999985
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=345.91 Aligned_cols=261 Identities=22% Similarity=0.332 Sum_probs=197.8
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCee----
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR---- 280 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~---- 280 (586)
.++|...+.||+|+||.||+|... +|+.||||++..... .....+.+|+.++.+++||||++++++|...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 368999999999999999999965 689999999976432 2346788999999999999999999999877654
Q ss_pred --EEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccc
Q 007892 281 --LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 358 (586)
Q Consensus 281 --~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~ 358 (586)
++||||+. ++|.+++.. .+++..+..++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred eEEEEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 99999997 688887732 389999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhh------HHHh
Q 007892 359 HSLDTDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAK------PFLA 431 (586)
Q Consensus 359 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~------~~~~ 431 (586)
..... .....||+.|+|||++.+ ..++.++|||||||+||||++|+.||...+... .+..... ..+.
T Consensus 193 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~ 266 (371)
T 4exu_A 193 HADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQILKVTGVPGTEFV 266 (371)
T ss_dssp -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCHHHH
T ss_pred ccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCcHHHH
Confidence 64322 234578999999999987 689999999999999999999999998654311 1111100 0000
Q ss_pred hcccCCChhhhhch-------hhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 432 QGLADGNFDALVDQ-------KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 432 ~~~~~~~~~~l~d~-------~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
..+........... ............+.+++.+||+.||.+||++.|+++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00000000000000 0001112234678999999999999999999999874
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=340.17 Aligned_cols=244 Identities=25% Similarity=0.357 Sum_probs=192.4
Q ss_pred HHHhcCccccceecccCcEEEEEEEE-eCCeEEEEEEeccCCch------hHHHHHHHHHHHHhc----CCCCcceEEEE
Q 007892 205 KIATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQ------GEREFQAEIEIISQV----HHRHLVSLVGY 273 (586)
Q Consensus 205 ~~~~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~------~~~~~~~Ei~il~~l----~Hpniv~l~g~ 273 (586)
+...++|.+.+.||+|+||.||+|+. .+++.||||++...... ....+.+|+.++.++ +|+||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 34457899999999999999999986 46889999999765332 123456799999999 89999999999
Q ss_pred EEeCCeeEEEEEe-cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeC-CCCCeEE
Q 007892 274 CTFGSQRLLVYEF-VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD-DSFEAKV 351 (586)
Q Consensus 274 ~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~-~~~~~kl 351 (586)
+...+..++|+|| +.+++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||++ +++.+||
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEE
Confidence 9999999999999 78999999997543 489999999999999999999998 999999999999999 8899999
Q ss_pred eecccccccCCCCCcccccccccccccCcccccCCCCC-CcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHH
Q 007892 352 ADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLT-EKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFL 430 (586)
Q Consensus 352 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 430 (586)
+|||+++...... .....|+..|+|||++.+..+. .++|||||||+||||++|+.||..... . .
T Consensus 182 ~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~-------~ 246 (312)
T 2iwi_A 182 IDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-----I-------L 246 (312)
T ss_dssp CCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----H-------H
T ss_pred EEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-----H-------h
Confidence 9999998754322 2345699999999998776664 589999999999999999999964321 0 0
Q ss_pred hhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 431 AQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 431 ~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
... . .+.......+.+++.+||+.||.+||++.||++.
T Consensus 247 ~~~-------------~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 247 EAE-------------L-HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp HTC-------------C-CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred hhc-------------c-CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0 1122234568899999999999999999999974
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=334.07 Aligned_cols=252 Identities=26% Similarity=0.407 Sum_probs=193.3
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEe----------
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF---------- 276 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~---------- 276 (586)
.++|+..+.||+|+||.||+|+.. +++.||||++... ......+.+|+.++.+++||||++++++|.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 467999999999999999999975 6899999999653 2345678999999999999999999999865
Q ss_pred ---CCeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEee
Q 007892 277 ---GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVAD 353 (586)
Q Consensus 277 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~D 353 (586)
.+..++||||+++++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||||+.++.+||+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEee
Confidence 356789999999999999997533 3478889999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCC-------------CcccccccccccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccc
Q 007892 354 FGLAKHSLDTD-------------THVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFAD 419 (586)
Q Consensus 354 FGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~ 419 (586)
||+++...... ........|++.|+|||.+.+. .++.++|||||||+||||++ ||....
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~---- 232 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM---- 232 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH----
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch----
Confidence 99998653221 1122345799999999999754 78999999999999999998 554211
Q ss_pred hhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 420 DSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 420 ~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
......... ..... .....+.......+.+++.+||+.||.+||++.||++.
T Consensus 233 -~~~~~~~~~-----~~~~~-----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 233 -ERVNILKKL-----RSVSI-----EFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp -HHHHHHHHH-----HSTTC-----CCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -hHHHHHHhc-----ccccc-----ccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 111111110 01000 00012333445678899999999999999999999974
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=331.84 Aligned_cols=251 Identities=23% Similarity=0.340 Sum_probs=202.0
Q ss_pred HhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEE
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV 283 (586)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++.+++||||+++++++...+..++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3468999999999999999999976 68899999986532 23467899999999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCC---CCeEEeeccccccc
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS---FEAKVADFGLAKHS 360 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~---~~~kl~DFGla~~~ 360 (586)
+||+++++|.+++.... .+++..++.++.|++.||.|||+. +|+||||||+||||+.+ +.+||+|||++...
T Consensus 100 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 100 GELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp ECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred EEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 99999999988886433 489999999999999999999998 99999999999999754 47999999999865
Q ss_pred CCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChh
Q 007892 361 LDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 440 (586)
Q Consensus 361 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (586)
..... .....|++.|+|||.+.+ .++.++||||||++||+|++|+.||...... . ...... .+.+.
T Consensus 175 ~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~---~~~~~~-----~~~~~ 240 (287)
T 2wei_A 175 QQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---D---ILKRVE-----TGKYA 240 (287)
T ss_dssp CCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---H---HHHHHH-----HCCCC
T ss_pred cCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH---H---HHHHHH-----cCCCC
Confidence 43322 233468999999999875 5899999999999999999999999765421 1 111111 11100
Q ss_pred hhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 441 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 441 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
. ..+.. ......+.+++.+||+.||.+||++.|+++
T Consensus 241 ~-~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 F-DLPQW----RTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp C-CSGGG----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C-Cchhh----hhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0 00001 112356889999999999999999999997
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=337.45 Aligned_cols=255 Identities=25% Similarity=0.427 Sum_probs=178.7
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc-hhHHHHHHHHH-HHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIE-IISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~-~~~~~~~~Ei~-il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
.++|...+.||+|+||.||+|... +|+.||||+++.... .....+..|+. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 478999999999999999999975 689999999976533 23345566666 667789999999999999999999999
Q ss_pred EecCCCcHHHHhcC---CCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccC
Q 007892 285 EFVPNKTLEFHLHG---KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 361 (586)
Q Consensus 285 E~~~~gsL~~~l~~---~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~ 361 (586)
||+++ +|.+++.. .....+++..+..++.|++.||.|||+.. +|+||||||+||||+.++.+||+|||+++...
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 99985 77666542 23456899999999999999999999853 79999999999999999999999999998654
Q ss_pred CCCCcccccccccccccCcccc----cCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCC
Q 007892 362 DTDTHVSTRVMGTFGYLAPEYA----SSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADG 437 (586)
Q Consensus 362 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (586)
... ......||+.|+|||++ .+..++.++|||||||+||||++|+.||....... +. +. .+..+
T Consensus 178 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~----~~-~~~~~ 245 (327)
T 3aln_A 178 DSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-----DQ----LT-QVVKG 245 (327)
T ss_dssp ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------------C-CCCCS
T ss_pred ccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-----HH----HH-HHhcC
Confidence 322 22334799999999998 45678999999999999999999999997543210 00 00 01111
Q ss_pred ChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 438 NFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 438 ~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
....+.. .........+.+++.+||+.||.+||++.||++
T Consensus 246 ~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 246 DPPQLSN----SEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCCCC----CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCC----cccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 1111100 111123457899999999999999999999976
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=339.75 Aligned_cols=260 Identities=22% Similarity=0.332 Sum_probs=197.2
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe------
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ------ 279 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~------ 279 (586)
++|...+.||+|+||.||+|+.. +|+.||||++..... .....+.+|+.++.+++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 67999999999999999999975 689999999965432 234678899999999999999999999987654
Q ss_pred eEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccc
Q 007892 280 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 359 (586)
Q Consensus 280 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~ 359 (586)
.++||||+. ++|.+++.. .+++..+..++.|++.||.|||++ +|+||||||+||||+.++.+||+|||+++.
T Consensus 104 ~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp CEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred EEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccC
Confidence 499999997 688877742 389999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCCcccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhh------HHHhh
Q 007892 360 SLDTDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAK------PFLAQ 432 (586)
Q Consensus 360 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~------~~~~~ 432 (586)
.... .....||+.|+|||++.+ ..++.++|||||||+||||++|+.||...+... .+..... ..+.+
T Consensus 176 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~ 249 (353)
T 3coi_A 176 ADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQILKVTGVPGTEFVQ 249 (353)
T ss_dssp ------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH--HHHHHHHHHCBCCHHHHT
T ss_pred CCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHHH
Confidence 4322 234578999999999876 678999999999999999999999998654311 1111000 00000
Q ss_pred cccCCChhhhhc-------hhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 433 GLADGNFDALVD-------QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 433 ~~~~~~~~~l~d-------~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.+.+......+. ..+..........+.+++.+||+.||.+||++.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp TCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000000000000 00111122345678999999999999999999999864
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=355.78 Aligned_cols=251 Identities=24% Similarity=0.324 Sum_probs=189.4
Q ss_pred HHhcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeEEEE
Q 007892 206 IATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 206 ~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
+...+|...++||+|+||+||.....+++.||||++..... ..+.+|+.+|.++ +|||||++++++.+....+|||
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 34467999999999999997665566889999999965432 2356899999999 7999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCC-----CCCeEEeecccccc
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD-----SFEAKVADFGLAKH 359 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~-----~~~~kl~DFGla~~ 359 (586)
||+. |+|.+++..... .+.+..++.|+.|++.||+|||+. +|+||||||+||||+. ...+||+|||+++.
T Consensus 98 E~~~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp ECCS-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred ECCC-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 9996 699999876543 344556678999999999999998 9999999999999943 34688999999987
Q ss_pred cCCCCC--cccccccccccccCccccc---CCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhc
Q 007892 360 SLDTDT--HVSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQG 433 (586)
Q Consensus 360 ~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 433 (586)
...... .......||+.|+|||++. ...++.++|||||||+||||++ |..||....... .. . +.
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~----~~---~-~~-- 242 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ----AN---I-LL-- 242 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH----HH---H-HT--
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH----HH---H-Hh--
Confidence 643321 2234467999999999997 4567889999999999999999 999996433210 00 0 00
Q ss_pred ccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 434 LADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 434 ~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
.......+ .........+.+++.+||+.||.+||++.||++
T Consensus 243 -~~~~~~~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 243 -GACSLDCL------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp -TCCCCTTS------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -ccCCcccc------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 00001000 112234456789999999999999999999983
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=340.35 Aligned_cols=245 Identities=22% Similarity=0.339 Sum_probs=199.7
Q ss_pred HHHHhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCch------hHHHHHHHHHHHHhcC--CCCcceEEEEE
Q 007892 204 LKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ------GEREFQAEIEIISQVH--HRHLVSLVGYC 274 (586)
Q Consensus 204 l~~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~------~~~~~~~Ei~il~~l~--Hpniv~l~g~~ 274 (586)
.....++|.+.+.||+|+||.||+|+.. +++.||||+++..... ....+.+|+.++.+++ |+||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 3445578999999999999999999964 6899999998654321 2245778999999996 59999999999
Q ss_pred EeCCeeEEEEEecCC-CcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeC-CCCCeEEe
Q 007892 275 TFGSQRLLVYEFVPN-KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD-DSFEAKVA 352 (586)
Q Consensus 275 ~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~-~~~~~kl~ 352 (586)
...+..++||||+.+ ++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||||+ +++.+||+
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEEC
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEe
Confidence 999999999999986 8999998653 3589999999999999999999998 999999999999999 78899999
Q ss_pred ecccccccCCCCCcccccccccccccCcccccCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHh
Q 007892 353 DFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLA 431 (586)
Q Consensus 353 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 431 (586)
|||+++..... ......||+.|+|||++.+..+ +.++|||||||+||||++|+.||..... . ..
T Consensus 193 Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~-------~~ 257 (320)
T 3a99_A 193 DFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----I-------IR 257 (320)
T ss_dssp CCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----H-------HH
T ss_pred eCccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-----h-------hc
Confidence 99999875432 2234569999999999987665 6889999999999999999999964321 0 00
Q ss_pred hcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 432 QGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 432 ~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
... .+.......+.+++.+||+.||.+||++.||++.
T Consensus 258 ~~~--------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 258 GQV--------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp CCC--------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ccc--------------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0111223568899999999999999999999874
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=332.41 Aligned_cols=253 Identities=23% Similarity=0.360 Sum_probs=180.8
Q ss_pred HhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchh--HHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEE
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQG--EREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~--~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV 283 (586)
..++|+..+.||+|+||.||+|... +|+.||||++....... .+.+.++..++..++||||+++++++...+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 3478999999999999999999975 68999999997653322 23445566678888999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCC
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 363 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 363 (586)
|||+ ++.+..++.. ....+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++......
T Consensus 103 ~e~~-~~~~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 103 MELM-GTCAEKLKKR-MQGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp ECCC-SEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHHH--CCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred Eecc-CCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhhC--CEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 9999 5555555432 2345899999999999999999999832 8999999999999999999999999999765432
Q ss_pred CCcccccccccccccCccccc-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCC
Q 007892 364 DTHVSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGN 438 (586)
Q Consensus 364 ~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (586)
. ......|++.|+|||++. ...++.++|||||||+||||++|+.||...... . +.....+.. .
T Consensus 179 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~---~~~~~~~~~-----~ 246 (318)
T 2dyl_A 179 K--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD--F---EVLTKVLQE-----E 246 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH--H---HHHHHHHHS-----C
T ss_pred c--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--H---HHHHHHhcc-----C
Confidence 2 223457999999999984 567899999999999999999999999753321 0 111111100 0
Q ss_pred hhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 439 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 439 ~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
. +.+ .........+.+++.+||+.||.+||++.||++
T Consensus 247 ~-----~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 247 P-----PLL-PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp C-----CCC-CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred C-----CCC-CccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0 000 001123456889999999999999999999986
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=321.28 Aligned_cols=232 Identities=12% Similarity=0.056 Sum_probs=185.0
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCch---hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ---GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~---~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
++|++.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|+.++.+++||||+++++++...+..+|||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 67999999999999999999976 4899999999765332 2467899999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
||+++++|.+++... ....+.++|+.|++.||+|||++ +|+||||||+||||++++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~--------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA--------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred EecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc---------
Confidence 999999999999532 35557889999999999999998 99999999999999999999997543
Q ss_pred CcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhc
Q 007892 365 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 444 (586)
Q Consensus 365 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 444 (586)
|++ .++.++|||||||+||||++|+.||......... ..+. +.+ .+...
T Consensus 175 ------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~---~~~~----~~~-~~~~~---- 223 (286)
T 3uqc_A 175 ------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL---APAE----RDT-AGQPI---- 223 (286)
T ss_dssp ------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS---EECC----BCT-TSCBC----
T ss_pred ------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh---HHHH----HHh-ccCCC----
Confidence 333 3688999999999999999999999875542110 0000 000 00000
Q ss_pred hhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCCC
Q 007892 445 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMPL 489 (586)
Q Consensus 445 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~~~ 489 (586)
............+.+++.+||+.||.+| ++.|+++.|+.....
T Consensus 224 -~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 224 -EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp -CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred -ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 0011222334568999999999999999 999999999976543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=357.68 Aligned_cols=238 Identities=20% Similarity=0.324 Sum_probs=193.3
Q ss_pred hcCccccceecccCcEEEEEEEEe--CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe-----
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT--NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ----- 279 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~--~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~----- 279 (586)
.++|++.+.||+|+||.||+|++. +|+.||||++.... ......+.+|+.+|.+++||||++++++|...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 378999999999999999999975 58999999986543 3345678999999999999999999999987655
Q ss_pred eEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccc
Q 007892 280 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 359 (586)
Q Consensus 280 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~ 359 (586)
.||||||+++++|.+++.. .++|.+++.|+.||+.||.|||++ +||||||||+||||+.+ .+||+|||+++.
T Consensus 159 ~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred eEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchh
Confidence 6999999999999887743 599999999999999999999998 99999999999999986 899999999987
Q ss_pred cCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCCh
Q 007892 360 SLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 439 (586)
Q Consensus 360 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (586)
.... ....||+.|+|||++.++. +.++|||||||+||||++|..||....... +...
T Consensus 231 ~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~---------------~~~~-- 287 (681)
T 2pzi_A 231 INSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG---------------LPED-- 287 (681)
T ss_dssp TTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS---------------CCTT--
T ss_pred cccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc---------------cccc--
Confidence 5432 3457999999999997654 889999999999999999998876422100 0000
Q ss_pred hhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCC-HHHHHHHHhc
Q 007892 440 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPR-MSQIVRALEG 485 (586)
Q Consensus 440 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPt-m~evl~~L~~ 485 (586)
.........+.+++.+||+.||.+||+ +.++.+.|.+
T Consensus 288 ---------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 288 ---------DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp ---------CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ---------ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 000112356889999999999999995 6666666654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=315.33 Aligned_cols=231 Identities=21% Similarity=0.338 Sum_probs=180.4
Q ss_pred cCcccc-ceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHH-HhcCCCCcceEEEEEEe----CCeeE
Q 007892 209 DNFSEA-NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEII-SQVHHRHLVSLVGYCTF----GSQRL 281 (586)
Q Consensus 209 ~~f~~~-~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il-~~l~Hpniv~l~g~~~~----~~~~~ 281 (586)
++|.+. +.||+|+||.||++... +++.||||+++.. ..+.+|++++ ..++||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 567666 78999999999999974 6889999999642 4677899988 55589999999999987 66789
Q ss_pred EEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCC---CCCeEEeeccccc
Q 007892 282 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD---SFEAKVADFGLAK 358 (586)
Q Consensus 282 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~---~~~~kl~DFGla~ 358 (586)
|||||+++++|.+++.......+++..++.++.|++.||+|||+. +|+||||||+||||+. ++.+||+|||++.
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 999999999999999876666799999999999999999999998 9999999999999998 7899999999986
Q ss_pred ccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCC
Q 007892 359 HSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGN 438 (586)
Q Consensus 359 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (586)
... +..++.++|||||||+||||++|+.||.......... . +...+..+.
T Consensus 169 ~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~--~-----~~~~~~~~~ 218 (299)
T 3m2w_A 169 ETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--G-----MKTRIRMGQ 218 (299)
T ss_dssp ECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C--C-----SCCSSCTTC
T ss_pred ccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH--H-----HHHHHhhcc
Confidence 432 2456789999999999999999999997544211000 0 000000000
Q ss_pred hhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 439 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 439 ~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.. ...+.. ......+.+++.+||+.||.+||++.|+++.
T Consensus 219 ~~-~~~~~~----~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 219 YE-FPNPEW----SEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp CS-SCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cc-CCchhc----ccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00 000000 1224568899999999999999999999973
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=354.14 Aligned_cols=269 Identities=28% Similarity=0.386 Sum_probs=204.0
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccC-CchhHHHHHHHHHHHHhcCCCCcceEEEEEEe------CCee
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG-SGQGEREFQAEIEIISQVHHRHLVSLVGYCTF------GSQR 280 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~-~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~------~~~~ 280 (586)
++|.+.+.||+|+||.||+|... +|+.||||+++.. .......+.+|++++.+++||||+++++++.. ++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 67999999999999999999964 6899999998764 33345678999999999999999999999765 6677
Q ss_pred EEEEEecCCCcHHHHhcCCC-CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCC---eEEeeccc
Q 007892 281 LLVYEFVPNKTLEFHLHGKD-RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE---AKVADFGL 356 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~---~kl~DFGl 356 (586)
++||||+++|+|.+++.... ...+++..++.|+.+++.||+|||+. +|+||||||+||||+.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 99999999999999997643 23589999999999999999999998 9999999999999987665 99999999
Q ss_pred ccccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcc--
Q 007892 357 AKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGL-- 434 (586)
Q Consensus 357 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~-- 434 (586)
++...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||..... ...|.........
T Consensus 171 a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-----~~~~~~~i~~~~~~~ 243 (676)
T 3qa8_A 171 AKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-----PVQWHGKVREKSNEH 243 (676)
T ss_dssp CCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-----HHHSSTTCC------
T ss_pred cccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-----hhhhhhhhhcccchh
Confidence 98754332 23446799999999999999999999999999999999999999975421 1222211110000
Q ss_pred ------cCCChhhhh-chhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHH-----HHHHHhcCC
Q 007892 435 ------ADGNFDALV-DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQ-----IVRALEGNM 487 (586)
Q Consensus 435 ------~~~~~~~l~-d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~e-----vl~~L~~~~ 487 (586)
..+.+.... .+............+.+++..||+.||.+||++.| +++.|+...
T Consensus 244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL 308 (676)
T 3qa8_A 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL 308 (676)
T ss_dssp CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence 001000000 00011344456788999999999999999999987 445555443
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=338.19 Aligned_cols=242 Identities=13% Similarity=0.142 Sum_probs=181.8
Q ss_pred HhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCch---hHHHHHHHHHHHHhcCC-CCcce------------
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ---GEREFQAEIEIISQVHH-RHLVS------------ 269 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~---~~~~~~~Ei~il~~l~H-pniv~------------ 269 (586)
...+|...++||+|+||.||+|++. +|+.||||+++..... ..+.|++|+.++..++| +|...
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 3356888899999999999999954 6899999998744332 24679999999999987 32211
Q ss_pred ---------EEEEEEe-----CCeeEEEEEecCCCcHHHHhc-----CCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCc
Q 007892 270 ---------LVGYCTF-----GSQRLLVYEFVPNKTLEFHLH-----GKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 330 (586)
Q Consensus 270 ---------l~g~~~~-----~~~~~lV~E~~~~gsL~~~l~-----~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ 330 (586)
++.++.. ....+++|+++ +++|.+++. ......++|..++.|+.|+++||+|||++ +
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---G 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence 1111111 12346667655 789988884 23344588899999999999999999998 9
Q ss_pred EEecCCCCceeEeCCCCCeEEeecccccccCCCCCcccccccccccccCcccc----------cCCCCCCcchHHHHHHH
Q 007892 331 IIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYA----------SSGKLTEKSDVFSFGVL 400 (586)
Q Consensus 331 ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~ksDVwSlGvv 400 (586)
||||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ ....++.++|||||||+
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 999999999999999999999999999864322 344578 999999999 55668899999999999
Q ss_pred HHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 007892 401 LLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIV 480 (586)
Q Consensus 401 L~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl 480 (586)
||||++|+.||....... + ...++... .. .+..+.+++.+||+.||.+||++.|++
T Consensus 307 l~elltg~~Pf~~~~~~~------~-------------~~~~~~~~-~~----~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALG------G-------------SEWIFRSC-KN----IPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHHHSSCCCCTTGGGS------C-------------SGGGGSSC-CC----CCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHHHCCCCCCCcchhh------h-------------HHHHHhhc-cc----CCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 999999999997654211 0 00111100 01 235689999999999999999998886
Q ss_pred H
Q 007892 481 R 481 (586)
Q Consensus 481 ~ 481 (586)
+
T Consensus 363 ~ 363 (413)
T 3dzo_A 363 E 363 (413)
T ss_dssp T
T ss_pred h
Confidence 4
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=311.96 Aligned_cols=243 Identities=16% Similarity=0.186 Sum_probs=186.6
Q ss_pred HhcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCC--------chhHHHHHHHHHHHHhcC---------CCCcce
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGS--------GQGEREFQAEIEIISQVH---------HRHLVS 269 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~--------~~~~~~~~~Ei~il~~l~---------Hpniv~ 269 (586)
..++|++.+.||+|+||.||+|+. +|+.||||++.... ....+.+.+|+.+|++++ |+|||+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 346788899999999999999998 78999999997543 223478899999999885 888888
Q ss_pred EEEEEE------------------------------eCCeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHH
Q 007892 270 LVGYCT------------------------------FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARG 319 (586)
Q Consensus 270 l~g~~~------------------------------~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~g 319 (586)
+.+++. ..+..+|||||+++|++.+.+.. ..+++..+..|+.|++.|
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHH
Confidence 888653 26789999999999977666633 458999999999999999
Q ss_pred hHhhh-hcCCCcEEecCCCCceeEeCCCC--------------------CeEEeecccccccCCCCCccccccccccccc
Q 007892 320 LAYLH-EDCQPKIIHRDIKSANILLDDSF--------------------EAKVADFGLAKHSLDTDTHVSTRVMGTFGYL 378 (586)
Q Consensus 320 L~yLH-~~~~~~ivHrDIk~~NILl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~ 378 (586)
|+||| +. +|+||||||+||||+.++ .+||+|||+++.... ...+||+.|+
T Consensus 174 L~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------~~~~gt~~y~ 244 (336)
T 2vuw_A 174 LAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------GIVVFCDVSM 244 (336)
T ss_dssp HHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------TEEECCCCTT
T ss_pred HHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------CcEEEeeccc
Confidence 99999 88 999999999999999887 899999999986543 2357999999
Q ss_pred CcccccCCCCCCcchHHHHHHH-HHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHH
Q 007892 379 APEYASSGKLTEKSDVFSFGVL-LLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTR 457 (586)
Q Consensus 379 aPE~~~~~~~s~ksDVwSlGvv-L~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~ 457 (586)
|||++.+.. +.++|||||+++ ++++++|..||... .|.............+.. .............
T Consensus 245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~---------~~~~~~~~~~~~~~~~~~---~~~~~~~~~~s~~ 311 (336)
T 2vuw_A 245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV---------LWLHYLTDKMLKQMTFKT---KCNTPAMKQIKRK 311 (336)
T ss_dssp CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH---------HHHHHHHHHHHHTCCCSS---CCCSHHHHHHHHH
T ss_pred ChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch---------hhhhHHHHhhhhhhccCc---ccchhhhhhcCHH
Confidence 999998665 889999998776 77788899998421 121111111000000000 0001123456678
Q ss_pred HHHHHHHhhccCCCCCCCHHHHH
Q 007892 458 MAACAAACIRHSARRRPRMSQIV 480 (586)
Q Consensus 458 l~~l~~~cl~~dp~~RPtm~evl 480 (586)
+.+++.+||+.| ++.|++
T Consensus 312 ~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 312 IQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHhccC-----CHHHHH
Confidence 999999999976 899988
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=296.32 Aligned_cols=186 Identities=18% Similarity=0.136 Sum_probs=131.3
Q ss_pred ceecccCcEEEEEEE-EeCCeEEEEEEeccCC----------chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeEE
Q 007892 215 NLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGS----------GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLL 282 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~-~~~g~~vAVK~l~~~~----------~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~~~~l 282 (586)
..++.|++|.+..++ .--|+.||||.+.... ....++|.+|+++|+++ +|+||+++++++++++..||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 346677777776655 3358899999996542 12235799999999999 69999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCC
Q 007892 283 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 283 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 362 (586)
||||++|++|.++|.... .++.. +|+.||+.||+|||++ +||||||||+||||++++.+||+|||+|+....
T Consensus 320 VMEyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EEECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EEecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 999999999999997643 35543 5889999999999999 999999999999999999999999999987544
Q ss_pred CCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCC
Q 007892 363 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRP 410 (586)
Q Consensus 363 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~P 410 (586)
... .....+||++|||||++.+ .+..++|+|++|+++++|.++..+
T Consensus 392 ~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 DCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 332 3455789999999999874 577889999999999887766544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.4e-28 Score=267.64 Aligned_cols=185 Identities=16% Similarity=0.175 Sum_probs=146.9
Q ss_pred cccceecccCcEEEEEEEEeCCeEEEEEEeccCCch--------hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEE
Q 007892 212 SEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQ--------GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 212 ~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~--------~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV 283 (586)
...++||+|+||.||+|.. .++.+++|++...... ..+.+.+|+++|.+++||||+++..++...+..+||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3357899999999999954 5678889886443211 124588999999999999999766677778888999
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCC
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 363 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 363 (586)
|||+++++|.+++.. ++.|+.|+++||+|||++ +|+||||||+||||++ .+||+|||+++.....
T Consensus 418 mE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 418 MSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred EECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 999999999999864 458999999999999998 9999999999999999 9999999999976443
Q ss_pred CCc------ccccccccccccCcccccC--CCCCCcchHHHHHHHHHHHHhCCCCCC
Q 007892 364 DTH------VSTRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVLLLELITGFRPFD 412 (586)
Q Consensus 364 ~~~------~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvvL~elltG~~Pf~ 412 (586)
... .....+||+.|||||++.. ..|+...|+|+..+-.++-+.++.+|.
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 221 1235689999999999986 568888999999999999988877764
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=8.4e-25 Score=221.80 Aligned_cols=152 Identities=14% Similarity=0.092 Sum_probs=122.3
Q ss_pred HHHHHhcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCc------------------hhHHHHHHHHHHHHhcCC
Q 007892 203 ELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSG------------------QGEREFQAEIEIISQVHH 264 (586)
Q Consensus 203 el~~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~------------------~~~~~~~~Ei~il~~l~H 264 (586)
.+......|.+.+.||+|+||.||+|...+|+.||||.++.... .....+.+|+.+|.+++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 34445566778899999999999999997799999999964321 13456889999999999
Q ss_pred CCcceEEEEEEeCCeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeC
Q 007892 265 RHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD 344 (586)
Q Consensus 265 pniv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~ 344 (586)
| +++.+++.. +..++||||+++++|.+ +.. .....++.|++.||.|||+. +|+||||||+||||+
T Consensus 163 -~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~ 227 (282)
T 1zar_A 163 -G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS 227 (282)
T ss_dssp -T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE
T ss_pred -C-CCcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE
Confidence 4 666665543 55699999999999987 421 23457999999999999998 999999999999999
Q ss_pred CCCCeEEeecccccccCCCCCcccccccccccccCcccccC
Q 007892 345 DSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS 385 (586)
Q Consensus 345 ~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 385 (586)
++.+||+|||+++. +..|+|||++..
T Consensus 228 -~~~vkl~DFG~a~~--------------~~~~~a~e~l~r 253 (282)
T 1zar_A 228 -EEGIWIIDFPQSVE--------------VGEEGWREILER 253 (282)
T ss_dssp -TTEEEECCCTTCEE--------------TTSTTHHHHHHH
T ss_pred -CCcEEEEECCCCeE--------------CCCCCHHHHHHH
Confidence 99999999999963 345788998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=2.8e-20 Score=185.93 Aligned_cols=136 Identities=18% Similarity=0.156 Sum_probs=107.3
Q ss_pred ccccceecccCcEEEEEEEE-eCCeE--EEEEEeccCCch------------------------hHHHHHHHHHHHHhcC
Q 007892 211 FSEANLLGQGGFGYVHKGVL-TNGKV--VAIKQLKAGSGQ------------------------GEREFQAEIEIISQVH 263 (586)
Q Consensus 211 f~~~~~LG~G~fG~Vyk~~~-~~g~~--vAVK~l~~~~~~------------------------~~~~~~~Ei~il~~l~ 263 (586)
|.+.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+.+|.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 66789999999999999997 78999 999987543211 1136789999999998
Q ss_pred CCCc--ceEEEEEEeCCeeEEEEEecCC-C----cHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhh-hcCCCcEEecC
Q 007892 264 HRHL--VSLVGYCTFGSQRLLVYEFVPN-K----TLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH-EDCQPKIIHRD 335 (586)
Q Consensus 264 Hpni--v~l~g~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH-~~~~~~ivHrD 335 (586)
|+++ ..++++ +..+|||||+.+ | .|.+++.. .++.....++.|++.+|.||| +. +|+|||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~---givHrD 196 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEA---ELVHAD 196 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTS---CEECSS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHC---CEEeCC
Confidence 8754 444432 356899999942 4 67665432 234567889999999999999 77 999999
Q ss_pred CCCceeEeCCCCCeEEeeccccccc
Q 007892 336 IKSANILLDDSFEAKVADFGLAKHS 360 (586)
Q Consensus 336 Ik~~NILl~~~~~~kl~DFGla~~~ 360 (586)
|||.||||++ .++|+|||++...
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEET
T ss_pred CCHHHEEEcC--cEEEEECcccccC
Confidence 9999999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.68 E-value=1.5e-17 Score=174.00 Aligned_cols=138 Identities=15% Similarity=0.134 Sum_probs=101.3
Q ss_pred cCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCc--------------hhHH--------HHHHHHHHHHhcCCCC
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSG--------------QGER--------EFQAEIEIISQVHHRH 266 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~--------------~~~~--------~~~~Ei~il~~l~Hpn 266 (586)
--|++.+.||.|+||.||+|...+|+.||||+++.... .... ....|...|.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 34899999999999999999988999999998753210 0011 1235677777775544
Q ss_pred cceEEEEEEeCCeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCC
Q 007892 267 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS 346 (586)
Q Consensus 267 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 346 (586)
+.-..-+.. ...+|||||++|+.|..++. ......++.|++.+|.|||.. +||||||||.||||+++
T Consensus 175 v~vp~p~~~--~~~~LVME~i~G~~L~~l~~--------~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 175 FPVPEPIAQ--SRHTIVMSLVDALPMRQVSS--------VPDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREE 241 (397)
T ss_dssp CSCCCEEEE--ETTEEEEECCSCEEGGGCCC--------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEE
T ss_pred CCCCeeeec--cCceEEEEecCCccHhhhcc--------cHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCC
Confidence 322111111 23479999999999865532 123456889999999999998 99999999999999877
Q ss_pred C----------CeEEeecccccc
Q 007892 347 F----------EAKVADFGLAKH 359 (586)
Q Consensus 347 ~----------~~kl~DFGla~~ 359 (586)
+ .+.|+||+-+..
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCcccccccccceEEEEeCCccc
Confidence 6 389999998754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=6.6e-13 Score=132.04 Aligned_cols=148 Identities=14% Similarity=0.056 Sum_probs=116.2
Q ss_pred HHHHHhcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeeE
Q 007892 203 ELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRL 281 (586)
Q Consensus 203 el~~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~~~~~ 281 (586)
.+....+.|.....++.|+++.||+.... ++.+++|............+.+|+.+|..+. +.++.++++++...+..+
T Consensus 8 ~l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~ 86 (263)
T 3tm0_A 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence 34445567888888999999999998754 6789999986532122346889999999995 677889999999999999
Q ss_pred EEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhc-----------------------------------
Q 007892 282 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED----------------------------------- 326 (586)
Q Consensus 282 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~----------------------------------- 326 (586)
+||||++|.+|.+.+. +......++.+++++|..||..
T Consensus 87 lv~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred EEEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 9999999999987642 1123457888999999999981
Q ss_pred ---------------------CCCcEEecCCCCceeEeCCCCCeEEeeccccc
Q 007892 327 ---------------------CQPKIIHRDIKSANILLDDSFEAKVADFGLAK 358 (586)
Q Consensus 327 ---------------------~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~ 358 (586)
..+.++|+|+++.|||++++..+.|+||+.+.
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01469999999999999876556799999874
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.28 E-value=4.2e-12 Score=125.38 Aligned_cols=137 Identities=17% Similarity=0.086 Sum_probs=100.7
Q ss_pred CccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCC--cceEEEEEEeCCeeEEEEEec
Q 007892 210 NFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH--LVSLVGYCTFGSQRLLVYEFV 287 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpn--iv~l~g~~~~~~~~~lV~E~~ 287 (586)
++....+.+.|..+.||+....+|..++||..... ....+..|+.++..+.+.+ +.++++++..++..++||||+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 34433333455669999998777888999997654 2246788999999986544 556888888777889999999
Q ss_pred CCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcC----------------------------------------
Q 007892 288 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC---------------------------------------- 327 (586)
Q Consensus 288 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~---------------------------------------- 327 (586)
+|.+|. ... .. ...++.++++.|..||...
T Consensus 98 ~G~~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
T 1nd4_A 98 PGQDLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP 167 (264)
T ss_dssp SSEETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred CCcccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccH
Confidence 999884 211 11 2356777788888888641
Q ss_pred ---------------CCcEEecCCCCceeEeCCCCCeEEeecccccc
Q 007892 328 ---------------QPKIIHRDIKSANILLDDSFEAKVADFGLAKH 359 (586)
Q Consensus 328 ---------------~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~ 359 (586)
...++|+|+++.|||++++..+.|+||+.+..
T Consensus 168 ~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 168 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998876677999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.14 E-value=1.2e-10 Score=121.43 Aligned_cols=143 Identities=16% Similarity=0.186 Sum_probs=107.9
Q ss_pred cccceecccCcEEEEEEEEeCCeEEEEEEec--cCCc-hhHHHHHHHHHHHHhcC--CCCcceEEEEEEeC---CeeEEE
Q 007892 212 SEANLLGQGGFGYVHKGVLTNGKVVAIKQLK--AGSG-QGEREFQAEIEIISQVH--HRHLVSLVGYCTFG---SQRLLV 283 (586)
Q Consensus 212 ~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~--~~~~-~~~~~~~~Ei~il~~l~--Hpniv~l~g~~~~~---~~~~lV 283 (586)
...+.|+.|.++.||+....+ ..+++|+.. .... .....+.+|+.+|..|. +..+.+++++|.+. +..++|
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp CEEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred ceEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 346789999999999988754 567888765 3321 22457889999999997 45688899998776 457999
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcC------------------------------------
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC------------------------------------ 327 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~------------------------------------ 327 (586)
|||++|..+.+.. ...++..++..++.++++.|..||...
T Consensus 120 me~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 120 MEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 9999998874321 123677888899999999999999730
Q ss_pred -------------------CCcEEecCCCCceeEeCCCCC--eEEeecccccc
Q 007892 328 -------------------QPKIIHRDIKSANILLDDSFE--AKVADFGLAKH 359 (586)
Q Consensus 328 -------------------~~~ivHrDIk~~NILl~~~~~--~kl~DFGla~~ 359 (586)
.+.++|+|+++.|||++.++. +.|+||+++..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999987753 68999999864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.09 E-value=6.9e-11 Score=120.30 Aligned_cols=185 Identities=19% Similarity=0.220 Sum_probs=121.5
Q ss_pred cceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCC--cceEEEEEEeCC---eeEEEEEec
Q 007892 214 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRH--LVSLVGYCTFGS---QRLLVYEFV 287 (586)
Q Consensus 214 ~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~-Hpn--iv~l~g~~~~~~---~~~lV~E~~ 287 (586)
.+.|+.|....||+.. ..++||+.... .....+.+|+.+|..+. +.. +.+++.++...+ ..|+||||+
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4679999999999853 45788886432 34567899999999884 332 445555544333 347899999
Q ss_pred CCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhc-----------------------------------------
Q 007892 288 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED----------------------------------------- 326 (586)
Q Consensus 288 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~----------------------------------------- 326 (586)
+|..|..... ..++..++..++.+++..|..||..
T Consensus 99 ~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 99 KGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 9998865332 1256667777888888888888851
Q ss_pred --------------CCCcEEecCCCCceeEeCC--CCCeEEeecccccccCCCCCcccc--------------ccccccc
Q 007892 327 --------------CQPKIIHRDIKSANILLDD--SFEAKVADFGLAKHSLDTDTHVST--------------RVMGTFG 376 (586)
Q Consensus 327 --------------~~~~ivHrDIk~~NILl~~--~~~~kl~DFGla~~~~~~~~~~~~--------------~~~gt~~ 376 (586)
..+.++|+|+++.|||+++ +..+.|+||+.+..... ...... ......+
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~-~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDP-DNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECT-THHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCCh-HHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 1246899999999999988 45678999998864311 100000 0000111
Q ss_pred ccC-cccccCCCCCCcchHHHHHHHHHHHHhCCCCC
Q 007892 377 YLA-PEYASSGKLTEKSDVFSFGVLLLELITGFRPF 411 (586)
Q Consensus 377 y~a-PE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf 411 (586)
+.. |+.... .....+.|++++++|.+.+|..+|
T Consensus 254 ~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 122 222211 122368999999999999997765
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.61 E-value=3.8e-07 Score=92.76 Aligned_cols=136 Identities=21% Similarity=0.204 Sum_probs=92.7
Q ss_pred cceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCC---CcceEEEEEE-eCCeeEEEEEecCC
Q 007892 214 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHR---HLVSLVGYCT-FGSQRLLVYEFVPN 289 (586)
Q Consensus 214 ~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hp---niv~l~g~~~-~~~~~~lV~E~~~~ 289 (586)
.+.++.|....||+. |..++||+-. .......+..|+.+|..|.+. .+.+++.++. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 467888999999987 5667888743 223356789999999999753 3566777774 34567899999999
Q ss_pred CcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhc-------------------------------------------
Q 007892 290 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED------------------------------------------- 326 (586)
Q Consensus 290 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~------------------------------------------- 326 (586)
..|...... .++..++..++.++++.|..||..
T Consensus 98 ~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 98 QILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp EECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred eECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 888653211 123333444444444444444431
Q ss_pred --------------CCCcEEecCCCCceeEeCC---CCCe-EEeecccccc
Q 007892 327 --------------CQPKIIHRDIKSANILLDD---SFEA-KVADFGLAKH 359 (586)
Q Consensus 327 --------------~~~~ivHrDIk~~NILl~~---~~~~-kl~DFGla~~ 359 (586)
..+.++|+|+++.|||++. ++.+ .|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2346799999999999987 4554 8999998754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.50 E-value=9.7e-07 Score=87.49 Aligned_cols=135 Identities=17% Similarity=0.091 Sum_probs=95.2
Q ss_pred eecccCcE-EEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeeEEEEEecCCCcH
Q 007892 216 LLGQGGFG-YVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLLVYEFVPNKTL 292 (586)
Q Consensus 216 ~LG~G~fG-~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~~~~~lV~E~~~~gsL 292 (586)
.+..|..| .||+.... ++..++||+-... ...++.+|+.+|..+. +--+.++++++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45555554 69987754 4567888976432 3567889999999885 33467889999999999999999999888
Q ss_pred HHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhc----------------------------------------------
Q 007892 293 EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED---------------------------------------------- 326 (586)
Q Consensus 293 ~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~---------------------------------------------- 326 (586)
.+..... ......++.+++..|.-||..
T Consensus 108 ~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 108 FQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred cccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 6654221 122334555555555555532
Q ss_pred ---------CCCcEEecCCCCceeEeCCCCCeEEeecccccc
Q 007892 327 ---------CQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 359 (586)
Q Consensus 327 ---------~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~ 359 (586)
..+.++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 122379999999999999877677999998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.47 E-value=3.1e-07 Score=95.16 Aligned_cols=80 Identities=10% Similarity=-0.004 Sum_probs=57.0
Q ss_pred ccee-cccCcEEEEEEEEe-------CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcC-C--CCcceEEEEEEeC--
Q 007892 214 ANLL-GQGGFGYVHKGVLT-------NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVH-H--RHLVSLVGYCTFG-- 277 (586)
Q Consensus 214 ~~~L-G~G~fG~Vyk~~~~-------~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~-H--pniv~l~g~~~~~-- 277 (586)
.+.| +.|....+|+.... ++..+++|+..... ......+.+|+.+|..|. + -.+.++++++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4677 88989999998765 26778888764432 111246788999988885 3 3567788887665
Q ss_pred -CeeEEEEEecCCCcHH
Q 007892 278 -SQRLLVYEFVPNKTLE 293 (586)
Q Consensus 278 -~~~~lV~E~~~~gsL~ 293 (586)
+..++||||++|..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3568999999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.26 E-value=2.8e-06 Score=86.92 Aligned_cols=140 Identities=19% Similarity=0.304 Sum_probs=81.4
Q ss_pred cceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcC-----CCCcceEE-E--EEEeCCeeEEEEE
Q 007892 214 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-----HRHLVSLV-G--YCTFGSQRLLVYE 285 (586)
Q Consensus 214 ~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~-----Hpniv~l~-g--~~~~~~~~~lV~E 285 (586)
.+.|+.|..+.||+....+| .+++|+.... ...+..|+.++..|. .|.++... | +....+..++|||
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EEECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 34566677899999987555 5889988652 234445566665553 34444310 1 1234677899999
Q ss_pred ecCCCcHH--------------HHhcC----CC-C-------CCCChHHHH-----------------------------
Q 007892 286 FVPNKTLE--------------FHLHG----KD-R-------PVMNWPTRM----------------------------- 310 (586)
Q Consensus 286 ~~~~gsL~--------------~~l~~----~~-~-------~~l~~~~~~----------------------------- 310 (586)
|++|..+. ..||. .. . ....|....
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986542 11221 10 0 112343211
Q ss_pred --HHHHHHHHHhHhhhh----------cCCCcEEecCCCCceeEeCCCCCeEEeeccccc
Q 007892 311 --KIALGSARGLAYLHE----------DCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 358 (586)
Q Consensus 311 --~ia~~ia~gL~yLH~----------~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~ 358 (586)
.+...+..++.+|+. .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 011123345666663 124589999999999999888889999999874
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.21 E-value=4.2e-06 Score=88.03 Aligned_cols=75 Identities=16% Similarity=0.105 Sum_probs=50.2
Q ss_pred cceecccCcEEEEEEEEe-CCeEEEEEEeccCCc-------hhHHHHHHHHHHHHhcCC--CCc-ceEEEEEEeCCeeEE
Q 007892 214 ANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-------QGEREFQAEIEIISQVHH--RHL-VSLVGYCTFGSQRLL 282 (586)
Q Consensus 214 ~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~-------~~~~~~~~Ei~il~~l~H--pni-v~l~g~~~~~~~~~l 282 (586)
.+.||.|.++.||++... +++.|+||....... .....+..|+++|..+.. +.+ .+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 568999999999999754 467899998653221 122456789999988742 443 456544 3455689
Q ss_pred EEEecCCC
Q 007892 283 VYEFVPNK 290 (586)
Q Consensus 283 V~E~~~~g 290 (586)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999874
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.09 E-value=9.2e-06 Score=81.45 Aligned_cols=80 Identities=16% Similarity=0.174 Sum_probs=59.8
Q ss_pred cCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCC---CCcceEEEEEEeCCeeEEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHH---RHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~H---pniv~l~g~~~~~~~~~lV~E 285 (586)
..+...+.+|.|..+.||+.++.||+.|.||+...........|..|+..|+.|.- --+.+++++. ..++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence 45666788999999999999999999999998755444444578899999998852 2344555442 2478999
Q ss_pred ecCCCcH
Q 007892 286 FVPNKTL 292 (586)
Q Consensus 286 ~~~~gsL 292 (586)
|++++..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9987643
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.07 E-value=7.7e-06 Score=86.79 Aligned_cols=78 Identities=10% Similarity=0.101 Sum_probs=48.5
Q ss_pred CCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCccccccc--ccccccCcccccCC---CCCCcchHHHHHHHHH
Q 007892 328 QPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM--GTFGYLAPEYASSG---KLTEKSDVFSFGVLLL 402 (586)
Q Consensus 328 ~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~---~~s~ksDVwSlGvvL~ 402 (586)
.+.++|+|+++.|||++.++ ++|+||+.+...... ... .... -...|++|++.... .-....++..+...+|
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~-~Dl-a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG-FDI-GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH-HHH-HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH-HHH-HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 45899999999999998876 999999998752111 000 0011 12346676665421 1112345567888888
Q ss_pred HHHhCC
Q 007892 403 ELITGF 408 (586)
Q Consensus 403 elltG~ 408 (586)
+.+.+.
T Consensus 308 ~~y~~~ 313 (420)
T 2pyw_A 308 NLFNKR 313 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 877753
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.02 E-value=2.9e-05 Score=79.04 Aligned_cols=139 Identities=16% Similarity=0.151 Sum_probs=93.7
Q ss_pred cccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcC---CCCcceEEEEEEeCCeeEEEEEecC
Q 007892 212 SEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH---HRHLVSLVGYCTFGSQRLLVYEFVP 288 (586)
Q Consensus 212 ~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~---Hpniv~l~g~~~~~~~~~lV~E~~~ 288 (586)
...+.|+.|....+|+... ++..++||+.... ....+..|+..|..|. ...+.++++++...+..++||||++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 3457799999999999875 4667888986532 3567889999998884 3568889999888888999999999
Q ss_pred CCcHH-----------HHhcCCCC-C-------------------CCChHHHH---HHH--HH--------------HHH
Q 007892 289 NKTLE-----------FHLHGKDR-P-------------------VMNWPTRM---KIA--LG--------------SAR 318 (586)
Q Consensus 289 ~gsL~-----------~~l~~~~~-~-------------------~l~~~~~~---~ia--~~--------------ia~ 318 (586)
+..+. -.||.... . .-+|.... ++. .+ ++.
T Consensus 115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~ 194 (312)
T 3jr1_A 115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ 194 (312)
T ss_dssp CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence 87642 12333211 0 12454321 111 11 111
Q ss_pred H-hHhhhh-cCCCcEEecCCCCceeEeCCCCCeEEeecc
Q 007892 319 G-LAYLHE-DCQPKIIHRDIKSANILLDDSFEAKVADFG 355 (586)
Q Consensus 319 g-L~yLH~-~~~~~ivHrDIk~~NILl~~~~~~kl~DFG 355 (586)
- ...|.. ...+.+||+|+.+.|||++.++ +.|.||.
T Consensus 195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1 123321 2256899999999999999887 8899974
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=97.78 E-value=4e-06 Score=56.36 Aligned_cols=21 Identities=24% Similarity=0.567 Sum_probs=16.2
Q ss_pred CCCCCCCcccceEehhhHHHH
Q 007892 65 NGYLPPGALAGMVVGVVIGAG 85 (586)
Q Consensus 65 ~~~l~~~~~~~~vvgv~~~~~ 85 (586)
+++++.|+++||+||+++|++
T Consensus 5 ~~~ls~GaIAGiVvG~v~gv~ 25 (38)
T 2k1k_A 5 SRGLTGGEIVAVIFGLLLGAA 25 (38)
T ss_dssp STTCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCceeeeehHHHHHHH
Confidence 457888889888888877654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.74 E-value=0.00011 Score=74.50 Aligned_cols=157 Identities=11% Similarity=0.095 Sum_probs=88.7
Q ss_pred cCHHHHHHHhcCccc-----cceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCC--cceEE
Q 007892 199 FTYEELKIATDNFSE-----ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH--LVSLV 271 (586)
Q Consensus 199 ~~~~el~~~~~~f~~-----~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpn--iv~l~ 271 (586)
++.+++......|.. .+.|+.|....+|+....+| .+++|..... .....+..|+.++..|...+ +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 455666666666654 34567788899999987666 5778987652 11235667788777764212 22222
Q ss_pred E------EEEeCCeeEEEEEecCCCcHHH--------------HhcCC----CCCC------CChHHHHHH---------
Q 007892 272 G------YCTFGSQRLLVYEFVPNKTLEF--------------HLHGK----DRPV------MNWPTRMKI--------- 312 (586)
Q Consensus 272 g------~~~~~~~~~lV~E~~~~gsL~~--------------~l~~~----~~~~------l~~~~~~~i--------- 312 (586)
. +....+..+++++|++|..+.. .+|.. .... ..|.....-
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 1 1123466789999999865311 12211 1110 123221110
Q ss_pred ---HHHHHHHhHhhhhc----CCCcEEecCCCCceeEeCCCCCeEEeeccccc
Q 007892 313 ---ALGSARGLAYLHED----CQPKIIHRDIKSANILLDDSFEAKVADFGLAK 358 (586)
Q Consensus 313 ---a~~ia~gL~yLH~~----~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~ 358 (586)
...+...+++|+.. ....++|+|+++.|||++++..+.|+||+.+.
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 01133445555432 23479999999999999887556799999874
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00014 Score=77.35 Aligned_cols=73 Identities=21% Similarity=0.233 Sum_probs=50.9
Q ss_pred cceecccCcEEEEEEEEeC--------CeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCc-ceEEEEEEeCCeeEEEE
Q 007892 214 ANLLGQGGFGYVHKGVLTN--------GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL-VSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 214 ~~~LG~G~fG~Vyk~~~~~--------g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpni-v~l~g~~~~~~~~~lV~ 284 (586)
.+.|+.|-...||+....+ ++.+++|+.... .....+..|+.++..|...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4678889899999998753 468889987432 122455679999988853333 667776542 2899
Q ss_pred EecCCCcH
Q 007892 285 EFVPNKTL 292 (586)
Q Consensus 285 E~~~~gsL 292 (586)
||++|.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986444
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00079 Score=68.29 Aligned_cols=142 Identities=15% Similarity=0.147 Sum_probs=83.4
Q ss_pred cceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCC--cceEEEE-----EEeCCeeEEEEEe
Q 007892 214 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH--LVSLVGY-----CTFGSQRLLVYEF 286 (586)
Q Consensus 214 ~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpn--iv~l~g~-----~~~~~~~~lV~E~ 286 (586)
...|+ |....||+....+|+.+++|...... .....+..|+.++..+.... +.+++.. ...++..++||||
T Consensus 31 ~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 31 LTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp CEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred EEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence 34577 88889999877677789999986432 23456777888888774212 3334332 2235567889999
Q ss_pred cCCCcHHH--------------HhcC----C---CCCCCChHHH----HHHH---------------HHHHHHhHhhhhc
Q 007892 287 VPNKTLEF--------------HLHG----K---DRPVMNWPTR----MKIA---------------LGSARGLAYLHED 326 (586)
Q Consensus 287 ~~~gsL~~--------------~l~~----~---~~~~l~~~~~----~~ia---------------~~ia~gL~yLH~~ 326 (586)
++|..+.. .+|. . ....+++... ..++ ..+...++.+...
T Consensus 109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 188 (328)
T 1zyl_A 109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH 188 (328)
T ss_dssp CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence 98855320 1121 1 0112232211 0000 0111122222221
Q ss_pred ----CCCcEEecCCCCceeEeCCCCCeEEeecccccc
Q 007892 327 ----CQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 359 (586)
Q Consensus 327 ----~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~ 359 (586)
....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234689999999999999 4 899999988754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00036 Score=70.20 Aligned_cols=137 Identities=12% Similarity=0.072 Sum_probs=76.3
Q ss_pred cceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCc-ceEEEEEEeCCeeEEEEEec-CCCc
Q 007892 214 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL-VSLVGYCTFGSQRLLVYEFV-PNKT 291 (586)
Q Consensus 214 ~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpni-v~l~g~~~~~~~~~lV~E~~-~~gs 291 (586)
.+.|+.|....+|+. ..+++|+....... .....+|+.++..+...++ .++++++ .+.-++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence 678999999999998 45778887543211 1233568888877753233 4666544 33456899999 6655
Q ss_pred HHH------------------HhcCCCCCC---CC-hHHHHHHHHH--------------HHHHhH----hhhh-cCCCc
Q 007892 292 LEF------------------HLHGKDRPV---MN-WPTRMKIALG--------------SARGLA----YLHE-DCQPK 330 (586)
Q Consensus 292 L~~------------------~l~~~~~~~---l~-~~~~~~ia~~--------------ia~gL~----yLH~-~~~~~ 330 (586)
|.. .||...... .. +.....+... +...+. .|.. .....
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 431 122221100 11 1111111100 111111 1111 12346
Q ss_pred EEecCCCCceeEeCCCCCeEEeecccccc
Q 007892 331 IIHRDIKSANILLDDSFEAKVADFGLAKH 359 (586)
Q Consensus 331 ivHrDIk~~NILl~~~~~~kl~DFGla~~ 359 (586)
++|+|+.+.||| ..++.+.|+||..+..
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 899999999999 5566789999988753
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00055 Score=69.76 Aligned_cols=141 Identities=13% Similarity=0.072 Sum_probs=73.0
Q ss_pred cceecccCcEE-EEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCC--CCcceEEEEEEeCCeeEEEEEecCCC
Q 007892 214 ANLLGQGGFGY-VHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHH--RHLVSLVGYCTFGSQRLLVYEFVPNK 290 (586)
Q Consensus 214 ~~~LG~G~fG~-Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~H--pniv~l~g~~~~~~~~~lV~E~~~~g 290 (586)
.+.|+.|.... +|+....+|..+++|...... ...+..|+.++..+.. -.+.+++.++...+ +++||++.+.
T Consensus 23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~ 97 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA 97 (333)
T ss_dssp ECC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred eeECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence 34566565444 667665346677777644321 1334567777776642 23556776644333 7899999776
Q ss_pred cHHHHhc---------------------CCCC---CCCChHHHH-------HH-------------HHHHHHHhHhhhh-
Q 007892 291 TLEFHLH---------------------GKDR---PVMNWPTRM-------KI-------------ALGSARGLAYLHE- 325 (586)
Q Consensus 291 sL~~~l~---------------------~~~~---~~l~~~~~~-------~i-------------a~~ia~gL~yLH~- 325 (586)
.+..++. .... ..++..... .+ ...+...++.|..
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 6643332 1111 111111000 00 0011112222211
Q ss_pred --cCCCcEEecCCCCceeEeCCC----CCeEEeecccccc
Q 007892 326 --DCQPKIIHRDIKSANILLDDS----FEAKVADFGLAKH 359 (586)
Q Consensus 326 --~~~~~ivHrDIk~~NILl~~~----~~~kl~DFGla~~ 359 (586)
.....++|+|+.+.|||++.+ ..+.|+||+.+..
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 123479999999999999874 6789999998864
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00058 Score=73.09 Aligned_cols=74 Identities=12% Similarity=0.086 Sum_probs=49.2
Q ss_pred cceecccCcEEEEEEEEeC-CeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCc-ceEEEEEEeCCeeEEEEEecCCCc
Q 007892 214 ANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL-VSLVGYCTFGSQRLLVYEFVPNKT 291 (586)
Q Consensus 214 ~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpni-v~l~g~~~~~~~~~lV~E~~~~gs 291 (586)
.+.|+.|-...+|+....+ +..+++|+....... ..+...|..++..|...++ .++++++. +. +||||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~G--~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--NG--RIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--TE--EEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--Ce--EEEEeeCCcc
Confidence 4678888889999998765 478889987443211 1123689999999875555 56777663 32 5999998755
Q ss_pred H
Q 007892 292 L 292 (586)
Q Consensus 292 L 292 (586)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.30 E-value=0.00067 Score=70.76 Aligned_cols=140 Identities=17% Similarity=0.178 Sum_probs=83.6
Q ss_pred cceecccCcEEEEEEEEeC--------CeEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeeEEEE
Q 007892 214 ANLLGQGGFGYVHKGVLTN--------GKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 214 ~~~LG~G~fG~Vyk~~~~~--------g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~~~~~lV~ 284 (586)
.+.|..|-...+|+....+ ++.+++|+.... ......+.+|..+++.|. +.-..++++++.+ .+||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 4567778889999988642 468889986332 223456778999998885 3333567766643 2899
Q ss_pred EecCCCcHHH-----------------HhcCCCC---CCCC--hHHHHHHHHHHHH-------------------HhHhh
Q 007892 285 EFVPNKTLEF-----------------HLHGKDR---PVMN--WPTRMKIALGSAR-------------------GLAYL 323 (586)
Q Consensus 285 E~~~~gsL~~-----------------~l~~~~~---~~l~--~~~~~~ia~~ia~-------------------gL~yL 323 (586)
||++|.+|.. .||.... .... |.++.++..++.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 9999866531 1232211 1122 3444444433322 12333
Q ss_pred hh----c-CCCcEEecCCCCceeEeCCC----CCeEEeeccccc
Q 007892 324 HE----D-CQPKIIHRDIKSANILLDDS----FEAKVADFGLAK 358 (586)
Q Consensus 324 H~----~-~~~~ivHrDIk~~NILl~~~----~~~kl~DFGla~ 358 (586)
.. . ....++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 21 1 23468999999999999876 789999998875
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.28 E-value=8.3e-05 Score=51.45 Aligned_cols=30 Identities=20% Similarity=0.244 Sum_probs=14.8
Q ss_pred cceEehhhHHHHHHHHHHHHHHHHHhhhhh
Q 007892 74 AGMVVGVVIGAGIVLAAVGIFLIFYKRRKR 103 (586)
Q Consensus 74 ~~~vvgv~~~~~~~~~~~~~~~~~~rrr~~ 103 (586)
.+|++|||+|++++++++++++|++|||++
T Consensus 11 ~~IA~gVVgGv~~~~ii~~~~~~~~RRr~~ 40 (44)
T 2ks1_B 11 PSIATGMVGALLLLLVVALGIGLFMRRRHI 40 (44)
T ss_dssp SSSTHHHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred ceEEeehhHHHHHHHHHHHHHHHHhhhhHh
Confidence 345566665554444444444444444443
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.24 E-value=0.00056 Score=70.90 Aligned_cols=74 Identities=11% Similarity=0.032 Sum_probs=45.3
Q ss_pred cceecccCcEEEEEEEEeC---------CeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCC-cceEEEEEEeCCeeEEE
Q 007892 214 ANLLGQGGFGYVHKGVLTN---------GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH-LVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 214 ~~~LG~G~fG~Vyk~~~~~---------g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpn-iv~l~g~~~~~~~~~lV 283 (586)
.+.|+.|....+|+....+ ++.+++|+....... ..+...|..++..+...+ ..++++.. . -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 4567888889999998754 267888886543211 123467888888875333 34666544 2 2689
Q ss_pred EEecCCCcH
Q 007892 284 YEFVPNKTL 292 (586)
Q Consensus 284 ~E~~~~gsL 292 (586)
|||++|..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987544
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.22 E-value=8.6e-05 Score=51.20 Aligned_cols=30 Identities=20% Similarity=0.298 Sum_probs=14.8
Q ss_pred cceEehhhHHHHHHHHHHHHHHHHHhhhhh
Q 007892 74 AGMVVGVVIGAGIVLAAVGIFLIFYKRRKR 103 (586)
Q Consensus 74 ~~~vvgv~~~~~~~~~~~~~~~~~~rrr~~ 103 (586)
.+|++|+++|+++++++++.+++++|||++
T Consensus 10 ~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~ 39 (44)
T 2l2t_A 10 PLIAAGVIGGLFILVIVGLTFAVYVRRKSI 39 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred ceEEEeehHHHHHHHHHHHHHHHHhhhhhh
Confidence 445566665554444444444444444443
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0012 Score=67.70 Aligned_cols=31 Identities=19% Similarity=0.293 Sum_probs=27.5
Q ss_pred CcEEecCCCCceeEeCCCCCeEEeecccccc
Q 007892 329 PKIIHRDIKSANILLDDSFEAKVADFGLAKH 359 (586)
Q Consensus 329 ~~ivHrDIk~~NILl~~~~~~kl~DFGla~~ 359 (586)
..++|+|+.+.|||+++++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4799999999999999888899999987753
|
| >2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.16 E-value=0.00096 Score=45.80 Aligned_cols=29 Identities=21% Similarity=0.416 Sum_probs=14.8
Q ss_pred cccceEehhhHHHHHHHHHHHHHHHHHhh
Q 007892 72 ALAGMVVGVVIGAGIVLAAVGIFLIFYKR 100 (586)
Q Consensus 72 ~~~~~vvgv~~~~~~~~~~~~~~~~~~rr 100 (586)
.+++|++|+++|++++++++++++++|||
T Consensus 11 ~~~~I~~~vv~Gv~ll~~iv~~~~~~~rR 39 (41)
T 2k9y_A 11 GNLAVIGGVAVGVVLLLVLAGVGFFIHRR 39 (41)
T ss_dssp SSTHHHHHHHHHHHHHHHHHHHHHSSSSS
T ss_pred ceEEEEeehhHHHHHHHHHHHHheeEeee
Confidence 44566666666655433244444444444
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.08 E-value=0.014 Score=61.65 Aligned_cols=74 Identities=8% Similarity=0.039 Sum_probs=49.3
Q ss_pred cceecccCcEEEEEEEEeC--------CeEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeeEEEE
Q 007892 214 ANLLGQGGFGYVHKGVLTN--------GKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 214 ~~~LG~G~fG~Vyk~~~~~--------g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~~~~~lV~ 284 (586)
.+.|..|-...+|+....+ ++.+++|+..... ....+..+|..++..+. +.-..++++.+ .+ ++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEE
Confidence 4678788889999998753 5778888864432 11223467888888875 33345566543 22 6899
Q ss_pred EecCCCcH
Q 007892 285 EFVPNKTL 292 (586)
Q Consensus 285 E~~~~gsL 292 (586)
||++|..|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998664
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=95.98 E-value=0.0022 Score=44.12 Aligned_cols=6 Identities=33% Similarity=0.927 Sum_probs=2.5
Q ss_pred ehhhHH
Q 007892 78 VGVVIG 83 (586)
Q Consensus 78 vgv~~~ 83 (586)
+++++|
T Consensus 15 a~~vVG 20 (44)
T 2jwa_A 15 ISAVVG 20 (44)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 344444
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.39 E-value=0.065 Score=50.86 Aligned_cols=99 Identities=17% Similarity=0.124 Sum_probs=64.4
Q ss_pred CcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcccc
Q 007892 290 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 369 (586)
Q Consensus 290 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 369 (586)
-+|.+.|...+. ++++.+++.++.|.++.|.-+-....+ ..+=+.+..|+|..+|.|.+.+ ..+.
T Consensus 33 vSL~eIL~~~~~-PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQ-PINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred ccHHHHHHHcCC-CcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc-----------
Confidence 478888876554 599999999999999998765221111 1233456899999999887754 1110
Q ss_pred cccccccccCcccccCCCCCCcchHHHHHHHHHHHHh
Q 007892 370 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT 406 (586)
Q Consensus 370 ~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt 406 (586)
.....+.+||... ...+.+.=|||||++||.-+-
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 0122456788764 345788999999999999876
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.47 E-value=0.097 Score=54.64 Aligned_cols=29 Identities=28% Similarity=0.444 Sum_probs=24.5
Q ss_pred cEEecCCCCceeEe------CCCCCeEEeeccccc
Q 007892 330 KIIHRDIKSANILL------DDSFEAKVADFGLAK 358 (586)
Q Consensus 330 ~ivHrDIk~~NILl------~~~~~~kl~DFGla~ 358 (586)
.++|+|+.+.|||+ +++..++|+||-+|.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 36799999999999 456679999998875
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=92.14 E-value=0.81 Score=43.16 Aligned_cols=116 Identities=9% Similarity=0.106 Sum_probs=80.2
Q ss_pred cCCCCcceEEEEEEeCCeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCcee
Q 007892 262 VHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANI 341 (586)
Q Consensus 262 l~Hpniv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NI 341 (586)
..||+++.. .+-...+...+.|+.-+.+.=...+ ..++...+++++..|+....+++.. +|--|.|.||
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i-----k~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL 110 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI-----KSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDEL 110 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG-----GGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGE
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHHH-----HhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceE
Confidence 368999977 4556666665656554322222223 2377889999999999988777654 7889999999
Q ss_pred EeCCCCCeEEeecccccccCCCCCcccccccccccccCcccccCCCCCCcchHH-HHHHHHHHHHhCCCCCC
Q 007892 342 LLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF-SFGVLLLELITGFRPFD 412 (586)
Q Consensus 342 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVw-SlGvvL~elltG~~Pf~ 412 (586)
+++.++.++|.-.|+-..+ .|. ..+ ..|.| .+=+++..+++++..|+
T Consensus 111 ~f~~~~~p~i~~RGik~~l------------------~P~-----~~~-ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQNVV------------------DPL-----PVS-EAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EECTTSCEEESCCEETTTB------------------SCC-----CCC-HHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEcCCCCEEEEEccCccCC------------------CCC-----CCC-HHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999887765332 221 111 22333 57788999999988875
|
| >2l34_A TYRO protein tyrosine kinase-binding protein; immunoreceptor, transmembrane assembly, DAP12, protein bindi; NMR {Homo sapiens} PDB: 2l35_B | Back alignment and structure |
|---|
Probab=91.19 E-value=0.086 Score=33.96 Aligned_cols=17 Identities=47% Similarity=0.806 Sum_probs=10.1
Q ss_pred CCCCCcccceEehhhHH
Q 007892 67 YLPPGALAGMVVGVVIG 83 (586)
Q Consensus 67 ~l~~~~~~~~vvgv~~~ 83 (586)
.++.++++||++|-+++
T Consensus 3 ~L~~gaIaGIVvgdi~~ 19 (33)
T 2l34_A 3 TVSPGVLAGIVVGDLVL 19 (33)
T ss_dssp CCCTHHHHHHHHHHHHH
T ss_pred ccCcceEEeEeHHHHHH
Confidence 35666666666665543
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.85 E-value=0.041 Score=37.89 Aligned_cols=35 Identities=17% Similarity=0.168 Sum_probs=27.6
Q ss_pred CCcccceEehhhHHHHHHHHHHHHHHHHHhhhhhh
Q 007892 70 PGALAGMVVGVVIGAGIVLAAVGIFLIFYKRRKRK 104 (586)
Q Consensus 70 ~~~~~~~vvgv~~~~~~~~~~~~~~~~~~rrr~~~ 104 (586)
.+++++-|||.+++++++++++.+++-.+|++++|
T Consensus 9 ~~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~~kr 43 (44)
T 2l2t_A 9 TPLIAAGVIGGLFILVIVGLTFAVYVRRKSIKKKR 43 (44)
T ss_dssp SHHHHHHHHHHHHHHHHHHHHHHHHHHTTCSSCCC
T ss_pred cceEEEeehHHHHHHHHHHHHHHHHhhhhhhhhcc
Confidence 45677777877777778888888999988887775
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.81 E-value=0.067 Score=36.87 Aligned_cols=34 Identities=18% Similarity=0.298 Sum_probs=25.7
Q ss_pred CcccceEehhhHHHHHHHHHHHHHHHHHhhhhhh
Q 007892 71 GALAGMVVGVVIGAGIVLAAVGIFLIFYKRRKRK 104 (586)
Q Consensus 71 ~~~~~~vvgv~~~~~~~~~~~~~~~~~~rrr~~~ 104 (586)
+++++-|||.+++++++++++.+++-.+++++++
T Consensus 11 ~~IA~gVVgGv~~~~ii~~~~~~~~RRr~~~~kR 44 (44)
T 2ks1_B 11 PSIATGMVGALLLLLVVALGIGLFMRRRHIVRKR 44 (44)
T ss_dssp SSSTHHHHHHHHHHHHHHHHHHHHHHTTTCCSCC
T ss_pred ceEEeehhHHHHHHHHHHHHHHHHhhhhHhhccC
Confidence 4567777776677777888888999888877653
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=88.82 E-value=2 Score=40.59 Aligned_cols=114 Identities=11% Similarity=0.107 Sum_probs=78.5
Q ss_pred CCCCcceEEEEEEeCCeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhH-hhhhcCCCcEEecCCCCcee
Q 007892 263 HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLA-YLHEDCQPKIIHRDIKSANI 341 (586)
Q Consensus 263 ~Hpniv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~-yLH~~~~~~ivHrDIk~~NI 341 (586)
.||++ -...-.+++...+.|+.-+++.=...+. .++...+++++..++.... +++. -+|--|.|+||
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-----~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL 115 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-----KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENL 115 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-----TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-----hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceE
Confidence 68888 3334466677777777654443333442 3778899999999998877 6664 47888999999
Q ss_pred EeCCCCCeEEeecccccccCCCCCcccccccccccccCcccccCCCCCCcchHH-HHHHHHHHHHhCCCCCC
Q 007892 342 LLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF-SFGVLLLELITGFRPFD 412 (586)
Q Consensus 342 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVw-SlGvvL~elltG~~Pf~ 412 (586)
++|.++.++|.-.|+-.. ++|.-+ ...|.| .+=|++..++.++..|+
T Consensus 116 ~f~~~~~p~i~hRGi~~~------------------lpP~e~------~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 116 MFNRALEPFFLHVGVKES------------------LPPDEW------DDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp EECTTCCEEESCCEETTT------------------BSSCSC------CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EEeCCCcEEEEEcCCccc------------------CCCCCC------CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999988876533 223211 123333 56688888888887774
|
| >2l34_A TYRO protein tyrosine kinase-binding protein; immunoreceptor, transmembrane assembly, DAP12, protein bindi; NMR {Homo sapiens} PDB: 2l35_B | Back alignment and structure |
|---|
Probab=87.09 E-value=0.19 Score=32.39 Aligned_cols=29 Identities=21% Similarity=0.516 Sum_probs=21.9
Q ss_pred cccceEehhhHHHHHHHHHHHHHHHHHhh
Q 007892 72 ALAGMVVGVVIGAGIVLAAVGIFLIFYKR 100 (586)
Q Consensus 72 ~~~~~vvgv~~~~~~~~~~~~~~~~~~rr 100 (586)
...|.++|+++|-+++.+++++.+|+++|
T Consensus 4 L~~gaIaGIVvgdi~~t~~i~~~vy~~~r 32 (33)
T 2l34_A 4 VSPGVLAGIVVGDLVLTVLIALAVYFLGR 32 (33)
T ss_dssp CCTHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred cCcceEEeEeHHHHHHHHHHHHHHhheec
Confidence 45678899999987777777777776654
|
| >2klu_A T-cell surface glycoprotein CD4; cell membrane, disulfide bond, HOST- virus interaction, immune response, immunoglobulin domain, lipoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=86.72 E-value=0.15 Score=37.77 Aligned_cols=7 Identities=43% Similarity=0.648 Sum_probs=2.9
Q ss_pred eEehhhH
Q 007892 76 MVVGVVI 82 (586)
Q Consensus 76 ~vvgv~~ 82 (586)
||+|.++
T Consensus 12 ivlGg~~ 18 (70)
T 2klu_A 12 IVLGGVA 18 (70)
T ss_dssp HHHHHHH
T ss_pred HHHhHHH
Confidence 3444443
|
| >1iij_A ERBB-2 receptor protein-tyrosine kinase; alpha-helix-PI-bulge-alpha-helix, signaling protein; NMR {Synthetic} SCOP: j.35.1.1 | Back alignment and structure |
|---|
Probab=86.22 E-value=0.094 Score=34.06 Aligned_cols=8 Identities=50% Similarity=0.567 Sum_probs=3.3
Q ss_pred HHHHHhhh
Q 007892 94 FLIFYKRR 101 (586)
Q Consensus 94 ~~~~~rrr 101 (586)
+.+++|||
T Consensus 27 ~~~~iRRr 34 (35)
T 1iij_A 27 VGILIKRR 34 (35)
T ss_dssp TTHHHHHC
T ss_pred hheEEeec
Confidence 33444444
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=86.00 E-value=0.16 Score=34.85 Aligned_cols=28 Identities=21% Similarity=0.469 Sum_probs=14.6
Q ss_pred cccceEehhhHHHHHHHHHHHHHHHHHhhhh
Q 007892 72 ALAGMVVGVVIGAGIVLAAVGIFLIFYKRRK 102 (586)
Q Consensus 72 ~~~~~vvgv~~~~~~~~~~~~~~~~~~rrr~ 102 (586)
.+++++||+++ + +++++++++|++|||.
T Consensus 13 ~Ia~~vVGvll-~--vi~~l~~~~~~RRR~~ 40 (44)
T 2jwa_A 13 SIISAVVGILL-V--VVLGVVFGILIKRRQQ 40 (44)
T ss_dssp HHHHHHHHHHH-H--HHHHHHHHHHHHHHCS
T ss_pred chHHHHHHHHH-H--HHHHHHHHhheehhhh
Confidence 47788888654 3 2333334444444443
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=83.65 E-value=0.096 Score=55.87 Aligned_cols=61 Identities=3% Similarity=-0.020 Sum_probs=18.1
Q ss_pred ccceecccCcEEEEEEEEeC-CeEEEE------EEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 007892 213 EANLLGQGGFGYVHKGVLTN-GKVVAI------KQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTF 276 (586)
Q Consensus 213 ~~~~LG~G~fG~Vyk~~~~~-g~~vAV------K~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~ 276 (586)
+.+.|| ||.||+|.+.. ...||| |.++... .+....|.+|..++..++|+|+++.+++...
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 346676 99999999864 357888 7665432 2223468889999999999999999887653
|
| >2l8s_A Integrin alpha-1; transmembrane region, detergent micelle, CE adhesion; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=81.54 E-value=0.89 Score=32.59 Aligned_cols=26 Identities=8% Similarity=-0.074 Sum_probs=16.2
Q ss_pred ccceEehhhHHHHHHHHHHHHHHHHH
Q 007892 73 LAGMVVGVVIGAGIVLAAVGIFLIFY 98 (586)
Q Consensus 73 ~~~~vvgv~~~~~~~~~~~~~~~~~~ 98 (586)
-..+|++.++|++++++++.+++|.|
T Consensus 8 p~WiIi~svl~GLLLL~Lii~~LwK~ 33 (54)
T 2l8s_A 8 PLWVILLSAFAGLLLLMLLILALWKI 33 (54)
T ss_dssp CTHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHHHHHHHHHHHHc
Confidence 35566666666666666666666643
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=81.40 E-value=0.82 Score=30.40 Aligned_cols=35 Identities=29% Similarity=0.364 Sum_probs=24.4
Q ss_pred CCCCCcccceEehhhHHHHHHHHHHHHHHHHHhhh
Q 007892 67 YLPPGALAGMVVGVVIGAGIVLAAVGIFLIFYKRR 101 (586)
Q Consensus 67 ~l~~~~~~~~vvgv~~~~~~~~~~~~~~~~~~rrr 101 (586)
..+.+...|.|+|+++|.++.+++++.+.||+.||
T Consensus 3 ~~~~~ls~GaIAGiVvG~v~gv~li~~l~~~~~rr 37 (38)
T 2k1k_A 3 PVSRGLTGGEIVAVIFGLLLGAALLLGILVFRSRR 37 (38)
T ss_dssp SSSTTCCHHHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCCceeeeehHHHHHHHHHHHHHHHHeec
Confidence 44667889999999999877666555544444433
|
| >2knc_B Integrin beta-3; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=81.15 E-value=1.1 Score=35.05 Aligned_cols=23 Identities=9% Similarity=0.225 Sum_probs=10.3
Q ss_pred ccceEehhhHHHHHHHHHHHHHHH
Q 007892 73 LAGMVVGVVIGAGIVLAAVGIFLI 96 (586)
Q Consensus 73 ~~~~vvgv~~~~~~~~~~~~~~~~ 96 (586)
+.+|++|+++ +++++.++++++|
T Consensus 10 ~~~Iv~gvi~-gilliGllllliw 32 (79)
T 2knc_B 10 ILVVLLSVMG-AILLIGLAALLIW 32 (79)
T ss_dssp SHHHHHHHHH-HHHHHHHHHHHHH
T ss_pred chhhHHHHHH-HHHHHHHHHHHHH
Confidence 3445445444 3444444444444
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 586 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-77 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-72 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-70 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-69 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-69 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-68 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-67 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-67 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-66 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-66 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 9e-66 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-64 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-64 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-63 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-63 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-62 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-61 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-61 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-60 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-60 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-60 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-59 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-59 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-59 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-57 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-57 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-57 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-56 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-56 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-56 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-53 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-53 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-51 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-50 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-50 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-48 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 9e-48 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-47 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-47 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-47 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-47 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-47 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-46 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-45 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-45 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-44 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-43 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-43 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-42 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-42 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-42 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-42 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-41 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-39 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-39 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-38 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-34 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-33 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-32 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-31 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-24 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 242 bits (620), Expect = 6e-77
Identities = 76/294 (25%), Positives = 135/294 (45%), Gaps = 26/294 (8%)
Query: 202 EELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQ 261
++ +I + +G G FG V+KG V + + A + Q + F+ E+ ++ +
Sbjct: 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK 60
Query: 262 VHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLA 321
H +++ +GY T Q +V ++ +L HLH + + IA +A+G+
Sbjct: 61 TRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMD 118
Query: 322 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH-SLDTDTHVSTRVMGTFGYLAP 380
YLH IIHRD+KS NI L + K+ DFGLA S + +H ++ G+ ++AP
Sbjct: 119 YLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
Query: 381 EYA---SSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADG 437
E + +SDV++FG++L EL+TG P+ + + D + +G
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIFMVGRG---- 225
Query: 438 NFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG---NMP 488
+ L + S M A C++ RP QI+ ++E ++P
Sbjct: 226 ----YLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (588), Expect = 3e-72
Identities = 79/283 (27%), Positives = 118/283 (41%), Gaps = 23/283 (8%)
Query: 202 EELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQ 261
+E ++ + LG G FG V G VA+K LK GS F AE ++ Q
Sbjct: 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQ 64
Query: 262 VHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLA 321
+ H+ LV L T ++ E++ N +L L + + +A A G+A
Sbjct: 65 LQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 322 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPE 381
++ E IHRD+++ANIL+ D+ K+ADFGLA+ D + + APE
Sbjct: 124 FIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 180
Query: 382 YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 441
+ G T KSDV+SFG+LL E++T R T + + Q L G
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE----------VIQNLERGYRMV 230
Query: 442 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484
D EE + C + RP + LE
Sbjct: 231 RPDNCPEE--------LYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (581), Expect = 2e-70
Identities = 56/221 (25%), Positives = 106/221 (47%), Gaps = 9/221 (4%)
Query: 204 LKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE-FQAEIEIISQ 261
+++ D+F + + LG G G V K +G V+A K + R E++++ +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 262 VHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLA 321
+ ++V G + + E + +L+ L R + K+++ +GL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLT 118
Query: 322 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPE 381
YL E KI+HRD+K +NIL++ E K+ DFG++ +D+ ++ +GT Y++PE
Sbjct: 119 YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPE 173
Query: 382 YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSM 422
+ +SD++S G+ L+E+ G P D + M
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (568), Expect = 2e-69
Identities = 71/276 (25%), Positives = 118/276 (42%), Gaps = 23/276 (8%)
Query: 209 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLV 268
+ +G G FG VH G N VAIK ++ G+ E +F E E++ ++ H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLV 63
Query: 269 SLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 328
L G C + LV+EF+ + L R + T + + L G+AYL E
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCL-SDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE--- 119
Query: 329 PKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKL 388
+IHRD+ + N L+ ++ KV+DFG+ + LD ST + +PE S +
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179
Query: 389 TEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLE 448
+ KSDV+SFGVL+ E+ + + + + ++ + +
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------------------VVEDISTGFRL 221
Query: 449 EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484
T + C + RP S+++R L
Sbjct: 222 YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (567), Expect = 5e-69
Identities = 75/288 (26%), Positives = 114/288 (39%), Gaps = 23/288 (7%)
Query: 197 STFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEI 256
+ +I ++ LGQG FG V G VAIK LK G+ F E
Sbjct: 5 QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEA 63
Query: 257 EIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS 316
+++ ++ H LV L + +V E++ +L L G+ + P + +A
Sbjct: 64 QVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI 122
Query: 317 ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG 376
A G+AY+ + +HRD+++ANIL+ ++ KVADFGLA+ D +
Sbjct: 123 ASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 179
Query: 377 YLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLAD 436
+ APE A G+ T KSDV+SFG+LL EL T R +
Sbjct: 180 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---------------- 223
Query: 437 GNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484
D + + C R RP + LE
Sbjct: 224 --LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 220 bits (562), Expect = 5e-68
Identities = 74/308 (24%), Positives = 128/308 (41%), Gaps = 40/308 (12%)
Query: 195 FKSTFTYEELKIATDNFSEA---------NLLGQGGFGYVHKGVLT----NGKVVAIKQL 241
F FT+E+ A F++ ++G G FG V G L VAIK L
Sbjct: 3 FIDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL 62
Query: 242 KAG-SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKD 300
K+G + + R+F +E I+ Q H +++ L G T + +++ EF+ N +L+ L D
Sbjct: 63 KSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND 122
Query: 301 RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 360
+ + G A G+ YL +HRD+ + NIL++ + KV+DFGL++
Sbjct: 123 GQ-FTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178
Query: 361 LDTDTHVSTR----VMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADT 416
D + + + APE K T SDV+S+G+++ E+++
Sbjct: 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP----- 233
Query: 417 FADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRM 476
+ D + D +A+ + + C + RP+
Sbjct: 234 YWDMTNQDV-------------INAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKF 280
Query: 477 SQIVRALE 484
QIV L+
Sbjct: 281 GQIVNTLD 288
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (559), Expect = 1e-67
Identities = 64/290 (22%), Positives = 122/290 (42%), Gaps = 29/290 (10%)
Query: 217 LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF 276
+G+G FG V +G G+ VA+K + + +AEI + H +++ +
Sbjct: 11 IGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 277 G----SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC----- 327
+Q LV ++ + +L +L+ R + +K+AL +A GLA+LH +
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 125
Query: 328 QPKIIHRDIKSANILLDDSFEAKVADFGLAK---HSLDTDTHVSTRVMGTFGYLAPEYAS 384
+P I HRD+KS NIL+ + +AD GLA + DT +GT Y+APE
Sbjct: 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 185
Query: 385 S------GKLTEKSDVFSFGVLLLELITGFRPF----DKADTFADDSMVDWAKPFLAQGL 434
+ +++D+++ G++ E+ D + D D + + + +
Sbjct: 186 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV 245
Query: 435 ADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484
+ + + + ++ MA C + R +I + L
Sbjct: 246 CEQKLRPNIPNRWQSCEALR--VMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (552), Expect = 4e-67
Identities = 65/277 (23%), Positives = 112/277 (40%), Gaps = 25/277 (9%)
Query: 209 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLV 268
+ + LG G FG V G VAIK +K GS E EF E +++ + H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 269 SLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 328
L G CT ++ E++ N L +L +++ + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLE---S 118
Query: 329 PKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKL 388
+ +HRD+ + N L++D KV+DFGL+++ LD + S + PE K
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 389 TEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLE 448
+ KSD+++FGVL+ E+ + + P+ + + + Q L
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKM-----------------PY--ERFTNSETAEHIAQGLR 219
Query: 449 EYDSAEMT-RMAACAAACIRHSARRRPRMSQIVRALE 484
Y + ++ +C A RP ++ +
Sbjct: 220 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (547), Expect = 2e-66
Identities = 68/277 (24%), Positives = 110/277 (39%), Gaps = 29/277 (10%)
Query: 209 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLV 268
+G+G FG V G G VA+K +K + + F AE +++Q+ H +LV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLV 63
Query: 269 SLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC 327
L+G L +V E++ +L +L + R V+ +K +L + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--- 120
Query: 328 QPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGK 387
+HRD+ + N+L+ + AKV+DFGL K + T + APE K
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG----KLPVKWTAPEALREKK 176
Query: 388 LTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 447
+ KSDV+SFG+LL E+ + R + + D +
Sbjct: 177 FSTKSDVWSFGILLWEIYSFGRVP-----YPRIPLKDV-------------VPRVEKGYK 218
Query: 448 EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484
+ + C A RP Q+ LE
Sbjct: 219 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 215 bits (548), Expect = 4e-66
Identities = 70/289 (24%), Positives = 125/289 (43%), Gaps = 23/289 (7%)
Query: 197 STFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGEREFQAE 255
S+ Y++ ++ + + + LG G +G V++GV VA+K LK + + E EF E
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKE 63
Query: 256 IEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALG 315
++ ++ H +LV L+G CT ++ EF+ L +L +R ++ + +A
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 123
Query: 316 SARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF 375
+ + YL + IHRD+ + N L+ ++ KVADFGL++
Sbjct: 124 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 180
Query: 376 GYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLA 435
+ APE + K + KSDV++FGVLL E+ T +
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--------------- 225
Query: 436 DGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484
++ L E ++ AC + + RP ++I +A E
Sbjct: 226 ---YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 214 bits (546), Expect = 9e-66
Identities = 64/314 (20%), Positives = 117/314 (37%), Gaps = 51/314 (16%)
Query: 201 YEELKIATDNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQLK-AGSGQGEREFQ 253
L+ +N +G+G FG V + +VA+K LK S + +FQ
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 254 AEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDR------------ 301
E ++++ + ++V L+G C G L++E++ L L
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 302 ----------PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKV 351
P ++ ++ IA A G+AYL E K +HRD+ + N L+ ++ K+
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKI 181
Query: 352 ADFGLAKHSLDTD-THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRP 410
ADFGL+++ D ++ PE + T +SDV+++GV+L E+ +
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
Query: 411 FDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSA 470
+ + + + D + + C
Sbjct: 242 P-----YYGMAHEEV-------------IYYVRDGNILACPENCPLELYNLMRLCWSKLP 283
Query: 471 RRRPRMSQIVRALE 484
RP I R L+
Sbjct: 284 ADRPSFCSIHRILQ 297
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 2e-64
Identities = 70/291 (24%), Positives = 123/291 (42%), Gaps = 32/291 (10%)
Query: 202 EELKIATDNFSEANL-LGQGGFGYVHKGVL---TNGKVVAIKQLKAGSGQGERE-FQAEI 256
++L + DN A++ LG G FG V +GV VAIK LK G+ + + E E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 257 EIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS 316
+I+ Q+ + ++V L+G C +LV E L L GK + ++
Sbjct: 61 QIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQV 118
Query: 317 ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK--HSLDTDTHVSTRVMGT 374
+ G+ YL + +HRD+ + N+LL + AK++DFGL+K + D+ +
Sbjct: 119 SMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175
Query: 375 FGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQG 433
+ APE + K + +SDV+S+GV + E ++ G +P+ +
Sbjct: 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK------KMKGPEV-------- 221
Query: 434 LADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484
+ K E + A + C + RP + + +
Sbjct: 222 -----MAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 7e-64
Identities = 75/296 (25%), Positives = 120/296 (40%), Gaps = 36/296 (12%)
Query: 198 TFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGK----VVAIKQLKAGSGQGE-REF 252
L + +F+E ++G+G FG V+ G L + A+K L + GE +F
Sbjct: 21 VIGPSSLIV---HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF 75
Query: 253 QAEIEIISQVHHRHLVSLVGYCTFG-SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMK 311
E I+ H +++SL+G C L+V ++ + L + + +
Sbjct: 76 LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIG 134
Query: 312 IALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD---THVS 368
L A+G+ K +HRD+ + N +LD+ F KVADFGLA+ D + H
Sbjct: 135 FGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 191
Query: 369 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKP 428
T ++A E + K T KSDV+SFGVLL EL+T P + D + D
Sbjct: 192 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP-----YPDVNTFDITV- 245
Query: 429 FLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484
L+ + + C A RP S++V +
Sbjct: 246 ------------YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (529), Expect = 2e-63
Identities = 66/282 (23%), Positives = 121/282 (42%), Gaps = 29/282 (10%)
Query: 209 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHR 265
+++ +G G +G K ++GK++ K+L GS ++ +E+ ++ ++ H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 266 HLVSLVGYCTFGSQRLL--VYEFVPNKTLEFHLH--GKDRPVMNWPTRMKIALGSARGLA 321
++V + L V E+ L + K+R ++ +++ L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 322 YLHE--DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLA 379
H D ++HRD+K AN+ LD K+ DFGLA+ L+ DT + +GT Y++
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI-LNHDTSFAKAFVGTPYYMS 182
Query: 380 PEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 439
PE + EKSD++S G LL EL PF S + LA + +G F
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT------AFSQKE-----LAGKIREGKF 231
Query: 440 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481
+++ S E+ + + RP + +I+
Sbjct: 232 -----RRIPYRYSDELNEI---ITRMLNLKDYHRPSVEEILE 265
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 2e-63
Identities = 70/295 (23%), Positives = 123/295 (41%), Gaps = 30/295 (10%)
Query: 205 KIATDNFSEANLLGQGGFGYVHKGVLTNG-----KVVAIKQLKAGSGQGER-EFQAEIEI 258
+I + ++G G FG V+KG+L VAIK LKAG + +R +F E I
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 259 ISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR 318
+ Q H +++ L G + +++ E++ N + + + + G A
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGA-LDKFLREKDGEFSVLQLVGMLRGIAA 121
Query: 319 GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD--THVSTRVMGTFG 376
G+ YL +HRD+ + NIL++ + KV+DFGL++ D T+ ++
Sbjct: 122 GMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 377 YLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLAD 436
+ APE S K T SDV+SFG+++ E++T + +
Sbjct: 179 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE----------------- 221
Query: 437 GNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMPLDD 491
A+ D + + C + RRP+ + IV L+ + D
Sbjct: 222 -VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 1e-62
Identities = 72/291 (24%), Positives = 117/291 (40%), Gaps = 34/291 (11%)
Query: 213 EANLLGQGGFGYVHKGVLTN---GKVVAIKQLKAGSGQGE--REFQAEIEIISQVHHRHL 267
E LG G FG V KG K VA+K LK + E AE ++ Q+ + ++
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 268 VSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC 327
V ++G C S +LV E L +L + +++ + G+ YL
Sbjct: 71 VRMIGICEAES-WMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLE--- 124
Query: 328 QPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTR--VMGTFGYLAPEYASS 385
+ +HRD+ + N+LL AK++DFGL+K + + + + APE +
Sbjct: 125 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 386 GKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 444
K + KSDV+SFGVL+ E + G +P+ +M++ +
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM--------------- 229
Query: 445 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMPLDDLNEG 495
E M C + RP + + L N D +NEG
Sbjct: 230 -GCPAGCPRE---MYDLMNLCWTYDVENRPGFAAVELRLR-NYYYDVVNEG 275
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 1e-61
Identities = 71/312 (22%), Positives = 119/312 (38%), Gaps = 47/312 (15%)
Query: 202 EELKIATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSGQGERE-FQA 254
+ + + S LG G FG V + VA+K LK + ERE +
Sbjct: 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 75
Query: 255 EIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGK-------------- 299
E++++S + +H ++V+L+G CT G L++ E+ L L K
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 300 --DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 357
D ++ + + A+G+A+L IHRD+ + NILL K+ DFGLA
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLA 192
Query: 358 KHSLDTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADT 416
+ + + V ++APE + T +SDV+S+G+ L EL +
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252
Query: 417 FADDSMVDWAKPFLAQGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPR 475
D F ++ + M C +RP
Sbjct: 253 V------------------DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPT 294
Query: 476 MSQIVRALEGNM 487
QIV+ +E +
Sbjct: 295 FKQIVQLIEKQI 306
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 3e-61
Identities = 67/277 (24%), Positives = 118/277 (42%), Gaps = 32/277 (11%)
Query: 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLK---AGSGQGEREFQAEIEIISQVHH 264
++F LG+G FG V+ + ++A+K L E + + E+EI S + H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 265 RHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH 324
+++ L GY ++ L+ E+ P T+ L + + A L+Y H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH 123
Query: 325 EDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYAS 384
++IHRDIK N+LL + E K+ADFG + H+ + + GT YL PE
Sbjct: 124 S---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEMIE 177
Query: 385 SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 444
EK D++S GVL E + G PF+ ++ + K + F V
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPPFE------ANTYQETYKRISR---VEFTFPDFVT 228
Query: 445 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481
+ + + ++H+ +RP + +++
Sbjct: 229 EGARD-----------LISRLLKHNPSQRPMLREVLE 254
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (511), Expect = 1e-60
Identities = 66/305 (21%), Positives = 122/305 (40%), Gaps = 35/305 (11%)
Query: 201 YEELKI---ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEI 256
YE + D + LG G FG V+K + A K + S + ++ EI
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60
Query: 257 EIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS 316
+I++ H ++V L+ + + ++ EF ++ + +RP + + +
Sbjct: 61 DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP-LTESQIQVVCKQT 119
Query: 317 ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG 376
L YLH+ KIIHRD+K+ NIL + K+ADFG++ + T + + GT
Sbjct: 120 LDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPY 175
Query: 377 YLAPEYA-----SSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLA 431
++APE K+DV+S G+ L+E+ P + + +
Sbjct: 176 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-----------VL 224
Query: 432 QGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR----ALEGNM 487
+A L S+ C+ + R SQ+++ ++ N
Sbjct: 225 LKIAKSEPPTL---AQPSRWSSNFKDF---LKKCLEKNVDARWTTSQLLQHPFVTVDSNK 278
Query: 488 PLDDL 492
P+ +L
Sbjct: 279 PIREL 283
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 2e-60
Identities = 72/321 (22%), Positives = 125/321 (38%), Gaps = 55/321 (17%)
Query: 197 STFTYEEL-KIATDNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQLKAGSGQGE 249
+ Y+ + +N +LG G FG V VA+K LK + E
Sbjct: 24 REYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE 83
Query: 250 RE-FQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGK-------- 299
RE +E+++++Q+ H ++V+L+G CT L++E+ L +L K
Sbjct: 84 REALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDE 143
Query: 300 -------------DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS 346
D V+ + + A A+G+ +L +HRD+ + N+L+
Sbjct: 144 IEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHG 200
Query: 347 FEAKVADFGLAKHSLDTDTHVS-TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELI 405
K+ DFGLA+ + +V ++APE G T KSDV+S+G+LL E+
Sbjct: 201 KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 260
Query: 406 T-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLE-EYDSAEMTRMAACAA 463
+ G P+ D NF L+ + + +
Sbjct: 261 SLGVNPYPGIPV-------------------DANFYKLIQNGFKMDQPFYATEEIYIIMQ 301
Query: 464 ACIRHSARRRPRMSQIVRALE 484
+C +R+RP + L
Sbjct: 302 SCWAFDSRKRPSFPNLTSFLG 322
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 4e-60
Identities = 65/273 (23%), Positives = 113/273 (41%), Gaps = 32/273 (11%)
Query: 217 LGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGY 273
+G+G F V+KG+ T VA +L+ + + F+ E E++ + H ++V
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 274 CTFGSQR----LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQP 329
+ +LV E + + TL+ +L VM +GL +LH P
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFLHTRT-P 133
Query: 330 KIIHRDIKSANILLDD-SFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKL 388
IIHRD+K NI + + K+ D GLA + V+GT ++APE K
Sbjct: 134 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEMYE-EKY 189
Query: 389 TEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLE 448
E DV++FG+ +LE+ T P+ + + G+ +FD + +++
Sbjct: 190 DESVDVYAFGMCMLEMATSEYPYS------ECQNAAQIYRRVTSGVKPASFDKVAIPEVK 243
Query: 449 EYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481
E CIR + R + ++
Sbjct: 244 E-----------IIEGCIRQNKDERYSIKDLLN 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 2e-59
Identities = 68/295 (23%), Positives = 121/295 (41%), Gaps = 42/295 (14%)
Query: 209 DNFSEANLLGQGGFGYVHKGVLTNG---KVVAIKQLK-AGSGQGEREFQAEIEIISQV-H 263
++ +++G+G FG V K + AIK++K S R+F E+E++ ++ H
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 264 HRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKD--------------RPVMNWPTR 309
H ++++L+G C L E+ P+ L L ++
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 310 MKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 369
+ A ARG+ YL Q + IHRD+ + NIL+ +++ AK+ADFGL++ T
Sbjct: 130 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--T 184
Query: 370 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPF 429
++A E + T SDV+S+GVLL E+++ + + +
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP-----YCGMTCAEL---- 235
Query: 430 LAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484
++ L E + C R RP +QI+ +L
Sbjct: 236 ---------YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 197 bits (503), Expect = 3e-59
Identities = 66/282 (23%), Positives = 110/282 (39%), Gaps = 37/282 (13%)
Query: 208 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGE---REFQAEIEIISQVH 263
FS+ +G G FG V+ + N +VVAIK++ Q ++ E+ + ++
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 264 HRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYL 323
H + + G LV E+ + K + + G+ +GLAYL
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYL 131
Query: 324 HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYA 383
H +IHRD+K+ NILL + K+ DFG A ++ V GT ++APE
Sbjct: 132 HS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVI 183
Query: 384 SS---GKLTEKSDVFSFGVLLLELITGFRPFDKADTFAD-DSMVDWAKPFLAQGLADGNF 439
+ G+ K DV+S G+ +EL P + + + P L G F
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYF 243
Query: 440 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481
VD C++ + RP +++
Sbjct: 244 RNFVDS-------------------CLQKIPQDRPTSEVLLK 266
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 4e-59
Identities = 62/284 (21%), Positives = 113/284 (39%), Gaps = 28/284 (9%)
Query: 206 IATDNFSEANLLGQGGFGYVHKGVLTN----GKVVAIKQLKAGSGQGERE-FQAEIEIIS 260
I + +G+G FG VH+G+ + VAIK K + RE F E +
Sbjct: 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 63
Query: 261 QVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGL 320
Q H H+V L+G T ++ E L L + ++ + + A + L
Sbjct: 64 QFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTAL 121
Query: 321 AYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAP 380
AYL + +HRDI + N+L+ + K+ DFGL+++ D+ + +++ ++AP
Sbjct: 122 AYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178
Query: 381 EYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 440
E + + T SDV+ FGV + E++ + D
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND------------------VIG 220
Query: 441 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484
+ + + + + C + RRPR +++ L
Sbjct: 221 RIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 264
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 3e-57
Identities = 62/289 (21%), Positives = 117/289 (40%), Gaps = 31/289 (10%)
Query: 204 LKIAT-DNFSEANLLGQGGFGYVHKGV-LTNGKV----VAIKQLK-AGSGQGEREFQAEI 256
L+I F + +LG G FG V+KG+ + G+ VAIK+L+ A S + +E E
Sbjct: 3 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 62
Query: 257 EIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS 316
+++ V + H+ L+G C + +L + + +P L + + + + +
Sbjct: 63 YVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCL-LDYVREHKDNIGSQYLLNWCVQI 120
Query: 317 ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT-HVSTRVMGTF 375
A+G+ YL +++HRD+ + N+L+ K+ DFGLAK + + +
Sbjct: 121 AKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 376 GYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLA 435
++A E T +SDV+S+GV + EL+T + +
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP-----YDGIPASEI---------- 222
Query: 436 DGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484
L + + C A RP+ +++
Sbjct: 223 ---SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (485), Expect = 4e-57
Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 9/208 (4%)
Query: 209 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE-FQAEIEIISQVHHRH 266
+++ LG+G +G V V + VA+K + E + EI I ++H +
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 267 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED 326
+V G+ G+ + L E+ L + M P + G+ YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHG- 121
Query: 327 CQPKIIHRDIKSANILLDDSFEAKVADFGLAK-HSLDTDTHVSTRVMGTFGYLAPEYASS 385
I HRDIK N+LLD+ K++DFGLA + + ++ GT Y+APE
Sbjct: 122 --IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 386 GKL-TEKSDVFSFGVLLLELITGFRPFD 412
+ E DV+S G++L ++ G P+D
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWD 207
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 5e-57
Identities = 63/288 (21%), Positives = 99/288 (34%), Gaps = 31/288 (10%)
Query: 206 IATDNFSEANLLGQGGFGYVHKGVLT----NGKVVAIKQLK---AGSGQGEREFQAEIEI 258
I + LG G FG V +G VA+K LK + +F E+
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 259 ISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR 318
+ + HR+L+ L G + +V E P +L K + T + A+ A
Sbjct: 65 MHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSL-LDRLRKHQGHFLLGTLSRYAVQVAE 122
Query: 319 GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH--VSTRVMGTFG 376
G+ YL + IHRD+ + N+LL K+ DFGL + D H + F
Sbjct: 123 GMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 377 YLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLAD 436
+ APE + + SD + FGV L E+ T + + + +G
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP-----WIGLNGSQILHKIDKEG--- 231
Query: 437 GNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484
+ + C H RP + L
Sbjct: 232 ---------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 5e-56
Identities = 68/302 (22%), Positives = 128/302 (42%), Gaps = 37/302 (12%)
Query: 202 EELKIATDNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQLKAGSGQGER-EFQA 254
+E ++A + + + LGQG FG V++GV VAIK + + ER EF
Sbjct: 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 72
Query: 255 EIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDR--------PVMNW 306
E ++ + + H+V L+G + G L++ E + L+ +L +
Sbjct: 73 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 132
Query: 307 PTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD-T 365
+++A A G+AYL K +HRD+ + N ++ + F K+ DFG+ + +TD
Sbjct: 133 SKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 189
Query: 366 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDW 425
+ + +++PE G T SDV+SFGV+L E+ T + S
Sbjct: 190 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-----YQGLSNEQV 244
Query: 426 AKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 485
+++ L + + C +++ + RP +I+ +++
Sbjct: 245 -------------LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 291
Query: 486 NM 487
M
Sbjct: 292 EM 293
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 7e-56
Identities = 74/303 (24%), Positives = 121/303 (39%), Gaps = 44/303 (14%)
Query: 206 IATDNFSEANLLGQGGFGYVHKGV------LTNGKVVAIKQLKAGSGQGE-REFQAEIEI 258
D LG+G FG V + + VA+K LK G+ E R +E++I
Sbjct: 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 69
Query: 259 ISQ-VHHRHLVSLVGYCTF-GSQRLLVYEFVPNKTLEFHLHGKD--------------RP 302
+ HH ++V+L+G CT G +++ EF L +L K +
Sbjct: 70 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 303 VMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362
+ + + A+G+ +L K IHRD+ + NILL + K+ DFGLA+
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186
Query: 363 TDTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDS 421
+V ++APE T +SDV+SFGVLL E+ + +
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----YPGVK 241
Query: 422 MVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481
+ + L +G + +Y + EM + C +RP S++V
Sbjct: 242 IDEEFCRRLKEG---------TRMRAPDYTTPEMYQT---MLDCWHGEPSQRPTFSELVE 289
Query: 482 ALE 484
L
Sbjct: 290 HLG 292
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 9e-56
Identities = 58/294 (19%), Positives = 120/294 (40%), Gaps = 27/294 (9%)
Query: 208 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH 266
++ +GQG G V+ + + G+ VAI+Q+ + EI ++ + + +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 267 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED 326
+V+ + G + +V E++ +L + M+ + + L +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLH-- 133
Query: 327 CQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSG 386
++IHRDIKS NILL K+ DFG + + + ++GT ++APE +
Sbjct: 134 -SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ-ITPEQSKRSTMVGTPYWMAPEVVTRK 191
Query: 387 KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 446
K D++S G++ +E+I G P+ +++ + G + +
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYL------NENPLRALYLIATNGTPELQNPEKLSAI 245
Query: 447 LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA--LEGNMPLDDLNEGITP 498
++ + R C+ +R ++++ L+ PL L I
Sbjct: 246 FRDF----LNR-------CLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAA 288
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 1e-53
Identities = 70/309 (22%), Positives = 121/309 (39%), Gaps = 46/309 (14%)
Query: 206 IATDNFSEANLLGQGGFGYVHKGVLT--------NGKVVAIKQLKAGSGQGE-REFQAEI 256
+ D LG+G FG V VA+K LK+ + + + + +E+
Sbjct: 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM 69
Query: 257 EIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRP------------- 302
E++ + H+++++L+G CT ++ E+ L +L + P
Sbjct: 70 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129
Query: 303 -VMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 361
++ + A ARG+ YL K IHRD+ + N+L+ + K+ADFGLA+
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 186
Query: 362 DTDTHVSTRVM-GTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADD 420
D + T ++APE T +SDV+SFGVLL E+ T +
Sbjct: 187 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP-----YPGV 241
Query: 421 SMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIV 480
+ + F L + + S + C +RP Q+V
Sbjct: 242 PVEEL-------------FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 288
Query: 481 RALEGNMPL 489
L+ + L
Sbjct: 289 EDLDRIVAL 297
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 9e-53
Identities = 51/219 (23%), Positives = 89/219 (40%), Gaps = 10/219 (4%)
Query: 205 KIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLK---AGSGQGEREFQAEIEIIS 260
K ++F +LG+G F V L + AIK L+ E +++S
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 261 QVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGL 320
++ H V L + + N L ++ + L
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSAL 121
Query: 321 AYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK-HSLDTDTHVSTRVMGTFGYLA 379
YLH IIHRD+K NILL++ ++ DFG AK S ++ + +GT Y++
Sbjct: 122 EYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178
Query: 380 PEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFA 418
PE + + SD+++ G ++ +L+ G PF + +
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 217
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 178 bits (452), Expect = 2e-51
Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 9/210 (4%)
Query: 209 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL 267
D++ LG G FG VH+ G A K + + + EI+ +S + H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 268 VSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC 327
V+L ++ +++YEF+ L + + M+ ++ +GL ++HE+
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMHENN 144
Query: 328 QPKIIHRDIKSANILL--DDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS 385
+H D+K NI+ S E K+ DFGL H + T GT + APE A
Sbjct: 145 ---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEG 199
Query: 386 GKLTEKSDVFSFGVLLLELITGFRPFDKAD 415
+ +D++S GVL L++G PF +
Sbjct: 200 KPVGYYTDMWSVGVLSYILLSGLSPFGGEN 229
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 174 bits (443), Expect = 4e-50
Identities = 56/210 (26%), Positives = 92/210 (43%), Gaps = 9/210 (4%)
Query: 209 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL 267
D + LG G FG VH+ V G+V K + + + EI I++Q+HH L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 268 VSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC 327
++L + +L+ EF+ L + +D M+ + + GL ++HE
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMHE-- 145
Query: 328 QPKIIHRDIKSANILLD--DSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS 385
I+H DIK NI+ + + K+ DFGLA + T + APE
Sbjct: 146 -HSIVHLDIKPENIMCETKKASSVKIIDFGLATKL--NPDEIVKVTTATAEFAAPEIVDR 202
Query: 386 GKLTEKSDVFSFGVLLLELITGFRPFDKAD 415
+ +D+++ GVL L++G PF D
Sbjct: 203 EPVGFYTDMWAIGVLGYVLLSGLSPFAGED 232
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 175 bits (444), Expect = 4e-50
Identities = 66/271 (24%), Positives = 107/271 (39%), Gaps = 20/271 (7%)
Query: 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLK---AGSGQGEREFQAEIEIISQVH- 263
++FS ++G+GGFG V+ GK+ A+K L QGE E ++S V
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 264 --HRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLA 321
+V + + + + + L +HL V + A GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS--QHGVFSEADMRFYAAEIILGLE 121
Query: 322 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPE 381
++H +++RD+K ANILLD+ +++D GLA H +GT GY+APE
Sbjct: 122 HMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAPE 175
Query: 382 YASSGK-LTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 440
G +D FS G +L +L+ G PF + T + + L D
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE-LPDSFSP 234
Query: 441 ALVD--QKLEEYDSAE-MTRMAACAAACIRH 468
L + L + D + + A
Sbjct: 235 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 166 bits (420), Expect = 8e-48
Identities = 71/288 (24%), Positives = 122/288 (42%), Gaps = 32/288 (11%)
Query: 208 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGE---REFQAEIEIISQVH 263
+D + +LG GG VH L + VA+K L+A + F+ E + + ++
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 264 HRHLVSLVGYC----TFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARG 319
H +V++ G +V E+V TL +H + M +++ + +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQA 123
Query: 320 LAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV--STRVMGTFGY 377
L + H+ IIHRD+K ANI++ + KV DFG+A+ D+ V + V+GT Y
Sbjct: 124 LNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180
Query: 378 LAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADG 437
L+PE A + +SDV+S G +L E++TG PF DS V D
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT------GDSPVSV---AYQHVREDP 231
Query: 438 NFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPR-MSQIVRALE 484
+ + L + A + + R + +++ L
Sbjct: 232 IPPSARHEGLSA-------DLDAVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 167 bits (423), Expect = 9e-48
Identities = 64/265 (24%), Positives = 104/265 (39%), Gaps = 16/265 (6%)
Query: 209 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLK---AGSGQGEREFQAEIEIISQVHH 264
+F LG G FG VH NG+ A+K LK + E ++S V H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 265 RHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH 324
++ + G Q ++ +++ L L R + L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV-----CLALE 118
Query: 325 EDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYAS 384
II+RD+K NILLD + K+ DFG AK+ D + GT Y+APE S
Sbjct: 119 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPEVVS 174
Query: 385 SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 444
+ + D +SFG+L+ E++ G+ PF ++T + A+ + D L
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLL-- 232
Query: 445 QKLEEYDSAE-MTRMAACAAACIRH 468
+L D ++ + + H
Sbjct: 233 SRLITRDLSQRLGNLQNGTEDVKNH 257
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 166 bits (421), Expect = 2e-47
Identities = 54/217 (24%), Positives = 100/217 (46%), Gaps = 12/217 (5%)
Query: 201 YEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE-FQAEIEI 258
+++ + D + ++LG G F V K+VAIK + + +G+ + EI +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 259 ISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR 318
+ ++ H ++V+L G L+ + V L + K ++
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRLIFQVLD 118
Query: 319 GLAYLHEDCQPKIIHRDIKSANILL---DDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF 375
+ YLH+ I+HRD+K N+L D+ + ++DFGL+K ++ V + GT
Sbjct: 119 AVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSK--MEDPGSVLSTACGTP 173
Query: 376 GYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFD 412
GY+APE + ++ D +S GV+ L+ G+ PF
Sbjct: 174 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFY 210
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 2e-47
Identities = 47/207 (22%), Positives = 95/207 (45%), Gaps = 7/207 (3%)
Query: 209 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHR 265
+NF + +G+G +G V+K G+VVA+K+++ + EI ++ +++H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 266 HLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHE 325
++V L+ ++ LV+EF+ ++ L+ + + P +GLA+ H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 326 DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS 385
++HRD+K N+L++ K+ADFGLA+ + V+ +
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 386 GKLTEKSDVFSFGVLLLELITGFRPFD 412
+ D++S G + E++T F
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFP 204
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 2e-47
Identities = 49/207 (23%), Positives = 89/207 (42%), Gaps = 10/207 (4%)
Query: 209 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL 267
+ + A LG+G FG VH+ V ++ K K +K G + + EI I++ HR++
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNI 63
Query: 268 VSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC 327
+ L + ++++EF+ + ++ +N + L +LH
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFLHS-- 120
Query: 328 QPKIIHRDIKSANILLD--DSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS 385
I H DI+ NI+ S K+ +FG A+ D + Y APE
Sbjct: 121 -HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAPEVHQH 177
Query: 386 GKLTEKSDVFSFGVLLLELITGFRPFD 412
++ +D++S G L+ L++G PF
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINPFL 204
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 2e-47
Identities = 61/292 (20%), Positives = 108/292 (36%), Gaps = 25/292 (8%)
Query: 207 ATDNFSEANLLGQGGFGYVHKG--VLTNGKVVAIKQLKAGSGQGEREFQAEIEI-----I 259
A + +G+G +G V K + G+ VA+K+++ +G+ E+ +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 260 SQVHHRHLVSLVGYCTFGSQR-----LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIAL 314
H ++V L CT LV+E V + P + T +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMF 123
Query: 315 GSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 374
RGL +LH +++HRD+K NIL+ S + K+ADFGLA+ + + T V+ T
Sbjct: 124 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR--IYSFQMALTSVVVT 178
Query: 375 FGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQ-- 432
Y APE D++S G + E+ F + + +
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 433 -----GLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQI 479
L F + Q +E++ + C+ + +R
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 164 bits (417), Expect = 3e-47
Identities = 54/224 (24%), Positives = 90/224 (40%), Gaps = 24/224 (10%)
Query: 209 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSG---------QGEREFQAEIEI 258
+N+ +LG+G V + + K A+K + G + E++I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 259 ISQVH-HRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA 317
+ +V H +++ L + LV++ + L +L K ++ KI
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALL 120
Query: 318 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGY 377
+ LH+ I+HRD+K NILLDD K+ DFG + V GT Y
Sbjct: 121 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTPSY 175
Query: 378 LAPEYASSG------KLTEKSDVFSFGVLLLELITGFRPFDKAD 415
LAPE ++ D++S GV++ L+ G PF
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 219
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 6e-47
Identities = 70/265 (26%), Positives = 105/265 (39%), Gaps = 16/265 (6%)
Query: 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGERE---FQAEIEIIS-QVH 263
++F +LG+G FG V + AIK LK + + E ++S
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 264 HRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYL 323
H L + V E++ L +H+ + + A GL +L
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFL 119
Query: 324 HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYA 383
H I++RD+K NILLD K+ADFG+ K ++ D +T GT Y+APE
Sbjct: 120 HS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEIL 175
Query: 384 SSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 443
K D +SFGVLL E++ G PF D + PF + L D L
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLL- 234
Query: 444 DQKLEEYDSAEMTRMAACAAACIRH 468
KL + + R+ +H
Sbjct: 235 -VKLFVREPEK--RLGV-RGDIRQH 255
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 163 bits (413), Expect = 1e-46
Identities = 52/285 (18%), Positives = 104/285 (36%), Gaps = 18/285 (6%)
Query: 209 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLK--AGSGQGEREFQAEIEIISQVHHRH 266
+ + +G+G +G V+K G+ A+K+++ EI I+ ++ H +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 267 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED 326
+V L + +LV+E + + + + T L G+AY H+
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCHD- 118
Query: 327 CQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSG 386
+++HRD+K N+L++ E K+ADFGLA+ + ++ + S
Sbjct: 119 --RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 387 KLTEKSDVFSFGVLLLELITGFRPFDKADT----------FADDSMVDWAKPFLAQGLAD 436
K + D++S G + E++ G F + +W D
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN-VTELPKYD 235
Query: 437 GNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481
NF E + + ++ +R Q +
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (406), Expect = 2e-45
Identities = 52/293 (17%), Positives = 98/293 (33%), Gaps = 31/293 (10%)
Query: 203 ELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQ 261
EL++ + + +G G FG ++ G + G+ VAIK + + E +I
Sbjct: 2 ELRVG-NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKM 58
Query: 262 VHHRHLVSLVGYC-TFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGL 320
+ + + +C G ++V E + + + + T + +A +
Sbjct: 59 MQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRI 116
Query: 321 AYLHEDCQPKIIHRDIKSANIL---LDDSFEAKVADFGLAKHSLDTDTHV------STRV 371
Y+H IHRD+K N L + DFGLAK D TH + +
Sbjct: 117 EYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL 173
Query: 372 MGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLA 431
GT Y + + + + D+ S G +L+ G P+ +
Sbjct: 174 TGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE--- 230
Query: 432 QGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484
+ + L + +E C +P S + +
Sbjct: 231 ------KKMSTPIEVLCKGYPSEFATYLNF---CRSLRFDDKPDYSYLRQLFR 274
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 8e-45
Identities = 64/282 (22%), Positives = 112/282 (39%), Gaps = 21/282 (7%)
Query: 215 NLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQG-----EREFQAEIEIISQVHHRHLV 268
+ LG+G F V+K N ++VAIK++K G R EI+++ ++ H +++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 269 SLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 328
L+ S LV++F+ + L + +GL YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV--LTPSHIKAYMLMTLQGLEYLHQHW- 120
Query: 329 PKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKL 388
I+HRD+K N+LLD++ K+ADFGLAK S + T + T Y APE ++
Sbjct: 121 --ILHRDLKPNNLLLDENGVLKLADFGLAK-SFGSPNRAYTHQVVTRWYRAPELLFGARM 177
Query: 389 -TEKSDVFSFGVLLLELITGFRPFDKADTFADDSMV--------DWAKPFLAQGLADGNF 439
D+++ G +L EL+ + + + P + F
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 440 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481
+ L SA + + R +Q ++
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 3e-44
Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 17/218 (7%)
Query: 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL 267
++++ ++G G FG V++ L +G++VAIK++ Q +R E++I+ ++ H ++
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNI 75
Query: 268 VSLVGYCTFGSQR------LLVYEFVPNKTLEFHLH-GKDRPVMNWPTRMKIALGSARGL 320
V L + ++ LV ++VP H + + + R L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 321 AYLHEDCQPKIIHRDIKSANILLD-DSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLA 379
AY+H I HRDIK N+LLD D+ K+ DFG AK L + + +
Sbjct: 136 AYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ-LVRGEPNVSYICSRYYRAP 191
Query: 380 PEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTF 417
+ T DV+S G +L EL+ G F
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV 229
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 4e-43
Identities = 59/269 (21%), Positives = 97/269 (36%), Gaps = 13/269 (4%)
Query: 205 KIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLK---AGSGQGEREFQAEIEIIS 260
K+ ++F LLG+G FG V G+ A+K L+ + E ++
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 261 QVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGL 320
H L +L + V E+ L FHL + A +
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYG---AEIV 115
Query: 321 AYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAP 380
+ L +++RDIK N++LD K+ DFGL K + GT YLAP
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAP 174
Query: 381 EYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 440
E D + GV++ E++ G PF D ++ + + L+
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKS 234
Query: 441 ALVDQKLEEYDSAE-MTRMAACAAACIRH 468
L L + D + + + A + H
Sbjct: 235 LL--AGLLKKDPKQRLGGGPSDAKEVMEH 261
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 154 bits (389), Expect = 4e-43
Identities = 40/282 (14%), Positives = 85/282 (30%), Gaps = 32/282 (11%)
Query: 216 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGY 273
+G+G FG + +G L N + VAIK + + E + + ++ +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEP--RRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 274 CTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIH 333
G +LV + + L + T A + +H + +++
Sbjct: 70 GQEGLHNVLVIDLLGP--SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVY 124
Query: 334 RDIKSANILLDDSFE-----AKVADFGLAKHSLDTDTHV------STRVMGTFGYLAPEY 382
RDIK N L+ V DFG+ K D T + GT Y++
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184
Query: 383 ASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 442
+ + + D+ + G + + + G P+ + + + +
Sbjct: 185 HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER--------IGEKKQSTP 236
Query: 443 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484
+ + + + P +
Sbjct: 237 LRELCAGFPEE----FYKYMHYARNLAFDATPDYDYLQGLFS 274
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 1e-42
Identities = 49/215 (22%), Positives = 95/215 (44%), Gaps = 11/215 (5%)
Query: 208 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE-FQAEIEIISQVHHR 265
++ + +G+G +G V N VAIK++ Q + EI+I+ + H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 266 HLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHG--KDRPVMNWPTRMKIALGSARGLAYL 323
+++ + + + ++ + L+ K + ++ RGL Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYI 125
Query: 324 HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS--TRVMGTFGYLAPE 381
H ++HRD+K +N+LL+ + + K+ DFGLA+ + H T + T Y APE
Sbjct: 126 HS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 382 YASSGKL-TEKSDVFSFGVLLLELITGFRPFDKAD 415
+ K T+ D++S G +L E+++ F
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 217
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 1e-42
Identities = 56/227 (24%), Positives = 94/227 (41%), Gaps = 21/227 (9%)
Query: 197 STFTYEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLK------AGSGQGE 249
+ F E + D + LG G F V K + G A K +K + G
Sbjct: 1 TVFRQENVD---DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSR 57
Query: 250 REFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR 309
+ + E+ I+ ++ H ++++L + +L+ E V L L K+ +
Sbjct: 58 EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEA 115
Query: 310 MKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD----SFEAKVADFGLAKHSLDTDT 365
+ G+ YLH I H D+K NI+L D K+ DFGLA +
Sbjct: 116 TEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 172
Query: 366 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFD 412
+ GT ++APE + L ++D++S GV+ L++G PF
Sbjct: 173 F--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 217
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 3e-42
Identities = 49/217 (22%), Positives = 83/217 (38%), Gaps = 19/217 (8%)
Query: 216 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGY 273
+LG G G V + + A+K L+ + + E+E+ + H+V +V
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDV 73
Query: 274 C----TFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQP 329
L+V E + L + + +I + YLH
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---I 130
Query: 330 KIIHRDIKSANILLDDSFE---AKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSG 386
I HRD+K N+L K+ DFG AK + ++ + T Y+APE
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEVLGPE 188
Query: 387 KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMV 423
K + D++S GV++ L+ G+ PF A +
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM 225
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 7e-42
Identities = 55/237 (23%), Positives = 94/237 (39%), Gaps = 24/237 (10%)
Query: 216 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE------FQAEIEIISQVHHRH-- 266
LLG GGFG V+ G+ +++ VAIK ++ E E+ ++ +V
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 267 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED 326
++ L+ + +L+ E F +R + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCHN- 128
Query: 327 CQPKIIHRDIKSANILLD-DSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS 385
++HRDIK NIL+D + E K+ DFG DT T GT Y PE+
Sbjct: 129 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRVYSPPEWIRY 183
Query: 386 GKL-TEKSDVFSFGVLLLELITGFRPFD------KADTFADDSMVDWAKPFLAQGLA 435
+ + V+S G+LL +++ G PF+ + F + + + LA
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLA 240
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 2e-41
Identities = 42/214 (19%), Positives = 85/214 (39%), Gaps = 8/214 (3%)
Query: 209 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHR 265
+ + +G+G +G V K ++VA+K+++ EI ++ ++ H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 266 HLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHE 325
++V L + LV+EF ++ ++ + L L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFL---FQLLKGLGF 116
Query: 326 DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS 385
++HRD+K N+L++ + E K+A+FGLA+ S V+ + +
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 386 GKLTEKSDVFSFGVLLLELITGFRPFDKADTFAD 419
+ D++S G + EL RP + D
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD 210
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 2e-39
Identities = 54/233 (23%), Positives = 98/233 (42%), Gaps = 23/233 (9%)
Query: 196 KSTFTYEELKIAT----DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAG--SGQG 248
+S F +E+ + + +G G +G V V G VAIK+L S
Sbjct: 1 RSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF 60
Query: 249 EREFQAEIEIISQVHHRHLVSLVGYCTFGSQR------LLVYEFVPNKTLEFHLHGKDRP 302
+ E+ ++ + H +++ L+ T LV F+ + H K
Sbjct: 61 AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK--- 117
Query: 303 VMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362
+ + +GL Y+H IIHRD+K N+ +++ E K+ DFGLA+
Sbjct: 118 -LGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQ--- 170
Query: 363 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKAD 415
D+ ++ V+ + + + T+ D++S G ++ E+ITG F +D
Sbjct: 171 ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 223
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 4e-39
Identities = 50/219 (22%), Positives = 95/219 (43%), Gaps = 20/219 (9%)
Query: 209 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQG--EREFQAEIEIISQVHHR 265
+ + +GQG FG V K G+ VA+K++ + + EI+I+ + H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 266 HLVSLVGYCTFGSQR--------LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA 317
++V+L+ C + LV++F + + + ++ R+ L
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML--- 126
Query: 318 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH---SLDTDTHVSTRVMGT 374
L L+ + KI+HRD+K+AN+L+ K+ADFGLA+ + ++ + T + T
Sbjct: 127 --LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184
Query: 375 FGYLAPEYASSGKL-TEKSDVFSFGVLLLELITGFRPFD 412
Y PE + D++ G ++ E+ T
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 223
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 144 bits (363), Expect = 6e-39
Identities = 62/264 (23%), Positives = 92/264 (34%), Gaps = 14/264 (5%)
Query: 209 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE---FQAEIEIISQVHH 264
D F LG G FG V +G A+K L ++ E I+ V+
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 265 RHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH 324
LV L S +V E+V + HL R + P A YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLH 158
Query: 325 EDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYAS 384
+I+RD+K N+L+D +V DFG AK + GT LAPE
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT----LCGTPEALAPEIIL 211
Query: 385 SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 444
S + D ++ GVL+ E+ G+ PF + K + + L+
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSS-DLKDLLR 270
Query: 445 QKLEEYDSAEMTRMAACAAACIRH 468
L+ + + H
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNH 294
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 3e-38
Identities = 58/219 (26%), Positives = 95/219 (43%), Gaps = 16/219 (7%)
Query: 205 KIATDNFSEANLLGQGGFGYVHKGVLT----NGKVVAIKQLK----AGSGQGEREFQAEI 256
K+ +NF +LG G +G V GK+ A+K LK + + E
Sbjct: 20 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 79
Query: 257 EIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALG 315
+++ + LV+L ++ L+ +++ L HL ++R +
Sbjct: 80 QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY----- 134
Query: 316 SARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF 375
+ L + II+RDIK NILLD + + DFGL+K + +T + GT
Sbjct: 135 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 194
Query: 376 GYLAPEYASSGK--LTEKSDVFSFGVLLLELITGFRPFD 412
Y+AP+ G + D +S GVL+ EL+TG PF
Sbjct: 195 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 233
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 131 bits (330), Expect = 1e-34
Identities = 47/233 (20%), Positives = 95/233 (40%), Gaps = 22/233 (9%)
Query: 196 KSTFTYEELKIAT---DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE 251
+ + YE + D++ LG+G + V + + +TN + V +K LK +++
Sbjct: 19 REYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKK 75
Query: 252 FQAEIEIISQV-HHRHLVSLVGYCTFGSQRL--LVYEFVPNKTLEFHLHGKDRPVMNWPT 308
+ EI+I+ + ++++L R LV+E V N + +
Sbjct: 76 IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYD 130
Query: 309 RMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD-DSFEAKVADFGLAKHSLDTDTHV 367
+ L Y H I+HRD+K N+++D + + ++ D+GLA+ +
Sbjct: 131 IRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY- 186
Query: 368 STRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVLLLELITGFRPFDKADTFAD 419
+ + + PE ++ D++S G +L +I PF D
Sbjct: 187 -NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD 238
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 2e-33
Identities = 48/230 (20%), Positives = 89/230 (38%), Gaps = 25/230 (10%)
Query: 201 YEELKIATDNFSEAN------LLGQGGFGYVHKGV-LTNGKVVAIKQLKAG--SGQGERE 251
+ +++ F+ +G G G V + VAIK+L + +
Sbjct: 3 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR 62
Query: 252 FQAEIEIISQVHHRHLVSLVGYCT------FGSQRLLVYEFVPNKTLEFHLHGKDRPVMN 305
E+ ++ V+H++++SL+ T LV E + + ++
Sbjct: 63 AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME-----LD 117
Query: 306 WPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365
+ G+ +LH IHRD+K +NI++ K+ DFGLA+ +
Sbjct: 118 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLART--AGTS 172
Query: 366 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKAD 415
+ T + T Y APE E D++S G ++ E++ F D
Sbjct: 173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 4e-32
Identities = 53/233 (22%), Positives = 93/233 (39%), Gaps = 23/233 (9%)
Query: 196 KSTFTYEELKIA----TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAG--SGQG 248
+ TF +EL + + + +G G +G V G VA+K+L S
Sbjct: 1 RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 60
Query: 249 EREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKD------RP 302
+ E+ ++ + H +++ L+ T + L HL G D
Sbjct: 61 AKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY----LVTHLMGADLNNIVKCQ 116
Query: 303 VMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362
+ + RGL Y+H HRD+K +N+ +++ E K+ DFGLA+H
Sbjct: 117 KLTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARH--- 170
Query: 363 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKAD 415
TD ++ V + + + D++S G ++ EL+TG F D
Sbjct: 171 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 122 bits (306), Expect = 4e-31
Identities = 46/227 (20%), Positives = 81/227 (35%), Gaps = 20/227 (8%)
Query: 216 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHH---------- 264
LG G F V + N VA+K ++ E + EI+++ +V+
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA-AEDEIKLLQRVNDADNTKEDSMG 78
Query: 265 -RHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLH---GKDRPVMNWPTRMKIALGSARGL 320
H++ L+ + + V E L + + +I+ GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 321 AYLHEDCQPKIIHRDIKSANILLD-DSFEAKVADFGLAKHSLDTDTHVSTR-VMGTFGYL 378
Y+H + IIH DIK N+L++ + +A + T Y
Sbjct: 139 DYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 379 APEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDW 425
+PE +D++S L+ ELITG F+ + + D
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 97.5 bits (242), Expect = 4e-24
Identities = 26/154 (16%), Positives = 47/154 (30%), Gaps = 19/154 (12%)
Query: 215 NLLGQGGFGYVHKGVLTNGKVVAIKQLKAGS----------GQGEREFQAEIEIISQVHH 264
L+G+G V +K K G G+ F ++
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 265 RHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH 324
R L L G VY + N L + K+ + ++ +A +
Sbjct: 66 RALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 325 EDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 358
I+H D+ N+L+ + + DF +
Sbjct: 121 HRG---IVHGDLSQYNVLVSE-EGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 586 | |||
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.75 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.2 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.71 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.33 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.03 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.55 |
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-54 Score=434.93 Aligned_cols=259 Identities=28% Similarity=0.401 Sum_probs=213.8
Q ss_pred HHHHhcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEE
Q 007892 204 LKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 204 l~~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV 283 (586)
+++..++|++.+.||+|+||.||+|++++++.||||+++... ...+.|.+|+++|++++|||||+++|+|.+ +..+||
T Consensus 8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv 85 (272)
T d1qpca_ 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85 (272)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEE
Confidence 345567899999999999999999999888999999997654 345789999999999999999999998864 567899
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCC
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 363 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 363 (586)
|||+++|+|.+++.......++|..+++|+.||++||+|||++ +|+||||||+||||++++.+||+|||+++.....
T Consensus 86 ~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCC
Confidence 9999999999988765555699999999999999999999998 9999999999999999999999999999987655
Q ss_pred CCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhh
Q 007892 364 DTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 443 (586)
Q Consensus 364 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 443 (586)
.........||+.|||||++.++.++.++|||||||+||||+||..|+..... ...+.... ..+.
T Consensus 163 ~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~--~~~~~~~i--------~~~~----- 227 (272)
T d1qpca_ 163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVIQNL--------ERGY----- 227 (272)
T ss_dssp CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHH--------HTTC-----
T ss_pred ccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC--HHHHHHHH--------HhcC-----
Confidence 44445566799999999999999999999999999999999996655543221 11111111 1110
Q ss_pred chhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 007892 444 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 485 (586)
Q Consensus 444 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~ 485 (586)
....+...+..+.+++.+||+.||.+||||.||++.|+.
T Consensus 228 ---~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 228 ---RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 001222344578999999999999999999999999984
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-54 Score=428.98 Aligned_cols=254 Identities=29% Similarity=0.456 Sum_probs=201.1
Q ss_pred cCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecC
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVP 288 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 288 (586)
++|++.+.||+|+||.||+|++.+++.||||+++... ...++|.+|++++++++|||||+++|+|...+..+|||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 5788999999999999999999889999999997644 446789999999999999999999999999999999999999
Q ss_pred CCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCccc
Q 007892 289 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 368 (586)
Q Consensus 289 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 368 (586)
+|+|.+++.... ..++|..++.|+.|++.||+|||++ +|+||||||+||||++++.+||+|||+++..........
T Consensus 84 ~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 159 (263)
T d1sm2a_ 84 HGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 159 (263)
T ss_dssp TCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceee
Confidence 999999987543 4589999999999999999999998 999999999999999999999999999987655544444
Q ss_pred ccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhh
Q 007892 369 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITG-FRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 447 (586)
Q Consensus 369 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 447 (586)
....||+.|+|||++.++.++.++|||||||+||||+|+ ++||..... ..+.... .. +. .
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~---~~~~~~i----~~----~~--------~ 220 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDI----ST----GF--------R 220 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH---HHHHHHH----HH----TC--------C
T ss_pred cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH---HHHHHHH----Hh----cC--------C
Confidence 556799999999999999999999999999999999995 555543221 1111111 11 00 0
Q ss_pred hccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 448 EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 448 ~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
...+.....++.+++.+||+.||.+||+|+||++.|+..
T Consensus 221 ~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 221 LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 012223345789999999999999999999999999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.1e-54 Score=437.31 Aligned_cols=261 Identities=26% Similarity=0.345 Sum_probs=218.8
Q ss_pred HHHHhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEE
Q 007892 204 LKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 282 (586)
Q Consensus 204 l~~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~l 282 (586)
+++..++|++.+.||+|+||+||+|++. +++.||||+++.... ..++|++|+.+|++++|||||+++|+|.+++..+|
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence 3455678999999999999999999986 588999999976543 45689999999999999999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCC
Q 007892 283 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 283 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 362 (586)
||||+++|+|.++|.......++|..++.|+.|++.||+|||++ +|+||||||+||||++++.+||+|||+++....
T Consensus 91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCC
Confidence 99999999999999877667899999999999999999999998 999999999999999999999999999997655
Q ss_pred CCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhh
Q 007892 363 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 442 (586)
Q Consensus 363 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 442 (586)
..........|++.|+|||++.++.++.++|||||||+||||++|..||..... ...+... +. .+.
T Consensus 168 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~--~~~~~~~----i~----~~~---- 233 (287)
T d1opja_ 168 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYEL----LE----KDY---- 233 (287)
T ss_dssp SSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHHHHH----HH----TTC----
T ss_pred CCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch--HHHHHHH----Hh----cCC----
Confidence 544444556789999999999999999999999999999999997776643322 1111111 11 110
Q ss_pred hchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 443 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 443 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
....+...+..+.+++.+||+.||.+||+|.||++.|+..
T Consensus 234 ----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 234 ----RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred ----CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 0122333456789999999999999999999999999865
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-53 Score=431.05 Aligned_cols=260 Identities=29% Similarity=0.485 Sum_probs=206.4
Q ss_pred HHhcCccccceecccCcEEEEEEEEeCCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEE
Q 007892 206 IATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 206 ~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~--~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV 283 (586)
+..++|++.+.||+|+||+||+|++. ..||||+++.. .....+.|++|+.+|++++|||||+++|+|.. ...+||
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv 81 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV 81 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence 44578999999999999999999864 35999998654 34456789999999999999999999999864 568999
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCC
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 363 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 363 (586)
||||++|+|.++|+... ..++|..++.|+.||++||+|||++ +||||||||+||||+.++.+||+|||+++.....
T Consensus 82 ~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp EECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 99999999999997543 3599999999999999999999998 9999999999999999999999999999875433
Q ss_pred C-CcccccccccccccCcccccC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCCh
Q 007892 364 D-THVSTRVMGTFGYLAPEYASS---GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 439 (586)
Q Consensus 364 ~-~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (586)
. ........||+.|||||++.+ +.|+.++|||||||+||||+||+.||....... .+ ...+.+.
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~--~~----~~~~~~~------ 225 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QI----IFMVGRG------ 225 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HH----HHHHHHT------
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH--HH----HHHHhcC------
Confidence 2 233455789999999999864 458999999999999999999999997654311 11 1111111
Q ss_pred hhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 440 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 440 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
...+.+.....+.+..+.+++.+||+.||.+||||.||++.|+..
T Consensus 226 --~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l 270 (276)
T d1uwha_ 226 --YLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270 (276)
T ss_dssp --SCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111222233444556789999999999999999999999999854
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=417.90 Aligned_cols=253 Identities=26% Similarity=0.401 Sum_probs=215.0
Q ss_pred cCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecC
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVP 288 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 288 (586)
++|++.++||+|+||+||+|++++++.||||.++.... ..++|++|+.++++++|||||+++|+|.+.+..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 67899999999999999999998899999999986543 45789999999999999999999999999999999999999
Q ss_pred CCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCccc
Q 007892 289 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 368 (586)
Q Consensus 289 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 368 (586)
+|+|..++.... ..+.+..+++|+.|+++||+|||+. +|+||||||+||||++++.+||+|||+++..........
T Consensus 83 ~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 83 NGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp TEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred CCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence 999999876543 3589999999999999999999998 999999999999999999999999999987655544444
Q ss_pred ccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhh
Q 007892 369 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 447 (586)
Q Consensus 369 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 447 (586)
....||+.|+|||.+.++.++.++|||||||++|||+| |+.||...... .+.. .+..+..
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~---~~~~--------~i~~~~~-------- 219 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETAE--------HIAQGLR-------- 219 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHHH--------HHHTTCC--------
T ss_pred cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH---HHHH--------HHHhCCC--------
Confidence 55679999999999999999999999999999999998 89999765431 1111 1111110
Q ss_pred hccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 007892 448 EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 485 (586)
Q Consensus 448 ~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~ 485 (586)
...+......+.+++.+||+.||.+||++.||++.|..
T Consensus 220 ~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 220 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 01223344678999999999999999999999999964
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.1e-53 Score=428.97 Aligned_cols=255 Identities=27% Similarity=0.435 Sum_probs=198.8
Q ss_pred cCccccceecccCcEEEEEEEEeC-C---eEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLTN-G---KVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~~-g---~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV 283 (586)
++|++.++||+|+||+||+|++.. + ..||||++.... ....+.|.+|+++|++++|||||+++|+|...+..+||
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 446667899999999999999752 2 368999986653 34456899999999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCC
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 363 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 363 (586)
||||++|+|.+++.... ..++|.+++.|+.||++||+|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 106 ~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp EECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccCC
Confidence 99999999999887543 3589999999999999999999998 9999999999999999999999999999876443
Q ss_pred CCc----ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCC
Q 007892 364 DTH----VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGN 438 (586)
Q Consensus 364 ~~~----~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (586)
... ......||+.|||||.+.++.++.++|||||||+||||+| |+.||..... ..+.... ..+.
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~---~~~~~~i--------~~~~ 250 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN---QDVINAI--------EQDY 250 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHH--------HTTC
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH---HHHHHHH--------HcCC
Confidence 221 1123468999999999999999999999999999999998 8999976442 1111111 1110
Q ss_pred hhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 439 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 439 ~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
....+.+.+..+.+++.+||+.||.+||+|.||++.|+..
T Consensus 251 --------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 251 --------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred --------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 0022334456789999999999999999999999999864
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-52 Score=417.57 Aligned_cols=251 Identities=24% Similarity=0.363 Sum_probs=203.1
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
++|++.+.||+|+||+||+|+.. +|+.||||++.... .+..+.+++|+++|++++|||||++++++.+++..+|||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 67999999999999999999975 68999999996543 23345789999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC-C
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD-T 365 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~-~ 365 (586)
+++|+|.++|... ..+++.++..++.|++.||+|||++ +|+||||||+||||++++.+||+|||+|+...... .
T Consensus 85 ~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 85 CSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp CTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 9999999999643 4599999999999999999999998 99999999999999999999999999998754332 2
Q ss_pred cccccccccccccCcccccCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhc
Q 007892 366 HVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 444 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 444 (586)
......+||+.|||||++.+..+ +.++|||||||+||||++|+.||....... .....+.. .....
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~-~~~~~~~~--------~~~~~---- 226 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKE--------KKTYL---- 226 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS-HHHHHHHT--------TCTTS----
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH-HHHHHHhc--------CCCCC----
Confidence 23455789999999999987776 578999999999999999999997654311 11111100 00000
Q ss_pred hhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 445 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 445 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
.........+.+++.+||+.||.+||++.||++
T Consensus 227 ----~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 227 ----NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 001122346788999999999999999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=419.33 Aligned_cols=249 Identities=21% Similarity=0.369 Sum_probs=208.5
Q ss_pred cCccccceecccCcEEEEEEEE-eCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEec
Q 007892 209 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 287 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 287 (586)
++|+..+.||+|+||+||+|+. .+|+.||||+++.......+.+.+|+++|++++|||||++++++.+.+..+||||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4799999999999999999996 468999999997665555678999999999999999999999999999999999999
Q ss_pred CCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcc
Q 007892 288 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 367 (586)
Q Consensus 288 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 367 (586)
++|+|.+++... .+++.++..|+.|++.||+|||++ +||||||||+||||+.++.+||+|||+++...... ..
T Consensus 100 ~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~~ 172 (293)
T d1yhwa1 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SK 172 (293)
T ss_dssp TTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CC
T ss_pred CCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccc-cc
Confidence 999999887643 489999999999999999999998 99999999999999999999999999998764332 23
Q ss_pred cccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhh
Q 007892 368 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 447 (586)
Q Consensus 368 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 447 (586)
....+||+.|||||++.++.++.++|||||||+||||++|+.||....... .+. ..... +.. .+
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~----~~~~~----~~~------~~ 236 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--ALY----LIATN----GTP------EL 236 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHH----HHHHH----CSC------CC
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH--HHH----HHHhC----CCC------CC
Confidence 345689999999999999999999999999999999999999997644211 111 11110 000 00
Q ss_pred hccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 448 EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 448 ~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
..+......+.+++.+||+.||.+||++.|+++
T Consensus 237 -~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 237 -QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp -SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112223456889999999999999999999986
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-52 Score=413.76 Aligned_cols=245 Identities=27% Similarity=0.438 Sum_probs=206.6
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
++|++.+.||+|+||+||+|+.. +++.||||++... .......+.+|+++|++++|||||++++++.+++..+|||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999975 6889999998643 2233567899999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
|||++|+|.+++.... .+++..+..|+.|++.||+|||++ +||||||||+||||+.++.+||+|||+++.....
T Consensus 86 Ey~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~- 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 159 (263)
T ss_dssp ECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-
T ss_pred eecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCC-
Confidence 9999999999996543 499999999999999999999998 9999999999999999999999999999865432
Q ss_pred CcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhc
Q 007892 365 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 444 (586)
Q Consensus 365 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 444 (586)
.....+||+.|||||++.+..++.++|||||||+||||++|+.||...... .+ .... ..+.+
T Consensus 160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~---~~~i-----~~~~~----- 221 (263)
T d2j4za1 160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ---ET---YKRI-----SRVEF----- 221 (263)
T ss_dssp --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HH---HHHH-----HTTCC-----
T ss_pred --cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH---HH---HHHH-----HcCCC-----
Confidence 234567999999999999999999999999999999999999999754321 11 1110 01110
Q ss_pred hhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 445 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 445 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
.++......+.+++.+||+.||.+|||+.||++
T Consensus 222 ----~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 ----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 122234467889999999999999999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=417.57 Aligned_cols=255 Identities=28% Similarity=0.441 Sum_probs=208.7
Q ss_pred HhcCccccce-ecccCcEEEEEEEEe---CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeE
Q 007892 207 ATDNFSEANL-LGQGGFGYVHKGVLT---NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 281 (586)
Q Consensus 207 ~~~~f~~~~~-LG~G~fG~Vyk~~~~---~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~ 281 (586)
..++|.+.+. ||+|+||.||+|++. ++..||||+++.... ...+.|++|+++|++++|||||+++|+|.. +..+
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~ 84 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 84 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEE
Confidence 3467777774 999999999999864 356899999976543 345789999999999999999999999965 5689
Q ss_pred EEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccC
Q 007892 282 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 361 (586)
Q Consensus 282 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~ 361 (586)
||||||++|+|.+++.... ..+++..+++|+.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 85 lvmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccc
Confidence 9999999999999886433 4599999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCc--ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCC
Q 007892 362 DTDTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGN 438 (586)
Q Consensus 362 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (586)
..... ......||+.|||||++..+.++.++|||||||+||||+| |+.||..... ..+... +..+.
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~---~~~~~~--------i~~~~ 229 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAF--------IEQGK 229 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHHHH--------HHTTC
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH---HHHHHH--------HHcCC
Confidence 44322 2234568999999999999999999999999999999998 9999976442 111111 11111
Q ss_pred hhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 007892 439 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 485 (586)
Q Consensus 439 ~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~ 485 (586)
. ...+...+..+.+++.+||+.||.+||+|.+|++.|+.
T Consensus 230 ~--------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 230 R--------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp C--------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred C--------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1 12233445678999999999999999999999999874
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-52 Score=419.10 Aligned_cols=253 Identities=22% Similarity=0.371 Sum_probs=194.7
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCeeEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTF--GSQRLLV 283 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~--~~~~~lV 283 (586)
++|++.+.||+|+||+||+|+.. +|+.||||.++... ....+.+.+|+++|++++|||||++++++.+ .+..+||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 68999999999999999999975 68999999997653 2334578899999999999999999999965 4567899
Q ss_pred EEecCCCcHHHHhcCC--CCCCCChHHHHHHHHHHHHHhHhhhhcC--CCcEEecCCCCceeEeCCCCCeEEeecccccc
Q 007892 284 YEFVPNKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDC--QPKIIHRDIKSANILLDDSFEAKVADFGLAKH 359 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~--~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~ 359 (586)
||||++|+|.+++... ....+++..++.++.|++.||+|||+.. ..+||||||||+||||+.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999988642 3456999999999999999999999862 12499999999999999999999999999987
Q ss_pred cCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCCh
Q 007892 360 SLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 439 (586)
Q Consensus 360 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (586)
..... ......+||+.|||||++.+..++.++|||||||+||||++|+.||...... .+. .. +..+.+
T Consensus 164 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~---~~~---~~-----i~~~~~ 231 (269)
T d2java1 164 LNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELA---GK-----IREGKF 231 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHH---HH-----HHHTCC
T ss_pred cccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH---HHH---HH-----HHcCCC
Confidence 64322 2334578999999999999999999999999999999999999999754321 111 11 111111
Q ss_pred hhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 440 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 440 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
...+......+.+++.+||+.||.+||++.||++
T Consensus 232 --------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 232 --------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1122233457889999999999999999999975
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-52 Score=421.94 Aligned_cols=258 Identities=29% Similarity=0.414 Sum_probs=207.3
Q ss_pred HhcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
..++|++.+.||+|+||.||+|++.+++.||||+++... ...+.|.+|+.+|++++|||||+++|+|.+ +..++||||
T Consensus 15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey 92 (285)
T d1fmka3 15 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 92 (285)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred CHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEe
Confidence 357899999999999999999999888899999997554 446789999999999999999999999954 568999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 366 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 366 (586)
+++|+|..++.......++|.+++.|+.||+.||+|||++ +|+||||||+||||++++.+||+|||+++........
T Consensus 93 ~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 93 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred cCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence 9999999988766556799999999999999999999998 9999999999999999999999999999876544444
Q ss_pred ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchh
Q 007892 367 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 446 (586)
Q Consensus 367 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 446 (586)
......||+.|+|||++..+.++.++|||||||+||||++|..||..... ...+..+.. .+.
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~--~~~~~~~i~--------~~~-------- 231 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLDQVE--------RGY-------- 231 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHH--------TTC--------
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC--HHHHHHHHH--------hcC--------
Confidence 44556799999999999999999999999999999999997666544332 112222211 110
Q ss_pred hhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 447 LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 447 l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
....+......+.+++.+||+.||++||+|.+|+++|+...
T Consensus 232 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 232 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 00122334567899999999999999999999999999754
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=418.40 Aligned_cols=251 Identities=23% Similarity=0.359 Sum_probs=206.8
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEec
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 287 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 287 (586)
+.|++.+.||+|+||+||+|+.. +|+.||||+++.......+.|.+|+++|++++|||||++++++.+.+..+||||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 56899999999999999999975 68899999998766666678999999999999999999999999999999999999
Q ss_pred CCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCcc
Q 007892 288 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 367 (586)
Q Consensus 288 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 367 (586)
++|+|.+++.... ..+++.++..++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++..... ...
T Consensus 92 ~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~-~~~ 166 (288)
T d2jfla1 92 AGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQR 166 (288)
T ss_dssp TTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH-HHH
T ss_pred CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCC-ccc
Confidence 9999999876432 3589999999999999999999998 9999999999999999999999999999754221 112
Q ss_pred cccccccccccCccccc-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhh
Q 007892 368 STRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 442 (586)
Q Consensus 368 ~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 442 (586)
....+||+.|||||++. ...|+.++|||||||+||||++|+.||....... .+.. .. .+....
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~--~~~~----i~-----~~~~~~- 234 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR--VLLK----IA-----KSEPPT- 234 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--HHHH----HH-----HSCCCC-
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH--HHHH----HH-----cCCCCC-
Confidence 34567999999999984 4568999999999999999999999997654321 1111 11 010000
Q ss_pred hchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 443 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 443 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
+ ..+......+.+++.+||+.||.+|||+.|+++
T Consensus 235 ----~-~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 235 ----L-AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ----C-SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----C-CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 112233457889999999999999999999976
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=426.29 Aligned_cols=258 Identities=25% Similarity=0.451 Sum_probs=209.6
Q ss_pred HHhcCccccceecccCcEEEEEEEEeC------CeEEEEEEeccCC-chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeC
Q 007892 206 IATDNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQLKAGS-GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFG 277 (586)
Q Consensus 206 ~~~~~f~~~~~LG~G~fG~Vyk~~~~~------g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~ 277 (586)
+..++|++.++||+|+||+||+|++.. ...||||.+.... ......|.+|+.+|.++ +|||||+++++|.+.
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 455789999999999999999999753 2369999986543 33346789999999998 899999999999999
Q ss_pred CeeEEEEEecCCCcHHHHhcCCCC---------------------CCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCC
Q 007892 278 SQRLLVYEFVPNKTLEFHLHGKDR---------------------PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDI 336 (586)
Q Consensus 278 ~~~~lV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDI 336 (586)
+..+||||||++|+|.++|+.... ..++|..++.|+.|+++||+|||++ +||||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDl 190 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDL 190 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTC
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccC
Confidence 999999999999999999975432 3589999999999999999999998 9999999
Q ss_pred CCceeEeCCCCCeEEeecccccccCCCCCc-ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCC
Q 007892 337 KSANILLDDSFEAKVADFGLAKHSLDTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKA 414 (586)
Q Consensus 337 k~~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~ 414 (586)
||+|||++.++.+||+|||+|+........ ......||+.|||||++.++.++.++|||||||+||||+| |+.||...
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999875443332 3345678999999999999999999999999999999998 89999764
Q ss_pred CcccchhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 007892 415 DTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 484 (586)
Q Consensus 415 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~ 484 (586)
... ..+... +. .+. ++ ..+......+.+++.+||+.||.+||||.||+++|.
T Consensus 271 ~~~--~~~~~~----~~----~~~-------~~-~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 271 PVD--ANFYKL----IQ----NGF-------KM-DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCS--HHHHHH----HH----TTC-------CC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CHH--HHHHHH----Hh----cCC-------CC-CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 431 111111 11 110 00 223334567899999999999999999999999996
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-51 Score=416.14 Aligned_cols=257 Identities=27% Similarity=0.390 Sum_probs=201.7
Q ss_pred cCccccceecccCcEEEEEEEEeCC-----eEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLTNG-----KVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 282 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~~g-----~~vAVK~l~~~~~~-~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~l 282 (586)
+.|++.++||+|+||.||+|.+.+. ..||||+++..... ...+|++|+++|++++|||||+++|+|.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 5688899999999999999997642 47999999765433 34579999999999999999999999999999999
Q ss_pred EEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCC
Q 007892 283 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 283 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 362 (586)
||||+.+++|.+++.... ..++|.++++|+.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++....
T Consensus 87 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 999999999988776443 4599999999999999999999998 999999999999999999999999999987544
Q ss_pred CCC--cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChh
Q 007892 363 TDT--HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 440 (586)
Q Consensus 363 ~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (586)
... .......||+.|||||++.++.++.++|||||||+||||++|..|+..... ...+... + ..+
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~--~~~~~~~----i----~~~--- 229 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--NHEVMKA----I----NDG--- 229 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHH----H----HTT---
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC--HHHHHHH----H----hcc---
Confidence 322 223345689999999999999999999999999999999997666543221 1111111 1 111
Q ss_pred hhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 441 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 441 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
.....+.+.+..+.+++.+||+.||.+||+|.||++.|+...
T Consensus 230 -----~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~ 271 (283)
T d1mqba_ 230 -----FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271 (283)
T ss_dssp -----CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -----CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence 111233345567899999999999999999999999998653
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-51 Score=414.01 Aligned_cols=246 Identities=27% Similarity=0.397 Sum_probs=199.4
Q ss_pred ceecccCcEEEEEEEEeC---CeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEecCC
Q 007892 215 NLLGQGGFGYVHKGVLTN---GKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPN 289 (586)
Q Consensus 215 ~~LG~G~fG~Vyk~~~~~---g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~ 289 (586)
++||+|+||+||+|.+.+ ++.||||+++... ....+.|.+|+++|++++|||||+++|+|.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999999753 4689999996543 2335689999999999999999999999964 567899999999
Q ss_pred CcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc--c
Q 007892 290 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH--V 367 (586)
Q Consensus 290 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~--~ 367 (586)
|+|.++++.. ..++|..+++|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+++........ .
T Consensus 92 g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 92 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 9999999754 3499999999999999999999998 9999999999999999999999999999876544332 2
Q ss_pred cccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchh
Q 007892 368 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 446 (586)
Q Consensus 368 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 446 (586)
.....||+.|||||.+.++.++.++|||||||+||||++ |+.||...... .+... + ..+..
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---~~~~~----i----~~~~~------- 228 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTAM----L----EKGER------- 228 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHH----H----HTTCC-------
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH---HHHHH----H----HcCCC-------
Confidence 234579999999999999999999999999999999998 89999764421 11111 1 11110
Q ss_pred hhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 007892 447 LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 485 (586)
Q Consensus 447 l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~ 485 (586)
...+...+..+.+++.+||+.||.+||+|.||++.|+.
T Consensus 229 -~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 229 -MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred -CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 12233345678899999999999999999999998874
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-51 Score=423.89 Aligned_cols=269 Identities=22% Similarity=0.336 Sum_probs=207.0
Q ss_pred HHhcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEE
Q 007892 206 IATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 206 ~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV 283 (586)
+..++|++.+.||+|+||+||+|+.. +|+.||||+++... ......+.+|+.+|++++|||||+++++|.+.+..+||
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 34678999999999999999999975 68999999997653 33356889999999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCC
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 363 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 363 (586)
|||+++|+|.+++.... .+++..+..++.|++.||.|||+++ +|+||||||+||||++++.+||+|||+|+...+
T Consensus 83 mEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~- 157 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 157 (322)
T ss_dssp EECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred EEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCC-
Confidence 99999999999997543 4899999999999999999999742 799999999999999999999999999986532
Q ss_pred CCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhh---------------hhhhH
Q 007892 364 DTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMV---------------DWAKP 428 (586)
Q Consensus 364 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~---------------~~~~~ 428 (586)
......+||+.|||||++.+..|+.++|||||||+||||++|+.||...+........ .+...
T Consensus 158 --~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 158 --SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp --HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred --CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 2234568999999999999999999999999999999999999999765431110000 00000
Q ss_pred HH----hhcccCCChhhhhchhhh----ccC-HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 429 FL----AQGLADGNFDALVDQKLE----EYD-SAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 429 ~~----~~~~~~~~~~~l~d~~l~----~~~-~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
.. ..........+..+.... ..+ ......+.+++.+||+.||.+|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 00 000000000111111110 000 112356889999999999999999999987
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=406.67 Aligned_cols=247 Identities=26% Similarity=0.411 Sum_probs=196.7
Q ss_pred ccccceecccCcEEEEEEEEe-CCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEe----CCeeEEE
Q 007892 211 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTF----GSQRLLV 283 (586)
Q Consensus 211 f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~----~~~~~lV 283 (586)
|++.++||+|+||+||+|+.. +++.||||.+... .....+.|.+|+++|++++|||||+++++|.. ....+||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 356678999999999999975 5889999998654 33345678999999999999999999999875 3457899
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeC-CCCCeEEeecccccccCC
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD-DSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~-~~~~~kl~DFGla~~~~~ 362 (586)
|||+++|+|.+++... ..+++..+..++.||++||+|||++ .++|+||||||+||||+ +++.+||+|||+++....
T Consensus 91 mE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 9999999999999654 3589999999999999999999997 12399999999999996 578999999999986432
Q ss_pred CCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhh
Q 007892 363 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 442 (586)
Q Consensus 363 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 442 (586)
. .....+||+.|||||++.+ .++.++|||||||+||||++|+.||...... ..+. +.+..+....
T Consensus 168 ~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~--~~~~--------~~i~~~~~~~- 232 (270)
T d1t4ha_ 168 S---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIY--------RRVTSGVKPA- 232 (270)
T ss_dssp T---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHH--------HHHTTTCCCG-
T ss_pred C---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH--HHHH--------HHHHcCCCCc-
Confidence 2 2345689999999999874 6999999999999999999999999754321 1111 1111111111
Q ss_pred hchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 443 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 443 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
.++......+.+++.+||+.||++||++.|+++
T Consensus 233 ------~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 233 ------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ------ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 111122345889999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.3e-51 Score=416.43 Aligned_cols=264 Identities=25% Similarity=0.423 Sum_probs=215.5
Q ss_pred HHHHHHHhcCccccceecccCcEEEEEEEEe------CCeEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCcceEEEE
Q 007892 201 YEELKIATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGY 273 (586)
Q Consensus 201 ~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~~~~-~~~~~~~Ei~il~~l~Hpniv~l~g~ 273 (586)
+.+++...++|++.+.||+|+||+||+|++. +++.||||+++..... ..++|.+|+++|++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 3456677889999999999999999999975 3578999999765443 35679999999999999999999999
Q ss_pred EEeCCeeEEEEEecCCCcHHHHhcCCC----------------------CCCCChHHHHHHHHHHHHHhHhhhhcCCCcE
Q 007892 274 CTFGSQRLLVYEFVPNKTLEFHLHGKD----------------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKI 331 (586)
Q Consensus 274 ~~~~~~~~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~i 331 (586)
|...+..++||||+++|+|.++|+... ...++|..++.|+.|++.||+|||++ +|
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---Ce
Confidence 999999999999999999999986422 23589999999999999999999998 99
Q ss_pred EecCCCCceeEeCCCCCeEEeecccccccCCCC-CcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCC-C
Q 007892 332 IHRDIKSANILLDDSFEAKVADFGLAKHSLDTD-THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGF-R 409 (586)
Q Consensus 332 vHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~-~ 409 (586)
|||||||+||||+.++.+||+|||+++...... ....+...|++.|+|||++.+..++.++|||||||+||||++|. .
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 999999999999999999999999998654332 22334567899999999999999999999999999999999986 5
Q ss_pred CCCCCCcccchhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 410 PFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 410 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
||...... .+... +..+.. ...+...+.++.+++.+||+.+|.+||+|.||++.|+..
T Consensus 242 p~~~~~~~---e~~~~--------v~~~~~--------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 242 PYYGMAHE---EVIYY--------VRDGNI--------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TTTTSCHH---HHHHH--------HHTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCCCHH---HHHHH--------HHcCCC--------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 67654321 11111 111111 122334456789999999999999999999999999865
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-51 Score=409.03 Aligned_cols=257 Identities=25% Similarity=0.406 Sum_probs=199.6
Q ss_pred HHhcCccccceecccCcEEEEEEEEeC----CeEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCee
Q 007892 206 IATDNFSEANLLGQGGFGYVHKGVLTN----GKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR 280 (586)
Q Consensus 206 ~~~~~f~~~~~LG~G~fG~Vyk~~~~~----g~~vAVK~l~~~~~~-~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~ 280 (586)
+..++|++.+.||+|+||.||+|++.. +..||||.++..... ....|.+|+++|++++|||||+++|+|. .+..
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 445789999999999999999998643 457999998765433 3467999999999999999999999996 4678
Q ss_pred EEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccccc
Q 007892 281 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 360 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~ 360 (586)
++||||+++|+|.+++.... ..+++..++.++.||+.||.|||++ +||||||||+|||+++++.+||+|||+++..
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheec
Confidence 99999999999998876543 4589999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCCh
Q 007892 361 LDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 439 (586)
Q Consensus 361 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (586)
............||+.|+|||++.++.++.++|||||||+||||++ |..||...... .+... +..+..
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~---~~~~~--------i~~~~~ 227 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGR--------IENGER 227 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHH--------HHTTCC
T ss_pred cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH---HHHHH--------HHcCCC
Confidence 5544445556778999999999999999999999999999999998 89999765432 11111 111111
Q ss_pred hhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 440 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 440 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
...+...+..+.+++.+||+.||.+||++.||++.|+..
T Consensus 228 --------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 228 --------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 122334456789999999999999999999999999754
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-51 Score=412.25 Aligned_cols=248 Identities=20% Similarity=0.330 Sum_probs=203.9
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++++|||||++++++.+.+..+|||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 67999999999999999999975 68999999986432 233467899999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +||||||||+||||++++.+||+|||+|+......
T Consensus 88 Ey~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 9999999999886543 499999999999999999999998 99999999999999999999999999998764332
Q ss_pred -CcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhh
Q 007892 365 -THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 443 (586)
Q Consensus 365 -~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 443 (586)
.......+||+.|||||++.+..++.++|||||||+||||++|+.||...+.. .+. .. +..+.+
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~---~~-----i~~~~~---- 227 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY---LIF---QK-----IIKLEY---- 227 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HH-----HHTTCC----
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH---HHH---HH-----HHcCCC----
Confidence 22334568999999999999999999999999999999999999999765421 110 11 111111
Q ss_pred chhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 444 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 444 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
.++......+.+++.+||+.||.+|||+.|++.
T Consensus 228 -----~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 -----DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp -----CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred -----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 122233456889999999999999999999754
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.6e-50 Score=416.72 Aligned_cols=253 Identities=24% Similarity=0.324 Sum_probs=209.2
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
.++|++.+.||+|+||.||+|+.. +|+.||||++........+.+++|+.+|++++|||||++++++.+++..+|||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 368999999999999999999975 6899999999877666677899999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeC--CCCCeEEeecccccccCCCC
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD--DSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~--~~~~~kl~DFGla~~~~~~~ 364 (586)
|++|+|.+++.... ..+++.++..|+.||+.||+|||++ +||||||||+||||+ .++.+||+|||+++......
T Consensus 105 ~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 105 MSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 99999999986443 3499999999999999999999998 999999999999995 46789999999998764332
Q ss_pred CcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhc
Q 007892 365 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 444 (586)
Q Consensus 365 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 444 (586)
......||+.|||||++.+..++.++|||||||+||||++|+.||...... +......... ..+. .
T Consensus 181 --~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~---~~~~---~ 246 (350)
T d1koaa2 181 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD------ETLRNVKSCD---WNMD---D 246 (350)
T ss_dssp --CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTC---CCSC---C
T ss_pred --ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH------HHHHHHHhCC---CCCC---c
Confidence 234568999999999999999999999999999999999999999754321 1111111100 0000 0
Q ss_pred hhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 445 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 445 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
. ........+.+++.+||+.||.+|||+.|++++
T Consensus 247 ~----~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 247 S----AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp G----GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred c----cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 111223568899999999999999999999874
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.7e-50 Score=412.00 Aligned_cols=252 Identities=23% Similarity=0.354 Sum_probs=191.4
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
.+.|++.+.||+|+||+||+|+.. +|+.||||++..... .....+.+|+.+|++++|||||++++++.+++..+||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999975 589999999975432 234568899999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeC---CCCCeEEeecccccccCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD---DSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~---~~~~~kl~DFGla~~~~~ 362 (586)
||++|+|.++|... ..+++.++..++.|++.||+|||++ +|+||||||+|||+. +++.+||+|||+++....
T Consensus 88 ~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 88 LVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp CCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred ccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 99999999999754 3599999999999999999999998 999999999999994 578999999999986533
Q ss_pred CCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhh
Q 007892 363 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 442 (586)
Q Consensus 363 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 442 (586)
.. .....+||+.|||||++.++.++.++|||||||+||||++|+.||...... .+... .+ .+... .
T Consensus 163 ~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~~~---i~-----~~~~~-~ 228 (307)
T d1a06a_ 163 GS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA---KLFEQ---IL-----KAEYE-F 228 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHH---HH-----TTCCC-C
T ss_pred CC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH---HHHHH---Hh-----ccCCC-C
Confidence 22 234568999999999999999999999999999999999999999764421 11111 11 11100 0
Q ss_pred hchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 443 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 443 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.. .........+.+++.+||+.||.+||++.|+++.
T Consensus 229 ~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 229 DS----PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CT----TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CC----ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 00 1112334568999999999999999999999874
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.8e-50 Score=411.10 Aligned_cols=245 Identities=25% Similarity=0.364 Sum_probs=201.4
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCch---hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ---GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~---~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
+.|+..+.||+|+||+||+|+.. +|+.||||++...... ..+.+.+|+++|++++|||||+++++|.+.+..+|||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 34899999999999999999964 6899999999765432 2356889999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
|||++|+|..++... ..+++.++..|+.||+.||.|||++ +||||||||+||||++++.+||+|||+++....
T Consensus 95 E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (309)
T ss_dssp ECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred EecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence 999999998766543 3599999999999999999999998 999999999999999999999999999986432
Q ss_pred CcccccccccccccCcccccC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhh
Q 007892 365 THVSTRVMGTFGYLAPEYASS---GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 441 (586)
Q Consensus 365 ~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (586)
....+||+.|||||++.+ +.|+.++|||||||+||||++|+.||...... +...... .+....
T Consensus 168 ---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~------~~~~~i~-----~~~~~~ 233 (309)
T d1u5ra_ 168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIA-----QNESPA 233 (309)
T ss_dssp ---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHH-----HSCCCC
T ss_pred ---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH------HHHHHHH-----hCCCCC
Confidence 234679999999999863 56899999999999999999999999754321 1011111 010000
Q ss_pred hhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 442 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 442 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
+ ........+.+++.+||+.||.+|||+.||++
T Consensus 234 ~-------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 234 L-------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp C-------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C-------CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 0 11123456889999999999999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=405.17 Aligned_cols=251 Identities=27% Similarity=0.421 Sum_probs=201.2
Q ss_pred HhcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEe-CCeeEEEEE
Q 007892 207 ATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF-GSQRLLVYE 285 (586)
Q Consensus 207 ~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~-~~~~~lV~E 285 (586)
..++|++.+.||+|+||.||+|++ .|+.||||+++... ..+.|++|+++|++++|||||+++|+|.+ .+..+||||
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred CHHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 346788899999999999999998 57899999997543 34689999999999999999999999965 456799999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 365 (586)
|+++|+|.++|+......++|..+++|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 y~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-- 156 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 156 (262)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC--
Confidence 99999999999765545689999999999999999999998 9999999999999999999999999999864322
Q ss_pred cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhc
Q 007892 366 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 444 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 444 (586)
.....++..|+|||++.++.++.++|||||||+||||+| |+.||..... ..+..+. ..+.
T Consensus 157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~---~~~~~~i--------~~~~------ 217 (262)
T d1byga_ 157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRV--------EKGY------ 217 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHHHH--------TTTC------
T ss_pred --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH---HHHHHHH--------HcCC------
Confidence 233568899999999999999999999999999999998 7888765432 2222221 1111
Q ss_pred hhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 445 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 445 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
...++.....++.+++.+||+.||.+||+|.||++.|+..
T Consensus 218 --~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 218 --KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 1122333446788999999999999999999999999853
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.3e-49 Score=414.34 Aligned_cols=252 Identities=24% Similarity=0.361 Sum_probs=209.1
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEec
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 287 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 287 (586)
++|++.+.||+|+||.||+|+.. +|+.||||+++.........+++|+.+|++++|||||++++++.+++..+||||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57999999999999999999974 69999999998766666678899999999999999999999999999999999999
Q ss_pred CCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeC--CCCCeEEeecccccccCCCCC
Q 007892 288 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD--DSFEAKVADFGLAKHSLDTDT 365 (586)
Q Consensus 288 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~--~~~~~kl~DFGla~~~~~~~~ 365 (586)
++|+|.+++.... ..+++.++..|+.||+.||+|||++ +||||||||+||||+ .++.+||+|||+|+.....
T Consensus 109 ~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-- 182 (352)
T d1koba_ 109 SGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-- 182 (352)
T ss_dssp CCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--
T ss_pred CCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCC--
Confidence 9999988875433 3589999999999999999999998 999999999999997 6789999999999876443
Q ss_pred cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhch
Q 007892 366 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQ 445 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 445 (586)
.......||+.|||||++.+..++.++|||||||+||||++|+.||...... .+.. ... .+.+. .
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~---~i~-----~~~~~-~--- 247 (352)
T d1koba_ 183 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETLQ---NVK-----RCDWE-F--- 247 (352)
T ss_dssp SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHH---HHH-----HCCCC-C---
T ss_pred CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHHH---HHH-----hCCCC-C---
Confidence 2334567999999999999999999999999999999999999999765421 1111 100 01000 0
Q ss_pred hhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 446 KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 446 ~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
...........+.+|+.+||+.||.+||++.|++++
T Consensus 248 -~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 248 -DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp -CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 001112334568899999999999999999999873
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=403.38 Aligned_cols=251 Identities=24% Similarity=0.342 Sum_probs=205.7
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC------chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCee
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS------GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR 280 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~------~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~ 280 (586)
.+.|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.|++|+.+|++++|||||+++++|.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 367999999999999999999974 68999999986432 12357899999999999999999999999999999
Q ss_pred EEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCC----CeEEeeccc
Q 007892 281 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF----EAKVADFGL 356 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~----~~kl~DFGl 356 (586)
+||||||++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||||+.++ .+||+|||+
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhh
Confidence 99999999999999996543 599999999999999999999998 999999999999998776 499999999
Q ss_pred ccccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccC
Q 007892 357 AKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLAD 436 (586)
Q Consensus 357 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (586)
++...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||....... .. .... .
T Consensus 164 a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~---~~i~-----~ 230 (293)
T d1jksa_ 164 AHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TL---ANVS-----A 230 (293)
T ss_dssp CEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHHH-----T
T ss_pred hhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH---HH---HHHH-----h
Confidence 98754332 2345679999999999999999999999999999999999999998654211 11 1000 1
Q ss_pred CChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 437 GNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 437 ~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
+... ... .........+.+++.+||+.||.+||++.||++
T Consensus 231 ~~~~-~~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 231 VNYE-FED----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp TCCC-CCH----HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCC-CCc----hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1100 000 011122356889999999999999999999986
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=405.67 Aligned_cols=265 Identities=26% Similarity=0.402 Sum_probs=203.5
Q ss_pred HHHHHHHhcCccccceecccCcEEEEEEEEe------CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhc-CCCCcceEEE
Q 007892 201 YEELKIATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSG-QGEREFQAEIEIISQV-HHRHLVSLVG 272 (586)
Q Consensus 201 ~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l-~Hpniv~l~g 272 (586)
..++++..++|++.++||+|+||.||+|++. +++.||||+++.... ...+.+.+|+.++.++ +|+|||.+++
T Consensus 5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence 4556667789999999999999999999964 246899999976533 3456788888888887 6899999999
Q ss_pred EEEeC-CeeEEEEEecCCCcHHHHhcCCC--------------CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCC
Q 007892 273 YCTFG-SQRLLVYEFVPNKTLEFHLHGKD--------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIK 337 (586)
Q Consensus 273 ~~~~~-~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk 337 (586)
++... ...++|||||++|+|.++|+... ...++|.+++.++.||++||+|||++ +|||||||
T Consensus 85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlK 161 (299)
T d1ywna1 85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA 161 (299)
T ss_dssp EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCC
T ss_pred eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCC
Confidence 98765 46799999999999999986532 23589999999999999999999998 99999999
Q ss_pred CceeEeCCCCCeEEeecccccccCCCCC-cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCC-CCCCCCC
Q 007892 338 SANILLDDSFEAKVADFGLAKHSLDTDT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGF-RPFDKAD 415 (586)
Q Consensus 338 ~~NILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~-~Pf~~~~ 415 (586)
|+||||++++.+||+|||+++....... .......||+.|||||++.++.++.++|||||||+||||++|. .||....
T Consensus 162 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~ 241 (299)
T d1ywna1 162 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241 (299)
T ss_dssp GGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999987544333 2334567999999999999999999999999999999999964 5776543
Q ss_pred cccchhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 416 TFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 416 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
.. ..+. ..+.+ +.. ...+......+.+++.+||+.||.+||||.||+++|+..
T Consensus 242 ~~--~~~~----~~~~~----~~~--------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 242 ID--EEFC----RRLKE----GTR--------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp CS--HHHH----HHHHH----TCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH--HHHH----HHHhc----CCC--------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 21 1111 11111 100 012223445789999999999999999999999999864
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-49 Score=406.61 Aligned_cols=254 Identities=25% Similarity=0.416 Sum_probs=202.4
Q ss_pred cCccccceecccCcEEEEEEEEe-CCe----EEEEEEeccC-CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGK----VVAIKQLKAG-SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 282 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~----~vAVK~l~~~-~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~l 282 (586)
++|++.++||+|+||+||+|++. +|+ .||||+++.. .....++|++|+.+|++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46999999999999999999964 343 6899998654 344567899999999999999999999999864 5678
Q ss_pred EEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCC
Q 007892 283 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 362 (586)
Q Consensus 283 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 362 (586)
++||+.+|+|.+++... ...+++..+++|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+++....
T Consensus 88 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 89999999998887654 34589999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCc-ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCChh
Q 007892 363 TDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 440 (586)
Q Consensus 363 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (586)
.... ......||+.|||||++.++.++.++|||||||+||||+| |..||....... +.. .+.. +.
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~~----~i~~----~~-- 230 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS----ILEK----GE-- 230 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HHH----HHHH----TC--
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HHH----HHHc----CC--
Confidence 3332 2334568999999999999999999999999999999999 889987654311 111 1111 10
Q ss_pred hhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 441 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 441 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
....+......+.+++.+||+.||.+||+|.||++.|+..
T Consensus 231 ------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 231 ------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp ------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 0022333456789999999999999999999999998754
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=404.33 Aligned_cols=248 Identities=23% Similarity=0.354 Sum_probs=207.9
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV 283 (586)
.++|++.+.||+|+||.||+|+.. +|+.||||+++.. .......+.+|+.+|++++|||||++++++.+.+..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 468999999999999999999974 6899999999653 223356788999999999999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCC
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 363 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 363 (586)
||||++|+|.+++.... .+++.....++.|++.||+|||++ +||||||||+||||+.++.+||+|||+++.....
T Consensus 84 ~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 99999999999987543 488899999999999999999999 9999999999999999999999999999865433
Q ss_pred CCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhh
Q 007892 364 DTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 443 (586)
Q Consensus 364 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 443 (586)
. ......+||+.|||||++.+..|+.++|||||||+||||++|+.||...+.. .+. .... .+.
T Consensus 159 ~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~---~~~---~~i~-----~~~----- 221 (337)
T d1o6la_ 159 G-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLF---ELIL-----MEE----- 221 (337)
T ss_dssp T-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HHHH-----HCC-----
T ss_pred C-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH---HHH---HHHh-----cCC-----
Confidence 2 2344578999999999999999999999999999999999999999865431 111 1111 010
Q ss_pred chhhhccCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 007892 444 DQKLEEYDSAEMTRMAACAAACIRHSARRRPR-----MSQIVR 481 (586)
Q Consensus 444 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----m~evl~ 481 (586)
+ .++......+.+++.+||+.||.+|++ +.||++
T Consensus 222 ---~-~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 222 ---I-RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ---C-CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---C-CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 0 223334566889999999999999995 788876
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=405.84 Aligned_cols=262 Identities=25% Similarity=0.425 Sum_probs=213.5
Q ss_pred HHHHhcCccccceecccCcEEEEEEEEe------CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 007892 204 LKIATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTF 276 (586)
Q Consensus 204 l~~~~~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~ 276 (586)
+++..++|.+.+.||+|+||.||+|.+. ++..||||+++.... .....|.+|++++++++|||||+++|+|..
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 3445578999999999999999999864 357899999976433 334578999999999999999999999999
Q ss_pred CCeeEEEEEecCCCcHHHHhcCC--------CCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCC
Q 007892 277 GSQRLLVYEFVPNKTLEFHLHGK--------DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE 348 (586)
Q Consensus 277 ~~~~~lV~E~~~~gsL~~~l~~~--------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 348 (586)
.+..++||||+++|+|.++++.. ....++|..+.+++.|+++||.|||++ +|+||||||+||||++++.
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCC
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCce
Confidence 99999999999999999987642 224578999999999999999999998 9999999999999999999
Q ss_pred eEEeecccccccCCCCCc-ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCC-CCCCCCCcccchhhhhhh
Q 007892 349 AKVADFGLAKHSLDTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGF-RPFDKADTFADDSMVDWA 426 (586)
Q Consensus 349 ~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~-~Pf~~~~~~~~~~~~~~~ 426 (586)
+||+|||+++........ ......||+.|+|||.+.++.++.++|||||||+||||+||. .||..... .++.
T Consensus 172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~------~~~~ 245 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------EQVL 245 (308)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH------HHHH
T ss_pred EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH------HHHH
Confidence 999999999876443332 234457999999999999999999999999999999999985 66754332 1111
Q ss_pred hHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 427 KPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 427 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
.. +.+......+......+.+++.+||+.+|.+||+|.||++.|+..+
T Consensus 246 ~~-------------i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 246 RF-------------VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp HH-------------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HH-------------HHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 11 1111111222334467999999999999999999999999998763
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-49 Score=403.30 Aligned_cols=259 Identities=26% Similarity=0.418 Sum_probs=212.1
Q ss_pred HHhcCccccceecccCcEEEEEEEEe------CCeEEEEEEeccCCch-hHHHHHHHHHHHHhc-CCCCcceEEEEEEeC
Q 007892 206 IATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSGQ-GEREFQAEIEIISQV-HHRHLVSLVGYCTFG 277 (586)
Q Consensus 206 ~~~~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~~~~-~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~ 277 (586)
+..++|++.++||+|+||.||+|++. +++.||||+++..... ....|.+|+.++.++ +|||||+++|+|.+.
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 44578999999999999999999863 4578999999765443 345789999999999 699999999999999
Q ss_pred CeeEEEEEecCCCcHHHHhcCCC----------------CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCcee
Q 007892 278 SQRLLVYEFVPNKTLEFHLHGKD----------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANI 341 (586)
Q Consensus 278 ~~~~lV~E~~~~gsL~~~l~~~~----------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NI 341 (586)
+..+||||||++|+|.++|+... ...+++..+++++.||++||+|||++ +||||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccc
Confidence 99999999999999999987532 23589999999999999999999998 999999999999
Q ss_pred EeCCCCCeEEeecccccccCCCCC-cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccc
Q 007892 342 LLDDSFEAKVADFGLAKHSLDTDT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFAD 419 (586)
Q Consensus 342 Ll~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~ 419 (586)
|++.++.+||+|||+++....... .......||+.|+|||++.++.++.++|||||||+||||+| |.+||......
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~-- 254 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-- 254 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS--
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH--
Confidence 999999999999999997654433 33345689999999999999999999999999999999999 55555443321
Q ss_pred hhhhhhhhHHHhhcccCCChhhhhchhhh-ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 420 DSMVDWAKPFLAQGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 420 ~~~~~~~~~~~~~~~~~~~~~~l~d~~l~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
..+... ++.... ..+......+.+++.+||+.||.+||+|.||+++|+..
T Consensus 255 ~~~~~~-----------------i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 255 SKFYKM-----------------IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp HHHHHH-----------------HHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHH-----------------HhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 111111 111111 12233446789999999999999999999999999865
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=399.08 Aligned_cols=251 Identities=27% Similarity=0.392 Sum_probs=202.2
Q ss_pred cceecccCcEEEEEEEEeCC----eEEEEEEeccC-CchhHHHHHHHHHHHHhcCCCCcceEEEEEEe-CCeeEEEEEec
Q 007892 214 ANLLGQGGFGYVHKGVLTNG----KVVAIKQLKAG-SGQGEREFQAEIEIISQVHHRHLVSLVGYCTF-GSQRLLVYEFV 287 (586)
Q Consensus 214 ~~~LG~G~fG~Vyk~~~~~g----~~vAVK~l~~~-~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~-~~~~~lV~E~~ 287 (586)
.++||+|+||+||+|++.++ ..||||+++.. ......+|.+|+++|++++|||||+++|+|.. ++..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 47899999999999997542 36899999754 34445789999999999999999999999876 46889999999
Q ss_pred CCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc-
Q 007892 288 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH- 366 (586)
Q Consensus 288 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~- 366 (586)
++|+|.++++... ..+.+..+++++.|+++||.|||+. +|+||||||+||||++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 112 KHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp TTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred ecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 9999999887543 4578899999999999999999998 9999999999999999999999999999876543322
Q ss_pred --ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhc
Q 007892 367 --VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 444 (586)
Q Consensus 367 --~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 444 (586)
......||+.|+|||++..+.++.++||||||++||||+||..||..... ...+..+ .. .+..
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~--~~~~~~~---i~-----~g~~----- 252 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN--TFDITVY---LL-----QGRR----- 252 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHH---HH-----TTCC-----
T ss_pred ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC--HHHHHHH---HH-----cCCC-----
Confidence 22345789999999999999999999999999999999998888764321 1111111 11 1110
Q ss_pred hhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 445 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 445 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
...+......+.+++.+||+.||.+||+|.||++.|+..
T Consensus 253 ---~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 253 ---LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 011223345788999999999999999999999999876
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=399.07 Aligned_cols=255 Identities=26% Similarity=0.402 Sum_probs=197.9
Q ss_pred cCccccceecccCcEEEEEEEEeC--C--eEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLTN--G--KVVAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 281 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~~--g--~~vAVK~l~~~---~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~ 281 (586)
++|++.+.||+|+||.||+|++.. + ..||||+++.. .....++|.+|+.+|++++|||||+++|+|.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 679999999999999999999643 2 37899998754 23345689999999999999999999999975 5678
Q ss_pred EEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccC
Q 007892 282 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 361 (586)
Q Consensus 282 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~ 361 (586)
+||||+++|+|.+++.... ..+++..+++++.|++.||.|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 87 lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 9999999999998876543 3499999999999999999999998 99999999999999999999999999999765
Q ss_pred CCCCc--ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHHhhcccCCC
Q 007892 362 DTDTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGN 438 (586)
Q Consensus 362 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (586)
..... ......|+..|+|||++.+..++.++|||||||+||||+| |+.||..... .....+.. . .+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~---~~~~~~i~---~----~~~ 232 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---SQILHKID---K----EGE 232 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHH---T----SCC
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH---HHHHHHHH---h----CCC
Confidence 44332 2334568889999999999999999999999999999998 8999975543 12222211 0 110
Q ss_pred hhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 439 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 439 ~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
. + ......+..+.+++..||+.||.+||+|.||++.|+.+
T Consensus 233 ~-------~-~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 233 R-------L-PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp C-------C-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C-------C-CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 0 0 11223345788999999999999999999999999853
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.4e-48 Score=399.09 Aligned_cols=245 Identities=27% Similarity=0.387 Sum_probs=205.4
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
++|++.+.||+|+||+||+|+.. +|+.||||+++.. .....+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999974 6899999999643 2233567899999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
|||+||+|..++.... .+.+.....++.||+.||+|||++ +||||||||+||||+.++.+||+|||+++.....
T Consensus 84 E~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 157 (316)
T ss_dssp CCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred eecCCccccccccccc--cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence 9999999999886544 478888899999999999999998 9999999999999999999999999999876432
Q ss_pred CcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhc
Q 007892 365 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 444 (586)
Q Consensus 365 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 444 (586)
....+||+.|||||++.+..++.++|||||||+||||++|+.||...+.. +.....+ .+..
T Consensus 158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~i~-----~~~~----- 218 (316)
T d1fota_ 158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------KTYEKIL-----NAEL----- 218 (316)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHH-----HCCC-----
T ss_pred ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH------HHHHHHH-----cCCC-----
Confidence 23568999999999999999999999999999999999999999765421 1111111 0100
Q ss_pred hhhhccCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 007892 445 QKLEEYDSAEMTRMAACAAACIRHSARRRP-----RMSQIVRA 482 (586)
Q Consensus 445 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RP-----tm~evl~~ 482 (586)
.++......+.+++.+||+.||.+|+ ++.||+++
T Consensus 219 ----~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 219 ----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ----CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 12223345688999999999999996 89999863
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-49 Score=402.53 Aligned_cols=255 Identities=27% Similarity=0.430 Sum_probs=204.4
Q ss_pred cCccccceecccCcEEEEEEEEeC-Ce--EEEEEEeccC-CchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLTN-GK--VVAIKQLKAG-SGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~~-g~--~vAVK~l~~~-~~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~~~~lV 283 (586)
++|++.++||+|+||.||+|++.+ |. .||||+++.. .....+.|.+|+++|+++ +|||||+++|+|.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 678889999999999999999754 44 5788887543 333456899999999999 799999999999999999999
Q ss_pred EEecCCCcHHHHhcCC--------------CCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCe
Q 007892 284 YEFVPNKTLEFHLHGK--------------DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA 349 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 349 (586)
|||+++|+|.++|+.. ....++|..+++++.||+.||.|||+. +|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 9999999999999754 235699999999999999999999998 99999999999999999999
Q ss_pred EEeecccccccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCC-CCCCCCCcccchhhhhhhhH
Q 007892 350 KVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGF-RPFDKADTFADDSMVDWAKP 428 (586)
Q Consensus 350 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~-~Pf~~~~~~~~~~~~~~~~~ 428 (586)
||+|||+++...... ......||..|+|||.+.++.++.++|||||||+||||++|. .||..... ..+..+.
T Consensus 167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~---~~~~~~i-- 239 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYEKL-- 239 (309)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHG--
T ss_pred EEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH---HHHHHHH--
Confidence 999999998643222 223456899999999999999999999999999999999976 46654432 1121111
Q ss_pred HHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 429 FLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 429 ~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
..+. ....+......+.+++.+||+.||++||+|.||++.|+...
T Consensus 240 ------~~~~--------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 240 ------PQGY--------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp ------GGTC--------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------HhcC--------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1110 01223334567999999999999999999999999998753
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-49 Score=401.06 Aligned_cols=267 Identities=23% Similarity=0.311 Sum_probs=200.6
Q ss_pred cCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHH--HHHHHHHhcCCCCcceEEEEEEeCC----eeEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQ--AEIEIISQVHHRHLVSLVGYCTFGS----QRLL 282 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~--~Ei~il~~l~Hpniv~l~g~~~~~~----~~~l 282 (586)
..|.+.+.||+|+||.||+|++ +|+.||||+++... .+.+. .|+..+.+++|||||+++|+|...+ ..+|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 4577889999999999999997 68999999996542 23333 4555566789999999999998754 5789
Q ss_pred EEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcC-----CCcEEecCCCCceeEeCCCCCeEEeecccc
Q 007892 283 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC-----QPKIIHRDIKSANILLDDSFEAKVADFGLA 357 (586)
Q Consensus 283 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~-----~~~ivHrDIk~~NILl~~~~~~kl~DFGla 357 (586)
|||||++|+|.++|+.. .++|..+++++.|++.||+|||+.+ ..+||||||||+||||++++.+||+|||++
T Consensus 79 v~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 99999999999999754 4899999999999999999999731 348999999999999999999999999999
Q ss_pred cccCCCCCc---ccccccccccccCcccccCCC------CCCcchHHHHHHHHHHHHhCCCCCCCCCcccch----hhhh
Q 007892 358 KHSLDTDTH---VSTRVMGTFGYLAPEYASSGK------LTEKSDVFSFGVLLLELITGFRPFDKADTFADD----SMVD 424 (586)
Q Consensus 358 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~----~~~~ 424 (586)
+........ .....+||+.|||||++.+.. ++.++|||||||+||||+||..||......... ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 876443322 234568999999999987543 577999999999999999999887543321110 0001
Q ss_pred hhhHHHhhcccCCChhhhhchhhh--ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 425 WAKPFLAQGLADGNFDALVDQKLE--EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 425 ~~~~~~~~~~~~~~~~~l~d~~l~--~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
+....+.+....+.+ ++.+. ....+....+.+++.+||+.||.+||+|.||++.|+..
T Consensus 236 ~~~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CCHHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred chHHHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 111111111111111 11111 11334567799999999999999999999999999754
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.7e-48 Score=391.51 Aligned_cols=257 Identities=25% Similarity=0.375 Sum_probs=200.9
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC----e
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGS----Q 279 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~----~ 279 (586)
.++|++.+.||+|+||+||+|+.. +|+.||||+++.... .....|.+|+++|++++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 367999999999999999999964 699999999976533 23457899999999999999999999997654 3
Q ss_pred eEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccc
Q 007892 280 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 359 (586)
Q Consensus 280 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~ 359 (586)
.||||||+++++|..++.... .+++.+++.|+.|++.||+|||++ +||||||||+||||+.++..+|+|||+++.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhh
Confidence 789999999999998886543 499999999999999999999998 999999999999999999999999999876
Q ss_pred cCCCC--CcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCC
Q 007892 360 SLDTD--THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADG 437 (586)
Q Consensus 360 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (586)
..... .......+||+.|||||++.+..++.++|||||||+||||+||+.||...... +.....+. .+
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~~~~----~~ 230 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVR----ED 230 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHH----CC
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH------HHHHHHHh----cC
Confidence 43322 22334568999999999999999999999999999999999999999764421 11111111 11
Q ss_pred ChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHhc
Q 007892 438 NFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRP-RMSQIVRALEG 485 (586)
Q Consensus 438 ~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RP-tm~evl~~L~~ 485 (586)
... + .....+.+..+.+++.+||+.||.+|| +++++++.|..
T Consensus 231 ~~~----~--~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 231 PIP----P--SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp CCC----G--GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCC----C--chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 100 0 011222345788999999999999999 89999988874
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=397.33 Aligned_cols=260 Identities=27% Similarity=0.435 Sum_probs=208.7
Q ss_pred HHhcCccccceecccCcEEEEEEEEeC--------CeEEEEEEeccCCch-hHHHHHHHHHHHHhc-CCCCcceEEEEEE
Q 007892 206 IATDNFSEANLLGQGGFGYVHKGVLTN--------GKVVAIKQLKAGSGQ-GEREFQAEIEIISQV-HHRHLVSLVGYCT 275 (586)
Q Consensus 206 ~~~~~f~~~~~LG~G~fG~Vyk~~~~~--------g~~vAVK~l~~~~~~-~~~~~~~Ei~il~~l-~Hpniv~l~g~~~ 275 (586)
+..++|++.+.||+|+||.||+|+... +..||||+++..... ...++.+|+.++.++ +|||||+++++|.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 345789999999999999999998642 247999999776543 346888999999998 7999999999999
Q ss_pred eCCeeEEEEEecCCCcHHHHhcCCC--------------CCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCcee
Q 007892 276 FGSQRLLVYEFVPNKTLEFHLHGKD--------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANI 341 (586)
Q Consensus 276 ~~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NI 341 (586)
+++..++||||+++|+|.++|.... ...+++.+++.++.|++.||+|||+. +||||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccce
Confidence 9999999999999999999997543 24589999999999999999999998 999999999999
Q ss_pred EeCCCCCeEEeecccccccCCCCC-cccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcccc
Q 007892 342 LLDDSFEAKVADFGLAKHSLDTDT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFAD 419 (586)
Q Consensus 342 Ll~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ellt-G~~Pf~~~~~~~~ 419 (586)
|++.++.+||+|||+++....... .......|++.|+|||.+.++.|+.++|||||||+||||++ |+.||.....
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~--- 243 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--- 243 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH---
Confidence 999999999999999987644332 23345679999999999999999999999999999999998 7888865442
Q ss_pred hhhhhhhhHHHhhcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 007892 420 DSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 487 (586)
Q Consensus 420 ~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~~ 487 (586)
..+..+ + ..+.. ...+......+.+++.+||+.||.+||++.||++.|+..+
T Consensus 244 ~~~~~~----i----~~~~~--------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 244 EELFKL----L----KEGHR--------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp HHHHHH----H----HTTCC--------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHH----H----HcCCC--------CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 111111 1 11110 0222334467899999999999999999999999998753
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.8e-48 Score=388.81 Aligned_cols=251 Identities=23% Similarity=0.344 Sum_probs=204.4
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCch---------hHHHHHHHHHHHHhcC-CCCcceEEEEEEeC
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ---------GEREFQAEIEIISQVH-HRHLVSLVGYCTFG 277 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~---------~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~ 277 (586)
++|++.+.||+|+||+||+|+.. +|+.||||++...... ..+.+.+|+.+|++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 68999999999999999999974 7899999998654321 1235789999999997 99999999999999
Q ss_pred CeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccc
Q 007892 278 SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 357 (586)
Q Consensus 278 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla 357 (586)
+..|||||||++|+|.++|.... .+++.++..++.||++||+|||++ +|+||||||+||||+.++.+||+|||++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchhe
Confidence 99999999999999999997543 599999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCcccccC------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHh
Q 007892 358 KHSLDTDTHVSTRVMGTFGYLAPEYASS------GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLA 431 (586)
Q Consensus 358 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 431 (586)
+...... .....+||+.|+|||++.+ ..++.++|||||||+||||++|+.||....... .. ....
T Consensus 158 ~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~---~~---~~i~- 228 (277)
T d1phka_ 158 CQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML---ML---RMIM- 228 (277)
T ss_dssp EECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHHH-
T ss_pred eEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH---HH---HHHH-
Confidence 8764422 3355789999999998853 357889999999999999999999998654211 10 0111
Q ss_pred hcccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 432 QGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 432 ~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.+... ...+. .......+.+++.+||+.||.+||++.||++.
T Consensus 229 ----~~~~~-~~~~~----~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 229 ----SGNYQ-FGSPE----WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp ----HTCCC-CCTTT----GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ----hCCCC-CCCcc----cccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 11110 00111 11234578899999999999999999999763
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=395.26 Aligned_cols=251 Identities=21% Similarity=0.306 Sum_probs=205.5
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
.++|++.+.||+|+||+||+|+.. +|+.||||.++... .....+++|+++|.+++|||||++++++.+.+..||||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 368999999999999999999975 68999999997654 3345788999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCC--CCCeEEeecccccccCCCC
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD--SFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~--~~~~kl~DFGla~~~~~~~ 364 (586)
|++|+|.+++.... ..+++.++..|+.||+.||+|||++ +|+||||||+||||+. .+.+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~- 157 (321)
T d1tkia_ 83 ISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp CCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred CCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccC-
Confidence 99999999996543 3489999999999999999999998 9999999999999985 458999999999875332
Q ss_pred CcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhc
Q 007892 365 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 444 (586)
Q Consensus 365 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 444 (586)
.......||+.|+|||.+.+..++.++|||||||+||||++|+.||...... +......... -.+..
T Consensus 158 -~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~------~~~~~i~~~~---~~~~~--- 224 (321)
T d1tkia_ 158 -DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIENIMNAE---YTFDE--- 224 (321)
T ss_dssp -CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTC---CCCCH---
T ss_pred -CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCC---CCCCh---
Confidence 2234467999999999999999999999999999999999999999765431 1111111000 00000
Q ss_pred hhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 445 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 445 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
... ......+.+++.+||+.||.+||++.|+++
T Consensus 225 ~~~----~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 225 EAF----KEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHH----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhc----cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 112346889999999999999999999997
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.9e-47 Score=399.85 Aligned_cols=249 Identities=24% Similarity=0.349 Sum_probs=199.5
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHH---HHHHHhcCCCCcceEEEEEEeCCee
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAE---IEIISQVHHRHLVSLVGYCTFGSQR 280 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E---i~il~~l~Hpniv~l~g~~~~~~~~ 280 (586)
.++|++.++||+|+||.||+|+.. +|+.||||++.... ......+.+| +.+++.++|||||++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 368999999999999999999975 68999999985421 1223334444 6667777899999999999999999
Q ss_pred EEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccccc
Q 007892 281 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 360 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~ 360 (586)
|||||||++|+|.++|... ..+++..+..++.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+..
T Consensus 83 ~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 9999999999999999654 3488999999999999999999998 9999999999999999999999999999875
Q ss_pred CCCCCcccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCCh
Q 007892 361 LDTDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 439 (586)
Q Consensus 361 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (586)
.... ....+||+.|||||++.. ..++.++|||||||+||||++|+.||..........+.. ......
T Consensus 158 ~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~--------~~~~~~- 225 (364)
T d1omwa3 158 SKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR--------MTLTMA- 225 (364)
T ss_dssp SSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH--------HSSSCC-
T ss_pred CCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--------hcccCC-
Confidence 4332 344679999999999975 468999999999999999999999998654322111110 000000
Q ss_pred hhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 007892 440 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPR-----MSQIVR 481 (586)
Q Consensus 440 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----m~evl~ 481 (586)
..++......+.+++.+||+.||.+||+ +.||++
T Consensus 226 --------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 226 --------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp --------CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred --------CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 0122233456899999999999999999 688875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=395.31 Aligned_cols=253 Identities=21% Similarity=0.302 Sum_probs=201.0
Q ss_pred hcCccccc-eecccCcEEEEEEEE-eCCeEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEEe----CCee
Q 007892 208 TDNFSEAN-LLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTF----GSQR 280 (586)
Q Consensus 208 ~~~f~~~~-~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~----~~~~ 280 (586)
.++|.+.+ .||+|+||+||+|+. .+++.||||+++.. ..+.+|++++.++ +|||||++++++.+ +...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 36788765 699999999999996 46899999999642 4678899997765 89999999999865 3567
Q ss_pred EEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCC---CCCeEEeecccc
Q 007892 281 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD---SFEAKVADFGLA 357 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~---~~~~kl~DFGla 357 (586)
|||||||+||+|.++|.......+++.++..|+.|++.||+|||++ +|+||||||+|||+++ ++.+||+|||++
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccccccee
Confidence 9999999999999999876656799999999999999999999998 9999999999999975 567999999999
Q ss_pred cccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCC
Q 007892 358 KHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADG 437 (586)
Q Consensus 358 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (586)
+...... .....+||+.|||||++.+..|+.++|||||||+||||+||+.||........ ... +...+..+
T Consensus 162 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~---~~~----~~~~i~~~ 232 (335)
T d2ozaa1 162 KETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPG----MKTRIRMG 232 (335)
T ss_dssp EECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------------CCCSC
T ss_pred eeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH---HHH----HHHHHhcC
Confidence 8764433 23456799999999999999999999999999999999999999976543211 000 01111111
Q ss_pred ChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 438 NFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 438 ~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.+. ...+ ........+.+++.+||+.||.+||++.|++++
T Consensus 233 ~~~-~~~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 233 QYE-FPNP----EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp SSS-CCTT----HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCC-CCCc----ccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 110 0000 112234578999999999999999999999873
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-47 Score=399.79 Aligned_cols=244 Identities=25% Similarity=0.313 Sum_probs=204.9
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~ 284 (586)
++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.+|++++|||||++++++......++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 67999999999999999999975 68999999986431 223467889999999999999999999999999999999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 364 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 364 (586)
||+.+|+|..++.... .+++..+..|+.||+.||.|||++ +||||||||+||||+.++.+||+|||+|+.....
T Consensus 121 e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred ccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 9999999999986543 489999999999999999999998 9999999999999999999999999999876432
Q ss_pred CcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhhc
Q 007892 365 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 444 (586)
Q Consensus 365 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 444 (586)
.....||+.|||||++.+..++.++|||||||+||||++|+.||...+.. ....... .+.
T Consensus 195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~i~-----~~~------ 254 (350)
T d1rdqe_ 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI------QIYEKIV-----SGK------ 254 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHH-----HCC------
T ss_pred ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH------HHHHHHh-----cCC------
Confidence 23467999999999999999999999999999999999999999754321 1111111 010
Q ss_pred hhhhccCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 007892 445 QKLEEYDSAEMTRMAACAAACIRHSARRRP-----RMSQIVR 481 (586)
Q Consensus 445 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RP-----tm~evl~ 481 (586)
. .++......+.+++.+||+.||.+|+ ++.||++
T Consensus 255 --~-~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 255 --V-RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --C-CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --C-CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 0 12223345788999999999999994 8999886
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=389.20 Aligned_cols=260 Identities=24% Similarity=0.304 Sum_probs=196.4
Q ss_pred ccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchh-----HHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 213 EANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQG-----EREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 213 ~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~-----~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
.+++||+|+||+||+|+.. +|+.||||+++...... .+.+.+|+++|++++|||||++++++..++..+|||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999964 68999999986543221 24688999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 366 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 366 (586)
+.++++..++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~- 155 (299)
T d1ua2a_ 82 METDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR- 155 (299)
T ss_dssp CSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred hcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc-
Confidence 999888776643 34588999999999999999999998 999999999999999999999999999987544332
Q ss_pred ccccccccccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHh----hcc-------
Q 007892 367 VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLA----QGL------- 434 (586)
Q Consensus 367 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~----~~~------- 434 (586)
.....+||+.|+|||++..+ .++.++|||||||+||||++|+.||......+ .+.... ..+. ..+
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~--~l~~i~-~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD--QLTRIF-ETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH-HHHCCCCTTTSSSTTSST
T ss_pred cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH--HHHHHH-HhcCCCChhhccchhccc
Confidence 23346799999999998754 57999999999999999999999997654321 111100 0000 000
Q ss_pred cCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 435 ADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 435 ~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
....+.......+..........+.+++.+||+.||.+|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00000000011111111223456899999999999999999999997
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-48 Score=395.26 Aligned_cols=247 Identities=26% Similarity=0.370 Sum_probs=202.7
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHH-hcCCCCcceEEEEEEeCCeeEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIIS-QVHHRHLVSLVGYCTFGSQRLLV 283 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~-~l~Hpniv~l~g~~~~~~~~~lV 283 (586)
++|.+.+.||+|+||+||+|+.. +|+.||||+++... ....+.+..|+.++. .++|||||++++++.+++..|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 68999999999999999999975 68999999996432 223455667777665 68999999999999999999999
Q ss_pred EEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCC
Q 007892 284 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 363 (586)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 363 (586)
||||++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 82 mEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 99999999999997543 488999999999999999999998 9999999999999999999999999999865433
Q ss_pred CCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCCChhhhh
Q 007892 364 DTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 443 (586)
Q Consensus 364 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 443 (586)
. .......||+.|+|||++.++.++.++|||||||+||||++|+.||...... .+. .... .+.
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~---~~~---~~i~-----~~~----- 219 (320)
T d1xjda_ 157 D-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELF---HSIR-----MDN----- 219 (320)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HHHH-----HCC-----
T ss_pred c-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH---HHH---HHHH-----cCC-----
Confidence 2 2334568999999999999999999999999999999999999999765421 111 0000 010
Q ss_pred chhhhccCHHHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 007892 444 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMS-QIVR 481 (586)
Q Consensus 444 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~-evl~ 481 (586)
+ .++......+.+++.+||+.||.+||++. ||++
T Consensus 220 -~---~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 220 -P---FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -C---CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -C---CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 0 12233446689999999999999999995 6754
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-47 Score=386.70 Aligned_cols=267 Identities=21% Similarity=0.305 Sum_probs=201.4
Q ss_pred cCccccceecccCcEEEEEEEE-eCCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
|+|++.++||+|+||+||+|+. .+|+.||||+++.... .....+.+|+++|++++|||||++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999997 4689999999965432 234678999999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 365 (586)
|+.++.+ .++.......+++..+..++.|++.||+|||++ +||||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~~-~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~- 156 (298)
T d1gz8a_ 82 FLHQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 156 (298)
T ss_dssp CCSEEHH-HHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-
T ss_pred ecCCchh-hhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCc-
Confidence 9976544 444444455699999999999999999999998 99999999999999999999999999998754332
Q ss_pred cccccccccccccCcccccCCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHH----------Hhhc-
Q 007892 366 HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPF----------LAQG- 433 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~----------~~~~- 433 (586)
.......||+.|+|||.+.... ++.++|||||||+||||++|+.||...+... .+..-.... ....
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTTSTTGGGST
T ss_pred ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH--HHHHHHHhcCCCchhhcccccccc
Confidence 2334467999999999877655 5889999999999999999999997654211 111000000 0000
Q ss_pred ccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 434 LADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 434 ~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.....+..................+.+++.+||+.||.+|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0000000000000011111223568899999999999999999999974
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.4e-46 Score=378.87 Aligned_cols=265 Identities=20% Similarity=0.287 Sum_probs=201.4
Q ss_pred cCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEEe
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E~ 286 (586)
++|+..++||+|+||+||+|+..+|+.||||+++.... .....+.+|+.+|++++|||||+++++|...+..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 68999999999999999999999999999999966432 2246899999999999999999999999999999999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCCc
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 366 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 366 (586)
+.++.+..+.... ..+++..+..|+.||+.||+|||+. +||||||||+||||+.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~- 155 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR- 155 (286)
T ss_dssp CSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred ehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcc-
Confidence 9888877776443 4599999999999999999999998 999999999999999999999999999987543322
Q ss_pred ccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHH-------HhhcccCCC
Q 007892 367 VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPF-------LAQGLADGN 438 (586)
Q Consensus 367 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~-------~~~~~~~~~ 438 (586)
......|++.|+|||.+.+ ..++.++|||||||+||||++|+.||....... .+....... +........
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--QLMRIFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH--HHHHHHHhhCCCChhhccchhhhhh
Confidence 2334568999999999875 457999999999999999999999997654211 111000000 000000000
Q ss_pred hhh---hhch-hhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 439 FDA---LVDQ-KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 439 ~~~---l~d~-~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
... ...+ ............+.+++.+||+.||++||+++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0000 001112223457889999999999999999999985
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-47 Score=382.17 Aligned_cols=239 Identities=23% Similarity=0.347 Sum_probs=195.4
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCch------hHHHHHHHHHHHHhcC--CCCcceEEEEEEeCCe
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ------GEREFQAEIEIISQVH--HRHLVSLVGYCTFGSQ 279 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~------~~~~~~~Ei~il~~l~--Hpniv~l~g~~~~~~~ 279 (586)
++|++.++||+|+||+||+|+.. +|+.||||+++..... ....+.+|+.+|++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57999999999999999999975 6899999998653211 1234678999999997 8999999999999999
Q ss_pred eEEEEEecCC-CcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCC-CCCeEEeecccc
Q 007892 280 RLLVYEFVPN-KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD-SFEAKVADFGLA 357 (586)
Q Consensus 280 ~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~-~~~~kl~DFGla 357 (586)
.++||||+.+ +++.+++... ..+++.++..++.|++.||+|||++ +|+||||||+||||+. ++.+||+|||++
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccccc
Confidence 9999999976 5777777543 3589999999999999999999998 9999999999999985 579999999999
Q ss_pred cccCCCCCcccccccccccccCcccccCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccC
Q 007892 358 KHSLDTDTHVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLAD 436 (586)
Q Consensus 358 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (586)
+..... ..+...||+.|+|||++.+..+ +.++|||||||+||||++|+.||...+. + .....
T Consensus 159 ~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----i-------~~~~~-- 221 (273)
T d1xwsa_ 159 ALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----I-------IRGQV-- 221 (273)
T ss_dssp EECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----H-------HHCCC--
T ss_pred eecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-----H-------hhccc--
Confidence 864332 3345689999999999987665 5778999999999999999999964321 0 00000
Q ss_pred CChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 437 GNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 437 ~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
.++......+.+++.+||+.||.+|||+.|+++
T Consensus 222 ------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 222 ------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 111122356889999999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-46 Score=379.00 Aligned_cols=267 Identities=22% Similarity=0.331 Sum_probs=199.6
Q ss_pred hcCccccceecccCcEEEEEEEEe-C-CeEEEEEEeccCCc--hhHHHHHHHHHHHHhc---CCCCcceEEEEEEe----
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-N-GKVVAIKQLKAGSG--QGEREFQAEIEIISQV---HHRHLVSLVGYCTF---- 276 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~-g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l---~Hpniv~l~g~~~~---- 276 (586)
.++|++.+.||+|+||+||+|+.. + ++.||||+++.... .....+.+|+.+|+.| +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 478999999999999999999974 3 67899999864322 2223566778877766 79999999999863
Q ss_pred -CCeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecc
Q 007892 277 -GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 355 (586)
Q Consensus 277 -~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFG 355 (586)
....+++|||+.++.+...... ....+++..+..++.|++.||+|||++ +||||||||+|||+++++.+||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchh
Confidence 2467899999999887655443 345689999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHH---Hhh
Q 007892 356 LAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPF---LAQ 432 (586)
Q Consensus 356 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~---~~~ 432 (586)
+++.... ........||+.|+|||++.+..|+.++|||||||+||||++|+.||....... .+....... ...
T Consensus 162 ~~~~~~~--~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 162 LARIYSF--QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QLGKILDVIGLPGEE 237 (305)
T ss_dssp SCCCCCG--GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCGG
T ss_pred hhhhhcc--cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH--HHHHHHHhhCCCchh
Confidence 9986432 223455789999999999999999999999999999999999999998654311 111000000 000
Q ss_pred ccc------CCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 433 GLA------DGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 433 ~~~------~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
.+. ...+.......+..+.......+.+|+.+||+.||.+|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 00000001111112223334568899999999999999999999874
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.4e-44 Score=364.45 Aligned_cols=258 Identities=20% Similarity=0.248 Sum_probs=196.8
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcce-EEEEEEeCCeeEEEEEe
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVS-LVGYCTFGSQRLLVYEF 286 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~-l~g~~~~~~~~~lV~E~ 286 (586)
++|++.+.||+|+||.||+|++. +|+.||||++..... ..++..|++++++++|+|++. +.+++.+++..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 57999999999999999999974 689999999876433 245788999999998776555 45555778888999999
Q ss_pred cCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeC---CCCCeEEeecccccccCCC
Q 007892 287 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD---DSFEAKVADFGLAKHSLDT 363 (586)
Q Consensus 287 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~---~~~~~kl~DFGla~~~~~~ 363 (586)
+. ++|.+.+... ...+++..++.++.|++.||+|||++ +||||||||+|||++ .+..+||+|||+++...+.
T Consensus 85 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 85 LG-PSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp CC-CBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred cC-Cchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 95 4555554432 23589999999999999999999998 999999999999985 4567999999999976543
Q ss_pred CCc------ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhh-hhhhHHHhhcccC
Q 007892 364 DTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMV-DWAKPFLAQGLAD 436 (586)
Q Consensus 364 ~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~-~~~~~~~~~~~~~ 436 (586)
... ......||+.|||||.+.+..++.++|||||||++|||++|+.||............ .+....
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~------- 232 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK------- 232 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHH-------
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhccc-------
Confidence 322 234567999999999999999999999999999999999999999765432211111 111100
Q ss_pred CChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 437 GNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 437 ~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
............+..+.+++..|++.+|.+||++.+|.+.|+..
T Consensus 233 ------~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 233 ------MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp ------HHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred ------CCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 00001111223346789999999999999999999998888753
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=370.70 Aligned_cols=266 Identities=20% Similarity=0.249 Sum_probs=196.0
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEe--------C
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTF--------G 277 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~--------~ 277 (586)
++|++.+.||+|+||+||+|+.. +|+.||||++... .......+.+|+++|++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 78999999999999999999974 7899999998543 22334678899999999999999999999855 3
Q ss_pred CeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccc
Q 007892 278 SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 357 (586)
Q Consensus 278 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla 357 (586)
+..++||||+.++.+...... ...+....+..|+.|++.||.|||++ +|+||||||+||||+.++.+||+|||++
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeeccee
Confidence 457899999998888766543 34588899999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCC---cccccccccccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhh-
Q 007892 358 KHSLDTDT---HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQ- 432 (586)
Q Consensus 358 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~- 432 (586)
+....... ......+||+.|+|||++.+. .++.++|||||||+||||++|+.||........... ....+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~---i~~~~~~~ 241 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL---ISQLCGSI 241 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCCC
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHH---HHHhcCCC
Confidence 76543221 122335799999999998754 689999999999999999999999976543111111 0000000
Q ss_pred ---c---ccCCC-hhhhhchhhhccC-------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 433 ---G---LADGN-FDALVDQKLEEYD-------SAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 433 ---~---~~~~~-~~~l~d~~l~~~~-------~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
. ..... ...+......... ......+++|+.+||+.||++|||+.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0 00000 0000000000000 0112456789999999999999999999974
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-44 Score=375.56 Aligned_cols=262 Identities=23% Similarity=0.324 Sum_probs=195.0
Q ss_pred CccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC------CeeEE
Q 007892 210 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG------SQRLL 282 (586)
Q Consensus 210 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~------~~~~l 282 (586)
+|...++||+|+||+||+|+.. +|+.||||+++.... .+.+|+++|++++|+|||+++++|... ...+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5788899999999999999975 689999999976532 234799999999999999999998653 24689
Q ss_pred EEEecCCCcHHHHhcC-CCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCC-CeEEeeccccccc
Q 007892 283 VYEFVPNKTLEFHLHG-KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF-EAKVADFGLAKHS 360 (586)
Q Consensus 283 V~E~~~~gsL~~~l~~-~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~-~~kl~DFGla~~~ 360 (586)
|||||+++.+...++. .....+++.++..|+.|++.||+|||++ +|+||||||+||||+.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987765544331 2344699999999999999999999998 999999999999999775 8999999999876
Q ss_pred CCCCCcccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhh-------HHHhh
Q 007892 361 LDTDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAK-------PFLAQ 432 (586)
Q Consensus 361 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~-------~~~~~ 432 (586)
..... .....||..|+|||.+.+ ..++.++|||||||++|||++|+.||......+ .+....+ ..+..
T Consensus 174 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~--~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 174 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH--HHHHHHHHHCCCCHHHHHH
T ss_pred cCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH--HHHHHHHHhCCChHHhhhh
Confidence 44332 234679999999998765 578999999999999999999999997654321 1111110 00000
Q ss_pred ---cccCCChhhhhchhh-hccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 433 ---GLADGNFDALVDQKL-EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 433 ---~~~~~~~~~l~d~~l-~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
......+..+..... ..........+.+|+.+||+.||.+|||+.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000001111000000 01122334568899999999999999999999863
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.3e-43 Score=360.03 Aligned_cols=260 Identities=17% Similarity=0.205 Sum_probs=206.0
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCC-CCcceEEEEEEeCCeeEEEEE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHH-RHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~H-pniv~l~g~~~~~~~~~lV~E 285 (586)
.++|++.+.||+|+||+||+|+.. +|+.||||++..... ...+++|++++..++| +|++.+++++..+...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999999999999965 689999999865432 3457889999999975 899999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCC-----CCCeEEeeccccccc
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD-----SFEAKVADFGLAKHS 360 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~-----~~~~kl~DFGla~~~ 360 (586)
|+ +++|.+++.... ..+++.++..++.|++.||+|||++ +|+||||||+||||+. ++.+||+|||+++..
T Consensus 82 ~~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 82 LL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 99 789988886543 3589999999999999999999998 9999999999999964 578999999999876
Q ss_pred CCCCCc------ccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcc
Q 007892 361 LDTDTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGL 434 (586)
Q Consensus 361 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 434 (586)
.+.... .....+||+.|||||.+.+..++.++|||||||++|||++|+.||................. . .
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~---~-~ 232 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE---K-K 232 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH---H-H
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHh---c-c
Confidence 543221 22346799999999999999999999999999999999999999986543222111111100 0 0
Q ss_pred cCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 007892 435 ADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 486 (586)
Q Consensus 435 ~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L~~~ 486 (586)
.... ........+..+.+++..|+..+|.+||++..+.+.|+..
T Consensus 233 ~~~~--------~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 233 QSTP--------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp HHSC--------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred CCCC--------hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 0000 1111122345688999999999999999999988887754
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=371.72 Aligned_cols=252 Identities=25% Similarity=0.349 Sum_probs=203.3
Q ss_pred cCccccceecccCcEEEEEEEEe----CCeEEEEEEeccCC----chhHHHHHHHHHHHHhcCC-CCcceEEEEEEeCCe
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT----NGKVVAIKQLKAGS----GQGEREFQAEIEIISQVHH-RHLVSLVGYCTFGSQ 279 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~----~g~~vAVK~l~~~~----~~~~~~~~~Ei~il~~l~H-pniv~l~g~~~~~~~ 279 (586)
++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999852 47899999986532 1234568899999999966 899999999999999
Q ss_pred eEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccc
Q 007892 280 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 359 (586)
Q Consensus 280 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~ 359 (586)
.++||||+.+|+|.+++.... .+.......++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhh
Confidence 999999999999999987554 367788889999999999999998 999999999999999999999999999987
Q ss_pred cCCCCCcccccccccccccCcccccCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHhhcccCC
Q 007892 360 SLDTDTHVSTRVMGTFGYLAPEYASSG--KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADG 437 (586)
Q Consensus 360 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (586)
.............|++.|++||.+.+. .++.++|||||||+||||++|+.||........ .........
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~--~~~i~~~~~------- 249 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRIL------- 249 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHHH-------
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcc-------
Confidence 655444445567899999999999754 478899999999999999999999976543221 111111000
Q ss_pred ChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 007892 438 NFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRP-----RMSQIVR 481 (586)
Q Consensus 438 ~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RP-----tm~evl~ 481 (586)
.... .++......+.+++.+||+.||.+|| +++|+++
T Consensus 250 ------~~~~-~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 250 ------KSEP-PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ------HCCC-CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ------cCCC-CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 0000 22334567889999999999999999 5888886
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-44 Score=372.28 Aligned_cols=269 Identities=18% Similarity=0.222 Sum_probs=196.7
Q ss_pred hcCccccceecccCcEEEEEEEE-eCCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC----eeE
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGS----QRL 281 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~----~~~ 281 (586)
+++|++.++||+|+||+||+|+. .+|+.||||+++.... ...+.+++|+++|++++||||++++++|.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 35799999999999999999996 4799999999975433 33567899999999999999999999997643 335
Q ss_pred EEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccC
Q 007892 282 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 361 (586)
Q Consensus 282 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~ 361 (586)
++++|+.+|+|.+++... .+++..+..++.|++.||+|||++ +||||||||+||||++++.+||+|||+++...
T Consensus 87 ~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 556677899999998643 489999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCC--cccccccccccccCccccc-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHH--hhcccC
Q 007892 362 DTDT--HVSTRVMGTFGYLAPEYAS-SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFL--AQGLAD 436 (586)
Q Consensus 362 ~~~~--~~~~~~~gt~~y~aPE~~~-~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~ 436 (586)
.... ......+||+.|+|||++. ...++.++||||+||++|||++|+.||................... ......
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence 3222 2234567999999999985 4567899999999999999999999997654321111000000000 000000
Q ss_pred C--Chhhhhch--h-----hhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 437 G--NFDALVDQ--K-----LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 437 ~--~~~~l~d~--~-----l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
. ........ . ..........++++++.+||+.||.+||++.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00000000 0 000011122468899999999999999999999975
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=359.35 Aligned_cols=265 Identities=18% Similarity=0.248 Sum_probs=203.8
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeEEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 285 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~~~lV~E 285 (586)
++|++.+.||+|+||+||+|+.. +++.||||+++... ......+++|+.+|++++|||||+++++|......++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 67999999999999999999974 68899999986543 2345788999999999999999999999999999999999
Q ss_pred ecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccccCCCCC
Q 007892 286 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 365 (586)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 365 (586)
++.+++|..++... ..+++..+..++.|++.||+|||++ +||||||||+||||+.++.+||+|||+++.......
T Consensus 82 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 82 FCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred eccccccccccccc--cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 99999998887654 4588999999999999999999998 999999999999999999999999999987644332
Q ss_pred cccccccccccccCcccccCCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHHh-----------hc
Q 007892 366 HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLA-----------QG 433 (586)
Q Consensus 366 ~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~-----------~~ 433 (586)
......++..|+|||.+.... ++.++|||||||++|||++|+.||....... ....-...... ..
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred -cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH--HHHHHHHhhcCCCChhhhhhhhhc
Confidence 223345788999999987655 6999999999999999999999975433211 11100000000 00
Q ss_pred ccCCChhhhh-chhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 434 LADGNFDALV-DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 434 ~~~~~~~~l~-d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
.......... ..............+.+++.+||+.||.+|||++||++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000000 00011122233456889999999999999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-44 Score=371.57 Aligned_cols=266 Identities=23% Similarity=0.315 Sum_probs=196.2
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC------
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS------ 278 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~------ 278 (586)
.++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999975 68999999997542 233457889999999999999999999997654
Q ss_pred eeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeeccccc
Q 007892 279 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 358 (586)
Q Consensus 279 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~ 358 (586)
..+|||||+ +.+|..+++. ..+++..+..++.|++.||+|||++ +||||||||+|||++.++.+||+|||+++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccccccee
Confidence 469999999 6677777643 3499999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHH------Hh
Q 007892 359 HSLDTDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPF------LA 431 (586)
Q Consensus 359 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~~~~~~~------~~ 431 (586)
..... .+...||+.|+|||.+.+ ..++.++|||||||+||||++|+.||...+.... +.....-. ..
T Consensus 170 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 170 QADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ--LKEIMKVTGTPPAEFV 243 (346)
T ss_dssp ECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHH
T ss_pred ccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH--HHHHHhccCCCcHHHH
Confidence 75332 244679999999999875 4578999999999999999999999986543211 11000000 00
Q ss_pred hcccCCChh-------hhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HhcC
Q 007892 432 QGLADGNFD-------ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA--LEGN 486 (586)
Q Consensus 432 ~~~~~~~~~-------~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~--L~~~ 486 (586)
......... ......+..........+.+|+.+||+.||.+|||+.|++++ |+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 000000000 000001111122234567899999999999999999999984 5543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.3e-43 Score=361.11 Aligned_cols=257 Identities=19% Similarity=0.282 Sum_probs=196.6
Q ss_pred cCccccceecccCcEEEEEEEE-eCCeEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCCcceEEEEEEeC--CeeEEEE
Q 007892 209 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGYCTFG--SQRLLVY 284 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~--~~~~lV~ 284 (586)
++|++.++||+|+||+||+|+. .+|+.||||+++... .+.+.+|+++|.+++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 6799999999999999999997 468999999997543 467899999999995 99999999999753 5689999
Q ss_pred EecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCC-CeEEeecccccccCCC
Q 007892 285 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF-EAKVADFGLAKHSLDT 363 (586)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~-~~kl~DFGla~~~~~~ 363 (586)
||+.+++|.... ..+++.++..++.||+.||+|||++ +|+||||||+||||+.++ .+||+|||+++.....
T Consensus 112 e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 112 EHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp ECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred eecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 999999997654 2489999999999999999999998 999999999999998655 6999999999875433
Q ss_pred CCcccccccccccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccch--hh---------hhhhhHHHh
Q 007892 364 DTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADD--SM---------VDWAKPFLA 431 (586)
Q Consensus 364 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~--~~---------~~~~~~~~~ 431 (586)
. ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||......... .+ ..|....-.
T Consensus 184 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 184 Q--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp C--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred C--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 2 23456799999999998765 4799999999999999999999999765431110 00 001000000
Q ss_pred h-------c---ccCCChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007892 432 Q-------G---LADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 481 (586)
Q Consensus 432 ~-------~---~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 481 (586)
. . ............ .........+.+|+.+||+.||.+|||++|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHS---ENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCT---TTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCcccchhcccccccchhhcccc---cccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0 000000011100 011122356889999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-42 Score=360.06 Aligned_cols=264 Identities=20% Similarity=0.260 Sum_probs=192.2
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEe------CCe
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTF------GSQ 279 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~------~~~ 279 (586)
++|++.++||+|+||+||+|+.. +|+.||||++.... ......+.+|+.+|++++|||||+++++|.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 67999999999999999999975 69999999997543 2334578899999999999999999999964 367
Q ss_pred eEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccc
Q 007892 280 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 359 (586)
Q Consensus 280 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~ 359 (586)
.|+||||+.++.+.. ++ ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 97 ~~iv~Ey~~~~l~~~-~~----~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 97 VYLVMELMDANLCQV-IQ----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEECCSEEHHHH-HT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred eEEEEeccchHHHHh-hh----cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhc
Confidence 899999997766554 42 2489999999999999999999998 999999999999999999999999999886
Q ss_pred cCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhh----------hh----
Q 007892 360 SLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMV----------DW---- 425 (586)
Q Consensus 360 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~----------~~---- 425 (586)
.... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||...........+ .|
T Consensus 169 ~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 169 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred cccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 5332 2335567999999999999999999999999999999999999999755421110000 00
Q ss_pred --hhHHHhhccc--CCChhhhhchhhh----ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007892 426 --AKPFLAQGLA--DGNFDALVDQKLE----EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 482 (586)
Q Consensus 426 --~~~~~~~~~~--~~~~~~l~d~~l~----~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 482 (586)
...+...... ......+...... .........+.+|+.+||+.||++|||++||+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000111000 0011111111111 1223456778999999999999999999999864
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=360.71 Aligned_cols=268 Identities=20% Similarity=0.293 Sum_probs=197.0
Q ss_pred hcCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeC-----Ce
Q 007892 208 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFG-----SQ 279 (586)
Q Consensus 208 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~-----~~ 279 (586)
.++|++.+.||+|+||+||+|+.. +|+.||||+++.... .....+.+|+++|++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 478999999999999999999964 699999999975432 3345788999999999999999999998643 34
Q ss_pred eEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEeecccccc
Q 007892 280 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 359 (586)
Q Consensus 280 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~~ 359 (586)
.+++++|+.+|+|.+++... .+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred eEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcc
Confidence 56777888999999998543 499999999999999999999998 999999999999999999999999999975
Q ss_pred cCCCCCcccccccccccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchhhh-hhh---hHHHhhcc
Q 007892 360 SLDTDTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMV-DWA---KPFLAQGL 434 (586)
Q Consensus 360 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~~~-~~~---~~~~~~~~ 434 (586)
.. .......|++.|+|||.+.+. .++.++|||||||+||||++|+.||...+.......+ ... ...+....
T Consensus 171 ~~----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (348)
T d2gfsa1 171 TD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246 (348)
T ss_dssp CT----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred cC----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhc
Confidence 42 223446799999999987654 5689999999999999999999999765432111000 000 00000000
Q ss_pred cCCChhhhh-------chhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHhc
Q 007892 435 ADGNFDALV-------DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR--ALEG 485 (586)
Q Consensus 435 ~~~~~~~l~-------d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~--~L~~ 485 (586)
......... ...+..........+.+|+.+||+.||.+|||+.|+++ .|..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~ 306 (348)
T d2gfsa1 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306 (348)
T ss_dssp CCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred cchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCC
Confidence 000000000 00000111123356789999999999999999999997 4543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.6e-38 Score=328.72 Aligned_cols=275 Identities=20% Similarity=0.276 Sum_probs=197.2
Q ss_pred cCccccceecccCcEEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcC-----------CCCcceEEEEEEe
Q 007892 209 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-----------HRHLVSLVGYCTF 276 (586)
Q Consensus 209 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~-----------Hpniv~l~g~~~~ 276 (586)
++|++.++||+|+||+||+|+.. +|+.||||+++... ...+.+.+|+.+|++++ |+|||++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 35999999999999999999974 79999999997643 23457788999988875 5789999988865
Q ss_pred --CCeeEEEEEecCCCcH-HHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCC------
Q 007892 277 --GSQRLLVYEFVPNKTL-EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF------ 347 (586)
Q Consensus 277 --~~~~~lV~E~~~~gsL-~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~------ 347 (586)
....+++++++..+.. ...........+.+..+..++.|++.||+|||+.. +|+||||||+||||+.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeeeeccCcccccc
Confidence 3456677777665543 33344445566889999999999999999999832 899999999999997654
Q ss_pred CeEEeecccccccCCCCCcccccccccccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccchh----hh
Q 007892 348 EAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDS----MV 423 (586)
Q Consensus 348 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~elltG~~Pf~~~~~~~~~~----~~ 423 (586)
.+||+|||.+...... ....+||+.|+|||++....++.++|||||||+|+||++|+.||.......... +.
T Consensus 170 ~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp EEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred eeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence 3999999999764322 244679999999999999999999999999999999999999997654321111 11
Q ss_pred hhhhHH-------Hh---------------hcccCC---ChhhhhchhhhccCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 007892 424 DWAKPF-------LA---------------QGLADG---NFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQ 478 (586)
Q Consensus 424 ~~~~~~-------~~---------------~~~~~~---~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~e 478 (586)
.+..-+ +. ..+... ....... ............+.+|+.+||+.||.+|||++|
T Consensus 246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT-EKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHH-HTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcc-cccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 110000 00 000000 0000000 111355677889999999999999999999999
Q ss_pred HHHH--HhcCCCCCC
Q 007892 479 IVRA--LEGNMPLDD 491 (586)
Q Consensus 479 vl~~--L~~~~~~~~ 491 (586)
++++ |+.....++
T Consensus 325 ~L~Hp~f~~~~~~~~ 339 (362)
T d1q8ya_ 325 LVNHPWLKDTLGMEE 339 (362)
T ss_dssp HHTCGGGTTCTTCTT
T ss_pred HhcCcccCCCCCccc
Confidence 9974 654433333
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=3.2e-24 Score=202.38 Aligned_cols=169 Identities=15% Similarity=0.132 Sum_probs=122.2
Q ss_pred cccceecccCcEEEEEEEEeCCeEEEEEEeccCCc------------------hhHHHHHHHHHHHHhcCCCCcceEEEE
Q 007892 212 SEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSG------------------QGEREFQAEIEIISQVHHRHLVSLVGY 273 (586)
Q Consensus 212 ~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~------------------~~~~~~~~Ei~il~~l~Hpniv~l~g~ 273 (586)
.+.++||+|+||+||+|+..+|+.||||+++.... .....+..|+..+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 45689999999999999998999999998753211 011234568899999999999998765
Q ss_pred EEeCCeeEEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhcCCCcEEecCCCCceeEeCCCCCeEEee
Q 007892 274 CTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVAD 353 (586)
Q Consensus 274 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kl~D 353 (586)
. ..+|+|||+++..+.. +.+.....++.|++.+|+|||++ +|+||||||+|||++++ .++|+|
T Consensus 83 ~----~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp E----TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECC
T ss_pred c----CCEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEE
Confidence 3 2379999998876643 33445568999999999999998 99999999999999976 589999
Q ss_pred cccccccCCCCCccc-ccccccccccCcccccCCCCCCcchHHHHHHHHH
Q 007892 354 FGLAKHSLDTDTHVS-TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLL 402 (586)
Q Consensus 354 FGla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvvL~ 402 (586)
||+++.......... .+.+. .+ .+.+ ...|..++|+||..--++
T Consensus 146 FG~a~~~~~~~~~~~l~rd~~---~~-~~~f-~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 146 FPQSVEVGEEGWREILERDVR---NI-ITYF-SRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CTTCEETTSTTHHHHHHHHHH---HH-HHHH-HHHHCCCCCHHHHHHHHH
T ss_pred CCCcccCCCCCcHHHHHHHHH---HH-HHHH-cCCCCCcccHHHHHHHHh
Confidence 999976533221100 00000 00 1222 256788999999765443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.75 E-value=2.2e-08 Score=96.62 Aligned_cols=149 Identities=13% Similarity=0.065 Sum_probs=103.8
Q ss_pred HHHHHHhcCccccceecccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCee
Q 007892 202 EELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQR 280 (586)
Q Consensus 202 ~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~~~~ 280 (586)
.|++..-+.|+..+..+.+....||+... +++.++||+...........+.+|+.++..+. +--+.+++.++..++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 46777777888776655555679999865 45567788876544333446788999988775 43467788888888999
Q ss_pred EEEEEecCCCcHHHHhcCCCCCCCChHHHHHHHHHHHHHhHhhhhc----------------------------------
Q 007892 281 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED---------------------------------- 326 (586)
Q Consensus 281 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~---------------------------------- 326 (586)
++||++++|.++....... .....++.++++.|..||+.
T Consensus 86 ~lv~~~l~G~~~~~~~~~~-------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC-------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEEeccccccccccccc-------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 9999999998886544211 11223445555555555532
Q ss_pred ----------------------CCCcEEecCCCCceeEeCCCCCeEEeeccccc
Q 007892 327 ----------------------CQPKIIHRDIKSANILLDDSFEAKVADFGLAK 358 (586)
Q Consensus 327 ----------------------~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~ 358 (586)
..+.++|+|+.+.|||++++..+-|+||+.+.
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 01237999999999999987666799999875
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.20 E-value=3.7e-06 Score=80.00 Aligned_cols=75 Identities=19% Similarity=0.109 Sum_probs=54.8
Q ss_pred eecccC-cEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCC--CCcceEEEEEEeCCeeEEEEEecCCCcH
Q 007892 216 LLGQGG-FGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHH--RHLVSLVGYCTFGSQRLLVYEFVPNKTL 292 (586)
Q Consensus 216 ~LG~G~-fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~H--pniv~l~g~~~~~~~~~lV~E~~~~gsL 292 (586)
.+..|. -..||+....++..++||....... ..+..|+..|..+.. -.+.++++++.+++..++||+|++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 444554 3689999887788888998655432 356778888877742 3366788888888889999999998766
Q ss_pred H
Q 007892 293 E 293 (586)
Q Consensus 293 ~ 293 (586)
.
T Consensus 94 ~ 94 (255)
T d1nd4a_ 94 L 94 (255)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.71 E-value=7.2e-05 Score=76.09 Aligned_cols=77 Identities=14% Similarity=0.094 Sum_probs=49.1
Q ss_pred cceecccCcEEEEEEEEeC-CeEEEEEEeccC-----C--chhHHHHHHHHHHHHhcC-C--CCcceEEEEEEeCCeeEE
Q 007892 214 ANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAG-----S--GQGEREFQAEIEIISQVH-H--RHLVSLVGYCTFGSQRLL 282 (586)
Q Consensus 214 ~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~-----~--~~~~~~~~~Ei~il~~l~-H--pniv~l~g~~~~~~~~~l 282 (586)
.+.||.|....||+....+ ++.|+||.-... . .........|++.|..+. + ..+.+++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4579999999999998654 678899974321 0 112234556888887663 2 345566544 4556689
Q ss_pred EEEecCCCcH
Q 007892 283 VYEFVPNKTL 292 (586)
Q Consensus 283 V~E~~~~gsL 292 (586)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.33 E-value=0.00033 Score=69.01 Aligned_cols=135 Identities=16% Similarity=0.184 Sum_probs=79.5
Q ss_pred cEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCc-----ceEE--EEEEeCCeeEEEEEecCCCcHHH
Q 007892 222 FGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL-----VSLV--GYCTFGSQRLLVYEFVPNKTLEF 294 (586)
Q Consensus 222 fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpni-----v~l~--g~~~~~~~~~lV~E~~~~gsL~~ 294 (586)
--.||+....+|..|++|+..... ....++..|...|..|...+| +..- ..+..++..+.+++|++|..+..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 358999999999999999976542 345778889998888752222 1111 12244667889999998744310
Q ss_pred --------------Hhc----CC---CCCCCChHH-------------------HHHHHHHHHHHhHhhh----hcCCCc
Q 007892 295 --------------HLH----GK---DRPVMNWPT-------------------RMKIALGSARGLAYLH----EDCQPK 330 (586)
Q Consensus 295 --------------~l~----~~---~~~~l~~~~-------------------~~~ia~~ia~gL~yLH----~~~~~~ 330 (586)
.+| .. .+..+++.. +..+...+...++.+. .....+
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 011 11 111222211 1111111222223332 223457
Q ss_pred EEecCCCCceeEeCCCCCeEEeecccccc
Q 007892 331 IIHRDIKSANILLDDSFEAKVADFGLAKH 359 (586)
Q Consensus 331 ivHrDIk~~NILl~~~~~~kl~DFGla~~ 359 (586)
+||+|+.+.|||++++ ..++||+-|..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 9999999999999754 46899998864
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.03 E-value=0.0011 Score=67.00 Aligned_cols=73 Identities=21% Similarity=0.234 Sum_probs=50.9
Q ss_pred cceecccCcEEEEEEEEeCC--------eEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCc-ceEEEEEEeCCeeEEEE
Q 007892 214 ANLLGQGGFGYVHKGVLTNG--------KVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL-VSLVGYCTFGSQRLLVY 284 (586)
Q Consensus 214 ~~~LG~G~fG~Vyk~~~~~g--------~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpni-v~l~g~~~~~~~~~lV~ 284 (586)
.+.|+.|---.+|+....++ +.|.+++.-. . .......+|..+++.+.-.++ .+++++|.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 46788899999999987543 4566666542 2 234566789999998853344 477777743 5789
Q ss_pred EecCCCcH
Q 007892 285 EFVPNKTL 292 (586)
Q Consensus 285 E~~~~gsL 292 (586)
||++|..|
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.55 E-value=0.0088 Score=57.74 Aligned_cols=157 Identities=13% Similarity=0.065 Sum_probs=84.0
Q ss_pred cCHHHHHHHhcCcccccee-----cccCcEEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCC-----CCcc
Q 007892 199 FTYEELKIATDNFSEANLL-----GQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHH-----RHLV 268 (586)
Q Consensus 199 ~~~~el~~~~~~f~~~~~L-----G~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~H-----pniv 268 (586)
.+.+|++....+|.+.+.. ..|---+.|+.+..+|+ +++|+..... ...++..|+++|..|.. |..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 4567888888888775544 35555788998876665 7889875432 22355566777776642 2222
Q ss_pred eEE---EEEEeCCeeEEEEEecCCCcHHH--------------Hhc----CCCC----CCCC-----------------h
Q 007892 269 SLV---GYCTFGSQRLLVYEFVPNKTLEF--------------HLH----GKDR----PVMN-----------------W 306 (586)
Q Consensus 269 ~l~---g~~~~~~~~~lV~E~~~~gsL~~--------------~l~----~~~~----~~l~-----------------~ 306 (586)
... .+.........++.++.+..... .++ .... .... .
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 210 01223455667777776543210 011 0000 0000 0
Q ss_pred HHHHHHHHHHHHHhHhhhh-cCCCcEEecCCCCceeEeCCCCCeEEeeccccc
Q 007892 307 PTRMKIALGSARGLAYLHE-DCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 358 (586)
Q Consensus 307 ~~~~~ia~~ia~gL~yLH~-~~~~~ivHrDIk~~NILl~~~~~~kl~DFGla~ 358 (586)
......+..+...+.-.+. ....++||+|+.+.|||++++...-|.||+.|.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 0111112222222222211 123479999999999999988767899999885
|